Citrus Sinensis ID: 029552

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-
Protein Sequence
MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK
Secondary Structure (PSIPRED)
ccccccccEEEEEEEEEccccEEEEEEccccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHcccccEEEEccccccEEEcccccEEEccccccEEccccccccccccccccccccHHHcccccccccHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccccHHHHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
ccccccccEEEEEEEEcccccEEEEEEEcccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHccccEEcccccHHHEEEcccccEEEccccccEccccccEEEccccccccHccHHHHHHccccHHHHHHHHHHHHHHHHHcccccccccHHHHHHHEEcccccccccccccHHHHHHHHHHHcc
Coil and Loop (DISEMBL)
mkrlrhpnivlfmgavtqppnlsIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKgmnylhrrnppivhrdlkspnllvdkkytVKVCDfglsrlkantflssksaagtpewmapevlrdepsneksdiySFGVILWELATlqqpwgnlnpAQVVAAVGfkgkrleiprnvnpHVASIIEACWAK
Flexible Loop (DISEMBL)
MKRLRHPNIVLFmgavtqppnlSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKgmnylhrrnppivhrdlkspnllvdKKYTVKVCDFGLSRLKANtflssksaagtpewmapevlrdepsneKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKrleiprnvnphvASIIEACWAK
Low Complexity Region (SEG)
MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK
Disordered region (IsUnstruct)
*******NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL**************************DIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACW**
Disordered Region (DISOPRED)
MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT***SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK
Disordered Region (DISEMBL)
MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK
Disordered Region (DISPRO)
**RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	191	2.2.26 [Sep-21-2011]
Q05609	821	Serine/threonine-protein	yes	no	0.994	0.231	0.931	1e-102
Q9FPR3	933	Serine/threonine-protein	no	no	0.979	0.200	0.714	5e-77
Q54TA1	749	Probable serine/threonine	yes	no	0.979	0.249	0.476	1e-46
Q54TM7	1288	Probable serine/threonine	no	no	0.952	0.141	0.497	4e-46
Q54H46	642	Probable serine/threonine	no	no	0.963	0.286	0.473	7e-46
Q54H45	690	Probable serine/threonine	no	no	0.963	0.266	0.462	5e-44
Q55GU0	916	Probable serine/threonine	no	no	0.963	0.200	0.470	1e-43
Q86HG9	1024	Probable serine/threonine	no	no	0.937	0.174	0.460	2e-39
Q54Y55	506	Dual specificity protein	no	no	0.989	0.373	0.453	4e-39
Q7T6Y2	1624	Putative serine/threonine	N/A	no	0.963	0.113	0.402	8e-39

>sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1

 Score =  369 bits (948), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 177/190 (93%), Positives = 182/190 (95%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK G RE LDERRRL+MAYDVA
Sbjct: 600 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 659

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           KGMNYLH RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA+TFLSSKSAAGTPEWMA
Sbjct: 660 KGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMA 719

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVLRDEPSNEKSD+YSFGVILWELATLQQPWGNLNPAQVVAAVGFK KRLEIPRN+NP 
Sbjct: 720 PEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQ 779

Query: 181 VASIIEACWA 190
           VA+IIE CW 
Sbjct: 780 VAAIIEGCWT 789

Acts as a negative regulator in the ethylene response pathway.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1

 Score =  286 bits (732), Expect = 5e-77,   Method: Compositional matrix adjust.
 Identities = 135/189 (71%), Positives = 156/189 (82%), Gaps = 2/189 (1%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M+RLRHPN+V F+GAVT+PPNLSIVTE+L RGSLYR+LH+P  +  +DERRR+ MA DVA
Sbjct: 718 MRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRP--KSHIDERRRIKMALDVA 775

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            GMN LH   P IVHRDLK+PNLLVD  + VKV DFGLSRLK NTFLSSKS AGTPEWMA
Sbjct: 776 MGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMA 835

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVLR+EPSNEK D+YSFGVILWELATL+ PW  +NP QVV AVGF+ +RLEIP+ ++P 
Sbjct: 836 PEVLRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDPV 895

Query: 181 VASIIEACW 189
           V  II  CW
Sbjct: 896 VGRIILECW 904

MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1

 Score =  186 bits (471), Expect = 1e-46,   Method: Composition-based stats.
 Identities = 93/195 (47%), Positives = 126/195 (64%), Gaps = 8/195 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +LRHPNI  F+G    PP + IV EY+  GSLYR+LH P +   LD  R  +MA D+A
Sbjct: 541 MSQLRHPNICQFLGTCNNPPEILIVMEYMPLGSLYRILHDPSIS--LDWPRMKSMALDIA 598

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSA---AGTP 116
           KGMNYLH  +P ++HRDLKS NLLVD+ Y VK+ DFGLS R K +  L  K+A    GTP
Sbjct: 599 KGMNYLHCCDPIVIHRDLKSHNLLVDEHYRVKISDFGLSTRFKKH--LDKKTAMTPVGTP 656

Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
            W APEVLR++P  EK+D++SF ++LWE+ T + P+  +   Q+V +VG    R  +P  
Sbjct: 657 CWTAPEVLRNDPYTEKADVFSFAIVLWEIVTREDPYQGMPTFQIVISVGQHKLRPIVPPQ 716

Query: 177 VNPHVASIIEACWAK 191
           V+     +I  CW++
Sbjct: 717 VSAPFTRLITECWSE 731

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1

 Score =  184 bits (466), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 93/187 (49%), Positives = 127/187 (67%), Gaps = 5/187 (2%)

Query: 3    RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
            +LRHPNIVLFMGA T+P +  IVTEYLSRGSL  +L    +   +D   RL + +D A+G
Sbjct: 902  KLRHPNIVLFMGACTEPSSPCIVTEYLSRGSLANILLDESIE--MDWGLRLQLGFDCARG 959

Query: 63   MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPE 122
            M YLH RNP I+HRDLK+ NLLVD  + VKV DFGL+ +K++TF  +K+  GT  W+APE
Sbjct: 960  MTYLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATVKSHTF--AKTMCGTTGWVAPE 1017

Query: 123  VLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVA 182
            VL +E   EK+D+YS+ ++LWEL T   P+   N  QVV ++  +G+RL +P    P  A
Sbjct: 1018 VLAEEGYTEKADVYSYAIVLWELLTRLIPYAGKNTMQVVRSID-RGERLPMPAWCPPKYA 1076

Query: 183  SIIEACW 189
            +++  CW
Sbjct: 1077 ALMNRCW 1083

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1

 Score =  183 bits (464), Expect = 7e-46,   Method: Composition-based stats.
 Identities = 89/188 (47%), Positives = 122/188 (64%), Gaps = 4/188 (2%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK LRHPN++ F+G+   PP++ I TEY+ RGSLY +LH   ++  L     + M  D A
Sbjct: 423 MKNLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQ--LQWSLLIKMMIDAA 480

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           KG+ YLH   P I+HRDLKS NLLVD+ + VKV DFGLS ++     ++ +A GTP W +
Sbjct: 481 KGVIYLHNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTACGTPCWTS 538

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVLR +   EK+D+YSFG+ILWE AT Q P+  + P QV+ AVG +G R  +P+N  P 
Sbjct: 539 PEVLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPVPQNGPPK 598

Query: 181 VASIIEAC 188
              ++  C
Sbjct: 599 YIQLLIDC 606

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1

 Score =  177 bits (448), Expect = 5e-44,   Method: Composition-based stats.
 Identities = 87/188 (46%), Positives = 120/188 (63%), Gaps = 4/188 (2%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK LRHPN++ F+G+    P++ I TEY+ RGSLY +LH   ++      +R  M  D A
Sbjct: 440 MKNLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKR--MMIDAA 497

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           KG+ YLH   P I+HRDLKS NLLVD+ + VKV DFGLS ++     ++ +A GTP W +
Sbjct: 498 KGIIYLHGSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTACGTPCWTS 555

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVLR +   EK+D+YSFG+ILWE AT Q P+  + P QV+ AVG +G R   P+   P 
Sbjct: 556 PEVLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPTPKYGPPK 615

Query: 181 VASIIEAC 188
              +++ C
Sbjct: 616 YIQLLKDC 623

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1

 Score =  176 bits (445), Expect = 1e-43,   Method: Composition-based stats.
 Identities = 89/189 (47%), Positives = 122/189 (64%), Gaps = 5/189 (2%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           + RLRHPNIVL M A T PPNL  +TEYL  GSLY  LH   ++  +   ++L  A  +A
Sbjct: 712 LSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIKMNMQLYKKL--AIQIA 769

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +GMNYLH     ++HRD+KS NLL+D+   VK+CDFGLS+LK+ +   +KS  G+P WM+
Sbjct: 770 QGMNYLHLSG--VIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKSI-GSPIWMS 826

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PE+L  E   EK D+Y+FG+ILWEL T + P+  L+  Q+  AV  K  R  IP      
Sbjct: 827 PELLMGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQ 886

Query: 181 VASIIEACW 189
           ++ +I+ACW
Sbjct: 887 LSHLIQACW 895

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q86HG9|Y9871_DICDI Probable serine/threonine-protein kinase DDB_G0271682 OS=Dictyostelium discoideum GN=DDB_G0271682 PE=3 SV=2

 Score =  161 bits (408), Expect = 2e-39,   Method: Composition-based stats.
 Identities = 87/189 (46%), Positives = 114/189 (60%), Gaps = 10/189 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K LRHPN+VLFMG      NL+I+TEYL+RGSL  +L      E L    ++ M  DVA
Sbjct: 409 LKCLRHPNVVLFMGTCLLNGNLAIITEYLNRGSLRDVLTTMNKSE-LSLSVKVKMLIDVA 467

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS-KSAAGTPEWM 119
           +GMNYLH  +PPI+HRDLKS NLLVD  + VKV DFGLSR  +    SS K+  GT  W+
Sbjct: 468 QGMNYLHTYSPPIIHRDLKSLNLLVDNNFNVKVSDFGLSRFISGGIGSSAKTFCGTLSWI 527

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 179
           APEV        K D+YSFG++LWE+ T +QP GN++   +           E+P N   
Sbjct: 528 APEVFNGSGYTTKVDVYSFGIVLWEILTHKQPSGNISATSL--------GHPELPSNCPQ 579

Query: 180 HVASIIEAC 188
             + +I+ C
Sbjct: 580 SFSDLIKEC 588

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54Y55|SHKC_DICDI Dual specificity protein kinase shkC OS=Dictyostelium discoideum GN=shkC PE=3 SV=1

 Score =  160 bits (406), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 88/194 (45%), Positives = 118/194 (60%), Gaps = 5/194 (2%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M ++ HPNI LFMGA T P    IVTE + +G+L  LLH   ++  L    R+ MA D A
Sbjct: 73  MSKIYHPNICLFMGACTIPGRCVIVTELVPKGNLETLLHDQKIQ--LPLYLRMRMARDAA 130

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEW 118
            G+N+LH  NP  VHRD+KS NLLVD+   VK+CDFGLS LK    +     SA GTP +
Sbjct: 131 LGINWLHESNPVFVHRDIKSSNLLVDENMRVKICDFGLSALKQKHKMLKDQSSAKGTPLY 190

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV-AAVGFKGKRLEIPRNV 177
           MAPEV+  +  NE SD+YSFG++LWE+ T ++P+ +    +    AV  K +R  IP + 
Sbjct: 191 MAPEVMMFKEFNESSDVYSFGIVLWEILTRKEPFSHHRELEKFREAVCVKHERPPIPNDC 250

Query: 178 NPHVASIIEACWAK 191
              +  +IE CW K
Sbjct: 251 LDSLRRLIEKCWDK 264

Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2

 Score =  159 bits (403), Expect = 8e-39,   Method: Composition-based stats.
 Identities = 76/189 (40%), Positives = 118/189 (62%), Gaps = 5/189 (2%)

Query: 1    MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
            +  L+H NIV F+GA  + PN+ IVTEY+  G+L  +L  P ++  +    +L + Y  A
Sbjct: 1413 LSELKHSNIVTFIGACIKKPNICIVTEYMRMGNLRDVLKNPDIK--ITFANKLKLLYGAA 1470

Query: 61   KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             G++YLH  NP IVHRD+K  N+LVD+ + VK+ DFG +R+K +   ++ +  GTP W A
Sbjct: 1471 MGIDYLHSSNPMIVHRDIKPANILVDEHFNVKIADFGFARIKEDN--TTMTRCGTPCWTA 1528

Query: 121  PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
            PEV+R E   EK+D++SFGV++WE+ T ++P+   N  +V   +  +G R  IP +    
Sbjct: 1529 PEVIRGEKYCEKADVFSFGVVMWEVLTGKEPFAECNFMKVSLDI-LEGGRPIIPSDCPHE 1587

Query: 181  VASIIEACW 189
             A +I+ CW
Sbjct: 1588 FAKLIKKCW 1596

Acanthamoeba polyphaga (taxid: 5757)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	191
156467297	701	putative serine/threonine-specific prote	1.0	0.272	0.952	1e-104
255575367	871	map3k delta-1 protein kinase, putative [	0.994	0.218	0.936	1e-103
359481975	850	PREDICTED: serine/threonine-protein kina	0.994	0.223	0.947	1e-103
297740063	745	unnamed protein product [Vitis vinifera]	0.994	0.255	0.947	1e-103
270268951	851	serine/threonine protein kinase 1 [Gossy	0.994	0.223	0.936	1e-103
237857405	843	serine/threonine protein kinase [Prunus	0.994	0.225	0.947	1e-103
350535513	837	CTR1-like protein kinase [Solanum lycope	1.0	0.228	0.937	1e-102
114229339	809	ethylene control element [Malus x domest	0.994	0.234	0.936	1e-102
114229341	843	ethylene control element variant [Malus	0.994	0.225	0.936	1e-101
114229343	843	ethylene control element variant [Malus	0.994	0.225	0.936	1e-101

>gi|156467297|gb|ABU68270.1| putative serine/threonine-specific protein kinase [Prunus salicina]

 Score =  381 bits (978), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 182/191 (95%), Positives = 186/191 (97%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MKRLRHPNIVLFMGAVT+PPNLSIVTEYLSRGSLYRLLHKPG  E LDERRRLNMAYDVA
Sbjct: 475 MKRLRHPNIVLFMGAVTKPPNLSIVTEYLSRGSLYRLLHKPGAMEALDERRRLNMAYDVA 534

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA
Sbjct: 535 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 594

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVLRDEPSNEKSD+YSFGVILWELATLQQPWGNLNPAQVVAAVGFK KRLEIPR++NP 
Sbjct: 595 PEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKNKRLEIPRDLNPQ 654

Query: 181 VASIIEACWAK 191
           VASIIEACWAK
Sbjct: 655 VASIIEACWAK 665

Source: Prunus salicina

Species: Prunus salicina

Genus: Prunus

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255575367|ref|XP_002528586.1| map3k delta-1 protein kinase, putative [Ricinus communis] gi|223531982|gb|EEF33794.1| map3k delta-1 protein kinase, putative [Ricinus communis]

 Score =  380 bits (976), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 178/190 (93%), Positives = 186/190 (97%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK G RE LDERRRL+MAYDVA
Sbjct: 646 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREALDERRRLSMAYDVA 705

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           KGMNYLH+RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA
Sbjct: 706 KGMNYLHKRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 765

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVLRDEPSNEKSD+YSFGVI+WELATLQQPWGNLNPAQVVAAVGFKG+RLEIPR++NP 
Sbjct: 766 PEVLRDEPSNEKSDVYSFGVIMWELATLQQPWGNLNPAQVVAAVGFKGRRLEIPRDLNPQ 825

Query: 181 VASIIEACWA 190
           VA+IIEACWA
Sbjct: 826 VATIIEACWA 835

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359481975|ref|XP_002277360.2| PREDICTED: serine/threonine-protein kinase CTR1-like [Vitis vinifera]

 Score =  379 bits (974), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 180/190 (94%), Positives = 185/190 (97%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG REMLDERRRL+MAYDVA
Sbjct: 625 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGAREMLDERRRLSMAYDVA 684

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           KGMNYLH+RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR KANTFLSSKSAAGTPEWMA
Sbjct: 685 KGMNYLHKRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRFKANTFLSSKSAAGTPEWMA 744

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVLRDE SNEKSDIYSFG+ILWELATLQQPW NLNPAQVVAAVGFKGKRLEIPR++NP 
Sbjct: 745 PEVLRDEASNEKSDIYSFGIILWELATLQQPWSNLNPAQVVAAVGFKGKRLEIPRDLNPQ 804

Query: 181 VASIIEACWA 190
           VASIIEACWA
Sbjct: 805 VASIIEACWA 814

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297740063|emb|CBI30245.3| unnamed protein product [Vitis vinifera]

 Score =  379 bits (972), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 180/190 (94%), Positives = 185/190 (97%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG REMLDERRRL+MAYDVA
Sbjct: 520 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGAREMLDERRRLSMAYDVA 579

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           KGMNYLH+RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR KANTFLSSKSAAGTPEWMA
Sbjct: 580 KGMNYLHKRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRFKANTFLSSKSAAGTPEWMA 639

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVLRDE SNEKSDIYSFG+ILWELATLQQPW NLNPAQVVAAVGFKGKRLEIPR++NP 
Sbjct: 640 PEVLRDEASNEKSDIYSFGIILWELATLQQPWSNLNPAQVVAAVGFKGKRLEIPRDLNPQ 699

Query: 181 VASIIEACWA 190
           VASIIEACWA
Sbjct: 700 VASIIEACWA 709

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|270268951|gb|ACZ66010.1| serine/threonine protein kinase 1 [Gossypium hirsutum] gi|357372870|gb|AET74054.1| constitutive triple response 1 [Gossypium hirsutum]

 Score =  378 bits (970), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 178/190 (93%), Positives = 187/190 (98%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL+RLLHKPGVRE+LDERRRL+MAYDVA
Sbjct: 626 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLFRLLHKPGVREVLDERRRLSMAYDVA 685

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           KGMNYLHR NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA
Sbjct: 686 KGMNYLHRHNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 745

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVLRDEPSNEKSD+YSFGVILWELATLQQPWGNLNPAQVVAAVGF+GKRL+IPR++NP 
Sbjct: 746 PEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFRGKRLDIPRDLNPQ 805

Query: 181 VASIIEACWA 190
           VA+IIE CWA
Sbjct: 806 VAAIIEDCWA 815

Source: Gossypium hirsutum

Species: Gossypium hirsutum

Genus: Gossypium

Family: Malvaceae

Order: Malvales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|237857405|gb|ACR23642.1| serine/threonine protein kinase [Prunus persica]

 Score =  377 bits (969), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 180/190 (94%), Positives = 185/190 (97%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MKRLRHPNIVLFMGAVT+PPNLSIVTEYLSRGSLYRLLHKPG  E LDE+RRLNMAYDVA
Sbjct: 618 MKRLRHPNIVLFMGAVTKPPNLSIVTEYLSRGSLYRLLHKPGAMEALDEKRRLNMAYDVA 677

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA
Sbjct: 678 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 737

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVLRDEPSNEKSD+YSFGVILWELATLQQPWGNLNPAQVVAAVGFK KRLEIPR++NP 
Sbjct: 738 PEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKNKRLEIPRDLNPQ 797

Query: 181 VASIIEACWA 190
           VASIIEACWA
Sbjct: 798 VASIIEACWA 807

Source: Prunus persica

Species: Prunus persica

Genus: Prunus

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|350535513|ref|NP_001234454.1| CTR1-like protein kinase [Solanum lycopersicum] gi|40781628|gb|AAR89820.1| CTR1-like protein kinase [Solanum lycopersicum] gi|40781634|gb|AAR89823.1| CTR1-like protein kinase [Solanum lycopersicum]

 Score =  376 bits (965), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 179/191 (93%), Positives = 186/191 (97%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MKRLRHPNIVLFMGAVTQ PNLSIVTEYLSRGSLYRLLHKPG RE+LDERRRL+MAYDVA
Sbjct: 610 MKRLRHPNIVLFMGAVTQRPNLSIVTEYLSRGSLYRLLHKPGAREVLDERRRLSMAYDVA 669

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           KGMNYLH+RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA
Sbjct: 670 KGMNYLHKRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 729

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVLRDEPSNEKSD+YSFGVILWELATLQQPW NLNPAQVVAAVGFKGKRL+IPR++ P 
Sbjct: 730 PEVLRDEPSNEKSDVYSFGVILWELATLQQPWSNLNPAQVVAAVGFKGKRLDIPRDLTPQ 789

Query: 181 VASIIEACWAK 191
           VASIIEACWAK
Sbjct: 790 VASIIEACWAK 800

Source: Solanum lycopersicum

Species: Solanum lycopersicum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|114229339|gb|ABI58288.1| ethylene control element [Malus x domestica]

 Score =  374 bits (961), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 178/190 (93%), Positives = 185/190 (97%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MKRLRHPNIVLFMGAVT+PPNLSIVTEYLSRGSLYRLLHK G RE LDERRRL+MAYDVA
Sbjct: 584 MKRLRHPNIVLFMGAVTKPPNLSIVTEYLSRGSLYRLLHKAGAREALDERRRLSMAYDVA 643

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           KGMNYLHRR PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA
Sbjct: 644 KGMNYLHRRKPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 703

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVLRDEPSNEKSDIYSFGVILWELAT+QQPWGNLNPAQVVAAVGFK KRLEIPR++NP+
Sbjct: 704 PEVLRDEPSNEKSDIYSFGVILWELATMQQPWGNLNPAQVVAAVGFKNKRLEIPRDLNPN 763

Query: 181 VASIIEACWA 190
           VA+IIEACWA
Sbjct: 764 VAAIIEACWA 773

Source: Malus x domestica

Species: Malus x domestica

Genus: Malus

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|114229341|gb|ABI58289.1| ethylene control element variant [Malus x domestica]

 Score =  373 bits (958), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 178/190 (93%), Positives = 185/190 (97%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MKRLRHPNIVLFMGAVT+PPNLSIVTEYLSRGSLYRLLHK G RE LDERRRL+MAYDVA
Sbjct: 618 MKRLRHPNIVLFMGAVTKPPNLSIVTEYLSRGSLYRLLHKAGAREALDERRRLSMAYDVA 677

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           KGMNYLHRR PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA
Sbjct: 678 KGMNYLHRRKPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 737

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVLRDEPSNEKSDIYSFGVILWELAT+QQPWGNLNPAQVVAAVGFK KRLEIPR++NP+
Sbjct: 738 PEVLRDEPSNEKSDIYSFGVILWELATMQQPWGNLNPAQVVAAVGFKNKRLEIPRDLNPN 797

Query: 181 VASIIEACWA 190
           VA+IIEACWA
Sbjct: 798 VAAIIEACWA 807

Source: Malus x domestica

Species: Malus x domestica

Genus: Malus

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|114229343|gb|ABI58290.1| ethylene control element variant [Malus x domestica]

 Score =  373 bits (958), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 178/190 (93%), Positives = 185/190 (97%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MKRLRHPNIVLFMGAVT+PPNLSIVTEYLSRGSLYRLLHK G RE LDERRRL+MAYDVA
Sbjct: 618 MKRLRHPNIVLFMGAVTKPPNLSIVTEYLSRGSLYRLLHKAGAREALDERRRLSMAYDVA 677

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           KGMNYLHRR PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA
Sbjct: 678 KGMNYLHRRKPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 737

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVLRDEPSNEKSDIYSFGVILWELAT+QQPWGNLNPAQVVAAVGFK KRLEIPR++NP+
Sbjct: 738 PEVLRDEPSNEKSDIYSFGVILWELATMQQPWGNLNPAQVVAAVGFKNKRLEIPRDLNPN 797

Query: 181 VASIIEACWA 190
           VA+IIEACWA
Sbjct: 798 VAAIIEACWA 807

Source: Malus x domestica

Species: Malus x domestica

Genus: Malus

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	191
TAIR|locus:2144613	821	CTR1 "CONSTITUTIVE TRIPLE RESP	0.989	0.230	0.936	6.1e-94
TAIR|locus:2194055	992	AT1G18160 [Arabidopsis thalian	0.979	0.188	0.730	1.4e-73
TAIR|locus:2027794	1030	AT1G73660 [Arabidopsis thalian	0.979	0.181	0.730	2.8e-73
TAIR|locus:2143009	880	AT5G11850 [Arabidopsis thalian	0.979	0.212	0.719	4.1e-72
TAIR|locus:2025515	933	EDR1 "ENHANCED DISEASE RESISTA	0.979	0.200	0.714	9.9e-71
TAIR|locus:2084314	773	AT3G06620 [Arabidopsis thalian	0.979	0.241	0.650	1.1e-64
TAIR|locus:2084304	671	AT3G06630 [Arabidopsis thalian	0.979	0.278	0.650	1.4e-64
TAIR|locus:2127228	736	AT4G23050 [Arabidopsis thalian	0.979	0.254	0.640	9.7e-64
TAIR|locus:2200296	765	AT1G67890 [Arabidopsis thalian	0.973	0.243	0.613	7.9e-62
TAIR|locus:2158019	831	AT5G49470 [Arabidopsis thalian	0.827	0.190	0.580	1.2e-55

TAIR|locus:2144613 CTR1 "CONSTITUTIVE TRIPLE RESPONSE 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 935 (334.2 bits), Expect = 6.1e-94, P = 6.1e-94
 Identities = 177/189 (93%), Positives = 182/189 (96%)

Query:     1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
             MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK G RE LDERRRL+MAYDVA
Sbjct:   600 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 659

Query:    61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             KGMNYLH RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA+TFLSSKSAAGTPEWMA
Sbjct:   660 KGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMA 719

Query:   121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
             PEVLRDEPSNEKSD+YSFGVILWELATLQQPWGNLNPAQVVAAVGFK KRLEIPRN+NP 
Sbjct:   720 PEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQ 779

Query:   181 VASIIEACW 189
             VA+IIE CW
Sbjct:   780 VAAIIEGCW 788

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009744 "response to sucrose stimulus" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0010105 "negative regulation of ethylene mediated signaling pathway" evidence=TAS

GO:0010182 "sugar mediated signaling pathway" evidence=TAS

GO:0005789 "endoplasmic reticulum membrane" evidence=IDA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0009686 "gibberellin biosynthetic process" evidence=IMP

GO:0048510 "regulation of timing of transition from vegetative to reproductive phase" evidence=IMP

GO:2000035 "regulation of stem cell division" evidence=IMP

GO:2000069 "regulation of post-embryonic root development" evidence=IMP

GO:0071281 "cellular response to iron ion" evidence=IEP

GO:0009750 "response to fructose stimulus" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009723 "response to ethylene stimulus" evidence=IMP

TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)]

 Score = 743 (266.6 bits), Expect = 1.4e-73, P = 1.4e-73
 Identities = 138/189 (73%), Positives = 160/189 (84%)

Query:     1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
             M+RLRHPNIVLFMGAVT+PPNLSIVTE+L RGSLYRL+H+P     LDER+RL MA D A
Sbjct:   764 MRRLRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPN--NQLDERKRLRMALDAA 821

Query:    61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             +GMNYLH  NP IVHRDLKSPNLLVDK + VKVCDFGLSR+K +T+LSSKS AGT EWMA
Sbjct:   822 RGMNYLHSCNPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKVSTYLSSKSTAGTAEWMA 881

Query:   121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
             PEVLR+EP++EK D+YS+GVILWEL TLQQPWG +NP QVV AVGF+ +RL+IP  V+P 
Sbjct:   882 PEVLRNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPEFVDPG 941

Query:   181 VASIIEACW 189
             +A II  CW
Sbjct:   942 IADIIRKCW 950

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)]

 Score = 740 (265.6 bits), Expect = 2.8e-73, P = 2.8e-73
 Identities = 138/189 (73%), Positives = 160/189 (84%)

Query:     1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
             MK+LRHPNIVLFMGAVT+PPNLSIVTE+L RGSLYRL+H+P     LDERRRL MA D A
Sbjct:   797 MKKLRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPN--NQLDERRRLRMALDAA 854

Query:    61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             +GMNYLH  NP IVHRDLKSPNLLVDK + VKVCDFGLSR+K +T+LSSKS AGT EWMA
Sbjct:   855 RGMNYLHSCNPMIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHSTYLSSKSTAGTAEWMA 914

Query:   121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
             PEVLR+EP++EK D+YS+GVILWEL TLQQPWG +NP QVV AVGF+ +RL+IP  V+P 
Sbjct:   915 PEVLRNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPDFVDPA 974

Query:   181 VASIIEACW 189
             +A +I  CW
Sbjct:   975 IADLISKCW 983

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS

GO:0009651 "response to salt stress" evidence=IMP

GO:0048573 "photoperiodism, flowering" evidence=RCA

TAIR|locus:2143009 AT5G11850 [Arabidopsis thaliana (taxid:3702)]

 Score = 729 (261.7 bits), Expect = 4.1e-72, P = 4.1e-72
 Identities = 136/189 (71%), Positives = 158/189 (83%)

Query:     1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
             M RLRHPN+VLFMGAVT+PPN SI+TE+L RGSLYRLLH+P     LDE+RR+ MA DVA
Sbjct:   658 MLRLRHPNVVLFMGAVTRPPNFSILTEFLPRGSLYRLLHRPN--HQLDEKRRMRMALDVA 715

Query:    61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             KGMNYLH  +P +VHRDLKSPNLLVDK + VKVCDFGLSR+K +T+LSSKS AGTPEWMA
Sbjct:   716 KGMNYLHTSHPTVVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHHTYLSSKSTAGTPEWMA 775

Query:   121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
             PEVLR+EP+NEK D+YSFGVILWELAT + PW  LNP QVV AVGF+ +RLEIP +++  
Sbjct:   776 PEVLRNEPANEKCDVYSFGVILWELATSRVPWKGLNPMQVVGAVGFQNRRLEIPDDIDLT 835

Query:   181 VASIIEACW 189
             VA II  CW
Sbjct:   836 VAQIIRECW 844

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 716 (257.1 bits), Expect = 9.9e-71, P = 9.9e-71
 Identities = 135/189 (71%), Positives = 156/189 (82%)

Query:     1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
             M+RLRHPN+V F+GAVT+PPNLSIVTE+L RGSLYR+LH+P  +  +DERRR+ MA DVA
Sbjct:   718 MRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRP--KSHIDERRRIKMALDVA 775

Query:    61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
              GMN LH   P IVHRDLK+PNLLVD  + VKV DFGLSRLK NTFLSSKS AGTPEWMA
Sbjct:   776 MGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMA 835

Query:   121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
             PEVLR+EPSNEK D+YSFGVILWELATL+ PW  +NP QVV AVGF+ +RLEIP+ ++P 
Sbjct:   836 PEVLRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDPV 895

Query:   181 VASIIEACW 189
             V  II  CW
Sbjct:   896 VGRIILECW 904

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0009723 "response to ethylene stimulus" evidence=IMP;NAS

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0000165 "MAPK cascade" evidence=ISS

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS;IMP

GO:0009620 "response to fungus" evidence=IMP

GO:1900150 "regulation of defense response to fungus" evidence=IMP

GO:2000031 "regulation of salicylic acid mediated signaling pathway" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

GO:0008219 "cell death" evidence=IMP

GO:0009414 "response to water deprivation" evidence=IMP

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0002229 "defense response to oomycetes" evidence=IMP

GO:0009617 "response to bacterium" evidence=IMP

GO:1900424 "regulation of defense response to bacterium" evidence=IMP

GO:0009788 "negative regulation of abscisic acid mediated signaling pathway" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0005769 "early endosome" evidence=IDA

GO:0005783 "endoplasmic reticulum" evidence=IDA

GO:0005802 "trans-Golgi network" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0005730 "nucleolus" evidence=IDA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

TAIR|locus:2084314 AT3G06620 [Arabidopsis thaliana (taxid:3702)]

 Score = 659 (237.0 bits), Expect = 1.1e-64, P = 1.1e-64
 Identities = 123/189 (65%), Positives = 154/189 (81%)

Query:     1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
             MKRLRHPN++LFMGAVT P  L IV+E+L RGSL+RLL K   +  LD RRR++MA D+A
Sbjct:   543 MKRLRHPNVLLFMGAVTSPQRLCIVSEFLPRGSLFRLLQKSTSK--LDWRRRIHMALDIA 600

Query:    61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             +GMNYLH  +PPI+HRDLKS NLLVDK +TVKV DFGLSR+K  T+L+SKS  GTP+WMA
Sbjct:   601 RGMNYLHHCSPPIIHRDLKSSNLLVDKNWTVKVADFGLSRIKHETYLTSKSGKGTPQWMA 660

Query:   121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
             PEVLR+E ++EKSDIYSFGV+LWELAT + PW  LN  QV+ AVGF  +RLEIP++++P 
Sbjct:   661 PEVLRNESADEKSDIYSFGVVLWELATEKIPWETLNSMQVIGAVGFMDQRLEIPKDIDPR 720

Query:   181 VASIIEACW 189
               S++E+CW
Sbjct:   721 WISLMESCW 729

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004871 "signal transducer activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0000956 "nuclear-transcribed mRNA catabolic process" evidence=RCA

GO:0010155 "regulation of proton transport" evidence=RCA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2084304 AT3G06630 [Arabidopsis thaliana (taxid:3702)]

 Score = 658 (236.7 bits), Expect = 1.4e-64, P = 1.4e-64
 Identities = 123/189 (65%), Positives = 153/189 (80%)

Query:     1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
             MKRLRHPN++LFMGAVT P  L IV+E++ RGSL+RLL +      LD RRR+NMA D+A
Sbjct:   483 MKRLRHPNVLLFMGAVTSPQRLCIVSEFVPRGSLFRLLQRS--MSKLDWRRRINMALDIA 540

Query:    61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             +GMNYLH  +PPI+HRDLKS NLLVD+ +TVKV DFGLSR+K  T+L+SKS  GTP+WMA
Sbjct:   541 RGMNYLHCCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHQTYLTSKSGKGTPQWMA 600

Query:   121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
             PEVLR+E ++EKSDIYSFGV+LWELAT + PW NLN  QV+ AVGF  +RLEIP++ +P 
Sbjct:   601 PEVLRNESADEKSDIYSFGVVLWELATEKIPWENLNSMQVIGAVGFMNQRLEIPKDTDPD 660

Query:   181 VASIIEACW 189
               S+IE+CW
Sbjct:   661 WISLIESCW 669

GO:0000155 "phosphorelay sensor kinase activity" evidence=IEA

GO:0000160 "phosphorelay signal transduction system" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004871 "signal transducer activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010155 "regulation of proton transport" evidence=RCA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2127228 AT4G23050 [Arabidopsis thaliana (taxid:3702)]

 Score = 650 (233.9 bits), Expect = 9.7e-64, P = 9.7e-64
 Identities = 121/189 (64%), Positives = 146/189 (77%)

Query:     1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
             MK+LRHPN++LFMGAV      +I+ EY+ RGSL+++LH     + LD++RRL MA DVA
Sbjct:   517 MKKLRHPNVLLFMGAVCTEEKSAIIMEYMPRGSLFKILHN--TNQPLDKKRRLRMALDVA 574

Query:    61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             +GMNYLHRRNPPIVHRDLKS NLLVDK + VKV DFGLS+ K  TFLS+KS  GTP+WMA
Sbjct:   575 RGMNYLHRRNPPIVHRDLKSSNLLVDKNWNVKVGDFGLSKWKNATFLSTKSGKGTPQWMA 634

Query:   121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
             PEVLR EPSNEK D++SFGVILWEL T   PW  LN  QVV  VGF  +RL++P  +NP 
Sbjct:   635 PEVLRSEPSNEKCDVFSFGVILWELMTTLVPWDRLNSIQVVGVVGFMDRRLDLPEGLNPR 694

Query:   181 VASIIEACW 189
             +ASII+ CW
Sbjct:   695 IASIIQDCW 703

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004871 "signal transducer activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0010155 "regulation of proton transport" evidence=RCA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)]

 Score = 632 (227.5 bits), Expect = 7.9e-62, P = 7.9e-62
 Identities = 116/189 (61%), Positives = 152/189 (80%)

Query:     1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
             MKRLRHPN++LFMGAV  P  L IVTE+L RGSL+RLL +   +  LD RRR++MA D+A
Sbjct:   536 MKRLRHPNVLLFMGAVASPQRLCIVTEFLPRGSLFRLLQRN--KSKLDLRRRIHMASDIA 593

Query:    61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             +GMNYLH  +PPI+HRDLKS NLLVD+ +TVKV DFGLSR+K  T+L++ +  GTP+WMA
Sbjct:   594 RGMNYLHHCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHETYLTT-NGRGTPQWMA 652

Query:   121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
             PEVLR+E ++EKSD+YSFGV+LWEL T + PW NLN  QV+ AVGF  +RLE+P++V+P 
Sbjct:   653 PEVLRNEAADEKSDVYSFGVVLWELVTEKIPWENLNAMQVIGAVGFMNQRLEVPKDVDPQ 712

Query:   181 VASIIEACW 189
               +++E+CW
Sbjct:   713 WIALMESCW 721

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0004871 "signal transducer activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005737 "cytoplasm" evidence=ISM

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

TAIR|locus:2158019 AT5G49470 [Arabidopsis thaliana (taxid:3702)]

 Score = 481 (174.4 bits), Expect = 1.2e-55, Sum P(2) = 1.2e-55
 Identities = 94/162 (58%), Positives = 120/162 (74%)

Query:    28 YLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK 87
             Y S  SL +LL+   V  ML     L   +  A+GMNYLH   PPI+HRDLKS NLLVDK
Sbjct:   630 YYSLDSLIQLLYL--VYNML--HIFLTYFFAQARGMNYLHHCTPPIIHRDLKSSNLLVDK 685

Query:    88 KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147
              +TVKV DFGLSR+K  T+L++K+  GTP+WMAPEVLR+E ++EKSD+YSFGVILWEL T
Sbjct:   686 NWTVKVADFGLSRIKHETYLTTKTGRGTPQWMAPEVLRNEAADEKSDVYSFGVILWELVT 745

Query:   148 LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACW 189
              + PW +LN  QV+ AVGF  +RLE+P+NV+P   S++E+CW
Sbjct:   746 EKIPWESLNAMQVIGAVGFMNQRLEVPKNVDPQWISLMESCW 787

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0004871 "signal transducer activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q05609	CTR1_ARATH	2, ., 7, ., 1, 1, ., 1	0.9315	0.9947	0.2314	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00021674001 SubName- Full=Chromosome chr8 scaffold_23, whole genome shotgun sequence; (777 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	191
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-64
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-64
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-64
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	9e-62
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	6e-56
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-53
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-52
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	8e-50
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-42
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-41
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-40
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-39
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-39
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-38
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-38
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-37
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-37
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-36
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-36
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-35
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-34
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-34
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-34
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	9e-34
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-33
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-33
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-33
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-33
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-33
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	8e-33
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-32
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-32
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-32
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	9e-32
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-31
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-31
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-31
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-31
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-31
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-31
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-30
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-30
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-30
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-30
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-30
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-30
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-30
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-30
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	9e-30
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-29
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-29
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-29
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-29
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-29
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-28
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-28
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-28
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-28
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-28
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-28
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-28
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-28
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-28
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-28
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-28
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-28
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	8e-28
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	8e-28
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	9e-28
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-27
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-27
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-27
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-27
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-27
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-27
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-27
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-27
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-27
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-27
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	8e-27
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	8e-27
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	9e-27
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-26
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-26
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-26
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-26
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-26
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-26
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-26
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-26
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-26
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-25
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-25
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-25
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-25
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-25
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	7e-25
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-24
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-24
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-24
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-24
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-24
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-24
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-24
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-24
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	9e-24
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-23
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-23
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-23
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-23
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-23
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-23
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-23
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-23
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-23
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-23
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	5e-23
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	9e-23
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-22
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-22
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-22
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-22
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-22
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-22
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-22
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-22
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-22
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-22
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-22
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-22
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-22
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	6e-22
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	9e-22
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	9e-22
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-21
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-21
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-21
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-21
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-21
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-21
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-21
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-21
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-21
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	7e-21
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	7e-21
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-20
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-20
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-20
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-20
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-20
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-20
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	9e-20
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-19
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-19
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-19
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-19
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-19
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-19
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-19
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-19
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-19
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-19
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-19
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-19
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-19
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-19
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-19
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-19
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-19
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-19
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-19
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-18
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-18
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-18
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-18
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-18
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-18
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-18
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-18
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-18
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-17
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-17
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-17
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-17
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-17
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-17
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-17
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-17
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-17
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-17
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-17
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	7e-17
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	9e-17
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-16
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-16
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-16
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-16
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-16
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-16
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	7e-16
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	7e-16
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	8e-16
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-15
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-15
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-15
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-15
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-15
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-15
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-15
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	7e-15
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	7e-15
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-14
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-14
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-14
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-14
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-14
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-14
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-14
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	6e-14
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	9e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-13
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-13
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-13
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-13
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-13
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-13
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-13
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	8e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-12
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-12
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-12
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-12
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-12
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-12
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	6e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	9e-12
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-11
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-11
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-11
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-11
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-11
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	4e-11
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-11
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-11
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-11
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-11
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-11
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	6e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-11
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-11
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-11
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	8e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-10
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-10
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	7e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-09
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-09
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-09
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	3e-09
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-09
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	9e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-08
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-08
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-08
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	7e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-07
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	4e-07
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	6e-07
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-05
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	5e-05
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	6e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	7e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	8e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	8e-04

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  198 bits (507), Expect = 1e-64
 Identities = 73/194 (37%), Positives = 104/194 (53%), Gaps = 11/194 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M++L HPN+V  +G  T+   L IV EY+  G L   L K   R  L     L+ A  +A
Sbjct: 55  MRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKN--RPKLSLSDLLSFALQIA 112

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 117
           +GM YL  +N   +HRDL + N LV +   VK+ DFGLSR   +         G      
Sbjct: 113 RGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--DYYRKRGGKLPIR 168

Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           WMAPE L++     KSD++SFGV+LWE+ TL +QP+  ++  +V+  +   G RL  P N
Sbjct: 169 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLK-NGYRLPQPPN 227

Query: 177 VNPHVASIIEACWA 190
             P +  ++  CWA
Sbjct: 228 CPPELYDLMLQCWA 241

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  198 bits (506), Expect = 3e-64
 Identities = 80/194 (41%), Positives = 108/194 (55%), Gaps = 8/194 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK+L HPNIV  +G  TQ   L IVTEY+  G L   L K G +  L  +  L MA  +A
Sbjct: 55  MKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK--LTLKDLLQMALQIA 112

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT-FLSSKSAAGTP-EW 118
           KGM YL  +N   VHRDL + N LV +   VK+ DFGLSR      +   +     P +W
Sbjct: 113 KGMEYLESKN--FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKW 170

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MAPE L+D     KSD++SFGV+LWE+ TL +QP+  ++  +V+  +   G RL  P N 
Sbjct: 171 MAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL-EDGYRLPRPENC 229

Query: 178 NPHVASIIEACWAK 191
              +  ++  CWA 
Sbjct: 230 PDELYELMLQCWAY 243

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  198 bits (506), Expect = 3e-64
 Identities = 75/194 (38%), Positives = 107/194 (55%), Gaps = 10/194 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M++L HPNIV  +G  T+   L IV EY+  G L   L K   +E L     L+ A  +A
Sbjct: 55  MRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE-LSLSDLLSFALQIA 113

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 117
           +GM YL  +N   +HRDL + N LV +   VK+ DFGLSR   +         G      
Sbjct: 114 RGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--DYYKVKGGKLPIR 169

Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           WMAPE L++     KSD++SFGV+LWE+ TL ++P+  ++ A+V+  +  KG RL  P N
Sbjct: 170 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLK-KGYRLPKPPN 228

Query: 177 VNPHVASIIEACWA 190
             P +  ++  CWA
Sbjct: 229 CPPELYKLMLQCWA 242

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  191 bits (489), Expect = 9e-62
 Identities = 71/201 (35%), Positives = 102/201 (50%), Gaps = 14/201 (6%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL------YRLLHKPGVREMLDERRRLN 54
           MK+L HPN+V  +G  T+   L +V EY+  G L       R +     +  L  +  L+
Sbjct: 50  MKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLS 109

Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
            A  +AKGM YL  +    VHRDL + N LV +   VK+ DFGLSR   +     +   G
Sbjct: 110 FAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD-DYYRKKTG 166

Query: 115 TPE---WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 170
                 WMAPE L+D     KSD++SFGV+LWE+ TL   P+  L+  +V+  +  KG R
Sbjct: 167 GKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR-KGYR 225

Query: 171 LEIPRNVNPHVASIIEACWAK 191
           L  P      +  ++ +CW  
Sbjct: 226 LPKPEYCPDELYELMLSCWQL 246

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  176 bits (450), Expect = 6e-56
 Identities = 66/193 (34%), Positives = 93/193 (48%), Gaps = 8/193 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K+L+HPNIV           L +V EY   G L+ LL K G    L E         + 
Sbjct: 51  LKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR---LSEDEARFYLRQIL 107

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             + YLH +   IVHRDLK  N+L+D+   VK+ DFGL+R          +  GTPE+MA
Sbjct: 108 SALEYLHSKG--IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL-TTFVGTPEYMA 164

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR--NVN 178
           PEVL  +   +  DI+S GVIL+EL T + P+   +    +     K K    P   +++
Sbjct: 165 PEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDIS 224

Query: 179 PHVASIIEACWAK 191
           P    +I     K
Sbjct: 225 PEAKDLIRKLLVK 237

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  168 bits (429), Expect = 3e-53
 Identities = 64/152 (42%), Positives = 87/152 (57%), Gaps = 6/152 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K+L HPNIV   G      +L +V EY   GSL  LL +   +  L E   L +   + 
Sbjct: 45  LKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQIL 102

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKK-YTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
           +G+ YLH     I+HRDLK  N+L+D     VK+ DFGLS+L  +     K+  GTP +M
Sbjct: 103 EGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYM 160

Query: 120 APEVLRDEPS-NEKSDIYSFGVILWELATLQQ 150
           APEVL  +   +EKSDI+S GVIL+EL  L+ 
Sbjct: 161 APEVLLGKGYYSEKSDIWSLGVILYELPELKD 192

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  168 bits (427), Expect = 2e-52
 Identities = 67/199 (33%), Positives = 100/199 (50%), Gaps = 15/199 (7%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++RL HPNIV  + A     +L +V EY   G L+  L + G    L E     +A  + 
Sbjct: 52  LRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQIL 108

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +G+ YLH     I+HRDLK  N+L+D+   VK+ DFGL++    +  S  +  GTP +MA
Sbjct: 109 RGLEYLHSNG--IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMA 166

Query: 121 PEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPA---QVVAAVGFKGKRLEIPR- 175
           PEVL        K D++S GVIL+EL T + P+   N     Q++  +   G  LE    
Sbjct: 167 PEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRI--LGPPLEFDEP 224

Query: 176 ---NVNPHVASIIEACWAK 191
              + +     +I+ C  K
Sbjct: 225 KWSSGSEEAKDLIKKCLNK 243

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  161 bits (410), Expect = 8e-50
 Identities = 71/195 (36%), Positives = 101/195 (51%), Gaps = 14/195 (7%)

Query: 1   MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDER--RRLNMA 56
           +  L+HPNIV + G+        L+I  EY+S GSL  LL K G    L E   R+    
Sbjct: 53  LSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK---LPEPVIRKY--T 107

Query: 57  YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS--SKSAAG 114
             + +G+ YLH     IVHRD+K  N+LVD    VK+ DFG ++   +      + S  G
Sbjct: 108 RQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRG 165

Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL-NPAQVVAAVGFKGKRLEI 173
           TP WMAPEV+R E     +DI+S G  + E+AT + PW  L NP   +  +G  G+  EI
Sbjct: 166 TPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEI 225

Query: 174 PRNVNPHVASIIEAC 188
           P +++      +  C
Sbjct: 226 PEHLSEEAKDFLRKC 240

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  142 bits (361), Expect = 2e-42
 Identities = 58/189 (30%), Positives = 105/189 (55%), Gaps = 4/189 (2%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-PGVREMLDERRRLNMAYDV 59
           +K+L HPNI+ +  +  +   L IV EY   G L + + K     +   E + L+    +
Sbjct: 53  LKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL 112

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
              + YLH R   I+HRD+K  N+ +     VK+ DFG+S++ ++T   +K+  GTP ++
Sbjct: 113 CLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYL 170

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 179
           +PE+ +++P N KSDI+S G +L+EL TL+ P+   N  ++   +  KG+   IP   + 
Sbjct: 171 SPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI-LKGQYPPIPSQYSS 229

Query: 180 HVASIIEAC 188
            + +++ + 
Sbjct: 230 ELRNLVSSL 238

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  139 bits (351), Expect = 4e-41
 Identities = 75/192 (39%), Positives = 109/192 (56%), Gaps = 8/192 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  LRHPN+V  +G V Q   L IVTEY+++GSL   L   G R ++   ++L  A DV 
Sbjct: 54  MTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRG-RAVITLAQQLGFALDVC 112

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +GM YL  +N   VHRDL + N+LV +    KV DFGL++  +    S K      +W A
Sbjct: 113 EGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPV---KWTA 167

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 179
           PE LR++  + KSD++SFG++LWE+ +  + P+  +    VV  V  KG R+E P    P
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPEGCPP 226

Query: 180 HVASIIEACWAK 191
            V  +++ CW  
Sbjct: 227 EVYKVMKDCWEL 238

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  137 bits (347), Expect = 2e-40
 Identities = 62/160 (38%), Positives = 91/160 (56%), Gaps = 11/160 (6%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAY--- 57
           +K+ +HPNIV + G+  +   L IV E+ S GSL  LL        L E     +AY   
Sbjct: 51  LKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT--LTES---QIAYVCK 105

Query: 58  DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 117
           ++ KG+ YLH     I+HRD+K+ N+L+     VK+ DFGLS   ++T  +  +  GTP 
Sbjct: 106 ELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK-ARNTMVGTPY 162

Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP 157
           WMAPEV+  +P + K+DI+S G+   ELA  + P+  L P
Sbjct: 163 WMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP 202

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  134 bits (340), Expect = 2e-39
 Identities = 66/189 (34%), Positives = 97/189 (51%), Gaps = 7/189 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           + +L+HPNIV ++G   +  NL I  E +  GSL +LL K G      E         + 
Sbjct: 56  LSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGS---FPEPVIRLYTRQIL 112

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ YLH RN   VHRD+K  N+LVD    VK+ DFG+++ +   F  +KS  G+P WMA
Sbjct: 113 LGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAK-QVVEFSFAKSFKGSPYWMA 169

Query: 121 PEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 179
           PEV+  +      +DI+S G  + E+AT + PW  L     V  +G   +   IP +++ 
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSD 229

Query: 180 HVASIIEAC 188
                I  C
Sbjct: 230 EAKDFILKC 238

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  133 bits (337), Expect = 5e-39
 Identities = 65/193 (33%), Positives = 105/193 (54%), Gaps = 6/193 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK+LRH  +V      ++   + IVTEY+S+GSL   L     ++ L   + ++MA  +A
Sbjct: 55  MKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKK-LRLPQLVDMAAQIA 113

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
           +GM YL  RN   +HRDL + N+LV +    K+ DFGL+RL  +   +++  A  P +W 
Sbjct: 114 EGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT 171

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE         KSD++SFG++L E+ T  + P+  +   +V+  V  +G R+  P N  
Sbjct: 172 APEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNCP 230

Query: 179 PHVASIIEACWAK 191
             +  ++  CW K
Sbjct: 231 EELYDLMLQCWDK 243

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  132 bits (333), Expect = 2e-38
 Identities = 71/191 (37%), Positives = 111/191 (58%), Gaps = 6/191 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK ++HPN+V  +G  T+ P   I+TE+++ G+L   L +   R+ ++    L MA  ++
Sbjct: 56  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQIS 114

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KANTFLSSKSAAGTPEWM 119
             M YL ++N   +HRDL + N LV + + VKV DFGLSRL   +T+ +   A    +W 
Sbjct: 115 SAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 172

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE L     + KSD+++FGV+LWE+AT    P+  ++ +QV   +  KG R+E P    
Sbjct: 173 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERPEGCP 231

Query: 179 PHVASIIEACW 189
           P V  ++ ACW
Sbjct: 232 PKVYELMRACW 242

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  131 bits (332), Expect = 3e-38
 Identities = 63/192 (32%), Positives = 103/192 (53%), Gaps = 8/192 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L+HPNIV ++G++    +L I+ EY   GSL +++ K G      E       Y V 
Sbjct: 53  LKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG---PFPESLVAVYVYQVL 109

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
           +G+ YLH +   ++HRD+K+ N+L  K   VK+ DFG++ +L   +     S  GTP WM
Sbjct: 110 QGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS-KDDASVVGTPYWM 166

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 179
           APEV+    ++  SDI+S G  + EL T   P+ +LNP   +  +  +     +P  ++P
Sbjct: 167 APEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISP 225

Query: 180 HVASIIEACWAK 191
            +   +  C+ K
Sbjct: 226 ELKDFLMQCFQK 237

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  130 bits (328), Expect = 1e-37
 Identities = 66/191 (34%), Positives = 100/191 (52%), Gaps = 7/191 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +L HPN+V   G  T+   + IVTEY++ G L   L +   +  L     L+M  DV 
Sbjct: 53  MMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRE--RKGKLGTEWLLDMCSDVC 110

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
           + M YL       +HRDL + N LV +   VKV DFGL+R   +   +S      P +W 
Sbjct: 111 EAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWA 168

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
            PEV      + KSD++SFGV++WE+ +  + P+   + ++VV +V   G RL  P+   
Sbjct: 169 PPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLAP 227

Query: 179 PHVASIIEACW 189
             V +I+ +CW
Sbjct: 228 TEVYTIMYSCW 238

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  129 bits (327), Expect = 2e-37
 Identities = 65/195 (33%), Positives = 97/195 (49%), Gaps = 8/195 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  L H N++   G V   P L +VTE    GSL   L K  +   L      + A  +A
Sbjct: 50  MHSLDHENLIRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTL-CDYAVQIA 107

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANT--FLSSKSAAGTPE 117
            GM YL  +    +HRDL + N+L+     VK+ DFGL R L  N   ++  +       
Sbjct: 108 NGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA 165

Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE LR    +  SD++ FGV LWE+ T  ++PW  L+ +Q++  +  +G+RLE P  
Sbjct: 166 WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEA 225

Query: 177 VNPHVASIIEACWAK 191
               + +++  CWA 
Sbjct: 226 CPQDIYNVMLQCWAH 240

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  126 bits (318), Expect = 3e-36
 Identities = 70/191 (36%), Positives = 103/191 (53%), Gaps = 7/191 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +L H  +V   G  T+   + IVTEY+S G L   L + G R      + L M  DV 
Sbjct: 53  MMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVC 110

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEWM 119
           +GM YL  +    +HRDL + N LVD +  VKV DFGLSR +  + + SS  +     W 
Sbjct: 111 EGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 168

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
            PEVL     + KSD+++FGV++WE+ +L + P+   N ++ V  V  +G RL  P   +
Sbjct: 169 PPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLAS 227

Query: 179 PHVASIIEACW 189
             V +I+ +CW
Sbjct: 228 EKVYAIMYSCW 238

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  126 bits (318), Expect = 6e-36
 Identities = 69/203 (33%), Positives = 105/203 (51%), Gaps = 17/203 (8%)

Query: 1   MKRLRHPNIVLFMGAVT--QPPNLSIVTEYLSRGSL--YRLLHKP-----GVREMLDERR 51
           MK     ++V  +G V+  QP    +V E +++G L  Y    +P             ++
Sbjct: 63  MKEFNCHHVVRLLGVVSTGQPT--LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQK 120

Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
            + MA ++A GM YL  +    VHRDL + N +V +  TVK+ DFG++R    T    K 
Sbjct: 121 FIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKG 178

Query: 112 AAGT-P-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             G  P  WMAPE L+D     KSD++SFGV+LWE+ATL +QP+  L+  +V+  V   G
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DG 237

Query: 169 KRLEIPRNVNPHVASIIEACWAK 191
             L++P N    +  ++  CW  
Sbjct: 238 GHLDLPENCPDKLLELMRMCWQY 260

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  124 bits (313), Expect = 4e-35
 Identities = 66/190 (34%), Positives = 104/190 (54%), Gaps = 22/190 (11%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAY--- 57
           MK  +HPNIV +  +      L +V EY+  GSL  ++ +  VR  ++E +   +AY   
Sbjct: 69  MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR--MNEPQ---IAYVCR 123

Query: 58  DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFG----LSRLKANTFLSSKSAA 113
           +V +G+ YLH +N  ++HRD+KS N+L+ K  +VK+ DFG    L++ K+       S  
Sbjct: 124 EVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK----RNSVV 177

Query: 114 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEI 173
           GTP WMAPEV++ +    K DI+S G++  E+A  + P+    P + +  +  KG    I
Sbjct: 178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG----I 233

Query: 174 PRNVNPHVAS 183
           P   NP   S
Sbjct: 234 PPLKNPEKWS 243

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  121 bits (307), Expect = 1e-34
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 11/195 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS---LYRLLHKPGVREMLDERRRLNMAY 57
           +K+   P IV + G+  +  +L IV EY   GS   + ++ +K      L E     + Y
Sbjct: 52  LKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT-----LTEEEIAAILY 106

Query: 58  DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 117
              KG+ YLH      +HRD+K+ N+L++++   K+ DFG+S    +T     +  GTP 
Sbjct: 107 QTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPF 164

Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-GKRLEIPRN 176
           WMAPEV+++   N K+DI+S G+   E+A  + P+ +++P + +  +  K    L  P  
Sbjct: 165 WMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEK 224

Query: 177 VNPHVASIIEACWAK 191
            +P     ++ C  K
Sbjct: 225 WSPEFNDFVKKCLVK 239

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  121 bits (306), Expect = 2e-34
 Identities = 70/194 (36%), Positives = 104/194 (53%), Gaps = 13/194 (6%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL-HKPGV--REMLDERRRLNMAY 57
           M +L HP +V   G  TQ   L IVTE++  G L   L  + G   ++ML     L+M  
Sbjct: 53  MMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML-----LSMCQ 107

Query: 58  DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP- 116
           DV +GM YL R +   +HRDL + N LV     VKV DFG++R   +   +S S A  P 
Sbjct: 108 DVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPV 165

Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPR 175
           +W  PEV      + KSD++SFGV++WE+ T  + P+   +  +VV  +  +G RL  P+
Sbjct: 166 KWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS-RGFRLYRPK 224

Query: 176 NVNPHVASIIEACW 189
             +  V  ++ +CW
Sbjct: 225 LASMTVYEVMYSCW 238

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  120 bits (303), Expect = 5e-34
 Identities = 70/191 (36%), Positives = 107/191 (56%), Gaps = 9/191 (4%)

Query: 1   MKRLRHPNIVLFMGA-VTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           M +LRH N+V  +G  V +   L IVTEY+++GSL   L   G R +L     L  + DV
Sbjct: 53  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDV 111

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
            + M YL   N   VHRDL + N+LV +    KV DFGL++  ++T  + K      +W 
Sbjct: 112 CEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWT 166

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE LR++  + KSD++SFG++LWE+ +  + P+  +    VV  V  KG +++ P    
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCP 225

Query: 179 PHVASIIEACW 189
           P V  +++ CW
Sbjct: 226 PVVYDVMKQCW 236

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  120 bits (303), Expect = 9e-34
 Identities = 60/194 (30%), Positives = 102/194 (52%), Gaps = 7/194 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHK-PGVREMLDERRRLNMAY 57
           ++ L+HPNIV +   +    N  L IV EY   G L +L+ K    R+ ++E     +  
Sbjct: 53  LRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT 112

Query: 58  DVAKGMNYLHRRNPP---IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
            +   +   H R+ P   ++HRDLK  N+ +D    VK+ DFGL+++  +    +K+  G
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVG 172

Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP 174
           TP +M+PE L     +EKSDI+S G +++EL  L  P+   N  Q+ + +  +GK   IP
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK-EGKFRRIP 231

Query: 175 RNVNPHVASIIEAC 188
              +  +  +I++ 
Sbjct: 232 YRYSSELNEVIKSM 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  120 bits (302), Expect = 1e-33
 Identities = 63/191 (32%), Positives = 98/191 (51%), Gaps = 5/191 (2%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +KRLRH +++      +    + I+TE + +GSL   L  P  + +L     ++MA  VA
Sbjct: 56  LKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ-VLPVASLIDMACQVA 114

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +GM YL  +N   +HRDL + N+LV +    KV DFGL+RL       S       +W A
Sbjct: 115 EGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTA 172

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVNP 179
           PE       + KSD++SFG++L+E+ T  Q P+  +N  +V   +   G R+  P     
Sbjct: 173 PEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQ 231

Query: 180 HVASIIEACWA 190
            +  I+  CWA
Sbjct: 232 EIYKIMLECWA 242

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  120 bits (302), Expect = 1e-33
 Identities = 60/188 (31%), Positives = 97/188 (51%), Gaps = 9/188 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L H NIV ++G  T    LSI  EY+  GS+   L   G     +E+        V 
Sbjct: 62  LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVL 118

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK--SAAGTPEW 118
           +G+ YLH +   I+HRDLK+ NLLVD     K+ DFG+S+   + + + +  S  G+  W
Sbjct: 119 EGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176

Query: 119 MAPEVLRDEPS--NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           MAPEV+       + K DI+S G ++ E+   ++PW +      +  +G K     IP +
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPD 236

Query: 177 VNPHVASI 184
           V+ +++ +
Sbjct: 237 VSMNLSPV 244

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  119 bits (300), Expect = 2e-33
 Identities = 63/194 (32%), Positives = 100/194 (51%), Gaps = 8/194 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +  HPNI+   G VT+   + I+TEY+  GSL + L +          + + M   +A
Sbjct: 59  MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIA 116

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG-TP-EW 118
            GM YL   N   VHRDL + N+LV+     KV DFGLSR   ++  +  +  G  P  W
Sbjct: 117 SGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRW 174

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            APE +        SD++SFG+++WE+ +  ++P+ +++   V+ AV   G RL  P + 
Sbjct: 175 TAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGYRLPPPMDC 233

Query: 178 NPHVASIIEACWAK 191
              +  ++  CW K
Sbjct: 234 PSALYQLMLDCWQK 247

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  119 bits (300), Expect = 3e-33
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 27/211 (12%)

Query: 1   MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           ++ L H NIV + G   +P   +L ++ EYL  GSL   L     R+ ++ +R L  +  
Sbjct: 60  LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQ 117

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP 116
           + KGM+YL  +    +HRDL + N+LV+ +  VK+ DFGL+++  +   +   K    +P
Sbjct: 118 ICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESP 175

Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP-AQVVAAVGFK------- 167
             W APE LR    +  SD++SFGV L+EL T   P  + +P A+ +  +G         
Sbjct: 176 IFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDP--SQSPPAEFLRMIGIAQGQMIVT 233

Query: 168 --------GKRLEIPRNVNPHVASIIEACWA 190
                   G+RL  P +    V  +++ CW 
Sbjct: 234 RLLELLKEGERLPRPPSCPDEVYDLMKLCWE 264

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  118 bits (297), Expect = 5e-33
 Identities = 65/191 (34%), Positives = 98/191 (51%), Gaps = 6/191 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK+LRHP ++      T    + IVTE +  GSL   L     R  L   + ++MA  VA
Sbjct: 55  MKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGR-ALKLPQLIDMAAQVA 113

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
            GM YL  +N   +HRDL + N+LV +    KV DFGL+R+       ++  A  P +W 
Sbjct: 114 SGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT 171

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE       + KSD++SFG++L E+ T  + P+  +  A+V+  V  +G R+  P    
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCP 230

Query: 179 PHVASIIEACW 189
             +  I+  CW
Sbjct: 231 KELYDIMLDCW 241

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  117 bits (295), Expect = 8e-33
 Identities = 66/194 (34%), Positives = 104/194 (53%), Gaps = 11/194 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +L HP IV  +G V +   L +V E    G L + L K   R  +       +A+ VA
Sbjct: 50  MAQLDHPCIVRLIG-VCKGEPLMLVMELAPLGPLLKYLKK---RREIPVSDLKELAHQVA 105

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKA-NTFLSSKSAAGTP-E 117
            GM YL  ++   VHRDL + N+L+  ++  K+ DFG+SR L A + +  + +A   P +
Sbjct: 106 MGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK 163

Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE +     + KSD++S+GV LWE  +   +P+G +  A+V+A +   G+RL  P  
Sbjct: 164 WYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEE 222

Query: 177 VNPHVASIIEACWA 190
               + SI+ +CW 
Sbjct: 223 CPQEIYSIMLSCWK 236

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  117 bits (294), Expect = 1e-32
 Identities = 62/193 (32%), Positives = 96/193 (49%), Gaps = 8/193 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K+  HPNIV  +G   Q   + IV E +  GSL   L K   R  L  ++ L M+ D A
Sbjct: 46  LKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNR--LTVKKLLQMSLDAA 103

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG-TP-EW 118
            GM YL  +N   +HRDL + N LV +   +K+ DFG+SR +     +        P +W
Sbjct: 104 AGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW 161

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            APE L       +SD++S+G++LWE  +L   P+  ++  Q    +   G R+  P+  
Sbjct: 162 TAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-SGYRMPAPQLC 220

Query: 178 NPHVASIIEACWA 190
              +  ++  CWA
Sbjct: 221 PEEIYRLMLQCWA 233

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  117 bits (295), Expect = 1e-32
 Identities = 65/183 (35%), Positives = 102/183 (55%), Gaps = 12/183 (6%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L+H NIV ++G+     +L+I  EY+  GS+  LL+  G     +E    N    + 
Sbjct: 60  LKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA---FEETLVRNFVRQIL 116

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSK-----SAAG 114
           KG+NYLH R   I+HRD+K  N+LVD K  +K+ DFG+S+ L+AN+  +       S  G
Sbjct: 117 KGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQG 174

Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP 174
           +  WMAPEV++      K+DI+S G ++ E+ T + P+ +    Q +  +G      EIP
Sbjct: 175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA-SPEIP 233

Query: 175 RNV 177
            N+
Sbjct: 234 SNI 236

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  117 bits (295), Expect = 1e-32
 Identities = 64/179 (35%), Positives = 92/179 (51%), Gaps = 27/179 (15%)

Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
            R P I  + G+  +   L I+ EY   GS   LL KPG    LDE     +  +V  G+
Sbjct: 56  CRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGK---LDETYIAFILREVLLGL 111

Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS------RLKANTFLSSKSAAGTPE 117
            YLH      +HRD+K+ N+L+ ++  VK+ DFG+S        K NTF       GTP 
Sbjct: 112 EYLHEEGK--IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF------VGTPF 163

Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           WMAPEV++    +EK+DI+S G+   ELA  + P  +L+P +V+           IP+N
Sbjct: 164 WMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL---------FLIPKN 213

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  115 bits (291), Expect = 9e-32
 Identities = 73/211 (34%), Positives = 103/211 (48%), Gaps = 28/211 (13%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLN------ 54
           + RL  PNI   +G  T  P L ++ EY+  G L + L K             N      
Sbjct: 73  LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQK---HVAETSGLACNSKSLSF 129

Query: 55  -----MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLS 108
                MA  +A GM YL   N   VHRDL + N LV K YT+K+ DFG+SR L ++ +  
Sbjct: 130 STLLYMATQIASGMRYLESLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYR 187

Query: 109 SKSAAGTP-EWMAPE-VLRDEPSNEKSDIYSFGVILWELATL--QQPWGNLNPAQVV--A 162
            +  A  P  WMA E VL  + +  KSD+++FGV LWE+ TL  +QP+ +L   QV+  A
Sbjct: 188 VQGRAPLPIRWMAWESVLLGKFT-TKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENA 246

Query: 163 AVGFKGKRLEI----PRNVNPHVASIIEACW 189
              F+    +I    P N    +  ++  CW
Sbjct: 247 GHFFRDDGRQIYLPRPPNCPKDIYELMLECW 277

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score =  116 bits (291), Expect = 1e-31
 Identities = 64/198 (32%), Positives = 97/198 (48%), Gaps = 26/198 (13%)

Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
           H NIV  +GA T    + ++TEY   G L   L +      L     L+ +Y VAKGM +
Sbjct: 98  HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAF 156

Query: 66  LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR---------LKANTFLSSKSAAGTP 116
           L  +N   +HRDL + N+L+     VK+CDFGL+R         +K N  L  K      
Sbjct: 157 LASKN--CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK------ 208

Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK----GKRLE 172
            WMAPE + +     +SD++S+G++LWE+ +L     N  P   V +  +K    G R+ 
Sbjct: 209 -WMAPESIFNCVYTFESDVWSYGILLWEIFSLG---SNPYPGMPVDSKFYKLIKEGYRMA 264

Query: 173 IPRNVNPHVASIIEACWA 190
            P +    +  I++ CW 
Sbjct: 265 QPEHAPAEIYDIMKTCWD 282

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  114 bits (286), Expect = 2e-31
 Identities = 66/190 (34%), Positives = 106/190 (55%), Gaps = 9/190 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +L H N+V  +G +     L IV E +S+G+L   L   G R ++   + L  + DVA
Sbjct: 53  MTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVA 110

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +GM YL  +   +VHRDL + N+LV +    KV DFGL+R+ +    +SK      +W A
Sbjct: 111 EGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV---KWTA 165

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 179
           PE L+ +  + KSD++S+GV+LWE+ +  + P+  ++  +V   V  KG R+E P     
Sbjct: 166 PEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPPEGCPA 224

Query: 180 HVASIIEACW 189
            V  ++ +CW
Sbjct: 225 DVYVLMTSCW 234

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  113 bits (286), Expect = 3e-31
 Identities = 64/167 (38%), Positives = 87/167 (52%), Gaps = 13/167 (7%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAY--- 57
           +K  RHPNIV + G+  +   L IV EY   GSL  +      R  L E   L +AY   
Sbjct: 54  LKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQV--TRGPLSE---LQIAYVCR 108

Query: 58  DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 117
           +  KG+ YLH      +HRD+K  N+L+ +   VK+ DFG+S     T    KS  GTP 
Sbjct: 109 ETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPY 166

Query: 118 WMAPEVL---RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161
           WMAPEV    R    + K DI++ G+   ELA LQ P  +L+P + +
Sbjct: 167 WMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score =  113 bits (284), Expect = 3e-31
 Identities = 66/193 (34%), Positives = 100/193 (51%), Gaps = 8/193 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K+  HPNIV  +G  TQ   + IV E +  G     L   G R  L  +  + M  + A
Sbjct: 47  LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR--LKVKELIQMVENAA 104

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN-TFLSSKSAAGTP-EW 118
            GM YL  ++   +HRDL + N LV +K  +K+ DFG+SR + +  + S+      P +W
Sbjct: 105 AGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW 162

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            APE L     + +SD++SFG++LWE  +L   P+ NL+  Q   A+  +G RL  P   
Sbjct: 163 TAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELC 221

Query: 178 NPHVASIIEACWA 190
              V  ++E CW 
Sbjct: 222 PDAVYRLMERCWE 234

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  113 bits (285), Expect = 3e-31
 Identities = 61/196 (31%), Positives = 94/196 (47%), Gaps = 12/196 (6%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L+H  IV + G +     LSI  EY+  GS+   L   G    L E         + 
Sbjct: 58  LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA---LTETVTRKYTRQIL 114

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKA----NTFLSSKSAAGT 115
           +G+ YLH     IVHRD+K  N+L D    VK+ DFG S RL+      T +  KS  GT
Sbjct: 115 EGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGM--KSVTGT 170

Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 175
           P WM+PEV+  E    K+D++S G  + E+ T + PW        +  +  +    ++P 
Sbjct: 171 PYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPS 230

Query: 176 NVNPHVASIIEACWAK 191
           +V+P   + +   + +
Sbjct: 231 HVSPDARNFLRRTFVE 246

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  113 bits (283), Expect = 4e-31
 Identities = 66/192 (34%), Positives = 107/192 (55%), Gaps = 16/192 (8%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L HPNI+ +     +   L IV EY   G+L   + K     +LDE   L+    + 
Sbjct: 53  LKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRC-NSLLDEDTILHFFVQIL 111

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFGLSRLKANTFLSSKSAA----GT 115
             ++++H +   I+HRDLK+ N+L+DK   V K+ DFG+S++     LSSKS A    GT
Sbjct: 112 LALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKI-----LSSKSKAYTVVGT 164

Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN-PAQVVAAVGFKGKRLEIP 174
           P +++PE+   +P N+KSDI++ G +L+ELA+L++ +   N PA V+  +   G    I 
Sbjct: 165 PCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM--SGTFAPIS 222

Query: 175 RNVNPHVASIIE 186
              +P +  +I 
Sbjct: 223 DRYSPDLRQLIL 234

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  112 bits (283), Expect = 1e-30
 Identities = 60/184 (32%), Positives = 92/184 (50%), Gaps = 19/184 (10%)

Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRL---LHKPGVREMLDERRRLNMAYDVAK 61
           +HPNIV    A      L I+ E+   G+L  +   L +      L E +   +   + +
Sbjct: 60  KHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG-----LTEPQIRYVCRQMLE 114

Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAP 121
            +N+LH     ++HRDLK+ N+L+     VK+ DFG+S    +T     +  GTP WMAP
Sbjct: 115 ALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAP 172

Query: 122 EVL-----RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           EV+     +D P + K+DI+S G+ L ELA ++ P   LNP +V+     K  + E P  
Sbjct: 173 EVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL----LKILKSEPPTL 228

Query: 177 VNPH 180
             P 
Sbjct: 229 DQPS 232

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  112 bits (281), Expect = 1e-30
 Identities = 65/192 (33%), Positives = 110/192 (57%), Gaps = 9/192 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDV 59
           MK+L+HP +V     VTQ P + I+TEY+  GSL   L  P G++  L   + ++MA  +
Sbjct: 55  MKQLQHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIK--LTINKLIDMAAQI 111

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           A+GM ++ R+N   +HRDL++ N+LV +    K+ DFGL+RL  +   +++  A  P +W
Sbjct: 112 AEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKW 169

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            APE +       KSD++SFG++L E+ T  + P+  +   +V+  +  +G R+  P N 
Sbjct: 170 TAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNC 228

Query: 178 NPHVASIIEACW 189
              +  ++  CW
Sbjct: 229 PEELYELMRLCW 240

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  112 bits (281), Expect = 1e-30
 Identities = 70/203 (34%), Positives = 102/203 (50%), Gaps = 15/203 (7%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVRE----MLDERRRLNMA 56
           M    HPNIV  +G         I+ E +  G L   L    V      +L  +  L++ 
Sbjct: 53  MSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDIC 112

Query: 57  YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-----YTVKVCDFGLSR-LKANTFLSSK 110
            DVAKG  YL + +   +HRDL + N LV +K       VK+ DFGL+R +  + +   +
Sbjct: 113 LDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKE 170

Query: 111 SAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
                P  WMAPE L D     +SD++SFGV++WE+ TL QQP+  LN  +V+  V   G
Sbjct: 171 GEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AG 229

Query: 169 KRLEIPRNVNPHVASIIEACWAK 191
            RL+ P N    +  ++  CWA+
Sbjct: 230 GRLQKPENCPDKIYQLMTNCWAQ 252

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  111 bits (279), Expect = 2e-30
 Identities = 71/193 (36%), Positives = 107/193 (55%), Gaps = 7/193 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK+LRH  +V     V++ P + IVTEY+S+GSL   L K G    L     ++MA  VA
Sbjct: 55  MKKLRHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVA 112

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
            GM Y+ R N   +HRDL+S N+LV      K+ DFGL+RL  +   +++  A  P +W 
Sbjct: 113 AGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT 170

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE         KSD++SFG++L EL T  + P+  +N  +V+  V  +G R+  P++  
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDCP 229

Query: 179 PHVASIIEACWAK 191
             +  ++  CW K
Sbjct: 230 ISLHELMLQCWKK 242

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  112 bits (281), Expect = 2e-30
 Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 19/205 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL--HKP-----------GVREML 47
           M  L+HPNIV  +G  T+     ++ EYL+ G L+  L  + P            V+  L
Sbjct: 62  MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL 121

Query: 48  DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KANTF 106
           D    L++A  +A GM YL   +   VHRDL + N LV +  TVK+ DFGLSR   +  +
Sbjct: 122 DCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY 179

Query: 107 LSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
              +S +  P  WM PE +       +SDI+SFGV+LWE+ +   QP+   +  +V+  +
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239

Query: 165 GFKGKRLEIPRNVNPHVASIIEACW 189
               + L  P +    V +++  CW
Sbjct: 240 R-SRQLLPCPEDCPARVYALMIECW 263

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 2e-30
 Identities = 57/193 (29%), Positives = 94/193 (48%), Gaps = 11/193 (5%)

Query: 1   MKRLRHPNIV-LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYD 58
           + R+ HP IV L     T+   L +V EY   G L+  L K        E R R   A +
Sbjct: 47  LSRINHPFIVKLHYAFQTEE-KLYLVLEYAPGGELFSHLSK---EGRFSEERARFYAA-E 101

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
           +   + YLH     I++RDLK  N+L+D    +K+ DFGL++  ++    + +  GTPE+
Sbjct: 102 IVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY 159

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           +APEVL  +   +  D +S GV+L+E+ T + P+   +  ++   +      L  P  ++
Sbjct: 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI--LKDPLRFPEFLS 217

Query: 179 PHVASIIEACWAK 191
           P    +I     K
Sbjct: 218 PEARDLISGLLQK 230

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  110 bits (278), Expect = 6e-30
 Identities = 65/206 (31%), Positives = 108/206 (52%), Gaps = 20/206 (9%)

Query: 1   MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL--HKP-----------GVREM 46
           MK + +H NI+  +G  TQ   L +V EY + G+L   L   +P              E 
Sbjct: 69  MKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEET 128

Query: 47  LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANT 105
           L ++  ++ AY VA+GM +L  +    +HRDL + N+LV + + +K+ DFGL+R +    
Sbjct: 129 LTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTEDHVMKIADFGLARDIHHID 186

Query: 106 FLSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ-QPWGNLNPAQVVAA 163
           +    +    P +WMAPE L D     +SD++SFGV+LWE+ TL   P+  +   ++   
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246

Query: 164 VGFKGKRLEIPRNVNPHVASIIEACW 189
           +  +G R+E P+N    +  ++  CW
Sbjct: 247 LK-EGYRMEKPQNCTQELYHLMRDCW 271

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score =  110 bits (277), Expect = 6e-30
 Identities = 61/199 (30%), Positives = 103/199 (51%), Gaps = 18/199 (9%)

Query: 4   LRHPNIVLFMGAVTQPPNLSIVTE-YLSRGSLYRLLHKP-----GVREMLDERRRLNMAY 57
           L H NI+  +    +      V   Y++ G+L   L +         + L  ++ ++MA 
Sbjct: 65  LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124

Query: 58  DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 117
            +A GM+YLH+R   ++H+D+ + N ++D++  VK+ D  LSR   + F       G  E
Sbjct: 125 QIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSR---DLFPMDYHCLGDNE 179

Query: 118 -----WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRL 171
                WMA E L ++  +  SD++SFGV+LWEL TL Q P+  ++P ++ A +   G RL
Sbjct: 180 NRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK-DGYRL 238

Query: 172 EIPRNVNPHVASIIEACWA 190
             P N    + +++  CWA
Sbjct: 239 AQPINCPDELFAVMACCWA 257

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  109 bits (274), Expect = 9e-30
 Identities = 63/191 (32%), Positives = 100/191 (52%), Gaps = 7/191 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +L HP +V   G  T+   + +V E++  G L   L     R    +   L M  DV 
Sbjct: 53  MMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQ--RGKFSQETLLGMCLDVC 110

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
           +GM YL   N  ++HRDL + N LV +   VKV DFG++R   +   +S +    P +W 
Sbjct: 111 EGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWS 168

Query: 120 APEVLRDEPSNEKSDIYSFGVILWEL-ATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           +PEV      + KSD++SFGV++WE+ +  + P+ N + ++VV  +   G RL  PR  +
Sbjct: 169 SPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN-AGFRLYKPRLAS 227

Query: 179 PHVASIIEACW 189
             V  +++ CW
Sbjct: 228 QSVYELMQHCW 238

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  109 bits (274), Expect = 2e-29
 Identities = 60/165 (36%), Positives = 88/165 (53%), Gaps = 7/165 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +  HPN+V +  +      L +V  YLS GSL  ++     R  LDE     +  +V 
Sbjct: 53  MSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL 112

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA----NTFLSSKSAAGTP 116
           KG+ YLH      +HRD+K+ N+L+ +  +VK+ DFG+S   A     T    K+  GTP
Sbjct: 113 KGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTP 170

Query: 117 EWMAPEVL-RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160
            WMAPEV+ +    + K+DI+SFG+   ELAT   P+    P +V
Sbjct: 171 CWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV 215

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  108 bits (273), Expect = 2e-29
 Identities = 59/155 (38%), Positives = 88/155 (56%), Gaps = 5/155 (3%)

Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK 61
            +   P IV F GA     ++SI  EY+  GSL ++L    V+  + ER    +A  V K
Sbjct: 54  HKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLK 111

Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAP 121
           G+ YLH     I+HRD+K  N+LV+ +  +K+CDFG+S    N+   +K+  GT  +MAP
Sbjct: 112 GLTYLHE-KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--AKTFVGTSSYMAP 168

Query: 122 EVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN 156
           E ++    + KSDI+S G+ L ELAT + P+   N
Sbjct: 169 ERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEN 203

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  108 bits (272), Expect = 2e-29
 Identities = 52/158 (32%), Positives = 86/158 (54%), Gaps = 13/158 (8%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL-HKPGVREMLDERRRLNMAYDV 59
           +K+L HPN++ ++ +  +   L+IV E    G L R++ H    + ++ ER        +
Sbjct: 56  LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA-----G 114
              + ++H +   I+HRD+K  N+ +     VK+ D GL R     F SSK+ A     G
Sbjct: 116 CSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVG 168

Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
           TP +M+PE + +   N KSDI+S G +L+E+A LQ P+
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  107 bits (269), Expect = 5e-29
 Identities = 53/188 (28%), Positives = 100/188 (53%), Gaps = 4/188 (2%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           + +L    I+ +  +      L+IV EY   G L++LL     R +  E +       + 
Sbjct: 53  LAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPL-PEDQVWRFFIQIL 111

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ +LH +   I+HRD+KS NL +D    VK+ D G+++L ++    + +  GTP +++
Sbjct: 112 LGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLS 169

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PE+  D+P NEKSD+++ GV+L+E  T + P+   N   ++  +  +G    + +  +  
Sbjct: 170 PELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI-IRGVFPPVSQMYSQQ 228

Query: 181 VASIIEAC 188
           +A +I+ C
Sbjct: 229 LAQLIDQC 236

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  107 bits (270), Expect = 7e-29
 Identities = 66/205 (32%), Positives = 99/205 (48%), Gaps = 17/205 (8%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL--HKPGVREM---------LDE 49
           +   +H NIV F G  T+     +V EY+  G L + L  H P    +         L  
Sbjct: 62  LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121

Query: 50  RRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLS 108
            + L +A  +A GM YL  ++   VHRDL + N LV     VK+ DFG+SR +    +  
Sbjct: 122 SQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR 179

Query: 109 SKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGF 166
                  P  WM PE +       +SD++SFGV+LWE+ T  +QPW  L+  +V+  +  
Sbjct: 180 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT- 238

Query: 167 KGKRLEIPRNVNPHVASIIEACWAK 191
           +G+ L+ PR     V  I+  CW +
Sbjct: 239 QGRLLQRPRTCPSEVYDIMLGCWKR 263

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  107 bits (269), Expect = 1e-28
 Identities = 70/204 (34%), Positives = 103/204 (50%), Gaps = 20/204 (9%)

Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL--HKPGVREMLDERR---------- 51
           L+H +IV F G  T+   L +V EY+  G L R L  H P  + +L              
Sbjct: 64  LQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAK-ILAGGEDVAPGQLTLG 122

Query: 52  -RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSS 109
             L +A  +A GM YL   +   VHRDL + N LV +   VK+ DFG+SR + +  +   
Sbjct: 123 QMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 180

Query: 110 KSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFK 167
                 P  WM PE +       +SDI+SFGV+LWE+ T  +QPW  L+  + +  +  +
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT-Q 239

Query: 168 GKRLEIPRNVNPHVASIIEACWAK 191
           G+ LE PR   P V +I++ CW +
Sbjct: 240 GRELERPRTCPPEVYAIMQGCWQR 263

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  106 bits (268), Expect = 1e-28
 Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 13/168 (7%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           + + + P +V    +     NL +V EYL  G L  LL   G    LDE        ++ 
Sbjct: 47  LSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGS---LDEDVARIYIAEIV 103

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--------KANTFLSSKSA 112
             + YLH     I+HRDLK  N+L+D    +K+ DFGLS++          +     K  
Sbjct: 104 LALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161

Query: 113 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160
            GTP+++APEV+  +  ++  D +S G IL+E      P+    P ++
Sbjct: 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI 209

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  107 bits (268), Expect = 1e-28
 Identities = 53/165 (32%), Positives = 91/165 (55%), Gaps = 10/165 (6%)

Query: 1   MKRLRH---PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAY 57
           + +LR    PNI  + G+  + P L I+ EY   GS+ R L K G    + E+    +  
Sbjct: 53  LSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGP---IAEKYISVIIR 108

Query: 58  DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 117
           +V   + Y+H+    ++HRD+K+ N+LV     VK+CDFG++ L         +  GTP 
Sbjct: 109 EVLVALKYIHKV--GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPY 166

Query: 118 WMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161
           WMAPEV+ +    + K+DI+S G+ ++E+AT   P+ +++  + +
Sbjct: 167 WMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM 211

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  106 bits (266), Expect = 2e-28
 Identities = 60/192 (31%), Positives = 111/192 (57%), Gaps = 8/192 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-KPGVREMLDERRRLNMAYDV 59
           MK L+H  +V     VT+   + I+TEY+++GSL   L    G + +L   + ++ +  +
Sbjct: 55  MKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQI 112

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           A+GM Y+ R+N   +HRDL++ N+LV +    K+ DFGL+R+  +   +++  A  P +W
Sbjct: 113 AEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW 170

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            APE +       KSD++SFG++L+E+ T  + P+  ++ + V++A+  +G R+    N 
Sbjct: 171 TAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ-RGYRMPRMENC 229

Query: 178 NPHVASIIEACW 189
              +  I++ CW
Sbjct: 230 PDELYDIMKTCW 241

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  106 bits (266), Expect = 2e-28
 Identities = 59/196 (30%), Positives = 97/196 (49%), Gaps = 13/196 (6%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M RL HP+I+  +GA  +  + ++  E+++ GS+  LL K G      E   +N    + 
Sbjct: 57  MARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA---FKEAVIINYTEQLL 113

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKK-YTVKVCDFGLS-RLKAN---TFLSSKSAAGT 115
           +G++YLH     I+HRD+K  NLL+D     +++ DFG + RL A             GT
Sbjct: 114 RGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGT 171

Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN---LNPAQVVAAVGFKGKRLE 172
             +MAPEVLR E      D++S G ++ E+AT + PW      N   ++  +        
Sbjct: 172 IAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS 231

Query: 173 IPRNVNPHVASIIEAC 188
           IP +++P +  +   C
Sbjct: 232 IPEHLSPGLRDVTLRC 247

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  106 bits (267), Expect = 2e-28
 Identities = 56/192 (29%), Positives = 96/192 (50%), Gaps = 9/192 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + HP++V  +G +     + ++T+ +  G L   +     ++ +  +  LN    +A
Sbjct: 63  MASVDHPHVVRLLG-ICLSSQVQLITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIA 119

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG-TP-EW 118
           KGM+YL  +   +VHRDL + N+LV     VK+ DFGL++L         +  G  P +W
Sbjct: 120 KGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKW 177

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       KSD++S+GV +WEL T   +P+  +   ++   +  KG+RL  P   
Sbjct: 178 MALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLPQPPIC 236

Query: 178 NPHVASIIEACW 189
              V  ++  CW
Sbjct: 237 TIDVYMVLVKCW 248

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  106 bits (265), Expect = 2e-28
 Identities = 56/163 (34%), Positives = 96/163 (58%), Gaps = 6/163 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
           + +++HPNIV F  +  +   L IV EY   G L  R+  + GV  +  E + L+    +
Sbjct: 53  LAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGV--LFSEDQILSWFVQI 110

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFGLSRLKANTFLSSKSAAGTPEW 118
           + G+ ++H R   I+HRD+KS N+ + K   V K+ DFG++R   ++   + +  GTP +
Sbjct: 111 SLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYY 168

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161
           ++PE+ ++ P N K+DI+S G +L+EL TL+ P+   N  Q+V
Sbjct: 169 LSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLV 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  105 bits (265), Expect = 3e-28
 Identities = 60/187 (32%), Positives = 95/187 (50%), Gaps = 9/187 (4%)

Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
            P +V   GA  +   +SIV EY+  GSL  LL K      + E     +A  + KG++Y
Sbjct: 58  SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDY 114

Query: 66  LHR-RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL 124
           LH  R+  I+HRD+K  NLL++ K  VK+ DFG+S++  NT     +  GT  +M+PE +
Sbjct: 115 LHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERI 172

Query: 125 RDEPSNEKSDIYSFGVILWELATLQQPW---GNLNPAQVVAAVGFKGKRLEIPRNVNPHV 181
           + E  +  +DI+S G+ L E A  + P+   G  +  +++ A+             +P  
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEF 232

Query: 182 ASIIEAC 188
              I AC
Sbjct: 233 RDFISAC 239

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  105 bits (264), Expect = 4e-28
 Identities = 61/192 (31%), Positives = 96/192 (50%), Gaps = 8/192 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M++  HP+IV  +G +T+ P + IV E    G L   L     +  LD    +  +Y ++
Sbjct: 61  MRQFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVN--KYSLDLASLILYSYQLS 117

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
             + YL  +    VHRD+ + N+LV     VK+ DFGLSR   +      S    P +WM
Sbjct: 118 TALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWM 175

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE +        SD++ FGV +WE+  L  +P+  +    V+  +   G+RL +P N  
Sbjct: 176 APESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLPMPPNCP 234

Query: 179 PHVASIIEACWA 190
           P + S++  CWA
Sbjct: 235 PTLYSLMTKCWA 246

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score =  106 bits (265), Expect = 4e-28
 Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 21/210 (10%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRR-------- 52
           M RL++PNI+  +G       L ++TEY+  G L + L +  +                 
Sbjct: 71  MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130

Query: 53  -LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSK 110
            L MA  +A GM YL   N   VHRDL + N LV   YT+K+ DFG+SR L +  +   +
Sbjct: 131 LLYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188

Query: 111 SAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL--QQPWGNLNPAQVVAAVG-- 165
             A  P  WMA E +        SD+++FGV LWE+ TL  +QP+  L+  QV+   G  
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEF 248

Query: 166 FKGKRLEIPRNVNP----HVASIIEACWAK 191
           F+ +  +I  +  P     V  ++  CW++
Sbjct: 249 FRNQGRQIYLSQTPLCPSPVFKLMMRCWSR 278

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  105 bits (263), Expect = 5e-28
 Identities = 49/160 (30%), Positives = 94/160 (58%), Gaps = 5/160 (3%)

Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDVAK 61
            L+HPNI+ +         L I  EY + G+LY +++ + G  ++ +E   L   + +  
Sbjct: 55  LLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKG--QLFEEEMVLWYLFQIVS 112

Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAP 121
            ++Y+H+    I+HRD+K+ N+ + K   +K+ DFG+S++  + +  +++  GTP +M+P
Sbjct: 113 AVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSP 170

Query: 122 EVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161
           E+ +    N KSDI++ G +L+EL TL++ +   NP  +V
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLV 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  105 bits (262), Expect = 6e-28
 Identities = 63/191 (32%), Positives = 98/191 (51%), Gaps = 7/191 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K+  HPNIV  +G  TQ   + IV E +  G     L K   ++ L  ++ +  A D A
Sbjct: 46  LKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKK--KDELKTKQLVKFALDAA 103

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
            GM YL  +N   +HRDL + N LV +   +K+ DFG+SR + +   SS      P +W 
Sbjct: 104 AGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWT 161

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE L     + +SD++S+G++LWE  +L   P+  +   Q    V  KG R+  P+   
Sbjct: 162 APEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCP 220

Query: 179 PHVASIIEACW 189
             V  +++ CW
Sbjct: 221 DDVYKVMQRCW 231

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  107 bits (266), Expect = 8e-28
 Identities = 62/195 (31%), Positives = 93/195 (47%), Gaps = 13/195 (6%)

Query: 1   MKRLRHP-NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           +  L HP NIV          +L +V EY+  GSL  LL K G +  L E   L +   +
Sbjct: 51  LASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQI 110

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT-VKVCDFGLSRLKANTFLSS------KSA 112
              + YLH +   I+HRD+K  N+L+D+    VK+ DFGL++L  +   +S       ++
Sbjct: 111 LSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTS 168

Query: 113 AGTPEWMAPEVLRD---EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK 169
            GTP +MAPEVL       ++  SDI+S G+ L+EL T   P+     +   +       
Sbjct: 169 VGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL 228

Query: 170 RLEIPRNVNPHVASI 184
            L  P   +P   S 
Sbjct: 229 ELPTPSLASPLSPSN 243

Length = 384

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score =  106 bits (265), Expect = 8e-28
 Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 19/201 (9%)

Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK---PGV----------REMLDERR 51
           +H NI+  +GA TQ   L ++ EY S+G+L   L     PG+           E L  + 
Sbjct: 76  KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135

Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
            ++ AY VA+GM YL  +    +HRDL + N+LV +   +K+ DFGL+R   N     K+
Sbjct: 136 LVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193

Query: 112 AAG--TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             G    +WMAPE L D     +SD++SFGV+LWE+ TL   P+  + P + +  +  +G
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEELFKLLKEG 252

Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R++ P N    +  I+  CW
Sbjct: 253 HRMDKPANCTHELYMIMRECW 273

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  104 bits (261), Expect = 9e-28
 Identities = 69/193 (35%), Positives = 107/193 (55%), Gaps = 7/193 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK+LRH  +V     V++ P + IVTEY+S+GSL   L K  + + L   + ++MA  +A
Sbjct: 55  MKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIA 112

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
            GM Y+ R N   VHRDL++ N+LV +    KV DFGL+RL  +   +++  A  P +W 
Sbjct: 113 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 170

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE         KSD++SFG++L EL T  + P+  +   +V+  V  +G R+  P    
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 229

Query: 179 PHVASIIEACWAK 191
             +  ++  CW K
Sbjct: 230 ESLHDLMCQCWRK 242

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score =  105 bits (262), Expect = 1e-27
 Identities = 69/200 (34%), Positives = 96/200 (48%), Gaps = 20/200 (10%)

Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM-------------LDERR 51
            HPNI+  +GA      L I  EY   G+L   L K  V E              L  ++
Sbjct: 61  HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120

Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
            L  A DVA GM YL  +    +HRDL + N+LV +    K+ DFGLSR         K+
Sbjct: 121 LLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKT 176

Query: 112 AAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGK 169
               P  WMA E L       KSD++SFGV+LWE+ +L   P+  +  A++   +  +G 
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGY 235

Query: 170 RLEIPRNVNPHVASIIEACW 189
           R+E PRN +  V  ++  CW
Sbjct: 236 RMEKPRNCDDEVYELMRQCW 255

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  104 bits (261), Expect = 1e-27
 Identities = 58/195 (29%), Positives = 97/195 (49%), Gaps = 12/195 (6%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L+H NIV ++G       +SI  E++  GS+  +L++ G    L E         + 
Sbjct: 56  LKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGP---LPEPVFCKYTKQIL 112

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS------KSAAG 114
            G+ YLH     +VHRD+K  N+++     +K+ DFG +R  A   L        KS  G
Sbjct: 113 DGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170

Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG-FKGKRLEI 173
           TP WMAPEV+ +     KSDI+S G  ++E+AT + P  +++    +  +G  +G    +
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRL 230

Query: 174 PRNVNPHVASIIEAC 188
           P + +      + +C
Sbjct: 231 PDSFSAAAIDFVTSC 245

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  104 bits (261), Expect = 1e-27
 Identities = 54/196 (27%), Positives = 96/196 (48%), Gaps = 10/196 (5%)

Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL--YRLLHKPGVREM----LDERRRLNMA 56
           +L H N+V  +G   +     ++ EY   G L  +    K    ++    L  ++++ + 
Sbjct: 64  KLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123

Query: 57  YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 116
             +A GM++L   N   VHRDL + N LV  +  VKV    LS+   N+       A  P
Sbjct: 124 TQIALGMDHLS--NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP 181

Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIP 174
             W+APE ++++  + KSD++SFGV++WE+ T  + P+  L+  +V+  +      L +P
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP 241

Query: 175 RNVNPHVASIIEACWA 190
                 +  ++  CWA
Sbjct: 242 EGCPSRLYKLMTRCWA 257

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  104 bits (261), Expect = 2e-27
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 27/215 (12%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-----------KPGVREML-- 47
           +K++ HP+++   GA +Q   L ++ EY   GSL   L              G R     
Sbjct: 57  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYL 116

Query: 48  --DERRRLNM------AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS 99
              + R L M      A+ +++GM YL      +VHRDL + N+LV +   +K+ DFGLS
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAEGRKMKISDFGLS 174

Query: 100 R--LKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLN 156
           R   + ++++         +WMA E L D     +SD++SFGV+LWE+ TL   P+  + 
Sbjct: 175 RDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234

Query: 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK 191
           P ++   +   G R+E P N +  + +++  CW +
Sbjct: 235 PERLFNLLK-TGYRMERPENCSEEMYNLMLTCWKQ 268

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  103 bits (258), Expect = 2e-27
 Identities = 66/193 (34%), Positives = 107/193 (55%), Gaps = 7/193 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK+LRH  +V     V++ P + IVTE++ +GSL   L K G  + L   + ++MA  +A
Sbjct: 55  MKKLRHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIA 112

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
            GM Y+ R N   +HRDL++ N+LV      K+ DFGL+RL  +   +++  A  P +W 
Sbjct: 113 DGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWT 170

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE         KSD++SFG++L EL T  + P+  +   +V+  V  +G R+  P+   
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCP 229

Query: 179 PHVASIIEACWAK 191
             +  +++ CW K
Sbjct: 230 ESLHELMKLCWKK 242

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 3e-27
 Identities = 67/199 (33%), Positives = 99/199 (49%), Gaps = 20/199 (10%)

Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM-------------LDERRR 52
           HPNI+  +GA      L +  EY   G+L   L K  V E              L  ++ 
Sbjct: 55  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114

Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
           L+ A DVA+GM+YL ++    +HRDL + N+LV + Y  K+ DFGLSR         K+ 
Sbjct: 115 LHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTM 170

Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 170
              P  WMA E L        SD++S+GV+LWE+ +L   P+  +  A++   +  +G R
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYR 229

Query: 171 LEIPRNVNPHVASIIEACW 189
           LE P N +  V  ++  CW
Sbjct: 230 LEKPLNCDDEVYDLMRQCW 248

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  102 bits (256), Expect = 5e-27
 Identities = 52/158 (32%), Positives = 95/158 (60%), Gaps = 7/158 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDV 59
           +  ++HPNIV +  +  +  NL IV +Y   G LY+ ++   GV  +  E + L+    +
Sbjct: 53  LSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGV--LFPEDQILDWFVQI 110

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
              + ++H R   I+HRD+KS N+ + K  T+K+ DFG++R+  +T   +++  GTP ++
Sbjct: 111 CLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYL 168

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPW--GNL 155
           +PE+  + P N KSDI++ G +L+E+ TL+  +  GN+
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  103 bits (258), Expect = 5e-27
 Identities = 69/207 (33%), Positives = 103/207 (49%), Gaps = 19/207 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL--HKPGVREMLDERRR------ 52
           +  L+H +IV F G       L +V EY+  G L + L  H P    ++D + R      
Sbjct: 61  LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 120

Query: 53  -----LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTF 106
                L++A  +A GM YL  ++   VHRDL + N LV     VK+ DFG+SR + +  +
Sbjct: 121 GLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 178

Query: 107 LSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
                    P  WM PE +       +SD++SFGVILWE+ T  +QPW  L+  +V+  +
Sbjct: 179 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238

Query: 165 GFKGKRLEIPRNVNPHVASIIEACWAK 191
             +G+ LE PR     V  I+  CW +
Sbjct: 239 T-QGRVLERPRVCPKEVYDIMLGCWQR 264

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  102 bits (258), Expect = 5e-27
 Identities = 47/153 (30%), Positives = 70/153 (45%), Gaps = 16/153 (10%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L+HPNIV  +  +     L +V EY     L + L K      L      ++ Y + 
Sbjct: 52  LKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGP--LSPNLIKSIMYQLL 108

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 117
           +G+ Y H     I+HRDLK  N+L+++   +K+ DFGL+R              T E   
Sbjct: 109 RGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLAR-----AFGIPLRTYTHEVVT 161

Query: 118 -WM-APEVLRDEPSNEKS-DIYSFGVILWELAT 147
            W  APE+L        + DI+S G I  E+ T
Sbjct: 162 LWYRAPEILLGSKHYSTAVDIWSVGCIFAEMIT 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score =  103 bits (257), Expect = 5e-27
 Identities = 67/205 (32%), Positives = 101/205 (49%), Gaps = 25/205 (12%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-------------PGVREML 47
           MK     ++V  +G V++     +V E ++ G L   L               P ++EM+
Sbjct: 63  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 122

Query: 48  DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 107
                  MA ++A GM YL+ +    VHRDL + N +V   +TVK+ DFG++R    T  
Sbjct: 123 ------QMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 174

Query: 108 SSKSAAG--TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
             K   G     WMAPE L+D      SD++SFGV+LWE+ +L +QP+  L+  QV+  V
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 234

Query: 165 GFKGKRLEIPRNVNPHVASIIEACW 189
              G  L+ P N    V  ++  CW
Sbjct: 235 -MDGGYLDQPDNCPERVTDLMRMCW 258

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  102 bits (255), Expect = 8e-27
 Identities = 53/152 (34%), Positives = 83/152 (54%), Gaps = 5/152 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-PGVREMLDERRRLNMAYDV 59
           +  + HPNI+ +  A      L IV EY   G L + + K    R+++ E+    +   +
Sbjct: 53  LASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL 112

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
            +G+  LH +   I+HRDLKS N+L+     VK+ D G+S++        K+  GTP +M
Sbjct: 113 LRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA--KTQIGTPHYM 168

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQP 151
           APEV +  P + KSDI+S G +L+E+AT   P
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score =  103 bits (257), Expect = 8e-27
 Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 19/201 (9%)

Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK---PGVREMLDERR---------- 51
           +H NI+  +GA TQ   L ++ EY S+G+L   L     PG+    D  R          
Sbjct: 79  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138

Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
            ++  Y VA+GM YL  +    +HRDL + N+LV +   +K+ DFGL+R   N     K+
Sbjct: 139 LVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196

Query: 112 AAG--TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             G    +WMAPE L D     +SD++SFGV++WE+ TL   P+  + P + +  +  +G
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEG 255

Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R++ P N    +  ++  CW
Sbjct: 256 HRMDKPANCTNELYMMMRDCW 276

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  102 bits (255), Expect = 9e-27
 Identities = 63/199 (31%), Positives = 101/199 (50%), Gaps = 19/199 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLS-IVTEYLSRGSLYRLL----HKPGVREMLDERRRLNM 55
           MK   HPN++  +G          +V  Y+  G L   +    H P V++++        
Sbjct: 50  MKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLI------GF 103

Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR---LKANTFLSSKSA 112
              VAKGM YL  +    VHRDL + N ++D+ +TVKV DFGL+R    K    + + + 
Sbjct: 104 GLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTG 161

Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 170
           A  P +WMA E L+ +    KSD++SFGV+LWEL T    P+ +++   +   +  +G+R
Sbjct: 162 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL-LQGRR 220

Query: 171 LEIPRNVNPHVASIIEACW 189
           L  P      +  ++ +CW
Sbjct: 221 LLQPEYCPDPLYEVMLSCW 239

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score =  102 bits (256), Expect = 1e-26
 Identities = 67/199 (33%), Positives = 99/199 (49%), Gaps = 20/199 (10%)

Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM-------------LDERRR 52
           HPNI+  +GA      L +  EY   G+L   L K  V E              L  ++ 
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
           L+ A DVA+GM+YL ++    +HRDL + N+LV + Y  K+ DFGLSR         K+ 
Sbjct: 127 LHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTM 182

Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 170
              P  WMA E L        SD++S+GV+LWE+ +L   P+  +  A++   +  +G R
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYR 241

Query: 171 LEIPRNVNPHVASIIEACW 189
           LE P N +  V  ++  CW
Sbjct: 242 LEKPLNCDDEVYDLMRQCW 260

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score =  102 bits (256), Expect = 1e-26
 Identities = 67/201 (33%), Positives = 106/201 (52%), Gaps = 19/201 (9%)

Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH---KPGVR----------EMLDERR 51
           +H NI+  +GA TQ   L ++ EY S+G+L   L     PG+           E L  + 
Sbjct: 82  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141

Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
            ++ AY VA+GM YL  +    +HRDL + N+LV +   +K+ DFGL+R   +     K+
Sbjct: 142 LVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199

Query: 112 AAG--TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             G    +WMAPE L D     +SD++SFGV+LWE+ TL   P+  + P + +  +  +G
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEG 258

Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R++ P N    +  ++  CW
Sbjct: 259 HRMDKPSNCTNELYMMMRDCW 279

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  101 bits (253), Expect = 2e-26
 Identities = 63/179 (35%), Positives = 94/179 (52%), Gaps = 17/179 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ L+HPN+V + G       + I  EY S G+L  LL    +   LDE   +   Y + 
Sbjct: 53  LELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRI---LDE--HVIRVYTLQ 107

Query: 61  --KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANT---FLSSKSAAG 114
             +G+ YLH     IVHRD+K  N+ +D    +K+ DFG + +LK NT       +S AG
Sbjct: 108 LLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAG 165

Query: 115 TPEWMAPEVLRDEPSNEK---SDIYSFGVILWELATLQQPWGNL-NPAQVVAAVGFKGK 169
           TP +MAPEV+           +DI+S G ++ E+AT ++PW  L N  Q++  VG   K
Sbjct: 166 TPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHK 224

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  101 bits (252), Expect = 2e-26
 Identities = 60/201 (29%), Positives = 101/201 (50%), Gaps = 15/201 (7%)

Query: 1   MKRLRHPNIVLFMG------AVTQPPNLSIVTEYLSRGSLYRLL---HKPGVREMLDERR 51
           MK   HPN++  +G      ++ + P   ++  ++  G L+  L      G+ E L  + 
Sbjct: 55  MKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQT 114

Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSK 110
            L    D+A GM YL  RN   +HRDL + N ++ +  TV V DFGLS+ + +  +    
Sbjct: 115 LLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQG 172

Query: 111 SAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             A  P +W+A E L D     KSD+++FGV +WE+AT  Q P+  +   ++   +   G
Sbjct: 173 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL-RHG 231

Query: 169 KRLEIPRNVNPHVASIIEACW 189
            RL+ P +    +  ++ +CW
Sbjct: 232 NRLKQPEDCLDELYDLMYSCW 252

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score =  101 bits (252), Expect = 3e-26
 Identities = 66/205 (32%), Positives = 104/205 (50%), Gaps = 25/205 (12%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-------------PGVREML 47
           MK     ++V  +G V+Q     ++ E ++RG L   L               P +++M+
Sbjct: 63  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122

Query: 48  DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 107
                  MA ++A GM YL+      VHRDL + N +V + +TVK+ DFG++R    T  
Sbjct: 123 ------QMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 174

Query: 108 SSKSAAG--TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
             K   G     WM+PE L+D      SD++SFGV+LWE+ATL +QP+  ++  QV+  V
Sbjct: 175 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234

Query: 165 GFKGKRLEIPRNVNPHVASIIEACW 189
             +G  L+ P N    +  ++  CW
Sbjct: 235 -MEGGLLDKPDNCPDMLFELMRMCW 258

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  101 bits (253), Expect = 3e-26
 Identities = 56/156 (35%), Positives = 87/156 (55%), Gaps = 11/156 (7%)

Query: 1   MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSL---YRLLHKPGVREMLDERRRLNM 55
            K  + P IV + GA       ++ I  EY   GSL   Y+ + K G R  + E+    +
Sbjct: 53  NKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGR--IGEKVLGKI 110

Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT 115
           A  V KG++YLH R   I+HRD+K  N+L+ +K  VK+CDFG+S    N+   + +  GT
Sbjct: 111 AESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL--AGTFTGT 166

Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQP 151
             +MAPE ++ +P +  SD++S G+ L E+A  + P
Sbjct: 167 SFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score =  101 bits (253), Expect = 3e-26
 Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 19/201 (9%)

Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK---PGV----------REMLDERR 51
           +H NI+  +G  TQ   L ++ EY ++G+L   L     PG            E L  + 
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
            ++ AY VA+GM YL  R    +HRDL + N+LV +   +K+ DFGL+R   +     K+
Sbjct: 136 LVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193

Query: 112 AAG--TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
           + G    +WMAPE L D     +SD++SFG+++WE+ TL   P+  + P + +  +  +G
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI-PVEELFKLLREG 252

Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R++ P N    +  ++  CW
Sbjct: 253 HRMDKPSNCTHELYMLMRECW 273

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score =  101 bits (252), Expect = 4e-26
 Identities = 68/207 (32%), Positives = 107/207 (51%), Gaps = 20/207 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL--HKPGVREMLDERRRL----- 53
           M RL+ PNI+  +        L ++TEY+  G L + L  H+P       +   +     
Sbjct: 73  MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132

Query: 54  -NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKS 111
             MA  +A GM YL   N   VHRDL + N LV K YT+K+ DFG+SR L +  +   + 
Sbjct: 133 IFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQG 190

Query: 112 AAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL--QQPWGNLNPAQVVAAVG--F 166
            A  P  WM+ E +        SD+++FGV LWE+ TL  +QP+  L+  QV+   G  F
Sbjct: 191 RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFF 250

Query: 167 K--GKRLEIPR-NVNPH-VASIIEACW 189
           +  G+++ +P+  + P  +  ++ +CW
Sbjct: 251 RDQGRQVYLPKPALCPDSLYKLMLSCW 277

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score =  100 bits (250), Expect = 5e-26
 Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 20/206 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL--------------HKPGVREM 46
           M  L HPNIV  +G VTQ   + ++ EYL++G L+  L                  V+  
Sbjct: 61  MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120

Query: 47  LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANT 105
           LD    L++A  +A GM YL       VH+DL + N+L+ ++  VK+ D GLSR + +  
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIGEQLHVKISDLGLSREIYSAD 178

Query: 106 FLSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ-QPWGNLNPAQVVAA 163
           +   +  +  P  WM PE +     +  SDI+SFGV+LWE+ +   QP+   +  +V+  
Sbjct: 179 YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238

Query: 164 VGFKGKRLEIPRNVNPHVASIIEACW 189
           V  K + L    +  P + S++  CW
Sbjct: 239 VR-KRQLLPCSEDCPPRMYSLMTECW 263

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 98.9 bits (246), Expect = 1e-25
 Identities = 56/192 (29%), Positives = 106/192 (55%), Gaps = 5/192 (2%)

Query: 1   MKRLRHPNIVLFMGAVT-QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           + +L+HPNIV +  +   +   L IV  +   G LY  L K    ++L E + +     +
Sbjct: 53  LSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLPENQVVEWFVQI 111

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
           A  + YLH ++  I+HRDLK+ N+ + +   +KV D G++R+  N    + +  GTP +M
Sbjct: 112 AMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYM 169

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 179
           +PE+  ++P N KSD+++ G  ++E+ATL+  +   +   +V  +  +GK   +P++ +P
Sbjct: 170 SPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI-IEGKLPPMPKDYSP 228

Query: 180 HVASIIEACWAK 191
            +  +I    +K
Sbjct: 229 ELGELIATMLSK 240

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 98.7 bits (246), Expect = 3e-25
 Identities = 69/210 (32%), Positives = 102/210 (48%), Gaps = 24/210 (11%)

Query: 1   MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +K L+H NIV + G        NL +V EYL  GSL   L K   RE LD R+ L  A  
Sbjct: 59  LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQ 116

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP 116
           + KGM YL  +    VHRDL + N+LV+ +  VK+ DFGL+++  +   +   +    +P
Sbjct: 117 ICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESP 174

Query: 117 E-WMAPEVLRDEPSNEKSDIYSFGVILWELAT-----------LQQPWGNLNPAQVV--- 161
             W APE L +   +  SD++SFGV+L+EL T             +  GN    Q++   
Sbjct: 175 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH 234

Query: 162 -AAVGFKGKRLEIPRNVNPHVASIIEACWA 190
              +     RL  P      + +I++ CW 
Sbjct: 235 LIELLKNNGRLPAPPGCPAEIYAIMKECWN 264

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 98.1 bits (245), Expect = 4e-25
 Identities = 65/195 (33%), Positives = 98/195 (50%), Gaps = 33/195 (16%)

Query: 6   HPNIVLFMGAVTQ--PPN----LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLN---MA 56
           HPNI  F GA  +  PP     L +V E    GS+  L     V+ +  + +RL    +A
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDL-----VKGLRKKGKRLKEEWIA 116

Query: 57  Y---DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
           Y   +  +G+ YLH     ++HRD+K  N+L+ K   VK+ DFG+S    +T     +  
Sbjct: 117 YILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI 174

Query: 114 GTPEWMAPEVL-----RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG 168
           GTP WMAPEV+      D   + +SD++S G+   ELA  + P  +++P + +    FK 
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL----FK- 229

Query: 169 KRLEIPRNVNPHVAS 183
               IPRN  P + S
Sbjct: 230 ----IPRNPPPTLKS 240

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 97.8 bits (243), Expect = 4e-25
 Identities = 63/193 (32%), Positives = 100/193 (51%), Gaps = 23/193 (11%)

Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P I  + G+  +   L I+ EYL  GS   LL KPG    L+E     +  ++ KG++YL
Sbjct: 62  PYITRYYGSYLKGTKLWIIMEYLGGGSALDLL-KPGP---LEETYIATILREILKGLDYL 117

Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 126
           H      +HRD+K+ N+L+ ++  VK+ DFG++    +T +   +  GTP WMAPEV++ 
Sbjct: 118 HSERK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 175

Query: 127 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHV----- 181
              + K+DI+S G+   ELA  + P  +L+P +V+           IP+N  P +     
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---------FLIPKNSPPTLEGQYS 226

Query: 182 ---ASIIEACWAK 191
                 +EAC  K
Sbjct: 227 KPFKEFVEACLNK 239

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 97.3 bits (243), Expect = 6e-25
 Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 28/207 (13%)

Query: 1   MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           + RL  HP I+          NL  V EY   G L + + K G    LDE+     A ++
Sbjct: 55  LTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS---LDEKCTRFYAAEI 111

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----------KANTFLSS 109
              + YLH +   I+HRDLK  N+L+DK   +K+ DFG +++          K +     
Sbjct: 112 LLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169

Query: 110 KSAA----------GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159
                         GT E+++PE+L ++P+ + SD+++ G I++++ T + P+   N   
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229

Query: 160 VVAAVGFKGKRLEIPRNVNPHVASIIE 186
               +         P N  P    +IE
Sbjct: 230 TFQKI--LKLEYSFPPNFPPDAKDLIE 254

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 96.9 bits (241), Expect = 7e-25
 Identities = 58/193 (30%), Positives = 108/193 (55%), Gaps = 10/193 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +L +P IV  +G V +   L +V E  S G L + L   G ++ +     + + + V+
Sbjct: 49  MHQLDNPYIVRMIG-VCEAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVS 105

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA--NTFLSSKSAAGTP-E 117
            GM YL  +N   VHRDL + N+L+  ++  K+ DFGLS+     +++  ++SA   P +
Sbjct: 106 MGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK 163

Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWE-LATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE +     + +SD++S+G+ +WE  +  Q+P+  +   +V++ +  +GKRL+ P  
Sbjct: 164 WYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAE 222

Query: 177 VNPHVASIIEACW 189
             P + ++++ CW
Sbjct: 223 CPPEMYALMKDCW 235

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 97.1 bits (241), Expect = 1e-24
 Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 16/204 (7%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL--HKPGVREM--------LDER 50
           +  L+H +IV F G   +   L +V EY+  G L + L  H P    M        L + 
Sbjct: 61  LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120

Query: 51  RRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSS 109
           + L++A  +A GM YL  ++   VHRDL + N LV +   VK+ DFG+SR + +  +   
Sbjct: 121 QMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV 178

Query: 110 KSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFK 167
                 P  WM PE +       +SD++S GV+LWE+ T  +QPW  L+  +V+  +  +
Sbjct: 179 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT-Q 237

Query: 168 GKRLEIPRNVNPHVASIIEACWAK 191
           G+ L+ PR     V  ++  CW +
Sbjct: 238 GRVLQRPRTCPKEVYDLMLGCWQR 261

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 95.9 bits (238), Expect = 2e-24
 Identities = 60/192 (31%), Positives = 110/192 (57%), Gaps = 9/192 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-KPGVREMLDERRRLNMAYDV 59
           MK L+H  +V     VT+ P + I+TE++++GSL   L    G ++ L   + ++ +  +
Sbjct: 55  MKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQI 111

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           A+GM ++ +RN   +HRDL++ N+LV      K+ DFGL+R+  +   +++  A  P +W
Sbjct: 112 AEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW 169

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            APE +       KSD++SFG++L E+ T  + P+  ++  +V+ A+  +G R+  P N 
Sbjct: 170 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENC 228

Query: 178 NPHVASIIEACW 189
              + +I+  CW
Sbjct: 229 PEELYNIMMRCW 240

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 95.8 bits (238), Expect = 2e-24
 Identities = 54/160 (33%), Positives = 87/160 (54%), Gaps = 8/160 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           + +++HPNIV F  +     +L IV EY   G L + + K    ++  E   L     + 
Sbjct: 52  LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKI-KLQRGKLFPEDTILQWFVQMC 110

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ ++H +   ++HRD+KS N+ + +   VK+ DFG +RL  +    + +  GTP ++ 
Sbjct: 111 LGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVP 168

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQP-----WGNL 155
           PE+  + P N KSDI+S G IL+EL TL+ P     W NL
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 96.3 bits (239), Expect = 2e-24
 Identities = 60/185 (32%), Positives = 99/185 (53%), Gaps = 7/185 (3%)

Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P +  + G+  +   L I+ EYL  GS   LL +PG    LDE +   +  ++ KG++YL
Sbjct: 62  PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGP---LDETQIATILREILKGLDYL 117

Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 126
           H      +HRD+K+ N+L+ +   VK+ DFG++    +T +   +  GTP WMAPEV++ 
Sbjct: 118 HSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 175

Query: 127 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIE 186
              + K+DI+S G+   ELA  + P   L+P +V+  +  K     +  N +  +   +E
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVE 234

Query: 187 ACWAK 191
           AC  K
Sbjct: 235 ACLNK 239

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 95.7 bits (238), Expect = 2e-24
 Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 9/195 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +  HPNI+   G VT+   + IVTEY+  GSL   L K   +  + +   + M   +A
Sbjct: 59  MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL--VGMLRGIA 116

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP---E 117
            GM YL   +   VHRDL + N+LV+     KV DFGLSR+  +   ++ +  G      
Sbjct: 117 SGMKYL--SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 174

Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE +        SD++S+G+++WE+ +  ++P+  ++   V+ A+  +G RL  P +
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EGYRLPAPMD 233

Query: 177 VNPHVASIIEACWAK 191
               +  ++  CW K
Sbjct: 234 CPAALHQLMLDCWQK 248

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 95.6 bits (238), Expect = 3e-24
 Identities = 48/158 (30%), Positives = 75/158 (47%), Gaps = 9/158 (5%)

Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P +     +      L +V EYL+ G    L+   G    L E        +V  G+  L
Sbjct: 57  PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG---LPEDWAKQYIAEVVLGVEDL 113

Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 126
           H+R   I+HRD+K  NLL+D+   +K+ DFGLSR      L +K   GTP+++APE +  
Sbjct: 114 HQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNG----LENKKFVGTPDYLAPETILG 167

Query: 127 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
              ++ SD +S G +++E      P+    P  V   +
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI 205

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 95.6 bits (238), Expect = 3e-24
 Identities = 52/159 (32%), Positives = 86/159 (54%), Gaps = 9/159 (5%)

Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYL---SRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           ++LRHPNIV +     +   L IV + +     G  +  L +   R    E R  N+   
Sbjct: 64  EQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQR--FTEERIWNIFVQ 121

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA-NTFLSSKSAAGTPE 117
           +   + YLH+    IVHRDL   N+++ +   V + DFGL++ K   + L   S  GT  
Sbjct: 122 MVLALRYLHKEKR-IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL--TSVVGTIL 178

Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN 156
           +  PE++++EP  EK+D+++FG IL+++ TLQ P+ + N
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN 217

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 95.1 bits (236), Expect = 4e-24
 Identities = 61/185 (32%), Positives = 88/185 (47%), Gaps = 10/185 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +K L H  IV + G +  P    LSI  E++  GS+   L   G    L E         
Sbjct: 58  LKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA---LTENVTRKYTRQ 114

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS---KSAAGT 115
           + +G++YLH     IVHRD+K  N+L D    VK+ DFG S+      LS    KS  GT
Sbjct: 115 ILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGT 172

Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 175
           P WM+PEV+  E    K+DI+S G  + E+ T + PW        +  +  +     +P 
Sbjct: 173 PYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPP 232

Query: 176 NVNPH 180
           +V+ H
Sbjct: 233 HVSDH 237

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 95.0 bits (236), Expect = 9e-24
 Identities = 61/188 (32%), Positives = 89/188 (47%), Gaps = 28/188 (14%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRR-------- 52
           + RL+ PNI+  +G       L ++TEY+  G L + L       + D+           
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSS---HHLDDKEENGNDAVPPA 129

Query: 53  -----------LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR- 100
                      L++A  +A GM YL   N   VHRDL + N LV +  T+K+ DFG+SR 
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENLTIKIADFGMSRN 187

Query: 101 LKANTFLSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL--QQPWGNLNP 157
           L A  +   +  A  P  WMA E +        SD+++FGV LWE+  L  +QP+G L  
Sbjct: 188 LYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTD 247

Query: 158 AQVVAAVG 165
            QV+   G
Sbjct: 248 EQVIENAG 255

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 94.3 bits (234), Expect = 1e-23
 Identities = 59/193 (30%), Positives = 97/193 (50%), Gaps = 23/193 (11%)

Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P +  + G+  +   L I+ EYL  GS   LL         DE +   M  ++ KG++YL
Sbjct: 62  PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP----FDEFQIATMLKEILKGLDYL 117

Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 126
           H      +HRD+K+ N+L+ ++  VK+ DFG++    +T +   +  GTP WMAPEV++ 
Sbjct: 118 HSEKK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQ 175

Query: 127 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVA---- 182
              + K+DI+S G+   ELA  + P  +++P +V+           IP+N  P +     
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL---------FLIPKNNPPTLTGEFS 226

Query: 183 ----SIIEACWAK 191
                 I+AC  K
Sbjct: 227 KPFKEFIDACLNK 239

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 94.0 bits (233), Expect = 1e-23
 Identities = 58/164 (35%), Positives = 85/164 (51%), Gaps = 8/164 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK  +H NIV + G+  +   L I  E+   GSL  + H  G    L E +   ++ +  
Sbjct: 60  MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP---LSESQIAYVSRETL 116

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +G+ YLH +    +HRD+K  N+L+     VK+ DFG+S     T    KS  GTP WMA
Sbjct: 117 QGLYYLHSKGK--MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMA 174

Query: 121 PEVL---RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161
           PEV    R    N+  DI++ G+   ELA LQ P  +L+P + +
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 93.9 bits (233), Expect = 1e-23
 Identities = 60/194 (30%), Positives = 98/194 (50%), Gaps = 11/194 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-KPGVREMLDERRRLNMAYDV 59
           M +  H NI+   G VT+     I+TEY+  G+L + L    G        + + M   +
Sbjct: 60  MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY---QLVGMLRGI 116

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--- 116
           A GM YL   N   VHRDL + N+LV+     KV DFGLSR+  +    + + +G     
Sbjct: 117 AAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPI 174

Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPR 175
            W APE +        SD++SFG+++WE+ +  ++P+ +++  +V+ A+   G RL  P 
Sbjct: 175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-DGFRLPAPM 233

Query: 176 NVNPHVASIIEACW 189
           +    V  ++  CW
Sbjct: 234 DCPSAVYQLMLQCW 247

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 93.5 bits (232), Expect = 1e-23
 Identities = 59/193 (30%), Positives = 105/193 (54%), Gaps = 11/193 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M++L +P IV  +G + +  +  +V E    G L + L K    + + E+    + + V+
Sbjct: 50  MQQLDNPYIVRMIG-ICEAESWMLVMELAELGPLNKFLQK---NKHVTEKNITELVHQVS 105

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKAN-TFLSSKSAAGTP-E 117
            GM YL   N   VHRDL + N+L+  ++  K+ DFGLS+ L A+  +  +K+    P +
Sbjct: 106 MGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK 163

Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE +     + KSD++SFGV++WE  +  Q+P+  +   +V   +   G+R+E P+ 
Sbjct: 164 WYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQR 222

Query: 177 VNPHVASIIEACW 189
             P +  +++ CW
Sbjct: 223 CPPEMYDLMKLCW 235

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 93.5 bits (232), Expect = 2e-23
 Identities = 47/153 (30%), Positives = 84/153 (54%), Gaps = 3/153 (1%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL-HKPGVREMLDERRRLNMAYDV 59
           +K+L HPN++ +  +  +   L+IV E    G L R++ H    + ++ E+        +
Sbjct: 56  LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQL 115

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
              + ++H R   ++HRD+K  N+ +     VK+ D GL R  ++   ++ S  GTP +M
Sbjct: 116 CSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +PE + +   N KSDI+S G +L+E+A LQ P+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 93.2 bits (231), Expect = 2e-23
 Identities = 59/183 (32%), Positives = 87/183 (47%), Gaps = 10/183 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +K LRH  IV + G +  P    LSI  EY+  GS+   L   G    L E         
Sbjct: 58  LKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA---LTENVTRRYTRQ 114

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS---KSAAGT 115
           + +G++YLH     IVHRD+K  N+L D    VK+ DFG S+      +S    KS  GT
Sbjct: 115 ILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGT 172

Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 175
           P WM+PEV+  E    K+D++S    + E+ T + PW        +  +  +  +  +P 
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPD 232

Query: 176 NVN 178
            V+
Sbjct: 233 GVS 235

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 93.3 bits (232), Expect = 2e-23
 Identities = 56/161 (34%), Positives = 86/161 (53%), Gaps = 24/161 (14%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK--PGVREMLDERRRLNMAYD 58
           M   R P IV F GA     N+ +  E++  GSL R+  K  P   E+L +     +A  
Sbjct: 57  MHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK-----IAVA 111

Query: 59  VAKGMNYL---HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS----RLKANTFLSSKS 111
           V +G+ YL   HR    I+HRD+K  N+LV+ +  +K+CDFG+S       A+TF+    
Sbjct: 112 VVEGLTYLYNVHR----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV---- 163

Query: 112 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
             GT  +M+PE ++      KSD++S G+ + ELA  + P+
Sbjct: 164 --GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPF 202

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 92.8 bits (230), Expect = 4e-23
 Identities = 58/172 (33%), Positives = 88/172 (51%), Gaps = 23/172 (13%)

Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGS-------LYRLLHKPGVREMLDERRRLNMAYD 58
           HPNIV  + A     NL I+ E+ + G+       L R L +P +R +  +         
Sbjct: 61  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQ--------- 111

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
             + +NYLH     I+HRDLK+ N+L      +K+ DFG+S     T     S  GTP W
Sbjct: 112 TLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYW 169

Query: 119 MAPEVL-----RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 165
           MAPEV+     +D P + K+D++S G+ L E+A ++ P   LNP +V+  + 
Sbjct: 170 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA 221

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 92.4 bits (229), Expect = 5e-23
 Identities = 46/153 (30%), Positives = 85/153 (55%), Gaps = 3/153 (1%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL-HKPGVREMLDERRRLNMAYDV 59
           +K+L HPN++ ++ +  +   L+IV E    G L +++ +    + ++ ER        +
Sbjct: 56  LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL 115

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
              + ++H R   ++HRD+K  N+ +     VK+ D GL R  ++   ++ S  GTP +M
Sbjct: 116 CSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +PE + +   N KSDI+S G +L+E+A LQ P+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 92.6 bits (231), Expect = 5e-23
 Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 36/199 (18%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +RHP +V   G+     NL +V EY+  G L+  L K           R      VA
Sbjct: 55  LQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK---------SGRFPE--PVA 103

Query: 61  K--------GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKS 111
           +         + YLH  +  IV+RDLK  NLL+D    +K+ DFG + R+K  T+    +
Sbjct: 104 RFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY----T 157

Query: 112 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ----VVAAVGFK 167
             GTPE++APE++  +   +  D ++ G++++E+     P+ + NP Q    ++      
Sbjct: 158 LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG---- 213

Query: 168 GKRLEIPRNVNPHVASIIE 186
             ++  P   +P    +I 
Sbjct: 214 --KVRFPSFFSPDAKDLIR 230

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 92.3 bits (229), Expect = 5e-23
 Identities = 57/193 (29%), Positives = 95/193 (49%), Gaps = 7/193 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           + +  H NIV   G +T+   + IVTEY+S G+L   L K      L   + + M   +A
Sbjct: 60  LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLA 117

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFG-LSRLKANTFLSSKSAAGTPEWM 119
            GM YL       VH+ L +  +LV+     K+  F  L   K+    ++ S      W 
Sbjct: 118 SGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWA 175

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE ++    +  SD++SFG+++WE+ +  ++P+ +++   V+ AV   G RL  PRN  
Sbjct: 176 APEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-DGFRLPAPRNCP 234

Query: 179 PHVASIIEACWAK 191
             +  ++  CW K
Sbjct: 235 NLLHQLMLDCWQK 247

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 92.6 bits (230), Expect = 9e-23
 Identities = 47/137 (34%), Positives = 76/137 (55%), Gaps = 5/137 (3%)

Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSSKSAA 113
           ++ VA+GM +L  R    +HRDL + N+L+ +   VK+CDFGL+R   K   ++    A 
Sbjct: 179 SFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236

Query: 114 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLE 172
              +WMAPE + D+    +SD++SFGV+LWE+ +L   P+  +   +       +G R+ 
Sbjct: 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR 296

Query: 173 IPRNVNPHVASIIEACW 189
            P    P + SI+  CW
Sbjct: 297 APEYATPEIYSIMLDCW 313

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 91.5 bits (227), Expect = 1e-22
 Identities = 65/209 (31%), Positives = 104/209 (49%), Gaps = 25/209 (11%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSI--VTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           ++ L H NIV + G  T+     I  + E+L  GSL   L  P  +  ++ +++L  A  
Sbjct: 60  LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQ 117

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANT-FLSSKSAAGTP 116
           + KGM+YL  R    VHRDL + N+LV+ ++ VK+ DFGL++ ++ +  + + K    +P
Sbjct: 118 ICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSP 175

Query: 117 E-WMAPEVLRDEPSNEKSDIYSFGVILWELAT---------------LQQPWGNLNPAQV 160
             W APE L        SD++SFGV L+EL T               +    G +   ++
Sbjct: 176 VFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235

Query: 161 VAAVGFKGKRLEIPRNVNPHVASIIEACW 189
           V  +  +GKRL  P N    V  ++  CW
Sbjct: 236 VRVLE-EGKRLPRPPNCPEEVYQLMRKCW 263

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 92.0 bits (228), Expect = 1e-22
 Identities = 59/172 (34%), Positives = 86/172 (50%), Gaps = 31/172 (18%)

Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGS-------LYRLLHKPGV----REMLDERRRLN 54
           HP IV  +GA      L I+ E+   G+       L R L +P +    R+ML+      
Sbjct: 68  HPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLE------ 121

Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
                   + YLH     I+HRDLK+ N+L+     +K+ DFG+S     T     S  G
Sbjct: 122 -------ALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIG 172

Query: 115 TPEWMAPEV-----LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161
           TP WMAPEV     ++D P + K+DI+S G+ L E+A ++ P   LNP +V+
Sbjct: 173 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL 224

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 91.6 bits (227), Expect = 1e-22
 Identities = 63/196 (32%), Positives = 99/196 (50%), Gaps = 17/196 (8%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  L H  IV  +G +    +L +VT+    GSL  L H    R+ LD +R LN    +A
Sbjct: 63  MGSLDHAYIVRLLG-ICPGASLQLVTQLSPLGSL--LDHVRQHRDSLDPQRLLNWCVQIA 119

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-----KANTFLSSKSAAGT 115
           KGM YL      +VHR+L + N+L+     V++ DFG++ L     K   +    S   T
Sbjct: 120 KGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFY----SEHKT 173

Query: 116 P-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEI 173
           P +WMA E +       +SD++S+GV +WE+ +   +P+  + P +V   +  KG+RL  
Sbjct: 174 PIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-KGERLAQ 232

Query: 174 PRNVNPHVASIIEACW 189
           P+     V  ++  CW
Sbjct: 233 PQICTIDVYMVMVKCW 248

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 91.2 bits (227), Expect = 2e-22
 Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 16/155 (10%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L HPNI+  +       +L +V E++    LY+L+     +  L E    +  Y + 
Sbjct: 52  LKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIK--DRQRGLPESLIKSYLYQLL 108

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 117
           +G+ + H     I+HRDLK  NLL++ +  +K+ DFGL+R        S     T     
Sbjct: 109 QGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARS-----FGSPVRPYTHYVVT 161

Query: 118 -WM-APEVL-RDEPSNEKSDIYSFGVILWELATLQ 149
            W  APE+L  D+  +   DI+S G I  EL + +
Sbjct: 162 RWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 91.3 bits (226), Expect = 2e-22
 Identities = 56/189 (29%), Positives = 94/189 (49%), Gaps = 7/189 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK L++PNIV F+ +      L +V EYL+ GSL  ++        +DE +   +  +  
Sbjct: 70  MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV----TETCMDEAQIAAVCRECL 125

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           + + +LH     ++HRD+KS N+L+    +VK+ DFG             +  GTP WMA
Sbjct: 126 QALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 183

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNP 179
           PEV+  +    K DI+S G++  E+   + P+ N NP + +  +   G   L+ P  ++P
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSP 243

Query: 180 HVASIIEAC 188
                +  C
Sbjct: 244 IFRDFLNRC 252

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 90.9 bits (225), Expect = 2e-22
 Identities = 57/164 (34%), Positives = 84/164 (51%), Gaps = 8/164 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K  +H NIV + G+      L I  EY   GSL  + H  G    L E +   +  +  
Sbjct: 60  VKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGP---LSELQIAYVCRETL 116

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +G+ YLH +    +HRD+K  N+L+     VK+ DFG++     T    KS  GTP WMA
Sbjct: 117 QGLAYLHSKGK--MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMA 174

Query: 121 PEVLRDEPS---NEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161
           PEV   E +   N+  DI++ G+   ELA LQ P  +L+P + +
Sbjct: 175 PEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 91.0 bits (226), Expect = 2e-22
 Identities = 66/215 (30%), Positives = 101/215 (46%), Gaps = 29/215 (13%)

Query: 1   MKRLRHPNIVLFMG--AVTQPPNLSIVTEYLSRGSLYRLLHK------------------ 40
           M    HPNIV  +G  AV +P  + ++ EY++ G L   L                    
Sbjct: 62  MAEFDHPNIVKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARK 119

Query: 41  -PGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS 99
                  L    +L +A  VA GM YL  R    VHRDL + N LV +   VK+ DFGLS
Sbjct: 120 CGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLS 177

Query: 100 R--LKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLN 156
           R    A+ + +S++ A    WM PE +       +SD++++GV+LWE+ +   QP+  + 
Sbjct: 178 RNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237

Query: 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK 191
             +V+  V   G  L  P N    + +++  CW+K
Sbjct: 238 HEEVIYYVR-DGNVLSCPDNCPLELYNLMRLCWSK 271

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 90.4 bits (224), Expect = 3e-22
 Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 15/201 (7%)

Query: 1   MKRLRHPNIVLFMG------AVTQPPNLSIVTEYLSRGSLYRLLHKPGVRE---MLDERR 51
           MK   HPN++  +G      A  + P   ++  ++  G L+  L    + E    L  + 
Sbjct: 55  MKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQT 114

Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSK 110
            +    D+A GM YL  +N   +HRDL + N ++++  TV V DFGLS+ + +  +    
Sbjct: 115 LVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQG 172

Query: 111 SAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
            A+  P +W+A E L D      SD+++FGV +WE+ T  Q P+  +  +++   +  KG
Sbjct: 173 CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL-IKG 231

Query: 169 KRLEIPRNVNPHVASIIEACW 189
            RL+ P +    V  ++  CW
Sbjct: 232 NRLKQPPDCLEDVYELMCQCW 252

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 90.9 bits (225), Expect = 3e-22
 Identities = 61/192 (31%), Positives = 98/192 (51%), Gaps = 9/192 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + HP++V  +G V   P + +VT+ +  G L   +H+   ++ +  +  LN    +A
Sbjct: 63  MASMDHPHLVRLLG-VCLSPTIQLVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIA 119

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGM YL  R   +VHRDL + N+LV     VK+ DFGL+RL         +  G    +W
Sbjct: 120 KGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW 177

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + P + +  +  KG+RL  P   
Sbjct: 178 MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPIC 236

Query: 178 NPHVASIIEACW 189
              V  ++  CW
Sbjct: 237 TIDVYMVMVKCW 248

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 90.1 bits (223), Expect = 3e-22
 Identities = 57/185 (30%), Positives = 89/185 (48%), Gaps = 10/185 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +K L+H  IV + G +       L+I  EY+  GS+   L   G    L E         
Sbjct: 58  LKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA---LTESVTRKYTRQ 114

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS---KSAAGT 115
           + +GM+YLH     IVHRD+K  N+L D    VK+ DFG S+      +S    +S  GT
Sbjct: 115 ILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172

Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 175
           P WM+PEV+  E    K+D++S G  + E+ T + PW        +  +  +    ++P 
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPS 232

Query: 176 NVNPH 180
           +++ H
Sbjct: 233 HISEH 237

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 89.9 bits (223), Expect = 4e-22
 Identities = 60/198 (30%), Positives = 100/198 (50%), Gaps = 13/198 (6%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-KPGVREMLDERRRLNMAYDV 59
           M +  HPNI+   G VT+   + I+TE++  G+L   L    G   ++   + + M   +
Sbjct: 59  MGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI---QLVGMLRGI 115

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN-----TFLSSKSAAG 114
           A GM YL   N   VHRDL + N+LV+     KV DFGLSR   +     T+ SS     
Sbjct: 116 AAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKI 173

Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEI 173
              W APE +        SD++S+G+++WE+ +  ++P+ +++   V+ A+  +  RL  
Sbjct: 174 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPP 232

Query: 174 PRNVNPHVASIIEACWAK 191
           P +    +  ++  CW K
Sbjct: 233 PMDCPTALHQLMLDCWQK 250

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 90.5 bits (224), Expect = 5e-22
 Identities = 55/185 (29%), Positives = 94/185 (50%), Gaps = 7/185 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++  RHP +     A      L  V EY + G L+   H    R   +ER R   A ++ 
Sbjct: 49  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIV 105

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             + YLH R+  +V+RD+K  NL++DK   +K+ DFGL +   +   + K+  GTPE++A
Sbjct: 106 SALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 163

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVL D       D +  GV+++E+   + P+ N +  ++   +  +  R   PR ++P 
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--PRTLSPE 221

Query: 181 VASII 185
             S++
Sbjct: 222 AKSLL 226

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 89.6 bits (222), Expect = 5e-22
 Identities = 49/173 (28%), Positives = 84/173 (48%), Gaps = 14/173 (8%)

Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK--PGVREMLDERRRLNMAYDVAK 61
           L HPN++  +G   +     +V E+   G L   L      V +M  +     MA +VA 
Sbjct: 52  LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS 111

Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGL--SRLKANTFLSSKSAAGTPEWM 119
           G+ +LH+ +   +H DL   N  +    +VK+ D+GL   +   + +++    A    W+
Sbjct: 112 GLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWL 169

Query: 120 APEVLRDEPSN-------EKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
           APE++     +       +KS+I+S GV +WEL T   QP+ +L+  QV+  V
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV 222

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 89.5 bits (222), Expect = 6e-22
 Identities = 62/196 (31%), Positives = 99/196 (50%), Gaps = 12/196 (6%)

Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-KPGVREMLDERRRLNM-AYDV 59
             L+H NIV ++G+ ++     I  E +  GSL  LL  K G   + D  + +      +
Sbjct: 60  SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWG--PLKDNEQTIIFYTKQI 117

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT--VKVCDFGLSRLKANTFLSSKSAAGTPE 117
            +G+ YLH     IVHRD+K  N+LV+  Y+  VK+ DFG S+  A     +++  GT +
Sbjct: 118 LEGLKYLHDNQ--IVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTLQ 174

Query: 118 WMAPEVLRDEPS--NEKSDIYSFGVILWELATLQQPWGNL-NPAQVVAAVGFKGKRLEIP 174
           +MAPEV+   P      +DI+S G  + E+AT + P+  L  P   +  VG      EIP
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIP 234

Query: 175 RNVNPHVASIIEACWA 190
            +++    + I  C+ 
Sbjct: 235 ESLSAEAKNFILRCFE 250

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 89.7 bits (223), Expect = 9e-22
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 10/151 (6%)

Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
             RHP +V          ++  V EY + G L   +H     ++  E R +  A  V  G
Sbjct: 58  SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLG 113

Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA--GTPEWMA 120
           + YLH     IV+RDLK  NLL+D +  VK+ DFGL   K       +++   GTPE++A
Sbjct: 114 LQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLC--KEGMGFGDRTSTFCGTPEFLA 169

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQP 151
           PEVL +       D +  GV+++E+   + P
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 88.8 bits (220), Expect = 9e-22
 Identities = 57/188 (30%), Positives = 97/188 (51%), Gaps = 5/188 (2%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL-YRLLHKPGVREMLDERRRLNMAYDV 59
           + +L HP IV F  +  +     I+TEY     L  +L       + L E +       +
Sbjct: 56  LSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
             G++Y+H+R   I+HRDLK+ N+ + K   +K+ DFG+SRL   +   + +  GTP +M
Sbjct: 116 LLGVHYMHQRR--ILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYM 172

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 179
           +PE L+ +  + KSDI+S G IL+E+  L   +   N   VV  +  +G    +P   + 
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI-VEGPTPSLPETYSR 231

Query: 180 HVASIIEA 187
            + SI+++
Sbjct: 232 QLNSIMQS 239

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 89.0 bits (221), Expect = 1e-21
 Identities = 53/189 (28%), Positives = 94/189 (49%), Gaps = 7/189 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M+  +HPNIV    +      L +V E+L  G+L  ++        ++E +   +   V 
Sbjct: 70  MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLAVL 125

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           K +++LH +   ++HRD+KS ++L+     VK+ DFG     +      KS  GTP WMA
Sbjct: 126 KALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 183

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV-GFKGKRLEIPRNVNP 179
           PEV+   P   + DI+S G+++ E+   + P+ N  P Q +  +      +L+    V+P
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSP 243

Query: 180 HVASIIEAC 188
            + S ++  
Sbjct: 244 RLRSFLDRM 252

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 88.6 bits (220), Expect = 1e-21
 Identities = 62/202 (30%), Positives = 93/202 (46%), Gaps = 19/202 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-------KPGVREMLDERRRL 53
           M +  H NIV  +G   +     I+ E ++ G L   L        +P    M D    L
Sbjct: 63  MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKD---LL 119

Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSR--LKANTFLS 108
             A DVAKG  YL   +   +HRD+ + N L+  K      K+ DFG++R   +A+ +  
Sbjct: 120 FCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRK 177

Query: 109 SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFK 167
              A    +WM PE   D     K+D++SFGV+LWE+ +L   P+      +V+  V   
Sbjct: 178 GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV-TG 236

Query: 168 GKRLEIPRNVNPHVASIIEACW 189
           G RL+ P+     V  I+  CW
Sbjct: 237 GGRLDPPKGCPGPVYRIMTDCW 258

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 88.9 bits (220), Expect = 2e-21
 Identities = 58/192 (30%), Positives = 99/192 (51%), Gaps = 9/192 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G +     + ++T+ +  G L   + +   ++ +  +  LN    +A
Sbjct: 63  MASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 119

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTP-EW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFGL++ L A+           P +W
Sbjct: 120 KGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKW 177

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + PA  ++++  KG+RL  P   
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPIC 236

Query: 178 NPHVASIIEACW 189
              V  I+  CW
Sbjct: 237 TIDVYMIMVKCW 248

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 89.3 bits (221), Expect = 2e-21
 Identities = 49/137 (35%), Positives = 77/137 (56%), Gaps = 5/137 (3%)

Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSSKSAA 113
           ++ VA+GM +L  R    +HRDL + N+L+ +   VK+CDFGL+R   K   ++   SA 
Sbjct: 180 SFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237

Query: 114 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLE 172
              +WMAPE + D+    +SD++SFGV+LWE+ +L   P+  +   +        G R+ 
Sbjct: 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR 297

Query: 173 IPRNVNPHVASIIEACW 189
            P N  P +  I+ ACW
Sbjct: 298 APENATPEIYRIMLACW 314

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 88.6 bits (220), Expect = 2e-21
 Identities = 50/189 (26%), Positives = 92/189 (48%), Gaps = 19/189 (10%)

Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
           +HP +            L  V EY++ G L   + + G     DE R    A ++  G+ 
Sbjct: 54  KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR---FDEPRARFYAAEIVLGLQ 110

Query: 65  YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS------RLKANTFLSSKSAAGTPEW 118
           +LH R   I++RDLK  N+L+D +  +K+ DFG+        +  +TF       GTP++
Sbjct: 111 FLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF------CGTPDY 162

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           +APE+L  +P     D ++ GV+L+E+   Q P+   +  ++  ++      +  PR ++
Sbjct: 163 IAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI--LEDEVRYPRWLS 220

Query: 179 PHVASIIEA 187
               SI+++
Sbjct: 221 KEAKSILKS 229

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 88.3 bits (219), Expect = 2e-21
 Identities = 56/195 (28%), Positives = 100/195 (51%), Gaps = 15/195 (7%)

Query: 1   MKRLRHPNIV----LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
           ++R+   NI+      +  V   P LS++ EY +RG L  +L K    + L  + +L+MA
Sbjct: 72  LRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK---EKDLSFKTKLDMA 128

Query: 57  YDVAKGMNYLHRR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT 115
            D  KG+  L++  N P  +++L S + LV + Y +K+   GL ++ ++     K+    
Sbjct: 129 IDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSP--PFKNV-NF 183

Query: 116 PEWMAPEVLRD--EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEI 173
             + + ++L D       K DIYS GV+LWE+ T + P+ NL   ++   +  K   L++
Sbjct: 184 MVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKL 243

Query: 174 PRNVNPHVASIIEAC 188
           P +    +  I+EAC
Sbjct: 244 PLDCPLEIKCIVEAC 258

Length = 283

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 87.8 bits (217), Expect = 3e-21
 Identities = 58/204 (28%), Positives = 102/204 (50%), Gaps = 21/204 (10%)

Query: 1   MKRLRHPNIVLFMGAVTQP------PNLSIVTEYLSRGSLY------RLLHKPGVREMLD 48
           MK   HPN++  +G   Q       P+  ++  ++  G L+      RL   P   + L 
Sbjct: 54  MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCP---QYLP 110

Query: 49  ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTF 106
            +  +    D+A GM YL  ++   +HRDL + N ++++   V V DFGLS+     + +
Sbjct: 111 TQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYY 168

Query: 107 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVG 165
              + A    +W+A E L D     KSD++SFGV +WE+AT  Q P+  +  +++   + 
Sbjct: 169 RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR 228

Query: 166 FKGKRLEIPRNVNPHVASIIEACW 189
            +G RL+ P +    + S++ +CW
Sbjct: 229 -QGNRLKQPPDCLDGLYSLMSSCW 251

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 88.9 bits (220), Expect = 4e-21
 Identities = 49/143 (34%), Positives = 78/143 (54%), Gaps = 11/143 (7%)

Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSSK 110
           L+  Y VA+GM +L  +N   VHRDL + N+L+ +   VK+CDFGL+R  +  + ++S  
Sbjct: 240 LSFTYQVARGMEFLASKN--CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG 297

Query: 111 SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK--- 167
           S     +WMAPE + D      SD++S+G++LWE+ +L    G   P  +V +  +    
Sbjct: 298 STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLG---GTPYPGMIVDSTFYNKIK 354

Query: 168 -GKRLEIPRNVNPHVASIIEACW 189
            G R+  P +    V  I+  CW
Sbjct: 355 SGYRMAKPDHATQEVYDIMVKCW 377

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 87.7 bits (217), Expect = 5e-21
 Identities = 51/145 (35%), Positives = 79/145 (54%), Gaps = 5/145 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L+HP +V    +      L  V +Y++ G L+   H    R  L+ R R   A +VA
Sbjct: 50  LKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELF--FHLQRERCFLEPRARF-YAAEVA 106

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             + YLH  N  I++RDLK  N+L+D +  V + DFGL +       ++ +  GTPE++A
Sbjct: 107 SAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLA 164

Query: 121 PEVLRDEPSNEKSDIYSFGVILWEL 145
           PEVLR EP +   D +  G +L+E+
Sbjct: 165 PEVLRKEPYDRTVDWWCLGAVLYEM 189

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 87.2 bits (216), Expect = 7e-21
 Identities = 50/138 (36%), Positives = 79/138 (57%), Gaps = 17/138 (12%)

Query: 21  NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80
           +L  V EYL+ G L   +   G     DE R    A ++  G+ +LH++   I++RDLK 
Sbjct: 70  HLFFVMEYLNGGDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKG--IIYRDLKL 124

Query: 81  PNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSD 134
            N+L+DK   +K+ DFG+ +       KA+TF       GTP+++APE+L+ +  NE  D
Sbjct: 125 DNVLLDKDGHIKIADFGMCKENMNGEGKASTF------CGTPDYIAPEILKGQKYNESVD 178

Query: 135 IYSFGVILWELATLQQPW 152
            +SFGV+L+E+   Q P+
Sbjct: 179 WWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 88.1 bits (218), Expect = 7e-21
 Identities = 47/140 (33%), Positives = 79/140 (56%), Gaps = 5/140 (3%)

Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSSK 110
           +  +Y VA GM +L  +N   VHRDL + N+L+ +   VK+CDFGL+R  ++ + ++S  
Sbjct: 242 VGFSYQVANGMEFLASKN--CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKG 299

Query: 111 SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGK 169
           S     +WMAPE + +      SD++SFG++LWE+ TL   P+  L   +       +G 
Sbjct: 300 STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGY 359

Query: 170 RLEIPRNVNPHVASIIEACW 189
           R+  P + +  +  I++ CW
Sbjct: 360 RMAKPAHASDEIYEIMQKCW 379

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 86.5 bits (214), Expect = 1e-20
 Identities = 53/189 (28%), Positives = 92/189 (48%), Gaps = 7/189 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M+  +HPNIV ++ +      L +V EYL+ GSL  ++        +DE +   +  +  
Sbjct: 70  MRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECL 125

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           + + +LH     ++HRD+KS N+L+    +VK+ DFG             +  GTP WMA
Sbjct: 126 QALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 183

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNP 179
           PEV+  +    K DI+S G++  E+   + P+ N NP + +  +   G   L+ P  ++ 
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 243

Query: 180 HVASIIEAC 188
                +  C
Sbjct: 244 IFRDFLNRC 252

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 87.3 bits (216), Expect = 1e-20
 Identities = 50/150 (33%), Positives = 84/150 (56%), Gaps = 13/150 (8%)

Query: 47  LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANT 105
           LD    L+ +Y VAKGM++L  +N   +HRDL + N+L+      K+CDFGL+R ++ ++
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268

Query: 106 FLSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAA 163
               K  A  P +WMAPE + +     +SD++S+G++LWE+ +L   P+    P   V +
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY----PGMPVDS 324

Query: 164 VGFK----GKRLEIPRNVNPHVASIIEACW 189
             +K    G R+  P      +  I+++CW
Sbjct: 325 KFYKMIKEGYRMLSPECAPSEMYDIMKSCW 354

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 85.1 bits (211), Expect = 2e-20
 Identities = 45/154 (29%), Positives = 81/154 (52%), Gaps = 10/154 (6%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL-YRLLHKPGVREMLDERRRLNMAYDV 59
           ++ L HP +V    +     N+ +V + L  G L Y L  K    +  +E+ +  +  ++
Sbjct: 54  LQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK---VKFSEEQVKFWIC-EI 109

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEW 118
              + YLH +   I+HRD+K  N+L+D++  V + DF ++  +  +T  +S S  GTP +
Sbjct: 110 VLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS--GTPGY 165

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
           MAPEVL  +  +   D +S GV  +E    ++P+
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY 199

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 84.6 bits (210), Expect = 3e-20
 Identities = 57/194 (29%), Positives = 89/194 (45%), Gaps = 20/194 (10%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++   HP IV           + ++ EY   G L+ +L   G   + DE         V 
Sbjct: 47  LEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG---LFDEYTARFYIACVV 103

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGL-----SRLKANTFLSSKSAAGT 115
               YLH R   I++RDLK  NLL+D    VK+ DFG      S  K  TF       GT
Sbjct: 104 LAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC------GT 155

Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV---AAVGFKGKRLE 172
           PE++APE++ ++  +   D +S G++L+EL T + P+G  +   +      +   GK LE
Sbjct: 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK-LE 214

Query: 173 IPRNVNPHVASIIE 186
            P  ++     +I+
Sbjct: 215 FPNYIDKAAKDLIK 228

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 85.8 bits (212), Expect = 3e-20
 Identities = 46/137 (33%), Positives = 73/137 (53%), Gaps = 5/137 (3%)

Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSSKSAA 113
           ++ VAKGM +L  R    +HRDL + N+L+ +   VK+CDFGL+R   K   ++    A 
Sbjct: 185 SFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242

Query: 114 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLE 172
              +WMAPE + D     +SD++SFGV+LWE+ +L   P+  +   +       +G R+ 
Sbjct: 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 302

Query: 173 IPRNVNPHVASIIEACW 189
            P    P +   +  CW
Sbjct: 303 APDYTTPEMYQTMLDCW 319

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 85.1 bits (210), Expect = 5e-20
 Identities = 54/191 (28%), Positives = 95/191 (49%), Gaps = 7/191 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K  RHP +     +      L  V EY++ G L+   H    R   ++R R   A ++ 
Sbjct: 49  LKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELF--FHLSRERVFSEDRTRFYGA-EIV 105

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             ++YLH  +  IV+RDLK  NL++DK   +K+ DFGL +       + K+  GTPE++A
Sbjct: 106 SALDYLH--SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLA 163

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVL D       D +  GV+++E+   + P+ N +  ++   +  +   ++ PR ++  
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED--IKFPRTLSAD 221

Query: 181 VASIIEACWAK 191
             S++     K
Sbjct: 222 AKSLLSGLLIK 232

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 84.0 bits (208), Expect = 9e-20
 Identities = 52/159 (32%), Positives = 76/159 (47%), Gaps = 26/159 (16%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L+HPNIV     + Q   L ++ E+LS   L + L      + +D     +  Y + 
Sbjct: 53  LKELQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQIL 111

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 117
           +G+ + H R   ++HRDLK  NLL+D K  +K+ DFGL+R           A G P    
Sbjct: 112 QGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLAR-----------AFGIPVRVY 158

Query: 118 --------WMAPEVLRDEPS-NEKSDIYSFGVILWELAT 147
                   + APEVL   P  +   DI+S G I  E+AT
Sbjct: 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 84.5 bits (209), Expect = 1e-19
 Identities = 53/191 (27%), Positives = 95/191 (49%), Gaps = 7/191 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++  RHP +     +      L  V EY + G L+  L +  V    ++R R   A ++ 
Sbjct: 49  LQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGA-EIV 105

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             + YLH  +  +V+RDLK  NL++DK   +K+ DFGL +   +   + K+  GTPE++A
Sbjct: 106 SALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 163

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVL D       D +  GV+++E+   + P+ N +  ++   +    + +  PR ++P 
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEIRFPRTLSPE 221

Query: 181 VASIIEACWAK 191
             S++     K
Sbjct: 222 AKSLLAGLLKK 232

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 83.8 bits (207), Expect = 1e-19
 Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 29/211 (13%)

Query: 1   MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLL--HKPGVREMLDERRRLNMA 56
           +K L H NIV + G  ++     L ++ EY+  GSL   L  HK  + ++L        A
Sbjct: 60  LKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL------LFA 113

Query: 57  YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAG 114
             + +GM YLH ++   +HRDL + N+L+D    VK+ DFGL++   + + +   +    
Sbjct: 114 QQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171

Query: 115 TPE-WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN--------LNPAQ----VV 161
           +P  W A E L++   +  SD++SFGV L+EL T      +        + P Q    VV
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVV 231

Query: 162 AAVGF--KGKRLEIPRNVNPHVASIIEACWA 190
             +    +G RL  P+N    V  +++ CW 
Sbjct: 232 RLIELLERGMRLPCPKNCPQEVYILMKNCWE 262

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 83.4 bits (207), Expect = 1e-19
 Identities = 50/154 (32%), Positives = 72/154 (46%), Gaps = 17/154 (11%)

Query: 2   KRLRHPNIVLFMGAVTQPPNLSI--VTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           ++LRHPNIV     VT     SI  V EY+    L  LL  P V+    + +       +
Sbjct: 53  QKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCY--MKQL 109

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE-- 117
            +G+ YLH     I+HRD+K  N+L++    +K+ DFGL+R     +    SA  T    
Sbjct: 110 LEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLAR----PYTKRNSADYTNRVI 163

Query: 118 --WM-APEVLRDEPS-NEKSDIYSFGVILWELAT 147
             W   PE+L        + D++S G IL EL  
Sbjct: 164 TLWYRPPELLLGATRYGPEVDMWSVGCILAELFL 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 84.3 bits (208), Expect = 1e-19
 Identities = 54/191 (28%), Positives = 93/191 (48%), Gaps = 6/191 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++  RHP +     +      L  V EY + G L+   H    R   ++R R   A ++ 
Sbjct: 49  LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIV 105

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             ++YLH     +V+RDLK  NL++DK   +K+ DFGL +       + K+  GTPE++A
Sbjct: 106 SALDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLA 164

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVL D       D +  GV+++E+   + P+ N +  ++   +  +  R   PR ++P 
Sbjct: 165 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF--PRTLSPE 222

Query: 181 VASIIEACWAK 191
             S++     K
Sbjct: 223 AKSLLSGLLKK 233

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 84.5 bits (209), Expect = 1e-19
 Identities = 47/144 (32%), Positives = 75/144 (52%), Gaps = 14/144 (9%)

Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
           HPN+V           + ++ E++  GSL           + DE+   ++A  +  G+ Y
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG-------THIADEQFLADVARQILSGIAY 183

Query: 66  LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 125
           LHRR+  IVHRD+K  NLL++    VK+ DFG+SR+ A T     S+ GT  +M+PE + 
Sbjct: 184 LHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERIN 241

Query: 126 DEPSNEK-----SDIYSFGVILWE 144
            + ++        DI+S GV + E
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILE 265

Length = 353

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 83.6 bits (207), Expect = 2e-19
 Identities = 59/182 (32%), Positives = 91/182 (50%), Gaps = 17/182 (9%)

Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P IV F GA      +SI  E++  GSL ++L K G    + E     ++  V +G+ YL
Sbjct: 59  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYL 115

Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----KANTFLSSKSAAGTPEWMAPE 122
            R    I+HRD+K  N+LV+ +  +K+CDFG+S       AN+F+      GT  +M+PE
Sbjct: 116 -REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE 168

Query: 123 VLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE---IPRNVNP 179
            L+      +SDI+S G+ L E+A  + P    +  ++ A  G      E     R V+ 
Sbjct: 169 RLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSG 228

Query: 180 HV 181
           H 
Sbjct: 229 HP 230

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 83.2 bits (206), Expect = 2e-19
 Identities = 52/182 (28%), Positives = 90/182 (49%), Gaps = 24/182 (13%)

Query: 1   MKRLRH-----------PNIVLFMGAVTQPPNLSIVTEY--LSRGSLYRLLHKPGVREML 47
            KRL             P IV F GA+ +  +  I  E   +S    Y+ +++   + ++
Sbjct: 46  QKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVL-KSVI 104

Query: 48  DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 107
            E     +A    K +NYL +    I+HRD+K  N+L+D+   +K+CDFG+S    ++  
Sbjct: 105 PEEILGKIAVATVKALNYL-KEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163

Query: 108 SSKSAAGTPEWMAPEVL---RDEPSNEKSDIYSFGVILWELATLQQPWGNLNP-----AQ 159
            ++ A   P +MAPE +     +  + +SD++S G+ L+E+AT + P+   N       Q
Sbjct: 164 KTRDAGCRP-YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQ 222

Query: 160 VV 161
           VV
Sbjct: 223 VV 224

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 83.2 bits (206), Expect = 2e-19
 Identities = 53/158 (33%), Positives = 80/158 (50%), Gaps = 17/158 (10%)

Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P IV   G      ++ I  E +S   L +LL +  ++  + E     M   + K ++YL
Sbjct: 74  PYIVKCYGYFITDSDVFICMELMST-CLDKLLKR--IQGPIPEDILGKMTVAIVKALHYL 130

Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RL---KANTFLSSKSAAGTPEWMAPE 122
            +    ++HRD+K  N+L+D    VK+CDFG+S RL   KA T      +AG   +MAPE
Sbjct: 131 -KEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT-----RSAGCAAYMAPE 184

Query: 123 VLRDEPSNEK----SDIYSFGVILWELATLQQPWGNLN 156
            +     N K    +D++S G+ L ELAT Q P+ N  
Sbjct: 185 RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK 222

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 83.2 bits (205), Expect = 2e-19
 Identities = 53/185 (28%), Positives = 91/185 (49%), Gaps = 10/185 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M+  ++PNIV ++ +      L +V EYL+ GSL  ++        +DE +   +  +  
Sbjct: 70  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECL 125

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           + +++LH     ++HRD+KS N+L+    +VK+ DFG             +  GTP WMA
Sbjct: 126 QALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 183

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEV+  +    K DI+S G++  E+   + P+ N NP + +  +   G     P   NP 
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT----PELQNPE 239

Query: 181 VASII 185
             S +
Sbjct: 240 RLSAV 244

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 82.4 bits (203), Expect = 3e-19
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 33/212 (15%)

Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL-------------HKPGVREMLDE 49
           RL+HPNIV  +G VT+   LS++  Y S   L+  L                 V+  L+ 
Sbjct: 64  RLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEP 123

Query: 50  RRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--------- 100
              +++   +A GM +L   +  +VH+DL + N+LV  K  VK+ D GL R         
Sbjct: 124 ADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYK 181

Query: 101 LKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ-QPWGNLNPAQ 159
           L  N+ L  +       WM+PE +     +  SDI+S+GV+LWE+ +   QP+   +   
Sbjct: 182 LMGNSLLPIR-------WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 234

Query: 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK 191
           V+  +  + + L  P +    V +++  CW +
Sbjct: 235 VIEMIRNR-QVLPCPDDCPAWVYTLMLECWNE 265

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 82.4 bits (203), Expect = 3e-19
 Identities = 60/187 (32%), Positives = 90/187 (48%), Gaps = 26/187 (13%)

Query: 6   HPNIVLFMGAVTQPPNLS-----IVTEYLSRGSLYRL---LHKPGVREMLDERRRLNMAY 57
           HPN+V F G   +   L      +V E  + GS+  L   L   G R  LDE     + Y
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR--LDEAMISYILY 135

Query: 58  DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 117
               G+ +LH  N  I+HRD+K  N+L+  +  VK+ DFG+S    +T L   ++ GTP 
Sbjct: 136 GALLGLQHLH--NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF 193

Query: 118 WMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE 172
           WMAPEV+      D   + + D++S G+   EL     P  +++P + +          +
Sbjct: 194 WMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL---------FK 244

Query: 173 IPRNVNP 179
           IPRN  P
Sbjct: 245 IPRNPPP 251

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 82.8 bits (204), Expect = 3e-19
 Identities = 54/189 (28%), Positives = 100/189 (52%), Gaps = 12/189 (6%)

Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
           HP +V           L  V EY++ G L  + H    R++ +E  R   A +++  +NY
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNY 111

Query: 66  LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 125
           LH R   I++RDLK  N+L+D +  +K+ D+G+ +       ++ +  GTP ++APE+LR
Sbjct: 112 LHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 169

Query: 126 DEPSNEKSDIYSFGVILWELATLQQPW----GNLNPAQVVAAVGFK---GKRLEIPRNVN 178
            E      D ++ GV+++E+   + P+     + NP Q      F+    K++ IPR+++
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 229

Query: 179 PHVASIIEA 187
              AS++++
Sbjct: 230 VKAASVLKS 238

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 82.5 bits (203), Expect = 3e-19
 Identities = 54/185 (29%), Positives = 90/185 (48%), Gaps = 10/185 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M+  ++PNIV ++ +      L +V EYL+ GSL  ++        +DE +   +  +  
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECL 126

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           + + +LH     ++HRD+KS N+L+    +VK+ DFG             +  GTP WMA
Sbjct: 127 QALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEV+  +    K DI+S G++  E+   + P+ N NP + +  +   G     P   NP 
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT----PELQNPE 240

Query: 181 VASII 185
             S I
Sbjct: 241 KLSAI 245

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 82.5 bits (204), Expect = 4e-19
 Identities = 53/186 (28%), Positives = 96/186 (51%), Gaps = 7/186 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K ++HP +V    +      L  V +Y++ G L+  L +   R   + R R   A ++A
Sbjct: 50  LKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARF-YAAEIA 106

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             + YLH  N  I++RDLK  N+L+D +  V + DFGL +       ++ +  GTPE++A
Sbjct: 107 SALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLA 164

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVLR +P +   D +  G +L+E+     P+ + + A++   +    K L +  N++  
Sbjct: 165 PEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI--LNKPLRLKPNISVS 222

Query: 181 VASIIE 186
              ++E
Sbjct: 223 ARHLLE 228

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 82.5 bits (204), Expect = 5e-19
 Identities = 51/176 (28%), Positives = 79/176 (44%), Gaps = 10/176 (5%)

Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYDVAKGM 63
           +   +V  + A      L +  EY+  G    LL+  GV   L E   R  MA      +
Sbjct: 59  KSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV---LSEDHARFYMAEMFE-AV 114

Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           + LH      +HRDLK  N L+D    +K+ DFGLS         + S  G+P++MAPEV
Sbjct: 115 DALHELG--YIHRDLKPENFLIDASGHIKLTDFGLS---KGIVTYANSVVGSPDYMAPEV 169

Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 179
           LR +  +   D +S G +L+E      P+    P +    + +  + L+ P   +P
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDP 225

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 83.4 bits (206), Expect = 5e-19
 Identities = 42/127 (33%), Positives = 81/127 (63%), Gaps = 5/127 (3%)

Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS--KSAAGTPEWMA 120
           ++++H ++  ++HRD+KS N+L+     VK+ DFG S++ A T      ++  GTP ++A
Sbjct: 156 VHHVHSKH--MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PE+ R +P ++K+D++S GV+L+EL TL++P+   N  +V+      G+   +P +++P 
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT-LAGRYDPLPPSISPE 272

Query: 181 VASIIEA 187
           +  I+ A
Sbjct: 273 MQEIVTA 279

Length = 496

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 81.8 bits (203), Expect = 5e-19
 Identities = 48/152 (31%), Positives = 72/152 (47%), Gaps = 18/152 (11%)

Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
            HPNIV       +   L  V EY+  G+LY+L+     +    E    ++ Y + +G+ 
Sbjct: 56  EHPNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGK-PFSESVIRSIIYQILQGLA 113

Query: 65  YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA------GTPEW 118
           ++H+      HRDLK  NLLV     VK+ DFGL+R         +S         T  +
Sbjct: 114 HIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYTDYVSTRWY 164

Query: 119 MAPEV-LRDEPSNEKSDIYSFGVILWELATLQ 149
            APE+ LR    +   DI++ G I+ EL TL+
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 82.2 bits (203), Expect = 5e-19
 Identities = 57/163 (34%), Positives = 88/163 (53%), Gaps = 20/163 (12%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL--HKPGVREMLDERRRLNMAYD 58
           +++LRHPN + + G   +     +V EY   GS   +L  HK  ++E   E   +   + 
Sbjct: 69  LQQLRHPNTIEYKGCYLREHTAWLVMEY-CLGSASDILEVHKKPLQE--VEIAAI--CHG 123

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK--ANTFLSSKSAAGTP 116
             +G+ YLH      +HRD+K+ N+L+ +  TVK+ DFG + L   AN+F+      GTP
Sbjct: 124 ALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTP 175

Query: 117 EWMAPEVL--RDEPS-NEKSDIYSFGVILWELATLQQPWGNLN 156
            WMAPEV+   DE   + K D++S G+   ELA  + P  N+N
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 82.3 bits (203), Expect = 6e-19
 Identities = 56/172 (32%), Positives = 94/172 (54%), Gaps = 8/172 (4%)

Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P IV    +     +L +VT+Y+S G L+  L K G     ++R +  +A ++   + +L
Sbjct: 56  PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS--EDRAKFYIA-ELVLALEHL 112

Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 126
           H+ +  IV+RDLK  N+L+D    + +CDFGLS+       ++ +  GT E++APEVL D
Sbjct: 113 HKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLD 170

Query: 127 EPSNEKS-DIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           E    K  D +S GV+++E+     P+   +  Q+   + F GK +  P+NV
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF-GK-VRFPKNV 220

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 81.6 bits (201), Expect = 1e-18
 Identities = 55/191 (28%), Positives = 97/191 (50%), Gaps = 7/191 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K ++HP +V    +      L  V +Y++ G L+  L +   R  L+ R R   A ++A
Sbjct: 50  LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARF-YAAEIA 106

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             + YLH  N  IV+RDLK  N+L+D +  + + DFGL +       ++ +  GTPE++A
Sbjct: 107 SALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLA 164

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVL  +P +   D +  G +L+E+     P+ + N A++   +    K L++  N+   
Sbjct: 165 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI--LNKPLQLKPNITNS 222

Query: 181 VASIIEACWAK 191
              ++E    K
Sbjct: 223 ARHLLEGLLQK 233

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 80.7 bits (199), Expect = 1e-18
 Identities = 56/165 (33%), Positives = 84/165 (50%), Gaps = 18/165 (10%)

Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P I+ F GA      +SI TE++  GSL        V   + E     +A  V KG+ YL
Sbjct: 59  PYIIGFYGAFFVENRISICTEFMDGGSL-------DVYRKIPEHVLGRIAVAVVKGLTYL 111

Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 126
                 I+HRD+K  N+LV+ +  VK+CDFG+S    N+   +K+  GT  +MAPE +  
Sbjct: 112 WSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKTYVGTNAYMAPERISG 167

Query: 127 EPSNEKSDIYSFGVILWELATLQQPW-------GNLNPAQVVAAV 164
           E     SD++S G+   ELA  + P+       G+L P Q++  +
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI 212

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 80.6 bits (199), Expect = 1e-18
 Identities = 54/187 (28%), Positives = 99/187 (52%), Gaps = 12/187 (6%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K + HP I+           L ++ EY+  G L+  L   G          L  A ++ 
Sbjct: 55  LKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG---RFSNSTGLFYASEIV 111

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEWM 119
             + YLH +   IV+RDLK  N+L+DK+  +K+ DFG ++ L+  T+    +  GTPE++
Sbjct: 112 CALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW----TLCGTPEYL 165

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 179
           APEV++ +  N+  D ++ G++++E+     P+ + NP  +   +   GK LE PR+++ 
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI-LAGK-LEFPRHLDL 223

Query: 180 HVASIIE 186
           +   +I+
Sbjct: 224 YAKDLIK 230

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 80.3 bits (198), Expect = 2e-18
 Identities = 50/153 (32%), Positives = 80/153 (52%), Gaps = 11/153 (7%)

Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P IV F GA      + +  EY+  GSL +L       E + E     + Y V KG+ +L
Sbjct: 59  PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118

Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLR 125
            +    I+HRD+K  N+LV+    VK+CDFG+S  L A+    +K+  G   +MAPE ++
Sbjct: 119 -KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL---AKTNIGCQSYMAPERIK 174

Query: 126 DEPSNE------KSDIYSFGVILWELATLQQPW 152
               N+      +SD++S G+ + E+A  + P+
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY 207

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 81.0 bits (200), Expect = 2e-18
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 27/157 (17%)

Query: 47  LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR------ 100
           LD    L  +  VA+GM++L  +N   +HRD+ + N+L+      K+CDFGL+R      
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266

Query: 101 ---LKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLN 156
              +K N  L  K       WMAPE + D     +SD++S+G++LWE+ +L + P+    
Sbjct: 267 NYVVKGNARLPVK-------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY---- 315

Query: 157 PAQVVAAVGFK----GKRLEIPRNVNPHVASIIEACW 189
           P  +V +  +K    G ++  P    P + SI++ CW
Sbjct: 316 PGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCW 352

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 79.8 bits (197), Expect = 3e-18
 Identities = 46/154 (29%), Positives = 83/154 (53%), Gaps = 10/154 (6%)

Query: 7   PNIVLFMGAVTQPPNLSIVTEYL--SRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
           P  V F GA+ +  ++ I  E +  S    Y+ ++  G+   + E     +A  + K + 
Sbjct: 60  PYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLT--IPEDILGKIAVSIVKALE 117

Query: 65  YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL 124
           YLH     ++HRD+K  N+L+++   VK+CDFG+S    ++ ++    AG   +MAPE +
Sbjct: 118 YLHS-KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS-VAKTIDAGCKPYMAPERI 175

Query: 125 RDEPS----NEKSDIYSFGVILWELATLQQPWGN 154
             E +    + KSD++S G+ + ELAT + P+ +
Sbjct: 176 NPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 79.7 bits (196), Expect = 3e-18
 Identities = 56/190 (29%), Positives = 88/190 (46%), Gaps = 32/190 (16%)

Query: 6   HPNIVLFMGA-----VTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLN------ 54
           HPN+V F G      V     L +V E  + GS+  L     V+  L    R+       
Sbjct: 74  HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDL-----VKGFLKRGERMEEPIIAY 128

Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
           + ++   G+ +LH      +HRD+K  N+L+  +  VK+ DFG+S    +T L   ++ G
Sbjct: 129 ILHEALMGLQHLH--VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVG 186

Query: 115 TPEWMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK 169
           TP WMAPEV+      D   + + D++S G+   EL     P  +L+P + +        
Sbjct: 187 TPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL-------- 238

Query: 170 RLEIPRNVNP 179
             +IPRN  P
Sbjct: 239 -FKIPRNPPP 247

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 78.8 bits (194), Expect = 5e-18
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 18/204 (8%)

Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREML--DERRRLNMAYDV 59
           + L+H N++  +G  T+     +V E+   G L   L      E++  D      MA ++
Sbjct: 50  RSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEI 109

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTPE 117
           A G+ +LH+ N   +H DL   N L+    TVK+ D+GLS    K + +++         
Sbjct: 110 ALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR 167

Query: 118 WMAPEVLRDEPSN-------EKSDIYSFGVILWELATL-QQPWGNLNPAQVVA-AVGFKG 168
           W+APE++ +   N       ++S+++S GV +WEL  L  QP+ +L+  QV+   V  + 
Sbjct: 168 WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ 227

Query: 169 KRLEIPRNVNPHVA---SIIEACW 189
            +L  PR   P       +++ CW
Sbjct: 228 LKLPKPRLKLPLSDRWYEVMQFCW 251

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 78.9 bits (194), Expect = 6e-18
 Identities = 47/161 (29%), Positives = 81/161 (50%), Gaps = 6/161 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M+   H N+V    +      L +V E+L  G+L  ++        ++E +   +   V 
Sbjct: 73  MRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLSVL 128

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           + ++YLH  N  ++HRD+KS ++L+     +K+ DFG     +      KS  GTP WMA
Sbjct: 129 RALSYLH--NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMA 186

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161
           PEV+   P   + DI+S G+++ E+   + P+ N  P Q +
Sbjct: 187 PEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM 227

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 78.1 bits (192), Expect = 1e-17
 Identities = 55/171 (32%), Positives = 87/171 (50%), Gaps = 8/171 (4%)

Query: 22  LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
           + +VT+ +  G L  L +    ++ +  +  LN    +AKGM+YL      +VHRDL + 
Sbjct: 83  VQLVTQLMPYGCL--LDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAAR 138

Query: 82  NLLVDKKYTVKVCDFGLSRLK--ANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFG 139
           N+LV     VK+ DFGL+RL     T   +       +WMA E +       +SD++S+G
Sbjct: 139 NVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYG 198

Query: 140 VILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACW 189
           V +WEL T   +P+  + PA+ +  +  KG+RL  P      V  I+  CW
Sbjct: 199 VTVWELMTFGAKPYDGI-PAREIPDLLEKGERLPQPPICTIDVYMIMVKCW 248

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 78.7 bits (194), Expect = 1e-17
 Identities = 50/154 (32%), Positives = 76/154 (49%), Gaps = 26/154 (16%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +  L HP IV  M +      +  + E++  G L+  L K G               DVA
Sbjct: 72  LMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG-----------RFPNDVA 120

Query: 61  K--------GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKS 111
           K           YLH ++  I++RDLK  NLL+D K  VKV DFG + ++   TF    +
Sbjct: 121 KFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF----T 174

Query: 112 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
             GTPE++APEV++ +   +  D ++ GV+L+E 
Sbjct: 175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEF 208

Length = 329

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 77.8 bits (191), Expect = 1e-17
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 32/210 (15%)

Query: 2   KRLRHPNIVLFMGAVTQ--PPNLS----IVTEYLSRGSLYRLLHKPGVREMLDERRRLNM 55
           K   H NI  + GA  +  PP +     +V E+   GS+  L+ K      L E     +
Sbjct: 58  KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYI 116

Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT 115
             ++ +G+++LH+    ++HRD+K  N+L+ +   VK+ DFG+S     T     +  GT
Sbjct: 117 CREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGT 174

Query: 116 PEWMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR 170
           P WMAPEV+      D   + KSD++S G+   E+A    P  +++P + +         
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL--------- 225

Query: 171 LEIPRNVNPHVA---------SIIEACWAK 191
             IPRN  P +          S IE+C  K
Sbjct: 226 FLIPRNPAPRLKSKKWSKKFQSFIESCLVK 255

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 77.8 bits (191), Expect = 2e-17
 Identities = 52/160 (32%), Positives = 84/160 (52%), Gaps = 14/160 (8%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEY-LSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           +++LRHPN + + G   +     +V EY L   S    +HK  ++E+        + +  
Sbjct: 69  LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV----EIAAVTHGA 124

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
            +G+ YLH  N  ++HRD+K+ N+L+ +   VK+ DFG     A+    +    GTP WM
Sbjct: 125 LQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFG----SASIMAPANXFVGTPYWM 178

Query: 120 APEVL--RDEPSNE-KSDIYSFGVILWELATLQQPWGNLN 156
           APEV+   DE   + K D++S G+   ELA  + P  N+N
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 77.8 bits (191), Expect = 3e-17
 Identities = 52/145 (35%), Positives = 82/145 (56%), Gaps = 6/145 (4%)

Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P IV F GA      +SI  E++  GSL ++L K G    + E+    ++  V KG+ YL
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYL 119

Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 126
            R    I+HRD+K  N+LV+ +  +K+CDFG+S    ++   + S  GT  +M+PE L+ 
Sbjct: 120 -REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQG 176

Query: 127 EPSNEKSDIYSFGVILWELATLQQP 151
              + +SDI+S G+ L E+A  + P
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 77.6 bits (192), Expect = 3e-17
 Identities = 49/165 (29%), Positives = 80/165 (48%), Gaps = 33/165 (20%)

Query: 1   MKRLRHPNIV-LFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRL 53
           ++ LRH NI+ L    + +PP+        IVTE +    L++++  P  + + D+  + 
Sbjct: 53  LRHLRHENIIGLL--DILRPPSPEDFNDVYIVTELM-ETDLHKVIKSP--QPLTDDHIQY 107

Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
            + Y + +G+ YLH  N  ++HRDLK  N+LV+    +K+CDFGL+R             
Sbjct: 108 FL-YQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE------- 157

Query: 114 GTPEWM----------APEVLRDEPSNEKS-DIYSFGVILWELAT 147
               ++          APE+L       K+ DI+S G I  EL T
Sbjct: 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLT 202

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 77.3 bits (190), Expect = 3e-17
 Identities = 50/153 (32%), Positives = 76/153 (49%), Gaps = 17/153 (11%)

Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
           HP +           NL  V EYL+ G L  + H     +  D  R    A ++  G+ +
Sbjct: 55  HPFLTHLYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHK-FDLPRATFYAAEIICGLQF 111

Query: 66  LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR------LKANTFLSSKSAAGTPEWM 119
           LH +   IV+RDLK  N+L+D    +K+ DFG+ +       K  TF       GTP+++
Sbjct: 112 LHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF------CGTPDYI 163

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
           APE+L  +  N   D +SFGV+L+E+   Q P+
Sbjct: 164 APEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 77.0 bits (189), Expect = 4e-17
 Identities = 47/161 (29%), Positives = 84/161 (52%), Gaps = 6/161 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M+  +H N+V    +      L ++ E+L  G+L  ++ +   R  L+E +   +   V 
Sbjct: 72  MRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--TR--LNEEQIATVCESVL 127

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           + + YLH +   ++HRD+KS ++L+     VK+ DFG     +      KS  GTP WMA
Sbjct: 128 QALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMA 185

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161
           PEV+   P   + DI+S G+++ E+   + P+ + +P Q +
Sbjct: 186 PEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 226

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 77.0 bits (189), Expect = 4e-17
 Identities = 46/145 (31%), Positives = 79/145 (54%), Gaps = 5/145 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K ++HP +V    +      L  V ++++ G L+  L +   R   + R R   A ++A
Sbjct: 50  LKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRE--RSFPEPRARFYAA-EIA 106

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             + YLH  N  IV+RDLK  N+L+D +  V + DFGL +       ++ +  GTPE++A
Sbjct: 107 SALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLA 164

Query: 121 PEVLRDEPSNEKSDIYSFGVILWEL 145
           PEV+R +P +   D +  G +L+E+
Sbjct: 165 PEVIRKQPYDNTVDWWCLGAVLYEM 189

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 77.3 bits (191), Expect = 4e-17
 Identities = 43/161 (26%), Positives = 67/161 (41%), Gaps = 50/161 (31%)

Query: 21  NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK--------GMNYLHRRNPP 72
           +L +V EY+  G L  LL +  V     E        + A+         ++ +H+    
Sbjct: 75  HLYLVMEYMPGGDLMNLLIRKDV---FPE--------ETARFYIAELVLALDSVHKLG-- 121

Query: 73  IVHRDLKSPNLLVDKKYTVKVCDFGLS-----------------------------RLKA 103
            +HRD+K  N+L+D    +K+ DFGL                              R   
Sbjct: 122 FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK 181

Query: 104 NTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWE 144
              + + S  GTP+++APEVLR  P   + D +S GVIL+E
Sbjct: 182 QRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 76.8 bits (189), Expect = 5e-17
 Identities = 55/184 (29%), Positives = 101/184 (54%), Gaps = 11/184 (5%)

Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREML--DERRRLNMAYDVAKGM 63
           HP IV    A      L ++ ++L  G L+  L K    E++  +E  +  +A ++A  +
Sbjct: 57  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLA-ELALAL 111

Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           ++LH     I++RDLK  N+L+D++  +K+ DFGLS+   +    + S  GT E+MAPEV
Sbjct: 112 DHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 169

Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVAS 183
           +      + +D +SFGV+++E+ T   P+   +  + +  +  K K L +P+ ++P   S
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI-LKAK-LGMPQFLSPEAQS 227

Query: 184 IIEA 187
           ++ A
Sbjct: 228 LLRA 231

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 76.7 bits (188), Expect = 6e-17
 Identities = 54/163 (33%), Positives = 86/163 (52%), Gaps = 20/163 (12%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYL--SRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           ++R++HPN + + G   +     +V EY   S   L  +  KP     L E     + + 
Sbjct: 79  LQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAITHG 133

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP 116
             +G+ YLH  N  ++HRD+K+ N+L+ +   VK+ DFG + +   AN+F+      GTP
Sbjct: 134 ALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV------GTP 185

Query: 117 EWMAPEVL--RDEPSNE-KSDIYSFGVILWELATLQQPWGNLN 156
            WMAPEV+   DE   + K D++S G+   ELA  + P  N+N
Sbjct: 186 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 228

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 76.0 bits (187), Expect = 7e-17
 Identities = 52/151 (34%), Positives = 78/151 (51%), Gaps = 10/151 (6%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK L+H NIV     +     L +V EY+    L + +   GVR  LD     +  Y + 
Sbjct: 52  MKELKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLL 110

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR---LKANTFLSSKSAAGTPE 117
           KG+ + H     ++HRDLK  NLL++K+  +K+ DFGL+R   +  NTF    +   T  
Sbjct: 111 KGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF---SNEVVTLW 165

Query: 118 WMAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
           + AP+VL    +   S DI+S G I+ E+ T
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT 196

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 76.2 bits (187), Expect = 9e-17
 Identities = 39/131 (29%), Positives = 79/131 (60%), Gaps = 5/131 (3%)

Query: 22  LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
           L  V EY++ G L   + + G      E + +  A +++ G+ +LHRR   I++RDLK  
Sbjct: 76  LYFVMEYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLD 130

Query: 82  NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVI 141
           N+++D +  +K+ DFG+ +      +++++  GTP+++APE++  +P  +  D +++GV+
Sbjct: 131 NVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVL 190

Query: 142 LWELATLQQPW 152
           L+E+   Q P+
Sbjct: 191 LYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 1e-16
 Identities = 48/155 (30%), Positives = 77/155 (49%), Gaps = 19/155 (12%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDV 59
           +++LRH NIV    A  +   L +V EY+ R  L  L   P G+    D  R     + +
Sbjct: 54  LRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPP--DAVRSY--IWQL 109

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA------ 113
            + + Y H  N  I+HRD+K  N+LV +   +K+CDFG +R      L ++ A+      
Sbjct: 110 LQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFAR-----ALRARPASPLTDYV 162

Query: 114 GTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
            T  + APE+L  + +  K  D+++ G I+ EL  
Sbjct: 163 ATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 75.4 bits (185), Expect = 1e-16
 Identities = 62/210 (29%), Positives = 95/210 (45%), Gaps = 32/210 (15%)

Query: 2   KRLRHPNIVLFMGAVTQ--PP----NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNM 55
           K   H NI  + GA  +  PP     L +V E+   GS+  L+ K      L E     +
Sbjct: 68  KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV-KNTKGNALKEDWIAYI 126

Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT 115
             ++ +G+ +LH     ++HRD+K  N+L+ +   VK+ DFG+S     T     +  GT
Sbjct: 127 CREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGT 184

Query: 116 PEWMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR 170
           P WMAPEV+      D   + +SDI+S G+   E+A    P  +++P + +         
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL--------- 235

Query: 171 LEIPRNVNPHVAS---------IIEACWAK 191
             IPRN  P + S          IE C  K
Sbjct: 236 FLIPRNPPPKLKSKKWSKKFIDFIEGCLVK 265

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 75.4 bits (185), Expect = 1e-16
 Identities = 54/163 (33%), Positives = 85/163 (52%), Gaps = 20/163 (12%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYL--SRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +++L+HPN + + G   +     +V EY   S   L  +  KP     L E     + + 
Sbjct: 75  LQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAITHG 129

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK--ANTFLSSKSAAGTP 116
             +G+ YLH  N  ++HRD+K+ N+L+ +   VK+ DFG +     AN+F+      GTP
Sbjct: 130 ALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTP 181

Query: 117 EWMAPEVL--RDEPSNE-KSDIYSFGVILWELATLQQPWGNLN 156
            WMAPEV+   DE   + K D++S G+   ELA  + P  N+N
Sbjct: 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 75.4 bits (185), Expect = 2e-16
 Identities = 40/131 (30%), Positives = 77/131 (58%), Gaps = 5/131 (3%)

Query: 22  LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
           L  V EY++ G L   + + G      E   +  A ++A G+ +LH +   I++RDLK  
Sbjct: 76  LYFVMEYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLD 130

Query: 82  NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVI 141
           N+++D +  +K+ DFG+ +      +++K+  GTP+++APE++  +P  +  D ++FGV+
Sbjct: 131 NVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVL 190

Query: 142 LWELATLQQPW 152
           L+E+   Q P+
Sbjct: 191 LYEMLAGQAPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 74.3 bits (182), Expect = 4e-16
 Identities = 47/171 (27%), Positives = 90/171 (52%), Gaps = 10/171 (5%)

Query: 22  LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
           L +V EY++ G L  + H    R++ +E  R   A ++   +N+LH R   I++RDLK  
Sbjct: 71  LFLVIEYVNGGDL--MFHMQRQRKLPEEHARF-YAAEICIALNFLHERG--IIYRDLKLD 125

Query: 82  NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVI 141
           N+L+D    +K+ D+G+ +       ++ +  GTP ++APE+LR E      D ++ GV+
Sbjct: 126 NVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVL 185

Query: 142 LWELATLQQPWGNL--NPAQVVAAVGFK---GKRLEIPRNVNPHVASIIEA 187
           ++E+   + P+  +  NP        F+    K + IPR ++   + +++ 
Sbjct: 186 MFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKG 236

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 74.0 bits (182), Expect = 4e-16
 Identities = 39/131 (29%), Positives = 76/131 (58%), Gaps = 5/131 (3%)

Query: 22  LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
           L  V EY++ G L   + + G      E   +  A ++A G+ +LH +   I++RDLK  
Sbjct: 76  LYFVMEYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLD 130

Query: 82  NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVI 141
           N+++D +  +K+ DFG+ +       ++++  GTP+++APE++  +P  +  D ++FGV+
Sbjct: 131 NVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVL 190

Query: 142 LWELATLQQPW 152
           L+E+   Q P+
Sbjct: 191 LYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 74.9 bits (184), Expect = 6e-16
 Identities = 52/156 (33%), Positives = 69/156 (44%), Gaps = 16/156 (10%)

Query: 3   RLRHPNIV-LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK 61
           RL HPNIV L       P  L  V EY+   +L  +L   G     +  R +    D   
Sbjct: 34  RLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLD--- 90

Query: 62  GMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRL-------KANTFLSSKS 111
            +   H +   IVHRDLK  N++V     +   KV DFG+  L          T   +  
Sbjct: 91  ALACAHNQG--IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTE 148

Query: 112 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147
             GTP + APE LR EP    SD+Y++G+I  E  T
Sbjct: 149 VLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLT 184

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 73.6 bits (181), Expect = 6e-16
 Identities = 45/148 (30%), Positives = 74/148 (50%), Gaps = 6/148 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K+LRH N+V  +    +   L +V E++    L  L   P     LDE R     + + 
Sbjct: 54  LKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN---GLDESRVRKYLFQIL 110

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +G+ + H  N  I+HRD+K  N+LV +   VK+CDFG +R  A           T  + A
Sbjct: 111 RGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRA 168

Query: 121 PEVLRDEPSNEKS-DIYSFGVILWELAT 147
           PE+L  +    ++ DI++ G ++ E+ T
Sbjct: 169 PELLVGDTKYGRAVDIWAVGCLVTEMLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 73.5 bits (180), Expect = 7e-16
 Identities = 45/164 (27%), Positives = 82/164 (50%), Gaps = 6/164 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M+  +H N+V    +      L +V E+L  G+L  ++        ++E +   +   V 
Sbjct: 71  MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVL 126

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           K ++ LH +   ++HRD+KS ++L+     VK+ DFG     +      KS  GTP WMA
Sbjct: 127 KALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 184

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           PE++   P   + DI+S G+++ E+   + P+ N  P + +  +
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 228

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 72.9 bits (179), Expect = 7e-16
 Identities = 47/147 (31%), Positives = 73/147 (49%), Gaps = 6/147 (4%)

Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
             IV    A     +L +V   ++ G L   ++  G      E R +  A  +  G+ +L
Sbjct: 53  RFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEP-GFPEARAIFYAAQIICGLEHL 111

Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLR 125
           H+R   IV+RDLK  N+L+D    V++ D GL+  LK       K  AGTP +MAPEVL+
Sbjct: 112 HQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRAGTPGYMAPEVLQ 167

Query: 126 DEPSNEKSDIYSFGVILWELATLQQPW 152
            E  +   D ++ G  L+E+   + P+
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAGRSPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 73.7 bits (181), Expect = 8e-16
 Identities = 52/188 (27%), Positives = 99/188 (52%), Gaps = 12/188 (6%)

Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
           HP +V           L  V E++S G L  + H    R++ +E  R   A +++  +N+
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNF 111

Query: 66  LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 125
           LH R   I++RDLK  N+L+D +  +K+ D+G+ +       ++ +  GTP ++APE+LR
Sbjct: 112 LHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR 169

Query: 126 DEPSNEKSDIYSFGVILWELATLQQPW----GNLNPAQVVAAVGFK---GKRLEIPRNVN 178
            E      D ++ GV+++E+   + P+     + NP Q      F+    K++ IPR+++
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLS 229

Query: 179 PHVASIIE 186
              +S+++
Sbjct: 230 VKASSVLK 237

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 72.9 bits (179), Expect = 1e-15
 Identities = 48/152 (31%), Positives = 82/152 (53%), Gaps = 10/152 (6%)

Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYDVAKGM 63
           R P +V    A      L ++ +Y++ G L+  L++   RE   E   R+ +A ++   +
Sbjct: 63  RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ---REHFTESEVRVYIA-EIVLAL 118

Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEWMAPE 122
           ++LH+    I++RD+K  N+L+D +  V + DFGLS+   A     + S  GT E+MAPE
Sbjct: 119 DHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPE 176

Query: 123 VLRDEPS--NEKSDIYSFGVILWELATLQQPW 152
           V+R      ++  D +S GV+ +EL T   P+
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 72.6 bits (178), Expect = 1e-15
 Identities = 35/106 (33%), Positives = 58/106 (54%), Gaps = 2/106 (1%)

Query: 47  LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 106
             E R       +  G+ +LH+R   I++RDLK  N+L+D    V++ D GL+    +  
Sbjct: 94  FPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ 151

Query: 107 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
             +K  AGTP +MAPE+L+ E  +   D ++ GV L+E+   + P+
Sbjct: 152 SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 73.2 bits (179), Expect = 1e-15
 Identities = 51/151 (33%), Positives = 81/151 (53%), Gaps = 18/151 (11%)

Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRL------NMAYDVA 60
           P IV F GA      +SI  E++  GSL          ++L E +R+       ++  V 
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSL---------DQVLKEAKRIPEEILGKVSIAVL 113

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +G+ YL R    I+HRD+K  N+LV+ +  +K+CDFG+S    ++   + S  GT  +M+
Sbjct: 114 RGLAYL-REKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMS 170

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQP 151
           PE L+    + +SDI+S G+ L ELA  + P
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 71.9 bits (176), Expect = 3e-15
 Identities = 43/134 (32%), Positives = 75/134 (55%), Gaps = 9/134 (6%)

Query: 21  NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80
           +L  V E+L+ G L   +   G     D  R    A ++  G+ +LH +   I++RDLK 
Sbjct: 70  HLFFVMEFLNGGDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKL 124

Query: 81  PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA--GTPEWMAPEVLRDEPSNEKSDIYSF 138
            N+++D+   +K+ DFG+   K N F  ++++   GTP+++APE+L+        D +SF
Sbjct: 125 DNVMLDRDGHIKIADFGMC--KENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSF 182

Query: 139 GVILWELATLQQPW 152
           GV+L+E+   Q P+
Sbjct: 183 GVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 71.8 bits (177), Expect = 3e-15
 Identities = 42/151 (27%), Positives = 73/151 (48%), Gaps = 16/151 (10%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREML-DERRRLNMAYDV 59
           ++ L+HPNI+  +       N+++V E++    L +++    +     D +  + M    
Sbjct: 56  LQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTL-- 112

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA--NTFLSSKSAAGTPE 117
            +G+ YLH     I+HRDLK  NLL+     +K+ DFGL+R     N  ++ +    T  
Sbjct: 113 -RGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRW 167

Query: 118 WMAPEVLRDEPSNEKS---DIYSFGVILWEL 145
           + APE+L    +       D++S G I  EL
Sbjct: 168 YRAPELLFG--ARHYGVGVDMWSVGCIFAEL 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 71.5 bits (175), Expect = 4e-15
 Identities = 43/152 (28%), Positives = 78/152 (51%), Gaps = 5/152 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           + ++  P IV    +   P  L +V  +++ G L+  L + G     D  R      ++ 
Sbjct: 47  LAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREG---RFDLSRARFYTAELL 103

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             +  LH+ N  +++RDLK  N+L+D +  + +CDFGL +L       + +  GTPE++A
Sbjct: 104 CALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLA 161

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
           PE+L      +  D ++ GV+L+E+ T   P+
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTGLPPF 193

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 71.4 bits (175), Expect = 4e-15
 Identities = 40/148 (27%), Positives = 75/148 (50%), Gaps = 5/148 (3%)

Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
           +HP +            L  V EY++ G L   + +       DE R    A +V   + 
Sbjct: 54  KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRS---RKFDEPRSRFYAAEVTLALM 110

Query: 65  YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL 124
           +LHR    +++RDLK  N+L+D +   K+ DFG+ +      +++ +  GTP+++APE+L
Sbjct: 111 FLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEIL 168

Query: 125 RDEPSNEKSDIYSFGVILWELATLQQPW 152
           ++       D ++ GV+++E+   Q P+
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 71.0 bits (174), Expect = 6e-15
 Identities = 48/143 (33%), Positives = 77/143 (53%), Gaps = 19/143 (13%)

Query: 21  NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAY----DVAKGMNYLHRRNPPIVHR 76
           NL +V EY   G L  LL++    +  DE    +MA     ++   ++ +H+     VHR
Sbjct: 75  NLYLVMEYQPGGDLLSLLNR--YEDQFDE----DMAQFYLAELVLAIHSVHQMG--YVHR 126

Query: 77  DLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKS-- 133
           D+K  N+L+D+   +K+ DFG + RL AN  ++SK   GTP+++APEVL     + K   
Sbjct: 127 DIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTY 186

Query: 134 ----DIYSFGVILWELATLQQPW 152
               D +S GVI +E+   + P+
Sbjct: 187 GVECDWWSLGVIAYEMIYGRSPF 209

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 70.4 bits (173), Expect = 7e-15
 Identities = 48/159 (30%), Positives = 68/159 (42%), Gaps = 27/159 (16%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L HPNIV  +  V     L +V E+L       +   P     LD     +  Y + 
Sbjct: 52  LKELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSP--LTGLDPPLIKSYLYQLL 109

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 117
           +G+ Y H     ++HRDLK  NLL+D++  +K+ DFGL+R           A G P    
Sbjct: 110 QGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLAR-----------AFGVPVRTY 156

Query: 118 -------WM-APEVLRDEPSNEKS-DIYSFGVILWELAT 147
                  W  APE+L          DI+S G I  E+  
Sbjct: 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 71.1 bits (174), Expect = 7e-15
 Identities = 41/147 (27%), Positives = 72/147 (48%), Gaps = 10/147 (6%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ + HP+++     +       +V  +     LY  L K      L   + L +   + 
Sbjct: 111 LQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRP--LPIDQALIIEKQIL 167

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEW 118
           +G+ YLH +   I+HRD+K+ N+ ++    V + D G ++       FL     AGT E 
Sbjct: 168 EGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG---LAGTVET 222

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWEL 145
            APEVL  +  N K+DI+S G++L+E+
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 70.1 bits (172), Expect = 1e-14
 Identities = 47/174 (27%), Positives = 82/174 (47%), Gaps = 24/174 (13%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL--HKP-GVREMLDERRRLNMAY 57
            ++L+HPNI+ ++ +      L +V+  ++ GS   LL  H P G+ E+        +A+
Sbjct: 53  SRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA-------IAF 105

Query: 58  ---DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-------LKANTFL 107
              DV   ++Y+H +    +HR +K+ ++L+     V +     S         +     
Sbjct: 106 ILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163

Query: 108 SSKSAAGTPEWMAPEVLRDEPS--NEKSDIYSFGVILWELATLQQPWGNLNPAQ 159
             KS+     W++PEVL+      NEKSDIYS G+   ELA    P+ ++   Q
Sbjct: 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ 217

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 70.2 bits (172), Expect = 1e-14
 Identities = 48/148 (32%), Positives = 79/148 (53%), Gaps = 14/148 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQP-PNLSIVTEYLSRGSLYRLLH-KPGVREMLDERRRLNMAYD 58
           +K LRH NI+        P  ++  VTE L    L+RLL  +P     L+++      Y 
Sbjct: 63  LKHLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRP-----LEKQFIQYFLYQ 116

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
           + +G+ Y+H  +  +VHRDLK  N+L+++   +K+CDFGL+R++        S   T  +
Sbjct: 117 ILRGLKYVH--SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS---TRYY 171

Query: 119 MAPEV-LRDEPSNEKSDIYSFGVILWEL 145
            APE+ L  +  + + DI+S G I  E+
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEM 199

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 69.6 bits (171), Expect = 1e-14
 Identities = 47/162 (29%), Positives = 77/162 (47%), Gaps = 29/162 (17%)

Query: 1   MKRLR-HPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAY 57
           ++RL  HPNI+  +  +       L++V E L   +LY L+   G +  L E+R  +  Y
Sbjct: 51  LRRLSPHPNILRLIEVLFDRKTGRLALVFE-LMDMNLYELIK--GRKRPLPEKRVKSYMY 107

Query: 58  DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP- 116
            + K ++++HR    I HRD+K  N+L+ K   +K+ DFG          S +     P 
Sbjct: 108 QLLKSLDHMHRNG--IFHRDIKPENILI-KDDILKLADFG----------SCRGIYSKPP 154

Query: 117 -------EWM-APE-VLRDEPSNEKSDIYSFGVILWELATLQ 149
                   W  APE +L D     K DI++ G + +E+ +L 
Sbjct: 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLF 196

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 69.0 bits (169), Expect = 4e-14
 Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 15/151 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
           MK + H NI+  +   T   +L       +V E L   +L +++        LD  R   
Sbjct: 69  MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVME-LMDANLCQVIQM-----DLDHERMSY 122

Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
           + Y +  G+ +LH  +  I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     
Sbjct: 123 LLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV- 179

Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
           T  + APEV+      E  DI+S G I+ E+
Sbjct: 180 TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 210

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 68.5 bits (168), Expect = 4e-14
 Identities = 41/150 (27%), Positives = 66/150 (44%), Gaps = 13/150 (8%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDE---RRRLNMAY 57
           ++  +HP +V  +          +V EY+    L  +L        L E   +  + M  
Sbjct: 53  LQACQHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRD--EERPLPEAQVKSYMRM-- 107

Query: 58  DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN-TFLSSKSAAGTP 116
            + KG+ Y+H     I+HRDLK  NLL+     +K+ DFGL+RL +            T 
Sbjct: 108 -LLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATR 164

Query: 117 EWMAPEVLRDEPS-NEKSDIYSFGVILWEL 145
            + APE+L      +   D+++ G I  EL
Sbjct: 165 WYRAPELLYGARKYDPGVDLWAVGCIFAEL 194

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 68.7 bits (168), Expect = 4e-14
 Identities = 50/182 (27%), Positives = 97/182 (53%), Gaps = 7/182 (3%)

Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           ++HP IV  + A      L ++ EYLS G L+  L + G+   +++     ++ +++  +
Sbjct: 57  VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGI--FMEDTACFYLS-EISLAL 113

Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
            +LH++   I++RDLK  N+L+D +  VK+ DFGL +   +    + +  GT E+MAPE+
Sbjct: 114 EHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEI 171

Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVAS 183
           L      +  D +S G +++++ T   P+   N  + +  +  KGK L +P  + P    
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI-LKGK-LNLPPYLTPEARD 229

Query: 184 II 185
           ++
Sbjct: 230 LL 231

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 68.4 bits (168), Expect = 4e-14
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 16/157 (10%)

Query: 1   MKRLRHPNIVLFMGAVTQPPN-----LSIVTEYLSRGSLYRLLHK---PGVREMLDERRR 52
           ++   HPNIV  +     P       L++V E++ +  L   L K   PG    L     
Sbjct: 55  LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPG----LPPETI 109

Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
            ++   + +G+++LH     IVHRDLK  N+LV     VK+ DFGL+R+ +   ++  S 
Sbjct: 110 KDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIYSFE-MALTSV 166

Query: 113 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ 149
             T  + APEVL         D++S G I  EL   +
Sbjct: 167 VVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRR 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 68.1 bits (167), Expect = 6e-14
 Identities = 39/108 (36%), Positives = 61/108 (56%), Gaps = 13/108 (12%)

Query: 1   MKRLRHPNIV-LFMGAVTQPPNLS-------IVTEYLSRGSLYRLLHKPGVREMLDERRR 52
           +K+L+HPN+V L   AV +P           +VT Y+    L  LL  P V+  L E + 
Sbjct: 61  LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVK--LTESQI 117

Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR 100
                 + +G+NYLH  +  I+HRD+K+ N+L+D +  +K+ DFGL+R
Sbjct: 118 KCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGLAR 163

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 67.6 bits (165), Expect = 6e-14
 Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 33/209 (15%)

Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL-----HKPGVREMLDERRRLNMAYD 58
           L+HPNI+  +G   +     +V EY   G L   L     H+   + +L +R    MA +
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR----MACE 107

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGL--SRLKANTFLSSKSAAGTP 116
           +A G+ ++H+ N   +H DL   N  +    TVKV D+G+  SR K +   +        
Sbjct: 108 IAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPL 165

Query: 117 EWMAPEV-------LRDEPSNEKSDIYSFGVILWEL-ATLQQPWGNLNPAQVVAAVGFKG 168
            W+APE+       L      + S++++ GV LWEL     QP+ +L+  +V+  V  K 
Sbjct: 166 RWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV-IKD 224

Query: 169 KRLEIPRNVNPHVA--------SIIEACW 189
           +++++ +   P +          +++ CW
Sbjct: 225 QQVKLFK---PQLELPYSERWYEVLQFCW 250

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 67.6 bits (165), Expect = 9e-14
 Identities = 41/147 (27%), Positives = 74/147 (50%), Gaps = 5/147 (3%)

Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
           HP +         P  L  V E+++ G L  + H    R   DE R    A ++   + +
Sbjct: 55  HPFLTQLYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRR-FDEARARFYAAEITSALMF 111

Query: 66  LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 125
           LH +   I++RDLK  N+L+D +   K+ DFG+ +       ++ +  GTP+++APE+L+
Sbjct: 112 LHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQ 169

Query: 126 DEPSNEKSDIYSFGVILWELATLQQPW 152
           +       D ++ GV+L+E+     P+
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 67.0 bits (164), Expect = 1e-13
 Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 6/153 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K+L+HPN+V  +    +   L +V EY     L  L   P     + E     + +   
Sbjct: 54  LKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNP---RGVPEHLIKKIIWQTL 110

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           + +N+ H+ N   +HRD+K  N+L+ K+  +K+CDFG +R+             T  + A
Sbjct: 111 QAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRA 168

Query: 121 PEVL-RDEPSNEKSDIYSFGVILWELATLQQPW 152
           PE+L  D       D+++ G +  EL T Q  W
Sbjct: 169 PELLVGDTQYGPPVDVWAIGCVFAELLTGQPLW 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 67.3 bits (164), Expect = 1e-13
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 16/169 (9%)

Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
            RHPNI+      T    L +++ +++ GS   LL K    E + E    N+ +   +G+
Sbjct: 56  FRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLL-KTYFPEGMSEALIGNILFGALRGL 114

Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA--NTFLSSKSAAGTPE---- 117
           NYLH+     +HR++K+ ++L+     V +   GLS L +       +K     P+    
Sbjct: 115 NYLHQNG--YIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTS 170

Query: 118 ---WMAPEVLRDEPS--NEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161
              W++PE+LR +    N KSDIYS G+   ELAT + P+ ++   Q++
Sbjct: 171 VLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML 219

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 67.5 bits (165), Expect = 2e-13
 Identities = 34/112 (30%), Positives = 55/112 (49%), Gaps = 20/112 (17%)

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA--NTFLSSKSA---- 112
           +   + Y+H +   ++HRDLK  N+L+     V + D+G +  K      L         
Sbjct: 122 ICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179

Query: 113 ------------AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
                        GTP++MAPE L   P++E +DIY+ GVIL+++ TL  P+
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231

Length = 932

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 67.0 bits (163), Expect = 2e-13
 Identities = 50/174 (28%), Positives = 96/174 (55%), Gaps = 8/174 (4%)

Query: 22  LSIVTEYLSRGSLYRLLHKPGVREML--DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK 79
           L ++ EY S G L + + K  ++E L   E     + Y +   ++ +H R   ++HRDLK
Sbjct: 140 LLLIMEYGSGGDLNKQI-KQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLK 196

Query: 80  SPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYS 137
           S N+ +     +K+ DFG S+  +++     + S  GTP ++APE+   +  ++K+D++S
Sbjct: 197 SANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWS 256

Query: 138 FGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK 191
            GVIL+EL TL +P+   +  +++  V + GK    P  V+  + ++++   +K
Sbjct: 257 LGVILYELLTLHRPFKGPSQREIMQQVLY-GKYDPFPCPVSSGMKALLDPLLSK 309

Length = 478

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 66.6 bits (163), Expect = 2e-13
 Identities = 48/157 (30%), Positives = 80/157 (50%), Gaps = 22/157 (14%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
           ++R +H NI+  +  + +PP+        IV E +    LY+L+      + L       
Sbjct: 57  LRRFKHENIIGIL-DIIRPPSFESFNDVYIVQELMET-DLYKLIKT----QHLSNDHIQY 110

Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT-----FLSS 109
             Y + +G+ Y+H  N  ++HRDLK  NLL++    +K+CDFGL+R+         FL+ 
Sbjct: 111 FLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTE 168

Query: 110 KSAAGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWEL 145
             A  T  + APE++ +     K+ DI+S G IL E+
Sbjct: 169 YVA--TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEM 203

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 65.6 bits (160), Expect = 4e-13
 Identities = 49/155 (31%), Positives = 73/155 (47%), Gaps = 22/155 (14%)

Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
           +P +V    +     +L +V EY+  G    LL   G   +  +  R+  A  V   + Y
Sbjct: 60  NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPV--DMARMYFAETVL-ALEY 116

Query: 66  LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----------------KANTFLSS 109
           LH  N  IVHRDLK  NLL+     +K+ DFGLS++                    FL  
Sbjct: 117 LH--NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL-D 173

Query: 110 KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWE 144
           K   GTPE++APEV+  +   +  D ++ G+IL+E
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYE 208

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 65.4 bits (159), Expect = 4e-13
 Identities = 48/150 (32%), Positives = 80/150 (53%), Gaps = 10/150 (6%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L+H NIV     +     L++V EYL       L +   +  M + +  +   + + 
Sbjct: 57  LKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFM---FQLL 113

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +G++Y H+R   I+HRDLK  NLL+++K  +K+ DFGL+R K+    +  +   T  +  
Sbjct: 114 RGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRP 171

Query: 121 PEVLRDEPSNEKS---DIYSFGVILWELAT 147
           P+VL    S E S   D++  G IL+E+AT
Sbjct: 172 PDVLLG--STEYSTPIDMWGVGCILYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 65.4 bits (159), Expect = 5e-13
 Identities = 44/155 (28%), Positives = 82/155 (52%), Gaps = 20/155 (12%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDE-RRRLNM---- 55
           +K L+H NIV     +    +L++V EYL +           +++ LD+    +NM    
Sbjct: 58  LKDLKHANIVTLHDIIHTEKSLTLVFEYLDKD----------LKQYLDDCGNSINMHNVK 107

Query: 56  --AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
              + + +G+NY HRR   ++HRDLK  NLL++++  +K+ DFGL+R K+    +  +  
Sbjct: 108 LFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEV 165

Query: 114 GTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELAT 147
            T  +  P++L      + + D++  G I +E++T
Sbjct: 166 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMST 200

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 65.0 bits (158), Expect = 8e-13
 Identities = 49/151 (32%), Positives = 83/151 (54%), Gaps = 12/151 (7%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDV 59
           +K L+H NIV     V    +L++V EYL +  L + +   G +  M + +  L   Y +
Sbjct: 58  LKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFL---YQI 113

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
            +G+ Y HRR   ++HRDLK  NLL++++  +K+ DFGL+R K+    +  +   T  + 
Sbjct: 114 LRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYR 171

Query: 120 APEVLRDEPSNEKS---DIYSFGVILWELAT 147
            P+VL    S+E S   D++  G I +E+A+
Sbjct: 172 PPDVLLG--SSEYSTQIDMWGVGCIFFEMAS 200

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 65.3 bits (159), Expect = 1e-12
 Identities = 49/152 (32%), Positives = 75/152 (49%), Gaps = 12/152 (7%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +L+HPNIV  +G         ++ EY+   +L  +L     R +  ERRR  +A  +A
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-----RNLSWERRR-KIAIGIA 790

Query: 61  KGMNYLHRR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
           K + +LH R +P +V  +L    +++D K    +    L  L         S+A    ++
Sbjct: 791 KALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA----YV 845

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQP 151
           APE    +   EKSDIY FG+IL EL T + P
Sbjct: 846 APETRETKDITEKSDIYGFGLILIELLTGKSP 877

Length = 968

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 64.3 bits (157), Expect = 1e-12
 Identities = 46/148 (31%), Positives = 69/148 (46%), Gaps = 8/148 (5%)

Query: 1   MKRLRHPNIVLFMGAVT--QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +  LRHPNIV     V      ++ +V EY  +  L  LL    +     E +   +   
Sbjct: 60  LLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDN--MPTPFSESQVKCLMLQ 116

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
           + +G+ YLH     I+HRDLK  NLL+  K  +K+ DFGL+R              T  +
Sbjct: 117 LLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWY 174

Query: 119 MAPEVLRDEPSNEKS-DIYSFGVILWEL 145
            APE+L    +   + D+++ G IL EL
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAEL 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 64.3 bits (156), Expect = 1e-12
 Identities = 46/150 (30%), Positives = 76/150 (50%), Gaps = 6/150 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ L+  NIV    A  +   L +V EY+ +  L  L   P    +  E+ R +  Y + 
Sbjct: 54  LRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMP--NGVPPEKVR-SYIYQLI 110

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEWM 119
           K +++ H+ +  IVHRD+K  NLL+     +K+CDFG +R L   +  +      T  + 
Sbjct: 111 KAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYR 168

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQ 149
           +PE+L   P  +  D++S G IL EL+  Q
Sbjct: 169 SPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 63.8 bits (155), Expect = 2e-12
 Identities = 46/152 (30%), Positives = 82/152 (53%), Gaps = 15/152 (9%)

Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P +V    A      L ++ +Y+S G ++  L++   R+   E      + ++   + +L
Sbjct: 65  PFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHL 121

Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK-----SAAGTPEWMAP 121
           H+    IV+RD+K  N+L+D +  V + DFGLS+     FLS +     S  GT E+MAP
Sbjct: 122 HKLG--IVYRDIKLENILLDSEGHVVLTDFGLSK----EFLSEEKERTYSFCGTIEYMAP 175

Query: 122 EVLRDEPSNEKS-DIYSFGVILWELATLQQPW 152
           E++R +  + K+ D +S G++++EL T   P+
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 63.7 bits (156), Expect = 3e-12
 Identities = 30/98 (30%), Positives = 46/98 (46%), Gaps = 21/98 (21%)

Query: 57  YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 116
           Y + K + Y+H  N  ++HRDLK  N+L++    VK+ DFGL+R    +    +     P
Sbjct: 114 YQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLAR----SLSELEENPENP 167

Query: 117 --------EWM-APEVLRDEPSNEKSDIYSFGVILWEL 145
                    W  APE+L        S  Y+ GV +W +
Sbjct: 168 VLTDYVATRWYRAPEILL------GSTRYTKGVDMWSV 199

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 63.2 bits (154), Expect = 4e-12
 Identities = 49/154 (31%), Positives = 73/154 (47%), Gaps = 23/154 (14%)

Query: 4   LRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVRE--MLDERRRLNM 55
            +H N VL    + QPP++       +VTE +        LHK  V    +  +  ++  
Sbjct: 56  FKHDN-VLSALDILQPPHIDPFEEIYVVTELMQSD-----LHKIIVSPQPLSSDHVKV-F 108

Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG- 114
            Y + +G+ YLH     I+HRD+K  NLLV+    +K+CDFGL+R++      SK     
Sbjct: 109 LYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVE--EPDESKHMTQE 164

Query: 115 --TPEWMAPEVLRDEPS-NEKSDIYSFGVILWEL 145
             T  + APE+L          DI+S G I  EL
Sbjct: 165 VVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAEL 198

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 62.2 bits (152), Expect = 5e-12
 Identities = 40/148 (27%), Positives = 73/148 (49%), Gaps = 12/148 (8%)

Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
           +PN +    +VT      ++ +Y+  G L+ LL K      L E     +   + + +N 
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALND 124

Query: 66  LHRRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKANTFLSSKSAA-GTPEWMAPEV 123
           LH+ N  I+H D+K  N+L D  K  + +CD+GL ++       + S   GT ++ +PE 
Sbjct: 125 LHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKII-----GTPSCYDGTLDYFSPEK 177

Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQP 151
           ++    +   D ++ GV+ +EL T + P
Sbjct: 178 IKGHNYDVSFDWWAVGVLTYELLTGKHP 205

Length = 267

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 62.4 bits (152), Expect = 5e-12
 Identities = 47/150 (31%), Positives = 76/150 (50%), Gaps = 10/150 (6%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L+H NIV     +     L++V EYL       +    G   M + R  L   + + 
Sbjct: 57  LKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFL---FQLL 113

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +G+ Y H+R   ++HRDLK  NLL+ ++  +K+ DFGL+R K+    +  +   T  +  
Sbjct: 114 RGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRP 171

Query: 121 PEVLRDEPSNEKS---DIYSFGVILWELAT 147
           P+VL    S E S   D++  G I +E+AT
Sbjct: 172 PDVLLG--STEYSTSLDMWGVGCIFYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 62.7 bits (152), Expect = 6e-12
 Identities = 47/151 (31%), Positives = 74/151 (49%), Gaps = 15/151 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
           +K + H NI+  +   T   +L       +V E L   +L +++H       LD  R   
Sbjct: 74  LKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME-LMDANLCQVIHME-----LDHERMSY 127

Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
           + Y +  G+ +LH  +  I+HRDLK  N++V    T+K+ DFGL+R     F+ +     
Sbjct: 128 LLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV- 184

Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
           T  + APEV+      E  DI+S G I+ EL
Sbjct: 185 TRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 61.9 bits (150), Expect = 9e-12
 Identities = 48/149 (32%), Positives = 75/149 (50%), Gaps = 12/149 (8%)

Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P IV    A   P  LS + + ++ G L+  L + GV     E      A ++  G+ ++
Sbjct: 57  PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV---FSEAEMRFYAAEIILGLEHM 113

Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA--GTPEWMAPEVL 124
           H R   +V+RDLK  N+L+D+   V++ D GL    A  F   K  A  GT  +MAPEVL
Sbjct: 114 HNRF--VVYRDLKPANILLDEHGHVRISDLGL----ACDFSKKKPHASVGTHGYMAPEVL 167

Query: 125 RDEPSNEKS-DIYSFGVILWELATLQQPW 152
           +   + + S D +S G +L++L     P+
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 61.9 bits (150), Expect = 1e-11
 Identities = 43/159 (27%), Positives = 71/159 (44%), Gaps = 25/159 (15%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRR------LN 54
           ++ + HP+I+   G  T          Y     L    +K  +   L  +R       L 
Sbjct: 137 LRAINHPSIIQLKGTFT----------YNKFTCLILPRYKTDLYCYLAAKRNIAICDILA 186

Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS----RLKANTFLSSK 110
           +   V + + YLH     I+HRD+K+ N+ ++    V + DFG +     + AN +    
Sbjct: 187 IERSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG-- 242

Query: 111 SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ 149
             AGT    APE+L  +P     DI+S G++L+E+AT  
Sbjct: 243 -WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 61.6 bits (149), Expect = 1e-11
 Identities = 43/149 (28%), Positives = 78/149 (52%), Gaps = 8/149 (5%)

Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P +V    A      L ++ +Y++ G L+  L +   RE   E+     + ++   + +L
Sbjct: 65  PFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHL 121

Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEWMAPEVLR 125
           H+    I++RD+K  N+L+D    V + DFGLS+    +    + S  GT E+MAP+++R
Sbjct: 122 HKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVR 179

Query: 126 --DEPSNEKSDIYSFGVILWELATLQQPW 152
             D   ++  D +S GV+++EL T   P+
Sbjct: 180 GGDGGHDKAVDWWSMGVLMYELLTGASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 61.2 bits (148), Expect = 2e-11
 Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 12/149 (8%)

Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P IV    A   P  L  + + ++ G L+  L + GV     E+     A ++  G+ ++
Sbjct: 57  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV---FSEKEMRFYATEIILGLEHM 113

Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK--SAAGTPEWMAPEVL 124
           H R   +V+RDLK  N+L+D+   V++ D GL    A  F   K  ++ GT  +MAPEVL
Sbjct: 114 HNRF--VVYRDLKPANILLDEHGHVRISDLGL----ACDFSKKKPHASVGTHGYMAPEVL 167

Query: 125 RDEPSNEKS-DIYSFGVILWELATLQQPW 152
           +   + + S D +S G +L++L     P+
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 60.7 bits (148), Expect = 2e-11
 Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 13/92 (14%)

Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-----LKANTFLSSKSAAGTP 116
           G+ +LH     I+HRDLK+ NLL++ +  +K+CDFGL+R     LK  T L       T 
Sbjct: 118 GVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-----TL 170

Query: 117 EWMAPEVLRDEPS-NEKSDIYSFGVILWELAT 147
            + APE+L      +   D++S G I  EL T
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLT 202

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 60.8 bits (147), Expect = 2e-11
 Identities = 47/151 (31%), Positives = 75/151 (49%), Gaps = 15/151 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
           MK + H NI+  +   T   +L       IV E L   +L ++     ++  LD  R   
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQV-----IQMELDHERMSY 130

Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
           + Y +  G+ +LH  +  I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     
Sbjct: 131 LLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV- 187

Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
           T  + APEV+      E  DI+S G I+ E+
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 60.9 bits (148), Expect = 3e-11
 Identities = 42/171 (24%), Positives = 73/171 (42%), Gaps = 39/171 (22%)

Query: 1   MKRLRHPNIVLFMGAV---TQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAY 57
           M  ++H NI   MG V    +   +++V + ++      L      ++++D + RL  + 
Sbjct: 74  MNEIKHENI---MGLVDVYVEGDFINLVMDIMA----SDL------KKVVDRKIRLTESQ 120

Query: 58  ------DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
                  +  G+N LH+     +HRDL   N+ ++ K   K+ DFGL+R       S   
Sbjct: 121 VKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178

Query: 112 AAG---------TPE-----WMAPEVLR-DEPSNEKSDIYSFGVILWELAT 147
           +           T +     + APE+L   E  +   D++S G I  EL T
Sbjct: 179 SKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229

Length = 335

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 60.9 bits (148), Expect = 3e-11
 Identities = 44/150 (29%), Positives = 75/150 (50%), Gaps = 11/150 (7%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M       IV    A      L +V EY+  G L  L+    + E   +  R   A +V 
Sbjct: 97  MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE---KWARFYTA-EVV 152

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
             ++ +H  +   +HRD+K  N+L+DK   +K+ DFG   ++ AN  +   +A GTP+++
Sbjct: 153 LALDAIH--SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYI 210

Query: 120 APEVLRDEPSN----EKSDIYSFGVILWEL 145
           +PEVL+ +  +     + D +S GV L+E+
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 60.4 bits (146), Expect = 3e-11
 Identities = 35/106 (33%), Positives = 57/106 (53%), Gaps = 3/106 (2%)

Query: 47  LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 106
            +E R L  A ++  G+  LHR N   V+RDLK  N+L+D    +++ D GL+ +K    
Sbjct: 99  FEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLA-VKIPEG 155

Query: 107 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
            S +   GT  +MAPEVL ++      D +  G +++E+   Q P+
Sbjct: 156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 60.4 bits (146), Expect = 4e-11
 Identities = 45/146 (30%), Positives = 72/146 (49%), Gaps = 6/146 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L+H NIVL    +     L+ V EY+       ++  PG   +     RL M + + 
Sbjct: 57  LKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPG--GLHPYNVRLFM-FQLL 113

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +G+ Y+H ++  I+HRDLK  NLL+     +K+ DFGL+R K+    +  S   T  +  
Sbjct: 114 RGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRP 171

Query: 121 PEVLRDEPSNEKS-DIYSFGVILWEL 145
           P+VL        + DI+  G I  E+
Sbjct: 172 PDVLLGATDYSSALDIWGAGCIFIEM 197

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 60.4 bits (146), Expect = 4e-11
 Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 40/179 (22%)

Query: 21  NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80
           NL ++ E+L  G +  LL K   ++ L E        +    ++ +H+     +HRD+K 
Sbjct: 75  NLYLIMEFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKP 129

Query: 81  PNLLVDKKYTVKVCDFGL------------------------------SRLKANTFLSSK 110
            NLL+D K  VK+ DFGL                              S+ KA T+  ++
Sbjct: 130 DNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNR 189

Query: 111 -----SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
                S  GTP+++APEV      N+  D +S GVI++E+     P+ +  P +    V
Sbjct: 190 RQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKV 248

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 60.5 bits (147), Expect = 4e-11
 Identities = 35/94 (37%), Positives = 52/94 (55%), Gaps = 7/94 (7%)

Query: 57  YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSS---KSA 112
           Y +  G+ Y+H  N  ++HRDLK  NLLV+    +K+CDFGL+R    N   ++      
Sbjct: 112 YQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEY 169

Query: 113 AGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWEL 145
             T  + APE++    S  K+ D++S G IL EL
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 60.4 bits (146), Expect = 4e-11
 Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 40/179 (22%)

Query: 21  NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80
           NL ++ E+L  G +  LL K   ++ L E        +    ++ +H+     +HRD+K 
Sbjct: 75  NLYLIMEFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKP 129

Query: 81  PNLLVDKKYTVKVCDFGL------------------------------SRLKANTFLSSK 110
            NLL+D K  VK+ DFGL                              S+ KA T+  ++
Sbjct: 130 DNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNR 189

Query: 111 -----SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
                S  GTP+++APEV      N+  D +S GVI++E+     P+ +  P +    V
Sbjct: 190 RQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKV 248

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 60.4 bits (146), Expect = 4e-11
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 11/151 (7%)

Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P +V    A      L +V EY+  G L  L+    V E   +        +V   ++ +
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKF----YTAEVVLALDAI 158

Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLR 125
           H     ++HRD+K  N+L+DK   +K+ DFG   ++     +   +A GTP++++PEVL+
Sbjct: 159 HSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLK 216

Query: 126 DEPSN----EKSDIYSFGVILWELATLQQPW 152
            +  +     + D +S GV L+E+     P+
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 60.7 bits (147), Expect = 4e-11
 Identities = 40/117 (34%), Positives = 59/117 (50%), Gaps = 5/117 (4%)

Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
           + P IV    ++    N+ +V EYL  G +  LLH  G     DE   +    +VA  ++
Sbjct: 62  KSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALD 118

Query: 65  YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAP 121
           YLHR    I+HRDLK  N+L+  +  +K+ DFGLS++  N  L+      TP    P
Sbjct: 119 YLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKP 173

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 60.0 bits (145), Expect = 5e-11
 Identities = 42/148 (28%), Positives = 72/148 (48%), Gaps = 20/148 (13%)

Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLN-----MAYD 58
           + HP  V   G+      L +V E++  G  +  L +         +R  N      A  
Sbjct: 88  INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR--------NKRFPNDVGCFYAAQ 139

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KANTFLSSKSAAGTPE 117
           +     YL   N  IV+RDLK  NLL+DK   +K+ DFG +++    T+    +  GTPE
Sbjct: 140 IVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY----TLCGTPE 193

Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWEL 145
           ++APE+L +    + +D ++ G+ ++E+
Sbjct: 194 YIAPEILLNVGHGKAADWWTLGIFIYEI 221

Length = 340

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 59.8 bits (145), Expect = 5e-11
 Identities = 43/133 (32%), Positives = 62/133 (46%), Gaps = 5/133 (3%)

Query: 20  PNLSIVTEYLSRG-SLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78
           P+L +V EYL      +   +  G    L  +   +  Y + KG+ + H+    ++HRDL
Sbjct: 79  PSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDL 136

Query: 79  KSPNLLVDK-KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKS-DIY 136
           K  NLLVDK K  +K+ D GL R  +    S      T  + APEVL          DI+
Sbjct: 137 KPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIW 196

Query: 137 SFGVILWELATLQ 149
           S G I  E++  Q
Sbjct: 197 SVGCIFAEMSRKQ 209

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 59.8 bits (145), Expect = 6e-11
 Identities = 45/182 (24%), Positives = 76/182 (41%), Gaps = 48/182 (26%)

Query: 21  NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80
           NL  V +Y+  G +  LL + G+ E  ++  R  +A ++   +  +H+     +HRD+K 
Sbjct: 75  NLYFVMDYIPGGDMMSLLIRLGIFE--EDLARFYIA-ELTCAIESVHKMG--FIHRDIKP 129

Query: 81  PNLLVDKKYTVKVCDFGLS----------------------------------------- 99
            N+L+D+   +K+ DFGL                                          
Sbjct: 130 DNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLE 189

Query: 100 --RLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP 157
             R + +    + S  GTP ++APEVL      +  D +S GVIL+E+   Q P+    P
Sbjct: 190 RRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTP 249

Query: 158 AQ 159
           A+
Sbjct: 250 AE 251

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 59.6 bits (144), Expect = 6e-11
 Identities = 33/106 (31%), Positives = 58/106 (54%), Gaps = 3/106 (2%)

Query: 47  LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 106
            +E R +  A ++  G+  LH+    IV+RDLK  N+L+D    +++ D GL+ +     
Sbjct: 99  FEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLA-VHVPEG 155

Query: 107 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
            + K   GT  +MAPEV+++E      D ++ G +L+E+   Q P+
Sbjct: 156 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 59.7 bits (144), Expect = 6e-11
 Identities = 43/145 (29%), Positives = 69/145 (47%), Gaps = 3/145 (2%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK + H NI+  +   T   +L    +      L        ++  LD  R   + Y + 
Sbjct: 70  MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 129

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ +LH  +  I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     T  + A
Sbjct: 130 CGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRA 186

Query: 121 PEVLRDEPSNEKSDIYSFGVILWEL 145
           PEV+      E  DI+S G I+ E+
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEM 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 59.2 bits (143), Expect = 7e-11
 Identities = 42/155 (27%), Positives = 84/155 (54%), Gaps = 6/155 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++++  P IV    A     +L +V   ++ G L   ++  G R  L+  R ++ +  + 
Sbjct: 47  LEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-LEMERVIHYSAQIT 105

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
            G+ +LH  +  IV+RD+K  N+L+D +   ++ D GL+  LK    ++ +  AGT  +M
Sbjct: 106 CGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR--AGTNGYM 161

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN 154
           APE+L++EP +   D ++ G  ++E+   + P+ +
Sbjct: 162 APEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 59.7 bits (145), Expect = 7e-11
 Identities = 45/164 (27%), Positives = 74/164 (45%), Gaps = 45/164 (27%)

Query: 21  NLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYDVAKGMNYLHRRNPPIVHRDLK 79
            L ++ EYL  G +  LL K   ++   E   R  +A +    ++ +H+     +HRD+K
Sbjct: 75  YLYLIMEYLPGGDMMTLLMK---KDTFTEEETRFYIA-ETILAIDSIHKLG--YIHRDIK 128

Query: 80  SPNLLVDKKYTVKVCDFGL---------------------------------SRLKANTF 106
             NLL+D K  +K+ DFGL                                 S+ KA T+
Sbjct: 129 PDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETW 188

Query: 107 LSSK-----SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
             ++     S  GTP+++APEV      N++ D +S GVI++E+
Sbjct: 189 KRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 59.4 bits (144), Expect = 8e-11
 Identities = 42/142 (29%), Positives = 74/142 (52%), Gaps = 18/142 (12%)

Query: 21  NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAY----DVAKGMNYLHRRNPPIVHR 76
           NL +V +Y   G L  LL K       ++R   +MA     ++   ++ +H+     VHR
Sbjct: 75  NLYLVMDYYVGGDLLTLLSK------FEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHR 126

Query: 77  DLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKS-- 133
           D+K  N+L+DK   +++ DFG   RL A+  + S  A GTP++++PE+L+     +    
Sbjct: 127 DIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYG 186

Query: 134 ---DIYSFGVILWELATLQQPW 152
              D +S GV ++E+   + P+
Sbjct: 187 PECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 59.3 bits (144), Expect = 1e-10
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 3/90 (3%)

Query: 57  YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 116
           Y + +G+ Y+H  N  ++HRDLK  NLL++    +K+CDFGL+R  +           T 
Sbjct: 115 YQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR 172

Query: 117 EWMAPEVLRDEPSNEKS-DIYSFGVILWEL 145
            + APE+L +      + D++S G I  EL
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAEL 202

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 58.7 bits (142), Expect = 1e-10
 Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 5/106 (4%)

Query: 48  DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTF 106
           DE R +  A ++  G+  LHR    IV+RDLK  N+L+D    +++ D GL+  +     
Sbjct: 100 DEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157

Query: 107 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +  +   GT  +MAPEV+++E      D +  G +++E+   + P+
Sbjct: 158 I--RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 58.4 bits (141), Expect = 2e-10
 Identities = 45/149 (30%), Positives = 76/149 (51%), Gaps = 7/149 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTE-YLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           +K ++H N++  +   T   +L    + YL    +   L K    E L E R   + Y +
Sbjct: 68  LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQM 127

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
            KG+ Y+H     I+HRDLK  NL V++   +K+ DFGL+R + ++ ++      T  + 
Sbjct: 128 LKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR-QTDSEMTGYVV--TRWYR 182

Query: 120 APEVLRD-EPSNEKSDIYSFGVILWELAT 147
           APEV+ +     +  DI+S G I+ E+ T
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLT 211

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 58.5 bits (142), Expect = 2e-10
 Identities = 41/154 (26%), Positives = 78/154 (50%), Gaps = 17/154 (11%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
           +K + H N++  +   T   +L       +VT  +    L  ++     +++ D+  +  
Sbjct: 68  LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIV---KCQKLSDDHIQF- 122

Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
           + Y + +G+ Y+H     I+HRDLK  N+ V++   +K+ DFGL+R   +  ++   A  
Sbjct: 123 LVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARH-TDDEMTGYVA-- 177

Query: 115 TPEWMAPEVLRDEPS-NEKSDIYSFGVILWELAT 147
           T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 211

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 58.1 bits (140), Expect = 3e-10
 Identities = 40/136 (29%), Positives = 70/136 (51%), Gaps = 11/136 (8%)

Query: 22  LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
           L +V EY+  G L  L+    V E   +  R   A +V   ++ +H      +HRD+K  
Sbjct: 118 LYMVMEYMPGGDLVNLMSNYDVPE---KWARFYTA-EVVLALDAIHSMG--FIHRDVKPD 171

Query: 82  NLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLRDEPSN----EKSDIY 136
           N+L+DK   +K+ DFG   ++     +   +A GTP++++PEVL+ +  +     + D +
Sbjct: 172 NMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 231

Query: 137 SFGVILWELATLQQPW 152
           S GV L+E+     P+
Sbjct: 232 SVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 57.7 bits (139), Expect = 3e-10
 Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 18/154 (11%)

Query: 1   MKRLRHPNIVLFMGAVT-----QPPNLSIVTEYLSRGSLYRLLHK---PGV-REMLDERR 51
           ++   HPN+V      T     +   L++V E++ +  L   L K   PGV  E + +  
Sbjct: 58  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD-- 114

Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
              M + + +G+++LH     +VHRDLK  N+LV     +K+ DFGL+R+ +     + S
Sbjct: 115 ---MMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT-S 168

Query: 112 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
              T  + APEVL         D++S G I  E+
Sbjct: 169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 57.1 bits (138), Expect = 4e-10
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 6/152 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L+H NIV     +     L++V EY  +  L +          +D     +  + + 
Sbjct: 53  LKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFD--SCNGDIDPEIVKSFMFQLL 109

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           KG+ + H  N  ++HRDLK  NLL++K   +K+ DFGL+R          +   T  +  
Sbjct: 110 KGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRP 167

Query: 121 PEVLRDEPSNEKS-DIYSFGVILWELATLQQP 151
           P+VL        S D++S G I  ELA   +P
Sbjct: 168 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 56.5 bits (136), Expect = 7e-10
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 3/106 (2%)

Query: 47  LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 106
            DE+R +  A ++  G+  L R    IV+RDLK  N+L+D +  +++ D GL+ ++    
Sbjct: 99  FDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLA-VQIPEG 155

Query: 107 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
            + +   GT  +MAPEV+ +E      D +  G +++E+   Q P+
Sbjct: 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 56.6 bits (136), Expect = 7e-10
 Identities = 46/148 (31%), Positives = 76/148 (51%), Gaps = 10/148 (6%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L+H NIVL    +     L++V EY+       +   PG   +  E  +L + + + 
Sbjct: 57  LKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPG--GLHPENVKLFL-FQLL 113

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +G++Y+H+R   I+HRDLK  NLL+     +K+ DFGL+R K+    +  +   T  +  
Sbjct: 114 RGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRP 171

Query: 121 PEVLRDEPSNEKS---DIYSFGVILWEL 145
           P+VL    S E S   D++  G I  E+
Sbjct: 172 PDVLLG--STEYSTCLDMWGVGCIFVEM 197

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 56.2 bits (136), Expect = 1e-09
 Identities = 40/156 (25%), Positives = 78/156 (50%), Gaps = 19/156 (12%)

Query: 1   MKRLRHPNIV----LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
           ++  +H NI+    +         ++ +V + L    L+ ++H    + + +E  R  + 
Sbjct: 58  LRHFKHDNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIH--SDQPLTEEHIRYFL- 113

Query: 57  YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN------TFLSSK 110
           Y + +G+ Y+H  N  ++HRDLK  NLLV++   +++ DFG++R  ++       F++  
Sbjct: 114 YQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171

Query: 111 SAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWEL 145
            A  T  + APE+L   P      D++S G I  E+
Sbjct: 172 VA--TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 55.8 bits (134), Expect = 1e-09
 Identities = 44/167 (26%), Positives = 78/167 (46%), Gaps = 18/167 (10%)

Query: 21  NLSIVTEYLSRGSLYRLLHKPGVREMLDERR----RLNMAYDVAKGMNYLHRRNPPIVHR 76
           NL +V +Y   G L  LL K   R   D  R     + +A D    ++Y        VHR
Sbjct: 75  NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY--------VHR 126

Query: 77  DLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLRDEPSNE---- 131
           D+K  N+L+D    +++ DFG   +L  +  + S  A GTP++++PE+L+     +    
Sbjct: 127 DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYG 186

Query: 132 -KSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            + D +S GV ++E+   + P+   +  +    +    +R + P  V
Sbjct: 187 PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQV 233

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 55.2 bits (133), Expect = 2e-09
 Identities = 50/163 (30%), Positives = 76/163 (46%), Gaps = 25/163 (15%)

Query: 1   MKRLRHPNIVLFMGAVT--QPP--------NLSIVTEYLSRGSLYRLLHKPGVREMLDER 50
           +++L H NIV     VT  Q             +V EY+    L  LL    V     E 
Sbjct: 60  LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVH--FSED 116

Query: 51  RRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK 110
              +    + +G+NY H++N   +HRD+K  N+L++ K  +K+ DFGL+RL    + S +
Sbjct: 117 HIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADFGLARL----YNSEE 170

Query: 111 SAAGTPE----WMAPE--VLRDEPSNEKSDIYSFGVILWELAT 147
           S   T +    W  P   +L +E      D++S G IL EL T
Sbjct: 171 SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 55.1 bits (133), Expect = 2e-09
 Identities = 42/167 (25%), Positives = 72/167 (43%), Gaps = 32/167 (19%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-----------RLLHKPGVREMLDE 49
           ++ L+H N+V  +                 +GS Y            LL    V+  L E
Sbjct: 65  LQLLKHENVVNLIEICRTKAT----PYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE 120

Query: 50  RRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS 109
            ++  +   +  G+ Y+HR    I+HRD+K+ N+L+ K   +K+ DFGL+R     F  S
Sbjct: 121 IKK--VMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLAR----AFSLS 172

Query: 110 KSAAG--------TPEWMAPEV-LRDEPSNEKSDIYSFGVILWELAT 147
           K++          T  +  PE+ L +       D++  G I+ E+ T
Sbjct: 173 KNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 54.9 bits (132), Expect = 3e-09
 Identities = 50/174 (28%), Positives = 77/174 (44%), Gaps = 24/174 (13%)

Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAY---D 58
           K   HPNIV +         L +VT +++ GS   L+        +D    L +AY    
Sbjct: 54  KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI----CTHFMDGMSELAIAYILQG 109

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGL----------SRLKANTFLS 108
           V K ++Y+H      VHR +K+ ++L+      KV   GL           RL+      
Sbjct: 110 VLKALDYIHHMG--YVHRSVKASHILI--SVDGKVYLSGLRSNLSMINHGQRLRVVHDFP 165

Query: 109 SKSAAGTPEWMAPEVLRD--EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160
             S    P W++PEVL+   +  + KSDIYS G+   ELA    P+ ++   Q+
Sbjct: 166 KYSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM 218

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 55.1 bits (132), Expect = 3e-09
 Identities = 50/187 (26%), Positives = 89/187 (47%), Gaps = 36/187 (19%)

Query: 1   MKRLRHPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKPGVREM---LDERRRLNM 55
           M+ L+H NIV ++       N  L I+ E+   G L R + K    +M   ++E   +++
Sbjct: 66  MRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQK--CYKMFGKIEEHAIVDI 123

Query: 56  AYDVAKGMNYLHR-RNPP----IVHRDLKSPNLLV-----------------DKKYTVKV 93
              +   + Y H  ++ P    ++HRDLK  N+ +                 + +   K+
Sbjct: 124 TRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKI 183

Query: 94  CDFGLSRLKANTFLSS--KSAAGTPEWMAPEVLRDEPS--NEKSDIYSFGVILWELATLQ 149
            DFGLS+   N  + S   S  GTP + +PE+L  E    ++KSD+++ G I++EL + +
Sbjct: 184 GDFGLSK---NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Query: 150 QPWGNLN 156
            P+   N
Sbjct: 241 TPFHKAN 247

Length = 1021

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 54.7 bits (131), Expect = 4e-09
 Identities = 41/156 (26%), Positives = 76/156 (48%), Gaps = 21/156 (13%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV--------REMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 70  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 123

Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +        
Sbjct: 124 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGY 177

Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 178 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 54.0 bits (130), Expect = 4e-09
 Identities = 41/154 (26%), Positives = 75/154 (48%), Gaps = 18/154 (11%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +L H ++V   G   +  N+ +V EY+  G L   LH+   +  +    +L++A  +A
Sbjct: 55  MSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHR--EKNNVSLHWKLDVAKQLA 111

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLV-----DKKYT--VKVCDFGLSRLKANTFLSSKSAA 113
             ++YL  +   +VH ++   N+LV     ++ Y   +K+ D G+      T LS +   
Sbjct: 112 SALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI----TVLSREERV 165

Query: 114 GTPEWMAPEVLRDEPSNEKS--DIYSFGVILWEL 145
               W+APE +R+  ++     D +SFG  L E+
Sbjct: 166 ERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 54.0 bits (130), Expect = 4e-09
 Identities = 40/148 (27%), Positives = 72/148 (48%), Gaps = 5/148 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L HPNIV  +  +     L +V E+L +  L + +    +  +     + +  + + 
Sbjct: 53  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIK-SYLFQLL 110

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +      T  + A
Sbjct: 111 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 168

Query: 121 PEVLRD-EPSNEKSDIYSFGVILWELAT 147
           PE+L   +  +   DI+S G I  E+ T
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 53.4 bits (129), Expect = 9e-09
 Identities = 46/173 (26%), Positives = 72/173 (41%), Gaps = 34/173 (19%)

Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-PGVREMLDERRRLNMAYDVAK 61
            L HP +     +      L +V +Y   G L+RLL + PG  + L E      A +V  
Sbjct: 57  TLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPG--KCLSEEVARFYAAEVLL 114

Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT---------------- 105
            + YLH     IV+RDLK  N+L+ +   + + DF LS+                     
Sbjct: 115 ALEYLH--LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172

Query: 106 -------FLS------SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
                    S      S S  GT E++APEV+  +      D ++ G++L+E+
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEM 225

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 53.0 bits (127), Expect = 1e-08
 Identities = 41/149 (27%), Positives = 75/149 (50%), Gaps = 8/149 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTE-YLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           +K ++H N++  +   T   +     + YL    +   L K     + +++ +  + Y +
Sbjct: 68  LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQY-LVYQM 126

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
             G+ Y+H     I+HRDLK  NL V++   +K+ DFGL+R  A+  ++      T  + 
Sbjct: 127 LCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTGYVV--TRWYR 181

Query: 120 APEVLRD-EPSNEKSDIYSFGVILWELAT 147
           APEV+ +    N+  DI+S G I+ E+ T
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLT 210

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 52.5 bits (126), Expect = 2e-08
 Identities = 45/153 (29%), Positives = 70/153 (45%), Gaps = 7/153 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K ++H NIV     V     L +V EYL       +   P   +  + R      Y + 
Sbjct: 55  LKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAK--NPRLIKTYLYQIL 112

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
           +G+ Y H     ++HRDLK  NLL+D++   +K+ DFGL+R       +      T  + 
Sbjct: 113 RGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYR 170

Query: 120 APEVLRDEPS-NEKSDIYSFGVILWELATLQQP 151
           APE+L      +   DI+S G I  E+   Q+P
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVN-QKP 202

Length = 294

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 51.4 bits (123), Expect = 3e-08
 Identities = 47/198 (23%), Positives = 92/198 (46%), Gaps = 21/198 (10%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +L H ++VL  G         +V EY+  GSL   L K   + +++   +L +A  +A
Sbjct: 53  MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKN--KNLINISWKLEVAKQLA 110

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLV----DKKYT----VKVCDFGLSRLKANTFLSSKSA 112
             +++L  +   + H ++ + N+L+    D+K      +K+ D G+S     T L  +  
Sbjct: 111 WALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI----TVLPKEIL 164

Query: 113 AGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKR 170
                W+ PE + +  + +  +D +SFG  LWE+ +   +P   L+  +    + F   R
Sbjct: 165 LERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KLQFYEDR 221

Query: 171 LEIPRNVNPHVASIIEAC 188
            ++P      +A++I  C
Sbjct: 222 HQLPAPKWTELANLINQC 239

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 51.5 bits (123), Expect = 4e-08
 Identities = 45/153 (29%), Positives = 71/153 (46%), Gaps = 13/153 (8%)

Query: 1   MKRLR---HPNIVLFMGAVT-----QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRR 52
           +KRL    HPNIV  M         +   +++V E++ +     L   P      +  + 
Sbjct: 53  LKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKD 112

Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
           L   +   +G+++LH     IVHRDLK  N+LV     VK+ DFGL+R+ +   ++    
Sbjct: 113 LMRQF--LRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ-MALTPV 167

Query: 113 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
             T  + APEVL         D++S G I  E+
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 51.5 bits (124), Expect = 4e-08
 Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 15/158 (9%)

Query: 4   LRHPNIVLFMGAVTQPPNLSI--VTEYLSRGSLYRLL--HKPGVREMLDERRRLNMAYDV 59
           L+H N+V  +    +  + S+  + +Y +   L++++  H+   R  +      ++ + +
Sbjct: 59  LKHENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSRLKAN---TFLSSKSA 112
             G++YLH     ++HRDLK  N+LV     ++  VK+ D GL+RL              
Sbjct: 118 LNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175

Query: 113 AGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQ 149
             T  + APE+L       K+ DI++ G I  EL TL+
Sbjct: 176 VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 50.8 bits (121), Expect = 7e-08
 Identities = 43/163 (26%), Positives = 83/163 (50%), Gaps = 12/163 (7%)

Query: 22  LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
           L +V +Y   G L  LL K   R + ++  R  +A ++   ++ +H+ +   VHRD+K  
Sbjct: 76  LYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIA-EMVLAIHSIHQLH--YVHRDIKPD 131

Query: 82  NLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEPS-----NEKSD 134
           N+L+D    +++ DFG S LK N    + S  A GTP++++PE+L+           + D
Sbjct: 132 NVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECD 190

Query: 135 IYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            +S GV ++E+   + P+   +  +    +    +R + P ++
Sbjct: 191 WWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI 233

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 50.4 bits (120), Expect = 1e-07
 Identities = 40/147 (27%), Positives = 77/147 (52%), Gaps = 7/147 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTE-YLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           +K ++H N++  +   T   ++    E YL    +   L+     + L +     + Y +
Sbjct: 68  LKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQL 127

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
            +G+ Y+H  +  I+HRDLK  N+ V++   +++ DFGL+R +A+  ++   A  T  + 
Sbjct: 128 LRGLKYIH--SAGIIHRDLKPSNVAVNEDCELRILDFGLAR-QADDEMTGYVA--TRWYR 182

Query: 120 APEVLRD-EPSNEKSDIYSFGVILWEL 145
           APE++ +    N+  DI+S G I+ EL
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAEL 209

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 50.2 bits (120), Expect = 1e-07
 Identities = 32/100 (32%), Positives = 56/100 (56%), Gaps = 8/100 (8%)

Query: 53  LNMAYDVAKGM----NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFL 107
           L  A  + + +     YLH R   I+HRD+K+ N+ +D+     + DFG + +L A+   
Sbjct: 184 LEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241

Query: 108 SSKSA-AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA 146
                 +GT E  +PE+L  +P   K+DI+S G++L+E++
Sbjct: 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281

Length = 392

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 49.0 bits (117), Expect = 3e-07
 Identities = 46/167 (27%), Positives = 78/167 (46%), Gaps = 28/167 (16%)

Query: 1   MKRLRHPNIV-----LFMGAVTQPPNLSIVTEY--------LSRGSLYRLLHKPGVREML 47
           ++RL H NIV     L         ++  +TE              L  +L +     + 
Sbjct: 56  IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ---GPLS 112

Query: 48  DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFGLSRLKANTF 106
           +E  RL M Y + +G+ Y+H  N  ++HRDLK  N+ ++ +  V K+ DFGL+R+  +  
Sbjct: 113 EEHARLFM-YQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARI-VDPH 168

Query: 107 LSSK---SAAGTPEWM-APEVLRDEPSN--EKSDIYSFGVILWELAT 147
            S K   S     +W  +P +L   P+N  +  D+++ G I  E+ T
Sbjct: 169 YSHKGYLSEGLVTKWYRSPRLLL-SPNNYTKAIDMWAAGCIFAEMLT 214

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 49.0 bits (117), Expect = 3e-07
 Identities = 33/98 (33%), Positives = 49/98 (50%), Gaps = 11/98 (11%)

Query: 57  YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN-----TFLSSKS 111
           Y + + + Y+H  N  + HRDLK  N+L +    +K+CDFGL+R+  N      F +   
Sbjct: 110 YQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 167

Query: 112 AAGTPEWMAPEVLRDEPSNEKS--DIYSFGVILWELAT 147
           A  T  + APE+     S      DI+S G I  E+ T
Sbjct: 168 A--TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 203

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 48.4 bits (115), Expect = 4e-07
 Identities = 39/153 (25%), Positives = 76/153 (49%), Gaps = 16/153 (10%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M+++ H +IVL  G   +     +V E++  G L   +H+    ++L    +  +A  +A
Sbjct: 58  MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLA 115

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLV-----DKKYT--VKVCDFGLSRLKANTFLSSKSAA 113
             ++YL  ++  +VH ++ + N+L+     D +    +K+ D G+      T LS +   
Sbjct: 116 SALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI----TVLSRQECV 169

Query: 114 GTPEWMAPEVLRDEPS-NEKSDIYSFGVILWEL 145
               W+APE + D  + +  +D +SFG  LWE+
Sbjct: 170 ERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 48.1 bits (114), Expect = 6e-07
 Identities = 51/214 (23%), Positives = 86/214 (40%), Gaps = 54/214 (25%)

Query: 21  NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80
           NL  V +Y+  G +  LL + G+    ++  R  +A ++   +  +H+     +HRD+K 
Sbjct: 75  NLYFVMDYIPGGDMMSLLIRMGIFP--EDLARFYIA-ELTCAVESVHKMG--FIHRDIKP 129

Query: 81  PNLLVDKKYTVKVCDFGL---------------------------------------SRL 101
            N+L+D+   +K+ DFGL                                        RL
Sbjct: 130 DNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRL 189

Query: 102 KANTFLSSK--------SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWG 153
           K     +++        S  GTP ++APEVL      +  D +S GVIL+E+   Q P+ 
Sbjct: 190 KPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFL 249

Query: 154 NLNPAQVVAAVGFKGKRLEIP--RNVNPHVASII 185
              P +    V      L IP    ++P  + +I
Sbjct: 250 AQTPLETQMKVINWQTSLHIPPQAKLSPEASDLI 283

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 47.7 bits (113), Expect = 1e-06
 Identities = 54/217 (24%), Positives = 81/217 (37%), Gaps = 60/217 (27%)

Query: 21  NLSIVTEYLSRGSLYRLLHKPGVREMLDER---RRLNMAYDVAKGMNYLHRRNPPIVHRD 77
           NL  V +Y+  G +  LL +  V   +  R     L +A +    M +        +HRD
Sbjct: 75  NLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF--------IHRD 126

Query: 78  LKSPNLLVDKKYTVKVCDFGL--------------------------------------- 98
           +K  N+L+D    +K+ DFGL                                       
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186

Query: 99  SRLKANTFLSSK--------SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ 150
            RLK     ++K        S  GTP ++APEVL  +   +  D +S GVIL+E+   Q 
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQP 246

Query: 151 PWGNLNPAQVVAAVGFKGKRLEIPRNV--NPHVASII 185
           P+    P +    V      L IP  V  +P    +I
Sbjct: 247 PFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLI 283

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 47.6 bits (113), Expect = 1e-06
 Identities = 49/161 (30%), Positives = 73/161 (45%), Gaps = 33/161 (20%)

Query: 1   MKRLRHPNIVLFM-----GAVT---QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRR 52
           ++RL HP ++  +     G +T    P   S +  YL      R L    V  +    R+
Sbjct: 214 LRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARL--RPLGLAQVTAV---ARQ 268

Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL-SSKS 111
           L  A D      Y+H     I+HRD+K+ N+LV+    + + DFG     A  F   S S
Sbjct: 269 LLSAID------YIHGEG--IIHRDIKTENVLVNGPEDICLGDFG-----AACFARGSWS 315

Query: 112 A------AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA 146
                  AGT +  APEVL  +P     DI+S G++++E A
Sbjct: 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356

Length = 461

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.5 bits (105), Expect = 1e-05
 Identities = 31/118 (26%), Positives = 51/118 (43%), Gaps = 47/118 (39%)

Query: 74  VHRDLKSPNLLVDKKYTVKVCDFGLS-------------RL---KANTF----------- 106
           +HRD+K  N+L+D+   +K+ DFGLS             +L   K+N             
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182

Query: 107 -----LSSK---------------SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWE 144
                +SSK               S  GTP+++APE+   +   ++ D +S G I++E
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 44.6 bits (105), Expect = 1e-05
 Identities = 29/97 (29%), Positives = 54/97 (55%), Gaps = 15/97 (15%)

Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD-KKYTVKVCDFG-----LSRLKANTFLSS 109
           +Y + + + Y+H +   I HRDLK  NLL+D   +T+K+CDFG     L+  ++ +++ S
Sbjct: 176 SYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICS 233

Query: 110 KSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWEL 145
           +       + APE++    +     D++S G I+ E+
Sbjct: 234 RF------YRAPELMLGATNYTTHIDLWSLGCIIAEM 264

Length = 440

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 42.6 bits (100), Expect = 5e-05
 Identities = 46/203 (22%), Positives = 87/203 (42%), Gaps = 32/203 (15%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV- 59
           M ++ H ++    G   +     +V E++  G L   L K        E+ R+ +A+ + 
Sbjct: 70  MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK--------EKGRVPVAWKIT 121

Query: 60  -----AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT-------VKVCDFGLSRLKANTFL 107
                A  ++YL  +N  +VH ++ + N+L+ +          +K+ D G+S     T L
Sbjct: 122 VAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSF----TAL 175

Query: 108 SSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELA-TLQQPWGNLNPAQVVAAVG 165
           S +       W+APE +    S +  +D +SFG  L E+    + P     P++      
Sbjct: 176 SREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE---KER 232

Query: 166 FKGKRLEIPRNVNPHVASIIEAC 188
           F  K+  +P      +A++I  C
Sbjct: 233 FYEKKHRLPEPSCKELATLISQC 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 38.5 bits (90), Expect = 6e-04
 Identities = 16/42 (38%), Positives = 26/42 (61%)

Query: 105 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA 146
            F + + +   P +MAPEV++ +   EK+DIYS G+ L+E  
Sbjct: 57  AFKTPEQSRPDPYFMAPEVIQGQSYTEKADIYSLGITLYEAL 98

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 39.3 bits (91), Expect = 7e-04
 Identities = 33/102 (32%), Positives = 51/102 (50%), Gaps = 10/102 (9%)

Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSRLKANTF--L 107
           ++ Y +  G++YLH     ++HRDLK  N+LV     ++  VK+ D G +RL  +    L
Sbjct: 112 SLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169

Query: 108 SSKSAAGTPEWM-APEVLRDEPSNEKS-DIYSFGVILWELAT 147
           +         W  APE+L       K+ DI++ G I  EL T
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 38.9 bits (90), Expect = 8e-04
 Identities = 37/156 (23%), Positives = 70/156 (44%), Gaps = 18/156 (11%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV----REMLDERRRLNMA 56
           + RL H NI+     +    N  ++T+      LY  ++        R +L + R +   
Sbjct: 217 LGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAI--M 273

Query: 57  YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA---- 112
             +   + Y+H +   ++HRD+K  N+ ++    + + DFG     A  F   + A    
Sbjct: 274 KQLLCAVEYIHDKK--LIHRDIKLENIFLNCDGKIVLGDFG----TAMPFEKEREAFDYG 327

Query: 113 -AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147
             GT    +PE+L  +   E +DI+S G+IL ++ +
Sbjct: 328 WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 38.9 bits (90), Expect = 8e-04
 Identities = 33/102 (32%), Positives = 51/102 (50%), Gaps = 10/102 (9%)

Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSRLKANTF--L 107
           ++ Y +  G++YLH     ++HRDLK  N+LV     ++  VK+ D G +RL  +    L
Sbjct: 112 SLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169

Query: 108 SSKSAAGTPEWM-APEVLRDEPSNEKS-DIYSFGVILWELAT 147
           +         W  APE+L       K+ DI++ G I  EL T
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	191
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.98
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.98
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.98
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.98
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.98
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.98
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.98
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.98
PLN00009	294	cyclin-dependent kinase A; Provisional	99.98
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.98
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.98
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.98
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.98
PHA03211	461	serine/threonine kinase US3; Provisional	99.97
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.97
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.97
PHA03209	357	serine/threonine kinase US3; Provisional	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.97
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.97
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.97
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.97
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.97
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.97
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.97
PHA02882	294	putative serine/threonine kinase; Provisional	99.97
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
PTZ00284	467	protein kinase; Provisional	99.97
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.97
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.97
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.97
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.97
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.97
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.97
PHA03210	501	serine/threonine kinase US3; Provisional	99.97
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.97
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.97
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.96
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.96
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.96
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.96
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.95
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.95
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.95
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.95
KOG3653	534	consensus Transforming growth factor beta/activin	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.94
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.93
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.93
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.93
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.92
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.92
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.92
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.91
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.91
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.91
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.91
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.9
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.89
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.85
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.85
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.85
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.83
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.83
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.83
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.83
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.82
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.8
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.77
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.75
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.75
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.71
PRK09188	365	serine/threonine protein kinase; Provisional	99.69
PRK12274	218	serine/threonine protein kinase; Provisional	99.67
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.66
KOG1243	690	consensus Protein kinase [General function predict	99.64
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.64
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.63
PRK10345	210	hypothetical protein; Provisional	99.62
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.61
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.6
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.51
PRK14879	211	serine/threonine protein kinase; Provisional	99.47
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.44
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.42
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.41
smart00090	237	RIO RIO-like kinase.	99.36
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.28
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.28
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.25
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.19
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.18
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.08
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.97
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.96
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.95
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.93
COG4248	637	Uncharacterized protein with protein kinase and he	98.92
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.84
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.82
KOG3087	229	consensus Serine/threonine protein kinase [General	98.81
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.79
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.76
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.68
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.64
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.58
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.54
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.34
PRK09902	216	hypothetical protein; Provisional	98.28
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.25
COG0478	304	RIO-like serine/threonine protein kinase fused to	97.99
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.98
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.79
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.55
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.42
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.4
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.27
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.25
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.08
KOG1235	538	consensus Predicted unusual protein kinase [Genera	96.93
PLN02876	822	acyl-CoA dehydrogenase	96.76
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.62
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.36
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	95.62
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	95.18
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.1
KOG2268	465	consensus Serine/threonine protein kinase [Signal	94.97
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	94.95
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	94.81
PF01636	239	APH: Phosphotransferase enzyme family This family	94.75
COG4499	434	Predicted membrane protein [Function unknown]	94.72
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	94.71
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	94.58
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	94.5
KOG1093	725	consensus Predicted protein kinase (contains TBC a	94.46
PRK14559	645	putative protein serine/threonine phosphatase; Pro	94.15
PRK10271	188	thiK thiamine kinase; Provisional	93.93
PRK05231	319	homoserine kinase; Provisional	93.76
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	93.53
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	93.33
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	92.5
PLN02236	344	choline kinase	91.94
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	91.93
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	91.4
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	90.83
COG2334	331	Putative homoserine kinase type II (protein kinase	89.68
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	89.32
PRK06148	1013	hypothetical protein; Provisional	89.06
PF10140	359	YukC: WXG100 protein secretion system (Wss), prote	88.71
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	88.67
PRK11768	325	serine/threonine protein kinase; Provisional	88.13
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	87.89
KOG1236	565	consensus Predicted unusual protein kinase [Genera	87.31
PRK09550	401	mtnK methylthioribose kinase; Reviewed	86.56
PRK12396	409	5-methylribose kinase; Reviewed	85.64

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=6e-45  Score=268.39  Aligned_cols=185  Identities=26%  Similarity=0.463  Sum_probs=169.6

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||+||+++..|++++.+|+|+||+.||.|...+++.+.   +++..++.++.+|+.||.|||+.|  |+|||+||
T Consensus        79 L~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKP  153 (357)
T KOG0598|consen   79 LSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSKG--IIYRDLKP  153 (357)
T ss_pred             HHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhCC--eeeccCCH
Confidence            4678999999999999999999999999999999999998664   999999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++..|.++|+|||++.............++++.|||||++.+..++.++|+||||+++|+|++|..||...+....
T Consensus       154 ENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~  233 (357)
T KOG0598|consen  154 ENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM  233 (357)
T ss_pred             HHeeecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH
Confidence            99999999999999999998766665667778999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+++... .....|..+|.+.+++|++.|++
T Consensus       234 ~~~I~~~-k~~~~p~~ls~~ardll~~LL~r  263 (357)
T KOG0598|consen  234 YDKILKG-KLPLPPGYLSEEARDLLKKLLKR  263 (357)
T ss_pred             HHHHhcC-cCCCCCccCCHHHHHHHHHHhcc
Confidence            9999532 22445556999999999999875

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-45  Score=269.04  Aligned_cols=183  Identities=35%  Similarity=0.586  Sum_probs=166.0

Q ss_pred             CCCCCCCCcccccceeecCCc-eEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCeeecCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPN-LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDL   78 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~~h~~l   78 (191)
                      |+..+|||||++++.|.+++. ++++||||++|+|++++...+   .++|.....++.++++||.|||. ++  |+||||
T Consensus       131 l~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDI  205 (364)
T KOG0581|consen  131 LRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEERK--IIHRDI  205 (364)
T ss_pred             HhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhccC--eeeccC
Confidence            356799999999999999885 999999999999999998754   39999999999999999999996 88  999999


Q ss_pred             CCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC---
Q 029552           79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL---  155 (191)
Q Consensus        79 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~---  155 (191)
                      ||+|++++..|.+||+|||.+....++  ......++..|||||.+.+..|+.++||||||+++.|+++|+.||...   
T Consensus       206 KPsNlLvNskGeVKicDFGVS~~lvnS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~  283 (364)
T KOG0581|consen  206 KPSNLLVNSKGEVKICDFGVSGILVNS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP  283 (364)
T ss_pred             CHHHeeeccCCCEEeccccccHHhhhh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC
Confidence            999999999999999999998766655  556778999999999999999999999999999999999999999874   


Q ss_pred             --CHHHHHHHHHhcCcccCCCCC-CCHHHHHHHHHHhcC
Q 029552          156 --NPAQVVAAVGFKGKRLEIPRN-VNPHVASIIEACWAK  191 (191)
Q Consensus       156 --~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~cl~~  191 (191)
                        +..+.+..|. .+.++..|.+ +|++++++|..||+|
T Consensus       284 ~~~~~~Ll~~Iv-~~ppP~lP~~~fS~ef~~FV~~CL~K  321 (364)
T KOG0581|consen  284 YLDIFELLCAIV-DEPPPRLPEGEFSPEFRSFVSCCLRK  321 (364)
T ss_pred             CCCHHHHHHHHh-cCCCCCCCcccCCHHHHHHHHHHhcC
Confidence              7777777774 5678888887 999999999999987

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.2e-45  Score=260.65  Aligned_cols=189  Identities=28%  Similarity=0.496  Sum_probs=168.4

Q ss_pred             CCCCCCCCcccccc-eeecCCc-eEEEEeccCCCCHHHHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhCCC--Ceee
Q 029552            1 MKRLRHPNIVLFMG-AVTQPPN-LSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDVAKGMNYLHRRNP--PIVH   75 (191)
Q Consensus         1 L~~l~h~~i~~~~~-~~~~~~~-~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~--~~~h   75 (191)
                      |++|+||||+++++ .|.+++. .++|||+|.+|+|..++... ..++.++|..+|+++.|++.||..+|..-+  .+.|
T Consensus        72 LkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmH  151 (375)
T KOG0591|consen   72 LKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMH  151 (375)
T ss_pred             HHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceee
Confidence            67999999999998 6655544 99999999999999999642 224569999999999999999999998222  3999


Q ss_pred             cCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        76 ~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      |||||.|||++.+|.+||+|||++.....+.......++++.||+||.+.+.+|+.++||||+||++|+|+.-+.||...
T Consensus       152 RDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~  231 (375)
T KOG0591|consen  152 RDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD  231 (375)
T ss_pred             ccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence            99999999999999999999999998888877888889999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHHhcCcccCCC-CCCCHHHHHHHHHHhc
Q 029552          156 NPAQVVAAVGFKGKRLEIP-RNVNPHVASIIEACWA  190 (191)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~cl~  190 (191)
                      +-.+...+|.+. ..+++| ..+|..+..+|+-|++
T Consensus       232 n~~~L~~KI~qg-d~~~~p~~~YS~~l~~li~~ci~  266 (375)
T KOG0591|consen  232 NLLSLCKKIEQG-DYPPLPDEHYSTDLRELINMCIA  266 (375)
T ss_pred             cHHHHHHHHHcC-CCCCCcHHHhhhHHHHHHHHHcc
Confidence            999999999744 555678 6799999999999985

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=254.33  Aligned_cols=180  Identities=28%  Similarity=0.544  Sum_probs=168.3

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |+.+.||+++++++.|.+.+..||||||.+||-|.+++++.+.   +++..++.++.||+.||+|||+++  +++||+||
T Consensus        98 L~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~~~--iiYRDLKP  172 (355)
T KOG0616|consen   98 LKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHSLD--IIYRDLKP  172 (355)
T ss_pred             HhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHhcC--eeeccCCh
Confidence            5678999999999999999999999999999999999998553   999999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.+|.+|++|||++......   .-..++++.|+|||++...++..++|+|+||+++|||+.|.+||.+.++..+
T Consensus       173 ENiLlD~~G~iKitDFGFAK~v~~r---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i  249 (355)
T KOG0616|consen  173 ENLLLDQNGHIKITDFGFAKRVSGR---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI  249 (355)
T ss_pred             HHeeeccCCcEEEEeccceEEecCc---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH
Confidence            9999999999999999999866544   4457899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhc
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~  190 (191)
                      .++|  ......+|+.+|+.+++||++.|+
T Consensus       250 Y~KI--~~~~v~fP~~fs~~~kdLl~~LL~  277 (355)
T KOG0616|consen  250 YEKI--LEGKVKFPSYFSSDAKDLLKKLLQ  277 (355)
T ss_pred             HHHH--HhCcccCCcccCHHHHHHHHHHHh
Confidence            9999  557888999999999999999886

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.7e-43  Score=272.61  Aligned_cols=183  Identities=30%  Similarity=0.488  Sum_probs=169.9

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++|+|||||+++++|+|.++.|+|.|.|..++|..++.+++   .++|.+++.++.||+.||.|||+++  |+|||||..
T Consensus        73 r~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk---~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLG  147 (592)
T KOG0575|consen   73 RSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRK---PLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLG  147 (592)
T ss_pred             HhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcC---CCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchh
Confidence            57899999999999999999999999999999999998644   4999999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      |+|++.+.++||+|||++.........-...+|++.|+|||++.....+.-+||||+||++|.|+.|++||...+-.+..
T Consensus       148 NlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety  227 (592)
T KOG0575|consen  148 NLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY  227 (592)
T ss_pred             heeecCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH
Confidence            99999999999999999987665556667789999999999999888899999999999999999999999999999999


Q ss_pred             HHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+|+  ......|..+|...++||.++|++
T Consensus       228 ~~Ik--~~~Y~~P~~ls~~A~dLI~~lL~~  255 (592)
T KOG0575|consen  228 NKIK--LNEYSMPSHLSAEAKDLIRKLLRP  255 (592)
T ss_pred             HHHH--hcCcccccccCHHHHHHHHHHhcC
Confidence            9994  456678889999999999999974

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5e-43  Score=260.95  Aligned_cols=184  Identities=27%  Similarity=0.523  Sum_probs=162.1

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |+.++|||||.+++++++++.+|+|||||+||+|.+++++.+.   +++..++.++.||+.|+++||+++  |+||||||
T Consensus        63 Lkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~---l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKP  137 (429)
T KOG0595|consen   63 LKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGR---LPEATARHFMQQLASALQFLHENN--IIHRDLKP  137 (429)
T ss_pred             HHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCc
Confidence            5788999999999999999999999999999999999988653   999999999999999999999999  99999999


Q ss_pred             CcEEecCC------CcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 029552           81 PNLLVDKK------YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN  154 (191)
Q Consensus        81 ~ni~~~~~------~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~  154 (191)
                      .||+++..      -.+||.|||+++.-.+. ......+|++-|||||++...+|+.|+|+||+|+++|++++|..||..
T Consensus       138 QNiLLs~~~~~~~~~~LKIADFGfAR~L~~~-~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  138 QNILLSTTARNDTSPVLKIADFGFARFLQPG-SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             ceEEeccCCCCCCCceEEecccchhhhCCch-hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence            99999765      45899999999865544 345667899999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHHhcCcccCC-CCCCCHHHHHHHHHHhc
Q 029552          155 LNPAQVVAAVGFKGKRLEI-PRNVNPHVASIIEACWA  190 (191)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~cl~  190 (191)
                      .++.+....++.+....+. |..+|....+++-.-+.
T Consensus       217 ~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~  253 (429)
T KOG0595|consen  217 ETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQ  253 (429)
T ss_pred             cCHHHHHHHHhccccccCchhhhccCchhhhhhHHHh
Confidence            9999999988766665554 45577777777665543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-41  Score=258.36  Aligned_cols=188  Identities=55%  Similarity=0.907  Sum_probs=169.1

Q ss_pred             CCCCCCCCcccccceeecCC-ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPP-NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      |++++||||+++++++.++. ..++||||+.+|+|.+++... ....++...++.|+.+|++|++|||+.+. ++|||||
T Consensus        93 l~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK  170 (362)
T KOG0192|consen   93 LSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLK  170 (362)
T ss_pred             HHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccC
Confidence            45689999999999999887 799999999999999999763 23349999999999999999999999985 7999999


Q ss_pred             CCcEEecCCC-cEEEcccccccccccccccCCCCCCCCcccCccccc--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 029552           80 SPNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR--DEPSNEKSDIYSFGVILWELATLQQPWGNLN  156 (191)
Q Consensus        80 p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~  156 (191)
                      |+|++++.++ .+||+|||++..............++..|||||+++  ...++.++||||+|+++|+|+||..||.+..
T Consensus       171 ~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~  250 (362)
T KOG0192|consen  171 SDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLA  250 (362)
T ss_pred             hhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCC
Confidence            9999999998 999999999976665433333467889999999999  6689999999999999999999999999999


Q ss_pred             HHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhc
Q 029552          157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~  190 (191)
                      +......+...+.++.+|..+++.+.++|++||+
T Consensus       251 ~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~  284 (362)
T KOG0192|consen  251 PVQVASAVVVGGLRPPIPKECPPHLSSLMERCWL  284 (362)
T ss_pred             HHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCC
Confidence            9888888888999999999999999999999997

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-41  Score=260.29  Aligned_cols=182  Identities=33%  Similarity=0.567  Sum_probs=166.2

Q ss_pred             CCCC-CCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            2 KRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         2 ~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +.++ ||||+++++++.....+++||||+.||+|.+++...+   .+.|.+++.++.|++.|++|+|++|  ++||||||
T Consensus        74 ~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~  148 (370)
T KOG0583|consen   74 RRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKP  148 (370)
T ss_pred             HHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCH
Confidence            4667 9999999999999999999999999999999998744   3899999999999999999999999  99999999


Q ss_pred             CcEEecCC-CcEEEcccccccccccccccCCCCCCCCcccCccccccCC-CC-CcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           81 PNLLVDKK-YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-SN-EKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~-~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      +|++++.+ +++||+|||++.............++++.|+|||++.+.. |+ .++|+||+|+++|.|++|..||.+.+.
T Consensus       149 ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~  228 (370)
T KOG0583|consen  149 ENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV  228 (370)
T ss_pred             HHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH
Confidence            99999999 9999999999987643445667789999999999999877 74 779999999999999999999999999


Q ss_pred             HHHHHHHHhcCcccCCCCCC-CHHHHHHHHHHhc
Q 029552          158 AQVVAAVGFKGKRLEIPRNV-NPHVASIIEACWA  190 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~-s~~~~~li~~cl~  190 (191)
                      .....++  ......+|..+ |+++++++.+||.
T Consensus       229 ~~l~~ki--~~~~~~~p~~~~S~~~~~Li~~mL~  260 (370)
T KOG0583|consen  229 PNLYRKI--RKGEFKIPSYLLSPEARSLIEKMLV  260 (370)
T ss_pred             HHHHHHH--hcCCccCCCCcCCHHHHHHHHHHcC
Confidence            9999887  66788899999 9999999999986

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-41  Score=262.09  Aligned_cols=184  Identities=32%  Similarity=0.610  Sum_probs=167.1

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |+..+|+|||++++.|..++.+|+||||++||+|.|++....    ++|.++..++.++++||+|||.+|  |+|||||.
T Consensus       324 m~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKS  397 (550)
T KOG0578|consen  324 MRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHARG--IIHRDIKS  397 (550)
T ss_pred             HHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhcc--eeeecccc
Confidence            456799999999999998899999999999999999997644    899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.+|.+||+|||++......-..-...++++.|||||+.....|+.+.||||||+++.||+-|.+||-..++...
T Consensus       398 DnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA  477 (550)
T KOG0578|consen  398 DNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA  477 (550)
T ss_pred             ceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH
Confidence            99999999999999999998766554444566899999999999999999999999999999999999999998888888


Q ss_pred             HHHHHhcCc-ccCCCCCCCHHHHHHHHHHhc
Q 029552          161 VAAVGFKGK-RLEIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       161 ~~~~~~~~~-~~~~~~~~s~~~~~li~~cl~  190 (191)
                      +..|...+. .+..|..+|+.+++++.+||+
T Consensus       478 lyLIa~ng~P~lk~~~klS~~~kdFL~~cL~  508 (550)
T KOG0578|consen  478 LYLIATNGTPKLKNPEKLSPELKDFLDRCLV  508 (550)
T ss_pred             HHHHhhcCCCCcCCccccCHHHHHHHHHHhh
Confidence            888765444 567889999999999999996

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-41  Score=258.88  Aligned_cols=182  Identities=31%  Similarity=0.524  Sum_probs=164.1

Q ss_pred             CCC-CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      ++| .||.|++++..|.|...+|.|+||+++|+|.+++.+.+.   +++..++.++.||++||+|||++|  |+||||||
T Consensus       128 ~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~~G--IIHRDlKP  202 (604)
T KOG0592|consen  128 TQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHSNG--IIHRDLKP  202 (604)
T ss_pred             HHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHhcC--ceeccCCh
Confidence            455 799999999999999999999999999999999998765   999999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccc-----------cC--CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFL-----------SS--KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT  147 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~-----------~~--~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~  147 (191)
                      +||+++.+|+++|+|||.+........           ..  ...+|+..|++||.+.....+..+|+|+|||++|+|++
T Consensus       203 ENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmla  282 (604)
T KOG0592|consen  203 ENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLA  282 (604)
T ss_pred             hheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhc
Confidence            999999999999999998875432211           11  34678899999999999999999999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhc
Q 029552          148 LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       148 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~  190 (191)
                      |.+||...+.--+..+|.  .....+|+++++.+++||++.|.
T Consensus       283 G~PPFra~NeyliFqkI~--~l~y~fp~~fp~~a~dLv~KLLv  323 (604)
T KOG0592|consen  283 GQPPFRAANEYLIFQKIQ--ALDYEFPEGFPEDARDLIKKLLV  323 (604)
T ss_pred             CCCCCccccHHHHHHHHH--HhcccCCCCCCHHHHHHHHHHHc
Confidence            999999999988888884  45678899999999999999885

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-41  Score=263.42  Aligned_cols=182  Identities=31%  Similarity=0.562  Sum_probs=167.8

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |+.++|||+++++++++++.++|+|.||+++|-|++++.+.+.   +++.+++++++||+.|+.|+|..+  ++|||+||
T Consensus        66 MkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKp  140 (786)
T KOG0588|consen   66 MKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCHAFN--ICHRDLKP  140 (786)
T ss_pred             HHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCc
Confidence            4567999999999999999999999999999999999987553   999999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      +|++++..+++||+|||.+.+..+. .....-+|.++|.+||++.|.+| +.++||||.|+++|.|++|.+||++.+-..
T Consensus       141 ENlLLd~~~nIKIADFGMAsLe~~g-klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~  219 (786)
T KOG0588|consen  141 ENLLLDVKNNIKIADFGMASLEVPG-KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV  219 (786)
T ss_pred             hhhhhhcccCEeeeccceeecccCC-ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH
Confidence            9999999999999999999876655 34556789999999999999987 568999999999999999999999999999


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhc
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~  190 (191)
                      .+.++  ..+.+..|.++|.++++||.+||+
T Consensus       220 LLlKV--~~G~f~MPs~Is~eaQdLLr~ml~  248 (786)
T KOG0588|consen  220 LLLKV--QRGVFEMPSNISSEAQDLLRRMLD  248 (786)
T ss_pred             HHHHH--HcCcccCCCcCCHHHHHHHHHHhc
Confidence            99999  456778899999999999999985

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-42  Score=257.61  Aligned_cols=184  Identities=26%  Similarity=0.394  Sum_probs=158.8

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++|+|||||+++++|+..+..|||+||+.||.|.+.+-..+.   +.++.-..+++|++.|+.|||++|  |.||||||
T Consensus       230 LkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKP  304 (475)
T KOG0615|consen  230 LKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKP  304 (475)
T ss_pred             HHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHcC--cccccCCc
Confidence            5789999999999999999999999999999999999977553   888888999999999999999999  99999999


Q ss_pred             CcEEecCC---CcEEEcccccccccccccccCCCCCCCCcccCccccccCCC---CCcchHHHHHHHHHHHHhCCCCCCC
Q 029552           81 PNLLVDKK---YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPS---NEKSDIYSFGVILWELATLQQPWGN  154 (191)
Q Consensus        81 ~ni~~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~---~~~~Dv~slG~~~~~l~~g~~pf~~  154 (191)
                      +||+++.+   -.+|++|||+++..+ ........++++.|.|||++.+...   ..+.|+||+||++|-+++|.+||.+
T Consensus       305 eNILl~~~~e~~llKItDFGlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~  383 (475)
T KOG0615|consen  305 ENILLSNDAEDCLLKITDFGLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSE  383 (475)
T ss_pred             ceEEeccCCcceEEEecccchhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccc
Confidence            99999876   568999999998776 3356778899999999999976653   2367999999999999999999998


Q ss_pred             CCHHH-HHHHHHhcCccc--CCCCCCCHHHHHHHHHHhc
Q 029552          155 LNPAQ-VVAAVGFKGKRL--EIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       155 ~~~~~-~~~~~~~~~~~~--~~~~~~s~~~~~li~~cl~  190 (191)
                      ...+. ..+.|..+....  .....+|++..++|++||.
T Consensus       384 ~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~  422 (475)
T KOG0615|consen  384 EYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLV  422 (475)
T ss_pred             ccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhE
Confidence            66665 777775444433  2336799999999999984

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-40  Score=254.53  Aligned_cols=186  Identities=37%  Similarity=0.664  Sum_probs=166.3

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++|+|++||++++++..++.+|||||||..|+|.++++... +..+...+.+.++.||++|.+||++++  ++||||-.
T Consensus       255 Mk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAA  331 (468)
T KOG0197|consen  255 MKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAA  331 (468)
T ss_pred             HHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhh
Confidence            578999999999999999889999999999999999998732 445889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccC-CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSS-KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA  158 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~  158 (191)
                      .||+++.+..+|++|||+++...+..... ....-...|.|||.+....++.++||||+|+++||++| |+.||...+..
T Consensus       332 RNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~  411 (468)
T KOG0197|consen  332 RNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE  411 (468)
T ss_pred             hheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH
Confidence            99999999999999999998544332222 22233457999999999999999999999999999998 58899999999


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhc
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~  190 (191)
                      ++++.+. .+.+++.|..||+.+.++|..||.
T Consensus       412 ev~~~le-~GyRlp~P~~CP~~vY~lM~~CW~  442 (468)
T KOG0197|consen  412 EVLELLE-RGYRLPRPEGCPDEVYELMKSCWH  442 (468)
T ss_pred             HHHHHHh-ccCcCCCCCCCCHHHHHHHHHHhh
Confidence            9999996 889999999999999999999996

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.1e-41  Score=255.56  Aligned_cols=187  Identities=32%  Similarity=0.560  Sum_probs=173.9

Q ss_pred             CCCCCCCCcccccceeecCCc-eEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPN-LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      |+++.||||+.+.++|+.++. .++||+||+||++.+.+.+.. +..++++.++.|+.|++.|+.|||+..  |+|||||
T Consensus        57 is~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK  133 (426)
T KOG0589|consen   57 LSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR--VLHRDLK  133 (426)
T ss_pred             HHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh--hhcccch
Confidence            467899999999999998887 999999999999999997655 456999999999999999999999999  9999999


Q ss_pred             CCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      +.|||++.++.++|+|||+++.............+++.|++||.+.+.+|..++|+|||||++|+|++-+.+|...+...
T Consensus       134 ~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~  213 (426)
T KOG0589|consen  134 CANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE  213 (426)
T ss_pred             hhhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH
Confidence            99999999999999999999988877667788899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+.++. ...-.+.|..+|.+++.+|+.||.+
T Consensus       214 Li~ki~-~~~~~Plp~~ys~el~~lv~~~l~~  244 (426)
T KOG0589|consen  214 LILKIN-RGLYSPLPSMYSSELRSLVKSMLRK  244 (426)
T ss_pred             HHHHHh-hccCCCCCccccHHHHHHHHHHhhc
Confidence            999996 3446789999999999999999975

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-40  Score=248.25  Aligned_cols=187  Identities=34%  Similarity=0.599  Sum_probs=159.8

Q ss_pred             CCCCCCCCcccccceeecCC--ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      |++++|||||++++......  .++++|||+.+|+|.+++.+.+.  .+++..++.++.|+++||+|||++|  ++|+||
T Consensus        68 L~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~Di  143 (313)
T KOG0198|consen   68 LSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG--IVHCDI  143 (313)
T ss_pred             HHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCc
Confidence            46788999999999754444  69999999999999999987653  3999999999999999999999999  999999


Q ss_pred             CCCcEEecC-CCcEEEccccccccccc---ccccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCC
Q 029552           79 KSPNLLVDK-KYTVKVCDFGLSRLKAN---TFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWG  153 (191)
Q Consensus        79 ~p~ni~~~~-~~~~~l~d~~~~~~~~~---~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~pf~  153 (191)
                      ||.||+++. ++.+||+|||.+.....   .........+++.|||||++.. .....++|+||+||++.+|+||..||.
T Consensus       144 K~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~  223 (313)
T KOG0198|consen  144 KPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWS  223 (313)
T ss_pred             ccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcch
Confidence            999999999 79999999998875442   2223445678999999999985 334458999999999999999999999


Q ss_pred             C-CCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          154 N-LNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       154 ~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      . ....+....+......+.+|..+|+..+++|++|+++
T Consensus       224 ~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~  262 (313)
T KOG0198|consen  224 EFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKR  262 (313)
T ss_pred             hhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhc
Confidence            8 6777777777666666789999999999999999975

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=9e-40  Score=250.59  Aligned_cols=183  Identities=25%  Similarity=0.404  Sum_probs=162.4

Q ss_pred             CCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCc
Q 029552            3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN   82 (191)
Q Consensus         3 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~n   82 (191)
                      ..++|+||+++.+|++.+.+|+||||++||++..++.+.+.   ++++.++.++.+++-|++.||++|  ++||||||+|
T Consensus       197 ~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~---L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdN  271 (550)
T KOG0605|consen  197 EVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDT---LTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDN  271 (550)
T ss_pred             hcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCc---CchHHHHHHHHHHHHHHHHHHHcC--cccccCChhh
Confidence            45899999999999999999999999999999999987664   999999999999999999999999  9999999999


Q ss_pred             EEecCCCcEEEccccccccccc---------------------cccc--------------------------CCCCCCC
Q 029552           83 LLVDKKYTVKVCDFGLSRLKAN---------------------TFLS--------------------------SKSAAGT  115 (191)
Q Consensus        83 i~~~~~~~~~l~d~~~~~~~~~---------------------~~~~--------------------------~~~~~~~  115 (191)
                      ++++..|++||+|||++.-...                     ....                          ....+|+
T Consensus       272 lLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGT  351 (550)
T KOG0605|consen  272 LLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGT  351 (550)
T ss_pred             eeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCC
Confidence            9999999999999999741000                     0000                          0113689


Q ss_pred             CcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCcccCCCC--CCCHHHHHHHHHHhc
Q 029552          116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR--NVNPHVASIIEACWA  190 (191)
Q Consensus       116 ~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~li~~cl~  190 (191)
                      +.|+|||++.+..++..+|+|||||++|||+.|.+||...++.++..+|......+.+|.  .+|++.++||.+|+.
T Consensus       352 PDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~  428 (550)
T KOG0605|consen  352 PDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC  428 (550)
T ss_pred             ccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc
Confidence            999999999999999999999999999999999999999999999999998887777775  578999999999873

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.3e-39  Score=247.00  Aligned_cols=184  Identities=28%  Similarity=0.491  Sum_probs=160.8

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++..++..|+||||+.+++|.+++...+   .+++.++..++.||+.||+|||+.|  ++||||||
T Consensus        49 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp  123 (323)
T cd05571          49 LQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKL  123 (323)
T ss_pred             HHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCH
Confidence            356899999999999999999999999999999999987644   3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.++.++|+|||++..............++..|+|||.+.+..++.++|+||+||++|+|++|..||...+....
T Consensus       124 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~  203 (323)
T cd05571         124 ENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL  203 (323)
T ss_pred             HHEEECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH
Confidence            99999999999999999876433222223344578899999999988899999999999999999999999998888877


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+.  .....+|..+++.++++|++||++
T Consensus       204 ~~~~~--~~~~~~p~~~~~~~~~li~~~L~~  232 (323)
T cd05571         204 FELIL--MEEIRFPRTLSPEAKSLLAGLLKK  232 (323)
T ss_pred             HHHHH--cCCCCCCCCCCHHHHHHHHHHccC
Confidence            77764  345677889999999999999974

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=6.7e-39  Score=244.40  Aligned_cols=184  Identities=28%  Similarity=0.504  Sum_probs=159.8

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||++++++|..++..|+||||+++++|.+++....   .+++.+++.++.|++.||+|||++|  ++||||+|
T Consensus        49 l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp  123 (323)
T cd05595          49 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKL  123 (323)
T ss_pred             HHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCH
Confidence            356899999999999999999999999999999998887643   3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.++.++|+|||++..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+....
T Consensus       124 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~  203 (323)
T cd05595         124 ENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL  203 (323)
T ss_pred             HHEEEcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH
Confidence            99999999999999999876432222222334578899999999888889999999999999999999999999888877


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+.  .....+|..+++.++++|.+||++
T Consensus       204 ~~~~~--~~~~~~p~~~~~~~~~li~~~L~~  232 (323)
T cd05595         204 FELIL--MEEIRFPRTLSPEAKSLLAGLLKK  232 (323)
T ss_pred             HHHHh--cCCCCCCCCCCHHHHHHHHHHccC
Confidence            77764  344567889999999999999974

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.7e-39  Score=239.01  Aligned_cols=188  Identities=27%  Similarity=0.357  Sum_probs=162.4

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |+.++||+++.++..|+.++..|++||||.||+|..+++++. .+.++++.++.++.+++-||+|||..|  |++|||||
T Consensus       131 L~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKP  207 (459)
T KOG0610|consen  131 LSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKP  207 (459)
T ss_pred             HHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCc
Confidence            567999999999999999999999999999999999998766 557999999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccc-----------------------------------cc-------------------
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKAN-----------------------------------TF-------------------  106 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~-----------------------------------~~-------------------  106 (191)
                      +||++..+|.+.|+||+++....-                                   ..                   
T Consensus       208 ENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep  287 (459)
T KOG0610|consen  208 ENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEP  287 (459)
T ss_pred             ceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCC
Confidence            999999999999999988642100                                   00                   


Q ss_pred             --ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHH
Q 029552          107 --LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASI  184 (191)
Q Consensus       107 --~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  184 (191)
                        ......+++-.|+|||+++|..-+.+.|+|+||+.+|||+.|..||...+..+.+.+|......++--..+|..+++|
T Consensus       288 ~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDL  367 (459)
T KOG0610|consen  288 TGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDL  367 (459)
T ss_pred             CCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHH
Confidence              001122456679999999999999999999999999999999999999999999999965444444445789999999


Q ss_pred             HHHHhcC
Q 029552          185 IEACWAK  191 (191)
Q Consensus       185 i~~cl~~  191 (191)
                      |++.|.|
T Consensus       368 Ir~LLvK  374 (459)
T KOG0610|consen  368 IRKLLVK  374 (459)
T ss_pred             HHHHhcc
Confidence            9999876

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-39  Score=243.35  Aligned_cols=184  Identities=25%  Similarity=0.458  Sum_probs=161.1

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++||||+++++|.+++...+   .+++.++..++.|++.||+|||+.+  ++||||+|
T Consensus        47 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp  121 (312)
T cd05585          47 LAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREG---RFDLSRARFYTAELLCALENLHKFN--VIYRDLKP  121 (312)
T ss_pred             HHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCH
Confidence            356899999999999999999999999999999999997643   3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.++.++|+|||++..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+.
T Consensus       122 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~  201 (312)
T cd05585         122 ENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM  201 (312)
T ss_pred             HHeEECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH
Confidence            99999999999999999886533332223344578899999999988899999999999999999999999998888877


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+.  .....+|..+++.++++|.+||++
T Consensus       202 ~~~~~--~~~~~~~~~~~~~~~~li~~~L~~  230 (312)
T cd05585         202 YRKIL--QEPLRFPDGFDRDAKDLLIGLLSR  230 (312)
T ss_pred             HHHHH--cCCCCCCCcCCHHHHHHHHHHcCC
Confidence            77764  346678889999999999999974

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.9e-39  Score=250.65  Aligned_cols=182  Identities=34%  Similarity=0.597  Sum_probs=168.4

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++||||++++++|+...++|+|.||+.| +|..++...+.   ++|+++.+++.+++.||.|||+++  |.|||+||.
T Consensus        56 r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPq  129 (808)
T KOG0597|consen   56 RSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQ  129 (808)
T ss_pred             HhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcc
Confidence            578999999999999999999999999987 99999987553   999999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      ||++..+|.+|++|||++...+....-.....+++.|||||...+.+++..+|.|||||++|++++|++||....-...+
T Consensus       130 niLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv  209 (808)
T KOG0597|consen  130 NILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLV  209 (808)
T ss_pred             eeeecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHH
Confidence            99999999999999999987776655566678999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..|  ...+...|...|.++.++++..|+|
T Consensus       210 ~~I--~~d~v~~p~~~S~~f~nfl~gLL~k  237 (808)
T KOG0597|consen  210 KSI--LKDPVKPPSTASSSFVNFLQGLLIK  237 (808)
T ss_pred             HHH--hcCCCCCcccccHHHHHHHHHHhhc
Confidence            988  4567777889999999999999876

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.4e-38  Score=243.08  Aligned_cols=184  Identities=28%  Similarity=0.495  Sum_probs=159.9

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++.+++.+++..++||||+++++|.+.+....   .+++.++..++.||+.||+|||+++  ++||||||
T Consensus        49 l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp  123 (328)
T cd05593          49 LKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKL  123 (328)
T ss_pred             HHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCH
Confidence            356899999999999999999999999999999998886543   3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.++.++|+|||++..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+....
T Consensus       124 ~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~  203 (328)
T cd05593         124 ENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL  203 (328)
T ss_pred             HHeEECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH
Confidence            99999999999999999876433222223344578899999999988889999999999999999999999998888777


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+.  .....+|..+++.+.++|++||++
T Consensus       204 ~~~~~--~~~~~~p~~~~~~~~~li~~~L~~  232 (328)
T cd05593         204 FELIL--MEDIKFPRTLSADAKSLLSGLLIK  232 (328)
T ss_pred             HHHhc--cCCccCCCCCCHHHHHHHHHHcCC
Confidence            77663  345678889999999999999974

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.3e-38  Score=242.92  Aligned_cols=184  Identities=26%  Similarity=0.464  Sum_probs=160.1

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||++++++|.+++..|+||||+.+++|.+++.+.+   .+++..+..++.|++.||+|||+.|  ++|+||+|
T Consensus        54 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp  128 (323)
T cd05584          54 LEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQG--IIYRDLKP  128 (323)
T ss_pred             HHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCH
Confidence            457899999999999999999999999999999999997644   3788999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.++.++|+|||++..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+....
T Consensus       129 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~  208 (323)
T cd05584         129 ENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT  208 (323)
T ss_pred             HHeEECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH
Confidence            99999999999999999876432222222334578899999999888888999999999999999999999999888877


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+.  .....+|..+++.+.++|.+||++
T Consensus       209 ~~~~~--~~~~~~~~~~~~~~~~li~~~l~~  237 (323)
T cd05584         209 IDKIL--KGKLNLPPYLTPEARDLLKKLLKR  237 (323)
T ss_pred             HHHHH--cCCCCCCCCCCHHHHHHHHHHccc
Confidence            77774  345678889999999999999974

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=239.00  Aligned_cols=181  Identities=28%  Similarity=0.520  Sum_probs=159.5

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++||||+.+++|.+++...+   .+++..+..++.|++.||+|||++|  ++||||+|
T Consensus        55 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp  129 (291)
T cd05612          55 LKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKP  129 (291)
T ss_pred             HHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCH
Confidence            357899999999999999999999999999999999997644   3889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.++.++|+|||++......   .....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+....
T Consensus       130 ~NIli~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~  206 (291)
T cd05612         130 ENILLDKEGHIKLTDFGFAKKLRDR---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI  206 (291)
T ss_pred             HHeEECCCCCEEEEecCcchhccCC---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9999999999999999987644322   1234567899999999988889999999999999999999999999888887


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+.  .....+|..+++.++++|++||++
T Consensus       207 ~~~i~--~~~~~~~~~~~~~~~~li~~~l~~  235 (291)
T cd05612         207 YEKIL--AGKLEFPRHLDLYAKDLIKKLLVV  235 (291)
T ss_pred             HHHHH--hCCcCCCccCCHHHHHHHHHHcCC
Confidence            77774  345677888999999999999974

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.9e-38  Score=239.75  Aligned_cols=182  Identities=29%  Similarity=0.467  Sum_probs=158.5

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++||||+++++++.+++..|+||||+.+++|...+...    .+++.+++.++.|++.||+|||+.|  ++||||+|+
T Consensus        57 ~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~  130 (324)
T cd05589          57 NSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLD  130 (324)
T ss_pred             cccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHH
Confidence            4678999999999999999999999999999999888642    3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      ||+++.++.++|+|||++..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+..
T Consensus       131 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~  210 (324)
T cd05589         131 NLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF  210 (324)
T ss_pred             HeEECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999999998764332222233445788999999999888899999999999999999999999998888877


Q ss_pred             HHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+..  ....+|..+|+.+.++|.+||++
T Consensus       211 ~~i~~--~~~~~p~~~~~~~~~li~~~L~~  238 (324)
T cd05589         211 DSIVN--DEVRYPRFLSREAISIMRRLLRR  238 (324)
T ss_pred             HHHHh--CCCCCCCCCCHHHHHHHHHHhhc
Confidence            77743  34567888999999999999974

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=252.00  Aligned_cols=185  Identities=38%  Similarity=0.739  Sum_probs=169.8

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++|+||||+++.++|.+..-+|+|||||..|-|..++....   .++......|..+|+.+..|||.+.  |+|||||.
T Consensus       166 LRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKS  240 (904)
T KOG4721|consen  166 LRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKS  240 (904)
T ss_pred             HHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCC
Confidence            578999999999999999999999999999999999997643   3889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      .||+++.+..+||+|||-++..... .....+.++..|||||+++..+.+++.||||+|+|+|+|+||..||.+.+..++
T Consensus       241 PNiLIs~~d~VKIsDFGTS~e~~~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI  319 (904)
T KOG4721|consen  241 PNILISYDDVVKISDFGTSKELSDK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI  319 (904)
T ss_pred             CceEeeccceEEeccccchHhhhhh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee
Confidence            9999999999999999987654443 345567889999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +.-+......+++|..+++.|+=||++||+.
T Consensus       320 IwGVGsNsL~LpvPstcP~GfklL~Kqcw~s  350 (904)
T KOG4721|consen  320 IWGVGSNSLHLPVPSTCPDGFKLLLKQCWNS  350 (904)
T ss_pred             EEeccCCcccccCcccCchHHHHHHHHHHhc
Confidence            8888777778899999999999999999973

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=5e-38  Score=238.94  Aligned_cols=181  Identities=29%  Similarity=0.521  Sum_probs=159.0

Q ss_pred             CCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcE
Q 029552            4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL   83 (191)
Q Consensus         4 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni   83 (191)
                      .+||||+++++++..++..++||||+++++|.+++...+   .+++.++..++.|++.||+|||+.+  ++||||+|+||
T Consensus        53 ~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Ni  127 (316)
T cd05592          53 WEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNV  127 (316)
T ss_pred             cCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHe
Confidence            489999999999999999999999999999999987644   3899999999999999999999999  99999999999


Q ss_pred             EecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 029552           84 LVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA  163 (191)
Q Consensus        84 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~  163 (191)
                      +++.++.++|+|||++..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+....
T Consensus       128 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~  207 (316)
T cd05592         128 LLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDS  207 (316)
T ss_pred             EECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999999886433222233344578899999999988899999999999999999999999999888887777


Q ss_pred             HHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          164 VGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       164 ~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +.  ...+.+|..++..+.++|.+||++
T Consensus       208 i~--~~~~~~~~~~~~~~~~ll~~~l~~  233 (316)
T cd05592         208 IL--NDRPHFPRWISKEAKDCLSKLFER  233 (316)
T ss_pred             HH--cCCCCCCCCCCHHHHHHHHHHccC
Confidence            73  345677888999999999999974

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.3e-38  Score=241.42  Aligned_cols=183  Identities=29%  Similarity=0.484  Sum_probs=159.5

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++||||+++++++.+++..++||||+.+++|.+++....   .+++..+..++.||++||+|||+.|  ++||||+|+
T Consensus        51 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~  125 (323)
T cd05575          51 KNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRER---SFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPE  125 (323)
T ss_pred             hhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHH
Confidence            46899999999999999999999999999999999987643   3889999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      ||+++.++.++|+|||++..............++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+..
T Consensus       126 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~  205 (323)
T cd05575         126 NILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY  205 (323)
T ss_pred             HeEECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHH
Confidence            99999999999999998764333222333445788999999999888999999999999999999999999998888877


Q ss_pred             HHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+.  ......+..+++.+.++|++||++
T Consensus       206 ~~i~--~~~~~~~~~~~~~~~~li~~~l~~  233 (323)
T cd05575         206 DNIL--NKPLRLKPNISVSARHLLEGLLQK  233 (323)
T ss_pred             HHHH--cCCCCCCCCCCHHHHHHHHHHhhc
Confidence            7774  345567778999999999999974

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.4e-38  Score=241.51  Aligned_cols=183  Identities=29%  Similarity=0.472  Sum_probs=159.3

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++||||+++++++.+++..++||||+.+++|.+++...+   .+++..+..++.||++||+|||++|  ++||||||+
T Consensus        51 ~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~  125 (325)
T cd05602          51 KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPE  125 (325)
T ss_pred             HhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHH
Confidence            46799999999999999999999999999999999997643   3788999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      ||+++.++.++|+|||++..............+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+..
T Consensus       126 Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  205 (325)
T cd05602         126 NILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY  205 (325)
T ss_pred             HeEECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH
Confidence            99999999999999998764332222233445788999999999888999999999999999999999999998888877


Q ss_pred             HHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+..  .....+.+++..+.++|++||++
T Consensus       206 ~~i~~--~~~~~~~~~~~~~~~li~~~l~~  233 (325)
T cd05602         206 DNILN--KPLQLKPNITNSARHLLEGLLQK  233 (325)
T ss_pred             HHHHh--CCcCCCCCCCHHHHHHHHHHccc
Confidence            77743  34566778999999999999974

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.2e-38  Score=242.20  Aligned_cols=181  Identities=27%  Similarity=0.486  Sum_probs=160.0

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++||||+.+++|.+.+...+   .++++.+..++.|++.||+|||++|  ++||||+|
T Consensus        72 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp  146 (329)
T PTZ00263         72 LMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKP  146 (329)
T ss_pred             HHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCH
Confidence            357899999999999999999999999999999999997644   3889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.++.++|+|||++......   .....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...++...
T Consensus       147 ~NIll~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  223 (329)
T PTZ00263        147 ENLLLDNKGHVKVTDFGFAKKVPDR---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI  223 (329)
T ss_pred             HHEEECCCCCEEEeeccCceEcCCC---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH
Confidence            9999999999999999988654322   1234577899999999988889999999999999999999999999888877


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+.  ....++|..++..++++|++||++
T Consensus       224 ~~~i~--~~~~~~p~~~~~~~~~li~~~L~~  252 (329)
T PTZ00263        224 YEKIL--AGRLKFPNWFDGRARDLVKGLLQT  252 (329)
T ss_pred             HHHHh--cCCcCCCCCCCHHHHHHHHHHhhc
Confidence            77774  345677888999999999999974

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.1e-38  Score=240.54  Aligned_cols=183  Identities=30%  Similarity=0.471  Sum_probs=159.5

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++||||+++++++.+.+..|+||||+++++|...+....   .+++.++..++.||+.||+|||+.+  ++||||||+
T Consensus        51 ~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~  125 (321)
T cd05603          51 KNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPE  125 (321)
T ss_pred             HhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHH
Confidence            56799999999999999999999999999999998886543   3889999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      ||+++.++.++|+|||++..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+.....
T Consensus       126 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  205 (321)
T cd05603         126 NILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMY  205 (321)
T ss_pred             HeEECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHH
Confidence            99999999999999998764322222233345678999999998888899999999999999999999999998887777


Q ss_pred             HHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+.  ..+..+|...+..+.++|.+||++
T Consensus       206 ~~i~--~~~~~~~~~~~~~~~~li~~~l~~  233 (321)
T cd05603         206 DNIL--HKPLQLPGGKTVAACDLLVGLLHK  233 (321)
T ss_pred             HHHh--cCCCCCCCCCCHHHHHHHHHHccC
Confidence            7774  345677888999999999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.6e-38  Score=242.61  Aligned_cols=181  Identities=23%  Similarity=0.427  Sum_probs=159.6

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |+.++||||+++++++.+++..++||||+.+++|.+++...+   .+++..+..++.|++.||+|||+.|  ++||||+|
T Consensus        85 l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp  159 (340)
T PTZ00426         85 LNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKP  159 (340)
T ss_pred             HHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCH
Confidence            356899999999999999999999999999999999997644   3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.++.++|+|||++......   .....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...++...
T Consensus       160 ~NILl~~~~~ikL~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~  236 (340)
T PTZ00426        160 ENLLLDKDGFIKMTDFGFAKVVDTR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI  236 (340)
T ss_pred             HHEEECCCCCEEEecCCCCeecCCC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH
Confidence            9999999999999999988654322   2234577889999999888889999999999999999999999999888887


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+.  .....+|..+++.++++|++||++
T Consensus       237 ~~~i~--~~~~~~p~~~~~~~~~li~~~l~~  265 (340)
T PTZ00426        237 YQKIL--EGIIYFPKFLDNNCKHLMKKLLSH  265 (340)
T ss_pred             HHHHh--cCCCCCCCCCCHHHHHHHHHHccc
Confidence            77774  334567888999999999999974

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=249.40  Aligned_cols=179  Identities=30%  Similarity=0.513  Sum_probs=165.2

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      +||++++++.+|+.+++.|.||||+.||++..+.+.    +.+++..++.++..++.||.|||++|  |+|||||.+||+
T Consensus       427 ~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~~----~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiL  500 (694)
T KOG0694|consen  427 RHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIHT----DVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLL  500 (694)
T ss_pred             cCCeEeecccccccCCeEEEEEEecCCCcEEEEEec----ccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheE
Confidence            699999999999999999999999999995444432    23999999999999999999999999  999999999999


Q ss_pred             ecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 029552           85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV  164 (191)
Q Consensus        85 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~  164 (191)
                      ++..|.+||.|||+++............++++.|+|||++.+..|+.+.|+|+||+++|+|+.|+.||...+.+++.+.|
T Consensus       501 LD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI  580 (694)
T KOG0694|consen  501 LDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI  580 (694)
T ss_pred             EcccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            99999999999999987665556778899999999999999999999999999999999999999999999999999999


Q ss_pred             HhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          165 GFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       165 ~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                        ......+|..+|.+..++|+++|.|
T Consensus       581 --~~d~~~yP~~ls~ea~~il~~ll~k  605 (694)
T KOG0694|consen  581 --VNDEVRYPRFLSKEAIAIMRRLLRK  605 (694)
T ss_pred             --hcCCCCCCCcccHHHHHHHHHHhcc
Confidence              4567789999999999999999875

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.8e-38  Score=242.26  Aligned_cols=183  Identities=28%  Similarity=0.502  Sum_probs=158.7

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCeeecCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKS   80 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~~h~~l~p   80 (191)
                      +.++||||+++.+++.+++..++||||+.+++|.+++....   .+++.++..++.||+.||+|||+ .|  ++||||||
T Consensus        50 ~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp  124 (325)
T cd05594          50 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKL  124 (325)
T ss_pred             HhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCC
Confidence            56789999999999999999999999999999999886543   38999999999999999999997 79  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.++.++|+|||++..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+....
T Consensus       125 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~  204 (325)
T cd05594         125 ENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL  204 (325)
T ss_pred             CeEEECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH
Confidence            99999999999999999876432222222334578899999999888899999999999999999999999998888777


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+.  .....+|..+++.+.++|++||++
T Consensus       205 ~~~i~--~~~~~~p~~~~~~~~~li~~~L~~  233 (325)
T cd05594         205 FELIL--MEEIRFPRTLSPEAKSLLSGLLKK  233 (325)
T ss_pred             HHHHh--cCCCCCCCCCCHHHHHHHHHHhhc
Confidence            77663  345667889999999999999974

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6.7e-38  Score=238.63  Aligned_cols=181  Identities=25%  Similarity=0.438  Sum_probs=158.5

Q ss_pred             CCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcE
Q 029552            4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL   83 (191)
Q Consensus         4 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni   83 (191)
                      .+||||+++++++.+.+..|+||||+++++|.+++.+..   .+++..+..++.|++.||+|||+++  ++||||+|+||
T Consensus        53 ~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NI  127 (320)
T cd05590          53 RNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNV  127 (320)
T ss_pred             cCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHe
Confidence            379999999999999999999999999999999887644   3899999999999999999999999  99999999999


Q ss_pred             EecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 029552           84 LVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA  163 (191)
Q Consensus        84 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~  163 (191)
                      +++.++.++|+|||++..............+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+....
T Consensus       128 li~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~  207 (320)
T cd05590         128 LLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA  207 (320)
T ss_pred             EECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH
Confidence            99999999999999876432222223344678899999999988889999999999999999999999999988888887


Q ss_pred             HHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          164 VGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       164 ~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +.  ......|..+++.++++|++||++
T Consensus       208 i~--~~~~~~~~~~~~~~~~li~~~L~~  233 (320)
T cd05590         208 IL--NDEVVYPTWLSQDAVDILKAFMTK  233 (320)
T ss_pred             Hh--cCCCCCCCCCCHHHHHHHHHHccc
Confidence            74  345567888999999999999974

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-38  Score=237.29  Aligned_cols=188  Identities=30%  Similarity=0.476  Sum_probs=155.9

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      ++.++||||++++.+|..+..+|+||++|.+||+.+++...-. ..+.|..+..++.++++||.|||++|  .+|||||+
T Consensus        78 msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKA  154 (516)
T KOG0582|consen   78 MSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG--HIHRDVKA  154 (516)
T ss_pred             hhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC--ceeccccc
Confidence            4678999999999999999999999999999999999965332 23999999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccC----CCCCCCCcccCccccc--cCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSS----KSAAGTPEWMAPEVLR--DEPSNEKSDIYSFGVILWELATLQQPWGN  154 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~----~~~~~~~~~~~pe~~~--~~~~~~~~Dv~slG~~~~~l~~g~~pf~~  154 (191)
                      .||+++.+|.++|+|||.+...-..-...    ....++++|||||++.  ...|+.++||||+|++..|+.+|+.||..
T Consensus       155 gnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k  234 (516)
T KOG0582|consen  155 GNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSK  234 (516)
T ss_pred             ccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCccc
Confidence            99999999999999998765321111111    4557899999999954  33589999999999999999999999999


Q ss_pred             CCHHHHHHHHHhcCcccC----CC----CCCCHHHHHHHHHHhcC
Q 029552          155 LNPAQVVAAVGFKGKRLE----IP----RNVNPHVASIIEACWAK  191 (191)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~----~~----~~~s~~~~~li~~cl~~  191 (191)
                      ..+..++-.-.+...+-.    .+    ..++.+++++|..||.|
T Consensus       235 ~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~k  279 (516)
T KOG0582|consen  235 YPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVK  279 (516)
T ss_pred             CChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhc
Confidence            999887776643333211    11    24788999999999986

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.7e-37  Score=236.02  Aligned_cols=182  Identities=25%  Similarity=0.438  Sum_probs=157.7

Q ss_pred             CCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCc
Q 029552            3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN   82 (191)
Q Consensus         3 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~n   82 (191)
                      .++||||+++++++.+++..|+||||+.+++|.+++...+   .+++.++..++.|++.||+|||++|  ++||||+|+|
T Consensus        52 ~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~N  126 (316)
T cd05620          52 AWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDN  126 (316)
T ss_pred             ccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHH
Confidence            3589999999999999999999999999999999987643   3889999999999999999999999  9999999999


Q ss_pred             EEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 029552           83 LLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVA  162 (191)
Q Consensus        83 i~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~  162 (191)
                      |+++.++.++|+|||++..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+...
T Consensus       127 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~  206 (316)
T cd05620         127 VMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE  206 (316)
T ss_pred             eEECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999987532222222334457889999999998889999999999999999999999999888887777


Q ss_pred             HHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          163 AVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       163 ~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+.  ...+.+|..++..++++|++||++
T Consensus       207 ~~~--~~~~~~~~~~~~~~~~li~~~l~~  233 (316)
T cd05620         207 SIR--VDTPHYPRWITKESKDILEKLFER  233 (316)
T ss_pred             HHH--hCCCCCCCCCCHHHHHHHHHHccC
Confidence            774  345567788999999999999974

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.8e-38  Score=241.51  Aligned_cols=184  Identities=28%  Similarity=0.470  Sum_probs=160.7

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..|+||||+.+++|.+++.+..   .+++.++..++.|++.||+|||+.+  ++|+||+|
T Consensus        52 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp  126 (318)
T cd05582          52 LAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG--IIYRDLKP  126 (318)
T ss_pred             HHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCH
Confidence            457899999999999999999999999999999999986543   3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.++.++|+|||++..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+....
T Consensus       127 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~  206 (318)
T cd05582         127 ENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET  206 (318)
T ss_pred             HHeEECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH
Confidence            99999999999999999876543332223344577899999999888888999999999999999999999999888887


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+.  .....+|..+++.++++|++||++
T Consensus       207 ~~~i~--~~~~~~p~~~~~~~~~li~~~l~~  235 (318)
T cd05582         207 MTMIL--KAKLGMPQFLSPEAQSLLRALFKR  235 (318)
T ss_pred             HHHHH--cCCCCCCCCCCHHHHHHHHHHhhc
Confidence            77774  345567888999999999999974

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.5e-37  Score=231.79  Aligned_cols=183  Identities=30%  Similarity=0.499  Sum_probs=158.2

Q ss_pred             CCCCCCCCcccccceeec----CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhC-CCCeee
Q 029552            1 MKRLRHPNIVLFMGAVTQ----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRR-NPPIVH   75 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~~~~~h   75 (191)
                      |++++||||+++++++.+    ....+++|||+++|+|.+++.+..   .+++.....++.+++.|+.+||+. +  ++|
T Consensus        72 l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~--~~H  146 (283)
T PHA02988         72 LRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYTN--KPY  146 (283)
T ss_pred             HHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcCC--CCC
Confidence            467899999999999876    347899999999999999997644   378889999999999999999984 8  889


Q ss_pred             cCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCC
Q 029552           76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD--EPSNEKSDIYSFGVILWELATLQQPWG  153 (191)
Q Consensus        76 ~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~pf~  153 (191)
                      |||+|+||+++.++.++++|||++......   .....++..|+|||.+.+  ..++.++|+||+|+++|+|++|..||.
T Consensus       147 rdlkp~nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~  223 (283)
T PHA02988        147 KNLTSVSFLVTENYKLKIICHGLEKILSSP---PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE  223 (283)
T ss_pred             CcCChhhEEECCCCcEEEcccchHhhhccc---cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCC
Confidence            999999999999999999999987643322   123456778999999876  578899999999999999999999999


Q ss_pred             CCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          154 NLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+..+....+.....+++.|..+++.++++|.+||++
T Consensus       224 ~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~  261 (283)
T PHA02988        224 NLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSH  261 (283)
T ss_pred             CCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcC
Confidence            98888888877666677788888999999999999974

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.6e-37  Score=236.67  Aligned_cols=181  Identities=25%  Similarity=0.438  Sum_probs=158.1

Q ss_pred             CCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcE
Q 029552            4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL   83 (191)
Q Consensus         4 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni   83 (191)
                      .+||||++++++|.+++..|+||||+++++|.+.+....   .+++..+..++.|++.||+|||+.|  ++||||+|+||
T Consensus        53 ~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Ni  127 (321)
T cd05591          53 AKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNI  127 (321)
T ss_pred             cCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHe
Confidence            379999999999999999999999999999999887643   3889999999999999999999999  99999999999


Q ss_pred             EecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 029552           84 LVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA  163 (191)
Q Consensus        84 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~  163 (191)
                      +++.++.++|+|||++..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......
T Consensus       128 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~  207 (321)
T cd05591         128 LLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES  207 (321)
T ss_pred             EECCCCCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            99999999999999876433222233344578899999999988899999999999999999999999999988888887


Q ss_pred             HHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          164 VGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       164 ~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +..  .....|..++..+.++|.+||++
T Consensus       208 i~~--~~~~~p~~~~~~~~~ll~~~L~~  233 (321)
T cd05591         208 ILH--DDVLYPVWLSKEAVSILKAFMTK  233 (321)
T ss_pred             HHc--CCCCCCCCCCHHHHHHHHHHhcc
Confidence            743  34556778999999999999974

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=8.4e-38  Score=238.57  Aligned_cols=183  Identities=29%  Similarity=0.446  Sum_probs=158.9

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++||||++++++++.++..++||||+.+++|.+.+....   .+++.++..++.||+.||+|||+.|  ++||||+|+
T Consensus        51 ~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~  125 (325)
T cd05604          51 KNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRER---SFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPE  125 (325)
T ss_pred             HhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHH
Confidence            46789999999999999999999999999999998887644   3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      ||+++.++.++|+|||++..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+..
T Consensus       126 NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~  205 (325)
T cd05604         126 NILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY  205 (325)
T ss_pred             HeEECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH
Confidence            99999999999999998764332222333445788999999999888899999999999999999999999998888877


Q ss_pred             HHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+..  .....+..++..+.++|.+||++
T Consensus       206 ~~~~~--~~~~~~~~~~~~~~~ll~~ll~~  233 (325)
T cd05604         206 DNILH--KPLVLRPGASLTAWSILEELLEK  233 (325)
T ss_pred             HHHHc--CCccCCCCCCHHHHHHHHHHhcc
Confidence            77743  34556678999999999999964

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.9e-37  Score=234.75  Aligned_cols=181  Identities=27%  Similarity=0.450  Sum_probs=156.9

Q ss_pred             CCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcE
Q 029552            4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL   83 (191)
Q Consensus         4 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni   83 (191)
                      ++||||+++++++.+++..++||||+++++|.+++....   .+++.++..++.|++.||+|||+.+  ++||||+|+||
T Consensus        53 ~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Ni  127 (316)
T cd05619          53 WEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNI  127 (316)
T ss_pred             cCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHE
Confidence            589999999999999999999999999999999997543   3889999999999999999999999  99999999999


Q ss_pred             EecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 029552           84 LVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA  163 (191)
Q Consensus        84 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~  163 (191)
                      +++.++.++|+|||++..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+....
T Consensus       128 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~  207 (316)
T cd05619         128 LLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQS  207 (316)
T ss_pred             EECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999999876432221222334567899999999988899999999999999999999999999888887777


Q ss_pred             HHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          164 VGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       164 ~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +..  ..+.+|..++..++++|.+||++
T Consensus       208 i~~--~~~~~~~~~~~~~~~li~~~l~~  233 (316)
T cd05619         208 IRM--DNPCYPRWLTREAKDILVKLFVR  233 (316)
T ss_pred             HHh--CCCCCCccCCHHHHHHHHHHhcc
Confidence            743  34556778999999999999974

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.1e-37  Score=234.57  Aligned_cols=180  Identities=24%  Similarity=0.485  Sum_probs=157.7

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      .||+|+++++++.+.+..++||||+++++|.+.+...+   .+++.++..++.|++.||+|||+++  ++||||+|+||+
T Consensus        59 ~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nil  133 (323)
T cd05616          59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVM  133 (323)
T ss_pred             CCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeE
Confidence            58999999999999999999999999999999987644   2889999999999999999999999  999999999999


Q ss_pred             ecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 029552           85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV  164 (191)
Q Consensus        85 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~  164 (191)
                      ++.++.++|+|||++..............+++.|+|||.+.+..++.++|+||+||++|+|++|..||...+.......+
T Consensus       134 l~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i  213 (323)
T cd05616         134 LDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI  213 (323)
T ss_pred             ECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999999998764332222233445788999999999888999999999999999999999999998888888777


Q ss_pred             HhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          165 GFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       165 ~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .  .....+|..+|..+.+++.+||++
T Consensus       214 ~--~~~~~~p~~~s~~~~~li~~~l~~  238 (323)
T cd05616         214 M--EHNVAYPKSMSKEAVAICKGLMTK  238 (323)
T ss_pred             H--hCCCCCCCcCCHHHHHHHHHHccc
Confidence            4  345667889999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5.9e-37  Score=233.28  Aligned_cols=180  Identities=27%  Similarity=0.505  Sum_probs=157.2

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      +||||+++++++.+.+..++||||+.+++|.+.+.+.+   .+++.++..++.|++.||+|||+.+  ++|+||+|+||+
T Consensus        54 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil  128 (318)
T cd05570          54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVL  128 (318)
T ss_pred             CCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeE
Confidence            69999999999999999999999999999999887643   3899999999999999999999999  999999999999


Q ss_pred             ecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 029552           85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV  164 (191)
Q Consensus        85 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~  164 (191)
                      ++.++.++|+|||++..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+
T Consensus       129 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i  208 (318)
T cd05570         129 LDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI  208 (318)
T ss_pred             ECCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence            99999999999998764322222233345778999999999988999999999999999999999999988888877777


Q ss_pred             HhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          165 GFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       165 ~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .  ......|..++..++++|++||++
T Consensus       209 ~--~~~~~~~~~~~~~~~~li~~~l~~  233 (318)
T cd05570         209 L--EDEVRYPRWLSKEAKSILKSFLTK  233 (318)
T ss_pred             H--cCCCCCCCcCCHHHHHHHHHHccC
Confidence            4  345567888999999999999974

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.8e-37  Score=244.60  Aligned_cols=188  Identities=27%  Similarity=0.447  Sum_probs=160.6

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      |+.++||||++++++|.+++..|+||||+++++|.+.+... ..+..+++.++..++.|++.||+|||+++  ++|||||
T Consensus       119 l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlk  196 (478)
T PTZ00267        119 LAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLK  196 (478)
T ss_pred             HHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcC
Confidence            45789999999999999999999999999999999887532 22334889999999999999999999999  9999999


Q ss_pred             CCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      |+||+++.++.++|+|||++.......  .......+++.|+|||.+.+..++.++|+||+||++|+|++|..||...+.
T Consensus       197 p~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~  276 (478)
T PTZ00267        197 SANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ  276 (478)
T ss_pred             HHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999999999999999987543321  122344578899999999988899999999999999999999999998888


Q ss_pred             HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+....+.. +...+.|..+|..++++|.+||++
T Consensus       277 ~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~  309 (478)
T PTZ00267        277 REIMQQVLY-GKYDPFPCPVSSGMKALLDPLLSK  309 (478)
T ss_pred             HHHHHHHHh-CCCCCCCccCCHHHHHHHHHHhcc
Confidence            887777753 344467788999999999999974

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-37  Score=235.94  Aligned_cols=181  Identities=27%  Similarity=0.429  Sum_probs=155.9

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..|+||||+++++|.+++...+   .+++.+++.++.|++.||.|||+.+  ++||||+|+
T Consensus        56 ~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~  130 (333)
T cd05600          56 TTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPE  130 (333)
T ss_pred             HhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHH
Confidence            46789999999999999999999999999999999997644   3889999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      ||+++.++.++|+|||++.....   ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+..
T Consensus       131 Nil~~~~~~~kL~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~  207 (333)
T cd05600         131 NFLIDASGHIKLTDFGLSKGIVT---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW  207 (333)
T ss_pred             HEEECCCCCEEEEeCcCCccccc---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH
Confidence            99999999999999998864433   223345778999999999888999999999999999999999999998888777


Q ss_pred             HHHHhcCcccCCCC------CCCHHHHHHHHHHhc
Q 029552          162 AAVGFKGKRLEIPR------NVNPHVASIIEACWA  190 (191)
Q Consensus       162 ~~~~~~~~~~~~~~------~~s~~~~~li~~cl~  190 (191)
                      ..+.........|.      .+|+.+.++|.+||+
T Consensus       208 ~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~  242 (333)
T cd05600         208 ENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLIN  242 (333)
T ss_pred             HHHHhccccccCCCCCccccccCHHHHHHHHHHhh
Confidence            76654333222222      569999999999996

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.8e-37  Score=237.62  Aligned_cols=183  Identities=26%  Similarity=0.382  Sum_probs=156.2

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++.+.++...|+||||+++++|.+++.+.+   .+++.++..++.|++.||+|||++|  ++||||||+
T Consensus        56 ~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~  130 (363)
T cd05628          56 VEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPD  130 (363)
T ss_pred             HhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHH
Confidence            56799999999999999999999999999999999997644   3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccccc-----------------------------------ccCCCCCCCCcccCcccccc
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTF-----------------------------------LSSKSAAGTPEWMAPEVLRD  126 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~pe~~~~  126 (191)
                      ||+++.++.++|+|||++.......                                   .......++..|+|||.+.+
T Consensus       131 NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~  210 (363)
T cd05628         131 NLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ  210 (363)
T ss_pred             HeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC
Confidence            9999999999999999875322110                                   00112357889999999998


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCcccCCCC--CCCHHHHHHHHHHh
Q 029552          127 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR--NVNPHVASIIEACW  189 (191)
Q Consensus       127 ~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~li~~cl  189 (191)
                      ..++.++|+||+||++|+|++|..||...++.+....+........+|.  .+|+.++++|.+++
T Consensus       211 ~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~  275 (363)
T cd05628         211 TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFC  275 (363)
T ss_pred             CCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHc
Confidence            8899999999999999999999999999888888888765444555554  57899999998854

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.9e-37  Score=233.81  Aligned_cols=182  Identities=24%  Similarity=0.463  Sum_probs=156.4

Q ss_pred             CCCC-CCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            3 RLRH-PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         3 ~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      .++| ++|+++++++.+++..|+||||+++++|.+++...+   .+++.++..++.|++.||+|||+.|  ++||||+|+
T Consensus        56 ~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~  130 (324)
T cd05587          56 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLD  130 (324)
T ss_pred             hcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHH
Confidence            3444 568899999999999999999999999999987644   2789999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      ||+++.++.++|+|||++..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+..
T Consensus       131 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~  210 (324)
T cd05587         131 NVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF  210 (324)
T ss_pred             HeEEcCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999999998764322222233345788999999999888899999999999999999999999998888888


Q ss_pred             HHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+.  .....+|..+++.+.++|.+||++
T Consensus       211 ~~i~--~~~~~~~~~~~~~~~~li~~~l~~  238 (324)
T cd05587         211 QSIM--EHNVSYPKSLSKEAVSICKGLLTK  238 (324)
T ss_pred             HHHH--cCCCCCCCCCCHHHHHHHHHHhhc
Confidence            7774  345677889999999999999974

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=235.61  Aligned_cols=186  Identities=29%  Similarity=0.435  Sum_probs=154.6

Q ss_pred             CCCCCCCCcccccceeecC--CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            1 MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      |+++.|||||+++++.-+.  +.+|||+|||..|.+...-..   ...+.+++++.++..++.||+|||.+|  ++||||
T Consensus       162 lKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d---~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDI  236 (576)
T KOG0585|consen  162 LKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPD---KPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDI  236 (576)
T ss_pred             HHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCC---cccccHHHHHHHHHHHHHHHHHHHhcC--eecccc
Confidence            5789999999999998654  579999999998876543322   222899999999999999999999999  999999


Q ss_pred             CCCcEEecCCCcEEEcccccccccc-----cccccCCCCCCCCcccCccccccCC----CCCcchHHHHHHHHHHHHhCC
Q 029552           79 KSPNLLVDKKYTVKVCDFGLSRLKA-----NTFLSSKSAAGTPEWMAPEVLRDEP----SNEKSDIYSFGVILWELATLQ  149 (191)
Q Consensus        79 ~p~ni~~~~~~~~~l~d~~~~~~~~-----~~~~~~~~~~~~~~~~~pe~~~~~~----~~~~~Dv~slG~~~~~l~~g~  149 (191)
                      ||.|++++.+|.+||+|||.+....     +.........++++|+|||...+..    .+.+.||||+|+++|+++.|+
T Consensus       237 KPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~  316 (576)
T KOG0585|consen  237 KPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQ  316 (576)
T ss_pred             chhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhcc
Confidence            9999999999999999999987542     2222334468999999999887632    356789999999999999999


Q ss_pred             CCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          150 QPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       150 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .||.+....+..++|......++.-+.+++.++++|.++|+|
T Consensus       317 ~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~K  358 (576)
T KOG0585|consen  317 LPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEK  358 (576)
T ss_pred             CCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhc
Confidence            999999999999999554434343345899999999999987

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5.6e-37  Score=234.40  Aligned_cols=180  Identities=26%  Similarity=0.469  Sum_probs=151.0

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      +||||++++++|.+++..|+||||+++++|.+++.+.+   .+++..++.++.|++.||+|||+.|  ++||||+|+||+
T Consensus        54 ~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil  128 (329)
T cd05588          54 NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVL  128 (329)
T ss_pred             CCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeE
Confidence            79999999999999999999999999999999886543   3899999999999999999999999  999999999999


Q ss_pred             ecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC--------
Q 029552           85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN--------  156 (191)
Q Consensus        85 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~--------  156 (191)
                      ++.++.++|+|||++..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||....        
T Consensus       129 i~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~  208 (329)
T cd05588         129 LDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN  208 (329)
T ss_pred             ECCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccccccc
Confidence            999999999999987642222222333457889999999998889999999999999999999999996311        


Q ss_pred             -HHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          157 -PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       157 -~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                       .......+  ......+|..+|..+.++|.+||++
T Consensus       209 ~~~~~~~~~--~~~~~~~p~~~~~~~~~li~~~L~~  242 (329)
T cd05588         209 TEDYLFQVI--LEKQIRIPRSLSVKASSVLKGFLNK  242 (329)
T ss_pred             chHHHHHHH--HcCCCCCCCCCCHHHHHHHHHHhcc
Confidence             11223333  3345678889999999999999974

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-37  Score=239.01  Aligned_cols=185  Identities=22%  Similarity=0.351  Sum_probs=155.9

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||++++++|.+++..|+||||+++++|.+++...+   .+++..++.++.|++.||+|||+.|  ++||||||
T Consensus        55 l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp  129 (377)
T cd05629          55 LAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKP  129 (377)
T ss_pred             HHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCH
Confidence            356899999999999999999999999999999999997643   3889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccc--------------cc---------------------------------cCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANT--------------FL---------------------------------SSKSAA  113 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~--------------~~---------------------------------~~~~~~  113 (191)
                      +||+++.++.++|+|||++......              ..                                 ......
T Consensus       130 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (377)
T cd05629         130 DNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTV  209 (377)
T ss_pred             HHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccC
Confidence            9999999999999999987421100              00                                 000134


Q ss_pred             CCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCcccCCCC--CCCHHHHHHHHHHhc
Q 029552          114 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR--NVNPHVASIIEACWA  190 (191)
Q Consensus       114 ~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~li~~cl~  190 (191)
                      ++..|+|||.+.+..++.++|+||+||++|+|++|..||...+..+....+........+|.  .+|..++++|.+||.
T Consensus       210 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~  288 (377)
T cd05629         210 GTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT  288 (377)
T ss_pred             CCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc
Confidence            77889999999888899999999999999999999999998888777777754444555554  589999999999985

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=7.6e-37  Score=237.02  Aligned_cols=183  Identities=24%  Similarity=0.374  Sum_probs=156.3

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++||||+++++++.+++..++||||+.+++|.+++....    +++..+..++.|++.||+|||+.+  ++||||+|+
T Consensus        98 ~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~----l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~  171 (370)
T cd05596          98 AHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD----IPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPD  171 (370)
T ss_pred             HhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHH
Confidence            56799999999999999999999999999999999986532    788999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccC----CCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDE----PSNEKSDIYSFGVILWELATLQQPWGNLN  156 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~----~~~~~~Dv~slG~~~~~l~~g~~pf~~~~  156 (191)
                      ||+++.++.++|+|||.+....... .......+++.|+|||.+.+.    .++.++|+||+||++|+|++|..||...+
T Consensus       172 NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~  251 (370)
T cd05596         172 NMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS  251 (370)
T ss_pred             HEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence            9999999999999999886433221 122334678899999988653    36789999999999999999999999988


Q ss_pred             HHHHHHHHHhcCcccCCCC--CCCHHHHHHHHHHhc
Q 029552          157 PAQVVAAVGFKGKRLEIPR--NVNPHVASIIEACWA  190 (191)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~--~~s~~~~~li~~cl~  190 (191)
                      .......+........+|.  .+|..++++|.+||+
T Consensus       252 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~  287 (370)
T cd05596         252 LVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLT  287 (370)
T ss_pred             HHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHcc
Confidence            8888887765545555665  589999999999996

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.5e-36  Score=231.43  Aligned_cols=180  Identities=24%  Similarity=0.496  Sum_probs=156.5

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      .|++|+++++++.+.+..|+||||+++++|.+++...+   .+++.++..++.|++.||+|||++|  ++||||+|+||+
T Consensus        59 ~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nil  133 (323)
T cd05615          59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVM  133 (323)
T ss_pred             CCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeE
Confidence            46888899999999999999999999999999987644   3899999999999999999999999  999999999999


Q ss_pred             ecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 029552           85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV  164 (191)
Q Consensus        85 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~  164 (191)
                      ++.++.++|+|||++..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+
T Consensus       134 l~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i  213 (323)
T cd05615         134 LDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI  213 (323)
T ss_pred             ECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999999998764332222233445788999999998888899999999999999999999999998888887777


Q ss_pred             HhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          165 GFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       165 ~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..  ....+|..+|..+++++.+||++
T Consensus       214 ~~--~~~~~p~~~~~~~~~li~~~l~~  238 (323)
T cd05615         214 ME--HNVSYPKSLSKEAVSICKGLMTK  238 (323)
T ss_pred             Hh--CCCCCCccCCHHHHHHHHHHccc
Confidence            43  45567889999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.3e-36  Score=232.30  Aligned_cols=181  Identities=27%  Similarity=0.465  Sum_probs=151.7

Q ss_pred             CCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcE
Q 029552            4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL   83 (191)
Q Consensus         4 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni   83 (191)
                      .+||||+++++++.+++..++||||+++++|.+++....   .+++..+..++.|++.||+|||+.+  ++||||+|+||
T Consensus        53 ~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Ni  127 (329)
T cd05618          53 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNV  127 (329)
T ss_pred             CCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHE
Confidence            479999999999999999999999999999998886543   3899999999999999999999999  99999999999


Q ss_pred             EecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC---------
Q 029552           84 LVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN---------  154 (191)
Q Consensus        84 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~---------  154 (191)
                      +++.++.++|+|||++..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||..         
T Consensus       128 li~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~  207 (329)
T cd05618         128 LLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ  207 (329)
T ss_pred             EECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCccc
Confidence            99999999999999876432222223344578899999999988889999999999999999999999952         


Q ss_pred             CCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          155 LNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .........+  ......+|..++..++++|++||++
T Consensus       208 ~~~~~~~~~i--~~~~~~~p~~~~~~~~~ll~~~L~~  242 (329)
T cd05618         208 NTEDYLFQVI--LEKQIRIPRSLSVKAASVLKSFLNK  242 (329)
T ss_pred             ccHHHHHHHH--hcCCCCCCCCCCHHHHHHHHHHhcC
Confidence            1112233333  3345678899999999999999974

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.5e-37  Score=215.16  Aligned_cols=182  Identities=26%  Similarity=0.500  Sum_probs=166.0

Q ss_pred             CCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCc
Q 029552            3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN   82 (191)
Q Consensus         3 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~n   82 (191)
                      .|+||||.+++++|-|...+|+++||..+|.+...++.+. .+.+++.....++.|++.|+.|+|..+  ++||||+|+|
T Consensus        78 ~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpen  154 (281)
T KOG0580|consen   78 HLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPEN  154 (281)
T ss_pred             ccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHH
Confidence            5799999999999999999999999999999999998433 334899999999999999999999999  9999999999


Q ss_pred             EEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 029552           83 LLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVA  162 (191)
Q Consensus        83 i~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~  162 (191)
                      ++++..|.+++.|||.+...+..  .-...+++..|++||...+...+...|+|++|++.|+++.|..||.+.+..+...
T Consensus       155 lLlg~~~~lkiAdfGwsV~~p~~--kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYk  232 (281)
T KOG0580|consen  155 LLLGSAGELKIADFGWSVHAPSN--KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYK  232 (281)
T ss_pred             hccCCCCCeeccCCCceeecCCC--CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHH
Confidence            99999999999999998765533  3345678999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          163 AVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       163 ~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +|  ......+|+.+|...+++|.+||.+
T Consensus       233 rI--~k~~~~~p~~is~~a~dlI~~ll~~  259 (281)
T KOG0580|consen  233 RI--RKVDLKFPSTISGGAADLISRLLVK  259 (281)
T ss_pred             HH--HHccccCCcccChhHHHHHHHHhcc
Confidence            99  5677888999999999999999864

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-37  Score=236.17  Aligned_cols=185  Identities=26%  Similarity=0.430  Sum_probs=156.8

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |+.++||||++++++|.+++..|+||||+.+++|.+++...+   .+++.++..++.|++.||+|||+.+  ++||||||
T Consensus        55 l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp  129 (364)
T cd05599          55 LAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLG--YIHRDIKP  129 (364)
T ss_pred             HHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCH
Confidence            356789999999999999999999999999999999997644   3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccc--------------------------------------cCCCCCCCCcccCcc
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFL--------------------------------------SSKSAAGTPEWMAPE  122 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~~pe  122 (191)
                      +||+++.++.++|+|||++........                                      ......+++.|+|||
T Consensus       130 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  209 (364)
T cd05599         130 DNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE  209 (364)
T ss_pred             HHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHH
Confidence            999999999999999998753211100                                      001234788999999


Q ss_pred             ccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCcccCCCC--CCCHHHHHHHHHHhc
Q 029552          123 VLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR--NVNPHVASIIEACWA  190 (191)
Q Consensus       123 ~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~li~~cl~  190 (191)
                      .+.+..++.++|+||+||++|+|++|..||...++.+....+.........|.  .+|+.++++|.+||.
T Consensus       210 ~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~  279 (364)
T cd05599         210 VFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC  279 (364)
T ss_pred             HHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc
Confidence            99888899999999999999999999999999888887777755444455554  579999999999984

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.3e-36  Score=235.67  Aligned_cols=183  Identities=24%  Similarity=0.404  Sum_probs=155.9

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++||||+++++++.+++..++||||+.+++|.+++....    +++.++..++.||+.||+|||+++  ++||||||+
T Consensus        98 ~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~  171 (371)
T cd05622          98 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD----VPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPD  171 (371)
T ss_pred             HhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHH
Confidence            45789999999999999999999999999999999986532    789999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccc-cccCCCCCCCCcccCccccccCC----CCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLRDEP----SNEKSDIYSFGVILWELATLQQPWGNLN  156 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~----~~~~~Dv~slG~~~~~l~~g~~pf~~~~  156 (191)
                      ||+++.++.++|+|||++...... ........+++.|+|||.+.+..    ++.++|+||+|+++|+|++|..||...+
T Consensus       172 NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~  251 (371)
T cd05622         172 NMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS  251 (371)
T ss_pred             HEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence            999999999999999998654322 11223446788999999987543    6789999999999999999999999988


Q ss_pred             HHHHHHHHHhcCcccCCC--CCCCHHHHHHHHHHhc
Q 029552          157 PAQVVAAVGFKGKRLEIP--RNVNPHVASIIEACWA  190 (191)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~cl~  190 (191)
                      .......+.......++|  ..+|..++++|.+||+
T Consensus       252 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~  287 (371)
T cd05622         252 LVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLT  287 (371)
T ss_pred             HHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcC
Confidence            888888876544444444  4699999999999985

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.6e-37  Score=223.19  Aligned_cols=185  Identities=24%  Similarity=0.407  Sum_probs=150.9

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++|+|+|.++++|..++..++|||||+..-|.++-+ ...+  .+.+.+..+++|+++|+.|+|+++  ++||||||
T Consensus        55 LKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~eLe~-~p~G--~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKP  129 (396)
T KOG0593|consen   55 LKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLHELER-YPNG--VPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKP  129 (396)
T ss_pred             HHhcccchHHHHHHHHHhcceeEEEeeecchHHHHHHHh-ccCC--CCHHHHHHHHHHHHHHhhhhhhcC--eecccCCh
Confidence            578999999999999999999999999999855555444 3323  899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      +||+++.+|.+||+|||++.....+...-..-+.+.+|.|||.+.| .+|+.+.|||++||++.+|++|.+-|.+.+..+
T Consensus       130 ENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiD  209 (396)
T KOG0593|consen  130 ENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDID  209 (396)
T ss_pred             hheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHH
Confidence            9999999999999999999754422111122244678999999988 579999999999999999999999998877776


Q ss_pred             HHHHHHhc-------------------CcccCCC----------CCCCHHHHHHHHHHhc
Q 029552          160 VVAAVGFK-------------------GKRLEIP----------RNVNPHVASIIEACWA  190 (191)
Q Consensus       160 ~~~~~~~~-------------------~~~~~~~----------~~~s~~~~~li~~cl~  190 (191)
                      .+..|...                   +.+++.|          +++|..+.+++++||+
T Consensus       210 QLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~  269 (396)
T KOG0593|consen  210 QLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLK  269 (396)
T ss_pred             HHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhc
Confidence            66555432                   1122222          3578899999999996

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2e-36  Score=227.07  Aligned_cols=187  Identities=24%  Similarity=0.362  Sum_probs=154.2

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++|+||+++.+++.+++..++++||+.+++|.+.+.... ...+++.++..++.|++.||+|||+.+  ++||||+|
T Consensus        54 l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp  130 (285)
T cd05631          54 LEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKP  130 (285)
T ss_pred             HHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCH
Confidence            356799999999999999999999999999999988875433 223889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||........
T Consensus       131 ~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~  209 (285)
T cd05631         131 ENILLDDRGHIRISDLGLAVQIPEGE-TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK  209 (285)
T ss_pred             HHEEECCCCCEEEeeCCCcEEcCCCC-eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh
Confidence            99999999999999999886543221 12334578899999999988899999999999999999999999987544322


Q ss_pred             HHHHH--hcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVG--FKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~--~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+.  .......++..+|+.+.++|++||++
T Consensus       210 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~  242 (285)
T cd05631         210 REEVDRRVKEDQEEYSEKFSEDAKSICRMLLTK  242 (285)
T ss_pred             HHHHHHHhhcccccCCccCCHHHHHHHHHHhhc
Confidence            22221  12334567788999999999999974

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=9.4e-37  Score=236.41  Aligned_cols=183  Identities=25%  Similarity=0.412  Sum_probs=156.5

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++||||+++++++.+++..|+||||+++++|.+++....    +++.++..++.||+.||+|||+++  ++||||||+
T Consensus        98 ~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~----~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~  171 (370)
T cd05621          98 AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD----VPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPD  171 (370)
T ss_pred             HhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHH
Confidence            46789999999999999999999999999999999996532    789999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccCC----CCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEP----SNEKSDIYSFGVILWELATLQQPWGNLN  156 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~----~~~~~Dv~slG~~~~~l~~g~~pf~~~~  156 (191)
                      ||+++.++.++|+|||++....... .......++..|+|||.+.+..    ++.++|+||+|+++|+|++|..||...+
T Consensus       172 NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~  251 (370)
T cd05621         172 NMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS  251 (370)
T ss_pred             HEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence            9999999999999999986543221 1223456788999999986543    6788999999999999999999999988


Q ss_pred             HHHHHHHHHhcCcccCCCC--CCCHHHHHHHHHHhc
Q 029552          157 PAQVVAAVGFKGKRLEIPR--NVNPHVASIIEACWA  190 (191)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~--~~s~~~~~li~~cl~  190 (191)
                      .......+.........|.  .+|..++++|.+||+
T Consensus       252 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~  287 (370)
T cd05621         252 LVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLT  287 (370)
T ss_pred             HHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHcc
Confidence            8888887765555556665  579999999999985

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.4e-36  Score=226.06  Aligned_cols=189  Identities=26%  Similarity=0.380  Sum_probs=153.6

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      |++++||||+++.+++..+...++||||+++++|.+.+... .....+++.+++.++.|++.||+|||+.+  ++|+||+
T Consensus        47 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlk  124 (280)
T cd05608          47 LAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLK  124 (280)
T ss_pred             HHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCC
Confidence            35789999999999999999999999999999998877432 12334899999999999999999999999  9999999


Q ss_pred             CCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      |+||+++.++.++|+|||.+..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||.......
T Consensus       125 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~  204 (280)
T cd05608         125 PENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV  204 (280)
T ss_pred             HHHEEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch
Confidence            99999999999999999988644333222333456789999999998889999999999999999999999997644322


Q ss_pred             HHHHH--HhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAV--GFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~--~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+  ........+|..+|+.+++++.+||++
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  238 (280)
T cd05608         205 ENKELKQRILNDSVTYPDKFSPASKSFCEALLAK  238 (280)
T ss_pred             hHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcC
Confidence            11111  112234566788999999999999974

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=213.64  Aligned_cols=183  Identities=28%  Similarity=0.440  Sum_probs=160.1

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.|+||||+++.+.....+..|+|+|+++|++|..-+-.   +.+++|..+-.++.||++||.|.|.+|  |+|||++|+
T Consensus        65 ~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~  139 (355)
T KOG0033|consen   65 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPE  139 (355)
T ss_pred             HhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChh
Confidence            468999999999999999999999999999999555533   245899999999999999999999999  999999999


Q ss_pred             cEEecC---CCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           82 NLLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        82 ni~~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      |+++-.   ...+||+|||++.... .-.......+++.|++||+++..+++..+|+|+-|+++|-++.|.+||.+.+..
T Consensus       140 nllLASK~~~A~vKL~~FGvAi~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~  218 (355)
T KOG0033|consen  140 NLLLASKAKGAAVKLADFGLAIEVN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH  218 (355)
T ss_pred             heeeeeccCCCceeecccceEEEeC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH
Confidence            999943   4468999999987655 323455678999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhcCccc--CCCCCCCHHHHHHHHHHhc
Q 029552          159 QVVAAVGFKGKRL--EIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       159 ~~~~~~~~~~~~~--~~~~~~s~~~~~li~~cl~  190 (191)
                      ...+.|..+....  +..+++|++.+++|++||+
T Consensus       219 rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~  252 (355)
T KOG0033|consen  219 RLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLT  252 (355)
T ss_pred             HHHHHHhccccCCCCcccCcCCHHHHHHHHHHhc
Confidence            9999997665543  3557899999999999986

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4.1e-36  Score=230.32  Aligned_cols=188  Identities=32%  Similarity=0.591  Sum_probs=150.3

Q ss_pred             CCC-CCCCcccccceeecC-CceEEEEeccCCCCHHHHhcCCCC------------------------------------
Q 029552            2 KRL-RHPNIVLFMGAVTQP-PNLSIVTEYLSRGSLYRLLHKPGV------------------------------------   43 (191)
Q Consensus         2 ~~l-~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~------------------------------------   43 (191)
                      +++ +||||+++++++... +..+++|||+++|+|.+++.....                                    
T Consensus        65 ~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (338)
T cd05102          65 IHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASV  144 (338)
T ss_pred             HHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCc
Confidence            345 899999999988754 468999999999999999864321                                    


Q ss_pred             -----------------------cccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecCCCcEEEccccccc
Q 029552           44 -----------------------REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR  100 (191)
Q Consensus        44 -----------------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~  100 (191)
                                             ...+++.++..++.|+++||+|||+.+  ++||||||+||+++.++.++|+|||++.
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~  222 (338)
T cd05102         145 LFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLAR  222 (338)
T ss_pred             cccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeeccccc
Confidence                                   123677888999999999999999999  9999999999999999999999999886


Q ss_pred             cccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCcccCCCCCC
Q 029552          101 LKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNV  177 (191)
Q Consensus       101 ~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  177 (191)
                      ......  .......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||......+........+.....|..+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  302 (338)
T cd05102         223 DIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENA  302 (338)
T ss_pred             ccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCC
Confidence            432221  11122234567999999988889999999999999999997 999998755444333333355566678889


Q ss_pred             CHHHHHHHHHHhcC
Q 029552          178 NPHVASIIEACWAK  191 (191)
Q Consensus       178 s~~~~~li~~cl~~  191 (191)
                      ++.++++|.+||++
T Consensus       303 ~~~l~~li~~cl~~  316 (338)
T cd05102         303 TPEIYRIMLACWQG  316 (338)
T ss_pred             CHHHHHHHHHHccC
Confidence            99999999999974

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-36  Score=227.75  Aligned_cols=180  Identities=28%  Similarity=0.506  Sum_probs=159.3

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      ++.|+||||+.++++|+..+.+.+||||..+|.|.|++...+.   +++.++++++.||+.|+.|.|+++  ++|||+|.
T Consensus       107 MSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKL  181 (668)
T KOG0611|consen  107 MSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCHKNR--VVHRDLKL  181 (668)
T ss_pred             HhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHhhcc--ceecccch
Confidence            4678999999999999999999999999999999999987654   999999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      +||+++.++++||.|||++...... .+....++++-|.+||++.|.+| .+..|-||||+++|.++.|.+||+..+...
T Consensus       182 ENILLD~N~NiKIADFGLSNly~~~-kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~  260 (668)
T KOG0611|consen  182 ENILLDQNNNIKIADFGLSNLYADK-KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR  260 (668)
T ss_pred             hheeecCCCCeeeeccchhhhhccc-cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH
Confidence            9999999999999999999876655 45677899999999999999987 567999999999999999999999999999


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHh
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACW  189 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl  189 (191)
                      .+.+|..+..+.+.   -+.+...||+.||
T Consensus       261 lvrQIs~GaYrEP~---~PSdA~gLIRwmL  287 (668)
T KOG0611|consen  261 LVRQISRGAYREPE---TPSDASGLIRWML  287 (668)
T ss_pred             HHHHhhcccccCCC---CCchHHHHHHHHH
Confidence            99999765554431   2334456676665

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=7.3e-36  Score=221.87  Aligned_cols=186  Identities=30%  Similarity=0.539  Sum_probs=157.0

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++..++..++||||+.+++|.+++....  ..+++.+++.++.|++.||+|||+.+  ++|+||+|
T Consensus        60 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp  135 (266)
T cd05064          60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAA  135 (266)
T ss_pred             HhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccH
Confidence            457899999999999999999999999999999999987543  23889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccccccc-CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLS-SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA  158 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~  158 (191)
                      +||+++.++.++++|||.+......... ......+..|+|||.+.+..++.++|+||+|+++|++++ |..||...+..
T Consensus       136 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~  215 (266)
T cd05064         136 HKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ  215 (266)
T ss_pred             hhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH
Confidence            9999999999999999976543222111 111223457999999988889999999999999999775 99999988888


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +....+. .+...+.|..++..+.+++.+||++
T Consensus       216 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~c~~~  247 (266)
T cd05064         216 DVIKAVE-DGFRLPAPRNCPNLLHQLMLDCWQK  247 (266)
T ss_pred             HHHHHHH-CCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            7777764 4456677889999999999999974

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-36  Score=221.49  Aligned_cols=186  Identities=32%  Similarity=0.565  Sum_probs=160.0

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++||||+++++++++++..++++||+++++|.+.+...+   .+++..+..++.|++.||.+||+.+  ++|+||+|
T Consensus        58 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p  132 (263)
T cd06625          58 LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKG  132 (263)
T ss_pred             HHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence            357899999999999999999999999999999999987644   3789999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccC---CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSS---KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      +||+++.++.++|+|||.+..........   ....+...|+|||.+.+...+.++|+||+|+++|++++|..||...+.
T Consensus       133 ~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~  212 (263)
T cd06625         133 ANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA  212 (263)
T ss_pred             HHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch
Confidence            99999999999999999876432221111   223456789999999988889999999999999999999999998877


Q ss_pred             HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ......+........+|..++..+.++|++||++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  246 (263)
T cd06625         213 MAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVE  246 (263)
T ss_pred             HHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhc
Confidence            7776666656567778889999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=234.41  Aligned_cols=184  Identities=27%  Similarity=0.432  Sum_probs=157.9

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++||||+++++++.+++..++||||+.+++|.+++.+.+   .+++.+++.++.|++.||+|||+.|  ++||||+|+
T Consensus        56 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~  130 (350)
T cd05573          56 ADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVHKLG--FIHRDIKPD  130 (350)
T ss_pred             HhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHH
Confidence            46789999999999999999999999999999999997653   3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccccc-----------------------------ccCCCCCCCCcccCccccccCCCCCc
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTF-----------------------------LSSKSAAGTPEWMAPEVLRDEPSNEK  132 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~  132 (191)
                      ||+++.++.++|+|||++.......                             .......++..|+|||.+.+..++.+
T Consensus       131 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  210 (350)
T cd05573         131 NILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE  210 (350)
T ss_pred             HeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCc
Confidence            9999999999999999886443321                             12233457889999999999889999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCcccCCC--CCCCHHHHHHHHHHhc
Q 029552          133 SDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP--RNVNPHVASIIEACWA  190 (191)
Q Consensus       133 ~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~cl~  190 (191)
                      +|+|||||++|+|++|..||...+.......+........+|  ..+|+.+.++|.+||.
T Consensus       211 ~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~  270 (350)
T cd05573         211 CDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC  270 (350)
T ss_pred             eeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc
Confidence            999999999999999999999988888777776533334444  3469999999999984

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=238.86  Aligned_cols=185  Identities=34%  Similarity=0.575  Sum_probs=166.5

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |.+++++||.++++++..+..+|++||||.||++.+.+....   .+.+.++..++.+++.|+.|||..+  .+|+|||+
T Consensus        65 Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKa  139 (467)
T KOG0201|consen   65 LSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKA  139 (467)
T ss_pred             HHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhcc--eecccccc
Confidence            457899999999999999999999999999999999997643   2588899999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      .||++..+|.+++.|||.+....+........++++.|||||++++..|+.++||||||++.++|++|.+|+.+..+..+
T Consensus       140 anil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv  219 (467)
T KOG0201|consen  140 ANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV  219 (467)
T ss_pred             cceeEeccCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE
Confidence            99999999999999999998777665555778999999999999998999999999999999999999999999999777


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +-.|- +..++.+..++|+.++++|+.||+|
T Consensus       220 lflIp-k~~PP~L~~~~S~~~kEFV~~CL~k  249 (467)
T KOG0201|consen  220 LFLIP-KSAPPRLDGDFSPPFKEFVEACLDK  249 (467)
T ss_pred             EEecc-CCCCCccccccCHHHHHHHHHHhhc
Confidence            66663 4455666678999999999999986

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=9e-37  Score=244.86  Aligned_cols=187  Identities=33%  Similarity=0.570  Sum_probs=164.7

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC-----------cccccHHHHHHHHHHHHHHHHHHHhCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-----------REMLDERRRLNMAYDVAKGMNYLHRRN   70 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~Lh~~~   70 (191)
                      ..|+|||||+++++|.+++..+||+|||..|+|.++++..++           ...++..+.+.++.||+.|.+||-++.
T Consensus       544 a~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~  623 (774)
T KOG1026|consen  544 AELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH  623 (774)
T ss_pred             HhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc
Confidence            468999999999999999999999999999999999975332           122778899999999999999999999


Q ss_pred             CCeeecCCCCCcEEecCCCcEEEccccccccccc--ccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-
Q 029552           71 PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN--TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-  147 (191)
Q Consensus        71 ~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~--~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-  147 (191)
                        ++||||-.+|++++.+-.+||+|||+++-...  ++.......-..+|||||.+...+++..+||||+|+++||+++ 
T Consensus       624 --FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsy  701 (774)
T KOG1026|consen  624 --FVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSY  701 (774)
T ss_pred             --ccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhcc
Confidence              99999999999999999999999999875432  2222334445669999999999999999999999999999988 


Q ss_pred             CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          148 LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       148 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      |..||......++++.++.+.. ++.|.++|.++.+||..||++
T Consensus       702 G~QPy~glSn~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~  744 (774)
T KOG1026|consen  702 GKQPYYGLSNQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNE  744 (774)
T ss_pred             ccCcccccchHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhc
Confidence            5789999999999999986555 999999999999999999974

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.3e-36  Score=229.33  Aligned_cols=180  Identities=26%  Similarity=0.460  Sum_probs=151.3

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      +||||+++++++.+.+..++||||+++++|.+++...+   .+++.++..++.|++.||+|||+.+  ++||||+|+||+
T Consensus        54 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nil  128 (327)
T cd05617          54 SNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVL  128 (327)
T ss_pred             CCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEE
Confidence            69999999999999999999999999999999886543   3899999999999999999999999  999999999999


Q ss_pred             ecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC------CHH
Q 029552           85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL------NPA  158 (191)
Q Consensus        85 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~------~~~  158 (191)
                      ++.++.++|+|||++..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||...      +..
T Consensus       129 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~  208 (327)
T cd05617         129 LDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTE  208 (327)
T ss_pred             EeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccH
Confidence            99999999999998764322222223445788999999999888999999999999999999999999531      222


Q ss_pred             -HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 -QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 -~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                       .....+  ...+..+|..+|..+.++|.+||++
T Consensus       209 ~~~~~~~--~~~~~~~p~~~~~~~~~li~~~L~~  240 (327)
T cd05617         209 DYLFQVI--LEKPIRIPRFLSVKASHVLKGFLNK  240 (327)
T ss_pred             HHHHHHH--HhCCCCCCCCCCHHHHHHHHHHhcc
Confidence             233333  3345668889999999999999974

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=8.9e-36  Score=219.76  Aligned_cols=187  Identities=29%  Similarity=0.516  Sum_probs=159.5

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++++||+.+++|.+++.... ...+++.+++.++.|++.||.|||+.+  ++|+||+|
T Consensus        53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~  129 (256)
T cd08529          53 LAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKS  129 (256)
T ss_pred             HHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCc
Confidence            357899999999999999999999999999999999997542 234889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.++.++|+|||.+..............+...|+|||...+...+.++|+||+|+++++|++|..||...+....
T Consensus       130 ~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~  209 (256)
T cd08529         130 LNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL  209 (256)
T ss_pred             ceEEEeCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99999999999999999876544332222334567789999999888889999999999999999999999998887776


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+. .+...+.+..++..++++|.+||++
T Consensus       210 ~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~  239 (256)
T cd08529         210 ILKII-RGVFPPVSQMYSQQLAQLIDQCLTK  239 (256)
T ss_pred             HHHHH-cCCCCCCccccCHHHHHHHHHHccC
Confidence            66664 3445566778999999999999963

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=233.06  Aligned_cols=183  Identities=26%  Similarity=0.448  Sum_probs=162.7

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++|||||++|++...+..+|+|+|.=++|+|+|++-+...+  +.|+.+.+++.||+.|+.|.|+..  ++|||+||+
T Consensus        72 KLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPE  147 (864)
T KOG4717|consen   72 KLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPE  147 (864)
T ss_pred             HHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcc
Confidence            4579999999999999999999999999999999999776644  899999999999999999999999  999999999


Q ss_pred             cEEe-cCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           82 NLLV-DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSN-EKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        82 ni~~-~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      |+++ .+-|-+||+|||++...... ......++...|.|||++.|..|+ ++.||||||+++|.+++|+.||...+..+
T Consensus       148 NVVFFEKlGlVKLTDFGFSNkf~PG-~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE  226 (864)
T KOG4717|consen  148 NVVFFEKLGLVKLTDFGFSNKFQPG-KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE  226 (864)
T ss_pred             eeEEeeecCceEeeeccccccCCCc-chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh
Confidence            9755 67799999999998755444 233456889999999999999885 56899999999999999999999999999


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+-.|  -..+..+|..+|.++++||.+||.+
T Consensus       227 TLTmI--mDCKYtvPshvS~eCrdLI~sMLvR  256 (864)
T KOG4717|consen  227 TLTMI--MDCKYTVPSHVSKECRDLIQSMLVR  256 (864)
T ss_pred             hhhhh--hcccccCchhhhHHHHHHHHHHHhc
Confidence            88888  4578899999999999999999964

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.9e-36  Score=233.99  Aligned_cols=185  Identities=26%  Similarity=0.395  Sum_probs=154.4

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||++++++|.+++..|+||||+++++|.+++.+.+   .+++..+..++.|++.||+|||+.+  ++||||||
T Consensus        55 l~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp  129 (382)
T cd05625          55 LAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKMG--FIHRDIKP  129 (382)
T ss_pred             HHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence            356799999999999999999999999999999999997643   3889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccc-----------------------------------------------cccCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANT-----------------------------------------------FLSSKSAA  113 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~-----------------------------------------------~~~~~~~~  113 (191)
                      +||+++.++.++|+|||++......                                               ........
T Consensus       130 ~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (382)
T cd05625         130 DNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLV  209 (382)
T ss_pred             HHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccc
Confidence            9999999999999999986321000                                               00011234


Q ss_pred             CCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCcccCCC--CCCCHHHHHHHHHHhc
Q 029552          114 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP--RNVNPHVASIIEACWA  190 (191)
Q Consensus       114 ~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~cl~  190 (191)
                      ++..|+|||.+.+..++.++|+||+||++|+|++|..||...++.+....+.........|  ..+|+.+.++|.+++.
T Consensus       210 gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~  288 (382)
T cd05625         210 GTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCR  288 (382)
T ss_pred             cCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHcc
Confidence            6788999999998889999999999999999999999999988887777765444444444  4689999999988753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.5e-36  Score=233.57  Aligned_cols=184  Identities=26%  Similarity=0.379  Sum_probs=152.9

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++||||+++++|.+++.+.+   .+++..+..++.|++.||+|||+.|  ++||||||
T Consensus        55 l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp  129 (381)
T cd05626          55 LAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMG--FIHRDIKP  129 (381)
T ss_pred             HHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcH
Confidence            356799999999999999999999999999999999997644   3889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccc-----------------------------------------------cccCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANT-----------------------------------------------FLSSKSAA  113 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~-----------------------------------------------~~~~~~~~  113 (191)
                      +||+++.++.++|+|||++......                                               ........
T Consensus       130 ~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (381)
T cd05626         130 DNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLV  209 (381)
T ss_pred             HHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccccccccccccc
Confidence            9999999999999999986421000                                               00011235


Q ss_pred             CCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCcccCCC--CCCCHHHHHHHHHHh
Q 029552          114 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP--RNVNPHVASIIEACW  189 (191)
Q Consensus       114 ~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~cl  189 (191)
                      ++..|+|||.+.+..++.++|+||+||++|+|++|..||...++.+....+.........|  ..+|+.++++|.+|+
T Consensus       210 gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll  287 (381)
T cd05626         210 GTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLC  287 (381)
T ss_pred             CCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHc
Confidence            7789999999988888999999999999999999999999888777666664333344444  368999999999854

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.4e-35  Score=221.90  Aligned_cols=187  Identities=33%  Similarity=0.568  Sum_probs=158.1

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC-------------cccccHHHHHHHHHHHHHHHHHHHh
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------------REMLDERRRLNMAYDVAKGMNYLHR   68 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~Lh~   68 (191)
                      ++++||||+++++++.+.+..++++||+.+++|.+++.....             ...+++.+++.++.|++.||+|||+
T Consensus        63 ~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~  142 (283)
T cd05048          63 SDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS  142 (283)
T ss_pred             HhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            567999999999999998999999999999999999965321             1347888999999999999999999


Q ss_pred             CCCCeeecCCCCCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHH
Q 029552           69 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA  146 (191)
Q Consensus        69 ~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~  146 (191)
                      .+  ++|+||+|+||+++.++.++|+|||++.......  ........+..|+|||.+.+..++.++|+||+|+++|+|+
T Consensus       143 ~~--i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~  220 (283)
T cd05048         143 HH--FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIF  220 (283)
T ss_pred             CC--eeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHH
Confidence            99  9999999999999999999999999876432221  1122234456899999988888899999999999999999


Q ss_pred             h-CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          147 T-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       147 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      + |..||...+..+....+. .+...+.|..+|+++.+++.+||++
T Consensus       221 ~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~l~~~c~~~  265 (283)
T cd05048         221 SYGLQPYYGFSNQEVIEMIR-SRQLLPCPEDCPARVYALMIECWNE  265 (283)
T ss_pred             cCCCCCCCCCCHHHHHHHHH-cCCcCCCcccCCHHHHHHHHHHccC
Confidence            8 999999888888777765 4455667889999999999999974

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.8e-36  Score=234.18  Aligned_cols=183  Identities=26%  Similarity=0.388  Sum_probs=155.7

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++.+.+++..|+||||+++++|.+++.+.+   .+++..+..++.|++.||+|||+.|  ++||||||+
T Consensus        56 ~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~  130 (360)
T cd05627          56 VEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPD  130 (360)
T ss_pred             HhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHH
Confidence            46799999999999999999999999999999999997644   3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccccc-----------------------------------ccCCCCCCCCcccCcccccc
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTF-----------------------------------LSSKSAAGTPEWMAPEVLRD  126 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~pe~~~~  126 (191)
                      ||+++.++.++|+|||++.......                                   .......++..|+|||.+.+
T Consensus       131 NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~  210 (360)
T cd05627         131 NLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ  210 (360)
T ss_pred             HEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC
Confidence            9999999999999999875321100                                   00112357889999999999


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCcccCCCC--CCCHHHHHHHHHHh
Q 029552          127 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR--NVNPHVASIIEACW  189 (191)
Q Consensus       127 ~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~li~~cl  189 (191)
                      ..++.++|+||+||++|+|++|..||...++......+........+|.  .+|+.++++|.+++
T Consensus       211 ~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~  275 (360)
T cd05627         211 TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC  275 (360)
T ss_pred             CCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc
Confidence            8899999999999999999999999999998888887765444455554  47999999999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.8e-36  Score=234.35  Aligned_cols=184  Identities=27%  Similarity=0.392  Sum_probs=153.7

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++.|.+++..++||||+++++|.+++.+.+   .+++..+..++.||+.||+|||+.|  ++||||||
T Consensus        55 l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp  129 (376)
T cd05598          55 LAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMG--FIHRDIKP  129 (376)
T ss_pred             HHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCH
Confidence            356899999999999999999999999999999999997644   3889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccc-------------------------------------------cccCCCCCCCCc
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANT-------------------------------------------FLSSKSAAGTPE  117 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~-------------------------------------------~~~~~~~~~~~~  117 (191)
                      +||+++.++.++|+|||++......                                           ........++..
T Consensus       130 ~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  209 (376)
T cd05598         130 DNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN  209 (376)
T ss_pred             HHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCcc
Confidence            9999999999999999986311000                                           000112357789


Q ss_pred             ccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCcccCCC--CCCCHHHHHHHHHHh
Q 029552          118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP--RNVNPHVASIIEACW  189 (191)
Q Consensus       118 ~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~cl  189 (191)
                      |+|||.+.+..++.++|+||+||++|+|++|..||...++.+....+.........|  ..+|+.+.++|.+|+
T Consensus       210 y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~  283 (376)
T cd05598         210 YIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC  283 (376)
T ss_pred             ccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh
Confidence            999999998889999999999999999999999999988877766664433333333  468999999999976

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-36  Score=230.48  Aligned_cols=180  Identities=28%  Similarity=0.484  Sum_probs=153.9

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      +||||+++++++.+++..|+||||+.+++|.+++.+.+   .+++..+..++.||++||+|||+.+  ++||||+|+||+
T Consensus        54 ~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nil  128 (330)
T cd05586          54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENIL  128 (330)
T ss_pred             CCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeE
Confidence            69999999999999999999999999999999987644   3899999999999999999999999  999999999999


Q ss_pred             ecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 029552           85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA  163 (191)
Q Consensus        85 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~  163 (191)
                      ++.++.++|+|||++..............++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+..+....
T Consensus       129 i~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~  208 (330)
T cd05586         129 LDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRN  208 (330)
T ss_pred             ECCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHH
Confidence            9999999999999876433322233345678899999998754 478899999999999999999999999888887777


Q ss_pred             HHhcCcccCCC-CCCCHHHHHHHHHHhcC
Q 029552          164 VGFKGKRLEIP-RNVNPHVASIIEACWAK  191 (191)
Q Consensus       164 ~~~~~~~~~~~-~~~s~~~~~li~~cl~~  191 (191)
                      +...  ...+| ..+++.++++|.+||++
T Consensus       209 i~~~--~~~~~~~~~~~~~~~li~~~L~~  235 (330)
T cd05586         209 IAFG--KVRFPKNVLSDEGRQFVKGLLNR  235 (330)
T ss_pred             HHcC--CCCCCCccCCHHHHHHHHHHcCC
Confidence            7533  33344 35899999999999974

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.8e-35  Score=221.29  Aligned_cols=181  Identities=29%  Similarity=0.517  Sum_probs=158.4

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++++||+.+++|.+++....   .+++..+..++.|++.||++||+.|  ++|+||+|
T Consensus        55 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p  129 (290)
T cd05580          55 LQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKP  129 (290)
T ss_pred             HHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCH
Confidence            356789999999999999999999999999999999997654   3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      .||+++.++.++|+|||++......   .....++..|++||.+.+...+.++|+||+|+++++|++|..||...+....
T Consensus       130 ~nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~  206 (290)
T cd05580         130 ENLLLDSDGYIKITDFGFAKRVKGR---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI  206 (290)
T ss_pred             HHEEECCCCCEEEeeCCCccccCCC---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9999999999999999987654333   2233567789999999888788899999999999999999999998887766


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+.  ....++|..++..++++|++||++
T Consensus       207 ~~~~~--~~~~~~~~~~~~~l~~li~~~l~~  235 (290)
T cd05580         207 YEKIL--EGKVRFPSFFSPDAKDLIRNLLQV  235 (290)
T ss_pred             HHHHh--cCCccCCccCCHHHHHHHHHHccC
Confidence            66663  456678888999999999999964

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.1e-35  Score=220.65  Aligned_cols=185  Identities=23%  Similarity=0.366  Sum_probs=149.8

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++.++++++...++||||+.+++|.+++...+. ..+++..+..++.|++.||+|||+.+  ++|+||+|
T Consensus        47 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp  123 (277)
T cd05607          47 LEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKP  123 (277)
T ss_pred             HHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCCh
Confidence            3578999999999999999999999999999999988854332 23788899999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH---
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP---  157 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~---  157 (191)
                      +||+++.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.....   
T Consensus       124 ~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~  202 (277)
T cd05607         124 ENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA  202 (277)
T ss_pred             HhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh
Confidence            99999999999999999876543321 12234567799999999888899999999999999999999999976433   


Q ss_pred             -HHHHHHHHhcCcccC-CCCCCCHHHHHHHHHHhcC
Q 029552          158 -AQVVAAVGFKGKRLE-IPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 -~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~cl~~  191 (191)
                       .........  .... ....+++.++++|.+||++
T Consensus       203 ~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~  236 (277)
T cd05607         203 KEELKRRTLE--DEVKFEHQNFTEESKDICRLFLAK  236 (277)
T ss_pred             HHHHHHHhhc--cccccccccCCHHHHHHHHHHhcc
Confidence             222222211  1122 2246899999999999974

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1e-35  Score=227.66  Aligned_cols=183  Identities=25%  Similarity=0.388  Sum_probs=150.5

Q ss_pred             CCC-CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++ +||||+++++++.+++..++||||+.+++|.+++....   .++++++..++.|++.||+|||+.+  ++||||||
T Consensus        59 ~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp  133 (332)
T cd05614          59 EHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKL  133 (332)
T ss_pred             HhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCH
Confidence            345 59999999999999999999999999999999986543   3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccc-cccCCCCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCCC---
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNL---  155 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~pf~~~---  155 (191)
                      +||+++.++.++|+|||++...... ........++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||...   
T Consensus       134 ~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  213 (332)
T cd05614         134 ENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER  213 (332)
T ss_pred             HHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC
Confidence            9999999999999999988643222 11222345788999999987653 678899999999999999999999642   


Q ss_pred             -CHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          156 -NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 -~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                       ........+  .....++|..+++.++++|.+||++
T Consensus       214 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~  248 (332)
T cd05614         214 NTQSEVSRRI--LKCDPPFPSFIGPEAQDLLHKLLRK  248 (332)
T ss_pred             CCHHHHHHHH--hcCCCCCCCCCCHHHHHHHHHHcCC
Confidence             222333333  2345567888999999999999974

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.7e-35  Score=218.42  Aligned_cols=186  Identities=30%  Similarity=0.515  Sum_probs=159.1

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++||||+++++++++++..++++||+++++|.+++.... ...++++.+..++.|++.||.+||+++  ++|+||+|+
T Consensus        53 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~  129 (255)
T cd08219          53 AKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSK  129 (255)
T ss_pred             HhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcc
Confidence            56799999999999999999999999999999999886432 234789999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      ||+++.++.++++|||.+..............++..|+|||.+.+...+.++|+||+|+++|+|++|..||...+.....
T Consensus       130 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~  209 (255)
T cd08219         130 NIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI  209 (255)
T ss_pred             eEEECCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHH
Confidence            99999999999999998765433322223345677899999998888899999999999999999999999988877776


Q ss_pred             HHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+. .+...+.|..++..++++|.+||++
T Consensus       210 ~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  238 (255)
T cd08219         210 LKVC-QGSYKPLPSHYSYELRSLIKQMFKR  238 (255)
T ss_pred             HHHh-cCCCCCCCcccCHHHHHHHHHHHhC
Confidence            6664 3445567788999999999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=221.34  Aligned_cols=184  Identities=30%  Similarity=0.508  Sum_probs=168.8

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |+..+||++..+..+|+.++.+|.||||.+||.|.-.+.+..   .++++..+.+..+|+.||.|||+++  |++||+|.
T Consensus       222 L~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKL  296 (516)
T KOG0690|consen  222 LQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKL  296 (516)
T ss_pred             HHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhCC--eeeeechh
Confidence            466799999999999999999999999999999999997644   3999999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +|.+++++|.+|+.|||+++-...........++++.|+|||++....|+.+.|+|.+|++||+|++|+.||...+....
T Consensus       297 ENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL  376 (516)
T KOG0690|consen  297 ENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL  376 (516)
T ss_pred             hhheeccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH
Confidence            99999999999999999988655554566778999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+.|.  -..+.+|..+|++.+.++...|.|
T Consensus       377 FeLIl--~ed~kFPr~ls~eAktLLsGLL~k  405 (516)
T KOG0690|consen  377 FELIL--MEDLKFPRTLSPEAKTLLSGLLKK  405 (516)
T ss_pred             HHHHH--hhhccCCccCCHHHHHHHHHHhhc
Confidence            99884  356788999999999999998875

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=9.3e-36  Score=227.85  Aligned_cols=185  Identities=23%  Similarity=0.327  Sum_probs=156.0

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++|+||+++++++.+++..|+||||+.+++|.+++.+...  .+++..+..++.|++.||+|||+++  ++||||||+
T Consensus        56 ~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~  131 (331)
T cd05624          56 VNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPD  131 (331)
T ss_pred             HhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchH
Confidence            456899999999999999999999999999999999975322  3889999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccc-cCCCCCCCCcccCcccccc-----CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRD-----EPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~-----~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      ||+++.++.++|+|||++........ ......++..|+|||.+.+     ..++.++|+||+|+++|+|++|..||...
T Consensus       132 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~  211 (331)
T cd05624         132 NVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             HEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence            99999999999999998764432211 1223457889999998875     34678899999999999999999999998


Q ss_pred             CHHHHHHHHHhcCcccCCCC---CCCHHHHHHHHHHhc
Q 029552          156 NPAQVVAAVGFKGKRLEIPR---NVNPHVASIIEACWA  190 (191)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~---~~s~~~~~li~~cl~  190 (191)
                      +..+....+.....+.++|.   ++|+.++++|.+||.
T Consensus       212 ~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~  249 (331)
T cd05624         212 SLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLIC  249 (331)
T ss_pred             CHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHcc
Confidence            88887777765555555554   469999999999885

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=6.9e-35  Score=215.76  Aligned_cols=187  Identities=34%  Similarity=0.599  Sum_probs=159.4

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |+.++||||+++++++.+.+..+++|||+++++|.+++.... ...+++.+++.++.|++.||.|||++|  ++|+||+|
T Consensus        56 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~  132 (261)
T cd05148          56 LKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAA  132 (261)
T ss_pred             HhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCc
Confidence            467899999999999999999999999999999999997643 234789999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ  159 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~~  159 (191)
                      +||+++.++.++|+|||.+..................|++||.+.+..++.++|+||+|+++++|++ |..||...+..+
T Consensus       133 ~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~  212 (261)
T cd05148         133 RNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE  212 (261)
T ss_pred             ceEEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence            9999999999999999988654433222222233457999999988888899999999999999998 899999888877


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+. ...+.+.|..+++++.++|.+||++
T Consensus       213 ~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~  243 (261)
T cd05148         213 VYDQIT-AGYRMPCPAKCPQEIYKIMLECWAA  243 (261)
T ss_pred             HHHHHH-hCCcCCCCCCCCHHHHHHHHHHcCC
Confidence            777775 4456677789999999999999974

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=6e-35  Score=223.35  Aligned_cols=153  Identities=32%  Similarity=0.510  Sum_probs=133.4

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhC-CCCeeecCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLK   79 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~~~~~h~~l~   79 (191)
                      |++++||||+++++++.+++..++||||+++++|.+++....   .+++..+..++.|++.||.|||+. +  ++|+||+
T Consensus        57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlk  131 (331)
T cd06649          57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVK  131 (331)
T ss_pred             HHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCC
Confidence            457899999999999999999999999999999999997644   388999999999999999999974 7  9999999


Q ss_pred             CCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      |+||+++.++.++|+|||++......  ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+
T Consensus       132 p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~  209 (331)
T cd06649         132 PSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE  209 (331)
T ss_pred             hhhEEEcCCCcEEEccCccccccccc--ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999999999999999987644332  2223457789999999998889999999999999999999999998766544


Q ss_pred             H
Q 029552          160 V  160 (191)
Q Consensus       160 ~  160 (191)
                      .
T Consensus       210 ~  210 (331)
T cd06649         210 L  210 (331)
T ss_pred             H
Confidence            4

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=7.5e-35  Score=216.01  Aligned_cols=187  Identities=37%  Similarity=0.665  Sum_probs=157.1

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |+.++||||+++++++...+..++++||+.+++|.+++.... ...+++..++.++.|++++|++||+.+  ++|+||+|
T Consensus        56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp  132 (263)
T cd05052          56 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAA  132 (263)
T ss_pred             HHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCc
Confidence            356899999999999999999999999999999999986533 223788899999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccC-CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSS-KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA  158 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~  158 (191)
                      +||+++.++.++|+|||.+.......... .....+..|++||.+.+..++.++|+||||+++|+|++ |..||...+..
T Consensus       133 ~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~  212 (263)
T cd05052         133 RNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS  212 (263)
T ss_pred             ceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            99999999999999999886544332111 11222457999999988888899999999999999998 89999888877


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +....+. ...+...|..+|..+.++|.+||++
T Consensus       213 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~  244 (263)
T cd05052         213 QVYELLE-KGYRMERPEGCPPKVYELMRACWQW  244 (263)
T ss_pred             HHHHHHH-CCCCCCCCCCCCHHHHHHHHHHccC
Confidence            7766664 3446677888999999999999973

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=6.6e-36  Score=221.41  Aligned_cols=186  Identities=37%  Similarity=0.681  Sum_probs=155.4

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+.+..++|+||+++++|.+++.... ...++..++..++.|+++||.|||+++  ++|++|+++
T Consensus        56 ~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~  132 (259)
T PF07714_consen   56 RKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPS  132 (259)
T ss_dssp             HTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGG
T ss_pred             ccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccc--ccccccccc
Confidence            46799999999999998888999999999999999997651 123899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccc--ccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKAN--TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA  158 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~--~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~  158 (191)
                      ||+++.++.+||+|||+......  .............|+|||.+....++.++||||||+++|++++ |..||.+.+..
T Consensus       133 nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~  212 (259)
T PF07714_consen  133 NILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE  212 (259)
T ss_dssp             GEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999999998865521  1122233445668999999988888999999999999999999 68999999888


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .....+ ..+.+.+.|..++..+.++|.+||+.
T Consensus       213 ~~~~~~-~~~~~~~~~~~~~~~~~~li~~C~~~  244 (259)
T PF07714_consen  213 EIIEKL-KQGQRLPIPDNCPKDIYSLIQQCWSH  244 (259)
T ss_dssp             HHHHHH-HTTEETTSBTTSBHHHHHHHHHHT-S
T ss_pred             cccccc-cccccceeccchhHHHHHHHHHHcCC
Confidence            888888 46677788889999999999999973

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6.7e-35  Score=215.73  Aligned_cols=185  Identities=29%  Similarity=0.554  Sum_probs=154.1

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||++++++++. +..++|+||+++++|.+++....  ..+++.+++.++.|++.|+++||+++  ++|+||+|
T Consensus        49 l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp  123 (257)
T cd05115          49 MHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAA  123 (257)
T ss_pred             HHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccch
Confidence            467899999999998764 57899999999999999986432  23899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccccccc---CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLS---SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLN  156 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~  156 (191)
                      +||+++.++.++|+|||.+.........   .........|+|||.+.+..++.++|+||||+++|++++ |..||....
T Consensus       124 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  203 (257)
T cd05115         124 RNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK  203 (257)
T ss_pred             heEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC
Confidence            9999999999999999988643322111   111122357999999988888899999999999999996 999999988


Q ss_pred             HHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+....+. .+.+...|..+++++.++|.+||.+
T Consensus       204 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~c~~~  237 (257)
T cd05115         204 GPEVMSFIE-QGKRLDCPAECPPEMYALMKDCWIY  237 (257)
T ss_pred             HHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            877776664 5556778889999999999999973

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2e-35  Score=226.06  Aligned_cols=185  Identities=23%  Similarity=0.348  Sum_probs=155.4

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++|+||+++++++.+++..++||||+.+++|.+++.+...  .+++..+..++.|++.||+|||+++  ++||||||+
T Consensus        56 ~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~  131 (332)
T cd05623          56 VNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPD  131 (332)
T ss_pred             hhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHH
Confidence            467899999999999999999999999999999999975322  3889999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccc-cccCCCCCCCCcccCcccccc-----CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLRD-----EPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      ||+++.++.++|+|||++...... ........++..|+|||.+.+     ..++.++|+||+|+++|+|++|..||...
T Consensus       132 Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~  211 (332)
T cd05623         132 NILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (332)
T ss_pred             HEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence            999999999999999987543221 111223457889999999862     34678999999999999999999999998


Q ss_pred             CHHHHHHHHHhcCcccCCC---CCCCHHHHHHHHHHhc
Q 029552          156 NPAQVVAAVGFKGKRLEIP---RNVNPHVASIIEACWA  190 (191)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~---~~~s~~~~~li~~cl~  190 (191)
                      +..+....+.....+.++|   ..+|+.++++|.+||.
T Consensus       212 ~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~  249 (332)
T cd05623         212 SLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLIC  249 (332)
T ss_pred             CHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHcc
Confidence            8888888876554444444   3689999999999884

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-35  Score=220.13  Aligned_cols=187  Identities=24%  Similarity=0.349  Sum_probs=154.2

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |+.++||||+++++.+.+++..++||||+.+++|.+++.... ...+++.++..++.|++.|++|||+.+  ++|+||+|
T Consensus        54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp  130 (285)
T cd05605          54 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKP  130 (285)
T ss_pred             HHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCH
Confidence            356799999999999999999999999999999998886533 223899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||+|+++|++++|..||........
T Consensus       131 ~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~  209 (285)
T cd05605         131 ENILLDDYGHIRISDLGLAVEIPEGE-TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK  209 (285)
T ss_pred             HHEEECCCCCEEEeeCCCceecCCCC-ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH
Confidence            99999999999999999876533221 12234567899999999888889999999999999999999999987655433


Q ss_pred             HHHHHh--cCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGF--KGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~--~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+..  ......++..++..++++|.+||++
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  242 (285)
T cd05605         210 REEVERRVKEDQEEYSEKFSEAARSICRQLLTK  242 (285)
T ss_pred             HHHHHHHhhhcccccCcccCHHHHHHHHHHccC
Confidence            222211  2334566778999999999999974

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-35  Score=225.14  Aligned_cols=185  Identities=23%  Similarity=0.333  Sum_probs=153.5

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++|+||+++++++++++..|+||||+.+++|.+++.+...  .+++.++..++.|++.||+|||+++  ++||||+|+
T Consensus        56 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~  131 (331)
T cd05597          56 VNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPD  131 (331)
T ss_pred             HhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHH
Confidence            457899999999999999999999999999999999965332  3889999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCcccccc-----CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRD-----EPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~-----~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      ||+++.++.++|+|||.+....... .......+++.|+|||.+.+     ..++.++|+||+|+++|+|++|..||...
T Consensus       132 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~  211 (331)
T cd05597         132 NVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             HEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence            9999999999999999875433221 11222357889999999863     34577899999999999999999999988


Q ss_pred             CHHHHHHHHHhcCcccCCC---CCCCHHHHHHHHHHhc
Q 029552          156 NPAQVVAAVGFKGKRLEIP---RNVNPHVASIIEACWA  190 (191)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~---~~~s~~~~~li~~cl~  190 (191)
                      +..+....+........+|   ..+|+.++++|++||.
T Consensus       212 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~  249 (331)
T cd05597         212 SLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLIC  249 (331)
T ss_pred             CHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHcc
Confidence            8877777775544444444   3589999999999874

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1e-34  Score=218.34  Aligned_cols=188  Identities=36%  Similarity=0.600  Sum_probs=157.9

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC-------------cccccHHHHHHHHHHHHHHHHHHH
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------------REMLDERRRLNMAYDVAKGMNYLH   67 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~Lh   67 (191)
                      +++++||||+++++++..++..++||||+++++|.+++...+.             .+.+++..++.++.|++.|+++||
T Consensus        61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH  140 (291)
T cd05094          61 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA  140 (291)
T ss_pred             HhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            3578999999999999999999999999999999999965321             223788999999999999999999


Q ss_pred             hCCCCeeecCCCCCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHH
Q 029552           68 RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL  145 (191)
Q Consensus        68 ~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l  145 (191)
                      +++  ++|+||+|+||+++.++.++|+|||.+.......  .......+...|+|||.+.+..++.++|+||+|+++|+|
T Consensus       141 ~~~--i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el  218 (291)
T cd05094         141 SQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI  218 (291)
T ss_pred             hCC--eeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHH
Confidence            999  9999999999999999999999999876433221  112223345689999999888889999999999999999


Q ss_pred             Hh-CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          146 AT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       146 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ++ |..||...+..+..+.+. .+.....+..+|..+.+++.+||++
T Consensus       219 ~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  264 (291)
T cd05094         219 FTYGKQPWFQLSNTEVIECIT-QGRVLERPRVCPKEVYDIMLGCWQR  264 (291)
T ss_pred             HhCCCCCCCCCCHHHHHHHHh-CCCCCCCCccCCHHHHHHHHHHccc
Confidence            98 999998888887777664 4445556778899999999999974

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1e-34  Score=213.96  Aligned_cols=186  Identities=34%  Similarity=0.595  Sum_probs=155.1

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++|+||+.+++|.+++...+.  .+++.+++.++.|++.||+|||+.+  ++|+||+|
T Consensus        47 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p  122 (252)
T cd05084          47 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGP--RLKVKELIQMVENAAAGMEYLESKH--CIHRDLAA  122 (252)
T ss_pred             HHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccccccch
Confidence            4678999999999999999999999999999999999865432  3789999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccC--CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSS--KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~  157 (191)
                      +||+++.++.++|+|||.+..........  ........|+|||.+.+..++.++|+||+|+++|++++ |..||.....
T Consensus       123 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~  202 (252)
T cd05084         123 RNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN  202 (252)
T ss_pred             heEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH
Confidence            99999999999999999876433221111  11122346999999988888999999999999999998 8889988777


Q ss_pred             HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ......+. ...+.+.|..++..+.+++.+||++
T Consensus       203 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  235 (252)
T cd05084         203 QQTREAIE-QGVRLPCPELCPDAVYRLMERCWEY  235 (252)
T ss_pred             HHHHHHHH-cCCCCCCcccCCHHHHHHHHHHcCC
Confidence            66666554 4456677888999999999999974

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1e-34  Score=218.01  Aligned_cols=188  Identities=34%  Similarity=0.598  Sum_probs=157.3

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC----------cccccHHHHHHHHHHHHHHHHHHHhCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV----------REMLDERRRLNMAYDVAKGMNYLHRRN   70 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~Lh~~~   70 (191)
                      |++++||||+++++++...+..++++||+++++|.+++...+.          ...+++.+++.++.|++.||++||+.|
T Consensus        61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~  140 (288)
T cd05093          61 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH  140 (288)
T ss_pred             HHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            3578999999999999999999999999999999999864321          123899999999999999999999999


Q ss_pred             CCeeecCCCCCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-
Q 029552           71 PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-  147 (191)
Q Consensus        71 ~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-  147 (191)
                        ++||||+|+||+++.++.++|+|||.+.......  .......++..|+|||.+.+..++.++|+||||+++++|++ 
T Consensus       141 --i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~  218 (288)
T cd05093         141 --FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTY  218 (288)
T ss_pred             --eeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence              9999999999999999999999999876432221  11122233567999999988888999999999999999998 


Q ss_pred             CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          148 LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       148 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      |..||...+.......+. .+.....+..++.++.+++.+||++
T Consensus       219 g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~l~~  261 (288)
T cd05093         219 GKQPWYQLSNNEVIECIT-QGRVLQRPRTCPKEVYDLMLGCWQR  261 (288)
T ss_pred             CCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHccC
Confidence            899999888888777775 3344456778999999999999974

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=8e-36  Score=228.07  Aligned_cols=185  Identities=26%  Similarity=0.404  Sum_probs=155.3

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+++++|.+++.+..  ..+++..+..++.|++.||+|||+.+  ++||||+|+
T Consensus        56 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~  131 (330)
T cd05601          56 SISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPE  131 (330)
T ss_pred             HhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchH
Confidence            46789999999999999999999999999999999997642  23899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccc-cccCCCCCCCCcccCccccc------cCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLR------DEPSNEKSDIYSFGVILWELATLQQPWGN  154 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~------~~~~~~~~Dv~slG~~~~~l~~g~~pf~~  154 (191)
                      ||+++.++.++|+|||++...... ........++..|+|||.+.      +..++.++|+||+|+++|+|++|..||..
T Consensus       132 NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~  211 (330)
T cd05601         132 NVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE  211 (330)
T ss_pred             heEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC
Confidence            999999999999999988643322 11222345678999999986      44567899999999999999999999998


Q ss_pred             CCHHHHHHHHHhcCcccCCC--CCCCHHHHHHHHHHhc
Q 029552          155 LNPAQVVAAVGFKGKRLEIP--RNVNPHVASIIEACWA  190 (191)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~cl~  190 (191)
                      .+.......+........+|  ..+++.++++|.+||+
T Consensus       212 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~  249 (330)
T cd05601         212 GTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC  249 (330)
T ss_pred             CCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc
Confidence            88887777775444334444  3689999999999985

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.1e-36  Score=214.25  Aligned_cols=180  Identities=25%  Similarity=0.439  Sum_probs=160.2

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      -||+|+++.++++.+.-.++|+|.|+.|-|+|++...-.   +++.+.+.++.|++++++|||.++  |+|||+||+||+
T Consensus        81 GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~Vt---lSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENIL  155 (411)
T KOG0599|consen   81 GHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVT---LSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENIL  155 (411)
T ss_pred             CCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhhee---ecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhhee
Confidence            599999999999999999999999999999999986443   899999999999999999999999  999999999999


Q ss_pred             ecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC------CCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE------PSNEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        85 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~------~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      ++++.+++|+|||++...... ......+++++|+|||.++.+      .|+...|.|+.|++||.++.|.+||-...+.
T Consensus       156 lddn~~i~isDFGFa~~l~~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm  234 (411)
T KOG0599|consen  156 LDDNMNIKISDFGFACQLEPG-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM  234 (411)
T ss_pred             eccccceEEeccceeeccCCc-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH
Confidence            999999999999999865544 344567899999999998543      4677799999999999999999999998888


Q ss_pred             HHHHHHHhcCcccCCC--CCCCHHHHHHHHHHhc
Q 029552          159 QVVAAVGFKGKRLEIP--RNVNPHVASIIEACWA  190 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~--~~~s~~~~~li~~cl~  190 (191)
                      -++..|..+...+.-|  .++|...+++|.+||+
T Consensus       235 lMLR~ImeGkyqF~speWadis~~~KdLIsrlLq  268 (411)
T KOG0599|consen  235 LMLRMIMEGKYQFRSPEWADISATVKDLISRLLQ  268 (411)
T ss_pred             HHHHHHHhcccccCCcchhhccccHHHHHHHHHe
Confidence            8888887776665544  6999999999999985

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.1e-34  Score=216.69  Aligned_cols=188  Identities=35%  Similarity=0.590  Sum_probs=157.9

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC-----------cccccHHHHHHHHHHHHHHHHHHHhC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-----------REMLDERRRLNMAYDVAKGMNYLHRR   69 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~Lh~~   69 (191)
                      |++++||||+++++++..+...+++|||+++++|.+++...+.           ...+++.++..++.|++.|+++||+.
T Consensus        62 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~  141 (280)
T cd05049          62 LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ  141 (280)
T ss_pred             HHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC
Confidence            3568999999999999999999999999999999999965321           23478889999999999999999999


Q ss_pred             CCCeeecCCCCCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh
Q 029552           70 NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT  147 (191)
Q Consensus        70 ~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~  147 (191)
                      +  ++|+||+|+||+++.++.++|+|||.+.......  ........+..|+|||.+.+..++.++|+||+|+++|+|++
T Consensus       142 ~--i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~  219 (280)
T cd05049         142 H--FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT  219 (280)
T ss_pred             C--eeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHh
Confidence            9  9999999999999999999999999876432111  11122234567999999998889999999999999999998


Q ss_pred             -CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          148 -LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       148 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                       |..||...+..+....+. .+.....+..++..++++|.+||++
T Consensus       220 ~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  263 (280)
T cd05049         220 YGKQPWYGLSNEEVIECIT-QGRLLQRPRTCPSEVYDIMLGCWKR  263 (280)
T ss_pred             cCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcCC
Confidence             999998888888887775 3444556778999999999999974

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.2e-34  Score=214.19  Aligned_cols=183  Identities=30%  Similarity=0.551  Sum_probs=154.1

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++||||+++++++. .+..++++||+.+++|.+++....   .+++..+..++.|++.|+++||+.|  ++|+||+|.
T Consensus        51 ~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~  124 (257)
T cd05116          51 QQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETN--FVHRDLAAR  124 (257)
T ss_pred             HhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--Eeecccchh
Confidence            5679999999999875 456789999999999999997543   3889999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccccccc---CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLS---SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP  157 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~  157 (191)
                      ||+++.++.++|+|||.+.........   ......+..|+|||.+.....+.++|+||||+++|+|++ |..||.....
T Consensus       125 nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~  204 (257)
T cd05116         125 NVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG  204 (257)
T ss_pred             hEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999988654332111   111222468999999988778889999999999999998 9999998888


Q ss_pred             HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ......+. .+..++.|..+|+.+.++|.+||+.
T Consensus       205 ~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~~~~  237 (257)
T cd05116         205 NEVTQMIE-SGERMECPQRCPPEMYDLMKLCWTY  237 (257)
T ss_pred             HHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHhcc
Confidence            77777775 4456778889999999999999963

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-34  Score=214.13  Aligned_cols=188  Identities=37%  Similarity=0.624  Sum_probs=161.5

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC------cccccHHHHHHHHHHHHHHHHHHHhCCCCee
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV------REMLDERRRLNMAYDVAKGMNYLHRRNPPIV   74 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~   74 (191)
                      ++.++|+||+++++++.++...++++||+++++|.+++.....      ...+++.+++.++.|+++||++||+.+  ++
T Consensus        50 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~  127 (262)
T cd00192          50 MKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FV  127 (262)
T ss_pred             HhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cc
Confidence            3567899999999999999999999999999999999976411      134899999999999999999999999  99


Q ss_pred             ecCCCCCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCC
Q 029552           75 HRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQP  151 (191)
Q Consensus        75 h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p  151 (191)
                      |+||+|+||+++.++.++|+|||.+.......  ........+..|+|||.+.+..++.++|+||+|+++++|++ |..|
T Consensus       128 H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p  207 (262)
T cd00192         128 HRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP  207 (262)
T ss_pred             cCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCC
Confidence            99999999999999999999999887554332  22233445678999999988888999999999999999999 5999


Q ss_pred             CCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          152 WGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       152 f~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      |...........+. .+.....|..+|..+.+++.+||+.
T Consensus       208 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  246 (262)
T cd00192         208 YPGLSNEEVLEYLR-KGYRLPKPEYCPDELYELMLSCWQL  246 (262)
T ss_pred             CCCCCHHHHHHHHH-cCCCCCCCccCChHHHHHHHHHccC
Confidence            99988888877775 3556778889999999999999963

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.1e-35  Score=215.90  Aligned_cols=184  Identities=28%  Similarity=0.487  Sum_probs=158.9

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++||||+++++++.++...++++||+.+++|.+++.+...   +++..+..++.|++.||++||+.+  ++|+||+|+
T Consensus        48 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~  122 (262)
T cd05572          48 EECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGL---FDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPE  122 (262)
T ss_pred             HhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHH
Confidence            567999999999999999999999999999999999976432   889999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC--HHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN--PAQ  159 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~--~~~  159 (191)
                      ||+++.++.++|+|||.+....... ......++..|++||.+.+..++.++|+||+|+++|++++|..||....  +..
T Consensus       123 nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~  201 (262)
T cd05572         123 NLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME  201 (262)
T ss_pred             HEEEcCCCCEEEeeCCcccccCccc-ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH
Confidence            9999999999999999887554332 2223355778999999888888899999999999999999999998766  666


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+.........|...++.++++|.+||++
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  233 (262)
T cd05572         202 IYNDILKGNGKLEFPNYIDKAAKDLIKQLLRR  233 (262)
T ss_pred             HHHHHhccCCCCCCCcccCHHHHHHHHHHccC
Confidence            66666544567778888899999999999964

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=6.7e-35  Score=218.75  Aligned_cols=186  Identities=24%  Similarity=0.349  Sum_probs=148.4

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++||||+++++++..++..++||||+.++++..+.....   .+++..++.++.|++.||+|||+.+  ++|+||+|
T Consensus        54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp  128 (287)
T cd07848          54 LRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPN---GVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKP  128 (287)
T ss_pred             HHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCH
Confidence            357899999999999999999999999999877766554322   3889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      +||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+...
T Consensus       129 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~  208 (287)
T cd07848         129 ENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID  208 (287)
T ss_pred             HHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999999999999999886543221 11223356788999999988888999999999999999999999998876555


Q ss_pred             HHHHHHhcCcc-----------------cC-------------CCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKR-----------------LE-------------IPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~-----------------~~-------------~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+......                 ..             ....+|..++++|++||++
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~  270 (287)
T cd07848         209 QLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKL  270 (287)
T ss_pred             HHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccC
Confidence            44333221100                 00             1124788999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.3e-34  Score=216.82  Aligned_cols=186  Identities=32%  Similarity=0.531  Sum_probs=154.1

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++||||+++++++..++..++|+||+.+++|.+++.+..  ..+++..+..++.|+++||++||+.+  ++|+||+|+
T Consensus        57 ~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~  132 (282)
T cd06643          57 ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAG  132 (282)
T ss_pred             HHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcc
Confidence            46799999999999999999999999999999998875422  23889999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQQPWGNLN  156 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~  156 (191)
                      ||+++.++.++++|||++..............++..|+|||.+.     +..++.++|+||+|+++|+|++|..||...+
T Consensus       133 nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~  212 (282)
T cd06643         133 NILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN  212 (282)
T ss_pred             cEEEccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC
Confidence            99999999999999998765433322233345677899999874     3446778999999999999999999999887


Q ss_pred             HHHHHHHHHhcC-cccCCCCCCCHHHHHHHHHHhcC
Q 029552          157 PAQVVAAVGFKG-KRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~~~~~~~~~~~-~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +.+....+.... .....|..++..++++|.+||++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  248 (282)
T cd06643         213 PMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEK  248 (282)
T ss_pred             HHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccC
Confidence            776666654322 23445778999999999999974

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.5e-34  Score=213.47  Aligned_cols=186  Identities=35%  Similarity=0.600  Sum_probs=156.7

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |+.++||||+++++++.+++..+++|||+++++|.+++.....  .+++..++.++.|++.||+|||+.+  ++|+||+|
T Consensus        53 l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p  128 (256)
T cd05114          53 MMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAA  128 (256)
T ss_pred             HHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCc
Confidence            4578999999999999999999999999999999999865332  3789999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccccccc-CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLS-SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA  158 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~  158 (191)
                      +||+++.++.++++|||.+......... .........|+|||.+.+..++.++|+||+|+++|++++ |..||...+..
T Consensus       129 ~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~  208 (256)
T cd05114         129 RNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY  208 (256)
T ss_pred             ceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            9999999999999999987643322111 112223457999999988888899999999999999999 89999998888


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .....+. .+.+...|...+..+.+++.+||++
T Consensus       209 ~~~~~i~-~~~~~~~~~~~~~~~~~li~~c~~~  240 (256)
T cd05114         209 EVVEMIS-RGFRLYRPKLASMTVYEVMYSCWHE  240 (256)
T ss_pred             HHHHHHH-CCCCCCCCCCCCHHHHHHHHHHccC
Confidence            8888775 3445556777899999999999974

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6.9e-35  Score=219.00  Aligned_cols=186  Identities=25%  Similarity=0.385  Sum_probs=149.3

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++||||+.+ +|.+++...+.  .+++.++..++.|++.||+|||+.|  ++||||+|
T Consensus        57 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp  131 (288)
T cd07871          57 LKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKP  131 (288)
T ss_pred             HHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCH
Confidence            3578999999999999999999999999975 89988865432  3788999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      +||+++.++.++|+|||.+..............++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+..+
T Consensus       132 ~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~  211 (288)
T cd07871         132 QNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE  211 (288)
T ss_pred             HHEEECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999999999999999988654333222333456778999998865 457889999999999999999999998877666


Q ss_pred             HHHHHHhcCcc----------------------------cCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKR----------------------------LEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~----------------------------~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+......                            ......++++.+++|.+||+.
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~  271 (288)
T cd07871         212 ELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLY  271 (288)
T ss_pred             HHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCc
Confidence            55544321110                            001235788999999999963

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.5e-34  Score=213.69  Aligned_cols=186  Identities=37%  Similarity=0.618  Sum_probs=156.5

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++||||+++++++.+++..+++|||+.+++|.+++.....  .+++.+++.++.|++.||+|||+.+  ++|+||+|
T Consensus        53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p  128 (256)
T cd05113          53 MMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAA  128 (256)
T ss_pred             HhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCc
Confidence            4678999999999999988899999999999999999975432  3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccc-cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA  158 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~  158 (191)
                      .||+++.++.++|+|||.+........ .......+..|++||.+.+..++.++|+||||+++|+|++ |..||...+..
T Consensus       129 ~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~  208 (256)
T cd05113         129 RNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS  208 (256)
T ss_pred             ceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH
Confidence            999999999999999998764332211 1111223457999999988888899999999999999998 99999988887


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .....+. .+.+...+...+..+++++.+||++
T Consensus       209 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~  240 (256)
T cd05113         209 ETVEKVS-QGLRLYRPHLASEKVYAIMYSCWHE  240 (256)
T ss_pred             HHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            7777774 3445566777899999999999964

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-34  Score=214.05  Aligned_cols=186  Identities=33%  Similarity=0.607  Sum_probs=157.4

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++++||+.+++|.+++.....  .+++.+++.++.|++.|+++||+++  ++|+||+|
T Consensus        59 l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p  134 (266)
T cd05033          59 MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAA  134 (266)
T ss_pred             HHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCc
Confidence            3578999999999999999999999999999999999965432  3889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccc--cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~  157 (191)
                      +||+++.++.++++|||.+........  .......+..|+|||.+.+..++.++|+||+|+++|++++ |..||.....
T Consensus       135 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~  214 (266)
T cd05033         135 RNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN  214 (266)
T ss_pred             ceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH
Confidence            999999999999999998875532111  1112223457999999988888999999999999999998 9999988887


Q ss_pred             HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ......+. .....+.+..+++.+.+++.+||++
T Consensus       215 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~  247 (266)
T cd05033         215 QDVIKAVE-DGYRLPPPMDCPSALYQLMLDCWQK  247 (266)
T ss_pred             HHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            77777664 3445567788999999999999974

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-34  Score=213.20  Aligned_cols=186  Identities=35%  Similarity=0.613  Sum_probs=156.3

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+.+..++|+||+++++|.+++.....  .++++.++.++.|++.|+++||+.+  ++|+||+|
T Consensus        53 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p  128 (256)
T cd05059          53 MMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAA  128 (256)
T ss_pred             HHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC--cccccccH
Confidence            3578999999999999999999999999999999999865432  3889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccC-CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSS-KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA  158 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~  158 (191)
                      +||+++.++.++++|||.+....+..... ........|+|||.+.+..++.++|+||+|+++|++++ |..||......
T Consensus       129 ~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~  208 (256)
T cd05059         129 RNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS  208 (256)
T ss_pred             hhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH
Confidence            99999999999999999876443321111 11122347999999988888999999999999999999 79999888877


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +....+. .......|..+|..+.+++.+||++
T Consensus       209 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~  240 (256)
T cd05059         209 EVVESVS-AGYRLYRPKLAPTEVYTIMYSCWHE  240 (256)
T ss_pred             HHHHHHH-cCCcCCCCCCCCHHHHHHHHHHhcC
Confidence            7777664 4445667788999999999999963

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.1e-35  Score=230.22  Aligned_cols=184  Identities=35%  Similarity=0.606  Sum_probs=160.3

Q ss_pred             CCCCCCCCcccccceeecCC--ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      |+.|+||||+++++++.+..  .+.+|+|.+++|+|..++.+.+.   .....+..|+.||++||.|||++.++|+||||
T Consensus        95 LKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~PPIIHRDL  171 (632)
T KOG0584|consen   95 LKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDL  171 (632)
T ss_pred             HccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCCCCcccccc
Confidence            67899999999999998655  58999999999999999987553   78889999999999999999999999999999


Q ss_pred             CCCcEEecC-CCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-CC
Q 029552           79 KSPNLLVDK-KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN-LN  156 (191)
Q Consensus        79 ~p~ni~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~-~~  156 (191)
                      |-+|||++. .|.+||+|+|++.....+  ......|++-|||||... ..|++..||||||+.|.+|+|+..||.. .+
T Consensus       172 KCDNIFinG~~G~VKIGDLGLAtl~r~s--~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n  248 (632)
T KOG0584|consen  172 KCDNIFVNGNLGEVKIGDLGLATLLRKS--HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN  248 (632)
T ss_pred             ccceEEEcCCcCceeecchhHHHHhhcc--ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC
Confidence            999999976 589999999999876655  333468999999999987 5589999999999999999999999986 88


Q ss_pred             HHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhc
Q 029552          157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~  190 (191)
                      +..++.++..+..+..+-.-=.+.++++|++||.
T Consensus       249 ~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~  282 (632)
T KOG0584|consen  249 PAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLA  282 (632)
T ss_pred             HHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhc
Confidence            8899999875544444545557999999999985

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.2e-34  Score=212.60  Aligned_cols=187  Identities=33%  Similarity=0.571  Sum_probs=159.6

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++.+.+ ...++++||+++++|.+.+..... ..+++..++.++.|++.||++||+.+  ++|+||+|
T Consensus        50 l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p  125 (257)
T cd05040          50 MHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAA  125 (257)
T ss_pred             HhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCc
Confidence            467899999999999988 889999999999999999976442 34889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccccc---ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLN  156 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~  156 (191)
                      +||+++.++.++|+|||.+.......   .......+...|+|||.+.+..++.++|+||+|+++++|++ |..||...+
T Consensus       126 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  205 (257)
T cd05040         126 RNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS  205 (257)
T ss_pred             ccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999886543321   11112334568999999988888999999999999999998 999999888


Q ss_pred             HHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+....+.........|..+|..+.+++.+||++
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  240 (257)
T cd05040         206 GSQILKKIDKEGERLERPEACPQDIYNVMLQCWAH  240 (257)
T ss_pred             HHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCC
Confidence            88877777655556667788999999999999974

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.7e-34  Score=218.32  Aligned_cols=189  Identities=32%  Similarity=0.531  Sum_probs=151.2

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCC----------------CcccccHHHHHHHHHHHHHHHH
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG----------------VREMLDERRRLNMAYDVAKGMN   64 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~~~~i~~~l~   64 (191)
                      |++++||||+++++++.+.+..+++|||+.+++|.+++....                ....++..+++.++.|++.||+
T Consensus        73 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~  152 (304)
T cd05096          73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMK  152 (304)
T ss_pred             HhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence            457899999999999999999999999999999999885422                1123677889999999999999


Q ss_pred             HHHhCCCCeeecCCCCCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHH
Q 029552           65 YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVIL  142 (191)
Q Consensus        65 ~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~  142 (191)
                      |||+.|  ++|+||+|+||+++.++.++|+|||++.......  ........+..|+|||.+.+..++.++|+||+|+++
T Consensus       153 ~lH~~~--ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l  230 (304)
T cd05096         153 YLSSLN--FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTL  230 (304)
T ss_pred             HHHHCC--ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHH
Confidence            999999  9999999999999999999999999886432221  112223345689999999888889999999999999


Q ss_pred             HHHHh--CCCCCCCCCHHHHHHHHHhc------CcccCCCCCCCHHHHHHHHHHhcC
Q 029552          143 WELAT--LQQPWGNLNPAQVVAAVGFK------GKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       143 ~~l~~--g~~pf~~~~~~~~~~~~~~~------~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      |+|++  +..||...+..+....+...      ......|..++..+.++|.+||++
T Consensus       231 ~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  287 (304)
T cd05096         231 WEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSR  287 (304)
T ss_pred             HHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccC
Confidence            99987  56789887776665544221      112334667899999999999974

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=8.9e-35  Score=224.23  Aligned_cols=181  Identities=30%  Similarity=0.529  Sum_probs=145.0

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++|+||+++++++.+++..++|+||+.+++|.+..       ...+..+..++.||+.||+|||+.+  ++|+||+|
T Consensus       126 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp  196 (353)
T PLN00034        126 LRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH--IVHRDIKP  196 (353)
T ss_pred             HHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCH
Confidence            35789999999999999999999999999999986532       1567788899999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC-----CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-----PSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-----~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      +||+++.++.++|+|||++..............++..|+|||.+...     ..+.++|+||||+++|+|++|..||...
T Consensus       197 ~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~  276 (353)
T PLN00034        197 SNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG  276 (353)
T ss_pred             HHEEEcCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999887543332222344678899999987432     2346899999999999999999999743


Q ss_pred             CHHH---HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          156 NPAQ---VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~~---~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+   ....+ ........+..++..++++|.+||++
T Consensus       277 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~  314 (353)
T PLN00034        277 RQGDWASLMCAI-CMSQPPEAPATASREFRHFISCCLQR  314 (353)
T ss_pred             CCccHHHHHHHH-hccCCCCCCCccCHHHHHHHHHHccC
Confidence            3222   22222 23345566788999999999999974

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=7.9e-35  Score=225.99  Aligned_cols=188  Identities=31%  Similarity=0.538  Sum_probs=153.1

Q ss_pred             CCC-CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCC--------------------------------------
Q 029552            2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------------------------------------   42 (191)
Q Consensus         2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------------------------------------   42 (191)
                      +++ +||||+++++++.+++..++||||+.+++|.+++....                                      
T Consensus        96 ~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (374)
T cd05106          96 SHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSS  175 (374)
T ss_pred             HhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccc
Confidence            456 79999999999999999999999999999999885321                                      


Q ss_pred             -----------------------------CcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecCCCcEEE
Q 029552           43 -----------------------------VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKV   93 (191)
Q Consensus        43 -----------------------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l   93 (191)
                                                   ....+++.+++.++.|+++||+|||+.+  ++||||||+||+++.++.++|
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL  253 (374)
T cd05106         176 QGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKI  253 (374)
T ss_pred             cccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEE
Confidence                                         0123678889999999999999999999  999999999999999999999


Q ss_pred             cccccccccccccc--cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCcc
Q 029552           94 CDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKR  170 (191)
Q Consensus        94 ~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  170 (191)
                      +|||++........  .......+..|+|||.+.+..++.++|+||+|+++|+|++ |..||...............+..
T Consensus       254 ~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~  333 (374)
T cd05106         254 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ  333 (374)
T ss_pred             eeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccC
Confidence            99998764322211  1111223457999999988889999999999999999997 99999886655544444445556


Q ss_pred             cCCCCCCCHHHHHHHHHHhcC
Q 029552          171 LEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       171 ~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...|..+|+.++++|.+||+.
T Consensus       334 ~~~~~~~~~~l~~li~~cl~~  354 (374)
T cd05106         334 MSRPDFAPPEIYSIMKMCWNL  354 (374)
T ss_pred             ccCCCCCCHHHHHHHHHHcCC
Confidence            667778899999999999974

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-35  Score=225.61  Aligned_cols=160  Identities=29%  Similarity=0.454  Sum_probs=140.9

Q ss_pred             CCCCCCCCcccccceeecC--CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            1 MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      |++|+||||+++.+...++  +.+|||||||++ +|..++...+..  |++.++.-++.||+.||+|+|.+|  ++||||
T Consensus       170 Lr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vk--ft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDI  244 (560)
T KOG0600|consen  170 LRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVK--FTEPQIKCYMKQLLEGLEYCHSRG--VLHRDI  244 (560)
T ss_pred             HHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCCcc--cChHHHHHHHHHHHHHHHHHhhcC--eeeccc
Confidence            5789999999999988765  689999999987 999999876654  999999999999999999999999  999999


Q ss_pred             CCCcEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 029552           79 KSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLN  156 (191)
Q Consensus        79 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf~~~~  156 (191)
                      |.+||+++.+|.+||+|||++.+..... ......+.+.+|.|||.+.|. .|+.+.|+||.|||+.||++|++.|...+
T Consensus       245 K~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t  324 (560)
T KOG0600|consen  245 KGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT  324 (560)
T ss_pred             cccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc
Confidence            9999999999999999999998654332 223345668899999999887 48999999999999999999999999888


Q ss_pred             HHHHHHHHH
Q 029552          157 PAQVVAAVG  165 (191)
Q Consensus       157 ~~~~~~~~~  165 (191)
                      ..+.+..|-
T Consensus       325 EveQl~kIf  333 (560)
T KOG0600|consen  325 EVEQLHKIF  333 (560)
T ss_pred             HHHHHHHHH
Confidence            887777664

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.2e-34  Score=218.43  Aligned_cols=184  Identities=28%  Similarity=0.514  Sum_probs=153.0

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++.|.++...++|+||+.+++|.+++...    .+++.++..++.|++.||+|||+.+  ++|+||+|+
T Consensus        72 ~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~  145 (296)
T cd06654          72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSD  145 (296)
T ss_pred             HhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHH
Confidence            5678999999999999999999999999999999998643    2788899999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      ||+++.++.++|+|||.+..............++..|+|||.+.+...+.++|+||+|+++|+|++|..||...++....
T Consensus       146 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~  225 (296)
T cd06654         146 NILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL  225 (296)
T ss_pred             HEEEcCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH
Confidence            99999999999999998764332222222345677899999998888889999999999999999999999887765544


Q ss_pred             HHHHhcC-cccCCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKG-KRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~-~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+.... ...+.|..++..+.++|.+||++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  256 (296)
T cd06654         226 YLIATNGTPELQNPEKLSAIFRDFLNRCLDM  256 (296)
T ss_pred             HHHhcCCCCCCCCccccCHHHHHHHHHHCcC
Confidence            3332222 23345678999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.2e-34  Score=217.06  Aligned_cols=185  Identities=30%  Similarity=0.552  Sum_probs=155.5

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++||||+++++++.+++..++|+||+++++|.+++...    .+++.++..++.|++.|+++||+.+  ++|+||+|
T Consensus        70 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p  143 (296)
T cd06655          70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKS  143 (296)
T ss_pred             HHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCH
Confidence            35689999999999999999999999999999999988643    2789999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.++.++|+|||.+..............++..|+|||.+.+...+.++|+||+|+++|++++|..||...++...
T Consensus       144 ~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~  223 (296)
T cd06655         144 DNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA  223 (296)
T ss_pred             HHEEECCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99999999999999999876433222222234566789999999888888999999999999999999999998777665


Q ss_pred             HHHHHhcC-cccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKG-KRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~-~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+.... .....|..+++.++++|.+||.+
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  255 (296)
T cd06655         224 LYLIATNGTPELQNPEKLSPIFRDFLNRCLEM  255 (296)
T ss_pred             HHHHHhcCCcccCCcccCCHHHHHHHHHHhhc
Confidence            55553222 23446678999999999999963

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.4e-34  Score=212.32  Aligned_cols=187  Identities=27%  Similarity=0.526  Sum_probs=160.5

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++|+||+++++++.+.+..++++||+++++|.+++.+.. ...+++.++..++.|+++++.+||+.+  ++|+||+|
T Consensus        53 l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p  129 (256)
T cd08221          53 LSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKT  129 (256)
T ss_pred             HHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCh
Confidence            357899999999999999999999999999999999997542 234789999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.++.++++|||.+..............++..|.|||...+...+.++|+||+|+++++|++|..||...+..+.
T Consensus       130 ~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~  209 (256)
T cd08221         130 LNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL  209 (256)
T ss_pred             HhEEEeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence            99999999999999999876544333223344567899999999888888899999999999999999999999888887


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+.. +...+.+..++..+.++|.+||.+
T Consensus       210 ~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~  239 (256)
T cd08221         210 VVKIVQ-GNYTPVVSVYSSELISLVHSLLQQ  239 (256)
T ss_pred             HHHHHc-CCCCCCccccCHHHHHHHHHHccc
Confidence            777753 344455678999999999999963

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.1e-34  Score=215.12  Aligned_cols=187  Identities=32%  Similarity=0.559  Sum_probs=154.1

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC-------cccccHHHHHHHHHHHHHHHHHHHhCCCCee
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------REMLDERRRLNMAYDVAKGMNYLHRRNPPIV   74 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~   74 (191)
                      +.++||||+++++++.++...++|+||+.+++|.+++.....       ...++...++.++.|+++||+|||+.+  ++
T Consensus        64 ~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~v  141 (277)
T cd05062          64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FV  141 (277)
T ss_pred             HhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cc
Confidence            567999999999999999999999999999999999864321       112567788999999999999999999  99


Q ss_pred             ecCCCCCcEEecCCCcEEEcccccccccccccc--cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCC
Q 029552           75 HRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQP  151 (191)
Q Consensus        75 h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p  151 (191)
                      |+||+|+||+++.++.++++|||++........  .......+..|+|||.+.+..++.++|+||||+++|+|++ |..|
T Consensus       142 H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p  221 (277)
T cd05062         142 HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP  221 (277)
T ss_pred             cCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999999998764322211  1112233567999999988888999999999999999999 6889


Q ss_pred             CCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          152 WGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       152 f~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      |...+.......+. .......+..++..++++|.+||++
T Consensus       222 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  260 (277)
T cd05062         222 YQGMSNEQVLRFVM-EGGLLDKPDNCPDMLFELMRMCWQY  260 (277)
T ss_pred             CCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcCC
Confidence            98888777766654 3445567788999999999999974

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.5e-34  Score=215.12  Aligned_cols=188  Identities=37%  Similarity=0.621  Sum_probs=156.6

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC------------cccccHHHHHHHHHHHHHHHHHHHh
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV------------REMLDERRRLNMAYDVAKGMNYLHR   68 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~Lh~   68 (191)
                      |+.++|+||+++++++.+++..++++||+.+++|.+++...+.            ...+++.+++.++.|++.|++|||+
T Consensus        61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~  140 (280)
T cd05092          61 LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS  140 (280)
T ss_pred             HhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH
Confidence            3578999999999999999999999999999999999865431            1237889999999999999999999


Q ss_pred             CCCCeeecCCCCCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHH
Q 029552           69 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA  146 (191)
Q Consensus        69 ~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~  146 (191)
                      .+  ++|+||+|+||+++.++.++|+|||++.......  ........+..|+|||.+.+..++.++|+||||+++|+|+
T Consensus       141 ~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~  218 (280)
T cd05092         141 LH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIF  218 (280)
T ss_pred             CC--eecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHH
Confidence            99  9999999999999999999999999875432211  1111222346799999998888899999999999999999


Q ss_pred             h-CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          147 T-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       147 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      + |..||...........+. .+.....|..+++.+.++|.+||++
T Consensus       219 ~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~  263 (280)
T cd05092         219 TYGKQPWYQLSNTEAIECIT-QGRELERPRTCPPEVYAIMQGCWQR  263 (280)
T ss_pred             cCCCCCCccCCHHHHHHHHH-cCccCCCCCCCCHHHHHHHHHHccC
Confidence            8 899998888777777664 4445567788999999999999974

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-35  Score=223.45  Aligned_cols=186  Identities=27%  Similarity=0.381  Sum_probs=161.4

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++.++||.+-..|+.++..++|+..|+||+|..++-+.+. +.++++.++.++.+|+-||++||+.+  |++||+||
T Consensus       239 L~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKP  315 (591)
T KOG0986|consen  239 LEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKP  315 (591)
T ss_pred             HHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCCh
Confidence            4678899999999999999999999999999999999977663 45999999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC---CCH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN---LNP  157 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~---~~~  157 (191)
                      +||++++.|+++|+|+|++.-.... ......+++..|||||++....|+.+.|+|||||++|+|+.|+-||..   ...
T Consensus       316 eNILLDd~GhvRISDLGLAvei~~g-~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk  394 (591)
T KOG0986|consen  316 ENILLDDHGHVRISDLGLAVEIPEG-KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK  394 (591)
T ss_pred             hheeeccCCCeEeeccceEEecCCC-CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh
Confidence            9999999999999999999865544 233445899999999999999999999999999999999999999975   233


Q ss_pred             HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+.+++.. ......+|..+|++.+++.+..|.|
T Consensus       395 ~eEvdrr~-~~~~~ey~~kFS~eakslc~~LL~K  427 (591)
T KOG0986|consen  395 REEVDRRT-LEDPEEYSDKFSEEAKSLCEGLLTK  427 (591)
T ss_pred             HHHHHHHH-hcchhhcccccCHHHHHHHHHHHcc
Confidence            32333321 4457788899999999999988875

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.8e-34  Score=214.18  Aligned_cols=185  Identities=35%  Similarity=0.617  Sum_probs=155.9

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+.+..++++||+++++|.+++...+   .+++.++..++.|++.||++||+.+  ++|+||+|
T Consensus        60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p  134 (267)
T cd06628          60 LKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKG  134 (267)
T ss_pred             HHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhcC--cccccCCH
Confidence            357899999999999999999999999999999999997644   3889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccc------cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFL------SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN  154 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~  154 (191)
                      +||+++.++.++|+|||.+........      ......+...|+|||.+.+..++.++|+||+|+++++|++|..||..
T Consensus       135 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  214 (267)
T cd06628         135 ANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD  214 (267)
T ss_pred             HHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence            999999999999999998764432110      11122356789999999888888899999999999999999999988


Q ss_pred             CCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          155 LNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+.......+. .......|..++..++++|.+||++
T Consensus       215 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  250 (267)
T cd06628         215 CTQLQAIFKIG-ENASPEIPSNISSEAIDFLEKTFEI  250 (267)
T ss_pred             ccHHHHHHHHh-ccCCCcCCcccCHHHHHHHHHHccC
Confidence            76666555543 3445677888999999999999974

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-35  Score=242.00  Aligned_cols=187  Identities=36%  Similarity=0.604  Sum_probs=163.4

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC----cccccHHHHHHHHHHHHHHHHHHHhCCCCeeec
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV----REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR   76 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~   76 (191)
                      |++++||||+++++++.+....++++|||.+|+|..++++...    ...++..+.+.++.++++|.+||++.+  ++||
T Consensus       749 m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHR  826 (1025)
T KOG1095|consen  749 MSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHR  826 (1025)
T ss_pred             HhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCc
Confidence            4689999999999999999999999999999999999987521    224888899999999999999999999  9999


Q ss_pred             CCCCCcEEecCCCcEEEccccccccccc--ccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q 029552           77 DLKSPNLLVDKKYTVKVCDFGLSRLKAN--TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWG  153 (191)
Q Consensus        77 ~l~p~ni~~~~~~~~~l~d~~~~~~~~~--~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~  153 (191)
                      ||..+|++++....+|++|||++.-...  .+...........|||||.+....++.++||||+|+++||+++ |..||.
T Consensus       827 DLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~  906 (1025)
T KOG1095|consen  827 DLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYP  906 (1025)
T ss_pred             chhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999983221  1122222234568999999999989999999999999999999 588999


Q ss_pred             CCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhc
Q 029552          154 NLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~  190 (191)
                      +.+..++......++ +++.|..|++.+.++|.+||+
T Consensus       907 ~~~n~~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~  942 (1025)
T KOG1095|consen  907 SRSNFEVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWK  942 (1025)
T ss_pred             CcchHHHHHHHHhCC-ccCCCCCCChHHHHHHHHHcc
Confidence            999999999887555 999999999999999999997

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.2e-34  Score=214.76  Aligned_cols=188  Identities=34%  Similarity=0.580  Sum_probs=155.9

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC--------------cccccHHHHHHHHHHHHHHHHHH
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV--------------REMLDERRRLNMAYDVAKGMNYL   66 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~~~~~~i~~~l~~L   66 (191)
                      |++++||||+++++++..++..|++|||+.+++|.+++.....              ...+++.++..++.|++.||+||
T Consensus        61 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l  140 (283)
T cd05090          61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL  140 (283)
T ss_pred             HhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence            4678999999999999999999999999999999999853211              12378889999999999999999


Q ss_pred             HhCCCCeeecCCCCCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHH
Q 029552           67 HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWE  144 (191)
Q Consensus        67 h~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~  144 (191)
                      |+.+  ++|+||+|+||+++.++.++|+|||++.......  ........+..|+|||.+.+..++.++|+||+|+++++
T Consensus       141 H~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e  218 (283)
T cd05090         141 SSHF--FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWE  218 (283)
T ss_pred             HhcC--eehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHH
Confidence            9999  9999999999999999999999999886432221  11122233457999999988888999999999999999


Q ss_pred             HHh-CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          145 LAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       145 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      |++ |..||....+......+. ....++.|..+++.++++|.+||++
T Consensus       219 l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~  265 (283)
T cd05090         219 IFSFGLQPYYGFSNQEVIEMVR-KRQLLPCSEDCPPRMYSLMTECWQE  265 (283)
T ss_pred             HHcCCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHccc
Confidence            998 889998877766666664 4455677889999999999999974

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.2e-34  Score=220.48  Aligned_cols=151  Identities=34%  Similarity=0.529  Sum_probs=131.0

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCeeecCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLK   79 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~~h~~l~   79 (191)
                      |++++||||++++++|.+++..++||||+.+++|.+++...+   .+++..+..++.|++.|+.|||+ .+  ++|+||+
T Consensus        57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlk  131 (333)
T cd06650          57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVK  131 (333)
T ss_pred             HHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCC
Confidence            357899999999999999999999999999999999997644   37899999999999999999997 57  9999999


Q ss_pred             CCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      |+||+++.++.++|+|||++......  ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||......
T Consensus       132 p~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~  208 (333)
T cd06650         132 PSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK  208 (333)
T ss_pred             hhhEEEcCCCCEEEeeCCcchhhhhh--ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            99999999999999999987643322  122335677999999999888899999999999999999999999765543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-34  Score=214.67  Aligned_cols=188  Identities=33%  Similarity=0.564  Sum_probs=158.1

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC-------cccccHHHHHHHHHHHHHHHHHHHhCCCCe
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------REMLDERRRLNMAYDVAKGMNYLHRRNPPI   73 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~   73 (191)
                      |+.++||||+++++++.++...++++||+.+++|.+++.....       ...+++.+++.++.|++.||.|||+.+  +
T Consensus        63 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i  140 (277)
T cd05032          63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--F  140 (277)
T ss_pred             HHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--c
Confidence            3567999999999999999999999999999999999864321       123678899999999999999999999  9


Q ss_pred             eecCCCCCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCC
Q 029552           74 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQ  150 (191)
Q Consensus        74 ~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~  150 (191)
                      +|+||+|+||+++.++.++|+|||.+.......  ........+..|+|||.+.+...+.++|+||||+++|++++ |..
T Consensus       141 ~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  220 (277)
T cd05032         141 VHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQ  220 (277)
T ss_pred             cccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCC
Confidence            999999999999999999999999876433221  11122334568999999988888999999999999999998 899


Q ss_pred             CCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          151 PWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       151 pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ||...+.......+. .+...+.|..++..+.++|.+||+.
T Consensus       221 p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  260 (277)
T cd05032         221 PYQGLSNEEVLKFVI-DGGHLDLPENCPDKLLELMRMCWQY  260 (277)
T ss_pred             CCccCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            999888888777775 5556778888999999999999973

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.1e-34  Score=216.30  Aligned_cols=186  Identities=35%  Similarity=0.609  Sum_probs=154.1

Q ss_pred             CCC-CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCC-------------CcccccHHHHHHHHHHHHHHHHHHH
Q 029552            2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-------------VREMLDERRRLNMAYDVAKGMNYLH   67 (191)
Q Consensus         2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~~~~~~i~~~l~~Lh   67 (191)
                      +++ +||||+++++++...+..++++||+++++|.+++....             ....+++.+++.++.|++.||++||
T Consensus        57 ~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH  136 (297)
T cd05089          57 CKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS  136 (297)
T ss_pred             HhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            345 69999999999999899999999999999999996432             1124788999999999999999999


Q ss_pred             hCCCCeeecCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh
Q 029552           68 RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT  147 (191)
Q Consensus        68 ~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~  147 (191)
                      ++|  ++|+||+|+||+++.++.++|+|||++....... ..........|++||.+.+..++.++|+||||+++|+|++
T Consensus       137 ~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t  213 (297)
T cd05089         137 EKQ--FIHRDLAARNVLVGENLASKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS  213 (297)
T ss_pred             HCC--cccCcCCcceEEECCCCeEEECCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHc
Confidence            999  9999999999999999999999999875322111 1111122346999999988888999999999999999997


Q ss_pred             -CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          148 -LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       148 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                       |..||...........+. .+.....|..++.+++++|.+||++
T Consensus       214 ~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  257 (297)
T cd05089         214 LGGTPYCGMTCAELYEKLP-QGYRMEKPRNCDDEVYELMRQCWRD  257 (297)
T ss_pred             CCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCC
Confidence             999999988888777764 3345567788999999999999974

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-34  Score=211.48  Aligned_cols=187  Identities=34%  Similarity=0.564  Sum_probs=157.1

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++...+..++++||+.+++|.+++.... ...++..++..++.|++.|+.+||+.+  ++|+||+|
T Consensus        55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p  131 (261)
T cd05068          55 MKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAA  131 (261)
T ss_pred             HHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCc
Confidence            356899999999999999999999999999999999997644 223789999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccccccc-CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLS-SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA  158 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~  158 (191)
                      +||+++.++.++|+|||.+......... .........|+|||.+.+..++.++|+||+|+++++|++ |..||...+..
T Consensus       132 ~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  211 (261)
T cd05068         132 RNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA  211 (261)
T ss_pred             ceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            9999999999999999988654422111 111122347999999988888999999999999999999 99999988887


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .....+. .....+.+..++..+.+++.+||++
T Consensus       212 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  243 (261)
T cd05068         212 EVLQQVD-QGYRMPCPPGCPKELYDIMLDCWKE  243 (261)
T ss_pred             HHHHHHH-cCCCCCCCCcCCHHHHHHHHHHhhc
Confidence            7777764 3345566788999999999999974

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.7e-34  Score=215.36  Aligned_cols=187  Identities=30%  Similarity=0.501  Sum_probs=152.7

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++||||+++++++..++..++||||+.+++|..++.+...  .+++.++..++.|++.++++||+.+  ++|+|++|
T Consensus        63 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp  138 (292)
T cd06644          63 LATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKA  138 (292)
T ss_pred             HHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCc
Confidence            3578999999999999999999999999999999888754332  3889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      +||+++.++.++|+|||.+..............++..|+|||.+.     ...++.++|+||+|+++|+|++|..||...
T Consensus       139 ~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  218 (292)
T cd06644         139 GNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL  218 (292)
T ss_pred             ceEEEcCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence            999999999999999998764332222222334567899999874     334577899999999999999999999887


Q ss_pred             CHHHHHHHHHhcCc-ccCCCCCCCHHHHHHHHHHhcC
Q 029552          156 NPAQVVAAVGFKGK-RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ++......+..... ....+..++..+.++|.+||++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  255 (292)
T cd06644         219 NPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDK  255 (292)
T ss_pred             cHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcC
Confidence            77766665532222 2345678899999999999974

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-34  Score=211.05  Aligned_cols=184  Identities=33%  Similarity=0.552  Sum_probs=154.4

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||++++++++ .+..++++||+.+++|.+++....   .+++..+..++.|++.++++||..+  ++|+||+|
T Consensus        50 l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p  123 (257)
T cd05060          50 MAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAA  123 (257)
T ss_pred             HHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC--eeccCccc
Confidence            35689999999999876 456899999999999999997654   3889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccC---CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSS---KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLN  156 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~  156 (191)
                      +||+++.++.++|+|||.+..........   ........|+|||.+.+..++.++|+||+|+++|++++ |..||...+
T Consensus       124 ~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~  203 (257)
T cd05060         124 RNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK  203 (257)
T ss_pred             ceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC
Confidence            99999999999999999876443221111   11112347999999988889999999999999999998 999999988


Q ss_pred             HHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+....+. ...+.+.|..++..++++|.+||+.
T Consensus       204 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~  237 (257)
T cd05060         204 GAEVIAMLE-SGERLPRPEECPQEIYSIMLSCWKY  237 (257)
T ss_pred             HHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHhcC
Confidence            877777764 4456677889999999999999973

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3e-34  Score=212.83  Aligned_cols=186  Identities=31%  Similarity=0.530  Sum_probs=155.5

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++|+||+++.+++.+.+..++++||+++++|.+++.+..   .+++..+..++.|++.||++||+.+  ++|+||+|
T Consensus        56 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p  130 (265)
T cd06631          56 LKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKG  130 (265)
T ss_pred             HHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCH
Confidence            357899999999999999999999999999999999997643   2789999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccc------cccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANT------FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN  154 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~  154 (191)
                      +||+++.++.++|+|||.+......      ........++..|+|||.+.+..++.++|+||+|++++++++|..||..
T Consensus       131 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~  210 (265)
T cd06631         131 NNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS  210 (265)
T ss_pred             HhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence            9999999999999999987643211      1111223466789999999888888999999999999999999999988


Q ss_pred             CCHHHHHHHHHhc-CcccCCCCCCCHHHHHHHHHHhcC
Q 029552          155 LNPAQVVAAVGFK-GKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       155 ~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+.......+... ....+.+..++..+.++|.+||++
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  248 (265)
T cd06631         211 MDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTR  248 (265)
T ss_pred             CChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcC
Confidence            7666554444322 334567788999999999999964

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=5.6e-34  Score=209.65  Aligned_cols=185  Identities=33%  Similarity=0.581  Sum_probs=155.8

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++...+..++||||+.+++|.+++.....  .+++.++..++.+++.+|.+||++|  ++|+|++|+
T Consensus        47 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~  122 (250)
T cd05085          47 KQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKD--ELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAAR  122 (250)
T ss_pred             HhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChh
Confidence            567999999999999999999999999999999999865432  3789999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccC-CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSS-KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ  159 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~~  159 (191)
                      ||+++.++.++++|||.+.......... ........|+|||.+.+..++.++|+||+|+++|++++ |..||...+...
T Consensus       123 nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~  202 (250)
T cd05085         123 NCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ  202 (250)
T ss_pred             eEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH
Confidence            9999999999999999876433221111 11223457999999988888899999999999999998 899999888777


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+. .+.+...+..++..+.+++.+||++
T Consensus       203 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  233 (250)
T cd05085         203 AREQVE-KGYRMSCPQKCPDDVYKVMQRCWDY  233 (250)
T ss_pred             HHHHHH-cCCCCCCCCCCCHHHHHHHHHHccc
Confidence            777664 4445667788999999999999974

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-35  Score=229.62  Aligned_cols=187  Identities=35%  Similarity=0.614  Sum_probs=167.1

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++||||++++++..+...+++|||+|+||+|.+++++.+.  .++..+...++.+.+.|++|||+.+  ++||||-.
T Consensus       215 Mr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAA  290 (474)
T KOG0194|consen  215 MRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAA  290 (474)
T ss_pred             HHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhH
Confidence            3578999999999999999999999999999999999988653  3889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ  159 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~~  159 (191)
                      +|++++.++.+|++|||++..............-...|+|||.+....++.++||||+|+++||+++ |..||.+....+
T Consensus       291 RNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~  370 (474)
T KOG0194|consen  291 RNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE  370 (474)
T ss_pred             HHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH
Confidence            9999999999999999998765423222212234568999999998899999999999999999998 788999999999


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +..++...+.+.+.|...+..+..++.+||.+
T Consensus       371 v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~  402 (474)
T KOG0194|consen  371 VKAKIVKNGYRMPIPSKTPKELAKVMKQCWKK  402 (474)
T ss_pred             HHHHHHhcCccCCCCCCCHHHHHHHHHHhccC
Confidence            99999878889999999999999999999974

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.2e-34  Score=215.06  Aligned_cols=184  Identities=30%  Similarity=0.548  Sum_probs=156.5

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++||||+++++++.++...++||||+.+++|.+++...    .+++.++..++.|++.|+++||+.+  ++|+||+|
T Consensus        56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p  129 (277)
T cd06640          56 LSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKA  129 (277)
T ss_pred             HHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCCh
Confidence            35689999999999999999999999999999999998653    2788899999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.++.++++|||.+..............++..|+|||.+.+...+.++|+||+|+++|+|++|..||...++...
T Consensus       130 ~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~  209 (277)
T cd06640         130 ANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV  209 (277)
T ss_pred             hhEEEcCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH
Confidence            99999999999999999886543332222233456689999999888888999999999999999999999998887776


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+. ....+.++..++..+.++|.+||++
T Consensus       210 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  239 (277)
T cd06640         210 LFLIP-KNNPPTLTGEFSKPFKEFIDACLNK  239 (277)
T ss_pred             hhhhh-cCCCCCCchhhhHHHHHHHHHHccc
Confidence            66553 3345566778899999999999974

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.6e-34  Score=212.16  Aligned_cols=187  Identities=27%  Similarity=0.537  Sum_probs=159.5

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++.+++++.+..++|+||+.+++|.+.+..... ..+++.++..++.|++.|+.+||+.+  ++|+||+|
T Consensus        53 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~  129 (256)
T cd08218          53 LSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKS  129 (256)
T ss_pred             HHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCH
Confidence            4678999999999999999999999999999999998865331 23789999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.++.++++|||.+..............+...|+|||...+...+.++|+||+|++++++++|..||...+..+.
T Consensus       130 ~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~  209 (256)
T cd08218         130 QNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL  209 (256)
T ss_pred             HHEEEcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH
Confidence            99999999999999999876543332222233456789999999888888899999999999999999999998888877


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+. .+...+.|..++.+++++|.+||++
T Consensus       210 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  239 (256)
T cd08218         210 VLKII-RGSYPPVSSHYSYDLRNLVSQLFKR  239 (256)
T ss_pred             HHHHh-cCCCCCCcccCCHHHHHHHHHHhhC
Confidence            77764 4455567888999999999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=252.48  Aligned_cols=186  Identities=31%  Similarity=0.515  Sum_probs=161.8

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |.-++|||+|+++++-.+++..++.||||.+|+|.+.++..+.   .++.....+..|++.|+.|||++|  ||||||||
T Consensus      1288 lE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~ 1362 (1509)
T KOG4645|consen 1288 LEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKP 1362 (1509)
T ss_pred             HHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCc
Confidence            3457999999999999999999999999999999999986442   666677778899999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccccc----ccCCCCCCCCcccCccccccCC---CCCcchHHHHHHHHHHHHhCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTF----LSSKSAAGTPEWMAPEVLRDEP---SNEKSDIYSFGVILWELATLQQPWG  153 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~---~~~~~Dv~slG~~~~~l~~g~~pf~  153 (191)
                      .||+++.+|.+|++|||.+....+..    .......|++.|||||++.+..   -.-++||||||||+.+|+||+.||.
T Consensus      1363 aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~ 1442 (1509)
T KOG4645|consen 1363 ANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWA 1442 (1509)
T ss_pred             cceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchh
Confidence            99999999999999999987655442    1223457899999999997664   3457899999999999999999999


Q ss_pred             CCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          154 NLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+....+......+..+++|..+|..-+++|+.||.+
T Consensus      1443 ~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~ 1480 (1509)
T KOG4645|consen 1443 ELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQ 1480 (1509)
T ss_pred             hccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhc
Confidence            98887777766668889999999999999999999974

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-34  Score=212.30  Aligned_cols=187  Identities=35%  Similarity=0.531  Sum_probs=154.3

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..+++|||+.+++|.+++....  ..+++.++..++.|++.|+++||+.+  ++|+||+|
T Consensus        54 l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p  129 (262)
T cd06613          54 LKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKG  129 (262)
T ss_pred             HHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCh
Confidence            357899999999999999999999999999999999987642  23889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE---PSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~---~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      +||+++.++.++++|||.+..............++..|++||.+.+.   ..+.++|+||+|+++++|++|..||...++
T Consensus       130 ~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~  209 (262)
T cd06613         130 ANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP  209 (262)
T ss_pred             hhEEECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999999999999999876543322222233556789999998776   678899999999999999999999988776


Q ss_pred             HHHHHHHHhcCcc---cCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKR---LEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~---~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ......+......   ...+..++.+++++|++||++
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  246 (262)
T cd06613         210 MRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTK  246 (262)
T ss_pred             HHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCC
Confidence            6665555433222   223456789999999999974

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-35  Score=212.12  Aligned_cols=182  Identities=26%  Similarity=0.393  Sum_probs=153.1

Q ss_pred             CCCCcccccceeec----CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            5 RHPNIVLFMGAVTQ----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         5 ~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      .|||||.++++++.    .+...+|||+++||.|+..++..+. ..++|.++..++.||..|+.|||+.+  |+||||||
T Consensus       113 ~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKp  189 (400)
T KOG0604|consen  113 GHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKP  189 (400)
T ss_pred             CCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCCh
Confidence            59999999999863    3457799999999999999987663 45999999999999999999999999  99999999


Q ss_pred             CcEEecCC---CcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           81 PNLLVDKK---YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      +|++++.+   ..+||+|||+++.... ......++.++.|.|||++....++.++|.||+|+++|-|++|.+||.++..
T Consensus       190 ENLLyt~t~~na~lKLtDfGFAK~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg  268 (400)
T KOG0604|consen  190 ENLLYTTTSPNAPLKLTDFGFAKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG  268 (400)
T ss_pred             hheeeecCCCCcceEecccccccccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC
Confidence            99999654   4689999999985543 3456678889999999999999999999999999999999999999987654


Q ss_pred             HH----HHHHHHhcCcccCCC--CCCCHHHHHHHHHHhc
Q 029552          158 AQ----VVAAVGFKGKRLEIP--RNVNPHVASIIEACWA  190 (191)
Q Consensus       158 ~~----~~~~~~~~~~~~~~~--~~~s~~~~~li~~cl~  190 (191)
                      ..    +..+|..+...++-|  +.+|+..+++|++.|+
T Consensus       269 ~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLk  307 (400)
T KOG0604|consen  269 LAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLK  307 (400)
T ss_pred             ccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhc
Confidence            43    455564444433333  5799999999999885

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.5e-34  Score=212.08  Aligned_cols=186  Identities=30%  Similarity=0.584  Sum_probs=155.9

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++|+||+++++++.+++..++++||+.+++|.+++.... ...++..+++.++.|++.||+|||+.+  ++|+||+|+
T Consensus        56 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~  132 (261)
T cd05072          56 KTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAA  132 (261)
T ss_pred             HhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchh
Confidence            56899999999999999999999999999999999986532 234788899999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccccccc-CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLS-SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ  159 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~~  159 (191)
                      ||+++.++.++|+|||.+......... ......+..|+|||.+.+..++.++|+||+|+++|+|++ |..||.......
T Consensus       133 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~  212 (261)
T cd05072         133 NVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD  212 (261)
T ss_pred             hEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH
Confidence            999999999999999998654332111 112223457999999988888889999999999999998 899999888777


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+. ...+.+.+..++..+.++|.+||++
T Consensus       213 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  243 (261)
T cd05072         213 VMSALQ-RGYRMPRMENCPDELYDIMKTCWKE  243 (261)
T ss_pred             HHHHHH-cCCCCCCCCCCCHHHHHHHHHHccC
Confidence            777764 3345566678999999999999963

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-35  Score=240.65  Aligned_cols=180  Identities=27%  Similarity=0.402  Sum_probs=163.7

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      +++.|+.++-.|+|+++.|+||||++||+|-.++.+.+   .+|+..++.++.+|+-||..||+.|  ++||||||+||+
T Consensus       133 ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvL  207 (1317)
T KOG0612|consen  133 NSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVL  207 (1317)
T ss_pred             CcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeE
Confidence            57789999999999999999999999999999998766   3999999999999999999999999  999999999999


Q ss_pred             ecCCCcEEEcccccccccc-cccccCCCCCCCCcccCccccc----c-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           85 VDKKYTVKVCDFGLSRLKA-NTFLSSKSAAGTPEWMAPEVLR----D-EPSNEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        85 ~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~~~~~~~~pe~~~----~-~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      ++..|.+||.|||.+.... ++.......+|+|.|++||++.    + +.|+.-+|+||+|+++|+|+.|..||...+..
T Consensus       208 ld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv  287 (1317)
T KOG0612|consen  208 LDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV  287 (1317)
T ss_pred             ecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH
Confidence            9999999999999876544 5556677889999999999985    2 45788999999999999999999999999999


Q ss_pred             HHHHHHHhcCcccCCC--CCCCHHHHHHHHHHh
Q 029552          159 QVVAAVGFKGKRLEIP--RNVNPHVASIIEACW  189 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~--~~~s~~~~~li~~cl  189 (191)
                      +.+.+|..-...+.+|  -.+|+..++||.+.+
T Consensus       288 eTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll  320 (1317)
T KOG0612|consen  288 ETYGKIMNHKESLSFPDETDVSEEAKDLIEALL  320 (1317)
T ss_pred             HHHHHHhchhhhcCCCcccccCHHHHHHHHHHh
Confidence            9999998887788888  569999999999865

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.1e-34  Score=217.89  Aligned_cols=186  Identities=34%  Similarity=0.632  Sum_probs=153.6

Q ss_pred             CCC-CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC-------------cccccHHHHHHHHHHHHHHHHHHH
Q 029552            2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------------REMLDERRRLNMAYDVAKGMNYLH   67 (191)
Q Consensus         2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~Lh   67 (191)
                      +++ +||||+++++++.+++..++++||+++++|.+++...+.             ...+++.+++.++.|++.|++|||
T Consensus        62 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH  141 (303)
T cd05088          62 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS  141 (303)
T ss_pred             HHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH
Confidence            356 899999999999999999999999999999999864321             224789999999999999999999


Q ss_pred             hCCCCeeecCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh
Q 029552           68 RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT  147 (191)
Q Consensus        68 ~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~  147 (191)
                      ++|  ++|+||+|+||+++.++.++|+|||++...... ...........|+|||.+.+..++.++|+||+|+++++|++
T Consensus       142 ~~g--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt  218 (303)
T cd05088         142 QKQ--FIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS  218 (303)
T ss_pred             hCC--ccccccchheEEecCCCcEEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHh
Confidence            999  999999999999999999999999987532211 11111223457999999988888899999999999999998


Q ss_pred             -CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          148 -LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       148 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                       |..||...+..+....+. .......|..+++.+.++|.+||++
T Consensus       219 ~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  262 (303)
T cd05088         219 LGGTPYCGMTCAELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWRE  262 (303)
T ss_pred             cCCCCcccCChHHHHHHHh-cCCcCCCCCCCCHHHHHHHHHHcCC
Confidence             999998877777666663 3334556778899999999999974

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.9e-34  Score=222.97  Aligned_cols=188  Identities=31%  Similarity=0.532  Sum_probs=151.6

Q ss_pred             CCC-CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC-------------------------------------
Q 029552            2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------------------------------------   43 (191)
Q Consensus         2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------------------------------   43 (191)
                      +.+ +||||+++++++.+++..++||||+++|+|.+++.....                                     
T Consensus        93 ~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  172 (375)
T cd05104          93 SYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMK  172 (375)
T ss_pred             HHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcC
Confidence            345 799999999999999999999999999999999864221                                     


Q ss_pred             -----------------------------------cccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecCC
Q 029552           44 -----------------------------------REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK   88 (191)
Q Consensus        44 -----------------------------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~   88 (191)
                                                         ...+++..++.++.|++.||+|||+.+  ++|+||||+||+++.+
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~  250 (375)
T cd05104         173 PGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHG  250 (375)
T ss_pred             CCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECC
Confidence                                               113678889999999999999999999  9999999999999999


Q ss_pred             CcEEEcccccccccccccc--cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 029552           89 YTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVG  165 (191)
Q Consensus        89 ~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~  165 (191)
                      +.++|+|||++........  .......+..|+|||.+.+..++.++|+||+|+++|+|++ |..||.............
T Consensus       251 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~  330 (375)
T cd05104         251 RITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI  330 (375)
T ss_pred             CcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHH
Confidence            9999999998864432211  1111223456999999998889999999999999999998 888998765544444443


Q ss_pred             hcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          166 FKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       166 ~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+.+...|...+..++++|.+||++
T Consensus       331 ~~~~~~~~~~~~~~~l~~li~~cl~~  356 (375)
T cd05104         331 KEGYRMLSPECAPSEMYDIMKSCWDA  356 (375)
T ss_pred             HhCccCCCCCCCCHHHHHHHHHHccC
Confidence            44455566777899999999999974

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.7e-34  Score=212.19  Aligned_cols=186  Identities=32%  Similarity=0.598  Sum_probs=155.5

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..+++|||+++++|.+++.....  .+++.++..++.|++.|+++||+.+  ++|+||+|
T Consensus        59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp  134 (267)
T cd05066          59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAA  134 (267)
T ss_pred             HHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--Eeehhhch
Confidence            3568999999999999999999999999999999999975432  3788999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccccccc---CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLS---SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLN  156 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~  156 (191)
                      +||+++.++.++++|||.+.........   ......+..|++||.+.+..++.++|+||+|++++++++ |..||....
T Consensus       135 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~  214 (267)
T cd05066         135 RNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS  214 (267)
T ss_pred             hcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC
Confidence            9999999999999999988654322111   111122457999999988888999999999999999886 999999887


Q ss_pred             HHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+....+. ...+.+.+..+++.+.+++.+||++
T Consensus       215 ~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  248 (267)
T cd05066         215 NQDVIKAIE-EGYRLPAPMDCPAALHQLMLDCWQK  248 (267)
T ss_pred             HHHHHHHHh-CCCcCCCCCCCCHHHHHHHHHHccc
Confidence            777766664 3345566778999999999999974

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.3e-34  Score=213.58  Aligned_cols=189  Identities=25%  Similarity=0.444  Sum_probs=152.7

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCC-CcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      |+.++||||+++++++.+++..++++||+++++|.+++.... ....++++++..++.|+++||+|||+++  ++|+||+
T Consensus        56 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~  133 (267)
T cd08228          56 LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIK  133 (267)
T ss_pred             HHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCC
Confidence            357899999999999999999999999999999998885322 1234789999999999999999999999  9999999


Q ss_pred             CCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC--H
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN--P  157 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~--~  157 (191)
                      |+||+++.++.++++|||.+..............+...|+|||.+.+...+.++|+||+|+++|+|++|..||....  .
T Consensus       134 ~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~  213 (267)
T cd08228         134 PANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL  213 (267)
T ss_pred             HHHEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH
Confidence            99999999999999999987654433222233456778999999988888889999999999999999999996543  3


Q ss_pred             HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ......+.....+...+..++..++++|.+||++
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  247 (267)
T cd08228         214 FSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYP  247 (267)
T ss_pred             HHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCC
Confidence            3444444322222233456889999999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.9e-34  Score=216.34  Aligned_cols=151  Identities=28%  Similarity=0.455  Sum_probs=127.4

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |+.++||||+++++++.++...++||||+. ++|.+++....  +.++++.+..++.|++.||+|||+.+  ++|+||||
T Consensus        57 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp  131 (303)
T cd07869          57 LKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKP  131 (303)
T ss_pred             HhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCH
Confidence            357899999999999999999999999996 58877776533  23789999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLN  156 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf~~~~  156 (191)
                      +||+++.++.++|+|||.+..............++..|+|||.+.+. .++.++|+||+|+++|+|++|..||....
T Consensus       132 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  208 (303)
T cd07869         132 QNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK  208 (303)
T ss_pred             HHEEECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence            99999999999999999876433222223334567889999988654 46888999999999999999999998743

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-34  Score=214.20  Aligned_cols=187  Identities=32%  Similarity=0.528  Sum_probs=155.0

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++..+...++||||+++++|.+++...+.  .+++.+++.++.|++.++.|||+.+  ++|+|++|
T Consensus        56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p  131 (280)
T cd06611          56 LSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKA  131 (280)
T ss_pred             HHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCh
Confidence            3578999999999999999999999999999999999876432  3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      +||+++.++.++|+|||.+..............++..|++||.+.     ...++.++|+||+|+++|+|++|..||...
T Consensus       132 ~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~  211 (280)
T cd06611         132 GNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL  211 (280)
T ss_pred             hhEEECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence            999999999999999998765433322223344677899999874     334567899999999999999999999988


Q ss_pred             CHHHHHHHHHhcCc-ccCCCCCCCHHHHHHHHHHhcC
Q 029552          156 NPAQVVAAVGFKGK-RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +.......+..... ....|..++..+.++|.+||++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  248 (280)
T cd06611         212 NPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVK  248 (280)
T ss_pred             CHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhcc
Confidence            87776666643222 3345678999999999999964

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.6e-34  Score=215.08  Aligned_cols=185  Identities=23%  Similarity=0.361  Sum_probs=148.4

Q ss_pred             CCCCCCCcccccceee-----cCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeec
Q 029552            2 KRLRHPNIVLFMGAVT-----QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR   76 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~   76 (191)
                      ++++||||+++++++.     .....++|+|++. ++|.+++.... ...+++.++..++.|++.||+|||+.|  ++|+
T Consensus        59 ~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~  134 (290)
T cd07862          59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR--VVHR  134 (290)
T ss_pred             cccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeC
Confidence            4568999999999885     3456899999996 58999886543 223789999999999999999999999  9999


Q ss_pred             CCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 029552           77 DLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN  156 (191)
Q Consensus        77 ~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~  156 (191)
                      ||+|+||+++.++.++|+|||.+...... .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+
T Consensus       135 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  213 (290)
T cd07862         135 DLKPQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS  213 (290)
T ss_pred             CCCHHHEEEcCCCCEEEccccceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence            99999999999999999999988654322 22233456789999999988888999999999999999999999999877


Q ss_pred             HHHHHHHHHhcCccc-------------------------CCCCCCCHHHHHHHHHHhcC
Q 029552          157 PAQVVAAVGFKGKRL-------------------------EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~~~~~~~~~~~~~~-------------------------~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+....+......+                         .....+++.++++|.+||++
T Consensus       214 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  273 (290)
T cd07862         214 DVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTF  273 (290)
T ss_pred             HHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhcc
Confidence            766665553211100                         01235788999999999964

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3e-34  Score=214.27  Aligned_cols=184  Identities=31%  Similarity=0.537  Sum_probs=155.0

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++||||+++++++..++..++|+||+.+++|.+++...    .+++..+..++.|+++|+.|||+.+  ++|+||+|
T Consensus        56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p  129 (277)
T cd06642          56 LSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSER--KIHRDIKA  129 (277)
T ss_pred             HHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCCh
Confidence            35789999999999999999999999999999999988643    2789999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.++.++++|||.+..............+...|+|||.+.+..++.++|+||+|+++++|++|..||....+...
T Consensus       130 ~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~  209 (277)
T cd06642         130 ANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV  209 (277)
T ss_pred             heEEEeCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH
Confidence            99999999999999999876443322222223456789999999888888999999999999999999999988776665


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+. .......+..++..+.++|.+||++
T Consensus       210 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  239 (277)
T cd06642         210 LFLIP-KNSPPTLEGQYSKPFKEFVEACLNK  239 (277)
T ss_pred             Hhhhh-cCCCCCCCcccCHHHHHHHHHHccC
Confidence            55543 3334456677899999999999974

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.2e-34  Score=210.85  Aligned_cols=187  Identities=30%  Similarity=0.563  Sum_probs=156.0

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++||||+++++++.++...|+++|++.+++|.+++.....  .+++.++..++.|++.|+.+||+.+  ++|+|++|
T Consensus        52 ~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~  127 (256)
T cd06612          52 LKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK--TLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKA  127 (256)
T ss_pred             HHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCc
Confidence            3567999999999999999999999999999999999965432  3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.++.++|+|||.+..............+...|++||.+.+..++.++|+||+|+++++|++|..||....+...
T Consensus       128 ~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~  207 (256)
T cd06612         128 GNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA  207 (256)
T ss_pred             ceEEECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh
Confidence            99999999999999999887554433223334456789999999888889999999999999999999999988776665


Q ss_pred             HHHHHhcC-cccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKG-KRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~-~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+.... .....+..++..+.++|.+||++
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  239 (256)
T cd06612         208 IFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVK  239 (256)
T ss_pred             hhhhccCCCCCCCchhhcCHHHHHHHHHHHhc
Confidence            54443211 12334567899999999999963

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=7.1e-34  Score=212.80  Aligned_cols=187  Identities=30%  Similarity=0.529  Sum_probs=156.1

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCC-------------CcccccHHHHHHHHHHHHHHHHHHHh
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-------------VREMLDERRRLNMAYDVAKGMNYLHR   68 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~~~~~~i~~~l~~Lh~   68 (191)
                      ++++||||+++++++.+++..++++||+.+++|.+++....             .+..++...+..++.|++.||+|||+
T Consensus        63 ~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~  142 (283)
T cd05091          63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS  142 (283)
T ss_pred             hcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH
Confidence            56899999999999999999999999999999999985321             12247888899999999999999999


Q ss_pred             CCCCeeecCCCCCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHH
Q 029552           69 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA  146 (191)
Q Consensus        69 ~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~  146 (191)
                      .+  ++||||||.||+++.++.++|+|||++.......  ........++.|+|||.+.+..++.++|+||+|+++++|+
T Consensus       143 ~g--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~  220 (283)
T cd05091         143 HH--VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF  220 (283)
T ss_pred             cC--ccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHH
Confidence            99  9999999999999999999999999876432211  1122233456899999998888889999999999999999


Q ss_pred             h-CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          147 T-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       147 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      + |..||......+....+. .....+.|.+++..+.+++.+||++
T Consensus       221 ~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~cl~~  265 (283)
T cd05091         221 SYGLQPYCGYSNQDVIEMIR-NRQVLPCPDDCPAWVYTLMLECWNE  265 (283)
T ss_pred             cCCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHhCC
Confidence            8 788999888887777775 4445567889999999999999974

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-34  Score=212.80  Aligned_cols=183  Identities=32%  Similarity=0.526  Sum_probs=156.8

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++.+++.++...++|+|++.+++|.+++...    .+++.+++.++.|++.|+.+||+.+  ++|+|++|+
T Consensus        54 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~  127 (274)
T cd06609          54 SQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAA  127 (274)
T ss_pred             HHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHH
Confidence            5678999999999999999999999999999999999754    3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      ||+++.++.++++|||.+..............++..|++||.+.+..++.++|+||+|+++|+|++|..||...++....
T Consensus       128 ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~  207 (274)
T cd06609         128 NILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL  207 (274)
T ss_pred             HEEECCCCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH
Confidence            99999999999999998865544322333445667899999998888899999999999999999999999987777766


Q ss_pred             HHHHhcCcccCCCCC-CCHHHHHHHHHHhcC
Q 029552          162 AAVGFKGKRLEIPRN-VNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~~~~~~~~~-~s~~~~~li~~cl~~  191 (191)
                      ..+.. ......+.. ++..+.+++.+||.+
T Consensus       208 ~~~~~-~~~~~~~~~~~~~~~~~~l~~~l~~  237 (274)
T cd06609         208 FLIPK-NNPPSLEGNKFSKPFKDFVSLCLNK  237 (274)
T ss_pred             HHhhh-cCCCCCcccccCHHHHHHHHHHhhC
Confidence            66543 334444555 899999999999963

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4.1e-34  Score=212.35  Aligned_cols=185  Identities=31%  Similarity=0.477  Sum_probs=150.3

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++||||+++++++.+++..++++||+.+++|.+++...+   .+++.+++.++.|++.|++|||+.|  ++|+||+|+
T Consensus        61 ~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~  135 (267)
T cd06645          61 KDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGA  135 (267)
T ss_pred             HhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHH
Confidence            46799999999999999999999999999999999987644   3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR---DEPSNEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      ||+++.++.++|+|||.+..............++..|+|||.+.   ...++.++|+||+|+++|+|++|..||....+.
T Consensus       136 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~  215 (267)
T cd06645         136 NILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM  215 (267)
T ss_pred             HEEECCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch
Confidence            99999999999999998765443322333445678899999874   345778999999999999999999999776655


Q ss_pred             HHHHHHHhcCcccC-C--CCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLE-I--PRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~-~--~~~~s~~~~~li~~cl~~  191 (191)
                      .............+ .  ...+|..++++|.+||++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  251 (267)
T cd06645         216 RALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTK  251 (267)
T ss_pred             hhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccC
Confidence            44443322222221 1  235789999999999964

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=6.8e-34  Score=212.41  Aligned_cols=188  Identities=31%  Similarity=0.500  Sum_probs=154.9

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC----cccccHHHHHHHHHHHHHHHHHHHhCCCCeeec
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV----REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR   76 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~   76 (191)
                      +++++|+||+++++++.+.+..++++||+.+++|.+++.....    ...+++.+++.++.||+.||+|||+.+  ++|+
T Consensus        63 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~  140 (277)
T cd05036          63 MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHR  140 (277)
T ss_pred             HHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--Eeec
Confidence            3578999999999999988899999999999999999865331    124788999999999999999999999  9999


Q ss_pred             CCCCCcEEecCCC---cEEEcccccccccccccc--cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCC
Q 029552           77 DLKSPNLLVDKKY---TVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQ  150 (191)
Q Consensus        77 ~l~p~ni~~~~~~---~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~  150 (191)
                      ||+|+||+++.++   .++|+|||.+........  ..........|+|||.+.+..++.++|+||||+++|+|++ |..
T Consensus       141 dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~  220 (277)
T cd05036         141 DIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYM  220 (277)
T ss_pred             ccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCC
Confidence            9999999998754   589999998865422211  1112223457999999988889999999999999999997 899


Q ss_pred             CCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          151 PWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       151 pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ||...........+. ...+...|..++..+.++|.+||++
T Consensus       221 pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~cl~~  260 (277)
T cd05036         221 PYPGRTNQEVMEFVT-GGGRLDPPKGCPGPVYRIMTDCWQH  260 (277)
T ss_pred             CCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcCC
Confidence            999887777766654 4456667888999999999999974

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=7.8e-34  Score=209.62  Aligned_cols=187  Identities=29%  Similarity=0.555  Sum_probs=155.1

Q ss_pred             CCCCCCCCcccccceeec-CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQ-PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      +++++|||++++.+.+.. +...++++||+++++|.+++.... ...+++.+++.++.+++.++++||+.|  ++|+||+
T Consensus        53 l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~  129 (257)
T cd08223          53 LSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLK  129 (257)
T ss_pred             HHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCC
Confidence            356799999999998864 446889999999999999986532 234899999999999999999999999  9999999


Q ss_pred             CCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      |+||+++.++.++|+|||.+..............++..|+|||...+...+.++|+||+|++++++++|..||...+...
T Consensus       130 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~  209 (257)
T cd08223         130 TQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS  209 (257)
T ss_pred             chhEEEecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH
Confidence            99999999999999999987654332222233456778999999988888899999999999999999999998877766


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+. .+.....+..+++.+.++|.+||++
T Consensus       210 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  240 (257)
T cd08223         210 LVYRII-EGKLPPMPKDYSPELGELIATMLSK  240 (257)
T ss_pred             HHHHHH-hcCCCCCccccCHHHHHHHHHHhcc
Confidence            665553 3334456788999999999999964

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.9e-34  Score=212.39  Aligned_cols=188  Identities=25%  Similarity=0.449  Sum_probs=151.4

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +.++||||+++++++.+++..++++||+++++|.+++... .....+++.+++.++.|+++|++|||++|  ++|+||+|
T Consensus        57 ~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p  134 (267)
T cd08229          57 KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKP  134 (267)
T ss_pred             HHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCH
Confidence            5679999999999999999999999999999999988632 22334899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH--H
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP--A  158 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~--~  158 (191)
                      +||+++.++.++++|||.+..............+...|+|||.+.+...+.++|+||+|+++|+|++|..||.....  .
T Consensus       135 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~  214 (267)
T cd08229         135 ANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY  214 (267)
T ss_pred             HHEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH
Confidence            99999999999999999876544332222334567789999999888888999999999999999999999975433  2


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .....+.....+...+..+++.++++|.+||++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  247 (267)
T cd08229         215 SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINP  247 (267)
T ss_pred             HHhhhhhcCCCCCCCcccccHHHHHHHHHhcCC
Confidence            333333222222223356899999999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-34  Score=216.12  Aligned_cols=188  Identities=26%  Similarity=0.394  Sum_probs=155.0

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |+.++||||+++++.+.+++..++++||+.+++|.+++.... +..+++..++.++.|+++||+|||+.+  ++|+||+|
T Consensus        55 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp  131 (316)
T cd05574          55 LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKP  131 (316)
T ss_pred             HHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCh
Confidence            356789999999999999999999999999999999986532 234899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccc-----------------------------cCCCCCCCCcccCccccccCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFL-----------------------------SSKSAAGTPEWMAPEVLRDEPSNE  131 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~pe~~~~~~~~~  131 (191)
                      +||+++.++.++|+|||.+........                             ......++..|+|||...+...+.
T Consensus       132 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~  211 (316)
T cd05574         132 ENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGS  211 (316)
T ss_pred             HHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCc
Confidence            999999999999999998754321110                             011224566799999998888899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          132 KSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       132 ~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ++|+||+|+++|+|++|..||...+.......+.......+....+++.++++|++||.+
T Consensus       212 ~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  271 (316)
T cd05574         212 AVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVK  271 (316)
T ss_pred             hHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccC
Confidence            999999999999999999999988877777666433333333344799999999999964

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-34  Score=220.21  Aligned_cols=184  Identities=26%  Similarity=0.433  Sum_probs=150.3

Q ss_pred             CCCCC-CCCcccccceeecCC-ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            1 MKRLR-HPNIVLFMGAVTQPP-NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         1 L~~l~-h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      |++++ ||||+++.+++.+++ .+|+|||||+. +|.+++..+  +..|++..++.|+.||++||+|+|++|  +.|||+
T Consensus        62 L~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G--fFHRDl  136 (538)
T KOG0661|consen   62 LRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDL  136 (538)
T ss_pred             HHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccC
Confidence            46788 999999999998888 99999999975 999999765  456999999999999999999999999  999999


Q ss_pred             CCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        79 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      ||+||++.....+||+|||++.-......... -+.+.+|.|||++.. ..|+.+.|+|++||+++|+.+-++-|.+.+.
T Consensus       137 KPENiLi~~~~~iKiaDFGLARev~SkpPYTe-YVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE  215 (538)
T KOG0661|consen  137 KPENILISGNDVIKIADFGLAREVRSKPPYTE-YVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE  215 (538)
T ss_pred             ChhheEecccceeEecccccccccccCCCcch-hhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH
Confidence            99999999888999999999976544433322 345779999998754 4589999999999999999999999988777


Q ss_pred             HHHHHHHHhcCc-----------------ccCCC-----------CCCCHHHHHHHHHHhc
Q 029552          158 AQVVAAVGFKGK-----------------RLEIP-----------RNVNPHVASIIEACWA  190 (191)
Q Consensus       158 ~~~~~~~~~~~~-----------------~~~~~-----------~~~s~~~~~li~~cl~  190 (191)
                      .+.+.+|-..-+                 .+.+|           ++.|.++.++|.+|+.
T Consensus       216 ~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~  276 (538)
T KOG0661|consen  216 IDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLA  276 (538)
T ss_pred             HHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhc
Confidence            766665432111                 11111           3478889999998874

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.3e-34  Score=228.12  Aligned_cols=187  Identities=27%  Similarity=0.449  Sum_probs=156.2

Q ss_pred             CCCCCCCcccccceeecCC--------ceEEEEeccCCCCHHHHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPP--------NLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDVAKGMNYLHRRNPP   72 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~   72 (191)
                      ..++|+||+++++.+...+        .+++||||+.+++|.+++... .....+++..+..++.|++.||.|||+.+  
T Consensus        86 ~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--  163 (496)
T PTZ00283         86 LNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--  163 (496)
T ss_pred             hcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence            4678999999988775332        368999999999999988542 22335899999999999999999999999  


Q ss_pred             eeecCCCCCcEEecCCCcEEEcccccccccccc--cccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ  150 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~  150 (191)
                      ++||||||+||+++.++.++|+|||++......  ........+++.|+|||.+.+..++.++|+||+|+++|+|++|..
T Consensus       164 IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~  243 (496)
T PTZ00283        164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR  243 (496)
T ss_pred             EecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence            999999999999999999999999998653322  112234467889999999999889999999999999999999999


Q ss_pred             CCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          151 PWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       151 pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ||...+..+....+. .+...+.|..+++.++++|.+||++
T Consensus       244 Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~  283 (496)
T PTZ00283        244 PFDGENMEEVMHKTL-AGRYDPLPPSISPEMQEIVTALLSS  283 (496)
T ss_pred             CCCCCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHccc
Confidence            999988877777764 3445567889999999999999974

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.8e-34  Score=213.55  Aligned_cols=187  Identities=29%  Similarity=0.486  Sum_probs=152.7

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCeeecCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLK   79 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~~h~~l~   79 (191)
                      |++++||||+++++++..++..++++||+++++|..++........+++..+..++.|++.|++|||+ .+  ++|+||+
T Consensus        53 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~  130 (286)
T cd06622          53 LHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVK  130 (286)
T ss_pred             HHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCC
Confidence            35689999999999999999999999999999999988764322348999999999999999999996 58  9999999


Q ss_pred             CCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCC------CCCcchHHHHHHHHHHHHhCCCCCC
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP------SNEKSDIYSFGVILWELATLQQPWG  153 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~------~~~~~Dv~slG~~~~~l~~g~~pf~  153 (191)
                      |+||+++.++.++|+|||.+......  ......+...|++||.+.+..      ++.++|+||+|+++|+|++|..||.
T Consensus       131 p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~  208 (286)
T cd06622         131 PTNVLVNGNGQVKLCDFGVSGNLVAS--LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP  208 (286)
T ss_pred             HHHEEECCCCCEEEeecCCcccccCC--ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence            99999999999999999987643322  222334567899999885543      3678999999999999999999998


Q ss_pred             CCCHHHHHHHHH--hcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          154 NLNPAQVVAAVG--FKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       154 ~~~~~~~~~~~~--~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..........+.  ..+....+|..++.+++++|.+||++
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  248 (286)
T cd06622         209 PETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNK  248 (286)
T ss_pred             CcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHccc
Confidence            766555444332  13345667888999999999999964

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.5e-34  Score=212.73  Aligned_cols=186  Identities=31%  Similarity=0.473  Sum_probs=149.1

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++..++..++|+||+.+++|.+++...+   .+++.++..++.|++.|++|||+.+  ++|+|++|
T Consensus        60 l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p  134 (267)
T cd06646          60 VKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKG  134 (267)
T ss_pred             HHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCH
Confidence            356899999999999999999999999999999999986543   3789999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR---DEPSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      +||+++.++.++|+|||.+..............++..|+|||.+.   ...++.++|+||+|+++++|++|..||....+
T Consensus       135 ~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~  214 (267)
T cd06646         135 ANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHP  214 (267)
T ss_pred             HHEEECCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccch
Confidence            999999999999999998875433322223345667899999874   33467789999999999999999999976655


Q ss_pred             HHHHHHHHhcCccc---CCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRL---EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~---~~~~~~s~~~~~li~~cl~~  191 (191)
                      ......+.......   ..+..+|..++++|.+||++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  251 (267)
T cd06646         215 MRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTK  251 (267)
T ss_pred             hhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhC
Confidence            44433332222121   12345789999999999964

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=9.8e-34  Score=210.83  Aligned_cols=186  Identities=34%  Similarity=0.626  Sum_probs=153.2

Q ss_pred             CCC-CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCC-------------CcccccHHHHHHHHHHHHHHHHHHH
Q 029552            2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-------------VREMLDERRRLNMAYDVAKGMNYLH   67 (191)
Q Consensus         2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~~~~~~i~~~l~~Lh   67 (191)
                      +++ +||||+++++++...+..+++|||+++++|.+++....             ....+++++++.++.|++.|++|||
T Consensus        50 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH  129 (270)
T cd05047          50 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS  129 (270)
T ss_pred             HhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            456 79999999999999999999999999999999986432             1123788999999999999999999


Q ss_pred             hCCCCeeecCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh
Q 029552           68 RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT  147 (191)
Q Consensus        68 ~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~  147 (191)
                      +.+  ++|+||+|+||+++.++.++++|||++...... ...........|+|||.+.+..++.++|+||||+++++|++
T Consensus       130 ~~~--i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~  206 (270)
T cd05047         130 QKQ--FIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS  206 (270)
T ss_pred             HCC--EeecccccceEEEcCCCeEEECCCCCccccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHc
Confidence            999  999999999999999999999999987532211 11111222456999999988888899999999999999997


Q ss_pred             -CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          148 -LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       148 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                       |..||...+.......+. .......+..++..+.+++.+||++
T Consensus       207 ~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  250 (270)
T cd05047         207 LGGTPYCGMTCAELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWRE  250 (270)
T ss_pred             CCCCCccccCHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHHccc
Confidence             999998887777776664 3345566778999999999999964

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.1e-33  Score=210.41  Aligned_cols=186  Identities=31%  Similarity=0.583  Sum_probs=155.1

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++||||+++.+++.+++..++++||+.+++|.+++....  +.+++.+++.++.|++.||++||+.+  ++|+||+|
T Consensus        59 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p  134 (269)
T cd05065          59 MGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAA  134 (269)
T ss_pred             HHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCh
Confidence            357899999999999999999999999999999999987543  23789999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccc---cCCCCC--CCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAA--GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGN  154 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~--~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~  154 (191)
                      +||+++.++.++++|||.+........   ......  .+..|++||.+.+..++.++|+||+|+++|++++ |..||..
T Consensus       135 ~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~  214 (269)
T cd05065         135 RNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD  214 (269)
T ss_pred             heEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCC
Confidence            999999999999999998754322211   111111  1346999999988888999999999999999886 9999998


Q ss_pred             CCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          155 LNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+.......+. ...+.+.+..++..+.+++.+||++
T Consensus       215 ~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~~l~~  250 (269)
T cd05065         215 MSNQDVINAIE-QDYRLPPPMDCPTALHQLMLDCWQK  250 (269)
T ss_pred             CCHHHHHHHHH-cCCcCCCcccCCHHHHHHHHHHcCC
Confidence            88877777764 4445666788999999999999974

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.2e-33  Score=208.65  Aligned_cols=184  Identities=37%  Similarity=0.689  Sum_probs=154.2

Q ss_pred             CCCCCCCCccccccee-ecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            1 MKRLRHPNIVLFMGAV-TQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      +++++|+|++++++++ .+++..++++||+++++|.+++.... ...+++..++.++.|++.||++||+.|  ++|+||+
T Consensus        53 l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk  129 (256)
T cd05082          53 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLA  129 (256)
T ss_pred             HHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--Eeccccc
Confidence            3578999999999875 45567999999999999999987543 223788999999999999999999999  9999999


Q ss_pred             CCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA  158 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~  158 (191)
                      |+||+++.++.++|+|||.+.......   ........|+|||.+.+..++.++|+||+|+++|+|++ |..||...+..
T Consensus       130 p~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~  206 (256)
T cd05082         130 ARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK  206 (256)
T ss_pred             hheEEEcCCCcEEecCCccceeccccC---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999999876433221   12233457999999988888999999999999999997 99999988887


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .....+. .+.....+..+++.++++|.+||++
T Consensus       207 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  238 (256)
T cd05082         207 DVVPRVE-KGYKMDAPDGCPPVVYDVMKQCWHL  238 (256)
T ss_pred             HHHHHHh-cCCCCCCCCCCCHHHHHHHHHHhcC
Confidence            7777664 3445567788999999999999974

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.1e-33  Score=213.97  Aligned_cols=187  Identities=32%  Similarity=0.565  Sum_probs=154.0

Q ss_pred             CCC-CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++ +||||+++++++...+..++++||+.+++|.+++.... ...+++.++..++.|++.||+|||+.+  ++|+||+|
T Consensus        93 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp  169 (302)
T cd05055          93 SHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAA  169 (302)
T ss_pred             HhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhcc
Confidence            456 79999999999999999999999999999999996533 223789999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccc--cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~  157 (191)
                      +||+++.++.++++|||.+........  ..........|+|||.+.+..++.++|+||+|+++|++++ |..||.....
T Consensus       170 ~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~  249 (302)
T cd05055         170 RNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV  249 (302)
T ss_pred             ceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc
Confidence            999999999999999998764332211  1112234567999999988888999999999999999998 8999988766


Q ss_pred             HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+........+.+...+...++.+.+++.+||++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  283 (302)
T cd05055         250 DSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDA  283 (302)
T ss_pred             hHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCC
Confidence            5555444434445566778899999999999974

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.9e-33  Score=210.26  Aligned_cols=185  Identities=30%  Similarity=0.524  Sum_probs=153.4

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++||||+++++++.. ...++++||+.+++|.+++....  +.+++..+..++.|++.||+|||+.+  ++|+||+|
T Consensus        63 l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp  137 (279)
T cd05111          63 MGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAA  137 (279)
T ss_pred             HhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCc
Confidence            357899999999998754 45789999999999999996533  23889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~  157 (191)
                      +||+++.++.++|+|||.+.......  .......+...|++||.+.+..++.++|+||+|+++|++++ |..||....+
T Consensus       138 ~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~  217 (279)
T cd05111         138 RNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP  217 (279)
T ss_pred             ceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            99999999999999999886432221  11122334567999999988889999999999999999998 9999998877


Q ss_pred             HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+.+ ..+..++.|..++.++.+++.+||++
T Consensus       218 ~~~~~~~-~~~~~~~~~~~~~~~~~~li~~c~~~  250 (279)
T cd05111         218 HEVPDLL-EKGERLAQPQICTIDVYMVMVKCWMI  250 (279)
T ss_pred             HHHHHHH-HCCCcCCCCCCCCHHHHHHHHHHcCC
Confidence            7766655 35566677778899999999999974

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=9.8e-34  Score=215.36  Aligned_cols=185  Identities=29%  Similarity=0.537  Sum_probs=153.0

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++||||+++++++... ..+++++|+.+|+|.+++.....  .++...++.++.|++.||+|||+.+  ++|+||+|
T Consensus        63 l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp  137 (316)
T cd05108          63 MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAA  137 (316)
T ss_pred             HHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHhcC--eeccccch
Confidence            3578999999999988764 57899999999999999976432  3788899999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccccccc--CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~  157 (191)
                      +||+++.++.++|+|||++.........  ......+..|++||.+.+..++.++|+||+|+++|++++ |..||.....
T Consensus       138 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~  217 (316)
T cd05108         138 RNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA  217 (316)
T ss_pred             hheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence            9999999999999999998754322111  111223457999999988889999999999999999997 9999988776


Q ss_pred             HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+....+ ..+...+.|..++..+.++|.+||++
T Consensus       218 ~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~  250 (316)
T cd05108         218 SEISSIL-EKGERLPQPPICTIDVYMIMVKCWMI  250 (316)
T ss_pred             HHHHHHH-hCCCCCCCCCCCCHHHHHHHHHHccC
Confidence            6654443 45566777888999999999999974

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-33  Score=208.66  Aligned_cols=180  Identities=28%  Similarity=0.433  Sum_probs=154.0

Q ss_pred             CCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCc
Q 029552            3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN   82 (191)
Q Consensus         3 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~n   82 (191)
                      +.+|||+++++++++.++..++++||+++++|.+++...+   .+++.++..++.|++.||.|||+.+  ++|+||+|+|
T Consensus        53 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~n  127 (260)
T cd05611          53 QGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPEN  127 (260)
T ss_pred             cCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHH
Confidence            4589999999999999999999999999999999997644   3889999999999999999999999  9999999999


Q ss_pred             EEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 029552           83 LLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVA  162 (191)
Q Consensus        83 i~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~  162 (191)
                      |+++.++.++|+|||.+.....    .....++..|++||.+.+..++.++|+||+|+++|++++|..||...+......
T Consensus       128 il~~~~~~~~l~dfg~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~  203 (260)
T cd05611         128 LLIDQTGHLKLTDFGLSRNGLE----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFD  203 (260)
T ss_pred             eEECCCCcEEEeecccceeccc----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            9999999999999998764332    223346678999999988878899999999999999999999999888877777


Q ss_pred             HHHhcCcc--cCCCCCCCHHHHHHHHHHhcC
Q 029552          163 AVGFKGKR--LEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       163 ~~~~~~~~--~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+......  ...+..+++.+.++|.+||++
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  234 (260)
T cd05611         204 NILSRRINWPEEVKEFCSPEAVDLINRLLCM  234 (260)
T ss_pred             HHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence            66543322  234456899999999999964

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.1e-33  Score=212.61  Aligned_cols=188  Identities=31%  Similarity=0.584  Sum_probs=156.1

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCC---------------------CcccccHHHHHHHHHHH
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG---------------------VREMLDERRRLNMAYDV   59 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---------------------~~~~~~~~~~~~~~~~i   59 (191)
                      |++++||||+++++.+.+++..++++||+.+++|.+++....                     ....++...++.++.|+
T Consensus        57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i  136 (290)
T cd05045          57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQI  136 (290)
T ss_pred             HhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHH
Confidence            357899999999999999999999999999999999885421                     01237788999999999


Q ss_pred             HHHHHHHHhCCCCeeecCCCCCcEEecCCCcEEEcccccccccccccc--cCCCCCCCCcccCccccccCCCCCcchHHH
Q 029552           60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYS  137 (191)
Q Consensus        60 ~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~s  137 (191)
                      +.||++||+.+  ++|+||+|+||+++.++.++|+|||.+........  ..........|++||.+.+..++.++|+||
T Consensus       137 ~~~l~~LH~~~--ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~s  214 (290)
T cd05045         137 SRGMQYLAEMK--LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWS  214 (290)
T ss_pred             HHHHHHHHHCC--eehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHH
Confidence            99999999999  99999999999999999999999998764322211  112223345799999988888899999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          138 FGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       138 lG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ||+++++|++ |..||....+....+.+. .....+.|..++.+++++|.+||++
T Consensus       215 lG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~cl~~  268 (290)
T cd05045         215 FGVLLWEIVTLGGNPYPGIAPERLFNLLK-TGYRMERPENCSEEMYNLMLTCWKQ  268 (290)
T ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHHHccC
Confidence            9999999998 999999888887777664 4445667888999999999999964

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-34  Score=219.81  Aligned_cols=184  Identities=29%  Similarity=0.450  Sum_probs=162.6

Q ss_pred             CCCCC-CCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            1 MKRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         1 L~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      |+++. ||||+.+.++|++....++|||++.||.|.+.+...    .+++..+..++.|++.+++|||+.|  ++|||+|
T Consensus        89 l~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g--vvHrDlK  162 (382)
T KOG0032|consen   89 LQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLK  162 (382)
T ss_pred             HHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCC
Confidence            45677 999999999999999999999999999999999765    2899999999999999999999999  9999999


Q ss_pred             CCcEEecCC----CcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           80 SPNLLVDKK----YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        80 p~ni~~~~~----~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      |+|+++...    +.++++|||++..... .......++++.|+|||++....++..+|+||+|+++|.|++|..||...
T Consensus       163 pEN~L~~~~~~~~~~ik~~DFGla~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~  241 (382)
T KOG0032|consen  163 PENLLLASKDEGSGRIKLIDFGLAKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGE  241 (382)
T ss_pred             HHHeeeccccCCCCcEEEeeCCCceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCC
Confidence            999999543    4799999999987666 34556678999999999999999999999999999999999999999998


Q ss_pred             CHHHHHHHHHhcCcccC--CCCCCCHHHHHHHHHHhcC
Q 029552          156 NPAQVVAAVGFKGKRLE--IPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~cl~~  191 (191)
                      +.......+......+.  .-+++|..++++|.+||.+
T Consensus       242 ~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~  279 (382)
T KOG0032|consen  242 TEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEF  279 (382)
T ss_pred             ChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhccc
Confidence            88888888865554333  3367999999999999864

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.1e-33  Score=209.27  Aligned_cols=186  Identities=33%  Similarity=0.639  Sum_probs=154.7

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++||||+++++++. .+..++++|++.+++|.+++.... +..+++.++..++.|++.||++||+.+  ++|+||+|
T Consensus        55 l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p  130 (260)
T cd05067          55 MKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRA  130 (260)
T ss_pred             HHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccH
Confidence            35789999999998874 456899999999999999986543 234889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccc-cccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA  158 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~  158 (191)
                      +||+++.++.++|+|||.+...... ............|+|||.+.+..++.++|+||+|++++++++ |..||...+..
T Consensus       131 ~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  210 (260)
T cd05067         131 ANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP  210 (260)
T ss_pred             HhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH
Confidence            9999999999999999987644322 111112233457999999988888899999999999999998 99999988887


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +....+. .....+.+..++..+.++|.+||++
T Consensus       211 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  242 (260)
T cd05067         211 EVIQNLE-RGYRMPRPDNCPEELYELMRLCWKE  242 (260)
T ss_pred             HHHHHHH-cCCCCCCCCCCCHHHHHHHHHHccC
Confidence            7777764 4455677888999999999999974

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.4e-33  Score=209.56  Aligned_cols=186  Identities=31%  Similarity=0.571  Sum_probs=155.3

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++||||+++.+++.+.+..+++|||+.+++|.+++....  +.+++.++..++.|++.|+++||+.+  ++|+|++|
T Consensus        60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp  135 (268)
T cd05063          60 MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAA  135 (268)
T ss_pred             HhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccch
Confidence            357899999999999999999999999999999999986533  23789999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccC---CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSS---KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLN  156 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~  156 (191)
                      +||+++.++.++++|||.+..........   ........|++||.+.+..++.++|+||+|+++|++++ |..||...+
T Consensus       136 ~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~  215 (268)
T cd05063         136 RNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS  215 (268)
T ss_pred             hhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence            99999999999999999876443221111   11122346999999988888899999999999999997 999998888


Q ss_pred             HHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .......+. ...+.+.+..++..+.+++.+||++
T Consensus       216 ~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~c~~~  249 (268)
T cd05063         216 NHEVMKAIN-DGFRLPAPMDCPSAVYQLMLQCWQQ  249 (268)
T ss_pred             HHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            777777775 3445566778999999999999963

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=6.9e-34  Score=214.51  Aligned_cols=185  Identities=26%  Similarity=0.487  Sum_probs=154.3

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++..++..++++||+++++|.+++...    .+++.+++.++.|++.||++||+.+  ++|+||+|
T Consensus        72 l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p  145 (297)
T cd06659          72 MRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT----RLNEEQIATVCESVLQALCYLHSQG--VIHRDIKS  145 (297)
T ss_pred             HHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence            35689999999999999999999999999999999987542    2789999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.++.++|+|||++..............++..|+|||.+.+..++.++|+||+|+++++|++|..||....+.+.
T Consensus       146 ~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~  225 (297)
T cd06659         146 DSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA  225 (297)
T ss_pred             HHeEEccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99999999999999999876433222222234567789999999888888999999999999999999999988777776


Q ss_pred             HHHHHhcCc-ccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGK-RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~-~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+..... ....+..++..+.++|.+||++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~  257 (297)
T cd06659         226 MKRLRDSPPPKLKNAHKISPVLRDFLERMLTR  257 (297)
T ss_pred             HHHHhccCCCCccccCCCCHHHHHHHHHHhcC
Confidence            666542211 2233457899999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-33  Score=209.01  Aligned_cols=187  Identities=34%  Similarity=0.588  Sum_probs=157.4

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+....++++|++++++|.+++.... ...+++.++..++.|++.|+.+||+++  ++|+||+|
T Consensus        55 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p  131 (261)
T cd05034          55 MKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAA  131 (261)
T ss_pred             HhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcch
Confidence            367899999999999998889999999999999999997643 224889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA  158 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~  158 (191)
                      +||+++.++.++++|||.+....... ...........|+|||.+.+...+.++|+||+|++++++++ |..||......
T Consensus       132 ~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  211 (261)
T cd05034         132 RNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR  211 (261)
T ss_pred             heEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999876543221 11112223457999999988888999999999999999998 99999988887


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .....+. .+...+.|...+..+++++.+||++
T Consensus       212 ~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~  243 (261)
T cd05034         212 EVLEQVE-RGYRMPRPPNCPEELYDLMLQCWDK  243 (261)
T ss_pred             HHHHHHH-cCCCCCCCCCCCHHHHHHHHHHccc
Confidence            7777774 4445667788899999999999964

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=7.8e-34  Score=221.79  Aligned_cols=188  Identities=35%  Similarity=0.560  Sum_probs=152.3

Q ss_pred             CCCC-CCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC-------------------------------------
Q 029552            2 KRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------------------------------------   43 (191)
Q Consensus         2 ~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------------------------------   43 (191)
                      +++. ||||+++++++.+.+..++||||+++++|.+++.....                                     
T Consensus        95 ~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (400)
T cd05105          95 THLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENK  174 (400)
T ss_pred             HhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccc
Confidence            4564 99999999999999999999999999999998753210                                     


Q ss_pred             --------------------------------------------------------cccccHHHHHHHHHHHHHHHHHHH
Q 029552           44 --------------------------------------------------------REMLDERRRLNMAYDVAKGMNYLH   67 (191)
Q Consensus        44 --------------------------------------------------------~~~~~~~~~~~~~~~i~~~l~~Lh   67 (191)
                                                                              ...+++.++..++.|+++||+|||
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH  254 (400)
T cd05105         175 GDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA  254 (400)
T ss_pred             ccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                                                    123677888999999999999999


Q ss_pred             hCCCCeeecCCCCCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHH
Q 029552           68 RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL  145 (191)
Q Consensus        68 ~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l  145 (191)
                      +.+  ++|+||+|+||+++.++.++|+|||++.......  .......++..|+|||.+.+..++.++|+||+|+++|+|
T Consensus       255 ~~~--ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~el  332 (400)
T cd05105         255 SKN--CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEI  332 (400)
T ss_pred             hCC--eeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHH
Confidence            999  9999999999999999999999999876432221  111223345679999999888889999999999999999


Q ss_pred             Hh-CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          146 AT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       146 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ++ |..||...............+.+.+.+..++..+.++|.+||++
T Consensus       333 lt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  379 (400)
T cd05105         333 FSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNS  379 (400)
T ss_pred             HHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCcc
Confidence            97 89999876554444333335556677888999999999999974

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=9.5e-34  Score=214.58  Aligned_cols=186  Identities=33%  Similarity=0.598  Sum_probs=153.9

Q ss_pred             CC-CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC-------------cccccHHHHHHHHHHHHHHHHHHHh
Q 029552            3 RL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------------REMLDERRRLNMAYDVAKGMNYLHR   68 (191)
Q Consensus         3 ~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~Lh~   68 (191)
                      ++ +||||+++++++.+++..++|+||+.+++|.+++.....             ...++..+++.++.|++.||+|||+
T Consensus        79 ~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~  158 (307)
T cd05098          79 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS  158 (307)
T ss_pred             HhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH
Confidence            45 799999999999999999999999999999999975321             1237888999999999999999999


Q ss_pred             CCCCeeecCCCCCcEEecCCCcEEEccccccccccccccc--CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHH
Q 029552           69 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA  146 (191)
Q Consensus        69 ~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~  146 (191)
                      +|  ++|+||+|+||+++.++.++|+|||.+.........  .........|+|||.+.+..++.++|+||+|+++|+|+
T Consensus       159 ~g--i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~  236 (307)
T cd05098         159 KK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF  236 (307)
T ss_pred             CC--cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHH
Confidence            99  999999999999999999999999987643322111  11112235799999998888899999999999999999


Q ss_pred             h-CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          147 T-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       147 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      + |..||......+....+. .......|..++..++++|.+||.+
T Consensus       237 ~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  281 (307)
T cd05098         237 TLGGSPYPGVPVEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHA  281 (307)
T ss_pred             cCCCCCCCcCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHccc
Confidence            8 888998877766666664 4445677888999999999999963

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.1e-33  Score=208.79  Aligned_cols=184  Identities=35%  Similarity=0.586  Sum_probs=157.0

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.++...++++||+++++|.+++.+..   .+++..++.++.|+++|+++||+.+  ++|+||+|+
T Consensus        57 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~  131 (258)
T cd06632          57 SKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGA  131 (258)
T ss_pred             HhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHH
Confidence            56799999999999999999999999999999999997644   2789999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      ||+++.++.++|+|||.+....... ......++..|++||.+.... ++.++|+||+|+++|++++|..||....+...
T Consensus       132 ni~~~~~~~~kl~d~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~  210 (258)
T cd06632         132 NILVDTNGVVKLADFGMAKQVVEFS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA  210 (258)
T ss_pred             HEEECCCCCEEEccCccceeccccc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH
Confidence            9999999999999999876543322 223345677899999887665 78899999999999999999999988777666


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+.........|..+++.++++|.+||++
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  241 (258)
T cd06632         211 VFKIGRSKELPPIPDHLSDEAKDFILKCLQR  241 (258)
T ss_pred             HHHHHhcccCCCcCCCcCHHHHHHHHHHhhc
Confidence            6666543456667888999999999999963

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.5e-33  Score=214.21  Aligned_cols=186  Identities=31%  Similarity=0.603  Sum_probs=154.2

Q ss_pred             CC-CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC-------------cccccHHHHHHHHHHHHHHHHHHHh
Q 029552            3 RL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------------REMLDERRRLNMAYDVAKGMNYLHR   68 (191)
Q Consensus         3 ~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~Lh~   68 (191)
                      ++ +||||+++++++.+++..++++||+.+++|.+++.....             ...++..++..++.|++.||+|||+
T Consensus        73 ~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~  152 (314)
T cd05099          73 LIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES  152 (314)
T ss_pred             hccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH
Confidence            45 699999999999998999999999999999999965321             2347888999999999999999999


Q ss_pred             CCCCeeecCCCCCcEEecCCCcEEEccccccccccccccc--CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHH
Q 029552           69 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA  146 (191)
Q Consensus        69 ~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~  146 (191)
                      +|  ++|+||+|+||+++.++.++|+|||.+.........  .........|+|||.+.+..++.++|+||+|+++|+++
T Consensus       153 ~g--i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~  230 (314)
T cd05099         153 RR--CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIF  230 (314)
T ss_pred             CC--eeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHH
Confidence            99  999999999999999999999999988643322111  11122235799999998888899999999999999999


Q ss_pred             h-CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          147 T-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       147 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      + |..||...........+. .......|..++..++++|.+||+.
T Consensus       231 ~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~  275 (314)
T cd05099         231 TLGGSPYPGIPVEELFKLLR-EGHRMDKPSNCTHELYMLMRECWHA  275 (314)
T ss_pred             hCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            9 889998888777777664 3445567888999999999999963

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.2e-33  Score=209.96  Aligned_cols=188  Identities=36%  Similarity=0.588  Sum_probs=155.9

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCC----CcccccHHHHHHHHHHHHHHHHHHHhCCCCeeec
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG----VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR   76 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~   76 (191)
                      |+.++||||+++++++.+++..++++||+++++|.+++....    ....+++.++..++.|++.||+|||+.+  ++|+
T Consensus        53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~  130 (269)
T cd05044          53 MSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHR  130 (269)
T ss_pred             HHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccC
Confidence            357899999999999999999999999999999999986421    1234788899999999999999999999  9999


Q ss_pred             CCCCCcEEecCCC-----cEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-C
Q 029552           77 DLKSPNLLVDKKY-----TVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-L  148 (191)
Q Consensus        77 ~l~p~ni~~~~~~-----~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g  148 (191)
                      |++|+||+++.++     .++++|||.+.......  ........+..|+|||.+.+...+.++|+||||+++|+|++ |
T Consensus       131 dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g  210 (269)
T cd05044         131 DLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLG  210 (269)
T ss_pred             CCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcC
Confidence            9999999999877     89999999875432211  11112234568999999988888999999999999999998 9


Q ss_pred             CCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          149 QQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       149 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..||...+..+....+. .+.....+..+|..+.++|.+||++
T Consensus       211 ~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  252 (269)
T cd05044         211 QQPYPALNNQEVLQHVT-AGGRLQKPENCPDKIYQLMTNCWAQ  252 (269)
T ss_pred             CCCCcccCHHHHHHHHh-cCCccCCcccchHHHHHHHHHHcCC
Confidence            99999888777777664 3445667788999999999999974

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-33  Score=207.70  Aligned_cols=184  Identities=40%  Similarity=0.708  Sum_probs=157.0

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++|+||+++++++.+.+..++|+||+.+++|.+++..... ..+++..+..++.|++.||.|||+.+  ++|+||+|
T Consensus        54 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p  130 (256)
T cd05039          54 MTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAA  130 (256)
T ss_pred             HHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhccc
Confidence            3568999999999999988999999999999999999975441 24899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ  159 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~~  159 (191)
                      +||+++.++.++|+|||.+........   .......|+|||.+.+...+.++|+||+|++++++++ |..||.......
T Consensus       131 ~Nili~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~  207 (256)
T cd05039         131 RNVLVSEDLVAKVSDFGLAKEASQGQD---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD  207 (256)
T ss_pred             ceEEEeCCCCEEEcccccccccccccc---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            999999999999999998875533211   2233457999999988888889999999999999997 999999888877


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+. ...+...|..+|+.+.++|.+||++
T Consensus       208 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  238 (256)
T cd05039         208 VVPHVE-KGYRMEAPEGCPPEVYKVMKDCWEL  238 (256)
T ss_pred             HHHHHh-cCCCCCCccCCCHHHHHHHHHHhcc
Confidence            777664 3345567788999999999999974

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=226.14  Aligned_cols=186  Identities=32%  Similarity=0.570  Sum_probs=162.6

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |..++||+|+++++.|...+.+|++.|||.||..+.++..-+.  ++++.++.-+++|+++||.|||+.+  |+|||||.
T Consensus        83 La~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKA  158 (1187)
T KOG0579|consen   83 LAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKA  158 (1187)
T ss_pred             hhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccc
Confidence            4567999999999999999999999999999999988865443  4999999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccc-----ccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL-----RDEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~-----~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      .||+++.+|.++|.|||.+.........-....+++.|||||++     +..+|+.++||||||+++.+|..+.+|-...
T Consensus       159 GNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel  238 (1187)
T KOG0579|consen  159 GNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL  238 (1187)
T ss_pred             cceEEEecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc
Confidence            99999999999999999987544433333456789999999986     4567899999999999999999999999999


Q ss_pred             CHHHHHHHHHhcCcccC--CCCCCCHHHHHHHHHHhcC
Q 029552          156 NPAQVVAAVGFKGKRLE--IPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~cl~~  191 (191)
                      ++..++-++. +..++.  .|+.-|.+|.+++.+||.|
T Consensus       239 npMRVllKia-KSePPTLlqPS~Ws~~F~DfLk~cL~K  275 (1187)
T KOG0579|consen  239 NPMRVLLKIA-KSEPPTLLQPSHWSRSFSDFLKRCLVK  275 (1187)
T ss_pred             chHHHHHHHh-hcCCCcccCcchhhhHHHHHHHHHHhc
Confidence            9999999886 333333  5788999999999999976

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.4e-33  Score=211.58  Aligned_cols=187  Identities=24%  Similarity=0.328  Sum_probs=154.6

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++|+||+++.+.+.+++..++++||+.+++|.+.+...+ ...+++.++..++.|++.||+|||+.+  ++|+||+|
T Consensus        54 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp  130 (285)
T cd05632          54 LEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKP  130 (285)
T ss_pred             HHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCH
Confidence            357899999999999999999999999999999998886533 224899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|++++++++|..||........
T Consensus       131 ~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~  209 (285)
T cd05632         131 ENILLDDYGHIRISDLGLAVKIPEGE-SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK  209 (285)
T ss_pred             HHEEECCCCCEEEecCCcceecCCCC-cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99999999999999999875432221 11233567899999999888889999999999999999999999988766544


Q ss_pred             HHHHHh--cCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGF--KGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~--~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+..  ......++..+++.+.+++.+||++
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  242 (285)
T cd05632         210 REEVDRRVLETEEVYSAKFSEEAKSICKMLLTK  242 (285)
T ss_pred             HHHHHHhhhccccccCccCCHHHHHHHHHHccC
Confidence            333322  2223456678999999999999974

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-33  Score=209.09  Aligned_cols=186  Identities=31%  Similarity=0.548  Sum_probs=155.8

Q ss_pred             CCCCCCCCcccccceeecC--CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            1 MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      +++++||||+++++++.+.  +..++++||+++++|.+++...+   .+++..+..++.|++.||.+||+.+  ++|+||
T Consensus        58 l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl  132 (264)
T cd06653          58 LKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNM--IVHRDI  132 (264)
T ss_pred             HHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCC
Confidence            3568999999999998764  46889999999999999987543   2789999999999999999999999  999999


Q ss_pred             CCCcEEecCCCcEEEccccccccccccc---ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           79 KSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        79 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      +|+||+++.++.++|+|||.+.......   .......++..|+|||.+.+...+.++|+||+|++++++++|..||...
T Consensus       133 ~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  212 (264)
T cd06653         133 KGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY  212 (264)
T ss_pred             CHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence            9999999999999999999886432211   1112234667899999998888889999999999999999999999987


Q ss_pred             CHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          156 NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+....+.....+..+|..+++.+.++|.+||++
T Consensus       213 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~~  248 (264)
T cd06653         213 EAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFVE  248 (264)
T ss_pred             CHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhcC
Confidence            777766666544456678899999999999999963

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=8.7e-34  Score=213.48  Aligned_cols=184  Identities=26%  Similarity=0.471  Sum_probs=153.1

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++.+..++..++++||+++++|.+++...    .+++++++.++.|++.|++|||+.+  ++|+||+|+
T Consensus        74 ~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~  147 (292)
T cd06658          74 RDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSD  147 (292)
T ss_pred             HhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHH
Confidence            5679999999999999999999999999999999988543    2789999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      ||+++.++.++|+|||++..............++..|+|||.+.+..++.++|+||+|++++++++|..||...++....
T Consensus       148 Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~  227 (292)
T cd06658         148 SILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM  227 (292)
T ss_pred             HEEEcCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999999998764433322222344677899999998888889999999999999999999999987777666


Q ss_pred             HHHHhcC-cccCCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKG-KRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~-~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+.... ...+....++..++++|.+||.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  258 (292)
T cd06658         228 RRIRDNLPPRVKDSHKVSSVLRGFLDLMLVR  258 (292)
T ss_pred             HHHHhcCCCccccccccCHHHHHHHHHHccC
Confidence            5553221 12223346899999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.3e-33  Score=210.14  Aligned_cols=184  Identities=29%  Similarity=0.486  Sum_probs=149.8

Q ss_pred             CCCCcccccceeecC------CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            5 RHPNIVLFMGAVTQP------PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      +||||+++++++...      ...++++||+.+++|.+++.... ...+++..+..++.|++.|++|||+.+  ++|+|+
T Consensus        61 ~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl  137 (272)
T cd06637          61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK--VIHRDI  137 (272)
T ss_pred             CCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCC
Confidence            699999999998643      45899999999999999987533 224889999999999999999999999  999999


Q ss_pred             CCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 029552           79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQQPWG  153 (191)
Q Consensus        79 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Dv~slG~~~~~l~~g~~pf~  153 (191)
                      +|+||+++.++.++|+|||++..............++..|+|||.+.     +..++.++|+||+|+++|+|++|..||.
T Consensus       138 ~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~  217 (272)
T cd06637         138 KGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC  217 (272)
T ss_pred             CHHHEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            99999999999999999999865433222233445677899999885     2346778999999999999999999998


Q ss_pred             CCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          154 NLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+............+...+..++..++++|.+||.+
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  255 (272)
T cd06637         218 DMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVK  255 (272)
T ss_pred             ccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCC
Confidence            87766666555433334444567899999999999964

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.4e-33  Score=207.57  Aligned_cols=186  Identities=33%  Similarity=0.597  Sum_probs=153.6

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++|||++++++++.. +..+++|||+.+++|.+++.... ...+++..+..++.|++.||+|||+.+  ++|+||+|
T Consensus        55 l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~  130 (260)
T cd05069          55 MKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRA  130 (260)
T ss_pred             HHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCc
Confidence            357899999999988754 56899999999999999996533 223788899999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA  158 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~  158 (191)
                      +||+++.++.++|+|||.+....... ........+..|++||...+...+.++|+||+|+++|+|++ |..||....+.
T Consensus       131 ~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  210 (260)
T cd05069         131 ANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR  210 (260)
T ss_pred             ceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999886443221 11112233457999999988888999999999999999999 89999988877


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +....+. .....+.+.+++..++++|++||++
T Consensus       211 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  242 (260)
T cd05069         211 EVLEQVE-RGYRMPCPQGCPESLHELMKLCWKK  242 (260)
T ss_pred             HHHHHHH-cCCCCCCCcccCHHHHHHHHHHccC
Confidence            7777664 3445567788999999999999974

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=9.6e-34  Score=211.60  Aligned_cols=187  Identities=27%  Similarity=0.388  Sum_probs=152.9

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++..++..|+|+||+++++|.+++.+... ..+++.++..++.|++.||.+||+.+  ++|+||+|
T Consensus        47 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p  123 (277)
T cd05577          47 LEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKP  123 (277)
T ss_pred             HHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCH
Confidence            4578999999999999999999999999999999999875442 24899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.++.++|+|||.+...... .......+...|++||.+.+..++.++|+||+|+++++|++|..||........
T Consensus       124 ~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~  202 (277)
T cd05577         124 ENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE  202 (277)
T ss_pred             HHEEECCCCCEEEccCcchhhhccC-CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc
Confidence            9999999999999999987643322 122233456789999999888788899999999999999999999976544211


Q ss_pred             HHHHHh--cCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGF--KGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~--~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+..  .......|..+++.++++|++||++
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  235 (277)
T cd05577         203 KEELKRRTLEMAVEYPDKFSPEAKDLCEALLQK  235 (277)
T ss_pred             HHHHHhccccccccCCccCCHHHHHHHHHHccC
Confidence            121111  2335567788999999999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.3e-33  Score=207.65  Aligned_cols=186  Identities=36%  Similarity=0.602  Sum_probs=154.6

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++|||++++++++.+ ...+++|||+.+++|.+++.... ...+++++++.++.|++.||+|||+.+  ++|+||+|
T Consensus        55 l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p  130 (260)
T cd05070          55 MKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRS  130 (260)
T ss_pred             HHhcCCCceEEEEeEECC-CCcEEEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCcc
Confidence            357899999999998754 56899999999999999986533 223789999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA  158 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~  158 (191)
                      +||+++.++.++|+|||.+....... .......+...|+|||...+..++.++|+||||+++|++++ |..||...+..
T Consensus       131 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~  210 (260)
T cd05070         131 ANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR  210 (260)
T ss_pred             ceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            99999999999999999886433221 11112223457999999888888899999999999999999 89999988887


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +....+. .+...+.+...+..+++++.+||++
T Consensus       211 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  242 (260)
T cd05070         211 EVLEQVE-RGYRMPCPQDCPISLHELMLQCWKK  242 (260)
T ss_pred             HHHHHHH-cCCCCCCCCcCCHHHHHHHHHHccc
Confidence            7777774 3456677888999999999999974

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.8e-33  Score=210.63  Aligned_cols=188  Identities=27%  Similarity=0.355  Sum_probs=147.8

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++||||+++++++.+++..++|+||+. ++|.+++........+++.+++.++.|+++||+|||+.+  ++|+||+|
T Consensus        53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p  129 (285)
T cd07861          53 LKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKP  129 (285)
T ss_pred             HHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCH
Confidence            356789999999999999999999999997 589888865443345899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      +||+++.++.++|+|||.+..............++..|+|||.+.+. .++.++|+||+|+++++|++|..||.......
T Consensus       130 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~  209 (285)
T cd07861         130 QNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID  209 (285)
T ss_pred             HHEEEcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence            99999999999999999876443222222233456789999988654 46788999999999999999999998765544


Q ss_pred             HHHHHHhcCc---------------------------ccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGK---------------------------RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~---------------------------~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+.....                           .......+|++++++|.+||+.
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  268 (285)
T cd07861         210 QLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIY  268 (285)
T ss_pred             HHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcC
Confidence            3322211000                           0011345899999999999973

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-33  Score=206.21  Aligned_cols=186  Identities=32%  Similarity=0.572  Sum_probs=155.2

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++||||+++++++.+....++++||+.+++|.+++.....  .+++..+..++.+++.+|++||+++  ++|+||+|
T Consensus        46 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p  121 (251)
T cd05041          46 LKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAA  121 (251)
T ss_pred             HHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCc
Confidence            3578999999999999999999999999999999999865432  3788999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccC--CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSS--KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~  157 (191)
                      +||+++.++.++|+|||.+..........  ........|+|||.+.+..++.++|+||+|+++++|++ |..||.....
T Consensus       122 ~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~  201 (251)
T cd05041         122 RNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN  201 (251)
T ss_pred             ceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH
Confidence            99999999999999999876543221111  11122446999999988888999999999999999999 7889988877


Q ss_pred             HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ......+. .....+.|..++..+.++|.+||++
T Consensus       202 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  234 (251)
T cd05041         202 QQTRERIE-SGYRMPAPQLCPEEIYRLMLQCWAY  234 (251)
T ss_pred             HHHHHHHh-cCCCCCCCccCCHHHHHHHHHHhcc
Confidence            77666664 3345667788999999999999964

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.2e-33  Score=209.87  Aligned_cols=180  Identities=26%  Similarity=0.436  Sum_probs=149.7

Q ss_pred             CCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCc
Q 029552            3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN   82 (191)
Q Consensus         3 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~n   82 (191)
                      ...||+|+++.+++.+++..++|+||+.+++|.+++...+   .+++.++..++.|++.|++|||+.+  ++|+||+|+|
T Consensus        53 ~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~n  127 (278)
T cd05606          53 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPAN  127 (278)
T ss_pred             hCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHH
Confidence            3579999999999999999999999999999999886543   3899999999999999999999999  9999999999


Q ss_pred             EEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCC---HH
Q 029552           83 LLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLN---PA  158 (191)
Q Consensus        83 i~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf~~~~---~~  158 (191)
                      |+++.++.++|+|||.+......  ......++..|+|||.+.+. .++.++|+||+|+++++|++|..||....   ..
T Consensus       128 ili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~  205 (278)
T cd05606         128 ILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH  205 (278)
T ss_pred             EEECCCCCEEEccCcCccccCcc--CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH
Confidence            99999999999999987643322  12233567889999998744 57889999999999999999999998652   22


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ......  .......|..+|..+.+++.+||++
T Consensus       206 ~~~~~~--~~~~~~~~~~~s~~~~~li~~~l~~  236 (278)
T cd05606         206 EIDRMT--LTMAVELPDSFSPELRSLLEGLLQR  236 (278)
T ss_pred             HHHHHh--hccCCCCCCcCCHHHHHHHHHHhhc
Confidence            222222  3345677888999999999999974

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=8e-34  Score=209.82  Aligned_cols=183  Identities=25%  Similarity=0.391  Sum_probs=155.6

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++||||+++++++.++...++++||+.+++|.+++....   .+++.++..++.|++++|.+||+.+  ++|+||+|
T Consensus        54 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~  128 (258)
T cd05578          54 LQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKV---KFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKP  128 (258)
T ss_pred             HHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCH
Confidence            357899999999999999999999999999999999997653   3889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH---
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP---  157 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~---  157 (191)
                      +||+++.++.++|+|||.+....... ......+...|+|||.+.+...+.++|+||+|+++|++++|..||...+.   
T Consensus       129 ~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  207 (258)
T cd05578         129 DNILLDEQGHVHITDFNIATKVTPDT-LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR  207 (258)
T ss_pred             HHeEEcCCCCEEEeecccccccCCCc-cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH
Confidence            99999999999999999876543321 22334566789999999888888999999999999999999999987663   


Q ss_pred             HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .......  .......|..++..+.++|.+||++
T Consensus       208 ~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~  239 (258)
T cd05578         208 DQIRAKQ--ETADVLYPATWSTEAIDAINKLLER  239 (258)
T ss_pred             HHHHHHh--ccccccCcccCcHHHHHHHHHHccC
Confidence            3333333  2256677888999999999999974

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.7e-33  Score=211.77  Aligned_cols=187  Identities=32%  Similarity=0.598  Sum_probs=155.4

Q ss_pred             CCC-CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC-------------cccccHHHHHHHHHHHHHHHHHHH
Q 029552            2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------------REMLDERRRLNMAYDVAKGMNYLH   67 (191)
Q Consensus         2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~Lh   67 (191)
                      +.+ +||||+++++++...+..+++|||+.+++|.+++.+...             ...++..++..++.|+++||+|||
T Consensus        75 ~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH  154 (304)
T cd05101          75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA  154 (304)
T ss_pred             HhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH
Confidence            345 799999999999999999999999999999999965321             124678889999999999999999


Q ss_pred             hCCCCeeecCCCCCcEEecCCCcEEEccccccccccccccc--CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHH
Q 029552           68 RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL  145 (191)
Q Consensus        68 ~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l  145 (191)
                      ++|  ++|+||+|+||+++.++.++|+|||.+.........  .........|+|||.+.+..++.++|+||+|+++|++
T Consensus       155 ~~g--ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el  232 (304)
T cd05101         155 SQK--CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI  232 (304)
T ss_pred             HCC--eeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHH
Confidence            999  999999999999999999999999988654332111  1122334579999999888888999999999999999


Q ss_pred             Hh-CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          146 AT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       146 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ++ |..||......+....+. .......|..++..++++|.+||.+
T Consensus       233 ~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~  278 (304)
T cd05101         233 FTLGGSPYPGIPVEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHA  278 (304)
T ss_pred             HcCCCCCcccCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHccc
Confidence            98 788998888888777774 4445566788999999999999963

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-33  Score=208.97  Aligned_cols=185  Identities=29%  Similarity=0.534  Sum_probs=155.5

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.. ...++++||+.+++|.+++.....  .+++..+..++.|++.||+|||+++  ++|+||+|
T Consensus        63 l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p  137 (279)
T cd05057          63 MASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAA  137 (279)
T ss_pred             HHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCc
Confidence            356899999999999887 789999999999999999976432  2889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccC--CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSS--KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~  157 (191)
                      +||+++.++.++|+|||.+..........  ........|++||.+....++.++|+||+|++++++++ |..||.....
T Consensus       138 ~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  217 (279)
T cd05057         138 RNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA  217 (279)
T ss_pred             ceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH
Confidence            99999999999999999886543221111  11112457999999988888899999999999999998 9999999888


Q ss_pred             HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+....+. .+...+.|..++..+.+++.+||.+
T Consensus       218 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~  250 (279)
T cd05057         218 VEIPDLLE-KGERLPQPPICTIDVYMVLVKCWMI  250 (279)
T ss_pred             HHHHHHHh-CCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            77776664 5556777888999999999999964

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3e-33  Score=209.04  Aligned_cols=184  Identities=29%  Similarity=0.519  Sum_probs=152.6

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.+.||||+++++++.. ...+++++++++++|.+++....  +.+++.++..++.|++.||+|||+.+  ++|+||+|+
T Consensus        64 ~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~  138 (279)
T cd05109          64 AGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAAR  138 (279)
T ss_pred             HhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccc
Confidence            45789999999998865 45789999999999999986533  23889999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccccccc--CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA  158 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~  158 (191)
                      ||+++.++.++|+|||++.........  ......+..|++||...+..++.++|+||+|+++|++++ |..||......
T Consensus       139 Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  218 (279)
T cd05109         139 NVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR  218 (279)
T ss_pred             eEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            999999999999999988654322111  112233467999999988888999999999999999998 89999887777


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .....+. .+...+.+..++..+.++|.+||++
T Consensus       219 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  250 (279)
T cd05109         219 EIPDLLE-KGERLPQPPICTIDVYMIMVKCWMI  250 (279)
T ss_pred             HHHHHHH-CCCcCCCCccCCHHHHHHHHHHcCC
Confidence            6666554 4556667788999999999999974

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.9e-33  Score=211.77  Aligned_cols=185  Identities=26%  Similarity=0.397  Sum_probs=152.8

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++||||+++++++..++..++||||+.+++|.+++...+   .+++..+..++.|++.|++|||+++  ++|+||+|+
T Consensus        56 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~  130 (305)
T cd05609          56 TFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPD  130 (305)
T ss_pred             HhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchH
Confidence            56789999999999999999999999999999999997644   3889999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccccc---------------ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTF---------------LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA  146 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~---------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~  146 (191)
                      ||+++.++.++++|||.+.......               .......++..|+|||.+.+...+.++|+||+|+++|+++
T Consensus       131 NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~  210 (305)
T cd05609         131 NLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL  210 (305)
T ss_pred             HEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHH
Confidence            9999999999999999875311100               0001123466799999998888899999999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHHHhcCcc-cCCCCCCCHHHHHHHHHHhcC
Q 029552          147 TLQQPWGNLNPAQVVAAVGFKGKR-LEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       147 ~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +|..||....+.+....+...... +..+..+|..++++|++||++
T Consensus       211 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  256 (305)
T cd05609         211 VGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQ  256 (305)
T ss_pred             hCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhcc
Confidence            999999988777777766433222 223346899999999999974

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.6e-33  Score=210.18  Aligned_cols=184  Identities=28%  Similarity=0.505  Sum_probs=154.4

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++..++..++++||+.+++|.+++...    .++++++..++.|++.|+++||+++  ++|+||+|+
T Consensus        71 ~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~  144 (285)
T cd06648          71 RDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSD  144 (285)
T ss_pred             HHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChh
Confidence            4678999999999999999999999999999999998762    2789999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      ||+++.++.++|+|||.+..............++..|+|||...+..++.++|+||+|+++++|++|..||...++....
T Consensus       145 Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~  224 (285)
T cd06648         145 SILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM  224 (285)
T ss_pred             hEEEcCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH
Confidence            99999999999999997654333222223345677899999998888889999999999999999999999888877777


Q ss_pred             HHHHhcCc-ccCCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKGK-RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~~-~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+..... ....+..++..+.++|.+||++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  255 (285)
T cd06648         225 KRIRDNLPPKLKNLHKVSPRLRSFLDRMLVR  255 (285)
T ss_pred             HHHHhcCCCCCcccccCCHHHHHHHHHHccc
Confidence            76653321 1223445899999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.9e-34  Score=202.74  Aligned_cols=162  Identities=25%  Similarity=0.370  Sum_probs=144.2

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      ||.++|+||+.++++|.+.+.+.+|+||++. +|...++...  ..++..++..|+.++++||+|+|+++  ++|||+||
T Consensus        55 Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKP  129 (318)
T KOG0659|consen   55 LQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKP  129 (318)
T ss_pred             HHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCc
Confidence            5778999999999999999999999999975 9999997543  34899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      +|++++.+|.+|+.|||++...+.........+.+.+|.|||.+-|+ .|+...|+||.||++.||+-|.+-|.+.++.+
T Consensus       130 nNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid  209 (318)
T KOG0659|consen  130 NNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID  209 (318)
T ss_pred             cceEEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH
Confidence            99999999999999999999887776555555778899999988776 48889999999999999999999998888887


Q ss_pred             HHHHHHhc
Q 029552          160 VVAAVGFK  167 (191)
Q Consensus       160 ~~~~~~~~  167 (191)
                      .+..|-..
T Consensus       210 QL~~If~~  217 (318)
T KOG0659|consen  210 QLSKIFRA  217 (318)
T ss_pred             HHHHHHHH
Confidence            77776543

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.6e-33  Score=205.98  Aligned_cols=183  Identities=35%  Similarity=0.669  Sum_probs=153.1

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.++ ..++++||+.+++|.+++.... ...+++.+++.++.|++.||.+||+.|  ++||||+|
T Consensus        53 l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p  128 (254)
T cd05083          53 MTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAA  128 (254)
T ss_pred             HHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCc
Confidence            3568999999999988764 4799999999999999997543 224789999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ  159 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~~  159 (191)
                      +||+++.++.++|+|||.+.......   ........|+|||.+.+..++.++|+||+|+++++|++ |..||...+..+
T Consensus       129 ~nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  205 (254)
T cd05083         129 RNILVSEDGVAKVSDFGLARVGSMGV---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE  205 (254)
T ss_pred             ceEEEcCCCcEEECCCccceeccccC---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH
Confidence            99999999999999999876433221   11223457999999988888899999999999999997 899999888877


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+. .+.++..+..++..+.+++.+||++
T Consensus       206 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  236 (254)
T cd05083         206 VKECVE-KGYRMEPPEGCPADVYVLMTSCWET  236 (254)
T ss_pred             HHHHHh-CCCCCCCCCcCCHHHHHHHHHHcCC
Confidence            766664 3445556778999999999999974

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.4e-33  Score=211.69  Aligned_cols=186  Identities=25%  Similarity=0.376  Sum_probs=151.8

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++|++|+++++.+.+++..+++|||+.+++|.+++...+. ..+++.++..++.|++.||.|||+.+  ++|+||+|
T Consensus        54 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp  130 (285)
T cd05630          54 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKP  130 (285)
T ss_pred             HHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCH
Confidence            3568999999999999999999999999999999998854332 23889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH--
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA--  158 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~--  158 (191)
                      +||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||......  
T Consensus       131 ~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~  209 (285)
T cd05630         131 ENILLDDHGHIRISDLGLAVHVPEGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK  209 (285)
T ss_pred             HHEEECCCCCEEEeeccceeecCCCc-cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch
Confidence            99999999999999999876433221 112335678999999998888899999999999999999999999864432  


Q ss_pred             -HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 -QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 -~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                       ....... .......+..++++++++|.+||+.
T Consensus       210 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  242 (285)
T cd05630         210 REEVERLV-KEVQEEYSEKFSPDARSLCKMLLCK  242 (285)
T ss_pred             HHHHHhhh-hhhhhhcCccCCHHHHHHHHHHhhc
Confidence             1222221 2223456778999999999999974

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.6e-33  Score=213.47  Aligned_cols=186  Identities=24%  Similarity=0.388  Sum_probs=147.9

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++..++..++||||+.+ +|.+.+...+.  .+++.++..++.|++.||+|||+.|  ++||||+|
T Consensus        58 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp  132 (309)
T cd07872          58 LKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKP  132 (309)
T ss_pred             HHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCH
Confidence            3568999999999999999999999999975 88887765432  3788999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      +||+++.++.++|+|||.+..............++..|+|||.+.+. .++.++|+||+|+++++|++|..||...+..+
T Consensus       133 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~  212 (309)
T cd07872         133 QNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED  212 (309)
T ss_pred             HHEEECCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence            99999999999999999886543332222334557789999988654 47889999999999999999999998877655


Q ss_pred             HHHHHHhcCcc-----------------c-----------CCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKR-----------------L-----------EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~-----------------~-----------~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+......                 .           .....+|+.++++|.+||+.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  272 (309)
T cd07872         213 ELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQY  272 (309)
T ss_pred             HHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccC
Confidence            54443211000                 0           01135789999999999973

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.8e-34  Score=214.53  Aligned_cols=184  Identities=27%  Similarity=0.502  Sum_probs=152.3

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++||||++++++|..++..++|+||+++++|.+++.+..    +++.++..++.|++.+|.+||+.+  ++|+||+|+
T Consensus        71 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~  144 (297)
T cd06656          71 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSD  144 (297)
T ss_pred             HhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHH
Confidence            56799999999999999999999999999999999986532    788899999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      ||+++.++.++++|||.+..............++..|++||...+...+.++|+||+|+++|++++|..||...++....
T Consensus       145 Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~  224 (297)
T cd06656         145 NILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL  224 (297)
T ss_pred             HEEECCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe
Confidence            99999999999999998764332222222345677899999998888889999999999999999999999876654443


Q ss_pred             HHHHhc-CcccCCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFK-GKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~-~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+... ......|..++..++++|.+||++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  255 (297)
T cd06656         225 YLIATNGTPELQNPERLSAVFRDFLNRCLEM  255 (297)
T ss_pred             eeeccCCCCCCCCccccCHHHHHHHHHHccC
Confidence            333222 223345677899999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.9e-33  Score=208.04  Aligned_cols=183  Identities=30%  Similarity=0.492  Sum_probs=155.3

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++.+..++..|+++||+.+++|.+++.+.+   .+++.++..++.|++.||++||+.+  ++|+||+|+
T Consensus        48 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~  122 (265)
T cd05579          48 SQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPD  122 (265)
T ss_pred             HhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHH
Confidence            56789999999999999999999999999999999997644   3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccc--------cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFL--------SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWG  153 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~  153 (191)
                      ||+++.++.++|+|||++........        ......++..|++||.......+.++|+||+|++++++++|..||.
T Consensus       123 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~  202 (265)
T cd05579         123 NILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFH  202 (265)
T ss_pred             HeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence            99999999999999998764332211        1223345678999999988878889999999999999999999999


Q ss_pred             CCCHHHHHHHHHhcCcccCCCCCC--CHHHHHHHHHHhcC
Q 029552          154 NLNPAQVVAAVGFKGKRLEIPRNV--NPHVASIIEACWAK  191 (191)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~--s~~~~~li~~cl~~  191 (191)
                      ...+......+..  .....|...  +..+.++|.+||+.
T Consensus       203 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~  240 (265)
T cd05579         203 GETPEEIFQNILN--GKIEWPEDVEVSDEAIDLISKLLVP  240 (265)
T ss_pred             CCCHHHHHHHHhc--CCcCCCccccCCHHHHHHHHHHhcC
Confidence            9888888777754  233444444  99999999999963

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.4e-33  Score=207.10  Aligned_cols=185  Identities=35%  Similarity=0.586  Sum_probs=152.5

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++.+.+ +..+++|||+.+++|.+++.+.. ...+++.++..++.|++.||++||+.+  ++|+||+|+
T Consensus        56 ~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~  131 (262)
T cd05071          56 KKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAA  131 (262)
T ss_pred             HhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcc
Confidence            56799999999988754 56899999999999999997532 223788999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccc-cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ  159 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~~  159 (191)
                      ||+++.++.++|+|||.+........ ......++..|++||...+..++.++|+||+|+++|++++ |..||.......
T Consensus       132 Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~  211 (262)
T cd05071         132 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE  211 (262)
T ss_pred             cEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH
Confidence            99999999999999998864432211 1122334567999999988888999999999999999999 788998887777


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+. .....+.+..++..+.++|.+||++
T Consensus       212 ~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~  242 (262)
T cd05071         212 VLDQVE-RGYRMPCPPECPESLHDLMCQCWRK  242 (262)
T ss_pred             HHHHHh-cCCCCCCccccCHHHHHHHHHHccC
Confidence            776664 3344566778999999999999974

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=5.3e-33  Score=205.80  Aligned_cols=186  Identities=31%  Similarity=0.565  Sum_probs=149.9

Q ss_pred             CCCCCCCCcccccceee-cCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            1 MKRLRHPNIVLFMGAVT-QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      ++.++||||+++++++. .++..++++||+.+++|.+++.+...  ......+..++.|+++||+|||+.+  ++|+||+
T Consensus        50 l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk  125 (262)
T cd05058          50 MKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLA  125 (262)
T ss_pred             HccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccccccC
Confidence            46789999999999765 45568999999999999999975432  2567778889999999999999999  9999999


Q ss_pred             CCcEEecCCCcEEEccccccccccccc----ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhC-CCCCCC
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTF----LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGN  154 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g-~~pf~~  154 (191)
                      |+||+++.++.++|+|||.+.......    ...........|+|||.+.+..++.++|+||+|+++|+|++| ..||..
T Consensus       126 ~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~  205 (262)
T cd05058         126 ARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD  205 (262)
T ss_pred             cceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC
Confidence            999999999999999999876432211    111122334579999999888888999999999999999995 667887


Q ss_pred             CCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          155 LNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+.......+. .+..+..+..+++.+.+++.+||+.
T Consensus       206 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~  241 (262)
T cd05058         206 VDSFDITVYLL-QGRRLLQPEYCPDPLYEVMLSCWHP  241 (262)
T ss_pred             CCHHHHHHHHh-cCCCCCCCCcCCHHHHHHHHHHcCC
Confidence            77777666654 4445566778899999999999963

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.7e-33  Score=212.24  Aligned_cols=153  Identities=33%  Similarity=0.527  Sum_probs=131.9

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCeeecCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLK   79 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~~h~~l~   79 (191)
                      |++++||||++++++|.+++..++++||+++++|.+++.+.+   .+++..+..++.|+++||.|||+ .+  ++|+||+
T Consensus        53 l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~  127 (308)
T cd06615          53 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKHK--IMHRDVK  127 (308)
T ss_pred             HHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCC
Confidence            356899999999999999999999999999999999997643   38899999999999999999997 68  9999999


Q ss_pred             CCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      |+||+++.++.++|+|||.+......  ......++..|++||.+.+..++.++|+||+|+++++|++|..||...+...
T Consensus       128 p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~  205 (308)
T cd06615         128 PSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE  205 (308)
T ss_pred             hHHEEEecCCcEEEccCCCccccccc--ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh
Confidence            99999999999999999987543322  1223456778999999988888899999999999999999999997655444


Q ss_pred             H
Q 029552          160 V  160 (191)
Q Consensus       160 ~  160 (191)
                      .
T Consensus       206 ~  206 (308)
T cd06615         206 L  206 (308)
T ss_pred             H
Confidence            3

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.9e-33  Score=207.50  Aligned_cols=184  Identities=31%  Similarity=0.580  Sum_probs=153.4

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+ ...++++||+++++|.+++.+...  .+++.+++.++.|++.||++||+.+  ++|+||+|
T Consensus        61 l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p  135 (270)
T cd05056          61 MRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESKR--FVHRDIAA  135 (270)
T ss_pred             HHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCh
Confidence            357899999999998876 457899999999999999975432  3789999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccc-cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA  158 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~  158 (191)
                      +||+++.++.++++|||++........ ..........|+|||.+.+..++.++|+||||++++++++ |..||......
T Consensus       136 ~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~  215 (270)
T cd05056         136 RNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN  215 (270)
T ss_pred             heEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence            999999999999999998764332211 1112223457999999888888899999999999999986 99999988877


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhc
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~  190 (191)
                      +....+. .+.+.+.|..+|..+.++|.+||+
T Consensus       216 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~  246 (270)
T cd05056         216 DVIGRIE-NGERLPMPPNCPPTLYSLMTKCWA  246 (270)
T ss_pred             HHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcC
Confidence            7776664 445667788999999999999996

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.5e-33  Score=207.66  Aligned_cols=178  Identities=24%  Similarity=0.483  Sum_probs=149.0

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      +||||++++++|..++..++||||+++++|.+++....   .+++++++.++.|+++||++||+.+  ++|+||+|+||+
T Consensus        67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil  141 (267)
T PHA03390         67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVL  141 (267)
T ss_pred             cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEE
Confidence            69999999999999999999999999999999997643   3899999999999999999999999  999999999999


Q ss_pred             ecCCC-cEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH-HH
Q 029552           85 VDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV-VA  162 (191)
Q Consensus        85 ~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~-~~  162 (191)
                      ++.++ .++++|||.+......    ....++..|+|||.+.+..++.++|+||+|+++++|++|..||........ ..
T Consensus       142 ~~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~  217 (267)
T PHA03390        142 YDRAKDRIYLCDYGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLE  217 (267)
T ss_pred             EeCCCCeEEEecCccceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHH
Confidence            99988 9999999987644322    223467789999999888889999999999999999999999985443221 11


Q ss_pred             HH-HhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          163 AV-GFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       163 ~~-~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .. .......+.+..+|+.++++|.+||+.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  247 (267)
T PHA03390        218 SLLKRQQKKLPFIKNVSKNANDFVQSMLKY  247 (267)
T ss_pred             HHHHhhcccCCcccccCHHHHHHHHHHhcc
Confidence            11 112334456678999999999999973

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.4e-33  Score=216.06  Aligned_cols=152  Identities=28%  Similarity=0.466  Sum_probs=126.0

Q ss_pred             CCCCCCCCcccccceeecC-----CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 029552            1 MKRLRHPNIVLFMGAVTQP-----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH   75 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h   75 (191)
                      |++++||||+++++++...     ...|+||||+. ++|.+++....   .+++..+..++.|+++||.|||+.|  ++|
T Consensus        53 l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivH  126 (338)
T cd07859          53 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTAN--VFH  126 (338)
T ss_pred             HHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHCC--eec
Confidence            3578999999999988543     24899999995 68998886543   3889999999999999999999999  999


Q ss_pred             cCCCCCcEEecCCCcEEEccccccccccccc---ccCCCCCCCCcccCcccccc--CCCCCcchHHHHHHHHHHHHhCCC
Q 029552           76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRD--EPSNEKSDIYSFGVILWELATLQQ  150 (191)
Q Consensus        76 ~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~  150 (191)
                      +||+|+||+++.++.++|+|||.+.......   .......++..|+|||.+.+  ..++.++|+||+|+++|+|++|..
T Consensus       127 ~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~  206 (338)
T cd07859         127 RDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP  206 (338)
T ss_pred             CCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCC
Confidence            9999999999999999999999886432211   11123456789999999865  567889999999999999999999


Q ss_pred             CCCCCCHH
Q 029552          151 PWGNLNPA  158 (191)
Q Consensus       151 pf~~~~~~  158 (191)
                      ||...+..
T Consensus       207 pf~~~~~~  214 (338)
T cd07859         207 LFPGKNVV  214 (338)
T ss_pred             CCCCCChH
Confidence            99776543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3e-33  Score=207.49  Aligned_cols=188  Identities=27%  Similarity=0.499  Sum_probs=152.9

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCC-CcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      |++++|+||+++++++.+++..+++|||+++++|.+++.... ....++++++..++.++++|+.+||+.|  ++|+||+
T Consensus        56 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~  133 (267)
T cd08224          56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIK  133 (267)
T ss_pred             HHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcC
Confidence            356899999999999999999999999999999999885422 1234789999999999999999999999  9999999


Q ss_pred             CCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC--H
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN--P  157 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~--~  157 (191)
                      |+||+++.++.++++|||.+..............+...|.|||.+.+..++.++|+||+|+++++|++|..||....  .
T Consensus       134 p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~  213 (267)
T cd08224         134 PANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL  213 (267)
T ss_pred             hhhEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH
Confidence            99999999999999999987644333222233456678999999988888899999999999999999999996533  3


Q ss_pred             HHHHHHHHhcCcccCCCC-CCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIPR-NVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~-~~s~~~~~li~~cl~~  191 (191)
                      ....+.+. .+...+.|. .++..++++|.+||++
T Consensus       214 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~cl~~  247 (267)
T cd08224         214 YSLCKKIE-KCDYPPLPADHYSEELRDLVSRCINP  247 (267)
T ss_pred             HHHHhhhh-cCCCCCCChhhcCHHHHHHHHHHcCC
Confidence            33444443 233444554 7899999999999964

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2e-33  Score=211.39  Aligned_cols=187  Identities=33%  Similarity=0.614  Sum_probs=155.4

Q ss_pred             CCC-CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCC-------------CCcccccHHHHHHHHHHHHHHHHHHH
Q 029552            2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-------------GVREMLDERRRLNMAYDVAKGMNYLH   67 (191)
Q Consensus         2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-------------~~~~~~~~~~~~~~~~~i~~~l~~Lh   67 (191)
                      +++ +||||+++++++.+++..+++|||+.+++|.+++...             .....+++..++.++.|++.||+|||
T Consensus        70 ~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH  149 (293)
T cd05053          70 KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA  149 (293)
T ss_pred             HhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence            345 7999999999999999999999999999999998542             11234889999999999999999999


Q ss_pred             hCCCCeeecCCCCCcEEecCCCcEEEcccccccccccccc--cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHH
Q 029552           68 RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL  145 (191)
Q Consensus        68 ~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l  145 (191)
                      +.+  ++|+||+|+||+++.++.++|+|||.+........  ..........|+|||...+..++.++|+||+|+++|++
T Consensus       150 ~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el  227 (293)
T cd05053         150 SKK--CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI  227 (293)
T ss_pred             HCC--ccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHH
Confidence            999  99999999999999999999999998864332211  11112234579999998888889999999999999999


Q ss_pred             Hh-CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          146 AT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       146 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ++ |..||......+....+. .+.....|..++..+.+++.+||+.
T Consensus       228 ~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  273 (293)
T cd05053         228 FTLGGSPYPGIPVEELFKLLK-EGYRMEKPQNCTQELYHLMRDCWHE  273 (293)
T ss_pred             hcCCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHccc
Confidence            97 899999888777777664 4455667788999999999999973

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.8e-33  Score=209.66  Aligned_cols=185  Identities=31%  Similarity=0.514  Sum_probs=146.7

Q ss_pred             CCCCCCCCcccccceeecC--CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            1 MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      |++++||||+++++++...  ...+++|||+.+++|.+++....    +++.+++.++.|+++||++||+.+  ++|+||
T Consensus        60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dl  133 (283)
T cd05080          60 LKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK----LNLAQLLLFAQQICEGMAYLHSQH--YIHRDL  133 (283)
T ss_pred             HHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHcC----CCHHHHHHHHHHHHHHHHHHHHCC--eecccc
Confidence            4578999999999988653  46899999999999999997532    899999999999999999999999  999999


Q ss_pred             CCCcEEecCCCcEEEcccccccccccccc---cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           79 KSPNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        79 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      +|+||+++.++.++|+|||.+........   ..........|+|||.+.+...+.++|+||||+++++|++|..||...
T Consensus       134 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~  213 (283)
T cd05080         134 AARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP  213 (283)
T ss_pred             ChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999998865433211   111223345699999998888899999999999999999999998653


Q ss_pred             CHHH--------------HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          156 NPAQ--------------VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~~--------------~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....              ............+.|..++..+.+++.+||++
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  263 (283)
T cd05080         214 PKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWET  263 (283)
T ss_pred             cchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhcc
Confidence            2211              11111112334456778999999999999973

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4.2e-33  Score=205.49  Aligned_cols=186  Identities=31%  Similarity=0.541  Sum_probs=156.9

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++.+..++..++|+||+++++|.+++.... ...+++..+..++.++++++++||+++  ++|+||+|
T Consensus        53 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~  129 (256)
T cd08220          53 LKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKT  129 (256)
T ss_pred             HhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence            467899999999999999999999999999999999997533 223789999999999999999999999  99999999


Q ss_pred             CcEEecCCC-cEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           81 PNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        81 ~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      +||+++.++ .++++|||.+....... ......+...|+|||.+.+...+.++|+||+|+++++|++|..||...+...
T Consensus       130 ~nil~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~  208 (256)
T cd08220         130 QNILLDKHKMVVKIGDFGISKILSSKS-KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA  208 (256)
T ss_pred             HHEEEcCCCCEEEEccCCCceecCCCc-cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH
Confidence            999998654 57999999887544331 2223345678999999988888889999999999999999999999888777


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+. .+...+.+..++..++++|.+||++
T Consensus       209 ~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~  239 (256)
T cd08220         209 LVLKIM-SGTFAPISDRYSPDLRQLILSMLNL  239 (256)
T ss_pred             HHHHHH-hcCCCCCCCCcCHHHHHHHHHHccC
Confidence            776664 3445567788999999999999964

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.2e-33  Score=205.65  Aligned_cols=186  Identities=33%  Similarity=0.616  Sum_probs=155.5

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++|||++++++++......++++||+.+++|.+++.....  .++++.++.++.|++.++++||+.+  ++|+||+|
T Consensus        53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p  128 (256)
T cd05112          53 MMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAA  128 (256)
T ss_pred             HHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC--cccccccc
Confidence            3578999999999999999999999999999999999865332  3789999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccc-cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA  158 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~  158 (191)
                      +||+++.++.++|+|||.+........ .......+..|+|||.+.+..++.++|+||+|+++|++++ |..||......
T Consensus       129 ~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~  208 (256)
T cd05112         129 RNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS  208 (256)
T ss_pred             ceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence            999999999999999998764432211 1112223457999999988888899999999999999998 89999988887


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .....+. .+.+...|...+..+.+++.+||++
T Consensus       209 ~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~l~~  240 (256)
T cd05112         209 EVVETIN-AGFRLYKPRLASQSVYELMQHCWKE  240 (256)
T ss_pred             HHHHHHh-CCCCCCCCCCCCHHHHHHHHHHccc
Confidence            7777764 3334455677899999999999964

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3e-33  Score=207.97  Aligned_cols=187  Identities=27%  Similarity=0.478  Sum_probs=147.6

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC--cccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV--REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      +.++||||+++++.+.+....++||||+.+++|.+++.....  ....++..+..++.|++.||+|||+++  ++|+||+
T Consensus        50 ~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlk  127 (269)
T cd05042          50 RELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLA  127 (269)
T ss_pred             HhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--Eeccccc
Confidence            467899999999999999999999999999999999965332  223567788899999999999999999  9999999


Q ss_pred             CCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCcccccc-------CCCCCcchHHHHHHHHHHHHh-CC
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRD-------EPSNEKSDIYSFGVILWELAT-LQ  149 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~-------~~~~~~~Dv~slG~~~~~l~~-g~  149 (191)
                      |+||+++.++.++++|||.+.......  ...........|+|||.+..       ...+.++|+||+|+++|+|++ |.
T Consensus       128 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~  207 (269)
T cd05042         128 LRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAAD  207 (269)
T ss_pred             HhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCC
Confidence            999999999999999999875432211  11122334567999998643       345778999999999999999 78


Q ss_pred             CCCCCCCHHHHHHHHHhcCc----ccCCCCCCCHHHHHHHHHHhc
Q 029552          150 QPWGNLNPAQVVAAVGFKGK----RLEIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       150 ~pf~~~~~~~~~~~~~~~~~----~~~~~~~~s~~~~~li~~cl~  190 (191)
                      .||....+.+..........    .+..+..+++.+.+++..||.
T Consensus       208 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (269)
T cd05042         208 QPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCWL  252 (269)
T ss_pred             CCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHhc
Confidence            89988777666555433222    223445789999999999984

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.3e-33  Score=209.85  Aligned_cols=180  Identities=26%  Similarity=0.447  Sum_probs=148.4

Q ss_pred             CCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcE
Q 029552            4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL   83 (191)
Q Consensus         4 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni   83 (191)
                      .+||||+++++++..++..++||||+.+++|.+++...+   .+++.++..++.|++.||++||+.+  ++|+||+|+||
T Consensus        54 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Ni  128 (279)
T cd05633          54 GDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANI  128 (279)
T ss_pred             CCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHE
Confidence            479999999999999899999999999999999987644   3899999999999999999999999  99999999999


Q ss_pred             EecCCCcEEEcccccccccccccccCCCCCCCCcccCccccc-cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH--HH
Q 029552           84 LVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR-DEPSNEKSDIYSFGVILWELATLQQPWGNLNPA--QV  160 (191)
Q Consensus        84 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~--~~  160 (191)
                      +++.++.++++|||++......  ......++..|+|||.+. +..++.++|+||+|+++++|++|..||......  ..
T Consensus       129 l~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  206 (279)
T cd05633         129 LLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE  206 (279)
T ss_pred             EECCCCCEEEccCCcceecccc--CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH
Confidence            9999999999999987543322  122345678999999886 455788999999999999999999999753322  22


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..... ......+|..++..++++|++||++
T Consensus       207 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  236 (279)
T cd05633         207 IDRMT-LTVNVELPDSFSPELKSLLEGLLQR  236 (279)
T ss_pred             HHHHh-hcCCcCCccccCHHHHHHHHHHhcC
Confidence            22221 2334567788999999999999974

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3e-33  Score=209.77  Aligned_cols=187  Identities=32%  Similarity=0.554  Sum_probs=155.2

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++|+|++++++++...+..++++||+++++|.+++....  ..++..++..++.|++.||++||+.|  ++|++++|
T Consensus        69 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p  144 (286)
T cd06614          69 MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKS  144 (286)
T ss_pred             HHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCh
Confidence            356899999999999999999999999999999999998654  13899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.++.++|+|||.+..............+...|++||.+.+..++.++|+||+|+++|+|++|..||...++...
T Consensus       145 ~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~  224 (286)
T cd06614         145 DNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA  224 (286)
T ss_pred             hhEEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99999999999999999875433222122233456789999999888889999999999999999999999998887766


Q ss_pred             HHHHHhcCc-ccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGK-RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~-~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+..... ....+..++..++++|.+||+.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  256 (286)
T cd06614         225 LFLITTKGIPPLKNPEKWSPEFKDFLNKCLVK  256 (286)
T ss_pred             HHHHHhcCCCCCcchhhCCHHHHHHHHHHhcc
Confidence            665543322 2223345899999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4e-33  Score=209.36  Aligned_cols=187  Identities=33%  Similarity=0.558  Sum_probs=153.8

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC-------cccccHHHHHHHHHHHHHHHHHHHhCCCCee
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------REMLDERRRLNMAYDVAKGMNYLHRRNPPIV   74 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~   74 (191)
                      +.++||||+++++++.+++..+++|||+.+++|.+++...+.       ...++...+..++.|++.||.|||+++  ++
T Consensus        64 ~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~  141 (288)
T cd05061          64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FV  141 (288)
T ss_pred             HhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--Cc
Confidence            567999999999999999999999999999999999964221       123466788899999999999999999  99


Q ss_pred             ecCCCCCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCC
Q 029552           75 HRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQP  151 (191)
Q Consensus        75 h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p  151 (191)
                      |+||+|+||+++.++.++|+|||++.......  ........+..|+|||.+.+..++.++|+||+|+++++|++ |..|
T Consensus       142 H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p  221 (288)
T cd05061         142 HRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP  221 (288)
T ss_pred             CCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999876432211  11112233457999999988888999999999999999998 7889


Q ss_pred             CCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          152 WGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       152 f~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      |......+....+. .+.....+..+++.++++|.+||++
T Consensus       222 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  260 (288)
T cd05061         222 YQGLSNEQVLKFVM-DGGYLDQPDNCPERVTDLMRMCWQF  260 (288)
T ss_pred             CCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            98888777666654 3445566778899999999999964

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.1e-33  Score=207.51  Aligned_cols=185  Identities=32%  Similarity=0.540  Sum_probs=152.9

Q ss_pred             CCCCCCCCcccccceeecC--CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            1 MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      |++++||||+++++++.+.  ...++++||+++++|.+++.+.+   .+++..+..++.|++.+|++||+.+  ++|+||
T Consensus        58 l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl  132 (265)
T cd06652          58 LKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNM--IVHRDI  132 (265)
T ss_pred             HHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCC
Confidence            3567999999999998764  46889999999999999987543   2788899999999999999999999  999999


Q ss_pred             CCCcEEecCCCcEEEccccccccccccc---ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           79 KSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        79 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      +|+||+++.++.++|+|||.+.......   .......++..|+|||.+.+...+.++|+||+|+++|++++|..||...
T Consensus       133 ~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  212 (265)
T cd06652         133 KGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF  212 (265)
T ss_pred             CHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence            9999999999999999999876432211   1112234567899999998888889999999999999999999999887


Q ss_pred             CHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhc
Q 029552          156 NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~  190 (191)
                      ...............+..|..++..+.++|.+||.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  247 (265)
T cd06652         213 EAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV  247 (265)
T ss_pred             chHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc
Confidence            66666655543444556778899999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-33  Score=207.06  Aligned_cols=188  Identities=30%  Similarity=0.552  Sum_probs=154.2

Q ss_pred             CCCCCCCCcccccceeecCCc------eEEEEeccCCCCHHHHhcCCC---CcccccHHHHHHHHHHHHHHHHHHHhCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPN------LSIVTEYLSRGSLYRLLHKPG---VREMLDERRRLNMAYDVAKGMNYLHRRNP   71 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~   71 (191)
                      |++++||||+++++++.....      .++++||+++++|.+++....   ....+++..++.++.|++.||+|||+.+ 
T Consensus        55 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~-  133 (273)
T cd05035          55 MKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN-  133 (273)
T ss_pred             HHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence            356889999999998765443      799999999999999884321   1234899999999999999999999999 


Q ss_pred             CeeecCCCCCcEEecCCCcEEEccccccccccccccc--CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-C
Q 029552           72 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-L  148 (191)
Q Consensus        72 ~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g  148 (191)
                       ++|+||+|+||+++.++.++|+|||.+.........  ......+..|++||.+.+..++.++|+||+|+++|+|++ |
T Consensus       134 -i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g  212 (273)
T cd05035         134 -FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRG  212 (273)
T ss_pred             -eeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCC
Confidence             999999999999999999999999988644322111  111223457999999988888999999999999999999 8


Q ss_pred             CCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          149 QQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       149 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..||......+..+.+. .+.....|..++..+.++|.+||+.
T Consensus       213 ~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  254 (273)
T cd05035         213 QTPYPGVENHEIYDYLR-HGNRLKQPEDCLDELYDLMYSCWRA  254 (273)
T ss_pred             CCCCCCCCHHHHHHHHH-cCCCCCCCcCCCHHHHHHHHHHcCC
Confidence            89999888877777664 4456677889999999999999973

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.8e-33  Score=208.38  Aligned_cols=183  Identities=32%  Similarity=0.564  Sum_probs=155.8

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++..++..++|+||+.+++|.+++...    .+++..+..++.|++.++++||+.+  ++|+||+|+
T Consensus        57 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~  130 (277)
T cd06641          57 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK--KIHRDIKAA  130 (277)
T ss_pred             HhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHH
Confidence            5689999999999999999999999999999999998643    2789999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      ||+++.++.++++|||.+..............++..|++||.+.+...+.++|+||+|++++++++|..||....+....
T Consensus       131 Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  210 (277)
T cd06641         131 NVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVL  210 (277)
T ss_pred             hEEECCCCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHH
Confidence            99999999999999998754333221222234567899999998887888999999999999999999999988777666


Q ss_pred             HHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+. ......++..++.++.++|.+||++
T Consensus       211 ~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~  239 (277)
T cd06641         211 FLIP-KNNPPTLEGNYSKPLKEFVEACLNK  239 (277)
T ss_pred             HHHh-cCCCCCCCcccCHHHHHHHHHHccC
Confidence            6653 3445567778999999999999964

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-33  Score=204.78  Aligned_cols=183  Identities=31%  Similarity=0.486  Sum_probs=159.5

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++.++.++..+++||++.+++|.+++....   .+++..+..++.|+++|+.+||+.+  ++|+||+|+
T Consensus        48 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~  122 (250)
T cd05123          48 SRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPE  122 (250)
T ss_pred             HHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcc
Confidence            56789999999999999999999999999999999997643   2889999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      ||+++.++.++|+|||.+..............++..|++||...+...+.++|+||+|++++++++|..||...+..+..
T Consensus       123 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~  202 (250)
T cd05123         123 NILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIY  202 (250)
T ss_pred             eEEEcCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence            99999999999999998875544322233445677899999998887888999999999999999999999988877777


Q ss_pred             HHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+..  ...++|..++..+.++|++||+.
T Consensus       203 ~~~~~--~~~~~~~~~~~~l~~~i~~~l~~  230 (250)
T cd05123         203 EKILK--DPLRFPEFLSPEARDLISGLLQK  230 (250)
T ss_pred             HHHhc--CCCCCCCCCCHHHHHHHHHHhcC
Confidence            76643  56778888999999999999963

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3.4e-33  Score=208.27  Aligned_cols=189  Identities=28%  Similarity=0.519  Sum_probs=157.3

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCc------ccccHHHHHHHHHHHHHHHHHHHhCCCCee
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVR------EMLDERRRLNMAYDVAKGMNYLHRRNPPIV   74 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~   74 (191)
                      |++++||||+++++++.+.+..+++|||+++++|.+++......      ..+++.++..++.|++.||+|||+.+  ++
T Consensus        62 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~  139 (275)
T cd05046          62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FV  139 (275)
T ss_pred             HHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cc
Confidence            46789999999999999989999999999999999999754411      14889999999999999999999999  99


Q ss_pred             ecCCCCCcEEecCCCcEEEcccccccccccc-cccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCC
Q 029552           75 HRDLKSPNLLVDKKYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPW  152 (191)
Q Consensus        75 h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf  152 (191)
                      |+||+|+||+++.++.++++|+|++...... .........+..|++||.+.+...+.++|+||+|++++++++ |..||
T Consensus       140 H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~  219 (275)
T cd05046         140 HRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF  219 (275)
T ss_pred             cCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence            9999999999999999999999987532211 111122233556999999887778889999999999999998 78899


Q ss_pred             CCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          153 GNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...........+.......+.+..++..+.++|.+||+.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~  258 (275)
T cd05046         220 YGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAV  258 (275)
T ss_pred             cccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCC
Confidence            988888888877655555566778999999999999963

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5.1e-33  Score=206.90  Aligned_cols=188  Identities=30%  Similarity=0.571  Sum_probs=152.3

Q ss_pred             CCCCCCCCcccccceeecC------CceEEEEeccCCCCHHHHhcCCC---CcccccHHHHHHHHHHHHHHHHHHHhCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQP------PNLSIVTEYLSRGSLYRLLHKPG---VREMLDERRRLNMAYDVAKGMNYLHRRNP   71 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~   71 (191)
                      |+.++||||+++++++.+.      ...++++||+.+++|.+++....   ....+++..+..++.|++.||+|||+.+ 
T Consensus        54 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-  132 (272)
T cd05075          54 MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS-  132 (272)
T ss_pred             HHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence            3568999999999876422      24789999999999998874211   1234789999999999999999999999 


Q ss_pred             CeeecCCCCCcEEecCCCcEEEcccccccccccccc--cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-C
Q 029552           72 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-L  148 (191)
Q Consensus        72 ~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g  148 (191)
                       ++|+||+|+||+++.++.++|+|||++........  .......+..|++||...+..++.++|+||+|+++|++++ |
T Consensus       133 -i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g  211 (272)
T cd05075         133 -FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRG  211 (272)
T ss_pred             -eeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCC
Confidence             99999999999999999999999999875432211  1122234557999999988888999999999999999999 7


Q ss_pred             CCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          149 QQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       149 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..||...........+. .+..++.+..++..++++|.+||++
T Consensus       212 ~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  253 (272)
T cd05075         212 QTPYPGVENSEIYDYLR-QGNRLKQPPDCLDGLYSLMSSCWLL  253 (272)
T ss_pred             CCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            89998887777777664 4455567788999999999999974

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.2e-33  Score=210.01  Aligned_cols=184  Identities=28%  Similarity=0.474  Sum_probs=147.9

Q ss_pred             CCCCcccccceee------cCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            5 RHPNIVLFMGAVT------QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         5 ~h~~i~~~~~~~~------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      +||||+++++++.      .....+++|||+.+++|.+++.... ...+++..+..++.|++.|+.|||+.+  ++|+|+
T Consensus        71 ~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl  147 (282)
T cd06636          71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK--VIHRDI  147 (282)
T ss_pred             CCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCC
Confidence            6999999999885      2457899999999999999996533 223788889999999999999999999  999999


Q ss_pred             CCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 029552           79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQQPWG  153 (191)
Q Consensus        79 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Dv~slG~~~~~l~~g~~pf~  153 (191)
                      +|+||+++.++.++|+|||.+..............++..|+|||.+.     ...++.++|+||+|+++|+|++|..||.
T Consensus       148 ~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~  227 (282)
T cd06636         148 KGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLC  227 (282)
T ss_pred             CHHHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcc
Confidence            99999999999999999998764432222223345677899999875     3346778999999999999999999998


Q ss_pred             CCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          154 NLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+......+.........+..+|..+.++|++||+.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  265 (282)
T cd06636         228 DMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVK  265 (282)
T ss_pred             ccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCC
Confidence            87766655555433333334457899999999999963

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-35  Score=230.15  Aligned_cols=185  Identities=32%  Similarity=0.504  Sum_probs=161.4

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccc--cHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREML--DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~--~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      ++++|.|||+|++++.+++.+-++||-++||+|.++++. . .+++  .+..+-.+..||++||.|||.+.  |+|||||
T Consensus       627 ~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrs-k-WGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIK  702 (1226)
T KOG4279|consen  627 STLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRS-K-WGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIK  702 (1226)
T ss_pred             HHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHh-c-cCCCccchhHHHHHHHHHHHHhhhhhhcc--eeecccc
Confidence            467999999999999999999999999999999999964 1 2235  67788889999999999999999  9999999


Q ss_pred             CCcEEec-CCCcEEEcccccccccccccccCCCCCCCCcccCccccccC--CCCCcchHHHHHHHHHHHHhCCCCCCC-C
Q 029552           80 SPNLLVD-KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE--PSNEKSDIYSFGVILWELATLQQPWGN-L  155 (191)
Q Consensus        80 p~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~pf~~-~  155 (191)
                      -+|++++ -.|.+||+|||-+++-..-..-....-++..|||||++..+  .|+.++|||||||++.+|.||++||-. .
T Consensus       703 GDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg  782 (1226)
T KOG4279|consen  703 GDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG  782 (1226)
T ss_pred             CCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC
Confidence            9999996 57899999999887655554556667789999999999765  478899999999999999999999976 6


Q ss_pred             CHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhc
Q 029552          156 NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~  190 (191)
                      ++.+..-++..-...+++|..+|...+.+|.+|+.
T Consensus       783 spqAAMFkVGmyKvHP~iPeelsaeak~FilrcFe  817 (1226)
T KOG4279|consen  783 SPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFE  817 (1226)
T ss_pred             ChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcC
Confidence            77777777766667889999999999999999985

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.4e-33  Score=206.76  Aligned_cols=184  Identities=34%  Similarity=0.554  Sum_probs=156.0

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCeeecCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKS   80 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~~h~~l~p   80 (191)
                      ++++|+||+++++++..++..++++||+++++|.+++....   .+++..+..++.|+++++++||+ .+  ++|+||+|
T Consensus        54 ~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~  128 (264)
T cd06623          54 RSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVG---KIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKP  128 (264)
T ss_pred             HhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCH
Confidence            46789999999999999999999999999999999997643   38999999999999999999999 99  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC---CH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL---NP  157 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~---~~  157 (191)
                      +||+++.++.++|+|||.+..............+...|+|||.+.+...+.++|+||||+++|++++|..||...   ..
T Consensus       129 ~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~  208 (264)
T cd06623         129 SNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF  208 (264)
T ss_pred             HHEEECCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCH
Confidence            999999999999999998765443322222334567899999998888889999999999999999999999876   44


Q ss_pred             HHHHHHHHhcCcccCCCCC-CCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIPRN-VNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~cl~~  191 (191)
                      .+....+. .......+.. +|..+.++|.+||++
T Consensus       209 ~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~  242 (264)
T cd06623         209 FELMQAIC-DGPPPSLPAEEFSPEFRDFISACLQK  242 (264)
T ss_pred             HHHHHHHh-cCCCCCCCcccCCHHHHHHHHHHccC
Confidence            55555554 4445566677 999999999999964

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=5.4e-33  Score=208.58  Aligned_cols=187  Identities=33%  Similarity=0.577  Sum_probs=154.5

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC-------------------cccccHHHHHHHHHHHHHH
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------------------REMLDERRRLNMAYDVAKG   62 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------------~~~~~~~~~~~~~~~i~~~   62 (191)
                      ++++||||+++++++.+++..++++||+.+++|.+++.....                   ...+++.+++.++.|++.|
T Consensus        63 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~a  142 (288)
T cd05050          63 AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAG  142 (288)
T ss_pred             HhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHH
Confidence            567999999999999999999999999999999999964211                   1236788899999999999


Q ss_pred             HHHHHhCCCCeeecCCCCCcEEecCCCcEEEcccccccccccc--cccCCCCCCCCcccCccccccCCCCCcchHHHHHH
Q 029552           63 MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGV  140 (191)
Q Consensus        63 l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~  140 (191)
                      |++||+.+  ++|+||+|+||+++.++.++++|||.+......  ............|+|||.+.+..++.++|+||+|+
T Consensus       143 L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~  220 (288)
T cd05050         143 MAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGV  220 (288)
T ss_pred             HHHHHhCC--eecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHH
Confidence            99999999  999999999999999999999999987643211  11112223345799999998888899999999999


Q ss_pred             HHHHHHh-CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          141 ILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       141 ~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ++|+|++ |..||...+..+....+. .+...+.|..++..+.++|.+||+.
T Consensus       221 il~el~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~  271 (288)
T cd05050         221 VLWEIFSYGMQPYYGMAHEEVIYYVR-DGNVLSCPDNCPLELYNLMRLCWSK  271 (288)
T ss_pred             HHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHccc
Confidence            9999998 788998888887777664 3445566788999999999999963

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4.4e-33  Score=206.85  Aligned_cols=184  Identities=31%  Similarity=0.569  Sum_probs=152.3

Q ss_pred             CCCCCCCCcccccceeec--CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            1 MKRLRHPNIVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      |++++||||+++++++.+  +...++++||+++++|.+++...+   .+++..++.++.|++.||++||+.+  ++|+||
T Consensus        58 l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l  132 (266)
T cd06651          58 LKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM--IVHRDI  132 (266)
T ss_pred             HHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCC
Confidence            356899999999998875  357889999999999999997644   2788999999999999999999999  999999


Q ss_pred             CCCcEEecCCCcEEEccccccccccccc---ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           79 KSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        79 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      +|+||+++.++.++|+|||++.......   .......++..|+|||.+.+...+.++|+||+|+++|++++|..||...
T Consensus       133 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~  212 (266)
T cd06651         133 KGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY  212 (266)
T ss_pred             CHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence            9999999999999999999876432211   1112234567899999998888889999999999999999999999987


Q ss_pred             CHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhc
Q 029552          156 NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~  190 (191)
                      ...............+.+|..+++.++++| +||.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~  246 (266)
T cd06651         213 EAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIF  246 (266)
T ss_pred             chHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhc
Confidence            776666665544456677888999999999 5664

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.5e-33  Score=206.33  Aligned_cols=180  Identities=22%  Similarity=0.386  Sum_probs=145.5

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++||||+++++++.++...++||||+++++|..++.+..  +.+++.++..++.|+++||+|||+.+  ++|+||+|
T Consensus        70 ~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp  145 (274)
T cd05076          70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCA  145 (274)
T ss_pred             HhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCc
Confidence            357899999999999999999999999999999999986533  23789999999999999999999999  99999999


Q ss_pred             CcEEecCCC-------cEEEcccccccccccccccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHH-hCCCC
Q 029552           81 PNLLVDKKY-------TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELA-TLQQP  151 (191)
Q Consensus        81 ~ni~~~~~~-------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~-~g~~p  151 (191)
                      +||+++..+       .++++|||.+......    ....++..|+|||.+.+ ..++.++|+||+|+++|+++ +|..|
T Consensus       146 ~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p  221 (274)
T cd05076         146 KNILLARLGLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP  221 (274)
T ss_pred             ccEEEeccCcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            999997643       3799999976533221    12345667999998865 45788999999999999984 68999


Q ss_pred             CCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          152 WGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       152 f~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      |....+.+......   .....|...++.+.++|.+||++
T Consensus       222 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~  258 (274)
T cd05076         222 LKERTPSEKERFYE---KKHRLPEPSCKELATLISQCLTY  258 (274)
T ss_pred             ccccChHHHHHHHH---hccCCCCCCChHHHHHHHHHccc
Confidence            98876665544332   23345666788999999999974

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=221.23  Aligned_cols=181  Identities=25%  Similarity=0.451  Sum_probs=167.0

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      .+.++|+||+++..|.+.+..|++||-|-||.|..+++..++   |++.....++.-+++|++|||+.|  |++|||||+
T Consensus       475 ~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPE  549 (732)
T KOG0614|consen  475 MECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPE  549 (732)
T ss_pred             HhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhcC--ceeccCChh
Confidence            456899999999999999999999999999999999998664   999999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      |.+++.+|-+||.|||+++...... ..-..++++.|.|||++.....+.++|.|+||+++|++++|.+||...++....
T Consensus       550 NllLd~~Gy~KLVDFGFAKki~~g~-KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY  628 (732)
T KOG0614|consen  550 NLLLDNRGYLKLVDFGFAKKIGSGR-KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY  628 (732)
T ss_pred             heeeccCCceEEeehhhHHHhccCC-ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH
Confidence            9999999999999999998766542 334578999999999999888899999999999999999999999999999999


Q ss_pred             HHHHhcCcccCCCCCCCHHHHHHHHHH
Q 029552          162 AAVGFKGKRLEIPRNVNPHVASIIEAC  188 (191)
Q Consensus       162 ~~~~~~~~~~~~~~~~s~~~~~li~~c  188 (191)
                      +.|..+-....+|..++....++|++.
T Consensus       629 n~ILkGid~i~~Pr~I~k~a~~Lik~L  655 (732)
T KOG0614|consen  629 NLILKGIDKIEFPRRITKTATDLIKKL  655 (732)
T ss_pred             HHHHhhhhhhhcccccchhHHHHHHHH
Confidence            999877778899999999999999864

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5.7e-33  Score=207.97  Aligned_cols=186  Identities=24%  Similarity=0.407  Sum_probs=148.7

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++||||+++++++..+...++|+||+++++|..+.....   .+++.++..++.|++.+|+|||+.+  ++|+||+|
T Consensus        54 l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p  128 (286)
T cd07847          54 LKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKP  128 (286)
T ss_pred             HHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCh
Confidence            356899999999999999999999999999988888775533   2899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      +||+++.++.++|+|||.+..............+...|++||.+.+ ..++.++|+||+|+++++|++|..||...+..+
T Consensus       129 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~  208 (286)
T cd07847         129 ENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD  208 (286)
T ss_pred             hhEEEcCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence            9999999999999999988754433222223345678999999876 346789999999999999999999998876655


Q ss_pred             HHHHHHhcCc-------------------ccCC----------CCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGK-------------------RLEI----------PRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~-------------------~~~~----------~~~~s~~~~~li~~cl~~  191 (191)
                      ....+.....                   ..+.          -+++|..+.++|.+||++
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  269 (286)
T cd07847         209 QLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQM  269 (286)
T ss_pred             HHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcC
Confidence            5444321100                   0011          135789999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=6e-33  Score=206.25  Aligned_cols=189  Identities=31%  Similarity=0.470  Sum_probs=150.2

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++|+||+++++++.+++..++++||+.+++|.+++.........++..+..++.|++.|++|||+.+  ++|+||+|
T Consensus        59 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p  136 (268)
T cd06624          59 HSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKG  136 (268)
T ss_pred             HHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCH
Confidence            3568999999999999999999999999999999999975321111278888999999999999999999  99999999


Q ss_pred             CcEEecC-CCcEEEcccccccccccccccCCCCCCCCcccCccccccCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           81 PNLLVDK-KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP--SNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      +||+++. .+.++|+|||.+..............++..|+|||.+.+..  ++.++|+||+|++++++++|..||.....
T Consensus       137 ~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~  216 (268)
T cd06624         137 DNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE  216 (268)
T ss_pred             HHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC
Confidence            9999976 67899999998764433222233344677899999986543  67889999999999999999999976443


Q ss_pred             H-HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 A-QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~-~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      . ............+.+|..+++.+++++.+||+.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  251 (268)
T cd06624         217 PQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEP  251 (268)
T ss_pred             hhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCC
Confidence            2 223233223345567888999999999999963

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.7e-33  Score=209.78  Aligned_cols=186  Identities=24%  Similarity=0.381  Sum_probs=147.6

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++|+||+. ++|.+++.....  .+++..+..++.|+++||++||+.+  ++|+||+|
T Consensus        58 l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp  132 (301)
T cd07873          58 LKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKP  132 (301)
T ss_pred             HHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCH
Confidence            357899999999999999999999999997 589888865432  3789999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      +||+++.++.++|+|||.+...............+..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+..+
T Consensus       133 ~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~  212 (301)
T cd07873         133 QNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE  212 (301)
T ss_pred             HHEEECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999999999999999886543322222233457789999988654 46788999999999999999999998877655


Q ss_pred             HHHHHHhcCc-----------------ccC-----------CCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGK-----------------RLE-----------IPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~-----------------~~~-----------~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+.....                 ...           ....+++.++++|.+||+.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~  272 (301)
T cd07873         213 QLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQF  272 (301)
T ss_pred             HHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcC
Confidence            4443321100                 001           1135789999999999963

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=8.4e-33  Score=206.71  Aligned_cols=188  Identities=30%  Similarity=0.528  Sum_probs=154.2

Q ss_pred             CCCCCCCCcccccceeec-CCceEEEEeccCCCCHHHHhcCCCCc-----ccccHHHHHHHHHHHHHHHHHHHhCCCCee
Q 029552            1 MKRLRHPNIVLFMGAVTQ-PPNLSIVTEYLSRGSLYRLLHKPGVR-----EMLDERRRLNMAYDVAKGMNYLHRRNPPIV   74 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~   74 (191)
                      |++++||||+++++++.+ +...+++++|+.+++|.+++......     ..+++.+++.++.|++.||+|||+.+  ++
T Consensus        62 l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~  139 (280)
T cd05043          62 LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VI  139 (280)
T ss_pred             HHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--Ee
Confidence            356799999999998765 56899999999999999998653321     34889999999999999999999999  99


Q ss_pred             ecCCCCCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCC
Q 029552           75 HRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQP  151 (191)
Q Consensus        75 h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p  151 (191)
                      |+||+|+||+++.++.++++|||++.......  .......+...|+|||.+.+..++.++|+||+|+++|++++ |..|
T Consensus       140 H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p  219 (280)
T cd05043         140 HKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP  219 (280)
T ss_pred             ecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCC
Confidence            99999999999999999999999986432111  11112233457999999988888999999999999999999 9999


Q ss_pred             CCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          152 WGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       152 f~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      |...++.+....+. .+..++.+..+++.+++++.+||..
T Consensus       220 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  258 (280)
T cd05043         220 YVEIDPFEMAAYLK-DGYRLAQPINCPDELFAVMACCWAL  258 (280)
T ss_pred             cCcCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcCC
Confidence            99888877776664 3445566778899999999999963

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=7e-33  Score=207.20  Aligned_cols=179  Identities=31%  Similarity=0.485  Sum_probs=144.9

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++..++..++++||+++++|..+..       +++..+..++.|++.|++|||+.+  ++|+||+|
T Consensus        53 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp  123 (279)
T cd06619          53 LYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRK-------IPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKP  123 (279)
T ss_pred             HHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhhc-------CCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCH
Confidence            356899999999999999999999999999999965531       678889999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH---
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP---  157 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~---  157 (191)
                      +||+++.++.++|+|||++......  ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.....   
T Consensus       124 ~Nill~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~  201 (279)
T cd06619         124 SNMLVNTRGQVKLCDFGVSTQLVNS--IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQG  201 (279)
T ss_pred             HHEEECCCCCEEEeeCCcceecccc--cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccc
Confidence            9999999999999999988644322  22234567789999999888889999999999999999999999965322   


Q ss_pred             ----HHHHHHHHhcCcccCC-CCCCCHHHHHHHHHHhcC
Q 029552          158 ----AQVVAAVGFKGKRLEI-PRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ----~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~cl~~  191 (191)
                          ......+. ....... ...+++.++++|.+||++
T Consensus       202 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~  239 (279)
T cd06619         202 SLMPLQLLQCIV-DEDPPVLPVGQFSEKFVHFITQCMRK  239 (279)
T ss_pred             ccchHHHHHHHh-ccCCCCCCCCcCCHHHHHHHHHHhhC
Confidence                12222221 1222222 345889999999999964

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.7e-33  Score=210.12  Aligned_cols=185  Identities=29%  Similarity=0.528  Sum_probs=151.9

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++||||+++++++..++..|+|+||+++++|.+++.+..    +++.++..++.|++.|+.+||+++  ++|+|++|
T Consensus        70 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p  143 (293)
T cd06647          70 MRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKS  143 (293)
T ss_pred             HhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCH
Confidence            356799999999999999999999999999999999987533    788899999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.++.++|+|||.+..............+...|++||.+.+...+.++|+||+|+++|++++|..||...+....
T Consensus       144 ~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~  223 (293)
T cd06647         144 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA  223 (293)
T ss_pred             HHEEEcCCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh
Confidence            99999999999999999775433222222223456679999998887788899999999999999999999988766554


Q ss_pred             HHHHHhcC-cccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKG-KRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~-~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+...+ .....+..++..++++|++||++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  255 (293)
T cd06647         224 LYLIATNGTPELQNPEKLSAIFRDFLNRCLEM  255 (293)
T ss_pred             eeehhcCCCCCCCCccccCHHHHHHHHHHccC
Confidence            44332222 22334556889999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=7.5e-33  Score=212.27  Aligned_cols=188  Identities=31%  Similarity=0.575  Sum_probs=150.8

Q ss_pred             CCC-CCCCcccccceeec-CCceEEEEeccCCCCHHHHhcCCCC------------------------------------
Q 029552            2 KRL-RHPNIVLFMGAVTQ-PPNLSIVTEYLSRGSLYRLLHKPGV------------------------------------   43 (191)
Q Consensus         2 ~~l-~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~------------------------------------   43 (191)
                      +++ +|+||+++++++.. +...++++||+.+++|.+++.....                                    
T Consensus        65 ~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (337)
T cd05054          65 IHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSAS  144 (337)
T ss_pred             HhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccc
Confidence            345 79999999998864 4578899999999999999853211                                    


Q ss_pred             ----------------------cccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecCCCcEEEcccccccc
Q 029552           44 ----------------------REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL  101 (191)
Q Consensus        44 ----------------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~  101 (191)
                                            ...+++..+..++.|++.||+|||+.+  ++||||+|+||+++.++.++|+|||++..
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~  222 (337)
T cd05054         145 SGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARD  222 (337)
T ss_pred             cccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchh
Confidence                                  114788899999999999999999999  99999999999999999999999998865


Q ss_pred             ccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCcccCCCCCCC
Q 029552          102 KANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVN  178 (191)
Q Consensus       102 ~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s  178 (191)
                      .....  .......++..|+|||.+.+..++.++|+||+||++++|++ |..||......+........+.....|..++
T Consensus       223 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (337)
T cd05054         223 IYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYAT  302 (337)
T ss_pred             cccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCC
Confidence            32211  11222334567999999988889999999999999999998 9999987555444444444555666778899


Q ss_pred             HHHHHHHHHHhcC
Q 029552          179 PHVASIIEACWAK  191 (191)
Q Consensus       179 ~~~~~li~~cl~~  191 (191)
                      +++.+++.+||++
T Consensus       303 ~~~~~l~~~cl~~  315 (337)
T cd05054         303 PEIYSIMLDCWHN  315 (337)
T ss_pred             HHHHHHHHHHccC
Confidence            9999999999974

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.5e-33  Score=220.75  Aligned_cols=187  Identities=22%  Similarity=0.312  Sum_probs=143.0

Q ss_pred             CCCCCCCCcccccceeecC--------CceEEEEeccCCCCHHHHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQP--------PNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDVAKGMNYLHRRNP   71 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~   71 (191)
                      |++++||||+++++++...        ...++||||+.+ +|.+++... .....+++..++.++.|++.||+|||+.+ 
T Consensus       113 l~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~-  190 (440)
T PTZ00036        113 MKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF-  190 (440)
T ss_pred             HHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence            4578999999998876421        246799999975 777666421 11234899999999999999999999999 


Q ss_pred             CeeecCCCCCcEEecCCC-cEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCC
Q 029552           72 PIVHRDLKSPNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQ  149 (191)
Q Consensus        72 ~~~h~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~  149 (191)
                       ++||||||+||+++.++ .++|+|||++....... ......+++.|+|||.+.+. .++.++|+||+||++|+|++|.
T Consensus       191 -IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~  268 (440)
T PTZ00036        191 -ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGY  268 (440)
T ss_pred             -EecCCcCHHHEEEcCCCCceeeeccccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence             99999999999998665 69999999987543221 12234567889999988664 5788999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHHhcCc---------------------------ccCCCCCCCHHHHHHHHHHhcC
Q 029552          150 QPWGNLNPAQVVAAVGFKGK---------------------------RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       150 ~pf~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .||...+..+....+.....                           ...+|...|++++++|.+||++
T Consensus       269 ~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~  337 (440)
T PTZ00036        269 PIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKY  337 (440)
T ss_pred             CCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCC
Confidence            99998776655544432110                           1123556789999999999974

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=202.89  Aligned_cols=189  Identities=19%  Similarity=0.356  Sum_probs=147.5

Q ss_pred             CCCCCCCcccccceeecCC-----ceEEEEeccCCCCHHHHhcCCCCcc-cccHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 029552            2 KRLRHPNIVLFMGAVTQPP-----NLSIVTEYLSRGSLYRLLHKPGVRE-MLDERRRLNMAYDVAKGMNYLHRRNPPIVH   75 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h   75 (191)
                      ++++|||+.+++++...+.     ..|++++|...|||.+.++..+..+ .+++.+++.|+.++++||++||....+++|
T Consensus        73 rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH  152 (302)
T KOG2345|consen   73 RKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAH  152 (302)
T ss_pred             HhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccc
Confidence            4789999999999885433     4999999999999999998655444 699999999999999999999999888999


Q ss_pred             cCCCCCcEEecCCCcEEEccccccccccccc---------ccCCCCCCCCcccCccccc---cCCCCCcchHHHHHHHHH
Q 029552           76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTF---------LSSKSAAGTPEWMAPEVLR---DEPSNEKSDIYSFGVILW  143 (191)
Q Consensus        76 ~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~---------~~~~~~~~~~~~~~pe~~~---~~~~~~~~Dv~slG~~~~  143 (191)
                      +||||.||+++..+.+.+.|||.+.......         ........+..|.|||.+.   +...++++|||||||++|
T Consensus       153 ~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLY  232 (302)
T KOG2345|consen  153 RDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLY  232 (302)
T ss_pred             cCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHH
Confidence            9999999999999999999999876432111         1112235688999999885   455789999999999999


Q ss_pred             HHHhCCCCCCCCCH--HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhc
Q 029552          144 ELATLQQPWGNLNP--AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       144 ~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~  190 (191)
                      +|+.|.-||+..-.  ..+.-.+.......+..+.+|+.+.++|++||+
T Consensus       233 a~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlq  281 (302)
T KOG2345|consen  233 AMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQ  281 (302)
T ss_pred             HHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhc
Confidence            99999999975211  011111111222333345699999999999996

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.4e-33  Score=206.31  Aligned_cols=186  Identities=30%  Similarity=0.554  Sum_probs=151.7

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++|+||+.+++|.+++.+.+   .+++..+..++.|++.||++||+.|  ++|+||+|
T Consensus        57 l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~  131 (268)
T cd06630          57 MARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKG  131 (268)
T ss_pred             HHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence            356899999999999999999999999999999999997643   3789999999999999999999999  99999999


Q ss_pred             CcEEecCCC-cEEEcccccccccccccc----cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           81 PNLLVDKKY-TVKVCDFGLSRLKANTFL----SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        81 ~ni~~~~~~-~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      +||+++.++ .++|+|||.+........    ......++..|+|||.+.+..++.++|+||+|++++++++|..||...
T Consensus       132 ~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  211 (268)
T cd06630         132 ANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE  211 (268)
T ss_pred             HHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence            999998775 599999998765432211    112234567899999998888889999999999999999999999754


Q ss_pred             CH---HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          156 NP---AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~---~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..   ......+.........|..+++.+.+++.+||+.
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  250 (268)
T cd06630         212 KHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLEL  250 (268)
T ss_pred             CCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCC
Confidence            33   2222233223445667788999999999999963

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.6e-33  Score=204.24  Aligned_cols=180  Identities=23%  Similarity=0.407  Sum_probs=147.7

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++..++..++||||+.+++|.+++...+.  .+++..+..++.|++.||+|||+.+  ++|+||+|
T Consensus        53 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp  128 (258)
T cd05078          53 MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG--LTHGNVCA  128 (258)
T ss_pred             HHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCcc
Confidence            3568999999999999998899999999999999999976442  3789999999999999999999999  99999999


Q ss_pred             CcEEecCCCc--------EEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhC-CC
Q 029552           81 PNLLVDKKYT--------VKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATL-QQ  150 (191)
Q Consensus        81 ~ni~~~~~~~--------~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g-~~  150 (191)
                      +||+++.++.        ++++|||.+......    ....++..|+|||.+.+. .++.++|+||+|+++|++++| ..
T Consensus       129 ~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~  204 (258)
T cd05078         129 KNVLLIREEDRKTGNPPFIKLSDPGISITVLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDK  204 (258)
T ss_pred             ceEEEecccccccCCCceEEecccccccccCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCC
Confidence            9999987664        689999987543322    223456689999998764 468899999999999999999 56


Q ss_pred             CCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          151 PWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       151 pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ||...++.......   .....+|...+..+.++|.+||++
T Consensus       205 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~  242 (258)
T cd05078         205 PLSALDSQKKLQFY---EDRHQLPAPKWTELANLINQCMDY  242 (258)
T ss_pred             ChhhccHHHHHHHH---HccccCCCCCcHHHHHHHHHHhcc
Confidence            77766665544433   234567778889999999999974

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.5e-34  Score=207.95  Aligned_cols=161  Identities=27%  Similarity=0.362  Sum_probs=142.4

Q ss_pred             CCCCCCCCcccccceee--cCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            1 MKRLRHPNIVLFMGAVT--QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      |.+++|||||.+.++..  +-+.+|+|||||++ +|..++.+.+.  .|...++.-++.|+++|++|||+++  |+|||+
T Consensus       129 Ll~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q--~F~~~evK~L~~QlL~glk~lH~~w--ilHRDL  203 (419)
T KOG0663|consen  129 LLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMKQ--PFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDL  203 (419)
T ss_pred             HHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHhhce--eEeccc
Confidence            35678999999999886  34579999999987 99999987763  3889999999999999999999999  999999


Q ss_pred             CCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        79 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      ||+|++++..|.+|++|||++...+.........+.+.+|.|||.+.+.. |+.+.|+||+||++.+++++.+-|.+...
T Consensus       204 K~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE  283 (419)
T KOG0663|consen  204 KTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE  283 (419)
T ss_pred             chhheeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch
Confidence            99999999999999999999988777755556667789999999988775 89999999999999999999999998888


Q ss_pred             HHHHHHHHh
Q 029552          158 AQVVAAVGF  166 (191)
Q Consensus       158 ~~~~~~~~~  166 (191)
                      ...+++|-.
T Consensus       284 ~dQl~~If~  292 (419)
T KOG0663|consen  284 IDQLDKIFK  292 (419)
T ss_pred             HHHHHHHHH
Confidence            777777654

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1e-32  Score=204.36  Aligned_cols=185  Identities=32%  Similarity=0.560  Sum_probs=150.7

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++|+||+++++++.+.+..++|+||+++++|.+++....   .+++..+..++.|+++|+++||+.+  ++|+||+|+
T Consensus        54 ~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~  128 (264)
T cd06626          54 ELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPA  128 (264)
T ss_pred             HhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHH
Confidence            56899999999999999999999999999999999997643   2788999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccC----CCCCCCCcccCccccccCC---CCCcchHHHHHHHHHHHHhCCCCCCC
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSS----KSAAGTPEWMAPEVLRDEP---SNEKSDIYSFGVILWELATLQQPWGN  154 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~----~~~~~~~~~~~pe~~~~~~---~~~~~Dv~slG~~~~~l~~g~~pf~~  154 (191)
                      ||+++.++.++|+|||.+..........    ....+...|++||.+.+..   .+.++|+||+|++++++++|..||..
T Consensus       129 nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~  208 (264)
T cd06626         129 NIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSE  208 (264)
T ss_pred             HEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccC
Confidence            9999999999999999876543332211    1234567899999988765   78899999999999999999999986


Q ss_pred             CCHHHHHHHHHhcCcccCCCCC--CCHHHHHHHHHHhcC
Q 029552          155 LNPAQVVAAVGFKGKRLEIPRN--VNPHVASIIEACWAK  191 (191)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~--~s~~~~~li~~cl~~  191 (191)
                      ...................|..  +++.+.++|.+||++
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  247 (264)
T cd06626         209 LDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLES  247 (264)
T ss_pred             CcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccC
Confidence            5433333322223444555554  499999999999964

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.2e-32  Score=203.14  Aligned_cols=186  Identities=39%  Similarity=0.669  Sum_probs=157.2

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++|+||+++++++.+.+..+++||++.+++|.+++..... ..+++.++..++.|++.||++||+.+  ++|+||+|+
T Consensus        56 ~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~  132 (258)
T smart00219       56 RKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN--FIHRDLAAR  132 (258)
T ss_pred             HhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccc
Confidence            567999999999999999999999999999999999975332 11789999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCC-CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSK-SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ  159 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~~  159 (191)
                      ||+++.++.++|+|||.+........... ....+..|++||.+.+..++.++|+||+|+++++|++ |..||...+...
T Consensus       133 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~  212 (258)
T smart00219      133 NCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE  212 (258)
T ss_pred             eEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999998865543311111 1224568999999987778999999999999999998 788999888877


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+. .......+..++..+.+++.+||+.
T Consensus       213 ~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~  243 (258)
T smart00219      213 VLEYLK-KGYRLPKPENCPPEIYKLMLQCWAE  243 (258)
T ss_pred             HHHHHh-cCCCCCCCCcCCHHHHHHHHHHCcC
Confidence            777775 3445667788999999999999974

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-35  Score=212.72  Aligned_cols=186  Identities=28%  Similarity=0.519  Sum_probs=162.7

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +|++++|++|+|++++..+...|+|||||.-|+..++++.+  ++.+.++++..++...+++|+|||...  -+|||||.
T Consensus        82 MQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKA  157 (502)
T KOG0574|consen   82 MQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKA  157 (502)
T ss_pred             HHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhccc
Confidence            46889999999999999999999999999999999999753  345999999999999999999999998  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      .||+++.+|..||.|||.+-..++....-....+++.|+|||++..-.|+.++|+||||++..+|..|++||.+..+...
T Consensus       158 GNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA  237 (502)
T KOG0574|consen  158 GNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA  237 (502)
T ss_pred             ccEEEcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce
Confidence            99999999999999999987666554444566789999999999999999999999999999999999999999998776


Q ss_pred             HHHHHhcCcccC--CCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLE--IPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~--~~~~~s~~~~~li~~cl~~  191 (191)
                      +.-|- ...++.  -|..-|.++-++|++||-|
T Consensus       238 IFMIP-T~PPPTF~KPE~WS~~F~DFi~~CLiK  269 (502)
T KOG0574|consen  238 IFMIP-TKPPPTFKKPEEWSSEFNDFIRSCLIK  269 (502)
T ss_pred             eEecc-CCCCCCCCChHhhhhHHHHHHHHHhcC
Confidence            66663 223332  3566899999999999965

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=6.1e-33  Score=205.29  Aligned_cols=188  Identities=30%  Similarity=0.521  Sum_probs=157.2

Q ss_pred             CCCCCCCCcccccceee--cCCceEEEEeccCCCCHHHHhcCCC-CcccccHHHHHHHHHHHHHHHHHHH-----hCCCC
Q 029552            1 MKRLRHPNIVLFMGAVT--QPPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLH-----RRNPP   72 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~Lh-----~~~~~   72 (191)
                      |++++||||+++++++.  .+...++++||+++++|.+++.... ....+++.+++.++.|+++||++||     +.+  
T Consensus        53 l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--  130 (265)
T cd08217          53 LRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--  130 (265)
T ss_pred             HHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--
Confidence            35789999999999775  3456899999999999999986431 1234889999999999999999999     888  


Q ss_pred             eeecCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW  152 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf  152 (191)
                      ++|+||+|+||+++.++.++++|||.+..............+...|++||.+.+...+.++|+||+|+++++|++|..||
T Consensus       131 i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~  210 (265)
T cd08217         131 VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF  210 (265)
T ss_pred             ceecCCCHHHEEEecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcc
Confidence            99999999999999999999999998875544332233345678899999998888889999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          153 GNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+.......+. .+....+|..++..+.+++.+||++
T Consensus       211 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~l~~  248 (265)
T cd08217         211 TARNQLQLASKIK-EGKFRRIPYRYSSELNEVIKSMLNV  248 (265)
T ss_pred             cCcCHHHHHHHHh-cCCCCCCccccCHHHHHHHHHHccC
Confidence            9888776666664 4445567889999999999999963

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.3e-32  Score=203.76  Aligned_cols=186  Identities=30%  Similarity=0.579  Sum_probs=154.0

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++|+||+++.+++.+ ...++++||+++++|.+++.+.. ...++..++..++.|++.||++||+.+  ++|+||+|
T Consensus        55 l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p  130 (260)
T cd05073          55 MKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRA  130 (260)
T ss_pred             HHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCc
Confidence            357899999999999887 77899999999999999997643 223788889999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA  158 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~  158 (191)
                      +||+++.++.++|+|||.+....... ...........|+|||.+.+..++.++|+||+|++++++++ |..||...+..
T Consensus       131 ~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~  210 (260)
T cd05073         131 ANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP  210 (260)
T ss_pred             ceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH
Confidence            99999999999999999876433221 11112223456999999988888889999999999999998 89999988777


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .....+. .+...+.+...+..+.+++.+||++
T Consensus       211 ~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~  242 (260)
T cd05073         211 EVIRALE-RGYRMPRPENCPEELYNIMMRCWKN  242 (260)
T ss_pred             HHHHHHh-CCCCCCCcccCCHHHHHHHHHHccc
Confidence            7776664 3345566778999999999999964

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=7e-33  Score=211.63  Aligned_cols=155  Identities=27%  Similarity=0.410  Sum_probs=127.2

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++||||++++++|.+++..++|+||+++++|.+++..... ..+++..+..++.|++.||+|||+.+  ++|+||+|+
T Consensus        54 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~  130 (327)
T cd08227          54 KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKAS  130 (327)
T ss_pred             HhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChh
Confidence            567999999999999999999999999999999999965321 23789999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccc-------cccCCCCCCCCcccCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCC
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANT-------FLSSKSAAGTPEWMAPEVLRD--EPSNEKSDIYSFGVILWELATLQQPW  152 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~-------~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~pf  152 (191)
                      ||+++.++.+++.||+........       ........++..|+|||.+.+  ..++.++|+||+|+++++|++|..||
T Consensus       131 Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf  210 (327)
T cd08227         131 HILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF  210 (327)
T ss_pred             hEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            999999999999998754321110       001112234567999999875  35788999999999999999999999


Q ss_pred             CCCCHHH
Q 029552          153 GNLNPAQ  159 (191)
Q Consensus       153 ~~~~~~~  159 (191)
                      .......
T Consensus       211 ~~~~~~~  217 (327)
T cd08227         211 KDMPATQ  217 (327)
T ss_pred             CCcchhH
Confidence            8755444

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-32  Score=204.26  Aligned_cols=179  Identities=21%  Similarity=0.409  Sum_probs=143.4

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.++...++++||+++++|..++....  ..+++.+++.++.|+++|++|||+.+  ++|+||+|+
T Consensus        59 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~  134 (262)
T cd05077          59 RQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTK  134 (262)
T ss_pred             HhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcc
Confidence            56899999999999999889999999999999998886533  23889999999999999999999999  999999999


Q ss_pred             cEEecCCCc-------EEEcccccccccccccccCCCCCCCCcccCccccc-cCCCCCcchHHHHHHHHHHHH-hCCCCC
Q 029552           82 NLLVDKKYT-------VKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR-DEPSNEKSDIYSFGVILWELA-TLQQPW  152 (191)
Q Consensus        82 ni~~~~~~~-------~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Dv~slG~~~~~l~-~g~~pf  152 (191)
                      ||+++.++.       ++++|||.+......    ....++..|+|||.+. +..++.++|+||+|+++|+|+ +|..||
T Consensus       135 Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~  210 (262)
T cd05077         135 NILLAREGIDGECGPFIKLSDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL  210 (262)
T ss_pred             cEEEecCCccCCCCceeEeCCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence            999987654       899999987543222    1234567899999886 456788999999999999997 588888


Q ss_pred             CCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          153 GNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ......+.....   ..........+++++++|.+||+.
T Consensus       211 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~  246 (262)
T cd05077         211 KDKTLAEKERFY---EGQCMLVTPSCKELADLMTHCMNY  246 (262)
T ss_pred             CCcchhHHHHHH---hcCccCCCCChHHHHHHHHHHcCC
Confidence            876654443322   122333445678999999999974

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.1e-32  Score=215.20  Aligned_cols=188  Identities=34%  Similarity=0.564  Sum_probs=153.4

Q ss_pred             CCCC-CCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC-------------------------------------
Q 029552            2 KRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------------------------------------   43 (191)
Q Consensus         2 ~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------------------------------   43 (191)
                      +++. ||||+++++++..++..++|+||+.+|+|.+++.+...                                     
T Consensus        95 ~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (401)
T cd05107          95 SHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSES  174 (401)
T ss_pred             HhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhcc
Confidence            4566 99999999999999999999999999999999864321                                     


Q ss_pred             ----------------------------------------------------------cccccHHHHHHHHHHHHHHHHH
Q 029552           44 ----------------------------------------------------------REMLDERRRLNMAYDVAKGMNY   65 (191)
Q Consensus        44 ----------------------------------------------------------~~~~~~~~~~~~~~~i~~~l~~   65 (191)
                                                                                ...++..+++.++.|++.||+|
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~  254 (401)
T cd05107         175 DGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEF  254 (401)
T ss_pred             CccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHH
Confidence                                                                      1135667788899999999999


Q ss_pred             HHhCCCCeeecCCCCCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHH
Q 029552           66 LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILW  143 (191)
Q Consensus        66 Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~  143 (191)
                      ||+.+  ++|+||+|+||+++.++.++|+|||++.......  .......++..|++||.+.+..++.++|+||+|++++
T Consensus       255 LH~~~--ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~  332 (401)
T cd05107         255 LASKN--CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLW  332 (401)
T ss_pred             HhcCC--cCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHH
Confidence            99999  9999999999999999999999999986432211  1112233456799999998888889999999999999


Q ss_pred             HHHh-CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          144 ELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       144 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +|++ |..||......+........+.+++.|..++..+.+++.+||++
T Consensus       333 e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~  381 (401)
T cd05107         333 EIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEE  381 (401)
T ss_pred             HHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            9998 88999876655554444445666778888999999999999974

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.1e-32  Score=214.07  Aligned_cols=185  Identities=24%  Similarity=0.398  Sum_probs=147.7

Q ss_pred             CCCCCCCCcccccceeecCC-----ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 029552            1 MKRLRHPNIVLFMGAVTQPP-----NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH   75 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h   75 (191)
                      |+.++||||+++++++..++     ..|+|+||+. ++|.+.+....   .+++..+..++.|++.||+|||+.|  ++|
T Consensus        53 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~--ivH  126 (372)
T cd07853          53 LCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSAG--ILH  126 (372)
T ss_pred             HHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeC
Confidence            35689999999999998776     7899999996 58888776533   3899999999999999999999999  999


Q ss_pred             cCCCCCcEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCC
Q 029552           76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWG  153 (191)
Q Consensus        76 ~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~pf~  153 (191)
                      |||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+.. ++.++|+||+||++++|++|..||.
T Consensus       127 ~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  206 (372)
T cd07853         127 RDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQ  206 (372)
T ss_pred             CCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCC
Confidence            9999999999999999999999886543221 1122234577899999987754 6889999999999999999999998


Q ss_pred             CCCHHHHHHHHHhcC-----------------------ccc-------CCCCCCCHHHHHHHHHHhcC
Q 029552          154 NLNPAQVVAAVGFKG-----------------------KRL-------EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       154 ~~~~~~~~~~~~~~~-----------------------~~~-------~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..++......+....                       ...       ......++.+.++|.+||+.
T Consensus       207 ~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~  274 (372)
T cd07853         207 AQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVF  274 (372)
T ss_pred             CCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCC
Confidence            877766555443210                       011       23345789999999999974

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.5e-32  Score=210.43  Aligned_cols=187  Identities=34%  Similarity=0.606  Sum_probs=154.0

Q ss_pred             CCC-CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCC-------------CcccccHHHHHHHHHHHHHHHHHHH
Q 029552            2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-------------VREMLDERRRLNMAYDVAKGMNYLH   67 (191)
Q Consensus         2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~~~~~~i~~~l~~Lh   67 (191)
                      +++ +||||+++++++.+++..++++||+.+++|.+++.+..             ....++..++..++.|++.||+|||
T Consensus        72 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH  151 (334)
T cd05100          72 KMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA  151 (334)
T ss_pred             HhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH
Confidence            356 79999999999999999999999999999999986432             1123677888999999999999999


Q ss_pred             hCCCCeeecCCCCCcEEecCCCcEEEccccccccccccccc--CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHH
Q 029552           68 RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL  145 (191)
Q Consensus        68 ~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l  145 (191)
                      ++|  ++|+||+|+||+++.++.++|+|||.+.........  .........|+|||.+.+..++.++|+||+|+++|+|
T Consensus       152 ~~g--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el  229 (334)
T cd05100         152 SQK--CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI  229 (334)
T ss_pred             HCC--eeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHH
Confidence            999  999999999999999999999999987643322111  1112223579999999888889999999999999999


Q ss_pred             Hh-CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          146 AT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       146 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ++ |..||...+..+....+. .......|..++..+.++|.+||++
T Consensus       230 ~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~  275 (334)
T cd05100         230 FTLGGSPYPGIPVEELFKLLK-EGHRMDKPANCTHELYMIMRECWHA  275 (334)
T ss_pred             HhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHccc
Confidence            98 889999888777777664 3445567788999999999999963

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.2e-32  Score=207.27  Aligned_cols=189  Identities=36%  Similarity=0.578  Sum_probs=153.3

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC--------cccccHHHHHHHHHHHHHHHHHHHhCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV--------REMLDERRRLNMAYDVAKGMNYLHRRNPP   72 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~   72 (191)
                      |++++||||+++++++.+++..++++|++.+++|.+++.+...        ...+++..++.++.|++.||+|||+.+  
T Consensus        73 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--  150 (296)
T cd05051          73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--  150 (296)
T ss_pred             HHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--
Confidence            3578999999999999998999999999999999999865431        124789999999999999999999999  


Q ss_pred             eeecCCCCCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh--C
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT--L  148 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~--g  148 (191)
                      ++|+||+|+||+++.++.++|+|||.+.......  ........+..|+|||.+.+..++.++|+||+|+++|++++  +
T Consensus       151 i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~  230 (296)
T cd05051         151 FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCR  230 (296)
T ss_pred             ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCC
Confidence            9999999999999999999999999876432221  11222334567999999888788999999999999999998  6


Q ss_pred             CCCCCCCCHHHHHHHHHhc------CcccCCCCCCCHHHHHHHHHHhcC
Q 029552          149 QQPWGNLNPAQVVAAVGFK------GKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       149 ~~pf~~~~~~~~~~~~~~~------~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..||...+...........      ....+.|..+|.++.++|.+||++
T Consensus       231 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  279 (296)
T cd05051         231 EQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRR  279 (296)
T ss_pred             CCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhcc
Confidence            7899887776666655422      112334567889999999999974

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=224.53  Aligned_cols=181  Identities=30%  Similarity=0.508  Sum_probs=158.3

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++|||++.|.++|....+.|+|||||- |+..|++.-..  +++.+.++..++.+.++||.|||+++  .+|||||.
T Consensus        80 L~~l~HPntieYkgCyLre~TaWLVMEYCl-GSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKA  154 (948)
T KOG0577|consen   80 LRQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKA  154 (948)
T ss_pred             HHhccCCCcccccceeeccchHHHHHHHHh-ccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccc
Confidence            578999999999999999999999999996 59999996543  34899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccc---ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL---RDEPSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~---~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      .||+++..|.+||.|||.+....    ....+++++.|||||++   ..+.|+-++||||||++..++.-..+|+-.++.
T Consensus       155 GNILLse~g~VKLaDFGSAsi~~----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA  230 (948)
T KOG0577|consen  155 GNILLSEPGLVKLADFGSASIMA----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA  230 (948)
T ss_pred             cceEecCCCeeeeccccchhhcC----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH
Confidence            99999999999999999887554    33457899999999986   456789999999999999999999999999888


Q ss_pred             HHHHHHHHhcCcccCCC-CCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIP-RNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~cl~~  191 (191)
                      ...+..|.+. ..+.++ +.-|..|+.+|.+||+|
T Consensus       231 MSALYHIAQN-esPtLqs~eWS~~F~~Fvd~CLqK  264 (948)
T KOG0577|consen  231 MSALYHIAQN-ESPTLQSNEWSDYFRNFVDSCLQK  264 (948)
T ss_pred             HHHHHHHHhc-CCCCCCCchhHHHHHHHHHHHHhh
Confidence            8888888643 344444 46899999999999986

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.5e-32  Score=203.10  Aligned_cols=187  Identities=25%  Similarity=0.457  Sum_probs=147.7

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC-cccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +.++||||+++++.+.+....+++|||+++++|.+++.+... ....+...+..++.|++.||+|||+.+  ++|+||+|
T Consensus        50 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp  127 (268)
T cd05086          50 RILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLAL  127 (268)
T ss_pred             hccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCcc
Confidence            467999999999999999999999999999999999975432 223667788899999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccc--cccCCCCCCCCcccCcccccc-------CCCCCcchHHHHHHHHHHHHhC-CC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRD-------EPSNEKSDIYSFGVILWELATL-QQ  150 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~Dv~slG~~~~~l~~g-~~  150 (191)
                      +||+++.++.++|+|||.+......  ........++..|+|||.+..       ..++.++|+||+|+++|+|+++ ..
T Consensus       128 ~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~  207 (268)
T cd05086         128 RNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQ  207 (268)
T ss_pred             ceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCC
Confidence            9999999999999999986532111  111223345678999998743       2346789999999999999975 67


Q ss_pred             CCCCCCHHHHHHHHHhcCc----ccCCCCCCCHHHHHHHHHHhc
Q 029552          151 PWGNLNPAQVVAAVGFKGK----RLEIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       151 pf~~~~~~~~~~~~~~~~~----~~~~~~~~s~~~~~li~~cl~  190 (191)
                      ||...++.+....+.....    .+..+..+++.+.+++..||.
T Consensus       208 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~  251 (268)
T cd05086         208 PYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCWL  251 (268)
T ss_pred             CCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHhh
Confidence            9988777766665533222    234455789999999999994

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.8e-32  Score=203.99  Aligned_cols=186  Identities=34%  Similarity=0.572  Sum_probs=151.8

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++..++..++|+||+++++|.++++..+   .+++.++..++.|++.||.+||+.+  ++|+||+|
T Consensus        62 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~  136 (272)
T cd06629          62 LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKA  136 (272)
T ss_pred             HHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCCh
Confidence            356789999999999999999999999999999999997653   3889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccc--cCCCCCCCCcccCccccccCC--CCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEP--SNEKSDIYSFGVILWELATLQQPWGNLN  156 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~--~~~~~Dv~slG~~~~~l~~g~~pf~~~~  156 (191)
                      +||+++.++.++++|||.+........  ......++..|++||.+....  ++.++|+||+|++++++++|..||....
T Consensus       137 ~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  216 (272)
T cd06629         137 DNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE  216 (272)
T ss_pred             hhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc
Confidence            999999999999999998764332211  112234567899999887654  6888999999999999999999998766


Q ss_pred             HHHHHHHHHhcCcccCCCC----CCCHHHHHHHHHHhcC
Q 029552          157 PAQVVAAVGFKGKRLEIPR----NVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~----~~s~~~~~li~~cl~~  191 (191)
                      ..+....+.........+.    .++..++++|.+||++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  255 (272)
T cd06629         217 AIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTI  255 (272)
T ss_pred             hHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcC
Confidence            6555544433333334443    5699999999999974

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.7e-32  Score=206.70  Aligned_cols=189  Identities=32%  Similarity=0.537  Sum_probs=150.8

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC--------cccccHHHHHHHHHHHHHHHHHHHhCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV--------REMLDERRRLNMAYDVAKGMNYLHRRNPP   72 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~   72 (191)
                      |++++||||+++++++.+++..++++||+.+++|.+++.....        ...+++.++..++.|++.||++||+.|  
T Consensus        73 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--  150 (296)
T cd05095          73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--  150 (296)
T ss_pred             HHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--
Confidence            3578999999999999999999999999999999999865321        123677889999999999999999999  


Q ss_pred             eeecCCCCCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh--C
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT--L  148 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~--g  148 (191)
                      ++|+||+|+||+++.++.++|+|||.+.......  ...........|++||...+..++.++|+||+|+++|+|++  |
T Consensus       151 i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~  230 (296)
T cd05095         151 FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCK  230 (296)
T ss_pred             eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCC
Confidence            9999999999999999999999999876432221  11112223457999998887788999999999999999998  6


Q ss_pred             CCCCCCCCHHHHHHHHHh------cCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          149 QQPWGNLNPAQVVAAVGF------KGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       149 ~~pf~~~~~~~~~~~~~~------~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..||...+..+.......      .....+.|..+++.++++|.+||++
T Consensus       231 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  279 (296)
T cd05095         231 EQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRR  279 (296)
T ss_pred             CCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCC
Confidence            789987776665543321      1123345667899999999999974

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.5e-32  Score=206.83  Aligned_cols=184  Identities=26%  Similarity=0.467  Sum_probs=152.7

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++|+||+++++++..++..++++||+++++|.+++....    +++..++.++.|++.++++||+.|  ++|+|++|+
T Consensus        72 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~  145 (292)
T cd06657          72 RDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSD  145 (292)
T ss_pred             HhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHH
Confidence            46789999999999999999999999999999999875432    788999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      ||+++.++.++++|||.+..............++..|++||.+.+..++.++|+||+|+++++|++|..||......+..
T Consensus       146 Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~  225 (292)
T cd06657         146 SILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM  225 (292)
T ss_pred             HEEECCCCCEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999999998754433222222334567899999988777888999999999999999999999887776666


Q ss_pred             HHHHhcC-cccCCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKG-KRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~-~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+.... ........++..+.++|.+||++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  256 (292)
T cd06657         226 KMIRDNLPPKLKNLHKVSPSLKGFLDRLLVR  256 (292)
T ss_pred             HHHHhhCCcccCCcccCCHHHHHHHHHHHhC
Confidence            5553221 12234457899999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=6.9e-33  Score=229.94  Aligned_cols=188  Identities=26%  Similarity=0.367  Sum_probs=148.5

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC--------cccccHHHHHHHHHHHHHHHHHHHhCCCCe
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV--------REMLDERRRLNMAYDVAKGMNYLHRRNPPI   73 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~   73 (191)
                      ++++||||+++++++.+++..+++|||+++++|.+++.....        ....+...++.++.|+++||+|||+.|  +
T Consensus        57 s~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--I  134 (932)
T PRK13184         57 ADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--V  134 (932)
T ss_pred             HhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--c
Confidence            567999999999999999999999999999999998853210        112456678889999999999999999  9


Q ss_pred             eecCCCCCcEEecCCCcEEEcccccccccccc------------------cccCCCCCCCCcccCccccccCCCCCcchH
Q 029552           74 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT------------------FLSSKSAAGTPEWMAPEVLRDEPSNEKSDI  135 (191)
Q Consensus        74 ~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv  135 (191)
                      +||||||+||+++.++.++++|||++......                  ........+++.|+|||.+.+..++.++|+
T Consensus       135 IHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDI  214 (932)
T PRK13184        135 LHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDI  214 (932)
T ss_pred             cccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHH
Confidence            99999999999999999999999988644110                  011112357889999999998889999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCccc-CCCCCCCHHHHHHHHHHhcC
Q 029552          136 YSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL-EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       136 ~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~cl~~  191 (191)
                      ||+|+++++|++|..||................... .....+++.+.+++.+||++
T Consensus       215 WSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~  271 (932)
T PRK13184        215 YALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAV  271 (932)
T ss_pred             HHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccC
Confidence            999999999999999998765544433321111111 11247899999999999974

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.6e-32  Score=207.54  Aligned_cols=184  Identities=31%  Similarity=0.574  Sum_probs=151.5

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++... ..+++++|+++++|.+++.....  .+++..+..++.|++.||+|||+++  ++|+||+|+
T Consensus        64 ~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~  138 (303)
T cd05110          64 ASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAAR  138 (303)
T ss_pred             HhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccc
Confidence            567999999999988754 46799999999999999875432  3788999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccc--cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA  158 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~  158 (191)
                      ||+++.++.++|+|||.+........  .......+..|++||.+.+..++.++|+||+|+++|++++ |..||......
T Consensus       139 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~  218 (303)
T cd05110         139 NVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR  218 (303)
T ss_pred             eeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999998864332211  1122233567999999988888999999999999999997 89999887666


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .....+. .+..++.+..++..+++++.+||.+
T Consensus       219 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~c~~~  250 (303)
T cd05110         219 EIPDLLE-KGERLPQPPICTIDVYMVMVKCWMI  250 (303)
T ss_pred             HHHHHHH-CCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            6555553 5556667778999999999999964

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.3e-32  Score=206.35  Aligned_cols=185  Identities=24%  Similarity=0.321  Sum_probs=146.1

Q ss_pred             CCCCCCCcccccceeec-----CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeec
Q 029552            2 KRLRHPNIVLFMGAVTQ-----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR   76 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~   76 (191)
                      ++++||||+++++++..     ....++++|++.+ +|.+++.... ...+++.++..++.|++.||+|||+.|  ++|+
T Consensus        57 ~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~  132 (288)
T cd07863          57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC--IVHR  132 (288)
T ss_pred             hhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecC
Confidence            35689999999998864     2458999999975 8888886533 223899999999999999999999999  9999


Q ss_pred             CCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 029552           77 DLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN  156 (191)
Q Consensus        77 ~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~  156 (191)
                      ||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||....
T Consensus       133 dikp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~  211 (288)
T cd07863         133 DLKPENILVTSGGQVKLADFGLARIYSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS  211 (288)
T ss_pred             CCCHHHEEECCCCCEEECccCccccccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC
Confidence            999999999999999999999886543221 1222345778999999988888999999999999999999999998877


Q ss_pred             HHHHHHHHHhcCc---c----------------------cCCCCCCCHHHHHHHHHHhcC
Q 029552          157 PAQVVAAVGFKGK---R----------------------LEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~~~~~~~~~~~~---~----------------------~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .......+.....   .                      ......+++.++++|.+||++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  271 (288)
T cd07863         212 EADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTF  271 (288)
T ss_pred             HHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhcc
Confidence            6655544422100   0                      011235788999999999964

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-32  Score=201.23  Aligned_cols=184  Identities=34%  Similarity=0.624  Sum_probs=157.8

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++|||++++.+++.+++..++++|++.+++|.+++...+   .+++..++.++.|++.++.+||+.|  ++|+||+|+
T Consensus        54 ~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~  128 (254)
T cd06627          54 KNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAA  128 (254)
T ss_pred             HhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHH
Confidence            56789999999999999999999999999999999997643   3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      ||+++.++.++|+|||.+..............+...|++||...+...+.++|+|++|++++++++|..||.........
T Consensus       129 ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~  208 (254)
T cd06627         129 NILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL  208 (254)
T ss_pred             HEEECCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence            99999999999999998876554433233445677899999988777888999999999999999999999887765555


Q ss_pred             HHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .... .......|..+++.++++|.+||++
T Consensus       209 ~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~  237 (254)
T cd06627         209 FRIV-QDDHPPLPEGISPELKDFLMQCFQK  237 (254)
T ss_pred             HHHh-ccCCCCCCCCCCHHHHHHHHHHHhC
Confidence            5543 3445567888999999999999963

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-34  Score=229.52  Aligned_cols=184  Identities=27%  Similarity=0.454  Sum_probs=149.7

Q ss_pred             CCCC-CCCcccccceee----cC---CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCe
Q 029552            2 KRLR-HPNIVLFMGAVT----QP---PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPI   73 (191)
Q Consensus         2 ~~l~-h~~i~~~~~~~~----~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~   73 (191)
                      ++|. |+|||.|+++..    .+   ..+.|.||||.|+.|-|+++++...+ +++.++++|+.++++|+.+||....++
T Consensus        89 K~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~pPi  167 (738)
T KOG1989|consen   89 KLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLKPPI  167 (738)
T ss_pred             HHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCCCcc
Confidence            5666 999999999442    11   24679999999999999998655433 999999999999999999999999899


Q ss_pred             eecCCCCCcEEecCCCcEEEcccccccccccccc---------cCCCCCCCCcccCcccc---ccCCCCCcchHHHHHHH
Q 029552           74 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL---------SSKSAAGTPEWMAPEVL---RDEPSNEKSDIYSFGVI  141 (191)
Q Consensus        74 ~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~---------~~~~~~~~~~~~~pe~~---~~~~~~~~~Dv~slG~~  141 (191)
                      +|||||.+||+++.+|..||+|||.+.-......         .......++.|.+||.+   .+..+++|+|||+|||+
T Consensus       168 IHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGcl  247 (738)
T KOG1989|consen  168 IHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCL  247 (738)
T ss_pred             chhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHH
Confidence            9999999999999999999999998753322211         11123467899999986   57788999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhc
Q 029552          142 LWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       142 ~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~  190 (191)
                      +|-|+.+..||+......+++    +...++..+.+|..+++||..||+
T Consensus       248 LYkLCy~t~PFe~sg~laIln----g~Y~~P~~p~ys~~l~~LI~~mL~  292 (738)
T KOG1989|consen  248 LYKLCYFTTPFEESGKLAILN----GNYSFPPFPNYSDRLKDLIRTMLQ  292 (738)
T ss_pred             HHHHHHhCCCcCcCcceeEEe----ccccCCCCccHHHHHHHHHHHHhc
Confidence            999999999999976655443    334445446899999999999996

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.5e-32  Score=202.61  Aligned_cols=187  Identities=30%  Similarity=0.562  Sum_probs=155.3

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++|+||+++++.+.+++..++++||+.+++|.+++..... ..+++..+..++.|+++|+.|||+.+  ++|+|++|
T Consensus        53 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~  129 (257)
T cd08225          53 LAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKS  129 (257)
T ss_pred             HHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCH
Confidence            3567999999999999999999999999999999999865432 23789999999999999999999999  99999999


Q ss_pred             CcEEecCCC-cEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           81 PNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        81 ~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      +||+++.++ .++++|||.+..............++..|+|||...+...+.++|+||+|++++++++|..||...+...
T Consensus       130 ~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  209 (257)
T cd08225         130 QNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ  209 (257)
T ss_pred             HHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence            999998876 4699999987654433222233346778999999988888899999999999999999999998877766


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+. .....+.+..++..++++|.+||++
T Consensus       210 ~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~  240 (257)
T cd08225         210 LVLKIC-QGYFAPISPNFSRDLRSLISQLFKV  240 (257)
T ss_pred             HHHHHh-cccCCCCCCCCCHHHHHHHHHHhcc
Confidence            665553 3334455667899999999999964

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=6.8e-33  Score=205.44  Aligned_cols=183  Identities=33%  Similarity=0.544  Sum_probs=150.9

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCeeecCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKS   80 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~~h~~l~p   80 (191)
                      ++++||||+++++++..++..++++||+.+++|.+++....  ..+++..+..++.|++.++++||+ .+  ++|+||+|
T Consensus        54 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~  129 (265)
T cd06605          54 HKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKP  129 (265)
T ss_pred             HHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCH
Confidence            46789999999999999999999999999999999997642  238899999999999999999999 99  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC-----
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL-----  155 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~-----  155 (191)
                      +||+++.++.++|+|||.+.........  ...++..|+|||.+.+..++.++|+||+|++++++++|..||...     
T Consensus       130 ~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  207 (265)
T cd06605         130 SNILVNSRGQIKLCDFGVSGQLVNSLAK--TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD  207 (265)
T ss_pred             HHEEECCCCCEEEeecccchhhHHHHhh--cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc
Confidence            9999999999999999987644322111  145667899999998888899999999999999999999999764     


Q ss_pred             CHHHHHHHHHhcCcccCCCCC-CCHHHHHHHHHHhcC
Q 029552          156 NPAQVVAAVGFKGKRLEIPRN-VNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~cl~~  191 (191)
                      ...+....+. ....+..+.. ++..++++|.+||..
T Consensus       208 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~  243 (265)
T cd06605         208 GIFELLQYIV-NEPPPRLPSGKFSPDFQDFVNLCLIK  243 (265)
T ss_pred             cHHHHHHHHh-cCCCCCCChhhcCHHHHHHHHHHcCC
Confidence            2223333332 2334445555 899999999999963

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-33  Score=205.45  Aligned_cols=188  Identities=30%  Similarity=0.519  Sum_probs=149.0

Q ss_pred             CCC-CCCCcccccceeecCC------ceEEEEeccCCCCHHHHhcCCC-CcccccHHHHHHHHHHHHHHHHHHHhCCCCe
Q 029552            2 KRL-RHPNIVLFMGAVTQPP------NLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLHRRNPPI   73 (191)
Q Consensus         2 ~~l-~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~   73 (191)
                      +++ +|+||+++++++.+..      ..++++||+.+++|.+++.... ....+++..+..++.|++.||+|||+.+  +
T Consensus        57 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i  134 (275)
T cd06608          57 RKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--V  134 (275)
T ss_pred             HHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--c
Confidence            345 6999999999997544      4899999999999999986422 1234899999999999999999999999  9


Q ss_pred             eecCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC-----CCCCcchHHHHHHHHHHHHhC
Q 029552           74 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-----PSNEKSDIYSFGVILWELATL  148 (191)
Q Consensus        74 ~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-----~~~~~~Dv~slG~~~~~l~~g  148 (191)
                      +|+||+|+||+++.++.++|+|||.+..............++..|+|||.+...     .++.++|+||+|++++++++|
T Consensus       135 ~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g  214 (275)
T cd06608         135 IHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG  214 (275)
T ss_pred             ccCCCCHHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhC
Confidence            999999999999999999999999876543332223334567789999987542     356789999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhcCc-ccCCCCCCCHHHHHHHHHHhcC
Q 029552          149 QQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       149 ~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..||...........+..... ....+..++..++++|.+||+.
T Consensus       215 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  258 (275)
T cd06608         215 KPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIK  258 (275)
T ss_pred             CCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhc
Confidence            999988776666665543222 2233445889999999999963

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-32  Score=204.53  Aligned_cols=180  Identities=29%  Similarity=0.559  Sum_probs=149.7

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      .|||++++++++.++...++++||+.+++|.++++..    .+++..++.++.|++.+|.+||+.+  ++|+||+|+||+
T Consensus        60 ~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~  133 (277)
T cd06917          60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANIL  133 (277)
T ss_pred             CCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEE
Confidence            5999999999999999999999999999999998653    3889999999999999999999999  999999999999


Q ss_pred             ecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 029552           85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA  163 (191)
Q Consensus        85 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~  163 (191)
                      ++.++.++++|||.+..............+...|+|||.+.+. .++.++|+||+|+++|+|++|..||...........
T Consensus       134 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~  213 (277)
T cd06917         134 VTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML  213 (277)
T ss_pred             EcCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc
Confidence            9999999999999876544332223334567789999988653 468899999999999999999999988777665554


Q ss_pred             HHhcCcccCCCC-CCCHHHHHHHHHHhcC
Q 029552          164 VGFKGKRLEIPR-NVNPHVASIIEACWAK  191 (191)
Q Consensus       164 ~~~~~~~~~~~~-~~s~~~~~li~~cl~~  191 (191)
                      +. ......++. .++..+.++|.+||++
T Consensus       214 ~~-~~~~~~~~~~~~~~~~~~~i~~~l~~  241 (277)
T cd06917         214 IP-KSKPPRLEDNGYSKLLREFVAACLDE  241 (277)
T ss_pred             cc-cCCCCCCCcccCCHHHHHHHHHHcCC
Confidence            43 222334444 3899999999999974

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.3e-32  Score=204.01  Aligned_cols=188  Identities=33%  Similarity=0.507  Sum_probs=153.7

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |+.++|+||+++++.+.+++..++++|++.+++|.+++........+++..+..++.|++.|+++||+.|  ++|+|++|
T Consensus        53 l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p  130 (267)
T cd06610          53 MSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKA  130 (267)
T ss_pred             HHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence            3568999999999999999999999999999999999976432234899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccccccc----CCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLS----SKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      +||+++.++.++|+|||.+.........    .....++..|++||.+... ..+.++|+||+|+++++|++|..||...
T Consensus       131 ~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~  210 (267)
T cd06610         131 GNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY  210 (267)
T ss_pred             HhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc
Confidence            9999999999999999987644332111    1223456789999998766 6788999999999999999999999887


Q ss_pred             CHHHHHHHHHhcCcccCCC-----CCCCHHHHHHHHHHhcC
Q 029552          156 NPAQVVAAVGFKGKRLEIP-----RNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~-----~~~s~~~~~li~~cl~~  191 (191)
                      +........... ....++     ..+++.+.+++.+||++
T Consensus       211 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~  250 (267)
T cd06610         211 PPMKVLMLTLQN-DPPSLETGADYKKYSKSFRKMISLCLQK  250 (267)
T ss_pred             ChhhhHHHHhcC-CCCCcCCccccccccHHHHHHHHHHcCC
Confidence            776665555432 222222     36789999999999974

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2e-32  Score=203.49  Aligned_cols=186  Identities=28%  Similarity=0.477  Sum_probs=154.1

Q ss_pred             CCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHh-CCCCeeecCCCC
Q 029552            3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKS   80 (191)
Q Consensus         3 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~~h~~l~p   80 (191)
                      .++||||+++++++.+++..++++||+.+++|.+++... .....+++..++.++.|++.++.+||+ .+  ++|+||+|
T Consensus        65 ~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~  142 (269)
T cd08528          65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTP  142 (269)
T ss_pred             cCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCH
Confidence            478999999999999999999999999999999987431 112348899999999999999999996 78  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      .||+++.++.++|+|||.+....... ......++..|++||.+.+..++.++|+||+|+++|++++|..||...+....
T Consensus       143 ~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~  221 (269)
T cd08528         143 NNIMLGEDDKVTITDFGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL  221 (269)
T ss_pred             HHEEECCCCcEEEecccceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH
Confidence            99999999999999999886543332 22334567789999999888888999999999999999999999998887777


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+......+.....+++.+.++|.+||++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  252 (269)
T cd08528         222 ATKIVEAVYEPLPEGMYSEDVTDVITSCLTP  252 (269)
T ss_pred             HHHHhhccCCcCCcccCCHHHHHHHHHHCCC
Confidence            7666533333223347899999999999964

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.2e-32  Score=206.27  Aligned_cols=185  Identities=24%  Similarity=0.337  Sum_probs=143.5

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+.+..++++||+.+ +|.+++....  +.+++..++.++.||++||.|||+.+  ++|+||+|+
T Consensus        54 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~  128 (284)
T cd07839          54 KELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQ  128 (284)
T ss_pred             HhcCCCCeeeHHHHhccCCceEEEEecCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHH
Confidence            567999999999999999999999999974 8888775432  23899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCC-CCCHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWG-NLNPAQ  159 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~pf~-~~~~~~  159 (191)
                      ||+++.++.++|+|||.+..............++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||. ..+..+
T Consensus       129 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~  208 (284)
T cd07839         129 NLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD  208 (284)
T ss_pred             HEEEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH
Confidence            99999999999999998764433222222344567899999887654 6889999999999999999988854 344333


Q ss_pred             HHHHHHhcCc------------------c---------cCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGK------------------R---------LEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~------------------~---------~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+.....                  .         ......+|+.++++|.+||++
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  267 (284)
T cd07839         209 QLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVC  267 (284)
T ss_pred             HHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcC
Confidence            3332211000                  0         111235789999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2e-32  Score=202.24  Aligned_cols=179  Identities=24%  Similarity=0.444  Sum_probs=145.7

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.. ...++|+||+.+++|.+++.....  .++...+..++.|++.||+|||+.+  ++|+||+|
T Consensus        55 l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp  129 (259)
T cd05037          55 MSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCG  129 (259)
T ss_pred             HHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC--eecccCcc
Confidence            467899999999999988 778999999999999999976442  3889999999999999999999999  99999999


Q ss_pred             CcEEecCCC-------cEEEcccccccccccccccCCCCCCCCcccCccccccC--CCCCcchHHHHHHHHHHHHh-CCC
Q 029552           81 PNLLVDKKY-------TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE--PSNEKSDIYSFGVILWELAT-LQQ  150 (191)
Q Consensus        81 ~ni~~~~~~-------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~-g~~  150 (191)
                      +||+++.++       .++++|||.+.....    .....+...|+|||.+.+.  .++.++|+||+|++++++++ |..
T Consensus       130 ~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~  205 (259)
T cd05037         130 KNILVARYGLNEGYVPFIKLSDPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEE  205 (259)
T ss_pred             ceEEEecCccccCCceeEEeCCCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCC
Confidence            999999887       799999998765433    1223445679999998876  67889999999999999999 588


Q ss_pred             CCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          151 PWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       151 pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ||...+.........   .....|...+..+.++|.+||++
T Consensus       206 p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~  243 (259)
T cd05037         206 PLSTLSSSEKERFYQ---DQHRLPMPDCAELANLINQCWTY  243 (259)
T ss_pred             CcccCCchhHHHHHh---cCCCCCCCCchHHHHHHHHHhcc
Confidence            888876554444332   22233344458999999999974

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-32  Score=205.64  Aligned_cols=189  Identities=33%  Similarity=0.540  Sum_probs=150.8

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC---------cccccHHHHHHHHHHHHHHHHHHHhCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV---------REMLDERRRLNMAYDVAKGMNYLHRRNP   71 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~   71 (191)
                      |++++||||+++++++..++..++||||+.+++|.+++.....         ...+++.+++.++.|++.||+|||+.+ 
T Consensus        71 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-  149 (295)
T cd05097          71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN-  149 (295)
T ss_pred             HHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC-
Confidence            3578999999999999999999999999999999999854321         112678889999999999999999999 


Q ss_pred             CeeecCCCCCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh--
Q 029552           72 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT--  147 (191)
Q Consensus        72 ~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~--  147 (191)
                       ++|+||+|+||+++.++.++|+|||.+.......  ...........|+|||...+..++.++|+||||+++++|++  
T Consensus       150 -i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~  228 (295)
T cd05097         150 -FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLC  228 (295)
T ss_pred             -eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcC
Confidence             9999999999999999999999999876432221  11112233568999999888888999999999999999988  


Q ss_pred             CCCCCCCCCHHHHHHHHHh------cCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          148 LQQPWGNLNPAQVVAAVGF------KGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       148 g~~pf~~~~~~~~~~~~~~------~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +..||...+..+....+..      .......+..+++.++++|.+||++
T Consensus       229 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  278 (295)
T cd05097         229 KEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSR  278 (295)
T ss_pred             CCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCC
Confidence            6779988776665554321      1112334667899999999999974

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.4e-32  Score=204.72  Aligned_cols=187  Identities=32%  Similarity=0.511  Sum_probs=146.5

Q ss_pred             CCCCCCCCcccccceeecC--CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            1 MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      |++++||||+++.+++.+.  ...++++||+++++|.+++.+...  .+++.++..++.|++.||++||++|  ++|+||
T Consensus        60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dl  135 (284)
T cd05079          60 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSRQ--YVHRDL  135 (284)
T ss_pred             HHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccc
Confidence            4578999999999988765  568999999999999999865432  3789999999999999999999999  999999


Q ss_pred             CCCcEEecCCCcEEEcccccccccccccc---cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           79 KSPNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        79 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      +|+||+++.++.++|+|||.+........   ......+...|+|||...+..++.++|+||+|+++++++++..|+...
T Consensus       136 kp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~  215 (284)
T cd05079         136 AARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSP  215 (284)
T ss_pred             chheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccc
Confidence            99999999999999999998764332211   112233455799999988888889999999999999999987654321


Q ss_pred             --------------CHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          156 --------------NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 --------------~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                                    ............+...+.+..+|..+.++|.+||++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  265 (284)
T cd05079         216 MTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEF  265 (284)
T ss_pred             cchhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccC
Confidence                          111111122223445566788999999999999974

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2e-32  Score=201.74  Aligned_cols=186  Identities=32%  Similarity=0.535  Sum_probs=158.4

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCC-CcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      +++++||||+++.+++.++...++|+||+++++|.+++.... ....++++.+..++.|++.||++||+.|  ++|++|+
T Consensus        53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~  130 (256)
T cd08530          53 LASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLK  130 (256)
T ss_pred             HHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCC
Confidence            357789999999999999999999999999999999986522 1234889999999999999999999999  9999999


Q ss_pred             CCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      |.||+++.++.++|+|||.+......  ......++..|++||.+.+..++.++|+||+|++++++++|..||...+..+
T Consensus       131 ~~ni~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~  208 (256)
T cd08530         131 SANILLVANDLVKIGDLGISKVLKKN--MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD  208 (256)
T ss_pred             cceEEEecCCcEEEeeccchhhhccC--CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999999999999999988655443  2223456778999999988888889999999999999999999999988777


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+. .+...+.+..++.+++++|.+||++
T Consensus       209 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  239 (256)
T cd08530         209 LRYKVQ-RGKYPPIPPIYSQDLQNFIRSMLQV  239 (256)
T ss_pred             HHHHHh-cCCCCCCchhhCHHHHHHHHHHcCC
Confidence            666664 3445566778999999999999963

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.5e-32  Score=205.28  Aligned_cols=185  Identities=30%  Similarity=0.470  Sum_probs=148.1

Q ss_pred             CCCCcccccceeecC-----CceEEEEeccCCCCHHHHhcCCC-CcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            5 RHPNIVLFMGAVTQP-----PNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      +|||++++++++...     +..++|+||+++++|.+++.... ....+++..++.++.|++.||++||+.+  ++|+||
T Consensus        77 ~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dl  154 (291)
T cd06639          77 NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDV  154 (291)
T ss_pred             CCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCC
Confidence            799999999998643     35899999999999999885311 1234889999999999999999999999  999999


Q ss_pred             CCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCC-----CCCcchHHHHHHHHHHHHhCCCCCC
Q 029552           79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-----SNEKSDIYSFGVILWELATLQQPWG  153 (191)
Q Consensus        79 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-----~~~~~Dv~slG~~~~~l~~g~~pf~  153 (191)
                      +|+||+++.++.++|+|||.+..............++..|+|||.+....     .+.++|+||+|+++|+|++|..||.
T Consensus       155 kp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~  234 (291)
T cd06639         155 KGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF  234 (291)
T ss_pred             CHHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCC
Confidence            99999999999999999998765332222222345677899999876432     5788999999999999999999999


Q ss_pred             CCCHHHHHHHHHhcCc-ccCCCCCCCHHHHHHHHHHhcC
Q 029552          154 NLNPAQVVAAVGFKGK-RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       154 ~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..++......+..... ....+..++..++++|.+||++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  273 (291)
T cd06639         235 DMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIK  273 (291)
T ss_pred             CCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhc
Confidence            8887666666543222 2234667889999999999974

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-33  Score=209.36  Aligned_cols=180  Identities=26%  Similarity=0.496  Sum_probs=165.0

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      +-|+++.++.+|+.-+.+|.||||++||+|-..+++-+.   +.+..+..++.+|+-||-+||+.|  |++||||.+|++
T Consensus       408 kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvm  482 (683)
T KOG0696|consen  408 KPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVM  482 (683)
T ss_pred             CCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceE
Confidence            468899999999999999999999999999999987553   899999999999999999999999  999999999999


Q ss_pred             ecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 029552           85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV  164 (191)
Q Consensus        85 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~  164 (191)
                      ++.+|.+||.|||.+.-..-........++++.|+|||++...+|+.++|+||+|+++|+|+.|+.||+..+.+++...|
T Consensus       483 Ld~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI  562 (683)
T KOG0696|consen  483 LDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI  562 (683)
T ss_pred             eccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            99999999999999875544445667789999999999999999999999999999999999999999999999999988


Q ss_pred             HhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          165 GFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       165 ~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                        ......+|..+|.+..++.+..|.|
T Consensus       563 --~ehnvsyPKslSkEAv~ickg~ltK  587 (683)
T KOG0696|consen  563 --MEHNVSYPKSLSKEAVAICKGLLTK  587 (683)
T ss_pred             --HHccCcCcccccHHHHHHHHHHhhc
Confidence              4567889999999999999888765

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-32  Score=213.21  Aligned_cols=147  Identities=27%  Similarity=0.415  Sum_probs=126.5

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||++++++|..+...++++|++. ++|.+++....   .+++.+++.++.|++.||+|||+.|  ++||||||
T Consensus       137 l~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP  210 (391)
T PHA03212        137 LRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHENR--IIHRDIKA  210 (391)
T ss_pred             HHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCh
Confidence            467899999999999999999999999995 58888886533   2789999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccc-cccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWG  153 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~  153 (191)
                      +||+++.++.++|+|||++...... ........+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.
T Consensus       211 ~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~  284 (391)
T PHA03212        211 ENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF  284 (391)
T ss_pred             HhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence            9999999999999999998643221 112223467889999999988889999999999999999999988764

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-33  Score=220.41  Aligned_cols=181  Identities=30%  Similarity=0.534  Sum_probs=163.0

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |+.++||||++++.+.+.+..+|+||||+.++.+++++.+.+.   ..+..+...+.|++.|++|+|+.+  ++|||||+
T Consensus       109 mk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~  183 (596)
T KOG0586|consen  109 MKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKA  183 (596)
T ss_pred             HHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc--eeccccch
Confidence            4678999999999999999999999999999999999988664   777899999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      +|++++.+.+++|+|||++...... ......++.+.|.|||.+.+..+ .+.+|+||+|+++|.++.|.+||+..+-.+
T Consensus       184 eNilL~~~mnikIaDfgfS~~~~~~-~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~  262 (596)
T KOG0586|consen  184 ENILLDENMNIKIADFGFSTFFDYG-LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE  262 (596)
T ss_pred             hhcccccccceeeeccccceeeccc-ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc
Confidence            9999999999999999999866633 45667889999999999998876 678999999999999999999999998888


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHh
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACW  189 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl  189 (191)
                      ...+.  ...+..+|..+|.++.++|+++|
T Consensus       263 Lr~rv--l~gk~rIp~~ms~dce~lLrk~l  290 (596)
T KOG0586|consen  263 LRPRV--LRGKYRIPFYMSCDCEDLLRKFL  290 (596)
T ss_pred             ccchh--eeeeecccceeechhHHHHHHhh
Confidence            88887  44566778888999999999885

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.9e-33  Score=206.69  Aligned_cols=185  Identities=36%  Similarity=0.555  Sum_probs=150.4

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+.+..+++||++.+++|.+++....   .+++.++..++.|+++||++||+.+  ++|+||+|+
T Consensus        53 ~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~  127 (260)
T PF00069_consen   53 RRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPE  127 (260)
T ss_dssp             HHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGG
T ss_pred             ccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccc--ccccccccc
Confidence            35689999999999999999999999999999999998322   3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccc-cCCCCCcchHHHHHHHHHHHHhCCCCCCCCC---H
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR-DEPSNEKSDIYSFGVILWELATLQQPWGNLN---P  157 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~---~  157 (191)
                      ||+++.++.++|+|||.+..............++..|.|||... +...+.++|+||+|+++++|++|..||....   .
T Consensus       128 NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~  207 (260)
T PF00069_consen  128 NILLDENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ  207 (260)
T ss_dssp             GEEESTTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhh
Confidence            99999999999999999865322323444556678999999998 7778999999999999999999999999873   3


Q ss_pred             HHHHHHHHhcCcccCCC--CCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIP--RNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~cl~~  191 (191)
                      .................  ...++.+.++|.+||++
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  243 (260)
T PF00069_consen  208 LEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSK  243 (260)
T ss_dssp             HHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSS
T ss_pred             hhhhhhcccccccccccccchhHHHHHHHHHHHccC
Confidence            33333332211222222  22348999999999974

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-34  Score=226.87  Aligned_cols=186  Identities=32%  Similarity=0.595  Sum_probs=164.5

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |-|++||||+++.++....+...+|.|||+.|+|+.++++.+..  |+..+...++..|+.|.+||-+.|  ++||||-.
T Consensus       684 MGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq--ftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAA  759 (996)
T KOG0196|consen  684 MGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ--FTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAA  759 (996)
T ss_pred             cccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc--eEeehHHHHHHHHHHHhHHHhhcC--chhhhhhh
Confidence            35899999999999999999999999999999999999887633  888899999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCC---CCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA---AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLN  156 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~---~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~  156 (191)
                      +||+++.+-.+|++|||++....+........   .-..+|.|||.+.-++++.++||||+|++|||.++ |..||=++.
T Consensus       760 RNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS  839 (996)
T KOG0196|consen  760 RNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS  839 (996)
T ss_pred             hheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc
Confidence            99999999999999999997543332111111   12358999999999999999999999999999776 688999999


Q ss_pred             HHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..++++.|. .+.+++-|.+++..+..||..||+|
T Consensus       840 NQdVIkaIe-~gyRLPpPmDCP~aL~qLMldCWqk  873 (996)
T KOG0196|consen  840 NQDVIKAIE-QGYRLPPPMDCPAALYQLMLDCWQK  873 (996)
T ss_pred             hHHHHHHHH-hccCCCCCCCCcHHHHHHHHHHHHH
Confidence            999999996 7789999999999999999999986

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.3e-32  Score=201.82  Aligned_cols=187  Identities=27%  Similarity=0.444  Sum_probs=145.1

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC--cccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV--REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      ++++||||+++++++.+....++||||+++++|.+++.....  ....+...+..++.|++.|++|||+.+  ++|+||+
T Consensus        50 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlk  127 (269)
T cd05087          50 RSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLA  127 (269)
T ss_pred             HhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccC
Confidence            568999999999999998899999999999999999864321  123566778889999999999999999  9999999


Q ss_pred             CCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccC-------CCCCcchHHHHHHHHHHHHh-CC
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDE-------PSNEKSDIYSFGVILWELAT-LQ  149 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~-------~~~~~~Dv~slG~~~~~l~~-g~  149 (191)
                      |+||+++.++.++|+|||.+.......  .......+...|+|||.+.+.       .++.++|+||+|+++++|++ |.
T Consensus       128 p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~  207 (269)
T cd05087         128 LRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGS  207 (269)
T ss_pred             cceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCC
Confidence            999999999999999999876433221  111223445679999987542       34678999999999999996 99


Q ss_pred             CCCCCCCHHHHHHHHHhc-CcccC---CCCCCCHHHHHHHHHHhc
Q 029552          150 QPWGNLNPAQVVAAVGFK-GKRLE---IPRNVNPHVASIIEACWA  190 (191)
Q Consensus       150 ~pf~~~~~~~~~~~~~~~-~~~~~---~~~~~s~~~~~li~~cl~  190 (191)
                      .||......+........ ..+.+   .....++.+.++|++||.
T Consensus       208 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~  252 (269)
T cd05087         208 QPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCWL  252 (269)
T ss_pred             CCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHhc
Confidence            999876666554433211 12222   233678999999999984

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2e-32  Score=202.60  Aligned_cols=186  Identities=31%  Similarity=0.510  Sum_probs=155.5

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      ++++||||+++++++.++...++++||+.+++|.+++... ..+..+++.+++.++.|++.|+++||+.+  ++|+|++|
T Consensus        57 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~  134 (260)
T cd08222          57 SKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKA  134 (260)
T ss_pred             HhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCh
Confidence            5679999999999999999999999999999999988642 12334899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++. +.++++|||.+..............++..|++||.+.+..++.++|+||+|++++++++|..||........
T Consensus       135 ~nili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~  213 (260)
T cd08222         135 KNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV  213 (260)
T ss_pred             hheEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence            9999976 569999999876544332233334566789999998887788899999999999999999999988777666


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+. .+.....+..++.++.++|.+||++
T Consensus       214 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  243 (260)
T cd08222         214 VLRIV-EGPTPSLPETYSRQLNSIMQSMLNK  243 (260)
T ss_pred             HHHHH-cCCCCCCcchhcHHHHHHHHHHhcC
Confidence            66654 3445566788999999999999964

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.9e-32  Score=204.30  Aligned_cols=182  Identities=30%  Similarity=0.515  Sum_probs=148.6

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCeeecCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKS   80 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~~h~~l~p   80 (191)
                      +.++||||+++++++.+.+..++|+||+++++|.+++.+.+   .+++..+..++.+++.++.|||+ .+  ++|+||+|
T Consensus        58 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p  132 (284)
T cd06620          58 HECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKP  132 (284)
T ss_pred             HHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCH
Confidence            56799999999999999999999999999999999987644   38899999999999999999997 68  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH--
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA--  158 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~--  158 (191)
                      +||+++.++.++|+|||++......  ......++..|+|||.+.+...+.++|+||+|++++++++|..||......  
T Consensus       133 ~nil~~~~~~~~l~d~gl~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~  210 (284)
T cd06620         133 SNILVNSRGQIKLCDFGVSGELINS--IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD  210 (284)
T ss_pred             HHEEECCCCcEEEccCCcccchhhh--ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhh
Confidence            9999999999999999987543222  122345678999999988888889999999999999999999999865542  


Q ss_pred             ---------HHHHHHHhcCcccCCCC-CCCHHHHHHHHHHhcC
Q 029552          159 ---------QVVAAVGFKGKRLEIPR-NVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ---------~~~~~~~~~~~~~~~~~-~~s~~~~~li~~cl~~  191 (191)
                               +....+. ......++. .++..+.++|.+||++
T Consensus       211 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~  252 (284)
T cd06620         211 GQDDPMGILDLLQQIV-QEPPPRLPSSDFPEDLRDFVDACLLK  252 (284)
T ss_pred             hhhhhhHHHHHHHHHh-hccCCCCCchhcCHHHHHHHHHHhcC
Confidence                     2222221 122233333 3889999999999974

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3e-32  Score=210.59  Aligned_cols=150  Identities=29%  Similarity=0.461  Sum_probs=125.2

Q ss_pred             CCCCCCCCcccccceeecCC------ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCee
Q 029552            1 MKRLRHPNIVLFMGAVTQPP------NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIV   74 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~   74 (191)
                      |++++||||+++++++...+      ..|+||||+.+ +|.+.+..     .+++.++..++.|++.||+|||+.|  ++
T Consensus        74 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~--iv  145 (359)
T cd07876          74 LKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG--II  145 (359)
T ss_pred             HHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC--cc
Confidence            35689999999999986443      47999999975 66666542     2788899999999999999999999  99


Q ss_pred             ecCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 029552           75 HRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN  154 (191)
Q Consensus        75 h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~  154 (191)
                      ||||+|+||+++.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||..
T Consensus       146 HrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~  224 (359)
T cd07876         146 HRDLKPSNIVVKSDCTLKILDFGLARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG  224 (359)
T ss_pred             cCCCCHHHEEECCCCCEEEecCCCccccccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999988643322 112234567789999999988899999999999999999999999987


Q ss_pred             CCHHH
Q 029552          155 LNPAQ  159 (191)
Q Consensus       155 ~~~~~  159 (191)
                      .+...
T Consensus       225 ~~~~~  229 (359)
T cd07876         225 TDHID  229 (359)
T ss_pred             CCHHH
Confidence            66544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.3e-32  Score=200.46  Aligned_cols=185  Identities=37%  Similarity=0.643  Sum_probs=157.0

Q ss_pred             CCCCCCCcccccceeecC--CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            2 KRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      ++++||||+++++.+.+.  +..++++|++.+++|.+++....   .+++.+++.++.|+++++++||+.+  ++|+|++
T Consensus        54 ~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~  128 (260)
T cd06606          54 SSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIK  128 (260)
T ss_pred             HHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCC
Confidence            567899999999999988  88999999999999999997644   3899999999999999999999999  9999999


Q ss_pred             CCcEEecCCCcEEEcccccccccccccc--cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN-  156 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~-  156 (191)
                      |+||+++.++.++|+|||.+........  ......+...|.+||...+...+.++|+||+|++++++++|..||.... 
T Consensus       129 p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  208 (260)
T cd06606         129 GANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN  208 (260)
T ss_pred             HHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence            9999999999999999998875554422  1233456778999999988888999999999999999999999998765 


Q ss_pred             HHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .......+.........|..++..++++|.+||+.
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~  243 (260)
T cd06606         209 PMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRR  243 (260)
T ss_pred             hHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcC
Confidence            44444444333456677888999999999999963

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-32  Score=215.59  Aligned_cols=174  Identities=24%  Similarity=0.368  Sum_probs=148.1

Q ss_pred             CCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcE
Q 029552            4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL   83 (191)
Q Consensus         4 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni   83 (191)
                      -+||||+++.+.+.++.+.|+|||.+.++-+.+.+.....   +. .++..|+.+|+.|+.|||.+|  ++|||+||+||
T Consensus       373 ~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NI  446 (612)
T KOG0603|consen  373 RDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNI  446 (612)
T ss_pred             cCCCcceeecceecCCceeeeeehhccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhhe
Confidence            3799999999999999999999999999988888876432   33 778889999999999999999  99999999999


Q ss_pred             Ee-cCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-HHH
Q 029552           84 LV-DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA-QVV  161 (191)
Q Consensus        84 ~~-~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~-~~~  161 (191)
                      ++ +..++++|+|||.+......   ...++-+..|.|||+.....+++++|+||||+++|+|++|+.||...... +..
T Consensus       447 L~~~~~g~lrltyFG~a~~~~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~  523 (612)
T KOG0603|consen  447 LLDGSAGHLRLTYFGFWSELERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIH  523 (612)
T ss_pred             eecCCCCcEEEEEechhhhCchh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHH
Confidence            99 68899999999988644433   33445677899999999889999999999999999999999999874444 455


Q ss_pred             HHHHhcCcccCCCCCCCHHHHHHHHHHhc
Q 029552          162 AAVGFKGKRLEIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       162 ~~~~~~~~~~~~~~~~s~~~~~li~~cl~  190 (191)
                      ..+    ..+++...+|+..++||++||+
T Consensus       524 ~~i----~~~~~s~~vS~~AKdLl~~LL~  548 (612)
T KOG0603|consen  524 TRI----QMPKFSECVSDEAKDLLQQLLQ  548 (612)
T ss_pred             Hhh----cCCccccccCHHHHHHHHHhcc
Confidence            544    3445558999999999999986

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5.5e-32  Score=198.58  Aligned_cols=185  Identities=34%  Similarity=0.581  Sum_probs=154.9

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++|||++++.+++..+...++++||+++++|.+++....  ..+++..+..++.|++.++++||+.+  ++|+|++|
T Consensus        51 l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p  126 (253)
T cd05122          51 LKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKA  126 (253)
T ss_pred             HHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCH
Confidence            356789999999999999999999999999999999997643  23899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.++.++|+|||.+........ .....+...|++||.+.+...+.++|+||+|+++++|++|..||...+....
T Consensus       127 ~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~  205 (253)
T cd05122         127 ANILLTSDGEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA  205 (253)
T ss_pred             HHEEEccCCeEEEeecccccccccccc-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH
Confidence            999999999999999998765543321 2334567789999999888888999999999999999999999998866666


Q ss_pred             HHHHHhcCcccCCCC--CCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPR--NVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~--~~s~~~~~li~~cl~~  191 (191)
                      ...... ......+.  .++..+.++|.+||++
T Consensus       206 ~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~  237 (253)
T cd05122         206 LFKIAT-NGPPGLRNPEKWSDEFKDFLKKCLQK  237 (253)
T ss_pred             HHHHHh-cCCCCcCcccccCHHHHHHHHHHccC
Confidence            655543 33333333  3489999999999974

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.6e-32  Score=199.76  Aligned_cols=186  Identities=31%  Similarity=0.558  Sum_probs=159.7

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCC-CcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      ++++|||++++.+.+.+++..++++|++++++|.+++.... ....+++.++..++.+++.|+.+||+.+  ++|+||+|
T Consensus        54 ~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~  131 (258)
T cd08215          54 KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKP  131 (258)
T ss_pred             HhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCCh
Confidence            56789999999999999999999999999999999997532 1234899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.++.++|+|||.+..............++..|+|||...+...+.++|+||+|+++++|++|..||...+....
T Consensus       132 ~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~  211 (258)
T cd08215         132 QNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL  211 (258)
T ss_pred             HHeEEcCCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH
Confidence            99999999999999999886554443233334567789999998888888999999999999999999999998887777


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhc
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~  190 (191)
                      ..... .....++|..++..+.++|.+||+
T Consensus       212 ~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~  240 (258)
T cd08215         212 ALKIL-KGQYPPIPSQYSSELRNLVSSLLQ  240 (258)
T ss_pred             HHHHh-cCCCCCCCCCCCHHHHHHHHHHcC
Confidence            77664 444666778999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-32  Score=202.99  Aligned_cols=186  Identities=26%  Similarity=0.380  Sum_probs=148.1

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++|+||+++++++.+++..++++||+.++.+..+..+..   .+++.++..++.|++.|+++||+.+  ++|+|++|
T Consensus        54 l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~  128 (288)
T cd07833          54 LRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKP  128 (288)
T ss_pred             HHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCH
Confidence            356889999999999999999999999999877766665433   2889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccc-cCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      +||+++.++.++|+|||.+........ ......+...|+|||.+.+. .++.++|+||+|+++++|++|..||...+..
T Consensus       129 ~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~  208 (288)
T cd07833         129 ENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI  208 (288)
T ss_pred             HHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            999999999999999998765443322 22233456789999999877 7788999999999999999999999876655


Q ss_pred             HHHHHHHhcCc------------------------------ccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGK------------------------------RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~------------------------------~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +....+.....                              ....+..+|..++++|++||+.
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  271 (288)
T cd07833         209 DQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRM  271 (288)
T ss_pred             HHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhcc
Confidence            44433221000                              0012344689999999999963

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.6e-32  Score=199.70  Aligned_cols=174  Identities=23%  Similarity=0.265  Sum_probs=144.9

Q ss_pred             CCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcE
Q 029552            4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL   83 (191)
Q Consensus         4 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni   83 (191)
                      ..||||+++++++.+++..+++|||+.+++|.+++.+..   .+++.++..++.|+++||++||+.+  ++|+||+|+||
T Consensus        42 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Ni  116 (237)
T cd05576          42 HCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL---NIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNI  116 (237)
T ss_pred             cCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHE
Confidence            468999999999999999999999999999999987643   2889999999999999999999999  99999999999


Q ss_pred             EecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 029552           84 LVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA  163 (191)
Q Consensus        84 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~  163 (191)
                      +++.++.++++|||.+......   .........|+|||...+..++.++|+||+|+++++|++|..|+......     
T Consensus       117 l~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----  188 (237)
T cd05576         117 LLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----  188 (237)
T ss_pred             EEcCCCCEEEecccchhccccc---cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----
Confidence            9999999999999976543322   11223456799999998887889999999999999999999887643221     


Q ss_pred             HHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          164 VGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       164 ~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      + .......+|..+++.++++|.+||++
T Consensus       189 ~-~~~~~~~~~~~~~~~~~~li~~~l~~  215 (237)
T cd05576         189 I-NTHTTLNIPEWVSEEARSLLQQLLQF  215 (237)
T ss_pred             c-ccccccCCcccCCHHHHHHHHHHccC
Confidence            1 11223457788999999999999974

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.1e-32  Score=228.17  Aligned_cols=189  Identities=25%  Similarity=0.433  Sum_probs=144.4

Q ss_pred             CCCCCCCCcccccceeec--CCceEEEEeccCCCCHHHHhcCCC-CcccccHHHHHHHHHHHHHHHHHHHhCC-----CC
Q 029552            1 MKRLRHPNIVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLHRRN-----PP   72 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~-----~~   72 (191)
                      |++++||||++++++|.+  ...+|+||||+.+++|.+++.... ....+++..++.++.||+.||.|||+.+     ..
T Consensus        66 L~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~  145 (1021)
T PTZ00266         66 MRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGER  145 (1021)
T ss_pred             HHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCC
Confidence            357899999999998854  456999999999999999986421 1234899999999999999999999842     12


Q ss_pred             eeecCCCCCcEEecC-----------------CCcEEEcccccccccccccccCCCCCCCCcccCccccccC--CCCCcc
Q 029552           73 IVHRDLKSPNLLVDK-----------------KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE--PSNEKS  133 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~-----------------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~  133 (191)
                      |+|+||+|+||+++.                 .+.++|+|||++....... ......+++.|+|||.+.+.  .++.++
T Consensus       146 IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KS  224 (1021)
T PTZ00266        146 VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKS  224 (1021)
T ss_pred             ceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchh
Confidence            999999999999964                 2348999999886543221 22234578899999998643  467899


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          134 DIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       134 Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      |||||||++|+|++|..||...+..............++ ...+|..+.+||.+||++
T Consensus       225 DVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lp-i~~~S~eL~dLI~~~L~~  281 (1021)
T PTZ00266        225 DMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLP-IKGKSKELNILIKNLLNL  281 (1021)
T ss_pred             HHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCC-cCCCCHHHHHHHHHHhcC
Confidence            999999999999999999986554443333322222222 246899999999999974

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.4e-32  Score=202.54  Aligned_cols=163  Identities=28%  Similarity=0.397  Sum_probs=140.2

Q ss_pred             CCCCCCCC-cccccceeecCC------ceEEEEeccCCCCHHHHhcCCCCc-ccccHHHHHHHHHHHHHHHHHHHhCCCC
Q 029552            1 MKRLRHPN-IVLFMGAVTQPP------NLSIVTEYLSRGSLYRLLHKPGVR-EMLDERRRLNMAYDVAKGMNYLHRRNPP   72 (191)
Q Consensus         1 L~~l~h~~-i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~   72 (191)
                      |+.++|+| |+++++++-..+      ..++||||++. +|..++...... ...+...+..++.||+.||+|||+++  
T Consensus        64 lk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--  140 (323)
T KOG0594|consen   64 LKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--  140 (323)
T ss_pred             HHHhCCCcceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence            46789999 999999997666      79999999965 999999764421 23777899999999999999999999  


Q ss_pred             eeecCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCC
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQP  151 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p  151 (191)
                      |+||||||.|++++++|.+||+|||++....-+...-...+.+.+|.|||++.+. .|+...|+||+||++++|++++.-
T Consensus       141 IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~L  220 (323)
T KOG0594|consen  141 ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPL  220 (323)
T ss_pred             eecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCC
Confidence            9999999999999999999999999998665454445566778899999999888 588999999999999999999999


Q ss_pred             CCCCCHHHHHHHHHh
Q 029552          152 WGNLNPAQVVAAVGF  166 (191)
Q Consensus       152 f~~~~~~~~~~~~~~  166 (191)
                      |......+....|-.
T Consensus       221 FpG~se~~ql~~If~  235 (323)
T KOG0594|consen  221 FPGDSEIDQLFRIFR  235 (323)
T ss_pred             CCCCcHHHHHHHHHH
Confidence            998877777666644

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.5e-32  Score=203.09  Aligned_cols=187  Identities=21%  Similarity=0.315  Sum_probs=147.1

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++++||+. ++|.+++.... ...+++.++..++.|++.||+|||+.+  ++|+||+|
T Consensus        53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p  128 (284)
T cd07860          53 LKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKP  128 (284)
T ss_pred             HHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCH
Confidence            356899999999999999999999999996 58988886533 234889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      +||+++.++.++|+|||.+..................|+|||.+.+.. .+.++|+||+|+++|+|++|..||...+...
T Consensus       129 ~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~  208 (284)
T cd07860         129 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID  208 (284)
T ss_pred             HHEEECCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence            999999999999999998764433222222334567899999887654 5778999999999999999999998766554


Q ss_pred             HHHHHHhcCcc---------------------------cCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKR---------------------------LEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~---------------------------~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+......                           ......+++.++++|.+||++
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  267 (284)
T cd07860         209 QLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHY  267 (284)
T ss_pred             HHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCC
Confidence            44332211110                           011235789999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.5e-32  Score=204.60  Aligned_cols=187  Identities=29%  Similarity=0.452  Sum_probs=146.9

Q ss_pred             CC-CCCCcccccceee-----cCCceEEEEeccCCCCHHHHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 029552            3 RL-RHPNIVLFMGAVT-----QPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH   75 (191)
Q Consensus         3 ~l-~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h   75 (191)
                      .+ +||||+++++++.     .++..+++|||+++++|.+++... ..+..+++..+..++.|+++|+.|||+.+  ++|
T Consensus        70 ~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H  147 (286)
T cd06638          70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIH  147 (286)
T ss_pred             HHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccc
Confidence            44 6999999999873     345789999999999999987531 12334889999999999999999999999  999


Q ss_pred             cCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc-----CCCCCcchHHHHHHHHHHHHhCCC
Q 029552           76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-----EPSNEKSDIYSFGVILWELATLQQ  150 (191)
Q Consensus        76 ~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~Dv~slG~~~~~l~~g~~  150 (191)
                      +|++|+||+++.++.++|+|||.+..............++..|+|||.+..     ..++.++|+||+|+++|+|++|..
T Consensus       148 ~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~  227 (286)
T cd06638         148 RDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP  227 (286)
T ss_pred             cCCCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCC
Confidence            999999999999999999999987654332222233456778999998753     336788999999999999999999


Q ss_pred             CCCCCCHHHHHHHHHhcC-cccCCCCCCCHHHHHHHHHHhcC
Q 029552          151 PWGNLNPAQVVAAVGFKG-KRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       151 pf~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ||....+........... .....|..++..+.++|.+||++
T Consensus       228 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  269 (286)
T cd06638         228 PLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTK  269 (286)
T ss_pred             CCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccC
Confidence            998876655544432221 12334566889999999999963

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3e-32  Score=203.32  Aligned_cols=183  Identities=30%  Similarity=0.528  Sum_probs=155.9

Q ss_pred             CCCC-CCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            2 KRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         2 ~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++. ||||+++++++.+++..+++||++.+++|.+++.+.+   .+++.+++.++.|++.||++||+.+  ++|+|++|
T Consensus        56 ~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~  130 (280)
T cd05581          56 TRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKP  130 (280)
T ss_pred             HhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCH
Confidence            3566 9999999999999999999999999999999997654   3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccc--------------------cCCCCCCCCcccCccccccCCCCCcchHHHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFL--------------------SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGV  140 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~--------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~  140 (191)
                      +||+++.++.++++|||.+........                    ......+...|++||...+...+.++|+||+|+
T Consensus       131 ~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~  210 (280)
T cd05581         131 ENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGC  210 (280)
T ss_pred             HHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHH
Confidence            999999999999999998764433221                    112223467899999988887888999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          141 ILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       141 ~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +++++++|..||...+.......+.  ......|..+++.+.++|.+||++
T Consensus       211 ~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~  259 (280)
T cd05581         211 IIYQMLTGKPPFRGSNEYLTFQKIL--KLEYSFPPNFPPDAKDLIEKLLVL  259 (280)
T ss_pred             HHHHHHhCCCCCCCccHHHHHHHHH--hcCCCCCCccCHHHHHHHHHHhcC
Confidence            9999999999999887766666653  345567788999999999999974

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-33  Score=212.54  Aligned_cols=153  Identities=41%  Similarity=0.647  Sum_probs=132.3

Q ss_pred             CCCCCCCCcccccceeecCC-ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCC-CeeecCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPP-NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNP-PIVHRDL   78 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~-~~~h~~l   78 (191)
                      |.+++|||+++++++|.+.+ ...+|+||+..|+|.+++...... .+++.++.+|+.++++||+|||.... +++||||
T Consensus       125 ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDi  203 (361)
T KOG1187|consen  125 LSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDI  203 (361)
T ss_pred             HhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCC
Confidence            45789999999999999888 599999999999999999765432 58999999999999999999999653 6999999


Q ss_pred             CCCcEEecCCCcEEEcccccccccccccccCCCC-CCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 029552           79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA-AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN  154 (191)
Q Consensus        79 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~-~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~  154 (191)
                      |++||+++.+.+.|++|||++............. .++..|++||+......+.++||||+|+++.++++|+.+.+.
T Consensus       204 KssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~  280 (361)
T KOG1187|consen  204 KSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQ  280 (361)
T ss_pred             CHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCC
Confidence            9999999999999999999996554311122222 788899999999988899999999999999999999987764

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.7e-32  Score=204.36  Aligned_cols=185  Identities=25%  Similarity=0.362  Sum_probs=146.8

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++||||+++++++.+++..++|+||+++++|.++.....   .+++.++..++.|++.|+.|||+.+  ++|+|++|+
T Consensus        55 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~  129 (286)
T cd07846          55 KQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPE  129 (286)
T ss_pred             HhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHH
Confidence            56899999999999999999999999999988888775433   2889999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      ||+++.++.++|+|||++..............+...|+|||.+.+. ..+.++|+||+|+++++|++|..||......+.
T Consensus       130 ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~  209 (286)
T cd07846         130 NILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQ  209 (286)
T ss_pred             HEEECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHH
Confidence            9999999999999999876543322222233456789999988754 367789999999999999999999976655443


Q ss_pred             HHHHHhcCcc-----------------------------cCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKR-----------------------------LEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~-----------------------------~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+......                             ...+++++..++++|.+||++
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  269 (286)
T cd07846         210 LYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRI  269 (286)
T ss_pred             HHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcC
Confidence            3332210000                             011346889999999999963

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=6.2e-32  Score=204.66  Aligned_cols=182  Identities=29%  Similarity=0.483  Sum_probs=148.6

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |+.++||||+++.+++.+++..++|+||+. +++.+.+....  +.+++.++..++.|++.||.|||+.+  ++|+||+|
T Consensus        69 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p  143 (307)
T cd06607          69 LQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKA  143 (307)
T ss_pred             HHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCc
Confidence            356899999999999999999999999997 47777775322  23889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR---DEPSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      +||+++.++.++|+|||.+......    ....+...|+|||.+.   ...++.++|+||+|+++|+|++|..||...+.
T Consensus       144 ~nIl~~~~~~~kL~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~  219 (307)
T cd06607         144 GNILLTEPGTVKLADFGSASLVSPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA  219 (307)
T ss_pred             ccEEECCCCCEEEeecCcceecCCC----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH
Confidence            9999999999999999987644322    2234566899999874   34577899999999999999999999998877


Q ss_pred             HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ......+.........+..++..++++|.+||++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  253 (307)
T cd06607         220 MSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQK  253 (307)
T ss_pred             HHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcC
Confidence            7766655433222223456889999999999974

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=6e-32  Score=203.77  Aligned_cols=186  Identities=22%  Similarity=0.294  Sum_probs=148.0

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++|+||+++++++.+++..++||||+ +++|.+++....  ..+++.++..++.|+++||.+||+.|  ++|+||+|
T Consensus        56 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p  130 (298)
T cd07841          56 LQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKP  130 (298)
T ss_pred             HhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCh
Confidence            35688999999999999999999999999 889999997644  13899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      +||+++.++.++|+|||.+...............+..|+|||.+.+. .++.++|+||+|+++++|++|..||....+..
T Consensus       131 ~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~  210 (298)
T cd07841         131 NNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID  210 (298)
T ss_pred             hhEEEcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH
Confidence            99999999999999999886544332222233446689999988653 46788999999999999999988887766555


Q ss_pred             HHHHHHhcCcc---------------------c-----CCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKR---------------------L-----EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~---------------------~-----~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...++......                     .     ......+..+.++|.+||++
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  268 (298)
T cd07841         211 QLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTL  268 (298)
T ss_pred             HHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcC
Confidence            44444211100                     0     01245688999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.1e-31  Score=204.26  Aligned_cols=182  Identities=28%  Similarity=0.476  Sum_probs=150.4

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++|||++++++++.++...++|+||+.+ +|.+.+....  ..+++.++..++.|++.|+.+||+.+  ++|+||+|
T Consensus        79 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p  153 (317)
T cd06635          79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKA  153 (317)
T ss_pred             HHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCc
Confidence            3568999999999999999999999999975 7877775432  23889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR---DEPSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      +||+++.++.++|+|||.+.....    .....++..|+|||.+.   ....+.++|+||+|+++++|++|..||...+.
T Consensus       154 ~Nil~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~  229 (317)
T cd06635         154 GNILLTEPGQVKLADFGSASIASP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA  229 (317)
T ss_pred             ccEEECCCCCEEEecCCCccccCC----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH
Confidence            999999999999999998754322    22334567899999873   34578899999999999999999999988777


Q ss_pred             HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ......+.........+..+++.++++|.+||++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  263 (317)
T cd06635         230 MSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQK  263 (317)
T ss_pred             HHHHHHHHhccCCCCCCccccHHHHHHHHHHccC
Confidence            7766666544444444567899999999999974

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.3e-32  Score=210.66  Aligned_cols=149  Identities=24%  Similarity=0.383  Sum_probs=128.6

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++......+++||++. ++|.+++....   .+++.+++.++.|++.||+|||+.|  ++||||||
T Consensus       140 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp  213 (392)
T PHA03207        140 LKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDRSG---PLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKT  213 (392)
T ss_pred             HHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCH
Confidence            467899999999999999999999999996 58888885433   3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccc--cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      +||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...
T Consensus       214 ~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~  290 (392)
T PHA03207        214 ENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK  290 (392)
T ss_pred             HHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            999999999999999998864433211  122345788999999999888999999999999999999999998653

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=5.9e-32  Score=202.26  Aligned_cols=185  Identities=28%  Similarity=0.508  Sum_probs=145.6

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhC-CCCeeecCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLK   79 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~~~~~h~~l~   79 (191)
                      +.++||||+++++++..++..++++||++ ++|.+++... .....+++.+++.++.|++.|++|||++ +  ++|+||+
T Consensus        55 ~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlk  131 (283)
T cd06617          55 RSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVK  131 (283)
T ss_pred             HHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCC
Confidence            45689999999999999999999999997 5888877532 2234589999999999999999999997 8  9999999


Q ss_pred             CCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc----CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD----EPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~----~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      |+||+++.++.++|+|||.+....... ......++..|+|||.+.+    ..++.++|+||+|+++|+|++|..||...
T Consensus       132 p~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  210 (283)
T cd06617         132 PSNVLINRNGQVKLCDFGISGYLVDSV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW  210 (283)
T ss_pred             HHHEEECCCCCEEEeeccccccccccc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcc
Confidence            999999999999999999876543221 1122345678999998865    33578899999999999999999999753


Q ss_pred             -CHHHHHHHHHhcCcccCCC-CCCCHHHHHHHHHHhcC
Q 029552          156 -NPAQVVAAVGFKGKRLEIP-RNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 -~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~cl~~  191 (191)
                       ...+...... .+.....| ..+|..+.++|.+||++
T Consensus       211 ~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~  247 (283)
T cd06617         211 KTPFQQLKQVV-EEPSPQLPAEKFSPEFQDFVNKCLKK  247 (283)
T ss_pred             ccCHHHHHHHH-hcCCCCCCccccCHHHHHHHHHHccC
Confidence             3333333332 23334444 46899999999999974

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.1e-31  Score=201.04  Aligned_cols=186  Identities=25%  Similarity=0.351  Sum_probs=148.8

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++||||+++++++.++...++|+||+ +++|.+++....  ..+++.+++.++.|++++|++||+.+  ++|+||+|
T Consensus        53 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p  127 (286)
T cd07832          53 LQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKP  127 (286)
T ss_pred             HHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCH
Confidence            35678999999999999999999999999 999999986533  23899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      +||+++.++.++++|||.+....... .......++..|+|||.+.+.. .+.++|+||+|+++++|++|..||......
T Consensus       128 ~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~  207 (286)
T cd07832         128 ANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI  207 (286)
T ss_pred             HHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH
Confidence            99999999999999999876543321 1122345677899999886544 578999999999999999998888876665


Q ss_pred             HHHHHHHhcCccc----------------------------CCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRL----------------------------EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~----------------------------~~~~~~s~~~~~li~~cl~~  191 (191)
                      .....+......+                            ....+++..+.++|++||++
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  268 (286)
T cd07832         208 EQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVY  268 (286)
T ss_pred             HHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhcc
Confidence            5544433211100                            11235689999999999974

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=6.9e-32  Score=202.00  Aligned_cols=188  Identities=27%  Similarity=0.399  Sum_probs=148.8

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++||||+++++++.+.+..++|+||+.+ +|.+++........++++++..++.|++.||++||+.|  ++|+||+|
T Consensus        52 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p  128 (284)
T cd07836          52 MKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKP  128 (284)
T ss_pred             HHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCH
Confidence            3567999999999999999999999999975 88888865443345899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      +||+++.++.++++|||.+..............++..|++||.+.+. .++.++|+||+|++++++++|..||...+..+
T Consensus       129 ~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~  208 (284)
T cd07836         129 QNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED  208 (284)
T ss_pred             HHEEECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            99999999999999999876433222122223456789999988664 46788999999999999999999998877665


Q ss_pred             HHHHHHhcCc----------------cc-----------CCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGK----------------RL-----------EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~----------------~~-----------~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+.....                ..           ...+.++..++++|.+||++
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  267 (284)
T cd07836         209 QLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQL  267 (284)
T ss_pred             HHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcC
Confidence            5444321100                00           01235688999999999964

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.9e-31  Score=202.60  Aligned_cols=182  Identities=29%  Similarity=0.478  Sum_probs=149.5

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      ++.++|||++++++++.++...|+++||+. +++.+.+....  ..+++.++..++.|++.++.|||+.|  ++|+||+|
T Consensus        75 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p  149 (313)
T cd06633          75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKA  149 (313)
T ss_pred             HHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCh
Confidence            356899999999999999999999999996 47877775433  23889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR---DEPSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      +||+++.++.++|+|||.+.....    .....++..|+|||.+.   ...++.++|+||+|+++++|++|..||...+.
T Consensus       150 ~nili~~~~~~kL~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~  225 (313)
T cd06633         150 GNILLTEPGQVKLADFGSASKSSP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA  225 (313)
T ss_pred             hhEEECCCCCEEEeecCCCcccCC----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence            999999999999999998753322    22345677899999874   34577889999999999999999999988777


Q ss_pred             HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ......+.....+......++..++++|.+||++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  259 (313)
T cd06633         226 MSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQK  259 (313)
T ss_pred             HHHHHHHHhcCCCCCCccccCHHHHHHHHHHccC
Confidence            6766666433333333456889999999999974

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.3e-31  Score=200.61  Aligned_cols=187  Identities=34%  Similarity=0.539  Sum_probs=144.5

Q ss_pred             CCCCCCCCcccccceee--cCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            1 MKRLRHPNIVLFMGAVT--QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      |++++||||+++.+++.  +....++|+||+++++|.+++....  ..+++..++.++.|++.||+|||++|  ++|+||
T Consensus        59 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dl  134 (284)
T cd05081          59 LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSKR--YVHRDL  134 (284)
T ss_pred             HHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccC
Confidence            35789999999999774  3456899999999999999996533  23789999999999999999999999  999999


Q ss_pred             CCCcEEecCCCcEEEccccccccccccccc---CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLS---SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        79 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      +|+||+++.++.++|+|||++.........   .........|+|||...+..++.++|+||+|+++++|++|..|+...
T Consensus       135 kp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~  214 (284)
T cd05081         135 ATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSP  214 (284)
T ss_pred             CHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCc
Confidence            999999999999999999988754322111   11112234589999998888889999999999999999987765432


Q ss_pred             CHHH---------------HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          156 NPAQ---------------VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~~---------------~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....               ............+.+..++..+.++|.+||++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  265 (284)
T cd05081         215 PAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNN  265 (284)
T ss_pred             chhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccC
Confidence            2110               01112223345566778999999999999973

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-33  Score=216.07  Aligned_cols=185  Identities=30%  Similarity=0.569  Sum_probs=162.2

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++||||+++++++.+. ..|+|||.++-|-|..+++..+.+  ++......++.||..|+.|||+.+  ++||||-.
T Consensus       445 MrnfdHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~nk~s--L~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAa  519 (974)
T KOG4257|consen  445 MRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQNKDS--LPLRTLTLYCYQICTALAYLESKR--FVHRDIAA  519 (974)
T ss_pred             HHhCCCcchhheeeeeecc-ceeEEEecccchhHHHHHHhcccc--chHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhh
Confidence            4689999999999999875 599999999999999999877655  888899999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA  158 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~  158 (191)
                      +||++.....+||+|||++....+.. .......-...|||||.+.-+.++.++|||-+|+.+|+++. |..||......
T Consensus       520 RNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs  599 (974)
T KOG4257|consen  520 RNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS  599 (974)
T ss_pred             hheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc
Confidence            99999999999999999998654432 22233344668999999999999999999999999999866 78899987777


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +++-.+. .+.+++.|++|++.+..++.+||+.
T Consensus       600 DVI~~iE-nGeRlP~P~nCPp~LYslmskcWay  631 (974)
T KOG4257|consen  600 DVIGHIE-NGERLPCPPNCPPALYSLMSKCWAY  631 (974)
T ss_pred             ceEEEec-CCCCCCCCCCCChHHHHHHHHHhcc
Confidence            7777775 7789999999999999999999973

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1e-31  Score=203.92  Aligned_cols=157  Identities=29%  Similarity=0.428  Sum_probs=129.6

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..+++|||+++++|.+++..... ..+++..+..++.|+++||+|||+.+  ++|+||+|
T Consensus        53 l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~  129 (314)
T cd08216          53 SRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKA  129 (314)
T ss_pred             HHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCc
Confidence            3567999999999999999999999999999999999975331 23789999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccccc-------ccCCCCCCCCcccCccccccC--CCCCcchHHHHHHHHHHHHhCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTF-------LSSKSAAGTPEWMAPEVLRDE--PSNEKSDIYSFGVILWELATLQQP  151 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~-------~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p  151 (191)
                      +||+++.++.++++||+.+.......       ........+..|+|||.+.+.  .++.++|+||+|+++++|++|..|
T Consensus       130 ~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~p  209 (314)
T cd08216         130 SHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP  209 (314)
T ss_pred             ceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCC
Confidence            99999999999999998765332111       111222345679999998663  477899999999999999999999


Q ss_pred             CCCCCHHHH
Q 029552          152 WGNLNPAQV  160 (191)
Q Consensus       152 f~~~~~~~~  160 (191)
                      |........
T Consensus       210 f~~~~~~~~  218 (314)
T cd08216         210 FKDMPATQM  218 (314)
T ss_pred             CCCCCHHHH
Confidence            987655443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-33  Score=197.46  Aligned_cols=183  Identities=28%  Similarity=0.456  Sum_probs=149.6

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCeeecCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKS   80 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~~h~~l~p   80 (191)
                      +..++|+||+.+++|..+...++.||.| +..+..++.+..  +.++|.-+-++...+++||.||-+ ++  ++|||+||
T Consensus       146 ~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKP  220 (391)
T KOG0983|consen  146 KSHDCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKP  220 (391)
T ss_pred             hccCCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCc
Confidence            3457899999999999999999999988 457777775433  238999999999999999999975 67  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC---CCCCcchHHHHHHHHHHHHhCCCCCCC-CC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE---PSNEKSDIYSFGVILWELATLQQPWGN-LN  156 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~---~~~~~~Dv~slG~~~~~l~~g~~pf~~-~~  156 (191)
                      +||+++..|++||+|||++-+..++.. .....+=+.||+||.+...   .|+.++||||||+++++++||+.||.. ..
T Consensus       221 SNILlDe~GniKlCDFGIsGrlvdSkA-htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t  299 (391)
T KOG0983|consen  221 SNILLDERGNIKLCDFGISGRLVDSKA-HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT  299 (391)
T ss_pred             cceEEccCCCEEeecccccceeecccc-cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc
Confidence            999999999999999999876655532 2334566789999998643   588999999999999999999999987 45


Q ss_pred             HHHHHHHHHhcCcccCCCC--CCCHHHHHHHHHHhcC
Q 029552          157 PAQVVAAVGFKGKRLEIPR--NVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~--~~s~~~~~li~~cl~~  191 (191)
                      .-+++.++.. ..++-+|.  .+|+.+++++..||.|
T Consensus       300 dFe~ltkvln-~ePP~L~~~~gFSp~F~~fv~~CL~k  335 (391)
T KOG0983|consen  300 DFEVLTKVLN-EEPPLLPGHMGFSPDFQSFVKDCLTK  335 (391)
T ss_pred             cHHHHHHHHh-cCCCCCCcccCcCHHHHHHHHHHhhc
Confidence            5566666654 33444443  5899999999999986

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.3e-31  Score=201.59  Aligned_cols=185  Identities=24%  Similarity=0.331  Sum_probs=147.9

Q ss_pred             CCCCCCCcccccceeecC--CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            2 KRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      ++++||||+++++++...  +..++++||+.+ +|.+++.....  .+++++++.++.|+++||+|||+.+  ++|+||+
T Consensus        59 ~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~  133 (293)
T cd07843          59 LKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLK  133 (293)
T ss_pred             HhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCC
Confidence            467899999999998876  889999999975 99988865332  3899999999999999999999999  9999999


Q ss_pred             CCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      |+||+++.++.++|+|||.+..............++..|+|||.+.+.. .+.++|+||+|+++++|++|..||......
T Consensus       134 p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~  213 (293)
T cd07843         134 TSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI  213 (293)
T ss_pred             HHHEEECCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH
Confidence            9999999999999999998775444322223334567899999987654 578899999999999999999999887766


Q ss_pred             HHHHHHHhcCc-----------------------------ccCCCCC-CCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGK-----------------------------RLEIPRN-VNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~-----------------------------~~~~~~~-~s~~~~~li~~cl~~  191 (191)
                      ....++...-.                             ...++.. +++.++++|++||+.
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  276 (293)
T cd07843         214 DQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTY  276 (293)
T ss_pred             HHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhcc
Confidence            65554321100                             1122333 689999999999974

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.8e-31  Score=200.48  Aligned_cols=183  Identities=25%  Similarity=0.396  Sum_probs=147.1

Q ss_pred             CCC-CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++ +|+||++++++++.+...++|+||+++++|.+++....   .+++.++..++.|++.||.+||+.+  ++|+||+|
T Consensus        59 ~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p  133 (290)
T cd05613          59 EHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKL  133 (290)
T ss_pred             HhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCH
Confidence            345 59999999999999999999999999999999997643   3789999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDE--PSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      +||+++.++.++|+|||.+....... .......+...|++||...+.  ..+.++|+||+|+++|+|++|..||...+.
T Consensus       134 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~  213 (290)
T cd05613         134 ENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE  213 (290)
T ss_pred             HHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc
Confidence            99999999999999999876432221 112233466789999998653  357789999999999999999999974322


Q ss_pred             ----HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 ----AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ----~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                          ......+  .....+.|..+++.+.+++.+||++
T Consensus       214 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ll~~~l~~  249 (290)
T cd05613         214 KNSQAEISRRI--LKSEPPYPQEMSALAKDIIQRLLMK  249 (290)
T ss_pred             cccHHHHHHHh--hccCCCCCccCCHHHHHHHHHHhcC
Confidence                2222222  2234456788999999999999974

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-31  Score=199.74  Aligned_cols=186  Identities=25%  Similarity=0.349  Sum_probs=147.1

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++|||++++++++.+++..++++||+. ++|.+++..... ..+++.++..++.|+++||++||+.+  ++|+||+|+
T Consensus        53 ~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~  128 (283)
T cd07835          53 KELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQ  128 (283)
T ss_pred             HhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHH
Confidence            56789999999999999999999999995 589998865441 23899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      ||+++.++.++|+|||.+..............++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+....
T Consensus       129 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  208 (283)
T cd07835         129 NLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ  208 (283)
T ss_pred             HEEEcCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9999999999999999876433221122223446789999987664 467889999999999999999999987666544


Q ss_pred             HHHHHhcCc---------------------------ccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGK---------------------------RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~---------------------------~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+.....                           .......++..+.++|.+||+.
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  266 (283)
T cd07835         209 LFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVY  266 (283)
T ss_pred             HHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcC
Confidence            333221100                           0112356889999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.1e-31  Score=207.73  Aligned_cols=154  Identities=29%  Similarity=0.434  Sum_probs=129.4

Q ss_pred             CCCCCCCcccccceeecC------CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 029552            2 KRLRHPNIVLFMGAVTQP------PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH   75 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h   75 (191)
                      +.++||||+++++++...      ...|+||||+.+ +|.+.+..     .+++..+..++.|++.||+|||++|  ++|
T Consensus        78 ~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH  149 (364)
T cd07875          78 KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIH  149 (364)
T ss_pred             HhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC--eec
Confidence            567999999999987543      357999999975 77777743     1678889999999999999999999  999


Q ss_pred             cCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        76 ~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      |||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...
T Consensus       150 ~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  228 (364)
T cd07875         150 RDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT  228 (364)
T ss_pred             CCCCHHHEEECCCCcEEEEeCCCccccCCCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999986543321 222345678999999999988999999999999999999999999887


Q ss_pred             CHHHHHHHH
Q 029552          156 NPAQVVAAV  164 (191)
Q Consensus       156 ~~~~~~~~~  164 (191)
                      +..+....+
T Consensus       229 ~~~~~~~~~  237 (364)
T cd07875         229 DHIDQWNKV  237 (364)
T ss_pred             CHHHHHHHH
Confidence            776655554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.98  E-value=1.1e-31  Score=206.20  Aligned_cols=153  Identities=24%  Similarity=0.447  Sum_probs=127.6

Q ss_pred             CCCCCCCCcccccceeecC------CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCee
Q 029552            1 MKRLRHPNIVLFMGAVTQP------PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIV   74 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~   74 (191)
                      |++++||||+++++++...      ...+++++++ +++|.+++...    .+++.++..++.|++.||+|||+++  ++
T Consensus        68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~--iv  140 (343)
T cd07878          68 LKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSAG--II  140 (343)
T ss_pred             HHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ee
Confidence            4678999999999988543      3478999988 67998888643    2899999999999999999999999  99


Q ss_pred             ecCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCC
Q 029552           75 HRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWG  153 (191)
Q Consensus        75 h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~pf~  153 (191)
                      ||||+|+||+++.++.++|+|||++......   .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.
T Consensus       141 Hrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  217 (343)
T cd07878         141 HRDLKPSNVAVNEDCELRILDFGLARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFP  217 (343)
T ss_pred             cccCChhhEEECCCCCEEEcCCccceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            9999999999999999999999988654332   223356788999999876 457889999999999999999999998


Q ss_pred             CCCHHHHHHH
Q 029552          154 NLNPAQVVAA  163 (191)
Q Consensus       154 ~~~~~~~~~~  163 (191)
                      ..+.......
T Consensus       218 ~~~~~~~~~~  227 (343)
T cd07878         218 GNDYIDQLKR  227 (343)
T ss_pred             CCCHHHHHHH
Confidence            7665544443

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.98  E-value=1.6e-31  Score=200.81  Aligned_cols=151  Identities=28%  Similarity=0.468  Sum_probs=126.9

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++||||+++++++.+++..++|+||+.+ +|.+++.....  .+++..+..++.|+++||+|||+.+  ++|+||+|
T Consensus        57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p  131 (291)
T cd07844          57 LKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKP  131 (291)
T ss_pred             HhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCH
Confidence            3578999999999999999999999999975 99998865432  3789999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLN  156 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~  156 (191)
                      +||+++.++.++|+|||.+...............+..|+|||.+.+ ..++.++|+||+|+++|+|++|..||....
T Consensus       132 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~  208 (291)
T cd07844         132 QNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST  208 (291)
T ss_pred             HHEEEcCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence            9999999999999999987643222112222334668999998865 447888999999999999999999997654

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.98  E-value=2.1e-31  Score=201.96  Aligned_cols=182  Identities=29%  Similarity=0.481  Sum_probs=148.5

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |+.++|+|++++.+++..+...++|+||+. +++.+.+....  ..+++.++..++.|++.|+.+||+.+  ++|+||+|
T Consensus        69 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p  143 (308)
T cd06634          69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKA  143 (308)
T ss_pred             HHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCH
Confidence            356799999999999999999999999997 58877775432  23789999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR---DEPSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      +||+++.++.++++|||.+......    ....++..|+|||.+.   ....+.++|+||+|+++++|++|..||...+.
T Consensus       144 ~nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~  219 (308)
T cd06634         144 GNILLSEPGLVKLGDFGSASIMAPA----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA  219 (308)
T ss_pred             HhEEECCCCcEEECCcccceeecCc----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH
Confidence            9999999999999999987643322    2234567899999874   34567889999999999999999999988776


Q ss_pred             HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ......+.........+..++..++++|++||++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  253 (308)
T cd06634         220 MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK  253 (308)
T ss_pred             HHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhC
Confidence            6655555433333334557899999999999964

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.98  E-value=1.4e-31  Score=200.21  Aligned_cols=187  Identities=31%  Similarity=0.535  Sum_probs=149.2

Q ss_pred             CCCCCCCCcccccceeec--CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            1 MKRLRHPNIVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      |++++||||+++++++..  +...++++||+++++|.+++.....  .+++..+..++.|++.||++||+.+  ++|+||
T Consensus        60 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl  135 (284)
T cd05038          60 LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQR--YIHRDL  135 (284)
T ss_pred             HHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCC--eecCCC
Confidence            357899999999999877  5579999999999999999976442  3889999999999999999999999  999999


Q ss_pred             CCCcEEecCCCcEEEccccccccccccccc---CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLS---SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        79 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      +|+||+++.++.++|+|||.+.........   .........|++||...+...+.++|+||+|+++++|++|..|+...
T Consensus       136 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~  215 (284)
T cd05038         136 AARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP  215 (284)
T ss_pred             CHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence            999999999999999999988755422111   11122344699999998888889999999999999999999988653


Q ss_pred             CHHH--------------HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          156 NPAQ--------------VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~~--------------~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....              ............+.+..++..+.+++.+||++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  265 (284)
T cd05038         216 PAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEA  265 (284)
T ss_pred             cchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhcc
Confidence            2211              11222223445566778899999999999974

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.98  E-value=9.9e-32  Score=207.39  Aligned_cols=151  Identities=28%  Similarity=0.444  Sum_probs=126.3

Q ss_pred             CCCCCCCcccccceeecC------CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 029552            2 KRLRHPNIVLFMGAVTQP------PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH   75 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h   75 (191)
                      +.++||||+++++++...      ...+++|||+++ +|.+.+..     .+++..+..++.|+++||+|||+.|  ++|
T Consensus        71 ~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g--ivH  142 (355)
T cd07874          71 KCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIH  142 (355)
T ss_pred             HHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC--ccc
Confidence            467999999999988643      357999999975 67666643     2788899999999999999999999  999


Q ss_pred             cCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        76 ~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      |||||+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...
T Consensus       143 rDikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  221 (355)
T cd07874         143 RDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR  221 (355)
T ss_pred             CCCChHHEEECCCCCEEEeeCcccccCCCcc-ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999987543321 222345678999999999888999999999999999999999999876


Q ss_pred             CHHHHH
Q 029552          156 NPAQVV  161 (191)
Q Consensus       156 ~~~~~~  161 (191)
                      +.....
T Consensus       222 ~~~~~~  227 (355)
T cd07874         222 DYIDQW  227 (355)
T ss_pred             CHHHHH
Confidence            654433

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.98  E-value=1.1e-31  Score=200.54  Aligned_cols=186  Identities=25%  Similarity=0.382  Sum_probs=149.3

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++++||+.+ +|.+++....  ..+++.++..++.|+++||++||+.+  ++|+||+|
T Consensus        52 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p  126 (283)
T cd05118          52 LKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKP  126 (283)
T ss_pred             HHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCH
Confidence            3567899999999999999999999999975 8888886533  23899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      +||+++.++.++++|||.+..................|+|||.+.+. ..+.++|+||+|+++|++++|+.||...+..+
T Consensus       127 ~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~  206 (283)
T cd05118         127 ENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID  206 (283)
T ss_pred             HHEEECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999999999999999876544332122233456689999998776 67889999999999999999999998877666


Q ss_pred             HHHHHHhcCccc----------------------------CCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRL----------------------------EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~----------------------------~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+......+                            .....++..++++|.+||++
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  266 (283)
T cd05118         207 QLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHY  266 (283)
T ss_pred             HHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhcc
Confidence            554443211110                            11235789999999999974

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.98  E-value=3.6e-31  Score=203.45  Aligned_cols=188  Identities=30%  Similarity=0.543  Sum_probs=147.5

Q ss_pred             CCC-CCCCcccccceeec-CCceEEEEeccCCCCHHHHhcCCCC------------------------------------
Q 029552            2 KRL-RHPNIVLFMGAVTQ-PPNLSIVTEYLSRGSLYRLLHKPGV------------------------------------   43 (191)
Q Consensus         2 ~~l-~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~------------------------------------   43 (191)
                      +++ +||||+++++++.. +...++++||+++++|.+++.....                                    
T Consensus        65 ~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (343)
T cd05103          65 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSS  144 (343)
T ss_pred             HhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccc
Confidence            345 68999999998764 4568899999999999999864210                                    


Q ss_pred             ----------------------------cccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecCCCcEEEcc
Q 029552           44 ----------------------------REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCD   95 (191)
Q Consensus        44 ----------------------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d   95 (191)
                                                  ...++..++..++.|+++||+|||+++  ++|+||+|.||+++.++.++++|
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~d  222 (343)
T cd05103         145 QSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICD  222 (343)
T ss_pred             cccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEe
Confidence                                        123677788899999999999999999  99999999999999999999999


Q ss_pred             ccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCcccC
Q 029552           96 FGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLE  172 (191)
Q Consensus        96 ~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  172 (191)
                      ||++.......  ........+..|+|||.+.+..++.++|+||+|++++++++ |..||...............+...+
T Consensus       223 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  302 (343)
T cd05103         223 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR  302 (343)
T ss_pred             cccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCC
Confidence            99876432221  11112233457999999988888999999999999999997 8999987554433333333555666


Q ss_pred             CCCCCCHHHHHHHHHHhcC
Q 029552          173 IPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       173 ~~~~~s~~~~~li~~cl~~  191 (191)
                      .|..+++.+.+++.+||++
T Consensus       303 ~~~~~~~~~~~~~~~cl~~  321 (343)
T cd05103         303 APDYTTPEMYQTMLDCWHG  321 (343)
T ss_pred             CCCCCCHHHHHHHHHHccC
Confidence            7777899999999999964

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.98  E-value=4.6e-31  Score=197.30  Aligned_cols=180  Identities=24%  Similarity=0.349  Sum_probs=142.4

Q ss_pred             CCCCcccccceeecC--CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCc
Q 029552            5 RHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN   82 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~n   82 (191)
                      +||||+++++++.++  +..++|+||+.+ +|.+.+....  ..+++.+++.++.|++.||++||+.+  ++|+||+|+|
T Consensus        56 ~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~n  130 (282)
T cd07831          56 PHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPEN  130 (282)
T ss_pred             CCCCccceEEEEecCCCCcEEEEEecCCc-cHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHH
Confidence            499999999999987  889999999975 7877775432  23899999999999999999999999  9999999999


Q ss_pred             EEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           83 LLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        83 i~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      |+++. +.++|+|||.+......... ....++..|+|||.+.. ...+.++|+||+|+++++|++|..||...+..+..
T Consensus       131 i~l~~-~~~kl~dfg~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~  208 (282)
T cd07831         131 ILIKD-DILKLADFGSCRGIYSKPPY-TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI  208 (282)
T ss_pred             EEEcC-CCeEEEecccccccccCCCc-CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHH
Confidence            99999 99999999988654332211 22345678999997654 44678999999999999999999999887766655


Q ss_pred             HHHHhcCc----------------ccCC-----------CCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKGK----------------RLEI-----------PRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~~----------------~~~~-----------~~~~s~~~~~li~~cl~~  191 (191)
                      ..+.....                ....           ...+|..++++|.+||++
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  265 (282)
T cd07831         209 AKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAY  265 (282)
T ss_pred             HHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhcc
Confidence            44432111                0111           235789999999999974

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.98  E-value=5e-31  Score=198.44  Aligned_cols=187  Identities=24%  Similarity=0.318  Sum_probs=145.2

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++||||+++++++.++...++|+||+. ++|.+.+..... ..+++..+..++.||+.||+|||+.+  ++|+||+|
T Consensus        55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p  130 (294)
T PLN00009         55 LKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKP  130 (294)
T ss_pred             HHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCc
Confidence            357899999999999999999999999996 588887754332 23678888999999999999999999  99999999


Q ss_pred             CcEEecC-CCcEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           81 PNLLVDK-KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        81 ~ni~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      +||+++. ++.++++|||.+..............++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+..
T Consensus       131 ~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~  210 (294)
T PLN00009        131 QNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI  210 (294)
T ss_pred             ceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999985 5579999999886543332222233456789999988664 4678999999999999999999999887665


Q ss_pred             HHHHHHHhcCcc-------------------c--------CCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKR-------------------L--------EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~-------------------~--------~~~~~~s~~~~~li~~cl~~  191 (191)
                      +....+......                   .        .....+++.+.++|.+||++
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  270 (294)
T PLN00009        211 DELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRL  270 (294)
T ss_pred             HHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccC
Confidence            555443211000                   0        01246789999999999974

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=1.4e-31  Score=195.19  Aligned_cols=179  Identities=25%  Similarity=0.459  Sum_probs=144.8

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      .|+||+.++++|+++..+|+|||-|.||+|...++++.   .|++.++.+++..|+.||.|||+.|  |+|||+||+||+
T Consensus       134 gh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiL  208 (463)
T KOG0607|consen  134 GHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENIL  208 (463)
T ss_pred             CCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhcC--cccccCCcccee
Confidence            59999999999999999999999999999999998855   4999999999999999999999999  999999999999


Q ss_pred             ecCCC---cEEEcccccccccc-------cccccCCCCCCCCcccCccccc-----cCCCCCcchHHHHHHHHHHHHhCC
Q 029552           85 VDKKY---TVKVCDFGLSRLKA-------NTFLSSKSAAGTPEWMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQ  149 (191)
Q Consensus        85 ~~~~~---~~~l~d~~~~~~~~-------~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Dv~slG~~~~~l~~g~  149 (191)
                      ....+   .+||+||.+..-..       ......-.++++..|||||+..     ..-|+.++|.||||+++|-|++|.
T Consensus       209 C~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGY  288 (463)
T KOG0607|consen  209 CESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGY  288 (463)
T ss_pred             ecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCC
Confidence            96544   58999998764211       1112233467788899999763     334788999999999999999999


Q ss_pred             CCCCCCC---------------HHHHHHHHHhcCcccCCCC----CCCHHHHHHHHHHhc
Q 029552          150 QPWGNLN---------------PAQVVAAVGFKGKRLEIPR----NVNPHVASIIEACWA  190 (191)
Q Consensus       150 ~pf~~~~---------------~~~~~~~~~~~~~~~~~~~----~~s~~~~~li~~cl~  190 (191)
                      +||...=               +....+.|.  .....+|.    .+|...+++|...|.
T Consensus       289 pPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ--EGkYeFPdkdWahIS~eakdlisnLlv  346 (463)
T KOG0607|consen  289 PPFVGHCGADCGWDRGEVCRVCQNKLFESIQ--EGKYEFPDKDWAHISSEAKDLISNLLV  346 (463)
T ss_pred             CCccCccCCcCCccCCCccHHHHHHHHHHHh--ccCCcCChhhhHHhhHHHHHHHHHHHh
Confidence            9995321               233445553  33555664    699999999998774

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.98  E-value=1.9e-32  Score=202.17  Aligned_cols=186  Identities=25%  Similarity=0.391  Sum_probs=143.0

Q ss_pred             CCCCCCCCcccccceeecCC-----ceEEEEeccCCCCHHHHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhCCCCee
Q 029552            1 MKRLRHPNIVLFMGAVTQPP-----NLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDVAKGMNYLHRRNPPIV   74 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~   74 (191)
                      |+.++|||||++..+|....     ...+||||++. +|.+.++.- ..+..++.-.+.-+++||++||.|||+.|  |+
T Consensus        71 m~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--Ic  147 (364)
T KOG0658|consen   71 MRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--IC  147 (364)
T ss_pred             HHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cc
Confidence            45789999999999885322     35589999975 999998731 11223888899999999999999999999  99


Q ss_pred             ecCCCCCcEEecCC-CcEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCC
Q 029552           75 HRDLKSPNLLVDKK-YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPW  152 (191)
Q Consensus        75 h~~l~p~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf  152 (191)
                      ||||||.|++++.+ |.+||+|||.++...... ....-.++..|.|||.+.|. .|+.+.|+||.|||+.||+-|++-|
T Consensus       148 HRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e-pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plF  226 (364)
T KOG0658|consen  148 HRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLF  226 (364)
T ss_pred             cCCCChheEEEcCCCCeEEeccCCcceeeccCC-CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCccc
Confidence            99999999999986 899999999887543331 22333456689999988776 4899999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhcCc----------ccC-----------------CCCCCCHHHHHHHHHHhc
Q 029552          153 GNLNPAQVVAAVGFKGK----------RLE-----------------IPRNVNPHVASIIEACWA  190 (191)
Q Consensus       153 ~~~~~~~~~~~~~~~~~----------~~~-----------------~~~~~s~~~~~li~~cl~  190 (191)
                      .+.+....+..|..-.+          .+.                 +....+++..+++.++|.
T Consensus       227 pG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~  291 (364)
T KOG0658|consen  227 PGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQ  291 (364)
T ss_pred             CCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhc
Confidence            88666555444322111          010                 224578899999999885

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.98  E-value=1.7e-32  Score=213.34  Aligned_cols=186  Identities=37%  Similarity=0.659  Sum_probs=156.0

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++-+|.||+=+.++|..+.. .+|+-+|+|-+|..++.....+  |.....+.|+.|+++|..|||..+  |+|+|||.
T Consensus       442 lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etk--fdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKS  516 (678)
T KOG0193|consen  442 LKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETK--FDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKS  516 (678)
T ss_pred             HhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhh--hhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccc
Confidence            467799999999999988776 9999999999999999765543  888999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccc--cccCCCCCCCCcccCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRD---EPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~---~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      .|||+..++.++|+|||++.....-  ..-.....+...|||||+++.   .+++..+||||+|+|+|||++|.+||...
T Consensus       517 nNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~  596 (678)
T KOG0193|consen  517 NNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ  596 (678)
T ss_pred             cceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC
Confidence            9999999999999999998643221  122334556778999999863   35788999999999999999999999988


Q ss_pred             CHHHHHHHHHhcCc---ccCCCCCCCHHHHHHHHHHhcC
Q 029552          156 NPAQVVAAVGFKGK---RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~~~~~~~~~~~~---~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +.+..+..+.++..   ....-.+++.++++|+..||++
T Consensus       597 ~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~  635 (678)
T KOG0193|consen  597 NRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKF  635 (678)
T ss_pred             ChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhc
Confidence            88888877754422   2234467889999999999974

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.98  E-value=5.6e-31  Score=199.59  Aligned_cols=186  Identities=25%  Similarity=0.325  Sum_probs=147.0

Q ss_pred             CCCCCCCCcccccceeecC--CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            1 MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      |++++|+||+++++++.+.  +..++|+||+.+ +|.+++....  ..+++.++..++.|+++||++||+.|  ++|+||
T Consensus        60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl  134 (309)
T cd07845          60 LLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF--IIHRDL  134 (309)
T ss_pred             HHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCC
Confidence            3578999999999998754  468999999975 8888886532  23899999999999999999999999  999999


Q ss_pred             CCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        79 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      +|+||+++.++.++|+|||.+...............+..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...++
T Consensus       135 ~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~  214 (309)
T cd07845         135 KVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE  214 (309)
T ss_pred             CHHHEEECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999999999999999988654432222222234667999998865 4468899999999999999999999998888


Q ss_pred             HHHHHHHHhcCcc-----------------cCCC-----------CCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKR-----------------LEIP-----------RNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~-----------------~~~~-----------~~~s~~~~~li~~cl~~  191 (191)
                      .+....+......                 ...+           ..+++.+.++|.+||+.
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~  276 (309)
T cd07845         215 IEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMY  276 (309)
T ss_pred             HHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcC
Confidence            7776665432110                 0111           13689999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=4.6e-31  Score=208.91  Aligned_cols=147  Identities=26%  Similarity=0.408  Sum_probs=125.2

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++..++..++++|++. ++|.+++.....  .+++.+++.++.|++.||+|||+.|  ++||||||
T Consensus       214 L~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP  288 (461)
T PHA03211        214 LRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLR--PLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKT  288 (461)
T ss_pred             HHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCH
Confidence            467899999999999999999999999995 688888754322  3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccc--cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW  152 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf  152 (191)
                      +||+++.++.++|+|||++........  ......++..|++||.+.+..++.++|+|||||++|+|++|..|+
T Consensus       289 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        289 ENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             HHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            999999999999999999864332211  112345788999999999988999999999999999999987654

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=5.3e-31  Score=197.76  Aligned_cols=186  Identities=31%  Similarity=0.505  Sum_probs=145.7

Q ss_pred             CCCCCCCCcccccceeec--CCceEEEEeccCCCCHHHHhcCCC-CcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecC
Q 029552            1 MKRLRHPNIVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRD   77 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~   77 (191)
                      |++++||||++++++|.+  ++..+++|||+++++|.+++.... ....+++..+..++.|++.||.|||+.+  ++|+|
T Consensus        53 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~d  130 (287)
T cd06621          53 NKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRD  130 (287)
T ss_pred             HHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCC
Confidence            357899999999998854  447899999999999998875311 1234789999999999999999999999  99999


Q ss_pred             CCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC--
Q 029552           78 LKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL--  155 (191)
Q Consensus        78 l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~--  155 (191)
                      ++|+||+++.++.++|+|||.+.......  .....++..|++||.+.+..++.++|+||+|+++|+|++|..||...  
T Consensus       131 l~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  208 (287)
T cd06621         131 IKPSNILLTRKGQVKLCDFGVSGELVNSL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGE  208 (287)
T ss_pred             CCHHHEEEecCCeEEEeeccccccccccc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccC
Confidence            99999999999999999999876433221  12234566899999998888899999999999999999999999765  


Q ss_pred             ---CHHHHHHHHHhcCcccCCC------CCCCHHHHHHHHHHhcC
Q 029552          156 ---NPAQVVAAVGFKGKRLEIP------RNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ---~~~~~~~~~~~~~~~~~~~------~~~s~~~~~li~~cl~~  191 (191)
                         .+.+....+.. ...+..+      ...++.++++|.+||++
T Consensus       209 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  252 (287)
T cd06621         209 PPLGPIELLSYIVN-MPNPELKDEPGNGIKWSEEFKDFIKQCLEK  252 (287)
T ss_pred             CCCChHHHHHHHhc-CCchhhccCCCCCCchHHHHHHHHHHHcCC
Confidence               33444444432 1122222      23568999999999964

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=210.31  Aligned_cols=186  Identities=37%  Similarity=0.666  Sum_probs=163.2

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      ++.++|||+|+++++|.....+|+|+|||..|+|.+++++.. +..++.-..+.++.||..|.+||.+.+  ++||||-.
T Consensus       317 MKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAA  393 (1157)
T KOG4278|consen  317 MKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAA  393 (1157)
T ss_pred             HHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhh
Confidence            467899999999999999999999999999999999998754 333666677788899999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccc-cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ-QPWGNLNPA  158 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~-~pf~~~~~~  158 (191)
                      .|+++..+..+|+.|||++.++..... ......-...|.|||.+.-..++.++|||++|+++|++.|.. -||...+..
T Consensus       394 RNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS  473 (1157)
T KOG4278|consen  394 RNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS  473 (1157)
T ss_pred             hhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH
Confidence            999999999999999999988765532 222333456899999999999999999999999999999964 599999988


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhc
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~  190 (191)
                      .+...+. .+.+..-|..|++.+.+||.+||+
T Consensus       474 qVY~LLE-kgyRM~~PeGCPpkVYeLMraCW~  504 (1157)
T KOG4278|consen  474 QVYGLLE-KGYRMDGPEGCPPKVYELMRACWN  504 (1157)
T ss_pred             HHHHHHh-ccccccCCCCCCHHHHHHHHHHhc
Confidence            8888774 788999999999999999999997

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=3.5e-31  Score=204.49  Aligned_cols=146  Identities=27%  Similarity=0.459  Sum_probs=124.1

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++|+|++. ++|.+++....  ..+++.++..++.|++.||+|||+++  ++||||||
T Consensus       111 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp  185 (357)
T PHA03209        111 LQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKT  185 (357)
T ss_pred             HHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCH
Confidence            467899999999999999999999999996 58888875433  23889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW  152 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf  152 (191)
                      +||+++.++.++|+|||.+...... .......++..|+|||.+.+..++.++|+||+|+++|+|+++..|+
T Consensus       186 ~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        186 ENIFINDVDQVCIGDLGAAQFPVVA-PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             HHEEECCCCCEEEecCccccccccC-cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            9999999999999999988643222 1122345678899999999888999999999999999999875543

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=5.2e-31  Score=197.81  Aligned_cols=183  Identities=25%  Similarity=0.391  Sum_probs=147.6

Q ss_pred             CCC-CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++ +||||+++++.+..++..++||||+.+++|.+.+....   .+++.++..++.|++++|++||+.+  ++|+||+|
T Consensus        59 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p  133 (288)
T cd05583          59 EAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKL  133 (288)
T ss_pred             HhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCH
Confidence            345 59999999999999999999999999999999987543   3789999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccc-cCCCCCCCCcccCccccccCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRDEP--SNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~--~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      +||+++.++.++++|||.+........ ......++..|++||...+..  .+.++|+||+|+++++|++|..||.....
T Consensus       134 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~  213 (288)
T cd05583         134 ENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE  213 (288)
T ss_pred             HHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc
Confidence            999999999999999998764332211 112234577899999987654  67889999999999999999999964322


Q ss_pred             ----HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 ----AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ----~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                          .+....+  .....+.|..++..++++|.+||++
T Consensus       214 ~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~  249 (288)
T cd05583         214 QNSQSEISRRI--LKSKPPFPKTMSAEARDFIQKLLEK  249 (288)
T ss_pred             cchHHHHHHHH--HccCCCCCcccCHHHHHHHHHHhcC
Confidence                2222222  2234567788999999999999974

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.97  E-value=1.2e-30  Score=194.19  Aligned_cols=188  Identities=28%  Similarity=0.522  Sum_probs=149.4

Q ss_pred             CCCCCCCCcccccceeecCC------ceEEEEeccCCCCHHHHhcCCC---CcccccHHHHHHHHHHHHHHHHHHHhCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPP------NLSIVTEYLSRGSLYRLLHKPG---VREMLDERRRLNMAYDVAKGMNYLHRRNP   71 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~   71 (191)
                      |++++||||+++++++...+      ..+++++|+.+++|.+++....   ....++...+..++.|++.||+|||+.+ 
T Consensus        55 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~-  133 (273)
T cd05074          55 MKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN-  133 (273)
T ss_pred             HhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence            46789999999999886432      2478899999999988874321   1123788899999999999999999999 


Q ss_pred             CeeecCCCCCcEEecCCCcEEEcccccccccccccc--cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-C
Q 029552           72 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-L  148 (191)
Q Consensus        72 ~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g  148 (191)
                       ++|+||+|+||+++.++.++++|||.+........  ..........|++||...+..++.++|+||+|+++|+|++ |
T Consensus       134 -i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g  212 (273)
T cd05074         134 -FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRG  212 (273)
T ss_pred             -EeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCC
Confidence             99999999999999999999999998764432211  1112223457899999888888889999999999999999 8


Q ss_pred             CCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          149 QQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       149 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..||...+..+....+. .......+..++..+.+++.+||++
T Consensus       213 ~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~l~~  254 (273)
T cd05074         213 QTPYAGVENSEIYNYLI-KGNRLKQPPDCLEDVYELMCQCWSP  254 (273)
T ss_pred             CCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcCC
Confidence            89998877766666554 3445566678999999999999964

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=4.2e-31  Score=201.94  Aligned_cols=185  Identities=26%  Similarity=0.410  Sum_probs=150.3

Q ss_pred             CCCCCCCCcccccceeecCC-----ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 029552            1 MKRLRHPNIVLFMGAVTQPP-----NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH   75 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h   75 (191)
                      |++++||||+++.+++...+     ..|+++||+. ++|.+++....   .+++..++.++.|++.||++||+.|  ++|
T Consensus        53 l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g--i~H  126 (330)
T cd07834          53 LRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN--VIH  126 (330)
T ss_pred             HHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC--eec
Confidence            35678999999999998765     7899999997 48988886543   3899999999999999999999999  999


Q ss_pred             cCCCCCcEEecCCCcEEEccccccccccccc---ccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCC
Q 029552           76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQP  151 (191)
Q Consensus        76 ~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p  151 (191)
                      +||+|.||+++.++.++|+|||.+.......   .......++..|+|||.+.+. ..+.++|+||+|+++++|++|..|
T Consensus       127 ~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~p  206 (330)
T cd07834         127 RDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPL  206 (330)
T ss_pred             CCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCC
Confidence            9999999999999999999999887554432   112233456789999999877 788899999999999999999999


Q ss_pred             CCCCCHHHHHHHHHhcCcccC-----------------------------CCCCCCHHHHHHHHHHhcC
Q 029552          152 WGNLNPAQVVAAVGFKGKRLE-----------------------------IPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       152 f~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~s~~~~~li~~cl~~  191 (191)
                      |...+..+....+......++                             ....++..+.++|.+||++
T Consensus       207 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  275 (330)
T cd07834         207 FPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVF  275 (330)
T ss_pred             cCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccC
Confidence            988777665555443211111                             1234789999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=9.1e-31  Score=200.52  Aligned_cols=185  Identities=22%  Similarity=0.285  Sum_probs=146.7

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++..++..+++||++. ++|.+++....   .++++.+..++.|++.||++||+.+  ++|+||+|
T Consensus        74 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~  147 (335)
T PTZ00024         74 MNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKWY--FMHRDLSP  147 (335)
T ss_pred             HHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eecccccH
Confidence            356899999999999999999999999997 58999886533   3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccc--------------cccCCCCCCCCcccCccccccCC-CCCcchHHHHHHHHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANT--------------FLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWEL  145 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~--------------~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l  145 (191)
                      +||+++.++.++|+|||.+.....+              .........+..|+|||.+.+.. ++.++|+||+|+++++|
T Consensus       148 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el  227 (335)
T PTZ00024        148 ANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAEL  227 (335)
T ss_pred             HHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHH
Confidence            9999999999999999987654311              01111223466799999987643 57889999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHHHhcCccc--------------------------CCCCCCCHHHHHHHHHHhcC
Q 029552          146 ATLQQPWGNLNPAQVVAAVGFKGKRL--------------------------EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       146 ~~g~~pf~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~s~~~~~li~~cl~~  191 (191)
                      ++|..||...+..+....+......+                          ......+..+.++|.+||++
T Consensus       228 ~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  299 (335)
T PTZ00024        228 LTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKL  299 (335)
T ss_pred             HhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCC
Confidence            99999999877766554442211100                          01235688999999999974

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=202.60  Aligned_cols=186  Identities=25%  Similarity=0.440  Sum_probs=151.9

Q ss_pred             CCCCCCCcccccceee-cCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            2 KRLRHPNIVLFMGAVT-QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +.|+||-||+++++|. +.+.+|-|+|||+|.+|+.++.....   +++.+++.|++||+.||.||....++|+|-||||
T Consensus       522 KeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhkl---mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKP  598 (775)
T KOG1151|consen  522 KELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKL---MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKP  598 (775)
T ss_pred             hccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhh---hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCC
Confidence            4689999999999995 77789999999999999999977554   9999999999999999999999988899999999


Q ss_pred             CcEEecC---CCcEEEcccccccccccc-------cccCCCCCCCCcccCccccccC----CCCCcchHHHHHHHHHHHH
Q 029552           81 PNLLVDK---KYTVKVCDFGLSRLKANT-------FLSSKSAAGTPEWMAPEVLRDE----PSNEKSDIYSFGVILWELA  146 (191)
Q Consensus        81 ~ni~~~~---~~~~~l~d~~~~~~~~~~-------~~~~~~~~~~~~~~~pe~~~~~----~~~~~~Dv~slG~~~~~l~  146 (191)
                      .||++..   .|.+||+|||++....+.       ........++.+|++||.+.-.    .++.+.||||+|+++|+.+
T Consensus       599 gNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQCl  678 (775)
T KOG1151|consen  599 GNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCL  678 (775)
T ss_pred             ccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhh
Confidence            9999954   478999999999875433       2334566788999999977433    3577899999999999999


Q ss_pred             hCCCCCCCC-CHHHHHHH---HHhcCcccCCCCCCCHHHHHHHHHHhc
Q 029552          147 TLQQPWGNL-NPAQVVAA---VGFKGKRLEIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       147 ~g~~pf~~~-~~~~~~~~---~~~~~~~~~~~~~~s~~~~~li~~cl~  190 (191)
                      .|+.||+.. ....++..   +......++..+.+|.+.+++|++||.
T Consensus       679 YGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLa  726 (775)
T KOG1151|consen  679 YGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLA  726 (775)
T ss_pred             ccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHH
Confidence            999999863 33333322   111223445556799999999999996

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=196.26  Aligned_cols=158  Identities=27%  Similarity=0.446  Sum_probs=130.5

Q ss_pred             CCCCCCCCcccccceeec-----CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 029552            1 MKRLRHPNIVLFMGAVTQ-----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH   75 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h   75 (191)
                      |+.++|+||+.+.+++.-     -+.+|+|+|+|+ .+|..++..+..   ++++.+..++.|++.||+|+|+.|  ++|
T Consensus        75 Lr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMe-tDL~~iik~~~~---L~d~H~q~f~YQiLrgLKyiHSAn--ViH  148 (359)
T KOG0660|consen   75 LRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELME-TDLHQIIKSQQD---LTDDHAQYFLYQILRGLKYIHSAN--VIH  148 (359)
T ss_pred             HHHhcCCCcceEEeecccccccccceeEEehhHHh-hHHHHHHHcCcc---ccHHHHHHHHHHHHHhcchhhccc--ccc
Confidence            456899999999999854     346999999995 599999987543   899999999999999999999999  999


Q ss_pred             cCCCCCcEEecCCCcEEEcccccccccccc--cccCCCCCCCCcccCccccc-cCCCCCcchHHHHHHHHHHHHhCCCCC
Q 029552           76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLR-DEPSNEKSDIYSFGVILWELATLQQPW  152 (191)
Q Consensus        76 ~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Dv~slG~~~~~l~~g~~pf  152 (191)
                      ||+||.|++++.+..+|++|||++......  ......-+.+.+|.|||.+. ...|+.+.|+||+||++.+|++|++-|
T Consensus       149 RDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplF  228 (359)
T KOG0660|consen  149 RDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLF  228 (359)
T ss_pred             cccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCC
Confidence            999999999999999999999998754321  11222335577999999875 446899999999999999999999988


Q ss_pred             CCCCHHHHHHHH
Q 029552          153 GNLNPAQVVAAV  164 (191)
Q Consensus       153 ~~~~~~~~~~~~  164 (191)
                      .+.+....+..+
T Consensus       229 pG~d~v~Ql~lI  240 (359)
T KOG0660|consen  229 PGKDYVHQLQLI  240 (359)
T ss_pred             CCCchHHHHHHH
Confidence            776655544443

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.97  E-value=1.1e-30  Score=196.27  Aligned_cols=152  Identities=28%  Similarity=0.425  Sum_probs=125.2

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |+.++|+||+++.+++.+++..++|+||+. ++|.+.+....  ..+++.++..++.|++.||+|||+.+  ++|+||+|
T Consensus        57 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp  131 (291)
T cd07870          57 LKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKP  131 (291)
T ss_pred             HHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCh
Confidence            356899999999999999999999999996 57776664332  22678888999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      +||+++.++.++|+|||.+..............++..|+|||.+.+. .++.++|+||+|+++++|++|..||.....
T Consensus       132 ~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~  209 (291)
T cd07870         132 QNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD  209 (291)
T ss_pred             HHEEEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence            99999999999999999876433222222333457789999998754 467789999999999999999999976543

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.97  E-value=1.3e-30  Score=196.20  Aligned_cols=186  Identities=26%  Similarity=0.305  Sum_probs=143.1

Q ss_pred             CC-CCCCcccccceeecCCc-----eEEEEeccCCCCHHHHhcCCCC--cccccHHHHHHHHHHHHHHHHHHHhCCCCee
Q 029552            3 RL-RHPNIVLFMGAVTQPPN-----LSIVTEYLSRGSLYRLLHKPGV--REMLDERRRLNMAYDVAKGMNYLHRRNPPIV   74 (191)
Q Consensus         3 ~l-~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~   74 (191)
                      ++ +||||+++++++...+.     .|+++||+.+ +|.+++.....  ...+++..++.++.|+++||+|||+.+  ++
T Consensus        56 ~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~  132 (295)
T cd07837          56 MLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VM  132 (295)
T ss_pred             HccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ee
Confidence            45 46999999999976665     8999999986 88888754321  234799999999999999999999999  99


Q ss_pred             ecCCCCCcEEecC-CCcEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCC
Q 029552           75 HRDLKSPNLLVDK-KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPW  152 (191)
Q Consensus        75 h~~l~p~ni~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf  152 (191)
                      |+||+|+||+++. ++.++|+|||.+..................|+|||.+.+. .++.++|+||+|+++|+|++|..||
T Consensus       133 H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~  212 (295)
T cd07837         133 HRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF  212 (295)
T ss_pred             ecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCC
Confidence            9999999999998 8899999999876433222222233456789999988653 4688999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhcCccc--------------------------CCCCCCCHHHHHHHHHHhcC
Q 029552          153 GNLNPAQVVAAVGFKGKRL--------------------------EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+.......+......+                          .....+++.+.++|.+||++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  277 (295)
T cd07837         213 PGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRY  277 (295)
T ss_pred             CCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccC
Confidence            8876665544432210000                          00135899999999999964

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.97  E-value=7.9e-31  Score=200.39  Aligned_cols=157  Identities=27%  Similarity=0.412  Sum_probs=127.2

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++||||++++++|..++..++++||+.+++|.+++.+... ..+++..+..++.|++.||+|||+.+  ++|+||||+
T Consensus        54 ~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~  130 (328)
T cd08226          54 HFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKAS  130 (328)
T ss_pred             HhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHH
Confidence            457999999999999999999999999999999999876432 23889999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccccc-------ccCCCCCCCCcccCccccccC--CCCCcchHHHHHHHHHHHHhCCCCC
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTF-------LSSKSAAGTPEWMAPEVLRDE--PSNEKSDIYSFGVILWELATLQQPW  152 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~-------~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~pf  152 (191)
                      ||+++.++.+++.||+.........       ...........|++||.+.+.  .++.++|+||+|+++++|++|..||
T Consensus       131 Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~  210 (328)
T cd08226         131 HILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF  210 (328)
T ss_pred             HEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999999986532211100       001111234569999998764  3678999999999999999999999


Q ss_pred             CCCCHHHHH
Q 029552          153 GNLNPAQVV  161 (191)
Q Consensus       153 ~~~~~~~~~  161 (191)
                      .........
T Consensus       211 ~~~~~~~~~  219 (328)
T cd08226         211 QDMLRTQML  219 (328)
T ss_pred             CCcChHHHH
Confidence            876654443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.4e-31  Score=194.21  Aligned_cols=182  Identities=25%  Similarity=0.457  Sum_probs=157.9

Q ss_pred             CCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcE
Q 029552            4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL   83 (191)
Q Consensus         4 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni   83 (191)
                      -+||++|-++.+|+.....+.|.||++||+|--..+++.-   ++++.++.+..+|.-||.|||++|  |++||+|.+|+
T Consensus       308 sn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrk---lpeeharfys~ei~lal~flh~rg--iiyrdlkldnv  382 (593)
T KOG0695|consen  308 SNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNV  382 (593)
T ss_pred             cCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhc---CcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccce
Confidence            4799999999999999999999999999999887766442   899999999999999999999999  99999999999


Q ss_pred             EecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCC-------CCC
Q 029552           84 LVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWG-------NLN  156 (191)
Q Consensus        84 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~-------~~~  156 (191)
                      +++..|.+||+|+|.++..-.+-...+..++++.|.|||++++..|..+.|+|+||++|++|++|+-||+       +.+
T Consensus       383 lldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~n  462 (593)
T KOG0695|consen  383 LLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMN  462 (593)
T ss_pred             EEccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccc
Confidence            9999999999999998765555556778899999999999999999999999999999999999999996       233


Q ss_pred             HHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+-.+. ......+|..+|-....+++..|+|
T Consensus       463 tedylfqvi-lekqiriprslsvkas~vlkgflnk  496 (593)
T KOG0695|consen  463 TEDYLFQVI-LEKQIRIPRSLSVKASHVLKGFLNK  496 (593)
T ss_pred             hhHHHHHHH-hhhcccccceeehhhHHHHHHhhcC
Confidence            333333332 3446678899998888898888876

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.1e-31  Score=208.88  Aligned_cols=181  Identities=25%  Similarity=0.407  Sum_probs=153.7

Q ss_pred             CCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCc
Q 029552            3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN   82 (191)
Q Consensus         3 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~n   82 (191)
                      .-+++.||+++.+|.|++.+|.||||++||++-.++-+.+-   |.|+.++.++.++..|+++.|+.|  ++||||||+|
T Consensus       685 EADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgI---FeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDN  759 (1034)
T KOG0608|consen  685 EADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI---FEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDN  759 (1034)
T ss_pred             hcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhcc---CHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccc
Confidence            34788999999999999999999999999999999977554   999999999999999999999999  9999999999


Q ss_pred             EEecCCCcEEEcccccccc-----------cccc-----c--------------------------ccCCCCCCCCcccC
Q 029552           83 LLVDKKYTVKVCDFGLSRL-----------KANT-----F--------------------------LSSKSAAGTPEWMA  120 (191)
Q Consensus        83 i~~~~~~~~~l~d~~~~~~-----------~~~~-----~--------------------------~~~~~~~~~~~~~~  120 (191)
                      |+++.+|.+||+|||++.-           .++.     .                          ......++++.|+|
T Consensus       760 ILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyia  839 (1034)
T KOG0608|consen  760 ILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIA  839 (1034)
T ss_pred             eEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccC
Confidence            9999999999999999741           0000     0                          00111357889999


Q ss_pred             ccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCccc--CCCCCCCHHHHHHHHHH
Q 029552          121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL--EIPRNVNPHVASIIEAC  188 (191)
Q Consensus       121 pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~li~~c  188 (191)
                      ||++....++..+|+||.|+++|+|+.|+.||-...+.+...++......+  +...++|.+..++|.+.
T Consensus       840 pevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kL  909 (1034)
T KOG0608|consen  840 PEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKL  909 (1034)
T ss_pred             hHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHH
Confidence            999999999999999999999999999999999988888777766555544  44468999999999764

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.97  E-value=1.7e-30  Score=197.57  Aligned_cols=151  Identities=25%  Similarity=0.424  Sum_probs=121.7

Q ss_pred             CCCCCCCCcccccceeec--CCceEEEEeccCCCCHHHHhcCCC------CcccccHHHHHHHHHHHHHHHHHHHhCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKPG------VREMLDERRRLNMAYDVAKGMNYLHRRNPP   72 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~   72 (191)
                      |++++||||+++++++..  +...++++||+. ++|.+++....      ....+++..+..++.|++.||+|||+.|  
T Consensus        52 l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--  128 (317)
T cd07868          52 LRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--  128 (317)
T ss_pred             HHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence            357899999999999854  456899999986 48888775321      1124889999999999999999999999  


Q ss_pred             eeecCCCCCcEEe----cCCCcEEEccccccccccccc---ccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHH
Q 029552           73 IVHRDLKSPNLLV----DKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWE  144 (191)
Q Consensus        73 ~~h~~l~p~ni~~----~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~  144 (191)
                      ++||||||+||++    +..+.++|+|||++.......   .......++..|+|||.+.+. .++.++|+||+||++++
T Consensus       129 ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e  208 (317)
T cd07868         129 VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAE  208 (317)
T ss_pred             EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHH
Confidence            9999999999999    455789999999986543221   112234567789999998764 47889999999999999


Q ss_pred             HHhCCCCCCC
Q 029552          145 LATLQQPWGN  154 (191)
Q Consensus       145 l~~g~~pf~~  154 (191)
                      |++|..||..
T Consensus       209 l~~g~~~f~~  218 (317)
T cd07868         209 LLTSEPIFHC  218 (317)
T ss_pred             HHhCCCCccC
Confidence            9999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.97  E-value=2.1e-30  Score=194.05  Aligned_cols=185  Identities=25%  Similarity=0.333  Sum_probs=147.4

Q ss_pred             CCCCCCCcccccceeecCCc-----eEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeec
Q 029552            2 KRLRHPNIVLFMGAVTQPPN-----LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR   76 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~   76 (191)
                      ++++||||+++++++.+.+.     .++++|++.+ +|.+++..... ..+++.+++.++.|+++||++||+.+  ++|+
T Consensus        56 ~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~  131 (287)
T cd07838          56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR--IVHR  131 (287)
T ss_pred             hccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeec
Confidence            45679999999999987776     9999999975 89888865332 23889999999999999999999999  9999


Q ss_pred             CCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 029552           77 DLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN  156 (191)
Q Consensus        77 ~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~  156 (191)
                      |++|+||+++.++.++|+|||.+....... ......+...|+|||.+.+..++.++|+||+|+++|+|++|..||...+
T Consensus       132 ~l~~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~  210 (287)
T cd07838         132 DLKPQNILVTSDGQVKIADFGLARIYSFEM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS  210 (287)
T ss_pred             cCChhhEEEccCCCEEEeccCcceeccCCc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence            999999999999999999999876543221 1122235678999999988888999999999999999999999999877


Q ss_pred             HHHHHHHHHhcCcc-------------------------cCCCCCCCHHHHHHHHHHhcC
Q 029552          157 PAQVVAAVGFKGKR-------------------------LEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~~~~~~~~~~~~~-------------------------~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+...++......                         ......+++.+.++|.+||+.
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  270 (287)
T cd07838         211 EADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTF  270 (287)
T ss_pred             hHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhcc
Confidence            77666555321110                         001124678889999999963

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.97  E-value=1.4e-30  Score=199.55  Aligned_cols=185  Identities=21%  Similarity=0.365  Sum_probs=143.7

Q ss_pred             CCCCCCCCcccccceeec----CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeec
Q 029552            1 MKRLRHPNIVLFMGAVTQ----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR   76 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~   76 (191)
                      |++++||||++++++|..    ....++|+||+. ++|.+++...+   .+++..+..++.|++.||+|||+.+  ++|+
T Consensus        58 l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~  131 (334)
T cd07855          58 LRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSAN--VIHR  131 (334)
T ss_pred             HHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecC
Confidence            457889999999998863    346899999996 58999886543   2899999999999999999999999  9999


Q ss_pred             CCCCCcEEecCCCcEEEcccccccccccccc----cCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCC
Q 029552           77 DLKSPNLLVDKKYTVKVCDFGLSRLKANTFL----SSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQP  151 (191)
Q Consensus        77 ~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p  151 (191)
                      ||+|+||+++.++.++|+|||.+........    ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..|
T Consensus       132 dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~p  211 (334)
T cd07855         132 DLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQL  211 (334)
T ss_pred             CCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCc
Confidence            9999999999999999999998864432211    1123356678999998765 4578899999999999999999999


Q ss_pred             CCCCCHHHHHHHHHhc------------------------CcccCC-----CCCCCHHHHHHHHHHhcC
Q 029552          152 WGNLNPAQVVAAVGFK------------------------GKRLEI-----PRNVNPHVASIIEACWAK  191 (191)
Q Consensus       152 f~~~~~~~~~~~~~~~------------------------~~~~~~-----~~~~s~~~~~li~~cl~~  191 (191)
                      |...+.......+...                        ......     ...+++.++++|.+||++
T Consensus       212 f~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  280 (334)
T cd07855         212 FPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQF  280 (334)
T ss_pred             cCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccC
Confidence            9876554433222110                        011111     245799999999999974

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=1.6e-30  Score=199.38  Aligned_cols=184  Identities=24%  Similarity=0.394  Sum_probs=143.2

Q ss_pred             CCCCCCCcccccceeecC-----CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeec
Q 029552            2 KRLRHPNIVLFMGAVTQP-----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR   76 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~   76 (191)
                      +.++||||+++++++...     ...++++||+. ++|.+++...+   .+++.++..++.|++.||++||+.+  ++|+
T Consensus        59 ~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~  132 (337)
T cd07858          59 RHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSAN--VLHR  132 (337)
T ss_pred             HhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC--EecC
Confidence            567999999999988644     34899999996 68988887644   3899999999999999999999999  9999


Q ss_pred             CCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           77 DLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        77 ~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      ||+|+||+++.++.++|+|||++..............++..|+|||.+.. ...+.++|+||+|+++|+|++|..||...
T Consensus       133 dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  212 (337)
T cd07858         133 DLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK  212 (337)
T ss_pred             CCCHHHEEEcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence            99999999999999999999988754333222223345678999998764 45788999999999999999999999765


Q ss_pred             CHHHHHHHHHhcC--------------------------cc---cCCCCCCCHHHHHHHHHHhcC
Q 029552          156 NPAQVVAAVGFKG--------------------------KR---LEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~~~~~~~~~~~--------------------------~~---~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +.......+....                          ..   ....+++|+.++++|.+||+.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  277 (337)
T cd07858         213 DYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVF  277 (337)
T ss_pred             ChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcC
Confidence            5433222221100                          00   112346899999999999973

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=2.2e-30  Score=193.56  Aligned_cols=185  Identities=25%  Similarity=0.350  Sum_probs=148.1

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++|+|++++++++.+.+..++|+|++. ++|.+++.+..  ..+++.++..++.|++.||++||+++  ++|+||+|+
T Consensus        53 ~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~  127 (282)
T cd07829          53 KELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQ  127 (282)
T ss_pred             HhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChh
Confidence            56789999999999999999999999997 59999997642  23899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      ||+++.++.++|+|||.+..................|+|||.+.+. ..+.++|+||+|++++++++|..||...+....
T Consensus       128 ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~  207 (282)
T cd07829         128 NILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ  207 (282)
T ss_pred             eEEEcCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence            9999999999999999876544332222233445679999998766 678899999999999999999999988776655


Q ss_pred             HHHHHhcCc-------------------cc--------CCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGK-------------------RL--------EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~-------------------~~--------~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+.....                   ..        ...+.++..+.++|.+||++
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  265 (282)
T cd07829         208 LFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQY  265 (282)
T ss_pred             HHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhcc
Confidence            444322100                   00        01124588999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.97  E-value=2.1e-30  Score=194.44  Aligned_cols=182  Identities=30%  Similarity=0.508  Sum_probs=139.2

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcC--CCCcccccHHHHHHHHHHHHHHHHHHHhC-CCCeeecCCCCC
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK--PGVREMLDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLKSP   81 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~~~~~h~~l~p~   81 (191)
                      +||||+++++++.+++..++++|++. +++.++...  ......+++..+..++.|++.||+|||+. +  ++|+||+|+
T Consensus        61 ~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~  137 (288)
T cd06616          61 DCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPS  137 (288)
T ss_pred             CCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHH
Confidence            49999999999999999999999986 466554421  01123489999999999999999999974 8  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE---PSNEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~---~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      ||+++.++.++|+|||++....... ......++..|+|||.+.+.   .++.++|+||+|+++++|++|..||......
T Consensus       138 Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~  216 (288)
T cd06616         138 NILLDRNGNIKLCDFGISGQLVDSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV  216 (288)
T ss_pred             HEEEccCCcEEEeecchhHHhccCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH
Confidence            9999999999999999876433221 11223456789999998766   5788999999999999999999999865432


Q ss_pred             -HHHHHHHhcCcccCC----CCCCCHHHHHHHHHHhcC
Q 029552          159 -QVVAAVGFKGKRLEI----PRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 -~~~~~~~~~~~~~~~----~~~~s~~~~~li~~cl~~  191 (191)
                       +....+. .+..+..    +..++..+.++|.+||++
T Consensus       217 ~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~  253 (288)
T cd06616         217 FDQLTQVV-KGDPPILSNSEEREFSPSFVNFINLCLIK  253 (288)
T ss_pred             HHHHhhhc-CCCCCcCCCcCCCccCHHHHHHHHHHccC
Confidence             2222221 2222222    235899999999999974

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.97  E-value=3.6e-30  Score=194.37  Aligned_cols=185  Identities=25%  Similarity=0.332  Sum_probs=144.6

Q ss_pred             CCCCCCCcccccceeecCC----------ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPP----------NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNP   71 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~----------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~   71 (191)
                      ++++||||+++++++.+..          ..++++||+++ ++.+.+....  ..+++++++.++.|++.||+|||+.+ 
T Consensus        61 ~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~-  136 (302)
T cd07864          61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKKN-  136 (302)
T ss_pred             HhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence            5679999999999887654          79999999976 7777775432  23899999999999999999999999 


Q ss_pred             CeeecCCCCCcEEecCCCcEEEcccccccccccccc-cCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCC
Q 029552           72 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQ  149 (191)
Q Consensus        72 ~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~  149 (191)
                       ++|+||+|+||+++.++.++|+|||.+........ ..........|++||.+.+. ..+.++|+||+|+++++|++|.
T Consensus       137 -i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~  215 (302)
T cd07864         137 -FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK  215 (302)
T ss_pred             -eecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCC
Confidence             99999999999999999999999998865433211 11222345679999987654 4678899999999999999999


Q ss_pred             CCCCCCCHHHHHHHHHhcCccc----------------------------CCCCCCCHHHHHHHHHHhcC
Q 029552          150 QPWGNLNPAQVVAAVGFKGKRL----------------------------EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       150 ~pf~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~s~~~~~li~~cl~~  191 (191)
                      .||...+..+....+.......                            .....+|..+.++|.+||++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  285 (302)
T cd07864         216 PIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTL  285 (302)
T ss_pred             CCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccC
Confidence            9998877766655544321110                            01235789999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.97  E-value=3e-30  Score=195.27  Aligned_cols=159  Identities=24%  Similarity=0.344  Sum_probs=127.8

Q ss_pred             CCCCCCCCcccccceeecCC--------ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPP--------NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPP   72 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~   72 (191)
                      +++++||||+++++++...+        ..++|+||+.+ +|.+.+.....  .+++.+++.++.|++.||+|||+++  
T Consensus        65 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~--  139 (310)
T cd07865          65 LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNV--KFTLSEIKKVMKMLLNGLYYIHRNK--  139 (310)
T ss_pred             HHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence            35789999999999886543        45999999964 88888765432  3899999999999999999999999  


Q ss_pred             eeecCCCCCcEEecCCCcEEEcccccccccccccc----cCCCCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHh
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL----SSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELAT  147 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~  147 (191)
                      ++|+||+|+||+++.++.++|+|||.+........    ......+...|+|||.+.+.. .+.++|+||+|+++|+|++
T Consensus       140 i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t  219 (310)
T cd07865         140 ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT  219 (310)
T ss_pred             eeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHh
Confidence            99999999999999999999999998864332211    112234566899999886653 6788999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHH
Q 029552          148 LQQPWGNLNPAQVVAAV  164 (191)
Q Consensus       148 g~~pf~~~~~~~~~~~~  164 (191)
                      |..||...++......+
T Consensus       220 ~~~~~~~~~~~~~~~~~  236 (310)
T cd07865         220 RSPIMQGNTEQHQLTLI  236 (310)
T ss_pred             CCCCCCCCCHHHHHHHH
Confidence            99999887766554443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.97  E-value=4e-30  Score=193.74  Aligned_cols=184  Identities=17%  Similarity=0.242  Sum_probs=138.0

Q ss_pred             CCCCCCCcccccceeecCC----ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecC
Q 029552            2 KRLRHPNIVLFMGAVTQPP----NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRD   77 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~   77 (191)
                      +.++|++++++++++....    ..+++++++. .++.+.+.....   .++..+..++.|+++||+|||+.+  ++|||
T Consensus        78 ~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~--iiHrD  151 (294)
T PHA02882         78 HNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKC---KNKKLIKNIMKDMLTTLEYIHEHG--ISHGD  151 (294)
T ss_pred             ccCCCCCCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhcc---CCHHHHHHHHHHHHHHHHHHHhCC--eecCC
Confidence            4568999999998765433    3467788764 477777654322   578889999999999999999999  99999


Q ss_pred             CCCCcEEecCCCcEEEccccccccccccc-------ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 029552           78 LKSPNLLVDKKYTVKVCDFGLSRLKANTF-------LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ  150 (191)
Q Consensus        78 l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~  150 (191)
                      |||+||+++.++.++|+|||++.......       .......++..|+|||.+.+..++.++|+||+|+++++|++|..
T Consensus       152 iKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~  231 (294)
T PHA02882        152 IKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKL  231 (294)
T ss_pred             CCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            99999999999999999999986432110       11122357889999999999989999999999999999999999


Q ss_pred             CCCCCCH-HHHHHH-----HHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          151 PWGNLNP-AQVVAA-----VGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       151 pf~~~~~-~~~~~~-----~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ||..... ......     +.........+.++++.+.++++.||+.
T Consensus       232 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (294)
T PHA02882        232 PWKGFGHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKL  278 (294)
T ss_pred             CCCccccchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhC
Confidence            9987632 221111     1111111112456789999999999963

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.97  E-value=4.4e-30  Score=198.14  Aligned_cols=154  Identities=29%  Similarity=0.437  Sum_probs=127.7

Q ss_pred             CCCCCCCCcccccceeecC------CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCee
Q 029552            1 MKRLRHPNIVLFMGAVTQP------PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIV   74 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~   74 (191)
                      +++++||||++++++|...      ...|+|+||+.+ +|.+.+...     +++.++..++.|++.||++||+.|  ++
T Consensus        69 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g--i~  140 (353)
T cd07850          69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG--II  140 (353)
T ss_pred             HHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCC-CHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence            3568999999999988643      357999999964 888877532     788899999999999999999999  99


Q ss_pred             ecCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 029552           75 HRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN  154 (191)
Q Consensus        75 h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~  154 (191)
                      |+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|+++++|++|..||..
T Consensus       141 H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~  219 (353)
T cd07850         141 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG  219 (353)
T ss_pred             eCCCCHHHEEECCCCCEEEccCccceeCCCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence            99999999999999999999999987543321 12223456789999999988899999999999999999999999987


Q ss_pred             CCHHHHHHH
Q 029552          155 LNPAQVVAA  163 (191)
Q Consensus       155 ~~~~~~~~~  163 (191)
                      .+.......
T Consensus       220 ~~~~~~~~~  228 (353)
T cd07850         220 TDHIDQWNK  228 (353)
T ss_pred             CCHHHHHHH
Confidence            665444433

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=8.8e-30  Score=191.94  Aligned_cols=181  Identities=29%  Similarity=0.475  Sum_probs=141.8

Q ss_pred             CCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCeeecCCCCCc
Q 029552            4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKSPN   82 (191)
Q Consensus         4 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~~h~~l~p~n   82 (191)
                      ..||||+++++++.++...++++||+. ++|.+++....  ..+++..+..++.|++.|++|||+ .+  ++|+||+|+|
T Consensus        71 ~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~n  145 (296)
T cd06618          71 HDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSN  145 (296)
T ss_pred             cCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHH
Confidence            369999999999999999999999985 47877775432  248899999999999999999997 58  9999999999


Q ss_pred             EEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCH-
Q 029552           83 LLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP----SNEKSDIYSFGVILWELATLQQPWGNLNP-  157 (191)
Q Consensus        83 i~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~----~~~~~Dv~slG~~~~~l~~g~~pf~~~~~-  157 (191)
                      |+++.++.++|+|||.+........ .....+...|+|||.+.+..    ++.++|+||+|+++|+|++|..||..... 
T Consensus       146 ill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~  224 (296)
T cd06618         146 ILLDASGNVKLCDFGISGRLVDSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE  224 (296)
T ss_pred             EEEcCCCCEEECccccchhccCCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH
Confidence            9999999999999998764432211 12234566899999987553    67889999999999999999999976433 


Q ss_pred             HHHHHHHHhcCcccCCC--CCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIP--RNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~cl~~  191 (191)
                      .+....+... .....+  ..++..++++|.+||++
T Consensus       225 ~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~  259 (296)
T cd06618         225 FEVLTKILQE-EPPSLPPNEGFSPDFCSFVDLCLTK  259 (296)
T ss_pred             HHHHHHHhcC-CCCCCCCCCCCCHHHHHHHHHHccC
Confidence            2334443322 222222  35899999999999974

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PTZ00284 protein kinase; Provisional

Probab=99.97  E-value=2.9e-30  Score=205.83  Aligned_cols=151  Identities=19%  Similarity=0.333  Sum_probs=124.5

Q ss_pred             CCCCcccccceeecC-CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCeeecCCCCCc
Q 029552            5 RHPNIVLFMGAVTQP-PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKSPN   82 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~~h~~l~p~n   82 (191)
                      .|+++++++++|..+ +..++|++++ +++|.+++.+.+   .+++.++..++.||+.||+|||+ .|  |+||||||+|
T Consensus       189 ~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~N  262 (467)
T PTZ00284        189 DRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPEN  262 (467)
T ss_pred             cCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHH
Confidence            466788999988754 5789999988 678988886643   38999999999999999999997 59  9999999999


Q ss_pred             EEecCCC----------------cEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHH
Q 029552           83 LLVDKKY----------------TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA  146 (191)
Q Consensus        83 i~~~~~~----------------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~  146 (191)
                      |+++.++                .+||+|||.+......   .....++..|+|||.+.+..++.++|+|||||++|+|+
T Consensus       263 ILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~---~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ell  339 (467)
T PTZ00284        263 ILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS---RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELY  339 (467)
T ss_pred             EEEecCCcccccccccccCCCCceEEECCCCccccCccc---cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHH
Confidence            9998765                4999999976532221   22346788999999999998999999999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHH
Q 029552          147 TLQQPWGNLNPAQVVAAV  164 (191)
Q Consensus       147 ~g~~pf~~~~~~~~~~~~  164 (191)
                      +|..||...+..+....+
T Consensus       340 tG~~pf~~~~~~~~~~~i  357 (467)
T PTZ00284        340 TGKLLYDTHDNLEHLHLM  357 (467)
T ss_pred             hCCCCCCCCChHHHHHHH
Confidence            999999887765544433

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.97  E-value=3.5e-30  Score=195.70  Aligned_cols=152  Identities=25%  Similarity=0.422  Sum_probs=121.3

Q ss_pred             CCCCCCCCcccccceee--cCCceEEEEeccCCCCHHHHhcCCC------CcccccHHHHHHHHHHHHHHHHHHHhCCCC
Q 029552            1 MKRLRHPNIVLFMGAVT--QPPNLSIVTEYLSRGSLYRLLHKPG------VREMLDERRRLNMAYDVAKGMNYLHRRNPP   72 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~   72 (191)
                      |++++||||+++++++.  .+...++++||+.+ +|.+++....      ....+++..+..++.|++.||+|||+.+  
T Consensus        52 l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--  128 (317)
T cd07867          52 LRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--  128 (317)
T ss_pred             HHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence            35789999999999885  35578999999865 7877764211      1224788999999999999999999999  


Q ss_pred             eeecCCCCCcEEe----cCCCcEEEcccccccccccccc---cCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHH
Q 029552           73 IVHRDLKSPNLLV----DKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWE  144 (191)
Q Consensus        73 ~~h~~l~p~ni~~----~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~  144 (191)
                      ++|+||||+||++    +.++.++|+|||++........   ......++..|+|||.+.+. .++.++|+||+|+++|+
T Consensus       129 ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~e  208 (317)
T cd07867         129 VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAE  208 (317)
T ss_pred             EEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHH
Confidence            9999999999999    4567899999999875433211   11223457789999998764 47889999999999999


Q ss_pred             HHhCCCCCCCC
Q 029552          145 LATLQQPWGNL  155 (191)
Q Consensus       145 l~~g~~pf~~~  155 (191)
                      |++|..||...
T Consensus       209 l~tg~~~f~~~  219 (317)
T cd07867         209 LLTSEPIFHCR  219 (317)
T ss_pred             HHhCCCCcccc
Confidence            99999999743

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.7e-30  Score=200.53  Aligned_cols=181  Identities=24%  Similarity=0.355  Sum_probs=143.4

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      .|.+|++++++-..++.+||||||= ..+|..++++....  .+.-.+..+..|++.|+.++|++|  |+|.||||.|++
T Consensus       418 g~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~~--~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFL  492 (677)
T KOG0596|consen  418 GHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKKKSI--DPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFL  492 (677)
T ss_pred             CCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEE
Confidence            3889999999999999999999965 56999999875532  444588889999999999999999  999999999999


Q ss_pred             ecCCCcEEEcccccccccccccc--cCCCCCCCCcccCccccccCC-----------CCCcchHHHHHHHHHHHHhCCCC
Q 029552           85 VDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEP-----------SNEKSDIYSFGVILWELATLQQP  151 (191)
Q Consensus        85 ~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~-----------~~~~~Dv~slG~~~~~l~~g~~p  151 (191)
                      +-. |.+||+|||++........  .-...+|+..||+||.+....           .+.++|||||||++|+|+.|..|
T Consensus       493 lVk-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktP  571 (677)
T KOG0596|consen  493 LVK-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTP  571 (677)
T ss_pred             EEe-eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCc
Confidence            877 4899999999976554432  234568899999999874332           35679999999999999999999


Q ss_pred             CCCCC-HHHHHHHHHhcCcccCCCCCCCHH-HHHHHHHHhcC
Q 029552          152 WGNLN-PAQVVAAVGFKGKRLEIPRNVNPH-VASIIEACWAK  191 (191)
Q Consensus       152 f~~~~-~~~~~~~~~~~~~~~~~~~~~s~~-~~~li~~cl~~  191 (191)
                      |...- .-..+..|..-+...++|.--+.. +.++|+.||++
T Consensus       572 f~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~r  613 (677)
T KOG0596|consen  572 FGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLAR  613 (677)
T ss_pred             hHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhc
Confidence            98743 444444443223345666654444 99999999974

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.97  E-value=8e-30  Score=190.84  Aligned_cols=185  Identities=25%  Similarity=0.361  Sum_probs=146.4

Q ss_pred             CCCCCCCcccccceeecC--CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            2 KRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      ++++|||++++++++.+.  +..++|+||+.+ +|.+++....  ..+++.+++.++.|+++||++||+.+  ++|+||+
T Consensus        53 ~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~  127 (287)
T cd07840          53 QKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIK  127 (287)
T ss_pred             HhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCc
Confidence            567899999999999887  789999999975 8988886543  23899999999999999999999999  9999999


Q ss_pred             CCcEEecCCCcEEEcccccccccccccc-cCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      |+||+++.++.++++|||.+........ .......+..|+|||.+.+. .++.++|+||+|+++++|++|..||...+.
T Consensus       128 p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~  207 (287)
T cd07840         128 GSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE  207 (287)
T ss_pred             HHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence            9999999999999999998765433311 12223456689999987654 468899999999999999999999988777


Q ss_pred             HHHHHHHHhcCccc---------------------C--------CCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRL---------------------E--------IPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~---------------------~--------~~~~~s~~~~~li~~cl~~  191 (191)
                      ......+......+                     .        +...++..+.++|.+||+.
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  270 (287)
T cd07840         208 LEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTL  270 (287)
T ss_pred             HHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCC
Confidence            66555543211100                     0        0111389999999999963

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=6.8e-31  Score=207.68  Aligned_cols=185  Identities=34%  Similarity=0.632  Sum_probs=162.8

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |.+|+|||++++|+++.+ ....||+|.++.|+|.+.+++.. +..+.......++.||+.|+.||...+  ++||||-.
T Consensus       165 M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~-~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAA  240 (1039)
T KOG0199|consen  165 MLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAK-KAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAA  240 (1039)
T ss_pred             HHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhcc-ccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhh
Confidence            357899999999999998 66889999999999999998733 445888899999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccc-c--cccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhC-CCCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKAN-T--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLN  156 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~-~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g-~~pf~~~~  156 (191)
                      .|+++-....+||+|||+...-+. .  +.-.........|+|||.++...++.++|+|++|+++|||+++ ..||....
T Consensus       241 RNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~  320 (1039)
T KOG0199|consen  241 RNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR  320 (1039)
T ss_pred             hhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC
Confidence            999999888999999998763222 1  2222333445689999999999999999999999999999995 77999999


Q ss_pred             HHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhc
Q 029552          157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~  190 (191)
                      ...++.++. .+.+++-|..||+++.+++..||.
T Consensus       321 g~qIL~~iD-~~erLpRPk~csedIY~imk~cWa  353 (1039)
T KOG0199|consen  321 GIQILKNID-AGERLPRPKYCSEDIYQIMKNCWA  353 (1039)
T ss_pred             HHHHHHhcc-ccccCCCCCCChHHHHHHHHHhcc
Confidence            999999998 889999999999999999999996

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.97  E-value=9.4e-30  Score=195.09  Aligned_cols=183  Identities=23%  Similarity=0.369  Sum_probs=141.6

Q ss_pred             CCC-CCCCcccccceeec--CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            2 KRL-RHPNIVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         2 ~~l-~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      +++ +||||++++++|..  +...++|+||+. ++|.+++...    .+++..+..++.|++.||++||+.|  ++|+||
T Consensus        61 ~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl  133 (337)
T cd07852          61 QELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDL  133 (337)
T ss_pred             HHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCC
Confidence            456 89999999998864  346899999997 4999988653    3788899999999999999999999  999999


Q ss_pred             CCCcEEecCCCcEEEcccccccccccccc-----cCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCC
Q 029552           79 KSPNLLVDKKYTVKVCDFGLSRLKANTFL-----SSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPW  152 (191)
Q Consensus        79 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~pf  152 (191)
                      +|+||+++.++.++|+|||.+........     ......++..|+|||.+.+ ...+.++|+||+|+++|+|++|..||
T Consensus       134 ~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf  213 (337)
T cd07852         134 KPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF  213 (337)
T ss_pred             CHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999998764332211     1122345678999998765 34678899999999999999999999


Q ss_pred             CCCCHHHHHHHHHhcCcc-----------------------------cCCCCCCCHHHHHHHHHHhcC
Q 029552          153 GNLNPAQVVAAVGFKGKR-----------------------------LEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+......+......                             ......++..+.++|.+||+.
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  281 (337)
T cd07852         214 PGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVF  281 (337)
T ss_pred             CCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccC
Confidence            876555443332211110                             011234799999999999963

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.97  E-value=1.3e-30  Score=204.61  Aligned_cols=157  Identities=29%  Similarity=0.330  Sum_probs=134.8

Q ss_pred             CCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEe
Q 029552            6 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV   85 (191)
Q Consensus         6 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~   85 (191)
                      --|+|+++++|..+++.|||+|.+ +.+|.+++....-+ .++...++.++.||++||.+||+.+  |+|+||||+||++
T Consensus       247 ~~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL  322 (586)
T KOG0667|consen  247 KYNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILL  322 (586)
T ss_pred             CeeEEEeeeccccccceeeeehhh-hhhHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheee
Confidence            458999999999999999999988 56999999765533 3899999999999999999999999  9999999999999


Q ss_pred             cCC--CcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 029552           86 DKK--YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA  163 (191)
Q Consensus        86 ~~~--~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~  163 (191)
                      ..-  ..+|++|||.+........   .-.-+..|.|||++.|.+++.+.|+||||||++||++|.+-|.+.+..+.+..
T Consensus       323 ~~~~r~~vKVIDFGSSc~~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~  399 (586)
T KOG0667|consen  323 KDPKRSRIKVIDFGSSCFESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLAR  399 (586)
T ss_pred             ccCCcCceeEEecccccccCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHH
Confidence            654  3699999999886655422   22335579999999999999999999999999999999999998888887777


Q ss_pred             HHhcCc
Q 029552          164 VGFKGK  169 (191)
Q Consensus       164 ~~~~~~  169 (191)
                      |....+
T Consensus       400 I~e~lG  405 (586)
T KOG0667|consen  400 IIEVLG  405 (586)
T ss_pred             HHHHhC
Confidence            754333

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=5.4e-30  Score=196.92  Aligned_cols=181  Identities=24%  Similarity=0.399  Sum_probs=144.5

Q ss_pred             CCCCCCCCcccccceeecCCc------eEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCee
Q 029552            1 MKRLRHPNIVLFMGAVTQPPN------LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIV   74 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~   74 (191)
                      +++++||||+++.+++...+.      .++|+|++ +++|.+++...    .+++.+++.++.|+++||++||+.|  ++
T Consensus        68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~g--i~  140 (343)
T cd07851          68 LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSAG--II  140 (343)
T ss_pred             HHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ee
Confidence            356799999999998876554      89999998 56999988652    3899999999999999999999999  99


Q ss_pred             ecCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCC
Q 029552           75 HRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWG  153 (191)
Q Consensus        75 h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~pf~  153 (191)
                      |+||+|+||+++.++.++|+|||.+......   .....++..|+|||.+.+ ..++.++|+||+|++++++++|..||.
T Consensus       141 H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~  217 (343)
T cd07851         141 HRDLKPSNIAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP  217 (343)
T ss_pred             cCCCCHHHeEECCCCCEEEcccccccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999987654322   222345668999998765 356789999999999999999999998


Q ss_pred             CCCHHHHHHHHHhcCccc-----------------------------CCCCCCCHHHHHHHHHHhcC
Q 029552          154 NLNPAQVVAAVGFKGKRL-----------------------------EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+....+..+......+                             .....+|+.+.++|.+||++
T Consensus       218 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~  284 (343)
T cd07851         218 GSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVL  284 (343)
T ss_pred             CCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCC
Confidence            877666555443211100                             11134699999999999974

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=1.4e-29  Score=189.37  Aligned_cols=185  Identities=27%  Similarity=0.405  Sum_probs=144.3

Q ss_pred             CCCC-CCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            2 KRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         2 ~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      ++++ ||||+++++++.+++..++||||+ +++|.+.+.... ...+++.++..++.|++.+|.+||+.+  ++|+||+|
T Consensus        52 ~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~  127 (283)
T cd07830          52 RKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKP  127 (283)
T ss_pred             HhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCh
Confidence            3566 999999999999999999999999 679988886543 224899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      +||+++.++.++|+|||.+........ .....++..|+|||.+.+ ...+.++|+||+|+++++|++|..||...+...
T Consensus       128 ~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~  206 (283)
T cd07830         128 ENLLVSGPEVVKIADFGLAREIRSRPP-YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID  206 (283)
T ss_pred             hhEEEcCCCCEEEeecccceeccCCCC-cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH
Confidence            999999999999999998764433211 122345668999998754 456889999999999999999999998766554


Q ss_pred             HHHHHHhcCccc----------------------------CCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRL----------------------------EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~----------------------------~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+......+                            ......+..++++|++||++
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  266 (283)
T cd07830         207 QLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRW  266 (283)
T ss_pred             HHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhccc
Confidence            443332111100                            01123378999999999963

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=5.1e-30  Score=205.64  Aligned_cols=150  Identities=22%  Similarity=0.348  Sum_probs=122.9

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC--cccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV--REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      |++++||||+++++++.+++..|++++++. ++|.+++.....  .......++..++.|++.||+|||++|  ++||||
T Consensus       217 l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDL  293 (501)
T PHA03210        217 LGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDI  293 (501)
T ss_pred             HHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCC
Confidence            356899999999999999999999999986 477776643221  112346678889999999999999999  999999


Q ss_pred             CCCcEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCC-CCC
Q 029552           79 KSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWG  153 (191)
Q Consensus        79 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~-pf~  153 (191)
                      ||+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++|+||+||++|+|++|.. ||.
T Consensus       294 KP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~  370 (501)
T PHA03210        294 KLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIG  370 (501)
T ss_pred             CHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCcc
Confidence            9999999999999999999986543321 12223467889999999998889999999999999999999875 454

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.97  E-value=8.5e-30  Score=193.39  Aligned_cols=153  Identities=25%  Similarity=0.425  Sum_probs=124.5

Q ss_pred             CCCCCCCCcccccceeecC--CceEEEEeccCCCCHHHHhcCCCC--cccccHHHHHHHHHHHHHHHHHHHhCCCCeeec
Q 029552            1 MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGV--REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR   76 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~   76 (191)
                      |++++||||+++++++.+.  +..++|+||+.+ +|.+.+.....  ...+++..++.++.|++.||.|||+.+  ++|+
T Consensus        56 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~  132 (316)
T cd07842          56 LRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHR  132 (316)
T ss_pred             HHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeC
Confidence            3568999999999999887  789999999975 77776643211  124889999999999999999999999  9999


Q ss_pred             CCCCCcEEecC----CCcEEEcccccccccccccc---cCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhC
Q 029552           77 DLKSPNLLVDK----KYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATL  148 (191)
Q Consensus        77 ~l~p~ni~~~~----~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g  148 (191)
                      ||+|+||+++.    ++.++++|||++........   ......++..|+|||.+.+. .++.++|+||+|+++++|++|
T Consensus       133 dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~  212 (316)
T cd07842         133 DLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTL  212 (316)
T ss_pred             CCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhc
Confidence            99999999999    89999999998765432211   11223456679999987664 468899999999999999999


Q ss_pred             CCCCCCCC
Q 029552          149 QQPWGNLN  156 (191)
Q Consensus       149 ~~pf~~~~  156 (191)
                      ..||....
T Consensus       213 ~~~~~~~~  220 (316)
T cd07842         213 EPIFKGRE  220 (316)
T ss_pred             CCCCcCCc
Confidence            99997544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.97  E-value=1.6e-29  Score=193.76  Aligned_cols=184  Identities=24%  Similarity=0.462  Sum_probs=139.6

Q ss_pred             CCCCCCCCcccccceeecC-----CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 029552            1 MKRLRHPNIVLFMGAVTQP-----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH   75 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h   75 (191)
                      |++++||||+++++++...     ...++++||+.+ +|.+.+...    .+++..+..++.|+++||++||+.+  ++|
T Consensus        57 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~~--ivH  129 (336)
T cd07849          57 LRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSAN--VLH  129 (336)
T ss_pred             HHhCCCCCcCchhheeecccccccceEEEEehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eec
Confidence            3568899999999987543     358999999964 888877543    2889999999999999999999999  999


Q ss_pred             cCCCCCcEEecCCCcEEEcccccccccccccc---cCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCC
Q 029552           76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQP  151 (191)
Q Consensus        76 ~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p  151 (191)
                      +||+|+||+++.++.++|+|||++........   ......++..|+|||.+.+ ..++.++|+||+|+++++|++|..|
T Consensus       130 ~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~  209 (336)
T cd07849         130 RDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPL  209 (336)
T ss_pred             cCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999998764332211   1122345678999998654 4578899999999999999999999


Q ss_pred             CCCCCHHHHHHHHHhcC--------------------------ccc---CCCCCCCHHHHHHHHHHhcC
Q 029552          152 WGNLNPAQVVAAVGFKG--------------------------KRL---EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       152 f~~~~~~~~~~~~~~~~--------------------------~~~---~~~~~~s~~~~~li~~cl~~  191 (191)
                      |...+.......+....                          ...   ...+.+++.+.++|.+||++
T Consensus       210 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  278 (336)
T cd07849         210 FPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTF  278 (336)
T ss_pred             CCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCC
Confidence            97655433222111000                          000   01235788999999999974

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=2e-29  Score=190.88  Aligned_cols=186  Identities=25%  Similarity=0.412  Sum_probs=141.0

Q ss_pred             CCCCCCCCcccccceeecCC--------ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPP--------NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPP   72 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~   72 (191)
                      |++++||||+++++++.+..        ..++++||+.+ +|.+.+....  ..+++.++..++.|+++||+|||+.|  
T Consensus        61 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~--  135 (311)
T cd07866          61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHENH--  135 (311)
T ss_pred             HHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence            35689999999999885433        46999999965 7777765432  23899999999999999999999999  


Q ss_pred             eeecCCCCCcEEecCCCcEEEcccccccccccccccC-----------CCCCCCCcccCccccccC-CCCCcchHHHHHH
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS-----------KSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGV  140 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~-----------~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~  140 (191)
                      ++|+||+|+||+++.++.++|+|||.+..........           ....++..|+|||.+.+. .++.++|+||+|+
T Consensus       136 i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~  215 (311)
T cd07866         136 ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGC  215 (311)
T ss_pred             eecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHH
Confidence            9999999999999999999999999876433221111           111335679999987654 4788999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHhcCccc---------------------CCC-------CCCCHHHHHHHHHHhcC
Q 029552          141 ILWELATLQQPWGNLNPAQVVAAVGFKGKRL---------------------EIP-------RNVNPHVASIIEACWAK  191 (191)
Q Consensus       141 ~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------------~~~-------~~~s~~~~~li~~cl~~  191 (191)
                      ++|+|++|..||...+.......+......+                     ..+       ..+++.+.++|.+||++
T Consensus       216 il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  294 (311)
T cd07866         216 VFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSL  294 (311)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHccc
Confidence            9999999999998877766555433211100                     011       24567899999999963

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.5e-29  Score=193.25  Aligned_cols=181  Identities=25%  Similarity=0.407  Sum_probs=142.6

Q ss_pred             CCCCCCCCcccccceeecCC------ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCee
Q 029552            1 MKRLRHPNIVLFMGAVTQPP------NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIV   74 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~   74 (191)
                      |++++||||+++++++..+.      .+++|+|++ +++|.+++...    .+++..+..++.|++.|+++||+.|  ++
T Consensus        68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~g--i~  140 (343)
T cd07880          68 LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAAG--II  140 (343)
T ss_pred             HHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence            45789999999999987543      358999998 67998888642    2889999999999999999999999  99


Q ss_pred             ecCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCC
Q 029552           75 HRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWG  153 (191)
Q Consensus        75 h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~pf~  153 (191)
                      |+||+|+||+++.++.++++|||.+......   .....++..|++||.+.+ ...+.++|+||+|++++++++|..||.
T Consensus       141 H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~  217 (343)
T cd07880         141 HRDLKPGNLAVNEDCELKILDFGLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK  217 (343)
T ss_pred             cCCCCHHHEEEcCCCCEEEeecccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999988654322   122345678999998865 347788999999999999999999998


Q ss_pred             CCCHHHHHHHHHhcCcc-----------------------------cCCCCCCCHHHHHHHHHHhcC
Q 029552          154 NLNPAQVVAAVGFKGKR-----------------------------LEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       154 ~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+.......+......                             ......+++.+.++|.+||.+
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  284 (343)
T cd07880         218 GHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVL  284 (343)
T ss_pred             CCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCC
Confidence            76654443332211100                             012246888999999999874

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=3.3e-29  Score=191.49  Aligned_cols=181  Identities=27%  Similarity=0.458  Sum_probs=141.1

Q ss_pred             CCCCCCCCcccccceeec-CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQ-PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      |++++||||+++.++|.. ....++++||+ +++|.+++....    +++..+..++.|+++||++||+.+  ++|++|+
T Consensus        63 l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~  135 (328)
T cd07856          63 LKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSRP----LEKQFIQYFLYQILRGLKYVHSAG--VVHRDLK  135 (328)
T ss_pred             HHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCC
Confidence            357899999999999875 56789999998 568988886432    788888899999999999999999  9999999


Q ss_pred             CCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      |.||+++.++.++|+|||.+......   .....++..|++||.+.+ ..++.++|+||+|++++++++|..||...+..
T Consensus       136 p~Nili~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~  212 (328)
T cd07856         136 PSNILINENCDLKICDFGLARIQDPQ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV  212 (328)
T ss_pred             HHHEeECCCCCEEeCccccccccCCC---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999999999999999987643222   122345678999998765 55788999999999999999999999876654


Q ss_pred             HHHHHHHhc------------------------CcccCC-----CCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFK------------------------GKRLEI-----PRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~------------------------~~~~~~-----~~~~s~~~~~li~~cl~~  191 (191)
                      .....+...                        ....+.     ...+++.++++|.+||+.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  274 (328)
T cd07856         213 NQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVF  274 (328)
T ss_pred             HHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCC
Confidence            332221110                        001111     135789999999999963

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=3.6e-29  Score=182.41  Aligned_cols=184  Identities=35%  Similarity=0.547  Sum_probs=151.9

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++|+||+++.+++......++++|++.+++|.+++.....   ++...++.++.+++.++.+||+.+  ++|+|++|.
T Consensus        42 ~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~  116 (244)
T smart00220       42 KKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGR---LSEDEARFYARQILSALEYLHSNG--IIHRDLKPE  116 (244)
T ss_pred             HhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHH
Confidence            467999999999999998999999999999999999876442   788999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-CCHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN-LNPAQV  160 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~-~~~~~~  160 (191)
                      ||+++.++.++++|||.+....... ......+...|++||...+...+.++|+|++|++++++++|..||.. .+....
T Consensus       117 ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~  195 (244)
T smart00220      117 NILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLEL  195 (244)
T ss_pred             HeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence            9999999999999999887554432 22334456789999999888888899999999999999999999988 555555


Q ss_pred             HHHHHhcCcccCCCCC-CCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRN-VNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~-~s~~~~~li~~cl~~  191 (191)
                      .............+.. ++..+.+++.+||.+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  227 (244)
T smart00220      196 FKKIGKPKPPFPPPEWKISPEAKDLIRKLLVK  227 (244)
T ss_pred             HHHHhccCCCCccccccCCHHHHHHHHHHccC
Confidence            5555322222222222 899999999999963

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-30  Score=201.83  Aligned_cols=188  Identities=33%  Similarity=0.568  Sum_probs=157.3

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |.+++||||+++.++|..++.+++|+||++.|+|-+++...... .+.......++.||+.|++||.+.+  ++|||+.+
T Consensus       589 LsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~  665 (807)
T KOG1094|consen  589 LSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESLN--FVHRDLAT  665 (807)
T ss_pred             HhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhhc--hhhccccc
Confidence            46789999999999999999999999999999999999875422 1334455669999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccc--cccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh--CCCCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT--LQQPWGNLN  156 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~--~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~--g~~pf~~~~  156 (191)
                      +|++++.+.++|++|||.+.-  .+++.......+-..+|+|+|.+.-.+++.++|+|++|+++||+++  ...||++..
T Consensus       666 rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt  745 (807)
T KOG1094|consen  666 RNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT  745 (807)
T ss_pred             cceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh
Confidence            999999999999999998762  3334344445566779999999998889999999999999999855  588999999


Q ss_pred             HHHHHHHHHhcC---c---ccCCCCCCCHHHHHHHHHHhcC
Q 029552          157 PAQVVAAVGFKG---K---RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~~~~~~~~~~~---~---~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+.+++....-.   .   -+..|.-++..+.++|..||.+
T Consensus       746 ~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~  786 (807)
T KOG1094|consen  746 DEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRR  786 (807)
T ss_pred             HHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhch
Confidence            998888764311   1   2345778999999999999974

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.97  E-value=6.2e-30  Score=202.21  Aligned_cols=155  Identities=32%  Similarity=0.458  Sum_probs=132.8

Q ss_pred             CCCCCCCCcccccceeecCC------ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCee
Q 029552            1 MKRLRHPNIVLFMGAVTQPP------NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIV   74 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~   74 (191)
                      |++++|||||++.++=+...      ...++||||.||||...+++......+++.+++.++..+..|+.|||++|  |+
T Consensus        65 lkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--Iv  142 (732)
T KOG4250|consen   65 LKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IV  142 (732)
T ss_pred             HHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ce
Confidence            57899999999998776543      47799999999999999998877777999999999999999999999999  99


Q ss_pred             ecCCCCCcEEecCC--C--cEEEcccccccccccccccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCC
Q 029552           75 HRDLKSPNLLVDKK--Y--TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQ  149 (191)
Q Consensus        75 h~~l~p~ni~~~~~--~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~  149 (191)
                      ||||||.||++-.+  |  .-||+|||.++-..+. .......|+..|++||.... ..++..+|.||+|+++|+.+||.
T Consensus       143 HRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~-s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~  221 (732)
T KOG4250|consen  143 HRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDN-SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGE  221 (732)
T ss_pred             eccCCCCcEEEeecCCCceEEeeecccccccCCCC-CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccC
Confidence            99999999988433  3  3699999988744333 35566789999999998874 77888999999999999999999


Q ss_pred             CCCCCCCHH
Q 029552          150 QPWGNLNPA  158 (191)
Q Consensus       150 ~pf~~~~~~  158 (191)
                      .||.....+
T Consensus       222 lPF~p~~~p  230 (732)
T KOG4250|consen  222 LPFIPFGGP  230 (732)
T ss_pred             CCCCcCCCc
Confidence            999864444

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=3.7e-29  Score=192.24  Aligned_cols=184  Identities=23%  Similarity=0.388  Sum_probs=139.6

Q ss_pred             CCCCCCCCcccccceeecC--------------CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHH
Q 029552            1 MKRLRHPNIVLFMGAVTQP--------------PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL   66 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~--------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L   66 (191)
                      |++++||||+++++++...              ...++++||+. ++|.+++...    .+++..++.++.|+++||+||
T Consensus        56 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~L  130 (342)
T cd07854          56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYI  130 (342)
T ss_pred             HHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHH
Confidence            3578999999999877543              35789999997 5898887542    278999999999999999999


Q ss_pred             HhCCCCeeecCCCCCcEEecC-CCcEEEccccccccccccc---ccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHH
Q 029552           67 HRRNPPIVHRDLKSPNLLVDK-KYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVI  141 (191)
Q Consensus        67 h~~~~~~~h~~l~p~ni~~~~-~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~  141 (191)
                      |+.|  ++|+||+|+||+++. ++.++++|||.+.......   .......++..|+|||.+.+ ..++.++|+||+|++
T Consensus       131 H~~g--ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvi  208 (342)
T cd07854         131 HSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCI  208 (342)
T ss_pred             HhCC--cccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHH
Confidence            9999  999999999999974 5578999999876432111   11122345668999997654 457788999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhcC-----------------------ccc-----CCCCCCCHHHHHHHHHHhcC
Q 029552          142 LWELATLQQPWGNLNPAQVVAAVGFKG-----------------------KRL-----EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       142 ~~~l~~g~~pf~~~~~~~~~~~~~~~~-----------------------~~~-----~~~~~~s~~~~~li~~cl~~  191 (191)
                      +|+|++|..||...++.+....+....                       ...     .....++..++++|.+||++
T Consensus       209 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  286 (342)
T cd07854         209 FAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTF  286 (342)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCC
Confidence            999999999998776655544332110                       000     11246889999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.96  E-value=9.2e-31  Score=201.76  Aligned_cols=183  Identities=27%  Similarity=0.438  Sum_probs=151.4

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |+++.||.||.+..-|+..+.+++|||-+.| +..+++.... .+.+++..-..++.||+.||+|||..|  |+|+|+||
T Consensus       617 Lq~l~HPGiV~le~M~ET~ervFVVMEKl~G-DMLEMILSsE-kgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKP  692 (888)
T KOG4236|consen  617 LQNLHHPGIVNLECMFETPERVFVVMEKLHG-DMLEMILSSE-KGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKP  692 (888)
T ss_pred             HHhcCCCCeeEEEEeecCCceEEEEehhhcc-hHHHHHHHhh-cccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCc
Confidence            5789999999999999999999999999965 6666664333 345889888889999999999999999  99999999


Q ss_pred             CcEEecCC---CcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           81 PNLLVDKK---YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      +|+++...   .++||+|||++...+++ ..-+..+++++|+|||+++...|..+.|+||+|+++|--++|.+||+....
T Consensus       693 ENVLLas~~~FPQvKlCDFGfARiIgEk-sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd  771 (888)
T KOG4236|consen  693 ENVLLASASPFPQVKLCDFGFARIIGEK-SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED  771 (888)
T ss_pred             hheeeccCCCCCceeeccccceeecchh-hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc
Confidence            99999654   46899999999988877 344556899999999999999999999999999999999999999987544


Q ss_pred             HHHHHHHHhc-CcccCC-CCCCCHHHHHHHHHHhc
Q 029552          158 AQVVAAVGFK-GKRLEI-PRNVNPHVASIIEACWA  190 (191)
Q Consensus       158 ~~~~~~~~~~-~~~~~~-~~~~s~~~~~li~~cl~  190 (191)
                        +-++|... ...++. ...+|+...++|+..|+
T Consensus       772 --IndQIQNAaFMyPp~PW~eis~~AidlIn~LLq  804 (888)
T KOG4236|consen  772 --INDQIQNAAFMYPPNPWSEISPEAIDLINNLLQ  804 (888)
T ss_pred             --hhHHhhccccccCCCchhhcCHHHHHHHHHHHH
Confidence              33333222 222222 25799999999998875

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.96  E-value=4.3e-29  Score=191.88  Aligned_cols=179  Identities=24%  Similarity=0.383  Sum_probs=139.6

Q ss_pred             CCCCCCCcccccceeecCC------ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 029552            2 KRLRHPNIVLFMGAVTQPP------NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH   75 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h   75 (191)
                      ++++||||+++++++....      .+++++||+. .+|.++...     .++++.+..++.|++.|+++||+.+  ++|
T Consensus        69 ~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--i~H  140 (342)
T cd07879          69 KHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMGH-----PLSEDKVQYLVYQMLCGLKYIHSAG--IIH  140 (342)
T ss_pred             HhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccc
Confidence            5678999999999987543      4699999986 477776531     2789999999999999999999999  999


Q ss_pred             cCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 029552           76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGN  154 (191)
Q Consensus        76 ~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~pf~~  154 (191)
                      |||+|+||+++.++.++|+|||++......   .....++..|+|||.+.+ ..++.++|+||+|+++++|++|..||..
T Consensus       141 ~dlkp~NIll~~~~~~kL~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~  217 (342)
T cd07879         141 RDLKPGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG  217 (342)
T ss_pred             CCCCHHHEEECCCCCEEEeeCCCCcCCCCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999987643221   122344668999998866 4578899999999999999999999998


Q ss_pred             CCHHHHHHHHHhcCc---------------------ccCC--------CCCCCHHHHHHHHHHhcC
Q 029552          155 LNPAQVVAAVGFKGK---------------------RLEI--------PRNVNPHVASIIEACWAK  191 (191)
Q Consensus       155 ~~~~~~~~~~~~~~~---------------------~~~~--------~~~~s~~~~~li~~cl~~  191 (191)
                      .+.......+.....                     ....        .+..+..+.++|++||++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  283 (342)
T cd07879         218 KDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLEL  283 (342)
T ss_pred             CCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCC
Confidence            776554444322110                     0001        135788899999999974

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.96  E-value=7.8e-29  Score=190.66  Aligned_cols=181  Identities=24%  Similarity=0.403  Sum_probs=140.4

Q ss_pred             CCCCCCCCcccccceeecC------CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCee
Q 029552            1 MKRLRHPNIVLFMGAVTQP------PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIV   74 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~   74 (191)
                      +++++||||+++.+++...      ...+++++++ +++|.+++....    +++..++.++.|+++||+|||+.+  ++
T Consensus        70 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~~----l~~~~~~~i~~qi~~aL~~LH~~~--iv  142 (345)
T cd07877          70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK----LTDDHVQFLIYQILRGLKYIHSAD--II  142 (345)
T ss_pred             HHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCC--ee
Confidence            3568999999999988543      3478888877 679988886432    789999999999999999999999  99


Q ss_pred             ecCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCC
Q 029552           75 HRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWG  153 (191)
Q Consensus        75 h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~pf~  153 (191)
                      |+||+|+||+++.++.++|+|||++......   .....++..|+|||.+.+ ..++.++|+||+|+++++|++|..||.
T Consensus       143 H~dlkp~NIll~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  219 (345)
T cd07877         143 HRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP  219 (345)
T ss_pred             ecCCChHHEEEcCCCCEEEeccccccccccc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999987643322   122345678999998866 457788999999999999999999998


Q ss_pred             CCCHHHHHHHHHhcCcc---------------------cC--------CCCCCCHHHHHHHHHHhcC
Q 029552          154 NLNPAQVVAAVGFKGKR---------------------LE--------IPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       154 ~~~~~~~~~~~~~~~~~---------------------~~--------~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+.......+......                     ..        .....++.++++|.+||++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  286 (345)
T cd07877         220 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVL  286 (345)
T ss_pred             CCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCC
Confidence            76655544333211100                     00        1124688899999999974

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.96  E-value=1.5e-28  Score=188.04  Aligned_cols=182  Identities=25%  Similarity=0.355  Sum_probs=138.9

Q ss_pred             CC-CCCCcccccceeec----CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecC
Q 029552            3 RL-RHPNIVLFMGAVTQ----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRD   77 (191)
Q Consensus         3 ~l-~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~   77 (191)
                      ++ +||||+++++.+..    ....+++++++. ++|.+++....   .+++.+++.++.|++.||++||+.|  ++|+|
T Consensus        57 ~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~d  130 (332)
T cd07857          57 HFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSAN--VLHRD  130 (332)
T ss_pred             HhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC--cccCC
Confidence            45 59999999987542    245789999886 58998886533   3899999999999999999999999  99999


Q ss_pred             CCCCcEEecCCCcEEEccccccccccccc----ccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCC
Q 029552           78 LKSPNLLVDKKYTVKVCDFGLSRLKANTF----LSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPW  152 (191)
Q Consensus        78 l~p~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~pf  152 (191)
                      |+|+||+++.++.++|+|||.+.......    .......++..|+|||.+.+ ..++.++|+||+|++++++++|..||
T Consensus       131 lkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf  210 (332)
T cd07857         131 LKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF  210 (332)
T ss_pred             CCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCC
Confidence            99999999999999999999886433211    11122346778999998765 45788999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhcC------------------------c--cc---CCCCCCCHHHHHHHHHHhc
Q 029552          153 GNLNPAQVVAAVGFKG------------------------K--RL---EIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       153 ~~~~~~~~~~~~~~~~------------------------~--~~---~~~~~~s~~~~~li~~cl~  190 (191)
                      ...+.......+....                        .  ..   .....++..++++|.+||+
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  277 (332)
T cd07857         211 KGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLA  277 (332)
T ss_pred             CCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHcc
Confidence            8766544333222110                        0  00   1113468899999999996

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-29  Score=202.80  Aligned_cols=184  Identities=28%  Similarity=0.498  Sum_probs=158.4

Q ss_pred             CCCCCcccccceee-----cCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            4 LRHPNIVLFMGAVT-----QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         4 l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      -+|||++.++++|.     .++.+|+|||||.+||..|++.... +..+.|+.+.-++..++.|+.+||.+.  ++|||+
T Consensus        73 ~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDi  149 (953)
T KOG0587|consen   73 SHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK--VIHRDI  149 (953)
T ss_pred             cCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecc
Confidence            37999999999885     3457999999999999999997655 456999999999999999999999999  999999


Q ss_pred             CCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC-----CCCCcchHHHHHHHHHHHHhCCCCCC
Q 029552           79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-----PSNEKSDIYSFGVILWELATLQQPWG  153 (191)
Q Consensus        79 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-----~~~~~~Dv~slG~~~~~l~~g~~pf~  153 (191)
                      +-.||+++.++.+||.|||.+...+.....-....+++.|||||++...     .++.++|+||||++..+|.-|.+|+.
T Consensus       150 kG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~  229 (953)
T KOG0587|consen  150 KGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLC  229 (953)
T ss_pred             cCceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCcc
Confidence            9999999999999999999988766655555667889999999998643     35778999999999999999999999


Q ss_pred             CCCHHHHHHHHHhcCcccC--CCCCCCHHHHHHHHHHhcC
Q 029552          154 NLNPAQVVAAVGFKGKRLE--IPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~cl~~  191 (191)
                      +..+...+-.|- +.++++  -|..-|..+-++|..||.|
T Consensus       230 DmHPmraLF~Ip-RNPPPkLkrp~kWs~~FndFIs~cL~K  268 (953)
T KOG0587|consen  230 DMHPMRALFLIP-RNPPPKLKRPKKWSKKFNDFISTCLVK  268 (953)
T ss_pred             CcchhhhhccCC-CCCCccccchhhHHHHHHHHHHHHHhh
Confidence            999988888774 333333  3567899999999999975

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-28  Score=199.58  Aligned_cols=183  Identities=37%  Similarity=0.653  Sum_probs=154.3

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCC-----Cc--------ccccHHHHHHHHHHHHHHHHHHHhCCC
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-----VR--------EMLDERRRLNMAYDVAKGMNYLHRRNP   71 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----~~--------~~~~~~~~~~~~~~i~~~l~~Lh~~~~   71 (191)
                      +||||+.+++++.+++..++|.||+..|+|.++++...     ..        ..++..+.+.+++||+.|.+||++.. 
T Consensus       360 ~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~-  438 (609)
T KOG0200|consen  360 KHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP-  438 (609)
T ss_pred             CCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC-
Confidence            69999999999999999999999999999999997644     01        12788899999999999999999999 


Q ss_pred             CeeecCCCCCcEEecCCCcEEEcccccccccccccccC-CCCC--CCCcccCccccccCCCCCcchHHHHHHHHHHHHh-
Q 029552           72 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS-KSAA--GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-  147 (191)
Q Consensus        72 ~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~--~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-  147 (191)
                       ++|||+-.+||+++.+..+|++|||++.......... ....  -...|||||.+....++.++||||+|+++|++++ 
T Consensus       439 -~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsL  517 (609)
T KOG0200|consen  439 -CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTL  517 (609)
T ss_pred             -ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhC
Confidence             9999999999999999999999999997533321111 1111  2446999999999989999999999999999998 


Q ss_pred             CCCCCCCCC-HHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhc
Q 029552          148 LQQPWGNLN-PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       148 g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~  190 (191)
                      |..||.... ..+..+ ....+.+...|..+++++.++|..||+
T Consensus       518 G~~PYp~~~~~~~l~~-~l~~G~r~~~P~~c~~eiY~iM~~CW~  560 (609)
T KOG0200|consen  518 GGTPYPGIPPTEELLE-FLKEGNRMEQPEHCSDEIYDLMKSCWN  560 (609)
T ss_pred             CCCCCCCCCcHHHHHH-HHhcCCCCCCCCCCCHHHHHHHHHHhC
Confidence            577998865 445555 445888999999999999999999995

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=4.4e-29  Score=172.11  Aligned_cols=170  Identities=28%  Similarity=0.466  Sum_probs=134.9

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcC-CCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-PGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +...+|++|.+++...+....|+.||.|. .||+.+..+ -..++.++|..+-+++..++.|+.|||+.- +++|||+||
T Consensus       100 r~~~CPf~V~FyGa~~regdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKP  177 (282)
T KOG0984|consen  100 RTVDCPFTVHFYGALFREGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKP  177 (282)
T ss_pred             cCCCCCeEEEeehhhhccccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCc
Confidence            35579999999999988899999999996 599877753 111334899999999999999999999852 299999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc----CCCCCcchHHHHHHHHHHHHhCCCCCCC-C
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD----EPSNEKSDIYSFGVILWELATLQQPWGN-L  155 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~----~~~~~~~Dv~slG~~~~~l~~g~~pf~~-~  155 (191)
                      +||+++..|++|++|||.+-.-.++... ....+=..|+|||.+..    ..|+.++|+||||+++.||.+++.||.. .
T Consensus       178 sNiLIn~~GqVKiCDFGIsG~L~dSiAk-t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  178 SNILINYDGQVKICDFGISGYLVDSIAK-TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             ceEEEccCCcEEEcccccceeehhhhHH-HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            9999999999999999998654444211 11344568999998753    3578899999999999999999999987 6


Q ss_pred             CHHHHHHHHHhcCcccCCCC
Q 029552          156 NPAQVVAAVGFKGKRLEIPR  175 (191)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~  175 (191)
                      ++-+.+..+. ....+.+|.
T Consensus       257 tpF~qLkqvV-eep~P~Lp~  275 (282)
T KOG0984|consen  257 TPFQQLKQVV-EEPSPQLPA  275 (282)
T ss_pred             CHHHHHHHHh-cCCCCCCcc
Confidence            6666777664 444555553

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.96  E-value=2.3e-30  Score=184.52  Aligned_cols=185  Identities=26%  Similarity=0.441  Sum_probs=142.5

Q ss_pred             CCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcC--CCCcccccHHHHHHHHHHHHHHHHHHHhC-CCCeeecCCC
Q 029552            3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK--PGVREMLDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLK   79 (191)
Q Consensus         3 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~~~~~h~~l~   79 (191)
                      .-+.||||++++....++..|+.||.|+ .||+.+...  ......++|+-+-+++.-.++||.||-+. +  ++|||+|
T Consensus       119 s~~cp~IVkfyGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvK  195 (361)
T KOG1006|consen  119 SSNCPNIVKFYGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVK  195 (361)
T ss_pred             hcCCcHHHHHhhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCC
Confidence            3478999999999988899999999995 588766532  11122388888888888999999999864 5  9999999


Q ss_pred             CCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE--PSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      |+||+++..|.+||+|||++-.-.++.. .....+=..|+|||.+...  .++.++|+||||++++|++||..||...+.
T Consensus       196 PSNILldr~G~vKLCDFGIcGqLv~SiA-kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s  274 (361)
T KOG1006|consen  196 PSNILLDRHGDVKLCDFGICGQLVDSIA-KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS  274 (361)
T ss_pred             hhheEEecCCCEeeecccchHhHHHHHH-hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH
Confidence            9999999999999999999864443321 2234455689999988644  488999999999999999999999998554


Q ss_pred             -HHHHHHHHhcCccc-CCCC---CCCHHHHHHHHHHhcC
Q 029552          158 -AQVVAAVGFKGKRL-EIPR---NVNPHVASIIEACWAK  191 (191)
Q Consensus       158 -~~~~~~~~~~~~~~-~~~~---~~s~~~~~li~~cl~~  191 (191)
                       .+.+..+..+..+. -.+.   .+|.+++.+|+-||-|
T Consensus       275 vfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~K  313 (361)
T KOG1006|consen  275 VFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIK  313 (361)
T ss_pred             HHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhc
Confidence             33444444333322 2233   4899999999999975

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.96  E-value=2.6e-29  Score=182.73  Aligned_cols=150  Identities=26%  Similarity=0.452  Sum_probs=127.5

Q ss_pred             CCCCCCCcccccceeec-CCceEEEEeccCCCCHHHHhcC--CCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            2 KRLRHPNIVLFMGAVTQ-PPNLSIVTEYLSRGSLYRLLHK--PGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      +.++||||+.+..+|.. +...|+++||.+. +|..++.-  ....+.++...+..+++||+.|+.|||++.  +.|||+
T Consensus        82 REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDL  158 (438)
T KOG0666|consen   82 RELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDL  158 (438)
T ss_pred             HHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccC
Confidence            56899999999999976 7789999999987 89888852  222346889999999999999999999999  999999


Q ss_pred             CCCcEEecCC----CcEEEccccccccccccccc---CCCCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCC
Q 029552           79 KSPNLLVDKK----YTVKVCDFGLSRLKANTFLS---SKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQ  150 (191)
Q Consensus        79 ~p~ni~~~~~----~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~  150 (191)
                      ||.||++..+    |.+||+|+|++....+....   ....+.+.+|.|||.+.|.. |+.+.|+|++||++.||+|..+
T Consensus       159 KPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~P  238 (438)
T KOG0666|consen  159 KPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEP  238 (438)
T ss_pred             CcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCc
Confidence            9999999887    89999999999876655322   22334578999999998875 8899999999999999999888


Q ss_pred             CCCC
Q 029552          151 PWGN  154 (191)
Q Consensus       151 pf~~  154 (191)
                      -|..
T Consensus       239 lF~g  242 (438)
T KOG0666|consen  239 LFKG  242 (438)
T ss_pred             cccc
Confidence            7754

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.95  E-value=3e-28  Score=208.97  Aligned_cols=141  Identities=30%  Similarity=0.493  Sum_probs=119.6

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHH---hCCCCeeecC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLH---RRNPPIVHRD   77 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh---~~~~~~~h~~   77 (191)
                      |++++||||+++++++.+++..++||||+++++|.+++..      +++.++..++.|+++|++|||   +.+  ++|||
T Consensus       737 l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiH~d  808 (968)
T PLN00113        737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPA--VVVGN  808 (968)
T ss_pred             HhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCC--eecCC
Confidence            4678999999999999999999999999999999999963      788899999999999999999   557  99999


Q ss_pred             CCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 029552           78 LKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN  154 (191)
Q Consensus        78 l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~  154 (191)
                      +||+||+++.++..++. ++.......    .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||..
T Consensus       809 lkp~Nil~~~~~~~~~~-~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~  880 (968)
T PLN00113        809 LSPEKIIIDGKDEPHLR-LSLPGLLCT----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA  880 (968)
T ss_pred             CCHHhEEECCCCceEEE-ecccccccc----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence            99999999988877664 433221111    1122456789999999988899999999999999999999999854

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.95  E-value=2.5e-27  Score=177.04  Aligned_cols=184  Identities=27%  Similarity=0.510  Sum_probs=158.0

Q ss_pred             CCCCCccccccee-ecCCceEEEEeccCCCCHHHHhc-----CCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecC
Q 029552            4 LRHPNIVLFMGAV-TQPPNLSIVTEYLSRGSLYRLLH-----KPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRD   77 (191)
Q Consensus         4 l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~   77 (191)
                      +.|||+..+.++. ++....+++++++.-|+|..+++     +......++-.+...++.|++.|++|||+++  ++|.|
T Consensus       344 ~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkD  421 (563)
T KOG1024|consen  344 ASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKD  421 (563)
T ss_pred             CcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccch
Confidence            4699999999977 46678999999999999999998     3333334667788889999999999999999  99999


Q ss_pred             CCCCcEEecCCCcEEEccccccc--ccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q 029552           78 LKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGN  154 (191)
Q Consensus        78 l~p~ni~~~~~~~~~l~d~~~~~--~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~  154 (191)
                      |-.+|.++++.-++||+|=.++.  +..+..-..........||+||.+....++.++|+||+|+++|||+| |+.|+.+
T Consensus       422 iAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae  501 (563)
T KOG1024|consen  422 IAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE  501 (563)
T ss_pred             hhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc
Confidence            99999999999999999977664  22333333334455668999999999999999999999999999988 6889999


Q ss_pred             CCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhc
Q 029552          155 LNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~  190 (191)
                      .+|.++...++ ++.++..|.++|+++..+|.-||.
T Consensus       502 IDPfEm~~ylk-dGyRlaQP~NCPDeLf~vMacCWa  536 (563)
T KOG1024|consen  502 IDPFEMEHYLK-DGYRLAQPFNCPDELFTVMACCWA  536 (563)
T ss_pred             cCHHHHHHHHh-ccceecCCCCCcHHHHHHHHHHHh
Confidence            99999988886 889999999999999999999995

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=2e-28  Score=196.59  Aligned_cols=184  Identities=33%  Similarity=0.592  Sum_probs=159.5

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |.+++|||++++++++.... ..+|++|++.|+|.|+++....  .+-.+..+.|+.||++|+.|||.+.  ++||||-.
T Consensus       752 masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaa  826 (1177)
T KOG1025|consen  752 MASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAA  826 (1177)
T ss_pred             HhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhh
Confidence            45789999999999998765 8899999999999999987544  3888899999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccc--cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~  157 (191)
                      +|+++..-..+++.|||++........  ....-...+.|+|-|.+....++..+||||+|+++||++| |..|+.....
T Consensus       827 RNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~  906 (1177)
T KOG1025|consen  827 RNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA  906 (1177)
T ss_pred             hheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH
Confidence            999999999999999999875433211  1222234568999999999999999999999999999988 6889999888


Q ss_pred             HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhc
Q 029552          158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~  190 (191)
                      .++-+.+. .+.+++.|+.++-++.-+|-+||.
T Consensus       907 ~eI~dlle-~geRLsqPpiCtiDVy~~mvkCwm  938 (1177)
T KOG1025|consen  907 EEIPDLLE-KGERLSQPPICTIDVYMVMVKCWM  938 (1177)
T ss_pred             HHhhHHHh-ccccCCCCCCccHHHHHHHHHHhc
Confidence            88777774 888999999999999999999995

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.95  E-value=4.8e-27  Score=193.96  Aligned_cols=94  Identities=37%  Similarity=0.608  Sum_probs=86.8

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++||||+++++++...+..|+||||+.+++|.+++...+   .+++..++.++.||+.||+|||+.+  |+|+||||+
T Consensus        59 ~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~  133 (669)
T cd05610          59 ALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPD  133 (669)
T ss_pred             HhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHH
Confidence            46789999999999999999999999999999999997644   3789999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccc
Q 029552           82 NLLVDKKYTVKVCDFGLSR  100 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~  100 (191)
                      ||+++.++.++|+|||++.
T Consensus       134 NILl~~~g~vkL~DFGls~  152 (669)
T cd05610         134 NMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             HEEEcCCCCEEEEeCCCCc
Confidence            9999999999999999764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-26  Score=176.70  Aligned_cols=185  Identities=33%  Similarity=0.545  Sum_probs=150.7

Q ss_pred             CCCCCCcccccceeecCC----ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCC-------C
Q 029552            3 RLRHPNIVLFMGAVTQPP----NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRN-------P   71 (191)
Q Consensus         3 ~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~-------~   71 (191)
                      -++|+||+++++.-+...    .+++|++|.+.|+|.+++...-    ++..+..+++..+++||+|||+--       +
T Consensus       260 ~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp  335 (534)
T KOG3653|consen  260 GMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKP  335 (534)
T ss_pred             CccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCC
Confidence            368999999998776554    7999999999999999997644    899999999999999999999632       3


Q ss_pred             CeeecCCCCCcEEecCCCcEEEcccccccccccc--cccCCCCCCCCcccCccccccCCCC------CcchHHHHHHHHH
Q 029552           72 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEPSN------EKSDIYSFGVILW  143 (191)
Q Consensus        72 ~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~------~~~Dv~slG~~~~  143 (191)
                      +|+|||||..||++..++.+.|+|||++.+....  .......+++.+|||||.+.+.-.-      .+.||||+|.|+|
T Consensus       336 ~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLW  415 (534)
T KOG3653|consen  336 PIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLW  415 (534)
T ss_pred             ccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHH
Confidence            5999999999999999999999999999764322  2333447889999999999776321      2579999999999


Q ss_pred             HHHhC------------CCCCC-----CCCHHHHHHHHHhcCcccCCCCC-----CCHHHHHHHHHHhcC
Q 029552          144 ELATL------------QQPWG-----NLNPAQVVAAVGFKGKRLEIPRN-----VNPHVASIIEACWAK  191 (191)
Q Consensus       144 ~l~~g------------~~pf~-----~~~~~~~~~~~~~~~~~~~~~~~-----~s~~~~~li~~cl~~  191 (191)
                      |+++.            ++||.     ...-+++.+.+.+++.++.+|..     --..+++.++.||+.
T Consensus       416 Ei~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDh  485 (534)
T KOG3653|consen  416 EIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDH  485 (534)
T ss_pred             HHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCC
Confidence            99884            34565     24556677778888888888853     457899999999973

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=5.3e-27  Score=197.37  Aligned_cols=182  Identities=19%  Similarity=0.185  Sum_probs=127.9

Q ss_pred             CCCCC-CCccccccee-------ecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCe
Q 029552            2 KRLRH-PNIVLFMGAV-------TQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPI   73 (191)
Q Consensus         2 ~~l~h-~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~   73 (191)
                      +.++| +||.+++++|       .+.+.++.++|++ +++|.+++....  ..+++.++..++.||++||+|||++|  |
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g--I  101 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQG--I  101 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhCC--e
Confidence            45677 7888999988       3345678889987 569999997533  23899999999999999999999999  9


Q ss_pred             eecCCCCCcEEecCCCcE-------------------EEccccccccccccc----------------ccCCCCCCCCcc
Q 029552           74 VHRDLKSPNLLVDKKYTV-------------------KVCDFGLSRLKANTF----------------LSSKSAAGTPEW  118 (191)
Q Consensus        74 ~h~~l~p~ni~~~~~~~~-------------------~l~d~~~~~~~~~~~----------------~~~~~~~~~~~~  118 (191)
                      +||||||+||+++..|.+                   +++|||++.......                .......+++.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            999999999999654444                   555555543211000                000012356779


Q ss_pred             cCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       119 ~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +|||.+.+..++.++||||+||++|+|++|..|+.....  ....+.....+ +.+....+....++.+||.+
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~L~~  251 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLP-PQILLNWPKEASFCLWLLHP  251 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcC-hhhhhcCHHHHHHHHHhCCC
Confidence            999999988899999999999999999999888764322  22222111111 11112345667888888863

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=4.3e-27  Score=166.93  Aligned_cols=160  Identities=24%  Similarity=0.366  Sum_probs=132.2

Q ss_pred             CCCCCCCCcccccceee--------cCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCC
Q 029552            1 MKRLRHPNIVLFMGAVT--------QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPP   72 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~--------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~   72 (191)
                      |+.++|+|++.+++.|.        +..++|+||++|++ +|..++.....+  ++..++..++.+++.||.|+|+..  
T Consensus        70 L~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr--~sls~Ikk~Mk~Lm~GL~~iHr~k--  144 (376)
T KOG0669|consen   70 LQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVR--FSLSEIKKVMKGLMNGLYYIHRNK--  144 (376)
T ss_pred             HHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCcccc--ccHHHHHHHHHHHHHHHHHHHHhh--
Confidence            46789999999999884        33469999999987 999999765444  899999999999999999999999  


Q ss_pred             eeecCCCCCcEEecCCCcEEEcccccccccccccc----cCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHh
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL----SSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELAT  147 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~  147 (191)
                      |+|||+|+.|++++.+|.++|.|||++.....+..    .-...+.+.+|.+||.+.|. .++++.|+|.-||++.+|++
T Consensus       145 ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwt  224 (376)
T KOG0669|consen  145 ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWT  224 (376)
T ss_pred             HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHc
Confidence            99999999999999999999999999853322211    11123457899999988776 58899999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHH
Q 029552          148 LQQPWGNLNPAQVVAAVG  165 (191)
Q Consensus       148 g~~pf~~~~~~~~~~~~~  165 (191)
                      +.+-+........+..|.
T Consensus       225 rspimqgnteqqql~~Is  242 (376)
T KOG0669|consen  225 RSPIMQGNTEQQQLHLIS  242 (376)
T ss_pred             cCccccCChHHHHHHHHH
Confidence            999888877766666554

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.94  E-value=7.4e-27  Score=158.41  Aligned_cols=160  Identities=25%  Similarity=0.384  Sum_probs=135.4

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |+.++|.|||++++..-.++..-+|+|+|.. +|..+...-  ++.++.+.++.++.|++++|.|.|+++  +.|||+||
T Consensus        55 lkelkhknivrl~dvlhsdkkltlvfe~cdq-dlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkp  129 (292)
T KOG0662|consen   55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKP  129 (292)
T ss_pred             HHHhhhcceeehhhhhccCceeEEeHHHhhH-HHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCc
Confidence            4678999999999999888899999999964 898888642  334899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCC-CCCCCCHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQ-PWGNLNPA  158 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~-pf~~~~~~  158 (191)
                      .|.+++.+|.+|+.|||++...+.+..--+....+.+|.+|+++-|.. ++.+.|+||-||++.++..... -|...+-+
T Consensus       130 qnllin~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd  209 (292)
T KOG0662|consen  130 QNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD  209 (292)
T ss_pred             ceEEeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH
Confidence            999999999999999999987666544444556788999999988775 7888999999999999987654 56666666


Q ss_pred             HHHHHHH
Q 029552          159 QVVAAVG  165 (191)
Q Consensus       159 ~~~~~~~  165 (191)
                      ..+.+|-
T Consensus       210 dqlkrif  216 (292)
T KOG0662|consen  210 DQLKRIF  216 (292)
T ss_pred             HHHHHHH
Confidence            6666653

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=1.3e-25  Score=162.17  Aligned_cols=160  Identities=37%  Similarity=0.575  Sum_probs=132.5

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++|+|++++++++......++++|++.+++|.+++......  +++..+..++.+++.++.+||+.+  ++|+|++|.
T Consensus        52 ~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~  127 (225)
T smart00221       52 KKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLG--IVHRDLKPE  127 (225)
T ss_pred             HhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHH
Confidence            4568999999999999889999999999999999999754321  688899999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCcccc-ccCCCCCcchHHHHHHHHHHHHhCCCCCCC-CCHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVL-RDEPSNEKSDIYSFGVILWELATLQQPWGN-LNPA  158 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~-~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~-~~~~  158 (191)
                      |++++.++.++|+|||.+....... .......+...|++||.. .....+.++|+|++|++++++++|..||.. .++.
T Consensus       128 ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~  207 (225)
T smart00221      128 NILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT  207 (225)
T ss_pred             HEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence            9999999999999999876544331 011223455679999998 566677799999999999999999999987 5555


Q ss_pred             -HHHHHHH
Q 029552          159 -QVVAAVG  165 (191)
Q Consensus       159 -~~~~~~~  165 (191)
                       ...+.+.
T Consensus       208 ~~~~~~~~  215 (225)
T smart00221      208 SLLSDVWS  215 (225)
T ss_pred             HHHHHHHh
Confidence             5555553

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.94  E-value=8.7e-27  Score=173.12  Aligned_cols=144  Identities=24%  Similarity=0.329  Sum_probs=123.2

Q ss_pred             cccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecC-
Q 029552            9 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK-   87 (191)
Q Consensus         9 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~-   87 (191)
                      ++.+.++|...++.|+|+|.+ |.|+.+++..+.. ..++..+++.+++|+++++++||+.+  ++|.||||+||++.+ 
T Consensus       153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss  228 (415)
T KOG0671|consen  153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSS  228 (415)
T ss_pred             EEeeehhhhccCceEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEecc
Confidence            566778899999999999977 6799999977553 34899999999999999999999999  999999999999832 


Q ss_pred             -------------------CCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhC
Q 029552           88 -------------------KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL  148 (191)
Q Consensus        88 -------------------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g  148 (191)
                                         +..++++|||.+.......   ...+.+..|.|||++.+...+.++||||+||+++|+.+|
T Consensus       229 ~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG  305 (415)
T KOG0671|consen  229 EYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTG  305 (415)
T ss_pred             ceEEEeccCCccceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecc
Confidence                               2348999999987665553   334567799999999999999999999999999999999


Q ss_pred             CCCCCCCCHHH
Q 029552          149 QQPWGNLNPAQ  159 (191)
Q Consensus       149 ~~pf~~~~~~~  159 (191)
                      ..-|...+..+
T Consensus       306 ~~LFqtHen~E  316 (415)
T KOG0671|consen  306 ETLFQTHENLE  316 (415)
T ss_pred             ceecccCCcHH
Confidence            99887766555

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=8.1e-26  Score=158.11  Aligned_cols=143  Identities=24%  Similarity=0.350  Sum_probs=109.6

Q ss_pred             CCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecCCCcEEEcccccccccccccccCCC
Q 029552           32 GSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS  111 (191)
Q Consensus        32 ~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~  111 (191)
                      |+|.+++...+.  .+++.+++.++.|++.||+|||+.+        ||+||+++.++.+++  ||.+......     .
T Consensus         1 GsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~   63 (176)
T smart00750        1 VSLADILEVRGR--PLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPE-----Q   63 (176)
T ss_pred             CcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeeccc-----c
Confidence            589999975332  3899999999999999999999987        999999999999998  8887654432     1


Q ss_pred             CCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCccc-----CCCCCCCH--HHHH
Q 029552          112 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA-QVVAAVGFKGKRL-----EIPRNVNP--HVAS  183 (191)
Q Consensus       112 ~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~-----~~~~~~s~--~~~~  183 (191)
                      ..++..|+|||.+.+..++.++||||+|+++|+|++|..||...... .....+.......     ..+..++.  .+++
T Consensus        64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  143 (176)
T smart00750       64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFAD  143 (176)
T ss_pred             CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHH
Confidence            24678999999999999999999999999999999999999764432 2222222111111     12233444  6999


Q ss_pred             HHHHHhcC
Q 029552          184 IIEACWAK  191 (191)
Q Consensus       184 li~~cl~~  191 (191)
                      +|.+||++
T Consensus       144 ~i~~cl~~  151 (176)
T smart00750      144 FMRVCASR  151 (176)
T ss_pred             HHHHHHhc
Confidence            99999964

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.93  E-value=7.5e-27  Score=181.49  Aligned_cols=144  Identities=28%  Similarity=0.431  Sum_probs=127.6

Q ss_pred             CCCCCcccccceeecCCceEEEEeccC-CCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCc
Q 029552            4 LRHPNIVLFMGAVTQPPNLSIVTEYLS-RGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN   82 (191)
Q Consensus         4 l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~n   82 (191)
                      -.|+||+|++++|++++.+|+++|.-. |.+|++++....   .++|.++..++.|++.|+++||+.|  |+|||||-+|
T Consensus       626 ~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikden  700 (772)
T KOG1152|consen  626 HSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDEN  700 (772)
T ss_pred             cCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhccccccccC--ceeccccccc
Confidence            359999999999999999999999753 578899997644   3999999999999999999999999  9999999999


Q ss_pred             EEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCC
Q 029552           83 LLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGN  154 (191)
Q Consensus        83 i~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~pf~~  154 (191)
                      +.++.+|-+||+|||.+....+.  ......++..|.|||.+.|.+| ...-|+|+||+++|.+.....||..
T Consensus       701 vivd~~g~~klidfgsaa~~ksg--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  701 VIVDSNGFVKLIDFGSAAYTKSG--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             EEEecCCeEEEeeccchhhhcCC--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            99999999999999988755544  4456688999999999999987 5567999999999999999999864

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.1e-25  Score=170.25  Aligned_cols=183  Identities=35%  Similarity=0.616  Sum_probs=139.1

Q ss_pred             CCCCCcccccceeecCC----ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHh-----CCC-Ce
Q 029552            4 LRHPNIVLFMGAVTQPP----NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-----RNP-PI   73 (191)
Q Consensus         4 l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-----~~~-~~   73 (191)
                      |+|+||..++.+=..++    ..|+|++|.+.|||.|++.+..    ++-+..++++..++.||++||.     +|+ +|
T Consensus       262 LRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~t----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaI  337 (513)
T KOG2052|consen  262 LRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNT----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAI  337 (513)
T ss_pred             hccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhcc----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchh
Confidence            69999999998664333    5899999999999999998744    7889999999999999999994     333 59


Q ss_pred             eecCCCCCcEEecCCCcEEEcccccccccccc----cccCCCCCCCCcccCccccccCCC------CCcchHHHHHHHHH
Q 029552           74 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT----FLSSKSAAGTPEWMAPEVLRDEPS------NEKSDIYSFGVILW  143 (191)
Q Consensus        74 ~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~~~~------~~~~Dv~slG~~~~  143 (191)
                      +|||||..||++.++|.+.|.|+|++......    .......+++.+|||||++...-.      -..+||||+|.|+|
T Consensus       338 AHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlW  417 (513)
T KOG2052|consen  338 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLW  417 (513)
T ss_pred             hccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHH
Confidence            99999999999999999999999999765443    233455688999999999865422      24689999999999


Q ss_pred             HHHhC----------CCCCCCCCHH-----HHHHHHHhcCcccCCCCCC--C---HHHHHHHHHHhc
Q 029552          144 ELATL----------QQPWGNLNPA-----QVVAAVGFKGKRLEIPRNV--N---PHVASIIEACWA  190 (191)
Q Consensus       144 ~l~~g----------~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~--s---~~~~~li~~cl~  190 (191)
                      |++-.          +.||.+..+.     ++.+-+=....++++|..-  .   ..+..+|+-||.
T Consensus       418 EiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~  484 (513)
T KOG2052|consen  418 EIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWY  484 (513)
T ss_pred             HHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhc
Confidence            99652          6788753332     2222222234466666532  2   445667888886

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.93  E-value=1.4e-26  Score=185.91  Aligned_cols=181  Identities=29%  Similarity=0.449  Sum_probs=136.9

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCC-CcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL   83 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni   83 (191)
                      +||||+++++.-.++...|+..|.|.. +|.+++.... ..........+....|+++||++||+.+  |+|||+||.||
T Consensus       561 ~H~NviRyyc~E~d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNI  637 (903)
T KOG1027|consen  561 EHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNI  637 (903)
T ss_pred             CCCceEEEEeeccCCceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceE
Confidence            699999999988899999999999975 9999998641 1111111355778899999999999999  99999999999


Q ss_pred             EecC---C--CcEEEcccccccccccc---cccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhC-CCCCCC
Q 029552           84 LVDK---K--YTVKVCDFGLSRLKANT---FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGN  154 (191)
Q Consensus        84 ~~~~---~--~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g-~~pf~~  154 (191)
                      +++.   .  .+++|+|||+++.....   ........++.+|.|||.+.......++|+||+||++|+.++| ..||++
T Consensus       638 LI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd  717 (903)
T KOG1027|consen  638 LISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD  717 (903)
T ss_pred             EEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc
Confidence            9976   2  46899999999864433   2334455678899999999998888899999999999999998 889987


Q ss_pred             CCHHHHHHHHHhcCcccC-CCCCCCHHHHHHHHHHhc
Q 029552          155 LNPAQVVAAVGFKGKRLE-IPRNVNPHVASIIEACWA  190 (191)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~cl~  190 (191)
                      .-..+  .+|......+. +-..-....++||.+|++
T Consensus       718 ~~~R~--~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~  752 (903)
T KOG1027|consen  718 SLERQ--ANILTGNYTLVHLEPLPDCEAKDLISRMLN  752 (903)
T ss_pred             hHHhh--hhhhcCccceeeeccCchHHHHHHHHHhcC
Confidence            43322  22222222111 111111288999999986

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.93  E-value=5e-26  Score=165.80  Aligned_cols=155  Identities=27%  Similarity=0.398  Sum_probs=132.1

Q ss_pred             CCCCCCCcccccceeecC------CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 029552            2 KRLRHPNIVLFMGAVTQP------PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH   75 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h   75 (191)
                      ..++|+||++++.+|.-.      ...|+|||+|. .+|...+...     ++.+.+..++.|++.|+++||+.|  |.|
T Consensus        70 ~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~~e-----lDH~tis~i~yq~~~~ik~lhs~~--Iih  141 (369)
T KOG0665|consen   70 KCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVILME-----LDHETISYILYQMLCGIKHLHSAG--IIH  141 (369)
T ss_pred             hhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHHHh-----cchHHHHHHHHHHHHHHHHHHhcc--eee
Confidence            467999999999999532      35899999995 5999988732     678899999999999999999999  999


Q ss_pred             cCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        76 ~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      |||||+||++..+...|+.|||++...... .....-..+..|.|||++.+..+++.+|+||+||++.+|++|..-|.+.
T Consensus       142 RdLkPsnivv~~~~~lKi~dfg~ar~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~  220 (369)
T KOG0665|consen  142 RDLKPSNIVVNSDCTLKILDFGLARTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK  220 (369)
T ss_pred             cccCcccceecchhheeeccchhhcccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc
Confidence            999999999999999999999998765544 1222234566899999999999999999999999999999999999988


Q ss_pred             CHHHHHHHHH
Q 029552          156 NPAQVVAAVG  165 (191)
Q Consensus       156 ~~~~~~~~~~  165 (191)
                      +......++.
T Consensus       221 d~idQ~~ki~  230 (369)
T KOG0665|consen  221 DHIDQWNKII  230 (369)
T ss_pred             hHHHHHHHHH
Confidence            8777776664

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.92  E-value=2.6e-25  Score=175.31  Aligned_cols=186  Identities=32%  Similarity=0.525  Sum_probs=161.3

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      ++..+||||+.|++.+...+..|+.||||.+|+|+++..-.+.   +++.++...+.+.+++++|||+.|  -.|||||-
T Consensus        66 ~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~Tgp---lselqiayvcRetl~gl~ylhs~g--k~hRdiKG  140 (829)
T KOG0576|consen   66 LRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTGP---LSELQIAYVCRETLQGLKYLHSQG--KIHRDIKG  140 (829)
T ss_pred             eecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeeccc---chhHHHHHHHhhhhccchhhhcCC--cccccccc
Confidence            3567999999999999999999999999999999999987554   899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccc---ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL---RDEPSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~---~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      .||+++..|.+++.|||.+...+..........+++.|++||+-   +...+...+|+|++|+...++.-.+.|..+..+
T Consensus       141 anilltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp  220 (829)
T KOG0576|consen  141 ANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP  220 (829)
T ss_pred             cceeecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch
Confidence            99999999999999999987766655555667899999999975   345588899999999999999999999999888


Q ss_pred             HHHHHHHHhcCcccCC---CCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEI---PRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~---~~~~s~~~~~li~~cl~~  191 (191)
                      ...+......+..++.   +..-++.+.++++.||.|
T Consensus       221 mr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altk  257 (829)
T KOG0576|consen  221 MRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTK  257 (829)
T ss_pred             HHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcC
Confidence            8888777544443332   345799999999999875

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.92  E-value=4.8e-24  Score=169.56  Aligned_cols=182  Identities=22%  Similarity=0.203  Sum_probs=127.2

Q ss_pred             Ccccccceeec--------CCceEEEEeccCCCCHHHHhcCCCC---------------------cccccHHHHHHHHHH
Q 029552            8 NIVLFMGAVTQ--------PPNLSIVTEYLSRGSLYRLLHKPGV---------------------REMLDERRRLNMAYD   58 (191)
Q Consensus         8 ~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~~---------------------~~~~~~~~~~~~~~~   58 (191)
                      ++++++++|..        ++..++|+||+.+++|.+++.....                     ...++...+..++.|
T Consensus       238 ~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~q  317 (507)
T PLN03224        238 SCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQ  317 (507)
T ss_pred             hhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHH
Confidence            34667776642        3568999999999999998863210                     011345678889999


Q ss_pred             HHHHHHHHHhCCCCeeecCCCCCcEEecCCCcEEEcccccccccccccc-cCCCCCCCCcccCccccccCCC--------
Q 029552           59 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRDEPS--------  129 (191)
Q Consensus        59 i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~--------  129 (191)
                      ++.+|+|||+.+  ++||||||+||+++.++.++|+|||++........ .......++.|++||.+.....        
T Consensus       318 l~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~  395 (507)
T PLN03224        318 VLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPA  395 (507)
T ss_pred             HHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhh
Confidence            999999999999  99999999999999999999999998854332211 1112233678999998753321        


Q ss_pred             --------------CCcchHHHHHHHHHHHHhCCC-CCCCCCHHH-----------HHHHHHhcCcccCCCCCCCHHHHH
Q 029552          130 --------------NEKSDIYSFGVILWELATLQQ-PWGNLNPAQ-----------VVAAVGFKGKRLEIPRNVNPHVAS  183 (191)
Q Consensus       130 --------------~~~~Dv~slG~~~~~l~~g~~-pf~~~~~~~-----------~~~~~~~~~~~~~~~~~~s~~~~~  183 (191)
                                    ..+.|+||+||++++|+++.. ||.......           ....+.............|+..++
T Consensus       396 ~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~d  475 (507)
T PLN03224        396 MAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWD  475 (507)
T ss_pred             hhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHH
Confidence                          124699999999999999976 775421111           011111112233344678999999


Q ss_pred             HHHHHhcC
Q 029552          184 IIEACWAK  191 (191)
Q Consensus       184 li~~cl~~  191 (191)
                      ++.++|.+
T Consensus       476 Li~~LL~~  483 (507)
T PLN03224        476 LACKLITK  483 (507)
T ss_pred             HHHHHhcc
Confidence            99999864

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.92  E-value=8.9e-24  Score=150.51  Aligned_cols=140  Identities=45%  Similarity=0.699  Sum_probs=120.7

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++|++++++++++......++++|++.+++|.+++....  ..++...++.++.++++++.+||+.+  ++|+|++|.
T Consensus        46 ~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~  121 (215)
T cd00180          46 KKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE--GKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPE  121 (215)
T ss_pred             HhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHh
Confidence            56789999999999999899999999999899999997642  12789999999999999999999999  999999999


Q ss_pred             cEEecC-CCcEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHH
Q 029552           82 NLLVDK-KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWEL  145 (191)
Q Consensus        82 ni~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l  145 (191)
                      ||+++. ++.++++||+.+..................|++||..... ..+.+.|+|++|++++++
T Consensus       122 ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         122 NILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             hEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            999999 8999999999876554432123334567789999998876 678889999999999999

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.1e-26  Score=165.36  Aligned_cols=157  Identities=29%  Similarity=0.489  Sum_probs=130.4

Q ss_pred             CCCCCCcccccceeecCC-----ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecC
Q 029552            3 RLRHPNIVLFMGAVTQPP-----NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRD   77 (191)
Q Consensus         3 ~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~   77 (191)
                      .++|.|+...+++..-..     .+|+++|.+.. +|..++-....   ++.+.+.-+++||++||+|||+.+  |.|||
T Consensus       108 fFkHdNVLSaLDILQPph~dfFqEiYV~TELmQS-DLHKIIVSPQ~---Ls~DHvKVFlYQILRGLKYLHsA~--ILHRD  181 (449)
T KOG0664|consen  108 SFRHDNVLSLLDILQPANPSFFQELYVLTELMQS-DLHKIIVSPQA---LTPDHVKVFVYQILRGLKYLHTAN--ILHRD  181 (449)
T ss_pred             hhccccHHHHHHhcCCCCchHHHHHHHHHHHHHh-hhhheeccCCC---CCcchhhhhHHHHHhhhHHHhhcc--hhhcc
Confidence            468999998888765332     47899998865 99998866443   788888889999999999999999  99999


Q ss_pred             CCCCcEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           78 LKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        78 l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      |||.|.+++.+-.+||+|||++....... ........+..|.+||++.|.. |+.+.||||+||++.+++..+.-|...
T Consensus       182 IKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq  261 (449)
T KOG0664|consen  182 IKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA  261 (449)
T ss_pred             CCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc
Confidence            99999999999999999999987554331 2223345577899999998875 788999999999999999999999998


Q ss_pred             CHHHHHHHHH
Q 029552          156 NPAQVVAAVG  165 (191)
Q Consensus       156 ~~~~~~~~~~  165 (191)
                      ++.+.++.|.
T Consensus       262 ~PiqQL~lIt  271 (449)
T KOG0664|consen  262 GPIEQLQMII  271 (449)
T ss_pred             ChHHHHHHHH
Confidence            8888777664

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.91  E-value=9.4e-24  Score=171.07  Aligned_cols=135  Identities=21%  Similarity=0.255  Sum_probs=101.2

Q ss_pred             cCCceEEEEeccCCCCHHHHhcCCCCc-----------------ccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552           18 QPPNLSIVTEYLSRGSLYRLLHKPGVR-----------------EMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus        18 ~~~~~~lv~e~~~~~~L~~~~~~~~~~-----------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      ++...++|+||+.+++|.+++......                 ....+..+..++.|++.||+|||+++  ++||||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRDLKP  283 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRDVKP  283 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCcCCH
Confidence            456799999999999999998643210                 00123456678999999999999999  99999999


Q ss_pred             CcEEecC-CCcEEEcccccccccccc-cccCCCCCCCCcccCccccccCC----------------------CCCcchHH
Q 029552           81 PNLLVDK-KYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLRDEP----------------------SNEKSDIY  136 (191)
Q Consensus        81 ~ni~~~~-~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~----------------------~~~~~Dv~  136 (191)
                      +||+++. ++.++|+|||++...... ........+++.|+|||.+....                      +..++|+|
T Consensus       284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw  363 (566)
T PLN03225        284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY  363 (566)
T ss_pred             HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence            9999986 578999999998642211 11223445678999999653221                      23456999


Q ss_pred             HHHHHHHHHHhCCCCCCC
Q 029552          137 SFGVILWELATLQQPWGN  154 (191)
Q Consensus       137 slG~~~~~l~~g~~pf~~  154 (191)
                      |+||++|+|+++..++..
T Consensus       364 SlGviL~el~~~~~~~~~  381 (566)
T PLN03225        364 SAGLIFLQMAFPNLRSDS  381 (566)
T ss_pred             HHHHHHHHHHhCcCCCch
Confidence            999999999998776543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.91  E-value=4.4e-24  Score=177.39  Aligned_cols=164  Identities=29%  Similarity=0.511  Sum_probs=126.7

Q ss_pred             cCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecCCCcEEEcccc
Q 029552           18 QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFG   97 (191)
Q Consensus        18 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~   97 (191)
                      ....+|+-||||+..+|.++++.....  -.....|+++.||+.||.|+|+.|  ++||||||.|||++..+.+||+|||
T Consensus       667 ~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYIH~~g--iIHRDLKP~NIFLd~~~~VKIGDFG  742 (1351)
T KOG1035|consen  667 KPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYIHDQG--IIHRDLKPRNIFLDSRNSVKIGDFG  742 (1351)
T ss_pred             cceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHHHhCc--eeeccCCcceeEEcCCCCeeecccc
Confidence            345689999999998888888765421  157899999999999999999999  9999999999999999999999999


Q ss_pred             ccccc------------------ccccccCCCCCCCCcccCccccccCC---CCCcchHHHHHHHHHHHHhCCCCCCC-C
Q 029552           98 LSRLK------------------ANTFLSSKSAAGTPEWMAPEVLRDEP---SNEKSDIYSFGVILWELATLQQPWGN-L  155 (191)
Q Consensus        98 ~~~~~------------------~~~~~~~~~~~~~~~~~~pe~~~~~~---~~~~~Dv~slG~~~~~l~~g~~pf~~-~  155 (191)
                      ++...                  +..........|+.-|+|||.+.+..   |+.+.|+||||++++||+.   ||.. +
T Consensus       743 LAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM  819 (1351)
T KOG1035|consen  743 LATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM  819 (1351)
T ss_pred             cchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchH
Confidence            98641                  01111234457888999999987654   8999999999999999986   4654 5


Q ss_pred             CHHHHHHHHHhcCcccCCC----CCCCHHHHHHHHHHhc
Q 029552          156 NPAQVVAAVGFKGKRLEIP----RNVNPHVASIIEACWA  190 (191)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~----~~~s~~~~~li~~cl~  190 (191)
                      +....+..++  ...++.|    .+--+.-+.+|..+++
T Consensus       820 ERa~iL~~LR--~g~iP~~~~f~~~~~~~e~slI~~Ll~  856 (1351)
T KOG1035|consen  820 ERASILTNLR--KGSIPEPADFFDPEHPEEASLIRWLLS  856 (1351)
T ss_pred             HHHHHHHhcc--cCCCCCCcccccccchHHHHHHHHHhc
Confidence            5556666664  3344444    2334566778888876

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.91  E-value=3.7e-24  Score=153.37  Aligned_cols=176  Identities=26%  Similarity=0.444  Sum_probs=132.5

Q ss_pred             CCCCcccccc-eeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcE
Q 029552            5 RHPNIVLFMG-AVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL   83 (191)
Q Consensus         5 ~h~~i~~~~~-~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni   83 (191)
                      .|.||+.-++ .|+..+.++.++||++.|+|.+-+...+    +.|.-...++.|++.||+|+|+.+  ++|||||.+||
T Consensus        79 ~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNi  152 (378)
T KOG1345|consen   79 PHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENI  152 (378)
T ss_pred             cchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceE
Confidence            4888887665 5677778889999999999999887655    678888899999999999999999  99999999999


Q ss_pred             EecC--CCcEEEcccccccccccccccCCCCCCCCcccCcccccc---C--CCCCcchHHHHHHHHHHHHhCCCCCCC--
Q 029552           84 LVDK--KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD---E--PSNEKSDIYSFGVILWELATLQQPWGN--  154 (191)
Q Consensus        84 ~~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~---~--~~~~~~Dv~slG~~~~~l~~g~~pf~~--  154 (191)
                      ++..  ..++||+|||.+...+....   .......|.+||....   +  ...+..|+|.+|+++++++||.+||..  
T Consensus       153 Lif~~df~rvKlcDFG~t~k~g~tV~---~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~  229 (378)
T KOG1345|consen  153 LIFDADFYRVKLCDFGLTRKVGTTVK---YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS  229 (378)
T ss_pred             EEecCCccEEEeeecccccccCceeh---hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh
Confidence            9843  34899999999875554322   1223446788886532   2  235678999999999999999999963  


Q ss_pred             -CCHHHHHHHHHhcCcccCCCC---CCCHHHHHHHHHHh
Q 029552          155 -LNPAQVVAAVGFKGKRLEIPR---NVNPHVASIIEACW  189 (191)
Q Consensus       155 -~~~~~~~~~~~~~~~~~~~~~---~~s~~~~~li~~cl  189 (191)
                       .++..........+..+.+|.   .+|+.+.++-++-|
T Consensus       230 ~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~l  268 (378)
T KOG1345|consen  230 IMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSL  268 (378)
T ss_pred             ccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhc
Confidence             444444444434555556664   46777766666554

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.90  E-value=1.9e-24  Score=166.63  Aligned_cols=154  Identities=22%  Similarity=0.294  Sum_probs=129.5

Q ss_pred             CCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEec
Q 029552            7 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD   86 (191)
Q Consensus         7 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~   86 (191)
                      -|+++++..|.+.+++|||||-+ ..+|.+++.+.+..-.+....++.++.|+.-||..|-+.|  ++|.||||.||+++
T Consensus       494 ~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVN  570 (752)
T KOG0670|consen  494 FHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVN  570 (752)
T ss_pred             hHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEec
Confidence            46788999999999999999977 6799999988776666888899999999999999999999  99999999999998


Q ss_pred             CCC-cEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 029552           87 KKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG  165 (191)
Q Consensus        87 ~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~~  165 (191)
                      .+. .+||+|||.+........  ..-..+-.|.|||++.|.+|+...|+||+||++|++.||+.-|.+.+...++....
T Consensus       571 E~k~iLKLCDfGSA~~~~enei--tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m  648 (752)
T KOG0670|consen  571 ESKNILKLCDFGSASFASENEI--TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM  648 (752)
T ss_pred             cCcceeeeccCccccccccccc--cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence            765 579999998865443311  11122346899999999999999999999999999999999998877666666553

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.89  E-value=5.2e-23  Score=144.46  Aligned_cols=151  Identities=25%  Similarity=0.433  Sum_probs=121.9

Q ss_pred             CCC-CCCcccccceeecC--CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            3 RLR-HPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         3 ~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      .|. ||||++++++..++  .+..+|+|+.+..+...+...      ++.-.++.++.++++||.|+|++|  |.|||+|
T Consensus        88 nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~t------l~d~dIryY~~elLkALdyCHS~G--ImHRDVK  159 (338)
T KOG0668|consen   88 NLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPT------LTDYDIRYYIYELLKALDYCHSMG--IMHRDVK  159 (338)
T ss_pred             hccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhh------hchhhHHHHHHHHHHHHhHHHhcC--cccccCC
Confidence            444 99999999999765  478899999999888877765      788899999999999999999999  9999999


Q ss_pred             CCcEEecCCC-cEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCC--CC
Q 029552           80 SPNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWG--NL  155 (191)
Q Consensus        80 p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf~--~~  155 (191)
                      |.|+.++... .++|+|+|++.+........ ..+.+..|-.||.+..- .++.+.|+||+||++..|.....||-  ..
T Consensus       160 PhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn-VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d  238 (338)
T KOG0668|consen  160 PHNVMIDHELRKLRLIDWGLAEFYHPGKEYN-VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD  238 (338)
T ss_pred             cceeeechhhceeeeeecchHhhcCCCceee-eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC
Confidence            9999998754 58999999997654442222 22334567889987655 47889999999999999999998884  34


Q ss_pred             CHHHHHH
Q 029552          156 NPAQVVA  162 (191)
Q Consensus       156 ~~~~~~~  162 (191)
                      +.+..+.
T Consensus       239 N~DQLVk  245 (338)
T KOG0668|consen  239 NYDQLVK  245 (338)
T ss_pred             CHHHHHH
Confidence            4444443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=9.9e-21  Score=142.47  Aligned_cols=181  Identities=23%  Similarity=0.328  Sum_probs=137.9

Q ss_pred             CCCCCcccccceeecC---------------------------CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHH
Q 029552            4 LRHPNIVLFMGAVTQP---------------------------PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA   56 (191)
Q Consensus         4 l~h~~i~~~~~~~~~~---------------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~   56 (191)
                      -+||||+++..+|.+.                           .+.|+||..... +|.+++-.+.    .+....+-++
T Consensus       273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~l  347 (598)
T KOG4158|consen  273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVIL  347 (598)
T ss_pred             CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHH
Confidence            4799999998887432                           358999999975 9999997655    3455666688


Q ss_pred             HHHHHHHHHHHhCCCCeeecCCCCCcEEecC--C--CcEEEcccccccccccc------cccCCCCCCCCcccCcccccc
Q 029552           57 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK--K--YTVKVCDFGLSRLKANT------FLSSKSAAGTPEWMAPEVLRD  126 (191)
Q Consensus        57 ~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~--~--~~~~l~d~~~~~~~~~~------~~~~~~~~~~~~~~~pe~~~~  126 (191)
                      .|+++|+.|||++|  +.|||+|.+||++.-  +  ..+.+.|||.+.-....      ........++...+|||+...
T Consensus       348 aQlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  348 AQLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            99999999999999  999999999999943  3  35789999987543321      112223345668899999865


Q ss_pred             CCC------CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          127 EPS------NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       127 ~~~------~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+-      -.++|.|+.|.+.||+++...||............-+....+..|+.+++.++.++...|++
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r  496 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKR  496 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcC
Confidence            432      24799999999999999999999874444333333445567789999999999999998874

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.85  E-value=7.1e-22  Score=155.33  Aligned_cols=170  Identities=28%  Similarity=0.445  Sum_probs=147.3

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      +||+++++...|+.+...+++.++..++.|...+.+...   +++.....+..+++-+++++|+.+  ++|+++|++||+
T Consensus        55 ~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~---f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enil  129 (612)
T KOG0603|consen   55 NTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVM---FDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVL  129 (612)
T ss_pred             CCCceeeeeeeeccccchhHhhhhcccchhhhccccCCc---hHHHHHHHHHHHHHHHHhhcchhH--HHHhccccccee
Confidence            499999999999999999999999999999888876443   888899999999999999999999  999999999999


Q ss_pred             ecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 029552           85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV  164 (191)
Q Consensus        85 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~  164 (191)
                      ++.+|.+++.|||.+...-....    .+++.-|+|||++.  ....++|+||+|+++++|++|..||..    ++...|
T Consensus       130 ld~~Ghi~~tdfglske~v~~~~----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~I  199 (612)
T KOG0603|consen  130 LLLEGHIKLTDFGLSKEAVKEKI----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRI  199 (612)
T ss_pred             ecccCccccCCchhhhHhHhhhh----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHH
Confidence            99999999999999875433311    17788999999998  346679999999999999999999998    555555


Q ss_pred             HhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          165 GFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       165 ~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                        -+..+..|..++...++++..++.+
T Consensus       200 --l~~~~~~p~~l~~~a~~~~~~l~~r  224 (612)
T KOG0603|consen  200 --LKAELEMPRELSAEARSLFRQLFKR  224 (612)
T ss_pred             --hhhccCCchhhhHHHHHHHHHHHhh
Confidence              3457788999999999999988754

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=2.9e-22  Score=162.54  Aligned_cols=182  Identities=24%  Similarity=0.355  Sum_probs=143.8

Q ss_pred             CCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCc
Q 029552            3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN   82 (191)
Q Consensus         3 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~n   82 (191)
                      ++.|||++.....+.+.....-.||||++ +|..++...+   .+...++.-++.|++.|++|+|..|  +.|||+|++|
T Consensus       377 ~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~en  450 (601)
T KOG0590|consen  377 SLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLEN  450 (601)
T ss_pred             cccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhcC--ceeccCcccc
Confidence            57999999988888877777777999998 9999997642   2888899999999999999999999  9999999999


Q ss_pred             EEecCCCcEEEcccccccccccccc----cCCCCCCCCcccCccccccCCCCCc-chHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           83 LLVDKKYTVKVCDFGLSRLKANTFL----SSKSAAGTPEWMAPEVLRDEPSNEK-SDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        83 i~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      +++..+|.++++|||.+........    ......++..|+|||.+.+..++++ .|+||.|+++..|.+|+.||.....
T Consensus       451 ll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~  530 (601)
T KOG0590|consen  451 LLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKK  530 (601)
T ss_pred             EEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccc
Confidence            9999999999999998865433322    2344567889999999999988765 6999999999999999999976444


Q ss_pred             HHHH--HH-----HHhcCcccCCCCCCCHHHHHHHHHHhc
Q 029552          158 AQVV--AA-----VGFKGKRLEIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       158 ~~~~--~~-----~~~~~~~~~~~~~~s~~~~~li~~cl~  190 (191)
                      ....  ..     ......+..+...++..-+.+|.+||+
T Consensus       531 ~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~  570 (601)
T KOG0590|consen  531 SDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQ  570 (601)
T ss_pred             cccchhhhccccccccccChHHHHHhchhhHHHHHHHHcc
Confidence            3322  11     111111222335678888888888875

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.4e-20  Score=135.53  Aligned_cols=182  Identities=32%  Similarity=0.689  Sum_probs=150.4

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |+-+.||||..+++.|..+.+..++..||+.++|...+.... +.+.+..++.+++..++++..|||+..+-+.--.++.
T Consensus       241 lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t-~vvvd~sqav~faldiargmaflhslep~ipr~~lns  319 (448)
T KOG0195|consen  241 LRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNS  319 (448)
T ss_pred             eeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhccc
Confidence            345689999999999999999999999999999999997644 4567888999999999999999999864233446788


Q ss_pred             CcEEecCCCcEEEc--ccccccccccccccCCCCCCCCcccCccccccCCC---CCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           81 PNLLVDKKYTVKVC--DFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPS---NEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        81 ~ni~~~~~~~~~l~--d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~---~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      ..+.++.+...+++  |.-++-..       ......+.|++||.+...+.   ..++|.||+++++|++.|...||.+.
T Consensus       320 ~hvmidedltarismad~kfsfqe-------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadl  392 (448)
T KOG0195|consen  320 KHVMIDEDLTARISMADTKFSFQE-------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADL  392 (448)
T ss_pred             ceEEecchhhhheecccceeeeec-------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccC
Confidence            88999887655443  32222111       12234678999999876654   34689999999999999999999999


Q ss_pred             CHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhc
Q 029552          156 NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~  190 (191)
                      .+.+.-.++.-.+.+..+|+++|.....+|+-|++
T Consensus       393 spmecgmkialeglrv~ippgis~hm~klm~icmn  427 (448)
T KOG0195|consen  393 SPMECGMKIALEGLRVHIPPGISRHMNKLMNICMN  427 (448)
T ss_pred             CchhhhhhhhhccccccCCCCccHHHHHHHHHHhc
Confidence            99999999999999999999999999999999986

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.83  E-value=4.8e-20  Score=144.29  Aligned_cols=187  Identities=33%  Similarity=0.587  Sum_probs=146.8

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |+++.|.|+.++++.+.++...++|.+||..|+|.|.+......  ++.--...++..|++|++|||.--. .+|+.++.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~--~d~~F~~s~~rdi~~Gl~ylh~s~i-~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIK--LDYFFILSFIRDISKGLAYLHNSPI-GYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccC--ccHHHHHHHHHHHHHHHHHHhcCcc-eeeeeecc
Confidence            68899999999999999999999999999999999999774432  6676777788999999999998762 38999999


Q ss_pred             CcEEecCCCcEEEcccccccccccc--cccCCCCCCCCcccCccccccCC-------CCCcchHHHHHHHHHHHHhCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEP-------SNEKSDIYSFGVILWELATLQQP  151 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~-------~~~~~Dv~slG~~~~~l~~g~~p  151 (191)
                      .|.+++....+|++|||+.......  ............|.|||.+++..       .+.++|+||+|++++++++...|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            9999999999999999998765431  11122223455799999987642       35679999999999999999999


Q ss_pred             CCC----CCHHHHHHHHHhcCcccCCCC-----CCCHHHHHHHHHHhc
Q 029552          152 WGN----LNPAQVVAAVGFKGKRLEIPR-----NVNPHVASIIEACWA  190 (191)
Q Consensus       152 f~~----~~~~~~~~~~~~~~~~~~~~~-----~~s~~~~~li~~cl~  190 (191)
                      |..    ..+.+....+...+..+.-|.     ...+.+..++++||.
T Consensus       158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~  205 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWE  205 (484)
T ss_pred             cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcc
Confidence            975    344456666654233333332     455689999999996

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=1.9e-19  Score=137.31  Aligned_cols=154  Identities=21%  Similarity=0.263  Sum_probs=125.5

Q ss_pred             CCCccccccee-ecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            6 HPNIVLFMGAV-TQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         6 h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      .+++.++++.+ ..+...|+||+.+ |.+|.++..... .+.++..++..++.|++.+|++||+.|  ++||||||.|+.
T Consensus        79 ~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~  154 (322)
T KOG1164|consen   79 PSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFV  154 (322)
T ss_pred             CCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHee
Confidence            35888888888 4777899999976 889999986555 345999999999999999999999999  999999999999


Q ss_pred             ecCC-----CcEEEccccccc--ccccccc----c----CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCC
Q 029552           85 VDKK-----YTVKVCDFGLSR--LKANTFL----S----SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ  149 (191)
Q Consensus        85 ~~~~-----~~~~l~d~~~~~--~~~~~~~----~----~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~  149 (191)
                      +...     ..+.+.|||++.  .......    .    .....++..|.++....+...+.+.|+||++.++.++..|.
T Consensus       155 ~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~  234 (322)
T KOG1164|consen  155 VGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGS  234 (322)
T ss_pred             ecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCC
Confidence            9865     358999999997  3211110    1    12334788999999999999999999999999999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 029552          150 QPWGNLNPAQVVAA  163 (191)
Q Consensus       150 ~pf~~~~~~~~~~~  163 (191)
                      .||...........
T Consensus       235 LPW~~~~~~~~~~~  248 (322)
T KOG1164|consen  235 LPWEALEMTDLKSK  248 (322)
T ss_pred             CCCccccccchHHH
Confidence            99977554333333

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=3.6e-20  Score=142.02  Aligned_cols=79  Identities=27%  Similarity=0.415  Sum_probs=67.5

Q ss_pred             CCCCcccccceeec----CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            5 RHPNIVLFMGAVTQ----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         5 ~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      .-.+||++++.|..    +.+.|||+|++ |.+|..++.....++ ++...+..|+.|++.||.|||+.. +|+|.||||
T Consensus       140 ~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrG-lpl~~VK~I~~qvL~GLdYLH~ec-gIIHTDlKP  216 (590)
T KOG1290|consen  140 GKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRG-LPLSCVKEICRQVLTGLDYLHREC-GIIHTDLKP  216 (590)
T ss_pred             CCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCC-CcHHHHHHHHHHHHHHHHHHHHhc-CccccCCCc
Confidence            44679999999964    45899999988 679999998766543 889999999999999999999853 299999999


Q ss_pred             CcEEec
Q 029552           81 PNLLVD   86 (191)
Q Consensus        81 ~ni~~~   86 (191)
                      +||++.
T Consensus       217 ENvLl~  222 (590)
T KOG1290|consen  217 ENVLLC  222 (590)
T ss_pred             ceeeee
Confidence            999983

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.83  E-value=5.3e-19  Score=133.55  Aligned_cols=187  Identities=33%  Similarity=0.501  Sum_probs=145.2

Q ss_pred             CCCCCC-CcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            2 KRLRHP-NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         2 ~~l~h~-~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +.+.|+ +|+++.+.+......+++++++.++++.+++........+++..+..++.|++.+++++|+.+  ++|||++|
T Consensus        52 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp  129 (384)
T COG0515          52 ASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKP  129 (384)
T ss_pred             HHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCH
Confidence            356777 799999999877778999999999999977765431123889999999999999999999999  99999999


Q ss_pred             CcEEecCCC-cEEEcccccccccccccc------cCCCCCCCCcccCcccccc---CCCCCcchHHHHHHHHHHHHhCCC
Q 029552           81 PNLLVDKKY-TVKVCDFGLSRLKANTFL------SSKSAAGTPEWMAPEVLRD---EPSNEKSDIYSFGVILWELATLQQ  150 (191)
Q Consensus        81 ~ni~~~~~~-~~~l~d~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~---~~~~~~~Dv~slG~~~~~l~~g~~  150 (191)
                      +||+++..+ .+++.|||.+........      ......++..|.+||.+.+   .......|+|++|++++++++|..
T Consensus       130 ~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~  209 (384)
T COG0515         130 ENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLP  209 (384)
T ss_pred             HHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCC
Confidence            999999988 799999998864333321      2345567889999999987   567888999999999999999999


Q ss_pred             CCCCCCH----HHHHHHHHhcCcc-cCCC--CCC----CHHHHHHHHHHhc
Q 029552          151 PWGNLNP----AQVVAAVGFKGKR-LEIP--RNV----NPHVASIIEACWA  190 (191)
Q Consensus       151 pf~~~~~----~~~~~~~~~~~~~-~~~~--~~~----s~~~~~li~~cl~  190 (191)
                      ||.....    ......+...... ...+  ...    +..+.+++..|+.
T Consensus       210 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (384)
T COG0515         210 PFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLA  260 (384)
T ss_pred             CCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHh
Confidence            9887653    4555555433322 1111  111    2578888888775

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.82  E-value=2.4e-20  Score=137.76  Aligned_cols=158  Identities=19%  Similarity=0.246  Sum_probs=104.0

Q ss_pred             eEEEEeccCCCCHHHHhcC----CCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecCCCcEEEcccc
Q 029552           22 LSIVTEYLSRGSLYRLLHK----PGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFG   97 (191)
Q Consensus        22 ~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~   97 (191)
                      .+++|+-+. ++|.+++..    ..........-...+..|+++.+++||+.|  ++|+||+|+|++++.+|.+.|+||+
T Consensus       114 ~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVHgdi~~~nfll~~~G~v~Lg~F~  190 (288)
T PF14531_consen  114 RFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVHGDIKPENFLLDQDGGVFLGDFS  190 (288)
T ss_dssp             EEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEE-TTS-EEE--GG
T ss_pred             hhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEecccceeeEEEcCCCCEEEcChH
Confidence            467888885 599888752    111112333344556689999999999999  9999999999999999999999998


Q ss_pred             cccccccccccCCCCCCCCcccCccccccC--------CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCc
Q 029552           98 LSRLKANTFLSSKSAAGTPEWMAPEVLRDE--------PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK  169 (191)
Q Consensus        98 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--------~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~  169 (191)
                      .....+.....   ...+..|.|||.....        .++.+.|.|+||+++|.++++..||+...+......     .
T Consensus       191 ~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~-----~  262 (288)
T PF14531_consen  191 SLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW-----D  262 (288)
T ss_dssp             GEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-----G
T ss_pred             HHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-----c
Confidence            77665554332   1223678899876432        357788999999999999999999997655433332     1


Q ss_pred             ccCCCCCCCHHHHHHHHHHhcC
Q 029552          170 RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       170 ~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      --.+. ++|+.++.||.++|++
T Consensus       263 f~~C~-~~Pe~v~~LI~~lL~~  283 (288)
T PF14531_consen  263 FSRCR-DMPEPVQFLIRGLLQR  283 (288)
T ss_dssp             GTTSS----HHHHHHHHHHT-S
T ss_pred             chhcC-CcCHHHHHHHHHHccC
Confidence            11344 8999999999999974

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.80  E-value=6.4e-20  Score=138.17  Aligned_cols=140  Identities=29%  Similarity=0.418  Sum_probs=117.1

Q ss_pred             CCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEe
Q 029552            6 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV   85 (191)
Q Consensus         6 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~   85 (191)
                      +.||+++.+++..++...+|+||+++....++...      ++..++..++..++.||+++|+.|  |+||||||.|+++
T Consensus        94 ~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~  165 (418)
T KOG1167|consen   94 SDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLY  165 (418)
T ss_pred             chhhhcchhhhccCCeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCcccccc
Confidence            78999999999999999999999999999999876      678889999999999999999999  9999999999999


Q ss_pred             cC-CCcEEEccccccccc-c--------c----ccc-------------------------------cCCCCCCCCcccC
Q 029552           86 DK-KYTVKVCDFGLSRLK-A--------N----TFL-------------------------------SSKSAAGTPEWMA  120 (191)
Q Consensus        86 ~~-~~~~~l~d~~~~~~~-~--------~----~~~-------------------------------~~~~~~~~~~~~~  120 (191)
                      +. .+.-.|.|||++... .        .    ...                               .-....++++|.|
T Consensus       166 n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRa  245 (418)
T KOG1167|consen  166 NRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRA  245 (418)
T ss_pred             ccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCc
Confidence            76 467899999998610 0        0    000                               0001257888999


Q ss_pred             ccccccC-CCCCcchHHHHHHHHHHHHhCCCCCC
Q 029552          121 PEVLRDE-PSNEKSDIYSFGVILWELATLQQPWG  153 (191)
Q Consensus       121 pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf~  153 (191)
                      ||++... ..+.+.|+||.|+++..++++..||-
T Consensus       246 PEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf  279 (418)
T KOG1167|consen  246 PEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFF  279 (418)
T ss_pred             hHHHhhccCcCCccceeeccceeehhhccccccc
Confidence            9987654 46888999999999999999999974

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.77  E-value=3.4e-19  Score=147.78  Aligned_cols=171  Identities=20%  Similarity=0.294  Sum_probs=128.9

Q ss_pred             CCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCc
Q 029552            3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN   82 (191)
Q Consensus         3 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~n   82 (191)
                      ..++||..++...-+.++..|+|-+|..+ +|.|.+..   ++.+..-+...++.|++.||...|+.|  ++|||||.+|
T Consensus        77 l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlST---RPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsEN  150 (1431)
T KOG1240|consen   77 LMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLST---RPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSEN  150 (1431)
T ss_pred             hhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhcc---chHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccce
Confidence            45899999999988888899999999987 99999976   445888899999999999999999999  9999999999


Q ss_pred             EEecCCCcEEEcccccccc----ccccccc---CCCCCCCCcccCccccccCC-----------CCCcchHHHHHHHHHH
Q 029552           83 LLVDKKYTVKVCDFGLSRL----KANTFLS---SKSAAGTPEWMAPEVLRDEP-----------SNEKSDIYSFGVILWE  144 (191)
Q Consensus        83 i~~~~~~~~~l~d~~~~~~----~~~~~~~---~~~~~~~~~~~~pe~~~~~~-----------~~~~~Dv~slG~~~~~  144 (191)
                      |+++.-+.+.|+||..-+.    ..++...   .........|+|||.+....           .+++.|+||+||+++|
T Consensus       151 ILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaE  230 (1431)
T KOG1240|consen  151 ILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAE  230 (1431)
T ss_pred             EEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHH
Confidence            9999999999999953321    1111111   11223455899999874421           3567899999999999


Q ss_pred             HHhC-CCCCCC-----------CCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          145 LATL-QQPWGN-----------LNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       145 l~~g-~~pf~~-----------~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +++- .++|.-           .++...+++|.            +.+++.+|..|+++
T Consensus       231 Lf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~Ie------------d~~~Rnlil~Mi~r  277 (1431)
T KOG1240|consen  231 LFLEGRPLFTLSQLLAYRSGNADDPEQLLEKIE------------DVSLRNLILSMIQR  277 (1431)
T ss_pred             HHhcCCCcccHHHHHhHhccCccCHHHHHHhCc------------CccHHHHHHHHHcc
Confidence            9885 667741           22333333331            23778888888763

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.75  E-value=6.5e-18  Score=119.76  Aligned_cols=176  Identities=21%  Similarity=0.307  Sum_probs=134.1

Q ss_pred             CcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecC
Q 029552            8 NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK   87 (191)
Q Consensus         8 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~   87 (191)
                      .|+.+..++.++....+|||.. |+||.++++-...+  ++..+++-++.|++.-++|+|.++  ++||||||+|++..-
T Consensus        72 GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~--ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGl  146 (341)
T KOG1163|consen   72 GIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRR--FTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGL  146 (341)
T ss_pred             CCchhhhhccccccceeeeecc-CccHHHHHHHHhhh--hhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeecc
Confidence            4555666777888899999977 89999999765433  889999999999999999999999  999999999999965


Q ss_pred             C---CcEEEcccccccccccc-------cccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           88 K---YTVKVCDFGLSRLKANT-------FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        88 ~---~~~~l~d~~~~~~~~~~-------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      +   ..+.++|||++...-+.       ........++..|.+-....+...+.+.|.-|+|.++.++.-|..||.+...
T Consensus       147 grh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka  226 (341)
T KOG1163|consen  147 GRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA  226 (341)
T ss_pred             ccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence            4   46899999999753222       2223344567788888888777788899999999999999999999987443


Q ss_pred             ---HHHHHHHHhcCcccC---CCCCCCHHHHHHHHHH
Q 029552          158 ---AQVVAAVGFKGKRLE---IPRNVNPHVASIIEAC  188 (191)
Q Consensus       158 ---~~~~~~~~~~~~~~~---~~~~~s~~~~~li~~c  188 (191)
                         ....++|.......+   +-..+|.++.-.+.-|
T Consensus       227 ~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~  263 (341)
T KOG1163|consen  227 ATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYC  263 (341)
T ss_pred             hhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHH
Confidence               344455533322222   2356777777776665

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.75  E-value=2.5e-17  Score=121.59  Aligned_cols=155  Identities=18%  Similarity=0.313  Sum_probs=128.5

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      -.++|+.++.+...+.+..+|+|.+ |.||.|++...+.+  |+..++.-++.|++.-++++|+++  +++|||||+|++
T Consensus        82 g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~--FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFL  156 (449)
T KOG1165|consen   82 GTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRR--FSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFL  156 (449)
T ss_pred             CCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCc--ccHHhHHHHHHHHHHHHHHHHhcc--eeecccCcccee
Confidence            3578888888778888889999977 89999999887755  999999999999999999999999  999999999999


Q ss_pred             ecCC-----CcEEEcccccccccccc-------cccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 029552           85 VDKK-----YTVKVCDFGLSRLKANT-------FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW  152 (191)
Q Consensus        85 ~~~~-----~~~~l~d~~~~~~~~~~-------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf  152 (191)
                      +..-     ..+.++|||+++..-++       ........++.+||+-.-..|...+.+.|+-|||-++.+.+-|.+||
T Consensus       157 IGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPW  236 (449)
T KOG1165|consen  157 IGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW  236 (449)
T ss_pred             ecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcc
Confidence            9643     35899999998753322       12223345788999999999999999999999999999999999999


Q ss_pred             CC---CCHHHHHHHH
Q 029552          153 GN---LNPAQVVAAV  164 (191)
Q Consensus       153 ~~---~~~~~~~~~~  164 (191)
                      ..   .+..+..++|
T Consensus       237 QGLKA~tnK~kYeKI  251 (449)
T KOG1165|consen  237 QGLKADTNKEKYEKI  251 (449)
T ss_pred             ccccCcchHHHHHHh
Confidence            76   3344455555

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.71  E-value=4.5e-18  Score=122.33  Aligned_cols=119  Identities=18%  Similarity=0.252  Sum_probs=88.8

Q ss_pred             CCCCCCCcccccceeecC--------CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCe
Q 029552            2 KRLRHPNIVLFMGAVTQP--------PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPI   73 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~   73 (191)
                      .+++||+|..+.+++.+.        +..+++|||++|.+|.++..       +++.    ...+++.++..+|+.|  +
T Consensus        90 ~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~~----~~~~i~~~l~~lH~~g--i  156 (232)
T PRK10359         90 DRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISED----VKAKIKASIESLHQHG--M  156 (232)
T ss_pred             HHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-------ccHH----HHHHHHHHHHHHHHcC--C
Confidence            456899999998887643        35789999999999988742       3332    3458999999999999  9


Q ss_pred             eecCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHH
Q 029552           74 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA  146 (191)
Q Consensus        74 ~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~  146 (191)
                      +|+|++|+||+++++| ++++|||........      ...      ..++....+..++|+|+||+++....
T Consensus       157 ~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~------~a~------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        157 VSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQR------KAK------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             ccCCCChHHEEEeCCC-EEEEECCCcccccch------hhH------HHHHHHhHhcccccccceeEeehHHH
Confidence            9999999999999988 999999876432211      000      11333344567899999998876553

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.69  E-value=7e-17  Score=123.99  Aligned_cols=111  Identities=20%  Similarity=0.205  Sum_probs=82.4

Q ss_pred             CCCCCCCCccc-ccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC-
Q 029552            1 MKRLRHPNIVL-FMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL-   78 (191)
Q Consensus         1 L~~l~h~~i~~-~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l-   78 (191)
                      |++++|+|+++ +++    .+..|+||||++|++|... ..      ..   ...++.|++++|++||+.|  ++|||| 
T Consensus        75 L~~L~h~~iv~~l~~----~~~~~LVmE~~~G~~L~~~-~~------~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~  138 (365)
T PRK09188         75 LKTVRGIGVVPQLLA----TGKDGLVRGWTEGVPLHLA-RP------HG---DPAWFRSAHRALRDLHRAG--ITHNDLA  138 (365)
T ss_pred             HHhccCCCCCcEEEE----cCCcEEEEEccCCCCHHHh-Cc------cc---hHHHHHHHHHHHHHHHHCC--CeeCCCC
Confidence            46789999985 443    2458999999999999632 11      11   1357889999999999999  999999 


Q ss_pred             CCCcEEecCCCcEEEccccccccccccccc--------CCCCCCCCcccCccccccC
Q 029552           79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLS--------SKSAAGTPEWMAPEVLRDE  127 (191)
Q Consensus        79 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~--------~~~~~~~~~~~~pe~~~~~  127 (191)
                      ||+||+++.++.++|+|||++.........        .....+...|.+||.+...
T Consensus       139 KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        139 KPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             CcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            999999999999999999998754332111        1223455678899887543

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.67  E-value=1.3e-16  Score=112.78  Aligned_cols=137  Identities=18%  Similarity=0.195  Sum_probs=97.9

Q ss_pred             CCCCC-CCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC-
Q 029552            1 MKRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL-   78 (191)
Q Consensus         1 L~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l-   78 (191)
                      |+++. ++++++++++    +..+++|+|+.|.+|......         . ...++.|++++|+++|++|  ++|+|| 
T Consensus        55 L~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~---------~-~~~~~~qi~~~L~~lH~~G--IvHrDL~  118 (218)
T PRK12274         55 LRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR---------G-DLAYFRAARRLLQQLHRCG--VAHNDLA  118 (218)
T ss_pred             HHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh---------h-hHHHHHHHHHHHHHHHHCc--CccCCCC
Confidence            34564 5788888875    347999999999998654321         1 1346789999999999999  999999 


Q ss_pred             CCCcEEecCCCcEEEccccccccccccccc----C---------CCCCCCCcccCccccccC-CC-CCcchHHHHHHHHH
Q 029552           79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLS----S---------KSAAGTPEWMAPEVLRDE-PS-NEKSDIYSFGVILW  143 (191)
Q Consensus        79 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~----~---------~~~~~~~~~~~pe~~~~~-~~-~~~~Dv~slG~~~~  143 (191)
                      +|+||+++.++.++|+|||++.........    .         .-....+.++.|+..+-. .. -.+.++++.|.-+|
T Consensus       119 kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~  198 (218)
T PRK12274        119 KEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVY  198 (218)
T ss_pred             CcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHH
Confidence            799999999999999999998744332210    0         001123455666543322 12 25678899999999


Q ss_pred             HHHhCCCCCC
Q 029552          144 ELATLQQPWG  153 (191)
Q Consensus       144 ~l~~g~~pf~  153 (191)
                      .++|+..+.-
T Consensus       199 ~~~~~~~~~~  208 (218)
T PRK12274        199 RFVTRRVLHW  208 (218)
T ss_pred             HHHhccCCcc
Confidence            9999988753

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.66  E-value=2.6e-16  Score=130.48  Aligned_cols=130  Identities=31%  Similarity=0.483  Sum_probs=108.4

Q ss_pred             HHHHHHHHhCCCCeeecCCCCCcEEecCCCcEEEccccccccccccc---------------ccCCCCCCCCcccCcccc
Q 029552           60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF---------------LSSKSAAGTPEWMAPEVL  124 (191)
Q Consensus        60 ~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~---------------~~~~~~~~~~~~~~pe~~  124 (191)
                      +.+++|||+.+  ++|+|++|+|.+++.-|.+|++|||+++.+....               ......++++.|.|||++
T Consensus       153 vla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi  230 (1205)
T KOG0606|consen  153 VLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI  230 (1205)
T ss_pred             hHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhh
Confidence            77999999999  9999999999999999999999999986532110               111234678999999999


Q ss_pred             ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCc-ccCCCCCCCHHHHHHHHHHhcC
Q 029552          125 RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       125 ~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....|....|+|++|+++|+.+-|..||....+++.+..+..... .++-...++++.+++|.+.|.+
T Consensus       231 lrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~q  298 (1205)
T KOG0606|consen  231 LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQ  298 (1205)
T ss_pred             hhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHh
Confidence            999999999999999999999999999999999999988754333 3333456899999999998864

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.64  E-value=9.1e-16  Score=122.32  Aligned_cols=136  Identities=21%  Similarity=0.305  Sum_probs=107.9

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCeeecCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLK   79 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~~h~~l~   79 (191)
                      |++++||||.+|++.++..++.|+|+|.+.  .|..++.+      +....+..-+.||+.||.|||. .+  ++|+||.
T Consensus        63 lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~  132 (690)
T KOG1243|consen   63 LKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEEVCLGLFQILAALSFLNDDCN--LVHGNVC  132 (690)
T ss_pred             hhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHHHHHHHHHHHHHHHHHhccCC--eeeccEe
Confidence            678999999999999999999999999984  78888866      4477788888999999999984 56  9999999


Q ss_pred             CCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhC
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL  148 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g  148 (191)
                      -.+++++..|.++|++|.....................|..|+.+....  ...|.|.||+++++++.|
T Consensus       133 ~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  133 KDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             eeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence            9999999999999999987643322211112222233566777654443  457999999999999999

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.64  E-value=5e-17  Score=126.04  Aligned_cols=122  Identities=30%  Similarity=0.452  Sum_probs=104.1

Q ss_pred             ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecCCCcEEEccccccc
Q 029552           21 NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR  100 (191)
Q Consensus        21 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~  100 (191)
                      ..|+.|++|.-.+|.++++........+......++.|+..+++|   .+  ..|+|++|.||++..+..++|+|||+..
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl~t  404 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGLVT  404 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhhee
Confidence            588999999999999999765544446777889999999999999   77  9999999999999999999999999875


Q ss_pred             ccccc------cccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh
Q 029552          101 LKANT------FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT  147 (191)
Q Consensus       101 ~~~~~------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~  147 (191)
                      .....      ........++..|++||.+.+..++.++|+|+||+++++++.
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            32221      122334567889999999999999999999999999999998

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.63  E-value=5.6e-16  Score=109.60  Aligned_cols=74  Identities=23%  Similarity=0.227  Sum_probs=62.7

Q ss_pred             eEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHH-HhCCCCeeecCCCCCcEEecCCCcEEEccccccc
Q 029552           22 LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL-HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR  100 (191)
Q Consensus        22 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L-h~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~  100 (191)
                      .++||||++++++........   .+++.++..++.|++.+|+++ |+.|  ++|||+||+||+++ ++.++|+|||++.
T Consensus        92 ~~iVmE~i~g~~l~~~~~~~~---~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-~~~v~LiDFG~a~  165 (190)
T cd05147          92 HVLVMEFIGDDGWAAPRLKDA---PLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-DGKLYIIDVSQSV  165 (190)
T ss_pred             CEEEEEEeCCCCCcchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-CCcEEEEEccccc
Confidence            389999999877765433222   378899999999999999999 7999  99999999999998 4789999999886


Q ss_pred             c
Q 029552          101 L  101 (191)
Q Consensus       101 ~  101 (191)
                      .
T Consensus       166 ~  166 (190)
T cd05147         166 E  166 (190)
T ss_pred             c
Confidence            3

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10345 hypothetical protein; Provisional

Probab=99.62  E-value=1.5e-15  Score=108.56  Aligned_cols=88  Identities=22%  Similarity=0.344  Sum_probs=69.9

Q ss_pred             CCCCcccccceeecCC---c-eEEEEec--cCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHH-HHHHhCCCCeeecC
Q 029552            5 RHPNIVLFMGAVTQPP---N-LSIVTEY--LSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM-NYLHRRNPPIVHRD   77 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~---~-~~lv~e~--~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l-~~Lh~~~~~~~h~~   77 (191)
                      +||||++++++++++.   . +.+|+||  +.+++|.+++.+..    +++.  ..++.|++.++ +|||+++  |+|+|
T Consensus        59 ~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh~~~--IvhrD  130 (210)
T PRK10345         59 DWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLLDNR--IVTME  130 (210)
T ss_pred             CCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHHHCC--EeecC
Confidence            6899999999998764   3 3378999  55799999996532    5555  35678888777 9999999  99999


Q ss_pred             CCCCcEEecCC----CcEEEcc-ccccc
Q 029552           78 LKSPNLLVDKK----YTVKVCD-FGLSR  100 (191)
Q Consensus        78 l~p~ni~~~~~----~~~~l~d-~~~~~  100 (191)
                      |||+||+++..    +.++|+| ||...
T Consensus       131 lKp~NILl~~~~~~~~~~~LiDg~G~~~  158 (210)
T PRK10345        131 LKPQNILCQRISESEVIPVVCDNIGEST  158 (210)
T ss_pred             CCHHHEEEeccCCCCCcEEEEECCCCcc
Confidence            99999999743    3799999 55443

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.61  E-value=1.8e-15  Score=126.67  Aligned_cols=137  Identities=20%  Similarity=0.270  Sum_probs=113.8

Q ss_pred             CCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEec
Q 029552            7 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD   86 (191)
Q Consensus         7 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~   86 (191)
                      +.|+++.....-.+.-++|++|.+.|||.++++.   .+++++..+..++.|+++.++.||..+  |+||||||+|+++.
T Consensus       754 ~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~---~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~  828 (974)
T KOG1166|consen  754 PSIMHISSAHVFQNASVLVSEYSPYGTLLDLINT---NKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLR  828 (974)
T ss_pred             cchHHHHHHHccCCcceeeeeccccccHHHhhcc---CCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEee
Confidence            4456666666677788999999999999999985   445999999999999999999999999  99999999999995


Q ss_pred             C-------CCcEEEccccccccc---ccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCC
Q 029552           87 K-------KYTVKVCDFGLSRLK---ANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ  149 (191)
Q Consensus        87 ~-------~~~~~l~d~~~~~~~---~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~  149 (191)
                      .       ...++|+|||.+.-.   .+. ......+.+-.+-++|...|.+.+...|.|.++.+++.|+.|.
T Consensus       829 ~~~~~~~~~~~l~lIDfG~siDm~lfp~~-~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  829 REICADSDSKGLYLIDFGRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             cccCCCCcccceEEEecccceeeeEcCCC-cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence            3       235899999987422   112 1233446677889999999999999999999999999999984

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.60  E-value=2.1e-15  Score=106.81  Aligned_cols=74  Identities=20%  Similarity=0.189  Sum_probs=62.4

Q ss_pred             eEEEEeccCCCCHHHH-hcCCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCeeecCCCCCcEEecCCCcEEEcccccc
Q 029552           22 LSIVTEYLSRGSLYRL-LHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS   99 (191)
Q Consensus        22 ~~lv~e~~~~~~L~~~-~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~   99 (191)
                      .++||||++++++... +.. .   .++..++..++.|++.++.++|+ .|  ++|+|++|+||+++ ++.++|+|||++
T Consensus        92 ~~lVmE~~~g~~~~~~~l~~-~---~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-~~~~~liDFG~a  164 (190)
T cd05145          92 NVLVMEFIGDDGSPAPRLKD-V---PLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-DGKPYIIDVSQA  164 (190)
T ss_pred             CEEEEEEecCCCchhhhhhh-c---cCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-CCCEEEEEcccc
Confidence            4899999998755433 332 2   26788899999999999999999 99  99999999999999 789999999987


Q ss_pred             ccc
Q 029552          100 RLK  102 (191)
Q Consensus       100 ~~~  102 (191)
                      ...
T Consensus       165 ~~~  167 (190)
T cd05145         165 VEL  167 (190)
T ss_pred             eec
Confidence            643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.51  E-value=2.6e-15  Score=122.29  Aligned_cols=180  Identities=24%  Similarity=0.393  Sum_probs=140.5

Q ss_pred             CCCcccccceeecCCceEEEEeccCCCCHHHHh-cCCCCcccccHHHHHHHHHHHHHHHHHHH-hCCCCeeecCCCCCcE
Q 029552            6 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL-HKPGVREMLDERRRLNMAYDVAKGMNYLH-RRNPPIVHRDLKSPNL   83 (191)
Q Consensus         6 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh-~~~~~~~h~~l~p~ni   83 (191)
                      |+|+++.++...+.+..++++++..++++.+-+ ......  .+...+-.++.|+..++.|+| ..+  +.|++++|+|.
T Consensus        80 h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~--~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~  155 (601)
T KOG0590|consen   80 HSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTG--TSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNS  155 (601)
T ss_pred             cccccccCCccCCCcccccccCcccccccccccccCCccC--CCCcchhhhhhhhccCccccCcccc--cccCCCCCccc
Confidence            999999999999999999999999999999988 332212  667778889999999999999 888  99999999999


Q ss_pred             EecCCC-cEEEccccccccccc---ccccCCCCCC-CCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           84 LVDKKY-TVKVCDFGLSRLKAN---TFLSSKSAAG-TPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        84 ~~~~~~-~~~l~d~~~~~~~~~---~~~~~~~~~~-~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      +++..+ .+++.||+++.....   .........+ +..|.+||...+. ...++.|+||.|+++..+++|..||.....
T Consensus       156 ~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~  235 (601)
T KOG0590|consen  156 LLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR  235 (601)
T ss_pred             hhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence            999999 999999999875443   1122334456 8899999998874 456788999999999999999999976443


Q ss_pred             HHH--HHHHHhcCc-ccCCCCCCCHHHHHHHHHHh
Q 029552          158 AQV--VAAVGFKGK-RLEIPRNVNPHVASIIEACW  189 (191)
Q Consensus       158 ~~~--~~~~~~~~~-~~~~~~~~s~~~~~li~~cl  189 (191)
                      ...  .......+. .......++.....++.+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l  270 (601)
T KOG0590|consen  236 KDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKIL  270 (601)
T ss_pred             ccccceeecccccccccCccccCChhhhhcccccc
Confidence            332  222221111 23345678888888888776

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.47  E-value=1.2e-13  Score=99.24  Aligned_cols=89  Identities=26%  Similarity=0.474  Sum_probs=76.1

Q ss_pred             CCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCc
Q 029552            3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN   82 (191)
Q Consensus         3 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~n   82 (191)
                      .+.|+++.....++.+.+..+++|||++|++|.+.+....      . +...++.+++.++.++|+.+  ++|+|++|.|
T Consensus        55 ~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~N  125 (211)
T PRK14879         55 RARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG--IIHGDLTTSN  125 (211)
T ss_pred             HHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC--cccCCCCccc
Confidence            3567777776666777778999999999999999986421      2 77889999999999999999  9999999999


Q ss_pred             EEecCCCcEEEcccccccc
Q 029552           83 LLVDKKYTVKVCDFGLSRL  101 (191)
Q Consensus        83 i~~~~~~~~~l~d~~~~~~  101 (191)
                      |+++ ++.++++|||.+..
T Consensus       126 il~~-~~~~~liDf~~a~~  143 (211)
T PRK14879        126 MILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEEE-CCCEEEEECCcccC
Confidence            9999 77899999998764

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.44  E-value=2.6e-13  Score=110.24  Aligned_cols=86  Identities=26%  Similarity=0.398  Sum_probs=74.5

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++|++++....++.++...++||||+++++|.+++.           ....++.+++++|.+||+.+  ++|||++|+
T Consensus       391 ~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~  457 (535)
T PRK09605        391 SEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG--IVHGDLTTS  457 (535)
T ss_pred             HhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC--CccCCCChH
Confidence            46788998887777777777899999999999988774           24568899999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccc
Q 029552           82 NLLVDKKYTVKVCDFGLSRL  101 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~  101 (191)
                      ||++ .++.++++|||++..
T Consensus       458 NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        458 NFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             HEEE-ECCcEEEEeCccccc
Confidence            9999 567899999998864

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.42  E-value=3.1e-13  Score=96.28  Aligned_cols=85  Identities=25%  Similarity=0.408  Sum_probs=69.2

Q ss_pred             CCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcE
Q 029552            4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL   83 (191)
Q Consensus         4 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni   83 (191)
                      ++|+++....-++.+.+..+++|||++|++|.+.+....    .      .++.+++.+|.+||+.+  ++|+|++|.||
T Consensus        54 l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Ni  121 (199)
T TIGR03724        54 ARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGN----D------ELLREIGRLVGKLHKAG--IVHGDLTTSNI  121 (199)
T ss_pred             HHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcH----H------HHHHHHHHHHHHHHHCC--eecCCCCcceE
Confidence            455655544444556667899999999999998875421    1      67889999999999999  99999999999


Q ss_pred             EecCCCcEEEcccccccc
Q 029552           84 LVDKKYTVKVCDFGLSRL  101 (191)
Q Consensus        84 ~~~~~~~~~l~d~~~~~~  101 (191)
                      +++ ++.++++|||.+..
T Consensus       122 l~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724       122 IVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EEE-CCcEEEEECCCCcC
Confidence            999 78999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.41  E-value=5.2e-13  Score=97.73  Aligned_cols=89  Identities=21%  Similarity=0.278  Sum_probs=68.2

Q ss_pred             CCCCCCc--ccccceeecCC----ceEEEEeccCC-CCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 029552            3 RLRHPNI--VLFMGAVTQPP----NLSIVTEYLSR-GSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH   75 (191)
Q Consensus         3 ~l~h~~i--~~~~~~~~~~~----~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h   75 (191)
                      .++|++|  ++.+.+...+.    ..++|+|++++ .+|.+++....    +++..    +.+++.++.+||+.|  ++|
T Consensus        96 ~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~~----l~~~~----~~~i~~~l~~lH~~G--I~H  165 (239)
T PRK01723         96 QLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEAP----LSEEQ----WQAIGQLIARFHDAG--VYH  165 (239)
T ss_pred             HHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcCC----CCHHH----HHHHHHHHHHHHHCC--CCC
Confidence            4566664  55665543322    23599999997 69998886422    44443    568999999999999  999


Q ss_pred             cCCCCCcEEecCCCcEEEcccccccc
Q 029552           76 RDLKSPNLLVDKKYTVKVCDFGLSRL  101 (191)
Q Consensus        76 ~~l~p~ni~~~~~~~~~l~d~~~~~~  101 (191)
                      +|++|.||+++.++.++|+|||.+..
T Consensus       166 rDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        166 ADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             CCCCchhEEEcCCCCEEEEECCCccc
Confidence            99999999999988999999998764

>smart00090 RIO RIO-like kinase

Probab=99.36  E-value=1.4e-12  Score=95.34  Aligned_cols=77  Identities=23%  Similarity=0.241  Sum_probs=63.4

Q ss_pred             ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecCCCcEEEccccccc
Q 029552           21 NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR  100 (191)
Q Consensus        21 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~  100 (191)
                      ..++||||+.+.+|........   .....++..++.|++.++++||+.| .++|+|++|+||+++ ++.++++|||.+.
T Consensus       122 ~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NIli~-~~~i~LiDFg~a~  196 (237)
T smart00090      122 RNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNILVH-DGKVVIIDVSQSV  196 (237)
T ss_pred             CceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhEEEE-CCCEEEEEChhhh
Confidence            3589999999988876653322   2566677889999999999999986 399999999999999 7889999999876


Q ss_pred             cc
Q 029552          101 LK  102 (191)
Q Consensus       101 ~~  102 (191)
                      ..
T Consensus       197 ~~  198 (237)
T smart00090      197 EL  198 (237)
T ss_pred             cc
Confidence            43

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.28  E-value=7.1e-12  Score=99.09  Aligned_cols=178  Identities=26%  Similarity=0.226  Sum_probs=134.1

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHH----HHHHHHhCCCCeeecCCCC
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK----GMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~----~l~~Lh~~~~~~~h~~l~p   80 (191)
                      .|++.++.+..++..+..++-+|.+. .+|.++.......  +++..++..+.+...    ||..+|..+  ++|.+++|
T Consensus       176 ~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~--~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp  250 (524)
T KOG0601|consen  176 SHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHTPCNF--LPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKP  250 (524)
T ss_pred             ccccccccCcccccCCcceeeecccc-chhHHhhhccccc--CCchhhhhHHhhhhhcccccccccCCCc--ccccccch
Confidence            48889998889999999999999985 6888888654432  788889999988888    999999999  99999999


Q ss_pred             CcEEecCC-CcEEEcccccccccccccccC-----CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 029552           81 PNLLVDKK-YTVKVCDFGLSRLKANTFLSS-----KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN  154 (191)
Q Consensus        81 ~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~-----~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~  154 (191)
                      .|++...+ ..++++||++.....+.....     ....++..|++||..++. ++.+.|++++|.++.+..++......
T Consensus       251 ~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~  329 (524)
T KOG0601|consen  251 ANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSV  329 (524)
T ss_pred             hheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccC
Confidence            99999999 889999999876544432111     223567889999998877 57789999999999998887554433


Q ss_pred             C-CHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhc
Q 029552          155 L-NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       155 ~-~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~  190 (191)
                      . +...  ..+.....+.++-...+.++...+.+|++
T Consensus       330 g~~~~W--~~~r~~~ip~e~~~~~s~~l~~~~~~~~d  364 (524)
T KOG0601|consen  330 GKNSSW--SQLRQGYIPLEFCEGGSSSLRSVTSQMLD  364 (524)
T ss_pred             CCCCCc--cccccccCchhhhcCcchhhhhHHHHhcC
Confidence            2 1111  11111223445556667777777777765

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.28  E-value=4.7e-12  Score=90.22  Aligned_cols=70  Identities=21%  Similarity=0.309  Sum_probs=60.0

Q ss_pred             CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecCCCcEEEcccccc
Q 029552           20 PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS   99 (191)
Q Consensus        20 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~   99 (191)
                      ...+++|||+++++|.+....         .....++.+++.++.++|+.|  ++|+|++|.||+++.++.++++|||.+
T Consensus       104 ~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~~~~~~liDfg~~  172 (198)
T cd05144         104 NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDDDEKIYIIDWPQM  172 (198)
T ss_pred             CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcCCCcEEEEECCcc
Confidence            456899999999998765431         234567889999999999999  999999999999999999999999987


Q ss_pred             c
Q 029552          100 R  100 (191)
Q Consensus       100 ~  100 (191)
                      .
T Consensus       173 ~  173 (198)
T cd05144         173 V  173 (198)
T ss_pred             c
Confidence            4

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.25  E-value=7.4e-12  Score=93.01  Aligned_cols=148  Identities=26%  Similarity=0.426  Sum_probs=111.4

Q ss_pred             CCCCCCcccccceeecCC-----ceEEEEeccCCCCHHHHhcCCCCc-ccccHHHHHHHHHHHHHHHHHHHhCCCCeeec
Q 029552            3 RLRHPNIVLFMGAVTQPP-----NLSIVTEYLSRGSLYRLLHKPGVR-EMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR   76 (191)
Q Consensus         3 ~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~   76 (191)
                      ++.|.||++++.++.+.+     ....+.||+..|+|..++++.... +.+....-.+|+-||+.||.|||+..+.+.|+
T Consensus       123 qlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihg  202 (458)
T KOG1266|consen  123 QLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHG  202 (458)
T ss_pred             HHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccC
Confidence            457999999999996543     467889999999999999764422 23566666789999999999999998889999


Q ss_pred             CCCCCcEEecCCCcEEEcccccccccc--cc--cccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 029552           77 DLKSPNLLVDKKYTVKVCDFGLSRLKA--NT--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ  150 (191)
Q Consensus        77 ~l~p~ni~~~~~~~~~l~d~~~~~~~~--~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~  150 (191)
                      ++..+.+++..+|-++++.........  ..  ........+-++|.+||+-.....+-++|||++|....+|..+..
T Consensus       203 nlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi  280 (458)
T KOG1266|consen  203 NLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI  280 (458)
T ss_pred             CcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence            999999999999988877542211110  00  011112234568899998776667778999999999999988754

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.19  E-value=4.9e-11  Score=99.87  Aligned_cols=180  Identities=25%  Similarity=0.344  Sum_probs=139.3

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      .+|.++...-.+......+++++|.++++|...+...+.   .+++-.+.....+.+++++||...  +.|++++|.|.+
T Consensus       862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l  936 (1205)
T KOG0606|consen  862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGC---LSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLL  936 (1205)
T ss_pred             CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCC---cccccccchhHHHHhhhhccccch--hhcccccccchh
Confidence            456666655556667789999999999999998877552   556666667788899999999998  999999999999


Q ss_pred             ecCCCcEEEcccccccccccc-------------------------------cccCCCCCCCCcccCccccccCCCCCcc
Q 029552           85 VDKKYTVKVCDFGLSRLKANT-------------------------------FLSSKSAAGTPEWMAPEVLRDEPSNEKS  133 (191)
Q Consensus        85 ~~~~~~~~l~d~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~  133 (191)
                      ....+...+.+++.....+..                               ........+++.|.+||...+......+
T Consensus       937 ~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~a 1016 (1205)
T KOG0606|consen  937 IAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAA 1016 (1205)
T ss_pred             hcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcc
Confidence            999999999998732211000                               0001123467789999999999888899


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCc-ccCCCCCCCHHHHHHHHHHh
Q 029552          134 DIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNPHVASIIEACW  189 (191)
Q Consensus       134 Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~cl  189 (191)
                      |+|+.|+++++.++|..||....+..+...+..... ++.-|...+...++++..-+
T Consensus      1017 d~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll 1073 (1205)
T KOG0606|consen 1017 DWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLL 1073 (1205)
T ss_pred             hhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhh
Confidence            999999999999999999999999999988854433 33345667888888887543

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.18  E-value=3.7e-11  Score=81.23  Aligned_cols=83  Identities=18%  Similarity=0.264  Sum_probs=69.4

Q ss_pred             CCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhC---CCCeeecCCCCCcE
Q 029552            7 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRR---NPPIVHRDLKSPNL   83 (191)
Q Consensus         7 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~---~~~~~h~~l~p~ni   83 (191)
                      .++++++.++..++..++++||+.+.++...          +......++.+++++++.+|..   +  ++|+|++|.||
T Consensus        53 ~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~--i~H~Dl~~~Ni  120 (155)
T cd05120          53 LPVPKVLASGESDGWSYLLMEWIEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLV--LCHGDLHPGNI  120 (155)
T ss_pred             CCCCeEEEEcCCCCccEEEEEecCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceE--EEecCCCcceE
Confidence            5788888888877889999999988766543          3445566788999999999984   6  99999999999


Q ss_pred             EecCCCcEEEcccccccc
Q 029552           84 LVDKKYTVKVCDFGLSRL  101 (191)
Q Consensus        84 ~~~~~~~~~l~d~~~~~~  101 (191)
                      ++++.+.+++.||+.+..
T Consensus       121 l~~~~~~~~l~Df~~~~~  138 (155)
T cd05120         121 LVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EEECCcEEEEEecccccC
Confidence            999989999999987653

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.08  E-value=3e-10  Score=80.08  Aligned_cols=72  Identities=22%  Similarity=0.212  Sum_probs=57.0

Q ss_pred             ceEEEEeccCCCCHHHH-hcCCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCeeecCCCCCcEEecCCCcEEEccccc
Q 029552           21 NLSIVTEYLSRGSLYRL-LHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKSPNLLVDKKYTVKVCDFGL   98 (191)
Q Consensus        21 ~~~lv~e~~~~~~L~~~-~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~   98 (191)
                      ..+++|||++++++... +...     ....++..++.+++.++.++|. .+  ++|+|++|+||+++ ++.++++|||.
T Consensus        89 ~~~lv~e~~~g~~~~~~~l~~~-----~~~~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~-~~~~~liDfg~  160 (187)
T cd05119          89 RHVLVMEFIGGDGIPAPRLKDV-----RLLEDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD-DGKVYIIDVPQ  160 (187)
T ss_pred             CCEEEEEEeCCCCccChhhhhh-----hhcccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE-CCcEEEEECcc
Confidence            46899999998543211 1110     1115678899999999999999 99  99999999999999 88999999998


Q ss_pred             cc
Q 029552           99 SR  100 (191)
Q Consensus        99 ~~  100 (191)
                      +.
T Consensus       161 a~  162 (187)
T cd05119         161 AV  162 (187)
T ss_pred             cc
Confidence            75

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.97  E-value=2.4e-10  Score=92.15  Aligned_cols=134  Identities=16%  Similarity=0.214  Sum_probs=95.4

Q ss_pred             HHHHHHHHHHHHhCCCCeeecCCCCCcEEecCCCcEEEccccccccccccccc---------CCCCCCCCcccCcccccc
Q 029552           56 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS---------SKSAAGTPEWMAPEVLRD  126 (191)
Q Consensus        56 ~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~---------~~~~~~~~~~~~pe~~~~  126 (191)
                      +.+.++|+.++|+.- +++|++|.|++|+++.++.+|+..|+++.........         ......+..|.+||++.+
T Consensus       105 l~~v~dgl~flh~sA-k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSA-KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hhcccchhhhhccCc-ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            456668999999873 3999999999999999999999999887643331111         111234567999999988


Q ss_pred             CCCCCcchHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcC--cccCCCCCCCHHHHHHHHHHhc
Q 029552          127 EPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG--KRLEIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       127 ~~~~~~~Dv~slG~~~~~l~~g-~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~li~~cl~  190 (191)
                      ...+.++|+||+|+++|.+..| ..-+...+............  ...-...+++.++++-+.+++.
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhc
Confidence            7788899999999999999855 44444443333333332222  2334557888999998888764

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.96  E-value=2.6e-09  Score=75.53  Aligned_cols=75  Identities=24%  Similarity=0.260  Sum_probs=57.0

Q ss_pred             CceEEEEeccCCCCHHH-HhcCCCCcccccHHHHHHHHHHHHHHHHHH-HhCCCCeeecCCCCCcEEecCCCcEEEcccc
Q 029552           20 PNLSIVTEYLSRGSLYR-LLHKPGVREMLDERRRLNMAYDVAKGMNYL-HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFG   97 (191)
Q Consensus        20 ~~~~lv~e~~~~~~L~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L-h~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~   97 (191)
                      ..-++||||+.+..+.. .+...    .+++++...+..+++.++..| |+.|  ++|+|+++.||++.. +.+.++||+
T Consensus        97 ~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~~NIL~~~-~~v~iIDF~  169 (197)
T cd05146          97 KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSEYNMLWHD-GKVWFIDVS  169 (197)
T ss_pred             cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEC-CcEEEEECC
Confidence            35689999997643321 22211    144556677789999999988 8999  999999999999974 679999999


Q ss_pred             cccc
Q 029552           98 LSRL  101 (191)
Q Consensus        98 ~~~~  101 (191)
                      .+..
T Consensus       170 qav~  173 (197)
T cd05146         170 QSVE  173 (197)
T ss_pred             Ccee
Confidence            8753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.95  E-value=1.4e-08  Score=80.01  Aligned_cols=130  Identities=21%  Similarity=0.322  Sum_probs=97.9

Q ss_pred             CCCCCCCcccccceee----cCCceEEEEeccCC-CCHHHHhcCCC------------CcccccHHHHHHHHHHHHHHHH
Q 029552            2 KRLRHPNIVLFMGAVT----QPPNLSIVTEYLSR-GSLYRLLHKPG------------VREMLDERRRLNMAYDVAKGMN   64 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~~-~~L~~~~~~~~------------~~~~~~~~~~~~~~~~i~~~l~   64 (191)
                      +++.|+|+|++.++|.    ++..+++|++|.++ ++|.+..-...            .+...+|..+|.++.|+..||.
T Consensus       328 kkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~  407 (655)
T KOG3741|consen  328 KKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALY  407 (655)
T ss_pred             HHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHH
Confidence            5788999999999996    34578999999774 67776653211            1224788999999999999999


Q ss_pred             HHHhCCCCeeecCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHH
Q 029552           65 YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWE  144 (191)
Q Consensus        65 ~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~  144 (191)
                      ++|+.|  +.-+-+.|.+|+++.+.+++++.-|.........            .  +-+.+   -++.|.-.||.++..
T Consensus       408 sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~------------~--~~le~---~Qq~D~~~lG~ll~a  468 (655)
T KOG3741|consen  408 SIHSSG--LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP------------T--EPLES---QQQNDLRDLGLLLLA  468 (655)
T ss_pred             HHHhcC--ceeecccHhHeEeeCcceEEEecccceeeecCCC------------C--cchhH---HhhhhHHHHHHHHHH
Confidence            999999  9999999999999999889888665533222111            0  11111   245688999999999


Q ss_pred             HHhCCC
Q 029552          145 LATLQQ  150 (191)
Q Consensus       145 l~~g~~  150 (191)
                      +.||..
T Consensus       469 LAt~~~  474 (655)
T KOG3741|consen  469 LATGTE  474 (655)
T ss_pred             Hhhccc
Confidence            999954

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.93  E-value=5.8e-09  Score=72.09  Aligned_cols=74  Identities=30%  Similarity=0.457  Sum_probs=61.0

Q ss_pred             eeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecCCCcEEEc
Q 029552           15 AVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVC   94 (191)
Q Consensus        15 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~   94 (191)
                      ++.+.+...++|||.+|..|.+.+...          ...++..+=.-+.-||..|  ++|+|++++||.++.++ +.++
T Consensus        67 ~dvD~~~~~I~me~I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~I  133 (204)
T COG3642          67 YDVDPDNGLIVMEYIEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFI  133 (204)
T ss_pred             EEEcCCCCEEEEEEeCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEE
Confidence            446777889999999999999988753          1334556666777899999  99999999999999875 9999


Q ss_pred             ccccccc
Q 029552           95 DFGLSRL  101 (191)
Q Consensus        95 d~~~~~~  101 (191)
                      |||++..
T Consensus       134 DfGLg~~  140 (204)
T COG3642         134 DFGLGEF  140 (204)
T ss_pred             ECCcccc
Confidence            9999863

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.92  E-value=1e-08  Score=79.12  Aligned_cols=130  Identities=17%  Similarity=0.218  Sum_probs=97.4

Q ss_pred             eEEEEeccCCC-CHHHHhcC---CCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecCCCcEEEcccc
Q 029552           22 LSIVTEYLSRG-SLYRLLHK---PGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFG   97 (191)
Q Consensus        22 ~~lv~e~~~~~-~L~~~~~~---~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~   97 (191)
                      +-++|+...+. ....+.+-   +.+..-..++-..+.+..++.+...||..|  ..-||++++|+++++++.+.|.|-+
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~LVdsD  162 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVLVDSD  162 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEEEccc
Confidence            56677776542 23333321   122233677888899999999999999999  9999999999999999999999975


Q ss_pred             cccccccccccCCCCCCCCcccCccccc-----cCCCCCcchHHHHHHHHHHHHhC-CCCCCC
Q 029552           98 LSRLKANTFLSSKSAAGTPEWMAPEVLR-----DEPSNEKSDIYSFGVILWELATL-QQPWGN  154 (191)
Q Consensus        98 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Dv~slG~~~~~l~~g-~~pf~~  154 (191)
                      .-....+ ......+++...|++||.-.     +...+...|.|.||+++++++.| ..||..
T Consensus       163 sfqi~~n-g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG  224 (637)
T COG4248         163 SFQINAN-GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG  224 (637)
T ss_pred             ceeeccC-CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence            4333322 23455677888999999643     44556778999999999999887 889964

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.84  E-value=2.5e-08  Score=74.13  Aligned_cols=77  Identities=23%  Similarity=0.187  Sum_probs=63.1

Q ss_pred             ceEEEEeccCCC-CHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecC-------CCcEE
Q 029552           21 NLSIVTEYLSRG-SLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK-------KYTVK   92 (191)
Q Consensus        21 ~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~-------~~~~~   92 (191)
                      ..++|+|++++. +|.+++..... ...++.....++.+++..+.-||..|  ++|+|+++.||+++.       ++.+.
T Consensus       109 ~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~  185 (268)
T PRK15123        109 TSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLS  185 (268)
T ss_pred             eeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEE
Confidence            478999999875 89998853211 12556777889999999999999999  999999999999975       45789


Q ss_pred             Eccccccc
Q 029552           93 VCDFGLSR  100 (191)
Q Consensus        93 l~d~~~~~  100 (191)
                      ++||+.+.
T Consensus       186 LIDl~r~~  193 (268)
T PRK15123        186 VIDLHRAQ  193 (268)
T ss_pred             EEECCccc
Confidence            99998764

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.82  E-value=9.7e-09  Score=81.54  Aligned_cols=76  Identities=24%  Similarity=0.300  Sum_probs=58.2

Q ss_pred             CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHH-HHHHHHhCCCCeeecCCCCCcEEecCCCcEEEccccc
Q 029552           20 PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK-GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGL   98 (191)
Q Consensus        20 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~-~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~   98 (191)
                      ...++||||++|.+|.++......+  .+   ...++.+++. .+..+|..|  ++|+|++|.||+++.++.++++|||.
T Consensus       231 ~~~vLvmE~i~G~~L~~~~~~~~~~--~~---~~~ia~~~~~~~l~ql~~~g--~~H~D~hPgNilv~~~g~i~liDfG~  303 (437)
T TIGR01982       231 SERVLTMEWIDGIPLSDIAALDEAG--LD---RKALAENLARSFLNQVLRDG--FFHADLHPGNIFVLKDGKIIALDFGI  303 (437)
T ss_pred             CCceEEEEeECCcccccHHHHHhcC--CC---HHHHHHHHHHHHHHHHHhCC--ceeCCCCcccEEECCCCcEEEEeCCC
Confidence            3468999999999998876432111  22   2335555555 477889999  99999999999999999999999998


Q ss_pred             cccc
Q 029552           99 SRLK  102 (191)
Q Consensus        99 ~~~~  102 (191)
                      +...
T Consensus       304 ~~~l  307 (437)
T TIGR01982       304 VGRL  307 (437)
T ss_pred             eeEC
Confidence            7643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.81  E-value=1.9e-08  Score=69.49  Aligned_cols=85  Identities=20%  Similarity=0.316  Sum_probs=65.8

Q ss_pred             eeecCCceEEEEeccCC-CCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecCCCc---
Q 029552           15 AVTQPPNLSIVTEYLSR-GSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT---   90 (191)
Q Consensus        15 ~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~---   90 (191)
                      +|.|...-.++|||++| .++.+++....... ..++-...++.+|=+.+.-||.++  ++||||..+||++.+.+.   
T Consensus        78 ~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~  154 (229)
T KOG3087|consen   78 IFIDTYGGQIYMEFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQIT  154 (229)
T ss_pred             EEEecCCCeEEEEeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCc
Confidence            56677788999999976 47888886544332 222333678889999999999999  999999999999976653   


Q ss_pred             EEEccccccccc
Q 029552           91 VKVCDFGLSRLK  102 (191)
Q Consensus        91 ~~l~d~~~~~~~  102 (191)
                      +.++|||++...
T Consensus       155 ~~lIdfgls~~s  166 (229)
T KOG3087|consen  155 PILIDFGLSSVS  166 (229)
T ss_pred             eEEEeecchhcc
Confidence            489999987643

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.79  E-value=3.8e-08  Score=70.56  Aligned_cols=76  Identities=29%  Similarity=0.357  Sum_probs=64.2

Q ss_pred             ceEEEEeccCC-CCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecCCC---cEEEccc
Q 029552           21 NLSIVTEYLSR-GSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY---TVKVCDF   96 (191)
Q Consensus        21 ~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~---~~~l~d~   96 (191)
                      ..++|+|++++ .+|.+++.....   .+......++.+++..+.-||..|  ++|+|+++.||+++.++   .+.++||
T Consensus        91 ~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~~lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDl  165 (206)
T PF06293_consen   91 RSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIAKLHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDL  165 (206)
T ss_pred             eEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHHHHHHCc--CCCCCCCcccEEEeCCCCceeEEEEcc
Confidence            35899999987 479999876332   556677888999999999999999  99999999999999887   8999999


Q ss_pred             ccccc
Q 029552           97 GLSRL  101 (191)
Q Consensus        97 ~~~~~  101 (191)
                      +.+..
T Consensus       166 d~~~~  170 (206)
T PF06293_consen  166 DRMRF  170 (206)
T ss_pred             hhcee
Confidence            86653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.76  E-value=2.4e-08  Score=69.14  Aligned_cols=77  Identities=18%  Similarity=0.164  Sum_probs=56.0

Q ss_pred             ccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCC---CeeecCCCCCcEEec
Q 029552           10 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNP---PIVHRDLKSPNLLVD   86 (191)
Q Consensus        10 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~---~~~h~~l~p~ni~~~   86 (191)
                      ++++.+..  ...++|||+++|.++.+.    .    .   .......+++++++.||+.+.   .++|+|++|.||+++
T Consensus        56 P~~~~~~~--~~~~lv~e~i~G~~l~~~----~----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~  122 (170)
T cd05151          56 PKLYYFDP--ETGVLITEFIEGSELLTE----D----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD  122 (170)
T ss_pred             CceEEEeC--CCCeEEEEecCCCccccc----c----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE
Confidence            34444332  345899999999877543    0    1   112345789999999999871   139999999999999


Q ss_pred             CCCcEEEccccccc
Q 029552           87 KKYTVKVCDFGLSR  100 (191)
Q Consensus        87 ~~~~~~l~d~~~~~  100 (191)
                       ++.++++||+.+.
T Consensus       123 -~~~~~liDf~~a~  135 (170)
T cd05151         123 -DGRLWLIDWEYAG  135 (170)
T ss_pred             -CCeEEEEeccccc
Confidence             6689999998765

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.68  E-value=2.4e-08  Score=80.73  Aligned_cols=72  Identities=21%  Similarity=0.232  Sum_probs=53.0

Q ss_pred             ceEEEEeccCCCCHHHHh--cCCC-CcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecCCC----cEEE
Q 029552           21 NLSIVTEYLSRGSLYRLL--HKPG-VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY----TVKV   93 (191)
Q Consensus        21 ~~~lv~e~~~~~~L~~~~--~~~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~----~~~l   93 (191)
                      ..++||||+.|+++.++-  ...+ ....+.+..+..++.|++       ..|  ++|+|++|.||+++.+|    .+++
T Consensus       235 ~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~G--ffHaDpHPGNIlv~~~g~~~~~i~l  305 (537)
T PRK04750        235 ETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDG--FFHADMHPGNIFVSYDPPENPRYIA  305 (537)
T ss_pred             CceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCC--eeeCCCChHHeEEecCCCCCCeEEE
Confidence            356999999999998753  2222 112244555555555554       578  99999999999999888    9999


Q ss_pred             cccccccc
Q 029552           94 CDFGLSRL  101 (191)
Q Consensus        94 ~d~~~~~~  101 (191)
                      .|||....
T Consensus       306 lDFGivg~  313 (537)
T PRK04750        306 LDFGIVGS  313 (537)
T ss_pred             EecceEEE
Confidence            99998653

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.64  E-value=1.1e-08  Score=81.38  Aligned_cols=138  Identities=28%  Similarity=0.283  Sum_probs=104.4

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      -|.+++.+...+...++.|+--|||.++++......   ...+++...++...|++.++.++|+..  ++|+|++|+||+
T Consensus       324 ~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~  398 (524)
T KOG0601|consen  324 SHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNIL  398 (524)
T ss_pred             cccccCCCCCCccccccccCchhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhccccccchh--hhccccccccee
Confidence            478888888888888888899999999888776632   234888899999999999999999999  999999999999


Q ss_pred             ecCC-CcEEEcccccccccccccccCCCCCCCCccc--CccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 029552           85 VDKK-YTVKVCDFGLSRLKANTFLSSKSAAGTPEWM--APEVLRDEPSNEKSDIYSFGVILWELATLQQ  150 (191)
Q Consensus        85 ~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~--~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~  150 (191)
                      +..+ +..+++|++......-.   .......-++.  ++..........++|+++||..+.+..++..
T Consensus       399 i~~~~~~~~~~~~~~~t~~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~  464 (524)
T KOG0601|consen  399 ISNDGFFSKLGDFGCWTRLAFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP  464 (524)
T ss_pred             eccchhhhhcccccccccccee---cccccccccccccchhhccccccccccccccccccccccccCcc
Confidence            9886 67788998876531111   11111122233  4444455567788999999999999888743

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.58  E-value=1e-07  Score=67.14  Aligned_cols=72  Identities=32%  Similarity=0.431  Sum_probs=49.3

Q ss_pred             eEEEEeccC--CCCHHHHhcCCCCcccccHHHHHHHHHHHHHH-HHHHHhCCCCeeecCCCCCcEEecCCCcEEEccccc
Q 029552           22 LSIVTEYLS--RGSLYRLLHKPGVREMLDERRRLNMAYDVAKG-MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGL   98 (191)
Q Consensus        22 ~~lv~e~~~--~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~-l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~   98 (191)
                      ..+||||+.  |..+..+....     +..+....++.+++.. ...+|+.|  ++|||+++.||+++.+ .+.++||+.
T Consensus        81 ~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~-~~~iIDf~q  152 (188)
T PF01163_consen   81 NVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG-KVYIIDFGQ  152 (188)
T ss_dssp             TEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT-CEEE--GTT
T ss_pred             CEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc-eEEEEecCc
Confidence            479999998  65665544331     2234455677788884 44468999  9999999999999988 899999997


Q ss_pred             ccc
Q 029552           99 SRL  101 (191)
Q Consensus        99 ~~~  101 (191)
                      +..
T Consensus       153 av~  155 (188)
T PF01163_consen  153 AVD  155 (188)
T ss_dssp             EEE
T ss_pred             cee
Confidence            753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.54  E-value=2.9e-07  Score=65.90  Aligned_cols=65  Identities=22%  Similarity=0.380  Sum_probs=51.5

Q ss_pred             ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecCCCcEEEcccccc
Q 029552           21 NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS   99 (191)
Q Consensus        21 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~   99 (191)
                      ..+++|||++|..|.+...       +++.    +...+.+++.-||+.|  ++|+|.+|.|+++++++ +++.|++..
T Consensus       117 ~~~ll~EYIeG~~l~d~~~-------i~e~----~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~~-i~iID~~~k  181 (229)
T PF06176_consen  117 SYVLLMEYIEGVELNDIED-------IDED----LAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNNG-IRIIDTQGK  181 (229)
T ss_pred             EEEEEEEEecCeecccchh-------cCHH----HHHHHHHHHHHHHHcC--CccCCCCcCcEEEECCc-EEEEECccc
Confidence            4568999999988766543       3332    3456778899999999  99999999999999765 999999653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.34  E-value=2.3e-06  Score=61.65  Aligned_cols=90  Identities=24%  Similarity=0.298  Sum_probs=64.2

Q ss_pred             CcccccceeecC---CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCC--------------
Q 029552            8 NIVLFMGAVTQP---PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRN--------------   70 (191)
Q Consensus         8 ~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~--------------   70 (191)
                      .+++++.+....   +..+++||+++|.++.+.... .   .+++++...++.+++++|..||+..              
T Consensus        58 ~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~-~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~  133 (223)
T cd05154          58 PVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR-P---ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGG  133 (223)
T ss_pred             CCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC-C---CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCc
Confidence            355666665543   367899999999888775532 1   1566666667777777777777421              


Q ss_pred             ----------------------------------------CCeeecCCCCCcEEecC--CCcEEEcccccccc
Q 029552           71 ----------------------------------------PPIVHRDLKSPNLLVDK--KYTVKVCDFGLSRL  101 (191)
Q Consensus        71 ----------------------------------------~~~~h~~l~p~ni~~~~--~~~~~l~d~~~~~~  101 (191)
                                                              ..++|+|++|.||+++.  ++.+.++||+.+..
T Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         134 YLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             hHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                                    12789999999999998  56689999987653

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK09902 hypothetical protein; Provisional

Probab=98.28  E-value=5e-06  Score=59.32  Aligned_cols=76  Identities=21%  Similarity=0.140  Sum_probs=62.1

Q ss_pred             eEEEEeccC-CCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecCCCc--EEEccccc
Q 029552           22 LSIVTEYLS-RGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT--VKVCDFGL   98 (191)
Q Consensus        22 ~~lv~e~~~-~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~--~~l~d~~~   98 (191)
                      .++|+|-+. -.+|.+++..... ...++.+...+..++++++.-||+.|  +.|+++.+.||+++..|.  +.++||.-
T Consensus       100 A~LVTe~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDlEk  176 (216)
T PRK09902        100 ALLVTEDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDLEK  176 (216)
T ss_pred             EEEEEEeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence            678888765 2689888865332 12567777889999999999999999  999999999999986666  99999976


Q ss_pred             cc
Q 029552           99 SR  100 (191)
Q Consensus        99 ~~  100 (191)
                      +.
T Consensus       177 ~r  178 (216)
T PRK09902        177 SR  178 (216)
T ss_pred             cc
Confidence            54

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.25  E-value=3.3e-06  Score=59.62  Aligned_cols=90  Identities=18%  Similarity=0.165  Sum_probs=67.4

Q ss_pred             CCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCC-CeeecCCCCCcEEe
Q 029552            7 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNP-PIVHRDLKSPNLLV   85 (191)
Q Consensus         7 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~-~~~h~~l~p~ni~~   85 (191)
                      +++++++++|-+    .++.|+...+++.............++.++.+++.++++.+++|+..-. .+.-+|++++|+.+
T Consensus        20 ~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv   95 (188)
T PF12260_consen   20 EPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGV   95 (188)
T ss_pred             CCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEE
Confidence            588999998853    6778998866554321100001116888999999999999999987311 28889999999999


Q ss_pred             cCCCcEEEccccccc
Q 029552           86 DKKYTVKVCDFGLSR  100 (191)
Q Consensus        86 ~~~~~~~l~d~~~~~  100 (191)
                      +.++++++.|++...
T Consensus        96 ~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   96 NDDGRLKLIDLDDVF  110 (188)
T ss_pred             eCCCcEEEEechhcc
Confidence            999999999997654

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=97.99  E-value=1.6e-05  Score=58.50  Aligned_cols=72  Identities=28%  Similarity=0.327  Sum_probs=53.9

Q ss_pred             CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecCCCcEEEccccc
Q 029552           19 PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGL   98 (191)
Q Consensus        19 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~   98 (191)
                      .+.-.+|||+.+|..|...-.        +.+..-.++..|+..+...-..|  ++|||+++-||+++.+|.+.++||-.
T Consensus       179 ~nRHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~~dg~~~vIDwPQ  248 (304)
T COG0478         179 WNRHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVTEDGDIVVIDWPQ  248 (304)
T ss_pred             cccceeeeehcccceeecccC--------cccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEecCCCEEEEeCcc
Confidence            345689999999866544331        23334445566666666666888  99999999999999999999999976


Q ss_pred             cc
Q 029552           99 SR  100 (191)
Q Consensus        99 ~~  100 (191)
                      +.
T Consensus       249 ~v  250 (304)
T COG0478         249 AV  250 (304)
T ss_pred             cc
Confidence            54

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.98  E-value=1.6e-06  Score=70.43  Aligned_cols=142  Identities=25%  Similarity=0.310  Sum_probs=96.3

Q ss_pred             CCCCCCCC-cccccceeecCCceEEEEeccCCC-CHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            1 MKRLRHPN-IVLFMGAVTQPPNLSIVTEYLSRG-SLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         1 L~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      |++++||| .+.+++.++.+...++.++++.++ +-..-.....  -.+.+-+.......-+++++++|+..  -+|+| 
T Consensus       287 LdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se--~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d-  361 (829)
T KOG0576|consen  287 LDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSE--IALEQYQFAYPLRKETRPLAELHSSY--KVHRD-  361 (829)
T ss_pred             HHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhh--Hhhhhhhhhhhhhhhccccccccccc--ccCcc-
Confidence            57889999 777777777777899999999776 1111111000  01333344445556677889998875  57776 


Q ss_pred             CCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 029552           79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW  152 (191)
Q Consensus        79 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf  152 (191)
                         ||+... +..+.++++....-.... .......++.+++||......++.+.|.|++|.-..++.-|..|-
T Consensus       362 ---~~l~s~-~~~~~~~~~v~~~L~~~~-~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  362 ---NILGSE-EEVKLLDFAVPPQLTRTM-KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             ---cccccc-cccccccccCCcccCccc-ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence               555444 568888887654333332 344556778999999999998999999999998777777775554

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.79  E-value=0.00024  Score=51.75  Aligned_cols=28  Identities=25%  Similarity=0.233  Sum_probs=25.0

Q ss_pred             eeecCCCCCcEEecCCCcEEEcccccccc
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRL  101 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~~  101 (191)
                      ++|+|++|.|++++.++ +.++||+.+..
T Consensus       155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       155 CLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             eEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            78999999999999988 99999987653

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.55  E-value=0.00021  Score=62.11  Aligned_cols=145  Identities=21%  Similarity=0.259  Sum_probs=99.2

Q ss_pred             CCCCCCCCcccccceeecCCc----eEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeec
Q 029552            1 MKRLRHPNIVLFMGAVTQPPN----LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR   76 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~   76 (191)
                      +++..|+|++.++.+..++..    ..+..+++...++.+.++.-+.   .+....+.+..+++++++++|+..  ..|.
T Consensus       236 l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~---i~~~~~r~~~~~~~~GL~~~h~~~--l~~v  310 (1351)
T KOG1035|consen  236 LSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS---IPLETLRILHQKLLEGLAYLHSLS--LEHV  310 (1351)
T ss_pred             HHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc---cCHHHHHHHHHHHhhhHHHHHHhc--ccee
Confidence            356789999998887754432    3456788888888888876443   889999999999999999999987  6666


Q ss_pred             CCCCC---cEEecCCCcEEEc--ccccccccccccccCCCCCCCCcccCccccccCCCC--CcchHHHHHHHHHHHHhCC
Q 029552           77 DLKSP---NLLVDKKYTVKVC--DFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSN--EKSDIYSFGVILWELATLQ  149 (191)
Q Consensus        77 ~l~p~---ni~~~~~~~~~l~--d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~--~~~Dv~slG~~~~~l~~g~  149 (191)
                      -+..+   +.-.+..+....+  |++.+....+. ...........+.++|.......+  ...|+|++|.....+..|.
T Consensus       311 ~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~-~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~  389 (1351)
T KOG1035|consen  311 VLSASSSKESTVDGEGVVAISLSDFDSSKPLPDN-EKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGE  389 (1351)
T ss_pred             EEecccccccccCccceeecchhhhcccccCCCc-ccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcC
Confidence            55555   3333444555555  77766544333 222233334456677766555443  3479999999999998875


Q ss_pred             CC
Q 029552          150 QP  151 (191)
Q Consensus       150 ~p  151 (191)
                      .+
T Consensus       390 ~i  391 (1351)
T KOG1035|consen  390 DI  391 (1351)
T ss_pred             cc
Confidence            43

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.42  E-value=0.00051  Score=55.77  Aligned_cols=75  Identities=17%  Similarity=0.260  Sum_probs=52.3

Q ss_pred             CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHH-HHHHHhCCCCeeecCCCCCcEEecCCCcEEEccccc
Q 029552           20 PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG-MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGL   98 (191)
Q Consensus        20 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~-l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~   98 (191)
                      +.-.++|||++|..+.++......+  .+...+   +..++++ +..+=..|  +.|+|.+|.||+++.+|.+.+.|||.
T Consensus       239 ~~~VLtmE~i~Gi~i~d~~~l~~~g--~d~k~i---a~~~~~~f~~q~~~dg--ffHaDpHpGNi~v~~~g~i~~lDfGi  311 (517)
T COG0661         239 TRRVLTMEWIDGIKISDIAALKSAG--IDRKEL---AELLVRAFLRQLLRDG--FFHADPHPGNILVRSDGRIVLLDFGI  311 (517)
T ss_pred             CCcEEEEEeeCCEecccHHHHHhcC--CCHHHH---HHHHHHHHHHHHHhcC--ccccCCCccceEEecCCcEEEEcCcc
Confidence            4578999999999998885322211  332222   2222222 33333477  99999999999999999999999998


Q ss_pred             ccc
Q 029552           99 SRL  101 (191)
Q Consensus        99 ~~~  101 (191)
                      ...
T Consensus       312 ~g~  314 (517)
T COG0661         312 VGR  314 (517)
T ss_pred             eec
Confidence            643

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.40  E-value=0.0012  Score=48.56  Aligned_cols=28  Identities=29%  Similarity=0.367  Sum_probs=25.1

Q ss_pred             eeecCCCCCcEEecCCCcEEEccccccc
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSR  100 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~  100 (191)
                      ++|+|+.|.||+++.++...|+|++.+.
T Consensus       165 l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         165 VTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             EECCCCCCccEEEeCCcEEEEEEccccc
Confidence            8999999999999998778899998664

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.27  E-value=0.003  Score=45.00  Aligned_cols=82  Identities=27%  Similarity=0.381  Sum_probs=59.7

Q ss_pred             CCCCCcccccceeecCCceEEEEeccC------CCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecC
Q 029552            4 LRHPNIVLFMGAVTQPPNLSIVTEYLS------RGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRD   77 (191)
Q Consensus         4 l~h~~i~~~~~~~~~~~~~~lv~e~~~------~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~   77 (191)
                      ..+.+|.+++++.+.+....+|+|...      ..||.+++....    +++ ...+   .+-+-.++|-+++  |+.+|
T Consensus        74 ~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~~~~---~L~~f~~~l~~~~--Iv~~d  143 (199)
T PF10707_consen   74 VDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-ELRQ---ALDEFKRYLLDHH--IVIRD  143 (199)
T ss_pred             CcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-HHHH---HHHHHHHHHHHcC--CeecC
Confidence            457899999999999999999988765      357888885433    444 3333   3334456777888  99999


Q ss_pred             CCCCcEEecCCC----cEEEcc
Q 029552           78 LKSPNLLVDKKY----TVKVCD   95 (191)
Q Consensus        78 l~p~ni~~~~~~----~~~l~d   95 (191)
                      ++|.||++...+    .+.++|
T Consensus       144 l~~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  144 LNPHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             CCcccEEEEecCCCceEEEEEe
Confidence            999999996432    466666

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.25  E-value=0.0011  Score=48.54  Aligned_cols=77  Identities=21%  Similarity=0.155  Sum_probs=53.3

Q ss_pred             ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCeeecCCCCCcEEecCCCcEEEcccccc
Q 029552           21 NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS   99 (191)
Q Consensus        21 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~   99 (191)
                      ...+|||++...  ..-.-+-..- .+...+...+..++++.+.-|-. .+  ++|+||+..||++. ++.+.++|++.+
T Consensus       140 ~nVLvMEfIg~~--g~pAP~LkDv-~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~-~~~p~iID~~Qa  213 (268)
T COG1718         140 NNVLVMEFIGDD--GLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH-DGEPYIIDVSQA  213 (268)
T ss_pred             CCeEEEEeccCC--CCCCCCcccC-CcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE-CCeEEEEECccc
Confidence            357999998643  1111000000 12333677777888888888877 78  99999999999999 778999999987


Q ss_pred             cccc
Q 029552          100 RLKA  103 (191)
Q Consensus       100 ~~~~  103 (191)
                      ....
T Consensus       214 V~~~  217 (268)
T COG1718         214 VTID  217 (268)
T ss_pred             cccC
Confidence            6433

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.08  E-value=3.5e-05  Score=68.69  Aligned_cols=162  Identities=14%  Similarity=0.076  Sum_probs=113.7

Q ss_pred             CCCCCCcccccceee--cCCceEEEEeccCCCCHHHHhcCCCCc-ccccHHHHHHHHHHHHHHHHHHHhC---CCCeeec
Q 029552            3 RLRHPNIVLFMGAVT--QPPNLSIVTEYLSRGSLYRLLHKPGVR-EMLDERRRLNMAYDVAKGMNYLHRR---NPPIVHR   76 (191)
Q Consensus         3 ~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~---~~~~~h~   76 (191)
                      +..|+++.....-..  .....|..++++.+|.+.+.+-+.... .+..+.-+.....+.+....-.|..   |-.-+|+
T Consensus      1285 ~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~ 1364 (2724)
T KOG1826|consen 1285 EAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSK 1364 (2724)
T ss_pred             hhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhh
Confidence            346777766555443  234578899999999999999764322 2333333333333335555554432   2136789


Q ss_pred             CCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 029552           77 DLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN  156 (191)
Q Consensus        77 ~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~  156 (191)
                      ++++-|.++..+.+++++++|+.+.............+++.|+.++....-.++.++|+|.+|+-+|....|..+|....
T Consensus      1365 ~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~fl 1444 (2724)
T KOG1826|consen 1365 SLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIFFL 1444 (2724)
T ss_pred             hhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHHHH
Confidence            99999999999999999999998855544445555667778888998888888888999999999999998888887665


Q ss_pred             HHHHHHHH
Q 029552          157 PAQVVAAV  164 (191)
Q Consensus       157 ~~~~~~~~  164 (191)
                      ....-..+
T Consensus      1445 q~~Lkgii 1452 (2724)
T KOG1826|consen 1445 QPALKGII 1452 (2724)
T ss_pred             HHHHcCcc
Confidence            55555544

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.93  E-value=0.0025  Score=51.86  Aligned_cols=72  Identities=19%  Similarity=0.320  Sum_probs=49.8

Q ss_pred             ceEEEEeccCCCCHHHHh--cCCCCcccccHHHHHHHHHHHHHH-HHHHHhCCCCeeecCCCCCcEEecC----CCcEEE
Q 029552           21 NLSIVTEYLSRGSLYRLL--HKPGVREMLDERRRLNMAYDVAKG-MNYLHRRNPPIVHRDLKSPNLLVDK----KYTVKV   93 (191)
Q Consensus        21 ~~~lv~e~~~~~~L~~~~--~~~~~~~~~~~~~~~~~~~~i~~~-l~~Lh~~~~~~~h~~l~p~ni~~~~----~~~~~l   93 (191)
                      .-.++||||+|..+.|.-  .+.+    ++...+.   ..+.++ ++-+=..|  ++|+|=+|.||++++    ++.+.+
T Consensus       276 ~RVLtME~~~G~~i~Dl~~i~~~g----i~~~~i~---~~l~~~~~~qIf~~G--ffHaDPHPGNilv~~~~~~~~~ivl  346 (538)
T KOG1235|consen  276 KRVLTMEYVDGIKINDLDAIDKRG----ISPHDIL---NKLVEAYLEQIFKTG--FFHADPHPGNILVRPNPEGDEEIVL  346 (538)
T ss_pred             ceEEEEEecCCccCCCHHHHHHcC----CCHHHHH---HHHHHHHHHHHHhcC--CccCCCCCCcEEEecCCCCCccEEE
Confidence            578999999997775553  3333    4444433   333333 23334567  999999999999984    568999


Q ss_pred             cccccccc
Q 029552           94 CDFGLSRL  101 (191)
Q Consensus        94 ~d~~~~~~  101 (191)
                      .|+|+...
T Consensus       347 lDhGl~~~  354 (538)
T KOG1235|consen  347 LDHGLYAV  354 (538)
T ss_pred             Eccccccc
Confidence            99998653

>PLN02876 acyl-CoA dehydrogenase

Probab=96.76  E-value=0.0052  Score=53.16  Aligned_cols=30  Identities=33%  Similarity=0.511  Sum_probs=24.2

Q ss_pred             eeecCCCCCcEEecCC-Cc-EEEccccccccc
Q 029552           73 IVHRDLKSPNLLVDKK-YT-VKVCDFGLSRLK  102 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~-~~-~~l~d~~~~~~~  102 (191)
                      ++|+|+++.|++++++ +. .-+.|++.+...
T Consensus       227 LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G  258 (822)
T PLN02876        227 IVHGDFRIDNLVFHPTEDRVIGILDWELSTLG  258 (822)
T ss_pred             eEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence            9999999999999853 33 579999887643

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.62  E-value=0.0071  Score=46.23  Aligned_cols=33  Identities=30%  Similarity=0.461  Sum_probs=28.9

Q ss_pred             CeeecCCCCCcEEecCCCcEEEccccccccccc
Q 029552           72 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN  104 (191)
Q Consensus        72 ~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~  104 (191)
                      .++|||+++.|+++++++.+-+.||+.+.....
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            389999999999999999999999998875543

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.36  E-value=0.013  Score=45.67  Aligned_cols=72  Identities=24%  Similarity=0.330  Sum_probs=53.9

Q ss_pred             ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecCCCcEEEccccccc
Q 029552           21 NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR  100 (191)
Q Consensus        21 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~  100 (191)
                      ..|++|++- |+++.-+-.       ...+++..++++.+..+.-+.+.- ++-|||+.-.||+++ +|++.|+||.++.
T Consensus       300 y~yl~~kdh-gt~is~ik~-------~~~~e~lsff~s~~sil~~lekkf-~fehrnlt~~niLId-~GnvtLIDfklsR  369 (488)
T COG5072         300 YLYLHFKDH-GTPISIIKA-------DRSEEELSFFWSCISILDILEKKF-PFEHRNLTLDNILID-EGNVTLIDFKLSR  369 (488)
T ss_pred             EEEEEEecC-Cceeeeeec-------ccHHHHHHHHHHHHHHHhhhhhcC-Ccccccccccceeee-cCceEEEEeeeee
Confidence            466777765 445533221       356677788888888877777653 488999999999999 8999999999887


Q ss_pred             cc
Q 029552          101 LK  102 (191)
Q Consensus       101 ~~  102 (191)
                      ..
T Consensus       370 l~  371 (488)
T COG5072         370 LS  371 (488)
T ss_pred             cc
Confidence            43

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=95.62  E-value=0.031  Score=41.87  Aligned_cols=52  Identities=17%  Similarity=0.222  Sum_probs=38.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecCCCcEEEcccccccc
Q 029552           50 RRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL  101 (191)
Q Consensus        50 ~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~  101 (191)
                      ..+...+..+-.++...+.....++|+|+.|+|++.++.+.++|+|+.-+..
T Consensus       132 ~~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         132 HLLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            3444455566666666665511289999999999999989999999987653

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=95.18  E-value=0.039  Score=40.13  Aligned_cols=28  Identities=32%  Similarity=0.527  Sum_probs=25.1

Q ss_pred             eeecCCCCCcEEecC-CCcEEEccccccc
Q 029552           73 IVHRDLKSPNLLVDK-KYTVKVCDFGLSR  100 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~-~~~~~l~d~~~~~  100 (191)
                      ++|+|+++.||+++. ++.+.++||..+.
T Consensus       172 l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         172 FCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            899999999999998 5789999998765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.10  E-value=0.027  Score=40.92  Aligned_cols=39  Identities=26%  Similarity=0.270  Sum_probs=33.1

Q ss_pred             HHHHHHHHhCCCCeeecCCCCCcEEecCCCcEEEccccc
Q 029552           60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGL   98 (191)
Q Consensus        60 ~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~   98 (191)
                      +++|.-.|+.+...+|||.+|+||..++.|.+||.|-+.
T Consensus       151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence            567888896544499999999999999999999999754

The function of this family is unknown.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=94.97  E-value=0.043  Score=42.27  Aligned_cols=70  Identities=20%  Similarity=0.239  Sum_probs=51.8

Q ss_pred             CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecCCCcEEEccccc
Q 029552           19 PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGL   98 (191)
Q Consensus        19 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~   98 (191)
                      .+.-++|||.+.+..|...-.-      .+...   +...+..-+--|..+|  ++|||.+--||++..++.+.++||..
T Consensus       180 ~~RH~Vvmelv~g~Pl~~v~~v------~d~~~---ly~~lm~~Iv~la~~G--lIHgDFNEFNimv~dd~~i~vIDFPQ  248 (465)
T KOG2268|consen  180 HNRHCVVMELVDGYPLRQVRHV------EDPPT---LYDDLMGLIVRLANHG--LIHGDFNEFNIMVKDDDKIVVIDFPQ  248 (465)
T ss_pred             ccceeeHHHhhcccceeeeeec------CChHH---HHHHHHHHHHHHHHcC--ceecccchheeEEecCCCEEEeechH
Confidence            3456899999998877554432      22222   3444555566788999  99999999999999999999999964


Q ss_pred             c
Q 029552           99 S   99 (191)
Q Consensus        99 ~   99 (191)
                      .
T Consensus       249 m  249 (465)
T KOG2268|consen  249 M  249 (465)
T ss_pred             h
Confidence            3

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=94.95  E-value=0.037  Score=40.39  Aligned_cols=29  Identities=38%  Similarity=0.452  Sum_probs=24.7

Q ss_pred             eeecCCCCCcEEecCCCcEEEcccccccc
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRL  101 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~~  101 (191)
                      ++|+|+++.|++++.++...++||+.+..
T Consensus       166 l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         166 WFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             EEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            89999999999998776567999987653

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=94.81  E-value=0.09  Score=39.96  Aligned_cols=27  Identities=30%  Similarity=0.458  Sum_probs=24.0

Q ss_pred             eeecCCCCCcEEecCCCcEEEccccccc
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSR  100 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~  100 (191)
                      ++|+|+++.|++++. +.+.++||+.+.
T Consensus       189 liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       189 FCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             eEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            899999999999988 678999998654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=94.75  E-value=0.032  Score=40.19  Aligned_cols=29  Identities=31%  Similarity=0.511  Sum_probs=20.2

Q ss_pred             eeecCCCCCcEEec-CCCcEEEcccccccc
Q 029552           73 IVHRDLKSPNLLVD-KKYTVKVCDFGLSRL  101 (191)
Q Consensus        73 ~~h~~l~p~ni~~~-~~~~~~l~d~~~~~~  101 (191)
                      ++|+|++|.||+++ .++.+.++||+.+..
T Consensus       168 ~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  168 LIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             EE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             EEEeccccccceeeeccceeEEEecccceE
Confidence            99999999999999 566678999987643

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG4499 Predicted membrane protein [Function unknown]

Probab=94.72  E-value=0.45  Score=37.05  Aligned_cols=83  Identities=16%  Similarity=0.110  Sum_probs=56.9

Q ss_pred             ccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc
Q 029552           47 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD  126 (191)
Q Consensus        47 ~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~  126 (191)
                      +.....++++.|.+..|.-+...   -.|--+.|+||+++.++.+...-+|+-...++.            =+.||.+  
T Consensus        82 ~~k~~Klr~a~~~I~~l~e~~~t---r~~~~laPeNilf~~~l~p~~vH~Glk~~lpPy------------e~tee~f--  144 (434)
T COG4499          82 KEKTRKLRLALQNIATLSELNNT---RYTFFLAPENILFDGGLTPFFVHRGLKNSLPPY------------EMTEERF--  144 (434)
T ss_pred             HHHHHHHHHHHHHHHHHHHhhcc---ceeEEecchheEEcCCCceEEEecchhccCCCC------------CCCHHHH--
Confidence            56777778777877777765443   456778999999999999999988874322211            1233322  


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 029552          127 EPSNEKSDIYSFGVILWELATLQQPWGN  154 (191)
Q Consensus       127 ~~~~~~~Dv~slG~~~~~l~~g~~pf~~  154 (191)
                              .-++-+++.+++.|..+|..
T Consensus       145 --------~~~ykA~~~~~fn~k~~Fe~  164 (434)
T COG4499         145 --------LKEYKALAIYAFNGKFSFES  164 (434)
T ss_pred             --------HHHHHHHHHHHHcCCccHHH
Confidence                    12566777888889888864

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=94.71  E-value=0.11  Score=39.39  Aligned_cols=29  Identities=24%  Similarity=0.407  Sum_probs=25.6

Q ss_pred             eeecCCCCCcEEecCC----CcEEEcccccccc
Q 029552           73 IVHRDLKSPNLLVDKK----YTVKVCDFGLSRL  101 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~----~~~~l~d~~~~~~  101 (191)
                      ++|+|+.+.||+++.+    +.++++||+.+..
T Consensus       181 lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         181 FCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             EEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            8999999999999884    7899999987653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=94.58  E-value=0.073  Score=40.19  Aligned_cols=29  Identities=31%  Similarity=0.385  Sum_probs=25.9

Q ss_pred             eeecCCCCCcEEecCCCcEEEcccccccc
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRL  101 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~~  101 (191)
                      ++|+|++|.|++++.++.+.++||+.+..
T Consensus       177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         177 VIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            99999999999999987778999987654

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=94.50  E-value=0.091  Score=40.03  Aligned_cols=29  Identities=31%  Similarity=0.408  Sum_probs=25.8

Q ss_pred             eeecCCCCCcEEecCCCcEEEcccccccc
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRL  101 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~~  101 (191)
                      ++|+|+++.|++++.++...++||+.+..
T Consensus       189 l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       189 VIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             cCCCCCCcCcEEEECCceEEEeecccccC
Confidence            99999999999999887678999987753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=94.46  E-value=0.053  Score=44.22  Aligned_cols=40  Identities=23%  Similarity=0.340  Sum_probs=31.4

Q ss_pred             CCCCCCCCcccccceee-cCCceEEEEeccCCCCHHHHhcCC
Q 029552            1 MKRLRHPNIVLFMGAVT-QPPNLSIVTEYLSRGSLYRLLHKP   41 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~   41 (191)
                      |+++.|+|+..++++-. ......+|+|+++ .+|.+.+..+
T Consensus        36 lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~   76 (725)
T KOG1093|consen   36 LKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTG   76 (725)
T ss_pred             HHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhc
Confidence            46788999999998775 3345889999995 5999988653

>PRK14559 putative protein serine/threonine phosphatase; Provisional

Probab=94.15  E-value=0.23  Score=41.78  Aligned_cols=86  Identities=19%  Similarity=0.068  Sum_probs=64.5

Q ss_pred             CCCCcccccceeecCCceEEEEeccC-CCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLS-RGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL   83 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni   83 (191)
                      ++.||+++++++..++.-.+++|+.. -.+|.+......    .+..+.+.|+.||++-=.-|...+  ++..=+.++|+
T Consensus       178 ~~~~iP~v~~~~~~~~~~i~Lle~~~~~~~l~~~w~~~~----~~~l~~l~Wl~q~~~LW~~l~~~~--~~~sll~~~nl  251 (645)
T PRK14559        178 FPTEIPKIHDAWQDGDLQVILLEDRSHWQPLLDLWQDQT----LPTLQILYWLNQMTQLWKALEPWG--CCQSLLELENL  251 (645)
T ss_pred             ccccCcchheeecCCCCcEEEeCCCCCCchHHHHhhhcC----CcHHHHHHHHHHHHHHHHHHHhcC--eehhccchhhe
Confidence            44569999999988777778888753 234445444322    456788899999999999999999  99999999999


Q ss_pred             EecCCCcEEEccc
Q 029552           84 LVDKKYTVKVCDF   96 (191)
Q Consensus        84 ~~~~~~~~~l~d~   96 (191)
                      .++.+..++|..|
T Consensus       252 rv~~~~~~~l~~l  264 (645)
T PRK14559        252 RVDEDQTLGLQQL  264 (645)
T ss_pred             eeCCCceehHhhh
Confidence            9986555554443

>PRK10271 thiK thiamine kinase; Provisional

Probab=93.93  E-value=0.057  Score=38.07  Aligned_cols=29  Identities=17%  Similarity=0.250  Sum_probs=25.2

Q ss_pred             eeecCCCCCcEEecCCCcEEEccccccccc
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLK  102 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~  102 (191)
                      .+|+|+.|.|+++++++ ++++|++.+...
T Consensus        79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~g  107 (188)
T PRK10271         79 PLHMDVHAGNLVHSASG-LRLIDWEYAGDG  107 (188)
T ss_pred             eecCCCCCccEEEECCC-EEEEeCCcccCC
Confidence            78999999999998877 999999877543

>PRK05231 homoserine kinase; Provisional

Probab=93.76  E-value=0.19  Score=38.46  Aligned_cols=29  Identities=24%  Similarity=0.315  Sum_probs=25.1

Q ss_pred             eeecCCCCCcEEecCCCcEEEcccccccc
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRL  101 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~~  101 (191)
                      ++|+|++|.||+++.+....++||+.+..
T Consensus       189 liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        189 VIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cCCCCCCCCcEEEECCceEEEEecccccC
Confidence            99999999999999766568999987754

>TIGR02721 ycfN_thiK thiamine kinase

Probab=93.53  E-value=0.063  Score=39.73  Aligned_cols=30  Identities=23%  Similarity=0.304  Sum_probs=25.8

Q ss_pred             eeecCCCCCcEEecCCCcEEEcccccccccc
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA  103 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~  103 (191)
                      ++|+|+.|.||++++++ +.++|++.+....
T Consensus       148 l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~gd  177 (256)
T TIGR02721       148 PLHMDVHAYNLVVTPQG-LKLIDWEYASDGD  177 (256)
T ss_pred             eecCCCCcCcEEEeCCC-CEEEeccccCcCC
Confidence            89999999999999877 7899998776443

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=93.33  E-value=0.19  Score=35.99  Aligned_cols=29  Identities=34%  Similarity=0.568  Sum_probs=20.7

Q ss_pred             eeecCCCCCcEEe-cCCCcEEEcccccccc
Q 029552           73 IVHRDLKSPNLLV-DKKYTVKVCDFGLSRL  101 (191)
Q Consensus        73 ~~h~~l~p~ni~~-~~~~~~~l~d~~~~~~  101 (191)
                      ++|+|+.+.||++ +.++.++++||..+..
T Consensus       145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  145 FCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             EeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            8899999999999 8888999999987754

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=92.50  E-value=0.27  Score=37.50  Aligned_cols=30  Identities=20%  Similarity=0.287  Sum_probs=26.8

Q ss_pred             eeecCCCCCcEEecCCCcEEEccccccccc
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLK  102 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~  102 (191)
                      ++|+|+.+.|++++.++.+.++||..+...
T Consensus       198 lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d  227 (309)
T TIGR02904       198 LVHGKLSLSHFLYDETRGGYFINFEKASFA  227 (309)
T ss_pred             eeCCCCcHHhEEEcCCCCEEEEEhhhcccC
Confidence            999999999999999989999999876543

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02236 choline kinase

Probab=91.94  E-value=0.32  Score=37.87  Aligned_cols=30  Identities=20%  Similarity=0.525  Sum_probs=25.7

Q ss_pred             eeecCCCCCcEEecC-CCcEEEccccccccc
Q 029552           73 IVHRDLKSPNLLVDK-KYTVKVCDFGLSRLK  102 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~-~~~~~l~d~~~~~~~  102 (191)
                      ++|+|+++.||+++. ++.+.++||+.+...
T Consensus       202 ~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~  232 (344)
T PLN02236        202 FCHNDLQYGNIMIDEETRAITIIDYEYASYN  232 (344)
T ss_pred             EEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence            899999999999976 467999999877543

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=91.93  E-value=0.17  Score=36.01  Aligned_cols=28  Identities=32%  Similarity=0.451  Sum_probs=23.6

Q ss_pred             eeecCCCCCcEEecCCC-----cEEEccccccc
Q 029552           73 IVHRDLKSPNLLVDKKY-----TVKVCDFGLSR  100 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~-----~~~l~d~~~~~  100 (191)
                      ++|||+.+.|+++..++     .+.++||..+.
T Consensus       122 l~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~  154 (196)
T smart00587      122 LNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH  154 (196)
T ss_pred             EeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence            89999999999997543     58999998764

subfamily of choline kinases

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=91.40  E-value=0.18  Score=37.92  Aligned_cols=31  Identities=23%  Similarity=0.459  Sum_probs=25.4

Q ss_pred             eeecCCCCCcEEecCCCc-EEEcccccccccc
Q 029552           73 IVHRDLKSPNLLVDKKYT-VKVCDFGLSRLKA  103 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~-~~l~d~~~~~~~~  103 (191)
                      ++|+|++|.||++++++. ..++|++.+....
T Consensus       187 lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGD  218 (276)
T cd05152         187 LVHGDLHPGHILIDEDARVTGLIDWTEAKVGD  218 (276)
T ss_pred             eEeCCCCCCcEEEeCCCCEEEEECcHhcccCC
Confidence            899999999999997555 5699998776443

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=90.83  E-value=0.32  Score=37.81  Aligned_cols=54  Identities=22%  Similarity=0.209  Sum_probs=34.2

Q ss_pred             cHHHHHHHHHHHHHHH---HHHH-hCCCCeeecCCCCCcEEecCCC------------------cEEEcccccccccc
Q 029552           48 DERRRLNMAYDVAKGM---NYLH-RRNPPIVHRDLKSPNLLVDKKY------------------TVKVCDFGLSRLKA  103 (191)
Q Consensus        48 ~~~~~~~~~~~i~~~l---~~Lh-~~~~~~~h~~l~p~ni~~~~~~------------------~~~l~d~~~~~~~~  103 (191)
                      -.+-+..++.|++--.   -.|- -.+  ++|.||||+||++-+..                  .++|.||++++..+
T Consensus       273 ~~~YvkfifLQiaLLyikIYelp~c~n--F~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~  348 (434)
T PF05445_consen  273 NVEYVKFIFLQIALLYIKIYELPCCTN--FLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVAN  348 (434)
T ss_pred             HHHHHHHHHHHHHHHHeeeecCCCcce--eeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhcc
Confidence            3445556667775543   1232 346  99999999999995432                  25677777766443

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=89.68  E-value=0.31  Score=37.67  Aligned_cols=28  Identities=32%  Similarity=0.470  Sum_probs=25.1

Q ss_pred             eeecCCCCCcEEecCCCc-EEEccccccc
Q 029552           73 IVHRDLKSPNLLVDKKYT-VKVCDFGLSR  100 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~-~~l~d~~~~~  100 (191)
                      ++|+|+.|.||+++.+.. +.+.||+-+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            799999999999999875 8899998764

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=89.32  E-value=1.1  Score=31.64  Aligned_cols=66  Identities=24%  Similarity=0.237  Sum_probs=45.1

Q ss_pred             EEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC-CcEEecCCCcEEEccccccc
Q 029552           23 SIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS-PNLLVDKKYTVKVCDFGLSR  100 (191)
Q Consensus        23 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p-~ni~~~~~~~~~l~d~~~~~  100 (191)
                      ++.|||..|..|.+.....      +..++.    .+++.---|...|  |-|+.++- ...++..++.+.|+||..+.
T Consensus        88 ~i~me~i~G~~L~~~~~~~------~rk~l~----~vlE~a~~LD~~G--I~H~El~~~~k~vlv~~~~~~iIDFd~At  154 (201)
T COG2112          88 FIRMEYIDGRPLGKLEIGG------DRKHLL----RVLEKAYKLDRLG--IEHGELSRPWKNVLVNDRDVYIIDFDSAT  154 (201)
T ss_pred             hhhhhhhcCcchhhhhhcc------cHHHHH----HHHHHHHHHHHhc--cchhhhcCCceeEEecCCcEEEEEccchh
Confidence            4559999998888776531      333333    3444555667788  99999874 44555555589999998776

>PRK06148 hypothetical protein; Provisional

Probab=89.06  E-value=1  Score=40.30  Aligned_cols=29  Identities=31%  Similarity=0.509  Sum_probs=24.3

Q ss_pred             eeecCCCCCcEEecCCC--cE-EEcccccccc
Q 029552           73 IVHRDLKSPNLLVDKKY--TV-KVCDFGLSRL  101 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~--~~-~l~d~~~~~~  101 (191)
                      ++|+|+++.||+++.++  .+ -++|||-+..
T Consensus       205 vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        205 VIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             eECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            99999999999998875  45 4999987653

>PF10140 YukC: WXG100 protein secretion system (Wss), protein YukC; InterPro: IPR018778 Members of this family are associated with type VII secretion of WXG100 family targets in the Firmicutes, but not in the Actinobacteria

Probab=88.71  E-value=0.95  Score=35.40  Aligned_cols=83  Identities=18%  Similarity=0.250  Sum_probs=42.1

Q ss_pred             CCCCcccccceeecCCceEEEEeccC-CCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLS-RGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL   83 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni   83 (191)
                      .||+.++. .+-++++.+.+.++.-+ +.++.. +.+      ++..+.++++.+| .+|.. |...  -+|--++|+|+
T Consensus        21 ~~~~f~~~-~i~~~ed~~~~~y~~~~~~~~f~~-i~~------~~~~eklr~~~ni-~~l~~-~~~~--~~~f~l~P~Nl   88 (359)
T PF10140_consen   21 HDPYFLPQ-EIEEDEDELTFTYQIPESYQSFEE-IKK------LDKSEKLRLLINI-AALKE-HLNS--RYTFILHPENL   88 (359)
T ss_dssp             --TTB--E-EEEE-SSEEEEEE---TTSEEGGG-GGG------S-HHHHHHHHHHG-GGGGG-GGGS--SEE---SGGGE
T ss_pred             cCcccCCc-eEEEeCCEEEEEEEcCcccCcHHH-HHh------cCHHHHHHHHHHH-HHHHH-HhcC--ceeEEEechhe
Confidence            57777763 44456666555555433 233333 222      6777888888884 33332 2233  56889999999


Q ss_pred             EecCCCcEEEcccccc
Q 029552           84 LVDKKYTVKVCDFGLS   99 (191)
Q Consensus        84 ~~~~~~~~~l~d~~~~   99 (191)
                      +++.++.+++.-.|+.
T Consensus        89 ~fd~~~~p~i~hrGi~  104 (359)
T PF10140_consen   89 VFDKNLMPKILHRGIK  104 (359)
T ss_dssp             EE-TTS-EEES--EET
T ss_pred             EEcCCCCEEEEEcCCc
Confidence            9999999999987753

This protein is designated YukC in Bacillus subtilis and EssB is Staphylococcus aureus. ; PDB: 4ANN_A.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=88.67  E-value=0.43  Score=36.88  Aligned_cols=29  Identities=28%  Similarity=0.432  Sum_probs=25.1

Q ss_pred             eeecCCCCCcEEecC-CCcEEEcccccccc
Q 029552           73 IVHRDLKSPNLLVDK-KYTVKVCDFGLSRL  101 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~-~~~~~l~d~~~~~~  101 (191)
                      ++|+|+.+.||++++ ++.++++||+.+..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            789999999999975 46899999987754

>PRK11768 serine/threonine protein kinase; Provisional

Probab=88.13  E-value=1.1  Score=34.56  Aligned_cols=27  Identities=22%  Similarity=0.303  Sum_probs=23.0

Q ss_pred             eeecCCCCCcEEecCCCcEEEcccccccc
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRL  101 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~~  101 (191)
                      ++|+|+.+.||+++ + .+.++||+-+..
T Consensus       198 liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        198 RLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             ceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            89999999999995 3 578999987654

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=87.89  E-value=2.6  Score=31.17  Aligned_cols=29  Identities=21%  Similarity=0.256  Sum_probs=23.9

Q ss_pred             CCcccccceeecCCceEEEEeccCCCCHH
Q 029552            7 PNIVLFMGAVTQPPNLSIVTEYLSRGSLY   35 (191)
Q Consensus         7 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   35 (191)
                      -.+++++.+..++++.|+|+||.+.+.+.
T Consensus        71 i~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          71 ITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             ccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            45778888889999999999999875554

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=87.31  E-value=2.7  Score=33.88  Aligned_cols=62  Identities=24%  Similarity=0.247  Sum_probs=43.8

Q ss_pred             ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHH-HHHHhCCCCeeecCCCCCcEEecCC
Q 029552           21 NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM-NYLHRRNPPIVHRDLKSPNLLVDKK   88 (191)
Q Consensus        21 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l-~~Lh~~~~~~~h~~l~p~ni~~~~~   88 (191)
                      ...++-+|..|.++..++...+    .++....+++.-..+|+ .-|--.+  ++|.|++|.||++..+
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~~----~pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWKS----QPEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLIRFN  381 (565)
T ss_pred             cceeeeeccccccHHhhhhccc----ChHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEEEec
Confidence            3567778888989888886543    45656666665555653 3334567  9999999999999644

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=86.56  E-value=1.8  Score=34.50  Aligned_cols=31  Identities=23%  Similarity=0.380  Sum_probs=25.8

Q ss_pred             CeeecCCCCCcEEecCCCcEEEcccccccccc
Q 029552           72 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA  103 (191)
Q Consensus        72 ~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~  103 (191)
                      .++|||+++.||+++.+ .++++|+.++..+.
T Consensus       224 ~l~HgDl~~gni~~~~~-~~~viD~E~a~~G~  254 (401)
T PRK09550        224 ALLHGDLHTGSIFVTEE-ETKVIDPEFAFYGP  254 (401)
T ss_pred             ceeeccCCcccEEeeCC-CcEEEeccccccCC
Confidence            39999999999999876 58999998765443

>PRK12396 5-methylribose kinase; Reviewed

Probab=85.64  E-value=1.5  Score=34.99  Aligned_cols=31  Identities=23%  Similarity=0.394  Sum_probs=26.0

Q ss_pred             CeeecCCCCCcEEecCCCcEEEcccccccccc
Q 029552           72 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA  103 (191)
Q Consensus        72 ~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~  103 (191)
                      ..+|||++|.||+++.+ ..+++|..++..++
T Consensus       228 aLlHGDlHtGSI~v~~~-~~kvIDpEFAfyGP  258 (409)
T PRK12396        228 ALIHGDLHTGSVFVKND-STKVIDPEFAFYGP  258 (409)
T ss_pred             hhccCcCCCCCEEecCC-ceEEEcccccccCC
Confidence            39999999999999987 59999988775443

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	191
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-102
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-101
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-30
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-29
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-29
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-29
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-29
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-28
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-28
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-28
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-28
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-28
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-28
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-28
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-28
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-28
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-28
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-28
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-28
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-28
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-28
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-28
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-28
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-28
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-28
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-28
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-28
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-28
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		7e-28
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		7e-28
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		7e-28
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-28
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		9e-28
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-27
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-27
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-27
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-27
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-27
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-27
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-27
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-27
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-27
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-27
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-26
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-26
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		7e-26
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		8e-26
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-26
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		9e-26
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-25
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-25
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-25
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-25
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-25
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		6e-25
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-24
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-24
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-24
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-24
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-24
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-24
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-24
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-24
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-24
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-24
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-24
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-24
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-24
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-24
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-24
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-24
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-24
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-24
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-24
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-24
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-24
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-24
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-24
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-24
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-24
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-24
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-24
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-24
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-24
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-24
1fvr_A	327	Tie2 Kinase Domain Length = 327		9e-24
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-23
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-23
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-23
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-23
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-23
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-23
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-23
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-23
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-23
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-23
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-23
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-23
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-23
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-23
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-23
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-23
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-23
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-23
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-23
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-23
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-23
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-23
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-23
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		5e-23
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-23
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-23
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-23
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		5e-23
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		5e-23
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-23
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		6e-23
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		6e-23
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-23
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-23
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		7e-23
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		7e-23
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		9e-23
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		9e-23
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		9e-23
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		9e-23
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		9e-23
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-23
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-22
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-22
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-22
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-22
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-22
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-22
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-22
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-22
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-22
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-22
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-22
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-22
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-22
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-22
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-22
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-22
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-22
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-22
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-22
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-22
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-22
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-22
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-22
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-22
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-22
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-22
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-22
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-22
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-22
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-22
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-22
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-22
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-22
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-22
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-22
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-22
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-22
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		6e-22
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		6e-22
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		6e-22
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-22
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		7e-22
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-22
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		8e-22
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		8e-22
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		8e-22
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		8e-22
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		8e-22
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		8e-22
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		8e-22
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		9e-22
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		9e-22
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		9e-22
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-21
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-21
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-21
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-21
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-21
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-21
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-21
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-21
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-21
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-21
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-21
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-21
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-21
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-21
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-21
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-21
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-21
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-21
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-21
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-21
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-21
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-21
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-21
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-21
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-21
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-21
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-21
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-21
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-21
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-21
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-21
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-21
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		7e-21
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		7e-21
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-21
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		9e-21
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		9e-21
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-20
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-20
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-20
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-20
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-20
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-20
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-20
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-20
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-20
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-20
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-20
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-20
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-20
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-20
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-20
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-20
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-20
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-20
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-20
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-20
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-20
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-20
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-20
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-20
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-20
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-20
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-20
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-20
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-20
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-20
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-20
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-20
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-20
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-20
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		6e-20
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		6e-20
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		6e-20
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-20
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-20
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		7e-20
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		7e-20
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		7e-20
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-20
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-20
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		8e-20
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-19
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-19
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-19
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-19
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-19
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-19
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-19
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-19
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-19
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-19
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-19
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-19
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		6e-19
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-19
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		7e-19
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		7e-19
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-18
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-18
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-18
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-18
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-18
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-18
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-18
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-18
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-18
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-18
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-18
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-18
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-18
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-18
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-18
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-18
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-18
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-18
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		5e-18
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-18
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		5e-18
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-18
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		6e-18
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-18
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-18
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		6e-18
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		6e-18
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		6e-18
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		6e-18
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-18
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-18
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-18
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		7e-18
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-18
4fl3_A	635	Structural And Biophysical Characterization Of The		7e-18
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		7e-18
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-18
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		8e-18
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		8e-18
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		8e-18
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		9e-18
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		9e-18
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-17
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-17
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-17
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-17
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-17
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-17
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-17
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-17
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-17
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-17
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-17
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-17
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-17
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-17
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-17
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-17
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-17
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-17
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-17
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-17
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-17
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-17
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-17
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-17
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-17
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-17
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-17
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-17
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-17
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-17
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-17
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-17
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-17
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-17
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-17
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-17
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-17
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-17
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-17
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-17
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-17
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-17
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-17
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-17
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-17
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-17
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-17
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-17
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-17
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-17
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-17
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-17
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		5e-17
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-17
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-17
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-17
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-17
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-17
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-17
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-17
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		5e-17
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-17
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		6e-17
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		7e-17
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		7e-17
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		7e-17
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		7e-17
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		8e-17
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-16
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-16
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-16
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-16
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-16
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-16
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-16
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-16
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-16
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-16
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-16
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-16
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-16
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-16
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-16
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-16
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-16
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-16
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-16
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-16
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-16
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-16
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-16
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-16
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-16
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-16
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-16
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-16
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-16
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-16
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-16
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		5e-16
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		6e-16
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-16
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-16
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		7e-16
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		7e-16
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		7e-16
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		7e-16
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		7e-16
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		7e-16
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		8e-16
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		9e-16
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-15
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-15
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-15
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-15
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-15
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-15
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-15
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-15
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-15
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-15
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-15
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-15
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-15
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-15
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-15
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-15
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-15
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-15
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-15
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-15
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-15
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-15
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-15
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-15
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-15
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-15
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-15
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-15
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-15
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-15
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-15
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-15
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-15
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-15
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-15
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-15
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-15
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-15
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-15
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-15
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-15
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-15
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-15
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-15
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-15
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-15
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-15
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		6e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-15
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-15
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		6e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-15
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-15
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		7e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-15
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		7e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		7e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-15
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		8e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-15
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		8e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		8e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		8e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		9e-15
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-14
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-14
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-14
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-14
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-14
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-14
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-14
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-14
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-14
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-14
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-14
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-14
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-14
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-14
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-14
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-14
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-14
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-14
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-14
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-14
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-14
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-14
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-14
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-14
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-14
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-14
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-14
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-14
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-14
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-14
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-14
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-14
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-14
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-14
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-14
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-14
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-14
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-14
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-14
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-14
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-14
4ae6_A	343	Structure And Function Of The Human Sperm-specific		6e-14
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		7e-14
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-14
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		7e-14
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-14
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		7e-14
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-14
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		7e-14
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		7e-14
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		8e-14
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		8e-14
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		8e-14
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		8e-14
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		8e-14
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		8e-14
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		8e-14
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-14
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		9e-14
4ae9_A	343	Structure And Function Of The Human Sperm-specific		9e-14
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-14
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-13
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-13
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-13
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-13
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-13
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-13
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-13
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-13
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-13
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-13
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-13
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-13
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-13
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-13
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-13
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-13
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-13
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-13
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-13
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-13
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-13
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-13
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-13
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-13
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-13
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-13
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-13
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-13
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-13
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-13
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-13
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-13
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-13
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-13
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-13
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-13
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-13
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-13
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-13
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-13
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-13
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-13
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-13
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-13
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-13
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		8e-13
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		8e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		9e-13
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-12
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-12
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-12
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-12
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-12
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-12
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-12
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-12
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-12
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-12
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-12
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-12
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-12
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-12
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		7e-12
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		8e-12
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		8e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		8e-12
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-11
3soa_A	444	Full-Length Human Camkii Length = 444		1e-11
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-11
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-11
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-11
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-11
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-11
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-11
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-11
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-11
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-11
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-11
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-11
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-11
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-11
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-11
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-11
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-11
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-11
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-11
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-11
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-11
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-11
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-11
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-11
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-11
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-11
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-11
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-11
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		4e-11
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-11
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		4e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-11
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-11
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-11
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-11
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-11
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		6e-11
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-11
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		6e-11
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		7e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-11
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		7e-11
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		7e-11
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		7e-11
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		7e-11
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		7e-11
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		7e-11
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		7e-11
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		7e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		7e-11
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		7e-11
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		8e-11
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-11
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-11
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		8e-11
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		8e-11
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		8e-11
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		8e-11
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		8e-11
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		8e-11
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-11
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		8e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-11
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		9e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		9e-11
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		9e-11
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-11
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-11
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-10
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-10
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-10
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-10
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-10
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-10
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-10
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-10
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-10
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-10
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-10
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-10
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-10
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-10
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-10
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-10
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-10
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-10
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-10
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-10
2oza_A	356	Structure Of P38alpha Complex Length = 356		4e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-10
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-10
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-10
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-10
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-10
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		6e-10
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		6e-10
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		7e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		9e-10
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-09
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-09
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-09
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-09
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-09
3gni_B	389	Structure Of Strad And Mo25 Length = 389		3e-09
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-09
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		6e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		6e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		6e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-09
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		6e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		6e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		6e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		7e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		7e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		7e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		9e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-08
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-08
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-08
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-08
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-08
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-08
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-08
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		5e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		7e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		7e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		8e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		8e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-08
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-07
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-07
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-07
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-07
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		7e-07
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		7e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		7e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		9e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		9e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-05
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		2e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-05
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-05
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-05
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		5e-05
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-05
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-05
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-05
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-05
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		5e-05
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-05
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-05
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		5e-05
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-05
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-05
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		6e-05
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		6e-05
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-05
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		6e-05
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-05
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		7e-05
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		7e-05
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		7e-05
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		7e-05
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		7e-05
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		8e-05
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-04
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-04
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-04
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-04
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-04
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-04
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-04
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-04
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-04
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-04
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-04

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  367 bits (943), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 176/190 (92%), Positives = 182/190 (95%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK G RE LDERRRL+MAYDVA
Sbjct: 88  MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           KGMNYLH RNPPIVHR+LKSPNLLVDKKYTVKVCDFGLSRLKA+TFLSSKSAAGTPEWMA
Sbjct: 148 KGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMA 207
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVLRDEPSNEKSD+YSFGVILWELATLQQPWGNLNPAQVVAAVGFK KRLEIPRN+NP 
Sbjct: 208 PEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQ 267
Query: 181 VASIIEACWA 190
           VA+IIE CW 
Sbjct: 268 VAAIIEGCWT 277

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  363 bits (932), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 174/190 (91%), Positives = 179/190 (94%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK G RE LDERRRL+MAYDVA
Sbjct: 88  MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           KGMNYLH RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA+ FL SK AAGTPEWMA
Sbjct: 148 KGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMA 207
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVLRDEPSNEKSD+YSFGVILWELATLQQPWGNLNPAQVVAAVGFK KRLEIPRN+NP 
Sbjct: 208 PEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQ 267
Query: 181 VASIIEACWA 190
           VA+IIE CW 
Sbjct: 268 VAAIIEGCWT 277

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  128 bits (322), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 74/191 (38%), Positives = 108/191 (56%), Gaps = 6/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK ++HPN+V  +G  T  P   IVTEY+  G+L   L +   RE +     L MA  ++
Sbjct: 82  MKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECN-REEVTAVVLLYMATQIS 140
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
             M YL ++N   +HRDL + N LV + + VKV DFGLSRL      ++ + A  P +W 
Sbjct: 141 SAMEYLEKKN--FIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 198
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE L     + KSD+++FGV+LWE+AT    P+  ++ +QV   +  KG R+E P    
Sbjct: 199 APESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLE-KGYRMEQPEGCP 257
Query: 179 PHVASIIEACW 189
           P V  ++ ACW
Sbjct: 258 PKVYELMRACW 268

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  125 bits (315), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 70/191 (36%), Positives = 109/191 (57%), Gaps = 6/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK ++HPN+V  +G  T+ P   I+TE+++ G+L   L +   R+ +     L MA  ++
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQIS 119
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
             M YL ++N   +HRDL + N LV + + VKV DFGLSRL      ++ + A  P +W 
Sbjct: 120 SAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWT 177
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE L     + KSD+++FGV+LWE+AT    P+  ++P+QV   +  K  R+E P    
Sbjct: 178 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE-KDYRMERPEGCP 236
Query: 179 PHVASIIEACW 189
             V  ++ ACW
Sbjct: 237 EKVYELMRACW 247

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  125 bits (313), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 70/191 (36%), Positives = 109/191 (57%), Gaps = 6/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK ++HPN+V  +G  T+ P   I+TE+++ G+L   L +   R+ +     L MA  ++
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQIS 119
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
             M YL ++N   +HRDL + N LV + + VKV DFGLSRL      ++ + A  P +W 
Sbjct: 120 SAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWT 177
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE L     + KSD+++FGV+LWE+AT    P+  ++P+QV   +  K  R+E P    
Sbjct: 178 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE-KDYRMERPEGCP 236
Query: 179 PHVASIIEACW 189
             V  ++ ACW
Sbjct: 237 EKVYELMRACW 247

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  124 bits (310), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 69/171 (40%), Positives = 111/171 (64%), Gaps = 11/171 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +++ RH NI+LFMG  T+P  L+IVT++    SLY  LH    +   + ++ +++A   A
Sbjct: 62  LRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTA 118
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK--SAAGTPEW 118
           +GM+YLH ++  I+HRDLKS N+ + +  TVK+ DFGL+ +K+    S +    +G+  W
Sbjct: 119 RGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 176
Query: 119 MAPEVLRDEPSNE---KSDIYSFGVILWELATLQQPWGNLNP-AQVVAAVG 165
           MAPEV+R + SN    +SD+Y+FG++L+EL T Q P+ N+N   Q++  VG
Sbjct: 177 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG 227

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  122 bits (307), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 69/191 (36%), Positives = 108/191 (56%), Gaps = 6/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK ++HPN+V  +G  T+ P   I+ E+++ G+L   L +   R+ +     L MA  ++
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQIS 119
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
             M YL ++N   +HRDL + N LV + + VKV DFGLSRL      ++ + A  P +W 
Sbjct: 120 SAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWT 177
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE L     + KSD+++FGV+LWE+AT    P+  ++P+QV   +  K  R+E P    
Sbjct: 178 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE-KDYRMERPEGCP 236
Query: 179 PHVASIIEACW 189
             V  ++ ACW
Sbjct: 237 EKVYELMRACW 247

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  122 bits (306), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 69/171 (40%), Positives = 110/171 (64%), Gaps = 11/171 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +++ RH NI+LFMG  T+P  L+IVT++    SLY  LH    +   + ++ +++A   A
Sbjct: 74  LRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTA 130
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK--SAAGTPEW 118
           +GM+YLH ++  I+HRDLKS N+ + +  TVK+ DFGL+  K+    S +    +G+  W
Sbjct: 131 RGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 188
Query: 119 MAPEVLRDEPSNE---KSDIYSFGVILWELATLQQPWGNLNP-AQVVAAVG 165
           MAPEV+R + SN    +SD+Y+FG++L+EL T Q P+ N+N   Q++  VG
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG 239

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  122 bits (305), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 69/171 (40%), Positives = 109/171 (63%), Gaps = 11/171 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +++ RH NI+LFMG  T  P L+IVT++    SLY  LH    +   + ++ +++A   A
Sbjct: 74  LRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTA 130
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK--SAAGTPEW 118
           +GM+YLH ++  I+HRDLKS N+ + +  TVK+ DFGL+  K+    S +    +G+  W
Sbjct: 131 RGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 188
Query: 119 MAPEVLRDEPSNE---KSDIYSFGVILWELATLQQPWGNLNP-AQVVAAVG 165
           MAPEV+R + SN    +SD+Y+FG++L+EL T Q P+ N+N   Q++  VG
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG 239

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  122 bits (305), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 69/191 (36%), Positives = 109/191 (57%), Gaps = 6/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK ++HPN+V  +G  T+ P   I+TE+++ G+L   L +   R+ ++    L MA  ++
Sbjct: 76  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQIS 134
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
             M YL ++N   +HRDL + N LV + + VKV DFGLSRL      ++ + A  P +W 
Sbjct: 135 SAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 192
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE L     + KSD+++FGV+LWE+AT    P+  ++ +QV   +  K  R+E P    
Sbjct: 193 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 251
Query: 179 PHVASIIEACW 189
             V  ++ ACW
Sbjct: 252 EKVYELMRACW 262

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  122 bits (305), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 69/191 (36%), Positives = 109/191 (57%), Gaps = 6/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK ++HPN+V  +G  T+ P   I+TE+++ G+L   L +   R+ ++    L MA  ++
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQIS 121
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
             M YL ++N   +HRDL + N LV + + VKV DFGLSRL      ++ + A  P +W 
Sbjct: 122 SAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE L     + KSD+++FGV+LWE+AT    P+  ++ +QV   +  K  R+E P    
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 238
Query: 179 PHVASIIEACW 189
             V  ++ ACW
Sbjct: 239 EKVYELMRACW 249

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  122 bits (305), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 69/191 (36%), Positives = 109/191 (57%), Gaps = 6/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK ++HPN+V  +G  T+ P   I+TE+++ G+L   L +   R+ ++    L MA  ++
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQIS 126
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
             M YL ++N   +HRDL + N LV + + VKV DFGLSRL      ++ + A  P +W 
Sbjct: 127 SAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 184
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE L     + KSD+++FGV+LWE+AT    P+  ++ +QV   +  K  R+E P    
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 243
Query: 179 PHVASIIEACW 189
             V  ++ ACW
Sbjct: 244 EKVYELMRACW 254

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  122 bits (305), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 69/191 (36%), Positives = 109/191 (57%), Gaps = 6/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK ++HPN+V  +G  T+ P   I+TE+++ G+L   L +   R+ ++    L MA  ++
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQIS 123
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
             M YL ++N   +HRDL + N LV + + VKV DFGLSRL      ++ + A  P +W 
Sbjct: 124 SAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 181
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE L     + KSD+++FGV+LWE+AT    P+  ++ +QV   +  K  R+E P    
Sbjct: 182 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 240
Query: 179 PHVASIIEACW 189
             V  ++ ACW
Sbjct: 241 EKVYELMRACW 251

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  122 bits (305), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 69/191 (36%), Positives = 109/191 (57%), Gaps = 6/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK ++HPN+V  +G  T+ P   I+TE+++ G+L   L +   R+ ++    L MA  ++
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQIS 121
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
             M YL ++N   +HRDL + N LV + + VKV DFGLSRL      ++ + A  P +W 
Sbjct: 122 SAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE L     + KSD+++FGV+LWE+AT    P+  ++ +QV   +  K  R+E P    
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 238
Query: 179 PHVASIIEACW 189
             V  ++ ACW
Sbjct: 239 EKVYELMRACW 249

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  122 bits (305), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 69/191 (36%), Positives = 109/191 (57%), Gaps = 6/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK ++HPN+V  +G  T+ P   I+TE+++ G+L   L +   R+ ++    L MA  ++
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQIS 123
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
             M YL ++N   +HRDL + N LV + + VKV DFGLSRL      ++ + A  P +W 
Sbjct: 124 SAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 181
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE L     + KSD+++FGV+LWE+AT    P+  ++ +QV   +  K  R+E P    
Sbjct: 182 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 240
Query: 179 PHVASIIEACW 189
             V  ++ ACW
Sbjct: 241 EKVYELMRACW 251

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  122 bits (305), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 69/191 (36%), Positives = 109/191 (57%), Gaps = 6/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK ++HPN+V  +G  T+ P   I+TE+++ G+L   L +   R+ ++    L MA  ++
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQIS 126
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
             M YL ++N   +HRDL + N LV + + VKV DFGLSRL      ++ + A  P +W 
Sbjct: 127 SAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 184
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE L     + KSD+++FGV+LWE+AT    P+  ++ +QV   +  K  R+E P    
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 243
Query: 179 PHVASIIEACW 189
             V  ++ ACW
Sbjct: 244 EKVYELMRACW 254

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  121 bits (304), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 69/191 (36%), Positives = 109/191 (57%), Gaps = 6/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK ++HPN+V  +G  T+ P   I+TE+++ G+L   L +   R+ ++    L MA  ++
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQIS 125
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
             M YL ++N   +HRDL + N LV + + VKV DFGLSRL      ++ + A  P +W 
Sbjct: 126 SAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 183
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE L     + KSD+++FGV+LWE+AT    P+  ++ +QV   +  K  R+E P    
Sbjct: 184 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 242
Query: 179 PHVASIIEACW 189
             V  ++ ACW
Sbjct: 243 EKVYELMRACW 253

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  121 bits (304), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 69/191 (36%), Positives = 109/191 (57%), Gaps = 6/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK ++HPN+V  +G  T+ P   I+TE+++ G+L   L +   R+ ++    L MA  ++
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQIS 126
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
             M YL ++N   +HRDL + N LV + + VKV DFGLSRL      ++ + A  P +W 
Sbjct: 127 SAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWT 184
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE L     + KSD+++FGV+LWE+AT    P+  ++ +QV   +  K  R+E P    
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 243
Query: 179 PHVASIIEACW 189
             V  ++ ACW
Sbjct: 244 EKVYELMRACW 254

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  121 bits (304), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 69/191 (36%), Positives = 109/191 (57%), Gaps = 6/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK ++HPN+V  +G  T+ P   I+TE+++ G+L   L +   R+ ++    L MA  ++
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQIS 122
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
             M YL ++N   +HRDL + N LV + + VKV DFGLSRL      ++ + A  P +W 
Sbjct: 123 SAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWT 180
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE L     + KSD+++FGV+LWE+AT    P+  ++ +QV   +  K  R+E P    
Sbjct: 181 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 239
Query: 179 PHVASIIEACW 189
             V  ++ ACW
Sbjct: 240 EKVYELMRACW 250

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  121 bits (304), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 69/191 (36%), Positives = 108/191 (56%), Gaps = 6/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK ++HPN+V  +G  T+ P   I+TE+++ G+L   L +   R+ +     L MA  ++
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQIS 121
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
             M YL ++N   +HRDL + N LV + + VKV DFGLSRL      ++ + A  P +W 
Sbjct: 122 SAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE L     + KSD+++FGV+LWE+AT    P+  ++ +QV   +  K  R+E P    
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 238
Query: 179 PHVASIIEACW 189
             V  ++ ACW
Sbjct: 239 EKVYELMRACW 249

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  121 bits (303), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 69/191 (36%), Positives = 109/191 (57%), Gaps = 6/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK ++HPN+V  +G  T+ P   I+TE+++ G+L   L +   R+ ++    L MA  ++
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQIS 123
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
             M YL ++N   +HRDL + N LV + + VKV DFGLSRL      ++ + A  P +W 
Sbjct: 124 SAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWT 181
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE L     + KSD+++FGV+LWE+AT    P+  ++ +QV   +  K  R+E P    
Sbjct: 182 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 240
Query: 179 PHVASIIEACW 189
             V  ++ ACW
Sbjct: 241 EKVYELMRACW 251

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  121 bits (303), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 69/191 (36%), Positives = 108/191 (56%), Gaps = 6/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK ++HPN+V  +G  T+ P   I+TE+++ G+L   L +   R+ +     L MA  ++
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQIS 121
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
             M YL ++N   +HRDL + N LV + + VKV DFGLSRL      ++ + A  P +W 
Sbjct: 122 SAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE L     + KSD+++FGV+LWE+AT    P+  ++ +QV   +  K  R+E P    
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 238
Query: 179 PHVASIIEACW 189
             V  ++ ACW
Sbjct: 239 EKVYELMRACW 249

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  121 bits (303), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 75/195 (38%), Positives = 106/195 (54%), Gaps = 15/195 (7%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           L+HPNI+   G   + PNL +V E+   G L R+L   G R  +     +N A  +A+GM
Sbjct: 63  LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--GKR--IPPDILVNWAVQIARGM 118
Query: 64  NYLHRRN-PPIVHRDLKSPNLLVDKKY--------TVKVCDFGLSRLKANTFLSSKSAAG 114
           NYLH     PI+HRDLKS N+L+ +K          +K+ DFGL+R    T  +  SAAG
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT--TKMSAAG 176
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP 174
              WMAPEV+R    ++ SD++S+GV+LWEL T + P+  ++   V   V      L IP
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP 236
Query: 175 RNVNPHVASIIEACW 189
                  A ++E CW
Sbjct: 237 STCPEPFAKLMEDCW 251

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  121 bits (303), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 69/191 (36%), Positives = 108/191 (56%), Gaps = 6/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK ++HPN+V  +G  T+ P   I+TE+++ G+L   L +   R+ +     L MA  ++
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQIS 126
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
             M YL ++N   +HRDL + N LV + + VKV DFGLSRL      ++ + A  P +W 
Sbjct: 127 SAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 184
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE L     + KSD+++FGV+LWE+AT    P+  ++ +QV   +  K  R+E P    
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 243
Query: 179 PHVASIIEACW 189
             V  ++ ACW
Sbjct: 244 EKVYELMRACW 254

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  120 bits (301), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 68/171 (39%), Positives = 110/171 (64%), Gaps = 11/171 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +++ RH NI+LFMG  T+P  L+IVT++    SLY  LH   +    +  + +++A   A
Sbjct: 60  LRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTA 116
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK--SAAGTPEW 118
           +GM+YLH ++  I+HRDLKS N+ + +  TVK+ DFGL+ +K+    S +    +G+  W
Sbjct: 117 QGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 174
Query: 119 MAPEVLRDE---PSNEKSDIYSFGVILWELATLQQPWGNLNP-AQVVAAVG 165
           MAPEV+R +   P + +SD+Y+FG++L+EL T Q P+ N+N   Q++  VG
Sbjct: 175 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 225

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  120 bits (301), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 68/171 (39%), Positives = 110/171 (64%), Gaps = 11/171 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +++ RH NI+LFMG  T+P  L+IVT++    SLY  LH   +    +  + +++A   A
Sbjct: 63  LRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTA 119
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK--SAAGTPEW 118
           +GM+YLH ++  I+HRDLKS N+ + +  TVK+ DFGL+ +K+    S +    +G+  W
Sbjct: 120 QGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 177
Query: 119 MAPEVLRDE---PSNEKSDIYSFGVILWELATLQQPWGNLNP-AQVVAAVG 165
           MAPEV+R +   P + +SD+Y+FG++L+EL T Q P+ N+N   Q++  VG
Sbjct: 178 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 228

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  120 bits (301), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 68/171 (39%), Positives = 110/171 (64%), Gaps = 11/171 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +++ RH NI+LFMG  T+P  L+IVT++    SLY  LH   +    +  + +++A   A
Sbjct: 58  LRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTA 114
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK--SAAGTPEW 118
           +GM+YLH ++  I+HRDLKS N+ + +  TVK+ DFGL+ +K+    S +    +G+  W
Sbjct: 115 QGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172
Query: 119 MAPEVLRDE---PSNEKSDIYSFGVILWELATLQQPWGNLNP-AQVVAAVG 165
           MAPEV+R +   P + +SD+Y+FG++L+EL T Q P+ N+N   Q++  VG
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 223

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  120 bits (300), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 68/171 (39%), Positives = 110/171 (64%), Gaps = 11/171 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +++ RH NI+LFMG  T+P  L+IVT++    SLY  LH   +    +  + +++A   A
Sbjct: 63  LRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTA 119
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK--SAAGTPEW 118
           +GM+YLH ++  I+HRDLKS N+ + +  TVK+ DFGL+ +K+    S +    +G+  W
Sbjct: 120 QGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 177
Query: 119 MAPEVLRDE---PSNEKSDIYSFGVILWELATLQQPWGNLNP-AQVVAAVG 165
           MAPEV+R +   P + +SD+Y+FG++L+EL T Q P+ N+N   Q++  VG
Sbjct: 178 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 228

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  120 bits (300), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 68/171 (39%), Positives = 110/171 (64%), Gaps = 11/171 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +++ RH NI+LFMG  T+P  L+IVT++    SLY  LH   +    +  + +++A   A
Sbjct: 85  LRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTA 141
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK--SAAGTPEW 118
           +GM+YLH ++  I+HRDLKS N+ + +  TVK+ DFGL+ +K+    S +    +G+  W
Sbjct: 142 QGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 199
Query: 119 MAPEVLRDE---PSNEKSDIYSFGVILWELATLQQPWGNLNP-AQVVAAVG 165
           MAPEV+R +   P + +SD+Y+FG++L+EL T Q P+ N+N   Q++  VG
Sbjct: 200 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 250

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  120 bits (300), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 68/191 (35%), Positives = 108/191 (56%), Gaps = 6/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK ++HPN+V  +G  T+ P   I+ E+++ G+L   L +   R+ ++    L MA  ++
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQIS 126
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
             M YL ++N   +HRDL + N LV + + VKV DFGLSRL      ++ + A  P +W 
Sbjct: 127 SAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 184
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE L     + KSD+++FGV+LWE+AT    P+  ++ +QV   +  K  R+E P    
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 243
Query: 179 PHVASIIEACW 189
             V  ++ ACW
Sbjct: 244 EKVYELMRACW 254

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  119 bits (299), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 68/171 (39%), Positives = 110/171 (64%), Gaps = 11/171 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +++ RH NI+LFMG  T+P  L+IVT++    SLY  LH   +    +  + +++A   A
Sbjct: 86  LRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTA 142
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK--SAAGTPEW 118
           +GM+YLH ++  I+HRDLKS N+ + +  TVK+ DFGL+ +K+    S +    +G+  W
Sbjct: 143 QGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 200
Query: 119 MAPEVLRDE---PSNEKSDIYSFGVILWELATLQQPWGNLNP-AQVVAAVG 165
           MAPEV+R +   P + +SD+Y+FG++L+EL T Q P+ N+N   Q++  VG
Sbjct: 201 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 251

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  119 bits (299), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 68/171 (39%), Positives = 109/171 (63%), Gaps = 11/171 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +++ RH NI+LFMG  T  P L+IVT++    SLY  LH   +    +  + +++A   A
Sbjct: 58  LRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTA 114
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK--SAAGTPEW 118
           +GM+YLH ++  I+HRDLKS N+ + +  TVK+ DFGL+ +K+    S +    +G+  W
Sbjct: 115 QGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172
Query: 119 MAPEVLRDE---PSNEKSDIYSFGVILWELATLQQPWGNLNP-AQVVAAVG 165
           MAPEV+R +   P + +SD+Y+FG++L+EL T Q P+ N+N   Q++  VG
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 223

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  119 bits (299), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 68/191 (35%), Positives = 108/191 (56%), Gaps = 6/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK ++HPN+V  +G  T+ P   I+ E+++ G+L   L +   R+ ++    L MA  ++
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQIS 122
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
             M YL ++N   +HRDL + N LV + + VKV DFGLSRL      ++ + A  P +W 
Sbjct: 123 SAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWT 180
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE L     + KSD+++FGV+LWE+AT    P+  ++ +QV   +  K  R+E P    
Sbjct: 181 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 239
Query: 179 PHVASIIEACW 189
             V  ++ ACW
Sbjct: 240 EKVYELMRACW 250

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  119 bits (298), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 68/191 (35%), Positives = 107/191 (56%), Gaps = 6/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK ++HPN+V  +G  T+ P   I+ E+++ G+L   L +   R+ +     L MA  ++
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQIS 121
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
             M YL ++N   +HRDL + N LV + + VKV DFGLSRL      ++ + A  P +W 
Sbjct: 122 SAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE L     + KSD+++FGV+LWE+AT    P+  ++ +QV   +  K  R+E P    
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 238
Query: 179 PHVASIIEACW 189
             V  ++ ACW
Sbjct: 239 EKVYELMRACW 249

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  119 bits (297), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 68/191 (35%), Positives = 107/191 (56%), Gaps = 6/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK ++HPN+V  +G  T+ P   I+ E+++ G+L   L +   R+ +     L MA  ++
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQIS 121
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
             M YL ++N   +HRDL + N LV + + VKV DFGLSRL      ++ + A  P +W 
Sbjct: 122 SAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE L     + KSD+++FGV+LWE+AT    P+  ++ +QV   +  K  R+E P    
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 238
Query: 179 PHVASIIEACW 189
             V  ++ ACW
Sbjct: 239 EKVYELMRACW 249

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  119 bits (297), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 68/171 (39%), Positives = 109/171 (63%), Gaps = 11/171 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +++ RH NI+LFMG  T+P  L+IVT++    SLY  LH   +    +  + +++A   A
Sbjct: 58  LRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTA 114
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK--SAAGTPEW 118
           +GM+YLH ++  I+HRDLKS N+ + +  TVK+ DFGL+  K+    S +    +G+  W
Sbjct: 115 QGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 172
Query: 119 MAPEVLRDE---PSNEKSDIYSFGVILWELATLQQPWGNLNP-AQVVAAVG 165
           MAPEV+R +   P + +SD+Y+FG++L+EL T Q P+ N+N   Q++  VG
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 223

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score =  118 bits (296), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 68/191 (35%), Positives = 109/191 (57%), Gaps = 6/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK ++HPN+V  +G  T+ P   I+TE+++ G+L   L +   R+ ++    L MA  ++
Sbjct: 309 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQIS 367
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
             M YL ++N   +HR+L + N LV + + VKV DFGLSRL      ++ + A  P +W 
Sbjct: 368 SAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 425
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE L     + KSD+++FGV+LWE+AT    P+  ++ +QV   +  K  R+E P    
Sbjct: 426 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 484
Query: 179 PHVASIIEACW 189
             V  ++ ACW
Sbjct: 485 EKVYELMRACW 495

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  118 bits (296), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 68/171 (39%), Positives = 109/171 (63%), Gaps = 11/171 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +++ RH NI+LFMG  T+P  L+IVT++    SLY  LH   +    +  + +++A   A
Sbjct: 78  LRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTA 134
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK--SAAGTPEW 118
           +GM+YLH ++  I+HRDLKS N+ + +  TVK+ DFGL+  K+    S +    +G+  W
Sbjct: 135 QGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 192
Query: 119 MAPEVLRDE---PSNEKSDIYSFGVILWELATLQQPWGNLNP-AQVVAAVG 165
           MAPEV+R +   P + +SD+Y+FG++L+EL T Q P+ N+N   Q++  VG
Sbjct: 193 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 243

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  118 bits (296), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 68/171 (39%), Positives = 109/171 (63%), Gaps = 11/171 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +++ RH NI+LFMG  T+P  L+IVT++    SLY  LH   +    +  + +++A   A
Sbjct: 86  LRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTA 142
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK--SAAGTPEW 118
           +GM+YLH ++  I+HRDLKS N+ + +  TVK+ DFGL+  K+    S +    +G+  W
Sbjct: 143 QGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 200
Query: 119 MAPEVLRDE---PSNEKSDIYSFGVILWELATLQQPWGNLNP-AQVVAAVG 165
           MAPEV+R +   P + +SD+Y+FG++L+EL T Q P+ N+N   Q++  VG
Sbjct: 201 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 251

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score =  118 bits (295), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 68/191 (35%), Positives = 108/191 (56%), Gaps = 6/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK ++HPN+V  +G  T+ P   I+TE+++ G+L   L +   R+ +     L MA  ++
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQIS 328
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
             M YL ++N   +HR+L + N LV + + VKV DFGLSRL      ++ + A  P +W 
Sbjct: 329 SAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 386
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE L     + KSD+++FGV+LWE+AT    P+  ++ +QV   +  K  R+E P    
Sbjct: 387 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 445
Query: 179 PHVASIIEACW 189
             V  ++ ACW
Sbjct: 446 EKVYELMRACW 456

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  118 bits (295), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 69/172 (40%), Positives = 113/172 (65%), Gaps = 13/172 (7%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRL-NMAYDV 59
           +++ RH NI+LFMG +T+  NL+IVT++    SLY+ LH   V+E   +  +L ++A   
Sbjct: 86  LRKTRHVNILLFMGYMTKD-NLAIVTQWCEGSSLYKHLH---VQETKFQMFQLIDIARQT 141
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK--SAAGTPE 117
           A+GM+YLH +N  I+HRD+KS N+ + +  TVK+ DFGL+ +K+    S +     G+  
Sbjct: 142 AQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVL 199
Query: 118 WMAPEVLR---DEPSNEKSDIYSFGVILWELATLQQPWGNLNP-AQVVAAVG 165
           WMAPEV+R   + P + +SD+YS+G++L+EL T + P+ ++N   Q++  VG
Sbjct: 200 WMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVG 251

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score =  117 bits (293), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 67/191 (35%), Positives = 106/191 (55%), Gaps = 7/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +L HP +V F G  ++   + IVTEY+S G L   L   G  + L+  + L M YDV 
Sbjct: 57  MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVC 114
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEWM 119
           +GM +L       +HRDL + N LVD+   VKV DFG++R +  + ++SS       +W 
Sbjct: 115 EGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS 172
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APEV      + KSD+++FG+++WE+ +L + P+     ++VV  V  +G RL  P   +
Sbjct: 173 APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLAS 231
Query: 179 PHVASIIEACW 189
             +  I+ +CW
Sbjct: 232 DTIYQIMYSCW 242

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  114 bits (284), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 104/194 (53%), Gaps = 8/194 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           + R+ HPNIV   GA   P  + +V EY   GSLY +LH             ++     +
Sbjct: 56  LSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 113
Query: 61  KGMNYLHRRNP-PIVHRDLKSPNLLVDKKYTV-KVCDFGLSRLKANTFLSSKSAAGTPEW 118
           +G+ YLH   P  ++HRDLK PNLL+    TV K+CDFG +     T +++    G+  W
Sbjct: 114 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG-TACDIQTHMTNNK--GSAAW 170
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL-NPAQVVAAVGFKGKRLEIPRNV 177
           MAPEV      +EK D++S+G+ILWE+ T ++P+  +  PA  +      G R  + +N+
Sbjct: 171 MAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL 230
Query: 178 NPHVASIIEACWAK 191
              + S++  CW+K
Sbjct: 231 PKPIESLMTRCWSK 244

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  114 bits (284), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 104/194 (53%), Gaps = 8/194 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           + R+ HPNIV   GA   P  + +V EY   GSLY +LH             ++     +
Sbjct: 55  LSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 61  KGMNYLHRRNP-PIVHRDLKSPNLLVDKKYTV-KVCDFGLSRLKANTFLSSKSAAGTPEW 118
           +G+ YLH   P  ++HRDLK PNLL+    TV K+CDFG +     T +++    G+  W
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG-TACDIQTHMTNNK--GSAAW 169
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL-NPAQVVAAVGFKGKRLEIPRNV 177
           MAPEV      +EK D++S+G+ILWE+ T ++P+  +  PA  +      G R  + +N+
Sbjct: 170 MAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL 229
Query: 178 NPHVASIIEACWAK 191
              + S++  CW+K
Sbjct: 230 PKPIESLMTRCWSK 243

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score =  113 bits (282), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 69/191 (36%), Positives = 107/191 (56%), Gaps = 9/191 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPN-LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           M +LRH N+V  +G + +    L IVTEY+++GSL   L   G R +L     L  + DV
Sbjct: 240 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDV 298
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
            + M YL   N   VHRDL + N+LV +    KV DFGL++  ++T  + K      +W 
Sbjct: 299 CEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWT 353
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE LR++  + KSD++SFG++LWE+ +  + P+  +    VV  V  KG +++ P    
Sbjct: 354 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCP 412
Query: 179 PHVASIIEACW 189
           P V  +++ CW
Sbjct: 413 PAVYDVMKNCW 423

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  113 bits (282), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 70/200 (35%), Positives = 107/200 (53%), Gaps = 18/200 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
           M  L HPNIV   G +  PP +  V E++  G LY RLL K      +    +L +  D+
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDI 131
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLV-----DKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
           A G+ Y+  +NPPIVHRDL+SPN+ +     +     KV DFGLS+   +   S     G
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH---SVSGLLG 188
Query: 115 TPEWMAPEVL--RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV--VAAVGFKGKR 170
             +WMAPE +   +E   EK+D YSF +IL+ + T + P+   +  ++  +  +  +G R
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248
Query: 171 LEIPRNVNPHVASIIEACWA 190
             IP +  P + ++IE CW+
Sbjct: 249 PTIPEDCPPRLRNVIELCWS 268

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score =  112 bits (281), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 69/191 (36%), Positives = 107/191 (56%), Gaps = 9/191 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPN-LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           M +LRH N+V  +G + +    L IVTEY+++GSL   L   G R +L     L  + DV
Sbjct: 68  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDV 126
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
            + M YL   N   VHRDL + N+LV +    KV DFGL++  ++T  + K      +W 
Sbjct: 127 CEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWT 181
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE LR++  + KSD++SFG++LWE+ +  + P+  +    VV  V  KG +++ P    
Sbjct: 182 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCP 240
Query: 179 PHVASIIEACW 189
           P V  +++ CW
Sbjct: 241 PAVYEVMKNCW 251

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score =  112 bits (281), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 69/191 (36%), Positives = 107/191 (56%), Gaps = 9/191 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPN-LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           M +LRH N+V  +G + +    L IVTEY+++GSL   L   G R +L     L  + DV
Sbjct: 53  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDV 111
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
            + M YL   N   VHRDL + N+LV +    KV DFGL++  ++T  + K      +W 
Sbjct: 112 CEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWT 166
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE LR++  + KSD++SFG++LWE+ +  + P+  +    VV  V  KG +++ P    
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCP 225
Query: 179 PHVASIIEACW 189
           P V  +++ CW
Sbjct: 226 PAVYEVMKNCW 236

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 69/191 (36%), Positives = 106/191 (55%), Gaps = 9/191 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPN-LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           M +LRH N+V  +G + +    L IVTEY+++GSL   L   G R +L     L  + DV
Sbjct: 59  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDV 117
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
            + M YL   N   VHRDL + N+LV +    KV DFGL++  ++T  + K      +W 
Sbjct: 118 CEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWT 172
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE LR+   + KSD++SFG++LWE+ +  + P+  +    VV  V  KG +++ P    
Sbjct: 173 APEALREAAFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCP 231
Query: 179 PHVASIIEACW 189
           P V  +++ CW
Sbjct: 232 PAVYEVMKNCW 242

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  110 bits (276), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 106/200 (53%), Gaps = 18/200 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
           M  L HPNIV   G +  PP +  V E++  G LY RLL K      +    +L +  D+
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDI 131
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLV-----DKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
           A G+ Y+  +NPPIVHRDL+SPN+ +     +     KV DFG S+   +   S     G
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVH---SVSGLLG 188
Query: 115 TPEWMAPEVL--RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV--VAAVGFKGKR 170
             +WMAPE +   +E   EK+D YSF +IL+ + T + P+   +  ++  +  +  +G R
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248
Query: 171 LEIPRNVNPHVASIIEACWA 190
             IP +  P + ++IE CW+
Sbjct: 249 PTIPEDCPPRLRNVIELCWS 268

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  110 bits (276), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 99/191 (51%), Gaps = 7/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +L HP +V   G   +   + +VTE++  G L   L     R +      L M  DV 
Sbjct: 57  MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVC 114
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
           +GM YL      ++HRDL + N LV +   +KV DFG++R   +   +S +    P +W 
Sbjct: 115 EGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 172
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           +PEV      + KSD++SFGV++WE+ +  + P+ N + ++VV  +   G RL  PR  +
Sbjct: 173 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLAS 231
Query: 179 PHVASIIEACW 189
            HV  I+  CW
Sbjct: 232 THVYQIMNHCW 242

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  110 bits (275), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 106/200 (53%), Gaps = 18/200 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
           M  L HPNIV   G +  PP +  V E++  G LY RLL K      +    +L +  D+
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDI 131
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLV-----DKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
           A G+ Y+  +NPPIVHRDL+SPN+ +     +     KV DF LS+   +   S     G
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVH---SVSGLLG 188
Query: 115 TPEWMAPEVL--RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV--VAAVGFKGKR 170
             +WMAPE +   +E   EK+D YSF +IL+ + T + P+   +  ++  +  +  +G R
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248
Query: 171 LEIPRNVNPHVASIIEACWA 190
             IP +  P + ++IE CW+
Sbjct: 249 PTIPEDCPPRLRNVIELCWS 268

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score =  110 bits (275), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 107/193 (55%), Gaps = 11/193 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           ++   HPN++  +GA   PP  + +++T ++  GSLY +LH+ G   ++D+ + +  A D
Sbjct: 61  LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE-GTNFVVDQSQAVKFALD 119
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
           +A+GM +LH   P I    L S ++++D+  T ++     S         S      P W
Sbjct: 120 MARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARI-----SMADVKFSFQSPGRMYAPAW 174
Query: 119 MAPEVLRDEPSN---EKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 175
           +APE L+ +P +     +D++SF V+LWEL T + P+ +L+  ++   V  +G R  IP 
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPP 234
Query: 176 NVNPHVASIIEAC 188
            ++PHV+ +++ C
Sbjct: 235 GISPHVSKLMKIC 247

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score =  110 bits (274), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 71/193 (36%), Positives = 100/193 (51%), Gaps = 8/193 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K+  HPNIV  +G  TQ   + IV E +  G     L   G R  L  +  L M  D A
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR--LRVKTLLQMVGDAA 223
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN-TFLSSKSAAGTP-EW 118
            GM YL  +    +HRDL + N LV +K  +K+ DFG+SR +A+  + +S      P +W
Sbjct: 224 AGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKW 281
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            APE L     + +SD++SFG++LWE  +L   P+ NL+  Q    V  KG RL  P   
Sbjct: 282 TAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELC 340
Query: 178 NPHVASIIEACWA 190
              V  ++E CWA
Sbjct: 341 PDAVFRLMEQCWA 353

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  109 bits (272), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 110/194 (56%), Gaps = 9/194 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDV 59
           MK+L+H  +V     VTQ P + I+TEY+  GSL   L  P G++  ++  + L+MA  +
Sbjct: 57  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 113
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           A+GM ++  RN   +HRDL++ N+LV    + K+ DFGL+RL  +   +++  A  P +W
Sbjct: 114 AEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 171
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            APE +       KSD++SFG++L E+ T  + P+  +   +V+  +  +G R+  P N 
Sbjct: 172 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNC 230
Query: 178 NPHVASIIEACWAK 191
              +  ++  CW +
Sbjct: 231 PEELYQLMRLCWKE 244

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  108 bits (271), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 110/194 (56%), Gaps = 9/194 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDV 59
           MK+L+H  +V     VTQ P + I+TEY+  GSL   L  P G++  ++  + L+MA  +
Sbjct: 62  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 118
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           A+GM ++  RN   +HRDL++ N+LV    + K+ DFGL+RL  +   +++  A  P +W
Sbjct: 119 AEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 176
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            APE +       KSD++SFG++L E+ T  + P+  +   +V+  +  +G R+  P N 
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNC 235
Query: 178 NPHVASIIEACWAK 191
              +  ++  CW +
Sbjct: 236 PEELYQLMRLCWKE 249

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  108 bits (271), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 110/194 (56%), Gaps = 9/194 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDV 59
           MK+L+H  +V     VTQ P + I+TEY+  GSL   L  P G++  ++  + L+MA  +
Sbjct: 62  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 118
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           A+GM ++  RN   +HRDL++ N+LV    + K+ DFGL+RL  +   +++  A  P +W
Sbjct: 119 AEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 176
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            APE +       KSD++SFG++L E+ T  + P+  +   +V+  +  +G R+  P N 
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNC 235
Query: 178 NPHVASIIEACWAK 191
              +  ++  CW +
Sbjct: 236 PEELYQLMRLCWKE 249

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  108 bits (271), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 110/194 (56%), Gaps = 9/194 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDV 59
           MK+L+H  +V     VTQ P + I+TEY+  GSL   L  P G++  ++  + L+MA  +
Sbjct: 64  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 120
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           A+GM ++  RN   +HRDL++ N+LV    + K+ DFGL+RL  +   +++  A  P +W
Sbjct: 121 AEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 178
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            APE +       KSD++SFG++L E+ T  + P+  +   +V+  +  +G R+  P N 
Sbjct: 179 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNC 237
Query: 178 NPHVASIIEACWAK 191
              +  ++  CW +
Sbjct: 238 PEELYQLMRLCWKE 251

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  108 bits (271), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 110/194 (56%), Gaps = 9/194 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDV 59
           MK+L+H  +V     VTQ P + I+TEY+  GSL   L  P G++  ++  + L+MA  +
Sbjct: 68  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 124
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           A+GM ++  RN   +HRDL++ N+LV    + K+ DFGL+RL  +   +++  A  P +W
Sbjct: 125 AEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 182
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            APE +       KSD++SFG++L E+ T  + P+  +   +V+  +  +G R+  P N 
Sbjct: 183 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNC 241
Query: 178 NPHVASIIEACWAK 191
              +  ++  CW +
Sbjct: 242 PEELYQLMRLCWKE 255

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  108 bits (271), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 110/194 (56%), Gaps = 9/194 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDV 59
           MK+L+H  +V     VTQ P + I+TEY+  GSL   L  P G++  ++  + L+MA  +
Sbjct: 62  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 118
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           A+GM ++  RN   +HRDL++ N+LV    + K+ DFGL+RL  +   +++  A  P +W
Sbjct: 119 AEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKW 176
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            APE +       KSD++SFG++L E+ T  + P+  +   +V+  +  +G R+  P N 
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNC 235
Query: 178 NPHVASIIEACWAK 191
              +  ++  CW +
Sbjct: 236 PEELYQLMRLCWKE 249

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  108 bits (271), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 110/194 (56%), Gaps = 9/194 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDV 59
           MK+L+H  +V     VTQ P + I+TEY+  GSL   L  P G++  ++  + L+MA  +
Sbjct: 63  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 119
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           A+GM ++  RN   +HRDL++ N+LV    + K+ DFGL+RL  +   +++  A  P +W
Sbjct: 120 AEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 177
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            APE +       KSD++SFG++L E+ T  + P+  +   +V+  +  +G R+  P N 
Sbjct: 178 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNC 236
Query: 178 NPHVASIIEACWAK 191
              +  ++  CW +
Sbjct: 237 PEELYQLMRLCWKE 250

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  108 bits (271), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 110/194 (56%), Gaps = 9/194 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDV 59
           MK+L+H  +V     VTQ P + I+TEY+  GSL   L  P G++  ++  + L+MA  +
Sbjct: 67  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 123
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           A+GM ++  RN   +HRDL++ N+LV    + K+ DFGL+RL  +   +++  A  P +W
Sbjct: 124 AEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 181
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            APE +       KSD++SFG++L E+ T  + P+  +   +V+  +  +G R+  P N 
Sbjct: 182 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNC 240
Query: 178 NPHVASIIEACWAK 191
              +  ++  CW +
Sbjct: 241 PEELYQLMRLCWKE 254

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  108 bits (271), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 110/194 (56%), Gaps = 9/194 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDV 59
           MK+L+H  +V     VTQ P + I+TEY+  GSL   L  P G++  ++  + L+MA  +
Sbjct: 71  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 127
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           A+GM ++  RN   +HRDL++ N+LV    + K+ DFGL+RL  +   +++  A  P +W
Sbjct: 128 AEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 185
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            APE +       KSD++SFG++L E+ T  + P+  +   +V+  +  +G R+  P N 
Sbjct: 186 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNC 244
Query: 178 NPHVASIIEACWAK 191
              +  ++  CW +
Sbjct: 245 PEELYQLMRLCWKE 258

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  108 bits (271), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 110/194 (56%), Gaps = 9/194 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDV 59
           MK+L+H  +V     VTQ P + I+TEY+  GSL   L  P G++  ++  + L+MA  +
Sbjct: 68  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 124
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           A+GM ++  RN   +HRDL++ N+LV    + K+ DFGL+RL  +   +++  A  P +W
Sbjct: 125 AEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 182
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            APE +       KSD++SFG++L E+ T  + P+  +   +V+  +  +G R+  P N 
Sbjct: 183 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNC 241
Query: 178 NPHVASIIEACWAK 191
              +  ++  CW +
Sbjct: 242 PEELYQLMRLCWKE 255

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  108 bits (271), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 110/194 (56%), Gaps = 9/194 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDV 59
           MK+L+H  +V     VTQ P + I+TEY+  GSL   L  P G++  ++  + L+MA  +
Sbjct: 72  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 128
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           A+GM ++  RN   +HRDL++ N+LV    + K+ DFGL+RL  +   +++  A  P +W
Sbjct: 129 AEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 186
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            APE +       KSD++SFG++L E+ T  + P+  +   +V+  +  +G R+  P N 
Sbjct: 187 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNC 245
Query: 178 NPHVASIIEACWAK 191
              +  ++  CW +
Sbjct: 246 PEELYQLMRLCWKE 259

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  108 bits (271), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 110/194 (56%), Gaps = 9/194 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDV 59
           MK+L+H  +V     VTQ P + I+TEY+  GSL   L  P G++  ++  + L+MA  +
Sbjct: 70  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 126
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           A+GM ++  RN   +HRDL++ N+LV    + K+ DFGL+RL  +   +++  A  P +W
Sbjct: 127 AEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 184
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            APE +       KSD++SFG++L E+ T  + P+  +   +V+  +  +G R+  P N 
Sbjct: 185 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNC 243
Query: 178 NPHVASIIEACWAK 191
              +  ++  CW +
Sbjct: 244 PEELYQLMRLCWKE 257

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  108 bits (271), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 110/194 (56%), Gaps = 9/194 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDV 59
           MK+L+H  +V     VTQ P + I+TEY+  GSL   L  P G++  ++  + L+MA  +
Sbjct: 62  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 118
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           A+GM ++  RN   +HRDL++ N+LV    + K+ DFGL+RL  +   +++  A  P +W
Sbjct: 119 AEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 176
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            APE +       KSD++SFG++L E+ T  + P+  +   +V+  +  +G R+  P N 
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNC 235
Query: 178 NPHVASIIEACWAK 191
              +  ++  CW +
Sbjct: 236 PEELYQLMRLCWKE 249

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 98/191 (51%), Gaps = 7/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +L HP +V   G   +   + +V E++  G L   L     R +      L M  DV 
Sbjct: 56  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVC 113
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
           +GM YL      ++HRDL + N LV +   +KV DFG++R   +   +S +    P +W 
Sbjct: 114 EGMAYL--EEASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 171
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           +PEV      + KSD++SFGV++WE+ +  + P+ N + ++VV  +   G RL  PR  +
Sbjct: 172 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLAS 230
Query: 179 PHVASIIEACW 189
            HV  I+  CW
Sbjct: 231 THVYQIMNHCW 241

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 69/193 (35%), Positives = 98/193 (50%), Gaps = 8/193 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K+  HPNIV  +G  TQ   + IV E +  G     L   G R  L  +  L M  D A
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR--LRVKTLLQMVGDAA 223
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
            GM YL  +    +HRDL + N LV +K  +K+ DFG+SR +A+   ++         +W
Sbjct: 224 AGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKW 281
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            APE L     + +SD++SFG++LWE  +L   P+ NL+  Q    V  KG RL  P   
Sbjct: 282 TAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELC 340
Query: 178 NPHVASIIEACWA 190
              V  ++E CWA
Sbjct: 341 PDAVFRLMEQCWA 353

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 99/193 (51%), Gaps = 7/193 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +L HP +V   G   +   + +V E++  G L   L     R +      L M  DV 
Sbjct: 54  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVC 111
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
           +GM YL      ++HRDL + N LV +   +KV DFG++R   +   +S +    P +W 
Sbjct: 112 EGMAYL--EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 169
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           +PEV      + KSD++SFGV++WE+ +  + P+ N + ++VV  +   G RL  PR  +
Sbjct: 170 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLAS 228
Query: 179 PHVASIIEACWAK 191
            HV  I+  CW +
Sbjct: 229 THVYQIMNHCWKE 241

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 99/193 (51%), Gaps = 7/193 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +L HP +V   G   +   + +V E++  G L   L     R +      L M  DV 
Sbjct: 76  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVC 133
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
           +GM YL      ++HRDL + N LV +   +KV DFG++R   +   +S +    P +W 
Sbjct: 134 EGMAYL--EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 191
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           +PEV      + KSD++SFGV++WE+ +  + P+ N + ++VV  +   G RL  PR  +
Sbjct: 192 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLAS 250
Query: 179 PHVASIIEACWAK 191
            HV  I+  CW +
Sbjct: 251 THVYQIMNHCWKE 263

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 99/193 (51%), Gaps = 7/193 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +L HP +V   G   +   + +V E++  G L   L     R +      L M  DV 
Sbjct: 56  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVC 113
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
           +GM YL      ++HRDL + N LV +   +KV DFG++R   +   +S +    P +W 
Sbjct: 114 EGMAYL--EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 171
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           +PEV      + KSD++SFGV++WE+ +  + P+ N + ++VV  +   G RL  PR  +
Sbjct: 172 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLAS 230
Query: 179 PHVASIIEACWAK 191
            HV  I+  CW +
Sbjct: 231 THVYQIMNHCWKE 243

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 98/191 (51%), Gaps = 7/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +L HP +V   G   +   + +V E++  G L   L     R +      L M  DV 
Sbjct: 59  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVC 116
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
           +GM YL      ++HRDL + N LV +   +KV DFG++R   +   +S +    P +W 
Sbjct: 117 EGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 174
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           +PEV      + KSD++SFGV++WE+ +  + P+ N + ++VV  +   G RL  PR  +
Sbjct: 175 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLAS 233
Query: 179 PHVASIIEACW 189
            HV  I+  CW
Sbjct: 234 THVYQIMNHCW 244

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 106/201 (52%), Gaps = 19/201 (9%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK---PGVR----------EMLDERR 51
           +H NI+  +GA TQ   L ++ EY S+G+L   L     PG+           E L  + 
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 151
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
            ++ AY VA+GM YL  +    +HRDL + N+LV +   +K+ DFGL+R   +     K+
Sbjct: 152 LVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 112 AAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             G    +WMAPE L D     +SD++SFGV+LWE+ TL   P+  + P + +  +  +G
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEG 268
Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R++ P N    +  ++  CW
Sbjct: 269 HRMDKPSNCTNELYMMMRDCW 289

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 106/201 (52%), Gaps = 19/201 (9%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK---PGVR----------EMLDERR 51
           +H NI+  +GA TQ   L ++ EY S+G+L   L     PG+           E L  + 
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKD 151
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
            ++ AY VA+GM YL  +    +HRDL + N+LV +   +K+ DFGL+R   +     K+
Sbjct: 152 LVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKT 209
Query: 112 AAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             G    +WMAPE L D     +SD++SFGV+LWE+ TL   P+  + P + +  +  +G
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEG 268
Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R++ P N    +  ++  CW
Sbjct: 269 HRMDKPSNCTNELYMMMRDCW 289

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 106/201 (52%), Gaps = 19/201 (9%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK---PGVR----------EMLDERR 51
           +H NI+  +GA TQ   L ++ EY S+G+L   L     PG+           E L  + 
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKD 151
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
            ++ AY VA+GM YL  +    +HRDL + N+LV +   +K+ DFGL+R   +     K+
Sbjct: 152 LVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 112 AAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             G    +WMAPE L D     +SD++SFGV+LWE+ TL   P+  + P + +  +  +G
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEG 268
Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R++ P N    +  ++  CW
Sbjct: 269 HRMDKPSNCTNELYMMMRDCW 289

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score =  108 bits (269), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 106/201 (52%), Gaps = 19/201 (9%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK---PGVR----------EMLDERR 51
           +H NI+  +GA TQ   L ++ EY S+G+L   L     PG+           E L  + 
Sbjct: 85  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 144
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
            ++ AY VA+GM YL  +    +HRDL + N+LV +   +K+ DFGL+R   +     K+
Sbjct: 145 LVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 202
Query: 112 AAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             G    +WMAPE L D     +SD++SFGV+LWE+ TL   P+  + P + +  +  +G
Sbjct: 203 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEG 261
Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R++ P N    +  ++  CW
Sbjct: 262 HRMDKPSNCTNELYMMMRDCW 282

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score =  108 bits (269), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 106/201 (52%), Gaps = 19/201 (9%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK---PGVR----------EMLDERR 51
           +H NI+  +GA TQ   L ++ EY S+G+L   L     PG+           E L  + 
Sbjct: 81  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 140
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
            ++ AY VA+GM YL  +    +HRDL + N+LV +   +K+ DFGL+R   +     K+
Sbjct: 141 LVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 198
Query: 112 AAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             G    +WMAPE L D     +SD++SFGV+LWE+ TL   P+  + P + +  +  +G
Sbjct: 199 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEG 257
Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R++ P N    +  ++  CW
Sbjct: 258 HRMDKPSNCTNELYMMMRDCW 278

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score =  108 bits (269), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 106/201 (52%), Gaps = 19/201 (9%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK---PGVR----------EMLDERR 51
           +H NI+  +GA TQ   L ++ EY S+G+L   L     PG+           E L  + 
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 151
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
            ++ AY VA+GM YL  +    +HRDL + N+LV +   +K+ DFGL+R   +     K+
Sbjct: 152 LVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 112 AAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             G    +WMAPE L D     +SD++SFGV+LWE+ TL   P+  + P + +  +  +G
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEG 268
Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R++ P N    +  ++  CW
Sbjct: 269 HRMDKPSNCTNELYMMMRDCW 289

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score =  108 bits (269), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 106/201 (52%), Gaps = 19/201 (9%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK---PGVR----------EMLDERR 51
           +H NI+  +GA TQ   L ++ EY S+G+L   L     PG+           E L  + 
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 136
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
            ++ AY VA+GM YL  +    +HRDL + N+LV +   +K+ DFGL+R   +     K+
Sbjct: 137 LVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 112 AAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             G    +WMAPE L D     +SD++SFGV+LWE+ TL   P+  + P + +  +  +G
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEG 253
Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R++ P N    +  ++  CW
Sbjct: 254 HRMDKPSNCTNELYMMMRDCW 274

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score =  107 bits (268), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 106/201 (52%), Gaps = 19/201 (9%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK---PGVR----------EMLDERR 51
           +H NI+  +GA TQ   L ++ EY S+G+L   L     PG+           E L  + 
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
            ++ AY VA+GM YL  +    +HRDL + N+LV +   +K+ DFGL+R   +     K+
Sbjct: 193 LVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 112 AAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             G    +WMAPE L D     +SD++SFGV+LWE+ TL   P+  + P + +  +  +G
Sbjct: 251 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEG 309
Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R++ P N    +  ++  CW
Sbjct: 310 HRMDKPSNCTNELYMMMRDCW 330

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score =  107 bits (268), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 106/201 (52%), Gaps = 19/201 (9%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK---PGVR----------EMLDERR 51
           +H NI+  +GA TQ   L ++ EY S+G+L   L     PG+           E L  + 
Sbjct: 84  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 143
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
            ++ AY VA+GM YL  +    +HRDL + N+LV +   +K+ DFGL+R   +     K+
Sbjct: 144 LVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 201
Query: 112 AAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             G    +WMAPE L D     +SD++SFGV+LWE+ TL   P+  + P + +  +  +G
Sbjct: 202 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEG 260
Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R++ P N    +  ++  CW
Sbjct: 261 HRMDKPSNCTNELYMMMRDCW 281

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  107 bits (267), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 110/194 (56%), Gaps = 9/194 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDV 59
           MK+L+H  +V     VTQ P + I+TEY+  GSL   L  P G++  ++  + L+MA  +
Sbjct: 58  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 114
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           A+GM ++  RN   +HR+L++ N+LV    + K+ DFGL+RL  +   +++  A  P +W
Sbjct: 115 AEGMAFIEERN--YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 172
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            APE +       KSD++SFG++L E+ T  + P+  +   +V+  +  +G R+  P N 
Sbjct: 173 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNC 231
Query: 178 NPHVASIIEACWAK 191
              +  ++  CW +
Sbjct: 232 PEELYQLMRLCWKE 245

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  107 bits (267), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 69/193 (35%), Positives = 107/193 (55%), Gaps = 7/193 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK+L+H  +V     V++ P + IVTEY+++GSL   L K G    L     ++MA  VA
Sbjct: 58  MKKLKHDKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFL-KDGEGRALKLPNLVDMAAQVA 115
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
            GM Y+ R N   +HRDL+S N+LV      K+ DFGL+RL  +   +++  A  P +W 
Sbjct: 116 AGMAYIERMN--YIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWT 173
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE         KSD++SFG++L EL T  + P+  +N  +V+  V  +G R+  P++  
Sbjct: 174 APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDCP 232
Query: 179 PHVASIIEACWAK 191
             +  ++  CW K
Sbjct: 233 ISLHELMIHCWKK 245

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score =  106 bits (264), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 99/199 (49%), Gaps = 20/199 (10%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM-------------LDERRR 52
           HPNI+  +GA      L +  EY   G+L   L K  V E              L  ++ 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
           L+ A DVA+GM+YL ++    +HRDL + N+LV + Y  K+ DFGLSR         K+ 
Sbjct: 145 LHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTM 200
Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 170
              P  WMA E L        SD++S+GV+LWE+ +L   P+  +  A++   +  +G R
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYR 259
Query: 171 LEIPRNVNPHVASIIEACW 189
           LE P N +  V  ++  CW
Sbjct: 260 LEKPLNCDDEVYDLMRQCW 278

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score =  106 bits (264), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 99/199 (49%), Gaps = 20/199 (10%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM-------------LDERRR 52
           HPNI+  +GA      L +  EY   G+L   L K  V E              L  ++ 
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
           L+ A DVA+GM+YL ++    +HRDL + N+LV + Y  K+ DFGLSR         K+ 
Sbjct: 135 LHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTM 190
Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 170
              P  WMA E L        SD++S+GV+LWE+ +L   P+  +  A++   +  +G R
Sbjct: 191 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYR 249
Query: 171 LEIPRNVNPHVASIIEACW 189
           LE P N +  V  ++  CW
Sbjct: 250 LEKPLNCDDEVYDLMRQCW 268

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score =  106 bits (264), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/203 (34%), Positives = 103/203 (50%), Gaps = 18/203 (8%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL--HKPGVREM----------LDERR 51
           L+H +IV F G  T+   L +V EY+  G L R L  H P  + +          L   +
Sbjct: 77  LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 136
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSK 110
            L +A  VA GM YL   +   VHRDL + N LV +   VK+ DFG+SR + +  +    
Sbjct: 137 LLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 194
Query: 111 SAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
                P  WM PE +       +SD++SFGV+LWE+ T  +QPW  L+  + +  +  +G
Sbjct: 195 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT-QG 253
Query: 169 KRLEIPRNVNPHVASIIEACWAK 191
           + LE PR   P V +I+  CW +
Sbjct: 254 RELERPRACPPEVYAIMRGCWQR 276

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score =  105 bits (263), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/203 (34%), Positives = 103/203 (50%), Gaps = 18/203 (8%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL--HKPGVREM----------LDERR 51
           L+H +IV F G  T+   L +V EY+  G L R L  H P  + +          L   +
Sbjct: 71  LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 130
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSK 110
            L +A  VA GM YL   +   VHRDL + N LV +   VK+ DFG+SR + +  +    
Sbjct: 131 LLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 188
Query: 111 SAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
                P  WM PE +       +SD++SFGV+LWE+ T  +QPW  L+  + +  +  +G
Sbjct: 189 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT-QG 247
Query: 169 KRLEIPRNVNPHVASIIEACWAK 191
           + LE PR   P V +I+  CW +
Sbjct: 248 RELERPRACPPEVYAIMRGCWQR 270

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score =  105 bits (263), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 104/206 (50%), Gaps = 18/206 (8%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL--HKPGVREM----------LD 48
           +  L+H +IV F G  T+   L +V EY+  G L R L  H P  + +          L 
Sbjct: 97  LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156
Query: 49  ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFL 107
             + L +A  VA GM YL   +   VHRDL + N LV +   VK+ DFG+SR + +  + 
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 214
Query: 108 SSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVG 165
                   P  WM PE +       +SD++SFGV+LWE+ T  +QPW  L+  + +  + 
Sbjct: 215 RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI- 273
Query: 166 FKGKRLEIPRNVNPHVASIIEACWAK 191
            +G+ LE PR   P V +I+  CW +
Sbjct: 274 TQGRELERPRACPPEVYAIMRGCWQR 299

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score =  105 bits (262), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 101/191 (52%), Gaps = 7/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  L H  +V   G  T+   + I+TEY++ G L   L +  +R     ++ L M  DV 
Sbjct: 58  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVC 115
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEWM 119
           + M YL  +    +HRDL + N LV+ +  VKV DFGLSR +  + + SS+ +     W 
Sbjct: 116 EAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWS 173
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
            PEVL     + KSDI++FGV++WE+ +L + P+     ++    +  +G RL  P   +
Sbjct: 174 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLAS 232
Query: 179 PHVASIIEACW 189
             V +I+ +CW
Sbjct: 233 EKVYTIMYSCW 243

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  105 bits (261), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 19/201 (9%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK---PGVR----------EMLDERR 51
           +H NI+  +GA TQ   L ++ EY S+G+L   L     PG+           E +  + 
Sbjct: 99  KHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
            ++  Y +A+GM YL  +    +HRDL + N+LV +   +K+ DFGL+R   N     K+
Sbjct: 159 LVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 112 AAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             G    +WMAPE L D     +SD++SFGV++WE+ TL   P+  + P + +  +  +G
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEG 275
Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R++ P N    +  ++  CW
Sbjct: 276 HRMDKPANCTNELYMMMRDCW 296

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score =  104 bits (260), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 99/191 (51%), Gaps = 7/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  L H  +V   G  T+   + I+TEY++ G L   L +  +R     ++ L M  DV 
Sbjct: 53  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVC 110
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
           + M YL  +    +HRDL + N LV+ +  VKV DFGLSR   +   +S   +  P  W 
Sbjct: 111 EAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 168
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
            PEVL     + KSDI++FGV++WE+ +L + P+     ++    +  +G RL  P   +
Sbjct: 169 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLAS 227
Query: 179 PHVASIIEACW 189
             V +I+ +CW
Sbjct: 228 EKVYTIMYSCW 238

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score =  104 bits (260), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 99/191 (51%), Gaps = 7/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  L H  +V   G  T+   + I+TEY++ G L   L +  +R     ++ L M  DV 
Sbjct: 64  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVC 121
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
           + M YL  +    +HRDL + N LV+ +  VKV DFGLSR   +   +S   +  P  W 
Sbjct: 122 EAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 179
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
            PEVL     + KSDI++FGV++WE+ +L + P+     ++    +  +G RL  P   +
Sbjct: 180 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLAS 238
Query: 179 PHVASIIEACW 189
             V +I+ +CW
Sbjct: 239 EKVYTIMYSCW 249

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score =  104 bits (260), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 99/191 (51%), Gaps = 7/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  L H  +V   G  T+   + I+TEY++ G L   L +  +R     ++ L M  DV 
Sbjct: 57  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVC 114
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
           + M YL  +    +HRDL + N LV+ +  VKV DFGLSR   +   +S   +  P  W 
Sbjct: 115 EAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 172
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
            PEVL     + KSDI++FGV++WE+ +L + P+     ++    +  +G RL  P   +
Sbjct: 173 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLAS 231
Query: 179 PHVASIIEACW 189
             V +I+ +CW
Sbjct: 232 EKVYTIMYSCW 242

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score =  104 bits (260), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 99/191 (51%), Gaps = 7/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  L H  +V   G  T+   + I+TEY++ G L   L +  +R     ++ L M  DV 
Sbjct: 58  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVC 115
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
           + M YL  +    +HRDL + N LV+ +  VKV DFGLSR   +   +S   +  P  W 
Sbjct: 116 EAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 173
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
            PEVL     + KSDI++FGV++WE+ +L + P+     ++    +  +G RL  P   +
Sbjct: 174 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLAS 232
Query: 179 PHVASIIEACW 189
             V +I+ +CW
Sbjct: 233 EKVYTIMYSCW 243

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score =  104 bits (259), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 99/191 (51%), Gaps = 7/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  L H  +V   G  T+   + I+TEY++ G L   L +  +R     ++ L M  DV 
Sbjct: 73  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVC 130
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
           + M YL  +    +HRDL + N LV+ +  VKV DFGLSR   +   +S   +  P  W 
Sbjct: 131 EAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 188
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
            PEVL     + KSDI++FGV++WE+ +L + P+     ++    +  +G RL  P   +
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLAS 247
Query: 179 PHVASIIEACW 189
             V +I+ +CW
Sbjct: 248 EKVYTIMYSCW 258

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score =  104 bits (259), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 104/201 (51%), Gaps = 19/201 (9%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK---PGVREMLDERR---------- 51
           +H NI+  +GA TQ   L ++ EY S+G+L   L     PG+    D  R          
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKD 158
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
            ++  Y +A+GM YL  +    +HRDL + N+LV +   +K+ DFGL+R   N     K+
Sbjct: 159 LVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKT 216
Query: 112 AAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             G    +WMAPE L D     +SD++SFGV++WE+ TL   P+  + P + +  +  +G
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEG 275
Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R++ P N    +  ++  CW
Sbjct: 276 HRMDKPANCTNELYMMMRDCW 296

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  104 bits (259), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 108/192 (56%), Gaps = 8/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-PGVREMLDERRRLNMAYDV 59
           MK L+H  +V     VT+   + I+TEY+++GSL   L    G + +L   + ++ +  +
Sbjct: 62  MKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQI 119
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           A+GM Y+ R+N   +HRDL++ N+LV +    K+ DFGL+R+  +   +++  A  P +W
Sbjct: 120 AEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW 177
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            APE +       KSD++SFG++L+E+ T  + P+     A V+ A+  +G R+    N 
Sbjct: 178 TAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALS-QGYRMPRVENC 236
Query: 178 NPHVASIIEACW 189
              +  I++ CW
Sbjct: 237 PDELYDIMKMCW 248

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score =  104 bits (259), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 19/201 (9%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK---PGVR----------EMLDERR 51
           +H NI+  +GA TQ   L ++ EY S+G+L   L     PG+           E +  + 
Sbjct: 99  KHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
            ++  Y +A+GM YL  +    +HRDL + N+LV +   +K+ DFGL+R   N     K+
Sbjct: 159 LVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 112 AAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             G    +WMAPE L D     +SD++SFGV++WE+ TL   P+  + P + +  +  +G
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEG 275
Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R++ P N    +  ++  CW
Sbjct: 276 HRMDKPANCTNELYMMMRDCW 296

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score =  104 bits (259), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 19/201 (9%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK---PGVR----------EMLDERR 51
           +H NI+  +GA TQ   L ++ EY S+G+L   L     PG+           E +  + 
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
            ++  Y +A+GM YL  +    +HRDL + N+LV +   +K+ DFGL+R   N     K+
Sbjct: 159 LVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKT 216
Query: 112 AAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             G    +WMAPE L D     +SD++SFGV++WE+ TL   P+  + P + +  +  +G
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEG 275
Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R++ P N    +  ++  CW
Sbjct: 276 HRMDKPANCTNELYMMMRDCW 296

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  103 bits (258), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 69/193 (35%), Positives = 107/193 (55%), Gaps = 7/193 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK+LRH  +V     V++ P + IVTEY+S+GSL   L K  + + L   + ++MA  +A
Sbjct: 67  MKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIA 124
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
            GM Y+ R N   VHRDL++ N+LV +    KV DFGL+RL  +   +++  A  P +W 
Sbjct: 125 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 182
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE         KSD++SFG++L EL T  + P+  +   +V+  V  +G R+  P    
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 241
Query: 179 PHVASIIEACWAK 191
             +  ++  CW K
Sbjct: 242 ESLHDLMCQCWRK 254

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score =  103 bits (258), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 99/199 (49%), Gaps = 20/199 (10%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM-------------LDERRR 52
           HPNI+  +GA      L +  EY   G+L   L K  V E              L  ++ 
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
           L+ A DVA+GM+YL ++    +HR+L + N+LV + Y  K+ DFGLSR         K+ 
Sbjct: 142 LHFAADVARGMDYLSQKQ--FIHRNLAARNILVGENYVAKIADFGLSR--GQEVYVKKTM 197
Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 170
              P  WMA E L        SD++S+GV+LWE+ +L   P+  +  A++   +  +G R
Sbjct: 198 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYR 256
Query: 171 LEIPRNVNPHVASIIEACW 189
           LE P N +  V  ++  CW
Sbjct: 257 LEKPLNCDDEVYDLMRQCW 275

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score =  103 bits (258), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 19/201 (9%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK---PGVR----------EMLDERR 51
           +H NI+  +GA TQ   L ++ EY S+G+L   L     PG+           E +  + 
Sbjct: 86  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 145
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
            ++  Y +A+GM YL  +    +HRDL + N+LV +   +K+ DFGL+R   N     K+
Sbjct: 146 LVSCTYQLARGMEYLASQK--CIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKT 203
Query: 112 AAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             G    +WMAPE L D     +SD++SFGV++WE+ TL   P+  + P + +  +  +G
Sbjct: 204 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEG 262
Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R++ P N    +  ++  CW
Sbjct: 263 HRMDKPANCTNELYMMMRDCW 283

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  103 bits (258), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 69/193 (35%), Positives = 106/193 (54%), Gaps = 7/193 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK+LRH  +V     V++ P + IVTEY+S+GSL   L K    + L   + ++MA  +A
Sbjct: 57  MKKLRHEKLVQLYAVVSEEP-IXIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIA 114
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
            GM Y+ R N   VHRDL++ N+LV +    KV DFGL+RL  +   +++  A  P +W 
Sbjct: 115 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWT 172
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE         KSD++SFG++L EL T  + P+  +   +V+  V  +G R+  P    
Sbjct: 173 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 231
Query: 179 PHVASIIEACWAK 191
             +  ++  CW K
Sbjct: 232 ESLHDLMCQCWRK 244

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  103 bits (258), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 69/193 (35%), Positives = 107/193 (55%), Gaps = 7/193 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK+LRH  +V     V++ P + IVTEY+S+GSL   L K  + + L   + ++MA  +A
Sbjct: 58  MKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIA 115
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
            GM Y+ R N   VHRDL++ N+LV +    KV DFGL+RL  +   +++  A  P +W 
Sbjct: 116 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 173
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE         KSD++SFG++L EL T  + P+  +   +V+  V  +G R+  P    
Sbjct: 174 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 232
Query: 179 PHVASIIEACWAK 191
             +  ++  CW K
Sbjct: 233 ESLHDLMCQCWRK 245

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score =  103 bits (258), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 19/201 (9%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK---PGVR----------EMLDERR 51
           +H NI+  +GA TQ   L ++ EY S+G+L   L     PG+           E +  + 
Sbjct: 91  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 150
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
            ++  Y +A+GM YL  +    +HRDL + N+LV +   +K+ DFGL+R   N     K+
Sbjct: 151 LVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 208
Query: 112 AAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             G    +WMAPE L D     +SD++SFGV++WE+ TL   P+  + P + +  +  +G
Sbjct: 209 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEG 267
Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R++ P N    +  ++  CW
Sbjct: 268 HRMDKPANCTNELYMMMRDCW 288

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score =  103 bits (258), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 19/201 (9%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK---PGVR----------EMLDERR 51
           +H NI+  +GA TQ   L ++ EY S+G+L   L     PG+           E +  + 
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
            ++  Y +A+GM YL  +    +HRDL + N+LV +   +K+ DFGL+R   N     K+
Sbjct: 159 LVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 112 AAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             G    +WMAPE L D     +SD++SFGV++WE+ TL   P+  + P + +  +  +G
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEG 275
Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R++ P N    +  ++  CW
Sbjct: 276 HRMDKPANCTNELYMMMRDCW 296

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  103 bits (258), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 69/193 (35%), Positives = 107/193 (55%), Gaps = 7/193 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK+LRH  +V     V++ P + IVTEY+S+GSL   L K  + + L   + ++MA  +A
Sbjct: 56  MKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIA 113
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
            GM Y+ R N   VHRDL++ N+LV +    KV DFGL+RL  +   +++  A  P +W 
Sbjct: 114 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 171
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE         KSD++SFG++L EL T  + P+  +   +V+  V  +G R+  P    
Sbjct: 172 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 230
Query: 179 PHVASIIEACWAK 191
             +  ++  CW K
Sbjct: 231 ESLHDLMCQCWRK 243

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score =  103 bits (258), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 25/205 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-------------PGVREML 47
           MK     ++V  +G V+Q     ++ E ++RG L   L               P + +M+
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 48  DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 107
                  MA ++A GM YL+      VHRDL + N +V + +TVK+ DFG++R    T  
Sbjct: 136 ------QMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDX 187
Query: 108 SSKSAAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
             K   G     WM+PE L+D      SD++SFGV+LWE+ATL +QP+  L+  QV+  V
Sbjct: 188 XRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 247
Query: 165 GFKGKRLEIPRNVNPHVASIIEACW 189
             +G  L+ P N    +  ++  CW
Sbjct: 248 -MEGGLLDKPDNCPDMLFELMRMCW 271

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score =  103 bits (258), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 19/201 (9%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK---PGVR----------EMLDERR 51
           +H NI+  +GA TQ   L ++ EY S+G+L   L     PG+           E +  + 
Sbjct: 88  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 147
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
            ++  Y +A+GM YL  +    +HRDL + N+LV +   +K+ DFGL+R   N     K+
Sbjct: 148 LVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 205
Query: 112 AAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             G    +WMAPE L D     +SD++SFGV++WE+ TL   P+  + P + +  +  +G
Sbjct: 206 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEG 264
Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R++ P N    +  ++  CW
Sbjct: 265 HRMDKPANCTNELYMMMRDCW 285

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  103 bits (258), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 69/193 (35%), Positives = 106/193 (54%), Gaps = 7/193 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK+LRH  +V     V++ P + IVTEY+S+GSL   L K    + L   + ++MA  +A
Sbjct: 233 MKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIA 290
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
            GM Y+ R N   VHRDL++ N+LV +    KV DFGL+RL  +   +++  A  P +W 
Sbjct: 291 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 348
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE         KSD++SFG++L EL T  + P+  +   +V+  V  +G R+  P    
Sbjct: 349 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 407
Query: 179 PHVASIIEACWAK 191
             +  ++  CW K
Sbjct: 408 ESLHDLMCQCWRK 420

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  103 bits (258), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 69/193 (35%), Positives = 106/193 (54%), Gaps = 7/193 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK+LRH  +V     V++ P + IVTEY+S+GSL   L K    + L   + ++MA  +A
Sbjct: 60  MKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIA 117
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
            GM Y+ R N   VHRDL++ N+LV +    KV DFGL+RL  +   +++  A  P +W 
Sbjct: 118 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 175
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE         KSD++SFG++L EL T  + P+  +   +V+  V  +G R+  P    
Sbjct: 176 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 234
Query: 179 PHVASIIEACWAK 191
             +  ++  CW K
Sbjct: 235 ESLHDLMCQCWRK 247

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  103 bits (258), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 69/193 (35%), Positives = 106/193 (54%), Gaps = 7/193 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK+LRH  +V     V++ P + IVTEY+S+GSL   L K    + L   + ++MA  +A
Sbjct: 233 MKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIA 290
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
            GM Y+ R N   VHRDL++ N+LV +    KV DFGL+RL  +   +++  A  P +W 
Sbjct: 291 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 348
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE         KSD++SFG++L EL T  + P+  +   +V+  V  +G R+  P    
Sbjct: 349 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 407
Query: 179 PHVASIIEACWAK 191
             +  ++  CW K
Sbjct: 408 ESLHDLMCQCWRK 420

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score =  103 bits (258), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 25/205 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-------------PGVREML 47
           MK     ++V  +G V+Q     ++ E ++RG L   L               P + +M+
Sbjct: 67  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 126
Query: 48  DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 107
                  MA ++A GM YL+      VHRDL + N +V + +TVK+ DFG++R    T  
Sbjct: 127 ------QMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDX 178
Query: 108 SSKSAAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
             K   G     WM+PE L+D      SD++SFGV+LWE+ATL +QP+  L+  QV+  V
Sbjct: 179 XRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 238
Query: 165 GFKGKRLEIPRNVNPHVASIIEACW 189
             +G  L+ P N    +  ++  CW
Sbjct: 239 -MEGGLLDKPDNCPDMLLELMRMCW 262

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score =  103 bits (257), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 99/191 (51%), Gaps = 7/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  L H  +V   G  T+   + I+TEY++ G L   L +  +R     ++ L M  DV 
Sbjct: 73  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVC 130
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
           + M YL  +    +HRDL + N LV+ +  VKV DFGLSR   +   +S   +  P  W 
Sbjct: 131 EAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWS 188
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
            PEVL     + KSDI++FGV++WE+ +L + P+     ++    +  +G RL  P   +
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLAS 247
Query: 179 PHVASIIEACW 189
             V +I+ +CW
Sbjct: 248 EKVYTIMYSCW 258

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score =  103 bits (257), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 19/201 (9%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK---PGVR----------EMLDERR 51
           +H NI+  +GA TQ   L ++ EY S+G+L   L     PG+           E +  + 
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
            ++  Y +A+GM YL  +    +HRDL + N+LV +   +K+ DFGL+R   N     K+
Sbjct: 205 LVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 112 AAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             G    +WMAPE L D     +SD++SFGV++WE+ TL   P+  + P + +  +  +G
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEG 321
Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R++ P N    +  ++  CW
Sbjct: 322 HRMDKPANCTNELYMMMRDCW 342

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  103 bits (257), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 69/193 (35%), Positives = 106/193 (54%), Gaps = 7/193 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK+LRH  +V     V++ P + IVTEY+S+GSL   L K  + + L   + ++MA  +A
Sbjct: 234 MKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIA 291
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
            GM Y+ R N   VHRDL++ N+LV +    KV DFGL RL  +   +++  A  P +W 
Sbjct: 292 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWT 349
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE         KSD++SFG++L EL T  + P+  +   +V+  V  +G R+  P    
Sbjct: 350 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 408
Query: 179 PHVASIIEACWAK 191
             +  ++  CW K
Sbjct: 409 ESLHDLMCQCWRK 421

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score =  103 bits (257), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 101/193 (52%), Gaps = 11/193 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           ++   HPN++  +GA   PP  + +++T +   GSLY +LH+ G   ++D+ + +  A D
Sbjct: 61  LRIFSHPNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHE-GTNFVVDQSQAVKFALD 119
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
            A+G  +LH   P I    L S ++ +D+  T ++     S         S      P W
Sbjct: 120 XARGXAFLHTLEPLIPRHALNSRSVXIDEDXTARI-----SXADVKFSFQSPGRXYAPAW 174
Query: 119 MAPEVLRDEPSN---EKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 175
           +APE L+ +P +     +D +SF V+LWEL T + P+ +L+  ++   V  +G R  IP 
Sbjct: 175 VAPEALQKKPEDTNRRSADXWSFAVLLWELVTREVPFADLSNXEIGXKVALEGLRPTIPP 234
Query: 176 NVNPHVASIIEAC 188
            ++PHV+ + + C
Sbjct: 235 GISPHVSKLXKIC 247

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  103 bits (256), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 69/193 (35%), Positives = 106/193 (54%), Gaps = 7/193 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK+LRH  +V     V++ P + IVTEY+S+GSL   L K    + L   + ++MA  +A
Sbjct: 316 MKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIA 373
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
            GM Y+ R N   VHRDL++ N+LV +    KV DFGL+RL  +   +++  A  P +W 
Sbjct: 374 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 431
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE         KSD++SFG++L EL T  + P+  +   +V+  V  +G R+  P    
Sbjct: 432 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 490
Query: 179 PHVASIIEACWAK 191
             +  ++  CW K
Sbjct: 491 ESLHDLMCQCWRK 503

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  103 bits (256), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 69/193 (35%), Positives = 106/193 (54%), Gaps = 7/193 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK+LRH  +V     V++ P + IVTEY+S+GSL   L K  + + L   + ++MA  +A
Sbjct: 67  MKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIA 124
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
            GM Y+ R N   VHRDL + N+LV +    KV DFGL+RL  +   +++  A  P +W 
Sbjct: 125 SGMAYVERMN--YVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 182
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE         KSD++SFG++L EL T  + P+  +   +V+  V  +G R+  P    
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 241
Query: 179 PHVASIIEACWAK 191
             +  ++  CW K
Sbjct: 242 ESLHDLMCQCWRK 254

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  103 bits (256), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 68/193 (35%), Positives = 107/193 (55%), Gaps = 7/193 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK++RH  +V     V++ P + IVTEY+S+GSL   L K  + + L   + ++MA  +A
Sbjct: 67  MKKIRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIA 124
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
            GM Y+ R N   VHRDL++ N+LV +    KV DFGL+RL  +   +++  A  P +W 
Sbjct: 125 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 182
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE         KSD++SFG++L EL T  + P+  +   +V+  V  +G R+  P    
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 241
Query: 179 PHVASIIEACWAK 191
             +  ++  CW K
Sbjct: 242 ESLHDLMCQCWRK 254

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score =  103 bits (256), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 25/205 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-------------PGVREML 47
           MK     ++V  +G V+Q     ++ E ++RG L   L               P + +M+
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 48  DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 107
                  MA ++A GM YL+      VHRDL + N +V + +TVK+ DFG++R    T  
Sbjct: 129 ------QMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 180
Query: 108 SSKSAAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
             K   G     WM+PE L+D      SD++SFGV+LWE+ATL +QP+  L+  QV+  V
Sbjct: 181 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 240
Query: 165 GFKGKRLEIPRNVNPHVASIIEACW 189
             +G  L+ P N    +  ++  CW
Sbjct: 241 -MEGGLLDKPDNCPDMLFELMRMCW 264

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score =  102 bits (255), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 25/205 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-------------PGVREML 47
           MK     ++V  +G V+Q     ++ E ++RG L   L               P + +M+
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 48  DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 107
                  MA ++A GM YL+      VHRDL + N +V + +TVK+ DFG++R    T  
Sbjct: 136 ------QMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 187
Query: 108 SSKSAAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
             K   G     WM+PE L+D      SD++SFGV+LWE+ATL +QP+  L+  QV+  V
Sbjct: 188 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 247
Query: 165 GFKGKRLEIPRNVNPHVASIIEACW 189
             +G  L+ P N    +  ++  CW
Sbjct: 248 -MEGGLLDKPDNCPDMLFELMRMCW 271

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score =  102 bits (255), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 68/194 (35%), Positives = 100/194 (51%), Gaps = 12/194 (6%)
Query: 1   MKRLRHPNIVLFMGA----VTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
           +K L+HPNIV F  +    V     + +VTE  + G+L   L +  V ++   R   +  
Sbjct: 79  LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLR---SWC 135
Query: 57  YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK-KYTVKVCDFGLSRLKANTFLSSKSAAGT 115
             + KG+ +LH R PPI+HRDLK  N+ +     +VK+ D GL+ LK  +F  +K+  GT
Sbjct: 136 RQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGT 193
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL-NPAQVVAAVGFKGKRLEIP 174
           PE+ APE   +E  +E  D+Y+FG    E AT + P+    N AQ+   V    K     
Sbjct: 194 PEFXAPEXY-EEKYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFD 252
Query: 175 RNVNPHVASIIEAC 188
           +   P V  IIE C
Sbjct: 253 KVAIPEVKEIIEGC 266

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  102 bits (255), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 64/191 (33%), Positives = 100/191 (52%), Gaps = 7/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHK-PGVREMLDERRRLNMAY 57
           ++ L+HPNIV +   +    N  L IV EY   G L  ++ K    R+ LDE   L +  
Sbjct: 59  LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 58  DVAKGMNYLHRRNP---PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
            +   +   HRR+     ++HRDLK  N+ +D K  VK+ DFGL+R+  +    +K+  G
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVG 178
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP 174
           TP +M+PE +     NEKSDI+S G +L+EL  L  P+   +  ++   +  +GK   IP
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIP 237
Query: 175 RNVNPHVASII 185
              +  +  II
Sbjct: 238 YRYSDELNEII 248

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score =  102 bits (255), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 25/205 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-------------PGVREML 47
           MK     ++V  +G V+Q     ++ E ++RG L   L               P + +M+
Sbjct: 72  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 131
Query: 48  DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 107
                  MA ++A GM YL+      VHRDL + N +V + +TVK+ DFG++R    T  
Sbjct: 132 ------QMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 183
Query: 108 SSKSAAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
             K   G     WM+PE L+D      SD++SFGV+LWE+ATL +QP+  L+  QV+  V
Sbjct: 184 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 243
Query: 165 GFKGKRLEIPRNVNPHVASIIEACW 189
             +G  L+ P N    +  ++  CW
Sbjct: 244 -MEGGLLDKPDNCPDMLFELMRMCW 267

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  102 bits (255), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 105/201 (52%), Gaps = 19/201 (9%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK---PGVR----------EMLDERR 51
           +H NI+  +GA TQ   L ++ EY S+G+L   L     PG+           E +  + 
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
            ++  Y +A+GM YL  +    +HRDL + N+LV +   +++ DFGL+R   N     K+
Sbjct: 159 LVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKT 216
Query: 112 AAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             G    +WMAPE L D     +SD++SFGV++WE+ TL   P+  + P + +  +  +G
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEG 275
Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R++ P N    +  ++  CW
Sbjct: 276 HRMDKPANCTNELYMMMRDCW 296

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score =  102 bits (255), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 25/205 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-------------PGVREML 47
           MK     ++V  +G V+Q     ++ E ++RG L   L               P + +M+
Sbjct: 73  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 132
Query: 48  DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 107
                  MA ++A GM YL+      VHRDL + N +V + +TVK+ DFG++R    T  
Sbjct: 133 ------QMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 184
Query: 108 SSKSAAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
             K   G     WM+PE L+D      SD++SFGV+LWE+ATL +QP+  L+  QV+  V
Sbjct: 185 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 244
Query: 165 GFKGKRLEIPRNVNPHVASIIEACW 189
             +G  L+ P N    +  ++  CW
Sbjct: 245 -MEGGLLDKPDNCPDMLFELMRMCW 268

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score =  102 bits (255), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 25/205 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-------------PGVREML 47
           MK     ++V  +G V+Q     ++ E ++RG L   L               P + +M+
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 48  DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 107
                  MA ++A GM YL+      VHRDL + N +V + +TVK+ DFG++R    T  
Sbjct: 135 ------QMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 186
Query: 108 SSKSAAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
             K   G     WM+PE L+D      SD++SFGV+LWE+ATL +QP+  L+  QV+  V
Sbjct: 187 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 246
Query: 165 GFKGKRLEIPRNVNPHVASIIEACW 189
             +G  L+ P N    +  ++  CW
Sbjct: 247 -MEGGLLDKPDNCPDMLFELMRMCW 270

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score =  102 bits (255), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 25/205 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-------------PGVREML 47
           MK     ++V  +G V+Q     ++ E ++RG L   L               P + +M+
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 48  DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 107
                  MA ++A GM YL+      VHRDL + N +V + +TVK+ DFG++R    T  
Sbjct: 135 ------QMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 186
Query: 108 SSKSAAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
             K   G     WM+PE L+D      SD++SFGV+LWE+ATL +QP+  L+  QV+  V
Sbjct: 187 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 246
Query: 165 GFKGKRLEIPRNVNPHVASIIEACW 189
             +G  L+ P N    +  ++  CW
Sbjct: 247 -MEGGLLDKPDNCPDMLFELMRMCW 270

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score =  102 bits (255), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 25/205 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-------------PGVREML 47
           MK     ++V  +G V+Q     ++ E ++RG L   L               P + +M+
Sbjct: 104 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 163
Query: 48  DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 107
                  MA ++A GM YL+      VHRDL + N +V + +TVK+ DFG++R    T  
Sbjct: 164 ------QMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 215
Query: 108 SSKSAAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
             K   G     WM+PE L+D      SD++SFGV+LWE+ATL +QP+  L+  QV+  V
Sbjct: 216 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 275
Query: 165 GFKGKRLEIPRNVNPHVASIIEACW 189
             +G  L+ P N    +  ++  CW
Sbjct: 276 -MEGGLLDKPDNCPDMLFELMRMCW 299

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score =  102 bits (255), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 25/205 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-------------PGVREML 47
           MK     ++V  +G V+Q     ++ E ++RG L   L               P + +M+
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 141
Query: 48  DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 107
                  MA ++A GM YL+      VHRDL + N +V + +TVK+ DFG++R    T  
Sbjct: 142 ------QMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 193
Query: 108 SSKSAAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
             K   G     WM+PE L+D      SD++SFGV+LWE+ATL +QP+  L+  QV+  V
Sbjct: 194 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253
Query: 165 GFKGKRLEIPRNVNPHVASIIEACW 189
             +G  L+ P N    +  ++  CW
Sbjct: 254 -MEGGLLDKPDNCPDMLFELMRMCW 277

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  102 bits (255), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/193 (35%), Positives = 106/193 (54%), Gaps = 7/193 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK+LRH  +V     V++ P + IVTEY+S+G L   L K  + + L   + ++MA  +A
Sbjct: 67  MKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIA 124
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
            GM Y+ R N   VHRDL++ N+LV +    KV DFGL+RL  +   +++  A  P +W 
Sbjct: 125 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 182
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE         KSD++SFG++L EL T  + P+  +   +V+  V  +G R+  P    
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 241
Query: 179 PHVASIIEACWAK 191
             +  ++  CW K
Sbjct: 242 ESLHDLMCQCWRK 254

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score =  102 bits (255), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 101/205 (49%), Gaps = 25/205 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-------------PGVREML 47
           MK     ++V  +G V++     +V E ++ G L   L               P ++EM+
Sbjct: 71  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 130
Query: 48  DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 107
                  MA ++A GM YL+ +    VHRDL + N +V   +TVK+ DFG++R    T  
Sbjct: 131 ------QMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDX 182
Query: 108 SSKSAAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
             K   G     WMAPE L+D      SD++SFGV+LWE+ +L +QP+  L+  QV+  V
Sbjct: 183 XRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 242
Query: 165 GFKGKRLEIPRNVNPHVASIIEACW 189
              G  L+ P N    V  ++  CW
Sbjct: 243 -MDGGYLDQPDNCPERVTDLMRMCW 266

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  102 bits (254), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 64/191 (33%), Positives = 100/191 (52%), Gaps = 7/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHK-PGVREMLDERRRLNMAY 57
           ++ L+HPNIV +   +    N  L IV EY   G L  ++ K    R+ LDE   L +  
Sbjct: 59  LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 58  DVAKGMNYLHRRNP---PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
            +   +   HRR+     ++HRDLK  N+ +D K  VK+ DFGL+R+  +    +K+  G
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG 178
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP 174
           TP +M+PE +     NEKSDI+S G +L+EL  L  P+   +  ++   +  +GK   IP
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIP 237
Query: 175 RNVNPHVASII 185
              +  +  II
Sbjct: 238 YRYSDELNEII 248

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score =  102 bits (254), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL--HKPGVREMLDERRR------ 52
           +  L+H +IV F G       L +V EY+  G L + L  H P    ++D + R      
Sbjct: 71  LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 53  -----LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTF 106
                L++A  +A GM YL  ++   VHRDL + N LV     VK+ DFG+SR + +  +
Sbjct: 131 GLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 188
Query: 107 LSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
                    P  WM PE +       +SD++SFGVILWE+ T  +QPW  L+  +V+  +
Sbjct: 189 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 248
Query: 165 GFKGKRLEIPRNVNPHVASIIEACWAK 191
             +G+ LE PR     V  ++  CW +
Sbjct: 249 T-QGRVLERPRVCPKEVYDVMLGCWQR 274

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score =  102 bits (254), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 25/205 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-------------PGVREML 47
           MK     ++V  +G V+Q     ++ E ++RG L   L               P + +M+
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 48  DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 107
                  MA ++A GM YL+      VHRDL + N +V + +TVK+ DFG++R    T  
Sbjct: 142 ------QMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 193
Query: 108 SSKSAAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
             K   G     WM+PE L+D      SD++SFGV+LWE+ATL +QP+  L+  QV+  V
Sbjct: 194 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253
Query: 165 GFKGKRLEIPRNVNPHVASIIEACW 189
             +G  L+ P N    +  ++  CW
Sbjct: 254 -MEGGLLDKPDNCPDMLFELMRMCW 277

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score =  102 bits (254), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 101/205 (49%), Gaps = 25/205 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-------------PGVREML 47
           MK     ++V  +G V++     +V E ++ G L   L               P ++EM+
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 48  DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 107
                  MA ++A GM YL+ +    VHRDL + N +V   +TVK+ DFG++R    T  
Sbjct: 134 ------QMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDX 185
Query: 108 SSKSAAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
             K   G     WMAPE L+D      SD++SFGV+LWE+ +L +QP+  L+  QV+  V
Sbjct: 186 XRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245
Query: 165 GFKGKRLEIPRNVNPHVASIIEACW 189
              G  L+ P N    V  ++  CW
Sbjct: 246 -MDGGYLDQPDNCPERVTDLMRMCW 269

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score =  102 bits (254), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 101/205 (49%), Gaps = 25/205 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-------------PGVREML 47
           MK     ++V  +G V++     +V E ++ G L   L               P ++EM+
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 48  DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 107
                  MA ++A GM YL+ +    VHRDL + N +V   +TVK+ DFG++R    T  
Sbjct: 134 ------QMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDX 185
Query: 108 SSKSAAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
             K   G     WMAPE L+D      SD++SFGV+LWE+ +L +QP+  L+  QV+  V
Sbjct: 186 XRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245
Query: 165 GFKGKRLEIPRNVNPHVASIIEACW 189
              G  L+ P N    V  ++  CW
Sbjct: 246 -MDGGYLDQPDNCPERVTDLMRMCW 269

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  102 bits (254), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/193 (35%), Positives = 106/193 (54%), Gaps = 7/193 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK+LRH  +V     V++ P + IV EY+S+GSL   L K  + + L   + ++MA  +A
Sbjct: 67  MKKLRHEKLVQLYAVVSEEP-IYIVCEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIA 124
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
            GM Y+ R N   VHRDL++ N+LV +    KV DFGL+RL  +   +++  A  P +W 
Sbjct: 125 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 182
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE         KSD++SFG++L EL T  + P+  +   +V+  V  +G R+  P    
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 241
Query: 179 PHVASIIEACWAK 191
             +  ++  CW K
Sbjct: 242 ESLHDLMCQCWRK 254

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score =  102 bits (253), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 104/201 (51%), Gaps = 19/201 (9%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK---PGVR----------EMLDERR 51
           +H NI+  +GA TQ   L ++ EY S+G+L   L     PG+           E +  + 
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
            ++  Y +A+GM YL  +    +HRDL + N+LV +   +K+ DFGL+R   N      +
Sbjct: 159 LVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNT 216
Query: 112 AAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             G    +WMAPE L D     +SD++SFGV++WE+ TL   P+  + P + +  +  +G
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEG 275
Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R++ P N    +  ++  CW
Sbjct: 276 HRMDKPANCTNELYMMMRDCW 296

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score =  102 bits (253), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 101/205 (49%), Gaps = 25/205 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-------------PGVREML 47
           MK     ++V  +G V++     +V E ++ G L   L               P ++EM+
Sbjct: 73  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 132
Query: 48  DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 107
                  MA ++A GM YL+ +    VHRDL + N +V   +TVK+ DFG++R    T  
Sbjct: 133 ------QMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 184
Query: 108 SSKSAAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
             K   G     WMAPE L+D      SD++SFGV+LWE+ +L +QP+  L+  QV+  V
Sbjct: 185 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 244
Query: 165 GFKGKRLEIPRNVNPHVASIIEACW 189
              G  L+ P N    V  ++  CW
Sbjct: 245 -MDGGYLDQPDNCPERVTDLMRMCW 268

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  102 bits (253), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/193 (35%), Positives = 106/193 (54%), Gaps = 7/193 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK+LRH  +V     V++ P + IV EY+S+GSL   L K  + + L   + ++MA  +A
Sbjct: 67  MKKLRHEKLVQLYAVVSEEP-IYIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIA 124
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
            GM Y+ R N   VHRDL++ N+LV +    KV DFGL+RL  +   +++  A  P +W 
Sbjct: 125 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 182
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE         KSD++SFG++L EL T  + P+  +   +V+  V  +G R+  P    
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 241
Query: 179 PHVASIIEACWAK 191
             +  ++  CW K
Sbjct: 242 ESLHDLMCQCWRK 254

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score =  102 bits (253), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 101/205 (49%), Gaps = 25/205 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-------------PGVREML 47
           MK     ++V  +G V++     +V E ++ G L   L               P ++EM+
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 48  DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 107
                  MA ++A GM YL+ +    VHRDL + N +V   +TVK+ DFG++R    T  
Sbjct: 134 ------QMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAY 185
Query: 108 SSKSAAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
             K   G     WMAPE L+D      SD++SFGV+LWE+ +L +QP+  L+  QV+  V
Sbjct: 186 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245
Query: 165 GFKGKRLEIPRNVNPHVASIIEACW 189
              G  L+ P N    V  ++  CW
Sbjct: 246 -MDGGYLDQPDNCPERVTDLMRMCW 269

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  102 bits (253), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/193 (35%), Positives = 106/193 (54%), Gaps = 7/193 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK+LRH  +V     V++ P + IV EY+S+GSL   L K  + + L   + ++MA  +A
Sbjct: 67  MKKLRHEKLVQLYAVVSEEP-IYIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIA 124
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
            GM Y+ R N   VHRDL++ N+LV +    KV DFGL+RL  +   +++  A  P +W 
Sbjct: 125 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWT 182
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE         KSD++SFG++L EL T  + P+  +   +V+  V  +G R+  P    
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 241
Query: 179 PHVASIIEACWAK 191
             +  ++  CW K
Sbjct: 242 ESLHDLMCQCWRK 254

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  101 bits (252), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 109/192 (56%), Gaps = 8/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-PGVREMLDERRRLNMAYDV 59
           MK L+H  +V     VT+   + I+TE++++GSL   L    G + +L   + ++ +  +
Sbjct: 61  MKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQI 118
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           A+GM Y+ R+N   +HRDL++ N+LV +    K+ DFGL+R+  +   +++  A  P +W
Sbjct: 119 AEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW 176
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            APE +       KS+++SFG++L+E+ T  + P+     A V++A+  +G R+    N 
Sbjct: 177 TAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALS-QGYRMPRMENC 235
Query: 178 NPHVASIIEACW 189
              +  I++ CW
Sbjct: 236 PDELYDIMKMCW 247

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score =  101 bits (252), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 102/205 (49%), Gaps = 25/205 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-------------PGVREML 47
           MK     ++V  +G V+Q     ++ E ++RG L   L               P + +M+
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 48  DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 107
                  MA ++A GM YL+      VHRDL + N  V + +TVK+ DFG++R    T  
Sbjct: 129 ------QMAGEIADGMAYLNANK--FVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDY 180
Query: 108 SSKSAAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
             K   G     WM+PE L+D      SD++SFGV+LWE+ATL +QP+  L+  QV+  V
Sbjct: 181 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 240
Query: 165 GFKGKRLEIPRNVNPHVASIIEACW 189
             +G  L+ P N    +  ++  CW
Sbjct: 241 -MEGGLLDKPDNCPDMLLELMRMCW 264

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score =  101 bits (252), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 101/205 (49%), Gaps = 25/205 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-------------PGVREML 47
           MK     ++V  +G V++     +V E ++ G L   L               P ++EM+
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 48  DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 107
                  MA ++A GM YL+ +    VHRDL + N +V   +TVK+ DFG++R    T  
Sbjct: 134 ------QMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 185
Query: 108 SSKSAAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
             K   G     WMAPE L+D      SD++SFGV+LWE+ +L +QP+  L+  QV+  V
Sbjct: 186 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245
Query: 165 GFKGKRLEIPRNVNPHVASIIEACW 189
              G  L+ P N    V  ++  CW
Sbjct: 246 -MDGGYLDQPDNCPERVTDLMRMCW 269

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  101 bits (252), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 104/201 (51%), Gaps = 19/201 (9%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK---PGVR----------EMLDERR 51
           +H NI+  +GA TQ   L ++  Y S+G+L   L     PG+           E +  + 
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
            ++  Y +A+GM YL  +    +HRDL + N+LV +   +K+ DFGL+R   N     K+
Sbjct: 159 LVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 112 AAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             G    +WMAPE L D     +SD++SFGV++WE+ TL   P+  + P + +  +  +G
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEG 275
Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R++ P N    +  ++  CW
Sbjct: 276 HRMDKPANCTNELYMMMRDCW 296

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score =  101 bits (252), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 110/192 (57%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-PGVREMLDERRRLNMAYDV 59
           MK L+H  +V     VT+ P + I+TE++++GSL   L    G ++ L   + ++ +  +
Sbjct: 64  MKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQI 120
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           A+GM ++ +RN   +HRDL++ N+LV      K+ DFGL+R+  +   +++  A  P +W
Sbjct: 121 AEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW 178
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            APE +       KSD++SFG++L E+ T  + P+  ++  +V+ A+  +G R+  P N 
Sbjct: 179 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENC 237
Query: 178 NPHVASIIEACW 189
              + +I+  CW
Sbjct: 238 PEELYNIMMRCW 249

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 64/191 (33%), Positives = 99/191 (51%), Gaps = 7/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHK-PGVREMLDERRRLNMAY 57
           ++ L+HPNIV +   +    N  L IV EY   G L  ++ K    R+ LDE   L +  
Sbjct: 59  LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 58  DVAKGMNYLHRRNP---PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
            +   +   HRR+     ++HRDLK  N+ +D K  VK+ DFGL+R+  +    +K   G
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVG 178
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP 174
           TP +M+PE +     NEKSDI+S G +L+EL  L  P+   +  ++   +  +GK   IP
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIP 237
Query: 175 RNVNPHVASII 185
              +  +  II
Sbjct: 238 YRYSDELNEII 248

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score =  101 bits (251), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 66/194 (34%), Positives = 98/194 (50%), Gaps = 9/194 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  L H N++   G V  PP + +VTE    GSL   L K     +L    R   A  VA
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVA 121
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAAGTPE 117
           +GM YL  +    +HRDL + NLL+  +  VK+ DFGL R      + ++  +       
Sbjct: 122 EGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE L+    +  SD + FGV LWE+ T  Q+PW  LN +Q++  +  +G+RL  P +
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239
Query: 177 VNPHVASIIEACWA 190
               + +++  CWA
Sbjct: 240 CPQDIYNVMVQCWA 253

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score =  101 bits (251), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 110/192 (57%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-PGVREMLDERRRLNMAYDV 59
           MK L+H  +V     VT+ P + I+TE++++GSL   L    G ++ L   + ++ +  +
Sbjct: 237 MKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQI 293
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           A+GM ++ +RN   +HRDL++ N+LV      K+ DFGL+R+  +   +++  A  P +W
Sbjct: 294 AEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW 351
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            APE +       KSD++SFG++L E+ T  + P+  ++  +V+ A+  +G R+  P N 
Sbjct: 352 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENC 410
Query: 178 NPHVASIIEACW 189
              + +I+  CW
Sbjct: 411 PEELYNIMMRCW 422

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score =  101 bits (251), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 108/193 (55%), Gaps = 10/193 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +L +P IV  +G V Q   L +V E    G L++ L   G RE +       + + V+
Sbjct: 64  MHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVS 120
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA--NTFLSSKSAAGTP-E 117
            GM YL  +N   VHRDL + N+L+  ++  K+ DFGLS+     +++ +++SA   P +
Sbjct: 121 MGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 178
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWE-LATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE +     + +SD++S+GV +WE L+  Q+P+  +   +V+A +  +GKR+E P  
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPE 237
Query: 177 VNPHVASIIEACW 189
             P + +++  CW
Sbjct: 238 CPPELYALMSDCW 250

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  101 bits (251), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 68/193 (35%), Positives = 105/193 (54%), Gaps = 7/193 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK+LRH  +V     V++ P + IV EY+S+GSL   L K    + L   + ++MA  +A
Sbjct: 233 MKKLRHEKLVQLYAVVSEEP-IYIVGEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIA 290
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
            GM Y+ R N   VHRDL++ N+LV +    KV DFGL+RL  +   +++  A  P +W 
Sbjct: 291 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 348
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE         KSD++SFG++L EL T  + P+  +   +V+  V  +G R+  P    
Sbjct: 349 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 407
Query: 179 PHVASIIEACWAK 191
             +  ++  CW K
Sbjct: 408 ESLHDLMCQCWRK 420

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score =  101 bits (251), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 66/194 (34%), Positives = 98/194 (50%), Gaps = 9/194 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  L H N++   G V  PP + +VTE    GSL   L K     +L    R   A  VA
Sbjct: 69  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVA 125
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAAGTPE 117
           +GM YL  +    +HRDL + NLL+  +  VK+ DFGL R      + ++  +       
Sbjct: 126 EGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 183
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE L+    +  SD + FGV LWE+ T  Q+PW  LN +Q++  +  +G+RL  P +
Sbjct: 184 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 243
Query: 177 VNPHVASIIEACWA 190
               + +++  CWA
Sbjct: 244 CPQDIYNVMVQCWA 257

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score =  101 bits (251), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 66/194 (34%), Positives = 98/194 (50%), Gaps = 9/194 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  L H N++   G V  PP + +VTE    GSL   L K     +L    R   A  VA
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVA 121
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAAGTPE 117
           +GM YL  +    +HRDL + NLL+  +  VK+ DFGL R      + ++  +       
Sbjct: 122 EGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE L+    +  SD + FGV LWE+ T  Q+PW  LN +Q++  +  +G+RL  P +
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239
Query: 177 VNPHVASIIEACWA 190
               + +++  CWA
Sbjct: 240 CPQDIYNVMVQCWA 253

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score =  101 bits (251), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 66/194 (34%), Positives = 98/194 (50%), Gaps = 9/194 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  L H N++   G V  PP + +VTE    GSL   L K     +L    R   A  VA
Sbjct: 75  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVA 131
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAAGTPE 117
           +GM YL  +    +HRDL + NLL+  +  VK+ DFGL R      + ++  +       
Sbjct: 132 EGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 189
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE L+    +  SD + FGV LWE+ T  Q+PW  LN +Q++  +  +G+RL  P +
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 249
Query: 177 VNPHVASIIEACWA 190
               + +++  CWA
Sbjct: 250 CPQDIYNVMVQCWA 263

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score =  101 bits (251), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 66/194 (34%), Positives = 98/194 (50%), Gaps = 9/194 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  L H N++   G V  PP + +VTE    GSL   L K     +L    R   A  VA
Sbjct: 69  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVA 125
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAAGTPE 117
           +GM YL  +    +HRDL + NLL+  +  VK+ DFGL R      + ++  +       
Sbjct: 126 EGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 183
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE L+    +  SD + FGV LWE+ T  Q+PW  LN +Q++  +  +G+RL  P +
Sbjct: 184 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 243
Query: 177 VNPHVASIIEACWA 190
               + +++  CWA
Sbjct: 244 CPQDIYNVMVQCWA 257

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  101 bits (251), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 104/201 (51%), Gaps = 19/201 (9%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK---PGVR----------EMLDERR 51
           +H NI+  +GA TQ   L ++  Y S+G+L   L     PG+           E +  + 
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
            ++  Y +A+GM YL  +    +HRDL + N+LV +   +K+ DFGL+R   N     K+
Sbjct: 159 LVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 112 AAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             G    +WMAPE L D     +SD++SFGV++WE+ TL   P+  + P + +  +  +G
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEG 275
Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R++ P N    +  ++  CW
Sbjct: 276 HRMDKPANCTNELYMMMRDCW 296

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  101 bits (251), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 67/193 (34%), Positives = 106/193 (54%), Gaps = 7/193 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK+LRH  +V     V++ P + IVTEY+++GSL   L K    + L   + ++M+  +A
Sbjct: 64  MKKLRHEKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFL-KGETGKYLRLPQLVDMSAQIA 121
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
            GM Y+ R N   VHRDL++ N+LV +    KV DFGL+RL  +   +++  A  P +W 
Sbjct: 122 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 179
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE         KSD++SFG++L EL T  + P+  +   +V+  V  +G R+  P    
Sbjct: 180 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 238
Query: 179 PHVASIIEACWAK 191
             +  ++  CW K
Sbjct: 239 ESLHDLMCQCWRK 251

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  100 bits (250), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 67/193 (34%), Positives = 106/193 (54%), Gaps = 7/193 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK+LRH  +V     V++ P + IVTEY+++GSL   L K    + L   + ++M+  +A
Sbjct: 64  MKKLRHEKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFL-KGETGKYLRLPQLVDMSAQIA 121
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
            GM Y+ R N   VHRDL++ N+LV +    KV DFGL+RL  +   +++  A  P +W 
Sbjct: 122 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWT 179
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE         KSD++SFG++L EL T  + P+  +   +V+  V  +G R+  P    
Sbjct: 180 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 238
Query: 179 PHVASIIEACWAK 191
             +  ++  CW K
Sbjct: 239 ESLHDLMCQCWRK 251

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score =  100 bits (249), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVT-EYLSRGSLYRLL----HKPGVREMLDERRRLNM 55
           MK   HPN++  +G   +     +V   Y+  G L   +    H P V++++        
Sbjct: 84  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI------GF 137
Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSA 112
              VAKGM YL  +    VHRDL + N ++D+K+TVKV DFGL+R    K    + +K+ 
Sbjct: 138 GLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTG 195
Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKR 170
           A  P +WMA E L+ +    KSD++SFGV+LWEL T    P+ ++N   +   +  +G+R
Sbjct: 196 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRR 254
Query: 171 LEIPRNVNPHVASIIEACW 189
           L  P      +  ++  CW
Sbjct: 255 LLQPEYCPDPLYEVMLKCW 273

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 67/193 (34%), Positives = 105/193 (54%), Gaps = 7/193 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK+LRH  +V     V++ P + IV EY+S+G L   L K  + + L   + ++MA  +A
Sbjct: 67  MKKLRHEKLVQLYAVVSEEP-IYIVMEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIA 124
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
            GM Y+ R N   VHRDL++ N+LV +    KV DFGL+RL  +   +++  A  P +W 
Sbjct: 125 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 182
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE         KSD++SFG++L EL T  + P+  +   +V+  V  +G R+  P    
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 241
Query: 179 PHVASIIEACWAK 191
             +  ++  CW K
Sbjct: 242 ESLHDLMCQCWRK 254

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  100 bits (248), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL--HKPGVREM--------LDER 50
           +  L+H +IV F G   +   L +V EY+  G L + L  H P    M        L + 
Sbjct: 69  LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQS 128
Query: 51  RRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSS 109
           + L++A  +A GM YL  ++   VHRDL + N LV +   VK+ DFG+SR + +  +   
Sbjct: 129 QMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV 186
Query: 110 KSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFK 167
                 P  WM PE +       +SD++S GV+LWE+ T  +QPW  L+  +V+  +  +
Sbjct: 187 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT-Q 245
Query: 168 GKRLEIPRNVNPHVASIIEACWAK 191
           G+ L+ PR     V  ++  CW +
Sbjct: 246 GRVLQRPRTCPQEVYELMLGCWQR 269

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score =  100 bits (248), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 98/194 (50%), Gaps = 9/194 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  L H N++   G V  PP + +VTE    GSL   L K     +L    R   A  VA
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVA 121
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP-E 117
           +GM YL  +    +HRDL + NLL+  +  VK+ DFGL R   + +     +     P  
Sbjct: 122 EGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFA 179
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE L+    +  SD + FGV LWE+ T  Q+PW  LN +Q++  +  +G+RL  P +
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239
Query: 177 VNPHVASIIEACWA 190
               + +++  CWA
Sbjct: 240 CPQDIYNVMVQCWA 253

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score =  100 bits (248), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 98/194 (50%), Gaps = 9/194 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  L H N++   G V  PP + +VTE    GSL   L K     +L    R   A  VA
Sbjct: 75  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVA 131
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP-E 117
           +GM YL  +    +HRDL + NLL+  +  VK+ DFGL R   + +     +     P  
Sbjct: 132 EGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFA 189
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE L+    +  SD + FGV LWE+ T  Q+PW  LN +Q++  +  +G+RL  P +
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 249
Query: 177 VNPHVASIIEACWA 190
               + +++  CWA
Sbjct: 250 CPQDIYNVMVQCWA 263

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 99.8 bits (247), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVT-EYLSRGSLYRLL----HKPGVREMLDERRRLNM 55
           MK   HPN++  +G   +     +V   Y+  G L   +    H P V++++        
Sbjct: 77  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI------GF 130
Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSA 112
              VAKGM YL  +    VHRDL + N ++D+K+TVKV DFGL+R    K    + +K+ 
Sbjct: 131 GLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 188
Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKR 170
           A  P +WMA E L+ +    KSD++SFGV+LWEL T    P+ ++N   +   +  +G+R
Sbjct: 189 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRR 247
Query: 171 LEIPRNVNPHVASIIEACW 189
           L  P      +  ++  CW
Sbjct: 248 LLQPEYCPDPLYEVMLKCW 266

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 99.8 bits (247), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 93/153 (60%), Gaps = 5/153 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
           +  ++HPNIV +  +  +  +L IV +Y   G L+ R+  + GV  +  E + L+    +
Sbjct: 77  LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGV--LFQEDQILDWFVQI 134
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
              + ++H R   I+HRD+KS N+ + K  TV++ DFG++R+  +T   +++  GTP ++
Sbjct: 135 CLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYL 192
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +PE+  ++P N KSDI++ G +L+EL TL+  +
Sbjct: 193 SPEICENKPYNNKSDIWALGCVLYELCTLKHAF 225

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 99.8 bits (247), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVT-EYLSRGSLYRLL----HKPGVREMLDERRRLNM 55
           MK   HPN++  +G   +     +V   Y+  G L   +    H P V++++        
Sbjct: 85  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI------GF 138
Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSA 112
              VAKGM YL  +    VHRDL + N ++D+K+TVKV DFGL+R    K    + +K+ 
Sbjct: 139 GLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 196
Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKR 170
           A  P +WMA E L+ +    KSD++SFGV+LWEL T    P+ ++N   +   +  +G+R
Sbjct: 197 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRR 255
Query: 171 LEIPRNVNPHVASIIEACW 189
           L  P      +  ++  CW
Sbjct: 256 LLQPEYCPDPLYEVMLKCW 274

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 99.8 bits (247), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 57/163 (34%), Positives = 89/163 (54%), Gaps = 26/163 (15%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDER----RRLNMA 56
           M+ L HPN++ F+G + +   L+ +TEY+  G+L       G+ + +D +    +R++ A
Sbjct: 61  MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLR------GIIKSMDSQYPWSQRVSFA 114
Query: 57  YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK------ 110
            D+A GM YLH  N  I+HRDL S N LV +   V V DFGL+RL  +     +      
Sbjct: 115 KDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLK 172
Query: 111 --------SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
                   +  G P WMAPE++     +EK D++SFG++L E+
Sbjct: 173 KPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEI 215

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 99.8 bits (247), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVT-EYLSRGSLYRLL----HKPGVREMLDERRRLNM 55
           MK   HPN++  +G   +     +V   Y+  G L   +    H P V++++        
Sbjct: 80  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI------GF 133
Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSA 112
              VAKGM YL  +    VHRDL + N ++D+K+TVKV DFGL+R    K    + +K+ 
Sbjct: 134 GLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 191
Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKR 170
           A  P +WMA E L+ +    KSD++SFGV+LWEL T    P+ ++N   +   +  +G+R
Sbjct: 192 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRR 250
Query: 171 LEIPRNVNPHVASIIEACW 189
           L  P      +  ++  CW
Sbjct: 251 LLQPEYCPDPLYEVMLKCW 269

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 99.8 bits (247), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVT-EYLSRGSLYRLL----HKPGVREMLDERRRLNM 55
           MK   HPN++  +G   +     +V   Y+  G L   +    H P V++++        
Sbjct: 85  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI------GF 138
Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSA 112
              VAKGM YL  +    VHRDL + N ++D+K+TVKV DFGL+R    K    + +K+ 
Sbjct: 139 GLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 196
Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKR 170
           A  P +WMA E L+ +    KSD++SFGV+LWEL T    P+ ++N   +   +  +G+R
Sbjct: 197 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRR 255
Query: 171 LEIPRNVNPHVASIIEACW 189
           L  P      +  ++  CW
Sbjct: 256 LLQPEYCPDPLYEVMLKCW 274

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 99.8 bits (247), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVT-EYLSRGSLYRLL----HKPGVREMLDERRRLNM 55
           MK   HPN++  +G   +     +V   Y+  G L   +    H P V++++        
Sbjct: 103 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI------GF 156
Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSA 112
              VAKGM YL  +    VHRDL + N ++D+K+TVKV DFGL+R    K    + +K+ 
Sbjct: 157 GLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 214
Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKR 170
           A  P +WMA E L+ +    KSD++SFGV+LWEL T    P+ ++N   +   +  +G+R
Sbjct: 215 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRR 273
Query: 171 LEIPRNVNPHVASIIEACW 189
           L  P      +  ++  CW
Sbjct: 274 LLQPEYCPDPLYEVMLKCW 292

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 99.8 bits (247), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVT-EYLSRGSLYRLL----HKPGVREMLDERRRLNM 55
           MK   HPN++  +G   +     +V   Y+  G L   +    H P V++++        
Sbjct: 104 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI------GF 157
Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSA 112
              VAKGM YL  +    VHRDL + N ++D+K+TVKV DFGL+R    K    + +K+ 
Sbjct: 158 GLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 215
Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKR 170
           A  P +WMA E L+ +    KSD++SFGV+LWEL T    P+ ++N   +   +  +G+R
Sbjct: 216 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRR 274
Query: 171 LEIPRNVNPHVASIIEACW 189
           L  P      +  ++  CW
Sbjct: 275 LLQPEYCPDPLYEVMLKCW 293

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 99.8 bits (247), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVT-EYLSRGSLYRLL----HKPGVREMLDERRRLNM 55
           MK   HPN++  +G   +     +V   Y+  G L   +    H P V++++        
Sbjct: 82  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI------GF 135
Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSA 112
              VAKGM YL  +    VHRDL + N ++D+K+TVKV DFGL+R    K    + +K+ 
Sbjct: 136 GLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 193
Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKR 170
           A  P +WMA E L+ +    KSD++SFGV+LWEL T    P+ ++N   +   +  +G+R
Sbjct: 194 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRR 252
Query: 171 LEIPRNVNPHVASIIEACW 189
           L  P      +  ++  CW
Sbjct: 253 LLQPEYCPDPLYEVMLKCW 271

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 99.8 bits (247), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVT-EYLSRGSLYRLL----HKPGVREMLDERRRLNM 55
           MK   HPN++  +G   +     +V   Y+  G L   +    H P V++++        
Sbjct: 83  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI------GF 136
Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSA 112
              VAKGM YL  +    VHRDL + N ++D+K+TVKV DFGL+R    K    + +K+ 
Sbjct: 137 GLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 194
Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKR 170
           A  P +WMA E L+ +    KSD++SFGV+LWEL T    P+ ++N   +   +  +G+R
Sbjct: 195 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRR 253
Query: 171 LEIPRNVNPHVASIIEACW 189
           L  P      +  ++  CW
Sbjct: 254 LLQPEYCPDPLYEVMLKCW 272

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 99.8 bits (247), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVT-EYLSRGSLYRLL----HKPGVREMLDERRRLNM 55
           MK   HPN++  +G   +     +V   Y+  G L   +    H P V++++        
Sbjct: 84  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI------GF 137
Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSA 112
              VAKGM YL  +    VHRDL + N ++D+K+TVKV DFGL+R    K    + +K+ 
Sbjct: 138 GLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 195
Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKR 170
           A  P +WMA E L+ +    KSD++SFGV+LWEL T    P+ ++N   +   +  +G+R
Sbjct: 196 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRR 254
Query: 171 LEIPRNVNPHVASIIEACW 189
           L  P      +  ++  CW
Sbjct: 255 LLQPEYCPDPLYEVMLKCW 273

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 99.8 bits (247), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 101/205 (49%), Gaps = 25/205 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-------------PGVREML 47
           MK     ++V  +G V++     +V E ++ G L   L               P ++EM+
Sbjct: 75  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 134
Query: 48  DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 107
                  MA ++A GM YL+ +    VHR+L + N +V   +TVK+ DFG++R    T  
Sbjct: 135 ------QMAAEIADGMAYLNAKK--FVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDY 186
Query: 108 SSKSAAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
             K   G     WMAPE L+D      SD++SFGV+LWE+ +L +QP+  L+  QV+  V
Sbjct: 187 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 246
Query: 165 GFKGKRLEIPRNVNPHVASIIEACW 189
              G  L+ P N    V  ++  CW
Sbjct: 247 -MDGGYLDQPDNCPERVTDLMRMCW 270

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 99.8 bits (247), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 108/193 (55%), Gaps = 10/193 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +L +P IV  +G V Q   L +V E    G L++ L   G RE +       + + V+
Sbjct: 390 MHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVS 446
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA--NTFLSSKSAAGTP-E 117
            GM YL  +N   VHR+L + N+L+  ++  K+ DFGLS+     +++ +++SA   P +
Sbjct: 447 MGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 504
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWE-LATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE +     + +SD++S+GV +WE L+  Q+P+  +   +V+A +  +GKR+E P  
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPE 563
Query: 177 VNPHVASIIEACW 189
             P + +++  CW
Sbjct: 564 CPPELYALMSDCW 576

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 103/196 (52%), Gaps = 11/196 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL-HKPGVREMLDERRRLNMAYDV 59
           M +  H NI+   G +++   + I+TEY+  G+L + L  K G   +L   + + M   +
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVL---QLVGMLRGI 156
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--- 116
           A GM YL   N   VHRDL + N+LV+     KV DFGLSR+  +   ++ + +G     
Sbjct: 157 AAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 214
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPR 175
            W APE +        SD++SFG+++WE+ T  ++P+  L+  +V+ A+   G RL  P 
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPM 273
Query: 176 NVNPHVASIIEACWAK 191
           +    +  ++  CW +
Sbjct: 274 DCPSAIYQLMMQCWQQ 289

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 99.4 bits (246), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 101/205 (49%), Gaps = 25/205 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-------------PGVREML 47
           MK     ++V  +G V++     +V E ++ G L   L               P ++EM+
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 48  DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 107
                  MA ++A GM YL+ +    VHR+L + N +V   +TVK+ DFG++R    T  
Sbjct: 134 ------QMAAEIADGMAYLNAKK--FVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDY 185
Query: 108 SSKSAAGT--PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
             K   G     WMAPE L+D      SD++SFGV+LWE+ +L +QP+  L+  QV+  V
Sbjct: 186 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245
Query: 165 GFKGKRLEIPRNVNPHVASIIEACW 189
              G  L+ P N    V  ++  CW
Sbjct: 246 -MDGGYLDQPDNCPERVTDLMRMCW 269

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 102/199 (51%), Gaps = 19/199 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVT-EYLSRGSLYRLL----HKPGVREMLDERRRLNM 55
           MK   HPN++  +G   +     +V   Y+  G L   +    H P V++++        
Sbjct: 85  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI------GF 138
Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS---KSA 112
              VAKGM +L  +    VHRDL + N ++D+K+TVKV DFGL+R   +    S   K+ 
Sbjct: 139 GLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 196
Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKR 170
           A  P +WMA E L+ +    KSD++SFGV+LWEL T    P+ ++N   +   +  +G+R
Sbjct: 197 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRR 255
Query: 171 LEIPRNVNPHVASIIEACW 189
           L  P      +  ++  CW
Sbjct: 256 LLQPEYCPDPLYEVMLKCW 274

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 99/195 (50%), Gaps = 9/195 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +  HPNI+   G VT+     IVTEY+  GSL   L     +  +   + + M   V 
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQLVGMLRGVG 161
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP---E 117
            GM YL   +   VHRDL + N+LVD     KV DFGLSR+  +   ++ +  G      
Sbjct: 162 AGMRYLS--DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIR 219
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWE-LATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE +     +  SD++SFGV++WE LA  ++P+ N+    V+++V  +G RL  P  
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPMG 278
Query: 177 VNPHVASIIEACWAK 191
               +  ++  CW K
Sbjct: 279 CPHALHQLMLDCWHK 293

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 102/199 (51%), Gaps = 19/199 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVT-EYLSRGSLYRLL----HKPGVREMLDERRRLNM 55
           MK   HPN++  +G   +     +V   Y+  G L   +    H P V++++        
Sbjct: 86  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI------GF 139
Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS---KSA 112
              VAKGM +L  +    VHRDL + N ++D+K+TVKV DFGL+R   +    S   K+ 
Sbjct: 140 GLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 197
Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKR 170
           A  P +WMA E L+ +    KSD++SFGV+LWEL T    P+ ++N   +   +  +G+R
Sbjct: 198 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRR 256
Query: 171 LEIPRNVNPHVASIIEACW 189
           L  P      +  ++  CW
Sbjct: 257 LLQPEYCPDPLYEVMLKCW 275

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 102/199 (51%), Gaps = 19/199 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVT-EYLSRGSLYRLL----HKPGVREMLDERRRLNM 55
           MK   HPN++  +G   +     +V   Y+  G L   +    H P V++++        
Sbjct: 86  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI------GF 139
Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS---KSA 112
              VAKGM +L  +    VHRDL + N ++D+K+TVKV DFGL+R   +    S   K+ 
Sbjct: 140 GLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTG 197
Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKR 170
           A  P +WMA E L+ +    KSD++SFGV+LWEL T    P+ ++N   +   +  +G+R
Sbjct: 198 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRR 256
Query: 171 LEIPRNVNPHVASIIEACW 189
           L  P      +  ++  CW
Sbjct: 257 LLQPEYCPDPLYEVMLKCW 275

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 102/199 (51%), Gaps = 19/199 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVT-EYLSRGSLYRLL----HKPGVREMLDERRRLNM 55
           MK   HPN++  +G   +     +V   Y+  G L   +    H P V++++        
Sbjct: 83  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI------GF 136
Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS---KSA 112
              VAKGM +L  +    VHRDL + N ++D+K+TVKV DFGL+R   +    S   K+ 
Sbjct: 137 GLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 194
Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKR 170
           A  P +WMA E L+ +    KSD++SFGV+LWEL T    P+ ++N   +   +  +G+R
Sbjct: 195 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRR 253
Query: 171 LEIPRNVNPHVASIIEACW 189
           L  P      +  ++  CW
Sbjct: 254 LLQPEYCPDPLYEVMLKCW 272

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 102/199 (51%), Gaps = 19/199 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVT-EYLSRGSLYRLL----HKPGVREMLDERRRLNM 55
           MK   HPN++  +G   +     +V   Y+  G L   +    H P V++++        
Sbjct: 90  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI------GF 143
Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS---KSA 112
              VAKGM +L  +    VHRDL + N ++D+K+TVKV DFGL+R   +    S   K+ 
Sbjct: 144 GLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 201
Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKR 170
           A  P +WMA E L+ +    KSD++SFGV+LWEL T    P+ ++N   +   +  +G+R
Sbjct: 202 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRR 260
Query: 171 LEIPRNVNPHVASIIEACW 189
           L  P      +  ++  CW
Sbjct: 261 LLQPEYCPDPLYEVMLKCW 279

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 102/199 (51%), Gaps = 19/199 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVT-EYLSRGSLYRLL----HKPGVREMLDERRRLNM 55
           MK   HPN++  +G   +     +V   Y+  G L   +    H P V++++        
Sbjct: 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI------GF 197
Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS---KSA 112
              VAKGM +L  +    VHRDL + N ++D+K+TVKV DFGL+R   +    S   K+ 
Sbjct: 198 GLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 255
Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKR 170
           A  P +WMA E L+ +    KSD++SFGV+LWEL T    P+ ++N   +   +  +G+R
Sbjct: 256 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRR 314
Query: 171 LEIPRNVNPHVASIIEACW 189
           L  P      +  ++  CW
Sbjct: 315 LLQPEYCPDPLYEVMLKCW 333

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 19/201 (9%)
Query: 6   HPNIVLFMGAVTQPPN-LSIVTEYLSRGSL-------------YRLLHKPGVREMLDERR 51
           H N+V  +GA T+P   L ++TE+   G+L             Y++  +   ++ L    
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSS 109
            +  ++ VAKGM +L  R    +HRDL + N+L+ +K  VK+CDFGL+R   K   ++  
Sbjct: 141 LICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 198
Query: 110 KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             A    +WMAPE + D     +SD++SFGV+LWE+ +L   P+  +   +       +G
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 258
Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R+  P    P +   +  CW
Sbjct: 259 TRMRAPDYTTPEMYQTMLDCW 279

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 102/199 (51%), Gaps = 19/199 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVT-EYLSRGSLYRLL----HKPGVREMLDERRRLNM 55
           MK   HPN++  +G   +     +V   Y+  G L   +    H P V++++        
Sbjct: 85  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI------GF 138
Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS---KSA 112
              VAKGM +L  +    VHRDL + N ++D+K+TVKV DFGL+R   +    S   K+ 
Sbjct: 139 GLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 196
Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKR 170
           A  P +WMA E L+ +    KSD++SFGV+LWEL T    P+ ++N   +   +  +G+R
Sbjct: 197 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRR 255
Query: 171 LEIPRNVNPHVASIIEACW 189
           L  P      +  ++  CW
Sbjct: 256 LLQPEYCPDPLYEVMLKCW 274

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 98.6 bits (244), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 19/201 (9%)
Query: 6   HPNIVLFMGAVTQPPN-LSIVTEYLSRGSL-------------YRLLHKPGVREMLDERR 51
           H N+V  +GA T+P   L ++TE+   G+L             Y++  +   ++ L    
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSS 109
            +  ++ VAKGM +L  R    +HRDL + N+L+ +K  VK+CDFGL+R   K   ++  
Sbjct: 141 LICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 198
Query: 110 KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             A    +WMAPE + D     +SD++SFGV+LWE+ +L   P+  +   +       +G
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 258
Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R+  P    P +   +  CW
Sbjct: 259 TRMRAPDYTTPEMYQTMLDCW 279

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 98.6 bits (244), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 99/195 (50%), Gaps = 9/195 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +  HPNI+   G VT+     IVTEY+  GSL   L     +  +   + + M   V 
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQLVGMLRGVG 161
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP---E 117
            GM YL   +   VHRDL + N+LVD     KV DFGLSR+  +   ++ +  G      
Sbjct: 162 AGMRYLS--DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR 219
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWE-LATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE +     +  SD++SFGV++WE LA  ++P+ N+    V+++V  +G RL  P  
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPMG 278
Query: 177 VNPHVASIIEACWAK 191
               +  ++  CW K
Sbjct: 279 CPHALHQLMLDCWHK 293

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 98.6 bits (244), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 59/150 (39%), Positives = 85/150 (56%), Gaps = 7/150 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M + +H N+V  +G  +   +L +V  Y+  GSL   L        L    R  +A   A
Sbjct: 84  MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAA 143
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK---ANTFLSSKSAAGTPE 117
            G+N+LH  +   +HRD+KS N+L+D+ +T K+ DFGL+R     A T + S+   GT  
Sbjct: 144 NGINFLHENHH--IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSR-IVGTTA 200
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELAT 147
           +MAPE LR E +  KSDIYSFGV+L E+ T
Sbjct: 201 YMAPEALRGEIT-PKSDIYSFGVVLLEIIT 229

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 98.6 bits (244), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 101/191 (52%), Gaps = 7/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           + +   P +  + G+  +   L I+ EYL  GS   LL +PG    LDE +   +  ++ 
Sbjct: 79  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGP---LDETQIATILREIL 134
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           KG++YLH      +HRD+K+ N+L+ +   VK+ DFG++    +T +   +  GTP WMA
Sbjct: 135 KGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 192
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEV++    + K+DI+S G+   ELA  + P   L+P +V+  +  K     +  N +  
Sbjct: 193 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKP 251
Query: 181 VASIIEACWAK 191
           +   +EAC  K
Sbjct: 252 LKEFVEACLNK 262

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 9/195 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +  HPNI+   G VT+   + IVTEY+  GSL   L K   +  + +   + M   +A
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIA 157
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP---E 117
            GM YL   +   VHRDL + N+L++     KV DFGLSR+  +   ++ +  G      
Sbjct: 158 SGMKYLS--DMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W +PE +        SD++S+G++LWE+ +  ++P+  ++   V+ AV  +G RL  P +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMD 274
Query: 177 VNPHVASIIEACWAK 191
               +  ++  CW K
Sbjct: 275 CPAALYQLMLDCWQK 289

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 98.2 bits (243), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 101/191 (52%), Gaps = 7/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           + +   P +  + G+  +   L I+ EYL  GS   LL +PG    LDE +   +  ++ 
Sbjct: 59  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGP---LDETQIATILREIL 114
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           KG++YLH      +HRD+K+ N+L+ +   VK+ DFG++    +T +   +  GTP WMA
Sbjct: 115 KGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 172
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEV++    + K+DI+S G+   ELA  + P   L+P +V+  +  K     +  N +  
Sbjct: 173 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKP 231
Query: 181 VASIIEACWAK 191
           +   +EAC  K
Sbjct: 232 LKEFVEACLNK 242

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 98.2 bits (243), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 19/201 (9%)
Query: 6   HPNIVLFMGAVTQPPN-LSIVTEYLSRGSL-------------YRLLHKPGVREMLDERR 51
           H N+V  +GA T+P   L ++TE+   G+L             Y++  +   ++ L    
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSK 110
            +  ++ VAKGM +L  R    +HRDL + N+L+ +K  VK+CDFGL+R +  +     K
Sbjct: 141 LICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 198
Query: 111 SAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             A  P +WMAPE + D     +SD++SFGV+LWE+ +L   P+  +   +       +G
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 258
Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R+  P    P +   +  CW
Sbjct: 259 TRMRAPDYTTPEMYQTMLDCW 279

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 99/197 (50%), Gaps = 15/197 (7%)
Query: 6   HPNIVLFMGAVTQPPN-LSIVTEYLSRGSLYRLL---------HKPGVREMLDERRRLNM 55
           H N+V  +GA T+P   L ++ E+   G+L   L         +K   ++ L     +  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICY 149
Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSSKSAA 113
           ++ VAKGM +L  R    +HRDL + N+L+ +K  VK+CDFGL+R   K   ++    A 
Sbjct: 150 SFQVAKGMEFLASRK--XIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 207
Query: 114 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLE 172
              +WMAPE + D     +SD++SFGV+LWE+ +L   P+  +   +       +G R+ 
Sbjct: 208 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 267
Query: 173 IPRNVNPHVASIIEACW 189
            P    P +   +  CW
Sbjct: 268 APDYTTPEMYQTMLDCW 284

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 9/195 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +  HPNI+   G VT+   + IVTEY+  GSL   L K   +  + +   + M   +A
Sbjct: 88  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIA 145
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP---E 117
            GM YL   +   VHRDL + N+L++     KV DFGLSR+  +   ++ +  G      
Sbjct: 146 SGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 203
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W +PE +        SD++S+G++LWE+ +  ++P+  ++   V+ AV  +G RL  P +
Sbjct: 204 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMD 262
Query: 177 VNPHVASIIEACWAK 191
               +  ++  CW K
Sbjct: 263 CPAALYQLMLDCWQK 277

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 9/195 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +  HPNI+   G VT+   + IVTEY+  GSL   L K   +  + +   + M   +A
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIA 128
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP---E 117
            GM YL   +   VHRDL + N+L++     KV DFGLSR+  +   ++ +  G      
Sbjct: 129 SGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 186
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W +PE +        SD++S+G++LWE+ +  ++P+  ++   V+ AV  +G RL  P +
Sbjct: 187 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMD 245
Query: 177 VNPHVASIIEACWAK 191
               +  ++  CW K
Sbjct: 246 CPAALYQLMLDCWQK 260

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 9/195 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +  HPNI+   G VT+   + IVTEY+  GSL   L K   +  + +   + M   +A
Sbjct: 98  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIA 155
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP---E 117
            GM YL   +   VHRDL + N+L++     KV DFGLSR+  +   ++ +  G      
Sbjct: 156 SGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 213
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W +PE +        SD++S+G++LWE+ +  ++P+  ++   V+ AV  +G RL  P +
Sbjct: 214 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMD 272
Query: 177 VNPHVASIIEACWAK 191
               +  ++  CW K
Sbjct: 273 CPAALYQLMLDCWQK 287

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 107/205 (52%), Gaps = 24/205 (11%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK---PGVR----------EMLDERR 51
           +H NIV  +GA T    + ++TEY   G L   L +   PG+           E L  R 
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRD 167
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSS 109
            L+ +  VA+GM +L  +N   +HRD+ + N+L+   +  K+ DFGL+R  +  + ++  
Sbjct: 168 LLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 225
Query: 110 KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-- 167
            +A    +WMAPE + D     +SD++S+G++LWE+ +L     N  P  +V +  +K  
Sbjct: 226 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL---NPYPGILVNSKFYKLV 282
Query: 168 --GKRLEIPRNVNPHVASIIEACWA 190
             G ++  P     ++ SI++ACWA
Sbjct: 283 KDGYQMAQPAFAPKNIYSIMQACWA 307

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 9/195 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +  HPNI+   G VT+   + IVTEY+  GSL   L K   +  + +   + M   +A
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIA 157
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP---E 117
            GM YL   +   VHRDL + N+L++     KV DFGLSR+  +   ++ +  G      
Sbjct: 158 SGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W +PE +        SD++S+G++LWE+ +  ++P+  ++   V+ AV  +G RL  P +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMD 274
Query: 177 VNPHVASIIEACWAK 191
               +  ++  CW K
Sbjct: 275 CPAALYQLMLDCWQK 289

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 9/195 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +  HPNI+   G VT+   + IVTEY+  GSL   L K   +  + +   + M   +A
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIA 157
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP---E 117
            GM YL   +   VHRDL + N+L++     KV DFGLSR+  +   ++ +  G      
Sbjct: 158 SGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W +PE +        SD++S+G++LWE+ +  ++P+  ++   V+ AV  +G RL  P +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMD 274
Query: 177 VNPHVASIIEACWAK 191
               +  ++  CW K
Sbjct: 275 CPAALYQLMLDCWQK 289

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 9/195 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +  HPNI+   G VT+   + IVTEY+  GSL   L K   +  + +   + M   +A
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIA 157
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP---E 117
            GM YL   +   VHRDL + N+L++     KV DFGLSR+  +   ++ +  G      
Sbjct: 158 SGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W +PE +        SD++S+G++LWE+ +  ++P+  ++   V+ AV  +G RL  P +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMD 274
Query: 177 VNPHVASIIEACWAK 191
               +  ++  CW K
Sbjct: 275 CPAALYQLMLDCWQK 289

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 97.8 bits (242), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 9/195 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +  HPNI+   G VT+   + IVTEY+  GSL   L K   +  + +   + M   +A
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIA 157
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP---E 117
            GM YL   +   VHRDL + N+L++     KV DFGLSR+  +   ++ +  G      
Sbjct: 158 SGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W +PE +        SD++S+G++LWE+ +  ++P+  ++   V+ AV  +G RL  P +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMD 274
Query: 177 VNPHVASIIEACWAK 191
               +  ++  CW K
Sbjct: 275 CPAALYQLMLDCWQK 289

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 97.8 bits (242), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 100/191 (52%), Gaps = 7/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           + +   P +  + G+  +   L I+ EYL  GS   LL +PG    LDE +   +  ++ 
Sbjct: 74  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGP---LDETQIATILREIL 129
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           KG++YLH      +HRD+K+ N+L+ +   VK+ DFG++    +T +      GTP WMA
Sbjct: 130 KGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMA 187
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEV++    + K+DI+S G+   ELA  + P   L+P +V+  +  K     +  N +  
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKP 246
Query: 181 VASIIEACWAK 191
           +   +EAC  K
Sbjct: 247 LKEFVEACLNK 257

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 97.4 bits (241), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 100/191 (52%), Gaps = 7/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           + +   P +  + G+  +   L I+ EYL  GS   LL +PG    LDE +   +  ++ 
Sbjct: 59  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGP---LDETQIATILREIL 114
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           KG++YLH      +HRD+K+ N+L+ +   VK+ DFG++    +T +      GTP WMA
Sbjct: 115 KGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMA 172
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEV++    + K+DI+S G+   ELA  + P   L+P +V+  +  K     +  N +  
Sbjct: 173 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKP 231
Query: 181 VASIIEACWAK 191
           +   +EAC  K
Sbjct: 232 LKEFVEACLNK 242

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 97.1 bits (240), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 19/201 (9%)
Query: 6   HPNIVLFMGAVTQPPN-LSIVTEYLSRGSL-------------YRLLHKPGVREMLDERR 51
           H N+V  +GA T+P   L ++ E+   G+L             Y++  +   ++ L    
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSS 109
            +  ++ VAKGM +L  R    +HRDL + N+L+ +K  VK+CDFGL+R   K   ++  
Sbjct: 150 LICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 110 KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             A    +WMAPE + D     +SD++SFGV+LWE+ +L   P+  +   +       +G
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267
Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R+  P    P +   +  CW
Sbjct: 268 TRMRAPDYTTPEMYQTMLDCW 288

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 97.1 bits (240), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 99/193 (51%), Gaps = 23/193 (11%)
Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P I  + G+  +   L I+ EYL  GS   LL KPG    L+E     +  ++ KG++YL
Sbjct: 77  PYITRYFGSYLKSTKLWIIMEYLGGGSALDLL-KPGP---LEETYIATILREILKGLDYL 132
Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 126
           H      +HRD+K+ N+L+ ++  VK+ DFG++    +T +      GTP WMAPEV++ 
Sbjct: 133 HSERK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQ 190
Query: 127 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVAS--- 183
              + K+DI+S G+   ELA  + P  +L+P +V+           IP+N  P +     
Sbjct: 191 SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---------FLIPKNSPPTLEGQHS 241
Query: 184 -----IIEACWAK 191
                 +EAC  K
Sbjct: 242 KPFKEFVEACLNK 254

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 96.7 bits (239), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 58/150 (38%), Positives = 84/150 (56%), Gaps = 7/150 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M + +H N+V  +G  +   +L +V  Y+  GSL   L        L    R  +A   A
Sbjct: 84  MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAA 143
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK---ANTFLSSKSAAGTPE 117
            G+N+LH  +   +HRD+KS N+L+D+ +T K+ DFGL+R     A T +  +   GT  
Sbjct: 144 NGINFLHENHH--IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXR-IVGTTA 200
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELAT 147
           +MAPE LR E +  KSDIYSFGV+L E+ T
Sbjct: 201 YMAPEALRGEIT-PKSDIYSFGVVLLEIIT 229

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 96.7 bits (239), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 19/201 (9%)
Query: 6   HPNIVLFMGAVTQPPN-LSIVTEYLSRGSL-------------YRLLHKPGVREMLDERR 51
           H N+V  +GA T+P   L ++ E+   G+L             Y++  +   ++ L    
Sbjct: 127 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 186
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSS 109
            +  ++ VAKGM +L  R    +HRDL + N+L+ +K  VK+CDFGL+R   K   ++  
Sbjct: 187 LICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 244
Query: 110 KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             A    +WMAPE + D     +SD++SFGV+LWE+ +L   P+  +   +       +G
Sbjct: 245 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 304
Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R+  P    P +   +  CW
Sbjct: 305 TRMRAPDYTTPEMYQTMLDCW 325

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 96.7 bits (239), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 106/199 (53%), Gaps = 18/199 (9%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM-------LDERRRLNMAY 57
           +H NIV  +GA T    + ++TEY   G L   L +    ++       L+ R  L+ + 
Sbjct: 100 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 159
Query: 58  DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSSKSAAGT 115
            VA+GM +L  +N   +HRD+ + N+L+   +  K+ DFGL+R  +  + ++   +A   
Sbjct: 160 QVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 217
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK----GKRL 171
            +WMAPE + D     +SD++S+G++LWE+ +L     N  P  +V +  +K    G ++
Sbjct: 218 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL---NPYPGILVNSKFYKLVKDGYQM 274
Query: 172 EIPRNVNPHVASIIEACWA 190
             P     ++ SI++ACWA
Sbjct: 275 AQPAFAPKNIYSIMQACWA 293

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 101/195 (51%), Gaps = 9/195 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +  HPNI+   G VT+   + IVTEY+  GSL   L K   +  + +   + M   +A
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIA 157
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP---E 117
            GM YL   +   VHRDL + N+L++     KV DFGL+R+  +   ++ +  G      
Sbjct: 158 SGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIR 215
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W +PE +        SD++S+G++LWE+ +  ++P+  ++   V+ AV  +G RL  P +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMD 274
Query: 177 VNPHVASIIEACWAK 191
               +  ++  CW K
Sbjct: 275 CPAALYQLMLDCWQK 289

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 96.3 bits (238), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 106/199 (53%), Gaps = 18/199 (9%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM-------LDERRRLNMAY 57
           +H NIV  +GA T    + ++TEY   G L   L +    ++       L+ R  L+ + 
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 167
Query: 58  DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSSKSAAGT 115
            VA+GM +L  +N   +HRD+ + N+L+   +  K+ DFGL+R  +  + ++   +A   
Sbjct: 168 QVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 225
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK----GKRL 171
            +WMAPE + D     +SD++S+G++LWE+ +L     N  P  +V +  +K    G ++
Sbjct: 226 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL---NPYPGILVNSKFYKLVKDGYQM 282
Query: 172 EIPRNVNPHVASIIEACWA 190
             P     ++ SI++ACWA
Sbjct: 283 AQPAFAPKNIYSIMQACWA 301

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 96.3 bits (238), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 109/215 (50%), Gaps = 27/215 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-----PGV--------REML 47
           +K++ HP+++   GA +Q   L ++ EY   GSL   L +     PG            L
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 48  D--ERRRLNM------AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS 99
           D  + R L M      A+ +++GM YL      +VHRDL + N+LV +   +K+ DFGLS
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 100 R--LKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLN 156
           R   + ++++         +WMA E L D     +SD++SFGV+LWE+ TL   P+  + 
Sbjct: 198 RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257
Query: 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK 191
           P ++   +   G R+E P N +  +  ++  CW +
Sbjct: 258 PERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQ 291

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 19/201 (9%)
Query: 6   HPNIVLFMGAVTQPPN-LSIVTEYLSRGSL-------------YRLLHKPGVREMLDERR 51
           H N+V  +GA T+P   L ++ E+   G+L             Y++  +   ++ L    
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSK 110
            +  ++ VAKGM +L  R    +HRDL + N+L+ +K  VK+CDFGL+R +  +     K
Sbjct: 150 LICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 111 SAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             A  P +WMAPE + D     +SD++SFGV+LWE+ +L   P+  +   +       +G
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267
Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R+  P    P +   +  CW
Sbjct: 268 TRMRAPDYTTPEMYQTMLDCW 288

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 100/195 (51%), Gaps = 9/195 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +  HPNI+   G VT+   + IVTEY+  GSL   L K   +  + +   + M   +A
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIA 157
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP---E 117
            GM YL   +   VHRDL + N+L++     KV DFGL R+  +   ++ +  G      
Sbjct: 158 SGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W +PE +        SD++S+G++LWE+ +  ++P+  ++   V+ AV  +G RL  P +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMD 274
Query: 177 VNPHVASIIEACWAK 191
               +  ++  CW K
Sbjct: 275 CPAALYQLMLDCWQK 289

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 101/199 (50%), Gaps = 17/199 (8%)
Query: 6   HPNIVLFMGAVTQPPN-LSIVTEYLSRGSLYRLL---------HKPG--VREMLDERRRL 53
           H N+V  +GA T+P   L ++ E+   G+L   L         +KP    ++ L     +
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLI 151
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSA 112
             ++ VAKGM +L  R    +HRDL + N+L+ +K  VK+CDFGL+R +  +     K  
Sbjct: 152 XYSFQVAKGMEFLASRK--XIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 170
           A  P +WMAPE + D     +SD++SFGV+LWE+ +L   P+  +   +       +G R
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 269
Query: 171 LEIPRNVNPHVASIIEACW 189
           +  P    P +   +  CW
Sbjct: 270 MRAPDYTTPEMYQTMLDCW 288

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 19/201 (9%)
Query: 6   HPNIVLFMGAVTQPPN-LSIVTEYLSRGSL-------------YRLLHKPGVREMLDERR 51
           H N+V  +GA T+P   L ++ E+   G+L             Y++  +   ++ L    
Sbjct: 81  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSK 110
            +  ++ VAKGM +L  R    +HRDL + N+L+ +K  VK+CDFGL+R +  +     K
Sbjct: 141 LICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 198
Query: 111 SAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             A  P +WMAPE + D     +SD++SFGV+LWE+ +L   P+  +   +       +G
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 258
Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R+  P    P +   +  CW
Sbjct: 259 TRMRAPDYTTPEMYQTMLDCW 279

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 19/201 (9%)
Query: 6   HPNIVLFMGAVTQPPN-LSIVTEYLSRGSL-------------YRLLHKPGVREMLDERR 51
           H N+V  +GA T+P   L ++ E+   G+L             Y++  +   ++ L    
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSK 110
            +  ++ VAKGM +L  R    +HRDL + N+L+ +K  VK+CDFGL+R +  +     K
Sbjct: 150 LICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRK 207
Query: 111 SAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             A  P +WMAPE + D     +SD++SFGV+LWE+ +L   P+  +   +       +G
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267
Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R+  P    P +   +  CW
Sbjct: 268 TRMRAPDYTTPEMYQTMLDCW 288

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 100/195 (51%), Gaps = 9/195 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +  HPNI+   G VT+   + IVTEY+  GSL   L K   +  + +   + M   ++
Sbjct: 77  MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQ--LVGMLRGIS 134
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP---E 117
            GM YL   +   VHRDL + N+L++     KV DFGLSR+  +   ++ +  G      
Sbjct: 135 AGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 192
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE +        SD++S+G+++WE+ +  ++P+  +    V+ AV  +G RL  P +
Sbjct: 193 WTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVE-EGYRLPSPMD 251
Query: 177 VNPHVASIIEACWAK 191
               +  ++  CW K
Sbjct: 252 CPAALYQLMLDCWQK 266

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 95.5 bits (236), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 57/149 (38%), Positives = 82/149 (55%), Gaps = 5/149 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M + +H N+V  +G  +   +L +V  Y+  GSL   L        L    R  +A   A
Sbjct: 78  MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAA 137
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTPEW 118
            G+N+LH  +   +HRD+KS N+L+D+ +T K+ DFGL+R   K    +      GT  +
Sbjct: 138 NGINFLHENHH--IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAY 195
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELAT 147
           MAPE LR E +  KSDIYSFGV+L E+ T
Sbjct: 196 MAPEALRGEIT-PKSDIYSFGVVLLEIIT 223

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 95.5 bits (236), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 101/195 (51%), Gaps = 9/195 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +  HPNI+   G VT+   + I+TEY+  GSL   L K   R  + +   + M   + 
Sbjct: 84  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQ--LVGMLRGIG 141
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP---E 117
            GM YL   +   VHRDL + N+LV+     KV DFG+SR+  +   ++ +  G      
Sbjct: 142 SGMKYLS--DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIR 199
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE +        SD++S+G+++WE+ +  ++P+ +++   V+ A+  +G RL  P +
Sbjct: 200 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-EGYRLPPPMD 258
Query: 177 VNPHVASIIEACWAK 191
               +  ++  CW K
Sbjct: 259 CPIALHQLMLDCWQK 273

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 95.5 bits (236), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 101/195 (51%), Gaps = 9/195 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +  HPNI+   G VT+   + I+TEY+  GSL   L K   R  + +   + M   + 
Sbjct: 63  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQ--LVGMLRGIG 120
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP---E 117
            GM YL   +   VHRDL + N+LV+     KV DFG+SR+  +   ++ +  G      
Sbjct: 121 SGMKYLS--DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIR 178
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE +        SD++S+G+++WE+ +  ++P+ +++   V+ A+  +G RL  P +
Sbjct: 179 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-EGYRLPPPMD 237
Query: 177 VNPHVASIIEACWAK 191
               +  ++  CW K
Sbjct: 238 CPIALHQLMLDCWQK 252

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 95.5 bits (236), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 101/195 (51%), Gaps = 9/195 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +  HPNI+   G VT+   + I+TEY+  GSL   L K   R  + +   + M   + 
Sbjct: 69  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQ--LVGMLRGIG 126
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP---E 117
            GM YL   +   VHRDL + N+LV+     KV DFG+SR+  +   ++ +  G      
Sbjct: 127 SGMKYLS--DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIR 184
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE +        SD++S+G+++WE+ +  ++P+ +++   V+ A+  +G RL  P +
Sbjct: 185 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-EGYRLPPPMD 243
Query: 177 VNPHVASIIEACWAK 191
               +  ++  CW K
Sbjct: 244 CPIALHQLMLDCWQK 258

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 6   HPNIVLFMGAVTQPPN-LSIVTEYLSRGSL-------------YRLLHKPGVREMLDERR 51
           H N+V  +GA T+P   L ++ E+   G+L             Y+   +   ++ L    
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEH 151
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSS 109
            +  ++ VAKGM +L  R    +HRDL + N+L+ +K  VK+CDFGL+R   K   ++  
Sbjct: 152 LICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 209
Query: 110 KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
             A    +WMAPE + D     +SD++SFGV+LWE+ +L   P+  +   +       +G
Sbjct: 210 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 269
Query: 169 KRLEIPRNVNPHVASIIEACW 189
            R+  P    P +   +  CW
Sbjct: 270 TRMRAPDYTTPEMYQTMLDCW 290

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 106/191 (55%), Gaps = 17/191 (8%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-PGVREMLDERRRLNMAYDV 59
           MK L+H  +V     VT+ P + I+TE++++GSL   L    G ++ L   + ++ +  +
Sbjct: 231 MKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQI 287
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
           A+GM ++ +RN   +HRDL++ N+LV      K+ DFGL+R+ A   +         +W 
Sbjct: 288 AEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVGAKFPI---------KWT 336
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE +       KSD++SFG++L E+ T  + P+  ++  +V+ A+  +G R+  P N  
Sbjct: 337 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCP 395
Query: 179 PHVASIIEACW 189
             + +I+  CW
Sbjct: 396 EELYNIMMRCW 406

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 101/195 (51%), Gaps = 11/195 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNL-SIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           M+ L HPN++  +G +  P  L  ++  Y+  G L + +  P     + +   ++    V
Sbjct: 76  MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL--ISFGLQV 133
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR----LKANTFLSSKSAAGT 115
           A+GM YL  +    VHRDL + N ++D+ +TVKV DFGL+R     +  +    + A   
Sbjct: 134 ARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP 191
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIP 174
            +W A E L+      KSD++SFGV+LWEL T    P+ +++P  +   +  +G+RL  P
Sbjct: 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-QGRRLPQP 250
Query: 175 RNVNPHVASIIEACW 189
                 +  +++ CW
Sbjct: 251 EYCPDSLYQVMQQCW 265

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 94.7 bits (234), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 109/215 (50%), Gaps = 27/215 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-----PG--------VREML 47
           +K++ HP+++   GA +Q   L ++ EY   GSL   L +     PG            L
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 48  D--ERRRLNM------AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS 99
           D  + R L M      A+ +++GM YL   +  +VHRDL + N+LV +   +K+ DFGLS
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMS--LVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 100 R--LKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLN 156
           R   + ++ +         +WMA E L D     +SD++SFGV+LWE+ TL   P+  + 
Sbjct: 198 RDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257
Query: 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK 191
           P ++   +   G R+E P N +  +  ++  CW +
Sbjct: 258 PERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQ 291

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 94.7 bits (234), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 100/197 (50%), Gaps = 11/197 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +  HPN++   G VT+   + I+TE++  GSL   L +   +  +   + + M   +A
Sbjct: 88  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIA 145
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN-----TFLSSKSAAGT 115
            GM YL   N   VHRDL + N+LV+     KV DFGLSR   +     T+ S+      
Sbjct: 146 AGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 203
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIP 174
             W APE ++       SD++S+G+++WE+ +  ++P+ ++    V+ A+  +  RL  P
Sbjct: 204 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPP 262
Query: 175 RNVNPHVASIIEACWAK 191
            +    +  ++  CW K
Sbjct: 263 MDCPSALHQLMLDCWQK 279

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 94.7 bits (234), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 95/191 (49%), Gaps = 7/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++  RHP +     A      L  V EY + G L+   H    R   +ER R   A ++ 
Sbjct: 59  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIV 115
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             + YLH R+  +V+RD+K  NL++DK   +K+ DFGL +   +   + K+  GTPE++A
Sbjct: 116 SALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 173
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVL D       D +  GV+++E+   + P+ N +  ++   +  +  R   PR ++P 
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--PRTLSPE 231
Query: 181 VASIIEACWAK 191
             S++     K
Sbjct: 232 AKSLLAGLLKK 242

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 94.7 bits (234), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 95/191 (49%), Gaps = 7/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++  RHP +     A      L  V EY + G L+   H    R   +ER R   A ++ 
Sbjct: 62  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIV 118
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             + YLH R+  +V+RD+K  NL++DK   +K+ DFGL +   +   + K+  GTPE++A
Sbjct: 119 SALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 176
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVL D       D +  GV+++E+   + P+ N +  ++   +  +  R   PR ++P 
Sbjct: 177 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--PRTLSPE 234
Query: 181 VASIIEACWAK 191
             S++     K
Sbjct: 235 AKSLLAGLLKK 245

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 94.7 bits (234), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 99/193 (51%), Gaps = 10/193 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM-LDERRRLNMAYDV 59
           M++  HP+IV  +G +T+ P + I+ E  + G L   L    VR+  LD    +  AY +
Sbjct: 65  MRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQL 120
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           +  + YL  +    VHRD+ + N+LV     VK+ DFGLSR   ++     S    P +W
Sbjct: 121 STALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKW 178
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWE-LATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MAPE +        SD++ FGV +WE L    +P+  +    V+  +   G+RL +P N 
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNC 237
Query: 178 NPHVASIIEACWA 190
            P + S++  CWA
Sbjct: 238 PPTLYSLMTKCWA 250

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 95/191 (49%), Gaps = 7/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++  RHP +     A      L  V EY + G L+   H    R   +ER R   A ++ 
Sbjct: 59  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIV 115
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             + YLH R+  +V+RD+K  NL++DK   +K+ DFGL +   +   + K+  GTPE++A
Sbjct: 116 SALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 173
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVL D       D +  GV+++E+   + P+ N +  ++   +  +  R   PR ++P 
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--PRTLSPE 231
Query: 181 VASIIEACWAK 191
             S++     K
Sbjct: 232 AKSLLAGLLKK 242

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 108/215 (50%), Gaps = 27/215 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-----PG--------VREML 47
           +K++ HP+++   GA +Q   L ++ EY   GSL   L +     PG            L
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 48  D--ERRRLNM------AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS 99
           D  + R L M      A+ +++GM YL      +VHRDL + N+LV +   +K+ DFGLS
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 100 R--LKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLN 156
           R   + ++ +         +WMA E L D     +SD++SFGV+LWE+ TL   P+  + 
Sbjct: 198 RDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257
Query: 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK 191
           P ++   +   G R+E P N +  +  ++  CW +
Sbjct: 258 PERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQ 291

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 105/211 (49%), Gaps = 31/211 (14%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL----HKPGVREM-------LDERRRLN 54
           H NIV  +GA T    + ++ EY   G L   L     K    E+       L+E   LN
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 55  M---------AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKA 103
           +         AY VAKGM +L  ++   VHRDL + N+LV     VK+CDFGL+R  +  
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 104 NTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA 163
           + ++   +A    +WMAPE L +     KSD++S+G++LWE+ +L     N  P   V A
Sbjct: 226 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV---NPYPGIPVDA 282
Query: 164 VGFK----GKRLEIPRNVNPHVASIIEACWA 190
             +K    G +++ P      +  I+++CWA
Sbjct: 283 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWA 313

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 100/195 (51%), Gaps = 9/195 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +  HPNI+   G VT+   + IVTE +  GSL   L K   +  + +   + M   +A
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQL--VGMLRGIA 128
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP---E 117
            GM YL   +   VHRDL + N+L++     KV DFGLSR+  +   ++ +  G      
Sbjct: 129 SGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 186
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W +PE +        SD++S+G++LWE+ +  ++P+  ++   V+ AV  +G RL  P +
Sbjct: 187 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMD 245
Query: 177 VNPHVASIIEACWAK 191
               +  ++  CW K
Sbjct: 246 CPAALYQLMLDCWQK 260

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 22/203 (10%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-----------VREMLDERRRL 53
           +H NIV  +GA T    + ++TEY   G L   L +                 L  R  L
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLL 167
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSSKS 111
           + +  VA+GM +L  +N   +HRD+ + N+L+   +  K+ DFGL+R  +  + ++   +
Sbjct: 168 HFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 112 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK---- 167
           A    +WMAPE + D     +SD++S+G++LWE+ +L     N  P  +V +  +K    
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL---NPYPGILVNSKFYKLVKD 282
Query: 168 GKRLEIPRNVNPHVASIIEACWA 190
           G ++  P     ++ SI++ACWA
Sbjct: 283 GYQMAQPAFAPKNIYSIMQACWA 305

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 100/195 (51%), Gaps = 9/195 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +  HPNI+   G VT+   + IVTE +  GSL   L K   +  + +   + M   +A
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQL--VGMLRGIA 157
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP---E 117
            GM YL   +   VHRDL + N+L++     KV DFGLSR+  +   ++ +  G      
Sbjct: 158 SGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W +PE +        SD++S+G++LWE+ +  ++P+  ++   V+ AV  +G RL  P +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMD 274
Query: 177 VNPHVASIIEACWAK 191
               +  ++  CW K
Sbjct: 275 CPAALYQLMLDCWQK 289

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 9/195 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +  HPNI+   G VT+   + IVTE +  GSL   L K   +  + +   + M   +A
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQL--VGMLRGIA 157
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP---E 117
            GM YL       VHRDL + N+L++     KV DFGLSR+  +   ++ +  G      
Sbjct: 158 SGMKYLSDMGA--VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W +PE +        SD++S+G++LWE+ +  ++P+  ++   V+ AV  +G RL  P +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMD 274
Query: 177 VNPHVASIIEACWAK 191
               +  ++  CW K
Sbjct: 275 CPAALYQLMLDCWQK 289

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 94.4 bits (233), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 18/200 (9%)
Query: 6   HPNIVLFMGAVTQPPN-LSIVTEYLSRGSLYRLLH------------KPGVREMLDERRR 52
           H N+V  +GA T+P   L ++ E+   G+L   L             +   ++ L     
Sbjct: 91  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHL 150
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKS 111
           +  ++ VAKGM +L  R    +HRDL + N+L+ +K  VK+CDFGL+R +  +     K 
Sbjct: 151 ICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 112 AAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGK 169
            A  P +WMAPE + D     +SD++SFGV+LWE+ +L   P+  +   +       +G 
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 268
Query: 170 RLEIPRNVNPHVASIIEACW 189
           R+  P    P +   +  CW
Sbjct: 269 RMRAPDYTTPEMYQTMLDCW 288

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 94.0 bits (232), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 84/153 (54%), Gaps = 3/153 (1%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL-HKPGVREMLDERRRLNMAYDV 59
           +K+L HPN++ +  +  +   L+IV E    G L R++ H    + ++ ER        +
Sbjct: 86  LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
              + ++H R   ++HRD+K  N+ +     VK+ D GL R  ++   ++ S  GTP +M
Sbjct: 146 CSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 203
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +PE + +   N KSDI+S G +L+E+A LQ P+
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 94.0 bits (232), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 99/193 (51%), Gaps = 10/193 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM-LDERRRLNMAYDV 59
           M++  HP+IV  +G +T+ P + I+ E  + G L   L    VR+  LD    +  AY +
Sbjct: 65  MRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQL 120
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           +  + YL  +    VHRD+ + N+LV     VK+ DFGLSR   ++     S    P +W
Sbjct: 121 STALAYLESKR--FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 178
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWE-LATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MAPE +        SD++ FGV +WE L    +P+  +    V+  +   G+RL +P N 
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNC 237
Query: 178 NPHVASIIEACWA 190
            P + S++  CWA
Sbjct: 238 PPTLYSLMTKCWA 250

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 94.0 bits (232), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 94/191 (49%), Gaps = 7/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++  RHP +     A      L  V EY + G L+   H    R   +ER R   A ++ 
Sbjct: 59  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIV 115
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             + YLH R+  +V+RD+K  NL++DK   +K+ DFGL +   +   + K   GTPE++A
Sbjct: 116 SALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLA 173
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVL D       D +  GV+++E+   + P+ N +  ++   +  +  R   PR ++P 
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--PRTLSPE 231
Query: 181 VASIIEACWAK 191
             S++     K
Sbjct: 232 AKSLLAGLLKK 242

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 94.0 bits (232), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 94/191 (49%), Gaps = 7/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++  RHP +     A      L  V EY + G L+   H    R   +ER R   A ++ 
Sbjct: 59  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIV 115
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             + YLH R+  +V+RD+K  NL++DK   +K+ DFGL +   +   + K   GTPE++A
Sbjct: 116 SALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLA 173
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVL D       D +  GV+++E+   + P+ N +  ++   +  +  R   PR ++P 
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--PRTLSPE 231
Query: 181 VASIIEACWAK 191
             S++     K
Sbjct: 232 AKSLLAGLLKK 242

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 93.6 bits (231), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 99/193 (51%), Gaps = 10/193 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM-LDERRRLNMAYDV 59
           M++  HP+IV  +G +T+ P + I+ E  + G L   L    VR+  LD    +  AY +
Sbjct: 65  MRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQL 120
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           +  + YL  +    VHRD+ + N+LV     VK+ DFGLSR   ++     S    P +W
Sbjct: 121 STALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 178
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWE-LATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MAPE +        SD++ FGV +WE L    +P+  +    V+  +   G+RL +P N 
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNC 237
Query: 178 NPHVASIIEACWA 190
            P + S++  CWA
Sbjct: 238 PPTLYSLMTKCWA 250

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 93.6 bits (231), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 99/193 (51%), Gaps = 10/193 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM-LDERRRLNMAYDV 59
           M++  HP+IV  +G +T+ P + I+ E  + G L   L    VR+  LD    +  AY +
Sbjct: 445 MRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQL 500
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           +  + YL  +    VHRD+ + N+LV     VK+ DFGLSR   ++     S    P +W
Sbjct: 501 STALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 558
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWE-LATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MAPE +        SD++ FGV +WE L    +P+  +    V+  +   G+RL +P N 
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNC 617
Query: 178 NPHVASIIEACWA 190
            P + S++  CWA
Sbjct: 618 PPTLYSLMTKCWA 630

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 93.6 bits (231), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 99/193 (51%), Gaps = 10/193 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM-LDERRRLNMAYDV 59
           M++  HP+IV  +G +T+ P + I+ E  + G L   L    VR+  LD    +  AY +
Sbjct: 65  MRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQL 120
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           +  + YL  +    VHRD+ + N+LV     VK+ DFGLSR   ++     S    P +W
Sbjct: 121 STALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 178
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWE-LATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MAPE +        SD++ FGV +WE L    +P+  +    V+  +   G+RL +P N 
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNC 237
Query: 178 NPHVASIIEACWA 190
            P + S++  CWA
Sbjct: 238 PPTLYSLMTKCWA 250

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 93.6 bits (231), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 94/191 (49%), Gaps = 7/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++  RHP +     A      L  V EY + G L+   H    R   +ER R   A ++ 
Sbjct: 64  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIV 120
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             + YLH R+  +V+RD+K  NL++DK   +K+ DFGL +   +   + K   GTPE++A
Sbjct: 121 SALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLA 178
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVL D       D +  GV+++E+   + P+ N +  ++   +  +  R   PR ++P 
Sbjct: 179 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--PRTLSPE 236
Query: 181 VASIIEACWAK 191
             S++     K
Sbjct: 237 AKSLLAGLLKK 247

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 93.6 bits (231), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 94/191 (49%), Gaps = 7/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++  RHP +     A      L  V EY + G L+   H    R   +ER R   A ++ 
Sbjct: 59  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIV 115
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             + YLH R+  +V+RD+K  NL++DK   +K+ DFGL +   +   + K   GTPE++A
Sbjct: 116 SALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLA 173
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVL D       D +  GV+++E+   + P+ N +  ++   +  +  R   PR ++P 
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--PRTLSPE 231
Query: 181 VASIIEACWAK 191
             S++     K
Sbjct: 232 AKSLLAGLLKK 242

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 93.6 bits (231), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 99/193 (51%), Gaps = 10/193 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM-LDERRRLNMAYDV 59
           M++  HP+IV  +G +T+ P + I+ E  + G L   L    VR+  LD    +  AY +
Sbjct: 62  MRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQL 117
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           +  + YL  +    VHRD+ + N+LV     VK+ DFGLSR   ++     S    P +W
Sbjct: 118 STALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 175
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWE-LATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MAPE +        SD++ FGV +WE L    +P+  +    V+  +   G+RL +P N 
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNC 234
Query: 178 NPHVASIIEACWA 190
            P + S++  CWA
Sbjct: 235 PPTLYSLMTKCWA 247

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 93.6 bits (231), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + HP++V  +G V   P + +VT+ +  G L   +H+   ++ +  +  LN    +A
Sbjct: 94  MASMDHPHLVRLLG-VCLSPTIQLVTQLMPHGCLLEYVHEH--KDNIGSQLLLNWCVQIA 150
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGM YL  R   +VHRDL + N+LV     VK+ DFGL+RL         +  G    +W
Sbjct: 151 KGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW 208
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + P + +  +  KG+RL  P   
Sbjct: 209 MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPIC 267
Query: 178 NPHVASIIEACW 189
              V  ++  CW
Sbjct: 268 TIDVYMVMVKCW 279

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 93.6 bits (231), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 99/193 (51%), Gaps = 10/193 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM-LDERRRLNMAYDV 59
           M++  HP+IV  +G +T+ P + I+ E  + G L   L    VR+  LD    +  AY +
Sbjct: 68  MRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQL 123
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           +  + YL  +    VHRD+ + N+LV     VK+ DFGLSR   ++     S    P +W
Sbjct: 124 STALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 181
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWE-LATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MAPE +        SD++ FGV +WE L    +P+  +    V+  +   G+RL +P N 
Sbjct: 182 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNC 240
Query: 178 NPHVASIIEACWA 190
            P + S++  CWA
Sbjct: 241 PPTLYSLMTKCWA 253

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 93.6 bits (231), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 99/193 (51%), Gaps = 10/193 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM-LDERRRLNMAYDV 59
           M++  HP+IV  +G +T+ P + I+ E  + G L   L    VR+  LD    +  AY +
Sbjct: 93  MRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQL 148
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           +  + YL  +    VHRD+ + N+LV     VK+ DFGLSR   ++     S    P +W
Sbjct: 149 STALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 206
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWE-LATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MAPE +        SD++ FGV +WE L    +P+  +    V+  +   G+RL +P N 
Sbjct: 207 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNC 265
Query: 178 NPHVASIIEACWA 190
            P + S++  CWA
Sbjct: 266 PPTLYSLMTKCWA 278

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 93.6 bits (231), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 99/193 (51%), Gaps = 10/193 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM-LDERRRLNMAYDV 59
           M++  HP+IV  +G +T+ P + I+ E  + G L   L    VR+  LD    +  AY +
Sbjct: 70  MRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQL 125
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           +  + YL  +    VHRD+ + N+LV     VK+ DFGLSR   ++     S    P +W
Sbjct: 126 STALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 183
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWE-LATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MAPE +        SD++ FGV +WE L    +P+  +    V+  +   G+RL +P N 
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNC 242
Query: 178 NPHVASIIEACWA 190
            P + S++  CWA
Sbjct: 243 PPTLYSLMTKCWA 255

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 93.6 bits (231), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 99/193 (51%), Gaps = 10/193 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM-LDERRRLNMAYDV 59
           M++  HP+IV  +G +T+ P + I+ E  + G L   L    VR+  LD    +  AY +
Sbjct: 67  MRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQL 122
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           +  + YL  +    VHRD+ + N+LV     VK+ DFGLSR   ++     S    P +W
Sbjct: 123 STALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 180
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWE-LATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MAPE +        SD++ FGV +WE L    +P+  +    V+  +   G+RL +P N 
Sbjct: 181 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNC 239
Query: 178 NPHVASIIEACWA 190
            P + S++  CWA
Sbjct: 240 PPTLYSLMTKCWA 252

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 93.6 bits (231), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + HP++V  +G V   P + +VT+ +  G L   +H+   ++ +  +  LN    +A
Sbjct: 71  MASMDHPHLVRLLG-VCLSPTIQLVTQLMPHGCLLEYVHEH--KDNIGSQLLLNWCVQIA 127
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGM YL  R   +VHRDL + N+LV     VK+ DFGL+RL         +  G    +W
Sbjct: 128 KGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW 185
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + P + +  +  KG+RL  P   
Sbjct: 186 MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPIC 244
Query: 178 NPHVASIIEACW 189
              V  ++  CW
Sbjct: 245 TIDVYMVMVKCW 256

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 93.6 bits (231), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 99/193 (51%), Gaps = 10/193 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM-LDERRRLNMAYDV 59
           M++  HP+IV  +G +T+ P + I+ E  + G L   L    VR+  LD    +  AY +
Sbjct: 445 MRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQL 500
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
           +  + YL  +    VHRD+ + N+LV     VK+ DFGLSR   ++     S    P +W
Sbjct: 501 STALAYLESKR--FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 558
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWE-LATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MAPE +        SD++ FGV +WE L    +P+  +    V+  +   G+RL +P N 
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNC 617
Query: 178 NPHVASIIEACWA 190
            P + S++  CWA
Sbjct: 618 PPTLYSLMTKCWA 630

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 93.2 bits (230), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 15/197 (7%)
Query: 6   HPNIVLFMGAVTQPPN-LSIVTEYLSRGSLYRLL---------HKPGVREMLDERRRLNM 55
           H N+V  +GA T+P   L ++ E+   G+L   L         +K   ++ L     +  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXY 149
Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSSKSAA 113
           ++ VAKGM +L  R    +HRDL + N+L+ +K  VK+ DFGL+R   K   ++    A 
Sbjct: 150 SFQVAKGMEFLASRK--XIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDAR 207
Query: 114 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLE 172
              +WMAPE + D     +SD++SFGV+LWE+ +L   P+  +   +       +G R+ 
Sbjct: 208 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGTRMR 267
Query: 173 IPRNVNPHVASIIEACW 189
            P    P +   +  CW
Sbjct: 268 APDYTTPEMYQTMLDCW 284

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 93.2 bits (230), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 58/187 (31%), Positives = 100/187 (53%), Gaps = 11/187 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K  RHP+I+     ++ P +  +V EY+S G L+  + K G  E ++ RR       + 
Sbjct: 65  LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ---QIL 121
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN-TFLSSKSAAGTPEWM 119
             ++Y HR    +VHRDLK  N+L+D     K+ DFGLS + ++  FL  +++ G+P + 
Sbjct: 122 SAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTSCGSPNYA 177
Query: 120 APEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APEV+     +  + DI+S GVIL+ L     P+ + +   +   +  +G    IP  +N
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI--RGGVFYIPEYLN 235
Query: 179 PHVASII 185
             VA+++
Sbjct: 236 RSVATLL 242

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 92.8 bits (229), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 101/195 (51%), Gaps = 9/195 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +  HPN+V   G VT+   + IV E++  G+L   L K   +  + +   + M   +A
Sbjct: 98  MGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQL--VGMLRGIA 155
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP---E 117
            GM YL   +   VHRDL + N+LV+     KV DFGLSR+  +   +  +  G      
Sbjct: 156 AGMRYL--ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVR 213
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE ++       SD++S+G+++WE+ +  ++P+ +++   V+ A+  +G RL  P +
Sbjct: 214 WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-EGYRLPAPMD 272
Query: 177 VNPHVASIIEACWAK 191
               +  ++  CW K
Sbjct: 273 CPAGLHQLMLDCWQK 287

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 96/191 (50%), Gaps = 23/191 (12%)
Query: 9   IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR 68
           +  + G+  +   L I+ EYL  GS   LL         DE +   M  ++ KG++YLH 
Sbjct: 83  VTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGP----FDEFQIATMLKEILKGLDYLHS 138
Query: 69  RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP 128
                +HRD+K+ N+L+ ++  VK+ DFG++    +T +   +  GTP WMAPEV++   
Sbjct: 139 EKK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA 196
Query: 129 SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVAS----- 183
            + K+DI+S G+   ELA  + P  +++P +V+           IP+N  P +       
Sbjct: 197 YDSKADIWSLGITAIELAKGEPPNSDMHPMRVL---------FLIPKNNPPTLVGDFTKS 247
Query: 184 ---IIEACWAK 191
               I+AC  K
Sbjct: 248 FKEFIDACLNK 258

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 55/165 (33%), Positives = 88/165 (53%), Gaps = 9/165 (5%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
           HPNIV  + A     NL I+ E+ + G++  ++ +  +   L E +   +       +NY
Sbjct: 93  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNY 150
Query: 66  LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL- 124
           LH  +  I+HRDLK+ N+L      +K+ DFG+S     T     S  GTP WMAPEV+ 
Sbjct: 151 LH--DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 208
Query: 125 ----RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 165
               +D P + K+D++S G+ L E+A ++ P   LNP +V+  + 
Sbjct: 209 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA 253

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 22/203 (10%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-----------VREMLDERRRL 53
           +H NIV  +GA T    + ++TEY   G L   L +                    R  L
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSSKS 111
           + +  VA+GM +L  +N   +HRD+ + N+L+   +  K+ DFGL+R  +  + ++   +
Sbjct: 168 HFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 112 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK---- 167
           A    +WMAPE + D     +SD++S+G++LWE+ +L     N  P  +V +  +K    
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL---NPYPGILVNSKFYKLVKD 282
Query: 168 GKRLEIPRNVNPHVASIIEACWA 190
           G ++  P     ++ SI++ACWA
Sbjct: 283 GYQMAQPAFAPKNIYSIMQACWA 305

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/187 (31%), Positives = 99/187 (52%), Gaps = 11/187 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K  RHP+I+     ++ P +  +V EY+S G L+  + K G  E ++ RR       + 
Sbjct: 65  LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ---QIL 121
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN-TFLSSKSAAGTPEWM 119
             ++Y HR    +VHRDLK  N+L+D     K+ DFGLS + ++  FL  + + G+P + 
Sbjct: 122 SAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RDSCGSPNYA 177
Query: 120 APEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APEV+     +  + DI+S GVIL+ L     P+ + +   +   +  +G    IP  +N
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI--RGGVFYIPEYLN 235
Query: 179 PHVASII 185
             VA+++
Sbjct: 236 RSVATLL 242

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 108/212 (50%), Gaps = 31/212 (14%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-----------PGVR-EMLDE--- 49
           +H NIV  +GA T    + ++TEY   G L   L +           PG   E LD+   
Sbjct: 93  QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDG 152
Query: 50  -----RRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LK 102
                R  L+ +  VA+GM +L  +N   +HRD+ + N+L+   +  K+ DFGL+R  + 
Sbjct: 153 RPLELRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 210
Query: 103 ANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVA 162
            + ++   +A    +WMAPE + D     +SD++S+G++LWE+ +L     N  P  +V 
Sbjct: 211 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL---NPYPGILVN 267
Query: 163 AVGFK----GKRLEIPRNVNPHVASIIEACWA 190
           +  +K    G ++  P     ++ SI++ACWA
Sbjct: 268 SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWA 299

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +  HPN++   G VT+   + I+TE++  GSL   L +   +  + +   + M   +A
Sbjct: 62  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQL--VGMLRGIA 119
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN-----TFLSSKSAAGT 115
            GM YL   N   VHR L + N+LV+     KV DFGLSR   +     T+ S+      
Sbjct: 120 AGMKYLADMN--YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 177
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIP 174
             W APE ++       SD++S+G+++WE+ +  ++P+ ++    V+ A+  +  RL  P
Sbjct: 178 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPP 236
Query: 175 RNVNPHVASIIEACWAK 191
            +    +  ++  CW K
Sbjct: 237 MDCPSALHQLMLDCWQK 253

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 90.9 bits (224), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 100/188 (53%), Gaps = 11/188 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K  RHP+I+     ++ P ++ +V EY+S G L+  + K G    LDE+    +   + 
Sbjct: 70  LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG---RLDEKESRRLFQQIL 126
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN-TFLSSKSAAGTPEWM 119
            G++Y HR    +VHRDLK  N+L+D     K+ DFGLS + ++  FL  + + G+P + 
Sbjct: 127 SGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RXSCGSPNYA 182
Query: 120 APEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APEV+     +  + DI+S GVIL+ L     P+ + +   +   +         P+ +N
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC--DGIFYTPQYLN 240
Query: 179 PHVASIIE 186
           P V S+++
Sbjct: 241 PSVISLLK 248

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 90.9 bits (224), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 55/147 (37%), Positives = 79/147 (53%), Gaps = 5/147 (3%)
Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
           + +H N+V  +G  +   +L +V  Y   GSL   L        L    R  +A   A G
Sbjct: 77  KCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANG 136
Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTPEWMA 120
           +N+LH  +   +HRD+KS N+L+D+ +T K+ DFGL+R   K    +      GT  + A
Sbjct: 137 INFLHENHH--IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXA 194
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELAT 147
           PE LR E +  KSDIYSFGV+L E+ T
Sbjct: 195 PEALRGEIT-PKSDIYSFGVVLLEIIT 220

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 90.9 bits (224), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 89/172 (51%), Gaps = 11/172 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L HPNI+             +VTE+   G L+  +     R   DE    N+   + 
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQIL 156
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYT---VKVCDFGLSRLKANTFLSSKSAAGTPE 117
            G+ YLH+ N  IVHRD+K  N+L++ K +   +K+ DFGLS   +  +   +   GT  
Sbjct: 157 SGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY-KLRDRLGTAY 213
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK 169
           ++APEVL+ +  NEK D++S GVI++ L     P+G  N   ++  V  KGK
Sbjct: 214 YIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE-KGK 263

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 90.5 bits (223), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 59/175 (33%), Positives = 92/175 (52%), Gaps = 19/175 (10%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL--------HKPGVREMLDERRR 52
           M +  HPNIV +  +      L +V + LS GS+  ++        HK GV   LDE   
Sbjct: 62  MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV---LDESTI 118
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS--- 109
             +  +V +G+ YLH+     +HRD+K+ N+L+ +  +V++ DFG+S   A     +   
Sbjct: 119 ATILREVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK 176
Query: 110 --KSAAGTPEWMAPEVLRDEPSNE-KSDIYSFGVILWELATLQQPWGNLNPAQVV 161
             K+  GTP WMAPEV+      + K+DI+SFG+   ELAT   P+    P +V+
Sbjct: 177 VRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL 231

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 90.5 bits (223), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 54/165 (32%), Positives = 87/165 (52%), Gaps = 9/165 (5%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
           HPNIV  + A     NL I+ E+ + G++  ++ +  +   L E +   +       +NY
Sbjct: 93  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNY 150
Query: 66  LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL- 124
           LH  +  I+HRDLK+ N+L      +K+ DFG+S           S  GTP WMAPEV+ 
Sbjct: 151 LH--DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVM 208
Query: 125 ----RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 165
               +D P + K+D++S G+ L E+A ++ P   LNP +V+  + 
Sbjct: 209 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA 253

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 90.5 bits (223), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 94/180 (52%), Gaps = 29/180 (16%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL--------HKPGVREMLDERRR 52
           M +  HPNIV +  +      L +V + LS GS+  ++        HK GV   LDE   
Sbjct: 67  MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV---LDESTI 123
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS--- 109
             +  +V +G+ YLH+     +HRD+K+ N+L+ +  +V++ DFG+S      FL++   
Sbjct: 124 ATILREVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVS-----AFLATGGD 176
Query: 110 -------KSAAGTPEWMAPEVLRDEPSNE-KSDIYSFGVILWELATLQQPWGNLNPAQVV 161
                  K+  GTP WMAPEV+      + K+DI+SFG+   ELAT   P+    P +V+
Sbjct: 177 ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL 236

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 90/165 (54%), Gaps = 9/165 (5%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
           HP IV  +GA      L I+ E+   G++  ++ +  +   L E +   +   + + +N+
Sbjct: 67  HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNF 124
Query: 66  LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV-- 123
           LH +   I+HRDLK+ N+L+  +  +++ DFG+S     T     S  GTP WMAPEV  
Sbjct: 125 LHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 182
Query: 124 ---LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 165
              ++D P + K+DI+S G+ L E+A ++ P   LNP +V+  + 
Sbjct: 183 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA 227

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 90.1 bits (222), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 90/165 (54%), Gaps = 9/165 (5%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
           HP IV  +GA      L I+ E+   G++  ++ +  +   L E +   +   + + +N+
Sbjct: 75  HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNF 132
Query: 66  LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV-- 123
           LH +   I+HRDLK+ N+L+  +  +++ DFG+S     T     S  GTP WMAPEV  
Sbjct: 133 LHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 190
Query: 124 ---LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 165
              ++D P + K+DI+S G+ L E+A ++ P   LNP +V+  + 
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA 235

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 59/170 (34%), Positives = 90/170 (52%), Gaps = 10/170 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +K L+H NIV + G        NL ++ EYL  GSL   L K   +E +D  + L     
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQ 122
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP 116
           + KGM YL  +    +HRDL + N+LV+ +  VK+ DFGL+++  +   F   K    +P
Sbjct: 123 ICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 165
             W APE L +   +  SD++SFGV+L+EL T  +      PA+ +  +G
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEFMRMIG 229

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-KPGVREMLDERRRLNMAYDV 59
           M +  HPNI+   G VT    + I+TE++  G+L   L    G   ++   + + M   +
Sbjct: 69  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGI 125
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKAN----TFLSSKSAAG 114
           A GM YL   +   VHRDL + N+LV+     KV DFGLSR L+ N    T+ SS     
Sbjct: 126 ASGMRYLAEMS--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKI 183
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEI 173
              W APE +        SD +S+G+++WE+ +  ++P+ +++   V+ A+  +  RL  
Sbjct: 184 PIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIE-QDYRLPP 242
Query: 174 PRNVNPHVASIIEACWAK 191
           P +    +  ++  CW K
Sbjct: 243 PPDCPTSLHQLMLDCWQK 260

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 90/187 (48%), Gaps = 6/187 (3%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
           RHP +     +      L  V EY + G L+   H    R   ++R R   A ++   ++
Sbjct: 209 RHPFLTALKYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALD 265
Query: 65  YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL 124
           YLH     +V+RDLK  NL++DK   +K+ DFGL +       + K+  GTPE++APEVL
Sbjct: 266 YLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 324
Query: 125 RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASI 184
            D       D +  GV+++E+   + P+ N +  ++   +  +  R   PR + P   S+
Sbjct: 325 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF--PRTLGPEAKSL 382
Query: 185 IEACWAK 191
           +     K
Sbjct: 383 LSGLLKK 389

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 90/187 (48%), Gaps = 6/187 (3%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
           RHP +     +      L  V EY + G L+   H    R   ++R R   A ++   ++
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALD 262
Query: 65  YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL 124
           YLH     +V+RDLK  NL++DK   +K+ DFGL +       + K+  GTPE++APEVL
Sbjct: 263 YLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 321
Query: 125 RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASI 184
            D       D +  GV+++E+   + P+ N +  ++   +    + +  PR + P   S+
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEIRFPRTLGPEAKSL 379
Query: 185 IEACWAK 191
           +     K
Sbjct: 380 LSGLLKK 386

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 86/165 (52%), Gaps = 9/165 (5%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
           HPNIV  + A     NL I+ E+ + G++  ++ +  +   L E +   +       +NY
Sbjct: 93  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNY 150
Query: 66  LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL- 124
           LH  +  I+HRDLK+ N+L      +K+ DFG+S              GTP WMAPEV+ 
Sbjct: 151 LH--DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVM 208
Query: 125 ----RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 165
               +D P + K+D++S G+ L E+A ++ P   LNP +V+  + 
Sbjct: 209 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA 253

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 19/203 (9%)
Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL-------------HKPGVREMLDE 49
           RL+HPN+V  +G VT+   LS++  Y S G L+  L                 V+  L+ 
Sbjct: 85  RLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEP 144
Query: 50  RRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFL 107
              +++   +A GM YL   +  +VH+DL + N+LV  K  VK+ D GL R    A+ + 
Sbjct: 145 PDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 202
Query: 108 SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ-QPWGNLNPAQVVAAVGF 166
              ++     WMAPE +     +  SDI+S+GV+LWE+ +   QP+   +   VV  +  
Sbjct: 203 LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN 262
Query: 167 KGKRLEIPRNVNPHVASIIEACW 189
           + + L  P +    V +++  CW
Sbjct: 263 R-QVLPCPDDCPAWVYALMIECW 284

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 19/203 (9%)
Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL-------------HKPGVREMLDE 49
           RL+HPN+V  +G VT+   LS++  Y S G L+  L                 V+  L+ 
Sbjct: 68  RLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEP 127
Query: 50  RRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFL 107
              +++   +A GM YL   +  +VH+DL + N+LV  K  VK+ D GL R    A+ + 
Sbjct: 128 PDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185
Query: 108 SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ-QPWGNLNPAQVVAAVGF 166
              ++     WMAPE +     +  SDI+S+GV+LWE+ +   QP+   +   VV  +  
Sbjct: 186 LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN 245
Query: 167 KGKRLEIPRNVNPHVASIIEACW 189
           + + L  P +    V +++  CW
Sbjct: 246 R-QVLPCPDDCPAWVYALMIECW 267

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 51/146 (34%), Positives = 83/146 (56%), Gaps = 9/146 (6%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM-LDERRRLNMAYDVAKGM 63
           RHP++V  +G   +   + ++ +Y+  G+L R L+   +  M +   +RL +    A+G+
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS----AAGTPEWM 119
           +YLH R   I+HRD+KS N+L+D+ +  K+ DFG+S  K  T L          GT  ++
Sbjct: 153 HYLHTR--AIIHRDVKSINILLDENFVPKITDFGIS--KKGTELGQTHLXXVVKGTLGYI 208
Query: 120 APEVLRDEPSNEKSDIYSFGVILWEL 145
            PE        EKSD+YSFGV+L+E+
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEV 234

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 6/187 (3%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
           RHP +     +      L  V EY + G L+   H    R   ++R R   A ++   ++
Sbjct: 66  RHPFLTALKYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALD 122
Query: 65  YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL 124
           YLH     +V+RDLK  NL++DK   +K+ DFGL +       + K   GTPE++APEVL
Sbjct: 123 YLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVL 181
Query: 125 RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASI 184
            D       D +  GV+++E+   + P+ N +  ++   +    + +  PR + P   S+
Sbjct: 182 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEIRFPRTLGPEAKSL 239
Query: 185 IEACWAK 191
           +     K
Sbjct: 240 LSGLLKK 246

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 51/146 (34%), Positives = 83/146 (56%), Gaps = 9/146 (6%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM-LDERRRLNMAYDVAKGM 63
           RHP++V  +G   +   + ++ +Y+  G+L R L+   +  M +   +RL +    A+G+
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS----AAGTPEWM 119
           +YLH R   I+HRD+KS N+L+D+ +  K+ DFG+S  K  T L          GT  ++
Sbjct: 153 HYLHTR--AIIHRDVKSINILLDENFVPKITDFGIS--KKGTELDQTHLXXVVKGTLGYI 208
Query: 120 APEVLRDEPSNEKSDIYSFGVILWEL 145
            PE        EKSD+YSFGV+L+E+
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEV 234

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 6/187 (3%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
           RHP +     +      L  V EY + G L+   H    R   ++R R   A ++   ++
Sbjct: 67  RHPFLTALKYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALD 123
Query: 65  YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL 124
           YLH     +V+RDLK  NL++DK   +K+ DFGL +       + K   GTPE++APEVL
Sbjct: 124 YLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVL 182
Query: 125 RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASI 184
            D       D +  GV+++E+   + P+ N +  ++   +    + +  PR + P   S+
Sbjct: 183 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEIRFPRTLGPEAKSL 240
Query: 185 IEACWAK 191
           +     K
Sbjct: 241 LSGLLKK 247

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 88.2 bits (217), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +K L    IV + G    P  P L +V EYL  G L   L +   R  LD  R L  +  
Sbjct: 62  LKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRAR--LDASRLLLYSSQ 119
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAAGT 115
           + KGM YL  R    VHRDL + N+LV+ +  VK+ DFGL++L     +  +  +     
Sbjct: 120 ICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSP 177
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP-AQVVAAVGFK------- 167
             W APE L D   + +SD++SFGV+L+EL T      + +P A+ +  +G +       
Sbjct: 178 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDK--SCSPSAEFLRMMGCERDVPALC 235
Query: 168 --------GKRLEIPRNVNPHVASIIEACWA 190
                   G+RL  P      V  +++ CWA
Sbjct: 236 RLLELLEEGQRLPAPPACPAEVHELMKLCWA 266

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 88.2 bits (217), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 6/187 (3%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
           RHP +     +      L  V EY + G L+   H    R   ++R R   A ++   ++
Sbjct: 68  RHPFLTALKYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALD 124
Query: 65  YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL 124
           YLH     +V+RDLK  NL++DK   +K+ DFGL +       + K   GTPE++APEVL
Sbjct: 125 YLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVL 183
Query: 125 RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASI 184
            D       D +  GV+++E+   + P+ N +  ++   +    + +  PR + P   S+
Sbjct: 184 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEIRFPRTLGPEAKSL 241
Query: 185 IEACWAK 191
           +     K
Sbjct: 242 LSGLLKK 248

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 99/194 (51%), Gaps = 11/194 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M++L +P IV  +G + +  +  +V E    G L + L +      + ++  + + + V+
Sbjct: 66  MQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVS 121
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKANTFLSSKSAAGTPE 117
            GM YL   N   VHRDL + N+L+  ++  K+ DFGLS   R   N + +        +
Sbjct: 122 MGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVK 179
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWE-LATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE +     + KSD++SFGV++WE  +  Q+P+  +  ++V A +  KG+R+  P  
Sbjct: 180 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAG 238
Query: 177 VNPHVASIIEACWA 190
               +  ++  CW 
Sbjct: 239 CPREMYDLMNLCWT 252

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-----------PGV----REMLDER 50
           H NIV  +GA T      ++TEY   G L   L +           P +       LD  
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 51  RRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSS 109
             L+ +Y VAKGM +L  +N   +HRDL + N+L+      K+CDFGL+R +K ++    
Sbjct: 146 DLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 110 KSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFK 167
           K  A  P +WMAPE + +     +SD++S+G+ LWEL +L   P+  +        +  +
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 263
Query: 168 GKRLEIPRNVNPHVASIIEACW 189
           G R+  P +    +  I++ CW
Sbjct: 264 GFRMLSPEHAPAEMYDIMKTCW 285

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 87.4 bits (215), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-----------PGV----REMLDER 50
           H NIV  +GA T      ++TEY   G L   L +           P +       LD  
Sbjct: 102 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 161
Query: 51  RRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSS 109
             L+ +Y VAKGM +L  +N   +HRDL + N+L+      K+CDFGL+R +K ++    
Sbjct: 162 DLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 219
Query: 110 KSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFK 167
           K  A  P +WMAPE + +     +SD++S+G+ LWEL +L   P+  +        +  +
Sbjct: 220 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 279
Query: 168 GKRLEIPRNVNPHVASIIEACW 189
           G R+  P +    +  I++ CW
Sbjct: 280 GFRMLSPEHAPAEMYDIMKTCW 301

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 87.4 bits (215), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-----------PGV----REMLDER 50
           H NIV  +GA T      ++TEY   G L   L +           P +       LD  
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 51  RRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSS 109
             L+ +Y VAKGM +L  +N   +HRDL + N+L+      K+CDFGL+R +K ++    
Sbjct: 169 DLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVV 226
Query: 110 KSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFK 167
           K  A  P +WMAPE + +     +SD++S+G+ LWEL +L   P+  +        +  +
Sbjct: 227 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 286
Query: 168 GKRLEIPRNVNPHVASIIEACW 189
           G R+  P +    +  I++ CW
Sbjct: 287 GFRMLSPEHAPAEMYDIMKTCW 308

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 87.4 bits (215), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-----------PGV----REMLDER 50
           H NIV  +GA T      ++TEY   G L   L +           P +       LD  
Sbjct: 104 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 163
Query: 51  RRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSS 109
             L+ +Y VAKGM +L  +N   +HRDL + N+L+      K+CDFGL+R +K ++    
Sbjct: 164 DLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 221
Query: 110 KSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFK 167
           K  A  P +WMAPE + +     +SD++S+G+ LWEL +L   P+  +        +  +
Sbjct: 222 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 281
Query: 168 GKRLEIPRNVNPHVASIIEACW 189
           G R+  P +    +  I++ CW
Sbjct: 282 GFRMLSPEHAPAEMYDIMKTCW 303

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 87.4 bits (215), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-----------PGV----REMLDER 50
           H NIV  +GA T      ++TEY   G L   L +           P +       LD  
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 51  RRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSS 109
             L+ +Y VAKGM +L  +N   +HRDL + N+L+      K+CDFGL+R +K ++    
Sbjct: 169 DLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 226
Query: 110 KSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFK 167
           K  A  P +WMAPE + +     +SD++S+G+ LWEL +L   P+  +        +  +
Sbjct: 227 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 286
Query: 168 GKRLEIPRNVNPHVASIIEACW 189
           G R+  P +    +  I++ CW
Sbjct: 287 GFRMLSPEHAPAEMYDIMKTCW 308

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 99/194 (51%), Gaps = 11/194 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M++L +P IV  +G + +  +  +V E    G L + L +      + ++  + + + V+
Sbjct: 66  MQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVS 121
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKANTFLSSKSAAGTPE 117
            GM YL   N   VHRDL + N+L+  ++  K+ DFGLS   R   N + +        +
Sbjct: 122 MGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 179
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWE-LATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE +     + KSD++SFGV++WE  +  Q+P+  +  ++V A +  KG+R+  P  
Sbjct: 180 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAG 238
Query: 177 VNPHVASIIEACWA 190
               +  ++  CW 
Sbjct: 239 CPREMYDLMNLCWT 252

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 37/212 (17%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK 61
           ++ RH N+VLFMGA   PP+L+I+T      +LY ++    +  +LD  +   +A ++ K
Sbjct: 84  RQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI--VLDVNKTRQIAQEIVK 141
Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE---- 117
           GM YLH +   I+H+DLKS N+  D    V + DFGL        +S    AG  E    
Sbjct: 142 GMGYLHAKG--ILHKDLKSKNVFYDNGKVV-ITDFGLFS------ISGVLQAGRREDKLR 192
Query: 118 ----W---MAPEVLRD---------EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161
               W   +APE++R           P ++ SD+++ G I +EL   + P+    PA+ +
Sbjct: 193 IQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF-KTQPAEAI 251
Query: 162 ---AAVGFKGKRLEIPRNVNPHVASIIEACWA 190
                 G K    +I   +   ++ I+  CWA
Sbjct: 252 IWQMGTGMKPNLSQI--GMGKEISDILLFCWA 281

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 87.0 bits (214), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 99/194 (51%), Gaps = 11/194 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M++L +P IV  +G + +  +  +V E    G L + L +      + ++  + + + V+
Sbjct: 80  MQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVS 135
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKANTFLSSKSAAGTPE 117
            GM YL   N   VHRDL + N+L+  ++  K+ DFGLS   R   N + +        +
Sbjct: 136 MGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 193
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWE-LATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE +     + KSD++SFGV++WE  +  Q+P+  +  ++V A +  KG+R+  P  
Sbjct: 194 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAG 252
Query: 177 VNPHVASIIEACWA 190
               +  ++  CW 
Sbjct: 253 CPREMYDLMNLCWT 266

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 87.0 bits (214), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 99/194 (51%), Gaps = 11/194 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M++L +P IV  +G + +  +  +V E    G L + L +      + ++  + + + V+
Sbjct: 62  MQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVS 117
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKANTFLSSKSAAGTPE 117
            GM YL   N   VHRDL + N+L+  ++  K+ DFGLS   R   N + +        +
Sbjct: 118 MGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWE-LATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE +     + KSD++SFGV++WE  +  Q+P+  +  ++V A +  KG+R+  P  
Sbjct: 176 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAG 234
Query: 177 VNPHVASIIEACWA 190
               +  ++  CW 
Sbjct: 235 CPREMYDLMNLCWT 248

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 87.0 bits (214), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 99/194 (51%), Gaps = 11/194 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M++L +P IV  +G + +  +  +V E    G L + L +      + ++  + + + V+
Sbjct: 82  MQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVS 137
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKANTFLSSKSAAGTPE 117
            GM YL   N   VHRDL + N+L+  ++  K+ DFGLS   R   N + +        +
Sbjct: 138 MGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 195
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWE-LATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE +     + KSD++SFGV++WE  +  Q+P+  +  ++V A +  KG+R+  P  
Sbjct: 196 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAG 254
Query: 177 VNPHVASIIEACWA 190
               +  ++  CW 
Sbjct: 255 CPREMYDLMNLCWT 268

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 87.0 bits (214), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 99/194 (51%), Gaps = 11/194 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M++L +P IV  +G + +  +  +V E    G L + L +      + ++  + + + V+
Sbjct: 82  MQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVS 137
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKANTFLSSKSAAGTPE 117
            GM YL   N   VHRDL + N+L+  ++  K+ DFGLS   R   N + +        +
Sbjct: 138 MGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 195
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWE-LATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE +     + KSD++SFGV++WE  +  Q+P+  +  ++V A +  KG+R+  P  
Sbjct: 196 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAG 254
Query: 177 VNPHVASIIEACWA 190
               +  ++  CW 
Sbjct: 255 CPREMYDLMNLCWT 268

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 87.0 bits (214), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 60/158 (37%), Positives = 85/158 (53%), Gaps = 13/158 (8%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK 61
           + LRHPNIV F   +  P +L+I+ EY S G LY  +   G R   DE R       +  
Sbjct: 71  RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG-RFSEDEARFFFQQ--LLS 127
Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKYT--VKVCDFGLSRLKANTFLSS--KSAAGTPE 117
           G++Y H     I HRDLK  N L+D      +K+CDFG S+   ++ L S  KS  GTP 
Sbjct: 128 GVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPA 182
Query: 118 WMAPEV-LRDEPSNEKSDIYSFGVILWELATLQQPWGN 154
           ++APEV LR E   + +D++S GV L+ +     P+ +
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 87.0 bits (214), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 99/194 (51%), Gaps = 11/194 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M++L +P IV  +G + +  +  +V E    G L + L +      + ++  + + + V+
Sbjct: 60  MQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVS 115
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKANTFLSSKSAAGTPE 117
            GM YL   N   VHRDL + N+L+  ++  K+ DFGLS   R   N + +        +
Sbjct: 116 MGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 173
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWE-LATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE +     + KSD++SFGV++WE  +  Q+P+  +  ++V A +  KG+R+  P  
Sbjct: 174 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAG 232
Query: 177 VNPHVASIIEACWA 190
               +  ++  CW 
Sbjct: 233 CPREMYDLMNLCWT 246

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 87.0 bits (214), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 99/194 (51%), Gaps = 11/194 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M++L +P IV  +G + +  +  +V E    G L + L +      + ++  + + + V+
Sbjct: 72  MQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVS 127
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKANTFLSSKSAAGTPE 117
            GM YL   N   VHRDL + N+L+  ++  K+ DFGLS   R   N + +        +
Sbjct: 128 MGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 185
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWE-LATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE +     + KSD++SFGV++WE  +  Q+P+  +  ++V A +  KG+R+  P  
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAG 244
Query: 177 VNPHVASIIEACWA 190
               +  ++  CW 
Sbjct: 245 CPREMYDLMNLCWT 258

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 101/211 (47%), Gaps = 27/211 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +K L    IV + G    P   +L +V EYL  G L   L +   R  LD  R L  +  
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR--LDASRLLLYSSQ 135
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAAGT 115
           + KGM YL  R    VHRDL + N+LV+ +  VK+ DFGL++L     + ++  +     
Sbjct: 136 ICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP-AQVVAAVGFK------- 167
             W APE L D   + +SD++SFGV+L+EL T      + +P A+ +  +G +       
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDK--SCSPSAEFLRMMGCERDVPALS 251
Query: 168 --------GKRLEIPRNVNPHVASIIEACWA 190
                   G+RL  P      V  +++ CWA
Sbjct: 252 RLLELLEEGQRLPAPPACPAEVHELMKLCWA 282

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G +     + ++T+ +  G L   + +   ++ +  +  LN    +A
Sbjct: 71  MASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 127
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFGL++L         +  G    +W
Sbjct: 128 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + PA  ++++  KG+RL  P   
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPIC 244
Query: 178 NPHVASIIEACW 189
              V  I+  CW
Sbjct: 245 TIDVYMIMRKCW 256

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 87.0 bits (214), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G +     + ++T+ +  G L   + +   ++ +  +  LN    +A
Sbjct: 74  MASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 130
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFGL++L         +  G    +W
Sbjct: 131 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + PA  ++++  KG+RL  P   
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPIC 247
Query: 178 NPHVASIIEACW 189
              V  I+  CW
Sbjct: 248 TIDVYMIMRKCW 259

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 1   MKRLRHPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           ++ L H NIV + G  T+     + ++ E+L  GSL   L  P  +  ++ +++L  A  
Sbjct: 65  LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQ 122
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP 116
           + KGM+YL  R    VHRDL + N+LV+ ++ VK+ DFGL++         + K    +P
Sbjct: 123 ICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSP 180
Query: 117 E-WMAPEVLRDEPSNEKSDIYSFGVILWELAT---------------LQQPWGNLNPAQV 160
             W APE L        SD++SFGV L EL T               +    G +   ++
Sbjct: 181 VFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 240
Query: 161 VAAVGFKGKRLEIPRNVNPHVASIIEACW 189
           V  +  +GKRL  P N    V  ++  CW
Sbjct: 241 VNTLK-EGKRLPCPPNCPDEVYQLMRKCW 268

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G +     + ++T+ +  G L   + +   ++ +  +  LN    +A
Sbjct: 81  MASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 137
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFGL++L         +  G    +W
Sbjct: 138 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 195
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + PA  ++++  KG+RL  P   
Sbjct: 196 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPIC 254
Query: 178 NPHVASIIEACW 189
              V  I+  CW
Sbjct: 255 TIDVYMIMRKCW 266

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 101/211 (47%), Gaps = 27/211 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +K L    IV + G    P   +L +V EYL  G L   L +   R  LD  R L  +  
Sbjct: 66  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQ 123
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAAGT 115
           + KGM YL  R    VHRDL + N+LV+ +  VK+ DFGL++L     + ++  +     
Sbjct: 124 ICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 181
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP-AQVVAAVGFK------- 167
             W APE L D   + +SD++SFGV+L+EL T      + +P A+ +  +G +       
Sbjct: 182 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDK--SCSPSAEFLRMMGCERDVPALC 239
Query: 168 --------GKRLEIPRNVNPHVASIIEACWA 190
                   G+RL  P      V  +++ CWA
Sbjct: 240 RLLELLEEGQRLPAPPACPAEVHELMKLCWA 270

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 99/194 (51%), Gaps = 11/194 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M++L +P IV  +G + +  +  +V E    G L + L +      + ++  + + + V+
Sbjct: 424 MQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVS 479
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKANTFLSSKSAAGTPE 117
            GM YL   N   VHRDL + N+L+  ++  K+ DFGLS   R   N + +        +
Sbjct: 480 MGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 537
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWE-LATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE +     + KSD++SFGV++WE  +  Q+P+  +  ++V A +  KG+R+  P  
Sbjct: 538 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAG 596
Query: 177 VNPHVASIIEACWA 190
               +  ++  CW 
Sbjct: 597 CPREMYDLMNLCWT 610

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 1   MKRLRHPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           ++ L H NIV + G  T+     + ++ E+L  GSL   L  P  +  ++ +++L  A  
Sbjct: 77  LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQ 134
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP 116
           + KGM+YL  R    VHRDL + N+LV+ ++ VK+ DFGL++         + K    +P
Sbjct: 135 ICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSP 192
Query: 117 E-WMAPEVLRDEPSNEKSDIYSFGVILWELAT---------------LQQPWGNLNPAQV 160
             W APE L        SD++SFGV L EL T               +    G +   ++
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252
Query: 161 VAAVGFKGKRLEIPRNVNPHVASIIEACW 189
           V  +  +GKRL  P N    V  ++  CW
Sbjct: 253 VNTLK-EGKRLPCPPNCPDEVYQLMRKCW 280

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 99/194 (51%), Gaps = 11/194 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M++L +P IV  +G + +  +  +V E    G L + L +      + ++  + + + V+
Sbjct: 425 MQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVS 480
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKANTFLSSKSAAGTPE 117
            GM YL   N   VHRDL + N+L+  ++  K+ DFGLS   R   N + +        +
Sbjct: 481 MGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 538
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWE-LATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE +     + KSD++SFGV++WE  +  Q+P+  +  ++V A +  KG+R+  P  
Sbjct: 539 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAG 597
Query: 177 VNPHVASIIEACWA 190
               +  ++  CW 
Sbjct: 598 CPREMYDLMNLCWT 611

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 86.7 bits (213), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-KPGVREMLDERRRLNMAYDV 59
           M +  HPNI+   G VT    + I+TE++  G+L   L    G   ++   + + M   +
Sbjct: 71  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGI 127
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKAN----TFLSSKSAAG 114
           A GM YL   +   VHRDL + N+LV+     KV DFGLSR L+ N    T  SS     
Sbjct: 128 ASGMRYLAEMS--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKI 185
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEI 173
              W APE +        SD +S+G+++WE+ +  ++P+ +++   V+ A+  +  RL  
Sbjct: 186 PIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIE-QDYRLPP 244
Query: 174 PRNVNPHVASIIEACWAK 191
           P +    +  ++  CW K
Sbjct: 245 PPDCPTSLHQLMLDCWQK 262

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 86.7 bits (213), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 86/164 (52%), Gaps = 12/164 (7%)
Query: 4   LRHPNIVLF--MGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           L HP IV     G    P  P   IV EY+   +L  ++H  G    +  +R + +  D 
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADA 125
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA---NTFLSSKSAAGTP 116
            + +N+ H+    I+HRD+K  N+L+     VKV DFG++R  A   N+   + +  GT 
Sbjct: 126 CQALNFSHQNG--IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTA 183
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160
           ++++PE  R +  + +SD+YS G +L+E+ T + P+   +P  V
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 227

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 86.7 bits (213), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 79/140 (56%), Gaps = 5/140 (3%)
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKS 111
           ++ ++ VA+GM +L  R    +HRDL + N+L+ +   VK+CDFGL+R +  N     K 
Sbjct: 202 ISYSFQVARGMEFLSSRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKG 259
Query: 112 AAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGK 169
               P +WMAPE + D+  + KSD++S+GV+LWE+ +L   P+  +   +   +   +G 
Sbjct: 260 DTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLREGM 319
Query: 170 RLEIPRNVNPHVASIIEACW 189
           R+  P    P +  I+  CW
Sbjct: 320 RMRAPEYSTPEIYQIMLDCW 339

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 86.3 bits (212), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 101/211 (47%), Gaps = 27/211 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +K L    IV + G    P   +L +V EYL  G L   L +   R  LD  R L  +  
Sbjct: 65  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR--LDASRLLLYSSQ 122
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAAGT 115
           + KGM YL  R    VHRDL + N+LV+ +  VK+ DFGL++L     + ++  +     
Sbjct: 123 ICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 180
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP-AQVVAAVGFK------- 167
             W APE L D   + +SD++SFGV+L+EL T      + +P A+ +  +G +       
Sbjct: 181 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDK--SCSPSAEFLRMMGSERDVPALS 238
Query: 168 --------GKRLEIPRNVNPHVASIIEACWA 190
                   G+RL  P      V  +++ CWA
Sbjct: 239 RLLELLEEGQRLPAPPACPAEVHELMKLCWA 269

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 97/191 (50%), Gaps = 7/191 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K ++HP +V    +      L  V +Y++ G L+  L +   R  L+ R R   A ++A
Sbjct: 93  LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAA-EIA 149
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             + YLH  N  IV+RDLK  N+L+D +  + + DFGL +       ++ +  GTPE++A
Sbjct: 150 SALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLA 207
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVL  +P +   D +  G +L+E+     P+ + N A++   +    K L++  N+   
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI--LNKPLQLKPNITNS 265
Query: 181 VASIIEACWAK 191
              ++E    K
Sbjct: 266 ARHLLEGLLQK 276

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G +     + ++T+ +  G L   + +   ++ +  +  LN    +A
Sbjct: 74  MASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 130
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFGL++L         +  G    +W
Sbjct: 131 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + PA  ++++  KG+RL  P   
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPIC 247
Query: 178 NPHVASIIEACW 189
              V  I+  CW
Sbjct: 248 TIDVYMIMVKCW 259

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G +     + ++T+ +  G L   + +   ++ +  +  LN    +A
Sbjct: 78  MASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 134
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFGL++L         +  G    +W
Sbjct: 135 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + PA  ++++  KG+RL  P   
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPIC 251
Query: 178 NPHVASIIEACW 189
              V  I+  CW
Sbjct: 252 TIDVYMIMVKCW 263

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G +     + ++T+ +  G L   + +   ++ +  +  LN    +A
Sbjct: 77  MASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 133
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFGL++L         +  G    +W
Sbjct: 134 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 191
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + PA  ++++  KG+RL  P   
Sbjct: 192 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPIC 250
Query: 178 NPHVASIIEACW 189
              V  I+  CW
Sbjct: 251 TIDVYMIMVKCW 262

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G +     + ++T+ +  G L   + +   ++ +  +  LN    +A
Sbjct: 74  MASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 130
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFGL++L         +  G    +W
Sbjct: 131 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + PA  ++++  KG+RL  P   
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPIC 247
Query: 178 NPHVASIIEACW 189
              V  I+  CW
Sbjct: 248 TIDVYMIMVKCW 259

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G +     + ++T+ +  G L   + +   ++ +  +  LN    +A
Sbjct: 73  MASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 129
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFGL++L         +  G    +W
Sbjct: 130 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + PA  ++++  KG+RL  P   
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPIC 246
Query: 178 NPHVASIIEACW 189
              V  I+  CW
Sbjct: 247 TIDVYMIMVKCW 258

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G +     + ++T+ +  G L   + +   ++ +  +  LN    +A
Sbjct: 78  MASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 134
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFGL++L         +  G    +W
Sbjct: 135 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + PA  ++++  KG+RL  P   
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPIC 251
Query: 178 NPHVASIIEACW 189
              V  I+  CW
Sbjct: 252 TIDVYMIMVKCW 263

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G +     + ++T+ +  G L   + +   ++ +  +  LN    +A
Sbjct: 65  MASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 121
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFGL++L         +  G    +W
Sbjct: 122 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + PA  ++++  KG+RL  P   
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPIC 238
Query: 178 NPHVASIIEACW 189
              V  I+  CW
Sbjct: 239 TIDVYMIMVKCW 250

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G +     + ++T+ +  G L   + +   ++ +  +  LN    +A
Sbjct: 71  MASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 127
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFGL++L         +  G    +W
Sbjct: 128 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + PA  ++++  KG+RL  P   
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPIC 244
Query: 178 NPHVASIIEACW 189
              V  I+  CW
Sbjct: 245 TIDVYMIMVKCW 256

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G +     + ++T+ +  G L   + +   ++ +  +  LN    +A
Sbjct: 71  MASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 127
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFGL++L         +  G    +W
Sbjct: 128 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + PA  ++++  KG+RL  P   
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPIC 244
Query: 178 NPHVASIIEACW 189
              V  I+  CW
Sbjct: 245 TIDVYMIMVKCW 256

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 78/149 (52%), Gaps = 5/149 (3%)
Query: 44  REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--L 101
           ++ L     +  ++ VAKGM +L  R    +HRDL + N+L+ +K  VK+CDFGL+R   
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIY 244
Query: 102 KANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQV 160
           K   ++    A    +WMAPE + D     +SD++SFGV+LWE+ +L   P+  +   + 
Sbjct: 245 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 304
Query: 161 VAAVGFKGKRLEIPRNVNPHVASIIEACW 189
                 +G R+  P    P +   +  CW
Sbjct: 305 FCRRLKEGTRMRAPDYTTPEMYQTMLDCW 333

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G +     + ++T+ +  G L   + +   ++ +  +  LN    +A
Sbjct: 96  MASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 152
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFGL++L         +  G    +W
Sbjct: 153 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 210
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + PA  ++++  KG+RL  P   
Sbjct: 211 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPIC 269
Query: 178 NPHVASIIEACW 189
              V  I+  CW
Sbjct: 270 TIDVYMIMVKCW 281

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 78/149 (52%), Gaps = 5/149 (3%)
Query: 44  REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--L 101
           ++ L     +  ++ VAKGM +L  R    +HRDL + N+L+ +K  VK+CDFGL+R   
Sbjct: 185 KDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIY 242
Query: 102 KANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQV 160
           K   ++    A    +WMAPE + D     +SD++SFGV+LWE+ +L   P+  +   + 
Sbjct: 243 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 302
Query: 161 VAAVGFKGKRLEIPRNVNPHVASIIEACW 189
                 +G R+  P    P +   +  CW
Sbjct: 303 FCRRLKEGTRMRAPDYTTPEMYQTMLDCW 331

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 47/137 (34%), Positives = 74/137 (54%), Gaps = 5/137 (3%)
Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSSKSAA 113
           ++ VAKGM +L  R    +HRDL + N+L+ +K  VK+CDFGL+R   K   ++    A 
Sbjct: 206 SFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 263
Query: 114 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLE 172
              +WMAPE + D     +SD++SFGV+LWE+ +L   P+  +   +       +G R+ 
Sbjct: 264 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 323
Query: 173 IPRNVNPHVASIIEACW 189
            P    P +   +  CW
Sbjct: 324 APDYTTPEMYQTMLDCW 340

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 47/137 (34%), Positives = 74/137 (54%), Gaps = 5/137 (3%)
Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSSKSAA 113
           ++ VAKGM +L  R    +HRDL + N+L+ +K  VK+CDFGL+R   K   ++    A 
Sbjct: 204 SFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 261
Query: 114 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLE 172
              +WMAPE + D     +SD++SFGV+LWE+ +L   P+  +   +       +G R+ 
Sbjct: 262 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 321
Query: 173 IPRNVNPHVASIIEACW 189
            P    P +   +  CW
Sbjct: 322 APDYTTPEMYQTMLDCW 338

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G +     + ++T+ +  G L   + +   ++ +  +  LN    +A
Sbjct: 105 MASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 161
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFGL++L         +  G    +W
Sbjct: 162 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 219
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + PA  ++++  KG+RL  P   
Sbjct: 220 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPIC 278
Query: 178 NPHVASIIEACW 189
              V  I+  CW
Sbjct: 279 TIDVYMIMVKCW 290

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 27/215 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM-------LDERRR- 52
           M    +PNIV  +G       + ++ EY++ G L   L       +       L  R R 
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 53  -------------LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS 99
                        L +A  VA GM YL  R    VHRDL + N LV +   VK+ DFGLS
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLS 221
Query: 100 R--LKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ-QPWGNLN 156
           R    A+ + +  + A    WM PE +       +SD++++GV+LWE+ +   QP+  + 
Sbjct: 222 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281
Query: 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK 191
             +V+  V   G  L  P N    + +++  CW+K
Sbjct: 282 HEEVIYYVR-DGNILACPENCPLELYNLMRLCWSK 315

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G +     + ++T+ +  G L   + +   ++ +  +  LN    +A
Sbjct: 71  MASVDNPHVCRLLG-ICLTSTVQLITQLMPFGXLLDYVREH--KDNIGSQYLLNWCVQIA 127
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFGL++L         +  G    +W
Sbjct: 128 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + PA  ++++  KG+RL  P   
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPIC 244
Query: 178 NPHVASIIEACW 189
              V  I+  CW
Sbjct: 245 TIDVYMIMVKCW 256

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 86/164 (52%), Gaps = 12/164 (7%)
Query: 4   LRHPNIVLF--MGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           L HP IV     G    P  P   IV EY+   +L  ++H  G    +  +R + +  D 
Sbjct: 69  LNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADA 125
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA---NTFLSSKSAAGTP 116
            + +N+ H+    I+HRD+K  N+++     VKV DFG++R  A   N+   + +  GT 
Sbjct: 126 CQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160
           ++++PE  R +  + +SD+YS G +L+E+ T + P+   +P  V
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 227

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 86/164 (52%), Gaps = 12/164 (7%)
Query: 4   LRHPNIVLF--MGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           L HP IV     G    P  P   IV EY+   +L  ++H  G    +  +R + +  D 
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADA 125
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA---NTFLSSKSAAGTP 116
            + +N+ H+    I+HRD+K  N+++     VKV DFG++R  A   N+   + +  GT 
Sbjct: 126 CQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160
           ++++PE  R +  + +SD+YS G +L+E+ T + P+   +P  V
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 227

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 86/164 (52%), Gaps = 12/164 (7%)
Query: 4   LRHPNIVLF--MGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           L HP IV     G    P  P   IV EY+   +L  ++H  G    +  +R + +  D 
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADA 125
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA---NTFLSSKSAAGTP 116
            + +N+ H+    I+HRD+K  N+++     VKV DFG++R  A   N+   + +  GT 
Sbjct: 126 CQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160
           ++++PE  R +  + +SD+YS G +L+E+ T + P+   +P  V
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 227

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 101/193 (52%), Gaps = 12/193 (6%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
           HP +V           L  V EY++ G L  + H    R++ +E  R   A +++  +NY
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNY 168
Query: 66  LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 125
           LH R   I++RDLK  N+L+D +  +K+ D+G+ +       ++ +  GTP ++APE+LR
Sbjct: 169 LHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 226
Query: 126 DEPSNEKSDIYSFGVILWELATLQQPW----GNLNPAQVVAAVGFK---GKRLEIPRNVN 178
            E      D ++ GV+++E+   + P+     + NP Q      F+    K++ IPR+++
Sbjct: 227 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 286
Query: 179 PHVASIIEACWAK 191
              AS++++   K
Sbjct: 287 VKAASVLKSFLNK 299

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 86/164 (52%), Gaps = 12/164 (7%)
Query: 4   LRHPNIVLF--MGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           L HP IV     G    P  P   IV EY+   +L  ++H  G    +  +R + +  D 
Sbjct: 86  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADA 142
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA---NTFLSSKSAAGTP 116
            + +N+ H+    I+HRD+K  N+++     VKV DFG++R  A   N+   + +  GT 
Sbjct: 143 CQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 200
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160
           ++++PE  R +  + +SD+YS G +L+E+ T + P+   +P  V
Sbjct: 201 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 244

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 90/170 (52%), Gaps = 10/170 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +K L+H NIV + G        NL ++ EYL  GSL   L K   +E +D  + L     
Sbjct: 66  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQ 123
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP 116
           + KGM YL  +    +HR+L + N+LV+ +  VK+ DFGL+++  +   +   K    +P
Sbjct: 124 ICKGMEYLGTKR--YIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 181
Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 165
             W APE L +   +  SD++SFGV+L+EL T  +      PA+ +  +G
Sbjct: 182 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEFMRMIG 230

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/152 (36%), Positives = 82/152 (53%), Gaps = 9/152 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +K L+H NIV + G        NL ++ EYL  GSL   L K   +E +D  + L     
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQ 122
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP 116
           + KGM YL  +    +HRDL + N+LV+ +  VK+ DFGL+++  +       K    +P
Sbjct: 123 ICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 180
Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147
             W APE L +   +  SD++SFGV+L+EL T
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/152 (36%), Positives = 82/152 (53%), Gaps = 9/152 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +K L+H NIV + G        NL ++ EYL  GSL   L K   +E +D  + L     
Sbjct: 96  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQ 153
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP 116
           + KGM YL  +    +HRDL + N+LV+ +  VK+ DFGL+++  +       K    +P
Sbjct: 154 ICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 211
Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147
             W APE L +   +  SD++SFGV+L+EL T
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 6/192 (3%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK 61
           K L+H NIV ++G+ ++   + I  E +  GSL  LL         +E+        + +
Sbjct: 60  KHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE 119
Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           G+ YLH     IVHRD+K  N+L++    V K+ DFG S+  A     +++  GT ++MA
Sbjct: 120 GLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMA 177
Query: 121 PEVLRDEPS--NEKSDIYSFGVILWELATLQQPWGNLN-PAQVVAAVGFKGKRLEIPRNV 177
           PE++   P    + +DI+S G  + E+AT + P+  L  P   +  VG      EIP ++
Sbjct: 178 PEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESM 237
Query: 178 NPHVASIIEACW 189
           +    + I  C+
Sbjct: 238 SAEAKAFILKCF 249

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/152 (36%), Positives = 82/152 (53%), Gaps = 9/152 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +K L+H NIV + G        NL ++ EYL  GSL   L K   +E +D  + L     
Sbjct: 70  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQ 127
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP 116
           + KGM YL  +    +HRDL + N+LV+ +  VK+ DFGL+++  +       K    +P
Sbjct: 128 ICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 185
Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147
             W APE L +   +  SD++SFGV+L+EL T
Sbjct: 186 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/152 (36%), Positives = 82/152 (53%), Gaps = 9/152 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +K L+H NIV + G        NL ++ EYL  GSL   L K   +E +D  + L     
Sbjct: 71  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQ 128
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP 116
           + KGM YL  +    +HRDL + N+LV+ +  VK+ DFGL+++  +       K    +P
Sbjct: 129 ICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 186
Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147
             W APE L +   +  SD++SFGV+L+EL T
Sbjct: 187 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/150 (34%), Positives = 84/150 (56%), Gaps = 3/150 (2%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL-HKPGVREMLDERRRLNMAYDVAKGMN 64
           H N++   G    P    +V  Y++ GS+   L  +P  +  LD  +R  +A   A+G+ 
Sbjct: 94  HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLA 153
Query: 65  YLHRR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA-GTPEWMAPE 122
           YLH   +P I+HRD+K+ N+L+D+++   V DFGL++L          A  GT   +APE
Sbjct: 154 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPE 213
Query: 123 VLRDEPSNEKSDIYSFGVILWELATLQQPW 152
            L    S+EK+D++ +GV+L EL T Q+ +
Sbjct: 214 YLSTGKSSEKTDVFGYGVMLLELITGQRAF 243

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/152 (36%), Positives = 82/152 (53%), Gaps = 9/152 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +K L+H NIV + G        NL ++ EYL  GSL   L K   +E +D  + L     
Sbjct: 83  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQ 140
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP 116
           + KGM YL  +    +HRDL + N+LV+ +  VK+ DFGL+++  +       K    +P
Sbjct: 141 ICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 198
Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147
             W APE L +   +  SD++SFGV+L+EL T
Sbjct: 199 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 86/164 (52%), Gaps = 12/164 (7%)
Query: 4   LRHPNIVLF--MGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           L HP IV     G    P  P   IV EY+   +L  ++H  G    +  +R + +  D 
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADA 125
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA---NTFLSSKSAAGTP 116
            + +N+ H+    I+HRD+K  N+++     VKV DFG++R  A   N+   + +  GT 
Sbjct: 126 CQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160
           ++++PE  R +  + +SD+YS G +L+E+ T + P+   +P  V
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSV 227

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/170 (34%), Positives = 89/170 (52%), Gaps = 10/170 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +K L+H NIV + G        NL ++ EYL  GSL   L K   +E +D  + L     
Sbjct: 68  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQ 125
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP 116
           + KGM YL  +    +HRDL + N+LV+ +  VK+ DFGL+++  +       K    +P
Sbjct: 126 ICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 165
             W APE L +   +  SD++SFGV+L+EL T  +      PA+ +  +G
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEFMRMIG 232

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/152 (36%), Positives = 82/152 (53%), Gaps = 9/152 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +K L+H NIV + G        NL ++ EYL  GSL   L K   +E +D  + L     
Sbjct: 83  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQ 140
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP 116
           + KGM YL  +    +HRDL + N+LV+ +  VK+ DFGL+++  +       K    +P
Sbjct: 141 ICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 198
Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147
             W APE L +   +  SD++SFGV+L+EL T
Sbjct: 199 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/170 (34%), Positives = 89/170 (52%), Gaps = 10/170 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +K L+H NIV + G        NL ++ EYL  GSL   L K   +E +D  + L     
Sbjct: 64  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQ 121
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP 116
           + KGM YL  +    +HRDL + N+LV+ +  VK+ DFGL+++  +       K    +P
Sbjct: 122 ICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 179
Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 165
             W APE L +   +  SD++SFGV+L+EL T  +      PA+ +  +G
Sbjct: 180 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEFMRMIG 228

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/152 (36%), Positives = 82/152 (53%), Gaps = 9/152 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +K L+H NIV + G        NL ++ EYL  GSL   L K   +E +D  + L     
Sbjct: 63  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQ 120
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP 116
           + KGM YL  +    +HRDL + N+LV+ +  VK+ DFGL+++  +       K    +P
Sbjct: 121 ICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 178
Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147
             W APE L +   +  SD++SFGV+L+EL T
Sbjct: 179 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 55/152 (36%), Positives = 82/152 (53%), Gaps = 9/152 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +K L+H NIV + G        NL ++ EYL  GSL   L K   +E +D  + L     
Sbjct: 72  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQ 129
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP 116
           + KGM YL  +    +HRDL + N+LV+ +  VK+ DFGL+++  +       K    +P
Sbjct: 130 ICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 187
Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147
             W APE L +   +  SD++SFGV+L+EL T
Sbjct: 188 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 6/192 (3%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK 61
           K L+H NIV ++G+ ++   + I  E +  GSL  LL         +E+        + +
Sbjct: 74  KHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE 133
Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           G+ YLH     IVHRD+K  N+L++    V K+ DFG S+  A     +++  GT ++MA
Sbjct: 134 GLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMA 191
Query: 121 PEVLRDEPS--NEKSDIYSFGVILWELATLQQPWGNLN-PAQVVAAVGFKGKRLEIPRNV 177
           PE++   P    + +DI+S G  + E+AT + P+  L  P   +  VG      EIP ++
Sbjct: 192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESM 251
Query: 178 NPHVASIIEACW 189
           +    + I  C+
Sbjct: 252 SAEAKAFILKCF 263

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/191 (35%), Positives = 99/191 (51%), Gaps = 13/191 (6%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           L H +IV  +G +    +L +VT+YL  GSL  L H    R  L  +  LN    +AKGM
Sbjct: 72  LDHAHIVRLLG-LCPGSSLQLVTQYLPLGSL--LDHVRQHRGALGPQLLLNWGVQIAKGM 128
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAAGTP-EWM 119
            YL      +VHR+L + N+L+     V+V DFG++ L        L S+  A TP +WM
Sbjct: 129 YYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE--AKTPIKWM 184
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           A E +       +SD++S+GV +WEL T   +P+  L  A+V   +  KG+RL  P+   
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQICT 243
Query: 179 PHVASIIEACW 189
             V  ++  CW
Sbjct: 244 IDVYMVMVKCW 254

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/170 (34%), Positives = 89/170 (52%), Gaps = 10/170 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +K L+H NIV + G        NL ++ EYL  GSL   L K   +E +D  + L     
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQ 122
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP 116
           + KGM YL  +    +HRDL + N+LV+ +  VK+ DFGL+++  +       K    +P
Sbjct: 123 ICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 180
Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 165
             W APE L +   +  SD++SFGV+L+EL T  +      PA+ +  +G
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEFMRMIG 229

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/170 (34%), Positives = 89/170 (52%), Gaps = 10/170 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +K L+H NIV + G        NL ++ EYL  GSL   L K   +E +D  + L     
Sbjct: 69  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQ 126
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP 116
           + KGM YL  +    +HRDL + N+LV+ +  VK+ DFGL+++  +       K    +P
Sbjct: 127 ICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 184
Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 165
             W APE L +   +  SD++SFGV+L+EL T  +      PA+ +  +G
Sbjct: 185 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEFMRMIG 233

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 84/148 (56%), Gaps = 6/148 (4%)
Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P IV F GA      +SI  E++  GSL ++L K G    + E+    ++  V KG+ YL
Sbjct: 83  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYL 139
Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 126
            R    I+HRD+K  N+LV+ +  +K+CDFG+S    ++   + S  GT  +M+PE L+ 
Sbjct: 140 -REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQG 196
Query: 127 EPSNEKSDIYSFGVILWELATLQQPWGN 154
              + +SDI+S G+ L E+A  + P G+
Sbjct: 197 THYSVQSDIWSMGLSLVEMAVGRYPIGS 224

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 1   MKRLRHPNIVLFMG------AVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM---LDERR 51
           MK   HP++   +G      A  + P   ++  ++  G L+  L    + E    L  + 
Sbjct: 79  MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT 138
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSK 110
            +    D+A GM YL  RN   +HRDL + N ++ +  TV V DFGLSR + +  +    
Sbjct: 139 LVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQG 196
Query: 111 SAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
            A+  P +W+A E L D      SD+++FGV +WE+ T  Q P+  +  A++   +   G
Sbjct: 197 CASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL-IGG 255
Query: 169 KRLEIPRNVNPHVASIIEACWA 190
            RL+ P      V  ++  CW+
Sbjct: 256 NRLKQPPECMEEVYDLMYQCWS 277

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G +     + ++T+ +  G L   + +   ++ +  +  LN    +A
Sbjct: 68  MASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 124
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           +GMNYL  R   +VHRDL + N+LV     VK+ DFGL++L         +  G    +W
Sbjct: 125 EGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 182
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + PA  ++++  KG+RL  P   
Sbjct: 183 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPIC 241
Query: 178 NPHVASIIEACW 189
              V  I+  CW
Sbjct: 242 TIDVYMIMVKCW 253

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 90/185 (48%), Gaps = 10/185 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M+  ++PNIV ++ +      L +V EYL+ GSL  ++        +DE +   +  +  
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECL 126
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           + + +LH     ++HRD+KS N+L+    +VK+ DFG             +  GTP WMA
Sbjct: 127 QALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEV+  +    K DI+S G++  E+   + P+ N NP + +  +   G     P   NP 
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG----TPELQNPE 240
Query: 181 VASII 185
             S I
Sbjct: 241 KLSAI 245

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 100/193 (51%), Gaps = 12/193 (6%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
           HP +V           L  V EY++ G L  + H    R++ +E  R   A +++  +NY
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNY 121
Query: 66  LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 125
           LH R   I++RDLK  N+L+D +  +K+ D+G+ +       ++    GTP ++APE+LR
Sbjct: 122 LHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILR 179
Query: 126 DEPSNEKSDIYSFGVILWELATLQQPW----GNLNPAQVVAAVGFK---GKRLEIPRNVN 178
            E      D ++ GV+++E+   + P+     + NP Q      F+    K++ IPR+++
Sbjct: 180 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 239
Query: 179 PHVASIIEACWAK 191
              AS++++   K
Sbjct: 240 VKAASVLKSFLNK 252

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 100/193 (51%), Gaps = 12/193 (6%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
           HP +V           L  V EY++ G L  + H    R++ +E  R   A +++  +NY
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNY 125
Query: 66  LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 125
           LH R   I++RDLK  N+L+D +  +K+ D+G+ +       ++    GTP ++APE+LR
Sbjct: 126 LHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILR 183
Query: 126 DEPSNEKSDIYSFGVILWELATLQQPW----GNLNPAQVVAAVGFK---GKRLEIPRNVN 178
            E      D ++ GV+++E+   + P+     + NP Q      F+    K++ IPR+++
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 243
Query: 179 PHVASIIEACWAK 191
              AS++++   K
Sbjct: 244 VKAASVLKSFLNK 256

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 100/193 (51%), Gaps = 12/193 (6%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
           HP +V           L  V EY++ G L  + H    R++ +E  R   A +++  +NY
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNY 136
Query: 66  LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 125
           LH R   I++RDLK  N+L+D +  +K+ D+G+ +       ++    GTP ++APE+LR
Sbjct: 137 LHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILR 194
Query: 126 DEPSNEKSDIYSFGVILWELATLQQPW----GNLNPAQVVAAVGFK---GKRLEIPRNVN 178
            E      D ++ GV+++E+   + P+     + NP Q      F+    K++ IPR+++
Sbjct: 195 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSMS 254
Query: 179 PHVASIIEACWAK 191
              AS++++   K
Sbjct: 255 VKAASVLKSFLNK 267

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/176 (33%), Positives = 85/176 (48%), Gaps = 25/176 (14%)
Query: 1   MKRLR-HPNIVLFMGAV--------TQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR 51
           MK+L  HPNIV F  A         T      ++TE L +G L   L K   R  L    
Sbjct: 79  MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTE-LCKGQLVEFLKKMESRGPLSCDT 137
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
            L + Y   + + ++HR+ PPI+HRDLK  NLL+  + T+K+CDFG +   ++    S S
Sbjct: 138 VLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWS 197
Query: 112 AA------------GTPEWMAPEVL---RDEPSNEKSDIYSFGVILWELATLQQPW 152
           A              TP +  PE++    + P  EK DI++ G IL+ L   Q P+
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 84.3 bits (207), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 80/160 (50%), Gaps = 5/160 (3%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
            HP +           NL  V EYL+ G L  + H     +  D  R    A ++  G+ 
Sbjct: 77  EHPFLTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHK-FDLSRATFYAAEIILGLQ 133
Query: 65  YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL 124
           +LH +   IV+RDLK  N+L+DK   +K+ DFG+ +        +    GTP+++APE+L
Sbjct: 134 FLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEIL 191
Query: 125 RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
             +  N   D +SFGV+L+E+   Q P+   +  ++  ++
Sbjct: 192 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 231

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 84.3 bits (207), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/191 (35%), Positives = 99/191 (51%), Gaps = 13/191 (6%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           L H +IV  +G +    +L +VT+YL  GSL  L H    R  L  +  LN    +AKGM
Sbjct: 90  LDHAHIVRLLG-LCPGSSLQLVTQYLPLGSL--LDHVRQHRGALGPQLLLNWGVQIAKGM 146
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAAGTP-EWM 119
            YL      +VHR+L + N+L+     V+V DFG++ L        L S+  A TP +WM
Sbjct: 147 YYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE--AKTPIKWM 202
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           A E +       +SD++S+GV +WEL T   +P+  L  A+V   +  KG+RL  P+   
Sbjct: 203 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQICT 261
Query: 179 PHVASIIEACW 189
             V  ++  CW
Sbjct: 262 IDVYMVMVKCW 272

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 84.3 bits (207), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 80/160 (50%), Gaps = 5/160 (3%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
            HP +           NL  V EYL+ G L  + H     +  D  R    A ++  G+ 
Sbjct: 76  EHPFLTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHK-FDLSRATFYAAEIILGLQ 132
Query: 65  YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL 124
           +LH +   IV+RDLK  N+L+DK   +K+ DFG+ +        +    GTP+++APE+L
Sbjct: 133 FLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEIL 190
Query: 125 RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
             +  N   D +SFGV+L+E+   Q P+   +  ++  ++
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 230

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 89/185 (48%), Gaps = 10/185 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M+  ++PNIV ++ +      L +V EYL+ GSL  ++        +DE +   +  +  
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECL 126
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           + + +LH     ++HRD+KS N+L+    +VK+ DFG                GTP WMA
Sbjct: 127 QALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMA 184
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEV+  +    K DI+S G++  E+   + P+ N NP + +  +   G     P   NP 
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG----TPELQNPE 240
Query: 181 VASII 185
             S I
Sbjct: 241 KLSAI 245

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 84.0 bits (206), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 97/192 (50%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G +     + ++ + +  G L   + +   ++ +  +  LN    +A
Sbjct: 74  MASVDNPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 130
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFGL++L         +  G    +W
Sbjct: 131 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + PA  ++++  KG+RL  P   
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPIC 247
Query: 178 NPHVASIIEACW 189
              V  I+  CW
Sbjct: 248 TIDVYMIMVKCW 259

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 89/170 (52%), Gaps = 10/170 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +K L+H NIV + G        NL ++ E+L  GSL   L K   +E +D  + L     
Sbjct: 68  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKH--KERIDHIKLLQYTSQ 125
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP 116
           + KGM YL  +    +HRDL + N+LV+ +  VK+ DFGL+++  +       K    +P
Sbjct: 126 ICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 165
             W APE L +   +  SD++SFGV+L+EL T  +      PA+ +  +G
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEFMRMIG 232

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 84.0 bits (206), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/168 (36%), Positives = 82/168 (48%), Gaps = 34/168 (20%)
Query: 4   LRHPNIVLFMGAVTQPP----NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           +RH NI+ F+ A  +       L ++T+Y   GSLY  L        LD +  L +AY  
Sbjct: 88  MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSS 143
Query: 60  AKGMNYLH------RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK--- 110
             G+ +LH      +  P I HRDLKS N+LV K  T  + D GL    A  F+S     
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL----AVKFISDTNEV 199
Query: 111 -----SAAGTPEWMAPEVLRDEPSNEK-------SDIYSFGVILWELA 146
                +  GT  +M PEVL DE  N         +D+YSFG+ILWE+A
Sbjct: 200 DIPPNTRVGTKRYMPPEVL-DESLNRNHFQSYIMADMYSFGLILWEVA 246

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 84.0 bits (206), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 97/192 (50%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G +     + ++T+ +  G L   + +   ++ +  +  LN    +A
Sbjct: 73  MASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 129
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFG ++L         +  G    +W
Sbjct: 130 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + PA  ++++  KG+RL  P   
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPIC 246
Query: 178 NPHVASIIEACW 189
              V  I+  CW
Sbjct: 247 TIDVYMIMRKCW 258

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 84.0 bits (206), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 89/185 (48%), Gaps = 10/185 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M+  ++PNIV ++ +      L +V EYL+ GSL  ++        +DE +   +  +  
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECL 126
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           + + +LH     ++HRD+KS N+L+    +VK+ DFG                GTP WMA
Sbjct: 127 QALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMA 184
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEV+  +    K DI+S G++  E+   + P+ N NP + +  +   G     P   NP 
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG----TPELQNPE 240
Query: 181 VASII 185
             S I
Sbjct: 241 KLSAI 245

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 84.0 bits (206), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 97/192 (50%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G +     + ++ + +  G L   + +   ++ +  +  LN    +A
Sbjct: 78  MASVDNPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 134
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFGL++L         +  G    +W
Sbjct: 135 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + PA  ++++  KG+RL  P   
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPIC 251
Query: 178 NPHVASIIEACW 189
              V  I+  CW
Sbjct: 252 TIDVYMIMVKCW 263

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 84.0 bits (206), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 97/192 (50%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G +     + ++ + +  G L   + +   ++ +  +  LN    +A
Sbjct: 72  MASVDNPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 128
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFGL++L         +  G    +W
Sbjct: 129 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + PA  ++++  KG+RL  P   
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPIC 245
Query: 178 NPHVASIIEACW 189
              V  I+  CW
Sbjct: 246 TIDVYMIMVKCW 257

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 97/192 (50%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G +     + ++ + +  G L   + +   ++ +  +  LN    +A
Sbjct: 71  MASVDNPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 127
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFGL++L         +  G    +W
Sbjct: 128 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + PA  ++++  KG+RL  P   
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPIC 244
Query: 178 NPHVASIIEACW 189
              V  I+  CW
Sbjct: 245 TIDVYMIMVKCW 256

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 84.0 bits (206), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 97/192 (50%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G +     + ++ + +  G L   + +   ++ +  +  LN    +A
Sbjct: 75  MASVDNPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 131
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFGL++L         +  G    +W
Sbjct: 132 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 189
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + PA  ++++  KG+RL  P   
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPIC 248
Query: 178 NPHVASIIEACW 189
              V  I+  CW
Sbjct: 249 TIDVYMIMVKCW 260

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 84.0 bits (206), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 97/192 (50%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G +     + ++ + +  G L   + +   ++ +  +  LN    +A
Sbjct: 73  MASVDNPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 129
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFGL++L         +  G    +W
Sbjct: 130 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + PA  ++++  KG+RL  P   
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPIC 246
Query: 178 NPHVASIIEACW 189
              V  I+  CW
Sbjct: 247 TIDVYMIMVKCW 258

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 84.0 bits (206), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/158 (36%), Positives = 85/158 (53%), Gaps = 13/158 (8%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK 61
           + LRHPNIV F   +  P +L+IV EY S G L+  +   G R   DE R       +  
Sbjct: 69  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQ--QLIS 125
Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKYT--VKVCDFGLSRLKANTFLSS--KSAAGTPE 117
           G++Y H     + HRDLK  N L+D      +K+CDFG S+   ++ L S  KS  GTP 
Sbjct: 126 GVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPA 180
Query: 118 WMAPEV-LRDEPSNEKSDIYSFGVILWELATLQQPWGN 154
           ++APEV L+ E   + +D++S GV L+ +     P+ +
Sbjct: 181 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 218

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 90/185 (48%), Gaps = 10/185 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M+  ++PNIV ++ +      L +V EYL+ GSL  ++ +      +DE +   +  +  
Sbjct: 72  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECL 127
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           + + +LH     ++HRD+KS N+L+    +VK+ DFG                GTP WMA
Sbjct: 128 QALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMA 185
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEV+  +    K DI+S G++  E+   + P+ N NP + +  +   G     P   NP 
Sbjct: 186 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT----PELQNPE 241
Query: 181 VASII 185
             S I
Sbjct: 242 KLSAI 246

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 83.6 bits (205), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 97/192 (50%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G +     + ++ + +  G L   + +   ++ +  +  LN    +A
Sbjct: 72  MASVDNPHVCRLLG-ICLTSTVQLIMQLMPFGXLLDYVREH--KDNIGSQYLLNWCVQIA 128
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFGL++L         +  G    +W
Sbjct: 129 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + PA  ++++  KG+RL  P   
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPIC 245
Query: 178 NPHVASIIEACW 189
              V  I+  CW
Sbjct: 246 TIDVYMIMVKCW 257

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 83.6 bits (205), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 1   MKRLRHPNIVLFMGAVTQP-----PNLSIVTEYLSRGSLYRLLHKPGVR---EMLDERRR 52
           MK   HPN++  +G   +      P   ++  ++  G L+  L    +    + +  +  
Sbjct: 90  MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL 149
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSSK 110
           L    D+A GM YL  RN   +HRDL + N ++    TV V DFGLS+     + +   +
Sbjct: 150 LKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGR 207
Query: 111 SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGK 169
            A    +W+A E L D     KSD+++FGV +WE+AT    P+  +   ++   +   G 
Sbjct: 208 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL-LHGH 266
Query: 170 RLEIPRNVNPHVASIIEACW 189
           RL+ P +    +  I+ +CW
Sbjct: 267 RLKQPEDCLDELYEIMYSCW 286

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/179 (32%), Positives = 92/179 (51%), Gaps = 12/179 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K+L HPNI+     +    +  IV E  + G L+  + K   R+   E     +   V 
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVF 131
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSR-LKANTFLSSKSAAGTP 116
            G+ Y+H+ N  IVHRDLK  N+L++ K     +K+ DFGLS   + NT +  K   GT 
Sbjct: 132 SGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTA 187
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 175
            ++APEVLR    +EK D++S GVIL+ L +   P+   N   ++  V       ++P+
Sbjct: 188 YYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ 245

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/179 (32%), Positives = 92/179 (51%), Gaps = 12/179 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K+L HPNI+     +    +  IV E  + G L+  + K   R+   E     +   V 
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVF 131
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSR-LKANTFLSSKSAAGTP 116
            G+ Y+H+ N  IVHRDLK  N+L++ K     +K+ DFGLS   + NT +  K   GT 
Sbjct: 132 SGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTA 187
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 175
            ++APEVLR    +EK D++S GVIL+ L +   P+   N   ++  V       ++P+
Sbjct: 188 YYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ 245

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 97/192 (50%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G +     + ++T+ +  G L   + +   ++ +  +  LN    +A
Sbjct: 71  MASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 127
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFG ++L         +  G    +W
Sbjct: 128 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 185
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + PA  ++++  KG+RL  P   
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPIC 244
Query: 178 NPHVASIIEACW 189
              V  I+  CW
Sbjct: 245 TIDVYMIMVKCW 256

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/158 (36%), Positives = 85/158 (53%), Gaps = 13/158 (8%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK 61
           + LRHPNIV F   +  P +L+IV EY S G L+  +   G R   DE R       +  
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQ--QLIS 126
Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKYT--VKVCDFGLSRLKANTFLSS--KSAAGTPE 117
           G++Y H     + HRDLK  N L+D      +K+CDFG S+   ++ L S  KS  GTP 
Sbjct: 127 GVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPA 181
Query: 118 WMAPEV-LRDEPSNEKSDIYSFGVILWELATLQQPWGN 154
           ++APEV L+ E   + +D++S GV L+ +     P+ +
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 97/192 (50%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G +     + ++T+ +  G L   + +   ++ +  +  LN    +A
Sbjct: 78  MASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 134
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFG ++L         +  G    +W
Sbjct: 135 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 192
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + PA  ++++  KG+RL  P   
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPIC 251
Query: 178 NPHVASIIEACW 189
              V  I+  CW
Sbjct: 252 TIDVYMIMVKCW 263

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 96/191 (50%), Gaps = 14/191 (7%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K+L HPNI+     +    +  IV E  + G L+  + K   R+   E     +   V 
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVF 131
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKY---TVKVCDFGLSR-LKANTFLSSKSAAGTP 116
            G+ Y+H+ N  IVHRDLK  N+L++ K     +K+ DFGLS   + NT +  K   GT 
Sbjct: 132 SGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTA 187
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP-- 174
            ++APEVLR    +EK D++S GVIL+ L +   P+   N   ++  V       ++P  
Sbjct: 188 YYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW 246
Query: 175 RNVNPHVASII 185
           R ++     +I
Sbjct: 247 RTISDDAKDLI 257

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 87/167 (52%), Gaps = 10/167 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS---LYRLLHKPGVREMLDERRRLNMAY 57
           M++   P++V + G+  +  +L IV EY   GS   + RL +K      L E     +  
Sbjct: 78  MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK-----TLTEDEIATILQ 132
Query: 58  DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 117
              KG+ YLH      +HRD+K+ N+L++ +   K+ DFG++    +         GTP 
Sbjct: 133 STLKGLEYLHFMRK--IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPF 190
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           WMAPEV+++   N  +DI+S G+   E+A  + P+ +++P + +  +
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI 237

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 83/150 (55%), Gaps = 3/150 (2%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL-HKPGVREMLDERRRLNMAYDVAKGMN 64
           H N++   G    P    +V  Y++ GS+   L  +P  +  LD  +R  +A   A+G+ 
Sbjct: 86  HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLA 145
Query: 65  YLHRR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA-GTPEWMAPE 122
           YLH   +P I+HRD+K+ N+L+D+++   V DFGL++L          A  G    +APE
Sbjct: 146 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPE 205
Query: 123 VLRDEPSNEKSDIYSFGVILWELATLQQPW 152
            L    S+EK+D++ +GV+L EL T Q+ +
Sbjct: 206 YLSTGKSSEKTDVFGYGVMLLELITGQRAF 235

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 91/185 (49%), Gaps = 10/185 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M+  ++PNIV ++ +      L +V EYL+ GSL  ++ +      +DE +   +  +  
Sbjct: 72  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECL 127
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           + + +LH     ++HR++KS N+L+    +VK+ DFG             +  GTP WMA
Sbjct: 128 QALEFLHSNQ--VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 185
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEV+  +    K DI+S G++  E+   + P+ N NP + +  +   G     P   NP 
Sbjct: 186 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT----PELQNPE 241
Query: 181 VASII 185
             S I
Sbjct: 242 KLSAI 246

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 85/156 (54%), Gaps = 10/156 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K LRHP+I+     +T P ++ +V EY        ++ K  + E  DE RR      + 
Sbjct: 63  LKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTE--DEGRRFFQQ--II 118
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN-TFLSSKSAAGTPEWM 119
             + Y HR    IVHRDLK  NLL+D    VK+ DFGLS +  +  FL  K++ G+P + 
Sbjct: 119 CAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL--KTSCGSPNYA 174
Query: 120 APEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGN 154
           APEV+  +  +  + D++S G++L+ +   + P+ +
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/152 (35%), Positives = 80/152 (52%), Gaps = 9/152 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +K L+H NIV + G        NL ++ EYL  GSL   L     R  +D  + L     
Sbjct: 68  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAER--IDHIKLLQYTSQ 125
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP 116
           + KGM YL  +    +HRDL + N+LV+ +  VK+ DFGL+++  +       K    +P
Sbjct: 126 ICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147
             W APE L +   +  SD++SFGV+L+EL T
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/157 (37%), Positives = 84/157 (53%), Gaps = 11/157 (7%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK 61
           + LRHPNIV F   +  P +L+IV EY S G L+  +   G R   DE R       +  
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQ--QLIS 126
Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKYT--VKVCDFGLSRLKANTFLSS-KSAAGTPEW 118
           G++Y H     + HRDLK  N L+D      +K+ DFG S  KA+   S  KSA GTP +
Sbjct: 127 GVSYAHAMQ--VAHRDLKLENTLLDGSPAPRLKIADFGYS--KASVLHSQPKSAVGTPAY 182
Query: 119 MAPEV-LRDEPSNEKSDIYSFGVILWELATLQQPWGN 154
           +APEV L+ E   + +D++S GV L+ +     P+ +
Sbjct: 183 IAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 96/192 (50%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G +     + ++ + +  G L   + +   ++ +  +  LN    +A
Sbjct: 73  MASVDNPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 129
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFG ++L         +  G    +W
Sbjct: 130 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + PA  ++++  KG+RL  P   
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPIC 246
Query: 178 NPHVASIIEACW 189
              V  I+  CW
Sbjct: 247 TIDVYMIMRKCW 258

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 101/186 (54%), Gaps = 7/186 (3%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
           HP IV    A      L ++ ++L  G L+  L K  +    +E  +  +A ++A  +++
Sbjct: 86  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM--FTEEDVKFYLA-ELALALDH 142
Query: 66  LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 125
           LH  +  I++RDLK  N+L+D++  +K+ DFGLS+   +    + S  GT E+MAPEV+ 
Sbjct: 143 LH--SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 200
Query: 126 DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASII 185
                + +D +SFGV+++E+ T   P+   +  + +  +  K K L +P+ ++P   S++
Sbjct: 201 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI-LKAK-LGMPQFLSPEAQSLL 258
Query: 186 EACWAK 191
              + +
Sbjct: 259 RMLFKR 264

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 101/186 (54%), Gaps = 7/186 (3%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
           HP IV    A      L ++ ++L  G L+  L K  +    +E  +  +A ++A  +++
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM--FTEEDVKFYLA-ELALALDH 141
Query: 66  LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 125
           LH  +  I++RDLK  N+L+D++  +K+ DFGLS+   +    + S  GT E+MAPEV+ 
Sbjct: 142 LH--SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 199
Query: 126 DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASII 185
                + +D +SFGV+++E+ T   P+   +  + +  +  K K L +P+ ++P   S++
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI-LKAK-LGMPQFLSPEAQSLL 257
Query: 186 EACWAK 191
              + +
Sbjct: 258 RMLFKR 263

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/145 (35%), Positives = 82/145 (56%), Gaps = 6/145 (4%)
Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P IV F GA      +SI  E++  GSL ++L K G    + E+    ++  V KG+ YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYL 120
Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 126
            R    I+HRD+K  N+LV+ +  +K+CDFG+S    ++   + S  GT  +M+PE L+ 
Sbjct: 121 -REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQG 177
Query: 127 EPSNEKSDIYSFGVILWELATLQQP 151
              + +SDI+S G+ L E+A  + P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/145 (35%), Positives = 82/145 (56%), Gaps = 6/145 (4%)
Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P IV F GA      +SI  E++  GSL ++L K G    + E+    ++  V KG+ YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYL 120
Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 126
            R    I+HRD+K  N+LV+ +  +K+CDFG+S    ++   + S  GT  +M+PE L+ 
Sbjct: 121 -REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQG 177
Query: 127 EPSNEKSDIYSFGVILWELATLQQP 151
              + +SDI+S G+ L E+A  + P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/145 (35%), Positives = 82/145 (56%), Gaps = 6/145 (4%)
Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P IV F GA      +SI  E++  GSL ++L K G    + E+    ++  V KG+ YL
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYL 147
Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 126
            R    I+HRD+K  N+LV+ +  +K+CDFG+S    ++   + S  GT  +M+PE L+ 
Sbjct: 148 -REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQG 204
Query: 127 EPSNEKSDIYSFGVILWELATLQQP 151
              + +SDI+S G+ L E+A  + P
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/145 (35%), Positives = 82/145 (56%), Gaps = 6/145 (4%)
Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P IV F GA      +SI  E++  GSL ++L K G    + E+    ++  V KG+ YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYL 120
Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 126
            R    I+HRD+K  N+LV+ +  +K+CDFG+S    ++   + S  GT  +M+PE L+ 
Sbjct: 121 -REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQG 177
Query: 127 EPSNEKSDIYSFGVILWELATLQQP 151
              + +SDI+S G+ L E+A  + P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 100/186 (53%), Gaps = 7/186 (3%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
           HP IV    A      L ++ ++L  G L+  L K  +    +E  +  +A ++A  +++
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM--FTEEDVKFYLA-ELALALDH 141
Query: 66  LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 125
           LH     I++RDLK  N+L+D++  +K+ DFGLS+   +    + S  GT E+MAPEV+ 
Sbjct: 142 LHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 199
Query: 126 DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASII 185
                + +D +SFGV+++E+ T   P+   +  + +  +  K K L +P+ ++P   S++
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI-LKAK-LGMPQFLSPEAQSLL 257
Query: 186 EACWAK 191
              + +
Sbjct: 258 RMLFKR 263

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 81.6 bits (200), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/145 (35%), Positives = 82/145 (56%), Gaps = 6/145 (4%)
Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P IV F GA      +SI  E++  GSL ++L K G    + E+    ++  V KG+ YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYL 120
Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 126
            R    I+HRD+K  N+LV+ +  +K+CDFG+S    ++   + S  GT  +M+PE L+ 
Sbjct: 121 -REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQG 177
Query: 127 EPSNEKSDIYSFGVILWELATLQQP 151
              + +SDI+S G+ L E+A  + P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 81.6 bits (200), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 89/167 (53%), Gaps = 9/167 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +++++H NIV        P +L +V + +S G L+  + + G      E+    +   V 
Sbjct: 74  LRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKG---FYTEKDASTLIRQVL 130
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 117
             + YLHR    IVHRDLK  NLL    D++  + + DFGLS+++    + S +A GTP 
Sbjct: 131 DAVYYLHRMG--IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMS-TACGTPG 187
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           ++APEVL  +P ++  D +S GVI + L     P+ + N +++   +
Sbjct: 188 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQI 234

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/145 (35%), Positives = 82/145 (56%), Gaps = 6/145 (4%)
Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P IV F GA      +SI  E++  GSL ++L K G    + E+    ++  V KG+ YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYL 120
Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 126
            R    I+HRD+K  N+LV+ +  +K+CDFG+S    ++   + S  GT  +M+PE L+ 
Sbjct: 121 -REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQG 177
Query: 127 EPSNEKSDIYSFGVILWELATLQQP 151
              + +SDI+S G+ L E+A  + P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 96/192 (50%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G +     + ++ + +  G L   + +   ++ +  +  LN    +A
Sbjct: 73  MASVDNPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 129
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFG ++L         +  G    +W
Sbjct: 130 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + PA  ++++  KG+RL  P   
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPIC 246
Query: 178 NPHVASIIEACW 189
              V  I+  CW
Sbjct: 247 TIDVYMIMVKCW 258

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 96/192 (50%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G +     + ++ + +  G L   + +   ++ +  +  LN    +A
Sbjct: 75  MASVDNPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 131
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFG ++L         +  G    +W
Sbjct: 132 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 189
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + PA  ++++  KG+RL  P   
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPIC 248
Query: 178 NPHVASIIEACW 189
              V  I+  CW
Sbjct: 249 TIDVYMIMVKCW 260

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 90/168 (53%), Gaps = 11/168 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           + +++HPNIV          +L ++ + +S G L+  + + G      ER    + + V 
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVL 126
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLL---VDKKYTVKVCDFGLSRLKA-NTFLSSKSAAGTP 116
             + YLH  +  IVHRDLK  NLL   +D+   + + DFGLS+++   + LS+  A GTP
Sbjct: 127 DAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST--ACGTP 182
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
            ++APEVL  +P ++  D +S GVI + L     P+ + N A++   +
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI 230

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 90/168 (53%), Gaps = 11/168 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           + +++HPNIV          +L ++ + +S G L+  + + G      ER    + + V 
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVL 126
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLL---VDKKYTVKVCDFGLSRLKA-NTFLSSKSAAGTP 116
             + YLH  +  IVHRDLK  NLL   +D+   + + DFGLS+++   + LS+  A GTP
Sbjct: 127 DAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST--ACGTP 182
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
            ++APEVL  +P ++  D +S GVI + L     P+ + N A++   +
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI 230

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 90/168 (53%), Gaps = 11/168 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           + +++HPNIV          +L ++ + +S G L+  + + G      ER    + + V 
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVL 126
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLL---VDKKYTVKVCDFGLSRLKA-NTFLSSKSAAGTP 116
             + YLH  +  IVHRDLK  NLL   +D+   + + DFGLS+++   + LS+  A GTP
Sbjct: 127 DAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST--ACGTP 182
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
            ++APEVL  +P ++  D +S GVI + L     P+ + N A++   +
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI 230

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 52/145 (35%), Positives = 82/145 (56%), Gaps = 6/145 (4%)
Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P IV F GA      +SI  E++  GSL ++L K G    + E+    ++  V KG+ YL
Sbjct: 126 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYL 182
Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 126
            R    I+HRD+K  N+LV+ +  +K+CDFG+S    ++   + S  GT  +M+PE L+ 
Sbjct: 183 -REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQG 239
Query: 127 EPSNEKSDIYSFGVILWELATLQQP 151
              + +SDI+S G+ L E+A  + P
Sbjct: 240 THYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 102/186 (54%), Gaps = 7/186 (3%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
           HP +V    A      L ++ ++L  G L+  L K  +    +E  +  +A ++A G+++
Sbjct: 89  HPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM--FTEEDVKFYLA-ELALGLDH 145
Query: 66  LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 125
           LH     I++RDLK  N+L+D++  +K+ DFGLS+   +    + S  GT E+MAPEV+ 
Sbjct: 146 LHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVN 203
Query: 126 DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASII 185
            +  +  +D +S+GV+++E+ T   P+   +  + +  +  K K L +P+ ++    S++
Sbjct: 204 RQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLI-LKAK-LGMPQFLSTEAQSLL 261
Query: 186 EACWAK 191
            A + +
Sbjct: 262 RALFKR 267

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 84/164 (51%), Gaps = 18/164 (10%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLN-----MAYDVA 60
           HP I+   G       + ++ +Y+  G L+ LL K         +R  N      A +V 
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK--------SQRFPNPVAKFYAAEVC 116
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             + YLH ++  I++RDLK  N+L+DK   +K+ DFG ++   +    +    GTP+++A
Sbjct: 117 LALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---TYXLCGTPDYIA 171
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           PEV+  +P N+  D +SFG++++E+     P+ + N  +    +
Sbjct: 172 PEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI 215

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 89/164 (54%), Gaps = 5/164 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ ++HP IV  + A      L ++ EYLS G L+  L + G+   +++     +A +++
Sbjct: 75  LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGI--FMEDTACFYLA-EIS 131
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             + +LH++   I++RDLK  N++++ +  VK+ DFGL +   +    + +  GT E+MA
Sbjct: 132 MALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMA 189
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           PE+L     N   D +S G +++++ T   P+   N  + +  +
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI 233

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 80.9 bits (198), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 90/168 (53%), Gaps = 11/168 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           + +++HPNIV          +L ++ + +S G L+  + + G      ER    + + V 
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVL 126
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLL---VDKKYTVKVCDFGLSRLKA-NTFLSSKSAAGTP 116
             + YLH  +  IVHRDLK  NLL   +D+   + + DFGLS+++   + LS+  A GTP
Sbjct: 127 DAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST--ACGTP 182
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
            ++APEVL  +P ++  D +S GVI + L     P+ + N A++   +
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI 230

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/173 (35%), Positives = 88/173 (50%), Gaps = 13/173 (7%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
           +K L HPNI+          N  +V E    G L+  ++H    R   +E     +   V
Sbjct: 90  LKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQV 145
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT---VKVCDFGLSRLKANTFLSSKSAAGTP 116
             G+ YLH+ N  IVHRDLK  NLL++ K     +K+ DFGLS +  N     K   GT 
Sbjct: 146 LSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-KKMKERLGTA 202
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK 169
            ++APEVLR +  +EK D++S GVIL+ L     P+G     +++  V  KGK
Sbjct: 203 YYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE-KGK 253

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 90/185 (48%), Gaps = 7/185 (3%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK 61
           + L H ++V F G       + +V E   R SL  L HK   R+ L E         +  
Sbjct: 72  RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL-HK--RRKALTEPEARYYLRQIVL 128
Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAP 121
           G  YLHR    ++HRDLK  NL +++   VK+ DFGL+          K+  GTP ++AP
Sbjct: 129 GCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAP 186
Query: 122 EVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHV 181
           EVL  +  + + D++S G I++ L   + P+      +    +  K     IP+++NP  
Sbjct: 187 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIPKHINPVA 244
Query: 182 ASIIE 186
           AS+I+
Sbjct: 245 ASLIQ 249

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 90/185 (48%), Gaps = 7/185 (3%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK 61
           + L H ++V F G       + +V E   R SL  L HK   R+ L E         +  
Sbjct: 76  RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL-HK--RRKALTEPEARYYLRQIVL 132
Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAP 121
           G  YLHR    ++HRDLK  NL +++   VK+ DFGL+          K+  GTP ++AP
Sbjct: 133 GCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAP 190
Query: 122 EVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHV 181
           EVL  +  + + D++S G I++ L   + P+      +    +  K     IP+++NP  
Sbjct: 191 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIPKHINPVA 248
Query: 182 ASIIE 186
           AS+I+
Sbjct: 249 ASLIQ 253

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 90/185 (48%), Gaps = 7/185 (3%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK 61
           + L H ++V F G       + +V E   R SL  L HK   R+ L E         +  
Sbjct: 72  RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL-HK--RRKALTEPEARYYLRQIVL 128
Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAP 121
           G  YLHR    ++HRDLK  NL +++   VK+ DFGL+          K+  GTP ++AP
Sbjct: 129 GCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAP 186
Query: 122 EVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHV 181
           EVL  +  + + D++S G I++ L   + P+      +    +  K     IP+++NP  
Sbjct: 187 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIPKHINPVA 244
Query: 182 ASIIE 186
           AS+I+
Sbjct: 245 ASLIQ 249

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 80/161 (49%), Gaps = 6/161 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M+   H N+V    +      L +V E+L  G+L  ++        ++E +   +   V 
Sbjct: 96  MRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLSVL 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           + ++YLH  N  ++HRD+KS ++L+     +K+ DFG     +      K   GTP WMA
Sbjct: 152 RALSYLH--NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMA 209
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161
           PEV+   P   + DI+S G+++ E+   + P+ N  P Q +
Sbjct: 210 PEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM 250

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 78/151 (51%), Gaps = 7/151 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+           + ++ E+  RG LY+ L K G     DE+R      ++A  +
Sbjct: 71  LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG---RFDEQRSATFMEELADAL 127
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           +Y H R   ++HRD+K  NLL+  K  +K+ DFG S    +  L  +   GT +++ PE+
Sbjct: 128 HYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAPS--LRRRXMCGTLDYLPPEM 183
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPWGN 154
           +  +  +EK D++  GV+ +E      P+ +
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 42/170 (24%), Positives = 93/170 (54%), Gaps = 7/170 (4%)
Query: 22  LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
           L  V EY++ G L   + + G      E + +  A +++ G+ +LH+R   I++RDLK  
Sbjct: 95  LYFVMEYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISIGLFFLHKRG--IIYRDLKLD 149
Query: 82  NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVI 141
           N+++D +  +K+ DFG+ +      ++++   GTP+++APE++  +P  +  D +++GV+
Sbjct: 150 NVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVL 209
Query: 142 LWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK 191
           L+E+   Q P+   +  ++  ++      +  P++++    SI +    K
Sbjct: 210 LYEMLAGQPPFDGEDEDELFQSI--MEHNVSYPKSLSKEAVSICKGLMTK 257

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 80.1 bits (196), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 78/151 (51%), Gaps = 7/151 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+           + ++ E+  RG LY+ L K G     DE+R      ++A  +
Sbjct: 72  LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG---RFDEQRSATFMEELADAL 128
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           +Y H R   ++HRD+K  NLL+  K  +K+ DFG S    +  L  +   GT +++ PE+
Sbjct: 129 HYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAPS--LRRRXMCGTLDYLPPEM 184
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPWGN 154
           +  +  +EK D++  GV+ +E      P+ +
Sbjct: 185 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 215

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 80.1 bits (196), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 89/191 (46%), Gaps = 8/191 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK L HP+IV  +G + + P   I+ E    G L   L +   +  L     +  +  + 
Sbjct: 67  MKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQIC 123
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
           K M YL   N   VHRD+   N+LV     VK+ DFGLSR   +      S    P +WM
Sbjct: 124 KAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 181
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           +PE +        SD++ F V +WE+ +  +QP+  L    V+  +  KG RL  P    
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPDLCP 240
Query: 179 PHVASIIEACW 189
           P + +++  CW
Sbjct: 241 PVLYTLMTRCW 251

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 80.1 bits (196), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 84/158 (53%), Gaps = 13/158 (8%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK 61
           + LRHPNIV F   +  P +L+IV EY S G L+  +   G R   DE R       +  
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQ--LIS 126
Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKYT--VKVCDFGLSRLKANTFLSS--KSAAGTPE 117
           G++Y H     + HRDLK  N L+D      +K+C FG S+   ++ L S  KS  GTP 
Sbjct: 127 GVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKSTVGTPA 181
Query: 118 WMAPEV-LRDEPSNEKSDIYSFGVILWELATLQQPWGN 154
           ++APEV L+ E   + +D++S GV L+ +     P+ +
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 80.1 bits (196), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 89/191 (46%), Gaps = 8/191 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK L HP+IV  +G + + P   I+ E    G L   L +   +  L     +  +  + 
Sbjct: 63  MKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQIC 119
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
           K M YL   N   VHRD+   N+LV     VK+ DFGLSR   +      S    P +WM
Sbjct: 120 KAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 177
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           +PE +        SD++ F V +WE+ +  +QP+  L    V+  +  KG RL  P    
Sbjct: 178 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPDLCP 236
Query: 179 PHVASIIEACW 189
           P + +++  CW
Sbjct: 237 PVLYTLMTRCW 247

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 80.1 bits (196), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 89/191 (46%), Gaps = 8/191 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK L HP+IV  +G + + P   I+ E    G L   L +   +  L     +  +  + 
Sbjct: 79  MKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQIC 135
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
           K M YL   N   VHRD+   N+LV     VK+ DFGLSR   +      S    P +WM
Sbjct: 136 KAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 193
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           +PE +        SD++ F V +WE+ +  +QP+  L    V+  +  KG RL  P    
Sbjct: 194 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPDLCP 252
Query: 179 PHVASIIEACW 189
           P + +++  CW
Sbjct: 253 PVLYTLMTRCW 263

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 88/164 (53%), Gaps = 5/164 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ ++HP IV  + A      L ++ EYLS G L+  L + G+   +++     +A +++
Sbjct: 75  LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGI--FMEDTACFYLA-EIS 131
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             + +LH++   I++RDLK  N++++ +  VK+ DFGL +   +    +    GT E+MA
Sbjct: 132 MALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMA 189
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           PE+L     N   D +S G +++++ T   P+   N  + +  +
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI 233

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/149 (36%), Positives = 82/149 (55%), Gaps = 14/149 (9%)
Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P IV F GA      +SI  E++  GSL ++L K G    + E+    ++  V KG+ YL
Sbjct: 67  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYL 123
Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----KANTFLSSKSAAGTPEWMAPE 122
            R    I+HRD+K  N+LV+ +  +K+CDFG+S       AN F+      GT  +M+PE
Sbjct: 124 -REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFV------GTRSYMSPE 176
Query: 123 VLRDEPSNEKSDIYSFGVILWELATLQQP 151
            L+    + +SDI+S G+ L E+A  + P
Sbjct: 177 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 79.7 bits (195), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 89/185 (48%), Gaps = 7/185 (3%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK 61
           + L H ++V F G       + +V E   R SL  L HK   R+ L E         +  
Sbjct: 70  RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL-HKR--RKALTEPEARYYLRQIVL 126
Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAP 121
           G  YLHR    ++HRDLK  NL +++   VK+ DFGL+          K   GTP ++AP
Sbjct: 127 GCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 184
Query: 122 EVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHV 181
           EVL  +  + + D++S G I++ L   + P+      +    +  K     IP+++NP  
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIPKHINPVA 242
Query: 182 ASIIE 186
           AS+I+
Sbjct: 243 ASLIQ 247

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 80/162 (49%), Gaps = 17/162 (10%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK L HPNIV     +     L ++ EY S G ++  L   G  +  + R +      + 
Sbjct: 65  MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ---IV 121
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-----KANTFLSSKSAAGT 115
             + Y H++   IVHRDLK+ NLL+D    +K+ DFG S       K +TF       G+
Sbjct: 122 SAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTF------CGS 173
Query: 116 PEWMAPEVLRDEPSNE-KSDIYSFGVILWELATLQQPWGNLN 156
           P + APE+ + +  +  + D++S GVIL+ L +   P+   N
Sbjct: 174 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 19/202 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-------KPGVREMLDERRRL 53
           + +L H NIV  +G   Q     I+ E ++ G L   L        +P    MLD    L
Sbjct: 102 ISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD---LL 158
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR--LKANTFLS 108
           ++A D+A G  YL   +   +HRD+ + N L+         K+ DFG++R   +A+ +  
Sbjct: 159 HVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 216
Query: 109 SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFK 167
              A    +WM PE   +     K+D +SFGV+LWE+ +L   P+ + +  +V+  V   
Sbjct: 217 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-S 275
Query: 168 GKRLEIPRNVNPHVASIIEACW 189
           G R++ P+N    V  I+  CW
Sbjct: 276 GGRMDPPKNCPGPVYRIMTQCW 297

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 80/151 (52%), Gaps = 6/151 (3%)
Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
           +L H NIV  +    +     +V EY+   +L   +   G    L     +N    +  G
Sbjct: 67  QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDG 123
Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS-SKSAAGTPEWMAP 121
           + + H  +  IVHRD+K  N+L+D   T+K+ DFG+++  + T L+ +    GT ++ +P
Sbjct: 124 IKHAH--DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSP 181
Query: 122 EVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
           E  + E ++E +DIYS G++L+E+   + P+
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPPF 212

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 89/185 (48%), Gaps = 7/185 (3%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK 61
           + L H ++V F G       + +V E   R SL  L HK   R+ L E         +  
Sbjct: 96  RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL-HK--RRKALTEPEARYYLRQIVL 152
Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAP 121
           G  YLHR    ++HRDLK  NL +++   VK+ DFGL+          K   GTP ++AP
Sbjct: 153 GCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 210
Query: 122 EVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHV 181
           EVL  +  + + D++S G I++ L   + P+      +    +  K     IP+++NP  
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIPKHINPVA 268
Query: 182 ASIIE 186
           AS+I+
Sbjct: 269 ASLIQ 273

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 19/202 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-------KPGVREMLDERRRL 53
           + +L H NIV  +G   Q     I+ E ++ G L   L        +P    MLD    L
Sbjct: 88  ISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD---LL 144
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR--LKANTFLS 108
           ++A D+A G  YL   +   +HRD+ + N L+         K+ DFG++R   +A+ +  
Sbjct: 145 HVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 202
Query: 109 SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFK 167
              A    +WM PE   +     K+D +SFGV+LWE+ +L   P+ + +  +V+  V   
Sbjct: 203 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-S 261
Query: 168 GKRLEIPRNVNPHVASIIEACW 189
           G R++ P+N    V  I+  CW
Sbjct: 262 GGRMDPPKNCPGPVYRIMTQCW 283

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 32/206 (15%)
Query: 6   HPNIVLFMGAVTQ--PPNLS----IVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           H NI  + GA  +  PP +     +V E+   GS+  L+ K      L E     +  ++
Sbjct: 80  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICREI 138
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
            +G+++LH+    ++HRD+K  N+L+ +   VK+ DFG+S     T     +  GTP WM
Sbjct: 139 LRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 196
Query: 120 APEVLR-----DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP 174
           APEV+      D   + KSD++S G+   E+A    P  +++P + +           IP
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---------FLIP 247
Query: 175 RNVNPHV---------ASIIEACWAK 191
           RN  P +          S IE+C  K
Sbjct: 248 RNPAPRLKSKKWSKKFQSFIESCLVK 273

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 89/185 (48%), Gaps = 7/185 (3%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK 61
           + L H ++V F G       + +V E   R SL  L HK   R+ L E         +  
Sbjct: 94  RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL-HK--RRKALTEPEARYYLRQIVL 150
Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAP 121
           G  YLHR    ++HRDLK  NL +++   VK+ DFGL+          K   GTP ++AP
Sbjct: 151 GCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 208
Query: 122 EVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHV 181
           EVL  +  + + D++S G I++ L   + P+      +    +  K     IP+++NP  
Sbjct: 209 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIPKHINPVA 266
Query: 182 ASIIE 186
           AS+I+
Sbjct: 267 ASLIQ 271

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 13/160 (8%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK L HPNIV     +     L +V EY S G ++  L   G  +  + R +      + 
Sbjct: 68  MKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ---IV 124
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS---KSAAGTPE 117
             + Y H++   IVHRDLK+ NLL+D    +K+ DFG S    N F       +  G+P 
Sbjct: 125 SAVQYCHQKY--IVHRDLKAENLLLDGDMNIKIADFGFS----NEFTVGNKLDTFCGSPP 178
Query: 118 WMAPEVLRDEPSNE-KSDIYSFGVILWELATLQQPWGNLN 156
           + APE+ + +  +  + D++S GVIL+ L +   P+   N
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 79/157 (50%), Gaps = 19/157 (12%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           L   N V  M AV +   L I  EY   G+LY L+H   + +  DE  RL     + + +
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL--FRQILEAL 129
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS----------RLKANTFLSSK--- 110
           +Y+H +   I+HRDLK  N+ +D+   VK+ DFGL+          +L +     S    
Sbjct: 130 SYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 111 -SAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWEL 145
            SA GT  ++A EVL      NEK D+YS G+I +E+
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 90/184 (48%), Gaps = 7/184 (3%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK 61
           K L +P++V F G       + +V E   R SL  L HK   R+ + E           +
Sbjct: 97  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLEL-HK--RRKAVTEPEARYFMRQTIQ 153
Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAP 121
           G+ YLH  N  ++HRDLK  NL ++    VK+ DFGL+          K+  GTP ++AP
Sbjct: 154 GVQYLH--NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAP 211
Query: 122 EVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHV 181
           EVL  +  + + DI+S G IL+ L   + P+      +    +  K     +PR++NP  
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETY--IRIKKNEYSVPRHINPVA 269
Query: 182 ASII 185
           +++I
Sbjct: 270 SALI 273

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 80/162 (49%), Gaps = 17/162 (10%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK L HPNIV     +     L +V EY S G ++  L   G  +  + R +      + 
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ---IV 123
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-----KANTFLSSKSAAGT 115
             + Y H++   IVHRDLK+ NLL+D    +K+ DFG S       K +TF       G+
Sbjct: 124 SAVQYCHQKF--IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTF------CGS 175
Query: 116 PEWMAPEVLRDEPSNE-KSDIYSFGVILWELATLQQPWGNLN 156
           P + APE+ + +  +  + D++S GVIL+ L +   P+   N
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 84/164 (51%), Gaps = 26/164 (15%)
Query: 4   LRHPNIVLFMGAVTQP----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           LRH NI+ F+ A  +       L +V++Y   GSL+  L+    R  +     + +A   
Sbjct: 57  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALST 112
Query: 60  AKGMNYLH------RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
           A G+ +LH      +  P I HRDLKS N+LV K  T  + D GL+ ++ ++   +   A
Sbjct: 113 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIA 171
Query: 114 -----GTPEWMAPEVLRDE------PSNEKSDIYSFGVILWELA 146
                GT  +MAPEVL D        S +++DIY+ G++ WE+A
Sbjct: 172 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 81/163 (49%), Gaps = 24/163 (14%)
Query: 4   LRHPNIVLFMGAVTQPPNLS----IVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           LRH NI+ F+ +     N S    ++T Y   GSLY  L     R+ L+    L +A   
Sbjct: 59  LRHDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQ----RQTLEPHLALRLAVSA 114
Query: 60  AKGMNYLH------RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF----LSS 109
           A G+ +LH      +  P I HRD KS N+LV       + D GL+ + +       + +
Sbjct: 115 ACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGN 174
Query: 110 KSAAGTPEWMAPEVLRDE------PSNEKSDIYSFGVILWELA 146
               GT  +MAPEVL ++       S + +DI++FG++LWE+A
Sbjct: 175 NPRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIA 217

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 89/184 (48%), Gaps = 7/184 (3%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK 61
           K L +P++V F G       + +V E   R SL  L HK   R+ + E           +
Sbjct: 81  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLEL-HK--RRKAVTEPEARYFMRQTIQ 137
Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAP 121
           G+ YLH  N  ++HRDLK  NL ++    VK+ DFGL+          K   GTP ++AP
Sbjct: 138 GVQYLH--NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAP 195
Query: 122 EVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHV 181
           EVL  +  + + DI+S G IL+ L   + P+      +    +  K     +PR++NP  
Sbjct: 196 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI--KKNEYSVPRHINPVA 253
Query: 182 ASII 185
           +++I
Sbjct: 254 SALI 257

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 84/164 (51%), Gaps = 26/164 (15%)
Query: 4   LRHPNIVLFMGAVTQP----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           LRH NI+ F+ A  +       L +V++Y   GSL+  L+    R  +     + +A   
Sbjct: 60  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALST 115
Query: 60  AKGMNYLH------RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
           A G+ +LH      +  P I HRDLKS N+LV K  T  + D GL+ ++ ++   +   A
Sbjct: 116 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIA 174
Query: 114 -----GTPEWMAPEVLRDE------PSNEKSDIYSFGVILWELA 146
                GT  +MAPEVL D        S +++DIY+ G++ WE+A
Sbjct: 175 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 80/162 (49%), Gaps = 17/162 (10%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK L HPNIV     +     L +V EY S G ++  L   G  +  + R +      + 
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ---IV 123
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-----KANTFLSSKSAAGT 115
             + Y H++   IVHRDLK+ NLL+D    +K+ DFG S       K +TF       G+
Sbjct: 124 SAVQYCHQKF--IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTF------CGS 175
Query: 116 PEWMAPEVLRDEPSNE-KSDIYSFGVILWELATLQQPWGNLN 156
           P + APE+ + +  +  + D++S GVIL+ L +   P+   N
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 79/158 (50%), Gaps = 9/158 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK L HPNIV     +     L +V EY S G ++  L   G  +  + R +      + 
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ---IV 123
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA-AGTPEWM 119
             + Y H++   IVHRDLK+ NLL+D    +K+ DFG S     TF +   A  G P + 
Sbjct: 124 SAVQYCHQKF--IVHRDLKAENLLLDADMNIKIADFGFS--NEFTFGNKLDAFCGAPPYA 179
Query: 120 APEVLRDEPSNE-KSDIYSFGVILWELATLQQPWGNLN 156
           APE+ + +  +  + D++S GVIL+ L +   P+   N
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 83/158 (52%), Gaps = 13/158 (8%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK 61
           + LRHPNIV F   +  P +L+IV EY S G L+  +   G R   DE R       +  
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQ--LIS 126
Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKYT--VKVCDFGLSRLKANTFLSS--KSAAGTPE 117
           G++Y H     + HRDLK  N L+D      +K+C FG S+   ++ L S  K   GTP 
Sbjct: 127 GVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKDTVGTPA 181
Query: 118 WMAPEV-LRDEPSNEKSDIYSFGVILWELATLQQPWGN 154
           ++APEV L+ E   + +D++S GV L+ +     P+ +
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 7/149 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY  RG +Y+ L K       DE+R      ++A  +
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLS---KFDEQRTATYITELANAL 126
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           +Y H +   ++HRD+K  NLL+     +K+ DFG S    ++     +  GT +++ PE+
Sbjct: 127 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEM 182
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +     +EK D++S GV+ +E    + P+
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 78/160 (48%), Gaps = 13/160 (8%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK L HPNIV     +     L ++ EY S G ++  L   G  +  + R +      + 
Sbjct: 68  MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ---IV 124
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS---KSAAGTPE 117
             + Y H++   IVHRDLK+ NLL+D    +K+ DFG S    N F       +  G P 
Sbjct: 125 SAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFS----NEFTVGGKLDAFCGAPP 178
Query: 118 WMAPEVLRDEPSNE-KSDIYSFGVILWELATLQQPWGNLN 156
           + APE+ + +  +  + D++S GVIL+ L +   P+   N
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 79/151 (52%), Gaps = 11/151 (7%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A  +
Sbjct: 65  LRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANAL 121
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA--GTPEWMAP 121
           +Y H +   ++HRD+K  NLL+     +K+ DFG S        SS+ AA  GT +++ P
Sbjct: 122 SYCHSKK--VIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAALCGTLDYLPP 175
Query: 122 EVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
           E++     +EK D++S GV+ +E    + P+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 80/162 (49%), Gaps = 17/162 (10%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK L HPNIV     +     L +V EY S G ++  L   G  +  + R +      + 
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ---IV 123
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-----KANTFLSSKSAAGT 115
             + Y H++   IVHRDLK+ NLL+D    +K+ DFG S       K +TF       G+
Sbjct: 124 SAVQYCHQKF--IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTF------CGS 175
Query: 116 PEWMAPEVLRDEPSNE-KSDIYSFGVILWELATLQQPWGNLN 156
           P + APE+ + +  +  + D++S GVIL+ L +   P+   N
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 79/151 (52%), Gaps = 11/151 (7%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A  +
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANAL 121
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA--GTPEWMAP 121
           +Y H +   ++HRD+K  NLL+     +K+ DFG S        SS+ AA  GT +++ P
Sbjct: 122 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAALCGTLDYLPP 175
Query: 122 EVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
           E++     +EK D++S GV+ +E    + P+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 84/164 (51%), Gaps = 26/164 (15%)
Query: 4   LRHPNIVLFMGAVTQP----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           LRH NI+ F+ A  +       L +V++Y   GSL+  L+    R  +     + +A   
Sbjct: 54  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALST 109
Query: 60  AKGMNYLH------RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
           A G+ +LH      +  P I HRDLKS N+LV K  T  + D GL+ ++ ++   +   A
Sbjct: 110 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIA 168
Query: 114 -----GTPEWMAPEVLRDE------PSNEKSDIYSFGVILWELA 146
                GT  +MAPEVL D        S +++DIY+ G++ WE+A
Sbjct: 169 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-------KPGVREMLDERRRL 53
           + +  H NIV  +G   Q     I+ E ++ G L   L        +P    MLD    L
Sbjct: 87  ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD---LL 143
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR--LKANTFLS 108
           ++A D+A G  YL   +   +HRD+ + N L+         K+ DFG++R   +A+ +  
Sbjct: 144 HVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 201
Query: 109 SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFK 167
              A    +WM PE   +     K+D +SFGV+LWE+ +L   P+ + +  +V+  V   
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-S 260
Query: 168 GKRLEIPRNVNPHVASIIEACW 189
           G R++ P+N    V  I+  CW
Sbjct: 261 GGRMDPPKNCPGPVYRIMTQCW 282

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 79/151 (52%), Gaps = 11/151 (7%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A  +
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANAL 124
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA--GTPEWMAP 121
           +Y H +   ++HRD+K  NLL+     +K+ DFG S        SS+ AA  GT +++ P
Sbjct: 125 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAALCGTLDYLPP 178
Query: 122 EVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
           E++     +EK D++S GV+ +E    + P+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 84/164 (51%), Gaps = 26/164 (15%)
Query: 4   LRHPNIVLFMGAVTQP----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           LRH NI+ F+ A  +       L +V++Y   GSL+  L+    R  +     + +A   
Sbjct: 55  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALST 110
Query: 60  AKGMNYLH------RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
           A G+ +LH      +  P I HRDLKS N+LV K  T  + D GL+ ++ ++   +   A
Sbjct: 111 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIA 169
Query: 114 -----GTPEWMAPEVLRDE------PSNEKSDIYSFGVILWELA 146
                GT  +MAPEVL D        S +++DIY+ G++ WE+A
Sbjct: 170 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 84/164 (51%), Gaps = 26/164 (15%)
Query: 4   LRHPNIVLFMGAVTQP----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           LRH NI+ F+ A  +       L +V++Y   GSL+  L+    R  +     + +A   
Sbjct: 80  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALST 135
Query: 60  AKGMNYLH------RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
           A G+ +LH      +  P I HRDLKS N+LV K  T  + D GL+ ++ ++   +   A
Sbjct: 136 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIA 194
Query: 114 -----GTPEWMAPEVLRDE------PSNEKSDIYSFGVILWELA 146
                GT  +MAPEVL D        S +++DIY+ G++ WE+A
Sbjct: 195 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-------KPGVREMLDERRRL 53
           + +  H NIV  +G   Q     I+ E ++ G L   L        +P    MLD    L
Sbjct: 102 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD---LL 158
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR--LKANTFLS 108
           ++A D+A G  YL   +   +HRD+ + N L+         K+ DFG++R   +A+ +  
Sbjct: 159 HVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 216
Query: 109 SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFK 167
              A    +WM PE   +     K+D +SFGV+LWE+ +L   P+ + +  +V+  V   
Sbjct: 217 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-S 275
Query: 168 GKRLEIPRNVNPHVASIIEACW 189
           G R++ P+N    V  I+  CW
Sbjct: 276 GGRMDPPKNCPGPVYRIMTQCW 297

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-------KPGVREMLDERRRL 53
           + +  H NIV  +G   Q     I+ E ++ G L   L        +P    MLD    L
Sbjct: 79  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD---LL 135
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR--LKANTFLS 108
           ++A D+A G  YL   +   +HRD+ + N L+         K+ DFG++R   +A+ +  
Sbjct: 136 HVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 193
Query: 109 SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ-QPWGNLNPAQVVAAVGFK 167
              A    +WM PE   +     K+D +SFGV+LWE+ +L   P+ + +  +V+  V   
Sbjct: 194 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-S 252
Query: 168 GKRLEIPRNVNPHVASIIEACW 189
           G R++ P+N    V  I+  CW
Sbjct: 253 GGRMDPPKNCPGPVYRIMTQCW 274

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-------KPGVREMLDERRRL 53
           + +  H NIV  +G   Q     I+ E ++ G L   L        +P    MLD    L
Sbjct: 104 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD---LL 160
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD---KKYTVKVCDFGLSR--LKANTFLS 108
           ++A D+A G  YL   +   +HRD+ + N L+         K+ DFG++R   +A+ +  
Sbjct: 161 HVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 218
Query: 109 SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFK 167
              A    +WM PE   +     K+D +SFGV+LWE+ +L   P+ + +  +V+  V   
Sbjct: 219 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-S 277
Query: 168 GKRLEIPRNVNPHVASIIEACW 189
           G R++ P+N    V  I+  CW
Sbjct: 278 GGRMDPPKNCPGPVYRIMTQCW 299

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 89/184 (48%), Gaps = 7/184 (3%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK 61
           K L +P++V F G       + +V E   R SL  L HK   R+ + E           +
Sbjct: 97  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLEL-HK--RRKAVTEPEARYFMRQTIQ 153
Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAP 121
           G+ YLH  N  ++HRDLK  NL ++    VK+ DFGL+          K   GTP ++AP
Sbjct: 154 GVQYLH--NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAP 211
Query: 122 EVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHV 181
           EVL  +  + + DI+S G IL+ L   + P+      +    +  K     +PR++NP  
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETY--IRIKKNEYSVPRHINPVA 269
Query: 182 ASII 185
           +++I
Sbjct: 270 SALI 273

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-------KPGVREMLDERRRL 53
           + +  H NIV  +G   Q     I+ E ++ G L   L        +P    MLD    L
Sbjct: 94  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD---LL 150
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD---KKYTVKVCDFGLSR--LKANTFLS 108
           ++A D+A G  YL   +   +HRD+ + N L+         K+ DFG++R   +A+ +  
Sbjct: 151 HVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 208
Query: 109 SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFK 167
              A    +WM PE   +     K+D +SFGV+LWE+ +L   P+ + +  +V+  V   
Sbjct: 209 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-S 267
Query: 168 GKRLEIPRNVNPHVASIIEACW 189
           G R++ P+N    V  I+  CW
Sbjct: 268 GGRMDPPKNCPGPVYRIMTQCW 289

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-------KPGVREMLDERRRL 53
           + +  H NIV  +G   Q     I+ E ++ G L   L        +P    MLD    L
Sbjct: 87  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD---LL 143
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR--LKANTFLS 108
           ++A D+A G  YL   +   +HRD+ + N L+         K+ DFG++R   +A+ +  
Sbjct: 144 HVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 201
Query: 109 SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFK 167
              A    +WM PE   +     K+D +SFGV+LWE+ +L   P+ + +  +V+  V   
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-S 260
Query: 168 GKRLEIPRNVNPHVASIIEACW 189
           G R++ P+N    V  I+  CW
Sbjct: 261 GGRMDPPKNCPGPVYRIMTQCW 282

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-------KPGVREMLDERRRL 53
           + +  H NIV  +G   Q     I+ E ++ G L   L        +P    MLD    L
Sbjct: 88  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD---LL 144
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR--LKANTFLS 108
           ++A D+A G  YL   +   +HRD+ + N L+         K+ DFG++R   +A+ +  
Sbjct: 145 HVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 202
Query: 109 SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFK 167
              A    +WM PE   +     K+D +SFGV+LWE+ +L   P+ + +  +V+  V   
Sbjct: 203 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-S 261
Query: 168 GKRLEIPRNVNPHVASIIEACW 189
           G R++ P+N    V  I+  CW
Sbjct: 262 GGRMDPPKNCPGPVYRIMTQCW 283

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 80/162 (49%), Gaps = 17/162 (10%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK L HPNIV     +     L +V EY S G ++  L   G  +  + R +      + 
Sbjct: 60  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR---QIV 116
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-----KANTFLSSKSAAGT 115
             + Y H++   IVHRDLK+ NLL+D    +K+ DFG S       K +TF       G+
Sbjct: 117 SAVQYCHQKF--IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTF------CGS 168
Query: 116 PEWMAPEVLRDEPSNE-KSDIYSFGVILWELATLQQPWGNLN 156
           P + APE+ + +  +  + D++S GVIL+ L +   P+   N
Sbjct: 169 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 210

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-------KPGVREMLDERRRL 53
           + +  H NIV  +G   Q     I+ E ++ G L   L        +P    MLD    L
Sbjct: 102 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD---LL 158
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR--LKANTFLS 108
           ++A D+A G  YL   +   +HRD+ + N L+         K+ DFG++R   +A+ +  
Sbjct: 159 HVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 216
Query: 109 SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFK 167
              A    +WM PE   +     K+D +SFGV+LWE+ +L   P+ + +  +V+  V   
Sbjct: 217 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-S 275
Query: 168 GKRLEIPRNVNPHVASIIEACW 189
           G R++ P+N    V  I+  CW
Sbjct: 276 GGRMDPPKNCPGPVYRIMTQCW 297

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 84/164 (51%), Gaps = 26/164 (15%)
Query: 4   LRHPNIVLFMGAVTQP----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           LRH NI+ F+ A  +       L +V++Y   GSL+  L+    R  +     + +A   
Sbjct: 93  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALST 148
Query: 60  AKGMNYLH------RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
           A G+ +LH      +  P I HRDLKS N+LV K  T  + D GL+ ++ ++   +   A
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIA 207
Query: 114 -----GTPEWMAPEVLRDE------PSNEKSDIYSFGVILWELA 146
                GT  +MAPEVL D        S +++DIY+ G++ WE+A
Sbjct: 208 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-------KPGVREMLDERRRL 53
           + +  H NIV  +G   Q     I+ E ++ G L   L        +P    MLD    L
Sbjct: 114 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD---LL 170
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD---KKYTVKVCDFGLSR--LKANTFLS 108
           ++A D+A G  YL   +   +HRD+ + N L+         K+ DFG++R   +A+ +  
Sbjct: 171 HVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 228
Query: 109 SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFK 167
              A    +WM PE   +     K+D +SFGV+LWE+ +L   P+ + +  +V+  V   
Sbjct: 229 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-S 287
Query: 168 GKRLEIPRNVNPHVASIIEACW 189
           G R++ P+N    V  I+  CW
Sbjct: 288 GGRMDPPKNCPGPVYRIMTQCW 309

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 89/184 (48%), Gaps = 7/184 (3%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK 61
           K L +P++V F G       + +V E   R SL  L HK   R+ + E           +
Sbjct: 97  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLEL-HK--RRKAVTEPEARYFMRQTIQ 153
Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAP 121
           G+ YLH  N  ++HRDLK  NL ++    VK+ DFGL+          K   GTP ++AP
Sbjct: 154 GVQYLH--NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAP 211
Query: 122 EVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHV 181
           EVL  +  + + DI+S G IL+ L   + P+      +    +  K     +PR++NP  
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETY--IRIKKNEYSVPRHINPVA 269
Query: 182 ASII 185
           +++I
Sbjct: 270 SALI 273

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 94/192 (48%), Gaps = 9/192 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  +  P +   +G +     + +VT+ +  G L  L H    R  L  +  LN    +A
Sbjct: 73  MAGVGSPYVSRLLG-ICLTSTVQLVTQLMPYGCL--LDHVRENRGRLGSQDLLNWCMQIA 129
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP--EW 118
           KGM+YL   +  +VHRDL + N+LV     VK+ DFGL+RL         +  G    +W
Sbjct: 130 KGMSYLE--DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 187
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  + PA+ +  +  KG+RL  P   
Sbjct: 188 MALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGI-PAREIPDLLEKGERLPQPPIC 246
Query: 178 NPHVASIIEACW 189
              V  I+  CW
Sbjct: 247 TIDVYMIMVKCW 258

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 78/149 (52%), Gaps = 7/149 (4%)
Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P ++           + ++ EY + G ++ L   P + EM+ E   + +   + +G+ YL
Sbjct: 89  PRVINLHEVYENTSEIILILEYAAGGEIFSLC-LPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 67  HRRNPPIVHRDLKSPNLLVDKKY---TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           H+ N  IVH DLK  N+L+   Y    +K+ DFG+SR K       +   GTPE++APE+
Sbjct: 148 HQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR-KIGHACELREIMGTPEYLAPEI 204
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPW 152
           L  +P    +D+++ G+I + L T   P+
Sbjct: 205 LNYDPITTATDMWNIGIIAYMLLTHTSPF 233

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-------KPGVREMLDERRRL 53
           + +  H NIV  +G   Q     I+ E ++ G L   L        +P    MLD    L
Sbjct: 105 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD---LL 161
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR--LKANTFLS 108
           ++A D+A G  YL   +   +HRD+ + N L+         K+ DFG++R   +A  +  
Sbjct: 162 HVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK 219
Query: 109 SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ-QPWGNLNPAQVVAAVGFK 167
              A    +WM PE   +     K+D +SFGV+LWE+ +L   P+ + +  +V+  V   
Sbjct: 220 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-S 278
Query: 168 GKRLEIPRNVNPHVASIIEACW 189
           G R++ P+N    V  I+  CW
Sbjct: 279 GGRMDPPKNCPGPVYRIMTQCW 300

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-------KPGVREMLDERRRL 53
           + +  H NIV  +G   Q     I+ E ++ G L   L        +P    MLD    L
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD---LL 184
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR--LKANTFLS 108
           ++A D+A G  YL   +   +HRD+ + N L+         K+ DFG++R   +A  +  
Sbjct: 185 HVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK 242
Query: 109 SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFK 167
              A    +WM PE   +     K+D +SFGV+LWE+ +L   P+ + +  +V+  V   
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-S 301
Query: 168 GKRLEIPRNVNPHVASIIEACW 189
           G R++ P+N    V  I+  CW
Sbjct: 302 GGRMDPPKNCPGPVYRIMTQCW 323

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 80/163 (49%), Gaps = 24/163 (14%)
Query: 4   LRHPNIVLF----MGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           LRH NI+ F    M +      L ++T Y   GSLY  L        LD    L +   +
Sbjct: 59  LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSI 114
Query: 60  AKGMNYLH------RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF----LSS 109
           A G+ +LH      +  P I HRDLKS N+LV K     + D GL+ + + +     + +
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174
Query: 110 KSAAGTPEWMAPEVLRDE------PSNEKSDIYSFGVILWELA 146
               GT  +MAPEVL +        S ++ DI++FG++LWE+A
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 85/163 (52%), Gaps = 20/163 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYL--SRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +++LRHPN + + G   +     +V EY   S   L  +  KP     L E     + + 
Sbjct: 108 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAVTHG 162
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK--ANTFLSSKSAAGTP 116
             +G+ YLH  N  ++HRD+K+ N+L+ +   VK+ DFG + +   AN F+      GTP
Sbjct: 163 ALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTP 214
Query: 117 EWMAPEVL--RDEPSNE-KSDIYSFGVILWELATLQQPWGNLN 156
            WMAPEV+   DE   + K D++S G+   ELA  + P  N+N
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 257

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 80/163 (49%), Gaps = 24/163 (14%)
Query: 4   LRHPNIVLF----MGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           LRH NI+ F    M +      L ++T Y   GSLY  L        LD    L +   +
Sbjct: 88  LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSI 143
Query: 60  AKGMNYLH------RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF----LSS 109
           A G+ +LH      +  P I HRDLKS N+LV K     + D GL+ + + +     + +
Sbjct: 144 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 203
Query: 110 KSAAGTPEWMAPEVLRDE------PSNEKSDIYSFGVILWELA 146
               GT  +MAPEVL +        S ++ DI++FG++LWE+A
Sbjct: 204 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 246

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 78/160 (48%), Gaps = 13/160 (8%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK L HPNIV     +     L +V EY S G ++  L   G  +  + R +      + 
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ---IV 123
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS---KSAAGTPE 117
             + Y H++   IVHRDLK+ NLL+D    +K+ DFG S    N F          G+P 
Sbjct: 124 SAVQYCHQKF--IVHRDLKAENLLLDADMNIKIADFGFS----NEFTFGNKLDEFCGSPP 177
Query: 118 WMAPEVLRDEPSNE-KSDIYSFGVILWELATLQQPWGNLN 156
           + APE+ + +  +  + D++S GVIL+ L +   P+   N
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 80/163 (49%), Gaps = 24/163 (14%)
Query: 4   LRHPNIVLF----MGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           LRH NI+ F    M +      L ++T Y   GSLY  L        LD    L +   +
Sbjct: 59  LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSI 114
Query: 60  AKGMNYLH------RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF----LSS 109
           A G+ +LH      +  P I HRDLKS N+LV K     + D GL+ + + +     + +
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174
Query: 110 KSAAGTPEWMAPEVLRDE------PSNEKSDIYSFGVILWELA 146
               GT  +MAPEVL +        S ++ DI++FG++LWE+A
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 39/215 (18%)
Query: 1   MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLL--HKPGVREMLDERRRLNMA 56
           ++ L H +I+ + G        +L +V EY+  GSL   L  H  G+ ++L        A
Sbjct: 87  LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLL------LFA 140
Query: 57  YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAG 114
             + +GM YLH ++   +HRDL + N+L+D    VK+ DFGL++   + +     +    
Sbjct: 141 QQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGD 198
Query: 115 TPE-WMAPEVLRDEPSNEKSDIYSFGVILWELAT----LQQPWGNLNPAQVVAAVGF--- 166
           +P  W APE L++      SD++SFGV L+EL T     Q P     P + +  +G    
Sbjct: 199 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP-----PTKFLELIGIAQG 253
Query: 167 ------------KGKRLEIPRNVNPHVASIIEACW 189
                       +G+RL  P      V  +++ CW
Sbjct: 254 QMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCW 288

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A  +
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANAL 122
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           +Y H +   ++HRD+K  NLL+     +K+ DFG S    ++  ++ S  GT +++ PE+
Sbjct: 123 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS--GTLDYLPPEM 178
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +     +EK D++S GV+ +E    + P+
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 207

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 85/163 (52%), Gaps = 20/163 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYL--SRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +++LRHPN + + G   +     +V EY   S   L  +  KP     L E     + + 
Sbjct: 69  LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAVTHG 123
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK--ANTFLSSKSAAGTP 116
             +G+ YLH  N  ++HRD+K+ N+L+ +   VK+ DFG + +   AN F+      GTP
Sbjct: 124 ALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTP 175
Query: 117 EWMAPEVL--RDEPSNE-KSDIYSFGVILWELATLQQPWGNLN 156
            WMAPEV+   DE   + K D++S G+   ELA  + P  N+N
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 7/149 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A  +
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANAL 125
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           +Y H +   ++HRD+K  NLL+     +K+ DFG S    ++     +  GT +++ PE+
Sbjct: 126 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEM 181
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +     +EK D++S GV+ +E    + P+
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 210

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 7/149 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A  +
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANAL 126
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           +Y H +   ++HRD+K  NLL+     +K+ DFG S    ++     +  GT +++ PE+
Sbjct: 127 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEM 182
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +     +EK D++S GV+ +E    + P+
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 7/149 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A  +
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANAL 121
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           +Y H +   ++HRD+K  NLL+     +K+ DFG S    ++     +  GT +++ PE+
Sbjct: 122 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEM 177
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +     +EK D++S GV+ +E    + P+
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 7/149 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A  +
Sbjct: 62  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANAL 118
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           +Y H +   ++HRD+K  NLL+     +K+ DFG S    ++     +  GT +++ PE+
Sbjct: 119 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEM 174
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +     +EK D++S GV+ +E    + P+
Sbjct: 175 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 203

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 7/149 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A  +
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANAL 122
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           +Y H +   ++HRD+K  NLL+     +K+ DFG S    ++     +  GT +++ PE+
Sbjct: 123 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRDTLCGTLDYLPPEM 178
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +     +EK D++S GV+ +E    + P+
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 207

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 7/149 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A  +
Sbjct: 64  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANAL 120
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           +Y H +   ++HRD+K  NLL+     +K+ DFG S    ++     +  GT +++ PE+
Sbjct: 121 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEM 176
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +     +EK D++S GV+ +E    + P+
Sbjct: 177 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 205

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 77.4 bits (189), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 81/145 (55%), Gaps = 6/145 (4%)
Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P IV F GA      +SI  E++  GSL ++L +    + + E     ++  V +G+ YL
Sbjct: 74  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYL 130
Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 126
            R    I+HRD+K  N+LV+ +  +K+CDFG+S    ++   + S  GT  +MAPE L+ 
Sbjct: 131 -REKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMAPERLQG 187
Query: 127 EPSNEKSDIYSFGVILWELATLQQP 151
              + +SDI+S G+ L ELA  + P
Sbjct: 188 THYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 77.4 bits (189), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 7/149 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A  +
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANAL 124
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           +Y H +   ++HRD+K  NLL+     +K+ DFG S    ++     +  GT +++ PE+
Sbjct: 125 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEM 180
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +     +EK D++S GV+ +E    + P+
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 77.4 bits (189), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 7/149 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A  +
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANAL 124
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           +Y H +   ++HRD+K  NLL+     +K+ DFG S    ++     +  GT +++ PE+
Sbjct: 125 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEM 180
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +     +EK D++S GV+ +E    + P+
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY  RG +Y+ L K       DE+R      ++A  +
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLS---KFDEQRTATYITELANAL 126
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           +Y H +   ++HRD+K  NLL+     +K+ DFG S    ++        GT +++ PE+
Sbjct: 127 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRXXLXGTLDYLPPEM 182
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +     +EK D++S GV+ +E    + P+
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/172 (34%), Positives = 85/172 (49%), Gaps = 11/172 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K+L HPNI+          N  +V E    G L+  +    +R+   E     +   V 
Sbjct: 75  LKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEII---LRQKFSEVDAAVIMKQVL 131
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKY---TVKVCDFGLSRLKANTFLSSKSAAGTPE 117
            G  YLH+ N  IVHRDLK  NLL++ K     +K+ DFGLS          K   GT  
Sbjct: 132 SGTTYLHKHN--IVHRDLKPENLLLESKSRDALIKIVDFGLSA-HFEVGGKMKERLGTAY 188
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK 169
           ++APEVLR +  +EK D++S GVIL+ L     P+G     +++  V  KGK
Sbjct: 189 YIAPEVLR-KKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVE-KGK 238

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 7/149 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A  +
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANAL 147
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           +Y H +   ++HRD+K  NLL+     +K+ DFG S    ++     +  GT +++ PE+
Sbjct: 148 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEM 203
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +     +EK D++S GV+ +E    + P+
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 232

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 78/157 (49%), Gaps = 9/157 (5%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK 61
           K L HPNIV     +     L +V EY S G ++  L   G  +  + R +      +  
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQ---IVS 124
Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA-AGTPEWMA 120
            + Y H++   IVHRDLK+ NLL+D    +K+ DFG S     TF +   A  G P + A
Sbjct: 125 AVQYCHQKF--IVHRDLKAENLLLDADXNIKIADFGFS--NEFTFGNKLDAFCGAPPYAA 180
Query: 121 PEVLRDEPSNE-KSDIYSFGVILWELATLQQPWGNLN 156
           PE+ + +  +  + D++S GVIL+ L +   P+   N
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 7/149 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A  +
Sbjct: 82  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANAL 138
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           +Y H +   ++HRD+K  NLL+     +K+ DFG S    ++     +  GT +++ PE+
Sbjct: 139 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEM 194
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +     +EK D++S GV+ +E    + P+
Sbjct: 195 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 223

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 39/215 (18%)
Query: 1   MKRLRHPNIVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLL--HKPGVREMLDERRRLNMA 56
           ++ L H +I+ + G        +L +V EY+  GSL   L  H  G+ ++L        A
Sbjct: 70  LRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLL------LFA 123
Query: 57  YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAG 114
             + +GM YLH ++   +HR+L + N+L+D    VK+ DFGL++   + + +   +    
Sbjct: 124 QQICEGMAYLHSQH--YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 181
Query: 115 TPE-WMAPEVLRDEPSNEKSDIYSFGVILWELAT----LQQPWGNLNPAQVVAAVGF--- 166
           +P  W APE L++      SD++SFGV L+EL T     Q P     P + +  +G    
Sbjct: 182 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP-----PTKFLELIGIAQG 236
Query: 167 ------------KGKRLEIPRNVNPHVASIIEACW 189
                       +G+RL  P      V  +++ CW
Sbjct: 237 QMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCW 271

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A  +
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANAL 126
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           +Y H +   ++HRD+K  NLL+     +K+ DFG S    ++     +  GT +++ PE 
Sbjct: 127 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEX 182
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +     +EK D++S GV+ +E    + P+
Sbjct: 183 IEGRXHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 78/148 (52%), Gaps = 10/148 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K+++H NIV          +  +V + +S G L+  + + GV    D    +     V 
Sbjct: 60  LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ---QVL 116
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 117
             + YLH     IVHRDLK  NLL    ++   + + DFGLS+++ N  +S+  A GTP 
Sbjct: 117 SAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST--ACGTPG 172
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWEL 145
           ++APEVL  +P ++  D +S GVI + L
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIGVITYIL 200

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A  +
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANAL 121
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           +Y H +   ++HRD+K  NLL+     +K+ DFG S    ++        GT +++ PE+
Sbjct: 122 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLDYLPPEM 177
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +     +EK D++S GV+ +E    + P+
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 77.0 bits (188), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A  +
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANAL 121
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           +Y H +   ++HRD+K  NLL+     +K+ DFG S    ++        GT +++ PE+
Sbjct: 122 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTELCGTLDYLPPEM 177
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +     +EK D++S GV+ +E    + P+
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 39/215 (18%)
Query: 1   MKRLRHPNIVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLL--HKPGVREMLDERRRLNMA 56
           ++ L H +I+ + G        +L +V EY+  GSL   L  H  G+ ++L        A
Sbjct: 70  LRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLL------LFA 123
Query: 57  YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAG 114
             + +GM YLH ++   +HR+L + N+L+D    VK+ DFGL++   + + +   +    
Sbjct: 124 QQICEGMAYLHAQH--YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 181
Query: 115 TPE-WMAPEVLRDEPSNEKSDIYSFGVILWELAT----LQQPWGNLNPAQVVAAVGF--- 166
           +P  W APE L++      SD++SFGV L+EL T     Q P     P + +  +G    
Sbjct: 182 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP-----PTKFLELIGIAQG 236
Query: 167 ------------KGKRLEIPRNVNPHVASIIEACW 189
                       +G+RL  P      V  +++ CW
Sbjct: 237 QMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCW 271

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A  +
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANAL 122
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           +Y H +   ++HRD+K  NLL+     +K+ DFG S    ++        GT +++ PE+
Sbjct: 123 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLDYLPPEM 178
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +     +EK D++S GV+ +E    + P+
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 207

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A  +
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANAL 124
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           +Y H +   ++HRD+K  NLL+     +K+ DFG S    ++        GT +++ PE+
Sbjct: 125 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRDDLCGTLDYLPPEM 180
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +     +EK D++S GV+ +E    + P+
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 77/153 (50%), Gaps = 9/153 (5%)
Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
           RL HPNI+        P  +S+V E ++ G L+  + + G      ER   +    + + 
Sbjct: 104 RLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG---YYSERDAADAVKQILEA 160
Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
           + YLH     IVHRDLK  NLL         +K+ DFGLS++  +  L  K+  GTP + 
Sbjct: 161 VAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM-KTVCGTPGYC 217
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
           APE+LR      + D++S G+I + L    +P+
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEPF 250

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A  +
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANAL 121
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           +Y H +   ++HRD+K  NLL+     +K+ DFG S    ++        GT +++ PE+
Sbjct: 122 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLDYLPPEM 177
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +     +EK D++S GV+ +E    + P+
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A  +
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---RFDEQRTATYITELANAL 125
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           +Y H +   ++HRD+K  NLL+     +K+ DFG S    ++     +  GT +++ PE+
Sbjct: 126 SYCHSKR--VIHRDIKPENLLLGSNGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEM 181
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +     +EK D++S GV+ +E      P+
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGMPPF 210

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 76.6 bits (187), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A  +
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANAL 121
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           +Y H +   ++HRD+K  NLL+     +K+ DFG S    ++        GT +++ PE+
Sbjct: 122 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTXLCGTLDYLPPEM 177
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +     +EK D++S GV+ +E    + P+
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A  +
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANAL 126
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           +Y H +   ++HRD+K  NLL+     +K+ DFG S    ++        GT +++ PE+
Sbjct: 127 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLDYLPPEM 182
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +     +EK D++S GV+ +E    + P+
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-------KPGVREMLDERRRL 53
           + +  H NIV  +G   Q     I+ E ++ G L   L        +P    MLD    L
Sbjct: 88  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD---LL 144
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR--LKANTFLS 108
           ++A D+A G  YL   +   +HRD+ + N L+         K+ DFG+++   +A+ +  
Sbjct: 145 HVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRK 202
Query: 109 SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFK 167
              A    +WM PE   +     K+D +SFGV+LWE+ +L   P+ + +  +V+  V   
Sbjct: 203 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-S 261
Query: 168 GKRLEIPRNVNPHVASIIEACW 189
           G R++ P+N    V  I+  CW
Sbjct: 262 GGRMDPPKNCPGPVYRIMTQCW 283

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 76.6 bits (187), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A  +
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANAL 121
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           +Y H +   ++HRD+K  NLL+     +K+ DFG S    ++        GT +++ PE+
Sbjct: 122 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRXXLCGTLDYLPPEM 177
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +     +EK D++S GV+ +E    + P+
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 76.6 bits (187), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/172 (34%), Positives = 85/172 (49%), Gaps = 11/172 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K+L HPNI+          N  +V E    G L+  +    +R+   E     +   V 
Sbjct: 58  LKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEII---LRQKFSEVDAAVIMKQVL 114
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKY---TVKVCDFGLSRLKANTFLSSKSAAGTPE 117
            G  YLH+ N  IVHRDLK  NLL++ K     +K+ DFGLS          K   GT  
Sbjct: 115 SGTTYLHKHN--IVHRDLKPENLLLESKSRDALIKIVDFGLSA-HFEVGGKMKERLGTAY 171
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK 169
           ++APEVLR +  +EK D++S GVIL+ L     P+G     +++  V  KGK
Sbjct: 172 YIAPEVLR-KKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVE-KGK 221

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 76.6 bits (187), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A  +
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---RFDEQRTATYITELANAL 125
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           +Y H +   ++HRD+K  NLL+     +K+ DFG S    ++     +  GT +++ PE+
Sbjct: 126 SYCHSKR--VIHRDIKPENLLLGSNGELKIADFGWSVHAPSS--RRDTLCGTLDYLPPEM 181
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +     +EK D++S GV+ +E      P+
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGMPPF 210

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A  +
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANAL 147
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           +Y H +   ++HRD+K  NLL+     +K+ DFG S    ++        GT +++ PE+
Sbjct: 148 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRDDLCGTLDYLPPEM 203
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +     +EK D++S GV+ +E    + P+
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 232

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 76.6 bits (187), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A  +
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANAL 124
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           +Y H +   ++HRD+K  NLL+     +K+ DFG S    ++        GT +++ PE+
Sbjct: 125 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRXXLCGTLDYLPPEM 180
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +     +EK D++S GV+ +E    + P+
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A  +
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANAL 123
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           +Y H +   ++HRD+K  NLL+     +K+ DFG S    ++        GT +++ PE+
Sbjct: 124 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRXXLCGTLDYLPPEM 179
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +     +EK D++S GV+ +E    + P+
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 208

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 86/165 (52%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY++ G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+      AGTPE++
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLAGTPEYL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 84/167 (50%), Gaps = 31/167 (18%)
Query: 4   LRHPNIVLFMGA----VTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           ++H NI+ F+GA     +   +L ++T +  +GSL   L       ++      ++A  +
Sbjct: 75  MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA----NVVSWNELCHIAETM 130
Query: 60  AKGMNYLHR--------RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
           A+G+ YLH           P I HRD+KS N+L+    T  + DFGL    A  F + KS
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL----ALKFEAGKS 186
Query: 112 AA------GTPEWMAPEVLRDEPSNEKS-----DIYSFGVILWELAT 147
           A       GT  +MAPEVL    + ++      D+Y+ G++LWELA+
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 88/158 (55%), Gaps = 13/158 (8%)
Query: 1   MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +K+L HPN+V  +  +  P   +L +V E +++G +  +   P ++ + +++ R     D
Sbjct: 90  LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV---PTLKPLSEDQARFYFQ-D 145
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPE 117
           + KG+ YLH +   I+HRD+K  NLLV +   +K+ DFG+S   K +  L S +  GTP 
Sbjct: 146 LIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT-VGTPA 202
Query: 118 WMAPEVL---RDEPSNEKSDIYSFGVILWELATLQQPW 152
           +MAPE L   R   S +  D+++ GV L+     Q P+
Sbjct: 203 FMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 80/143 (55%), Gaps = 5/143 (3%)
Query: 22  LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
           L  V EY++ G L   + + G      E   +  A ++A G+ +L  +   I++RDLK  
Sbjct: 96  LYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLD 150
Query: 82  NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVI 141
           N+++D +  +K+ DFG+ +      +++K   GTP+++APE++  +P  +  D ++FGV+
Sbjct: 151 NVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVL 210
Query: 142 LWELATLQQPWGNLNPAQVVAAV 164
           L+E+   Q P+   +  ++  ++
Sbjct: 211 LYEMLAGQAPFEGEDEDELFQSI 233

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 84/156 (53%), Gaps = 10/156 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ LRHP+I+     +     + +V EY +   L+  + +   R+ + E+        + 
Sbjct: 62  LRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQ---RDKMSEQEARRFFQQII 117
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN-TFLSSKSAAGTPEWM 119
             + Y HR    IVHRDLK  NLL+D+   VK+ DFGLS +  +  FL  K++ G+P + 
Sbjct: 118 SAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL--KTSCGSPNYA 173
Query: 120 APEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGN 154
           APEV+  +  +  + D++S GVIL+ +   + P+ +
Sbjct: 174 APEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 209

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 84/156 (53%), Gaps = 10/156 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ LRHP+I+     +     + +V EY +   L+  + +   R+ + E+        + 
Sbjct: 58  LRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQ---RDKMSEQEARRFFQQII 113
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN-TFLSSKSAAGTPEWM 119
             + Y HR    IVHRDLK  NLL+D+   VK+ DFGLS +  +  FL  K++ G+P + 
Sbjct: 114 SAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL--KTSCGSPNYA 169
Query: 120 APEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGN 154
           APEV+  +  +  + D++S GVIL+ +   + P+ +
Sbjct: 170 APEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 205

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 84/156 (53%), Gaps = 10/156 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ LRHP+I+     +     + +V EY +   L+  + +   R+ + E+        + 
Sbjct: 67  LRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQ---RDKMSEQEARRFFQQII 122
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN-TFLSSKSAAGTPEWM 119
             + Y HR    IVHRDLK  NLL+D+   VK+ DFGLS +  +  FL  K++ G+P + 
Sbjct: 123 SAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL--KTSCGSPNYA 178
Query: 120 APEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGN 154
           APEV+  +  +  + D++S GVIL+ +   + P+ +
Sbjct: 179 APEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 214

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 84/156 (53%), Gaps = 10/156 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ LRHP+I+     +     + +V EY +   L+  + +   R+ + E+        + 
Sbjct: 68  LRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQ---RDKMSEQEARRFFQQII 123
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN-TFLSSKSAAGTPEWM 119
             + Y HR    IVHRDLK  NLL+D+   VK+ DFGLS +  +  FL  K++ G+P + 
Sbjct: 124 SAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL--KTSCGSPNYA 179
Query: 120 APEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGN 154
           APEV+  +  +  + D++S GVIL+ +   + P+ +
Sbjct: 180 APEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 215

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 88/169 (52%), Gaps = 14/169 (8%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
           +HPNI+           + +VTE +  G    LL K   ++   ER    + + + K + 
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGG---ELLDKILRQKFFSEREASAVLFTITKTVE 130
Query: 65  YLHRRNPPIVHRDLKSPNLL-VDKK---YTVKVCDFGLSR-LKANTFLSSKSAAGTPEWM 119
           YLH +   +VHRDLK  N+L VD+     ++++CDFG ++ L+A   L   +   T  ++
Sbjct: 131 YLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL-MTPCYTANFV 187
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL---NPAQVVAAVG 165
           APEVL  +  +   DI+S GV+L+ + T   P+ N     P +++A +G
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG 236

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 80/145 (55%), Gaps = 8/145 (5%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           L+HPNIV    ++++     +V + ++ G L+  +     RE   E    +  + + + +
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDI---VAREYYSEADASHCIHQILESV 143
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKY---TVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           N++H+ +  IVHRDLK  NLL+  K     VK+ DFGL+        +    AGTP +++
Sbjct: 144 NHIHQHD--IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLS 201
Query: 121 PEVLRDEPSNEKSDIYSFGVILWEL 145
           PEVLR +P  +  DI++ GVIL+ L
Sbjct: 202 PEVLRKDPYGKPVDIWACGVILYIL 226

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 87/158 (55%), Gaps = 14/158 (8%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +RHPNI+          ++ ++ E +S G L+  L +   +E L E         + 
Sbjct: 69  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE---KESLTEDEATQFLKQIL 125
Query: 61  KGMNYLHRRNPPIVHRDLKSPN-LLVDKKY---TVKVCDFGLS-RLKA-NTFLSSKSAAG 114
            G++YLH +   I H DLK  N +L+DK      +K+ DFG++ +++A N F   K+  G
Sbjct: 126 DGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFG 180
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
           TPE++APE++  EP   ++D++S GVI + L +   P+
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 80/143 (55%), Gaps = 5/143 (3%)
Query: 22  LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
           L  V EY++ G L   + + G      E   +  A ++A G+ +L  +   I++RDLK  
Sbjct: 417 LYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLD 471
Query: 82  NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVI 141
           N+++D +  +K+ DFG+ +      +++K   GTP+++APE++  +P  +  D ++FGV+
Sbjct: 472 NVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVL 531
Query: 142 LWELATLQQPWGNLNPAQVVAAV 164
           L+E+   Q P+   +  ++  ++
Sbjct: 532 LYEMLAGQAPFEGEDEDELFQSI 554

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 77/149 (51%), Gaps = 7/149 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A  +
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANAL 124
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           +Y H +   ++HRD+K  NLL+     +K+ +FG S    ++     +  GT +++ PE+
Sbjct: 125 SYCHSKR--VIHRDIKPENLLLGSAGELKIANFGWSVHAPSS--RRTTLCGTLDYLPPEM 180
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +     +EK D++S GV+ +E    + P+
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 84/165 (50%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY+  G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIG---RFSEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  +KV DFG + R+K  T+       GTPE++
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTW----XLCGTPEYL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 88/168 (52%), Gaps = 10/168 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++++ HPNI+          ++ ++ E +S G L+  L +   +E L E    +    + 
Sbjct: 69  LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQIL 125
Query: 61  KGMNYLHRRNPPIVHRDLKSPN-LLVDKKY---TVKVCDFGLSRLKANTFLSSKSAAGTP 116
            G+NYLH +   I H DLK  N +L+DK      +K+ DFGL+  +    +  K+  GTP
Sbjct: 126 DGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFGTP 182
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           E++APE++  EP   ++D++S GVI + L +   P+      + +A +
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 77/149 (51%), Gaps = 7/149 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A  +
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANAL 123
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
           +Y H +   ++HRD+K  NLL+     +K+ +FG S    ++     +  GT +++ PE+
Sbjct: 124 SYCHSKR--VIHRDIKPENLLLGSAGELKIANFGWSVHAPSS--RRTTLCGTLDYLPPEM 179
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +     +EK D++S GV+ +E    + P+
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 208

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 87/158 (55%), Gaps = 14/158 (8%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +RHPNI+          ++ ++ E +S G L+  L +   +E L E         + 
Sbjct: 83  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE---KESLTEDEATQFLKQIL 139
Query: 61  KGMNYLHRRNPPIVHRDLKSPN-LLVDKKY---TVKVCDFGLS-RLKA-NTFLSSKSAAG 114
            G++YLH +   I H DLK  N +L+DK      +K+ DFG++ +++A N F   K+  G
Sbjct: 140 DGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFG 194
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
           TPE++APE++  EP   ++D++S GVI + L +   P+
Sbjct: 195 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 232

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 84/165 (50%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY+  G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIG---RFSEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  +KV DFG + R+K  T+       GTPE++
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTW----XLCGTPEYL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 86/165 (52%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY++ G ++  L + G      E      A  + 
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIV 172
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+    +  GTPE++
Sbjct: 173 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATW----TLCGTPEYL 226
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 227 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 271

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 87/158 (55%), Gaps = 14/158 (8%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +RHPNI+          ++ ++ E +S G L+  L +   +E L E         + 
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE---KESLTEDEATQFLKQIL 118
Query: 61  KGMNYLHRRNPPIVHRDLKSPN-LLVDKKY---TVKVCDFGLS-RLKA-NTFLSSKSAAG 114
            G++YLH +   I H DLK  N +L+DK      +K+ DFG++ +++A N F   K+  G
Sbjct: 119 DGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFG 173
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
           TPE++APE++  EP   ++D++S GVI + L +   P+
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 211

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 78/157 (49%), Gaps = 19/157 (12%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           L   N V  M AV +   L I  EY    +LY L+H   + +  DE  RL     + + +
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRL--FRQILEAL 129
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS----------RLKANTFLSSK--- 110
           +Y+H +   I+HRDLK  N+ +D+   VK+ DFGL+          +L +     S    
Sbjct: 130 SYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 111 -SAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWEL 145
            SA GT  ++A EVL      NEK D+YS G+I +E+
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 84/165 (50%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY+  G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFSEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  +KV DFG + R+K  T+       GTPE++
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTW----XLCGTPEYL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 85/165 (51%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY++ G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 85/165 (51%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY++ G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 85/165 (51%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY++ G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 85/165 (51%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY++ G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 79/159 (49%), Gaps = 5/159 (3%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
           HP +         P  L  V E+++ G L  + H    R   DE R    A ++   + +
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRR-FDEARARFYAAEIISALMF 139
Query: 66  LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 125
           LH +   I++RDLK  N+L+D +   K+ DFG+ +      +++ +  GTP+++APE+L+
Sbjct: 140 LHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQ 197
Query: 126 DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           +       D ++ GV+L+E+     P+   N   +  A+
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 236

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 85/165 (51%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY++ G ++  L + G      E      A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIV 152
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 206
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 251

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 85/165 (51%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY++ G ++  L + G      E      A  + 
Sbjct: 82  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIV 138
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 139 LTFEYLHSLD--LIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 192
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 193 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 237

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 85/165 (51%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY++ G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 85/165 (51%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY++ G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKI 250

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 85/165 (51%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY+  G ++  L + G      E      A  + 
Sbjct: 81  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFSEPHARFYAAQIV 137
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+    +  GTPE++
Sbjct: 138 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----TLCGTPEYL 191
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 192 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 236

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 96/191 (50%), Gaps = 11/191 (5%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK 61
           ++L+HPNIV    ++ +     +V + ++ G L+  +     RE   E    +    + +
Sbjct: 60  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILE 116
Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKY---TVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
            + Y H     IVHR+LK  NLL+  K     VK+ DFGL+ ++ N   +    AGTP +
Sbjct: 117 SIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGTPGY 173
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR--N 176
           ++PEVL+ +P ++  DI++ GVIL+ L     P+ + +  ++ A +         P    
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT 233
Query: 177 VNPHVASIIEA 187
           V P   S+I++
Sbjct: 234 VTPEAKSLIDS 244

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 85/165 (51%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY++ G ++  L + G      E      A  + 
Sbjct: 90  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFXEPHARFYAAQIV 146
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 147 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 200
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 201 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 245

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 85/165 (51%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY++ G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFXEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 85/165 (51%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY++ G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFXEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 85/165 (51%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY++ G ++  L + G      E      A  + 
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFXEPHARFYAAQIV 172
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 173 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 226
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 227 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 271

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 96/191 (50%), Gaps = 11/191 (5%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK 61
           ++L+HPNIV    ++ +     +V + ++ G L+  +     RE   E    +    + +
Sbjct: 60  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILE 116
Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKY---TVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
            + Y H     IVHR+LK  NLL+  K     VK+ DFGL+ ++ N   +    AGTP +
Sbjct: 117 SIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGTPGY 173
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR--N 176
           ++PEVL+ +P ++  DI++ GVIL+ L     P+ + +  ++ A +         P    
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT 233
Query: 177 VNPHVASIIEA 187
           V P   S+I++
Sbjct: 234 VTPEAKSLIDS 244

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 85/165 (51%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY++ G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLXGTPEYL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 96/191 (50%), Gaps = 11/191 (5%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK 61
           ++L+HPNIV    ++ +     +V + ++ G L+  +     RE   E    +    + +
Sbjct: 59  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILE 115
Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKY---TVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
            + Y H     IVHR+LK  NLL+  K     VK+ DFGL+ ++ N   +    AGTP +
Sbjct: 116 SIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGTPGY 172
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR--N 176
           ++PEVL+ +P ++  DI++ GVIL+ L     P+ + +  ++ A +         P    
Sbjct: 173 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT 232
Query: 177 VNPHVASIIEA 187
           V P   S+I++
Sbjct: 233 VTPEAKSLIDS 243

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 85/165 (51%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY++ G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFXEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 85/165 (51%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY+  G ++  L + G      E      A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFSEPHARFYAAQIV 152
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+    +  GTPE++
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----TLCGTPEYL 206
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 251

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 84/165 (50%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY   G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG---RFSEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NL++D++  +KV DFGL+ R+K  T+       GTPE++
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTW----XLCGTPEYL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 17/203 (8%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG--SLYRLLHKPGVREMLDERRRLNMAYD 58
           M+    P IV F GA+ +  +  I  E +S      Y+ ++   + +++ E     +   
Sbjct: 75  MRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSV-LDDVIPEEILGKITLA 133
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
             K +N+L + N  I+HRD+K  N+L+D+   +K+CDFG+S    ++   ++ A   P +
Sbjct: 134 TVKALNHL-KENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRP-Y 191
Query: 119 MAPEVLRDEPS------NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE 172
           MAPE  R +PS      + +SD++S G+ L+ELAT + P+   N          KG   +
Sbjct: 192 MAPE--RIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQ 249
Query: 173 IP----RNVNPHVASIIEACWAK 191
           +     R  +P   + +  C  K
Sbjct: 250 LSNSEEREFSPSFINFVNLCLTK 272

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 85/165 (51%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY++ G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFAEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 85/165 (51%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY++ G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NL++D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 206 APEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY+  G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFSEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY+  G ++  L + G      E      A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFSEPHARFYAAQIV 152
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 206
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 251

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY+  G ++  L + G      E      A  + 
Sbjct: 88  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFSEPHARFYAAQIV 144
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 145 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 198
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 199 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 243

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY+  G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFSEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 73.6 bits (179), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY+  G ++  L + G      E      A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFSEPHARFYAAQIV 152
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 206
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 251

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY+  G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFSEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 73.6 bits (179), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY+  G ++  L + G      E      A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFSEPHARFYAAQIV 152
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 206
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 251

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 73.6 bits (179), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY+  G ++  L + G      E      A  + 
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFSEPHARFYAAQIV 172
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 173 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 226
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 227 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 271

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 73.6 bits (179), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY+  G ++  L + G      E      A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFSEPHARFYAAQIV 152
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 206
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 251

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 86/169 (50%), Gaps = 14/169 (8%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
           +HPNI+           + +VTE    G    LL K   ++   ER    + + + K + 
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELXKGG---ELLDKILRQKFFSEREASAVLFTITKTVE 130
Query: 65  YLHRRNPPIVHRDLKSPNLL-VDKK---YTVKVCDFGLSR-LKANTFLSSKSAAGTPEWM 119
           YLH +   +VHRDLK  N+L VD+     ++++CDFG ++ L+A   L   +   T  ++
Sbjct: 131 YLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLX-TPCYTANFV 187
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL---NPAQVVAAVG 165
           APEVL  +  +   DI+S GV+L+   T   P+ N     P +++A +G
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIG 236

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 83/161 (51%), Gaps = 6/161 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M+  +H N+V    +      L ++ E+L  G+L  ++ +  VR  L+E +   +   V 
Sbjct: 96  MRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VR--LNEEQIATVCEAVL 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           + + YLH +   ++HRD+KS ++L+     VK+ DFG     +      K   GTP WMA
Sbjct: 152 QALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMA 209
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161
           PEV+       + DI+S G+++ E+   + P+ + +P Q +
Sbjct: 210 PEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 250

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY+  G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFSEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY+  G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFSEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 10/159 (6%)
Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P +V    +     NL +V EY   G ++  L + G      E      A  +     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYL 158
Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLR 125
           H  +  +++RDLK  NLL+D++  +KV DFG + R+K  T+       GTPE++APE++ 
Sbjct: 159 HSLD--LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTW----XLCGTPEYLAPEIIL 212
Query: 126 DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
            +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 251

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY+  G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFSEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY+  G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFXEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 96/191 (50%), Gaps = 11/191 (5%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK 61
           ++L+HPNIV    ++ +     +V + ++ G L+  +     RE   E    +    + +
Sbjct: 83  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILE 139
Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKY---TVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
            + Y H     IVHR+LK  NLL+  K     VK+ DFGL+ ++ N   +    AGTP +
Sbjct: 140 SIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGTPGY 196
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR--N 176
           ++PEVL+ +P ++  DI++ GVIL+ L     P+ + +  ++ A +         P    
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT 256
Query: 177 VNPHVASIIEA 187
           V P   S+I++
Sbjct: 257 VTPEAKSLIDS 267

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 85/165 (51%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY++ G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++++A    P+    P Q+   +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKI 250

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY+  G ++  L + G      E      A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFXEPHARFYAAQIV 152
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 206
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 251

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 83/165 (50%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY   G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG---RFSEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NL++D++  +KV DFG + R+K  T+       GTPE++
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW----XLCGTPEYL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 73.2 bits (178), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY+  G ++  L + G      E      A  + 
Sbjct: 88  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFXEPHARFYAAQIV 144
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 145 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 198
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 199 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 243

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY+  G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFXEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 88/169 (52%), Gaps = 14/169 (8%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
           +HPNI+          ++ +VTE +  G    LL K   ++   ER    + + + K + 
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGG---ELLDKILRQKFFSEREASFVLHTIGKTVE 135
Query: 65  YLHRRNPPIVHRDLKSPNLL-VDKK---YTVKVCDFGLSR-LKANTFLSSKSAAGTPEWM 119
           YLH +   +VHRDLK  N+L VD+      +++CDFG ++ L+A   L   +   T  ++
Sbjct: 136 YLHSQG--VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLL-MTPCYTANFV 192
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL---NPAQVVAAVG 165
           APEVL+ +  +E  DI+S G++L+ +     P+ N     P +++  +G
Sbjct: 193 APEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIG 241

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 83/165 (50%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY   G ++  L + G      E      A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG---RFSEPHARFYAAQIV 152
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NL++D++  +KV DFG + R+K  T+       GTPE++
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW----XLCGTPEYL 206
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 251

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY   G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG---RFSEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NL++D++  ++V DFGL+ R+K  T+       GTPE++
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTW----XLCGTPEYL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 88/169 (52%), Gaps = 14/169 (8%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
           +HPNI+          ++ +VTE +  G    LL K   ++   ER    + + + K + 
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGG---ELLDKILRQKFFSEREASFVLHTIGKTVE 135
Query: 65  YLHRRNPPIVHRDLKSPNLL-VDKK---YTVKVCDFGLSR-LKANTFLSSKSAAGTPEWM 119
           YLH +   +VHRDLK  N+L VD+      +++CDFG ++ L+A   L   +   T  ++
Sbjct: 136 YLHSQG--VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLL-MTPCYTANFV 192
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL---NPAQVVAAVG 165
           APEVL+ +  +E  DI+S G++L+ +     P+ N     P +++  +G
Sbjct: 193 APEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIG 241

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 81/164 (49%), Gaps = 6/164 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M+  +H N+V    +      L +V E+L  G+L  ++        ++E +   +   V 
Sbjct: 75  MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVL 130
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           + ++ LH +   ++HRD+KS ++L+     VK+ DFG     +      K   GTP WMA
Sbjct: 131 QALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 188
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           PE++   P   + DI+S G+++ E+   + P+ N  P + +  +
Sbjct: 189 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 232

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 81/164 (49%), Gaps = 6/164 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M+  +H N+V    +      L +V E+L  G+L  ++        ++E +   +   V 
Sbjct: 82  MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVL 137
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           + ++ LH +   ++HRD+KS ++L+     VK+ DFG     +      K   GTP WMA
Sbjct: 138 QALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 195
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           PE++   P   + DI+S G+++ E+   + P+ N  P + +  +
Sbjct: 196 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 239

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 81/164 (49%), Gaps = 6/164 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M+  +H N+V    +      L +V E+L  G+L  ++        ++E +   +   V 
Sbjct: 125 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVL 180
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           + ++ LH +   ++HRD+KS ++L+     VK+ DFG     +      K   GTP WMA
Sbjct: 181 QALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 238
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           PE++   P   + DI+S G+++ E+   + P+ N  P + +  +
Sbjct: 239 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 282

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 81/164 (49%), Gaps = 6/164 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M+  +H N+V    +      L +V E+L  G+L  ++        ++E +   +   V 
Sbjct: 80  MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVL 135
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           + ++ LH +   ++HRD+KS ++L+     VK+ DFG     +      K   GTP WMA
Sbjct: 136 QALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 193
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           PE++   P   + DI+S G+++ E+   + P+ N  P + +  +
Sbjct: 194 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 237

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 81/164 (49%), Gaps = 6/164 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M+  +H N+V    +      L +V E+L  G+L  ++        ++E +   +   V 
Sbjct: 71  MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVL 126
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           + ++ LH +   ++HRD+KS ++L+     VK+ DFG     +      K   GTP WMA
Sbjct: 127 QALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 184
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           PE++   P   + DI+S G+++ E+   + P+ N  P + +  +
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 228

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 83/165 (50%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY   G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG---RFXEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NL++D++  +KV DFG + R+K  T+       GTPE++
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW----XLCGTPEYL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY++ G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE +
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEAL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 33/212 (15%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSI--VTEYLSRGSLYRLL--HKPGVREMLDERRRLNMA 56
           ++ L H +IV + G        S+  V EY+  GSL   L  H  G+ ++L        A
Sbjct: 64  LRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLL------LFA 117
Query: 57  YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAG 114
             + +GM YLH ++   +HR L + N+L+D    VK+ DFGL++   + + +   +    
Sbjct: 118 QQICEGMAYLHAQH--YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 175
Query: 115 TPE-WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP-AQVVAAVGF------ 166
           +P  W APE L++      SD++SFGV L+EL T      N +P  +    +G       
Sbjct: 176 SPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCD--SNQSPHTKFTELIGHTQGQMT 233
Query: 167 ---------KGKRLEIPRNVNPHVASIIEACW 189
                    +G+RL  P      +  +++ CW
Sbjct: 234 VLRLTELLERGERLPRPDRCPCEIYHLMKNCW 265

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 87/168 (51%), Gaps = 10/168 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K ++HPN++          ++ ++ E ++ G L+  L +   +E L E         + 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQIL 124
Query: 61  KGMNYLHRRNPPIVHRDLKSPN-LLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTP 116
            G+ YLH  +  I H DLK  N +L+D+   K  +K+ DFGL+  K +     K+  GTP
Sbjct: 125 NGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIFGTP 181
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           E++APE++  EP   ++D++S GVI + L +   P+      + +A V
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV 229

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 33/212 (15%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSI--VTEYLSRGSLYRLL--HKPGVREMLDERRRLNMA 56
           ++ L H +IV + G        S+  V EY+  GSL   L  H  G+ ++L        A
Sbjct: 65  LRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLL------LFA 118
Query: 57  YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAG 114
             + +GM YLH ++   +HR L + N+L+D    VK+ DFGL++   + + +   +    
Sbjct: 119 QQICEGMAYLHAQH--YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 176
Query: 115 TPE-WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP-AQVVAAVGF------ 166
           +P  W APE L++      SD++SFGV L+EL T      N +P  +    +G       
Sbjct: 177 SPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCD--SNQSPHTKFTELIGHTQGQMT 234
Query: 167 ---------KGKRLEIPRNVNPHVASIIEACW 189
                    +G+RL  P      +  +++ CW
Sbjct: 235 VLRLTELLERGERLPRPDRCPCEIYHLMKNCW 266

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 87/168 (51%), Gaps = 10/168 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K ++HPN++          ++ ++ E ++ G L+  L +   +E L E         + 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQIL 124
Query: 61  KGMNYLHRRNPPIVHRDLKSPN-LLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTP 116
            G+ YLH  +  I H DLK  N +L+D+   K  +K+ DFGL+  K +     K+  GTP
Sbjct: 125 NGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIFGTP 181
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           E++APE++  EP   ++D++S GVI + L +   P+      + +A V
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV 229

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 87/168 (51%), Gaps = 10/168 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++++ H N++          ++ ++ E +S G L+  L +   +E L E    +    + 
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQIL 125
Query: 61  KGMNYLHRRNPPIVHRDLKSPN-LLVDKKY---TVKVCDFGLSRLKANTFLSSKSAAGTP 116
            G+NYLH +   I H DLK  N +L+DK      +K+ DFGL+  +    +  K+  GTP
Sbjct: 126 DGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFGTP 182
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           E++APE++  EP   ++D++S GVI + L +   P+      + +A +
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 81/164 (49%), Gaps = 6/164 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M+  +H N+V    +      L +V E+L  G+L  ++        ++E +   +   V 
Sbjct: 202 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVL 257
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           + ++ LH +   ++HRD+KS ++L+     VK+ DFG     +      K   GTP WMA
Sbjct: 258 QALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 315
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           PE++   P   + DI+S G+++ E+   + P+ N  P + +  +
Sbjct: 316 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 359

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 87/168 (51%), Gaps = 10/168 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K ++HPN++          ++ ++ E ++ G L+  L +   +E L E         + 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQIL 124
Query: 61  KGMNYLHRRNPPIVHRDLKSPN-LLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTP 116
            G+ YLH  +  I H DLK  N +L+D+   K  +K+ DFGL+  K +     K+  GTP
Sbjct: 125 NGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIFGTP 181
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           E++APE++  EP   ++D++S GVI + L +   P+      + +A V
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV 229

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 87/168 (51%), Gaps = 10/168 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K ++HPN++          ++ ++ E ++ G L+  L +   +E L E         + 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQIL 124
Query: 61  KGMNYLHRRNPPIVHRDLKSPN-LLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTP 116
            G+ YLH  +  I H DLK  N +L+D+   K  +K+ DFGL+  K +     K+  GTP
Sbjct: 125 NGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIFGTP 181
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           E++APE++  EP   ++D++S GVI + L +   P+      + +A V
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV 229

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 87/169 (51%), Gaps = 10/169 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K ++HPN++          ++ ++ E ++ G L+  L +   +E L E         + 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQIL 124
Query: 61  KGMNYLHRRNPPIVHRDLKSPN-LLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTP 116
            G+ YLH  +  I H DLK  N +L+D+   K  +K+ DFGL+  K +     K+  GTP
Sbjct: 125 NGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIFGTP 181
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 165
           E++APE++  EP   ++D++S GVI + L +   P+      + +A V 
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 87/168 (51%), Gaps = 10/168 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K ++HPN++          ++ ++ E ++ G L+  L +   +E L E         + 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAE---KESLTEEEATEFLKQIL 124
Query: 61  KGMNYLHRRNPPIVHRDLKSPN-LLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTP 116
            G+ YLH  +  I H DLK  N +L+D+   K  +K+ DFGL+  K +     K+  GTP
Sbjct: 125 NGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIFGTP 181
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           E++APE++  EP   ++D++S GVI + L +   P+      + +A V
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV 229

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 87/169 (51%), Gaps = 10/169 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K ++HPN++          ++ ++ E ++ G L+  L +   +E L E         + 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQIL 124
Query: 61  KGMNYLHRRNPPIVHRDLKSPN-LLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTP 116
            G+ YLH  +  I H DLK  N +L+D+   K  +K+ DFGL+  K +     K+  GTP
Sbjct: 125 NGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIFGTP 181
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 165
           E++APE++  EP   ++D++S GVI + L +   P+      + +A V 
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 87/169 (51%), Gaps = 10/169 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K ++HPN++          ++ ++ E ++ G L+  L +   +E L E         + 
Sbjct: 67  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQIL 123
Query: 61  KGMNYLHRRNPPIVHRDLKSPN-LLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTP 116
            G+ YLH  +  I H DLK  N +L+D+   K  +K+ DFGL+  K +     K+  GTP
Sbjct: 124 NGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIFGTP 180
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 165
           E++APE++  EP   ++D++S GVI + L +   P+      + +A V 
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 229

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 84/165 (50%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY++ G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NLL+D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           AP ++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 206 APAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 87/169 (51%), Gaps = 10/169 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K ++HPN++          ++ ++ E ++ G L+  L +   +E L E         + 
Sbjct: 67  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQIL 123
Query: 61  KGMNYLHRRNPPIVHRDLKSPN-LLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTP 116
            G+ YLH  +  I H DLK  N +L+D+   K  +K+ DFGL+  K +     K+  GTP
Sbjct: 124 NGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIFGTP 180
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 165
           E++APE++  EP   ++D++S GVI + L +   P+      + +A V 
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 229

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 87/168 (51%), Gaps = 10/168 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K ++HPN++          ++ ++ E ++ G L+  L +   +E L E         + 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQIL 124
Query: 61  KGMNYLHRRNPPIVHRDLKSPN-LLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTP 116
            G+ YLH  +  I H DLK  N +L+D+   K  +K+ DFGL+  K +     K+  GTP
Sbjct: 125 NGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIFGTP 181
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           E++APE++  EP   ++D++S GVI + L +   P+      + +A V
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV 229

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 87/169 (51%), Gaps = 10/169 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K ++HPN++          ++ ++ E ++ G L+  L +   +E L E         + 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQIL 124
Query: 61  KGMNYLHRRNPPIVHRDLKSPN-LLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTP 116
            G+ YLH  +  I H DLK  N +L+D+   K  +K+ DFGL+  K +     K+  GTP
Sbjct: 125 NGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIFGTP 181
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 165
           E++APE++  EP   ++D++S GVI + L +   P+      + +A V 
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 87/168 (51%), Gaps = 10/168 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++++ H N++          ++ ++ E +S G L+  L +   +E L E    +    + 
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQIL 125
Query: 61  KGMNYLHRRNPPIVHRDLKSPN-LLVDKKY---TVKVCDFGLSRLKANTFLSSKSAAGTP 116
            G+NYLH +   I H DLK  N +L+DK      +K+ DFGL+  +    +  K+  GTP
Sbjct: 126 DGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFGTP 182
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           E++APE++  EP   ++D++S GVI + L +   P+      + +A +
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 87/168 (51%), Gaps = 10/168 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++++ H N++          ++ ++ E +S G L+  L +   +E L E    +    + 
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQIL 125
Query: 61  KGMNYLHRRNPPIVHRDLKSPN-LLVDKKY---TVKVCDFGLSRLKANTFLSSKSAAGTP 116
            G+NYLH +   I H DLK  N +L+DK      +K+ DFGL+  +    +  K+  GTP
Sbjct: 126 DGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFGTP 182
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           E++APE++  EP   ++D++S GVI + L +   P+      + +A +
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 87/169 (51%), Gaps = 10/169 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K ++HPN++          ++ ++ E ++ G L+  L +   +E L E         + 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQIL 124
Query: 61  KGMNYLHRRNPPIVHRDLKSPN-LLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTP 116
            G+ YLH  +  I H DLK  N +L+D+   K  +K+ DFGL+  K +     K+  GTP
Sbjct: 125 NGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIFGTP 181
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 165
           E++APE++  EP   ++D++S GVI + L +   P+      + +A V 
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 87/168 (51%), Gaps = 10/168 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++++ H N++          ++ ++ E +S G L+  L +   +E L E    +    + 
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQIL 125
Query: 61  KGMNYLHRRNPPIVHRDLKSPN-LLVDKKY---TVKVCDFGLSRLKANTFLSSKSAAGTP 116
            G+NYLH +   I H DLK  N +L+DK      +K+ DFGL+  +    +  K+  GTP
Sbjct: 126 DGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFGTP 182
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           E++APE++  EP   ++D++S GVI + L +   P+      + +A +
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 87/168 (51%), Gaps = 10/168 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++++ H N++          ++ ++ E +S G L+  L +   +E L E    +    + 
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQIL 125
Query: 61  KGMNYLHRRNPPIVHRDLKSPN-LLVDKKY---TVKVCDFGLSRLKANTFLSSKSAAGTP 116
            G+NYLH +   I H DLK  N +L+DK      +K+ DFGL+  +    +  K+  GTP
Sbjct: 126 DGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFGTP 182
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           E++APE++  EP   ++D++S GVI + L +   P+      + +A +
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 76/145 (52%), Gaps = 10/145 (6%)
Query: 21  NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80
           NL +V EY   G ++  L + G      E      A  +     YLH  +  +++RDLK 
Sbjct: 116 NLYMVMEYAPGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKP 170
Query: 81  PNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFG 139
            NL++D++  +KV DFG + R+K  T+       GTPE++APE++  +  N+  D ++ G
Sbjct: 171 ENLMIDQQGYIKVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYNKAVDWWALG 226
Query: 140 VILWELATLQQPWGNLNPAQVVAAV 164
           V+++E+A    P+    P Q+   +
Sbjct: 227 VLIYEMAAGYPPFFADQPIQIYEKI 251

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 87/169 (51%), Gaps = 10/169 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K ++HPN++          ++ ++ E ++ G L+  L +   +E L E         + 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQIL 124
Query: 61  KGMNYLHRRNPPIVHRDLKSPN-LLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTP 116
            G+ YLH  +  I H DLK  N +L+D+   K  +K+ DFGL+  K +     K+  GTP
Sbjct: 125 NGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIFGTP 181
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 165
           E++APE++  EP   ++D++S GVI + L +   P+      + +A V 
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 76/145 (52%), Gaps = 10/145 (6%)
Query: 21  NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80
           NL +V EY   G ++  L + G      E      A  +     YLH  +  +++RDLK 
Sbjct: 116 NLYMVMEYAPGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKP 170
Query: 81  PNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFG 139
            NL++D++  +KV DFG + R+K  T+       GTPE++APE++  +  N+  D ++ G
Sbjct: 171 ENLMIDQQGYIKVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYNKAVDWWALG 226
Query: 140 VILWELATLQQPWGNLNPAQVVAAV 164
           V+++E+A    P+    P Q+   +
Sbjct: 227 VLIYEMAAGYPPFFADQPIQIYEKI 251

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 81/172 (47%), Gaps = 19/172 (11%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M RL HP  V           L     Y   G L + + K G     DE        ++ 
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIV 142
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--------KANTFLSSKSA 112
             + YLH +   I+HRDLK  N+L+++   +++ DFG +++        +AN F+     
Sbjct: 143 SALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----- 195
Query: 113 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
            GT ++++PE+L ++ + + SD+++ G I+++L     P+   N   + A +
Sbjct: 196 -GTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKI 246

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 83/165 (50%), Gaps = 10/165 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY   G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG---RFSEPHARFYAAQIV 151
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
               YLH  +  +++RDLK  NL++D++  ++V DFG + R+K  T+       GTPE++
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYL 205
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 75/155 (48%), Gaps = 11/155 (7%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           L  P IV   GAV + P ++I  E L  GSL +L+ + G    L E R L       +G+
Sbjct: 107 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC---LPEDRALYYLGQALEGL 163
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYT-VKVCDFGLSRLK-----ANTFLSSKSAAGTPE 117
            YLH R   I+H D+K+ N+L+    +   +CDFG +          + L+     GT  
Sbjct: 164 EYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 221
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
            MAPEV+  +P + K DI+S   ++  +     PW
Sbjct: 222 HMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW 256

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 75/155 (48%), Gaps = 11/155 (7%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           L  P IV   GAV + P ++I  E L  GSL +L+ + G    L E R L       +G+
Sbjct: 123 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC---LPEDRALYYLGQALEGL 179
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYT-VKVCDFGLSRLK-----ANTFLSSKSAAGTPE 117
            YLH R   I+H D+K+ N+L+    +   +CDFG +          + L+     GT  
Sbjct: 180 EYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 237
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
            MAPEV+  +P + K DI+S   ++  +     PW
Sbjct: 238 HMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW 272

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 90/180 (50%), Gaps = 14/180 (7%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K+L HPNI+             +V E  + G L+  +     R+   E     +   V 
Sbjct: 86  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVL 142
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKY---TVKVCDFGLS-RLKANTFLSSKSAAGTP 116
            G+ Y+H+    IVHRDLK  NLL++ K     +++ DFGLS   +A+  +  K   GT 
Sbjct: 143 SGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--IGTA 198
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPR 175
            ++APEVL     +EK D++S GVIL+ L +   P+   N   ++  V  KGK   E+P+
Sbjct: 199 YYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE-KGKYTFELPQ 256

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 75/155 (48%), Gaps = 11/155 (7%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           L  P IV   GAV + P ++I  E L  GSL +L+ + G    L E R L       +G+
Sbjct: 121 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC---LPEDRALYYLGQALEGL 177
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYT-VKVCDFGLSRLK-----ANTFLSSKSAAGTPE 117
            YLH R   I+H D+K+ N+L+    +   +CDFG +          + L+     GT  
Sbjct: 178 EYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 235
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
            MAPEV+  +P + K DI+S   ++  +     PW
Sbjct: 236 HMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW 270

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 81/172 (47%), Gaps = 19/172 (11%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M RL HP  V           L     Y   G L + + K G     DE        ++ 
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIV 142
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--------KANTFLSSKSA 112
             + YLH +   I+HRDLK  N+L+++   +++ DFG +++        +AN F+     
Sbjct: 143 SALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----- 195
Query: 113 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
            GT ++++PE+L ++ + + SD+++ G I+++L     P+   N   + A +
Sbjct: 196 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKI 246

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 76/145 (52%), Gaps = 10/145 (6%)
Query: 21  NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80
           NL +V EY   G ++  L + G      E      A  +     YLH  +  +++RDLK 
Sbjct: 116 NLYMVMEYAPGGEMFSHLRRIG---RFXEPHARFYAAQIVLTFEYLHSLD--LIYRDLKP 170
Query: 81  PNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFG 139
            NL++D++  +KV DFG + R+K  T+       GTPE++APE++  +  N+  D ++ G
Sbjct: 171 ENLMIDQQGYIKVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYNKAVDWWALG 226
Query: 140 VILWELATLQQPWGNLNPAQVVAAV 164
           V+++E+A    P+    P Q+   +
Sbjct: 227 VLIYEMAAGYPPFFADQPIQIYEKI 251

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 79/160 (49%), Gaps = 19/160 (11%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M RL HP  V           L     Y   G L + + K G     DE        ++ 
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIG---SFDETCTRFYTAEIV 142
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--------KANTFLSSKSA 112
             + YLH +   I+HRDLK  N+L+++   +++ DFG +++        +AN+F+     
Sbjct: 143 SALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV----- 195
Query: 113 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
            GT ++++PE+L ++ +++ SD+++ G I+++L     P+
Sbjct: 196 -GTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPF 234

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           L HPNI+           + ++ EY  RG LY+ L K       DE+R   +  ++A  +
Sbjct: 80  LHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCT---FDEQRTATIMEELADAL 136
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 123
            Y H +   ++HRD+K  NLL+  K  +K+ DFG S    +  L  K+  GT +++ PE+
Sbjct: 137 MYCHGKK--VIHRDIKPENLLLGLKGELKIADFGWSVHAPS--LRRKTMCGTLDYLPPEM 192
Query: 124 LRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +     NEK D++  GV+ +EL     P+
Sbjct: 193 IEGRMHNEKVDLWCIGVLCYELLVGNPPF 221

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 90/180 (50%), Gaps = 14/180 (7%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K+L HPNI+             +V E  + G L+  +     R+   E     +   V 
Sbjct: 80  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVL 136
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKY---TVKVCDFGLS-RLKANTFLSSKSAAGTP 116
            G+ Y+H+    IVHRDLK  NLL++ K     +++ DFGLS   +A+  +  K   GT 
Sbjct: 137 SGITYMHKN--KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--IGTA 192
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPR 175
            ++APEVL     +EK D++S GVIL+ L +   P+   N   ++  V  KGK   E+P+
Sbjct: 193 YYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE-KGKYTFELPQ 250

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 90/180 (50%), Gaps = 14/180 (7%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K+L HPNI+             +V E  + G L+  +     R+   E     +   V 
Sbjct: 103 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVL 159
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKY---TVKVCDFGLS-RLKANTFLSSKSAAGTP 116
            G+ Y+H+    IVHRDLK  NLL++ K     +++ DFGLS   +A+  +  K   GT 
Sbjct: 160 SGITYMHKN--KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--IGTA 215
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPR 175
            ++APEVL     +EK D++S GVIL+ L +   P+   N   ++  V  KGK   E+P+
Sbjct: 216 YYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE-KGKYTFELPQ 273

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 90/180 (50%), Gaps = 14/180 (7%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K+L HPNI+             +V E  + G L+  +     R+   E     +   V 
Sbjct: 104 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVL 160
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKY---TVKVCDFGLS-RLKANTFLSSKSAAGTP 116
            G+ Y+H+    IVHRDLK  NLL++ K     +++ DFGLS   +A+  +  K   GT 
Sbjct: 161 SGITYMHKN--KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--IGTA 216
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPR 175
            ++APEVL     +EK D++S GVIL+ L +   P+   N   ++  V  KGK   E+P+
Sbjct: 217 YYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE-KGKYTFELPQ 274

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 75/146 (51%), Gaps = 5/146 (3%)
Query: 9   IVLFMGAVTQPPNLSIVTEYLSRGSL-YRLLHKPGVREMLDERRRLNMAYDVAKGMNYLH 67
           IV    A     +L +V   ++ G + Y + +         E R +     +  G+ +LH
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 68  RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLRD 126
           +RN  I++RDLK  N+L+D    V++ D GL+  LKA     +K  AGTP +MAPE+L  
Sbjct: 307 QRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ-TKTKGYAGTPGFMAPELLLG 363
Query: 127 EPSNEKSDIYSFGVILWELATLQQPW 152
           E  +   D ++ GV L+E+   + P+
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 75/146 (51%), Gaps = 5/146 (3%)
Query: 9   IVLFMGAVTQPPNLSIVTEYLSRGSL-YRLLHKPGVREMLDERRRLNMAYDVAKGMNYLH 67
           IV    A     +L +V   ++ G + Y + +         E R +     +  G+ +LH
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 68  RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLRD 126
           +RN  I++RDLK  N+L+D    V++ D GL+  LKA     +K  AGTP +MAPE+L  
Sbjct: 307 QRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ-TKTKGYAGTPGFMAPELLLG 363
Query: 127 EPSNEKSDIYSFGVILWELATLQQPW 152
           E  +   D ++ GV L+E+   + P+
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 75/146 (51%), Gaps = 5/146 (3%)
Query: 9   IVLFMGAVTQPPNLSIVTEYLSRGSL-YRLLHKPGVREMLDERRRLNMAYDVAKGMNYLH 67
           IV    A     +L +V   ++ G + Y + +         E R +     +  G+ +LH
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 68  RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLRD 126
           +RN  I++RDLK  N+L+D    V++ D GL+  LKA     +K  AGTP +MAPE+L  
Sbjct: 307 QRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ-TKTKGYAGTPGFMAPELLLG 363
Query: 127 EPSNEKSDIYSFGVILWELATLQQPW 152
           E  +   D ++ GV L+E+   + P+
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 75/146 (51%), Gaps = 5/146 (3%)
Query: 9   IVLFMGAVTQPPNLSIVTEYLSRGSL-YRLLHKPGVREMLDERRRLNMAYDVAKGMNYLH 67
           IV    A     +L +V   ++ G + Y + +         E R +     +  G+ +LH
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 68  RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLRD 126
           +RN  I++RDLK  N+L+D    V++ D GL+  LKA     +K  AGTP +MAPE+L  
Sbjct: 307 QRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ-TKTKGYAGTPGFMAPELLLG 363
Query: 127 EPSNEKSDIYSFGVILWELATLQQPW 152
           E  +   D ++ GV L+E+   + P+
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 78/160 (48%), Gaps = 19/160 (11%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M RL HP  V           L     Y   G L + + K G     DE        ++ 
Sbjct: 87  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIV 143
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--------KANTFLSSKSA 112
             + YLH +   I+HRDLK  N+L+++   +++ DFG +++        +AN+F+     
Sbjct: 144 SALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV----- 196
Query: 113 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
            GT ++++PE+L ++ + + SD+++ G I+++L     P+
Sbjct: 197 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 78/160 (48%), Gaps = 19/160 (11%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M RL HP  V           L     Y   G L + + K G     DE        ++ 
Sbjct: 83  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIV 139
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--------KANTFLSSKSA 112
             + YLH +   I+HRDLK  N+L+++   +++ DFG +++        +AN+F+     
Sbjct: 140 SALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV----- 192
Query: 113 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
            GT ++++PE+L ++ + + SD+++ G I+++L     P+
Sbjct: 193 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 77/160 (48%), Gaps = 19/160 (11%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M RL HP  V           L     Y   G L + + K G     DE        ++ 
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIV 140
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--------KANTFLSSKSA 112
             + YLH +   I+HRDLK  N+L+++   +++ DFG +++        +AN F+     
Sbjct: 141 SALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFV----- 193
Query: 113 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
            GT ++++PE+L ++ + + SD+++ G I+++L     P+
Sbjct: 194 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 76/145 (52%), Gaps = 8/145 (5%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           L+HPNIV    ++++     +V + ++ G L+  +     RE   E    +    + + +
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDI---VAREYYSEADASHCIQQILESV 116
Query: 64  NYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           N+ H     IVHRDLK  NLL+    K   VK+ DFGL+        +    AGTP +++
Sbjct: 117 NHCHLNG--IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLS 174
Query: 121 PEVLRDEPSNEKSDIYSFGVILWEL 145
           PEVLR +P  +  D+++ GVIL+ L
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYIL 199

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 77/160 (48%), Gaps = 19/160 (11%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M RL HP  V           L     Y   G L + + K G     DE        ++ 
Sbjct: 91  MSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIV 147
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--------KANTFLSSKSA 112
             + YLH +   I+HRDLK  N+L+++   +++ DFG +++        +AN F+     
Sbjct: 148 SALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----- 200
Query: 113 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
            GT ++++PE+L ++ + + SD+++ G I+++L     P+
Sbjct: 201 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 239

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 75/156 (48%), Gaps = 19/156 (12%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           L   N V    AV +   L I  EY    +LY L+H   + +  DE  RL     + + +
Sbjct: 72  LERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRL--FRQILEAL 129
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS----------RLKANTFLSSK--- 110
           +Y+H +   I+HR+LK  N+ +D+   VK+ DFGL+          +L +     S    
Sbjct: 130 SYIHSQG--IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 111 -SAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWE 144
            SA GT  ++A EVL      NEK D YS G+I +E
Sbjct: 188 TSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 77/160 (48%), Gaps = 19/160 (11%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M RL HP  V           L     Y   G L + + K G     DE        ++ 
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIV 142
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--------KANTFLSSKSA 112
             + YLH +   I+HRDLK  N+L+++   +++ DFG +++        +AN F+     
Sbjct: 143 SALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----- 195
Query: 113 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
            GT ++++PE+L ++ + + SD+++ G I+++L     P+
Sbjct: 196 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 77/160 (48%), Gaps = 19/160 (11%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M RL HP  V           L     Y   G L + + K G     DE        ++ 
Sbjct: 89  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIV 145
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--------KANTFLSSKSA 112
             + YLH +   I+HRDLK  N+L+++   +++ DFG +++        +AN F+     
Sbjct: 146 SALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----- 198
Query: 113 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
            GT ++++PE+L ++ + + SD+++ G I+++L     P+
Sbjct: 199 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 237

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 77/160 (48%), Gaps = 19/160 (11%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M RL HP  V           L     Y   G L + + K G     DE        ++ 
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIV 142
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--------KANTFLSSKSA 112
             + YLH +   I+HRDLK  N+L+++   +++ DFG +++        +AN F+     
Sbjct: 143 SALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----- 195
Query: 113 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
            GT ++++PE+L ++ + + SD+++ G I+++L     P+
Sbjct: 196 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 77/160 (48%), Gaps = 19/160 (11%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M RL HP  V           L     Y   G L + + K G     DE        ++ 
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIV 140
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--------KANTFLSSKSA 112
             + YLH +   I+HRDLK  N+L+++   +++ DFG +++        +AN F+     
Sbjct: 141 SALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----- 193
Query: 113 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
            GT ++++PE+L ++ + + SD+++ G I+++L     P+
Sbjct: 194 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 76/145 (52%), Gaps = 8/145 (5%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           L+HPNIV    ++++     +V + ++ G L+  +     RE   E    +    + + +
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDI---VAREYYSEADASHCIQQILESV 116
Query: 64  NYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           N+ H     IVHRDLK  NLL+    K   VK+ DFGL+        +    AGTP +++
Sbjct: 117 NHCHLNG--IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLS 174
Query: 121 PEVLRDEPSNEKSDIYSFGVILWEL 145
           PEVLR +P  +  D+++ GVIL+ L
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYIL 199

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 77/160 (48%), Gaps = 19/160 (11%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M RL HP  V           L     Y   G L + + K G     DE        ++ 
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIV 142
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--------KANTFLSSKSA 112
             + YLH +   I+HRDLK  N+L+++   +++ DFG +++        +AN F+     
Sbjct: 143 SALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----- 195
Query: 113 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
            GT ++++PE+L ++ + + SD+++ G I+++L     P+
Sbjct: 196 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 77/160 (48%), Gaps = 19/160 (11%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M RL HP  V           L     Y   G L + + K G     DE        ++ 
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIV 140
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--------KANTFLSSKSA 112
             + YLH +   I+HRDLK  N+L+++   +++ DFG +++        +AN F+     
Sbjct: 141 SALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----- 193
Query: 113 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
            GT ++++PE+L ++ + + SD+++ G I+++L     P+
Sbjct: 194 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 77/160 (48%), Gaps = 19/160 (11%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M RL HP  V           L     Y   G L + + K G     DE        ++ 
Sbjct: 87  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIV 143
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--------KANTFLSSKSA 112
             + YLH +   I+HRDLK  N+L+++   +++ DFG +++        +AN F+     
Sbjct: 144 SALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----- 196
Query: 113 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
            GT ++++PE+L ++ + + SD+++ G I+++L     P+
Sbjct: 197 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 77/160 (48%), Gaps = 19/160 (11%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M RL HP  V           L     Y   G L + + K G     DE        ++ 
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIV 140
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--------KANTFLSSKSA 112
             + YLH +   I+HRDLK  N+L+++   +++ DFG +++        +AN F+     
Sbjct: 141 SALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----- 193
Query: 113 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
            GT ++++PE+L ++ + + SD+++ G I+++L     P+
Sbjct: 194 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 87/180 (48%), Gaps = 14/180 (7%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K+L HPNI              +V E  + G L+  +     R+   E     +   V 
Sbjct: 80  LKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVL 136
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKY---TVKVCDFGLS-RLKANTFLSSKSAAGTP 116
            G+ Y H+    IVHRDLK  NLL++ K     +++ DFGLS   +A+     K   GT 
Sbjct: 137 SGITYXHKN--KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KXKDKIGTA 192
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPR 175
            ++APEVL     +EK D++S GVIL+ L +   P+   N   ++  V  KGK   E+P+
Sbjct: 193 YYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE-KGKYTFELPQ 250

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 77/160 (48%), Gaps = 19/160 (11%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M RL HP  V           L     Y   G L + + K G     DE        ++ 
Sbjct: 83  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIV 139
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--------KANTFLSSKSA 112
             + YLH +   I+HRDLK  N+L+++   +++ DFG +++        +AN F+     
Sbjct: 140 SALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----- 192
Query: 113 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
            GT ++++PE+L ++ + + SD+++ G I+++L     P+
Sbjct: 193 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 86/169 (50%), Gaps = 10/169 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K ++HPN++          ++ ++ E ++ G L+  L +   +E L E         + 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQIL 124
Query: 61  KGMNYLHRRNPPIVHRDLKSPN-LLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTP 116
            G+ YLH  +  I H DLK  N +L+D+   K  +K+ DFGL+  K +     K+  GTP
Sbjct: 125 NGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIFGTP 181
Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 165
            ++APE++  EP   ++D++S GVI + L +   P+      + +A V 
Sbjct: 182 AFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 77/160 (48%), Gaps = 19/160 (11%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M RL HP  V           L     Y   G L + + K G     DE        ++ 
Sbjct: 68  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIV 124
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--------KANTFLSSKSA 112
             + YLH +   I+HRDLK  N+L+++   +++ DFG +++        +AN F+     
Sbjct: 125 SALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----- 177
Query: 113 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
            GT ++++PE+L ++ + + SD+++ G I+++L     P+
Sbjct: 178 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 216

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 77/160 (48%), Gaps = 19/160 (11%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M RL HP  V           L     Y   G L + + K G     DE        ++ 
Sbjct: 62  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIV 118
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--------KANTFLSSKSA 112
             + YLH +   I+HRDLK  N+L+++   +++ DFG +++        +AN F+     
Sbjct: 119 SALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----- 171
Query: 113 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
            GT ++++PE+L ++ + + SD+++ G I+++L     P+
Sbjct: 172 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 210

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 77/160 (48%), Gaps = 19/160 (11%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M RL HP  V           L     Y   G L + + K G     DE        ++ 
Sbjct: 61  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIV 117
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--------KANTFLSSKSA 112
             + YLH +   I+HRDLK  N+L+++   +++ DFG +++        +AN F+     
Sbjct: 118 SALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----- 170
Query: 113 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
            GT ++++PE+L ++ + + SD+++ G I+++L     P+
Sbjct: 171 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 209

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 77/160 (48%), Gaps = 19/160 (11%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M RL HP  V           L     Y   G L + + K G     DE        ++ 
Sbjct: 63  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIV 119
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--------KANTFLSSKSA 112
             + YLH +   I+HRDLK  N+L+++   +++ DFG +++        +AN F+     
Sbjct: 120 SALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----- 172
Query: 113 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
            GT ++++PE+L ++ + + SD+++ G I+++L     P+
Sbjct: 173 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 211

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 77/160 (48%), Gaps = 19/160 (11%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M RL HP  V           L     Y   G L + + K G     DE        ++ 
Sbjct: 64  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIV 120
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--------KANTFLSSKSA 112
             + YLH +   I+HRDLK  N+L+++   +++ DFG +++        +AN F+     
Sbjct: 121 SALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----- 173
Query: 113 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
            GT ++++PE+L ++ + + SD+++ G I+++L     P+
Sbjct: 174 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 212

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 74/145 (51%), Gaps = 14/145 (9%)
Query: 42  GVREMLD--ERRRL--NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL--VDKKYTVKVCD 95
           G RE LD  +R +L  N+   +   ++YLH  N  I HRD+K  N L   +K + +K+ D
Sbjct: 156 GFRESLDFVQREKLISNIMRQIFSALHYLH--NQGICHRDIKPENFLFSTNKSFEIKLVD 213
Query: 96  FGLSR----LKANTFLSSKSAAGTPEWMAPEVLR--DEPSNEKSDIYSFGVILWELATLQ 149
           FGLS+    L    +    + AGTP ++APEVL   +E    K D +S GV+L  L    
Sbjct: 214 FGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
Query: 150 QPWGNLNPAQVVAAVGFKGKRLEIP 174
            P+  +N A  ++ V  K    E P
Sbjct: 274 VPFPGVNDADTISQVLNKKLCFENP 298

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 6/153 (3%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL-YRLLHKPGVREMLDERRRLNMAYDVAKG 62
           L+HP+IV  +   +    L +V E++    L + ++ +     +  E    +    + + 
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYT---VKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
           + Y H  N  I+HRD+K  N+L+  K     VK+ DFG++     + L +    GTP +M
Sbjct: 143 LRYCHDNN--IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFM 200
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
           APEV++ EP  +  D++  GVIL+ L +   P+
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 84/172 (48%), Gaps = 10/172 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
           +K L HPNI+          N+ IV E    G L  R++      + L E     +   +
Sbjct: 74  LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM 133
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSRL-KANTFLSSKSAAGT 115
              + Y H ++  +VH+DLK  N+L         +K+ DFGL+ L K++    S +AAGT
Sbjct: 134 MNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAAGT 189
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK 167
             +MAPEV + + +  K DI+S GV+++ L T   P+   +  +V     +K
Sbjct: 190 ALYMAPEVFKRDVTF-KCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK 240

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 84/163 (51%), Gaps = 13/163 (7%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYL--SRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           M+ +  P  V F GA+ +  ++ I  E +  S    Y+ +   G  + + E     +A  
Sbjct: 104 MRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKG--QTIPEDILGKIAVS 161
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
           + K + +LH +   ++HRD+K  N+L++    VK+CDFG+S    ++   +  A   P +
Sbjct: 162 IVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKP-Y 219
Query: 119 MAPEVLRDEPSNE----KSDIYSFGVILWELATLQQP---WGN 154
           MAPE +  E + +    KSDI+S G+ + ELA L+ P   WG 
Sbjct: 220 MAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT 262

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 80/171 (46%), Gaps = 35/171 (20%)
Query: 4   LRHPNIVLFMGA---VTQPPNLS--IVTEYLSRGSL--YRLLHKPGVREMLDERRRLNMA 56
           + H NI  F+     VT    +   +V EY   GSL  Y  LH        D      +A
Sbjct: 64  MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS------DWVSSCRLA 117
Query: 57  YDVAKGMNYLHRR-------NPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFL- 107
           + V +G+ YLH          P I HRDL S N+LV    T  + DFGLS RL  N  + 
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 108 ------SSKSAAGTPEWMAPEV------LRD-EPSNEKSDIYSFGVILWEL 145
                 ++ S  GT  +MAPEV      LRD E + ++ D+Y+ G+I WE+
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 77/145 (53%), Gaps = 8/145 (5%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           L+HPNIV    ++++  +  ++ + ++ G L+  +     RE   E    +    + + +
Sbjct: 78  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI---VAREYYSEADASHCIQQILEAV 134
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKY---TVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            + H+    +VHRDLK  NLL+  K     VK+ DFGL+        +    AGTP +++
Sbjct: 135 LHCHQMG--VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLS 192
Query: 121 PEVLRDEPSNEKSDIYSFGVILWEL 145
           PEVLR +P  +  D+++ GVIL+ L
Sbjct: 193 PEVLRKDPYGKPVDLWACGVILYIL 217

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 79/166 (47%), Gaps = 7/166 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  LRHP +V    A      + ++ E++S G L+  +        + E   +     V 
Sbjct: 208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVC 265
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYT--VKVCDFGLSRLKANTFLSSKSAAGTPEW 118
           KG+ ++H  N   VH DLK  N++   K +  +K+ DFGL+    +   S K   GT E+
Sbjct: 266 KGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLT-AHLDPKQSVKVTTGTAEF 322
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
            APEV   +P    +D++S GV+ + L +   P+G  N  + +  V
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV 368

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 79/166 (47%), Gaps = 7/166 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  LRHP +V    A      + ++ E++S G L+  +        + E   +     V 
Sbjct: 102 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV--ADEHNKMSEDEAVEYMRQVC 159
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYT--VKVCDFGLSRLKANTFLSSKSAAGTPEW 118
           KG+ ++H  N   VH DLK  N++   K +  +K+ DFGL+    +   S K   GT E+
Sbjct: 160 KGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLT-AHLDPKQSVKVTTGTAEF 216
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
            APEV   +P    +D++S GV+ + L +   P+G  N  + +  V
Sbjct: 217 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV 262

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 84/163 (51%), Gaps = 13/163 (7%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYL--SRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           M+ +  P  V F GA+ +  ++ I  E +  S    Y+ +   G  + + E     +A  
Sbjct: 60  MRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKG--QTIPEDILGKIAVS 117
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
           + K + +LH +   ++HRD+K  N+L++    VK+CDFG+S    +  ++    AG   +
Sbjct: 118 IVKALEHLHSK-LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD-VAKDIDAGCKPY 175
Query: 119 MAPEVLRDEPSNE----KSDIYSFGVILWELATLQQP---WGN 154
           MAPE +  E + +    KSDI+S G+ + ELA L+ P   WG 
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT 218

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 85/190 (44%), Gaps = 12/190 (6%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           L  P IV   GAV + P ++I  E L  GSL +L+ + G    L E R L       +G+
Sbjct: 142 LTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGC---LPEDRALYYLGQALEGL 198
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYT-VKVCDFGLSRL-----KANTFLSSKSAAGTPE 117
            YLH R   I+H D+K+ N+L+    +   +CDFG +          + L+     GT  
Sbjct: 199 EYLHSRR--ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTET 256
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL-EIPRN 176
            MAPEV+     + K D++S   ++  +     PW       +   +  +   + EIP +
Sbjct: 257 HMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPS 316
Query: 177 VNPHVASIIE 186
             P  A  I+
Sbjct: 317 CAPLTAQAIQ 326

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 75/149 (50%), Gaps = 8/149 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRL-LHKPGVREMLDERRRLNMAYDV 59
           +K+L+HPN+V  +    +   L +V EY     L+ L  ++ GV E L +    ++ +  
Sbjct: 56  LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVK----SITWQT 111
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
            + +N+ H+ N   +HRD+K  N+L+ K   +K+CDFG +RL             T  + 
Sbjct: 112 LQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR 169
Query: 120 APEVL-RDEPSNEKSDIYSFGVILWELAT 147
           +PE+L  D       D+++ G +  EL +
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLS 198

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 84/190 (44%), Gaps = 12/190 (6%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           L  P IV   GAV + P ++I  E L  GSL +L+ + G    L E R L       +G+
Sbjct: 123 LTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGC---LPEDRALYYLGQALEGL 179
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYT-VKVCDFGLSRL-----KANTFLSSKSAAGTPE 117
            YLH R   I+H D+K+ N+L+    +   +CDFG +            L+     GT  
Sbjct: 180 EYLHSRR--ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTET 237
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL-EIPRN 176
            MAPEV+     + K D++S   ++  +     PW       +   +  +   + EIP +
Sbjct: 238 HMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPS 297
Query: 177 VNPHVASIIE 186
             P  A  I+
Sbjct: 298 CAPLTAQAIQ 307

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 83/162 (51%), Gaps = 20/162 (12%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
           H N++  +    +     +V E +  GS+   +HK   R   +E     +  DVA  +++
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDF 126
Query: 66  LHRRNPPIVHRDLKSPNLLVD---KKYTVKVCDFGL-SRLKANTFLSSKSA------AGT 115
           LH  N  I HRDLK  N+L +   +   VK+CDFGL S +K N   S  S        G+
Sbjct: 127 LH--NKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 116 PEWMAPEVLR---DEPS--NEKSDIYSFGVILWELATLQQPW 152
            E+MAPEV+    +E S  +++ D++S GVIL+ L +   P+
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 80/164 (48%), Gaps = 24/164 (14%)
Query: 4   LRHPNIVLFMGAVTQPPNLSI----VTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           ++H N++ F+ A  +  NL +    +T +  +GSL   L       ++      ++A  +
Sbjct: 66  MKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLKG----NIITWNELCHVAETM 121
Query: 60  AKGMNYLHR---------RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLK-ANTFLS 108
           ++G++YLH            P I HRD KS N+L+    T  + DFGL+ R +       
Sbjct: 122 SRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGD 181
Query: 109 SKSAAGTPEWMAPEVLRDEPSNEKS-----DIYSFGVILWELAT 147
           +    GT  +MAPEVL    + ++      D+Y+ G++LWEL +
Sbjct: 182 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 81/166 (48%), Gaps = 7/166 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +L HP ++    A      + ++ E+LS G L+  +     +  + E   +N      
Sbjct: 102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQAC 159
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKK--YTVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
           +G+ ++H  +  IVH D+K  N++ + K   +VK+ DFGL+  K N     K    T E+
Sbjct: 160 EGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLA-TKLNPDEIVKVTTATAEF 216
Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
            APE++  EP    +D+++ GV+ + L +   P+   +  + +  V
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV 262

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 77/145 (53%), Gaps = 8/145 (5%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           L+HPNIV    ++++  +  ++ + ++ G L+  +     RE   E    +    + + +
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI---VAREYYSEADASHCIQQILEAV 123
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKY---TVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            + H+    +VHR+LK  NLL+  K     VK+ DFGL+        +    AGTP +++
Sbjct: 124 LHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLS 181
Query: 121 PEVLRDEPSNEKSDIYSFGVILWEL 145
           PEVLR +P  +  D+++ GVIL+ L
Sbjct: 182 PEVLRKDPYGKPVDLWACGVILYIL 206

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
           R RH NI+     +  P    +   Y+ +  +   L+K    + L         Y + +G
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 136
Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-----KANTFLSSKSAAGTPE 117
           + Y+H  N  ++HRDLK  NLL++    +K+CDFGL+R+         FL+   A  T  
Sbjct: 137 LKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA--TRW 192
Query: 118 WMAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
           + APE++ +     KS DI+S G IL E+ +
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 79/156 (50%), Gaps = 20/156 (12%)
Query: 3   RLRHPNIV-----LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAY 57
           R RH NI+     +    + Q  ++ +VT +L    LY+LL      + L         Y
Sbjct: 97  RFRHENIIGINDIIRAPTIEQMKDVYLVT-HLMGADLYKLLKT----QHLSNDHICYFLY 151
Query: 58  DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-----KANTFLSSKSA 112
            + +G+ Y+H  N  ++HRDLK  NLL++    +K+CDFGL+R+         FL+   A
Sbjct: 152 QILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 113 AGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
             T  + APE++ +     KS DI+S G IL E+ +
Sbjct: 210 --TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 93/192 (48%), Gaps = 27/192 (14%)
Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P IV    A   P  LS + + ++ G L+  L + GV    D R     A ++  G+ ++
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR---FYAAEIILGLEHM 308
Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK--SAAGTPEWMAPEVL 124
           H R   +V+RDLK  N+L+D+   V++ D GL    A  F   K  ++ GT  +MAPEVL
Sbjct: 309 HNRF--VVYRDLKPANILLDEHGHVRISDLGL----ACDFSKKKPHASVGTHGYMAPEVL 362
Query: 125 RDEPSNEKS-DIYSFGVILWELATLQQPW--------GNLNPAQVVAAVGFKGKRLEIPR 175
           +   + + S D +S G +L++L     P+          ++   +  AV       E+P 
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-------ELPD 415
Query: 176 NVNPHVASIIEA 187
           + +P + S++E 
Sbjct: 416 SFSPELRSLLEG 427

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 93/192 (48%), Gaps = 27/192 (14%)
Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P IV    A   P  LS + + ++ G L+  L + GV    D R     A ++  G+ ++
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR---FYAAEIILGLEHM 308
Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK--SAAGTPEWMAPEVL 124
           H R   +V+RDLK  N+L+D+   V++ D GL    A  F   K  ++ GT  +MAPEVL
Sbjct: 309 HNRF--VVYRDLKPANILLDEHGHVRISDLGL----ACDFSKKKPHASVGTHGYMAPEVL 362
Query: 125 RDEPSNEKS-DIYSFGVILWELATLQQPW--------GNLNPAQVVAAVGFKGKRLEIPR 175
           +   + + S D +S G +L++L     P+          ++   +  AV       E+P 
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-------ELPD 415
Query: 176 NVNPHVASIIEA 187
           + +P + S++E 
Sbjct: 416 SFSPELRSLLEG 427

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
           R RH NI+     +  P    +   Y+ +  +   L+K    + L         Y + +G
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 140
Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-----KANTFLSSKSAAGTPE 117
           + Y+H  N  ++HRDLK  NLL++    +K+CDFGL+R+         FL+   A  T  
Sbjct: 141 LKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA--TRW 196
Query: 118 WMAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
           + APE++ +     KS DI+S G IL E+ +
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
           R RH NI+     +  P    +   Y+ +  +   L+K    + L         Y + +G
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 136
Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-----KANTFLSSKSAAGTPE 117
           + Y+H  N  ++HRDLK  NLL++    +K+CDFGL+R+         FL+   A  T  
Sbjct: 137 LKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA--TRW 192
Query: 118 WMAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
           + APE++ +     KS DI+S G IL E+ +
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 75/155 (48%), Gaps = 18/155 (11%)
Query: 3   RLRHPNIV----LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           R RH N++    +   +  +      + + L    LY+LL      + L         Y 
Sbjct: 97  RFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKS----QQLSNDHICYFLYQ 152
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-----KANTFLSSKSAA 113
           + +G+ Y+H  N  ++HRDLK  NLL++    +K+CDFGL+R+         FL+   A 
Sbjct: 153 ILRGLKYIHSAN--VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVA- 209
Query: 114 GTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
            T  + APE++ +     KS DI+S G IL E+ +
Sbjct: 210 -TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
           R RH NI+     +  P    +   Y+ +  +   L+K    + L         Y + +G
Sbjct: 75  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 134
Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-----KANTFLSSKSAAGTPE 117
           + Y+H  N  ++HRDLK  NLL++    +K+CDFGL+R+         FL+   A  T  
Sbjct: 135 LKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--TRW 190
Query: 118 WMAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
           + APE++ +     KS DI+S G IL E+ +
Sbjct: 191 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 221

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
           R RH NI+     +  P    +   Y+ +  +   L+K    + L         Y + +G
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 140
Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-----KANTFLSSKSAAGTPE 117
           + Y+H  N  ++HRDLK  NLL++    +K+CDFGL+R+         FL+   A  T  
Sbjct: 141 LKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA--TRW 196
Query: 118 WMAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
           + APE++ +     KS DI+S G IL E+ +
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
           R RH NI+     +  P    +   Y+ +  +   L+K    + L         Y + +G
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 136
Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-----KANTFLSSKSAAGTPE 117
           + Y+H  N  ++HRDLK  NLL++    +K+CDFGL+R+         FL+   A  T  
Sbjct: 137 LKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--TRW 192
Query: 118 WMAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
           + APE++ +     KS DI+S G IL E+ +
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
           R RH NI+     +  P    +   Y+ +  +   L+K    + L         Y + +G
Sbjct: 82  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 141
Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-----KANTFLSSKSAAGTPE 117
           + Y+H  N  ++HRDLK  NLL++    +K+CDFGL+R+         FL+   A  T  
Sbjct: 142 LKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--TRW 197
Query: 118 WMAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
           + APE++ +     KS DI+S G IL E+ +
Sbjct: 198 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 228

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
           R RH NI+     +  P    +   Y+ +  +   L+K    + L         Y + +G
Sbjct: 83  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 142
Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-----KANTFLSSKSAAGTPE 117
           + Y+H  N  ++HRDLK  NLL++    +K+CDFGL+R+         FL+   A  T  
Sbjct: 143 LKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--TRW 198
Query: 118 WMAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
           + APE++ +     KS DI+S G IL E+ +
Sbjct: 199 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 229

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
           R RH NI+     +  P    +   Y+ +  +   L+K    + L         Y + +G
Sbjct: 74  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 133
Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-----KANTFLSSKSAAGTPE 117
           + Y+H  N  ++HRDLK  NLL++    +K+CDFGL+R+         FL+   A  T  
Sbjct: 134 LKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--TRW 189
Query: 118 WMAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
           + APE++ +     KS DI+S G IL E+ +
Sbjct: 190 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 220

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
           R RH NI+     +  P    +   Y+ +  +   L+K    + L         Y + +G
Sbjct: 97  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 156
Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-----KANTFLSSKSAAGTPE 117
           + Y+H  N  ++HRDLK  NLL++    +K+CDFGL+R+         FL+   A  T  
Sbjct: 157 LKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--TRW 212
Query: 118 WMAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
           + APE++ +     KS DI+S G IL E+ +
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
           R RH NI+     +  P    +   Y+ +  +   L+K    + L         Y + +G
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 140
Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-----KANTFLSSKSAAGTPE 117
           + Y+H  N  ++HRDLK  NLL++    +K+CDFGL+R+         FL+   A  T  
Sbjct: 141 LKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--TRW 196
Query: 118 WMAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
           + APE++ +     KS DI+S G IL E+ +
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
           R RH NI+     +  P    +   Y+ +  +   L+K    + L         Y + +G
Sbjct: 79  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 138
Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-----KANTFLSSKSAAGTPE 117
           + Y+H  N  ++HRDLK  NLL++    +K+CDFGL+R+         FL+   A  T  
Sbjct: 139 LKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--TRW 194
Query: 118 WMAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
           + APE++ +     KS DI+S G IL E+ +
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 225

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
           R RH NI+     +  P    +   Y+ +  +   L+K    + L         Y + +G
Sbjct: 75  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 134
Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-----KANTFLSSKSAAGTPE 117
           + Y+H  N  ++HRDLK  NLL++    +K+CDFGL+R+         FL+   A  T  
Sbjct: 135 LKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--TRW 190
Query: 118 WMAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
           + APE++ +     KS DI+S G IL E+ +
Sbjct: 191 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 221

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 76/149 (51%), Gaps = 8/149 (5%)
Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P +V    A      L ++ +Y++ G L+  L +   RE   E        ++   + +L
Sbjct: 119 PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHL 175
Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEWMAPEVLR 125
           H+    I++RD+K  N+L+D    V + DFGLS+   A+    +    GT E+MAP+++R
Sbjct: 176 HKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 233
Query: 126 --DEPSNEKSDIYSFGVILWELATLQQPW 152
             D   ++  D +S GV+++EL T   P+
Sbjct: 234 GGDSGHDKAVDWWSLGVLMYELLTGASPF 262

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
           R RH NI+     +  P    +   Y+ +  +   L+K    + L         Y + +G
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 140
Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-----KANTFLSSKSAAGTPE 117
           + Y+H  N  ++HRDLK  NLL++    +K+CDFGL+R+         FL+   A  T  
Sbjct: 141 LKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--TRW 196
Query: 118 WMAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
           + APE++ +     KS DI+S G IL E+ +
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 93/192 (48%), Gaps = 27/192 (14%)
Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P IV    A   P  LS + + ++ G L+  L + GV    D R     A ++  G+ ++
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR---FYAAEIILGLEHM 308
Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK--SAAGTPEWMAPEVL 124
           H R   +V+RDLK  N+L+D+   V++ D GL    A  F   K  ++ GT  +MAPEVL
Sbjct: 309 HNRF--VVYRDLKPANILLDEHGHVRISDLGL----ACDFSKKKPHASVGTHGYMAPEVL 362
Query: 125 RDEPSNEKS-DIYSFGVILWELATLQQPW--------GNLNPAQVVAAVGFKGKRLEIPR 175
           +   + + S D +S G +L++L     P+          ++   +  AV       E+P 
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-------ELPD 415
Query: 176 NVNPHVASIIEA 187
           + +P + S++E 
Sbjct: 416 SFSPELRSLLEG 427

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 93/192 (48%), Gaps = 27/192 (14%)
Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P IV    A   P  LS + + ++ G L+  L + GV    D R     A ++  G+ ++
Sbjct: 251 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR---FYAAEIILGLEHM 307
Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK--SAAGTPEWMAPEVL 124
           H R   +V+RDLK  N+L+D+   V++ D GL    A  F   K  ++ GT  +MAPEVL
Sbjct: 308 HNRF--VVYRDLKPANILLDEHGHVRISDLGL----ACDFSKKKPHASVGTHGYMAPEVL 361
Query: 125 RDEPSNEKS-DIYSFGVILWELATLQQPW--------GNLNPAQVVAAVGFKGKRLEIPR 175
           +   + + S D +S G +L++L     P+          ++   +  AV       E+P 
Sbjct: 362 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-------ELPD 414
Query: 176 NVNPHVASIIEA 187
           + +P + S++E 
Sbjct: 415 SFSPELRSLLEG 426

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 70/145 (48%), Gaps = 3/145 (2%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK + H NI+  +   T   +L    +      L        ++  LD  R   + Y + 
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ +LH  +  I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     T  + A
Sbjct: 137 VGIKHLH--SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV-TRYYRA 193
Query: 121 PEVLRDEPSNEKSDIYSFGVILWEL 145
           PEV+      E  DI+S GVI+ E+
Sbjct: 194 PEVILGMGYKENVDIWSVGVIMGEM 218

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 70/145 (48%), Gaps = 3/145 (2%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK + H NI+  +   T   +L    +      L        ++  LD  R   + Y + 
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ +LH  +  I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     T  + A
Sbjct: 137 VGIKHLH--SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV-TRYYRA 193
Query: 121 PEVLRDEPSNEKSDIYSFGVILWEL 145
           PEV+      E  DI+S GVI+ E+
Sbjct: 194 PEVILGMGYKENVDIWSVGVIMGEM 218

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
           R RH NI+     +  P    +   Y+ +  +   L+K    + L         Y + +G
Sbjct: 85  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 144
Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-----KANTFLSSKSAAGTPE 117
           + Y+H  N  ++HRDLK  NLL++    +K+CDFGL+R+         FL+   A  T  
Sbjct: 145 LKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--TRW 200
Query: 118 WMAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
           + APE++ +     KS DI+S G IL E+ +
Sbjct: 201 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 231

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
           R RH NI+     +  P    +   Y+ +  +   L+K    + L         Y + +G
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 136
Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-----KANTFLSSKSAAGTPE 117
           + Y+H  N  ++HRDLK  NLL++    +K+CDFGL+R+         FL+   A  T  
Sbjct: 137 LKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--TRW 192
Query: 118 WMAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
           + APE++ +     KS DI+S G IL E+ +
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 3/146 (2%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK + H NI+  +   T    L    +      L        ++  LD  R   + Y + 
Sbjct: 77  MKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQML 136
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ +LH  +  I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     T  + A
Sbjct: 137 XGIKHLH--SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV-TRYYRA 193
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELA 146
           PEV+      E  DI+S G I+ E+ 
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 73/151 (48%), Gaps = 10/151 (6%)
Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
           R RH NI+     +  P    +   Y+ +  +   L+K    + L         Y + +G
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 140
Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-----KANTFLSSKSAAGTPE 117
           + Y+H  N  ++HRDLK  NLL++    +K+CDFGL+R+         FL    A  T  
Sbjct: 141 LKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA--TRW 196
Query: 118 WMAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
           + APE++ +     KS DI+S G IL E+ +
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 73/151 (48%), Gaps = 10/151 (6%)
Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
           R RH NI+     +  P    +   Y+ +  +   L+K    + L         Y + +G
Sbjct: 82  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 141
Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-----KANTFLSSKSAAGTPE 117
           + Y+H  N  ++HRDLK  NLL++    +K+CDFGL+R+         FL    A  T  
Sbjct: 142 LKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA--TRW 197
Query: 118 WMAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
           + APE++ +     KS DI+S G IL E+ +
Sbjct: 198 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 228

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
           R RH NI+     +  P    +   Y+ +  +   L+K    + L         Y + +G
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRG 140
Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-----KANTFLSSKSAAGTPE 117
           + Y+H  N  ++HRDLK  NLL++    +K+CDFGL+R+         FL+   A  T  
Sbjct: 141 LKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--TRW 196
Query: 118 WMAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
           + APE++ +     KS DI+S G IL E+ +
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 79/154 (51%), Gaps = 12/154 (7%)
Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P IV   G      ++ I  E +  G+    L K  ++  + ER    M   + K + YL
Sbjct: 84  PYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYL 140
Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 126
             ++  ++HRD+K  N+L+D++  +K+CDFG+S    +     +S AG   +MAPE + D
Sbjct: 141 KEKHG-VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS-AGCAAYMAPERI-D 197
Query: 127 EPSNEK------SDIYSFGVILWELATLQQPWGN 154
            P   K      +D++S G+ L ELAT Q P+ N
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 8/150 (5%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
           HPNIV          +  +V E L+ G L+  + K   ++   E     +   +   +++
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK---KKHFSETEASYIMRKLVSAVSH 121
Query: 66  LHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPE 122
           +H  +  +VHRDLK  NLL    +    +K+ DFG +RLK       K+   T  + APE
Sbjct: 122 MH--DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE 179
Query: 123 VLRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +L     +E  D++S GVIL+ + + Q P+
Sbjct: 180 LLNQNGYDESCDLWSLGVILYTMLSGQVPF 209

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 3/146 (2%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK + H NI+  +   T    L    +      L        ++  LD  R   + Y + 
Sbjct: 77  MKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQML 136
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ +LH  +  I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     T  + A
Sbjct: 137 CGIKHLH--SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV-TRYYRA 193
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELA 146
           PEV+      E  DI+S G I+ E+ 
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 82/154 (53%), Gaps = 14/154 (9%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
           HP+I+  + +      + +V + + +G L+  L +   +  L E+   ++   + + +++
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSF 215
Query: 66  LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVL 124
           LH  N  IVHRDLK  N+L+D    +++ DFG S  L+    L  +   GTP ++APE+L
Sbjct: 216 LHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL--RELCGTPGYLAPEIL 271
Query: 125 R---DEPS---NEKSDIYSFGVILWELATLQQPW 152
           +   DE      ++ D+++ GVIL+ L     P+
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 71/150 (47%), Gaps = 4/150 (2%)
Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
           +L+HP+I+           + +V E    G + R L K  V+   +   R +  + +  G
Sbjct: 67  QLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYL-KNRVKPFSENEAR-HFMHQIITG 124
Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPE 122
           M YLH     I+HRDL   NLL+ +   +K+ DFGL+           +  GTP +++PE
Sbjct: 125 MLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPE 182
Query: 123 VLRDEPSNEKSDIYSFGVILWELATLQQPW 152
           +        +SD++S G + + L   + P+
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGRPPF 212

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 74/152 (48%), Gaps = 15/152 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
           +K + H NI+  +   T    L       +V E L   +L +++H       LD  R   
Sbjct: 75  LKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIHME-----LDHERMSY 128
Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
           + Y +  G+ +LH  +  I+HRDLK  N++V    T+K+ DFGL+R  +  F+ +     
Sbjct: 129 LLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVV- 185
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELA 146
           T  + APEV+      E  DI+S G I+ EL 
Sbjct: 186 TRYYRAPEVILGMGYKENVDIWSVGCIMGELV 217

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 67/146 (45%), Gaps = 3/146 (2%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK + H NI+  +   T    L    +      L        ++  LD  R   + Y + 
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQML 129
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ +LH     I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     T  + A
Sbjct: 130 XGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV-TRYYRA 186
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELA 146
           PEV+      E  DI+S G I+ E+ 
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 3/146 (2%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK + H NI+  +   T    L    +      L        ++  LD  R   + Y + 
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQML 136
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ +LH  +  I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     T  + A
Sbjct: 137 XGIKHLH--SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV-TRYYRA 193
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELA 146
           PEV+      E  DI+S G I+ E+ 
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 40/127 (31%), Positives = 66/127 (51%), Gaps = 8/127 (6%)
Query: 22  LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
           L I+ E +  G L+  + + G  +   ER    +  D+   + +LH  N  I HRD+K  
Sbjct: 101 LLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPE 157
Query: 82  NLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSF 138
           NLL    +K   +K+ DFG ++      L  ++   TP ++APEVL  E  ++  D++S 
Sbjct: 158 NLLYTSKEKDAVLKLTDFGFAKETTQNAL--QTPCYTPYYVAPEVLGPEKYDKSCDMWSL 215
Query: 139 GVILWEL 145
           GVI++ L
Sbjct: 216 GVIMYIL 222

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 3/146 (2%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK + H NI+  +   T    L    +      L        ++  LD  R   + Y + 
Sbjct: 77  MKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 136
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ +LH  +  I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     T  + A
Sbjct: 137 CGIKHLH--SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV-TRYYRA 193
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELA 146
           PEV+      E  DI+S G I+ E+ 
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 67/127 (52%), Gaps = 8/127 (6%)
Query: 22  LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
           L I+ E +  G L+  + + G  +   ER    +  D+   + +LH  N  I HRD+K  
Sbjct: 82  LLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPE 138
Query: 82  NLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSF 138
           NLL    +K   +K+ DFG +  K  T  + ++   TP ++APEVL  E  ++  D++S 
Sbjct: 139 NLLYTSKEKDAVLKLTDFGFA--KETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSL 196
Query: 139 GVILWEL 145
           GVI++ L
Sbjct: 197 GVIMYIL 203

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 73/145 (50%), Gaps = 8/145 (5%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
           L+H NIV    ++++     +V + ++ G L+  +     RE   E    +    + + +
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDI---VAREYYSEADASHCIQQILEAV 116
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKY---TVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             LH     +VHRDLK  NLL+  K     VK+ DFGL+        +    AGTP +++
Sbjct: 117 --LHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLS 174
Query: 121 PEVLRDEPSNEKSDIYSFGVILWEL 145
           PEVLR E   +  DI++ GVIL+ L
Sbjct: 175 PEVLRKEAYGKPVDIWACGVILYIL 199

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 79/148 (53%), Gaps = 6/148 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L+H NIV     +    +L++V EYL +  L + L   G   +++        + + 
Sbjct: 54  LKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCG--NIINMHNVKLFLFQLL 110
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +G+ Y HR+   ++HRDLK  NLL++++  +K+ DFGL+R K+    +  +   T  +  
Sbjct: 111 RGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRP 168
Query: 121 PEVLRDEPS-NEKSDIYSFGVILWELAT 147
           P++L      + + D++  G I +E+AT
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMAT 196

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 68/145 (46%), Gaps = 3/145 (2%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK + H NI+  +   T   +L    +      L        ++  LD  R   + Y + 
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQML 136
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ +LH     I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     T  + A
Sbjct: 137 CGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVV-TRYYRA 193
Query: 121 PEVLRDEPSNEKSDIYSFGVILWEL 145
           PEV+      E  DI+S G I+ E+
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 69/145 (47%), Gaps = 3/145 (2%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK + H NI+  +   T   +L    +      L        ++  LD  R   + Y + 
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ +LH  +  I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     T  + A
Sbjct: 137 CGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRA 193
Query: 121 PEVLRDEPSNEKSDIYSFGVILWEL 145
           PEV+      E  DI+S G I+ E+
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 69/145 (47%), Gaps = 3/145 (2%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK + H NI+  +   T   +L    +      L        ++  LD  R   + Y + 
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ +LH  +  I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     T  + A
Sbjct: 137 VGIKHLH--SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV-TRYYRA 193
Query: 121 PEVLRDEPSNEKSDIYSFGVILWEL 145
           PEV+      E  DI+S G I+ E+
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 69/145 (47%), Gaps = 3/145 (2%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK + H NI+  +   T   +L    +      L        ++  LD  R   + Y + 
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ +LH  +  I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     T  + A
Sbjct: 137 CGIKHLH--SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV-TRYYRA 193
Query: 121 PEVLRDEPSNEKSDIYSFGVILWEL 145
           PEV+      E  DI+S G I+ E+
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 69/145 (47%), Gaps = 3/145 (2%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK + H NI+  +   T   +L    +      L        ++  LD  R   + Y + 
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ +LH  +  I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     T  + A
Sbjct: 137 CGIKHLH--SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV-TRYYRA 193
Query: 121 PEVLRDEPSNEKSDIYSFGVILWEL 145
           PEV+      E  DI+S G I+ E+
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 73/150 (48%), Gaps = 10/150 (6%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
            RH NI+     +  P    +   Y+ +  +   L+K    + L         Y + +G+
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 139
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-----KANTFLSSKSAAGTPEW 118
            Y+H  N  ++HRDLK  NLL++    +K+CDFGL+R+         FL+   A  T  +
Sbjct: 140 KYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--TRWY 195
Query: 119 MAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
            APE++ +     KS DI+S G IL E+ +
Sbjct: 196 RAPEIMLNSKGYTKSIDIWSVGCILAEMLS 225

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 82/162 (50%), Gaps = 20/162 (12%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
           H N++  +    +     +V E +  GS+   +HK   R   +E     +  DVA  +++
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDF 126
Query: 66  LHRRNPPIVHRDLKSPNLLVD---KKYTVKVCDFGL-SRLKANTFLSSKSA------AGT 115
           LH  N  I HRDLK  N+L +   +   VK+CDF L S +K N   S  S        G+
Sbjct: 127 LH--NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 116 PEWMAPEVLR---DEPS--NEKSDIYSFGVILWELATLQQPW 152
            E+MAPEV+    +E S  +++ D++S GVIL+ L +   P+
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 73/153 (47%), Gaps = 15/153 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
           MK + H NI+  +   T   +L       IV E L   +L +++        LD  R   
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME-----LDHERMSY 130
Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
           + Y +  G+ +LH  +  I+HRDLK  N++V    T+K+ DFGL+R    +F+       
Sbjct: 131 LLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV- 187
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147
           T  + APEV+      E  DI+S G I+ E+  
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVC 220

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 73/150 (48%), Gaps = 10/150 (6%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGM 63
            RH NI+     +  P    +   Y+ +  +   L+K    + L         Y + +G+
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 139
Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-----KANTFLSSKSAAGTPEW 118
            Y+H  N  ++HRDLK  NLL++    +K+CDFGL+R+         FL+   A  T  +
Sbjct: 140 KYIHSAN--VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVA--TRWY 195
Query: 119 MAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
            APE++ +     KS DI+S G IL E+ +
Sbjct: 196 RAPEIMLNSKGYTKSIDIWSVGCILAEMLS 225

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 3/146 (2%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK + H NI+  +   T    L    +      L        ++  LD  R   + Y + 
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 129
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ +LH  +  I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     T  + A
Sbjct: 130 CGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRA 186
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELA 146
           PEV+      E  DI+S G I+ E+ 
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 74/151 (49%), Gaps = 15/151 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
           MK + H NI+  +   T   +L       IV E L   +L +++        LD  R   
Sbjct: 78  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME-----LDHERMSY 131
Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
           + Y +  G+ +LH  +  I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     
Sbjct: 132 LLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV- 188
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
           T  + APEV+      E  DI+S G I+ E+
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 67/146 (45%), Gaps = 3/146 (2%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK + H NI+  +   T    L    +      L        ++  LD  R   + Y + 
Sbjct: 71  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 130
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ +LH     I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     T  + A
Sbjct: 131 CGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRA 187
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELA 146
           PEV+      E  DI+S G I+ E+ 
Sbjct: 188 PEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 67/146 (45%), Gaps = 3/146 (2%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK + H NI+  +   T    L    +      L        ++  LD  R   + Y + 
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 174
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ +LH     I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     T  + A
Sbjct: 175 CGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRA 231
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELA 146
           PEV+      E  DI+S G I+ E+ 
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 67/145 (46%), Gaps = 3/145 (2%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK + H NI+  +   T    L    +      L        ++  LD  R   + Y + 
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 174
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ +LH     I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     T  + A
Sbjct: 175 CGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRA 231
Query: 121 PEVLRDEPSNEKSDIYSFGVILWEL 145
           PEV+      E  DI+S G I+ E+
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEM 256

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 3/146 (2%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK + H NI+  +   T    L    +      L        ++  LD  R   + Y + 
Sbjct: 78  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 137
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ +LH  +  I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     T  + A
Sbjct: 138 CGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRA 194
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELA 146
           PEV+      E  DI+S G I+ E+ 
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 74/151 (49%), Gaps = 15/151 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
           MK + H NI+  +   T   +L       IV E L   +L +++        LD  R   
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME-----LDHERMSY 130
Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
           + Y +  G+ +LH  +  I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     
Sbjct: 131 LLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV- 187
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
           T  + APEV+      E  DI+S G I+ E+
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 67/146 (45%), Gaps = 3/146 (2%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK + H NI+  +   T    L    +      L        ++  LD  R   + Y + 
Sbjct: 71  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 130
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ +LH     I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     T  + A
Sbjct: 131 CGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRA 187
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELA 146
           PEV+      E  DI+S G I+ E+ 
Sbjct: 188 PEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 12/156 (7%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDVA 60
           K L H N+V F G   +     +  EY S G L+ R+    G+ E   +R      + + 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR----FFHQLM 114
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKANTFLSSKSAAGTPE 117
            G+ YLH     I HRD+K  NLL+D++  +K+ DFGL+   R      L +K   GT  
Sbjct: 115 AGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLP 171
Query: 118 WMAPEVL-RDEPSNEKSDIYSFGVILWELATLQQPW 152
           ++APE+L R E   E  D++S G++L  +   + PW
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 3/146 (2%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK + H NI+  +   T    L    +      L        ++  LD  R   + Y + 
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 136
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ +LH  +  I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     T  + A
Sbjct: 137 CGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRA 193
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELA 146
           PEV+      E  DI+S G I+ E+ 
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 3/146 (2%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK + H NI+  +   T    L    +      L        ++  LD  R   + Y + 
Sbjct: 78  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 137
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ +LH  +  I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     T  + A
Sbjct: 138 CGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRA 194
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELA 146
           PEV+      E  DI+S G I+ E+ 
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 12/156 (7%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDVA 60
           K L H N+V F G   +     +  EY S G L+ R+    G+ E   +R      + + 
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR----FFHQLM 115
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKANTFLSSKSAAGTPE 117
            G+ YLH     I HRD+K  NLL+D++  +K+ DFGL+   R      L +K   GT  
Sbjct: 116 AGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLP 172
Query: 118 WMAPEVL-RDEPSNEKSDIYSFGVILWELATLQQPW 152
           ++APE+L R E   E  D++S G++L  +   + PW
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 74/151 (49%), Gaps = 15/151 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
           MK + H NI+  +   T   +L       IV E L   +L +++        LD  R   
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME-----LDHERMSY 130
Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
           + Y +  G+ +LH  +  I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     
Sbjct: 131 LLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV- 187
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
           T  + APEV+      E  DI+S G I+ E+
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 12/156 (7%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDVA 60
           K L H N+V F G   +     +  EY S G L+ R+    G+ E   +R      + + 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR----FFHQLM 114
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKANTFLSSKSAAGTPE 117
            G+ YLH     I HRD+K  NLL+D++  +K+ DFGL+   R      L +K   GT  
Sbjct: 115 AGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLP 171
Query: 118 WMAPEVL-RDEPSNEKSDIYSFGVILWELATLQQPW 152
           ++APE+L R E   E  D++S G++L  +   + PW
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 12/156 (7%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDVA 60
           K L H N+V F G   +     +  EY S G L+ R+    G+ E   +R      + + 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR----FFHQLM 114
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKANTFLSSKSAAGTPE 117
            G+ YLH     I HRD+K  NLL+D++  +K+ DFGL+   R      L +K   GT  
Sbjct: 115 AGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLP 171
Query: 118 WMAPEVL-RDEPSNEKSDIYSFGVILWELATLQQPW 152
           ++APE+L R E   E  D++S G++L  +   + PW
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 12/156 (7%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDVA 60
           K L H N+V F G   +     +  EY S G L+ R+    G+ E   +R      + + 
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR----FFHQLM 115
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKANTFLSSKSAAGTPE 117
            G+ YLH     I HRD+K  NLL+D++  +K+ DFGL+   R      L +K   GT  
Sbjct: 116 AGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLP 172
Query: 118 WMAPEVL-RDEPSNEKSDIYSFGVILWELATLQQPW 152
           ++APE+L R E   E  D++S G++L  +   + PW
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 12/156 (7%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDVA 60
           K L H N+V F G   +     +  EY S G L+ R+    G+ E   +R      + + 
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR----FFHQLM 115
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKANTFLSSKSAAGTPE 117
            G+ YLH     I HRD+K  NLL+D++  +K+ DFGL+   R      L +K   GT  
Sbjct: 116 AGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLP 172
Query: 118 WMAPEVL-RDEPSNEKSDIYSFGVILWELATLQQPW 152
           ++APE+L R E   E  D++S G++L  +   + PW
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 12/156 (7%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDVA 60
           K L H N+V F G   +     +  EY S G L+ R+    G+ E   +R      + + 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR----FFHQLM 114
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKANTFLSSKSAAGTPE 117
            G+ YLH     I HRD+K  NLL+D++  +K+ DFGL+   R      L +K   GT  
Sbjct: 115 AGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLP 171
Query: 118 WMAPEVL-RDEPSNEKSDIYSFGVILWELATLQQPW 152
           ++APE+L R E   E  D++S G++L  +   + PW
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 12/156 (7%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDVA 60
           K L H N+V F G   +     +  EY S G L+ R+    G+ E   +R      + + 
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR----FFHQLM 115
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKANTFLSSKSAAGTPE 117
            G+ YLH     I HRD+K  NLL+D++  +K+ DFGL+   R      L +K   GT  
Sbjct: 116 AGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLP 172
Query: 118 WMAPEVL-RDEPSNEKSDIYSFGVILWELATLQQPW 152
           ++APE+L R E   E  D++S G++L  +   + PW
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 3/146 (2%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK + H NI+  +   T    L    +      L        ++  LD  R   + Y + 
Sbjct: 76  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 135
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ +LH  +  I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     T  + A
Sbjct: 136 CGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRA 192
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELA 146
           PEV+      E  DI+S G I+ E+ 
Sbjct: 193 PEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 3/146 (2%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK + H NI+  +   T    L    +      L        ++  LD  R   + Y + 
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 136
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ +LH  +  I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     T  + A
Sbjct: 137 CGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRA 193
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELA 146
           PEV+      E  DI+S G I+ E+ 
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 12/156 (7%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDVA 60
           K L H N+V F G   +     +  EY S G L+ R+    G+ E   +R      + + 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR----FFHQLM 114
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKANTFLSSKSAAGTPE 117
            G+ YLH     I HRD+K  NLL+D++  +K+ DFGL+   R      L +K   GT  
Sbjct: 115 AGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLP 171
Query: 118 WMAPEVL-RDEPSNEKSDIYSFGVILWELATLQQPW 152
           ++APE+L R E   E  D++S G++L  +   + PW
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 12/156 (7%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDVA 60
           K L H N+V F G   +     +  EY S G L+ R+    G+ E   +R      + + 
Sbjct: 58  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR----FFHQLM 113
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKANTFLSSKSAAGTPE 117
            G+ YLH     I HRD+K  NLL+D++  +K+ DFGL+   R      L +K   GT  
Sbjct: 114 AGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLP 170
Query: 118 WMAPEVL-RDEPSNEKSDIYSFGVILWELATLQQPW 152
           ++APE+L R E   E  D++S G++L  +   + PW
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 206

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 12/156 (7%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDVA 60
           K L H N+V F G   +     +  EY S G L+ R+    G+ E   +R      + + 
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR----FFHQLM 115
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKANTFLSSKSAAGTPE 117
            G+ YLH     I HRD+K  NLL+D++  +K+ DFGL+   R      L +K   GT  
Sbjct: 116 AGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLP 172
Query: 118 WMAPEVL-RDEPSNEKSDIYSFGVILWELATLQQPW 152
           ++APE+L R E   E  D++S G++L  +   + PW
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 12/156 (7%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDVA 60
           K L H N+V F G   +     +  EY S G L+ R+    G+ E   +R      + + 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR----FFHQLM 114
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKANTFLSSKSAAGTPE 117
            G+ YLH     I HRD+K  NLL+D++  +K+ DFGL+   R      L +K   GT  
Sbjct: 115 AGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLP 171
Query: 118 WMAPEVL-RDEPSNEKSDIYSFGVILWELATLQQPW 152
           ++APE+L R E   E  D++S G++L  +   + PW
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 12/156 (7%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDVA 60
           K L H N+V F G   +     +  EY S G L+ R+    G+ E   +R      + + 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR----FFHQLM 114
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKANTFLSSKSAAGTPE 117
            G+ YLH     I HRD+K  NLL+D++  +K+ DFGL+   R      L +K   GT  
Sbjct: 115 AGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLP 171
Query: 118 WMAPEVL-RDEPSNEKSDIYSFGVILWELATLQQPW 152
           ++APE+L R E   E  D++S G++L  +   + PW
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 63.2 bits (152), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 12/156 (7%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDVA 60
           K L H N+V F G   +     +  EY S G L+ R+    G+ E   +R      + + 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR----FFHQLM 114
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKANTFLSSKSAAGTPE 117
            G+ YLH     I HRD+K  NLL+D++  +K+ DFGL+   R      L +K   GT  
Sbjct: 115 AGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLP 171
Query: 118 WMAPEVL-RDEPSNEKSDIYSFGVILWELATLQQPW 152
           ++APE+L R E   E  D++S G++L  +   + PW
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 63.2 bits (152), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 12/156 (7%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDVA 60
           K L H N+V F G   +     +  EY S G L+ R+    G+ E   +R      + + 
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR----FFHQLM 115
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKANTFLSSKSAAGTPE 117
            G+ YLH     I HRD+K  NLL+D++  +K+ DFGL+   R      L +K   GT  
Sbjct: 116 AGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLP 172
Query: 118 WMAPEVL-RDEPSNEKSDIYSFGVILWELATLQQPW 152
           ++APE+L R E   E  D++S G++L  +   + PW
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 63.2 bits (152), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 82/161 (50%), Gaps = 12/161 (7%)
Query: 22  LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
           L +V EY   G L  LL K G R +  E  R  +A ++   ++ +HR     VHRD+K  
Sbjct: 136 LYLVMEYYVGGDLLTLLSKFGER-IPAEMARFYLA-EIVMAIDSVHRLG--YVHRDIKPD 191
Query: 82  NLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLR-------DEPSNEKS 133
           N+L+D+   +++ DFG   +L+A+  + S  A GTP++++PE+L+             + 
Sbjct: 192 NILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPEC 251
Query: 134 DIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP 174
           D ++ GV  +E+   Q P+   + A+    +    + L +P
Sbjct: 252 DWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLP 292

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 79/150 (52%), Gaps = 10/150 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL--HKPGVREMLDERRRLNMAYD 58
           +K L HPNIV  +  +     L++V E++ +  L ++L  +K G++   D + ++ + Y 
Sbjct: 73  LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQ---DSQIKIYL-YQ 127
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
           + +G+ + H+    I+HRDLK  NLL++    +K+ DFGL+R       S      T  +
Sbjct: 128 LLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWY 185
Query: 119 MAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
            AP+VL        S DI+S G I  E+ T
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 79/150 (52%), Gaps = 10/150 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL--HKPGVREMLDERRRLNMAYD 58
           +K L HPNIV  +  +     L++V E++ +  L ++L  +K G++   D + ++ + Y 
Sbjct: 73  LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQ---DSQIKIYL-YQ 127
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
           + +G+ + H+    I+HRDLK  NLL++    +K+ DFGL+R       S      T  +
Sbjct: 128 LLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWY 185
Query: 119 MAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
            AP+VL        S DI+S G I  E+ T
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 6/153 (3%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL-YRLLHKPGVREMLDERRRLNMAYDVAKG 62
           L+HP+IV  +   +    L +V E++    L + ++ +     +  E    +    + + 
Sbjct: 85  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 144
Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYT---VKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
           + Y H  N  I+HRD+K   +L+  K     VK+  FG++     + L +    GTP +M
Sbjct: 145 LRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 202
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
           APEV++ EP  +  D++  GVIL+ L +   P+
Sbjct: 203 APEVVKREPYGKPVDVWGCGVILFILLSGCLPF 235

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/130 (33%), Positives = 73/130 (56%), Gaps = 6/130 (4%)
Query: 17  TQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR 76
           ++   L I  E+  +G+L + + K    E LD+   L +   + KG++Y+H +   ++HR
Sbjct: 104 SKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSK--KLIHR 160
Query: 77  DLKSPNL-LVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDI 135
           DLK  N+ LVD K  VK+ DFGL     N    ++S  GT  +M+PE +  +   ++ D+
Sbjct: 161 DLKPSNIFLVDTK-QVKIGDFGLVTSLKNDGKRTRS-KGTLRYMSPEQISSQDYGKEVDL 218
Query: 136 YSFGVILWEL 145
           Y+ G+IL EL
Sbjct: 219 YALGLILAEL 228

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 12/156 (7%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDVA 60
           K L H N+V F G   +     +  EY S G L+ R+    G+ E   +R      + + 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR----FFHQLM 114
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKANTFLSSKSAAGTPE 117
            G+ YLH     I HRD+K  NLL+D++  +K+ DFGL+   R      L +K   GT  
Sbjct: 115 AGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MXGTLP 171
Query: 118 WMAPEVL-RDEPSNEKSDIYSFGVILWELATLQQPW 152
           ++APE+L R E   E  D++S G++L  +   + PW
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 12/156 (7%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDVA 60
           K L H N+V F G   +     +  EY S G L+ R+    G+ E   +R      + + 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR----FFHQLM 114
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKANTFLSSKSAAGTPE 117
            G+ YLH     I HRD+K  NLL+D++  +K+ DFGL+   R      L +K   GT  
Sbjct: 115 AGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MXGTLP 171
Query: 118 WMAPEVL-RDEPSNEKSDIYSFGVILWELATLQQPW 152
           ++APE+L R E   E  D++S G++L  +   + PW
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 6/153 (3%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL-YRLLHKPGVREMLDERRRLNMAYDVAKG 62
           L+HP+IV  +   +    L +V E++    L + ++ +     +  E    +    + + 
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYT---VKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
           + Y H  N  I+HRD+K   +L+  K     VK+  FG++     + L +    GTP +M
Sbjct: 143 LRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 200
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
           APEV++ EP  +  D++  GVIL+ L +   P+
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 12/156 (7%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDVA 60
           K L H N+V F G   +     +  EY S G L+ R+    G+ E   +R      + + 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR----FFHQLM 114
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKANTFLSSKSAAGTPE 117
            G+ YLH     I HRD+K  NLL+D++  +K+ DFGL+   R      L +K   GT  
Sbjct: 115 AGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MXGTLP 171
Query: 118 WMAPEVL-RDEPSNEKSDIYSFGVILWELATLQQPW 152
           ++APE+L R E   E  D++S G++L  +   + PW
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 12/156 (7%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDVA 60
           K L H N+V F G   +     +  EY S G L+ R+    G+ E   +R      + + 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR----FFHQLM 114
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKANTFLSSKSAAGTPE 117
            G+ YLH     I HRD+K  NLL+D++  +K+ DFGL+   R      L +K   GT  
Sbjct: 115 AGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MXGTLP 171
Query: 118 WMAPEVL-RDEPSNEKSDIYSFGVILWELATLQQPW 152
           ++APE+L R E   E  D++S G++L  +   + PW
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 89/194 (45%), Gaps = 20/194 (10%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
           MK L HPNI+          ++ +V E  + G L+ R++HK   RE    R    +  DV
Sbjct: 77  MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR----IMKDV 132
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGL-SRLKANTFLSSKSAAGT 115
              + Y H+ N  + HRDLK  N L         +K+ DFGL +R K    + +K   GT
Sbjct: 133 LSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK--VGT 188
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 175
           P +++P+VL      E  D +S GV+++ L     P+      +V+  +  +      P 
Sbjct: 189 PYYVSPQVLEGLYGPE-CDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKI--REGTFTFPE 245
Query: 176 ----NVNPHVASII 185
               NV+P   S+I
Sbjct: 246 KDWLNVSPQAESLI 259

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 89/194 (45%), Gaps = 20/194 (10%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
           MK L HPNI+          ++ +V E  + G L+ R++HK   RE    R    +  DV
Sbjct: 60  MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR----IMKDV 115
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGL-SRLKANTFLSSKSAAGT 115
              + Y H+ N  + HRDLK  N L         +K+ DFGL +R K    + +K   GT
Sbjct: 116 LSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK--VGT 171
Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 175
           P +++P+VL      E  D +S GV+++ L     P+      +V+  +  +      P 
Sbjct: 172 PYYVSPQVLEGLYGPE-CDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKI--REGTFTFPE 228
Query: 176 ----NVNPHVASII 185
               NV+P   S+I
Sbjct: 229 KDWLNVSPQAESLI 242

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 12/153 (7%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
           HPNI+             +V + + +G L+  L +   +  L E+    +   + + +  
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICA 139
Query: 66  LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 125
           LH+ N  IVHRDLK  N+L+D    +K+ DFG S  + +     +S  GTP ++APE++ 
Sbjct: 140 LHKLN--IVHRDLKPENILLDDDMNIKLTDFGFS-CQLDPGEKLRSVCGTPSYLAPEIIE 196
Query: 126 -----DEPSNEKS-DIYSFGVILWELATLQQPW 152
                + P   K  D++S GVI++ L     P+
Sbjct: 197 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 12/156 (7%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDVA 60
           K L H N+V F G   +     +  EY S G L+ R+    G+ E   +R      + + 
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR----FFHQLM 115
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKANTFLSSKSAAGTPE 117
            G+ YLH     I HRD+K  NLL+D++  +K+ DFGL+   R      L +K   GT  
Sbjct: 116 AGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MXGTLP 172
Query: 118 WMAPEVL-RDEPSNEKSDIYSFGVILWELATLQQPW 152
           ++APE+L R E   E  D++S G++L  +   + PW
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 69/147 (46%), Gaps = 3/147 (2%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK + H NI+  +   T   +L    +      L        ++  LD  R   + Y + 
Sbjct: 71  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQML 130
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ +LH  +  I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     T  + A
Sbjct: 131 CGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRA 187
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELAT 147
           PEV+      E  D++S G I+ E+  
Sbjct: 188 PEVILGMGYKENVDLWSVGCIMGEMVC 214

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 74/153 (48%), Gaps = 15/153 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
           MK + H NI+  +   T   +L       IV E L   +L +++        LD  R   
Sbjct: 82  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME-----LDHERMSY 135
Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
           + Y +  G+ +LH  +  I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     
Sbjct: 136 LLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV- 192
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147
           T  + APEV+      E  D++S G I+ E+  
Sbjct: 193 TRYYRAPEVILGMGYKENVDLWSVGCIMGEMVC 225

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 73/153 (47%), Gaps = 15/153 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
           MK + H NI+  +   T   +L       IV E L   +L +++        LD  R   
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME-----LDHERMSY 130
Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
           + Y +  G+ +LH  +  I+HRDLK  N++V    T+K+ DFGL+R    +F+       
Sbjct: 131 LLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV- 187
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147
           T  + APEV+      E  D++S G I+ E+  
Sbjct: 188 TRYYRAPEVILGMGYKENVDLWSVGCIMGEMVC 220

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 76/157 (48%), Gaps = 15/157 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTE-YLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           +K  +H NI+     + +P +     E Y+ +  +   LH+    +ML +       Y  
Sbjct: 63  LKHFKHENIITIFN-IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT 121
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----KANTFLSSKSAAGT 115
            + +  LH  N  ++HRDLK  NLL++    +KVCDFGL+R+     A+    +   +G 
Sbjct: 122 LRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 116 PEWM------APEVLRDEPSNEKS-DIYSFGVILWEL 145
            E++      APEV+       ++ D++S G IL EL
Sbjct: 180 TEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 73/151 (48%), Gaps = 15/151 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
           MK + H NI+  +   T   +L       IV E L   +L +++        LD  R   
Sbjct: 79  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME-----LDHERMSY 132
Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
           + Y +  G+ +LH  +  I+HRDLK  N++V    T+K+ DFGL+R    +F+       
Sbjct: 133 LLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVV- 189
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
           T  + APEV+      E  DI+S G I+ E+
Sbjct: 190 TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 220

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 12/154 (7%)
Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDVAKG 62
           L H N+V F G   +     +  EY S G L+ R+    G+ E   +R      + +  G
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR----FFHQLMAG 117
Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKANTFLSSKSAAGTPEWM 119
           + YLH     I HRD+K  NLL+D++  +K+ DFGL+   R      L +K   GT  ++
Sbjct: 118 VVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYV 174
Query: 120 APEVL-RDEPSNEKSDIYSFGVILWELATLQQPW 152
           APE+L R E   E  D++S G++L  +   + PW
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 83/171 (48%), Gaps = 23/171 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +L H N++    A     ++ +V EY+  G L+  +        L E   +     + 
Sbjct: 140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYN--LTELDTILFMKQIC 197
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR-------LKANTFLSSK 110
           +G+ ++H+    I+H DLK  N+L    D K  +K+ DFGL+R       LK N      
Sbjct: 198 EGIRHMHQMY--ILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVNF----- 249
Query: 111 SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161
              GTPE++APEV+  +  +  +D++S GVI + L +   P+   N A+ +
Sbjct: 250 ---GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL 297

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 15/157 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTE-YLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           +K  +H NI+     + +P +     E Y+ +  +   LH+    +ML +       Y  
Sbjct: 63  LKHFKHENIITIFN-IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT 121
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
            + +  LH  N  ++HRDLK  NLL++    +KVCDFGL+R+   +   +    G    M
Sbjct: 122 LRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 120 ----------APEVLRDEPSNEKS-DIYSFGVILWEL 145
                     APEV+       ++ D++S G IL EL
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 15/157 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTE-YLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           +K  +H NI+     + +P +     E Y+ +  +   LH+    +ML +       Y  
Sbjct: 63  LKHFKHENIITIFN-IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT 121
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
            + +  LH  N  ++HRDLK  NLL++    +KVCDFGL+R+   +   +    G    M
Sbjct: 122 LRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 120 ----------APEVLRDEPSNEKS-DIYSFGVILWEL 145
                     APEV+       ++ D++S G IL EL
Sbjct: 180 TEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTE-YLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           +K +RH N++  +   T    L   T+ YL    +   L K    E L E R   + Y +
Sbjct: 78  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQM 137
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
            KG+ Y+H     I+HRDLK  NL V++   +K+ DFGL+R +A++ +       T  + 
Sbjct: 138 LKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR-QADSEMXGXVV--TRWYR 192
Query: 120 APEVLRD-EPSNEKSDIYSFGVILWELAT 147
           APEV+ +     +  DI+S G I+ E+ T
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMIT 221

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 15/152 (9%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
           +K + H NI+  +   T    L       +V E L   +L +++H       LD  R   
Sbjct: 77  LKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIHME-----LDHERMSY 130
Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
           + Y +  G+ +LH  +  I+HRDLK  N++V    T+K+ DFGL+R     F+ +     
Sbjct: 131 LLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV- 187
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELA 146
           T  + APEV+         DI+S G I+ EL 
Sbjct: 188 TRYYRAPEVILGMGYAANVDIWSVGCIMGELV 219

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 65/127 (51%), Gaps = 7/127 (5%)
Query: 22  LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
           L IV E L  G L+  +   G  +   ER    +   + + + YLH  N  I HRD+K  
Sbjct: 104 LLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPE 160
Query: 82  NLLVDKK---YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSF 138
           NLL   K     +K+ DFG ++ +  +  S  +   TP ++APEVL  E  ++  D++S 
Sbjct: 161 NLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 219
Query: 139 GVILWEL 145
           GVI++ L
Sbjct: 220 GVIMYIL 226

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 65/127 (51%), Gaps = 7/127 (5%)
Query: 22  LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
           L IV E L  G L+  +   G  +   ER    +   + + + YLH  N  I HRD+K  
Sbjct: 94  LLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPE 150
Query: 82  NLLVDKK---YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSF 138
           NLL   K     +K+ DFG ++ +  +  S  +   TP ++APEVL  E  ++  D++S 
Sbjct: 151 NLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 209
Query: 139 GVILWEL 145
           GVI++ L
Sbjct: 210 GVIMYIL 216

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 65/127 (51%), Gaps = 7/127 (5%)
Query: 22  LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
           L IV E L  G L+  +   G  +   ER    +   + + + YLH  N  I HRD+K  
Sbjct: 95  LLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPE 151
Query: 82  NLLVDKK---YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSF 138
           NLL   K     +K+ DFG ++ +  +  S  +   TP ++APEVL  E  ++  D++S 
Sbjct: 152 NLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 210
Query: 139 GVILWEL 145
           GVI++ L
Sbjct: 211 GVIMYIL 217

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 65/127 (51%), Gaps = 7/127 (5%)
Query: 22  LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
           L IV E L  G L+  +   G  +   ER    +   + + + YLH  N  I HRD+K  
Sbjct: 96  LLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPE 152
Query: 82  NLLVDKK---YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSF 138
           NLL   K     +K+ DFG ++ +  +  S  +   TP ++APEVL  E  ++  D++S 
Sbjct: 153 NLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 211
Query: 139 GVILWEL 145
           GVI++ L
Sbjct: 212 GVIMYIL 218

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 65/127 (51%), Gaps = 7/127 (5%)
Query: 22  LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
           L IV E L  G L+  +   G  +   ER    +   + + + YLH  N  I HRD+K  
Sbjct: 89  LLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPE 145
Query: 82  NLLVDKK---YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSF 138
           NLL   K     +K+ DFG ++ +  +  S  +   TP ++APEVL  E  ++  D++S 
Sbjct: 146 NLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 204
Query: 139 GVILWEL 145
           GVI++ L
Sbjct: 205 GVIMYIL 211

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 77/151 (50%), Gaps = 20/151 (13%)
Query: 8   NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLH 67
           NI+  +          +V E L  GS+   + K   ++  +ER    +  DVA  +++LH
Sbjct: 72  NILELIEFFEDDTRFYLVFEKLQGGSILAHIQK---QKHFNEREASRVVRDVAAALDFLH 128
Query: 68  RRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGL-SRLKANTFLSS------KSAAGTPE 117
            +   I HRDLK  N+L    +K   VK+CDF L S +K N   +        +  G+ E
Sbjct: 129 TKG--IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAE 186
Query: 118 WMAPEVLR---DEPS--NEKSDIYSFGVILW 143
           +MAPEV+    D+ +  +++ D++S GV+L+
Sbjct: 187 YMAPEVVEVFTDQATFYDKRCDLWSLGVVLY 217

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 65/127 (51%), Gaps = 7/127 (5%)
Query: 22  LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
           L IV E L  G L+  +   G  +   ER    +   + + + YLH  N  I HRD+K  
Sbjct: 88  LLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPE 144
Query: 82  NLLVDKK---YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSF 138
           NLL   K     +K+ DFG ++ +  +  S  +   TP ++APEVL  E  ++  D++S 
Sbjct: 145 NLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 203
Query: 139 GVILWEL 145
           GVI++ L
Sbjct: 204 GVIMYIL 210

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 75/151 (49%), Gaps = 11/151 (7%)
Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P +V    A      L +V EY+  G L  L+    V E   +  +   A +V   ++ +
Sbjct: 135 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE---KWAKFYTA-EVVLALDAI 190
Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLR 125
           H     ++HRD+K  N+L+DK   +K+ DFG   ++     +   +A GTP++++PEVL+
Sbjct: 191 HSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLK 248
Query: 126 DEPSN----EKSDIYSFGVILWELATLQQPW 152
            +  +     + D +S GV L+E+     P+
Sbjct: 249 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 65/127 (51%), Gaps = 7/127 (5%)
Query: 22  LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
           L IV E L  G L+  +   G  +   ER    +   + + + YLH  N  I HRD+K  
Sbjct: 90  LLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPE 146
Query: 82  NLLVDKK---YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSF 138
           NLL   K     +K+ DFG ++ +  +  S  +   TP ++APEVL  E  ++  D++S 
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 205
Query: 139 GVILWEL 145
           GVI++ L
Sbjct: 206 GVIMYIL 212

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 65/127 (51%), Gaps = 7/127 (5%)
Query: 22  LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
           L IV E L  G L+  +   G  +   ER    +   + + + YLH  N  I HRD+K  
Sbjct: 140 LLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPE 196
Query: 82  NLLVDKK---YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSF 138
           NLL   K     +K+ DFG ++ +  +  S  +   TP ++APEVL  E  ++  D++S 
Sbjct: 197 NLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 255
Query: 139 GVILWEL 145
           GVI++ L
Sbjct: 256 GVIMYIL 262

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 12/153 (7%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
           HPNI+             +V + + +G L+  L +   +  L E+    +   + + +  
Sbjct: 70  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICA 126
Query: 66  LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 125
           LH+ N  IVHRDLK  N+L+D    +K+ DFG S  + +     +   GTP ++APE++ 
Sbjct: 127 LHKLN--IVHRDLKPENILLDDDMNIKLTDFGFS-CQLDPGEKLREVCGTPSYLAPEIIE 183
Query: 126 -----DEPSNEKS-DIYSFGVILWELATLQQPW 152
                + P   K  D++S GVI++ L     P+
Sbjct: 184 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 65/127 (51%), Gaps = 7/127 (5%)
Query: 22  LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
           L IV E L  G L+  +   G  +   ER    +   + + + YLH  N  I HRD+K  
Sbjct: 134 LLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPE 190
Query: 82  NLLVDKK---YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSF 138
           NLL   K     +K+ DFG ++ +  +  S  +   TP ++APEVL  E  ++  D++S 
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 249
Query: 139 GVILWEL 145
           GVI++ L
Sbjct: 250 GVIMYIL 256

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 65/127 (51%), Gaps = 7/127 (5%)
Query: 22  LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
           L IV E L  G L+  +   G  +   ER    +   + + + YLH  N  I HRD+K  
Sbjct: 90  LLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPE 146
Query: 82  NLLVDKK---YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSF 138
           NLL   K     +K+ DFG ++ +  +  S  +   TP ++APEVL  E  ++  D++S 
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 205
Query: 139 GVILWEL 145
           GVI++ L
Sbjct: 206 GVIMYIL 212

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 10/151 (6%)
Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
           R RH NI+     +  P    +   Y+ +  +   L+K    + L         Y + +G
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 136
Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-----KANTFLSSKSAAGTPE 117
           + Y+H  N  ++HRDLK  NLL++    +K+ DFGL+R+         FL+   A  T  
Sbjct: 137 LKYIHSAN--VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVA--TRW 192
Query: 118 WMAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
           + APE++ +     KS DI+S G IL E+ +
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 12/153 (7%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
           HPNI+             +V + + +G L+  L +   +  L E+    +   + + +  
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICA 139
Query: 66  LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 125
           LH+ N  IVHRDLK  N+L+D    +K+ DFG S  + +     +   GTP ++APE++ 
Sbjct: 140 LHKLN--IVHRDLKPENILLDDDMNIKLTDFGFS-CQLDPGEKLREVCGTPSYLAPEIIE 196
Query: 126 -----DEPSNEKS-DIYSFGVILWELATLQQPW 152
                + P   K  D++S GVI++ L     P+
Sbjct: 197 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 82/162 (50%), Gaps = 22/162 (13%)
Query: 1   MKRLRHPNIVLFMG----------------AVTQPPNLSIVTEYLSRGSLYRLLHKPGVR 44
           + +L H NIV + G                + ++   L I  E+  +G+L + + K    
Sbjct: 58  LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RG 116
Query: 45  EMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL-LVDKKYTVKVCDFGLSRLKA 103
           E LD+   L +   + KG++Y+H +   +++RDLK  N+ LVD K  VK+ DFGL     
Sbjct: 117 EKLDKVLALELFEQITKGVDYIHSK--KLINRDLKPSNIFLVDTK-QVKIGDFGLVTSLK 173
Query: 104 NTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
           N     +S  GT  +M+PE +  +   ++ D+Y+ G+IL EL
Sbjct: 174 NDGKRXRSK-GTLRYMSPEQISSQDYGKEVDLYALGLILAEL 214

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 79/163 (48%), Gaps = 31/163 (19%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR--------R 52
           MK L+H NIV     +     L++V E++             +++ +D R          
Sbjct: 57  MKELKHENIVRLYDVIHTENKLTLVFEFMDND----------LKKYMDSRTVGNTPRGLE 106
Query: 53  LNMA----YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR---LKANT 105
           LN+     + + +G+ + H     I+HRDLK  NLL++K+  +K+ DFGL+R   +  NT
Sbjct: 107 LNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT 164
Query: 106 FLSSKSAAGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
           F    S   T  + AP+VL    +   S DI+S G IL E+ T
Sbjct: 165 F---SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT 204

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 64/127 (50%), Gaps = 7/127 (5%)
Query: 22  LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
           L IV E L  G L+  +   G  +   ER    +   + + + YLH  N  I HRD+K  
Sbjct: 88  LLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPE 144
Query: 82  NLLVDKK---YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSF 138
           NLL   K     +K+ DFG ++ +  +  S      TP ++APEVL  E  ++  D++S 
Sbjct: 145 NLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWSL 203
Query: 139 GVILWEL 145
           GVI++ L
Sbjct: 204 GVIMYIL 210

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 11/151 (7%)
Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P +V    A      L +V EY+  G L  L+    V E   +  R   A +V   ++ +
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE---KWARFYTA-EVVLALDAI 189
Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLR 125
           H      +HRD+K  N+L+DK   +K+ DFG   ++     +   +A GTP++++PEVL+
Sbjct: 190 HSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 247
Query: 126 DEPSN----EKSDIYSFGVILWELATLQQPW 152
            +  +     + D +S GV L+E+     P+
Sbjct: 248 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 11/151 (7%)
Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P +V    A      L +V EY+  G L  L+    V E   +  R   A +V   ++ +
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE---KWARFYTA-EVVLALDAI 189
Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLR 125
           H      +HRD+K  N+L+DK   +K+ DFG   ++     +   +A GTP++++PEVL+
Sbjct: 190 HSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 247
Query: 126 DEPSN----EKSDIYSFGVILWELATLQQPW 152
            +  +     + D +S GV L+E+     P+
Sbjct: 248 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 11/151 (7%)
Query: 7   PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL 66
           P +V    A      L +V EY+  G L  L+    V E   +  R   A +V   ++ +
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE---KWARFYTA-EVVLALDAI 184
Query: 67  HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLR 125
           H      +HRD+K  N+L+DK   +K+ DFG   ++     +   +A GTP++++PEVL+
Sbjct: 185 HSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 242
Query: 126 DEPSN----EKSDIYSFGVILWELATLQQPW 152
            +  +     + D +S GV L+E+     P+
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 84/170 (49%), Gaps = 10/170 (5%)
Query: 15  AVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIV 74
           A     NL +V +Y   G L  LL K   R + +E  R  +A ++   ++ +H+ +   V
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDR-LPEEMARFYLA-EMVIAIDSVHQLH--YV 197
Query: 75  HRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLRDEPSNE-- 131
           HRD+K  N+L+D    +++ DFG   +L  +  + S  A GTP++++PE+L+     +  
Sbjct: 198 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGR 257
Query: 132 ---KSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
              + D +S GV ++E+   + P+   +  +    +    +R + P  V 
Sbjct: 258 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVT 307

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 77/157 (49%), Gaps = 13/157 (8%)
Query: 7   PNIVLFMGAVTQPPNLSIVTEY--LSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
           P  V F GA+ +  ++ I  E    S    Y+ +   G  + + E     +A  + K + 
Sbjct: 93  PFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKG--QTIPEDILGKIAVSIVKALE 150
Query: 65  YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL 124
           +LH +   ++HRD+K  N+L++    VK CDFG+S    +  ++    AG   + APE +
Sbjct: 151 HLHSK-LSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDD-VAKDIDAGCKPYXAPERI 208
Query: 125 RDEPSNE----KSDIYSFGVILWELATLQQP---WGN 154
             E + +    KSDI+S G+   ELA L+ P   WG 
Sbjct: 209 NPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGT 245

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 70/146 (47%), Gaps = 6/146 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K+LRH N+V  +    +     +V E++    L  L   P     LD +      + + 
Sbjct: 78  LKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPN---GLDYQVVQKYLFQII 134
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ + H  N  I+HRD+K  N+LV +   VK+CDFG +R  A           T  + A
Sbjct: 135 NGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRA 192
Query: 121 PEVLRDEPSNEKS-DIYSFGVILWEL 145
           PE+L  +    K+ D+++ G ++ E+
Sbjct: 193 PELLVGDVKYGKAVDVWAIGCLVTEM 218

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 83/168 (49%), Gaps = 21/168 (12%)
Query: 1   MKRLRHPNIV-LF-MGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +K+L H NIV LF +   T   +  ++ E+   GSLY +L +P     L E   L +  D
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLL----VDKKYTVKVCDFGLSRLKAN--TFLSSKSA 112
           V  GMN+L  R   IVHR++K  N++     D +   K+ DFG +R   +   F+   S 
Sbjct: 121 VVGGMNHL--RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV---SL 175
Query: 113 AGTPEWMAPE-----VLRDEPSNEKS---DIYSFGVILWELATLQQPW 152
            GT E++ P+     VLR +   +     D++S GV  +  AT   P+
Sbjct: 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 76/154 (49%), Gaps = 18/154 (11%)
Query: 1   MKRLRHPNIVLFMGAVT-----QPPNLSIVTEYLSRGSLYRLLHK---PGV-REMLDERR 51
           ++   HPN+V      T     +   L++V E++ +  L   L K   PGV  E +    
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK--- 123
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
             +M + + +G+++LH     +VHRDLK  N+LV     +K+ DFGL+R+ +   ++  S
Sbjct: 124 --DMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-MALTS 178
Query: 112 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
              T  + APEVL         D++S G I  E+
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 76/154 (49%), Gaps = 18/154 (11%)
Query: 1   MKRLRHPNIVLFMGAVT-----QPPNLSIVTEYLSRGSLYRLLHK---PGV-REMLDERR 51
           ++   HPN+V      T     +   L++V E++ +  L   L K   PGV  E +    
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK--- 123
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
             +M + + +G+++LH     +VHRDLK  N+LV     +K+ DFGL+R+ +   ++  S
Sbjct: 124 --DMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-MALTS 178
Query: 112 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
              T  + APEVL         D++S G I  E+
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 13/149 (8%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K+L HP I+          +  IV E +  G L+  +   G + + +   +L   Y + 
Sbjct: 75  LKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKV--VGNKRLKEATCKLYF-YQML 130
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 117
             + YLH     I+HRDLK  N+L+   ++   +K+ DFG S++   T L  ++  GTP 
Sbjct: 131 LAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM-RTLCGTPT 187
Query: 118 WMAPEVLRDEPS---NEKSDIYSFGVILW 143
           ++APEVL    +   N   D +S GVIL+
Sbjct: 188 YLAPEVLVSVGTAGYNRAVDCWSLGVILF 216

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 63/127 (49%), Gaps = 7/127 (5%)
Query: 22  LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
           L IV E L  G L+  +   G  +   ER    +   + + + YLH  N  I HRD+K  
Sbjct: 134 LLIVXECLDGGELFSRIQDRG-DQAFTEREASEIXKSIGEAIQYLHSIN--IAHRDVKPE 190
Query: 82  NLLVDKK---YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSF 138
           NLL   K     +K+ DFG ++ +  +  S  +   TP ++APEVL  E  ++  D +S 
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXWSL 249
Query: 139 GVILWEL 145
           GVI + L
Sbjct: 250 GVIXYIL 256

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 13/149 (8%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K+L HP I+          +  IV E +  G L+  +   G + + +   +L   Y + 
Sbjct: 68  LKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKV--VGNKRLKEATCKLYF-YQML 123
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 117
             + YLH     I+HRDLK  N+L+   ++   +K+ DFG S++   T L  ++  GTP 
Sbjct: 124 LAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM-RTLCGTPT 180
Query: 118 WMAPEVLRDEPS---NEKSDIYSFGVILW 143
           ++APEVL    +   N   D +S GVIL+
Sbjct: 181 YLAPEVLVSVGTAGYNRAVDCWSLGVILF 209

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 13/149 (8%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K+L HP I+          +  IV E +  G L+  +   G + + +   +L   Y + 
Sbjct: 69  LKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKV--VGNKRLKEATCKLYF-YQML 124
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 117
             + YLH     I+HRDLK  N+L+   ++   +K+ DFG S++   T L  ++  GTP 
Sbjct: 125 LAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM-RTLCGTPT 181
Query: 118 WMAPEVLRDEPS---NEKSDIYSFGVILW 143
           ++APEVL    +   N   D +S GVIL+
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILF 210

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 13/149 (8%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K+L HP I+          +  IV E +  G L+  +   G + + +   +L   Y + 
Sbjct: 69  LKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKV--VGNKRLKEATCKLYF-YQML 124
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 117
             + YLH     I+HRDLK  N+L+   ++   +K+ DFG S++   T L  ++  GTP 
Sbjct: 125 LAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM-RTLCGTPT 181
Query: 118 WMAPEVLRDEPS---NEKSDIYSFGVILW 143
           ++APEVL    +   N   D +S GVIL+
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILF 210

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 13/149 (8%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K+L HP I+          +  IV E +  G L+  +   G + + +   +L   Y + 
Sbjct: 69  LKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKV--VGNKRLKEATCKLYF-YQML 124
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 117
             + YLH     I+HRDLK  N+L+   ++   +K+ DFG S++   T L  ++  GTP 
Sbjct: 125 LAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM-RTLCGTPT 181
Query: 118 WMAPEVLRDEPS---NEKSDIYSFGVILW 143
           ++APEVL    +   N   D +S GVIL+
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILF 210

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 76/154 (49%), Gaps = 18/154 (11%)
Query: 1   MKRLRHPNIVLFMGAVT-----QPPNLSIVTEYLSRGSLYRLLHK---PGV-REMLDERR 51
           ++   HPN+V      T     +   L++V E++ +  L   L K   PGV  E +    
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK--- 123
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 111
             +M + + +G+++LH     +VHRDLK  N+LV     +K+ DFGL+R+ +   ++  S
Sbjct: 124 --DMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-MALTS 178
Query: 112 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
              T  + APEVL         D++S G I  E+
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 32/203 (15%)
Query: 1   MKRLRHPNIVLFMGAV--TQPPNLSIVTEYLSRGSLYRLLHKPGVREMLD----ERRRLN 54
           ++RLRH N++  +  +   +   + +V EY   G          ++EMLD    +R  + 
Sbjct: 60  LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG----------MQEMLDSVPEKRFPVC 109
Query: 55  MAY----DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR----LKANTF 106
            A+     +  G+ YLH +   IVH+D+K  NLL+    T+K+   G++       A+  
Sbjct: 110 QAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADD- 166
Query: 107 LSSKSAAGTPEWMAPEVLR--DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
            + +++ G+P +  PE+    D  S  K DI+S GV L+ + T   P+   N  ++   +
Sbjct: 167 -TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI 225
Query: 165 GFKGKRLEIPRNVNPHVASIIEA 187
           G KG    IP +  P ++ +++ 
Sbjct: 226 G-KGS-YAIPGDCGPPLSDLLKG 246

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 135
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R  A+        
Sbjct: 136 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEM---TGY 189
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 135
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R  A+        
Sbjct: 136 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEM---TGY 189
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 135
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R  A+        
Sbjct: 136 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEM---TGY 189
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 13/149 (8%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K+L HP I+  +       +  IV E +  G L+  +   G + + +   +L   Y + 
Sbjct: 208 LKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKV--VGNKRLKEATCKLYF-YQML 263
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 117
             + YLH     I+HRDLK  N+L+   ++   +K+ DFG S++   T L  ++  GTP 
Sbjct: 264 LAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM-RTLCGTPT 320
Query: 118 WMAPEVLRDEPS---NEKSDIYSFGVILW 143
           ++APEVL    +   N   D +S GVIL+
Sbjct: 321 YLAPEVLVSVGTAGYNRAVDCWSLGVILF 349

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 13/149 (8%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K+L HP I+  +       +  IV E +  G L+  +   G + + +   +L   Y + 
Sbjct: 194 LKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKV--VGNKRLKEATCKLYF-YQML 249
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 117
             + YLH     I+HRDLK  N+L+   ++   +K+ DFG S++   T L  ++  GTP 
Sbjct: 250 LAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM-RTLCGTPT 306
Query: 118 WMAPEVLRDEPS---NEKSDIYSFGVILW 143
           ++APEVL    +   N   D +S GVIL+
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILF 335

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 68/131 (51%), Gaps = 4/131 (3%)
Query: 22  LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
           L +V   ++ G L   ++  G +    E R +  A ++  G+  LHR    IV+RDLK  
Sbjct: 259 LCLVLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPE 315
Query: 82  NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVI 141
           N+L+D    +++ D GL+ +      + K   GT  +MAPEV+++E      D ++ G +
Sbjct: 316 NILLDDHGHIRISDLGLA-VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCL 374
Query: 142 LWELATLQQPW 152
           L+E+   Q P+
Sbjct: 375 LYEMIAGQSPF 385

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 68/131 (51%), Gaps = 4/131 (3%)
Query: 22  LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
           L +V   ++ G L   ++  G +    E R +  A ++  G+  LHR    IV+RDLK  
Sbjct: 259 LCLVLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPE 315
Query: 82  NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVI 141
           N+L+D    +++ D GL+ +      + K   GT  +MAPEV+++E      D ++ G +
Sbjct: 316 NILLDDHGHIRISDLGLA-VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCL 374
Query: 142 LWELATLQQPW 152
           L+E+   Q P+
Sbjct: 375 LYEMIAGQSPF 385

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 28/177 (15%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAY---D 58
           K   HPNIV +         L +VT +++ GS   L+        +D    L +AY    
Sbjct: 81  KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI----CTHFMDGMNELAIAYILQG 136
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS--------- 109
           V K ++Y+H      VHR +K+ ++L+     V      LS L++N  + S         
Sbjct: 137 VLKALDYIHHMG--YVHRSVKASHILISVDGKVY-----LSGLRSNLSMISHGQRQRVVH 189
Query: 110 ---KSAAGTPEWMAPEVLRD--EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161
              K +     W++PEVL+   +  + KSDIYS G+   ELA    P+ ++   Q++
Sbjct: 190 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML 246

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 28/177 (15%)
Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAY---D 58
           K   HPNIV +         L +VT +++ GS   L+        +D    L +AY    
Sbjct: 65  KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI----CTHFMDGMNELAIAYILQG 120
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS--------- 109
           V K ++Y+H      VHR +K+ ++L+     V      LS L++N  + S         
Sbjct: 121 VLKALDYIHHMG--YVHRSVKASHILISVDGKVY-----LSGLRSNLSMISHGQRQRVVH 173
Query: 110 ---KSAAGTPEWMAPEVLRD--EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 161
              K +     W++PEVL+   +  + KSDIYS G+   ELA    P+ ++   Q++
Sbjct: 174 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML 230

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L+H NIV     +     L++V E+  +  L +          LD     +  + + 
Sbjct: 55  LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFD--SCNGDLDPEIVKSFLFQLL 111
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           KG+ + H RN  ++HRDLK  NLL+++   +K+ DFGL+R          +   T  +  
Sbjct: 112 KGLGFCHSRN--VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRP 169
Query: 121 PEVLRDEPSNEKS-DIYSFGVILWELATLQQP 151
           P+VL        S D++S G I  ELA   +P
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAARP 201

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 80/166 (48%), Gaps = 17/166 (10%)
Query: 1   MKRLRHPNIV-LF-MGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +K+L H NIV LF +   T   +  ++ E+   GSLY +L +P     L E   L +  D
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLL----VDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
           V  GMN+L  R   IVHR++K  N++     D +   K+ DFG +R +           G
Sbjct: 121 VVGGMNHL--RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR-ELEDDEQFVXLYG 177
Query: 115 TPEWMAPE-----VLRDEPSNEKS---DIYSFGVILWELATLQQPW 152
           T E++ P+     VLR +   +     D++S GV  +  AT   P+
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 129 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 182
Query: 113 AGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 183 VATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLT 218

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 129 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGX 182
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 148
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 149 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMXGX 202
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 203 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 74/149 (49%), Gaps = 7/149 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTE-YLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           +K ++H N++  +   T   +L    + YL    +   L+     + L +     + Y +
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQI 134
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
            +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T         T  + 
Sbjct: 135 LRGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMTGYVATRWYR 189
Query: 120 APEVLRD-EPSNEKSDIYSFGVILWELAT 147
           APE++ +    N+  DI+S G I+ EL T
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV--------REMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 86  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 139
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 140 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMTGY 193
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 194 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 129 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 182
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV--------REMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 133
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 134 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMTGY 187
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 188 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV--------REMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 133
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 134 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMTGY 187
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 188 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 134
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 135 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 188
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 129 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 182
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 129 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 182
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 94  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 147
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 148 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 201
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 202 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 85  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 138
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 139 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 192
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 193 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 228

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 124
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 125 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 178
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 148
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 149 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 202
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 203 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 148
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 149 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 202
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 203 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 98  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 151
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 152 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMXGY 205
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 206 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 241

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 130
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 131 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 184
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 185 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 129 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 182
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 86  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 139
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 140 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 193
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 194 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 73  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 126
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 127 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 180
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 181 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 216

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 135
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 136 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 189
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 125
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 126 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 179
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 180 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 134
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 135 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 188
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 134
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 135 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 188
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 133
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 134 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 187
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 188 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 78/147 (53%), Gaps = 7/147 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTE-YLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           +K L+H N++  +   T   ++   +E YL    +   L+     + L +     + Y +
Sbjct: 81  LKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQL 140
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
            +G+ Y+H  +  I+HRDLK  N+ V++   +++ DFGL+R +A+  ++   A  T  + 
Sbjct: 141 LRGLKYIH--SAGIIHRDLKPSNVAVNEDSELRILDFGLAR-QADEEMTGYVA--TRWYR 195
Query: 120 APEVLRD-EPSNEKSDIYSFGVILWEL 145
           APE++ +    N+  DI+S G I+ EL
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAEL 222

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 124
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 125 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMAGF 178
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 140
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 141 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 194
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 195 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 74/149 (49%), Gaps = 7/149 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTE-YLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           +K ++H N++  +   T   +L    + YL    +   L+     + L +     + Y +
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQI 134
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
            +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T         T  + 
Sbjct: 135 LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYR 189
Query: 120 APEVLRD-EPSNEKSDIYSFGVILWELAT 147
           APE++ +    N+  DI+S G I+ EL T
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 124
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 125 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 178
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 140
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 141 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 194
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 195 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 94  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 147
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 148 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 201
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 202 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 133
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 134 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 187
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 188 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 74  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 127
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 128 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 181
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 182 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 217

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 129 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 182
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 140
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 141 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 194
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 195 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 130
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 131 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 184
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 185 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 98  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 151
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 152 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 205
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 206 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 241

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV--------REMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 134
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 135 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLAR---HTDDEMTGY 188
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 76/156 (48%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L           +Y + H  G         +++ D+  +
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLE------EFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 129 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 182
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 129 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 182
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 130
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 131 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 184
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 185 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 129 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMAGF 182
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 125
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 126 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 179
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 180 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV--------REMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 130
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 131 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLAR---HTDDEMTGY 184
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 185 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 129 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMAGF 182
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 129 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 182
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 73/149 (48%), Gaps = 7/149 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTE-YLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           +K ++H N++  +   T   +L    + YL    +   L+     + L +     + Y +
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQI 134
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
            +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL R   +T         T  + 
Sbjct: 135 LRGLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLCR---HTDDEMTGYVATRWYR 189
Query: 120 APEVLRD-EPSNEKSDIYSFGVILWELAT 147
           APE++ +    N+  DI+S G I+ EL T
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 71/156 (45%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNM----- 55
           +K L HPNIV  +  +     L +V E+LS            +++ +D      +     
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEFLSMD----------LKDFMDASALTGIPLPLI 108
Query: 56  ---AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
               + + +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +    
Sbjct: 109 KSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE 166
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE+L   +  +   DI+S G I  E+ T
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 78/147 (53%), Gaps = 7/147 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTE-YLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           +K L+H N++  +   T   ++   +E YL    +   L+     + L +     + Y +
Sbjct: 81  LKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQL 140
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
            +G+ Y+H  +  I+HRDLK  N+ V++   +++ DFGL+R +A+  ++   A  T  + 
Sbjct: 141 LRGLKYIH--SAGIIHRDLKPSNVAVNEDSELRILDFGLAR-QADEEMTGYVA--TRWYR 195
Query: 120 APEVLRD-EPSNEKSDIYSFGVILWEL 145
           APE++ +    N+  DI+S G I+ EL
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAEL 222

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 71/156 (45%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNM----- 55
           +K L HPNIV  +  +     L +V E+LS            +++ +D      +     
Sbjct: 58  LKELNHPNIVKLLDVIHTENKLYLVFEFLSMD----------LKDFMDASALTGIPLPLI 107
Query: 56  ---AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
               + + +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +    
Sbjct: 108 KSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE 165
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE+L   +  +   DI+S G I  E+ T
Sbjct: 166 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 78/175 (44%), Gaps = 17/175 (9%)
Query: 14  GAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK--------GMNY 65
           G +T    + I+ EY+   S+ +      V   LD+     +   V K          +Y
Sbjct: 110 GIITNYDEVYIIYEYMENDSILKFDEYFFV---LDKNYTCFIPIQVIKCIIKSVLNSFSY 166
Query: 66  LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 125
           +H     I HRD+K  N+L+DK   VK+ DFG S    +  +  K + GT E+M PE   
Sbjct: 167 IHNE-KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI--KGSRGTYEFMPPEFFS 223
Query: 126 DEPS--NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           +E S    K DI+S G+ L+ +     P+  L  + V      + K +E P + N
Sbjct: 224 NESSYNGAKVDIWSLGICLYVMFYNVVPFS-LKISLVELFNNIRTKNIEYPLDRN 277

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 78/147 (53%), Gaps = 7/147 (4%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTE-YLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           +K L+H N++  +   T   ++   +E YL    +   L+     + L +     + Y +
Sbjct: 73  LKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQL 132
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
            +G+ Y+H  +  I+HRDLK  N+ V++   +++ DFGL+R +A+  ++   A  T  + 
Sbjct: 133 LRGLKYIH--SAGIIHRDLKPSNVAVNEDCELRILDFGLAR-QADEEMTGYVA--TRWYR 187
Query: 120 APEVLRD-EPSNEKSDIYSFGVILWEL 145
           APE++ +    N+  DI+S G I+ EL
Sbjct: 188 APEIMLNWMHYNQTVDIWSVGCIMAEL 214

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 76/156 (48%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVR--------EMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G          ++ D+  +
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCAKLTDDHVQ 124
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 125 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 178
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 78/169 (46%), Gaps = 26/169 (15%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY---RLLHKPGVRE------MLDERR 51
           + +L HP IV +  A  +      +     +  LY   +L  K  +++       ++ER 
Sbjct: 57  LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 52  R---LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGL-----SRLKA 103
           R   L++   +A+ + +LH +   ++HRDLK  N+       VKV DFGL        + 
Sbjct: 117 RSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174
Query: 104 NTFLSSKSA-------AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
            T L+   A        GT  +M+PE +     + K DI+S G+IL+EL
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR-------GSLYRLLHKPGVREMLDERRRL 53
           +K L HPNIV  +  +     L +V E+LS         S    +  P ++  L      
Sbjct: 57  LKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYL------ 110
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
              + + +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +     
Sbjct: 111 ---FQLLQGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV 165
Query: 114 GTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
            T  + APE+L   +  +   DI+S G I  E+ T
Sbjct: 166 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLS-------RGSLYRLLHKPGVREMLDERRRL 53
           +K L HPNIV  +  +     L +V E+LS         S    +  P ++  L      
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYL------ 112
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
              + + +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +     
Sbjct: 113 ---FQLLQGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV 167
Query: 114 GTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
            T  + APE+L   +  +   DI+S G I  E+ T
Sbjct: 168 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 72/155 (46%), Gaps = 19/155 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR-------GSLYRLLHKPGVREMLDERRRL 53
           +K L HPNIV  +  +     L +V E+L +        S    +  P ++  L      
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL------ 109
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
              + + +G+++ H     ++HRDLK  NLL++ +  +K+ DFGL+R       +     
Sbjct: 110 ---FQLLQGLSFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 164
Query: 114 GTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
            T  + APE+L   +  +   DI+S G I  E+ T
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 77/149 (51%), Gaps = 8/149 (5%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNL-SIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           +K ++H N++  +   T   +L +    YL    +   L K    E  +E+ +  + Y +
Sbjct: 95  LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQY-LVYQM 153
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
            KG+ Y+H  +  +VHRDLK  NL V++   +K+ DFGL+R  A+  ++      T  + 
Sbjct: 154 LKGLKYIH--SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTGYVV--TRWYR 208
Query: 120 APEVLRD-EPSNEKSDIYSFGVILWELAT 147
           APEV+      N+  DI+S G I+ E+ T
Sbjct: 209 APEVILSWMHYNQTVDIWSVGCIMAEMLT 237

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 79/172 (45%), Gaps = 19/172 (11%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLS---------IVTEYLSRGSLYRLLHKPGVREMLDERR 51
           MK+L HPN+V    A   P  L          +  EY   G L + L++      L E  
Sbjct: 66  MKKLNHPNVV---SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP 122
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD---KKYTVKVCDFGLSRLKANTFLS 108
              +  D++  + YLH     I+HRDLK  N+++    ++   K+ D G ++      L 
Sbjct: 123 IRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC 180
Query: 109 SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW-GNLNPAQ 159
           ++   GT +++APE+L  +      D +SFG + +E  T  +P+  N  P Q
Sbjct: 181 TE-FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ 231

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 70/155 (45%), Gaps = 19/155 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR-------GSLYRLLHKPGVREMLDERRRL 53
           +K L HPNIV  +  +     L +V E+L +        S    +  P ++  L      
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL------ 109
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
              + + +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +     
Sbjct: 110 ---FQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 164
Query: 114 GTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELAT 147
            T  + APE+L        + DI+S G I  E+ T
Sbjct: 165 VTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 76/156 (48%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L           +Y + H  G         +++ D+  +
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLE------EFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ D+GL+R   +T       
Sbjct: 129 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDYGLAR---HTDDEMTGY 182
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 79/172 (45%), Gaps = 19/172 (11%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLS---------IVTEYLSRGSLYRLLHKPGVREMLDERR 51
           MK+L HPN+V    A   P  L          +  EY   G L + L++      L E  
Sbjct: 67  MKKLNHPNVV---SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP 123
Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD---KKYTVKVCDFGLSRLKANTFLS 108
              +  D++  + YLH     I+HRDLK  N+++    ++   K+ D G ++      L 
Sbjct: 124 IRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC 181
Query: 109 SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW-GNLNPAQ 159
           ++   GT +++APE+L  +      D +SFG + +E  T  +P+  N  P Q
Sbjct: 182 TE-FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ 232

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 76/156 (48%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 104 LKHMKHENVIGLLDVFTPATSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 157
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +T       
Sbjct: 158 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY 211
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N   DI+S G I+ EL T
Sbjct: 212 VATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLT 247

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 71/156 (45%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNM----- 55
           +K L HPNIV  +  +     L +V E+L +           +++ +D      +     
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQD----------LKDFMDASALTGIPLPLI 105
Query: 56  ---AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
               + + +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +    
Sbjct: 106 KSYLFQLLQGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE 163
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE+L   +  +   DI+S G I  E+ T
Sbjct: 164 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 5/148 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L HPNIV  +  +     L +V E+L +  L + +    +  +     + +  + + 
Sbjct: 63  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK-SYLFQLL 120
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +      T  + A
Sbjct: 121 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 178
Query: 121 PEVLRDEPSNEKS-DIYSFGVILWELAT 147
           PE+L        + DI+S G I  E+ T
Sbjct: 179 PEILLGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR-------GSLYRLLHKPGVREMLDERRRL 53
           +K L HPNIV  +  +     L +V E+L +        S    +  P ++  L      
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL------ 108
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
              + + +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +     
Sbjct: 109 ---FQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV 163
Query: 114 GTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
            T  + APE+L   +  +   DI+S G I  E+ T
Sbjct: 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR-------GSLYRLLHKPGVREMLDERRRL 53
           +K L HPNIV  +  +     L +V E+L +        S    +  P ++  L      
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYL------ 112
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
              + + +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +     
Sbjct: 113 ---FQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV 167
Query: 114 GTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
            T  + APE+L   +  +   DI+S G I  E+ T
Sbjct: 168 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR-------GSLYRLLHKPGVREMLDERRRL 53
           +K L HPNIV  +  +     L +V E+L +        S    +  P ++  L      
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL------ 109
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
              + + +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +     
Sbjct: 110 ---FQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 164
Query: 114 GTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
            T  + APE+L   +  +   DI+S G I  E+ T
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L+H NIV     +     L++V E+  +  L +          LD     +  + + 
Sbjct: 55  LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFD--SCNGDLDPEIVKSFLFQLL 111
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           KG+ + H RN  ++HRDLK  NLL+++   +K+ +FGL+R          +   T  +  
Sbjct: 112 KGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRP 169
Query: 121 PEVLRDEPSNEKS-DIYSFGVILWELATLQQP 151
           P+VL        S D++S G I  ELA   +P
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 72/148 (48%), Gaps = 5/148 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L HPNIV  +  +     L +V E+L +  L + +    +  +     + +  + + 
Sbjct: 57  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK-SYLFQLL 114
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +      T  + A
Sbjct: 115 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 172
Query: 121 PEVLRD-EPSNEKSDIYSFGVILWELAT 147
           PE+L   +  +   DI+S G I  E+ T
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR-------GSLYRLLHKPGVREMLDERRRL 53
           +K L HPNIV  +  +     L +V E+L +        S    +  P ++  L      
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL------ 108
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
              + + +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +     
Sbjct: 109 ---FQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 163
Query: 114 GTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
            T  + APE+L   +  +   DI+S G I  E+ T
Sbjct: 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 72/148 (48%), Gaps = 5/148 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L HPNIV  +  +     L +V E+L +  L + +    +  +     + +  + + 
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK-SYLFQLL 116
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +      T  + A
Sbjct: 117 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 121 PEVLRD-EPSNEKSDIYSFGVILWELAT 147
           PE+L   +  +   DI+S G I  E+ T
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR-------GSLYRLLHKPGVREMLDERRRL 53
           +K L HPNIV  +  +     L +V E+L +        S    +  P ++  L      
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL------ 109
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
              + + +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +     
Sbjct: 110 ---FQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 164
Query: 114 GTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
            T  + APE+L   +  +   DI+S G I  E+ T
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR-------GSLYRLLHKPGVREMLDERRRL 53
           +K L HPNIV  +  +     L +V E+L +        S    +  P ++  L      
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL------ 108
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
              + + +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +     
Sbjct: 109 ---FQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 163
Query: 114 GTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
            T  + APE+L   +  +   DI+S G I  E+ T
Sbjct: 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR-------GSLYRLLHKPGVREMLDERRRL 53
           +K L HPNIV  +  +     L +V E+L +        S    +  P ++  L      
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL------ 109
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
              + + +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +     
Sbjct: 110 ---FQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV 164
Query: 114 GTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
            T  + APE+L   +  +   DI+S G I  E+ T
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR-------GSLYRLLHKPGVREMLDERRRL 53
           +K L HPNIV  +  +     L +V E+L +        S    +  P ++  L      
Sbjct: 57  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL------ 110
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
              + + +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +     
Sbjct: 111 ---FQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV 165
Query: 114 GTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
            T  + APE+L   +  +   DI+S G I  E+ T
Sbjct: 166 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR-------GSLYRLLHKPGVREMLDERRRL 53
           +K L HPNIV  +  +     L +V E+L +        S    +  P ++  L      
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL------ 108
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
              + + +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +     
Sbjct: 109 ---FQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 163
Query: 114 GTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
            T  + APE+L   +  +   DI+S G I  E+ T
Sbjct: 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR-------GSLYRLLHKPGVREMLDERRRL 53
           +K L HPNIV  +  +     L +V E+L +        S    +  P ++  L      
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL------ 109
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
              + + +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +     
Sbjct: 110 ---FQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 164
Query: 114 GTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
            T  + APE+L   +  +   DI+S G I  E+ T
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR-------GSLYRLLHKPGVREMLDERRRL 53
           +K L HPNIV  +  +     L +V E+L +        S    +  P ++  L      
Sbjct: 57  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL------ 110
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
              + + +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +     
Sbjct: 111 ---FQLLQGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV 165
Query: 114 GTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
            T  + APE+L   +  +   DI+S G I  E+ T
Sbjct: 166 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR-------GSLYRLLHKPGVREMLDERRRL 53
           +K L HPNIV  +  +     L +V E+L +        S    +  P ++  L      
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL------ 109
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
              + + +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +     
Sbjct: 110 ---FQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV 164
Query: 114 GTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
            T  + APE+L   +  +   DI+S G I  E+ T
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR-------GSLYRLLHKPGVREMLDERRRL 53
           +K L HPNIV  +  +     L +V E+L +        S    +  P ++  L      
Sbjct: 57  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL------ 110
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
              + + +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +     
Sbjct: 111 ---FQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV 165
Query: 114 GTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
            T  + APE+L   +  +   DI+S G I  E+ T
Sbjct: 166 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 72/148 (48%), Gaps = 5/148 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L HPNIV  +  +     L +V E+L +  L + +    +  +     + +  + + 
Sbjct: 60  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK-SYLFQLL 117
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +      T  + A
Sbjct: 118 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 175
Query: 121 PEVLRD-EPSNEKSDIYSFGVILWELAT 147
           PE+L   +  +   DI+S G I  E+ T
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR-------GSLYRLLHKPGVREMLDERRRL 53
           +K L HPNIV  +  +     L +V E+L +        S    +  P ++  L      
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL------ 109
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
              + + +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +     
Sbjct: 110 ---FQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV 164
Query: 114 GTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
            T  + APE+L   +  +   DI+S G I  E+ T
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 72/148 (48%), Gaps = 5/148 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L HPNIV  +  +     L +V E+L +  L + +    +  +     + +  + + 
Sbjct: 63  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK-SYLFQLL 120
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +      T  + A
Sbjct: 121 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 178
Query: 121 PEVLRD-EPSNEKSDIYSFGVILWELAT 147
           PE+L   +  +   DI+S G I  E+ T
Sbjct: 179 PEILLGCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR-------GSLYRLLHKPGVREMLDERRRL 53
           +K L HPNIV  +  +     L +V E+L +        S    +  P ++  L      
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL------ 109
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
              + + +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +     
Sbjct: 110 ---FQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV 164
Query: 114 GTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
            T  + APE+L   +  +   DI+S G I  E+ T
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 72/148 (48%), Gaps = 5/148 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L HPNIV  +  +     L +V E+L +  L + +    +  +     + +  + + 
Sbjct: 58  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK-SYLFQLL 115
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +      T  + A
Sbjct: 116 QGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 173
Query: 121 PEVLRD-EPSNEKSDIYSFGVILWELAT 147
           PE+L   +  +   DI+S G I  E+ T
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 72/148 (48%), Gaps = 5/148 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L HPNIV  +  +     L +V E+L +  L + +    +  +     + +  + + 
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK-SYLFQLL 116
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +      T  + A
Sbjct: 117 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 121 PEVLRD-EPSNEKSDIYSFGVILWELAT 147
           PE+L   +  +   DI+S G I  E+ T
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 72/148 (48%), Gaps = 5/148 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L HPNIV  +  +     L +V E+L +  L + +    +  +     + +  + + 
Sbjct: 58  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK-SYLFQLL 115
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +      T  + A
Sbjct: 116 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 173
Query: 121 PEVLRD-EPSNEKSDIYSFGVILWELAT 147
           PE+L   +  +   DI+S G I  E+ T
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR-------GSLYRLLHKPGVREMLDERRRL 53
           +K L HPNIV  +  +     L +V E+L +        S    +  P ++  L      
Sbjct: 60  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL------ 113
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
              + + +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +     
Sbjct: 114 ---FQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 168
Query: 114 GTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
            T  + APE+L   +  +   DI+S G I  E+ T
Sbjct: 169 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 72/148 (48%), Gaps = 5/148 (3%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L HPNIV  +  +     L +V E+L +  L + +    +  +     + +  + + 
Sbjct: 58  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK-SYLFQLL 115
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +      T  + A
Sbjct: 116 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 173
Query: 121 PEVLRD-EPSNEKSDIYSFGVILWELAT 147
           PE+L   +  +   DI+S G I  E+ T
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR-------GSLYRLLHKPGVREMLDERRRL 53
           +K L HPNIV  +  +     L +V E+L +        S    +  P ++  L      
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL------ 108
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
              + + +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +     
Sbjct: 109 ---FQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV 163
Query: 114 GTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
            T  + APE+L   +  +   DI+S G I  E+ T
Sbjct: 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 72/159 (45%), Gaps = 10/159 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           + R+ H NI+  +          +V E    GS   L         LDE     +   + 
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVME--KHGSGLDLFAFIDRHPRLDEPLASYIFRQLV 140
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTPEW 118
             + YL  ++  I+HRD+K  N+++ + +T+K+ DFG +    +   F    +  GT E+
Sbjct: 141 SAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY---TFCGTIEY 195
Query: 119 MAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLN 156
            APEVL   P    + +++S GV L+ L   + P+  L 
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE 234

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 10/149 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH--KPGVREMLDERRRLNMAYD 58
           +K L+H NIV     +     L +V E+L +  L +LL   + G+  +  +   L +   
Sbjct: 54  LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL-- 110
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
              G+ Y H R   ++HRDLK  NLL++++  +K+ DFGL+R              T  +
Sbjct: 111 --NGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWY 166
Query: 119 MAPEVLRDEPSNEKS-DIYSFGVILWELA 146
            AP+VL        + DI+S G I  E+ 
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMV 195

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 10/149 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH--KPGVREMLDERRRLNMAYD 58
           +K L+H NIV     +     L +V E+L +  L +LL   + G+  +  +   L +   
Sbjct: 54  LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL-- 110
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
              G+ Y H R   ++HRDLK  NLL++++  +K+ DFGL+R              T  +
Sbjct: 111 --NGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWY 166
Query: 119 MAPEVLRDEPSNEKS-DIYSFGVILWELA 146
            AP+VL        + DI+S G I  E+ 
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMV 195

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 10/149 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH--KPGVREMLDERRRLNMAYD 58
           +K L+H NIV     +     L +V E+L +  L +LL   + G+  +  +   L +   
Sbjct: 54  LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL-- 110
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
              G+ Y H R   ++HRDLK  NLL++++  +K+ DFGL+R              T  +
Sbjct: 111 --NGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWY 166
Query: 119 MAPEVLRDEPSNEKS-DIYSFGVILWELA 146
            AP+VL        + DI+S G I  E+ 
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMV 195

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 81/171 (47%), Gaps = 12/171 (7%)
Query: 15  AVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIV 74
           A     +L +V +Y   G L  LL K    + L E        ++   ++ +H+ +   V
Sbjct: 158 AFQDENHLYLVMDYYVGGDLLTLLSK--FEDKLPEDMARFYIGEMVLAIDSIHQLH--YV 213
Query: 75  HRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEPSNE- 131
           HRD+K  N+L+D    +++ DFG S LK N    + S  A GTP++++PE+L+       
Sbjct: 214 HRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 272
Query: 132 ----KSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
               + D +S GV ++E+   + P+   +  +    +    +R + P +V 
Sbjct: 273 KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVT 323

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 81/171 (47%), Gaps = 12/171 (7%)
Query: 15  AVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIV 74
           A     +L +V +Y   G L  LL K    + L E        ++   ++ +H+ +   V
Sbjct: 142 AFQDENHLYLVMDYYVGGDLLTLLSK--FEDKLPEDMARFYIGEMVLAIDSIHQLH--YV 197
Query: 75  HRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEPSNE- 131
           HRD+K  N+L+D    +++ DFG S LK N    + S  A GTP++++PE+L+       
Sbjct: 198 HRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 256
Query: 132 ----KSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
               + D +S GV ++E+   + P+   +  +    +    +R + P +V 
Sbjct: 257 KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVT 307

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 77/150 (51%), Gaps = 10/150 (6%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNL-SIVTEYLSRGSLYRLLHK-PGVREMLDERRRLNMAYD 58
           +K ++H N++  +   T   +L +    YL    +   L K  G++    E +   + Y 
Sbjct: 77  LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK--FSEEKIQYLVYQ 134
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
           + KG+ Y+H  +  +VHRDLK  NL V++   +K+ DFGL+R  A+  ++      T  +
Sbjct: 135 MLKGLKYIH--SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTGYVV--TRWY 189
Query: 119 MAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
            APEV+      N+  DI+S G I+ E+ T
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLT 219

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 76/156 (48%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+  FGL+R   +T       
Sbjct: 129 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILGFGLAR---HTDDEMTGY 182
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR-------GSLYRLLHKPGVREMLDERRRL 53
           +K L HPNIV  +  +     L +V E++ +        S    +  P ++  L      
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYL------ 112
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
              + + +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +     
Sbjct: 113 ---FQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV 167
Query: 114 GTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
            T  + APE+L   +  +   DI+S G I  E+ T
Sbjct: 168 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 75/156 (48%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L           +Y + H  G         +++ D+  +
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLE------EFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DF L+R   +T       
Sbjct: 129 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFYLAR---HTDDEMTGY 182
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 76/156 (48%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ D GL+R   +T       
Sbjct: 129 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDAGLAR---HTDDEMTGY 182
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 71/147 (48%), Gaps = 12/147 (8%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL-YRLLHKPGVREMLDERRRLNMAYDV 59
           M+ L HP +V    +     ++ +V + L  G L Y L      +E   E  +L +  ++
Sbjct: 69  MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKE---ETVKLFIC-EL 124
Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
              ++YL  +N  I+HRD+K  N+L+D+   V + DF ++ +         + AGT  +M
Sbjct: 125 VMALDYL--QNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITTMAGTKPYM 181
Query: 120 APEVLRDEPSNEKSDIYSFGVILWELA 146
           APE+     S+ K   YSF V  W L 
Sbjct: 182 APEMF----SSRKGAGYSFAVDWWSLG 204

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR-------GSLYRLLHKPGVREMLDERRRL 53
           +K L HPNIV  +  +     L +V E++ +        S    +  P ++  L      
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYL------ 108
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
              + + +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +     
Sbjct: 109 ---FQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 163
Query: 114 GTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
            T  + APE+L   +  +   DI+S G I  E+ T
Sbjct: 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 76/156 (48%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ D GL+R   +T       
Sbjct: 129 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDGGLAR---HTDDEMTGY 182
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 81/164 (49%), Gaps = 11/164 (6%)
Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
           RH NI+    +      L ++ E++S   ++  ++       L+ER  ++  + V + + 
Sbjct: 59  RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQ 116
Query: 65  YLHRRNPPIVHRDLKSPNLLVD--KKYTVKVCDFGLSR-LK-ANTFLSSKSAAGTPEWMA 120
           +LH  N  I H D++  N++    +  T+K+ +FG +R LK  + F   +     PE+ A
Sbjct: 117 FLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYA 171
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           PEV + +  +  +D++S G +++ L +   P+      Q++  +
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI 215

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 76/156 (48%), Gaps = 21/156 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--------VREMLDERRR 52
           +K ++H N++  +   T   +L    +      +Y + H  G         +++ D+  +
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQ 128
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
             + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ D GL+R   +T       
Sbjct: 129 F-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDRGLAR---HTDDEMTGY 182
Query: 113 AGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 147
             T  + APE++ +    N+  DI+S G I+ EL T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 72/148 (48%), Gaps = 11/148 (7%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ L HPNI+  + A     N+S+V +++       ++ K     +     +  M   + 
Sbjct: 66  LQELSHPNIIGLLDAFGHKSNISLVFDFMETD--LEVIIKDNSLVLTPSHIKAYMLMTL- 122
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +G+ YLH+    I+HRDLK  NLL+D+   +K+ DFGL++   +   +      T  + A
Sbjct: 123 QGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRA 180
Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATL 148
           PE+L        + +Y  GV +W +  +
Sbjct: 181 PELLFG------ARMYGVGVDMWAVGCI 202

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 83/167 (49%), Gaps = 28/167 (16%)
Query: 1   MKRLRHPNIV-LF-------------MGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM 46
           ++RL H NIV +F             +G++T+  ++ IV EY+       L   P    +
Sbjct: 62  IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP----L 117
Query: 47  LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKANT 105
           L+E  RL M Y + +G+ Y+H  N  ++HRDLK  NL ++ +   +K+ DFGL+R+  + 
Sbjct: 118 LEEHARLFM-YQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARI-MDP 173
Query: 106 FLSSK---SAAGTPEWMAPEVLRDEPSN--EKSDIYSFGVILWELAT 147
             S K   S     +W     L   P+N  +  D+++ G I  E+ T
Sbjct: 174 HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 220

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/85 (37%), Positives = 47/85 (55%), Gaps = 3/85 (3%)
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +G+++LH     IVHRDLK  N+LV    TVK+ DFGL+R+ +   ++      T  + A
Sbjct: 131 RGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ-MALTPVVVTLWYRA 187
Query: 121 PEVLRDEPSNEKSDIYSFGVILWEL 145
           PEVL         D++S G I  E+
Sbjct: 188 PEVLLQSTYATPVDMWSVGCIFAEM 212

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/85 (37%), Positives = 47/85 (55%), Gaps = 3/85 (3%)
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +G+++LH     IVHRDLK  N+LV    TVK+ DFGL+R+ +   ++      T  + A
Sbjct: 123 RGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ-MALAPVVVTLWYRA 179
Query: 121 PEVLRDEPSNEKSDIYSFGVILWEL 145
           PEVL         D++S G I  E+
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/85 (37%), Positives = 47/85 (55%), Gaps = 3/85 (3%)
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +G+++LH     IVHRDLK  N+LV    TVK+ DFGL+R+ +   ++      T  + A
Sbjct: 123 RGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ-MALDPVVVTLWYRA 179
Query: 121 PEVLRDEPSNEKSDIYSFGVILWEL 145
           PEVL         D++S G I  E+
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 53/105 (50%), Gaps = 14/105 (13%)
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGL-----SRLKANTFL 107
           L++   +A+ + +LH +   ++HRDLK  N+       VKV DFGL        +  T L
Sbjct: 167 LHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 108 SSKSA-------AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
           +   A        GT  +M+PE +     + K DI+S G+IL+EL
Sbjct: 225 TPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL 269

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/85 (37%), Positives = 47/85 (55%), Gaps = 3/85 (3%)
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +G+++LH     IVHRDLK  N+LV    TVK+ DFGL+R+ +   ++      T  + A
Sbjct: 123 RGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ-MALFPVVVTLWYRA 179
Query: 121 PEVLRDEPSNEKSDIYSFGVILWEL 145
           PEVL         D++S G I  E+
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 66/156 (42%), Gaps = 29/156 (18%)
Query: 22  LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
           L IV E ++   L +L   P     L E     + Y++  G N++H     I+HRDLK  
Sbjct: 105 LYIVLE-IADSDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPA 158
Query: 82  NLLVDKKYTVKVCDFGLSRL----------------------KANTFLSSKSAAGTPEWM 119
           N L+++  +VKVCDFGL+R                         N      S   T  + 
Sbjct: 159 NCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYR 218
Query: 120 APE-VLRDEPSNEKSDIYSFGVILWELATLQQPWGN 154
           APE +L  E   +  DI+S G I  EL  + Q   N
Sbjct: 219 APELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 78/181 (43%), Gaps = 39/181 (21%)
Query: 1   MKRLRHPNIVLFMGAVT-----QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNM 55
           + RL H ++V  +  V      +   L +V E ++     +L   P     L E     +
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLE-IADSDFKKLFRTPV---YLTELHIKTL 161
Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--------------- 100
            Y++  G+ Y+H  +  I+HRDLK  N LV++  +VKVCDFGL+R               
Sbjct: 162 LYNLLVGVKYVH--SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPIS 219
Query: 101 -----LKANTFLSSKS-------AAGTPEWMAPE-VLRDEPSNEKSDIYSFGVILWELAT 147
                +   TF  +K+          T  + APE +L  E   E  D++S G I  EL  
Sbjct: 220 PREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279
Query: 148 L 148
           +
Sbjct: 280 M 280

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 87/183 (47%), Gaps = 42/183 (22%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD------- 58
           HPN++ +  + T    L I  E L   +L  L+    V    DE  +L   Y+       
Sbjct: 68  HPNVIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVS---DENLKLQKEYNPISLLRQ 123
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLV--DKKYT-----------VKVCDFGLSRLKANT 105
           +A G+ +LH  +  I+HRDLK  N+LV    ++T           + + DFGL + K ++
Sbjct: 124 IASGVAHLH--SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK-KLDS 180
Query: 106 FLSS-----KSAAGTPEWMAPEVLRDEPSNEKS--------DIYSFGVILWE-LATLQQP 151
             SS      + +GT  W APE+L +E +N ++        DI+S G + +  L+  + P
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELL-EESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
Query: 152 WGN 154
           +G+
Sbjct: 240 FGD 242

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 54/113 (47%), Gaps = 14/113 (12%)
Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD-----KKYTVKVCDFGLSRLKA---N 104
           + +      G+ +LH  N  IVHRDLK  N+L+       K    + DFGL +  A   +
Sbjct: 121 ITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178
Query: 105 TFLSSKSAAGTPEWMAPEVLRDEPSNEKS---DIYSFGVILWE-LATLQQPWG 153
           +F       GT  W+APE+L ++     +   DI+S G + +  ++    P+G
Sbjct: 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/107 (28%), Positives = 56/107 (52%), Gaps = 11/107 (10%)
Query: 57  YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR------LKANTFLSSK 110
           Y + +G+ Y+H  +  ++HRDLK  NLLV++   +K+ DFG++R       +   F++  
Sbjct: 165 YQLLRGLKYMH--SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEY 222
Query: 111 SAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLN 156
            A  T  + APE++       +  D++S G I  E+   +Q +   N
Sbjct: 223 VA--TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN 267

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 57  YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR------LKANTFLSSK 110
           Y + +G+ Y+H     ++HRDLK  NLLV++   +K+ DFG++R       +   F++  
Sbjct: 166 YQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEY 223
Query: 111 SAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQ 150
            A  T  + APE++       +  D++S G I  E+   +Q
Sbjct: 224 VA--TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 77/153 (50%), Gaps = 16/153 (10%)
Query: 1   MKRLRHPNIV----LFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
           +    HPNI+    +F+    +P    L +VTE L R  L +++H    R ++  +    
Sbjct: 83  LNHFHHPNILGLRDIFVH-FEEPAMHKLYLVTE-LMRTDLAQVIHDQ--RIVISPQHIQY 138
Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
             Y +  G++ LH     +VHRDL   N+L+     + +CDF L+R   +T  ++K+   
Sbjct: 139 FMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAR--EDTADANKTHYV 194
Query: 115 TPEWM-APE-VLRDEPSNEKSDIYSFGVILWEL 145
           T  W  APE V++ +   +  D++S G ++ E+
Sbjct: 195 THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 77/153 (50%), Gaps = 16/153 (10%)
Query: 1   MKRLRHPNIV----LFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
           +    HPNI+    +F+    +P    L +VTE L R  L +++H    R ++  +    
Sbjct: 83  LNHFHHPNILGLRDIFVH-FEEPAMHKLYLVTE-LMRTDLAQVIHDQ--RIVISPQHIQY 138
Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
             Y +  G++ LH     +VHRDL   N+L+     + +CDF L+R   +T  ++K+   
Sbjct: 139 FMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAR--EDTADANKTHYV 194
Query: 115 TPEWM-APE-VLRDEPSNEKSDIYSFGVILWEL 145
           T  W  APE V++ +   +  D++S G ++ E+
Sbjct: 195 THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 46.6 bits (109), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 80/177 (45%), Gaps = 34/177 (19%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD------- 58
           HPN++ +  + T    L I  E L   +L  L+    V    DE  +L   Y+       
Sbjct: 86  HPNVIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVS---DENLKLQKEYNPISLLRQ 141
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLV--DKKYT-----------VKVCDFGLSRL---- 101
           +A G+ +LH  +  I+HRDLK  N+LV    ++T           + + DFGL +     
Sbjct: 142 IASGVAHLH--SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 199
Query: 102 KANTFLSSKSAAGTPEWMAPEVLRDEPSNEKS---DIYSFGVILWE-LATLQQPWGN 154
           +     +  + +GT  W APE+L +      +   DI+S G + +  L+  + P+G+
Sbjct: 200 QXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 256

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 46.6 bits (109), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 80/177 (45%), Gaps = 34/177 (19%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD------- 58
           HPN++ +  + T    L I  E L   +L  L+    V    DE  +L   Y+       
Sbjct: 86  HPNVIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVS---DENLKLQKEYNPISLLRQ 141
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLV--DKKYT-----------VKVCDFGLSRL---- 101
           +A G+ +LH  +  I+HRDLK  N+LV    ++T           + + DFGL +     
Sbjct: 142 IASGVAHLH--SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 199
Query: 102 KANTFLSSKSAAGTPEWMAPEVLRDEPSNEKS---DIYSFGVILWE-LATLQQPWGN 154
           +     +  + +GT  W APE+L +      +   DI+S G + +  L+  + P+G+
Sbjct: 200 QXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 256

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 67/163 (41%), Gaps = 33/163 (20%)
Query: 22  LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP 81
           L IV E ++   L +L   P     L E+    + Y++  G  ++H     I+HRDLK  
Sbjct: 107 LYIVLE-IADSDLKKLFKTPI---FLTEQHVKTILYNLLLGEKFIHESG--IIHRDLKPA 160
Query: 82  NLLVDKKYTVKVCDFGLSRL-------------------------KANTFLSSKSAAGTP 116
           N L+++  +VK+CDFGL+R                            N      S   T 
Sbjct: 161 NCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTR 220
Query: 117 EWMAPE-VLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA 158
            + APE +L  E      DI+S G I  EL  + +   N NP 
Sbjct: 221 WYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHIN-NPT 262

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/90 (28%), Positives = 48/90 (53%), Gaps = 4/90 (4%)
Query: 58  DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 117
           D    + +LH +   +VH D+K  N+ +  +   K+ DFGL  ++  T  + +   G P 
Sbjct: 165 DTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGL-LVELGTAGAGEVQEGDPR 221
Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELAT 147
           +MAPE+L+       +D++S G+ + E+A 
Sbjct: 222 YMAPELLQGS-YGTAADVFSLGLTILEVAC 250

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 84/182 (46%), Gaps = 40/182 (21%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD------- 58
           HPN++ +  + T    L I  E L   +L  L+    V    DE  +L   Y+       
Sbjct: 68  HPNVIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVS---DENLKLQKEYNPISLLRQ 123
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLV--DKKYT-----------VKVCDFGLSRL---- 101
           +A G+ +LH  +  I+HRDLK  N+LV    ++T           + + DFGL +     
Sbjct: 124 IASGVAHLH--SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 102 KANTFLSSKSAAGTPEWMAPEVLRDEPSNEKS--------DIYSFGVILWE-LATLQQPW 152
           +     +  + +GT  W APE+L +E +N ++        DI+S G + +  L+  + P+
Sbjct: 182 QXXFRXNLNNPSGTSGWRAPELL-EESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 153 GN 154
           G+
Sbjct: 241 GD 242

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 52/115 (45%), Gaps = 30/115 (26%)
Query: 58  DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY-------------------------TVK 92
           ++ K +NYL  R   + H DLK  N+L+D  Y                          +K
Sbjct: 145 EILKALNYL--RKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202
Query: 93  VCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147
           + DFG +  K++      S   T ++ APEV+ +   +  SD++SFG +L EL T
Sbjct: 203 LIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 23/80 (28%), Positives = 40/80 (50%), Gaps = 1/80 (1%)
Query: 74  VHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS-KSAAGTPEWMAPEVLRDEPSNEK 132
            HRD+K  N+LV       + DFG++    +  L+   +  GT  + APE   +  +  +
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYR 215
Query: 133 SDIYSFGVILWELATLQQPW 152
           +DIY+   +L+E  T   P+
Sbjct: 216 ADIYALTCVLYECLTGSPPY 235

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/136 (24%), Positives = 62/136 (45%), Gaps = 18/136 (13%)
Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRL---KANTFLSSKSAAG 114
           V   + + H R   +VHRD+K  N+L+D ++   K+ DFG   L   +  T         
Sbjct: 148 VVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYS 205
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP 174
            PEW++    R +     + ++S G++L+++     P+      +++ A       L  P
Sbjct: 206 PPEWIS----RHQYHALPATVWSLGILLYDMVCGDIPFERDQ--EILEA------ELHFP 253
Query: 175 RNVNPHVASIIEACWA 190
            +V+P   ++I  C A
Sbjct: 254 AHVSPDCCALIRRCLA 269

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 90/198 (45%), Gaps = 21/198 (10%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +L H ++VL  G         +V E++  GSL   L K   +  ++   +L +A  +A
Sbjct: 66  MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLA 123
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLV----DKKYT----VKVCDFGLSRLKANTFLSSKSA 112
             M++L      ++H ++ + N+L+    D+K      +K+ D G+S     T L     
Sbjct: 124 AAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI----TVLPKDIL 177
Query: 113 AGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKR 170
                W+ PE + +  + N  +D +SFG  LWE+ +   +P   L+  +    + F   R
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR---KLQFYEDR 234
Query: 171 LEIPRNVNPHVASIIEAC 188
            ++P      +A++I  C
Sbjct: 235 HQLPAPKAAELANLINNC 252

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 90/197 (45%), Gaps = 27/197 (13%)
Query: 1   MKRLRHPNIVLF------MGAVTQPPNLSIVTEYLSRGSLYRLL-HKPGVREMLDERRRL 53
           M++L H NIV         G       L++V +Y+   ++YR+  H    ++ L      
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ATVYRVARHYSRAKQTLPVIYVK 125
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFG----LSRLKANTFLS 108
              Y + + + Y+H     I HRD+K  NLL+D    V K+CDFG    L R + N    
Sbjct: 126 LYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--- 180
Query: 109 SKSAAGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW--GNLNPAQVVAAVG 165
             S   +  + APE++        S D++S G +L EL  L QP   G+    Q+V  + 
Sbjct: 181 --SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL-LLGQPIFPGDSGVDQLVEIIK 237
Query: 166 FKG--KRLEIPRNVNPH 180
             G   R +I R +NP+
Sbjct: 238 VLGTPTREQI-REMNPN 253

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 29/198 (14%)
Query: 1   MKRLRHPNIVLF------MGAVTQPPNLSIVTEYLSRGSLYRLL-HKPGVREMLDERRRL 53
           M++L H NIV         G       L++V +Y+   ++YR+  H    ++ L      
Sbjct: 72  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 130
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFG----LSRLKAN-TFL 107
              Y + + + Y+H     I HRD+K  NLL+D    V K+CDFG    L R + N +++
Sbjct: 131 LYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 188
Query: 108 SSKSAAGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW--GNLNPAQVVAAV 164
            S+       + APE++        S D++S G +L EL  L QP   G+    Q+V  +
Sbjct: 189 CSRY------YRAPELIFGATDYTSSIDVWSAGCVLAEL-LLGQPIFPGDSGVDQLVEII 241
Query: 165 GFKG--KRLEIPRNVNPH 180
              G   R +I R +NP+
Sbjct: 242 KVLGTPTREQI-REMNPN 258

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 29/198 (14%)
Query: 1   MKRLRHPNIVLF------MGAVTQPPNLSIVTEYLSRGSLYRLL-HKPGVREMLDERRRL 53
           M++L H NIV         G       L++V +Y+   ++YR+  H    ++ L      
Sbjct: 105 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 163
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFG----LSRLKAN-TFL 107
              Y + + + Y+H     I HRD+K  NLL+D    V K+CDFG    L R + N +++
Sbjct: 164 LYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 221
Query: 108 SSKSAAGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW--GNLNPAQVVAAV 164
            S+       + APE++        S D++S G +L EL  L QP   G+    Q+V  +
Sbjct: 222 CSRY------YRAPELIFGATDYTSSIDVWSAGCVLAEL-LLGQPIFPGDSGVDQLVEII 274
Query: 165 GFKG--KRLEIPRNVNPH 180
              G   R +I R +NP+
Sbjct: 275 KVLGTPTREQI-REMNPN 291

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 29/198 (14%)
Query: 1   MKRLRHPNIV----LFM--GAVTQPPNLSIVTEYLSRGSLYRLL-HKPGVREMLDERRRL 53
           M++L H NIV     F   G       L++V +Y+   ++YR+  H    ++ L      
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 125
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFG----LSRLKAN-TFL 107
              Y + + + Y+H     I HRD+K  NLL+D    V K+CDFG    L R + N +++
Sbjct: 126 LYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 108 SSKSAAGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW--GNLNPAQVVAAV 164
            S+       + APE++        S D++S G +L EL  L QP   G+    Q+V  +
Sbjct: 184 CSRY------YRAPELIFGATDYTSSIDVWSAGCVLAEL-LLGQPIFPGDSGVDQLVEII 236
Query: 165 GFKG--KRLEIPRNVNPH 180
              G   R +I R +NP+
Sbjct: 237 KVLGTPTREQI-REMNPN 253

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 29/198 (14%)
Query: 1   MKRLRHPNIVLF------MGAVTQPPNLSIVTEYLSRGSLYRLL-HKPGVREMLDERRRL 53
           M++L H NIV         G       L++V +Y+   ++YR+  H    ++ L      
Sbjct: 103 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 161
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFG----LSRLKAN-TFL 107
              Y + + + Y+H     I HRD+K  NLL+D    V K+CDFG    L R + N +++
Sbjct: 162 LYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 219
Query: 108 SSKSAAGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW--GNLNPAQVVAAV 164
            S+       + APE++        S D++S G +L EL  L QP   G+    Q+V  +
Sbjct: 220 CSRY------YRAPELIFGATDYTSSIDVWSAGCVLAEL-LLGQPIFPGDSGVDQLVEII 272
Query: 165 GFKG--KRLEIPRNVNPH 180
              G   R +I R +NP+
Sbjct: 273 KVLGTPTREQI-REMNPN 289

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 29/198 (14%)
Query: 1   MKRLRHPNIVLF------MGAVTQPPNLSIVTEYLSRGSLYRLL-HKPGVREMLDERRRL 53
           M++L H NIV         G       L++V +Y+   ++YR+  H    ++ L      
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 159
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFG----LSRLKAN-TFL 107
              Y + + + Y+H     I HRD+K  NLL+D    V K+CDFG    L R + N +++
Sbjct: 160 LYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 217
Query: 108 SSKSAAGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW--GNLNPAQVVAAV 164
            S+       + APE++        S D++S G +L EL  L QP   G+    Q+V  +
Sbjct: 218 CSRY------YRAPELIFGATDYTSSIDVWSAGCVLAEL-LLGQPIFPGDSGVDQLVEII 270
Query: 165 GFKG--KRLEIPRNVNPH 180
              G   R +I R +NP+
Sbjct: 271 KVLGTPTREQI-REMNPN 287

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 29/198 (14%)
Query: 1   MKRLRHPNIVLF------MGAVTQPPNLSIVTEYLSRGSLYRLL-HKPGVREMLDERRRL 53
           M++L H NIV         G       L++V +Y+   ++YR+  H    ++ L      
Sbjct: 146 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 204
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFG----LSRLKAN-TFL 107
              Y + + + Y+H     I HRD+K  NLL+D    V K+CDFG    L R + N +++
Sbjct: 205 LYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 262
Query: 108 SSKSAAGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW--GNLNPAQVVAAV 164
            S+       + APE++        S D++S G +L EL  L QP   G+    Q+V  +
Sbjct: 263 CSRY------YRAPELIFGATDYTSSIDVWSAGCVLAEL-LLGQPIFPGDSGVDQLVEII 315
Query: 165 GFKG--KRLEIPRNVNPH 180
              G   R +I R +NP+
Sbjct: 316 KVLGTPTREQI-REMNPN 332

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 29/198 (14%)
Query: 1   MKRLRHPNIVLF------MGAVTQPPNLSIVTEYLSRGSLYRLL-HKPGVREMLDERRRL 53
           M++L H NIV         G       L++V +Y+   ++YR+  H    ++ L      
Sbjct: 95  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 153
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFG----LSRLKAN-TFL 107
              Y + + + Y+H     I HRD+K  NLL+D    V K+CDFG    L R + N +++
Sbjct: 154 LYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 211
Query: 108 SSKSAAGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW--GNLNPAQVVAAV 164
            S+       + APE++        S D++S G +L EL  L QP   G+    Q+V  +
Sbjct: 212 CSRY------YRAPELIFGATDYTSSIDVWSAGCVLAEL-LLGQPIFPGDSGVDQLVEII 264
Query: 165 GFKG--KRLEIPRNVNPH 180
              G   R +I R +NP+
Sbjct: 265 KVLGTPTREQI-REMNPN 281

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 29/198 (14%)
Query: 1   MKRLRHPNIV----LFM--GAVTQPPNLSIVTEYLSRGSLYRLL-HKPGVREMLDERRRL 53
           M++L H NIV     F   G       L++V +Y+   ++YR+  H    ++ L      
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 125
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFG----LSRLKAN-TFL 107
              Y + + + Y+H     I HRD+K  NLL+D    V K+CDFG    L R + N +++
Sbjct: 126 LYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 108 SSKSAAGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW--GNLNPAQVVAAV 164
            S+       + APE++        S D++S G +L EL  L QP   G+    Q+V  +
Sbjct: 184 CSRY------YRAPELIFGATDYTSSIDVWSAGCVLAEL-LLGQPIFPGDSGVDQLVEII 236
Query: 165 GFKG--KRLEIPRNVNPH 180
              G   R +I R +NP+
Sbjct: 237 KVLGTPTREQI-REMNPN 253

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 29/198 (14%)
Query: 1   MKRLRHPNIVLF------MGAVTQPPNLSIVTEYLSRGSLYRLL-HKPGVREMLDERRRL 53
           M++L H NIV         G       L++V +Y+   ++YR+  H    ++ L      
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 125
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFG----LSRLKAN-TFL 107
              Y + + + Y+H     I HRD+K  NLL+D    V K+CDFG    L R + N +++
Sbjct: 126 LYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 108 SSKSAAGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW--GNLNPAQVVAAV 164
            S+       + APE++        S D++S G +L EL  L QP   G+    Q+V  +
Sbjct: 184 CSRY------YRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFPGDSGVDQLVEII 236
Query: 165 GFKG--KRLEIPRNVNPH 180
              G   R +I R +NP+
Sbjct: 237 KVLGTPTREQI-REMNPN 253

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 29/198 (14%)
Query: 1   MKRLRHPNIVLF------MGAVTQPPNLSIVTEYLSRGSLYRLL-HKPGVREMLDERRRL 53
           M++L H NIV         G       L++V +Y+   ++YR+  H    ++ L      
Sbjct: 80  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 138
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFG----LSRLKAN-TFL 107
              Y + + + Y+H     I HRD+K  NLL+D    V K+CDFG    L R + N +++
Sbjct: 139 LYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 196
Query: 108 SSKSAAGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW--GNLNPAQVVAAV 164
            S+       + APE++        S D++S G +L EL  L QP   G+    Q+V  +
Sbjct: 197 CSRY------YRAPELIFGATDYTSSIDVWSAGCVLAEL-LLGQPIFPGDSGVDQLVEII 249
Query: 165 GFKG--KRLEIPRNVNPH 180
              G   R +I R +NP+
Sbjct: 250 KVLGTPTREQI-REMNPN 266

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 90/197 (45%), Gaps = 27/197 (13%)
Query: 1   MKRLRHPNIVLF------MGAVTQPPNLSIVTEYLSRGSLYRLL-HKPGVREMLDERRRL 53
           M++L H NIV         G       L++V +Y+   ++YR+  H    ++ L      
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 125
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFG----LSRLKANTFLS 108
              Y + + + Y+H     I HRD+K  NLL+D    V K+CDFG    L R + N    
Sbjct: 126 LYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--- 180
Query: 109 SKSAAGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW--GNLNPAQVVAAVG 165
             S   +  + APE++        S D++S G +L EL  L QP   G+    Q+V  + 
Sbjct: 181 --SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL-LLGQPIFPGDSGVDQLVEIIK 237
Query: 166 FKG--KRLEIPRNVNPH 180
             G   R +I R +NP+
Sbjct: 238 VLGTPTREQI-REMNPN 253

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 90/197 (45%), Gaps = 27/197 (13%)
Query: 1   MKRLRHPNIVLF------MGAVTQPPNLSIVTEYLSRGSLYRLL-HKPGVREMLDERRRL 53
           M++L H NIV         G       L++V +Y+   ++YR+  H    ++ L      
Sbjct: 68  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 126
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFG----LSRLKANTFLS 108
              Y + + + Y+H     I HRD+K  NLL+D    V K+CDFG    L R + N    
Sbjct: 127 LYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--- 181
Query: 109 SKSAAGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW--GNLNPAQVVAAVG 165
             S   +  + APE++        S D++S G +L EL  L QP   G+    Q+V  + 
Sbjct: 182 --SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFPGDSGVDQLVEIIK 238
Query: 166 FKG--KRLEIPRNVNPH 180
             G   R +I R +NP+
Sbjct: 239 VLGTPTREQI-REMNPN 254

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 90/197 (45%), Gaps = 27/197 (13%)
Query: 1   MKRLRHPNIVLF------MGAVTQPPNLSIVTEYLSRGSLYRLL-HKPGVREMLDERRRL 53
           M++L H NIV         G       L++V +Y+   ++YR+  H    ++ L      
Sbjct: 86  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 144
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFG----LSRLKANTFLS 108
              Y + + + Y+H     I HRD+K  NLL+D    V K+CDFG    L R + N    
Sbjct: 145 LYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--- 199
Query: 109 SKSAAGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW--GNLNPAQVVAAVG 165
             S   +  + APE++        S D++S G +L EL  L QP   G+    Q+V  + 
Sbjct: 200 --SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL-LLGQPIFPGDSGVDQLVEIIK 256
Query: 166 FKG--KRLEIPRNVNPH 180
             G   R +I R +NP+
Sbjct: 257 VLGTPTREQI-REMNPN 272

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 90/197 (45%), Gaps = 27/197 (13%)
Query: 1   MKRLRHPNIVLF------MGAVTQPPNLSIVTEYLSRGSLYRLL-HKPGVREMLDERRRL 53
           M++L H NIV         G       L++V +Y+   ++YR+  H    ++ L      
Sbjct: 71  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 129
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFG----LSRLKANTFLS 108
              Y + + + Y+H     I HRD+K  NLL+D    V K+CDFG    L R + N    
Sbjct: 130 LYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--- 184
Query: 109 SKSAAGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW--GNLNPAQVVAAVG 165
             S   +  + APE++        S D++S G +L EL  L QP   G+    Q+V  + 
Sbjct: 185 --SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL-LLGQPIFPGDSGVDQLVEIIK 241
Query: 166 FKG--KRLEIPRNVNPH 180
             G   R +I R +NP+
Sbjct: 242 VLGTPTREQI-REMNPN 257

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 90/197 (45%), Gaps = 27/197 (13%)
Query: 1   MKRLRHPNIVLF------MGAVTQPPNLSIVTEYLSRGSLYRLL-HKPGVREMLDERRRL 53
           M++L H NIV         G       L++V +Y+   ++YR+  H    ++ L      
Sbjct: 75  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 133
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFG----LSRLKANTFLS 108
              Y + + + Y+H     I HRD+K  NLL+D    V K+CDFG    L R + N    
Sbjct: 134 LYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--- 188
Query: 109 SKSAAGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW--GNLNPAQVVAAVG 165
             S   +  + APE++        S D++S G +L EL  L QP   G+    Q+V  + 
Sbjct: 189 --SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL-LLGQPIFPGDSGVDQLVEIIK 245
Query: 166 FKG--KRLEIPRNVNPH 180
             G   R +I R +NP+
Sbjct: 246 VLGTPTREQI-REMNPN 261

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 90/197 (45%), Gaps = 27/197 (13%)
Query: 1   MKRLRHPNIVLF------MGAVTQPPNLSIVTEYLSRGSLYRLL-HKPGVREMLDERRRL 53
           M++L H NIV         G       L++V +Y+   ++YR+  H    ++ L      
Sbjct: 79  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 137
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFG----LSRLKANTFLS 108
              Y + + + Y+H     I HRD+K  NLL+D    V K+CDFG    L R + N    
Sbjct: 138 LYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--- 192
Query: 109 SKSAAGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW--GNLNPAQVVAAVG 165
             S   +  + APE++        S D++S G +L EL  L QP   G+    Q+V  + 
Sbjct: 193 --SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL-LLGQPIFPGDSGVDQLVEIIK 249
Query: 166 FKG--KRLEIPRNVNPH 180
             G   R +I R +NP+
Sbjct: 250 VLGTPTREQI-REMNPN 265

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 90/197 (45%), Gaps = 27/197 (13%)
Query: 1   MKRLRHPNIVLF------MGAVTQPPNLSIVTEYLSRGSLYRLL-HKPGVREMLDERRRL 53
           M++L H NIV         G       L++V +Y+   ++YR+  H    ++ L      
Sbjct: 79  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 137
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFG----LSRLKANTFLS 108
              Y + + + Y+H     I HRD+K  NLL+D    V K+CDFG    L R + N    
Sbjct: 138 LYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--- 192
Query: 109 SKSAAGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW--GNLNPAQVVAAVG 165
             S   +  + APE++        S D++S G +L EL  L QP   G+    Q+V  + 
Sbjct: 193 --SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL-LLGQPIFPGDSGVDQLVEIIK 249
Query: 166 FKG--KRLEIPRNVNPH 180
             G   R +I R +NP+
Sbjct: 250 VLGTPTREQI-REMNPN 265

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 90/197 (45%), Gaps = 27/197 (13%)
Query: 1   MKRLRHPNIVLF------MGAVTQPPNLSIVTEYLSRGSLYRLL-HKPGVREMLDERRRL 53
           M++L H NIV         G       L++V +Y+   ++YR+  H    ++ L      
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 125
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFG----LSRLKANTFLS 108
              Y + + + Y+H     I HRD+K  NLL+D    V K+CDFG    L R + N    
Sbjct: 126 LYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--- 180
Query: 109 SKSAAGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW--GNLNPAQVVAAVG 165
             S   +  + APE++        S D++S G +L EL  L QP   G+    Q+V  + 
Sbjct: 181 --SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL-LLGQPIFPGDSGVDQLVEIIK 237
Query: 166 FKG--KRLEIPRNVNPH 180
             G   R +I R +NP+
Sbjct: 238 VLGTPTREQI-REMNPN 253

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 84/166 (50%), Gaps = 25/166 (15%)
Query: 7   PNIVLFMGAVTQPPNLS--IVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
           PNI+     V  P + +  +V E+++     +L      + + D   R  M Y++ K ++
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYM-YEILKALD 145
Query: 65  YLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRL-----KANTFLSSKSAAGTPEW 118
           Y H  +  I+HRD+K  N+L+D ++  +++ D+GL+       + N  ++S+   G    
Sbjct: 146 YCH--SMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---- 199
Query: 119 MAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW--GNLNPAQVV 161
             PE+L D    + S D++S G +L  +   ++P+  G+ N  Q+V
Sbjct: 200 --PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 27/197 (13%)
Query: 1   MKRLRHPNIV---LFMGAVTQPPN---LSIVTEYLSRGSLYRLL-HKPGVREMLDERRRL 53
           M++L H NIV    F  +  +  +   L++V +Y+   ++YR+  H    ++ L      
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 125
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFG----LSRLKANTFLS 108
              Y + + + Y+H     I HRD+K  NLL+D    V K+CDFG    L R + N    
Sbjct: 126 LYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--- 180
Query: 109 SKSAAGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW--GNLNPAQVVAAVG 165
             S   +  + APE++        S D++S G +L EL  L QP   G+    Q+V  + 
Sbjct: 181 --SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL-LLGQPIFPGDSGVDQLVEIIK 237
Query: 166 FKG--KRLEIPRNVNPH 180
             G   R +I R +NP+
Sbjct: 238 VLGTPTREQI-REMNPN 253

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 90/197 (45%), Gaps = 27/197 (13%)
Query: 1   MKRLRHPNIVLF------MGAVTQPPNLSIVTEYLSRGSLYRLL-HKPGVREMLDERRRL 53
           M++L H NIV         G       L++V +Y+   ++YR+  H    ++ L      
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 159
Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFG----LSRLKANTFLS 108
              Y + + + Y+H     I HRD+K  NLL+D    V K+CDFG    L R + N    
Sbjct: 160 LYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--- 214
Query: 109 SKSAAGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW--GNLNPAQVVAAVG 165
             S   +  + APE++        S D++S G +L EL  L QP   G+    Q+V  + 
Sbjct: 215 --SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL-LLGQPIFPGDSGVDQLVEIIK 271
Query: 166 FKG--KRLEIPRNVNPH 180
             G   R +I R +NP+
Sbjct: 272 VLGTPTREQI-REMNPN 287

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 21/160 (13%)
Query: 1   MKRLRHPNIVLFMGAVTQP-----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNM 55
           +  + HP+IV     V        P   IV EY+   SL R        + L     +  
Sbjct: 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKR-----SKGQKLPVAEAIAY 187
Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFG-LSRLKANTFLSSKSAAG 114
             ++   ++YLH     +V+ DLK  N+++ ++  +K+ D G +SR+ +  +L      G
Sbjct: 188 LLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLY-----G 239
Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN 154
           TP + APE++R  P+   +DIY+ G  L  L TL  P  N
Sbjct: 240 TPGFQAPEIVRTGPT-VATDIYTVGRTLAAL-TLDLPTRN 277

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 84/166 (50%), Gaps = 25/166 (15%)
Query: 7   PNIVLFMGAVTQPPNLS--IVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
           PNI+     V  P + +  +V E+++     +L      + + D   R  M Y++ K ++
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYM-YEILKALD 145
Query: 65  YLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRL-----KANTFLSSKSAAGTPEW 118
           Y H  +  I+HRD+K  N+++D ++  +++ D+GL+       + N  ++S+   G    
Sbjct: 146 YCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---- 199
Query: 119 MAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW--GNLNPAQVV 161
             PE+L D    + S D++S G +L  +   ++P+  G+ N  Q+V
Sbjct: 200 --PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 95/200 (47%), Gaps = 41/200 (20%)
Query: 8   NIVLFMGAVTQPPNLS--IVTEYLSRGS---LYRLLHKPGVREMLDERRRLNMAYDVAKG 62
           NI+  +  V  P + +  +V EY++      LY++L    +R  +         Y++ K 
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRFYM---------YELLKA 144
Query: 63  MNYLHRRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRL-----KANTFLSSKSAAGTP 116
           ++Y H +   I+HRD+K  N+++D ++  +++ D+GL+       + N  ++S+   G  
Sbjct: 145 LDYCHSKG--IMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKG-- 200
Query: 117 EWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW--GNLNPAQVVAAVGFKG----- 168
               PE+L D    + S D++S G +L  +   ++P+  G  N  Q+V      G     
Sbjct: 201 ----PELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELY 256
Query: 169 ---KRLEIPRNVNPHVASII 185
              K+  I  +++PH   I+
Sbjct: 257 GYLKKYHI--DLDPHFNDIL 274

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 27/162 (16%)
Query: 6   HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY 65
           H NIV  +  +    +  +   YL    +   LH      +L+   +  + Y + K + Y
Sbjct: 68  HENIVNLLNVLRADNDRDV---YLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKY 124
Query: 66  LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR---------------LKANT--FLS 108
           LH  +  ++HRD+K  N+L++ +  VKV DFGLSR               +  NT  F  
Sbjct: 125 LH--SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 109 SK----SAAGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWEL 145
            +        T  + APE+L       K  D++S G IL E+
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 84/166 (50%), Gaps = 25/166 (15%)
Query: 7   PNIVLFMGAVTQPPNLS--IVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
           PNI+     V  P + +  +V E+++     +L      + + D   R  M Y++ K ++
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYM-YEILKALD 145
Query: 65  YLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRL-----KANTFLSSKSAAGTPEW 118
           Y H  +  I+HRD+K  N+++D ++  +++ D+GL+       + N  ++S+   G    
Sbjct: 146 YCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---- 199
Query: 119 MAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW--GNLNPAQVV 161
             PE+L D    + S D++S G +L  +   ++P+  G+ N  Q+V
Sbjct: 200 --PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 84/166 (50%), Gaps = 25/166 (15%)
Query: 7   PNIVLFMGAVTQPPNLS--IVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
           PNI+     V  P + +  +V E+++     +L      + + D   R  M Y++ K ++
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYM-YEILKALD 144
Query: 65  YLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRL-----KANTFLSSKSAAGTPEW 118
           Y H  +  I+HRD+K  N+++D ++  +++ D+GL+       + N  ++S+   G    
Sbjct: 145 YCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---- 198
Query: 119 MAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW--GNLNPAQVV 161
             PE+L D    + S D++S G +L  +   ++P+  G+ N  Q+V
Sbjct: 199 --PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 242

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 84/166 (50%), Gaps = 25/166 (15%)
Query: 7   PNIVLFMGAVTQPPNLS--IVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
           PNI+     V  P + +  +V E+++     +L      + + D   R  M Y++ K ++
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYM-YEILKALD 145
Query: 65  YLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRL-----KANTFLSSKSAAGTPEW 118
           Y H  +  I+HRD+K  N+++D ++  +++ D+GL+       + N  ++S+   G    
Sbjct: 146 YCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---- 199
Query: 119 MAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW--GNLNPAQVV 161
             PE+L D    + S D++S G +L  +   ++P+  G+ N  Q+V
Sbjct: 200 --PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 84/166 (50%), Gaps = 25/166 (15%)
Query: 7   PNIVLFMGAVTQPPNLS--IVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
           PNI+     V  P + +  +V E+++     +L      + + D   R  M Y++ K ++
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYM-YEILKALD 145
Query: 65  YLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRL-----KANTFLSSKSAAGTPEW 118
           Y H  +  I+HRD+K  N+++D ++  +++ D+GL+       + N  ++S+   G    
Sbjct: 146 YCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---- 199
Query: 119 MAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW--GNLNPAQVV 161
             PE+L D    + S D++S G +L  +   ++P+  G+ N  Q+V
Sbjct: 200 --PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 90/198 (45%), Gaps = 21/198 (10%)
Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +L H ++VL  G         +V E++  GSL   L K   +  ++   +L +A  +A
Sbjct: 66  MSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLA 123
Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLV----DKKYT----VKVCDFGLSRLKANTFLSSKSA 112
             M++L      ++H ++ + N+L+    D+K      +K+ D G+S     T L     
Sbjct: 124 WAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI----TVLPKDIL 177
Query: 113 AGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKR 170
                W+ PE + +  + N  +D +SFG  LWE+ +   +P   L+  +    + F   R
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR---KLQFYEDR 234
Query: 171 LEIPRNVNPHVASIIEAC 188
            ++P      +A++I  C
Sbjct: 235 HQLPAPKAAELANLINNC 252

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 84/166 (50%), Gaps = 25/166 (15%)
Query: 7   PNIVLFMGAVTQPPNLS--IVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
           PNI+     V  P + +  +V E+++     +L      + + D   R  M Y++ K ++
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYM-YEILKALD 145
Query: 65  YLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRL-----KANTFLSSKSAAGTPEW 118
           Y H  +  I+HRD+K  N+++D ++  +++ D+GL+       + N  ++S+   G    
Sbjct: 146 YCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---- 199
Query: 119 MAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW--GNLNPAQVV 161
             PE+L D    + S D++S G +L  +   ++P+  G+ N  Q+V
Sbjct: 200 --PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/130 (24%), Positives = 58/130 (44%), Gaps = 15/130 (11%)
Query: 73  IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA--NTFLSSKSAAGTPEWMAPEVLRDEPSN 130
           IVH DLK  N L+     +K+ DFG++       T +   S  GT  +M PE ++D  S+
Sbjct: 128 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 186
Query: 131 EKS-----------DIYSFGVILWELATLQQPWGN-LNPAQVVAAVGFKGKRLEIPRNVN 178
            ++           D++S G IL+ +   + P+   +N    + A+      +E P    
Sbjct: 187 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 246
Query: 179 PHVASIIEAC 188
             +  +++ C
Sbjct: 247 KDLQDVLKCC 256

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 83/166 (50%), Gaps = 25/166 (15%)
Query: 7   PNIVLFMGAVTQPPNLS--IVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
           PNI+     V  P + +  +V E+++     +L      + + D   R  M Y++ K ++
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYM-YEILKALD 145
Query: 65  YLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRL-----KANTFLSSKSAAGTPEW 118
           Y H     I+HRD+K  N+++D ++  +++ D+GL+       + N  ++S+   G    
Sbjct: 146 YCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---- 199
Query: 119 MAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW--GNLNPAQVV 161
             PE+L D    + S D++S G +L  +   ++P+  G+ N  Q+V
Sbjct: 200 --PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 84/166 (50%), Gaps = 25/166 (15%)
Query: 7   PNIVLFMGAVTQPPNLS--IVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
           PNI+     V  P + +  +V E+++     +L      + + D   R  M Y++ K ++
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYM-YEILKALD 145
Query: 65  YLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRL-----KANTFLSSKSAAGTPEW 118
           Y H  +  I+HRD+K  N+++D ++  +++ D+GL+       + N  ++S+   G    
Sbjct: 146 YCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---- 199
Query: 119 MAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW--GNLNPAQVV 161
             PE+L D    + S D++S G +L  +   ++P+  G+ N  Q+V
Sbjct: 200 --PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	191
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-125
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-111
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-110
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-107
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-104
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-103
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-103
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-103
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-102
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-89
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-89
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-86
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-83
3soc_A	322	Activin receptor type-2A; structural genomics cons	8e-82
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	8e-73
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-61
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	7e-56
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-54
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-54
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-53
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-53
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-53
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-53
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-53
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-52
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-52
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-52
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-52
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	9e-52
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	9e-52
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-51
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-51
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-51
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-51
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-51
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-51
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-50
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-50
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-50
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-50
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-50
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-50
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	6e-50
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	6e-50
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	8e-50
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-49
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-49
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-49
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-49
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-49
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-49
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-49
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-49
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-48
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-48
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-48
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-48
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-48
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-48
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-48
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-47
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-47
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-47
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	9e-47
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-46
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-46
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-46
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-46
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	8e-46
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-45
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-45
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-45
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-44
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-44
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-43
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-42
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	8e-42
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-41
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-40
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-40
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-40
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-40
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-40
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-40
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-40
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	7e-40
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-39
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-39
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-38
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-37
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-37
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-37
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-36
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-36
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-36
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-36
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-36
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-36
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-35
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-35
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-35
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-35
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-34
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-34
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-33
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-33
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-06
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-33
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-33
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-33
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-32
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-32
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-32
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-32
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-32
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	8e-32
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	8e-32
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-31
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-31
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-31
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-31
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-31
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-31
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-31
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-31
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-31
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	9e-31
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-30
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-30
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-30
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-30
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-30
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-30
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-30
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	8e-30
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-30
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-29
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-29
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-29
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-29
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-29
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-29
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-29
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-29
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-29
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	7e-29
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-28
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-28
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-28
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-28
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-28
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-28
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-28
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-27
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-27
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-27
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-26
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-26
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-26
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-26
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-26
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-26
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-26
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-26
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	8e-26
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	9e-26
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-25
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-25
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-25
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-25
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-25
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-25
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-25
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	7e-25
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-24
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-24
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-24
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-24
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	8e-24
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-23
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-23
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-23
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-23
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-23
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-23
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-23
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	9e-23
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-22
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-22
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-22
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-22
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-21
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-21
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-21
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-21
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	9e-21
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-20
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-20
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-20
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	8e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-19
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-19
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-18
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-18
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-18
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-18
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	7e-18
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	9e-18
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-17
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-17
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-17
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	8e-17
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-16
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-16
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-16
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	9e-16
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-15
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	6e-15
3uqc_A	286	Probable conserved transmembrane protein; structur	7e-15
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-14
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-13
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-12
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-12
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-11
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-08
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-08
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	7e-08
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-07
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-04

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  354 bits (910), Expect = e-125
 Identities = 176/191 (92%), Positives = 182/191 (95%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK G RE LDERRRL+MAYDVA
Sbjct: 88  MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           KGMNYLH RNPPIVHR+LKSPNLLVDKKYTVKVCDFGLSRLKA+TFLSSKSAAGTPEWMA
Sbjct: 148 KGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMA 207

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVLRDEPSNEKSD+YSFGVILWELATLQQPWGNLNPAQVVAAVGFK KRLEIPRN+NP 
Sbjct: 208 PEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQ 267

Query: 181 VASIIEACWAK 191
           VA+IIE CW  
Sbjct: 268 VAAIIEGCWTN 278

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  317 bits (815), Expect = e-111
 Identities = 73/200 (36%), Positives = 105/200 (52%), Gaps = 15/200 (7%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
              L+HPNI+   G   + PNL +V E+   G L R+L      + +     +N A  +A
Sbjct: 60  FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIA 115

Query: 61  KGMNYLHRRNP-PIVHRDLKSPNLLVDKKY--------TVKVCDFGLSRLKANTFLSSKS 111
           +GMNYLH     PI+HRDLKS N+L+ +K          +K+ DFGL+R    T  +  S
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT--TKMS 173

Query: 112 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL 171
           AAG   WMAPEV+R    ++ SD++S+GV+LWEL T + P+  ++   V   V      L
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL 233

Query: 172 EIPRNVNPHVASIIEACWAK 191
            IP       A ++E CW  
Sbjct: 234 PIPSTCPEPFAKLMEDCWNP 253

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  313 bits (805), Expect = e-110
 Identities = 56/196 (28%), Positives = 107/196 (54%), Gaps = 11/196 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           ++   HPN++  +GA   PP  + +++T ++  GSLY +LH+     ++D+ + +  A D
Sbjct: 61  LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALD 119

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
           +A+GM +LH   P I    L S ++++D+  T ++    +          S      P W
Sbjct: 120 MARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF-----SFQSPGRMYAPAW 174

Query: 119 MAPEVLRDEPSN---EKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 175
           +APE L+ +P +     +D++SF V+LWEL T + P+ +L+  ++   V  +G R  IP 
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPP 234

Query: 176 NVNPHVASIIEACWAK 191
            ++PHV+ +++ C  +
Sbjct: 235 GISPHVSKLMKICMNE 250

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  307 bits (789), Expect = e-107
 Identities = 66/200 (33%), Positives = 103/200 (51%), Gaps = 16/200 (8%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  L HPNIV   G +  PP   +V E++  G LY  L        +    +L +  D+A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIA 132

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKK-----YTVKVCDFGLSRLKANTFLSSKSAAGT 115
            G+ Y+  +NPPIVHRDL+SPN+ +           KV DFGLS+   ++        G 
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS---VSGLLGN 189

Query: 116 PEWMAPEVL--RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV--VAAVGFKGKRL 171
            +WMAPE +   +E   EK+D YSF +IL+ + T + P+   +  ++  +  +  +G R 
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249

Query: 172 EIPRNVNPHVASIIEACWAK 191
            IP +  P + ++IE CW+ 
Sbjct: 250 TIPEDCPPRLRNVIELCWSG 269

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  301 bits (772), Expect = e-104
 Identities = 67/194 (34%), Positives = 103/194 (53%), Gaps = 8/194 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           + R+ HPNIV   GA   P  + +V EY   GSLY +LH             ++     +
Sbjct: 55  LSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112

Query: 61  KGMNYLHRRNP-PIVHRDLKSPNLLVDKKYTV-KVCDFGLSRLKANTFLSSKSAAGTPEW 118
           +G+ YLH   P  ++HRDLK PNLL+    TV K+CDFG +        ++K   G+  W
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAW 169

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN-PAQVVAAVGFKGKRLEIPRNV 177
           MAPEV      +EK D++S+G+ILWE+ T ++P+  +  PA  +      G R  + +N+
Sbjct: 170 MAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL 229

Query: 178 NPHVASIIEACWAK 191
              + S++  CW+K
Sbjct: 230 PKPIESLMTRCWSK 243

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  298 bits (764), Expect = e-103
 Identities = 62/206 (30%), Positives = 95/206 (46%), Gaps = 19/206 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M+ L HPN++ F+G + +   L+ +TEY+  G+L  ++     +      +R++ A D+A
Sbjct: 61  MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIA 118

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--------------KANTF 106
            GM YLH  N  I+HRDL S N LV +   V V DFGL+RL              K    
Sbjct: 119 SGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176

Query: 107 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 166
               +  G P WMAPE++     +EK D++SFG++L E+        +  P  +   +  
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV 236

Query: 167 K-GKRLEIPRNVNPHVASIIEACWAK 191
           +       P N  P    I   C   
Sbjct: 237 RGFLDRYCPPNCPPSFFPITVRCCDL 262

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  296 bits (760), Expect = e-103
 Identities = 72/200 (36%), Positives = 117/200 (58%), Gaps = 14/200 (7%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +++ RH NI+LFMG  T P  L+IVT++    SLY  LH    +   + ++ +++A   A
Sbjct: 74  LRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTA 130

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK--SAAGTPEW 118
           +GM+YLH ++  I+HRDLKS N+ + +  TVK+ DFGL+  K+    S +    +G+  W
Sbjct: 131 RGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 188

Query: 119 MAPEVLRDEPSN---EKSDIYSFGVILWELATLQQPWGNLNPA-QVVAAVGFKGKR---L 171
           MAPEV+R + SN    +SD+Y+FG++L+EL T Q P+ N+N   Q++  VG         
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLS 248

Query: 172 EIPRNVNPHVASIIEACWAK 191
           ++  N    +  ++  C  K
Sbjct: 249 KVRSNCPKRMKRLMAECLKK 268

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  296 bits (760), Expect = e-102
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 19/205 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
            ++ RH N+VLFMGA   PP+L+I+T      +LY ++     + +LD  +   +A ++ 
Sbjct: 83  YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIV 140

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS-----AAGT 115
           KGM YLH +   I+H+DLKS N+  D    V + DFGL  +        +        G 
Sbjct: 141 KGMGYLHAKG--ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGW 197

Query: 116 PEWMAPEVLR---------DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 166
              +APE++R           P ++ SD+++ G I +EL   + P+       ++  +G 
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT 257

Query: 167 KGKRLEIPRNVNPHVASIIEACWAK 191
             K       +   ++ I+  CWA 
Sbjct: 258 GMKPNLSQIGMGKEISDILLFCWAF 282

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  263 bits (675), Expect = 1e-89
 Identities = 62/231 (26%), Positives = 100/231 (43%), Gaps = 44/231 (19%)

Query: 1   MKRLRHPNIVLFMGAVT----QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
              LRH NI+ F+ +          L ++T Y   GSLY  L        LD    L + 
Sbjct: 56  TVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIV 111

Query: 57  YDVAKGMNYLH------RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF---- 106
             +A G+ +LH      +  P I HRDLKS N+LV K     + D GL+ + + +     
Sbjct: 112 LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLD 171

Query: 107 LSSKSAAGTPEWMAPEVLRDEP------SNEKSDIYSFGVILWELAT----------LQQ 150
           + +    GT  +MAPEVL +        S ++ DI++FG++LWE+A            + 
Sbjct: 172 VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231

Query: 151 PWGNLNP-----AQVVAAVGFKGKRLEIPRNVNPH-----VASIIEACWAK 191
           P+ ++ P       +   V    +R  IP           +A +++ CW +
Sbjct: 232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQ 282

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  263 bits (674), Expect = 5e-89
 Identities = 67/231 (29%), Positives = 98/231 (42%), Gaps = 44/231 (19%)

Query: 1   MKRLRHPNIVLFMGAVTQP----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
              +RH NI+ F+ A  +       L ++T+Y   GSLY  L        LD +  L +A
Sbjct: 85  TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLA 140

Query: 57  YDVAKGMNYLH------RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT----F 106
           Y    G+ +LH      +  P I HRDLKS N+LV K  T  + D GL+    +      
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVD 200

Query: 107 LSSKSAAGTPEWMAPEVL------RDEPSNEKSDIYSFGVILWELAT----------LQQ 150
           +   +  GT  +M PEVL          S   +D+YSFG+ILWE+A            Q 
Sbjct: 201 IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260

Query: 151 PWGNLNPAQ-----VVAAVGFKGKRLEIPRNVNPH-----VASIIEACWAK 191
           P+ +L P+      +   V  K  R   P   +       +  ++  CWA 
Sbjct: 261 PYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAH 311

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  249 bits (638), Expect = 2e-83
 Identities = 65/231 (28%), Positives = 101/231 (43%), Gaps = 44/231 (19%)

Query: 1   MKRLRHPNIVLFMGAVTQ----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
              LRH NI+ F+ A  +       L +V++Y   GSL+  L+    R  +     + +A
Sbjct: 90  TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLA 145

Query: 57  YDVAKGMNYLH------RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT----F 106
              A G+ +LH      +  P I HRDLKS N+LV K  T  + D GL+    +      
Sbjct: 146 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 205

Query: 107 LSSKSAAGTPEWMAPEVLRDE------PSNEKSDIYSFGVILWELATL----------QQ 150
           ++     GT  +MAPEVL D        S +++DIY+ G++ WE+A            Q 
Sbjct: 206 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265

Query: 151 PWGNLNPA-----QVVAAVGFKGKRLEIPRNVNPH-----VASIIEACWAK 191
           P+ +L P+     ++   V  +  R  IP           +A I+  CW  
Sbjct: 266 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 316

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  244 bits (625), Expect = 8e-82
 Identities = 57/229 (24%), Positives = 93/229 (40%), Gaps = 44/229 (19%)

Query: 1   MKRLRHPNIVLFMGAVTQPPN----LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
           +  ++H NI+ F+GA  +  +    L ++T +  +GSL   L       ++      ++A
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK----ANVVSWNELCHIA 127

Query: 57  YDVAKGMNYLH--------RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK--ANTF 106
             +A+G+ YLH           P I HRD+KS N+L+    T  + DFGL+       + 
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 107 LSSKSAAGTPEWMAPEVLRDEP-----SNEKSDIYSFGVILWELATLQQPWGNLNPA--- 158
             +    GT  +MAPEVL         +  + D+Y+ G++LWELA+              
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247

Query: 159 -------------QVVAAVGFKGKRLEIPRNVNPH-----VASIIEACW 189
                         +   V  K KR  +      H     +   IE CW
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECW 296

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  222 bits (567), Expect = 8e-73
 Identities = 61/240 (25%), Positives = 91/240 (37%), Gaps = 55/240 (22%)

Query: 1   MKRLRHPNIVLFMGAVTQPP-----NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNM 55
           +  + H NI  F+    +          +V EY   GSL + L         D      +
Sbjct: 61  VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS----LHTSDWVSSCRL 116

Query: 56  AYDVAKGMNYLH-------RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL- 107
           A+ V +G+ YLH          P I HRDL S N+LV    T  + DFGLS       L 
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176

Query: 108 -------SSKSAAGTPEWMAPEVLRD-------EPSNEKSDIYSFGVILWELA---TLQQ 150
                  ++ S  GT  +MAPEVL         E + ++ D+Y+ G+I WE+    T   
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236

Query: 151 PWGNLNPAQV---------------VAAVGFKGKRLEIPRNVNPH------VASIIEACW 189
           P  ++   Q+                  V  + +R + P     +      +   IE CW
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  191 bits (488), Expect = 2e-61
 Identities = 68/197 (34%), Positives = 106/197 (53%), Gaps = 12/197 (6%)

Query: 1   MKRLRHPNIVLFMGA----VTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
           +K L+HPNIV F  +    V     + +VTE ++ G+L   L +  V   +  +   +  
Sbjct: 79  LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWC 135

Query: 57  YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGT 115
             + KG+ +LH R PPI+HRDLK  N+ +     +VK+ D GL+ LK  +F  +K+  GT
Sbjct: 136 RQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGT 193

Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL-NPAQVVAAVGFKGKRLEIP 174
           PE+MAPE+  +E  +E  D+Y+FG+ + E+AT + P+    N AQ+   V    K     
Sbjct: 194 PEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 252

Query: 175 RNVNPHVASIIEACWAK 191
           +   P V  IIE C  +
Sbjct: 253 KVAIPEVKEIIEGCIRQ 269

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  179 bits (457), Expect = 7e-56
 Identities = 69/194 (35%), Positives = 96/194 (49%), Gaps = 8/194 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K+  HPNIV  +G  TQ   + IV E +  G     L   G    L  +  L M  D A
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAA 223

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTP-EW 118
            GM YL  +    +HRDL + N LV +K  +K+ DFG+SR      + +S      P +W
Sbjct: 224 AGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKW 281

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            APE L     + +SD++SFG++LWE  +L   P+ NL+  Q    V  KG RL  P   
Sbjct: 282 TAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELC 340

Query: 178 NPHVASIIEACWAK 191
              V  ++E CWA 
Sbjct: 341 PDAVFRLMEQCWAY 354

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  172 bits (439), Expect = 4e-54
 Identities = 64/193 (33%), Positives = 105/193 (54%), Gaps = 7/193 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK+L+H  +V     VTQ P   I+TEY+  GSL   L  P     L   + L+MA  +A
Sbjct: 62  MKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIA 119

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
           +GM ++  RN   +HRDL++ N+LV    + K+ DFGL+RL  +   +++  A  P +W 
Sbjct: 120 EGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE +       KSD++SFG++L E+ T  + P+  +   +V+  +  +G R+  P N  
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCP 236

Query: 179 PHVASIIEACWAK 191
             +  ++  CW +
Sbjct: 237 EELYQLMRLCWKE 249

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  172 bits (437), Expect = 8e-54
 Identities = 69/193 (35%), Positives = 108/193 (55%), Gaps = 6/193 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK ++HPN+V  +G  T+ P   I+TE+++ G+L   L +   R+ +     L MA  ++
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQIS 121

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
             M YL ++N   +HRDL + N LV + + VKV DFGLSRL      ++ + A  P +W 
Sbjct: 122 SAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE L     + KSD+++FGV+LWE+AT    P+  ++ +QV   +  K  R+E P    
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 238

Query: 179 PHVASIIEACWAK 191
             V  ++ ACW  
Sbjct: 239 EKVYELMRACWQW 251

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  176 bits (449), Expect = 2e-53
 Identities = 67/193 (34%), Positives = 108/193 (55%), Gaps = 6/193 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK ++HPN+V  +G  T+ P   I+TE+++ G+L   L +   R+ +     L MA  ++
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQIS 328

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEWM 119
             M YL ++N   +HR+L + N LV + + VKV DFGLSR +  +T+ +   A    +W 
Sbjct: 329 SAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 386

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE L     + KSD+++FGV+LWE+AT    P+  ++ +QV   +  K  R+E P    
Sbjct: 387 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 445

Query: 179 PHVASIIEACWAK 191
             V  ++ ACW  
Sbjct: 446 EKVYELMRACWQW 458

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  172 bits (438), Expect = 2e-53
 Identities = 56/194 (28%), Positives = 96/194 (49%), Gaps = 9/194 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G       + ++T+ +  G L   + +   ++ +  +  LN    +A
Sbjct: 71  MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 127

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTP-EW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFGL++ L A            P +W
Sbjct: 128 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  +  +++ + +  KG+RL  P   
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPIC 244

Query: 178 NPHVASIIEACWAK 191
              V  I+  CW  
Sbjct: 245 TIDVYMIMRKCWMI 258

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  170 bits (433), Expect = 2e-53
 Identities = 67/193 (34%), Positives = 104/193 (53%), Gaps = 7/193 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +L HP +V F G  ++   + IVTEY+S G L   L   G  + L+  + L M YDV 
Sbjct: 57  MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVC 114

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
           +GM +L       +HRDL + N LVD+   VKV DFG++R   +    S      P +W 
Sbjct: 115 EGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS 172

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APEV      + KSD+++FG+++WE+ +L + P+     ++VV  V  +G RL  P   +
Sbjct: 173 APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLAS 231

Query: 179 PHVASIIEACWAK 191
             +  I+ +CW +
Sbjct: 232 DTIYQIMYSCWHE 244

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  170 bits (434), Expect = 2e-53
 Identities = 63/193 (32%), Positives = 99/193 (51%), Gaps = 7/193 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  L H  +V   G  T+   + I+TEY++ G L   L +   R     ++ L M  DV 
Sbjct: 73  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVC 130

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
           + M YL  +    +HRDL + N LV+ +  VKV DFGLSR   +   +S   +  P  W 
Sbjct: 131 EAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 188

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
            PEVL     + KSDI++FGV++WE+ +L + P+     ++    +  +G RL  P   +
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLAS 247

Query: 179 PHVASIIEACWAK 191
             V +I+ +CW +
Sbjct: 248 EKVYTIMYSCWHE 260

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  169 bits (431), Expect = 4e-53
 Identities = 63/193 (32%), Positives = 100/193 (51%), Gaps = 7/193 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +L HP +V   G   +   + +VTE++  G L   L     R +      L M  DV 
Sbjct: 57  MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVC 114

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
           +GM YL      ++HRDL + N LV +   +KV DFG++R   +   +S +    P +W 
Sbjct: 115 EGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 172

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           +PEV      + KSD++SFGV++WE+ +  + P+ N + ++VV  +   G RL  PR  +
Sbjct: 173 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLAS 231

Query: 179 PHVASIIEACWAK 191
            HV  I+  CW +
Sbjct: 232 THVYQIMNHCWRE 244

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  173 bits (440), Expect = 1e-52
 Identities = 68/193 (35%), Positives = 104/193 (53%), Gaps = 7/193 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK+LRH  +V     V++ P   IVTEY+S+GSL   L      + L   + ++MA  +A
Sbjct: 233 MKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIA 290

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
            GM Y+ R N   VHRDL++ N+LV +    KV DFGL+RL  +   +++  A  P +W 
Sbjct: 291 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 348

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE         KSD++SFG++L EL T  + P+  +   +V+  V  +G R+  P    
Sbjct: 349 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 407

Query: 179 PHVASIIEACWAK 191
             +  ++  CW K
Sbjct: 408 ESLHDLMCQCWRK 420

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  168 bits (429), Expect = 1e-52
 Identities = 70/194 (36%), Positives = 108/194 (55%), Gaps = 11/194 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQ-PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           M +LRH N+V  +G + +    L IVTEY+++GSL   L   G R +L     L  + DV
Sbjct: 68  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDV 126

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
            + M YL   N   VHRDL + N+LV +    KV DFGL++  ++T  + K     P +W
Sbjct: 127 CEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKW 180

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            APE LR++  + KSD++SFG++LWE+ +  + P+  +    VV  V  KG +++ P   
Sbjct: 181 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGC 239

Query: 178 NPHVASIIEACWAK 191
            P V  +++ CW  
Sbjct: 240 PPAVYEVMKNCWHL 253

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  169 bits (431), Expect = 3e-52
 Identities = 50/188 (26%), Positives = 103/188 (54%), Gaps = 4/188 (2%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +  ++HPNIV +  +  +  +L IV +Y   G L++ ++      +  E + L+    + 
Sbjct: 77  LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQK-GVLFQEDQILDWFVQIC 135

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             + ++H R   I+HRD+KS N+ + K  TV++ DFG++R+  +T   +++  GTP +++
Sbjct: 136 LALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLS 193

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PE+  ++P N KSDI++ G +L+EL TL+  +   +   +V  +   G    +  + +  
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII-SGSFPPVSLHYSYD 252

Query: 181 VASIIEAC 188
           + S++   
Sbjct: 253 LRSLVSQL 260

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  167 bits (425), Expect = 5e-52
 Identities = 65/195 (33%), Positives = 96/195 (49%), Gaps = 9/195 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  L H N++   G V  PP + +VTE    GSL   L K   +           A  VA
Sbjct: 75  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVA 131

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP-E 117
           +GM YL  +    +HRDL + NLL+  +  VK+ DFGL R   + +     +     P  
Sbjct: 132 EGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 189

Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE L+    +  SD + FGV LWE+ T  Q+PW  LN +Q++  +  +G+RL  P +
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 249

Query: 177 VNPHVASIIEACWAK 191
               + +++  CWA 
Sbjct: 250 CPQDIYNVMVQCWAH 264

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  171 bits (435), Expect = 9e-52
 Identities = 58/193 (30%), Positives = 105/193 (54%), Gaps = 7/193 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK L+H  +V     VT+ P   I+TE++++GSL   L            + ++ +  +A
Sbjct: 237 MKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIA 294

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
           +GM ++ +RN   +HRDL++ N+LV      K+ DFGL+R+  +   +++  A  P +W 
Sbjct: 295 EGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT 352

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE +       KSD++SFG++L E+ T  + P+  ++  +V+ A+  +G R+  P N  
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCP 411

Query: 179 PHVASIIEACWAK 191
             + +I+  CW  
Sbjct: 412 EELYNIMMRCWKN 424

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  166 bits (423), Expect = 9e-52
 Identities = 59/193 (30%), Positives = 89/193 (46%), Gaps = 8/193 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK L HP+IV  +G + + P   I+ E    G L   L +   +  L     +  +  + 
Sbjct: 67  MKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQIC 123

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
           K M YL   N   VHRD+   N+LV     VK+ DFGLSR   +      S    P +WM
Sbjct: 124 KAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 181

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           +PE +        SD++ F V +WE+ +  +QP+  L    V+  +  KG RL  P    
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPDLCP 240

Query: 179 PHVASIIEACWAK 191
           P + +++  CW  
Sbjct: 241 PVLYTLMTRCWDY 253

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  172 bits (438), Expect = 1e-51
 Identities = 68/193 (35%), Positives = 104/193 (53%), Gaps = 7/193 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK+LRH  +V     V++ P   IVTEY+S+GSL   L      + L   + ++MA  +A
Sbjct: 316 MKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIA 373

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
            GM Y+ R N   VHRDL++ N+LV +    KV DFGL+RL  +   +++  A  P +W 
Sbjct: 374 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 431

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE         KSD++SFG++L EL T  + P+  +   +V+  V  +G R+  P    
Sbjct: 432 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 490

Query: 179 PHVASIIEACWAK 191
             +  ++  CW K
Sbjct: 491 ESLHDLMCQCWRK 503

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  167 bits (425), Expect = 1e-51
 Identities = 64/194 (32%), Positives = 97/194 (50%), Gaps = 9/194 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +  L H +IV  +G       L +VT+YL  GSL   + +   R  L  +  LN    +A
Sbjct: 69  IGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIA 125

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTP-EW 118
           KGM YL      +VHR+L + N+L+     V+V DFG++  L  +      S A TP +W
Sbjct: 126 KGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  L  A+V   +  KG+RL  P+  
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQIC 242

Query: 178 NPHVASIIEACWAK 191
              V  ++  CW  
Sbjct: 243 TIDVYMVMVKCWMI 256

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  169 bits (431), Expect = 3e-51
 Identities = 70/194 (36%), Positives = 108/194 (55%), Gaps = 11/194 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQ-PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           M +LRH N+V  +G + +    L IVTEY+++GSL   L   G R +L     L  + DV
Sbjct: 240 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDV 298

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EW 118
            + M YL   N   VHRDL + N+LV +    KV DFGL++  ++T  + K     P +W
Sbjct: 299 CEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKW 352

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            APE LR++  + KSD++SFG++LWE+ +  + P+  +    VV  V  KG +++ P   
Sbjct: 353 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGC 411

Query: 178 NPHVASIIEACWAK 191
            P V  +++ CW  
Sbjct: 412 PPAVYDVMKNCWHL 425

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  165 bits (419), Expect = 5e-51
 Identities = 58/197 (29%), Positives = 99/197 (50%), Gaps = 11/197 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQP-PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           M+ L HPN++  +G +  P     ++  Y+  G L + +  P  +     +  ++    V
Sbjct: 76  MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQV 133

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGT-P 116
           A+GM YL  +    VHRDL + N ++D+ +TVKV DFGL+R       +   +      P
Sbjct: 134 ARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP 191

Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIP 174
            +W A E L+      KSD++SFGV+LWEL T    P+ +++P  +   +  +G+RL  P
Sbjct: 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-QGRRLPQP 250

Query: 175 RNVNPHVASIIEACWAK 191
                 +  +++ CW  
Sbjct: 251 EYCPDSLYQVMQQCWEA 267

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  165 bits (419), Expect = 5e-51
 Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 19/207 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL-------------HKPGVREML 47
           +  L+H +IV F G       L +V EY+  G L + L                  +  L
Sbjct: 71  LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130

Query: 48  DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTF 106
              + L++A  +A GM YL  ++   VHRDL + N LV     VK+ DFG+SR + +  +
Sbjct: 131 GLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 188

Query: 107 LSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
                    P  WM PE +       +SD++SFGVILWE+ T  +QPW  L+  +V+  +
Sbjct: 189 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 248

Query: 165 GFKGKRLEIPRNVNPHVASIIEACWAK 191
             +G+ LE PR     V  ++  CW +
Sbjct: 249 T-QGRVLERPRVCPKEVYDVMLGCWQR 274

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  165 bits (420), Expect = 7e-51
 Identities = 56/194 (28%), Positives = 96/194 (49%), Gaps = 9/194 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G       + ++T+ +  G L   + +   ++ +  +  LN    +A
Sbjct: 71  MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 127

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTP-EW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFGL++ L A            P +W
Sbjct: 128 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           MA E +       +SD++S+GV +WEL T   +P+  +  +++ + +  KG+RL  P   
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPIC 244

Query: 178 NPHVASIIEACWAK 191
              V  I+  CW  
Sbjct: 245 TIDVYMIMVKCWMI 258

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  163 bits (415), Expect = 2e-50
 Identities = 60/193 (31%), Positives = 96/193 (49%), Gaps = 8/193 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M++  HP+IV  +G +T+ P   I+ E  + G L   L     +  LD    +  AY ++
Sbjct: 70  MRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLS 126

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
             + YL  +    VHRD+ + N+LV     VK+ DFGLSR   ++     S    P +WM
Sbjct: 127 TALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 184

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE +        SD++ FGV +WE+     +P+  +    V+  +   G+RL +P N  
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCP 243

Query: 179 PHVASIIEACWAK 191
           P + S++  CWA 
Sbjct: 244 PTLYSLMTKCWAY 256

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  164 bits (418), Expect = 2e-50
 Identities = 68/206 (33%), Positives = 101/206 (49%), Gaps = 18/206 (8%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL------------HKPGVREMLD 48
           +  L+H +IV F G  T+   L +V EY+  G L R L             +      L 
Sbjct: 97  LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156

Query: 49  ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFL 107
             + L +A  VA GM YL   +   VHRDL + N LV +   VK+ DFG+SR + +  + 
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 214

Query: 108 SSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVG 165
                   P  WM PE +       +SD++SFGV+LWE+ T  +QPW  L+  + +  + 
Sbjct: 215 RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274

Query: 166 FKGKRLEIPRNVNPHVASIIEACWAK 191
            +G+ LE PR   P V +I+  CW +
Sbjct: 275 -QGRELERPRACPPEVYAIMRGCWQR 299

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  162 bits (413), Expect = 4e-50
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 11/197 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQP-PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           MK   HPN++  +G   +   +  +V  Y+  G L   +           +  +     V
Sbjct: 80  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQV 137

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSSKSAAGT-P 116
           AKGM YL  +    VHRDL + N ++D+K+TVKV DFGL+R       +          P
Sbjct: 138 AKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 195

Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIP 174
            +WMA E L+ +    KSD++SFGV+LWEL T    P+ ++N   +   +  +G+RL  P
Sbjct: 196 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQP 254

Query: 175 RNVNPHVASIIEACWAK 191
                 +  ++  CW  
Sbjct: 255 EYCPDPLYEVMLKCWHP 271

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  163 bits (414), Expect = 5e-50
 Identities = 65/195 (33%), Positives = 96/195 (49%), Gaps = 9/195 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +  HPNI+   G VT+     IVTEY+  GSL   L            + + M   V 
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVG 161

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT--P-E 117
            GM YL       VHRDL + N+LVD     KV DFGLSR+  +   ++ +  G   P  
Sbjct: 162 AGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR 219

Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE +     +  SD++SFGV++WE+    ++P+ N+    V+++V  +G RL  P  
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPMG 278

Query: 177 VNPHVASIIEACWAK 191
               +  ++  CW K
Sbjct: 279 CPHALHQLMLDCWHK 293

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  163 bits (414), Expect = 5e-50
 Identities = 64/201 (31%), Positives = 101/201 (50%), Gaps = 13/201 (6%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-------PGVREMLDERRRL 53
           MK     ++V  +G V+Q     ++ E ++RG L   L           V       + +
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141

Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSA 112
            MA ++A GM YL+      VHRDL + N +V + +TVK+ DFG++R +    +      
Sbjct: 142 QMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199

Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 170
              P  WM+PE L+D      SD++SFGV+LWE+ATL +QP+  L+  QV+  V  +G  
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-MEGGL 258

Query: 171 LEIPRNVNPHVASIIEACWAK 191
           L+ P N    +  ++  CW  
Sbjct: 259 LDKPDNCPDMLFELMRMCWQY 279

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  162 bits (411), Expect = 5e-50
 Identities = 64/194 (32%), Positives = 100/194 (51%), Gaps = 7/194 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAY 57
           ++ L+HPNIV +   +    N  L IV EY   G L  ++ K    R+ LDE   L +  
Sbjct: 59  LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118

Query: 58  DVAKGMNYLHRRNPP---IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
            +   +   HRR+     ++HRDLK  N+ +D K  VK+ DFGL+R+  +    +K+  G
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVG 178

Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP 174
           TP +M+PE +     NEKSDI+S G +L+EL  L  P+   +  ++   +  +GK   IP
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIP 237

Query: 175 RNVNPHVASIIEAC 188
              +  +  II   
Sbjct: 238 YRYSDELNEIITRM 251

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  162 bits (413), Expect = 6e-50
 Identities = 49/176 (27%), Positives = 91/176 (51%), Gaps = 5/176 (2%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDV 59
           +K+L HPN++ +  +  +   L+IV E    G L R++      + ++ ER        +
Sbjct: 86  LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
              + ++H R   ++HRD+K  N+ +     VK+ D GL R  ++   ++ S  GTP +M
Sbjct: 146 CSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 203

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 175
           +PE + +   N KSDI+S G +L+E+A LQ P+        + ++  K ++ + P 
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKKIEQCDYPP 257

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  162 bits (413), Expect = 6e-50
 Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 15/203 (7%)

Query: 1   MKRLRHPNIVLFMGAVTQ------PPNLSIVTEYLSRGSLY---RLLHKPGVREMLDERR 51
           MK   HP++   +G   +       P   ++  ++  G L+              L  + 
Sbjct: 79  MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT 138

Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSK 110
            +    D+A GM YL  RN   +HRDL + N ++ +  TV V DFGLSR + +  +    
Sbjct: 139 LVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQG 196

Query: 111 SAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 168
            A+  P +W+A E L D      SD+++FGV +WE+ T  Q P+  +  A++   +   G
Sbjct: 197 CASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI-GG 255

Query: 169 KRLEIPRNVNPHVASIIEACWAK 191
            RL+ P      V  ++  CW+ 
Sbjct: 256 NRLKQPPECMEEVYDLMYQCWSA 278

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  162 bits (412), Expect = 8e-50
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 14/202 (6%)

Query: 1   MKRLRHPNIVLFMGAVTQ-----PPNLSIVTEYLSRGSLY---RLLHKPGVREMLDERRR 52
           MK   HPN++  +G   +      P   ++  ++  G L+            + +  +  
Sbjct: 90  MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL 149

Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKS 111
           L    D+A GM YL  RN   +HRDL + N ++    TV V DFGLS+ + +  +     
Sbjct: 150 LKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGR 207

Query: 112 AAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGK 169
            A  P +W+A E L D     KSD+++FGV +WE+AT    P+  +   ++   +   G 
Sbjct: 208 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL-HGH 266

Query: 170 RLEIPRNVNPHVASIIEACWAK 191
           RL+ P +    +  I+ +CW  
Sbjct: 267 RLKQPEDCLDELYEIMYSCWRT 288

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  162 bits (412), Expect = 1e-49
 Identities = 59/195 (30%), Positives = 101/195 (51%), Gaps = 9/195 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +  H NI+   G +++   + I+TEY+  G+L + L +          + + M   +A
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIA 157

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT--P-E 117
            GM YL   N   VHRDL + N+LV+     KV DFGLSR+  +   ++ + +G   P  
Sbjct: 158 AGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 215

Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE +        SD++SFG+++WE+ T  ++P+  L+  +V+ A+   G RL  P +
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMD 274

Query: 177 VNPHVASIIEACWAK 191
               +  ++  CW +
Sbjct: 275 CPSAIYQLMMQCWQQ 289

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  160 bits (407), Expect = 3e-49
 Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 26/212 (12%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLS--IVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +K L+H NIV + G        +  ++ EYL  GSL   L K   +E +D  + L     
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQ 122

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP 116
           + KGM YL  +    +HRDL + N+LV+ +  VK+ DFGL+++  +   F   K    +P
Sbjct: 123 ICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180

Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELATL----------------QQPWGNLNPAQ 159
             W APE L +   +  SD++SFGV+L+EL T                     G +    
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240

Query: 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK 191
           ++  +     RL  P      +  I+  CW  
Sbjct: 241 LIELLK-NNGRLPRPDGCPDEIYMIMTECWNN 271

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  167 bits (425), Expect = 3e-49
 Identities = 60/193 (31%), Positives = 96/193 (49%), Gaps = 8/193 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M++  HP+IV  +G +T+ P   I+ E  + G L   L     +  LD    +  AY ++
Sbjct: 445 MRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLS 501

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP-EWM 119
             + YL  +    VHRD+ + N+LV     VK+ DFGLSR   ++     S    P +WM
Sbjct: 502 TALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 559

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE +        SD++ FGV +WE+     +P+  +    V+  +   G+RL +P N  
Sbjct: 560 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCP 618

Query: 179 PHVASIIEACWAK 191
           P + S++  CWA 
Sbjct: 619 PTLYSLMTKCWAY 631

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  160 bits (406), Expect = 4e-49
 Identities = 54/195 (27%), Positives = 99/195 (50%), Gaps = 11/195 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M++L +P IV  +G       + +V E    G L + L +      + ++  + + + V+
Sbjct: 72  MQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVS 127

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP-E 117
            GM YL   N   VHRDL + N+L+  ++  K+ DFGLS+       +  +++    P +
Sbjct: 128 MGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 185

Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE +     + KSD++SFGV++WE  +  Q+P+  +  ++V A +  KG+R+  P  
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAG 244

Query: 177 VNPHVASIIEACWAK 191
               +  ++  CW  
Sbjct: 245 CPREMYDLMNLCWTY 259

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  161 bits (409), Expect = 4e-49
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 13/201 (6%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL----HKPGVREMLDERRRLNMA 56
           + +  H NIV  +G   Q     I+ E ++ G L   L     +P     L     L++A
Sbjct: 87  ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146

Query: 57  YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSR-LKANTFLSSKSA 112
            D+A G  YL   +   +HRD+ + N L+         K+ DFG++R +   ++      
Sbjct: 147 RDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 204

Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 170
           A  P +WM PE   +     K+D +SFGV+LWE+ +L   P+ + +  +V+  V   G R
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SGGR 263

Query: 171 LEIPRNVNPHVASIIEACWAK 191
           ++ P+N    V  I+  CW  
Sbjct: 264 MDPPKNCPGPVYRIMTQCWQH 284

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  161 bits (408), Expect = 4e-49
 Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 26/212 (12%)

Query: 1   MKRLRHPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +K L+H NIV + G         L ++ EYL  GSL   L K   +E +D  + L     
Sbjct: 96  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQ 153

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAG-TP 116
           + KGM YL  +    +HRDL + N+LV+ +  VK+ DFGL++ L  +         G +P
Sbjct: 154 ICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211

Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELATL----------------QQPWGNLNPAQ 159
             W APE L +   +  SD++SFGV+L+EL T                     G +    
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271

Query: 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK 191
           ++  +     RL  P      +  I+  CW  
Sbjct: 272 LIELLK-NNGRLPRPDGCPDEIYMIMTECWNN 302

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  160 bits (406), Expect = 4e-49
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 19/207 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-------------PGVREML 47
             RL+HPN+V  +G VT+   LS++  Y S G L+  L                 V+  L
Sbjct: 66  RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125

Query: 48  DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTF 106
           +    +++   +A GM YL   +  +VH+DL + N+LV  K  VK+ D GL R + A  +
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY 183

Query: 107 LSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 164
                 +  P  WMAPE +     +  SDI+S+GV+LWE+ +   QP+   +   VV  +
Sbjct: 184 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 243

Query: 165 GFKGKRLEIPRNVNPHVASIIEACWAK 191
               + L  P +    V +++  CW +
Sbjct: 244 R-NRQVLPCPDDCPAWVYALMIECWNE 269

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  162 bits (411), Expect = 5e-49
 Identities = 62/197 (31%), Positives = 98/197 (49%), Gaps = 11/197 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQP-PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           MK   HPN++  +G   +   +  +V  Y+  G L   +           +  +     V
Sbjct: 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQV 201

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGT--P 116
           AKGM +L  +    VHRDL + N ++D+K+TVKV DFGL+R +    F S  +  G   P
Sbjct: 202 AKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 259

Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIP 174
            +WMA E L+ +    KSD++SFGV+LWEL T    P+ ++N   +   +  +G+RL  P
Sbjct: 260 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQP 318

Query: 175 RNVNPHVASIIEACWAK 191
                 +  ++  CW  
Sbjct: 319 EYCPDPLYEVMLKCWHP 335

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  158 bits (403), Expect = 1e-48
 Identities = 56/195 (28%), Positives = 102/195 (52%), Gaps = 10/195 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +L +P IV  +G       + +V E    G L++ L        +       + + V+
Sbjct: 64  MHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVS 120

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP-E 117
            GM YL  +N   VHRDL + N+L+  ++  K+ DFGLS+     +++ +++SA   P +
Sbjct: 121 MGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 178

Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE +     + +SD++S+GV +WE  +  Q+P+  +   +V+A +  +GKR+E P  
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPE 237

Query: 177 VNPHVASIIEACWAK 191
             P + +++  CW  
Sbjct: 238 CPPELYALMSDCWIY 252

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  160 bits (408), Expect = 1e-48
 Identities = 61/195 (31%), Positives = 98/195 (50%), Gaps = 9/195 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +  HPNI+   G VT+   + IVTEY+  GSL   L K          + + M   +A
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIA 157

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT--P-E 117
            GM YL       VHRDL + N+L++     KV DFGL R+  +   ++ +  G   P  
Sbjct: 158 SGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215

Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W +PE +        SD++S+G++LWE+ +  ++P+  ++   V+ AV  +G RL  P +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMD 274

Query: 177 VNPHVASIIEACWAK 191
               +  ++  CW K
Sbjct: 275 CPAALYQLMLDCWQK 289

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  160 bits (406), Expect = 2e-48
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 13/201 (6%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL----HKPGVREMLDERRRLNMA 56
           + +  H NIV  +G   Q     I+ E ++ G L   L     +P     L     L++A
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187

Query: 57  YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSR-LKANTFLSSKSA 112
            D+A G  YL   +   +HRD+ + N L+         K+ DFG++R +    +      
Sbjct: 188 RDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGC 245

Query: 113 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 170
           A  P +WM PE   +     K+D +SFGV+LWE+ +L   P+ + +  +V+  V   G R
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SGGR 304

Query: 171 LEIPRNVNPHVASIIEACWAK 191
           ++ P+N    V  I+  CW  
Sbjct: 305 MDPPKNCPGPVYRIMTQCWQH 325

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  159 bits (405), Expect = 4e-48
 Identities = 67/208 (32%), Positives = 106/208 (50%), Gaps = 20/208 (9%)

Query: 1   MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSL-------------YRLLHKPGVREM 46
           MK + +H NI+  +GA TQ   L ++ EY S+G+L             Y         E 
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187

Query: 47  LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 106
           L  +  ++ AY VA+GM YL  +    +HRDL + N+LV +   +K+ DFGL+R   +  
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245

Query: 107 LSSKSAAGT-P-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAA 163
              K+  G  P +WMAPE L D     +SD++SFGV+LWE+ TL   P+  +   ++   
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305

Query: 164 VGFKGKRLEIPRNVNPHVASIIEACWAK 191
           +  +G R++ P N    +  ++  CW  
Sbjct: 306 LK-EGHRMDKPSNCTNELYMMMRDCWHA 332

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  159 bits (403), Expect = 4e-48
 Identities = 60/222 (27%), Positives = 92/222 (41%), Gaps = 41/222 (18%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-------------------- 40
           M    +PNIV  +G       + ++ EY++ G L   L                      
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163

Query: 41  -PGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS 99
                  L    +L +A  VA GM YL  R    VHRDL + N LV +   VK+ DFGLS
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLS 221

Query: 100 R---------LKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-Q 149
           R            N  +  +       WM PE +       +SD++++GV+LWE+ +   
Sbjct: 222 RNIYSADYYKADGNDAIPIR-------WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274

Query: 150 QPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK 191
           QP+  +   +V+  V   G  L  P N    + +++  CW+K
Sbjct: 275 QPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSK 315

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  158 bits (402), Expect = 5e-48
 Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 20/208 (9%)

Query: 1   MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSL-------------YRLLHKPGVREM 46
           MK + +H NI+  +GA TQ   L ++ EY S+G+L             Y         E 
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153

Query: 47  LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 106
           +  +  ++  Y +A+GM YL  +    +HRDL + N+LV +   +K+ DFGL+R   N  
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNID 211

Query: 107 LSSKSAAGT-P-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAA 163
              K+  G  P +WMAPE L D     +SD++SFGV++WE+ TL   P+  +   ++   
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271

Query: 164 VGFKGKRLEIPRNVNPHVASIIEACWAK 191
           +  +G R++ P N    +  ++  CW  
Sbjct: 272 LK-EGHRMDKPANCTNELYMMMRDCWHA 298

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  157 bits (400), Expect = 6e-48
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 27/215 (12%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL---------------------YRLLH 39
           +K++ HP+++   GA +Q   L ++ EY   GSL                          
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139

Query: 40  KPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS 99
                  L     ++ A+ +++GM YL      +VHRDL + N+LV +   +K+ DFGLS
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEGRKMKISDFGLS 197

Query: 100 RLKANTFLSSKSAAGT-P-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLN 156
           R         K + G  P +WMA E L D     +SD++SFGV+LWE+ TL   P+  + 
Sbjct: 198 RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257

Query: 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK 191
           P ++   +   G R+E P N +  +  ++  CW +
Sbjct: 258 PERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQ 291

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  157 bits (399), Expect = 1e-47
 Identities = 56/195 (28%), Positives = 85/195 (43%), Gaps = 12/195 (6%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
              L  P IV   GAV + P ++I  E L  GSL +L+ + G    L E R L       
Sbjct: 104 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC---LPEDRALYYLGQAL 160

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKK-YTVKVCDFGLSR-----LKANTFLSSKSAAG 114
           +G+ YLH R   I+H D+K+ N+L+        +CDFG +          + L+     G
Sbjct: 161 EGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218

Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEI 173
           T   MAPEV+  +P + K DI+S   ++  +     PW       +   +  +     EI
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREI 278

Query: 174 PRNVNPHVASIIEAC 188
           P +  P  A  I+  
Sbjct: 279 PPSCAPLTAQAIQEG 293

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  155 bits (394), Expect = 3e-47
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 25/211 (11%)

Query: 1   MKRLRHPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           ++ L H NIV + G  T+     + ++ E+L  GSL   L K   +  ++ +++L  A  
Sbjct: 77  LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQ 134

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP 116
           + KGM+YL  R    VHRDL + N+LV+ ++ VK+ DFGL++       + + K    +P
Sbjct: 135 ICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP 192

Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELATL---------------QQPWGNLNPAQV 160
             W APE L        SD++SFGV L EL T                    G +   ++
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252

Query: 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK 191
           V  +  +GKRL  P N    V  ++  CW  
Sbjct: 253 VNTLK-EGKRLPCPPNCPDEVYQLMRKCWEF 282

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  156 bits (396), Expect = 3e-47
 Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 19/207 (9%)

Query: 1   MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-----------PGVREMLD 48
           M  L +H NIV  +GA T    + ++TEY   G L   L +                   
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162

Query: 49  ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTF 106
            R  L+ +  VA+GM +L  +N   +HRD+ + N+L+   +  K+ DFGL+R     + +
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 220

Query: 107 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPW-GNLNPAQVVAAV 164
           +   +A    +WMAPE + D     +SD++S+G++LWE+ +L   P+ G L  ++    V
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 280

Query: 165 GFKGKRLEIPRNVNPHVASIIEACWAK 191
              G ++  P     ++ SI++ACWA 
Sbjct: 281 K-DGYQMAQPAFAPKNIYSIMQACWAL 306

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  156 bits (396), Expect = 9e-47
 Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 20/208 (9%)

Query: 1   MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSL-------------YRLLHKPGVREM 46
           MK + +H NI+  +GA TQ   L ++ EY S+G+L             Y         E 
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199

Query: 47  LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 106
           +  +  ++  Y +A+GM YL  +    +HRDL + N+LV +   +K+ DFGL+R   N  
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNID 257

Query: 107 LSSKSAAGT-P-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAA 163
              K+  G  P +WMAPE L D     +SD++SFGV++WE+ TL   P+  +   ++   
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 317

Query: 164 VGFKGKRLEIPRNVNPHVASIIEACWAK 191
           +  +G R++ P N    +  ++  CW  
Sbjct: 318 LK-EGHRMDKPANCTNELYMMMRDCWHA 344

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  154 bits (392), Expect = 1e-46
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 19/206 (9%)

Query: 1   MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSL-------------YRLLHKPGVREM 46
           + +L  HPNI+  +GA      L +  EY   G+L                         
Sbjct: 79  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138

Query: 47  LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 106
           L  ++ L+ A DVA+GM+YL ++    +HRDL + N+LV + Y  K+ DFGLSR     +
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSR-GQEVY 195

Query: 107 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVG 165
           +          WMA E L        SD++S+GV+LWE+ +L   P+  +  A++   + 
Sbjct: 196 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255

Query: 166 FKGKRLEIPRNVNPHVASIIEACWAK 191
            +G RLE P N +  V  ++  CW +
Sbjct: 256 -QGYRLEKPLNCDDEVYDLMRQCWRE 280

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  153 bits (388), Expect = 1e-46
 Identities = 47/205 (22%), Positives = 89/205 (43%), Gaps = 28/205 (13%)

Query: 1   MKRLRHPNIVLFMGA----------------VTQPPNLSIVTEYLSRGSLYRLLHKPGVR 44
           + +L H NIV + G                  ++   L I  E+  +G+L + + K    
Sbjct: 58  LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-G 116

Query: 45  EMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKA 103
           E LD+   L +   + KG++Y+H +   +++RDLK  N+ +     VK+ DFGL   LK 
Sbjct: 117 EKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 174

Query: 104 NTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA 163
           +       + GT  +M+PE +  +   ++ D+Y+ G+IL EL  +         A   + 
Sbjct: 175 DGKR--TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD------TAFETSK 226

Query: 164 VGFKGKRLEIPRNVNPHVASIIEAC 188
                +   I    +    ++++  
Sbjct: 227 FFTDLRDGIISDIFDKKEKTLLQKL 251

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  152 bits (386), Expect = 4e-46
 Identities = 44/202 (21%), Positives = 88/202 (43%), Gaps = 23/202 (11%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +L H ++VL  G         +V E++  GSL   L K   +  ++   +L +A  +A
Sbjct: 66  MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLA 123

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYT--------VKVCDFGLSRLKANTFLSSKSA 112
             M++L      ++H ++ + N+L+ ++          +K+ D G+S       +  K  
Sbjct: 124 AAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-----VLPKDI 176

Query: 113 AGTP-EWMAPEVLRDEPS-NEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGK 169
                 W+ PE + +  + N  +D +SFG  LWE+ +   +P   L+  + +        
Sbjct: 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE-DRH 235

Query: 170 RLEIPRNVNPHVASIIEACWAK 191
           +L  P+     +A++I  C   
Sbjct: 236 QLPAPK--AAELANLINNCMDY 255

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  152 bits (387), Expect = 6e-46
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 31/213 (14%)

Query: 1   MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLL--HKPGVREMLDERRRLNMA 56
           ++ L H +I+ + G        +L +V EY+  GSL   L  H  G+ ++L        A
Sbjct: 87  LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLL------FA 140

Query: 57  YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAG 114
             + +GM YLH ++   +HRDL + N+L+D    VK+ DFGL++   + + +   +    
Sbjct: 141 QQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198

Query: 115 TP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL---------------QQPWGNLNPA 158
           +P  W APE L++      SD++SFGV L+EL T                    G +   
Sbjct: 199 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 258

Query: 159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK 191
           ++   +  +G+RL  P      V  +++ CW  
Sbjct: 259 RLTELLE-RGERLPRPDKCPAEVYHLMKNCWET 290

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  152 bits (386), Expect = 8e-46
 Identities = 65/210 (30%), Positives = 95/210 (45%), Gaps = 23/210 (10%)

Query: 1   MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +K L    IV + G    P   +L +V EYL  G L   L +   R  LD  R L  +  
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQ 135

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP 116
           + KGM YL  R    VHRDL + N+LV+ +  VK+ DFGL++L      +   +    +P
Sbjct: 136 ICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193

Query: 117 -EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGF-------- 166
             W APE L D   + +SD++SFGV+L+EL T   +          +             
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253

Query: 167 -----KGKRLEIPRNVNPHVASIIEACWAK 191
                +G+RL  P      V  +++ CWA 
Sbjct: 254 LELLEEGQRLPAPPACPAEVHELMKLCWAP 283

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  151 bits (384), Expect = 1e-45
 Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 23/211 (10%)

Query: 1   MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL---------------HKPGVR 44
           +  L  H NIV  +GA T      ++TEY   G L   L                     
Sbjct: 80  LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 45  EMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN 104
             LD    L+ +Y VAKGM +L  +N   +HRDL + N+L+      K+CDFGL+R   N
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 105 TFLSSKSAAGT-P-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPW-GNLNPAQV 160
                       P +WMAPE + +     +SD++S+G+ LWEL +L   P+ G    ++ 
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257

Query: 161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK 191
              +  +G R+  P +    +  I++ CW  
Sbjct: 258 YKMIK-EGFRMLSPEHAPAEMYDIMKTCWDA 287

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  151 bits (384), Expect = 1e-45
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 22/210 (10%)

Query: 1   MKRL-RHPNIVLFMGAVTQPPN-LSIVTEYLSRGSL-------------YRLLHKPGVRE 45
           +  +  H N+V  +GA T+P   L ++ E+   G+L             Y++  +   ++
Sbjct: 84  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143

Query: 46  MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKAN 104
            L     +  ++ VAKGM +L  R    +HRDL + N+L+ +K  VK+CDFGL+R +  +
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKD 201

Query: 105 TFLSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPW-GNLNPAQVV 161
                K  A  P +WMAPE + D     +SD++SFGV+LWE+ +L   P+ G     +  
Sbjct: 202 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261

Query: 162 AAVGFKGKRLEIPRNVNPHVASIIEACWAK 191
             +  +G R+  P    P +   +  CW  
Sbjct: 262 RRLK-EGTRMRAPDYTTPEMYQTMLDCWHG 290

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  156 bits (396), Expect = 3e-45
 Identities = 57/195 (29%), Positives = 104/195 (53%), Gaps = 10/195 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +L +P IV  +G       + +V E    G L++ L     RE +       + + V+
Sbjct: 390 MHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVS 446

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTP-E 117
            GM YL  +N   VHR+L + N+L+  ++  K+ DFGLS+     +++ +++SA   P +
Sbjct: 447 MGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 504

Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE +     + +SD++S+GV +WE  +  Q+P+  +   +V+A +  +GKR+E P  
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPE 563

Query: 177 VNPHVASIIEACWAK 191
             P + +++  CW  
Sbjct: 564 CPPELYALMSDCWIY 578

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  149 bits (377), Expect = 1e-44
 Identities = 43/189 (22%), Positives = 77/189 (40%), Gaps = 12/189 (6%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
            K  +HP  V    A  +   L + TE     SL +     G    L E +      D  
Sbjct: 111 EKVGQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGAS--LPEAQVWGYLRDTL 167

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             + +LH +   +VH D+K  N+ +  +   K+ DFGL   +  T  + +   G P +MA
Sbjct: 168 LALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLV-ELGTAGAGEVQEGDPRYMA 224

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNP 179
           PE+L+       +D++S G+ + E+A   +        Q +     +G    E    ++ 
Sbjct: 225 PELLQ-GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQL----RQGYLPPEFTAGLSS 279

Query: 180 HVASIIEAC 188
            + S++   
Sbjct: 280 ELRSVLVMM 288

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  149 bits (378), Expect = 2e-44
 Identities = 65/216 (30%), Positives = 99/216 (45%), Gaps = 28/216 (12%)

Query: 1   MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSL--------------------YRLLH 39
           M +L  H NIV  +GA T    + ++ EY   G L                     + L 
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161

Query: 40  KPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS 99
           +     +L     L  AY VAKGM +L  ++   VHRDL + N+LV     VK+CDFGL+
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGKVVKICDFGLA 219

Query: 100 RLKANTFLSSKSAAGT-P-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPW-GNL 155
           R   +            P +WMAPE L +     KSD++S+G++LWE+ +L   P+ G  
Sbjct: 220 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279

Query: 156 NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK 191
             A     +   G +++ P      +  I+++CWA 
Sbjct: 280 VDANFYKLIQ-NGFKMDQPFYATEEIYIIMQSCWAF 314

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  146 bits (370), Expect = 1e-43
 Identities = 58/193 (30%), Positives = 97/193 (50%), Gaps = 8/193 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
            K L+H NIV ++G+ ++   + I  E +  GSL  LL         +E+        + 
Sbjct: 73  HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL 132

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
           +G+ YLH     IVHRD+K  N+L++     +K+ DFG S+  A     +++  GT ++M
Sbjct: 133 EGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYM 190

Query: 120 APEVLRDEPS--NEKSDIYSFG-VILWELATLQQPWGNL-NPAQVVAAVGFKGKRLEIPR 175
           APE++   P    + +DI+S G  I+ E+AT + P+  L  P   +  VG      EIP 
Sbjct: 191 APEIIDKGPRGYGKAADIWSLGCTII-EMATGKPPFYELGEPQAAMFKVGMFKVHPEIPE 249

Query: 176 NVNPHVASIIEAC 188
           +++    + I  C
Sbjct: 250 SMSAEAKAFILKC 262

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  141 bits (358), Expect = 5e-42
 Identities = 36/209 (17%), Positives = 82/209 (39%), Gaps = 31/209 (14%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDV 59
               +H ++V +  A  +  ++ I  EY + GSL   + +   +     E    ++   V
Sbjct: 65  AVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDK-------------------KYTVKVCDFGLSR 100
            +G+ Y+H  +  +VH D+K  N+ + +                   K   K+ D G   
Sbjct: 125 GRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182

Query: 101 LKANTFLSSKSAAGTPEWMAPEVLR-DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159
             ++     +   G   ++A EVL+ +     K+DI++  + +   A  +    N +   
Sbjct: 183 RISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH 238

Query: 160 VVAAVGFKGKRLEIPRNVNPHVASIIEAC 188
            +     +G+   IP+ ++     +++  
Sbjct: 239 EIR----QGRLPRIPQVLSQEFTELLKVM 263

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  141 bits (357), Expect = 8e-42
 Identities = 45/212 (21%), Positives = 79/212 (37%), Gaps = 29/212 (13%)

Query: 1   MKRLRHPNIVLFMGA------------VTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLD 48
           + +L HP IV +  A             +    L I  +   + +L   ++     E  +
Sbjct: 57  LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116

Query: 49  ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS 108
               L++   +A+ + +LH +   ++HRDLK  N+       VKV DFGL          
Sbjct: 117 RSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174

Query: 109 SK------------SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN 156
                            GT  +M+PE +     + K DI+S G+IL+EL  L      + 
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL--LYPFSTQME 232

Query: 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEAC 188
             + +  V    K   +     P    +++  
Sbjct: 233 RVRTLTDVR-NLKFPPLFTQKYPCEYVMVQDM 263

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  141 bits (357), Expect = 2e-41
 Identities = 33/168 (19%), Positives = 67/168 (39%), Gaps = 19/168 (11%)

Query: 1   MKRLRHPNIVLFMGAVTQPPN----LSIVTEYLSRGSLYRLLHKPGVR-EMLDERRRLNM 55
            +   HPNI+  +    +         ++  +  RG+L+  + +   +   L E + L +
Sbjct: 80  HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWL 139

Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA-- 113
              + +G+  +H       HRDLK  N+L+  +    + D G           S+ A   
Sbjct: 140 LLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197

Query: 114 -------GTPEWMAPEVL---RDEPSNEKSDIYSFGVILWELATLQQP 151
                   T  + APE+         +E++D++S G +L+ +   + P
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  139 bits (352), Expect = 1e-40
 Identities = 58/186 (31%), Positives = 88/186 (47%), Gaps = 23/186 (12%)

Query: 1   MKRLR-HPNIVLFMGAVTQPPNLS-------IVTEYLSRGSLYRLLHKPGVREMLDERRR 52
           MK+L  HPNIV F  A +     S       ++   L +G L   L K   R  L     
Sbjct: 79  MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV 138

Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
           L + Y   + + ++HR+ PPI+HRDLK  NLL+  + T+K+CDFG +   ++    S SA
Sbjct: 139 LKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA 198

Query: 113 A------------GTPEWMAPEVL---RDEPSNEKSDIYSFGVILWELATLQQPWGNLNP 157
                         TP +  PE++    + P  EK DI++ G IL+ L   Q P+ +   
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258

Query: 158 AQVVAA 163
            ++V  
Sbjct: 259 LRIVNG 264

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  139 bits (352), Expect = 2e-40
 Identities = 55/187 (29%), Positives = 90/187 (48%), Gaps = 14/187 (7%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +     P IV F GA      +SI  E++  GSL ++L K G    + E+    ++  V 
Sbjct: 85  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVI 141

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFG----LSRLKANTFLSSKSAAGTP 116
           KG+ YL  ++  I+HRD+K  N+LV+ +  +K+CDFG    L    AN+F       GT 
Sbjct: 142 KGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF------VGTR 194

Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
            +M+PE L+    + +SDI+S G+ L E+A  + P    +  ++    G + +       
Sbjct: 195 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 254

Query: 177 VNPHVAS 183
             P    
Sbjct: 255 PRPRTPG 261

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  137 bits (347), Expect = 3e-40
 Identities = 61/185 (32%), Positives = 97/185 (52%), Gaps = 27/185 (14%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           + +   P +  + G+  +   L I+ EYL  GS   LL +PG    LDE +   +  ++ 
Sbjct: 74  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGP---LDETQIATILREIL 129

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS------RLKANTFLSSKSAAG 114
           KG++YLH      +HRD+K+ N+L+ +   VK+ DFG++      ++K NTF       G
Sbjct: 130 KGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF------VG 181

Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP 174
           TP WMAPEV++    + K+DI+S G+   ELA  + P   L+P +V+           IP
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL---------FLIP 232

Query: 175 RNVNP 179
           +N  P
Sbjct: 233 KNNPP 237

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  138 bits (349), Expect = 4e-40
 Identities = 44/204 (21%), Positives = 86/204 (42%), Gaps = 23/204 (11%)

Query: 1   MKRLRHPN--IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           + +L+  +  I+           + +V E      L   L K   ++ +D   R +   +
Sbjct: 61  LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK---KKSIDPWERKSYWKN 116

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN--TFLSSKSAAGTP 116
           + + ++ +H+    IVH DLK  N L+     +K+ DFG++       T +   S  GT 
Sbjct: 117 MLEAVHTIHQHG--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTV 173

Query: 117 EWMAPEVLRDEPS-----------NEKSDIYSFGVILWELATLQQPWGNL-NPAQVVAAV 164
            +M PE ++D  S           + KSD++S G IL+ +   + P+  + N    + A+
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 233

Query: 165 GFKGKRLEIPRNVNPHVASIIEAC 188
                 +E P      +  +++ C
Sbjct: 234 IDPNHEIEFPDIPEKDLQDVLKCC 257

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  137 bits (347), Expect = 4e-40
 Identities = 44/204 (21%), Positives = 86/204 (42%), Gaps = 23/204 (11%)

Query: 1   MKRLRHPN--IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           + +L+  +  I+           + +V E      L   L K   ++ +D   R +   +
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK---KKSIDPWERKSYWKN 135

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN--TFLSSKSAAGTP 116
           + + ++ +H+    IVH DLK  N L+     +K+ DFG++       T +   S  GT 
Sbjct: 136 MLEAVHTIHQHG--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTV 192

Query: 117 EWMAPEVLRDEPS-----------NEKSDIYSFGVILWELATLQQPWGNL-NPAQVVAAV 164
            +M PE ++D  S           + KSD++S G IL+ +   + P+  + N    + A+
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252

Query: 165 GFKGKRLEIPRNVNPHVASIIEAC 188
                 +E P      +  +++ C
Sbjct: 253 IDPNHEIEFPDIPEKDLQDVLKCC 276

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  139 bits (351), Expect = 4e-40
 Identities = 43/204 (21%), Positives = 85/204 (41%), Gaps = 23/204 (11%)

Query: 1   MKRLRHPN--IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           + +L+  +  I+           + +V E      L   L K   ++ +D   R +   +
Sbjct: 108 LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK---KKSIDPWERKSYWKN 163

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN--TFLSSKSAAGTP 116
           + + ++ +H+    IVH DLK  N L+     +K+ DFG++       T +   S  G  
Sbjct: 164 MLEAVHTIHQHG--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAV 220

Query: 117 EWMAPEVLRDEPSN-----------EKSDIYSFGVILWELATLQQPWGNL-NPAQVVAAV 164
            +M PE ++D  S+            KSD++S G IL+ +   + P+  + N    + A+
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 280

Query: 165 GFKGKRLEIPRNVNPHVASIIEAC 188
                 +E P      +  +++ C
Sbjct: 281 IDPNHEIEFPDIPEKDLQDVLKCC 304

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  137 bits (346), Expect = 5e-40
 Identities = 53/187 (28%), Positives = 83/187 (44%), Gaps = 23/187 (12%)

Query: 1   MKRLRHPNIV-LFMGAV---TQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
           +K+L H NIV LF  A+   T   +  ++ E+   GSLY +L +P     L E   L + 
Sbjct: 61  LKKLNHKNIVKLF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118

Query: 57  YDVAKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSR-LKANTFLSSKS 111
            DV  GMN+L      IVHR++K  N++     D +   K+ DFG +R L+ +      S
Sbjct: 119 RDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VS 174

Query: 112 AAGTPEWMAPEVLRDEPS--------NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA 163
             GT E++ P++                  D++S GV  +  AT   P+      +    
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234

Query: 164 VGFKGKR 170
           V +K   
Sbjct: 235 VMYKIIT 241

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  136 bits (345), Expect = 7e-40
 Identities = 46/175 (26%), Positives = 74/175 (42%), Gaps = 32/175 (18%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLS-------------IVTEYLSRGSLYRLLHKPGVREML 47
           +  L H  +V +  A  +  N               I  EY   G+LY L+H   +    
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN--Q 113

Query: 48  DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 107
                  +   + + ++Y+H +   I+HRDLK  N+ +D+   VK+ DFGL++    +  
Sbjct: 114 QRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171

Query: 108 SS--------------KSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELAT 147
                            SA GT  ++A EVL      NEK D+YS G+I +E+  
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  140 bits (353), Expect = 4e-39
 Identities = 45/170 (26%), Positives = 74/170 (43%), Gaps = 15/170 (8%)

Query: 1   MKRLRHPNIV-LF-----MGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
           MK+L HPN+V        +  +       +  EY   G L + L++      L E     
Sbjct: 66  MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125

Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSR-LKANTFLSSK 110
           +  D++  + YLH     I+HRDLK  N+++         K+ D G ++ L         
Sbjct: 126 LLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC--T 181

Query: 111 SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW-GNLNPAQ 159
              GT +++APE+L  +      D +SFG + +E  T  +P+  N  P Q
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ 231

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  136 bits (344), Expect = 5e-39
 Identities = 50/164 (30%), Positives = 77/164 (46%), Gaps = 23/164 (14%)

Query: 1   MKRLRHPNIV-LFMGAV---TQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
           +K+L H NIV LF  A+   T   +  ++ E+   GSLY +L +P     L E   L + 
Sbjct: 61  LKKLNHKNIVKLF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118

Query: 57  YDVAKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSR-LKANTFLSSKS 111
            DV  GMN+L      IVHR++K  N++     D +   K+ DFG +R L+ +      S
Sbjct: 119 RDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VS 174

Query: 112 AAGTPEWMAPEVLRDEPS--------NEKSDIYSFGVILWELAT 147
             GT E++ P++                  D++S GV  +  AT
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  135 bits (342), Expect = 1e-38
 Identities = 44/188 (23%), Positives = 76/188 (40%), Gaps = 21/188 (11%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
            K   HPNIV +         L +VT +++ GS   L+      + ++E     +   V 
Sbjct: 80  SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI-CTHFMDGMNELAIAYILQGVL 138

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS------RLKANT-FLSSKSAA 113
           K ++Y+H      VHR +K+ ++L+     V +     +        +        K + 
Sbjct: 139 KALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196

Query: 114 GTPEWMAPEVLRDEPS--NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL 171
               W++PEVL+      + KSDIYS G+   ELA    P+ ++   Q++         L
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML---------L 247

Query: 172 EIPRNVNP 179
           E      P
Sbjct: 248 EKLNGTVP 255

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  130 bits (330), Expect = 1e-37
 Identities = 47/152 (30%), Positives = 81/152 (53%), Gaps = 5/152 (3%)

Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-KPGVREMLDERRRLNMAYDVAK 61
             RHP++V  +G   +   + ++ +Y+  G+L R L+        +   +RL +    A+
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150

Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS--SKSAAGTPEWM 119
           G++YLH     I+HRD+KS N+L+D+ +  K+ DFG+S+       +  S    GT  ++
Sbjct: 151 GLHYLH--TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYI 208

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQP 151
            PE        EKSD+YSFGV+L+E+   +  
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  129 bits (327), Expect = 3e-37
 Identities = 54/195 (27%), Positives = 96/195 (49%), Gaps = 19/195 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M+  ++PNIV ++ +      L +V EYL+ GSL  ++ +      +DE +   +  +  
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECL 126

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS------RLKANTFLSSKSAAG 114
           + + +LH     ++HRD+KS N+L+    +VK+ DFG        + K +T        G
Sbjct: 127 QALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM------VG 178

Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEI 173
           TP WMAPEV+  +    K DI+S G++  E+   + P+ N NP + +  +   G   L+ 
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN 238

Query: 174 PRNVNPHVASIIEAC 188
           P  ++      +  C
Sbjct: 239 PEKLSAIFRDFLNRC 253

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  129 bits (327), Expect = 3e-37
 Identities = 53/185 (28%), Positives = 91/185 (49%), Gaps = 25/185 (13%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M++   P++V + G+  +  +L IV EY   GS+  ++        L E     +     
Sbjct: 78  MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT--LTEDEIATILQSTL 135

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS------RLKANTFLSSKSAAG 114
           KG+ YLH      +HRD+K+ N+L++ +   K+ DFG++        K NT +      G
Sbjct: 136 KGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI------G 187

Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP 174
           TP WMAPEV+++   N  +DI+S G+   E+A  + P+ +++P + +           IP
Sbjct: 188 TPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI---------FMIP 238

Query: 175 RNVNP 179
            N  P
Sbjct: 239 TNPPP 243

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  128 bits (324), Expect = 1e-36
 Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 18/166 (10%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M+  +H N+V    +      L ++ E+L  G+L  ++ +      L+E +   +   V 
Sbjct: 96  MRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVL 151

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS------RLKANTFLSSKSAAG 114
           + + YLH +   ++HRD+KS ++L+     VK+ DFG          K  +        G
Sbjct: 152 QALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL------VG 203

Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160
           TP WMAPEV+       + DI+S G+++ E+   + P+ + +P Q 
Sbjct: 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA 249

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  128 bits (323), Expect = 2e-36
 Identities = 51/149 (34%), Positives = 85/149 (57%), Gaps = 5/149 (3%)

Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-KPGVREMLDERRRLNMAYDVAK 61
              H N++   G    P    +V  Y++ GS+   L  +P  +  LD  +R  +A   A+
Sbjct: 83  MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR 142

Query: 62  GMNYLHRR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTPEW 118
           G+ YLH   +P I+HRD+K+ N+L+D+++   V DFGL++L    +T +++    GT   
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGTIGH 201

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELAT 147
           +APE L    S+EK+D++ +GV+L EL T
Sbjct: 202 IAPEYLSTGKSSEKTDVFGYGVMLLELIT 230

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  127 bits (321), Expect = 2e-36
 Identities = 58/148 (39%), Positives = 83/148 (56%), Gaps = 7/148 (4%)

Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
           + +H N+V  +G  +   +L +V  Y+  GSL   L        L    R  +A   A G
Sbjct: 86  KCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANG 145

Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAAGTPEWM 119
           +N+LH      +HRD+KS N+L+D+ +T K+ DFGL+R     A T ++S+   GT  +M
Sbjct: 146 INFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR-IVGTTAYM 202

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELAT 147
           APE LR E    KSDIYSFGV+L E+ T
Sbjct: 203 APEALRGE-ITPKSDIYSFGVVLLEIIT 229

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  127 bits (320), Expect = 3e-36
 Identities = 55/177 (31%), Positives = 87/177 (49%), Gaps = 25/177 (14%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL-----HKPGVREMLDERRRLNM 55
           M +  HPNIV +  +      L +V + LS GS+  ++            +LDE     +
Sbjct: 67  MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126

Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-----------RLKAN 104
             +V +G+ YLH+     +HRD+K+ N+L+ +  +V++ DFG+S                
Sbjct: 127 LREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 184

Query: 105 TFLSSKSAAGTPEWMAPEVL-RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160
           TF       GTP WMAPEV+ +    + K+DI+SFG+   ELAT   P+    P +V
Sbjct: 185 TF------VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV 235

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  126 bits (318), Expect = 4e-36
 Identities = 43/145 (29%), Positives = 73/145 (50%), Gaps = 7/145 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
              LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A
Sbjct: 63  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELA 119

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             ++Y H +   ++HRD+K  NLL+     +K+ DFG S    ++        GT +++ 
Sbjct: 120 NALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TDLCGTLDYLP 175

Query: 121 PEVLRDEPSNEKSDIYSFGVILWEL 145
           PE++     +EK D++S GV+ +E 
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEF 200

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  126 bits (319), Expect = 4e-36
 Identities = 44/145 (30%), Positives = 75/145 (51%), Gaps = 7/145 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
              LRHPNI+           + ++ E+  RG LY+ L K G     DE+R      ++A
Sbjct: 68  QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG---RFDEQRSATFMEELA 124

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             ++Y H R   ++HRD+K  NLL+  K  +K+ DFG S    +     ++  GT +++ 
Sbjct: 125 DALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RTMCGTLDYLP 180

Query: 121 PEVLRDEPSNEKSDIYSFGVILWEL 145
           PE++  +  +EK D++  GV+ +E 
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEF 205

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  125 bits (316), Expect = 1e-35
 Identities = 56/190 (29%), Positives = 98/190 (51%), Gaps = 30/190 (15%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +    HP IV  +GA      L I+ E+   G++  ++ +  +   L E +   +   + 
Sbjct: 70  LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLE--LDRGLTEPQIQVVCRQML 127

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS------RLKANTFLSSKSAAG 114
           + +N+LH +   I+HRDLK+ N+L+  +  +++ DFG+S        K ++F+      G
Sbjct: 128 EALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------G 179

Query: 115 TPEWMAPEV-----LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK 169
           TP WMAPEV     ++D P + K+DI+S G+ L E+A ++ P   LNP +V+     K  
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL----LK-- 233

Query: 170 RLEIPRNVNP 179
              I ++  P
Sbjct: 234 ---IAKSDPP 240

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  126 bits (317), Expect = 1e-35
 Identities = 38/159 (23%), Positives = 64/159 (40%), Gaps = 14/159 (8%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M      N V  +   +    L I  +   + +L   +++    E  +    L++   +A
Sbjct: 115 MDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIA 174

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA------- 113
           + + +LH +   ++HRDLK  N+       VKV DFGL                      
Sbjct: 175 EAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232

Query: 114 -----GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147
                GT  +M+PE +     + K DI+S G+IL+EL  
Sbjct: 233 HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY 271

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  125 bits (315), Expect = 2e-35
 Identities = 44/167 (26%), Positives = 74/167 (44%), Gaps = 20/167 (11%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K    P IV   G      ++ I  E +   +        G    + ER    M   + 
Sbjct: 78  LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGP---IPERILGKMTVAIV 134

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-----RLKANTFLSSKSAAGT 115
           K + YL  ++  ++HRD+K  N+L+D++  +K+CDFG+S         +        AG 
Sbjct: 135 KALYYLKEKHG-VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS------AGC 187

Query: 116 PEWMAPEVLRDEPSNE-----KSDIYSFGVILWELATLQQPWGNLNP 157
             +MAPE +      +     ++D++S G+ L ELAT Q P+ N   
Sbjct: 188 AAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT 234

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  125 bits (316), Expect = 3e-35
 Identities = 39/152 (25%), Positives = 69/152 (45%), Gaps = 10/152 (6%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-----REMLDERRRLNM 55
           +  +++   +   G +T    + I+ EY+   S+ +      V        +  +    +
Sbjct: 97  ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156

Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT 115
              V    +Y+H     I HRD+K  N+L+DK   VK+ DFG S    +  +  K + GT
Sbjct: 157 IKSVLNSFSYIHNEKN-ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI--KGSRGT 213

Query: 116 PEWMAPEVLRDEP--SNEKSDIYSFGVILWEL 145
            E+M PE   +E   +  K DI+S G+ L+ +
Sbjct: 214 YEFMPPEFFSNESSYNGAKVDIWSLGICLYVM 245

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  120 bits (304), Expect = 5e-34
 Identities = 38/145 (26%), Positives = 64/145 (44%), Gaps = 4/145 (2%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
             +L+HP+I+           + +V E    G + R L          E    +  + + 
Sbjct: 65  HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP--FSENEARHFMHQII 122

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            GM YLH     I+HRDL   NLL+ +   +K+ DFGL+           +  GTP +++
Sbjct: 123 TGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYIS 180

Query: 121 PEVLRDEPSNEKSDIYSFGVILWEL 145
           PE+        +SD++S G + + L
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTL 205

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  121 bits (306), Expect = 6e-34
 Identities = 48/163 (29%), Positives = 83/163 (50%), Gaps = 9/163 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK--PGVREMLDERRRLNMAYD 58
           M+    P IV F GA+ +  +  I  E +S  S  +        + +++ E     +   
Sbjct: 75  MRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLA 133

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
             K +N+L   N  I+HRD+K  N+L+D+   +K+CDFG+S    ++ ++    AG   +
Sbjct: 134 TVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS-IAKTRDAGCRPY 191

Query: 119 MAPEVLRDEPSNE----KSDIYSFGVILWELATLQQPWGNLNP 157
           MAPE +    S +    +SD++S G+ L+ELAT + P+   N 
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS 234

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  120 bits (304), Expect = 1e-33
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 23/186 (12%)

Query: 5   RHPNIVLFMGA------VTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
            H NI  + GA            L +V E+   GS+  L+ K      L E     +  +
Sbjct: 79  HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICRE 137

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
           + +G+++LH+    ++HRD+K  N+L+ +   VK+ DFG+S     T     +  GTP W
Sbjct: 138 ILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW 195

Query: 119 MAPEVLRDEPS-----NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEI 173
           MAPEV+  + +     + KSD++S G+   E+A    P  +++P + +    F      I
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL----FL-----I 246

Query: 174 PRNVNP 179
           PRN  P
Sbjct: 247 PRNPAP 252

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score =  121 bits (305), Expect = 1e-33
 Identities = 50/152 (32%), Positives = 80/152 (52%), Gaps = 7/152 (4%)

Query: 44  REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LK 102
           ++ L     +  ++ VAKGM +L  R    +HRDL + N+L+ +K  VK+CDFGL+R + 
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIY 244

Query: 103 ANTFLSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPW-GNLNPAQ 159
            +     K  A  P +WMAPE + D     +SD++SFGV+LWE+ +L   P+ G     +
Sbjct: 245 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 304

Query: 160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK 191
               +  +G R+  P    P +   +  CW  
Sbjct: 305 FCRRL-KEGTRMRAPDYTTPEMYQTMLDCWHG 335

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 46.5 bits (110), Expect = 1e-06
 Identities = 18/102 (17%), Positives = 34/102 (33%), Gaps = 11/102 (10%)

Query: 1   MKRL-RHPNIVLFMGAVTQPPN-LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +  +  H N+V  +GA T+P   L ++ E+   G+L   L           +R   + Y 
Sbjct: 79  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS---------KRNEFVPYK 129

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR 100
                    +     +  DLK     +    +     F   +
Sbjct: 130 TKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  119 bits (301), Expect = 1e-33
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 20/168 (11%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYL--SRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           M+ +  P  V F GA+ +  ++ I  E +  S    Y+ +   G    + E     +A  
Sbjct: 60  MRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQT--IPEDILGKIAVS 117

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-----LKANTFLSSKSAA 113
           + K + +LH +   ++HRD+K  N+L++    VK+CDFG+S      +  +        A
Sbjct: 118 IVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID------A 170

Query: 114 GTPEWMAPEVLRDEPS----NEKSDIYSFGVILWELATLQQPWGNLNP 157
           G   +MAPE +  E +    + KSDI+S G+ + ELA L+ P+ +   
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT 218

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  120 bits (304), Expect = 2e-33
 Identities = 53/165 (32%), Positives = 84/165 (50%), Gaps = 16/165 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +++LRHPN + + G   +     +V EY   GS   LL     ++ L E     + +   
Sbjct: 108 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGAL 164

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS--RLKANTFLSSKSAAGTPEW 118
           +G+ YLH  N  ++HRD+K+ N+L+ +   VK+ DFG +     AN+F       GTP W
Sbjct: 165 QGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF------VGTPYW 216

Query: 119 MAPEV---LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160
           MAPEV   + +   + K D++S G+   ELA  + P  N+N    
Sbjct: 217 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 261

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  122 bits (307), Expect = 2e-33
 Identities = 42/202 (20%), Positives = 76/202 (37%), Gaps = 19/202 (9%)

Query: 1   MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           ++    HPN++ +           I  E  +  +L   + +            + +    
Sbjct: 71  LRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAH--LGLEPITLLQQT 127

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKK-----YTVKVCDFGLSRL---KANTFLSSKS 111
             G+ +LH  N  IVHRDLK  N+L+            + DFGL +      ++F     
Sbjct: 128 TSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185

Query: 112 AAGTPEWMAPEVLRDEPS---NEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVG-F 166
             GT  W+APE+L ++         DI+S G + + + +    P+G     Q    +G  
Sbjct: 186 VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGAC 245

Query: 167 KGKRLEIPRNVNPHVASIIEAC 188
               L   ++ +     +IE  
Sbjct: 246 SLDCLHPEKHEDVIARELIEKM 267

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  117 bits (295), Expect = 1e-32
 Identities = 46/145 (31%), Positives = 70/145 (48%), Gaps = 5/145 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
            + L H ++V F G       + +V E   R SL  L  +   R+ L E         + 
Sbjct: 69  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR---RKALTEPEARYYLRQIV 125

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G  YLHR    ++HRDLK  NL +++   VK+ DFGL+          K   GTP ++A
Sbjct: 126 LGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 183

Query: 121 PEVLRDEPSNEKSDIYSFGVILWEL 145
           PEVL  +  + + D++S G I++ L
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTL 208

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  117 bits (295), Expect = 2e-32
 Identities = 50/151 (33%), Positives = 79/151 (52%), Gaps = 19/151 (12%)

Query: 1   MKRLRHPNIV-LFMGAVTQPPN---LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
           +K+L HPN+V L    V   PN   L +V E +++G +  +     + E  D+ R     
Sbjct: 90  LKKLDHPNVVKLV--EVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSE--DQARFY--F 143

Query: 57  YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAG 114
            D+ KG+ YLH +   I+HRD+K  NLLV +   +K+ DFG+S     ++  L   +  G
Sbjct: 144 QDLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL--SNTVG 199

Query: 115 TPEWMAPEVLRDEPSN---EKSDIYSFGVIL 142
           TP +MAPE L +       +  D+++ GV L
Sbjct: 200 TPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  116 bits (293), Expect = 3e-32
 Identities = 45/147 (30%), Positives = 77/147 (52%), Gaps = 13/147 (8%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
            ++L+HPNIV    ++ +     +V + ++ G L+  ++     RE   E    +    +
Sbjct: 59  CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQI 114

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKY---TVKVCDFGLSR-LKANTFLSSKSAAGT 115
            + + Y H     IVHR+LK  NLL+  K     VK+ DFGL+  +  +        AGT
Sbjct: 115 LESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGT 170

Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVIL 142
           P +++PEVL+ +P ++  DI++ GVIL
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVIL 197

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  117 bits (294), Expect = 4e-32
 Identities = 46/145 (31%), Positives = 70/145 (48%), Gaps = 5/145 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
            + L H ++V F G       + +V E   R SL  L  +   R+ L E         + 
Sbjct: 95  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR---RKALTEPEARYYLRQIV 151

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G  YLHR    ++HRDLK  NL +++   VK+ DFGL+          K   GTP ++A
Sbjct: 152 LGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 209

Query: 121 PEVLRDEPSNEKSDIYSFGVILWEL 145
           PEVL  +  + + D++S G I++ L
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTL 234

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  116 bits (292), Expect = 4e-32
 Identities = 47/146 (32%), Positives = 77/146 (52%), Gaps = 12/146 (8%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
           +K+++H NIV          +  +V + +S G L+ R+L +     +  E+    +   V
Sbjct: 60  LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER----GVYTEKDASLVIQQV 115

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 116
              + YLH     IVHRDLK  NLL    ++   + + DFGLS+++ N  +   +A GTP
Sbjct: 116 LSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM--STACGTP 171

Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVIL 142
            ++APEVL  +P ++  D +S GVI 
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVIT 197

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  115 bits (289), Expect = 8e-32
 Identities = 45/147 (30%), Positives = 70/147 (47%), Gaps = 10/147 (6%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
           +K L HPNI+          N+ IV E    G L  R++      + L E     +   +
Sbjct: 74  LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM 133

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR-LKANTFLSSKSAAGT 115
              + Y H ++  +VH+DLK  N+L         +K+ DFGL+   K++      +AAGT
Sbjct: 134 MNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGT 189

Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVIL 142
             +MAPEV +      K DI+S GV++
Sbjct: 190 ALYMAPEVFK-RDVTFKCDIWSAGVVM 215

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  115 bits (290), Expect = 8e-32
 Identities = 47/194 (24%), Positives = 88/194 (45%), Gaps = 11/194 (5%)

Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
           +L H NIV  +    +     +V EY+   +L   +   G    L     +N    +  G
Sbjct: 67  QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDG 123

Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEWMAP 121
           + + H     IVHRD+K  N+L+D   T+K+ DFG+++ L   +   +    GT ++ +P
Sbjct: 124 IKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSP 181

Query: 122 EVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHV 181
           E  + E ++E +DIYS G++L+E+   + P+        +A    +     +  +V   +
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS-IAIKHIQDSVPNVTTDVRKDI 240

Query: 182 A----SIIEACWAK 191
                ++I     K
Sbjct: 241 PQSLSNVILRATEK 254

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  114 bits (287), Expect = 2e-31
 Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 14/148 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
           ++ +RHPNI+          ++ ++ E +S G L+  L  K    E L E         +
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK----ESLTEDEATQFLKQI 117

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSR-LKANTFLSSKSAAG 114
             G++YLH +   I H DLK  N+++         +K+ DFG++  ++A      K+  G
Sbjct: 118 LDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFG 173

Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVIL 142
           TPE++APE++  EP   ++D++S GVI 
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  115 bits (291), Expect = 2e-31
 Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 6/146 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
              L+HP+IV  +   +    L +V E++    L   ++ +     +  E    +    +
Sbjct: 80  CHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI 139

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 116
            + + Y H  N  I+HRD+K   +L+   +    VK+  FG++     + L +    GTP
Sbjct: 140 LEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTP 197

Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVIL 142
            +MAPEV++ EP  +  D++  GVIL
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVIL 223

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  115 bits (290), Expect = 3e-31
 Identities = 44/146 (30%), Positives = 76/146 (52%), Gaps = 11/146 (7%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
           M +L H N++    A     ++ +V EY+  G L+ R++ +      L E   +     +
Sbjct: 140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDE---SYNLTELDTILFMKQI 196

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKK--YTVKVCDFGLSR-LKANTFLSSKSAAGTP 116
            +G+ ++H+    I+H DLK  N+L   +    +K+ DFGL+R  K    L  K   GTP
Sbjct: 197 CEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--KVNFGTP 252

Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVIL 142
           E++APEV+  +  +  +D++S GVI 
Sbjct: 253 EFLAPEVVNYDFVSFPTDMWSVGVIA 278

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  114 bits (288), Expect = 3e-31
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 14/148 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
           +K ++HPN++          ++ ++ E ++ G L+  L  K    E L E         +
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQI 123

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSR-LKANTFLSSKSAAG 114
             G+ YLH     I H DLK  N+++      K  +K+ DFGL+  +        K+  G
Sbjct: 124 LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFG 179

Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVIL 142
           TPE++APE++  EP   ++D++S GVI 
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  115 bits (289), Expect = 3e-31
 Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 14/148 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
           ++++ HPNI+          ++ ++ E +S G L+  L  K    E L E    +    +
Sbjct: 69  LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQI 124

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSR-LKANTFLSSKSAAG 114
             G+NYLH +   I H DLK  N+++         +K+ DFGL+  ++       K+  G
Sbjct: 125 LDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFG 180

Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVIL 142
           TPE++APE++  EP   ++D++S GVI 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  114 bits (288), Expect = 3e-31
 Identities = 48/147 (32%), Positives = 74/147 (50%), Gaps = 13/147 (8%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
           + RL HPNI+        P  +S+V E ++ G L+ R++ K        ER   +    +
Sbjct: 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEK----GYYSERDAADAVKQI 157

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR-LKANTFLSSKSAAGT 115
            + + YLH     IVHRDLK  NLL         +K+ DFGLS+ ++    +  K+  GT
Sbjct: 158 LEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGT 213

Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVIL 142
           P + APE+LR      + D++S G+I 
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIIT 240

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  113 bits (286), Expect = 3e-31
 Identities = 42/151 (27%), Positives = 73/151 (48%), Gaps = 17/151 (11%)

Query: 1   MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYD 58
           ++++  HPNI+             +V + + +G L+  L  K      L E+    +   
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRA 132

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPE 117
           + + +  LH+ N  IVHRDLK  N+L+D    +K+ DFG S  L     L  +   GTP 
Sbjct: 133 LLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPS 188

Query: 118 WMAPEVLRDEPS------NEKSDIYSFGVIL 142
           ++APE++    +       ++ D++S GVI+
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  113 bits (286), Expect = 6e-31
 Identities = 42/148 (28%), Positives = 75/148 (50%), Gaps = 14/148 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
           ++++ H N++          ++ ++ E +S G L+  L  K    E L E    +    +
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQI 124

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSR-LKANTFLSSKSAAG 114
             G+NYLH +   I H DLK  N+++         +K+ DFGL+  ++       K+  G
Sbjct: 125 LDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFG 180

Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVIL 142
           TPE++APE++  EP   ++D++S GVI 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  113 bits (286), Expect = 9e-31
 Identities = 45/147 (30%), Positives = 77/147 (52%), Gaps = 13/147 (8%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
            ++L+HPNIV    ++ +     +V + ++ G L+  ++     RE   E    +    +
Sbjct: 82  CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQI 137

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR-LKANTFLSSKSAAGT 115
            + + Y H     IVHR+LK  NLL+    K   VK+ DFGL+  +  +        AGT
Sbjct: 138 LESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGT 193

Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVIL 142
           P +++PEVL+ +P ++  DI++ GVIL
Sbjct: 194 PGYLSPEVLKKDPYSKPVDIWACGVIL 220

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  111 bits (281), Expect = 1e-30
 Identities = 43/147 (29%), Positives = 70/147 (47%), Gaps = 14/147 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
           MK L HPNI+          ++ +V E  + G L+ R++HK     +  E     +  DV
Sbjct: 60  MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK----RVFRESDAARIMKDV 115

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR-LKANTFLSSKSAAGT 115
              + Y H+ N  + HRDLK  N L         +K+ DFGL+   K    +  ++  GT
Sbjct: 116 LSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGT 171

Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVIL 142
           P +++P+VL       + D +S GV++
Sbjct: 172 PYYVSPQVLE-GLYGPECDEWSAGVMM 197

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  111 bits (281), Expect = 1e-30
 Identities = 53/147 (36%), Positives = 79/147 (53%), Gaps = 14/147 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
           +K+L HPNI+     +    +  IV E  + G L+  ++     R+   E     +   V
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQV 130

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR-LKANTFLSSKSAAGT 115
             G+ Y+H+ N  IVHRDLK  N+L+   +K   +K+ DFGLS   + NT +  K   GT
Sbjct: 131 FSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGT 186

Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVIL 142
             ++APEVLR    +EK D++S GVIL
Sbjct: 187 AYYIAPEVLR-GTYDEKCDVWSAGVIL 212

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  114 bits (286), Expect = 1e-30
 Identities = 40/146 (27%), Positives = 74/146 (50%), Gaps = 11/146 (7%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
           M +L HP ++    A      + ++ E+LS G L+ R+  +      + E   +N     
Sbjct: 102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQA 158

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKK--YTVKVCDFGLSR-LKANTFLSSKSAAGTP 116
            +G+ ++H  +  IVH D+K  N++ + K   +VK+ DFGL+  L  +  +  K    T 
Sbjct: 159 CEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTATA 214

Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVIL 142
           E+ APE++  EP    +D+++ GV+ 
Sbjct: 215 EFAAPEIVDREPVGFYTDMWAIGVLG 240

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  115 bits (289), Expect = 2e-30
 Identities = 43/146 (29%), Positives = 70/146 (47%), Gaps = 11/146 (7%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
           M  LRHP +V    A      + ++ E++S G L+ ++  +      + E   +     V
Sbjct: 208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQV 264

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKK--YTVKVCDFGLSR-LKANTFLSSKSAAGTP 116
            KG+ ++H  N   VH DLK  N++   K    +K+ DFGL+  L     +  K   GT 
Sbjct: 265 CKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--KVTTGTA 320

Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVIL 142
           E+ APEV   +P    +D++S GV+ 
Sbjct: 321 EFAAPEVAEGKPVGYYTDMWSVGVLS 346

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  112 bits (282), Expect = 3e-30
 Identities = 41/151 (27%), Positives = 79/151 (52%), Gaps = 17/151 (11%)

Query: 1   MKRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYD 58
           ++++  HP+I+  + +      + +V + + +G L+  L  K      L E+   ++   
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRS 208

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPE 117
           + + +++LH  N  IVHRDLK  N+L+D    +++ DFG S  L+    L  +   GTP 
Sbjct: 209 LLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL--RELCGTPG 264

Query: 118 WMAPEVLRDEPS------NEKSDIYSFGVIL 142
           ++APE+L+           ++ D+++ GVIL
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  111 bits (279), Expect = 5e-30
 Identities = 40/148 (27%), Positives = 75/148 (50%), Gaps = 12/148 (8%)

Query: 1   MKRLRH-PNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYD 58
           ++  +  P ++           + ++ EY + G ++   L +    EM+ E   + +   
Sbjct: 82  LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQ 139

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR-LKANTFLSSKSAAG 114
           + +G+ YLH+ N  IVH DLK  N+L+        +K+ DFG+SR +     L  +   G
Sbjct: 140 ILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--REIMG 195

Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVIL 142
           TPE++APE+L  +P    +D+++ G+I 
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIGIIA 223

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  113 bits (284), Expect = 6e-30
 Identities = 42/146 (28%), Positives = 77/146 (52%), Gaps = 10/146 (6%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
            + L+HPNIV    ++++  +  ++ + ++ G L+  ++     RE   E    +    +
Sbjct: 64  CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQI 119

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 116
            + + + H+    +VHR+LK  NLL+    K   VK+ DFGL+        +    AGTP
Sbjct: 120 LEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTP 177

Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVIL 142
            +++PEVLR +P  +  D+++ GVIL
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVIL 203

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  111 bits (279), Expect = 8e-30
 Identities = 26/162 (16%), Positives = 57/162 (35%), Gaps = 21/162 (12%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVR--EMLDERRRLNMAYD 58
           +K       + F  A        +V E  S G+L   ++       +++ +   ++ A  
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLV-----------DKKYTVKVCDFGLSR----LKA 103
           +   +  +H     I+H D+K  N ++           D    + + D G S        
Sbjct: 181 MLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238

Query: 104 NTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
            T     +   T  +   E+L ++P N + D +     ++ +
Sbjct: 239 GTIF--TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCM 278

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  110 bits (278), Expect = 8e-30
 Identities = 54/188 (28%), Positives = 89/188 (47%), Gaps = 13/188 (6%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDV 59
           MK L HPNIV     +     L ++ EY S G ++  L   G ++E   E R       +
Sbjct: 68  MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKE--KEARSK--FRQI 123

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KANTFLSSKSAAGTPEW 118
              + Y H++   IVHRDLK+ NLL+D    +K+ DFG S        L   +  G P +
Sbjct: 124 VSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL--DAFCGAPPY 179

Query: 119 MAPEVLRDEPSN-EKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            APE+ + +  +  + D++S GVIL+ L +   P+   N  ++   V     +  IP  +
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV--LRGKYRIPFYM 237

Query: 178 NPHVASII 185
           +    +++
Sbjct: 238 STDCENLL 245

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  110 bits (277), Expect = 1e-29
 Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 11/147 (7%)

Query: 1   MKRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYD 58
           +K    HPNIV          +  +V E L+ G L+ R+      ++   E     +   
Sbjct: 59  LKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK----KKHFSETEASYIMRK 114

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGT 115
           +   ++++H     +VHRDLK  NLL    +    +K+ DFG +RLK       K+   T
Sbjct: 115 LVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFT 172

Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVIL 142
             + APE+L     +E  D++S GVIL
Sbjct: 173 LHYAAPELLNQNGYDESCDLWSLGVIL 199

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  110 bits (276), Expect = 1e-29
 Identities = 35/154 (22%), Positives = 64/154 (41%), Gaps = 14/154 (9%)

Query: 3   RLRHPNIVLFMGAV----TQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           RL+ P++V     +         L +    ++   L  +L + G    L   R + +   
Sbjct: 90  RLQEPHVV----PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQ 142

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA-GTPE 117
           +   ++  H       HRD+K  N+LV       + DFG++    +  L+      GT  
Sbjct: 143 IGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLY 200

Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQP 151
           +MAPE   +  +  ++DIY+   +L+E  T   P
Sbjct: 201 YMAPERFSESHATYRADIYALTCVLYECLTGSPP 234

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  109 bits (274), Expect = 1e-29
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 24/156 (15%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRR-----LN 54
            K L H N+V F G   +     +  EY S G L+ R+    G+ E   + +R     + 
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRFFHQLMA 116

Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----KANTFLSSK 110
                  G+ YLH     I HRD+K  NLL+D++  +K+ DFGL+ +         L   
Sbjct: 117 -------GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--N 165

Query: 111 SAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWEL 145
              GT  ++APE+L+      E  D++S G++L  +
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  111 bits (279), Expect = 2e-29
 Identities = 45/150 (30%), Positives = 73/150 (48%), Gaps = 17/150 (11%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
           +K+L HP I+          +  IV E +  G L+ +++      + L E       Y +
Sbjct: 194 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQM 248

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR-LKANTFLSSKSAAGT 115
              + YLH     I+HRDLK  N+L+   ++   +K+ DFG S+ L   + +  ++  GT
Sbjct: 249 LLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCGT 304

Query: 116 PEWMAPEVLRDEPS---NEKSDIYSFGVIL 142
           P ++APEVL    +   N   D +S GVIL
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  111 bits (280), Expect = 3e-29
 Identities = 52/150 (34%), Positives = 81/150 (54%), Gaps = 14/150 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
           +K L HPNI+             +VTE+   G L+ ++++    R   DE    N+   +
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQI 155

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSR-LKANTFLSSKSAAGT 115
             G+ YLH+ N  IVHRD+K  N+L++ K     +K+ DFGLS     +  L  +   GT
Sbjct: 156 LSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL--RDRLGT 211

Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
             ++APEVL+ +  NEK D++S GVI++ L
Sbjct: 212 AYYIAPEVLK-KKYNEKCDVWSCGVIMYIL 240

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  108 bits (273), Expect = 3e-29
 Identities = 50/202 (24%), Positives = 98/202 (48%), Gaps = 22/202 (10%)

Query: 3   RLRHPNIV-LFMGAVTQPPNLS---IVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
            L HP IV ++     + P      IV EY+   +L  ++H  G    +  +R + +  D
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIAD 124

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAAGT 115
             + +N+ H+    I+HRD+K  N+++     VKV DFG++R      N+   + +  GT
Sbjct: 125 ACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182

Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 175
            ++++PE  R +  + +SD+YS G +L+E+ T + P+   +P  V     ++  R +   
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA----YQHVREDPIP 238

Query: 176 ------NVNPHVASIIEACWAK 191
                  ++  + +++    AK
Sbjct: 239 PSARHEGLSADLDAVVLKALAK 260

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  108 bits (273), Expect = 4e-29
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 24/156 (15%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRR-----LN 54
            K L H N+V F G   +     +  EY S G L+ R+    G+ E   + +R     + 
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRFFHQLMA 116

Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----KANTFLSSK 110
                  G+ YLH     I HRD+K  NLL+D++  +K+ DFGL+ +         L   
Sbjct: 117 -------GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--N 165

Query: 111 SAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWEL 145
              GT  ++APE+L+      E  D++S G++L  +
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  108 bits (273), Expect = 4e-29
 Identities = 45/150 (30%), Positives = 72/150 (48%), Gaps = 17/150 (11%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
           +K+L HP I+          +  IV E +  G L+ +++      + L E       Y +
Sbjct: 69  LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQM 123

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSR-LKANTFLSSKSAAGT 115
              + YLH     I+HRDLK  N+L+  +     +K+ DFG S+ L   + +  ++  GT
Sbjct: 124 LLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCGT 179

Query: 116 PEWMAPEVLRDEPS---NEKSDIYSFGVIL 142
           P ++APEVL    +   N   D +S GVIL
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  108 bits (273), Expect = 4e-29
 Identities = 35/146 (23%), Positives = 71/146 (48%), Gaps = 11/146 (7%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
           +   RH NI+    +      L ++ E++S   ++ R+         L+ER  ++  + V
Sbjct: 55  LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS---AFELNEREIVSYVHQV 111

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKK--YTVKVCDFGLSR-LKANTFLSSKSAAGTP 116
            + + +LH  N  I H D++  N++   +   T+K+ +FG +R LK       +     P
Sbjct: 112 CEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAP 167

Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVIL 142
           E+ APEV + +  +  +D++S G ++
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLV 193

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  110 bits (277), Expect = 7e-29
 Identities = 54/150 (36%), Positives = 81/150 (54%), Gaps = 14/150 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
           +K+L HPNI+     +    +  IV E  + G L+  ++     R+   E     +   V
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQV 130

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSRL-KANTFLSSKSAAGT 115
             G+ Y+H+ N  IVHRDLK  N+L++ K     +K+ DFGLS   + NT +  K   GT
Sbjct: 131 FSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGT 186

Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
             ++APEVLR    +EK D++S GVIL+ L
Sbjct: 187 AYYIAPEVLR-GTYDEKCDVWSAGVILYIL 215

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  110 bits (276), Expect = 1e-28
 Identities = 55/150 (36%), Positives = 79/150 (52%), Gaps = 14/150 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
           +K L HPNI+          N  +V E    G L+  ++H    R   +E     +   V
Sbjct: 90  LKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQV 145

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSRL-KANTFLSSKSAAGT 115
             G+ YLH+ N  IVHRDLK  NLL++ K     +K+ DFGLS + +    +  K   GT
Sbjct: 146 LSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--KERLGT 201

Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
             ++APEVLR +  +EK D++S GVIL+ L
Sbjct: 202 AYYIAPEVLR-KKYDEKCDVWSIGVILFIL 230

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  109 bits (275), Expect = 1e-28
 Identities = 50/150 (33%), Positives = 77/150 (51%), Gaps = 14/150 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
           +K+L HPNI+             +V E  + G L+  ++     R+   E     +   V
Sbjct: 80  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQV 135

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSRL-KANTFLSSKSAAGT 115
             G+ Y+H+    IVHRDLK  NLL++ K     +++ DFGLS   +A+  +  K   GT
Sbjct: 136 LSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIGT 191

Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
             ++APEVL     +EK D++S GVIL+ L
Sbjct: 192 AYYIAPEVLH-GTYDEKCDVWSTGVILYIL 220

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  106 bits (268), Expect = 2e-28
 Identities = 45/158 (28%), Positives = 73/158 (46%), Gaps = 21/158 (13%)

Query: 1   MKRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           + + + H N++  +    +     +V E +  GS+   +HK   R   +E     +  DV
Sbjct: 64  LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK---RRHFNELEASVVVQDV 120

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR-LKANTFLSS------ 109
           A  +++LH +   I HRDLK  N+L    ++   VK+CDF L   +K N   S       
Sbjct: 121 ASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178

Query: 110 KSAAGTPEWMAPEVLRDEPSNEKS-----DIYSFGVIL 142
            +  G+ E+MAPEV+              D++S GVIL
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  107 bits (269), Expect = 2e-28
 Identities = 55/150 (36%), Positives = 81/150 (54%), Gaps = 13/150 (8%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
            + LRHPNIV F   +  P +L+I+ EY S G LY R+ +     E  DE R       +
Sbjct: 70  HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSE--DEARFFFQ--QL 125

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT--VKVCDFGLSRL-KANTFLSSKSAAGTP 116
             G++Y H     I HRDLK  N L+D      +K+CDFG S+    ++    KS  GTP
Sbjct: 126 LSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTP 181

Query: 117 EWMAPEVLRDEPSN-EKSDIYSFGVILWEL 145
            ++APEVL  +  + + +D++S GV L+ +
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVTLYVM 211

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  106 bits (267), Expect = 3e-28
 Identities = 49/198 (24%), Positives = 90/198 (45%), Gaps = 29/198 (14%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYDV 59
           M RL HP  V           L     Y   G L + + K G     DE   R   A ++
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTA-EI 139

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--------KANTFLSSKS 111
              + YLH +   I+HRDLK  N+L+++   +++ DFG +++        +AN+F+    
Sbjct: 140 VSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV---- 193

Query: 112 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK---G 168
             GT ++++PE+L ++ + + SD+++ G I+++L     P+   N   +     F+    
Sbjct: 194 --GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-----FQKIIK 246

Query: 169 KRLEIPRNVNPHVASIIE 186
              + P    P    ++E
Sbjct: 247 LEYDFPEKFFPKARDLVE 264

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  106 bits (267), Expect = 4e-28
 Identities = 42/151 (27%), Positives = 69/151 (45%), Gaps = 15/151 (9%)

Query: 1   MKRL-RHPNIVLFMGA----VTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLN 54
             +    P+IV  +            L I+ E +  G L+ R+  +        ER    
Sbjct: 75  HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA--FTEREAAE 132

Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKS 111
           +  D+   + +LH  N  I HRD+K  NLL    +K   +K+ DFG ++      L  ++
Sbjct: 133 IMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL--QT 188

Query: 112 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVIL 142
              TP ++APEVL  E  ++  D++S GVI+
Sbjct: 189 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  106 bits (266), Expect = 5e-28
 Identities = 40/147 (27%), Positives = 70/147 (47%), Gaps = 10/147 (6%)

Query: 1   MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           + R  +HPNI+           + +VTE +  G L   + +   ++   ER    + + +
Sbjct: 69  LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR---QKFFSEREASAVLFTI 125

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSRLKANTFLSSKSAAGT 115
            K + YLH +   +VHRDLK  N+L         ++++CDFG ++          +   T
Sbjct: 126 TKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYT 183

Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVIL 142
             ++APEVL  +  +   DI+S GV+L
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLL 210

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  104 bits (261), Expect = 1e-27
 Identities = 52/148 (35%), Positives = 80/148 (54%), Gaps = 11/148 (7%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
           +K  RHP+I+     ++ P +  +V EY+S G L+  +     V E   E RRL     +
Sbjct: 65  LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEE--MEARRL--FQQI 120

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KANTFLSSKSAAGTPEW 118
              ++Y HR    +VHRDLK  N+L+D     K+ DFGLS +     FL  +++ G+P +
Sbjct: 121 LSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTSCGSPNY 176

Query: 119 MAPEVLRDEP-SNEKSDIYSFGVILWEL 145
            APEV+     +  + DI+S GVIL+ L
Sbjct: 177 AAPEVISGRLYAGPEVDIWSCGVILYAL 204

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  105 bits (262), Expect = 3e-27
 Identities = 27/199 (13%), Positives = 67/199 (33%), Gaps = 22/199 (11%)

Query: 4   LRHPNIVLFMGAVTQPPNLSIVTEYL----SRGSLYR----LLHKPGVREMLDERRRLNM 55
           ++ P     +       ++ +++ +      + +L      LL      + L    RL +
Sbjct: 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 216

Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAG 114
              V + +  LH     +VH  L+  ++++D++  V +  F       A+          
Sbjct: 217 TLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFA 274

Query: 115 TPEWMAPEVLRDEPSNEK-----SDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK 169
            PE  A  +L     +        D ++ G+ ++ +     P  +         +     
Sbjct: 275 PPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI----- 329

Query: 170 RLEIPRNVNPHVASIIEAC 188
                +N+   V +++E  
Sbjct: 330 -FRSCKNIPQPVRALLEGF 347

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  105 bits (263), Expect = 3e-27
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 16/152 (10%)

Query: 1   MKRL-RHPNIVLFMGA----VTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLN 54
             R  + P+IV  +            L IV E L  G L+ R+  +    +   ER    
Sbjct: 108 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASE 165

Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR-LKANTFLSSK 110
           +   + + + YLH  N  I HRD+K  NLL         +K+ DFG ++   ++  L   
Sbjct: 166 IMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--T 221

Query: 111 SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVIL 142
           +   TP ++APEVL  E  ++  D++S GVI+
Sbjct: 222 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  103 bits (258), Expect = 6e-27
 Identities = 47/190 (24%), Positives = 70/190 (36%), Gaps = 47/190 (24%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVRE--------------- 45
           MK+L HPNI            + +V E    G L   L+                     
Sbjct: 82  MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141

Query: 46  ----------------------MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL 83
                                 +  E+   N+   +   ++YLH +   I HRD+K  N 
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENF 199

Query: 84  LVDKK--YTVKVCDFGLSRL----KANTFLSSKSAAGTPEWMAPEVLR--DEPSNEKSDI 135
           L      + +K+ DFGLS+         +    + AGTP ++APEVL   +E    K D 
Sbjct: 200 LFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259

Query: 136 YSFGVILWEL 145
           +S GV+L  L
Sbjct: 260 WSAGVLLHLL 269

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  102 bits (256), Expect = 1e-26
 Identities = 44/189 (23%), Positives = 83/189 (43%), Gaps = 20/189 (10%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS-LY-RLLHKPGVREMLDERRRLNMAYD 58
           + R+ H NI+  +          +V E    G  L+  +   P + E       +     
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE--PLASYI--FRQ 138

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KANTFLSSKSAAGTPE 117
           +   + YL  ++  I+HRD+K  N+++ + +T+K+ DFG +   +        +  GT E
Sbjct: 139 LVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF--YTFCGTIE 194

Query: 118 WMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           + APEVL   P    + +++S GV L+ L   + P+  L   + V A       +  P  
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE--ETVEA------AIHPPYL 246

Query: 177 VNPHVASII 185
           V+  + S++
Sbjct: 247 VSKELMSLV 255

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  101 bits (255), Expect = 1e-26
 Identities = 45/166 (27%), Positives = 74/166 (44%), Gaps = 36/166 (21%)

Query: 1   MKRLRHPNIV-LF--MGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDE--RRRLNM 55
           ++RLRH N++ L   +        + +V EY   G           +EMLD    +R  +
Sbjct: 60  LRRLRHKNVIQLVDVLYNEE-KQKMYMVMEYCVCGM----------QEMLDSVPEKRFPV 108

Query: 56  AYDVAK--------GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----KA 103
               A         G+ YLH +   IVH+D+K  NLL+    T+K+   G++       A
Sbjct: 109 --CQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164

Query: 104 NTFLSSKSAAGTPEWMAPEVLRDEP--SNEKSDIYSFGVILWELAT 147
           +     +++ G+P +  PE+       S  K DI+S GV L+ + T
Sbjct: 165 DDTC--RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITT 208

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  103 bits (257), Expect = 1e-26
 Identities = 28/204 (13%), Positives = 65/204 (31%), Gaps = 28/204 (13%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEY-LSRGSLYR----LLHKPGVREMLDERRRLNM 55
           +K  +   ++           LS    Y   + +L      LL      + L    RL +
Sbjct: 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 211

Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT 115
              V + +  LH     +VH  L+  ++++D++  V +  F     +    + S   + +
Sbjct: 212 TLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLV-RDGARVVS---SVS 265

Query: 116 PEWMAPEVLRDE-----------PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
             +  PE+                     D ++ G++++ +     P             
Sbjct: 266 RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE-- 323

Query: 165 GFKGKRLEIPRNVNPHVASIIEAC 188
                     +N+   V +++E  
Sbjct: 324 ----WIFRSCKNIPQPVRALLEGF 343

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  103 bits (258), Expect = 2e-26
 Identities = 39/176 (22%), Positives = 73/176 (41%), Gaps = 32/176 (18%)

Query: 1   MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVRE----MLDERRRLNM 55
           +     HPN++ +  + T    L I  E  +  +L  L+    V +    +  E   +++
Sbjct: 62  LTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISL 120

Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-------------YTVKVCDFGLSRL- 101
              +A G+ +LH     I+HRDLK  N+LV                  + + DFGL +  
Sbjct: 121 LRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178

Query: 102 ---KANTFLSSKSAAGTPEWMAPEVLRD-------EPSNEKSDIYSFGVILWELAT 147
              +++   +  + +GT  W APE+L +              DI+S G + + + +
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  102 bits (257), Expect = 2e-26
 Identities = 49/199 (24%), Positives = 86/199 (43%), Gaps = 17/199 (8%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYDV 59
           +       I     A      L +V EY   G L  LL K G R  +     R  +A ++
Sbjct: 115 LVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGER--IPAEMARFYLA-EI 171

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEW 118
              ++ +HR     VHRD+K  N+L+D+   +++ DFG   +L+A+  + S  A GTP++
Sbjct: 172 VMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDY 229

Query: 119 MAPEVLRDEPSNEKSDIY-------SFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL 171
           ++PE+L+       +  Y       + GV  +E+   Q P+   + A+    +    + L
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL 289

Query: 172 EIP---RNVNPHVASIIEA 187
            +P     V       I+ 
Sbjct: 290 SLPLVDEGVPEEARDFIQR 308

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  102 bits (256), Expect = 4e-26
 Identities = 47/197 (23%), Positives = 89/197 (45%), Gaps = 15/197 (7%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYDV 59
           +       I     A     NL +V +Y   G L  LL K   R  L E   R  +A ++
Sbjct: 128 LVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR--LPEEMARFYLA-EM 184

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEW 118
              ++ +H+ +   VHRD+K  N+L+D    +++ DFG   +L  +  + S  A GTP++
Sbjct: 185 VIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDY 242

Query: 119 MAPEVLRDEPSNEKS-----DIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEI 173
           ++PE+L+     +       D +S GV ++E+   + P+   +  +    +    +R + 
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF 302

Query: 174 PR---NVNPHVASIIEA 187
           P    +V+ +   +I  
Sbjct: 303 PTQVTDVSENAKDLIRR 319

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  101 bits (253), Expect = 4e-26
 Identities = 53/189 (28%), Positives = 87/189 (46%), Gaps = 19/189 (10%)

Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
            HP +           NL  V EYL+ G L   +         D  R    A ++  G+ 
Sbjct: 76  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQ 132

Query: 65  YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSAAGTPEW 118
           +LH +   IV+RDLK  N+L+DK   +K+ DFG+ +       K NTF       GTP++
Sbjct: 133 FLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF------CGTPDY 184

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           +APE+L  +  N   D +SFGV+L+E+   Q P+   +  ++  ++  +      PR + 
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRWLE 242

Query: 179 PHVASIIEA 187
                ++  
Sbjct: 243 KEAKDLLVK 251

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  100 bits (252), Expect = 5e-26
 Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 21/194 (10%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYDV 59
           ++  RHP +     A      L  V EY + G L+  L +  V     E R R   A ++
Sbjct: 59  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---FTEERARFYGA-EI 114

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSAA 113
              + YLH R+  +V+RD+K  NL++DK   +K+ DFGL +          TF       
Sbjct: 115 VSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF------C 166

Query: 114 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEI 173
           GTPE++APEVL D       D +  GV+++E+   + P+ N +  ++   +    + +  
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LMEEIRF 224

Query: 174 PRNVNPHVASIIEA 187
           PR ++P   S++  
Sbjct: 225 PRTLSPEAKSLLAG 238

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  102 bits (256), Expect = 8e-26
 Identities = 39/154 (25%), Positives = 63/154 (40%), Gaps = 18/154 (11%)

Query: 3   RLRHPNIVL-----FMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAY 57
            + HP+IV              P   IV EY+   SL R   +      L     +    
Sbjct: 135 EVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLL 189

Query: 58  DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 117
           ++   ++YLH     +V+ DLK  N+++ ++  +K+ D G          S     GTP 
Sbjct: 190 EILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAVS----RINSFGYLYGTPG 242

Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQP 151
           + APE++R  P+   +DIY+ G  L  L      
Sbjct: 243 FQAPEIVRTGPT-VATDIYTVGRTLAALTLDLPT 275

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  101 bits (254), Expect = 9e-26
 Identities = 52/148 (35%), Positives = 82/148 (55%), Gaps = 11/148 (7%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
           +K  RHP+I+     ++ P ++ +V EY+S G L+  +     + E   E RRL     +
Sbjct: 70  LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDE--KESRRL--FQQI 125

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KANTFLSSKSAAGTPEW 118
             G++Y HR    +VHRDLK  N+L+D     K+ DFGLS +     FL  +++ G+P +
Sbjct: 126 LSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTSCGSPNY 181

Query: 119 MAPEVLRDEP-SNEKSDIYSFGVILWEL 145
            APEV+     +  + DI+S GVIL+ L
Sbjct: 182 AAPEVISGRLYAGPEVDIWSSGVILYAL 209

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  100 bits (250), Expect = 1e-25
 Identities = 47/189 (24%), Positives = 91/189 (48%), Gaps = 16/189 (8%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY++ G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIV 151

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAAGTPE 117
               YLH  +  +++RDLK  NLL+D++  ++V DFG ++    +  T        GTPE
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL------CGTPE 203

Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
            +APE++  +  N+  D ++ GV+++E+A    P+    P Q+   +   GK +  P + 
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGK-VRFPSHF 261

Query: 178 NPHVASIIE 186
           +  +  ++ 
Sbjct: 262 SSDLKDLLR 270

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 99.7 bits (249), Expect = 1e-25
 Identities = 53/148 (35%), Positives = 83/148 (56%), Gaps = 12/148 (8%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLNMAYDV 59
           +K LRHP+I+     +T P ++ +V EY   G L+  ++ K  + E  DE RR      +
Sbjct: 63  LKLLRHPHIIKLYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTE--DEGRRF--FQQI 117

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KANTFLSSKSAAGTPEW 118
              + Y HR    IVHRDLK  NLL+D    VK+ DFGLS +     FL  K++ G+P +
Sbjct: 118 ICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL--KTSCGSPNY 173

Query: 119 MAPEVLRDEP-SNEKSDIYSFGVILWEL 145
            APEV+  +  +  + D++S G++L+ +
Sbjct: 174 AAPEVINGKLYAGPEVDVWSCGIVLYVM 201

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  100 bits (251), Expect = 3e-25
 Identities = 43/189 (22%), Positives = 90/189 (47%), Gaps = 19/189 (10%)

Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
           + P +            L  V EY++ G L   + + G      E   +  A ++A G+ 
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLF 456

Query: 65  YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSAAGTPEW 118
           +L  +   I++RDLK  N+++D +  +K+ DFG+ +          TF       GTP++
Sbjct: 457 FLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF------CGTPDY 508

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           +APE++  +P  +  D ++FGV+L+E+   Q P+   +  ++  ++      +  P++++
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--MEHNVAYPKSMS 566

Query: 179 PHVASIIEA 187
               +I + 
Sbjct: 567 KEAVAICKG 575

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 98.4 bits (246), Expect = 4e-25
 Identities = 49/194 (25%), Positives = 95/194 (48%), Gaps = 21/194 (10%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYDV 59
           ++ ++HP IV  + A      L ++ EYLS G L+  L + G   +  E      +A ++
Sbjct: 75  LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG---IFMEDTACFYLA-EI 130

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSAA 113
           +  + +LH++   I++RDLK  N++++ +  VK+ DFGL +         +TF       
Sbjct: 131 SMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC------ 182

Query: 114 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEI 173
           GT E+MAPE+L     N   D +S G +++++ T   P+   N  + +  +     +L +
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI--LKCKLNL 240

Query: 174 PRNVNPHVASIIEA 187
           P  +      +++ 
Sbjct: 241 PPYLTQEARDLLKK 254

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 98.4 bits (246), Expect = 4e-25
 Identities = 54/194 (27%), Positives = 99/194 (51%), Gaps = 21/194 (10%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYDV 59
           +  + HP IV    A      L ++ ++L  G L+  L K     M  E   +  +A ++
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLA-EL 135

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSAA 113
           A  +++LH     I++RDLK  N+L+D++  +K+ DFGLS+       KA +F       
Sbjct: 136 ALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC------ 187

Query: 114 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEI 173
           GT E+MAPEV+      + +D +SFGV+++E+ T   P+   +  + +  +     +L +
Sbjct: 188 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK--AKLGM 245

Query: 174 PRNVNPHVASIIEA 187
           P+ ++P   S++  
Sbjct: 246 PQFLSPEAQSLLRM 259

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 99.4 bits (248), Expect = 5e-25
 Identities = 53/188 (28%), Positives = 91/188 (48%), Gaps = 8/188 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYDV 59
           ++  RHP +     +      L  V EY + G L+  L +  V     E R R   A ++
Sbjct: 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV---FSEDRARFYGA-EI 257

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
              ++YLH     +V+RDLK  NL++DK   +K+ DFGL +       + K+  GTPE++
Sbjct: 258 VSALDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYL 316

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 179
           APEVL D       D +  GV+++E+   + P+ N +  ++   +    + +  PR + P
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--LMEEIRFPRTLGP 374

Query: 180 HVASIIEA 187
              S++  
Sbjct: 375 EAKSLLSG 382

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 98.5 bits (246), Expect = 7e-25
 Identities = 55/193 (28%), Positives = 93/193 (48%), Gaps = 21/193 (10%)

Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYDVA 60
           K ++HP +V    +      L  V +Y++ G L+  L +        E R R   A ++A
Sbjct: 94  KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER---CFLEPRARFYAA-EIA 149

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSAAG 114
             + YLH  N  IV+RDLK  N+L+D +  + + DFGL +         +TF       G
Sbjct: 150 SALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTF------CG 201

Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP 174
           TPE++APEVL  +P +   D +  G +L+E+     P+ + N A++   +    K L++ 
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI--LNKPLQLK 259

Query: 175 RNVNPHVASIIEA 187
            N+      ++E 
Sbjct: 260 PNITNSARHLLEG 272

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 98.2 bits (245), Expect = 1e-24
 Identities = 45/194 (23%), Positives = 91/194 (46%), Gaps = 16/194 (8%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M+ L HP +V    +     ++ +V + L  G L   L +       +E  +L +  ++ 
Sbjct: 69  MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFIC-ELV 125

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
             ++YL  +   I+HRD+K  N+L+D+   V + DF ++  L   T +++ +  GT  +M
Sbjct: 126 MALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--GTKPYM 181

Query: 120 APEVLRDEPSNEKS---DIYSFGVILWELATLQQPW---GNLNPAQVVAAVGFKGKRLEI 173
           APE+         S   D +S GV  +EL   ++P+    + +  ++V    F+   +  
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT--FETTVVTY 239

Query: 174 PRNVNPHVASIIEA 187
           P   +  + S+++ 
Sbjct: 240 PSAWSQEMVSLLKK 253

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 98.2 bits (245), Expect = 1e-24
 Identities = 46/183 (25%), Positives = 81/183 (44%), Gaps = 11/183 (6%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M     P +V    A      L +V EY+  G L  L+    V E   +  R   A +V 
Sbjct: 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE---KWARFYTA-EVV 178

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWM 119
             ++ +H      +HRD+K  N+L+DK   +K+ DFG   ++     +   +A GTP+++
Sbjct: 179 LALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 236

Query: 120 APEVLRDEPSNEK----SDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 175
           +PEVL+ +  +       D +S GV L+E+     P+   +     + +      L  P 
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 296

Query: 176 NVN 178
           + +
Sbjct: 297 DND 299

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 95.8 bits (239), Expect = 5e-24
 Identities = 43/189 (22%), Positives = 90/189 (47%), Gaps = 19/189 (10%)

Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN 64
           + P +            L  V EY++ G L   + + G      E   +  A ++A G+ 
Sbjct: 79  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLF 135

Query: 65  YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSAAGTPEW 118
           +L  +   I++RDLK  N+++D +  +K+ DFG+ +          TF       GTP++
Sbjct: 136 FLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF------CGTPDY 187

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           +APE++  +P  +  D ++FGV+L+E+   Q P+   +  ++  ++      +  P++++
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--MEHNVAYPKSMS 245

Query: 179 PHVASIIEA 187
               +I + 
Sbjct: 246 KEAVAICKG 254

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 95.9 bits (238), Expect = 6e-24
 Identities = 21/167 (12%), Positives = 42/167 (25%), Gaps = 14/167 (8%)

Query: 1   MKRLRHPNIVLFMGA--VTQPPNLSIVTEYL--SRGSLYRLLHKPGV-REMLDERRRLNM 55
           +     P               N  ++          L+  L    V R          +
Sbjct: 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHIL 199

Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT 115
              + +    L  +   +VH      NL +     + + D                A+  
Sbjct: 200 TAQLIRLAANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSV 253

Query: 116 PEWMAPEVL---RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 159
           P   AP               + +  G+ ++ +  L  P+G + P  
Sbjct: 254 PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 95.0 bits (237), Expect = 8e-24
 Identities = 47/190 (24%), Positives = 85/190 (44%), Gaps = 21/190 (11%)

Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYDVAKGM 63
            HP +         P  L  V E+++ G L   + K       DE R R   A ++   +
Sbjct: 82  NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAA-EIISAL 137

Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSAAGTPE 117
            +LH +   I++RDLK  N+L+D +   K+ DFG+ +          TF       GTP+
Sbjct: 138 MFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF------CGTPD 189

Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           ++APE+L++       D ++ GV+L+E+     P+   N   +  A+      +  P  +
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI--LNDEVVYPTWL 247

Query: 178 NPHVASIIEA 187
           +     I+++
Sbjct: 248 HEDATGILKS 257

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 94.1 bits (235), Expect = 1e-23
 Identities = 49/192 (25%), Positives = 89/192 (46%), Gaps = 22/192 (11%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +  + HP I+   G       + ++ +Y+  G L+ LL K               A +V 
Sbjct: 60  LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVC 116

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAAGTPE 117
             + YLH ++  I++RDLK  N+L+DK   +K+ DFG ++       T        GTP+
Sbjct: 117 LALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL------CGTPD 168

Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK---GKRLEIP 174
           ++APEV+  +P N+  D +SFG++++E+     P+ + N  +      ++      L  P
Sbjct: 169 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-----YEKILNAELRFP 223

Query: 175 RNVNPHVASIIE 186
              N  V  ++ 
Sbjct: 224 PFFNEDVKDLLS 235

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 95.6 bits (238), Expect = 2e-23
 Identities = 45/189 (23%), Positives = 81/189 (42%), Gaps = 7/189 (3%)

Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVRE-MLDERRRLNMAYDVA 60
            ++    IV    A     +L +V   ++ G +   ++          E R +     + 
Sbjct: 240 AKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ +LH+RN  I++RDLK  N+L+D    V++ D GL+         +K  AGTP +MA
Sbjct: 300 SGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMA 357

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK---GKRLEIPRNV 177
           PE+L  E  +   D ++ GV L+E+   + P+           +  +    + +  P   
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL-KQRVLEQAVTYPDKF 416

Query: 178 NPHVASIIE 186
           +P      E
Sbjct: 417 SPASKDFCE 425

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 95.6 bits (238), Expect = 2e-23
 Identities = 44/193 (22%), Positives = 77/193 (39%), Gaps = 16/193 (8%)

Query: 2   KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAK 61
           +++    +V    A      L +V   ++ G L   ++  G +    E R +  A ++  
Sbjct: 239 EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICC 297

Query: 62  GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-----LKANTFLSSKSAAGTP 116
           G+  LHR    IV+RDLK  N+L+D    +++ D GL+                   GT 
Sbjct: 298 GLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR------VGTV 349

Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK--GKRLEIP 174
            +MAPEV+++E      D ++ G +L+E+   Q P+           V         E  
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS 409

Query: 175 RNVNPHVASIIEA 187
              +P   S+   
Sbjct: 410 ERFSPQARSLCSQ 422

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 95.0 bits (236), Expect = 4e-23
 Identities = 50/195 (25%), Positives = 90/195 (46%), Gaps = 21/195 (10%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +     P IV    A   P  LS + + ++ G L+  L + GV     E      A ++ 
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEII 302

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----KANTFLSSKSAAGTP 116
            G+ ++H R   +V+RDLK  N+L+D+   V++ D GL+      K +         GT 
Sbjct: 303 LGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS------VGTH 354

Query: 117 EWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW---GNLNPAQVVAAVGFKGKRLE 172
            +MAPEVL+   + + S D +S G +L++L     P+      +  ++          +E
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVE 412

Query: 173 IPRNVNPHVASIIEA 187
           +P + +P + S++E 
Sbjct: 413 LPDSFSPELRSLLEG 427

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 93.1 bits (232), Expect = 5e-23
 Identities = 52/197 (26%), Positives = 95/197 (48%), Gaps = 26/197 (13%)

Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYDVAKGM 63
            HP +V           L  V EY++ G L   + +      L E   R   A +++  +
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSA-EISLAL 123

Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSAAGTPE 117
           NYLH R   I++RDLK  N+L+D +  +K+ D+G+ +         +TF       GTP 
Sbjct: 124 NYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF------CGTPN 175

Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG----FKG---KR 170
           ++APE+LR E      D ++ GV+++E+   + P+  +  +           F+    K+
Sbjct: 176 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 235

Query: 171 LEIPRNVNPHVASIIEA 187
           + IPR+++   AS++++
Sbjct: 236 IRIPRSLSVKAASVLKS 252

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 92.4 bits (230), Expect = 6e-23
 Identities = 30/150 (20%), Positives = 67/150 (44%), Gaps = 12/150 (8%)

Query: 1   MKRLRH--PNIVLFMGAVTQPPNLSIVTEYLS-RGSLYRLLHKPGVREMLDERRRLNMAY 57
           +K++      ++  +    +P +  ++ E       L+  + + G    L E    +  +
Sbjct: 100 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFW 156

Query: 58  DVAKGMNYLHRRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKANTFLSSKSAAGTP 116
            V + + + H     ++HRD+K  N+L+D  +  +K+ DFG   L  +T        GT 
Sbjct: 157 QVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTR 212

Query: 117 EWMAPEVLRDEP-SNEKSDIYSFGVILWEL 145
            +  PE +R        + ++S G++L+++
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM 242

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 91.8 bits (229), Expect = 7e-23
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 16/157 (10%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L+H NIV     +     L++V E+  +  L +          LD     +  + + 
Sbjct: 55  LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGD--LDPEIVKSFLFQLL 111

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 117
           KG+ + H RN  ++HRDLK  NLL+++   +K+ +FGL+R              + E   
Sbjct: 112 KGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAF-----GIPVRCYSAEVVT 164

Query: 118 -WM-APEVLRDEPS-NEKSDIYSFGVILWELATLQQP 151
            W   P+VL      +   D++S G I  ELA   +P
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 92.8 bits (231), Expect = 9e-23
 Identities = 52/197 (26%), Positives = 95/197 (48%), Gaps = 26/197 (13%)

Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYDVAKGM 63
            HP +V           L  V EY++ G L   + +      L E   R   A +++  +
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSA-EISLAL 166

Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSAAGTPE 117
           NYLH R   I++RDLK  N+L+D +  +K+ D+G+ +         +TF       GTP 
Sbjct: 167 NYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF------CGTPN 218

Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG----FKG---KR 170
           ++APE+LR E      D ++ GV+++E+   + P+  +  +           F+    K+
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 278

Query: 171 LEIPRNVNPHVASIIEA 187
           + IPR+++   AS++++
Sbjct: 279 IRIPRSLSVKAASVLKS 295

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 91.2 bits (227), Expect = 2e-22
 Identities = 31/152 (20%), Positives = 60/152 (39%), Gaps = 14/152 (9%)

Query: 1   MKRLR----HPNIVLFMGAVTQPPNLSIVTEYLSRGS-LYRLLHKPGVREMLDERRRLNM 55
           + ++     HP ++  +          +V E       L+  + + G    L E      
Sbjct: 88  LWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCF 144

Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAG 114
              V   + + H R   +VHRD+K  N+L+D +    K+ DFG   L  +         G
Sbjct: 145 FGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY--TDFDG 200

Query: 115 TPEWMAPEVLRDEP-SNEKSDIYSFGVILWEL 145
           T  +  PE +         + ++S G++L+++
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDM 232

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 89.5 bits (223), Expect = 5e-22
 Identities = 41/155 (26%), Positives = 74/155 (47%), Gaps = 16/155 (10%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K+L+HPN+V  +    +   L +V EY    ++   L +      + E    ++ +   
Sbjct: 56  LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQR--GVPEHLVKSITWQTL 112

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 117
           + +N+ H+ N   +HRD+K  N+L+ K   +K+CDFG +RL     L+  S     E   
Sbjct: 113 QAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARL-----LTGPSDYYDDEVAT 165

Query: 118 -WM-APEVL-RDEPSNEKSDIYSFGVILWELATLQ 149
            W  +PE+L  D       D+++ G +  EL +  
Sbjct: 166 RWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 89.7 bits (223), Expect = 8e-22
 Identities = 45/196 (22%), Positives = 88/196 (44%), Gaps = 26/196 (13%)

Query: 5   RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERR-RLNMAYDVAKGM 63
           + P +V    A      L ++ +Y++ G L+  L +        E   ++ +  ++   +
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVG-EIVLAL 172

Query: 64  NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-------KANTFLSSKSAAGTP 116
            +LH+    I++RD+K  N+L+D    V + DFGLS+        +A  F       GT 
Sbjct: 173 EHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC------GTI 224

Query: 117 EWMAPEVLRDEPS--NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK---GKRL 171
           E+MAP+++R   S  ++  D +S GV+++EL T   P+         A +  +       
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-SRRILKSEP 283

Query: 172 EIPRNVNPHVASIIEA 187
             P+ ++     +I+ 
Sbjct: 284 PYPQEMSALAKDLIQR 299

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 88.0 bits (219), Expect = 3e-21
 Identities = 40/155 (25%), Positives = 72/155 (46%), Gaps = 16/155 (10%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K+LRH N+V  +    +     +V E++   ++   L        LD +      + + 
Sbjct: 78  LKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNG--LDYQVVQKYLFQII 134

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 117
            G+ + H  N  I+HRD+K  N+LV +   VK+CDFG +R      L++       E   
Sbjct: 135 NGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFART-----LAAPGEVYDDEVAT 187

Query: 118 -WM-APEVL-RDEPSNEKSDIYSFGVILWELATLQ 149
            W  APE+L  D    +  D+++ G ++ E+   +
Sbjct: 188 RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 87.2 bits (217), Expect = 4e-21
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 16/153 (10%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L HPNIV  +  +     L++V E++ +  L ++L +        + +     Y + 
Sbjct: 73  LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIY--LYQLL 129

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 117
           +G+ + H+    I+HRDLK  NLL++    +K+ DFGL+R            + T E   
Sbjct: 130 RGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAF-----GIPVRSYTHEVVT 182

Query: 118 -WM-APEVLRDEPS-NEKSDIYSFGVILWELAT 147
            W  AP+VL      +   DI+S G I  E+ T
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 87.3 bits (217), Expect = 4e-21
 Identities = 45/156 (28%), Positives = 72/156 (46%), Gaps = 17/156 (10%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM---LDERRRLNMAY 57
           MK L+H NIV     +     L++V E++    L + +    V      L+        +
Sbjct: 57  MKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQW 115

Query: 58  DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 117
            + +G+ + H     I+HRDLK  NLL++K+  +K+ DFGL+R              + E
Sbjct: 116 QLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAF-----GIPVNTFSSE 168

Query: 118 ----WM-APEVLRDEPS-NEKSDIYSFGVILWELAT 147
               W  AP+VL    + +   DI+S G IL E+ T
Sbjct: 169 VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT 204

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 86.4 bits (215), Expect = 6e-21
 Identities = 44/153 (28%), Positives = 67/153 (43%), Gaps = 16/153 (10%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L+H NIV     +     L +V E+L +  L +LL            +       + 
Sbjct: 54  LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSF--LLQLL 110

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 117
            G+ Y H R   ++HRDLK  NLL++++  +K+ DFGL+R              T E   
Sbjct: 111 NGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAF-----GIPVRKYTHEIVT 163

Query: 118 -WM-APEVLRDEPS-NEKSDIYSFGVILWELAT 147
            W  AP+VL      +   DI+S G I  E+  
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN 196

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 86.5 bits (215), Expect = 9e-21
 Identities = 44/153 (28%), Positives = 77/153 (50%), Gaps = 16/153 (10%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L+H NIV     +    +L++V EYL +  L + L   G    +   +     + + 
Sbjct: 54  LKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLF--LFQLL 110

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 117
           +G+ Y HR+   ++HRDLK  NLL++++  +K+ DFGL+R K     S  +     E   
Sbjct: 111 RGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAK-----SIPTKTYDNEVVT 163

Query: 118 -WM-APEVLRDEPS-NEKSDIYSFGVILWELAT 147
            W   P++L      + + D++  G I +E+AT
Sbjct: 164 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMAT 196

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 87.1 bits (216), Expect = 1e-20
 Identities = 46/151 (30%), Positives = 73/151 (48%), Gaps = 15/151 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
           MK + H NI+  +   T   +L       IV E +   +L +++        LD  R   
Sbjct: 78  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQME-----LDHERMSY 131

Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
           + Y +  G+ +LH     I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     
Sbjct: 132 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV- 188

Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
           T  + APEV+      E  DI+S G I+ E+
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 86.1 bits (213), Expect = 3e-20
 Identities = 45/151 (29%), Positives = 72/151 (47%), Gaps = 15/151 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
           MK + H NI+  +   T    L       +V E +   +L +++        LD  R   
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQME-----LDHERMSY 168

Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
           + Y +  G+ +LH     I+HRDLK  N++V    T+K+ DFGL+R    +F+ +     
Sbjct: 169 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV- 225

Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 145
           T  + APEV+      E  DI+S G I+ E+
Sbjct: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 84.3 bits (209), Expect = 4e-20
 Identities = 38/151 (25%), Positives = 57/151 (37%), Gaps = 35/151 (23%)

Query: 1   MKRL-RHPNIVLFMGA----VTQPPNLSIVTEYLSRGSLY-RLLHKPGVREMLDERRRLN 54
             R  + P+IV  +            L IV E L  G L+ R+  +    +   ER    
Sbjct: 64  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASE 121

Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKS 111
           +   + + + YLH  N  I HRD+K  NLL         +K+ DFG              
Sbjct: 122 IMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF------------- 166

Query: 112 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVIL 142
                   A E    E  ++  D++S GVI+
Sbjct: 167 --------AKETTG-EKYDKSCDMWSLGVIM 188

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 84.2 bits (209), Expect = 8e-20
 Identities = 44/153 (28%), Positives = 72/153 (47%), Gaps = 16/153 (10%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ L HPNI+  + A     N+S+V +++    L  ++    +   L             
Sbjct: 66  LQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLV--LTPSHIKAYMLMTL 122

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 117
           +G+ YLH+    I+HRDLK  NLL+D+   +K+ DFGL++        S + A T +   
Sbjct: 123 QGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSF-----GSPNRAYTHQVVT 175

Query: 118 -WM-APEVLRDEPS-NEKSDIYSFGVILWELAT 147
            W  APE+L          D+++ G IL EL  
Sbjct: 176 RWYRAPELLFGARMYGVGVDMWAVGCILAELLL 208

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 82.3 bits (204), Expect = 4e-19
 Identities = 41/158 (25%), Positives = 63/158 (39%), Gaps = 22/158 (13%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L+H NI+     +     L ++ EY     L + + K      +  R   +  Y + 
Sbjct: 87  LKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD---VSMRVIKSFLYQLI 142

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYT-----VKVCDFGLSRLKANTFLSSKSAAGT 115
            G+N+ H R    +HRDLK  NLL+          +K+ DFGL+R              T
Sbjct: 143 NGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-----GIPIRQFT 195

Query: 116 PE----WM-APEVLRDEPS-NEKSDIYSFGVILWELAT 147
            E    W   PE+L      +   DI+S   I  E+  
Sbjct: 196 HEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM 233

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 82.3 bits (204), Expect = 4e-19
 Identities = 41/161 (25%), Positives = 74/161 (45%), Gaps = 20/161 (12%)

Query: 1   MKRLRHPNIVLFMGAVTQP--------PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRR 52
           ++ L+H N+V  +               ++ +V ++     L  LL    V+  L E +R
Sbjct: 70  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR 128

Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 112
           +     +  G+ Y+HR    I+HRD+K+ N+L+ +   +K+ DFGL+R   +   +S+  
Sbjct: 129 V--MQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAF-SLAKNSQPN 183

Query: 113 AGTPE----WM-APEVLRDEPS-NEKSDIYSFGVILWELAT 147
             T      W   PE+L  E       D++  G I+ E+ T
Sbjct: 184 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 79.9 bits (198), Expect = 2e-18
 Identities = 44/157 (28%), Positives = 71/157 (45%), Gaps = 20/157 (12%)

Query: 1   MKRLRHPNIV-----LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNM 55
           ++   HPN+V       +    +   L++V E++ +  L   L K     +  E  +  M
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126

Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT 115
            + + +G+++LH     +VHRDLK  N+LV     +K+ DFGL+R+       S   A T
Sbjct: 127 -FQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIY------SFQMALT 177

Query: 116 PE----WM-APEVLRDEPSNEKSDIYSFGVILWELAT 147
                 W  APEVL         D++S G I  E+  
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR 214

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 79.6 bits (197), Expect = 3e-18
 Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 25/162 (15%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
           +K  +H NI+     + +P +        I+ E +    L+R++     + + D+  +  
Sbjct: 63  LKHFKHENIITIF-NIQRPDSFENFNEVYIIQELMQT-DLHRVIST---QMLSDDHIQYF 117

Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
           + Y   + +  LH  N  ++HRDLK  NLL++    +KVCDFGL+R+   +   +    G
Sbjct: 118 I-YQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174

Query: 115 TPEWM----------APEVLRDEPS-NEKSDIYSFGVILWEL 145
               M          APEV+      +   D++S G IL EL
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 78.8 bits (195), Expect = 5e-18
 Identities = 45/159 (28%), Positives = 69/159 (43%), Gaps = 24/159 (15%)

Query: 1   MKRLRHPNIV-----LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNM 55
           ++   HPN+V            +   +++V E++ +  L   L K     +  E  +  M
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM 126

Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA--NTFLSSKSAA 113
                +G+++LH     IVHRDLK  N+LV    TVK+ DFGL+R+ +            
Sbjct: 127 -RQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL------- 176

Query: 114 GTPE----WM-APEVLRDEPSNEKSDIYSFGVILWELAT 147
            TP     W  APEVL         D++S G I  E+  
Sbjct: 177 -TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR 214

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 78.9 bits (195), Expect = 6e-18
 Identities = 40/152 (26%), Positives = 76/152 (50%), Gaps = 18/152 (11%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
           +K ++H N++  +   T   +L       +V  ++    L +++         +E+ +  
Sbjct: 77  LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK----FSEEKIQYL 131

Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
           + Y + KG+ Y+H     +VHRDLK  NL V++   +K+ DFGL+R  A+  ++      
Sbjct: 132 V-YQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTGYVV-- 185

Query: 115 TPEWMAPEVLRDEPSNEKS-DIYSFGVILWEL 145
           T  + APEV+       ++ DI+S G I+ E+
Sbjct: 186 TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEM 217

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 78.9 bits (195), Expect = 7e-18
 Identities = 34/152 (22%), Positives = 62/152 (40%), Gaps = 14/152 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
           +    HPNI+                   +VTE +    L +++H    R ++  +    
Sbjct: 83  LNHFHHPNILGLRDIFV-HFEEPAMHKLYLVTELMRT-DLAQVIHDQ--RIVISPQHIQY 138

Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
             Y +  G++ LH     +VHRDL   N+L+     + +CDF L+R        +     
Sbjct: 139 FMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT- 195

Query: 115 TPEWMAPEVLRDEPSNEKS-DIYSFGVILWEL 145
              + APE++       K  D++S G ++ E+
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 78.5 bits (194), Expect = 9e-18
 Identities = 42/152 (27%), Positives = 80/152 (52%), Gaps = 17/152 (11%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
           +K +RH N++  +   T    L       +V  ++    L +L+      ++ ++R +  
Sbjct: 78  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKH---EKLGEDRIQFL 133

Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
           + Y + KG+ Y+H     I+HRDLK  NL V++   +K+ DFGL+R +A++ ++      
Sbjct: 134 V-YQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR-QADSEMTGYVV-- 187

Query: 115 TPEWMAPEVLRDEPSNEKS-DIYSFGVILWEL 145
           T  + APEV+ +     ++ DI+S G I+ E+
Sbjct: 188 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM 219

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 77.4 bits (191), Expect = 2e-17
 Identities = 41/152 (26%), Positives = 78/152 (51%), Gaps = 17/152 (11%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
           +K ++H N++  +   T   +L       +VT  +    L  ++     +++ D+  +  
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKC---QKLTDDHVQFL 137

Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
           + Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R      ++   A  
Sbjct: 138 I-YQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTGYVA-- 191

Query: 115 TPEWMAPEVLRDEPS-NEKSDIYSFGVILWEL 145
           T  + APE++ +    N+  DI+S G I+ EL
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 77.4 bits (191), Expect = 3e-17
 Identities = 38/163 (23%), Positives = 70/163 (42%), Gaps = 23/163 (14%)

Query: 1   MKRLRHPNIVLFMGAVTQPPN------LSIVTEYLSRGSLYRLL-HKPGVREMLDERRRL 53
           M+ ++HPN+V          +      L++V EY+   ++YR   H   +++ +      
Sbjct: 86  MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIK 144

Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK-KYTVKVCDFGLSRLKANTFLSSKSA 112
              Y + + + Y+H     I HRD+K  NLL+D     +K+ DFG ++      +     
Sbjct: 145 LYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAK------ILIAGE 196

Query: 113 AGTPE----WM-APEVLRDEPS-NEKSDIYSFGVILWELATLQ 149
                    +  APE++    +     DI+S G ++ EL   Q
Sbjct: 197 PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 77.1 bits (190), Expect = 5e-17
 Identities = 44/174 (25%), Positives = 70/174 (40%), Gaps = 36/174 (20%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
           + RL+   I+     +  P +L       IV E      L +L   P     L E     
Sbjct: 79  LNRLKSDYIIRLY-DLIIPDDLLKFDELYIVLEIADS-DLKKLFKTP---IFLTEEHIKT 133

Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
           + Y++  G N++H     I+HRDLK  N L+++  +VKVCDFGL+R   +   ++     
Sbjct: 134 ILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191

Query: 115 TPEWM----------------------APEVLRDEPS-NEKSDIYSFGVILWEL 145
                                      APE++  + +  +  DI+S G I  EL
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 76.4 bits (188), Expect = 8e-17
 Identities = 41/172 (23%), Positives = 71/172 (41%), Gaps = 33/172 (19%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSI--VTEYLSRGSLYRLLHKPGVREMLDERRRLNMA-- 56
           ++ L+HPN++          +  +  + +Y     L+ ++      +   +  +L     
Sbjct: 72  LRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMV 130

Query: 57  ----YDVAKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSR-----LKA 103
               Y +  G++YLH     ++HRDLK  N+LV     ++  VK+ D G +R     LK 
Sbjct: 131 KSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 188

Query: 104 NTFLSSKSAAGTPE----WM-APEVLRDEPSNEKS-DIYSFGVILWELATLQ 149
                       P     W  APE+L       K+ DI++ G I  EL T +
Sbjct: 189 LA-------DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 75.8 bits (187), Expect = 1e-16
 Identities = 42/162 (25%), Positives = 74/162 (45%), Gaps = 32/162 (19%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
           + R RH NI+     +   P +       IV + +    LY+LL     + + ++     
Sbjct: 79  LLRFRHENIIGINDIIR-APTIEQMKDVYIVQDLME-TDLYKLLKT---QHLSNDHICYF 133

Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
           + Y + +G+ Y+H  N  ++HRDLK  NLL++    +K+CDFGL+R        +     
Sbjct: 134 L-YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR-------VADPDHD 183

Query: 115 TPEWM----------APEVLRDEPS-NEKSDIYSFGVILWEL 145
              ++          APE++ +     +  DI+S G IL E+
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 75.9 bits (187), Expect = 1e-16
 Identities = 42/160 (26%), Positives = 69/160 (43%), Gaps = 17/160 (10%)

Query: 1   MKRLRHPNIVLFMGAVTQPPN------LSIVTEYLSRGSLYRLL-HKPGVREMLDERRRL 53
           M++L H NIV                 L++V +Y+   ++YR+  H    ++ L      
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 159

Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-YTVKVCDFGLSR-LKANTFLSSKS 111
              Y + + + Y+H     I HRD+K  NLL+D     +K+CDFG ++ L       S  
Sbjct: 160 LYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 217

Query: 112 AAGTPEWM-APEV-LRDEPSNEKSDIYSFGVILWELATLQ 149
            +    +  APE+           D++S G +L EL   Q
Sbjct: 218 CSR---YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 73.7 bits (181), Expect = 7e-16
 Identities = 32/142 (22%), Positives = 59/142 (41%), Gaps = 13/142 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
           + RL H ++V  +  +  P ++       +V E        +L   P    + +   +  
Sbjct: 106 LNRLNHDHVVKVL-DIVIPKDVEKFDELYVVLEIADS-DFKKLFRTP--VYLTELHIKTL 161

Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
           + Y++  G+ Y+H     I+HRDLK  N LV++  +VKVCDFGL+R        +     
Sbjct: 162 L-YNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218

Query: 115 TPEWMAPEVLRDEPSNEKSDIY 136
           +P      ++    +       
Sbjct: 219 SPREDDMNLVTFPHTKNLKRQL 240

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 73.1 bits (180), Expect = 9e-16
 Identities = 39/165 (23%), Positives = 70/165 (42%), Gaps = 24/165 (14%)

Query: 1   MKRLRHPNIV----LFMGAVTQPPN---LSIVTEYLSRGSLYRLL--HKPGVREMLDERR 51
           +  L HPNIV     F     +      L++V EY+   +L+R    +            
Sbjct: 73  LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILI 131

Query: 52  RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-YTVKVCDFGLSRLKANTFLSSK 110
           ++ + + + + +  LH  +  + HRD+K  N+LV++   T+K+CDFG ++        S 
Sbjct: 132 KVFL-FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK------KLSP 184

Query: 111 SAAGTPEWM-----APEVLRDEPSNEKS-DIYSFGVILWELATLQ 149
           S             APE++        + DI+S G I  E+   +
Sbjct: 185 SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 70.8 bits (174), Expect = 5e-15
 Identities = 38/157 (24%), Positives = 76/157 (48%), Gaps = 16/157 (10%)

Query: 1   MKRLR-HPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAY 57
           ++ LR  PNI+     V  P     ++V E+++     +L        + D   R  M Y
Sbjct: 84  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYM-Y 137

Query: 58  DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRL-KANTFLSSKSAAGT 115
           ++ K ++Y H     I+HRD+K  N+++D ++  +++ D+GL+         + + A  +
Sbjct: 138 EILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA--S 193

Query: 116 PEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQP 151
             +  PE+L D    + S D++S G +L  +   ++P
Sbjct: 194 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 70.4 bits (173), Expect = 6e-15
 Identities = 42/172 (24%), Positives = 71/172 (41%), Gaps = 42/172 (24%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLS---------------IVTEYLSRGSLYRLLHKPGVRE 45
           ++RL H NIV     +  P                   IV EY+    L  +L +     
Sbjct: 62  IRRLDHDNIVKVF-EILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GP 116

Query: 46  MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-YTVKVCDFGLSRLKAN 104
           +L+E  RL M Y + +G+ Y+H  N  ++HRDLK  NL ++ +   +K+ DFGL+R    
Sbjct: 117 LLEEHARLFM-YQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLAR---- 169

Query: 105 TFLSSKSAAGTPEWM----------APEVLRDEPS-NEKSDIYSFGVILWEL 145
                         +          +P +L    +  +  D+++ G I  E+
Sbjct: 170 ---IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 218

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 69.8 bits (171), Expect = 7e-15
 Identities = 24/186 (12%), Positives = 47/186 (25%), Gaps = 35/186 (18%)

Query: 3   RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKG 62
           R+  P +   +  V       +V E++  GSL  +               +     +A  
Sbjct: 87  RIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAA 141

Query: 63  MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPE 122
            +  HR    +         + V     V +                             
Sbjct: 142 ADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPATMP---------------------- 177

Query: 123 VLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF-KGKRLEIPRNVNPHV 181
                 +N + DI   G  L+ L   + P         +A        +   P +++  +
Sbjct: 178 -----DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI 232

Query: 182 ASIIEA 187
              I A
Sbjct: 233 PFQISA 238

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 69.3 bits (170), Expect = 2e-14
 Identities = 41/171 (23%), Positives = 75/171 (43%), Gaps = 34/171 (19%)

Query: 1   MKRLR-HPNIVLFMGAVTQPPNLS---IVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
           +  L  H NIV  +  V +  N     +V +Y+    L+ ++       +L+   +  + 
Sbjct: 62  LTELSGHENIVNLL-NVLRADNDRDVYLVFDYME-TDLHAVIRA----NILEPVHKQYVV 115

Query: 57  YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-----------LKANT 105
           Y + K + YLH     ++HRD+K  N+L++ +  VKV DFGLSR           +  + 
Sbjct: 116 YQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173

Query: 106 FLSSKSAAGTPEWM----------APEVLRDEPS-NEKSDIYSFGVILWEL 145
             ++++       +          APE+L       +  D++S G IL E+
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 65.5 bits (160), Expect = 4e-13
 Identities = 43/170 (25%), Positives = 76/170 (44%), Gaps = 28/170 (16%)

Query: 24  IVTEYLSRGSLYRLLHKPGVREM-LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN 82
           +V E L   +L  L+ K   R + L   ++  ++  +  G++Y+HRR   I+H D+K  N
Sbjct: 107 MVFEVLGE-NLLALIKKYEHRGIPLIYVKQ--ISKQLLLGLDYMHRRCG-IIHTDIKPEN 162

Query: 83  LLVD------KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIY 136
           +L++          +K+ D G +      + +S     T E+ +PEVL   P    +DI+
Sbjct: 163 VLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ---TREYRSPEVLLGAPWGCGADIW 219

Query: 137 SFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIE 186
           S   +++EL T     G+           F+          + H+A IIE
Sbjct: 220 STACLIFELIT-----GD---------FLFEPDEGHSYTKDDDHIAQIIE 255

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 64.0 bits (156), Expect = 1e-12
 Identities = 38/129 (29%), Positives = 59/129 (45%), Gaps = 13/129 (10%)

Query: 24  IVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL 83
           +V E LS  +LY LL     R +     R   A  +   + +L      I+H DLK  N+
Sbjct: 133 LVFEMLSY-NLYDLLRNTNFRGVSLNLTR-KFAQQMCTALLFLATPELSIIHCDLKPENI 190

Query: 84  LV--DKKYTVKVCDFGLSRLKAN---TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSF 138
           L+   K+  +K+ DFG S         ++ S+       + +PEVL   P +   D++S 
Sbjct: 191 LLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF------YRSPEVLLGMPYDLAIDMWSL 244

Query: 139 GVILWELAT 147
           G IL E+ T
Sbjct: 245 GCILVEMHT 253

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 62.4 bits (152), Expect = 5e-12
 Identities = 38/129 (29%), Positives = 61/129 (47%), Gaps = 15/129 (11%)

Query: 24  IVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL 83
           +  E LS  +LY L+ K   +       R   A+ + + ++ LH+    I+H DLK  N+
Sbjct: 176 MTFELLSM-NLYELIKKNKFQGFSLPLVR-KFAHSILQCLDALHKNR--IIHCDLKPENI 231

Query: 84  LV--DKKYTVKVCDFGLSRLKAN---TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSF 138
           L+    +  +KV DFG S  +     T++ S+       + APEV+         D++S 
Sbjct: 232 LLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF------YRAPEVILGARYGMPIDMWSL 285

Query: 139 GVILWELAT 147
           G IL EL T
Sbjct: 286 GCILAELLT 294

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 60.5 bits (147), Expect = 2e-11
 Identities = 39/192 (20%), Positives = 74/192 (38%), Gaps = 49/192 (25%)

Query: 1   MKRLRHPNIV--------------------------------LFMGAVTQPPN------L 22
           MK L H NI+                                +     +   N      L
Sbjct: 54  MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113

Query: 23  SIVTEYLSRGSLYRLLHKPGVR--EMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 80
           +++ EY+   +L+++L         +      + + Y + + + ++H     I HRD+K 
Sbjct: 114 NVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYI-YQLFRAVGFIHSLG--ICHRDIKP 169

Query: 81  PNLLVD-KKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYS 137
            NLLV+ K  T+K+CDFG ++ L  +    +     +  + APE++          D++S
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWS 227

Query: 138 FGVILWELATLQ 149
            G +  EL   +
Sbjct: 228 IGCVFGELILGK 239

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 52.2 bits (125), Expect = 2e-08
 Identities = 35/173 (20%), Positives = 58/173 (33%), Gaps = 55/173 (31%)

Query: 24  IVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL 83
           +V E L    L + + K   +  L       +   V +G++YLH +   I+H D+K  N+
Sbjct: 122 MVFEVL-GHHLLKWIIKSNYQ-GLPLPCVKKIIQQVLQGLDYLHTKCR-IIHTDIKPENI 178

Query: 84  LV-------------------------------------------------DKKYTVKVC 94
           L+                                                  +K  VK+ 
Sbjct: 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238

Query: 95  DFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147
           D G +      F        T ++ + EVL     N  +DI+S   + +ELAT
Sbjct: 239 DLGNACWVHKHFTEDIQ---TRQYRSLEVLIGSGYNTPADIWSTACMAFELAT 288

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 50.8 bits (122), Expect = 4e-08
 Identities = 31/146 (21%), Positives = 57/146 (39%), Gaps = 32/146 (21%)

Query: 24  IVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN- 82
           I  E L + + +  L +   +       R +MAY +   + +LH     + H DLK  N 
Sbjct: 99  IAFELLGK-NTFEFLKENNFQPYPLPHVR-HMAYQLCHALRFLHENQ--LTHTDLKPENI 154

Query: 83  LLVDKKYT------------------VKVCDFG---LSRLKANTFLSSKSAAGTPEWMAP 121
           L V+ ++                   ++V DFG          T ++++       +  P
Sbjct: 155 LFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRH------YRPP 208

Query: 122 EVLRDEPSNEKSDIYSFGVILWELAT 147
           EV+ +    +  D++S G IL+E   
Sbjct: 209 EVILELGWAQPCDVWSIGCILFEYYR 234

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 50.4 bits (121), Expect = 7e-08
 Identities = 41/146 (28%), Positives = 59/146 (40%), Gaps = 32/146 (21%)

Query: 24  IVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN- 82
           IV E L   S Y  + + G      +  R  MAY + K +N+LH     + H DLK  N 
Sbjct: 94  IVFELLGL-STYDFIKENGFLPFRLDHIR-KMAYQICKSVNFLHSNK--LTHTDLKPENI 149

Query: 83  LLVDKKYT------------------VKVCDFG---LSRLKANTFLSSKSAAGTPEWMAP 121
           L V   YT                  +KV DFG         +T +S++       + AP
Sbjct: 150 LFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRH------YRAP 203

Query: 122 EVLRDEPSNEKSDIYSFGVILWELAT 147
           EV+     ++  D++S G IL E   
Sbjct: 204 EVILALGWSQPCDVWSIGCILIEYYL 229

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 48.9 bits (117), Expect = 2e-07
 Identities = 34/153 (22%), Positives = 64/153 (41%), Gaps = 40/153 (26%)

Query: 24  IVTEYLSRGSLYRLLHKPGVREM-LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN 82
           ++ E L   SLY ++ +       +++ +      ++ K +NYL + +  + H DLK  N
Sbjct: 113 LIFEPLGP-SLYEIITRNNYNGFHIEDIKL--YCIEILKALNYLRKMS--LTHTDLKPEN 167

Query: 83  -LLVDKKYT------------------------VKVCDFG---LSRLKANTFLSSKSAAG 114
            LL D  +                         +K+ DFG          + ++++    
Sbjct: 168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQ--- 224

Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT 147
              + APEV+ +   +  SD++SFG +L EL T
Sbjct: 225 ---YRAPEVILNLGWDVSSDMWSFGCVLAELYT 254

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 43.3 bits (101), Expect = 2e-05
 Identities = 13/82 (15%), Positives = 26/82 (31%), Gaps = 5/82 (6%)

Query: 19  PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL 78
              L IV E+   G     +      ++       ++ + +   +           HRDL
Sbjct: 134 DDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASLAVAEAS-LRFEHRDL 188

Query: 79  KSPNLLVDKKYTVKVCDFGLSR 100
              N+L+ K    K+      +
Sbjct: 189 HWGNVLLKKTSLKKLHYTLNGK 210

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 42.4 bits (100), Expect = 3e-05
 Identities = 26/101 (25%), Positives = 43/101 (42%), Gaps = 13/101 (12%)

Query: 65  YLHRRNPPIVHRDLKSPNLLVDKKYTVKV--CDFGLSRL-------KANTFLSSKSAAGT 115
           Y+H      VH D+K+ NLL++ K   +V   D+GL+         KA      +   GT
Sbjct: 167 YIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGT 224

Query: 116 PEWMAPEV-LRDEPSNEKSDIYSFGVILWELATLQQPWGNL 155
            E+ + +      PS  + D+   G  + +  T   PW + 
Sbjct: 225 IEFTSIDAHNGVAPS-RRGDLEILGYCMIQWLTGHLPWEDN 264

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 40.9 bits (96), Expect = 1e-04
 Identities = 28/108 (25%), Positives = 43/108 (39%), Gaps = 15/108 (13%)

Query: 65  YLHRRNPPIVHRDLKSPNLLVDKKYTVKV--CDFGLSRL-------KANTFLSSKSAAGT 115
           Y+H      VH D+K+ NLL+  K   +V   D+GLS         K       K   GT
Sbjct: 166 YIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGT 223

Query: 116 PEWMAPEVLR-DEPSNEKSDIYSFGVILWELATLQQPWGNL--NPAQV 160
            E+ + +  +    S  +SD+   G  +      + PW     +P  V
Sbjct: 224 IEFTSLDAHKGVALS-RRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 40.0 bits (94), Expect = 2e-04
 Identities = 21/104 (20%), Positives = 43/104 (41%), Gaps = 14/104 (13%)

Query: 65  YLHRRNPPIVHRDLKSPNLLVDKKYT-----VKVCDFGLSR--LKANT-----FLSSKSA 112
            +H ++  +V+RD+K  N L+ +  +     + V DFG+ +      T     +   K+ 
Sbjct: 121 SIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 178

Query: 113 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN 156
           +GT  +M+         + + D+ + G +         PW  L 
Sbjct: 179 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 39.7 bits (93), Expect = 3e-04
 Identities = 22/104 (21%), Positives = 44/104 (42%), Gaps = 14/104 (13%)

Query: 65  YLHRRNPPIVHRDLKSPNLLV-----DKKYTVKVCDFGLSR--LKANT-----FLSSKSA 112
           Y+H +N  +++RD+K  N L+       +  + + DF L++  +   T     +   KS 
Sbjct: 120 YVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSL 177

Query: 113 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN 156
            GT  +M+      +  + + D+ + G +         PW  L 
Sbjct: 178 TGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK 221

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 39.0 bits (91), Expect = 5e-04
 Identities = 22/105 (20%), Positives = 39/105 (37%), Gaps = 21/105 (20%)

Query: 65  YLHRRNPPIVHRDLKSPNLLVDKKYTVKV--CDFGLSRLKANT-------FLSSKSAAGT 115
           +LH      VH ++ + N+ VD +   +V    +G +     +         S     G 
Sbjct: 174 FLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGD 231

Query: 116 PEWMAPEVLRD-----EPSNEKSDIYSFGVILWELATLQQPWGNL 155
            E+++     D      PS  +SD+ S G  + +      PW N 
Sbjct: 232 LEFIS----MDLHKGCGPS-RRSDLQSLGYCMLKWLYGFLPWTNC 271

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	191
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.98
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.97
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.97
3uqc_A	286	Probable conserved transmembrane protein; structur	99.97
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.97
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.87
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.66
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.45
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.23
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.89
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.61
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.44
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.44
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.25
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.17
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.01
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.8
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.36
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.34
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	96.26
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	95.43
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	95.4
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	94.42
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	93.62
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	93.5
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	93.43
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	93.41
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	92.84
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	92.78
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	91.48
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	90.07
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	89.84
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	88.51
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	88.25
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	88.13
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	87.43
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	85.61
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	81.02
3mes_A	424	Choline kinase; malaria, structural genomics, stru	80.95

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.4e-50  Score=303.40  Aligned_cols=184  Identities=28%  Similarity=0.457  Sum_probs=165.5

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||++++++|++++.+|+|||||+||+|.+++.+.+   .+++.++..++.||+.||+|||++|  |+||||||
T Consensus        80 l~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp  154 (304)
T 3ubd_A           80 LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG--IIYRDLKP  154 (304)
T ss_dssp             CCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCG
T ss_pred             HHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCH
Confidence            578899999999999999999999999999999999997644   3999999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.+|.+||+|||++..............+++.|+|||.+.+..++.++|+||+||++|+|++|..||...+..+.
T Consensus       155 ~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~  234 (304)
T 3ubd_A          155 ENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET  234 (304)
T ss_dssp             GGEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             HHeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH
Confidence            99999999999999999997654443445566899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+..  ..+++|..+|++++++|.+||++
T Consensus       235 ~~~i~~--~~~~~p~~~s~~~~~li~~~L~~  263 (304)
T 3ubd_A          235 MTMILK--AKLGMPQFLSPEAQSLLRMLFKR  263 (304)
T ss_dssp             HHHHHH--CCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHc--CCCCCCCcCCHHHHHHHHHHccc
Confidence            888854  45677899999999999999975

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.7e-50  Score=303.14  Aligned_cols=184  Identities=24%  Similarity=0.466  Sum_probs=166.4

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||++++++|++++.+|+|||||+||+|.+++.+.+   .+++.+++.++.||+.||+|||++|  |+||||||
T Consensus        86 l~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKP  160 (311)
T 4aw0_A           86 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKP  160 (311)
T ss_dssp             HTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSG
T ss_pred             HHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCH
Confidence            468899999999999999999999999999999999997644   3999999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccc--cccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      +||+++.+|.+||+|||++......  .......++++.|+|||++.+..++.++|+||+||++|+|++|..||...+..
T Consensus       161 eNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~  240 (311)
T 4aw0_A          161 ENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG  240 (311)
T ss_dssp             GGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             HHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999999999999999999754322  22344568999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +....+..  ....+|..+|++++++|.+||++
T Consensus       241 ~~~~~i~~--~~~~~p~~~s~~~~dli~~lL~~  271 (311)
T 4aw0_A          241 LIFAKIIK--LEYDFPEKFFPKARDLVEKLLVL  271 (311)
T ss_dssp             HHHHHHHH--TCCCCCTTCCHHHHHHHHHHSCS
T ss_pred             HHHHHHHc--CCCCCCcccCHHHHHHHHHHccC
Confidence            99988864  35678899999999999999975

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.8e-50  Score=306.52  Aligned_cols=187  Identities=27%  Similarity=0.513  Sum_probs=165.3

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||++++++|++++.+|+|||||+||+|.+++...+ +..+++.+++.++.||+.||+|||++|  |+||||||
T Consensus        77 l~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp  153 (350)
T 4b9d_A           77 LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKS  153 (350)
T ss_dssp             HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCG
T ss_pred             HHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCH
Confidence            356899999999999999999999999999999999996533 234789999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.+|.+||+|||++..............+++.|+|||.+.+..++.++|||||||++|+|++|..||...+..+.
T Consensus       154 ~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~  233 (350)
T 4b9d_A          154 QNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL  233 (350)
T ss_dssp             GGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             HHEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH
Confidence            99999999999999999997654332223334689999999999999999999999999999999999999999999998


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+.. +..++.+..+|++++++|.+||++
T Consensus       234 ~~~i~~-~~~~~~~~~~s~~~~~li~~~L~~  263 (350)
T 4b9d_A          234 VLKIIS-GSFPPVSLHYSYDLRSLVSQLFKR  263 (350)
T ss_dssp             HHHHHH-TCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHc-CCCCCCCccCCHHHHHHHHHHccC
Confidence            888864 345567889999999999999975

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.6e-49  Score=301.89  Aligned_cols=185  Identities=26%  Similarity=0.473  Sum_probs=165.1

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||++++++|++++.+|+|||||++|+|.+++.+..    +++.++..++.||+.||+|||++|  |+||||||
T Consensus       125 l~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~----l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp  198 (346)
T 4fih_A          125 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKS  198 (346)
T ss_dssp             HHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred             HHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCC--cccccCCH
Confidence            356899999999999999999999999999999999997532    899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.+|.+||+|||++.............++++.|+|||++.+..++.++||||+||++|+|++|..||...+..+.
T Consensus       199 ~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~  278 (346)
T 4fih_A          199 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA  278 (346)
T ss_dssp             GGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred             HHEEECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH
Confidence            99999999999999999997655444445567899999999999999999999999999999999999999999999988


Q ss_pred             HHHHHhcCc-ccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGK-RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~-~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+..... ..+.+..+|+++++||.+||++
T Consensus       279 ~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~  310 (346)
T 4fih_A          279 MKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVR  310 (346)
T ss_dssp             HHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCS
T ss_pred             HHHHHcCCCCCCCccccCCHHHHHHHHHHcCC
Confidence            888864322 3345568999999999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=8.5e-49  Score=297.07  Aligned_cols=186  Identities=31%  Similarity=0.464  Sum_probs=161.6

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++|||||+++++|++++.+|+|||||+||+|.+++.+.+   .+++.++..++.||+.||+|||++|  |+||||||
T Consensus       104 l~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp  178 (336)
T 4g3f_A          104 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKA  178 (336)
T ss_dssp             TTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCG
T ss_pred             HHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCH
Confidence            578999999999999999999999999999999999997644   3999999999999999999999999  99999999


Q ss_pred             CcEEecCCC-cEEEccccccccccccc-----ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 029552           81 PNLLVDKKY-TVKVCDFGLSRLKANTF-----LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN  154 (191)
Q Consensus        81 ~ni~~~~~~-~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~  154 (191)
                      +||+++.+| .+||+|||++.......     .......+++.|+|||.+.+..++.++||||+||++|+|++|..||..
T Consensus       179 ~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~  258 (336)
T 4g3f_A          179 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ  258 (336)
T ss_dssp             GGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred             HHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCC
Confidence            999999887 59999999987543221     122335689999999999999999999999999999999999999998


Q ss_pred             CCHHHHHHHHHhcCcc-cCCCCCCCHHHHHHHHHHhcC
Q 029552          155 LNPAQVVAAVGFKGKR-LEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       155 ~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+..+....+.....+ ..+|+.+|+.++++|.+||++
T Consensus       259 ~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~  296 (336)
T 4g3f_A          259 YFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRK  296 (336)
T ss_dssp             TCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCS
T ss_pred             CCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccC
Confidence            7777777777655443 357889999999999999975

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.6e-48  Score=303.03  Aligned_cols=185  Identities=26%  Similarity=0.473  Sum_probs=165.4

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||++++++|++++.+|+|||||+||+|.+++....    +++.++..++.||+.||+|||++|  |+||||||
T Consensus       202 l~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~~~----l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp  275 (423)
T 4fie_A          202 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKS  275 (423)
T ss_dssp             HHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCST
T ss_pred             HHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHHCC--eecccCCH
Confidence            356899999999999999999999999999999999997532    899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.+|.+||+|||++.............++++.|+|||++.+..++.++|||||||++|+|++|..||...+..+.
T Consensus       276 ~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~  355 (423)
T 4fie_A          276 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA  355 (423)
T ss_dssp             TTEEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred             HHEEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH
Confidence            99999999999999999987655443444566789999999999999999999999999999999999999999999998


Q ss_pred             HHHHHhcCc-ccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGK-RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~-~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+..... ....+..+|+.+++||.+||++
T Consensus       356 ~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~  387 (423)
T 4fie_A          356 MKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVR  387 (423)
T ss_dssp             HHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCS
T ss_pred             HHHHHcCCCCCCcccccCCHHHHHHHHHHcCC
Confidence            888864432 3455678999999999999975

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.5e-48  Score=291.38  Aligned_cols=188  Identities=34%  Similarity=0.615  Sum_probs=165.6

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCC----------CcccccHHHHHHHHHHHHHHHHHHHhCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG----------VREMLDERRRLNMAYDVAKGMNYLHRRN   70 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~   70 (191)
                      |++++|||||+++++|.+++..++|||||++|+|.+++...+          ....+++.+++.++.|+++|++|||+++
T Consensus        69 l~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~  148 (299)
T 4asz_A           69 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH  148 (299)
T ss_dssp             HTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            468999999999999999999999999999999999996532          1234899999999999999999999999


Q ss_pred             CCeeecCCCCCcEEecCCCcEEEcccccccccccc--cccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-
Q 029552           71 PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-  147 (191)
Q Consensus        71 ~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-  147 (191)
                        ++||||||+||+++.++.+||+|||++......  ........+++.|+|||.+.+..++.++||||+||++|+|+| 
T Consensus       149 --iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~  226 (299)
T 4asz_A          149 --FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTY  226 (299)
T ss_dssp             --CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             --cccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcC
Confidence              999999999999999999999999998754322  122233457889999999999999999999999999999998 


Q ss_pred             CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          148 LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       148 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      |..||...+..+....+. .+.+++.|..+|+.+.++|.+||++
T Consensus       227 G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~~li~~cl~~  269 (299)
T 4asz_A          227 GKQPWYQLSNNEVIECIT-QGRVLQRPRTCPQEVYELMLGCWQR  269 (299)
T ss_dssp             TCCTTTTSCHHHHHHHHH-HTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCCCCCCCCHHHHHHHHH-cCCCCCCCccchHHHHHHHHHHcCC
Confidence            899999999999888886 4566788999999999999999975

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.5e-48  Score=286.78  Aligned_cols=182  Identities=27%  Similarity=0.510  Sum_probs=153.4

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||++++++|++++..|+||||+ +|+|.+++.+.+   .+++.++..++.||+.||+|||++|  ++||||||
T Consensus        67 l~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP  140 (275)
T 3hyh_A           67 LRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKP  140 (275)
T ss_dssp             HHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCT
T ss_pred             HHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCh
Confidence            35689999999999999999999999999 579999987644   3999999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      +||+++.++.+||+|||++...... .......+++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+..+
T Consensus       141 ~NILl~~~~~vkl~DFGla~~~~~~-~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~  219 (275)
T 3hyh_A          141 ENLLLDEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV  219 (275)
T ss_dssp             TTEEECTTCCEEECCSSCC----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             HHeEECCCCCEEEeecCCCeecCCC-CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH
Confidence            9999999999999999999754433 23345678999999999998876 578999999999999999999999999888


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+..  ...++|..+|++++++|++||++
T Consensus       220 ~~~~i~~--~~~~~p~~~s~~~~~li~~~L~~  249 (275)
T 3hyh_A          220 LFKNISN--GVYTLPKFLSPGAAGLIKRMLIV  249 (275)
T ss_dssp             HHHHHHH--TCCCCCTTSCHHHHHHHHHHSCS
T ss_pred             HHHHHHc--CCCCCCCCCCHHHHHHHHHHccC
Confidence            8888854  45677889999999999999975

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=8.2e-48  Score=286.98  Aligned_cols=185  Identities=35%  Similarity=0.592  Sum_probs=155.8

Q ss_pred             CCCCCCCCcccccceeec----CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeec
Q 029552            1 MKRLRHPNIVLFMGAVTQ----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR   76 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~   76 (191)
                      |++++|||||+++++|++    ++.+|+|||||++|+|.+++.+.+   .+++.++..++.||+.||+|||+++.+|+||
T Consensus        79 l~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHR  155 (290)
T 3fpq_A           79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRTPPIIHR  155 (290)
T ss_dssp             HHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCC
T ss_pred             HHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCCEEec
Confidence            467899999999999975    346899999999999999997643   3899999999999999999999987669999


Q ss_pred             CCCCCcEEecC-CCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           77 DLKSPNLLVDK-KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        77 ~l~p~ni~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      ||||+||+++. +|.+||+|||++......  ......+++.|+|||.+.+ .++.++||||+||++|+|+||..||...
T Consensus       156 DlKp~NILl~~~~g~vKl~DFGla~~~~~~--~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~  232 (290)
T 3fpq_A          156 DLKCDNIFITGPTGSVKIGDLGLATLKRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC  232 (290)
T ss_dssp             CCCGGGEEESSTTSCEEECCTTGGGGCCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             ccChhheeEECCCCCEEEEeCcCCEeCCCC--ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            99999999974 789999999999754433  3334578999999999876 5899999999999999999999999764


Q ss_pred             -CHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          156 -NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 -~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                       +.......+.....+...+..+|+.++++|.+||++
T Consensus       233 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~  269 (290)
T 3fpq_A          233 QNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQ  269 (290)
T ss_dssp             SSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCS
T ss_pred             CcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccC
Confidence             445555556444344566778999999999999975

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.5e-47  Score=289.43  Aligned_cols=188  Identities=37%  Similarity=0.629  Sum_probs=160.1

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC------------cccccHHHHHHHHHHHHHHHHHHHh
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV------------REMLDERRRLNMAYDVAKGMNYLHR   68 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~Lh~   68 (191)
                      |++++|||||+++++|.+++..++|||||++|+|.+++.+...            .+.+++.+++.++.|+++||+|||+
T Consensus        97 l~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~  176 (329)
T 4aoj_A           97 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG  176 (329)
T ss_dssp             HTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence            4689999999999999999999999999999999999965321            2348999999999999999999999


Q ss_pred             CCCCeeecCCCCCcEEecCCCcEEEcccccccccccc--cccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHH
Q 029552           69 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA  146 (191)
Q Consensus        69 ~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~  146 (191)
                      .+  ++||||||+||+++.++.+||+|||++......  ........+++.|+|||.+.+..++.++||||+||++|+|+
T Consensus       177 ~~--iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ell  254 (329)
T 4aoj_A          177 LH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF  254 (329)
T ss_dssp             TT--CCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             CC--eecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHH
Confidence            99  999999999999999999999999998754322  12233456788999999999999999999999999999999


Q ss_pred             h-CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          147 T-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       147 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      | |..||...+..+....+. .+.+++.|..+|+.+.++|.+||++
T Consensus       255 t~G~~Pf~~~~~~~~~~~i~-~g~~~~~p~~~~~~~~~li~~cl~~  299 (329)
T 4aoj_A          255 TYGKQPWYQLSNTEAIDCIT-QGRELERPRACPPEVYAIMRGCWQR  299 (329)
T ss_dssp             TTSCCTTCSSCHHHHHHHHH-HTCCCCCCTTCCHHHHHHHHHHCCS
T ss_pred             cCCCCCCCCCCHHHHHHHHH-cCCCCCCcccccHHHHHHHHHHcCc
Confidence            9 899999999999888886 4567888999999999999999975

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.1e-47  Score=287.41  Aligned_cols=187  Identities=32%  Similarity=0.553  Sum_probs=165.0

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC-------------cccccHHHHHHHHHHHHHHHHHHHh
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------------REMLDERRRLNMAYDVAKGMNYLHR   68 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~Lh~   68 (191)
                      ++++||||+++++++.+++..++|||||++|+|.+++.....             ...+++.++..++.||++|++|||+
T Consensus        84 ~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~  163 (308)
T 4gt4_A           84 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS  163 (308)
T ss_dssp             HHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            568999999999999999999999999999999999964321             2348899999999999999999999


Q ss_pred             CCCCeeecCCCCCcEEecCCCcEEEcccccccccccc--cccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHH
Q 029552           69 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA  146 (191)
Q Consensus        69 ~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~  146 (191)
                      ++  ++||||||+||+++.++.+||+|||++......  ........+++.|+|||.+.+..++.++||||+|+++|||+
T Consensus       164 ~~--iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~  241 (308)
T 4gt4_A          164 HH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF  241 (308)
T ss_dssp             TT--CCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             CC--CCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHH
Confidence            99  999999999999999999999999998754322  22334456788999999999999999999999999999999


Q ss_pred             h-CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          147 T-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       147 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      | |..||...+..+....+. .+.+++.|.++|+.+.++|.+||++
T Consensus       242 t~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~~li~~C~~~  286 (308)
T 4gt4_A          242 SYGLQPYCGYSNQDVVEMIR-NRQVLPCPDDCPAWVYALMIECWNE  286 (308)
T ss_dssp             TTTCCTTTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             hCCCCCCCCCCHHHHHHHHH-cCCCCCCcccchHHHHHHHHHHcCC
Confidence            8 899999999999888886 5667788999999999999999974

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=7.5e-47  Score=283.71  Aligned_cols=186  Identities=35%  Similarity=0.632  Sum_probs=151.7

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+ +..++|||||++|+|.+++.....  .+++.++..++.|+++||+|||+++  |+||||||
T Consensus        86 l~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp  160 (307)
T 3omv_A           86 LRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKS  160 (307)
T ss_dssp             HTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCS
T ss_pred             HHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCH
Confidence            468999999999998765 568999999999999999965432  3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccc--cccCCCCCCCCcccCccccccC---CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDE---PSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~---~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      +||+++.++.+||+|||++......  ........+++.|+|||.+.+.   .++.++||||+||++|+|+||..||...
T Consensus       161 ~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~  240 (307)
T 3omv_A          161 NNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHI  240 (307)
T ss_dssp             SSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             HHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCC
Confidence            9999999999999999999754322  2233456789999999998643   5788999999999999999999999886


Q ss_pred             CHHHHHHHHHhcCcc----cCCCCCCCHHHHHHHHHHhcC
Q 029552          156 NPAQVVAAVGFKGKR----LEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~~~~~~~~~~~~~----~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +.......+...+..    ...+.++|+.++++|.+||++
T Consensus       241 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~  280 (307)
T 3omv_A          241 NNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKK  280 (307)
T ss_dssp             CCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCS
T ss_pred             ChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCC
Confidence            665555444333332    235678999999999999975

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.2e-45  Score=282.31  Aligned_cols=187  Identities=30%  Similarity=0.573  Sum_probs=157.8

Q ss_pred             CCCC-CCcccccceeec-CCceEEEEeccCCCCHHHHhcCCCC-------------cccccHHHHHHHHHHHHHHHHHHH
Q 029552            3 RLRH-PNIVLFMGAVTQ-PPNLSIVTEYLSRGSLYRLLHKPGV-------------REMLDERRRLNMAYDVAKGMNYLH   67 (191)
Q Consensus         3 ~l~h-~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~Lh   67 (191)
                      +++| ||||+++++|.+ ++.+++|||||++|+|.++++....             +..+++.++..++.||++|++|||
T Consensus       123 ~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH  202 (353)
T 4ase_A          123 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA  202 (353)
T ss_dssp             HHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH
T ss_pred             HcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh
Confidence            4554 999999999865 4568999999999999999964321             234889999999999999999999


Q ss_pred             hCCCCeeecCCCCCcEEecCCCcEEEcccccccccccc--cccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHH
Q 029552           68 RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL  145 (191)
Q Consensus        68 ~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l  145 (191)
                      +++  ++||||||+||+++.++.+||+|||++......  ........+++.|+|||.+.+..++.++||||+||++|||
T Consensus       203 ~~~--iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El  280 (353)
T 4ase_A          203 SRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI  280 (353)
T ss_dssp             HTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred             hCC--eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHH
Confidence            999  999999999999999999999999999753322  1122334567899999999999999999999999999999


Q ss_pred             Hh-CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          146 AT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       146 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +| |..||...+..+.+......+.+++.|..+|+.+.++|.+||++
T Consensus       281 ~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~  327 (353)
T 4ase_A          281 FSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG  327 (353)
T ss_dssp             TTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             HhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCc
Confidence            98 89999887655555555457778899999999999999999975

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.2e-44  Score=291.90  Aligned_cols=181  Identities=26%  Similarity=0.432  Sum_probs=158.0

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++||||++++++|++++.+|+|||||+||+|.+++.+.+   .+++.+++.++.||+.||+|||++|  |+||||||+
T Consensus       247 ~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPe  321 (689)
T 3v5w_A          247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPA  321 (689)
T ss_dssp             SSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGG
T ss_pred             hhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchH
Confidence            56799999999999999999999999999999999997644   3999999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccc-cCCCCCcchHHHHHHHHHHHHhCCCCCCCC---CH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR-DEPSNEKSDIYSFGVILWELATLQQPWGNL---NP  157 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~---~~  157 (191)
                      ||+++.+|.+||+|||++......  .....+|++.|+|||++. +..++.++|+|||||++|+|++|..||...   +.
T Consensus       322 NILld~~G~vKL~DFGlA~~~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~  399 (689)
T 3v5w_A          322 NILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK  399 (689)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH
T ss_pred             HeEEeCCCCEEecccceeeecCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence            999999999999999999755433  334568999999999986 457899999999999999999999999753   33


Q ss_pred             HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+....+  ......+|..+|+.++++|.+||++
T Consensus       400 ~~i~~~i--~~~~~~~p~~~S~~a~dLI~~lL~~  431 (689)
T 3v5w_A          400 HEIDRMT--LTMAVELPDSFSPELRSLLEGLLQR  431 (689)
T ss_dssp             HHHHHHH--HHCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHhh--cCCCCCCCccCCHHHHHHHHHHccC
Confidence            3444444  2346678899999999999999975

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.2e-44  Score=269.28  Aligned_cols=185  Identities=24%  Similarity=0.377  Sum_probs=142.1

Q ss_pred             CCCCCCCCcccccceeecCC------------ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHh
Q 029552            1 MKRLRHPNIVLFMGAVTQPP------------NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR   68 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~------------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~   68 (191)
                      |++++||||++++++|.+.+            ..|+|||||.+|+|.+++.........++..++.++.||++||+|||+
T Consensus        57 l~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~  136 (299)
T 4g31_A           57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS  136 (299)
T ss_dssp             HTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH
Confidence            46899999999999997544            379999999999999999875543345667788999999999999999


Q ss_pred             CCCCeeecCCCCCcEEecCCCcEEEcccccccccccccc------------cCCCCCCCCcccCccccccCCCCCcchHH
Q 029552           69 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL------------SSKSAAGTPEWMAPEVLRDEPSNEKSDIY  136 (191)
Q Consensus        69 ~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~  136 (191)
                      +|  |+||||||+||+++.+|.+||+|||++........            ......+++.|+|||.+.+..++.++|||
T Consensus       137 ~~--IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~Diw  214 (299)
T 4g31_A          137 KG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIF  214 (299)
T ss_dssp             TT--CCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHH
T ss_pred             Cc--CccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHH
Confidence            99  99999999999999999999999999875432211            11234689999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          137 SFGVILWELATLQQPWGNLNP-AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       137 slG~~~~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      |+||++|+|++   ||..... ......+. ....++.+...++.++++|++||++
T Consensus       215 SlGvilyell~---Pf~~~~~~~~~~~~~~-~~~~p~~~~~~~~~~~~li~~~L~~  266 (299)
T 4g31_A          215 SLGLILFELLY---PFSTQMERVRTLTDVR-NLKFPPLFTQKYPCEYVMVQDMLSP  266 (299)
T ss_dssp             HHHHHHHHHHS---CCSSHHHHHHHHHHHH-TTCCCHHHHHHCHHHHHHHHHHTCS
T ss_pred             HHHHHHHHHcc---CCCCccHHHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHcCC
Confidence            99999999996   8865332 22333332 2222233345678889999999975

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2e-42  Score=279.67  Aligned_cols=186  Identities=26%  Similarity=0.412  Sum_probs=161.4

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||++++++|++++.+|+|||||.||+|.+++....  +.+++.++..++.||+.||+|||++|  |+||||||
T Consensus       208 l~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp  283 (573)
T 3uto_A          208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKP  283 (573)
T ss_dssp             HHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCG
T ss_pred             HHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCh
Confidence            356899999999999999999999999999999999986533  23999999999999999999999999  99999999


Q ss_pred             CcEEecCC--CcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           81 PNLLVDKK--YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        81 ~ni~~~~~--~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      +||+++.+  +.+||+|||++...... .......+++.|+|||++.+..++.++|+||+||++|+|++|..||...+..
T Consensus       284 ~Nill~~~~~~~vKl~DFG~a~~~~~~-~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~  362 (573)
T 3uto_A          284 ENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD  362 (573)
T ss_dssp             GGEEESSSSCCCEEECCCSSCEECCTT-SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred             hhccccCCCCCCEEEeeccceeEccCC-CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH
Confidence            99999854  78999999998754332 1223346899999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhcCccc--CCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRL--EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~--~~~~~~s~~~~~li~~cl~~  191 (191)
                      +....+......+  ..+..+|+.+++||++||.+
T Consensus       363 ~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~  397 (573)
T 3uto_A          363 ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLA  397 (573)
T ss_dssp             HHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCS
T ss_pred             HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccC
Confidence            9998886544333  23468999999999999974

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.2e-42  Score=260.11  Aligned_cols=185  Identities=33%  Similarity=0.525  Sum_probs=144.3

Q ss_pred             CCCCCCCCcccccceeecCC----ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhC-------
Q 029552            1 MKRLRHPNIVLFMGAVTQPP----NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRR-------   69 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-------   69 (191)
                      +.+++||||+++++++.+++    ..|+|||||++|+|.+++....    ++++++..++.|++.||+|||++       
T Consensus        51 ~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~  126 (303)
T 3hmm_A           51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGK  126 (303)
T ss_dssp             STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCB
T ss_pred             HhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHhhhhccCC
Confidence            35789999999999997654    5799999999999999997543    88999999999999999999987       


Q ss_pred             -CCCeeecCCCCCcEEecCCCcEEEcccccccccccccc----cCCCCCCCCcccCccccccC------CCCCcchHHHH
Q 029552           70 -NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL----SSKSAAGTPEWMAPEVLRDE------PSNEKSDIYSF  138 (191)
Q Consensus        70 -~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~------~~~~~~Dv~sl  138 (191)
                       +  |+||||||+||+++.++.+||+|||++........    ......+++.|+|||.+.+.      .++.++||||+
T Consensus       127 ~~--IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~  204 (303)
T 3hmm_A          127 PA--IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM  204 (303)
T ss_dssp             CC--EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHH
T ss_pred             CC--EeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhH
Confidence             7  99999999999999999999999999875433211    22345689999999998765      24668999999


Q ss_pred             HHHHHHHHhCCCCCC----------CC-----CHHHHHHHHHhcCcccCCCCC-----CCHHHHHHHHHHhcC
Q 029552          139 GVILWELATLQQPWG----------NL-----NPAQVVAAVGFKGKRLEIPRN-----VNPHVASIIEACWAK  191 (191)
Q Consensus       139 G~~~~~l~~g~~pf~----------~~-----~~~~~~~~~~~~~~~~~~~~~-----~s~~~~~li~~cl~~  191 (191)
                      ||++|+|+||..||.          ..     ........+.....++++|..     .++.+.++|.+||++
T Consensus       205 Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~  277 (303)
T 3hmm_A          205 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA  277 (303)
T ss_dssp             HHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCS
T ss_pred             HHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHccc
Confidence            999999999966543          21     223444444444455666643     345789999999974

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=263.80  Aligned_cols=185  Identities=21%  Similarity=0.338  Sum_probs=152.4

Q ss_pred             CCCCCCCCcccccceee------cCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCee
Q 029552            1 MKRLRHPNIVLFMGAVT------QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIV   74 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~   74 (191)
                      |++++||||+++++++.      +.+..|+|||||. |+|.+++.+.+   .+++.++..++.||+.||+|||++|  |+
T Consensus       107 l~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~~--ii  180 (398)
T 4b99_A          107 LKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSAQ--VI  180 (398)
T ss_dssp             HHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHTT--CB
T ss_pred             HHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc--Cc
Confidence            35689999999999875      3467899999996 58999997644   3999999999999999999999999  99


Q ss_pred             ecCCCCCcEEecCCCcEEEcccccccccccc----cccCCCCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCC
Q 029552           75 HRDLKSPNLLVDKKYTVKVCDFGLSRLKANT----FLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQ  149 (191)
Q Consensus        75 h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~  149 (191)
                      ||||||+||+++.+|.+||+|||++......    ........+++.|+|||++.+.. ++.++|+||+||++|+|++|.
T Consensus       181 HRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~  260 (398)
T 4b99_A          181 HRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR  260 (398)
T ss_dssp             CCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTS
T ss_pred             CCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCC
Confidence            9999999999999999999999998754322    12234567899999999988764 688999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHHhcCcccC-----------------------------CCCCCCHHHHHHHHHHhcC
Q 029552          150 QPWGNLNPAQVVAAVGFKGKRLE-----------------------------IPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       150 ~pf~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~s~~~~~li~~cl~~  191 (191)
                      .||...+..+....+......++                             ..+++|+.+++||.+||.+
T Consensus       261 ~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~  331 (398)
T 4b99_A          261 QLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRF  331 (398)
T ss_dssp             CSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCS
T ss_pred             CCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcC
Confidence            99999888887777643221111                             1135799999999999974

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4.2e-41  Score=256.74  Aligned_cols=183  Identities=28%  Similarity=0.511  Sum_probs=162.9

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||++++++|.+++..|+||||+++++|.+++.+.+   .+++.+++.++.||+.||+|||++|  ++||||||+
T Consensus        60 ~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~  134 (337)
T 1o6l_A           60 QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLE  134 (337)
T ss_dssp             HSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGG
T ss_pred             HhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHH
Confidence            56799999999999999999999999999999999997643   3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      ||+++.+|.++|+|||++..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.....
T Consensus       135 NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~  214 (337)
T 1o6l_A          135 NLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF  214 (337)
T ss_dssp             GEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             HEEECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHH
Confidence            99999999999999999875433323344556788999999999988999999999999999999999999999888888


Q ss_pred             HHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+..  ....+|..+|+.++++|.+||++
T Consensus       215 ~~i~~--~~~~~p~~~s~~~~~li~~lL~~  242 (337)
T 1o6l_A          215 ELILM--EEIRFPRTLSPEAKSLLAGLLKK  242 (337)
T ss_dssp             HHHHH--CCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             HHHHc--CCCCCCCCCCHHHHHHHHHHhhc
Confidence            88754  35567889999999999999974

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.8e-41  Score=257.62  Aligned_cols=142  Identities=27%  Similarity=0.425  Sum_probs=123.7

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      +||||++++++|++++++|+||||+++++|.+++..      +++.++..++.||+.||+|||++|  |+||||||+||+
T Consensus        78 ~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~~------l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiL  149 (361)
T 4f9c_A           78 GQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS------LSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFL  149 (361)
T ss_dssp             SBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHTT------CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred             CCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHcC------CCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeE
Confidence            699999999999999999999999999999999853      889999999999999999999999  999999999999


Q ss_pred             ecCC-CcEEEccccccccccccc----------------------------ccCCCCCCCCcccCccccccCC-CCCcch
Q 029552           85 VDKK-YTVKVCDFGLSRLKANTF----------------------------LSSKSAAGTPEWMAPEVLRDEP-SNEKSD  134 (191)
Q Consensus        85 ~~~~-~~~~l~d~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~pe~~~~~~-~~~~~D  134 (191)
                      ++.+ +.+||+|||++.......                            ......++++.|+|||.+.+.. ++.++|
T Consensus       150 l~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~D  229 (361)
T 4f9c_A          150 YNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAID  229 (361)
T ss_dssp             EETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHH
T ss_pred             EeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccc
Confidence            9876 799999999986432210                            0112346899999999988764 789999


Q ss_pred             HHHHHHHHHHHHhCCCCCCC
Q 029552          135 IYSFGVILWELATLQQPWGN  154 (191)
Q Consensus       135 v~slG~~~~~l~~g~~pf~~  154 (191)
                      +||+||++|+|++|..||..
T Consensus       230 iWSlG~il~ell~G~~Pf~~  249 (361)
T 4f9c_A          230 MWSAGVIFLSLLSGRYPFYK  249 (361)
T ss_dssp             HHHHHHHHHHHHHTCSSSSC
T ss_pred             hhhhHHHHHHHHHCCCCCCC
Confidence            99999999999999999954

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.6e-41  Score=253.31  Aligned_cols=190  Identities=92%  Similarity=1.437  Sum_probs=161.2

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+.+++|.+++...+....+++.+++.++.|++.||+|||+.|.+++||||+|+
T Consensus        89 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~  168 (309)
T 3p86_A           89 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSP  168 (309)
T ss_dssp             HHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGG
T ss_pred             HhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChh
Confidence            46799999999999999999999999999999999998765444589999999999999999999998766999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      ||+++.++.++|+|||++..............+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+.....
T Consensus       169 NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~  248 (309)
T 3p86_A          169 NLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV  248 (309)
T ss_dssp             GEEECTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH
T ss_pred             hEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999999999876554433444566788999999999998999999999999999999999999999999988


Q ss_pred             HHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+.........|..+|+.+.++|++||++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  278 (309)
T 3p86_A          249 AAVGFKCKRLEIPRNLNPQVAAIIEGCWTN  278 (309)
T ss_dssp             HHHHHSCCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             HHHHhcCCCCCCCccCCHHHHHHHHHHccC
Confidence            888777788889999999999999999974

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1e-40  Score=257.72  Aligned_cols=183  Identities=29%  Similarity=0.476  Sum_probs=164.0

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++||||++++++|.+.+..|+||||+.+++|.+++.+.+   .+++.+++.++.||+.||+|||++|  ++||||||+
T Consensus        94 ~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~  168 (373)
T 2r5t_A           94 KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPE  168 (373)
T ss_dssp             CCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGG
T ss_pred             HhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHH
Confidence            56799999999999999999999999999999999997643   3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      ||+++.+|.++|+|||++..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+..
T Consensus       169 NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~  248 (373)
T 2r5t_A          169 NILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY  248 (373)
T ss_dssp             GEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH
T ss_pred             HEEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence            99999999999999999875443333445567889999999999988999999999999999999999999999998888


Q ss_pred             HHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+...  ...+|..+|+.++++|++||++
T Consensus       249 ~~i~~~--~~~~~~~~~~~~~~li~~lL~~  276 (373)
T 2r5t_A          249 DNILNK--PLQLKPNITNSARHLLEGLLQK  276 (373)
T ss_dssp             HHHHHS--CCCCCSSSCHHHHHHHHHHTCS
T ss_pred             HHHHhc--ccCCCCCCCHHHHHHHHHHccc
Confidence            888543  5567889999999999999974

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.1e-40  Score=254.30  Aligned_cols=180  Identities=24%  Similarity=0.470  Sum_probs=161.9

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      +||||++++++|.+.+..|+||||+++++|.+++.+.+   .+++.+++.++.|++.||+|||++|  ++||||||+||+
T Consensus        79 ~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIl  153 (353)
T 2i0e_A           79 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVM  153 (353)
T ss_dssp             CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEE
T ss_pred             CCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEE
Confidence            79999999999999999999999999999999997643   3899999999999999999999999  999999999999


Q ss_pred             ecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 029552           85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV  164 (191)
Q Consensus        85 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~  164 (191)
                      ++.+|.++|+|||++..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+
T Consensus       154 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i  233 (353)
T 2i0e_A          154 LDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI  233 (353)
T ss_dssp             ECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             EcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            99999999999999875433333445567899999999999888999999999999999999999999999998888888


Q ss_pred             HhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          165 GFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       165 ~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..  ....+|..+|+.++++|.+||++
T Consensus       234 ~~--~~~~~p~~~s~~~~~li~~lL~~  258 (353)
T 2i0e_A          234 ME--HNVAYPKSMSKEAVAICKGLMTK  258 (353)
T ss_dssp             HH--CCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             Hh--CCCCCCCCCCHHHHHHHHHHhhc
Confidence            54  35567889999999999999974

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.1e-40  Score=252.59  Aligned_cols=181  Identities=27%  Similarity=0.468  Sum_probs=161.9

Q ss_pred             CCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcE
Q 029552            4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL   83 (191)
Q Consensus         4 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni   83 (191)
                      .+||||++++++|.+++..|+||||+.+++|.+++...+   .+++.+++.++.|++.||+|||++|  ++||||||+||
T Consensus        75 ~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NI  149 (345)
T 1xjd_A           75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNI  149 (345)
T ss_dssp             TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGE
T ss_pred             CCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhE
Confidence            389999999999999999999999999999999997643   3899999999999999999999999  99999999999


Q ss_pred             EecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 029552           84 LVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA  163 (191)
Q Consensus        84 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~  163 (191)
                      +++.+|.++|+|||++..............+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+....
T Consensus       150 ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~  229 (345)
T 1xjd_A          150 LLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS  229 (345)
T ss_dssp             EECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             EECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            99999999999999987543333334556789999999999998899999999999999999999999999999888888


Q ss_pred             HHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          164 VGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       164 ~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +...  ...+|..+|+.++++|.+||++
T Consensus       230 i~~~--~~~~p~~~s~~~~~li~~lL~~  255 (345)
T 1xjd_A          230 IRMD--NPFYPRWLEKEAKDLLVKLFVR  255 (345)
T ss_dssp             HHHC--CCCCCTTSCHHHHHHHHHHSCS
T ss_pred             HHhC--CCCCCcccCHHHHHHHHHHhcC
Confidence            8543  4567888999999999999974

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.5e-40  Score=248.49  Aligned_cols=184  Identities=28%  Similarity=0.514  Sum_probs=161.9

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+.+++|.+++....    +++.++..++.|++.||+|||+.|  ++||||+|+
T Consensus        72 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~  145 (297)
T 3fxz_A           72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSD  145 (297)
T ss_dssp             HHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred             hcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHH
Confidence            45799999999999999999999999999999999997543    889999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      ||+++.++.++|+|||++..............+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...++....
T Consensus       146 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  225 (297)
T 3fxz_A          146 NILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL  225 (297)
T ss_dssp             GEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred             HEEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999999999876554433444567889999999999988999999999999999999999999998887776


Q ss_pred             HHHHhcCc-ccCCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKGK-RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~~-~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+..... ....|..+|+.++++|.+||++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  256 (297)
T 3fxz_A          226 YLIATNGTPELQNPEKLSAIFRDFLNRCLEM  256 (297)
T ss_dssp             HHHHHHCSCCCSCGGGSCHHHHHHHHHHSCS
T ss_pred             HHHHhCCCCCCCCccccCHHHHHHHHHHccC
Confidence            66544333 4556788999999999999974

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=255.59  Aligned_cols=180  Identities=25%  Similarity=0.445  Sum_probs=157.7

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      +||||++++++|.+++..|+||||+.+++|.+++.+.+   .+++.+++.++.||+.||+|||++|  ++||||||+||+
T Consensus        82 ~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIL  156 (353)
T 3txo_A           82 NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVL  156 (353)
T ss_dssp             TCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEE
T ss_pred             CCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEE
Confidence            79999999999999999999999999999999997643   3899999999999999999999999  999999999999


Q ss_pred             ecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 029552           85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV  164 (191)
Q Consensus        85 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~  164 (191)
                      ++.+|.++|+|||++..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+
T Consensus       157 l~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i  236 (353)
T 3txo_A          157 LDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI  236 (353)
T ss_dssp             ECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             ECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999999999875443333444567899999999999888999999999999999999999999999999988888


Q ss_pred             HhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          165 GFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       165 ~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..  ....+|..+|+.++++|.+||++
T Consensus       237 ~~--~~~~~p~~~~~~~~~li~~lL~~  261 (353)
T 3txo_A          237 LN--DEVVYPTWLHEDATGILKSFMTK  261 (353)
T ss_dssp             HH--CCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             Hc--CCCCCCCCCCHHHHHHHHHHhhh
Confidence            54  45667888999999999999975

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-40  Score=249.35  Aligned_cols=180  Identities=27%  Similarity=0.522  Sum_probs=161.6

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++||||+++++++.+.+..|+||||+.+++|.+++.+..   .+++..++.++.|++.||+|||++|  ++||||+|+
T Consensus        61 ~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~  135 (318)
T 1fot_A           61 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPE  135 (318)
T ss_dssp             HSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGG
T ss_pred             hhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChh
Confidence            46799999999999999999999999999999999997644   3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      ||+++.+|.++|+|||++......   .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.....
T Consensus       136 NIll~~~g~~kL~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  212 (318)
T 1fot_A          136 NILLDKNGHIKITDFGFAKYVPDV---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY  212 (318)
T ss_dssp             GEEECTTSCEEECCCSSCEECSSC---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred             eEEEcCCCCEEEeecCcceecCCc---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999999999999999998754432   23456788999999999988999999999999999999999999998888888


Q ss_pred             HHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+...  ...+|..+|+.++++|.+||++
T Consensus       213 ~~i~~~--~~~~p~~~~~~~~~li~~lL~~  240 (318)
T 1fot_A          213 EKILNA--ELRFPPFFNEDVKDLLSRLITR  240 (318)
T ss_dssp             HHHHHC--CCCCCTTSCHHHHHHHHHHTCS
T ss_pred             HHHHhC--CCCCCCCCCHHHHHHHHHHhcc
Confidence            887543  4567889999999999999974

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4.2e-40  Score=250.28  Aligned_cols=183  Identities=25%  Similarity=0.446  Sum_probs=157.8

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..|+||||+.+++|.+++...+   .+++.+++.++.|++.||+|||+.|  ++||||+|+
T Consensus        76 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~  150 (327)
T 3a62_A           76 EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPE  150 (327)
T ss_dssp             HHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTT
T ss_pred             HhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHH
Confidence            46789999999999999999999999999999999997643   3889999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      ||+++.++.++|+|||++..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.....
T Consensus       151 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  230 (327)
T 3a62_A          151 NIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI  230 (327)
T ss_dssp             TEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             HeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence            99999999999999998865433323334456788999999999888999999999999999999999999998888888


Q ss_pred             HHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+..  ....+|..+++.++++|.+||++
T Consensus       231 ~~i~~--~~~~~p~~~~~~~~~li~~~L~~  258 (327)
T 3a62_A          231 DKILK--CKLNLPPYLTQEARDLLKKLLKR  258 (327)
T ss_dssp             HHHHH--TCCCCCTTSCHHHHHHHHHHSCS
T ss_pred             HHHHh--CCCCCCCCCCHHHHHHHHHHHhc
Confidence            87754  35567889999999999999974

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=6.9e-40  Score=251.21  Aligned_cols=181  Identities=24%  Similarity=0.447  Sum_probs=162.5

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..|+||||+.+++|.+++.+.+   .+++.+++.++.||+.||+|||++|  ++||||+|
T Consensus        95 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp  169 (350)
T 1rdq_E           95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKP  169 (350)
T ss_dssp             HTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred             HHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCcc
Confidence            467899999999999999999999999999999999997643   3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.+|.++|+|||++......   .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+.
T Consensus       170 ~NIll~~~g~~kL~DFg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~  246 (350)
T 1rdq_E          170 ENLLIDQQGYIQVTDFGFAKRVKGR---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI  246 (350)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSC---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             ceEEECCCCCEEEcccccceeccCC---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH
Confidence            9999999999999999998754432   2344678899999999988899999999999999999999999999999888


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+...  ...+|..+|+.++++|.+||++
T Consensus       247 ~~~i~~~--~~~~p~~~~~~~~~li~~lL~~  275 (350)
T 1rdq_E          247 YEKIVSG--KVRFPSHFSSDLKDLLRNLLQV  275 (350)
T ss_dssp             HHHHHHC--CCCCCTTCCHHHHHHHHHHSCS
T ss_pred             HHHHHcC--CCCCCCCCCHHHHHHHHHHhhc
Confidence            8888643  5677889999999999999974

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=7.3e-40  Score=250.67  Aligned_cols=180  Identities=27%  Similarity=0.468  Sum_probs=155.6

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      +||||++++++|.+++..|+||||+.+++|.+++.+.+   .+++.+++.++.|++.||+|||++|  ++||||||+||+
T Consensus        68 ~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIl  142 (345)
T 3a8x_A           68 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVL  142 (345)
T ss_dssp             TCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEE
T ss_pred             CCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEE
Confidence            89999999999999999999999999999999997643   3899999999999999999999999  999999999999


Q ss_pred             ecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC---------C
Q 029552           85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN---------L  155 (191)
Q Consensus        85 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~---------~  155 (191)
                      ++.+|.++|+|||++..............+++.|+|||.+.+..++.++|+||+|+++|+|++|..||..         .
T Consensus       143 l~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  222 (345)
T 3a8x_A          143 LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN  222 (345)
T ss_dssp             ECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------
T ss_pred             ECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccc
Confidence            9999999999999987543333334456789999999999998899999999999999999999999975         2


Q ss_pred             CHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          156 NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ........+.  .....+|..+|+.++++|++||++
T Consensus       223 ~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~lL~~  256 (345)
T 3a8x_A          223 TEDYLFQVIL--EKQIRIPRSLSVKAASVLKSFLNK  256 (345)
T ss_dssp             CHHHHHHHHH--HCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             cHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhcC
Confidence            3334444443  235667889999999999999974

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.3e-39  Score=252.98  Aligned_cols=180  Identities=27%  Similarity=0.476  Sum_probs=156.5

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      +||||++++++|.+++..|+||||+.+++|.+++.+.+   .+++.+++.++.||+.||+|||++|  ++||||||+||+
T Consensus       111 ~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NIL  185 (396)
T 4dc2_A          111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVL  185 (396)
T ss_dssp             TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEE
T ss_pred             CCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEE
Confidence            79999999999999999999999999999999997643   3899999999999999999999999  999999999999


Q ss_pred             ecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC---------
Q 029552           85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL---------  155 (191)
Q Consensus        85 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~---------  155 (191)
                      ++.+|.++|+|||++..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||...         
T Consensus       186 l~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~  265 (396)
T 4dc2_A          186 LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN  265 (396)
T ss_dssp             ECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------C
T ss_pred             ECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchh
Confidence            99999999999999875433333455567899999999999999999999999999999999999999632         


Q ss_pred             CHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          156 NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ........+.  .....+|..+|+.++++|++||++
T Consensus       266 ~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~lL~~  299 (396)
T 4dc2_A          266 TEDYLFQVIL--EKQIRIPRSLSVKAASVLKSFLNK  299 (396)
T ss_dssp             CHHHHHHHHH--HCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             hHHHHHHHHh--ccccCCCCcCCHHHHHHHHHHhcC
Confidence            2233444442  346678899999999999999974

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=5.5e-40  Score=249.75  Aligned_cols=182  Identities=27%  Similarity=0.481  Sum_probs=160.6

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..|+||||+++++|.+++...+   .+++.+++.++.|++.||+|||+.|  ++||||||+
T Consensus        69 ~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~  143 (328)
T 3fe3_A           69 KILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAE  143 (328)
T ss_dssp             HHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGG
T ss_pred             HhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHH
Confidence            46799999999999999999999999999999999997643   3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSN-EKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      ||+++.++.++|+|||++...... .......+++.|+|||.+.+..+. .++|+||+|+++|+|++|..||...+..+.
T Consensus       144 NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  222 (328)
T 3fe3_A          144 NLLLDADMNIKIADFGFSNEFTVG-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL  222 (328)
T ss_dssp             GEEECTTSCEEECSTTCCGGGSSS-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             HEEEcCCCCEEEeeccCceecCCC-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH
Confidence            999999999999999998654333 223345688999999999888764 789999999999999999999999999988


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+..  .....|..+|+.+.++|++||+.
T Consensus       223 ~~~i~~--~~~~~p~~~s~~~~~li~~~L~~  251 (328)
T 3fe3_A          223 RERVLR--GKYRIPFYMSTDCENLLKRFLVL  251 (328)
T ss_dssp             HHHHHH--CCCCCCTTSCHHHHHHHHHHCCS
T ss_pred             HHHHHh--CCCCCCCCCCHHHHHHHHHHCCC
Confidence            888854  35567888999999999999974

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.2e-39  Score=257.10  Aligned_cols=184  Identities=28%  Similarity=0.513  Sum_probs=162.2

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCeeecCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLK   79 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~~h~~l~   79 (191)
                      |++++||||++++++|.+++..++||||+++++|.+++....   .+++.++..++.|++.||+|||+ .|  ++|||||
T Consensus       202 l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlk  276 (446)
T 4ejn_A          202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLK  276 (446)
T ss_dssp             CCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCC
T ss_pred             HHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCC
Confidence            567899999999999999999999999999999999997643   38999999999999999999998 99  9999999


Q ss_pred             CCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      |+||+++.++.++|+|||++..............+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+...
T Consensus       277 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~  356 (446)
T 4ejn_A          277 LENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK  356 (446)
T ss_dssp             GGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             HHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH
Confidence            99999999999999999998754333333445678899999999999999999999999999999999999999999988


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+..  ....+|..+|+.++++|.+||++
T Consensus       357 ~~~~i~~--~~~~~p~~~~~~~~~li~~~L~~  386 (446)
T 4ejn_A          357 LFELILM--EEIRFPRTLGPEAKSLLSGLLKK  386 (446)
T ss_dssp             HHHHHHH--CCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHHh--CCCCCCccCCHHHHHHHHHHccc
Confidence            8888854  34567889999999999999974

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=5.3e-40  Score=256.35  Aligned_cols=183  Identities=24%  Similarity=0.404  Sum_probs=159.8

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++||||++++++|.+++..|+||||+++++|.+++....    +++..++.++.|++.||+|||++|  ++||||||+
T Consensus       124 ~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~  197 (410)
T 3v8s_A          124 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD----VPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPD  197 (410)
T ss_dssp             HHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred             HhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHH
Confidence            45789999999999999999999999999999999997532    899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccc-cccCCCCCCCCcccCccccccCC----CCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLRDEP----SNEKSDIYSFGVILWELATLQQPWGNLN  156 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~----~~~~~Dv~slG~~~~~l~~g~~pf~~~~  156 (191)
                      ||+++.+|.++|+|||++...... ........+++.|+|||.+.+..    ++.++|+||||+++|+|++|..||...+
T Consensus       198 NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~  277 (410)
T 3v8s_A          198 NMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS  277 (410)
T ss_dssp             GEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             HeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC
Confidence            999999999999999998654332 12234567899999999997665    6789999999999999999999999999


Q ss_pred             HHHHHHHHHhcCcccCCC--CCCCHHHHHHHHHHhc
Q 029552          157 PAQVVAAVGFKGKRLEIP--RNVNPHVASIIEACWA  190 (191)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~cl~  190 (191)
                      .......+........+|  ..+|+.++++|.+||+
T Consensus       278 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~  313 (410)
T 3v8s_A          278 LVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLT  313 (410)
T ss_dssp             HHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSS
T ss_pred             hhhHHHHHHhccccccCCCcccccHHHHHHHHHHcc
Confidence            999888886544444555  4799999999999996

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.6e-39  Score=247.03  Aligned_cols=185  Identities=26%  Similarity=0.457  Sum_probs=160.7

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||++++++|++++..++||||+.+++|.+++...+   .+++.++..++.||+.||+|||+.|  ++|+||+|
T Consensus        69 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp  143 (361)
T 2yab_A           69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKP  143 (361)
T ss_dssp             HTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred             HHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCH
Confidence            467899999999999999999999999999999999997644   3899999999999999999999999  99999999


Q ss_pred             CcEEecCCC----cEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 029552           81 PNLLVDKKY----TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN  156 (191)
Q Consensus        81 ~ni~~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~  156 (191)
                      +||+++.++    .++|+|||++...... .......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+
T Consensus       144 ~NIll~~~~~~~~~vkl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~  222 (361)
T 2yab_A          144 ENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT  222 (361)
T ss_dssp             GGEEESCTTSSSCCEEECCCSSCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred             HHEEEeCCCCCccCEEEEecCCceEcCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence            999998776    7999999998754433 22334568899999999998889999999999999999999999999999


Q ss_pred             HHHHHHHHHhcCccc--CCCCCCCHHHHHHHHHHhcC
Q 029552          157 PAQVVAAVGFKGKRL--EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~~~~~~~~~~~~~~--~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+....+.......  ..+..+|+.++++|.+||.+
T Consensus       223 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  259 (361)
T 2yab_A          223 KQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVK  259 (361)
T ss_dssp             HHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCS
T ss_pred             HHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCC
Confidence            888888885443322  23368999999999999974

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=9.8e-40  Score=256.61  Aligned_cols=185  Identities=23%  Similarity=0.358  Sum_probs=159.6

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||++++++|.+++..|+||||+.+++|.+++.+..  +.+++.+++.++.|++.||+|||+.+  ++||||||+
T Consensus       129 ~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~  204 (437)
T 4aw2_A          129 VNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPD  204 (437)
T ss_dssp             HHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred             HhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHH
Confidence            35789999999999999999999999999999999997632  23899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccc-cccCCCCCCCCcccCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      ||+++.++.++|+|||++...... ........+++.|+|||.+.     ...++.++|+||+|+++|+|++|..||...
T Consensus       205 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~  284 (437)
T 4aw2_A          205 NILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE  284 (437)
T ss_dssp             GEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             HeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999998654332 22233457899999999986     455788999999999999999999999999


Q ss_pred             CHHHHHHHHHhcCcccCCC---CCCCHHHHHHHHHHhc
Q 029552          156 NPAQVVAAVGFKGKRLEIP---RNVNPHVASIIEACWA  190 (191)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~---~~~s~~~~~li~~cl~  190 (191)
                      +..+....+........+|   ..+|+.++++|++||.
T Consensus       285 ~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~  322 (437)
T 4aw2_A          285 SLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLIC  322 (437)
T ss_dssp             SHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSS
T ss_pred             ChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhc
Confidence            9998888886544445555   4599999999999985

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.9e-39  Score=253.85  Aligned_cols=185  Identities=25%  Similarity=0.411  Sum_probs=162.6

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+.+++|.+.+...+   .+++.++..++.||+.||+|||+.|  ++||||||+
T Consensus        65 ~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~  139 (444)
T 3soa_A           65 RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPE  139 (444)
T ss_dssp             HHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSST
T ss_pred             HhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHH
Confidence            46799999999999999999999999999999999997644   3899999999999999999999999  999999999


Q ss_pred             cEEec---CCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           82 NLLVD---KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        82 ni~~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      ||+++   .++.++|+|||++..............+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+..
T Consensus       140 NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~  219 (444)
T 3soa_A          140 NLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH  219 (444)
T ss_dssp             TEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             HEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH
Confidence            99998   457899999999876554433344567899999999999988999999999999999999999999999999


Q ss_pred             HHHHHHHhcCcccCCC--CCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIP--RNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~--~~~s~~~~~li~~cl~~  191 (191)
                      .....+.......+.+  ..+|+.++++|.+||++
T Consensus       220 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  254 (444)
T 3soa_A          220 RLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTI  254 (444)
T ss_dssp             HHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCS
T ss_pred             HHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCC
Confidence            9888887655544433  57999999999999974

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=9.6e-39  Score=247.33  Aligned_cols=183  Identities=22%  Similarity=0.386  Sum_probs=156.5

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||++++++|.+.+..|+||||+.+++|.+++....   .+++.+++.++.|++.||+|||+.|  ++||||||
T Consensus        69 l~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp  143 (384)
T 4fr4_A           69 MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQR--IIHRDMKP  143 (384)
T ss_dssp             HHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred             HHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcH
Confidence            357899999999999999999999999999999999998644   3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCCCC---
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD---EPSNEKSDIYSFGVILWELATLQQPWGN---  154 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~---~~~~~~~Dv~slG~~~~~l~~g~~pf~~---  154 (191)
                      +||+++.+|.++|+|||++...... .......+++.|+|||.+.+   ..++.++|+||||+++|+|++|..||..   
T Consensus       144 ~NIll~~~g~vkL~DFG~a~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~  222 (384)
T 4fr4_A          144 DNILLDEHGHVHITDFNIAAMLPRE-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS  222 (384)
T ss_dssp             GGEEECTTSCEEECCCTTCEECCTT-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT
T ss_pred             HHeEECCCCCEEEeccceeeeccCC-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999998754332 23345678899999999864   3478899999999999999999999974   


Q ss_pred             CCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          155 LNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+....+  ......+|..+|+.+.++|.+||++
T Consensus       223 ~~~~~~~~~~--~~~~~~~p~~~s~~~~~li~~lL~~  257 (384)
T 4fr4_A          223 TSSKEIVHTF--ETTVVTYPSAWSQEMVSLLKKLLEP  257 (384)
T ss_dssp             SCHHHHHHHH--HHCCCCCCTTSCHHHHHHHHHHSCS
T ss_pred             ccHHHHHHHH--hhcccCCCCcCCHHHHHHHHHHhcC
Confidence            3344444444  2345677889999999999999974

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.4e-39  Score=239.73  Aligned_cols=184  Identities=26%  Similarity=0.420  Sum_probs=157.8

Q ss_pred             CCCCCCCcccccceeec--CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            2 KRLRHPNIVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      ++++||||+++++++.+  .+..++||||+++++|.++....    .+++.+++.++.|+++||+|||+.|  ++|+||+
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlk  164 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----PLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIK  164 (298)
T ss_dssp             HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCC
T ss_pred             HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCC
Confidence            56899999999999986  56799999999999998876432    3899999999999999999999999  9999999


Q ss_pred             CCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCC---CCcchHHHHHHHHHHHHhCCCCCCCCC
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPS---NEKSDIYSFGVILWELATLQQPWGNLN  156 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~---~~~~Dv~slG~~~~~l~~g~~pf~~~~  156 (191)
                      |+||+++.++.++|+|||++..............+++.|+|||.+.+...   +.++|+||+|+++|+|++|..||....
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            99999999999999999998765443333345578899999999977653   677899999999999999999999988


Q ss_pred             HHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .......+.......+.+..+++.++++|.+||++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  279 (298)
T 2zv2_A          245 IMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDK  279 (298)
T ss_dssp             HHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCS
T ss_pred             HHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhc
Confidence            88887777655555555678999999999999974

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=7.3e-39  Score=240.11  Aligned_cols=186  Identities=24%  Similarity=0.442  Sum_probs=155.0

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++||||+++++++.+++..++||||+++++|.+++...+   .+++.+++.++.|++.||+|||+.|  ++|+||+|
T Consensus        65 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp  139 (294)
T 4eqm_A           65 SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKP  139 (294)
T ss_dssp             HTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCG
T ss_pred             HhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCH
Confidence            357899999999999999999999999999999999997644   3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      +||+++.++.++|+|||.+....... .......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+...
T Consensus       140 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~  219 (294)
T 4eqm_A          140 QNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS  219 (294)
T ss_dssp             GGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH
T ss_pred             HHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence            99999999999999999987543321 22233457889999999999989999999999999999999999999988877


Q ss_pred             HHHHHHhcCcc---cCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKR---LEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~---~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..........+   ...+.++|+.+.++|.+||++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  254 (294)
T 4eqm_A          220 IAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEK  254 (294)
T ss_dssp             HHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCS
T ss_pred             HHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcC
Confidence            66555433221   235678999999999999974

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-39  Score=253.07  Aligned_cols=185  Identities=24%  Similarity=0.337  Sum_probs=157.9

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||++++++|.+++..|+||||+.+++|.+++.+.+.  .+++..++.++.|++.||+|||+.|  ++||||||+
T Consensus       116 ~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~  191 (412)
T 2vd5_A          116 VNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPD  191 (412)
T ss_dssp             HHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred             HhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHH
Confidence            356899999999999999999999999999999999975432  3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccc-------cCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLR-------DEPSNEKSDIYSFGVILWELATLQQPWG  153 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~-------~~~~~~~~Dv~slG~~~~~l~~g~~pf~  153 (191)
                      ||+++.+|.++|+|||++....... .......+++.|+|||.+.       +..++.++|+||+|+++|+|++|..||.
T Consensus       192 NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~  271 (412)
T 2vd5_A          192 NILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY  271 (412)
T ss_dssp             GEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             HeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCC
Confidence            9999999999999999986543321 1233457899999999987       3457889999999999999999999999


Q ss_pred             CCCHHHHHHHHHhcCcccCCC---CCCCHHHHHHHHHHhc
Q 029552          154 NLNPAQVVAAVGFKGKRLEIP---RNVNPHVASIIEACWA  190 (191)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~---~~~s~~~~~li~~cl~  190 (191)
                      ..+..+....+........+|   ..+|+.++++|++||.
T Consensus       272 ~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~  311 (412)
T 2vd5_A          272 ADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC  311 (412)
T ss_dssp             CSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS
T ss_pred             CCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC
Confidence            999988888876433333344   6899999999999985

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.1e-38  Score=262.36  Aligned_cols=180  Identities=24%  Similarity=0.476  Sum_probs=163.2

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      +||+|++++++|++.+..|+||||+++++|.+++...+   .+++.+++.++.||+.||+|||+.|  |+||||||+||+
T Consensus       400 ~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NIL  474 (674)
T 3pfq_A          400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVM  474 (674)
T ss_dssp             CCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEE
T ss_pred             CCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEE
Confidence            79999999999999999999999999999999997644   3899999999999999999999999  999999999999


Q ss_pred             ecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 029552           85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV  164 (191)
Q Consensus        85 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~  164 (191)
                      ++.++.++|+|||++..............+++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+
T Consensus       475 l~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i  554 (674)
T 3pfq_A          475 LDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI  554 (674)
T ss_dssp             ECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             EcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            99999999999999875433333445567899999999999999999999999999999999999999999999999888


Q ss_pred             HhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          165 GFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       165 ~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .  .....+|..+|+.++++|++||++
T Consensus       555 ~--~~~~~~p~~~s~~~~~li~~lL~~  579 (674)
T 3pfq_A          555 M--EHNVAYPKSMSKEAVAICKGLMTK  579 (674)
T ss_dssp             H--SSCCCCCTTSCHHHHHHHHHHSCS
T ss_pred             H--hCCCCCCccCCHHHHHHHHHHccC
Confidence            5  355678899999999999999975

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.5e-38  Score=244.81  Aligned_cols=184  Identities=28%  Similarity=0.471  Sum_probs=159.1

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..|+||||+.+++|.+.+....   .+++.++..++.||+.||+|||+.|  ++|+||+|+
T Consensus        83 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~  157 (362)
T 2bdw_A           83 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG--IVHRNLKPE  157 (362)
T ss_dssp             HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGG
T ss_pred             HhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchH
Confidence            46799999999999999999999999999999999997644   3899999999999999999999999  999999999


Q ss_pred             cEEecCCC---cEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           82 NLLVDKKY---TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        82 ni~~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      ||+++.++   .++|+|||++...... .......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+..
T Consensus       158 NIll~~~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~  236 (362)
T 2bdw_A          158 NLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH  236 (362)
T ss_dssp             GEEESCSSTTCCEEECCCTTCBCCTTC-CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             HEEEecCCCCCCEEEeecCcceEecCC-cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH
Confidence            99997654   5999999998754433 2233456788999999999988999999999999999999999999999988


Q ss_pred             HHHHHHHhcCcccCCC--CCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIP--RNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~--~~~s~~~~~li~~cl~~  191 (191)
                      .....+.......+.+  ..+|+.++++|.+||++
T Consensus       237 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~  271 (362)
T 2bdw_A          237 RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTV  271 (362)
T ss_dssp             HHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCS
T ss_pred             HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCC
Confidence            8888886554443333  46899999999999974

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.8e-38  Score=239.67  Aligned_cols=185  Identities=26%  Similarity=0.460  Sum_probs=160.4

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++..++..++||||+.+++|.+++....    +++.++..++.|++.||+|||+.|  ++|+||+|
T Consensus        96 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp  169 (321)
T 2c30_A           96 MRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR----LNEEQIATVCEAVLQALAYLHAQG--VIHRDIKS  169 (321)
T ss_dssp             HTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCC----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred             HHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCH
Confidence            367899999999999999999999999999999999987532    899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.++.++|+|||++..............+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+....
T Consensus       170 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~  249 (321)
T 2c30_A          170 DSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA  249 (321)
T ss_dssp             GGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred             HHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99999999999999999987554433333455788899999999988899999999999999999999999999888888


Q ss_pred             HHHHHhcCc-ccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGK-RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~-~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+..... ....+..+|+.++++|.+||++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  281 (321)
T 2c30_A          250 MKRLRDSPPPKLKNSHKVSPVLRDFLERMLVR  281 (321)
T ss_dssp             HHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCS
T ss_pred             HHHHhcCCCCCcCccccCCHHHHHHHHHHccC
Confidence            777754322 2233457899999999999974

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.5e-38  Score=255.17  Aligned_cols=186  Identities=26%  Similarity=0.390  Sum_probs=160.1

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCC-CcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      ++++||||++++++|.+++..|+||||+++++|.+++.... ....+++.+++.++.||+.||+|||++|  ++||||||
T Consensus       240 ~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP  317 (543)
T 3c4z_A          240 AKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKP  317 (543)
T ss_dssp             HHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCG
T ss_pred             HhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCCh
Confidence            46799999999999999999999999999999999986543 1334899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC----C
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL----N  156 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~----~  156 (191)
                      +||+++.+|.++|+|||++..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||...    .
T Consensus       318 ~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~  397 (543)
T 3c4z_A          318 ENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE  397 (543)
T ss_dssp             GGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC
T ss_pred             HHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh
Confidence            999999999999999999876544433334457899999999999988999999999999999999999999764    3


Q ss_pred             HHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+....+.  .....+|..+|+.++++|.+||++
T Consensus       398 ~~~~~~~i~--~~~~~~p~~~s~~~~~li~~lL~~  430 (543)
T 3c4z_A          398 NKELKQRVL--EQAVTYPDKFSPASKDFCEALLQK  430 (543)
T ss_dssp             HHHHHHHHH--HCCCCCCTTSCHHHHHHHHHHSCS
T ss_pred             HHHHHHHHh--hcccCCCcccCHHHHHHHHHhccC
Confidence            455555553  235567889999999999999974

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=242.27  Aligned_cols=186  Identities=34%  Similarity=0.568  Sum_probs=159.7

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++||||+++++|.+++.....  .+++.+++.++.|++.||+|||+.|  ++||||+|
T Consensus       104 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp  179 (325)
T 3kul_A          104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAA  179 (325)
T ss_dssp             HTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSG
T ss_pred             HHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCc
Confidence            4678999999999999999999999999999999999965432  3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccc---cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLN  156 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~  156 (191)
                      +||+++.++.++|+|||++........   ......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||....
T Consensus       180 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~  259 (325)
T 3kul_A          180 RNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT  259 (325)
T ss_dssp             GGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred             ceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC
Confidence            999999999999999999875433211   1122234567999999998888999999999999999999 999999999


Q ss_pred             HHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .......+. .+...+.|..+++.+.++|.+||++
T Consensus       260 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~  293 (325)
T 3kul_A          260 NRDVISSVE-EGYRLPAPMGCPHALHQLMLDCWHK  293 (325)
T ss_dssp             HHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHHHHH-cCCCCCCCCCcCHHHHHHHHHHccC
Confidence            988888875 4567778889999999999999974

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.8e-38  Score=245.04  Aligned_cols=187  Identities=32%  Similarity=0.596  Sum_probs=159.8

Q ss_pred             CCC-CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC-------------cccccHHHHHHHHHHHHHHHHHHH
Q 029552            2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------------REMLDERRRLNMAYDVAKGMNYLH   67 (191)
Q Consensus         2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~Lh   67 (191)
                      +++ +||||+++++++.+++..|+||||+.+++|.+++.....             ...++..+++.++.||+.||+|||
T Consensus       141 ~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH  220 (370)
T 2psq_A          141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA  220 (370)
T ss_dssp             HHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence            346 899999999999999999999999999999999975431             123788999999999999999999


Q ss_pred             hCCCCeeecCCCCCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHH
Q 029552           68 RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL  145 (191)
Q Consensus        68 ~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l  145 (191)
                      +.|  ++||||||+||+++.++.++|+|||++.......  .......+++.|+|||.+.+..++.++|+||||+++|+|
T Consensus       221 ~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el  298 (370)
T 2psq_A          221 SQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI  298 (370)
T ss_dssp             HTT--EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred             hCC--eeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHH
Confidence            999  9999999999999999999999999987543321  112223446789999999988899999999999999999


Q ss_pred             Hh-CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          146 AT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       146 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ++ |..||......+....+. .+.+...|..+++.+.++|.+||++
T Consensus       299 lt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~  344 (370)
T 2psq_A          299 FTLGGSPYPGIPVEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHA  344 (370)
T ss_dssp             HTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             HcCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            99 999999888877777664 4556778899999999999999974

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.1e-38  Score=239.27  Aligned_cols=184  Identities=26%  Similarity=0.428  Sum_probs=158.9

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+.+++|.+++....   .+++.+++.++.|++.||+|||+.|  ++|+||+|+
T Consensus        69 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~  143 (326)
T 2y0a_A           69 KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPE  143 (326)
T ss_dssp             HHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGG
T ss_pred             HhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHH
Confidence            46789999999999999999999999999999999997643   3899999999999999999999999  999999999


Q ss_pred             cEEecCCC----cEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           82 NLLVDKKY----TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        82 ni~~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      ||+++.++    .++|+|||++....... ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+.
T Consensus       144 NIll~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  222 (326)
T 2y0a_A          144 NIMLLDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK  222 (326)
T ss_dssp             GEEESCSSSSSCCEEECCCTTCEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred             HEEEecCCCCCCCEEEEECCCCeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence            99998877    79999999987544321 23345678899999999988899999999999999999999999999888


Q ss_pred             HHHHHHHHhcCcccC--CCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLE--IPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~cl~~  191 (191)
                      .+....+.......+  .+..+|+.++++|.+||++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  258 (326)
T 2y0a_A          223 QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK  258 (326)
T ss_dssp             HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCS
T ss_pred             HHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccC
Confidence            888777754433222  2367999999999999974

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.2e-38  Score=233.58  Aligned_cols=186  Identities=33%  Similarity=0.611  Sum_probs=161.8

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++||||+++++|.+++.....  .+++.+++.++.|+++||++||+.+  ++|+||+|
T Consensus        59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp  134 (269)
T 4hcu_A           59 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAA  134 (269)
T ss_dssp             HHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred             HHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcch
Confidence            3578999999999999999999999999999999999965432  3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA  158 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~  158 (191)
                      +||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||+|+++++|++ |..||......
T Consensus       135 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~  214 (269)
T 4hcu_A          135 RNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS  214 (269)
T ss_dssp             GGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred             heEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH
Confidence            99999999999999999987543321 22233445668999999998889999999999999999999 89999999998


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +....+. .......|..+|+.+.++|.+||++
T Consensus       215 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  246 (269)
T 4hcu_A          215 EVVEDIS-TGFRLYKPRLASTHVYQIMNHCWRE  246 (269)
T ss_dssp             HHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHHh-cCccCCCCCcCCHHHHHHHHHHccC
Confidence            8888875 4456677888999999999999974

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.2e-38  Score=250.29  Aligned_cols=183  Identities=31%  Similarity=0.567  Sum_probs=161.4

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++||||+.+++|.+++.+.+   .+++.+++.++.||+.||+|||+.|  ++||||||
T Consensus        70 l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp  144 (476)
T 2y94_A           70 LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKP  144 (476)
T ss_dssp             HTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSG
T ss_pred             HHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccH
Confidence            467899999999999999999999999999999999997644   3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      +||+++.++.++|+|||++...... .......+++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+...
T Consensus       145 ~NIll~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~  223 (476)
T 2y94_A          145 ENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT  223 (476)
T ss_dssp             GGEEECTTCCEEECCCSSCEECCTT-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH
T ss_pred             HHEEEecCCCeEEEeccchhhcccc-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH
Confidence            9999999999999999998754433 22344568899999999988765 678999999999999999999999988888


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+.  ......|..+|+.++++|.+||++
T Consensus       224 ~~~~i~--~~~~~~p~~~s~~~~~Li~~~L~~  253 (476)
T 2y94_A          224 LFKKIC--DGIFYTPQYLNPSVISLLKHMLQV  253 (476)
T ss_dssp             HHHHHH--TTCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHh--cCCcCCCccCCHHHHHHHHHHcCC
Confidence            888774  345567888999999999999974

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.1e-38  Score=246.87  Aligned_cols=186  Identities=36%  Similarity=0.598  Sum_probs=160.2

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++||||+++++|.+++...+.  .+++.+++.++.|++.||+|||+.|  ++||||+|
T Consensus       166 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp  241 (377)
T 3cbl_A          166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAA  241 (377)
T ss_dssp             HTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSG
T ss_pred             HHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCH
Confidence            4678999999999999999999999999999999999975432  3889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccC--CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSS--KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~  157 (191)
                      +||+++.++.++|+|||++..........  .....+..|+|||.+.+..++.++|+||+|+++|+|++ |..||.....
T Consensus       242 ~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~  321 (377)
T 3cbl_A          242 RNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN  321 (377)
T ss_dssp             GGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH
T ss_pred             HHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999987543321111  11223457999999988888999999999999999998 9999999888


Q ss_pred             HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+....+. .+.+.+.|..+|+.+.++|.+||++
T Consensus       322 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~  354 (377)
T 3cbl_A          322 QQTREFVE-KGGRLPCPELCPDAVFRLMEQCWAY  354 (377)
T ss_dssp             HHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            88777765 5567788999999999999999974

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.2e-38  Score=234.07  Aligned_cols=182  Identities=26%  Similarity=0.486  Sum_probs=157.9

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++||||+++++++.+.+..++||||+++++|.+++....   .+++.+++.++.|++.||+|||+.|  ++|+||+|
T Consensus        63 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp  137 (279)
T 3fdn_A           63 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR--VIHRDIKP  137 (279)
T ss_dssp             HTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCG
T ss_pred             HHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--EecccCCh
Confidence            357899999999999999999999999999999999997643   2899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.++.++|+|||.+......  ......++..|+|||.+.+..++.++|+||+|+++++|++|..||...+....
T Consensus       138 ~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~  215 (279)
T 3fdn_A          138 ENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET  215 (279)
T ss_dssp             GGEEECTTSCEEECSCCEESCC----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred             HhEEEcCCCCEEEEeccccccCCcc--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH
Confidence            9999999999999999987544333  22344678899999999988889999999999999999999999999988888


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+..  .....|..+++.++++|.+||+.
T Consensus       216 ~~~~~~--~~~~~~~~~~~~~~~li~~~l~~  244 (279)
T 3fdn_A          216 YKRISR--VEFTFPDFVTEGARDLISRLLKH  244 (279)
T ss_dssp             HHHHHH--TCCCCCTTSCHHHHHHHHHHCCS
T ss_pred             HHHHHh--CCCCCCCcCCHHHHHHHHHHhcc
Confidence            887743  45567888999999999999963

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=8.8e-38  Score=233.96  Aligned_cols=183  Identities=29%  Similarity=0.456  Sum_probs=161.2

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+.+++|.+++....   .+++.+++.++.|+++||++||+.|  ++|+||+|+
T Consensus        70 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~  144 (294)
T 2rku_A           70 RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLG  144 (294)
T ss_dssp             HTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGG
T ss_pred             HhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChH
Confidence            56899999999999999999999999999999999987543   3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      ||+++.++.++|+|||.+..............++..|+|||.+.+..++.++|+||+|+++++|++|..||......+..
T Consensus       145 Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~  224 (294)
T 2rku_A          145 NLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY  224 (294)
T ss_dssp             GEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred             hEEEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999999999876543333334456788999999998888899999999999999999999999998888777


Q ss_pred             HHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+.  ......|..+++.+.++|.+||+.
T Consensus       225 ~~~~--~~~~~~~~~~~~~~~~li~~~l~~  252 (294)
T 2rku_A          225 LRIK--KNEYSIPKHINPVAASLIQKMLQT  252 (294)
T ss_dssp             HHHH--TTCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             HHHh--hccCCCccccCHHHHHHHHHHccc
Confidence            7664  345667889999999999999974

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.1e-38  Score=243.31  Aligned_cols=186  Identities=32%  Similarity=0.596  Sum_probs=151.7

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++||||+++++|.+++...+.  .+++.+++.++.|++.||+|||+.+  ++||||+|
T Consensus       100 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp  175 (373)
T 2qol_A          100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAA  175 (373)
T ss_dssp             HTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred             HHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCc
Confidence            4678999999999999999999999999999999999976442  3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccccccc---CCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLS---SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLN  156 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~  156 (191)
                      +||+++.++.++|+|||++.........   .....++..|+|||.+.+..++.++|+||+|+++|++++ |..||...+
T Consensus       176 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~  255 (373)
T 2qol_A          176 RNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS  255 (373)
T ss_dssp             GGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC
T ss_pred             ceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999998754332111   111223557999999998889999999999999999998 999999988


Q ss_pred             HHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+....+. .+.+.+.+..++..+.++|.+||++
T Consensus       256 ~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~  289 (373)
T 2qol_A          256 NQDVIKAVD-EGYRLPPPMDCPAALYQLMLDCWQK  289 (373)
T ss_dssp             HHHHHHHHH-TTEECCCCTTCBHHHHHHHHHHTCS
T ss_pred             HHHHHHHHH-cCCCCCCCccccHHHHHHHHHHhCc
Confidence            888877775 4556777889999999999999974

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-38  Score=241.84  Aligned_cols=185  Identities=19%  Similarity=0.354  Sum_probs=158.3

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++++.+..++||||+++++|.+++.....  .+++.+++.++.|++.||+|||+.|  ++|+||+|+
T Consensus        56 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~  131 (321)
T 1tki_A           56 NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPE  131 (321)
T ss_dssp             HHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGG
T ss_pred             HhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHH
Confidence            467899999999999999999999999999999999976432  3899999999999999999999999  999999999


Q ss_pred             cEEecC--CCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           82 NLLVDK--KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        82 ni~~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      ||+++.  ++.++|+|||.+....... ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+...
T Consensus       132 NIl~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  210 (321)
T 1tki_A          132 NIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ  210 (321)
T ss_dssp             GEEESSSSCCCEEECCCTTCEECCTTC-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred             HEEEccCCCCCEEEEECCCCeECCCCC-ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH
Confidence            999987  7899999999987543321 1223356789999999988888899999999999999999999999999888


Q ss_pred             HHHHHHhcCcccC--CCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLE--IPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~--~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+.......+  ....+|+.++++|.+||++
T Consensus       211 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  244 (321)
T 1tki_A          211 IIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVK  244 (321)
T ss_dssp             HHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCS
T ss_pred             HHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCC
Confidence            8888865443322  2257999999999999974

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-38  Score=240.51  Aligned_cols=187  Identities=32%  Similarity=0.544  Sum_probs=160.1

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC---------------------cccccHHHHHHHHHHHH
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV---------------------REMLDERRRLNMAYDVA   60 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------------------~~~~~~~~~~~~~~~i~   60 (191)
                      ++++||||+++++++.+++..++||||+.+++|.+++.....                     ...+++.+++.++.|++
T Consensus       105 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~  184 (343)
T 1luf_A          105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA  184 (343)
T ss_dssp             HTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHH
T ss_pred             HhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHH
Confidence            568999999999999999999999999999999999975321                     13489999999999999


Q ss_pred             HHHHHHHhCCCCeeecCCCCCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHH
Q 029552           61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSF  138 (191)
Q Consensus        61 ~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~sl  138 (191)
                      +||+|||++|  ++|+||+|+||+++.++.++|+|||.+.......  .......++..|+|||.+.+..++.++|+||+
T Consensus       185 ~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl  262 (343)
T 1luf_A          185 AGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAY  262 (343)
T ss_dssp             HHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHHHHHhCC--eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHH
Confidence            9999999999  9999999999999999999999999986543221  12233455778999999998889999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          139 GVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       139 G~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      |+++|+|++ |..||......+....+. .+.....|..+|+.+.++|.+||++
T Consensus       263 G~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~  315 (343)
T 1luf_A          263 GVVLWEIFSYGLQPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSK  315 (343)
T ss_dssp             HHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHHHHhcCCCcCCCCChHHHHHHHh-CCCcCCCCCCCCHHHHHHHHHHccc
Confidence            999999999 999999988888887775 4556678889999999999999974

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=6.5e-39  Score=244.50  Aligned_cols=182  Identities=29%  Similarity=0.520  Sum_probs=155.0

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++||||+ +++|.+++...+   .+++.+++.++.|++.||+|||+.|  ++||||+|
T Consensus        63 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp  136 (336)
T 3h4j_B           63 LKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKP  136 (336)
T ss_dssp             HTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCST
T ss_pred             HHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCch
Confidence            46789999999999999999999999999 678988886533   3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      +||+++.++.++|+|||++...... .......+++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||.......
T Consensus       137 ~NIll~~~~~~kl~DFG~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~  215 (336)
T 3h4j_B          137 ENLLLDDNLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN  215 (336)
T ss_dssp             TTEEECTTCCEEECCSSCTBTTTTS-BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT
T ss_pred             hhEEEcCCCCEEEEEeccceeccCC-cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH
Confidence            9999999999999999998755433 22344568899999999988765 678999999999999999999998765554


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+  .......|..+|+.++++|++||+.
T Consensus       216 ~~~~i--~~~~~~~p~~~s~~~~~li~~~L~~  245 (336)
T 3h4j_B          216 LFKKV--NSCVYVMPDFLSPGAQSLIRRMIVA  245 (336)
T ss_dssp             CBCCC--CSSCCCCCTTSCHHHHHHHHTTSCS
T ss_pred             HHHHH--HcCCCCCcccCCHHHHHHHHHHcCC
Confidence            44433  3335567888999999999999964

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.4e-38  Score=241.94  Aligned_cols=187  Identities=23%  Similarity=0.362  Sum_probs=154.2

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCC-CcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      ++++||||+++++++.+++..|+||||+++++|.+.+.... ....+++.+++.++.||+.||+|||+++  ++||||||
T Consensus        81 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp  158 (351)
T 3c0i_A           81 HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKP  158 (351)
T ss_dssp             HHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSG
T ss_pred             HhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCh
Confidence            46799999999999999999999999999999988875422 1234899999999999999999999999  99999999


Q ss_pred             CcEEecCCCc---EEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           81 PNLLVDKKYT---VKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      +||+++.++.   ++|+|||++..............+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.... 
T Consensus       159 ~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-  237 (351)
T 3c0i_A          159 HCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-  237 (351)
T ss_dssp             GGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-
T ss_pred             HHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-
Confidence            9999987654   999999998765544333445578899999999998889999999999999999999999998754 


Q ss_pred             HHHHHHHHhcCcccC--CCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLE--IPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~cl~~  191 (191)
                      ......+........  ....+|+.++++|.+||++
T Consensus       238 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  273 (351)
T 3c0i_A          238 ERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLML  273 (351)
T ss_dssp             HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCC
Confidence            444444433322211  2257999999999999974

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=7e-38  Score=238.74  Aligned_cols=183  Identities=29%  Similarity=0.452  Sum_probs=161.0

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+.+++|.+++....   .+++.+++.++.|+++||+|||+.|  ++|+||+|+
T Consensus        96 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~  170 (335)
T 2owb_A           96 RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLG  170 (335)
T ss_dssp             HTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGG
T ss_pred             HhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCch
Confidence            56899999999999999999999999999999999987533   3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      ||+++.++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++|+|++|..||......+..
T Consensus       171 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  250 (335)
T 2owb_A          171 NLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY  250 (335)
T ss_dssp             GEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred             hEEEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH
Confidence            99999999999999999875543333344456788999999999888899999999999999999999999998887777


Q ss_pred             HHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+..  .....|..+++.+.++|.+||+.
T Consensus       251 ~~~~~--~~~~~~~~~~~~~~~li~~~l~~  278 (335)
T 2owb_A          251 LRIKK--NEYSIPKHINPVAASLIQKMLQT  278 (335)
T ss_dssp             HHHHH--TCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             HHHhc--CCCCCCccCCHHHHHHHHHHccC
Confidence            76643  34567889999999999999974

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=7.5e-38  Score=242.74  Aligned_cols=186  Identities=24%  Similarity=0.415  Sum_probs=159.0

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++||||+.+++|.+++.....  .+++.+++.++.|++.||+|||+.|  ++||||+|
T Consensus       102 l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp  177 (387)
T 1kob_A          102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKP  177 (387)
T ss_dssp             HTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCG
T ss_pred             HHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeecccch
Confidence            4678999999999999999999999999999999999976432  3899999999999999999999999  99999999


Q ss_pred             CcEEecC--CCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           81 PNLLVDK--KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        81 ~ni~~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      +||+++.  .+.++|+|||++....... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..
T Consensus       178 ~NIll~~~~~~~vkL~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~  256 (387)
T 1kob_A          178 ENIMCETKKASSVKIIDFGLATKLNPDE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL  256 (387)
T ss_dssp             GGEEESSTTCCCEEECCCTTCEECCTTS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred             HHeEEecCCCCceEEEecccceecCCCc-ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH
Confidence            9999974  4679999999987543321 122335788999999999888999999999999999999999999998888


Q ss_pred             HHHHHHHhcCccc--CCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRL--EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~--~~~~~~s~~~~~li~~cl~~  191 (191)
                      +....+.......  ..+..+|+.++++|++||++
T Consensus       257 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  291 (387)
T 1kob_A          257 ETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQK  291 (387)
T ss_dssp             HHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCS
T ss_pred             HHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCC
Confidence            8888776544322  33467999999999999974

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=9.1e-38  Score=232.81  Aligned_cols=181  Identities=27%  Similarity=0.498  Sum_probs=159.9

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+.+++|.+++...+   .+++.+++.++.|++.||++||+.|  ++|+||+|+
T Consensus        69 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~  143 (284)
T 2vgo_A           69 SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK--VIHRDIKPE  143 (284)
T ss_dssp             HTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGG
T ss_pred             hcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHH
Confidence            56799999999999999999999999999999999997643   3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      ||+++.++.++|+|||.+......  ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.........
T Consensus       144 Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  221 (284)
T 2vgo_A          144 NLLMGYKGELKIADFGWSVHAPSL--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH  221 (284)
T ss_dssp             GEEECTTCCEEECCCTTCEECSSS--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred             HEEEcCCCCEEEecccccccCccc--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH
Confidence            999999999999999988644332  223456788999999999888899999999999999999999999998888877


Q ss_pred             HHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+.  .....+|..+|+.++++|.+||+.
T Consensus       222 ~~~~--~~~~~~~~~~~~~~~~li~~~l~~  249 (284)
T 2vgo_A          222 RRIV--NVDLKFPPFLSDGSKDLISKLLRY  249 (284)
T ss_dssp             HHHH--TTCCCCCTTSCHHHHHHHHHHSCS
T ss_pred             HHHh--ccccCCCCcCCHHHHHHHHHHhhc
Confidence            7764  345567889999999999999963

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6.3e-38  Score=236.46  Aligned_cols=188  Identities=31%  Similarity=0.591  Sum_probs=161.0

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC---------------------cccccHHHHHHHHHHH
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV---------------------REMLDERRRLNMAYDV   59 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------------------~~~~~~~~~~~~~~~i   59 (191)
                      |++++||||+++++++.+++..++||||+.+++|.+++.....                     ...+++.+++.++.|+
T Consensus        80 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi  159 (314)
T 2ivs_A           80 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQI  159 (314)
T ss_dssp             HTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHH
T ss_pred             HhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHH
Confidence            4678999999999999999999999999999999999975432                     1248899999999999


Q ss_pred             HHHHHHHHhCCCCeeecCCCCCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHH
Q 029552           60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYS  137 (191)
Q Consensus        60 ~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~s  137 (191)
                      ++||+|||+.|  ++|+||+|+||+++.++.++|+|||.+.......  .......++..|+|||.+.+..++.++|+||
T Consensus       160 ~~~l~~lH~~~--ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  237 (314)
T 2ivs_A          160 SQGMQYLAEMK--LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWS  237 (314)
T ss_dssp             HHHHHHHHHTT--EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHH
T ss_pred             HHHHHHHHHCC--CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHH
Confidence            99999999999  9999999999999999999999999986543321  1223334567899999998888899999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          138 FGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       138 lG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +|+++|+|++ |..||...........+. .+.....|..+|+.+.++|.+||++
T Consensus       238 lG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  291 (314)
T 2ivs_A          238 FGVLLWEIVTLGGNPYPGIPPERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQ  291 (314)
T ss_dssp             HHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHHHHHhCCCCCCCCCCHHHHHHHhh-cCCcCCCCccCCHHHHHHHHHHccC
Confidence            9999999999 999999888877777664 4556778889999999999999974

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.2e-38  Score=233.39  Aligned_cols=185  Identities=23%  Similarity=0.415  Sum_probs=135.5

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++++||||+++++++.+.+..++|+||+++++|.+++....  ..+++.+++.++.|+++||+|||+.|  ++|+||+|
T Consensus        65 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p  140 (278)
T 3cok_A           65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTL  140 (278)
T ss_dssp             HTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCG
T ss_pred             HHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCH
Confidence            357899999999999999999999999999999999997643  23899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.++.++|+|||.+..............+++.|+|||.+.+..++.++|+||+|+++++|++|..||........
T Consensus       141 ~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~  220 (278)
T 3cok_A          141 SNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT  220 (278)
T ss_dssp             GGEEECTTCCEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--
T ss_pred             HHEEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH
Confidence            99999999999999999887544332233344578899999999888889999999999999999999999987665555


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+  .......|..+|..++++|.+||++
T Consensus       221 ~~~~--~~~~~~~~~~~~~~~~~li~~~l~~  249 (278)
T 3cok_A          221 LNKV--VLADYEMPSFLSIEAKDLIHQLLRR  249 (278)
T ss_dssp             ---C--CSSCCCCCTTSCHHHHHHHHHHSCS
T ss_pred             HHHH--hhcccCCccccCHHHHHHHHHHccc
Confidence            5544  2234567788999999999999974

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.9e-37  Score=229.22  Aligned_cols=185  Identities=30%  Similarity=0.651  Sum_probs=160.7

Q ss_pred             CCCCCCCCcccccceeecC--CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            1 MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      |++++||||+++++++.+.  +..++||||+++++|.+++.... ...+++.+++.++.|+++||+|||+.+..++|+||
T Consensus        61 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~di  139 (271)
T 3kmu_A           61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHAL  139 (271)
T ss_dssp             GCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCC
T ss_pred             HHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCC
Confidence            4678999999999999877  78899999999999999997644 22489999999999999999999998766999999


Q ss_pred             CCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCC---cchHHHHHHHHHHHHhCCCCCCCC
Q 029552           79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNE---KSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        79 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~---~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      +|+||+++.++.+++.|++++....     .....+++.|+|||.+.+...+.   ++|+||+|+++|+|++|..||...
T Consensus       140 kp~Nil~~~~~~~~l~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  214 (271)
T 3kmu_A          140 NSRSVMIDEDMTARISMADVKFSFQ-----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL  214 (271)
T ss_dssp             SGGGEEECTTSCEEEEGGGSCCTTS-----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS
T ss_pred             ccceEEEcCCcceeEEeccceeeec-----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            9999999999999999888764322     12345678999999998765444   799999999999999999999999


Q ss_pred             CHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          156 NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +.......+......+..|..+|+.+.++|.+||++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  250 (271)
T 3kmu_A          215 SNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNE  250 (271)
T ss_dssp             CHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             ChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            998888888778888889999999999999999974

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.4e-38  Score=232.17  Aligned_cols=185  Identities=35%  Similarity=0.648  Sum_probs=160.0

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+++++|.+++...+  ..+++.+++.++.|++.||++||+.|  ++|+||+|+
T Consensus        58 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~  133 (268)
T 3sxs_A           58 MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAAR  133 (268)
T ss_dssp             HHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGG
T ss_pred             HhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcc
Confidence            46789999999999999999999999999999999997543  23899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ  159 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~~  159 (191)
                      ||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||+|+++++|++ |..||.......
T Consensus       134 Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~  213 (268)
T 3sxs_A          134 NCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE  213 (268)
T ss_dssp             GEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred             eEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH
Confidence            9999999999999999887543331 12223344567999999988888999999999999999999 999999988888


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+. .+.....|..+|+.+.++|.+||++
T Consensus       214 ~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~  244 (268)
T 3sxs_A          214 VVLKVS-QGHRLYRPHLASDTIYQIMYSCWHE  244 (268)
T ss_dssp             HHHHHH-TTCCCCCCTTSCHHHHHHHHHTTCS
T ss_pred             HHHHHH-cCCCCCCCCcChHHHHHHHHHHcCC
Confidence            887775 4456667888999999999999974

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.5e-38  Score=252.82  Aligned_cols=184  Identities=26%  Similarity=0.376  Sum_probs=157.9

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..|+||||+.+++|.+++...+ ...+++.+++.++.||+.||+|||++|  ++||||||+
T Consensus       239 ~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPe  315 (576)
T 2acx_A          239 EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPE  315 (576)
T ss_dssp             HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGG
T ss_pred             HHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchh
Confidence            46799999999999999999999999999999999997644 233899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC----H
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN----P  157 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~----~  157 (191)
                      ||+++.+|.++|+|||++....... ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||....    .
T Consensus       316 NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~  394 (576)
T 2acx_A          316 NILLDDHGHIRISDLGLAVHVPEGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR  394 (576)
T ss_dssp             GEEECTTSCEEECCCTTCEECCTTC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH
T ss_pred             eEEEeCCCCeEEEecccceecccCc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH
Confidence            9999999999999999987544331 2233478899999999998889999999999999999999999998743    3


Q ss_pred             HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ......+.  ..+..+|..+|+.++++|.+||++
T Consensus       395 ~~i~~~i~--~~~~~~p~~~s~~~~dLI~~lL~~  426 (576)
T 2acx_A          395 EEVERLVK--EVPEEYSERFSPQARSLCSQLLCK  426 (576)
T ss_dssp             HHHHHHHH--HCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHHhh--cccccCCccCCHHHHHHHHHhccC
Confidence            44444443  345667889999999999999974

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.9e-38  Score=238.54  Aligned_cols=186  Identities=26%  Similarity=0.461  Sum_probs=151.1

Q ss_pred             CCCCCCCCcccccceeecCCc----eEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeec
Q 029552            1 MKRLRHPNIVLFMGAVTQPPN----LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR   76 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~   76 (191)
                      +++++||||+++++++.....    .|+||||+++++|.+++...+   .+++.+++.++.|++.||+|||+.+  ++|+
T Consensus        66 l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~  140 (311)
T 3ork_A           66 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG--IIHR  140 (311)
T ss_dssp             CCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCC
T ss_pred             HHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CCcC
Confidence            467899999999999976543    499999999999999997643   3899999999999999999999999  9999


Q ss_pred             CCCCCcEEecCCCcEEEccccccccccccc---ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 029552           77 DLKSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWG  153 (191)
Q Consensus        77 ~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~  153 (191)
                      ||+|+||+++.++.++|+|||.+.......   .......++..|+|||.+.+..++.++|+||||+++|+|++|..||.
T Consensus       141 dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~  220 (311)
T 3ork_A          141 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT  220 (311)
T ss_dssp             CCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence            999999999999999999999986543321   12223457889999999999889999999999999999999999999


Q ss_pred             CCCHHHHHHHHHhcCccc--CCCCCCCHHHHHHHHHHhcC
Q 029552          154 NLNPAQVVAAVGFKGKRL--EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+...............  ..+..+|+.+.++|.+||++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  260 (311)
T 3ork_A          221 GDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAK  260 (311)
T ss_dssp             CSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCS
T ss_pred             CCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhc
Confidence            988887776665443322  23467999999999999974

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.1e-37  Score=232.13  Aligned_cols=185  Identities=32%  Similarity=0.568  Sum_probs=160.9

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+.+++|.+++.....  .+++.+++.++.|++.||++||+.|  ++|+||+|+
T Consensus        74 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~  149 (283)
T 3gen_A           74 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAAR  149 (283)
T ss_dssp             HTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGG--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGG
T ss_pred             hcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccc
Confidence            568999999999999999999999999999999999976332  3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ  159 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~~  159 (191)
                      ||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...+...
T Consensus       150 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~  229 (283)
T 3gen_A          150 NCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE  229 (283)
T ss_dssp             GEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred             eEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH
Confidence            9999999999999999987543321 22223344668999999998889999999999999999998 999999999888


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+. .......|..+++.+.++|.+||++
T Consensus       230 ~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~  260 (283)
T 3gen_A          230 TAEHIA-QGLRLYRPHLASEKVYTIMYSCWHE  260 (283)
T ss_dssp             HHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCS
T ss_pred             HHHHHh-cccCCCCCCcCCHHHHHHHHHHccC
Confidence            888775 4456677888999999999999974

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=5.1e-38  Score=238.65  Aligned_cols=182  Identities=26%  Similarity=0.427  Sum_probs=134.3

Q ss_pred             CCC-CCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            3 RLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         3 ~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++. ||||+++++++.+++..|+||||+++++|.+++...+   .+++.+++.++.|++.||+|||+.|  ++||||+|+
T Consensus        61 ~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~  135 (325)
T 3kn6_A           61 LCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK---HFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPE  135 (325)
T ss_dssp             HTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGG
T ss_pred             HhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHH
Confidence            344 9999999999999999999999999999999997644   3899999999999999999999999  999999999


Q ss_pred             cEEecCCC---cEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH-
Q 029552           82 NLLVDKKY---TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP-  157 (191)
Q Consensus        82 ni~~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~-  157 (191)
                      ||+++.++   .++|+|||++..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+. 
T Consensus       136 NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  215 (325)
T 3kn6_A          136 NLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRS  215 (325)
T ss_dssp             GEEEEC----CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-----
T ss_pred             HEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccc
Confidence            99998765   79999999987654443344455678899999999998899999999999999999999999986433 


Q ss_pred             ------HHHHHHHHhcCcccCCC----CCCCHHHHHHHHHHhcC
Q 029552          158 ------AQVVAAVGFKGKRLEIP----RNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ------~~~~~~~~~~~~~~~~~----~~~s~~~~~li~~cl~~  191 (191)
                            .+....+...  ....+    ..+|+.++++|.+||+.
T Consensus       216 ~~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li~~~L~~  257 (325)
T 3kn6_A          216 LTCTSAVEIMKKIKKG--DFSFEGEAWKNVSQEAKDLIQGLLTV  257 (325)
T ss_dssp             --CCCHHHHHHHHTTT--CCCCCSHHHHTSCHHHHHHHHHHHCC
T ss_pred             cccccHHHHHHHHHcC--CCCCCcccccCCCHHHHHHHHHHCCC
Confidence                  4555555322  22333    36899999999999974

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=240.64  Aligned_cols=186  Identities=26%  Similarity=0.390  Sum_probs=158.8

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++||||+++++|.+++....  ..+++.+++.++.|++.||+|||+.+  ++||||+|
T Consensus       140 l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp  215 (373)
T 2x4f_A          140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKP  215 (373)
T ss_dssp             HTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCG
T ss_pred             HHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCH
Confidence            467899999999999999999999999999999999886533  23899999999999999999999999  99999999


Q ss_pred             CcEEe--cCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           81 PNLLV--DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        81 ~ni~~--~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      +||++  +.++.++|+|||++....... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..
T Consensus       216 ~NIll~~~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  294 (373)
T 2x4f_A          216 ENILCVNRDAKQIKIIDFGLARRYKPRE-KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA  294 (373)
T ss_dssp             GGEEEEETTTTEEEECCCSSCEECCTTC-BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred             HHEEEecCCCCcEEEEeCCCceecCCcc-ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999  566789999999987544332 233446788999999998888899999999999999999999999999888


Q ss_pred             HHHHHHHhcCcccC--CCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLE--IPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~--~~~~~s~~~~~li~~cl~~  191 (191)
                      +....+.......+  ....+|+.++++|.+||++
T Consensus       295 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~  329 (373)
T 2x4f_A          295 ETLNNILACRWDLEDEEFQDISEEAKEFISKLLIK  329 (373)
T ss_dssp             HHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCS
T ss_pred             HHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCC
Confidence            88887765433322  2357999999999999974

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.7e-37  Score=232.25  Aligned_cols=183  Identities=32%  Similarity=0.563  Sum_probs=161.5

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+.+++|.+++...    .+++.+++.++.|++.||++||+.|  ++|+||+|+
T Consensus        75 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~  148 (303)
T 3a7i_A           75 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK--KIHRDIKAA  148 (303)
T ss_dssp             HHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred             HhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChh
Confidence            4578999999999999999999999999999999999753    3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      ||+++.++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++++|++|..||.........
T Consensus       149 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~  228 (303)
T 3a7i_A          149 NVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL  228 (303)
T ss_dssp             GEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred             eEEECCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH
Confidence            99999999999999999876544433344556788999999999888899999999999999999999999998888777


Q ss_pred             HHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+. .......+..++..+.++|.+||++
T Consensus       229 ~~~~-~~~~~~~~~~~~~~l~~li~~~l~~  257 (303)
T 3a7i_A          229 FLIP-KNNPPTLEGNYSKPLKEFVEACLNK  257 (303)
T ss_dssp             HHHH-HSCCCCCCSSCCHHHHHHHHHHCCS
T ss_pred             HHhh-cCCCCCCccccCHHHHHHHHHHcCC
Confidence            7664 3445667889999999999999974

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-37  Score=240.88  Aligned_cols=186  Identities=33%  Similarity=0.606  Sum_probs=160.6

Q ss_pred             CC-CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC-------------cccccHHHHHHHHHHHHHHHHHHHh
Q 029552            3 RL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------------REMLDERRRLNMAYDVAKGMNYLHR   68 (191)
Q Consensus         3 ~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~Lh~   68 (191)
                      ++ +||||+++++++.+++..++||||+.+++|.+++.....             ...+++.+++.++.|++.||+|||+
T Consensus       130 ~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  209 (382)
T 3tt0_A          130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS  209 (382)
T ss_dssp             HHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh
Confidence            44 899999999999999999999999999999999975431             1348999999999999999999999


Q ss_pred             CCCCeeecCCCCCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHH
Q 029552           69 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA  146 (191)
Q Consensus        69 ~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~  146 (191)
                      .+  ++||||||+||+++.++.++|+|||++.......  .......++..|+|||.+.+..++.++|+||||+++++|+
T Consensus       210 ~~--ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ell  287 (382)
T 3tt0_A          210 KK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF  287 (382)
T ss_dssp             TT--CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHH
T ss_pred             CC--EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHH
Confidence            99  9999999999999999999999999987543321  1222334456899999999988999999999999999999


Q ss_pred             h-CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          147 T-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       147 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      + |..||......+....+. .+.....|..+++.+.++|.+||++
T Consensus       288 t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~  332 (382)
T 3tt0_A          288 TLGGSPYPGVPVEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHA  332 (382)
T ss_dssp             TTSCCSSTTCCHHHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCS
T ss_pred             hCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCHHHHHHHHHHcCC
Confidence            9 999999988888887775 5557778889999999999999974

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=9.9e-38  Score=246.49  Aligned_cols=184  Identities=37%  Similarity=0.697  Sum_probs=157.3

Q ss_pred             CCCCCCCCcccccceeecCC-ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPP-NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      |++++||||+++++++.+.+ ..++||||+.+++|.+++...+ ...+++..++.++.|++.||+|||+++  ++||||+
T Consensus       240 l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlk  316 (450)
T 1k9a_A          240 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLA  316 (450)
T ss_dssp             HHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCC
T ss_pred             HHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCC
Confidence            35789999999999987655 7999999999999999997643 223689999999999999999999999  9999999


Q ss_pred             CCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA  158 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~  158 (191)
                      |+||+++.++.++|+|||++......   ......+..|+|||.+.+..++.++|+||+|+++|+|++ |..||......
T Consensus       317 p~Nill~~~~~~kl~DfG~a~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~  393 (450)
T 1k9a_A          317 ARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK  393 (450)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECC---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT
T ss_pred             HhhEEECCCCCEEEeeCCCccccccc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999998743322   112245678999999999889999999999999999998 99999988777


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +....+. .+.+.+.|..+|+.+.++|.+||+.
T Consensus       394 ~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~  425 (450)
T 1k9a_A          394 DVVPRVE-KGYKMDAPDGCPPAVYDVMKNCWHL  425 (450)
T ss_dssp             THHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcCC
Confidence            7777765 5567788999999999999999974

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.5e-37  Score=237.55  Aligned_cols=182  Identities=26%  Similarity=0.461  Sum_probs=154.3

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      +||||+++++++++++..|+||||+.+++|.+++...+   .+++.++..++.|++.||+|||+.|  ++||||||+||+
T Consensus        74 ~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl  148 (342)
T 2qr7_A           74 QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNIL  148 (342)
T ss_dssp             TSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEE
T ss_pred             CCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEE
Confidence            79999999999999999999999999999999997654   3899999999999999999999999  999999999999


Q ss_pred             ecCC----CcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC---CCH
Q 029552           85 VDKK----YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN---LNP  157 (191)
Q Consensus        85 ~~~~----~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~---~~~  157 (191)
                      +...    +.++|+|||++..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||..   ...
T Consensus       149 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~  228 (342)
T 2qr7_A          149 YVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP  228 (342)
T ss_dssp             ESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH
T ss_pred             EecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH
Confidence            8543    359999999987654443344456778999999999887788899999999999999999999975   456


Q ss_pred             HHHHHHHHhcCcccC--CCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLE--IPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~cl~~  191 (191)
                      .+....+.......+  .+..+|+.++++|++||++
T Consensus       229 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  264 (342)
T 2qr7_A          229 EEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHV  264 (342)
T ss_dssp             HHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHHHccCCcccCccccccCCHHHHHHHHHHCCC
Confidence            667777754433322  3467999999999999974

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2e-37  Score=231.55  Aligned_cols=186  Identities=24%  Similarity=0.320  Sum_probs=150.5

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++|||++.+ +|.+++.....  .+++.++..++.|++.||+|||+.|  ++|+||+|
T Consensus        54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp  128 (288)
T 1ob3_A           54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKP  128 (288)
T ss_dssp             GGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred             HHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCH
Confidence            4678999999999999999999999999976 99998875432  3889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      +||+++.++.++|+|||.+..............++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+...
T Consensus       129 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  208 (288)
T 1ob3_A          129 QNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD  208 (288)
T ss_dssp             GGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             HHEEEcCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999999999999999987544332233344668899999998764 47899999999999999999999999888777


Q ss_pred             HHHHHHhcCcc---------------------------cCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKR---------------------------LEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~---------------------------~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+......                           ...+..+++.+.++|.+||++
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  267 (288)
T 1ob3_A          209 QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKL  267 (288)
T ss_dssp             HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCS
T ss_pred             HHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCC
Confidence            66655321100                           012346899999999999974

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.9e-38  Score=238.24  Aligned_cols=187  Identities=33%  Similarity=0.530  Sum_probs=151.1

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++||||+.+++|.+++.....  .+++.++..++.|+++||+|||+.+  ++|+||+|
T Consensus        61 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp  136 (310)
T 3s95_A           61 MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNS  136 (310)
T ss_dssp             HTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCST
T ss_pred             HHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCc
Confidence            4678999999999999999999999999999999999976432  3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccC--------------CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSS--------------KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA  146 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~--------------~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~  146 (191)
                      +||+++.++.++|+|||.+..........              ....+++.|+|||.+.+..++.++|+||+|+++|+|+
T Consensus       137 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~  216 (310)
T 3s95_A          137 HNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII  216 (310)
T ss_dssp             TSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred             CeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHh
Confidence            99999999999999999987543321111              1346788999999999998999999999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHH-HhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          147 TLQQPWGNLNPAQVVAAV-GFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       147 ~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +|..||....+....... .........|..+|+.+.++|.+||+.
T Consensus       217 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  262 (310)
T 3s95_A          217 GRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDL  262 (310)
T ss_dssp             HTCCSSTTTSCBCTTSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCS
T ss_pred             cCCCCCcchhhhHHHHhhhhhccccccCCCCCCHHHHHHHHHHccC
Confidence            999988753321110000 001112345788999999999999974

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.3e-37  Score=230.33  Aligned_cols=184  Identities=39%  Similarity=0.660  Sum_probs=154.0

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCC-eeecCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPP-IVHRDLKS   80 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~-~~h~~l~p   80 (191)
                      ++++||||+++++++.+++..++||||+++++|.+++...    .+++.+++.++.|++.||+|||+.+.. ++|+||+|
T Consensus        61 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp  136 (271)
T 3dtc_A           61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKS  136 (271)
T ss_dssp             HHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSG
T ss_pred             HhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCch
Confidence            4578999999999999999999999999999999999643    389999999999999999999998732 67999999


Q ss_pred             CcEEecC--------CCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 029552           81 PNLLVDK--------KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW  152 (191)
Q Consensus        81 ~ni~~~~--------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf  152 (191)
                      +||+++.        ++.++|+|||.+......  ......++..|+|||.+.+..++.++|+||+|+++++|++|..||
T Consensus       137 ~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  214 (271)
T 3dtc_A          137 SNILILQKVENGDLSNKILKITDFGLAREWHRT--TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF  214 (271)
T ss_dssp             GGEEESSCCSSSCCSSCCEEECCCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTT
T ss_pred             HHEEEecccccccccCcceEEccCCcccccccc--cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999986        678999999998754433  222346788999999999888999999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          153 GNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+.......+.......+.|..+|+.+.++|.+||++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  253 (271)
T 3dtc_A          215 RGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNP  253 (271)
T ss_dssp             TTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcC
Confidence            999988888888777777888999999999999999974

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2e-37  Score=228.80  Aligned_cols=185  Identities=33%  Similarity=0.619  Sum_probs=160.2

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+++++|.+++....  ..+++..++.++.|++.||++||+.|  ++|+||+|+
T Consensus        58 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~  133 (267)
T 3t9t_A           58 MKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAAR  133 (267)
T ss_dssp             HTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGG
T ss_pred             HhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchh
Confidence            56899999999999999999999999999999999997543  23889999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ  159 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~~  159 (191)
                      ||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...+..+
T Consensus       134 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~  213 (267)
T 3t9t_A          134 NCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE  213 (267)
T ss_dssp             GEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             eEEECCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH
Confidence            9999999999999999887543321 22233445678999999998888999999999999999999 899999988888


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+. .+.....|..+|+.+.++|.+||++
T Consensus       214 ~~~~i~-~~~~~~~~~~~~~~l~~li~~~l~~  244 (267)
T 3t9t_A          214 VVEDIS-TGFRLYKPRLASTHVYQIMNHCWRE  244 (267)
T ss_dssp             HHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHh-cCCcCCCCccCcHHHHHHHHHHccC
Confidence            888775 4445667888999999999999974

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.4e-37  Score=229.53  Aligned_cols=186  Identities=23%  Similarity=0.350  Sum_probs=150.7

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++||||+.+ ++.+.+....  +.+++.+++.++.|++.||+|||+.|  ++|+||||
T Consensus        55 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp  129 (292)
T 3o0g_A           55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKP  129 (292)
T ss_dssp             HTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred             HhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence            4678999999999999999999999999986 5655554322  23899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCCC-CCCCCHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQP-WGNLNPA  158 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p-f~~~~~~  158 (191)
                      +||+++.++.++|+|||.+..............++..|+|||.+.+.. ++.++|+||+|+++|+|++|..| |...+..
T Consensus       130 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~  209 (292)
T 3o0g_A          130 QNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD  209 (292)
T ss_dssp             GGEEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH
T ss_pred             HHEEEcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH
Confidence            999999999999999999876554434444556788999999987765 78999999999999999988777 5566666


Q ss_pred             HHHHHHHhcCc---------------------------ccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGK---------------------------RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~---------------------------~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .....+.....                           .......+|+.++++|.+||+.
T Consensus       210 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  269 (292)
T 3o0g_A          210 DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKC  269 (292)
T ss_dssp             HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCS
T ss_pred             HHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhcc
Confidence            66655532111                           1122346899999999999974

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=7.6e-38  Score=232.99  Aligned_cols=184  Identities=30%  Similarity=0.579  Sum_probs=148.0

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++. ++..++||||+.+++|.+++.....  .+++.+++.++.|++.||+|||+.|  ++|+||+|+
T Consensus        71 ~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~  145 (281)
T 1mp8_A           71 RQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESKR--FVHRDIAAR  145 (281)
T ss_dssp             HTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred             HhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHH
Confidence            5689999999999885 4578999999999999999975432  3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccc-cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ  159 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~~  159 (191)
                      ||+++.++.++|+|||.+........ ......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||......+
T Consensus       146 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~  225 (281)
T 1mp8_A          146 NVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND  225 (281)
T ss_dssp             GEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred             HEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH
Confidence            99999999999999998875433211 1222344568999999988888999999999999999996 899999888777


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+. .+...+.|..+|+.+.++|.+||++
T Consensus       226 ~~~~i~-~~~~~~~~~~~~~~l~~li~~~l~~  256 (281)
T 1mp8_A          226 VIGRIE-NGERLPMPPNCPPTLYSLMTKCWAY  256 (281)
T ss_dssp             HHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHH-cCCCCCCCCCCCHHHHHHHHHHccC
Confidence            777775 4456678899999999999999974

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-38  Score=239.56  Aligned_cols=188  Identities=32%  Similarity=0.534  Sum_probs=158.2

Q ss_pred             CCC-CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCc--------------------ccccHHHHHHHHHHHH
Q 029552            2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVR--------------------EMLDERRRLNMAYDVA   60 (191)
Q Consensus         2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~--------------------~~~~~~~~~~~~~~i~   60 (191)
                      +++ +||||+++++++.+++..++||||+++++|.+++......                    ..+++.+++.++.|++
T Consensus       103 ~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~  182 (344)
T 1rjb_A          103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVA  182 (344)
T ss_dssp             HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHH
T ss_pred             HhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHH
Confidence            345 8999999999999999999999999999999999764321                    2378999999999999


Q ss_pred             HHHHHHHhCCCCeeecCCCCCcEEecCCCcEEEcccccccccccccc--cCCCCCCCCcccCccccccCCCCCcchHHHH
Q 029552           61 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSF  138 (191)
Q Consensus        61 ~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~sl  138 (191)
                      .||+|||+.|  ++|+||+|+||+++.++.++|+|||.+........  ......++..|+|||.+.+..++.++|+|||
T Consensus       183 ~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl  260 (344)
T 1rjb_A          183 KGMEFLEFKS--CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY  260 (344)
T ss_dssp             HHHHHHHHTT--EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHHHHHhCC--cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHH
Confidence            9999999999  99999999999999999999999999865433211  1222334567999999988889999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          139 GVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       139 G~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      |+++|+|++ |..||...............+.....|..+++.+.++|.+||+.
T Consensus       261 G~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  314 (344)
T 1rjb_A          261 GILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAF  314 (344)
T ss_dssp             HHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            999999998 99999887666555555556667788889999999999999974

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-37  Score=236.40  Aligned_cols=185  Identities=30%  Similarity=0.580  Sum_probs=154.8

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+.+..++||||+.+++|.+++....  ..+++.+++.++.|+++||++||+.|  ++|+||+|+
T Consensus       101 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~  176 (333)
T 1mqb_A          101 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAAR  176 (333)
T ss_dssp             HTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGG
T ss_pred             HhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChh
Confidence            56899999999999999999999999999999999997543  23899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccc---cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP  157 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~  157 (191)
                      ||+++.++.++|+|||.+........   ......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||.....
T Consensus       177 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~  256 (333)
T 1mqb_A          177 NILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN  256 (333)
T ss_dssp             GEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             eEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH
Confidence            99999999999999999875433211   1112234567999999998889999999999999999999 9999999888


Q ss_pred             HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+....+. .+.+.+.+..+++.+.++|.+||++
T Consensus       257 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~  289 (333)
T 1mqb_A          257 HEVMKAIN-DGFRLPTPMDCPSAIYQLMMQCWQQ  289 (333)
T ss_dssp             HHHHHHHH-TTCCCCCCTTCBHHHHHHHHHHTCS
T ss_pred             HHHHHHHH-CCCcCCCcccCCHHHHHHHHHHcCC
Confidence            88877775 4456777889999999999999974

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=6.8e-38  Score=237.79  Aligned_cols=185  Identities=25%  Similarity=0.379  Sum_probs=153.5

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+.+++|.+++....   .+++.+++.++.|++.||+|||+.|  ++|+||+|+
T Consensus        60 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~  134 (323)
T 3tki_A           60 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPE  134 (323)
T ss_dssp             HHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred             HhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchH
Confidence            45799999999999999999999999999999999997644   3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccc--cccCCCCCCCCcccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      ||+++.++.++|+|||++......  ........+++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||......
T Consensus       135 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  214 (323)
T 3tki_A          135 NLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS  214 (323)
T ss_dssp             GEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT
T ss_pred             HEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH
Confidence            999999999999999998653322  122334567889999999987765 67899999999999999999999865443


Q ss_pred             -HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 -QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 -~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                       .............+....+++.+.++|.+||++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  248 (323)
T 3tki_A          215 CQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVE  248 (323)
T ss_dssp             SHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCS
T ss_pred             HHHHHHHhcccccCCccccCCHHHHHHHHHHccC
Confidence             333333333333444467999999999999974

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=7.7e-38  Score=237.55  Aligned_cols=184  Identities=33%  Similarity=0.544  Sum_probs=156.2

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+ +..++|+||+.+++|.+++....  +.+++.+++.++.|++.||+|||+.|  ++||||||+
T Consensus        70 ~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~  144 (325)
T 3kex_A           70 GSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAAR  144 (325)
T ss_dssp             HTCCCTTBCCEEEEECB-SSEEEEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSST
T ss_pred             hcCCCCCcCeEEEEEcC-CccEEEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchh
Confidence            46799999999998864 56899999999999999997642  24889999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA  158 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~  158 (191)
                      ||+++.++.++|+|||++.......  .......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||......
T Consensus       145 Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  224 (325)
T 3kex_A          145 NVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA  224 (325)
T ss_dssp             TEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT
T ss_pred             eEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH
Confidence            9999999999999999987643321  11233345668999999998889999999999999999999 99999988877


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +....+. .+.....|..++..+.++|.+||++
T Consensus       225 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  256 (325)
T 3kex_A          225 EVPDLLE-KGERLAQPQICTIDVYMVMVKCWMI  256 (325)
T ss_dssp             HHHHHHH-TTCBCCCCTTBCTTTTHHHHHHTCS
T ss_pred             HHHHHHH-cCCCCCCCCcCcHHHHHHHHHHcCC
Confidence            7777664 5567778888999999999999974

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.1e-37  Score=232.88  Aligned_cols=188  Identities=24%  Similarity=0.335  Sum_probs=155.1

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCC---CcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG---VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRD   77 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~   77 (191)
                      |++++||||+++++++.+++..++||||+. ++|.+++....   ....+++..+..++.|++.||+|||+.|  ++|||
T Consensus        57 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~D  133 (317)
T 2pmi_A           57 MKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRD  133 (317)
T ss_dssp             HTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCC
T ss_pred             HHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCC
Confidence            467899999999999999999999999998 59999885421   1224889999999999999999999999  99999


Q ss_pred             CCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 029552           78 LKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLN  156 (191)
Q Consensus        78 l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf~~~~  156 (191)
                      |||+||+++.++.++|+|||.+..............++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+
T Consensus       134 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  213 (317)
T 2pmi_A          134 LKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN  213 (317)
T ss_dssp             CCGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999987654433333445678899999998764 57899999999999999999999999988


Q ss_pred             HHHHHHHHHhcCc--------------------------------ccCCCCCCCHHHHHHHHHHhcC
Q 029552          157 PAQVVAAVGFKGK--------------------------------RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~~~~~~~~~~~~--------------------------------~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+....+.....                                ....+..+|+.++++|.+||++
T Consensus       214 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  280 (317)
T 2pmi_A          214 DEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQL  280 (317)
T ss_dssp             HHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCS
T ss_pred             hHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCC
Confidence            8777666532111                                0112346899999999999974

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.7e-38  Score=241.61  Aligned_cols=187  Identities=29%  Similarity=0.489  Sum_probs=158.9

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCC----CcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG----VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRD   77 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~   77 (191)
                      ++++||||+++++++.+++..++||||+.+++|.+++....    ....+++.+++.++.|++.||+|||+.|  ++|||
T Consensus       129 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrD  206 (367)
T 3l9p_A          129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRD  206 (367)
T ss_dssp             HHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred             HhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCC
Confidence            46799999999999999999999999999999999996532    1234889999999999999999999999  99999


Q ss_pred             CCCCcEEecCCC---cEEEcccccccccccc--cccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCC
Q 029552           78 LKSPNLLVDKKY---TVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQP  151 (191)
Q Consensus        78 l~p~ni~~~~~~---~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p  151 (191)
                      |||+||+++.++   .++|+|||++......  ........+++.|+|||.+.+..++.++|+||||+++|+|++ |..|
T Consensus       207 lkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p  286 (367)
T 3l9p_A          207 IAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP  286 (367)
T ss_dssp             CCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             CChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            999999998555   4999999998643222  112223345678999999988889999999999999999998 9999


Q ss_pred             CCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          152 WGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       152 f~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      |...+..+....+. .+.....|..+++.+.++|.+||++
T Consensus       287 f~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~l~~  325 (367)
T 3l9p_A          287 YPSKSNQEVLEFVT-SGGRMDPPKNCPGPVYRIMTQCWQH  325 (367)
T ss_dssp             STTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCCCCHHHHHHHHH-cCCCCCCCccCCHHHHHHHHHHcCC
Confidence            99999888888775 4556677889999999999999974

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.3e-37  Score=228.91  Aligned_cols=183  Identities=26%  Similarity=0.408  Sum_probs=156.7

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+.+++|.+++....   .+++.+++.++.|++.||++||+.|  ++|+||+|+
T Consensus        61 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~  135 (277)
T 3f3z_A           61 KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPE  135 (277)
T ss_dssp             HTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred             HhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHH
Confidence            57899999999999999999999999999999999887643   3899999999999999999999999  999999999


Q ss_pred             cEEe---cCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           82 NLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        82 ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      ||++   +.++.++|+|||.+...... .......+++.|+|||.+.+. ++.++|+||+|+++++|++|..||......
T Consensus       136 Nil~~~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  213 (277)
T 3f3z_A          136 NFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS  213 (277)
T ss_dssp             GEEESSSSTTCCEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             HEEEecCCCCCcEEEEecccceeccCc-cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH
Confidence            9999   77889999999988654433 223345678899999998765 888999999999999999999999999988


Q ss_pred             HHHHHHHhcCcccCCC--CCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIP--RNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~--~~~s~~~~~li~~cl~~  191 (191)
                      +....+.......+..  ..+|+.+.++|.+||++
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  248 (277)
T 3f3z_A          214 EVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTK  248 (277)
T ss_dssp             HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccC
Confidence            8888876443322211  37999999999999974

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.5e-37  Score=234.79  Aligned_cols=187  Identities=34%  Similarity=0.628  Sum_probs=159.2

Q ss_pred             CCCC-CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCC-------------CcccccHHHHHHHHHHHHHHHHHH
Q 029552            1 MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-------------VREMLDERRRLNMAYDVAKGMNYL   66 (191)
Q Consensus         1 L~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~~~~~~i~~~l~~L   66 (191)
                      |+++ +||||+++++++.+++..++||||+++++|.+++....             ....+++.+++.++.|+++||+||
T Consensus        79 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L  158 (327)
T 1fvr_A           79 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL  158 (327)
T ss_dssp             HTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred             HHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence            3567 89999999999999999999999999999999997643             123489999999999999999999


Q ss_pred             HhCCCCeeecCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHH
Q 029552           67 HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA  146 (191)
Q Consensus        67 h~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~  146 (191)
                      |+.|  ++|+||+|+||+++.++.++|+|||++...... ........+..|+|||.+.+..++.++|+||||+++|+|+
T Consensus       159 H~~~--ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell  235 (327)
T 1fvr_A          159 SQKQ--FIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV  235 (327)
T ss_dssp             HHTT--EECSCCSGGGEEECGGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred             HhCC--ccCCCCccceEEEcCCCeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHH
Confidence            9999  999999999999999999999999988643322 1222334567899999998888889999999999999999


Q ss_pred             h-CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          147 T-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       147 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      + |..||...+..+....+. .+.....|..+++.++++|.+||++
T Consensus       236 t~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~  280 (327)
T 1fvr_A          236 SLGGTPYCGMTCAELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWRE  280 (327)
T ss_dssp             TTSCCTTTTCCHHHHHHHGG-GTCCCCCCTTBCHHHHHHHHHHTCS
T ss_pred             cCCCCCCCCCcHHHHHHHhh-cCCCCCCCCCCCHHHHHHHHHHccC
Confidence            8 999999999888887775 4456677889999999999999974

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.4e-37  Score=245.88  Aligned_cols=186  Identities=30%  Similarity=0.575  Sum_probs=159.6

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++. .+..++||||+.+++|.+++.... ...++..+++.++.|++.||+|||+.+  ++||||+|
T Consensus       237 l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp  312 (454)
T 1qcf_A          237 MKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRA  312 (454)
T ss_dssp             HTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSG
T ss_pred             HhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCH
Confidence            46789999999999886 567999999999999999997532 123788899999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA  158 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~  158 (191)
                      +||+++.++.++|+|||++....... ........+..|+|||.+....++.++|+||||+++|+|++ |..||...+..
T Consensus       313 ~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~  392 (454)
T 1qcf_A          313 ANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP  392 (454)
T ss_dssp             GGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             HHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987543321 11222334668999999998889999999999999999999 99999999888


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +....+. .+.+.+.|..+|+.+.++|.+||++
T Consensus       393 ~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~  424 (454)
T 1qcf_A          393 EVIRALE-RGYRMPRPENCPEELYNIMMRCWKN  424 (454)
T ss_dssp             HHHHHHH-HTCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHHH-cCCCCCCCCCCCHHHHHHHHHHccC
Confidence            8888775 4567778899999999999999974

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.6e-37  Score=233.39  Aligned_cols=185  Identities=24%  Similarity=0.340  Sum_probs=150.7

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+.+ +|.+.+.....  .+++.++..++.|++.||+|||+.|  ++||||||+
T Consensus        74 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~  148 (311)
T 3niz_A           74 KELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKT--GLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQ  148 (311)
T ss_dssp             HHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGG
T ss_pred             HHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchH
Confidence            467999999999999999999999999985 88888865432  3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      ||+++.++.++|+|||.+..............++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||........
T Consensus       149 NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  228 (311)
T 3niz_A          149 NLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ  228 (311)
T ss_dssp             GEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH
T ss_pred             hEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence            999999999999999998765444334444567889999999876 4578999999999999999999999987666555


Q ss_pred             HHHHHhcCcc----------------------------cCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKR----------------------------LEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~----------------------------~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+......                            ....+.+++.+.++|.+||++
T Consensus       229 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  287 (311)
T 3niz_A          229 LPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCF  287 (311)
T ss_dssp             HHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCS
T ss_pred             HHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCC
Confidence            5554321110                            012245889999999999974

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.8e-37  Score=235.09  Aligned_cols=188  Identities=29%  Similarity=0.499  Sum_probs=151.5

Q ss_pred             CCCCCCCCcccccceeecCCce------EEEEeccCCCCHHHHhcCCC---CcccccHHHHHHHHHHHHHHHHHHHhCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNL------SIVTEYLSRGSLYRLLHKPG---VREMLDERRRLNMAYDVAKGMNYLHRRNP   71 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~   71 (191)
                      |++++||||+++++++.+.+..      ++|+||+.+++|.+++....   ....+++.+++.++.|++.||+|||+.| 
T Consensus        79 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-  157 (323)
T 3qup_A           79 MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN-  157 (323)
T ss_dssp             HTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             HHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC-
Confidence            4678999999999999877655      99999999999999995422   1124899999999999999999999999 


Q ss_pred             CeeecCCCCCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-C
Q 029552           72 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-L  148 (191)
Q Consensus        72 ~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g  148 (191)
                       ++|+||||+||+++.++.++|+|||.+.......  .......++..|+|||.+.+..++.++|+||+|+++|+|++ |
T Consensus       158 -ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g  236 (323)
T 3qup_A          158 -FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRG  236 (323)
T ss_dssp             -CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred             -cccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCC
Confidence             9999999999999999999999999986543321  11222334568999999999889999999999999999999 8


Q ss_pred             CCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          149 QQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       149 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..||...+..+....+. .+.....+..+++.+.++|.+||++
T Consensus       237 ~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~  278 (323)
T 3qup_A          237 QTPYAGIENAEIYNYLI-GGNRLKQPPECMEEVYDLMYQCWSA  278 (323)
T ss_dssp             CCTTTTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCS
T ss_pred             CCCccccChHHHHHHHh-cCCCCCCCCccCHHHHHHHHHHccC
Confidence            99999988888777774 4556778889999999999999974

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.2e-37  Score=236.35  Aligned_cols=184  Identities=28%  Similarity=0.445  Sum_probs=146.8

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+.+++|.+++...+   .+++.+++.++.|++.||+|||+.|  ++||||+|+
T Consensus       103 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~  177 (349)
T 2w4o_A          103 LRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHENG--IVHRDLKPE  177 (349)
T ss_dssp             HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGG
T ss_pred             HhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcc
Confidence            46789999999999999999999999999999999997644   3899999999999999999999999  999999999


Q ss_pred             cEEecC---CCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           82 NLLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        82 ni~~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      ||+++.   ++.++|+|||++...... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||......
T Consensus       178 NIll~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  256 (349)
T 2w4o_A          178 NLLYATPAPDAPLKIADFGLSKIVEHQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD  256 (349)
T ss_dssp             GEEESSSSTTCCEEECCCC-----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH
T ss_pred             cEEEecCCCCCCEEEccCccccccCcc-cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc
Confidence            999975   789999999998754332 1223446788999999999988999999999999999999999999775554


Q ss_pred             H-HHHHHHhcCccc--CCCCCCCHHHHHHHHHHhcC
Q 029552          159 Q-VVAAVGFKGKRL--EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~-~~~~~~~~~~~~--~~~~~~s~~~~~li~~cl~~  191 (191)
                      . ....+.......  +....+|..++++|.+||++
T Consensus       257 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~  292 (349)
T 2w4o_A          257 QFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVL  292 (349)
T ss_dssp             HHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCS
T ss_pred             HHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccC
Confidence            4 555554333222  23367999999999999964

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.1e-37  Score=238.40  Aligned_cols=184  Identities=30%  Similarity=0.516  Sum_probs=143.4

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+.+++|.+++...+   .+++.+++.++.|++.||+|||++|  ++||||||+
T Consensus        71 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~  145 (361)
T 3uc3_A           71 RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLE  145 (361)
T ss_dssp             HHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGG
T ss_pred             HhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHH
Confidence            46799999999999999999999999999999999997643   3899999999999999999999999  999999999


Q ss_pred             cEEecCCCc--EEEcccccccccccccccCCCCCCCCcccCccccccCCCCCc-chHHHHHHHHHHHHhCCCCCCCCCH-
Q 029552           82 NLLVDKKYT--VKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEK-SDIYSFGVILWELATLQQPWGNLNP-  157 (191)
Q Consensus        82 ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~pf~~~~~-  157 (191)
                      ||+++.++.  ++|+|||++...... .......+++.|+|||.+.+..+..+ +|+||+|+++|+|++|..||..... 
T Consensus       146 Nill~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~  224 (361)
T 3uc3_A          146 NTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP  224 (361)
T ss_dssp             GEEECSSSSCCEEECCCCCC----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C
T ss_pred             HEEEcCCCCceEEEeecCcccccccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH
Confidence            999987765  999999988643222 12234467889999999988776555 8999999999999999999986433 


Q ss_pred             ---HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 ---AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ---~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                         ......+.......+.+..+|+.++++|.+||++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  261 (361)
T 3uc3_A          225 RDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVA  261 (361)
T ss_dssp             CCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCS
T ss_pred             HHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccC
Confidence               4444545433334444457899999999999974

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.6e-37  Score=231.80  Aligned_cols=186  Identities=20%  Similarity=0.296  Sum_probs=148.7

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++|+||+++++|.+++...+   .+++.+++.++.|++.||+|||+.|  ++|+||+|
T Consensus        88 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp  162 (309)
T 2h34_A           88 AGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKP  162 (309)
T ss_dssp             HTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred             HhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCCh
Confidence            367899999999999999999999999999999999997643   3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      +||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+...
T Consensus       163 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  242 (309)
T 2h34_A          163 ENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV  242 (309)
T ss_dssp             GGEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH
T ss_pred             HHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH
Confidence            99999999999999999886543321 22234457889999999998888999999999999999999999999877765


Q ss_pred             HHHHHHhcCc-ccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGK-RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~-~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+..... ....+..+|+.+.++|.+||++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  275 (309)
T 2h34_A          243 MGAHINQAIPRPSTVRPGIPVAFDAVIARGMAK  275 (309)
T ss_dssp             HHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCS
T ss_pred             HHHHhccCCCCccccCCCCCHHHHHHHHHhccC
Confidence            5555543322 2246778999999999999974

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=7.8e-37  Score=227.61  Aligned_cols=184  Identities=28%  Similarity=0.468  Sum_probs=159.0

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+.+++|.+.+....   .+++.++..++.|++.||++||+.|  ++|+||+|+
T Consensus        60 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~  134 (284)
T 3kk8_A           60 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG--IVHRNLKPE  134 (284)
T ss_dssp             HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGG
T ss_pred             HHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHH
Confidence            46799999999999999999999999999999988886543   3899999999999999999999999  999999999


Q ss_pred             cEEecCCCc---EEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           82 NLLVDKKYT---VKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        82 ni~~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      ||+++.++.   ++|+|||.+....... ......+++.|+|||.+.+..++.++|+||+|+++++|++|..||...+..
T Consensus       135 Nil~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~  213 (284)
T 3kk8_A          135 NLLLASKAKGAAVKLADFGLAIEVNDSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH  213 (284)
T ss_dssp             GEEESSSSTTCCEEECCCTTCEECCSSC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             HEEEecCCCCCcEEEeeceeeEEcccCc-cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh
Confidence            999987655   9999999986544332 223456788999999999988999999999999999999999999999988


Q ss_pred             HHHHHHHhcCcccCCC--CCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIP--RNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~--~~~s~~~~~li~~cl~~  191 (191)
                      .....+.......+.+  ..+|+.+.++|.+||+.
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  248 (284)
T 3kk8_A          214 RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTV  248 (284)
T ss_dssp             HHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCS
T ss_pred             HHHHHHHhccccCCchhhcccCHHHHHHHHHHccc
Confidence            8888886555444333  57999999999999974

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.3e-37  Score=248.41  Aligned_cols=186  Identities=35%  Similarity=0.622  Sum_probs=160.6

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+.+++|.+++.... ...+++..++.++.|++.||+|||+++  ++||||+|+
T Consensus       271 ~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~  347 (495)
T 1opk_A          271 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAAR  347 (495)
T ss_dssp             HHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred             HhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChh
Confidence            46799999999999999999999999999999999997533 234889999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ  159 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~~  159 (191)
                      ||+++.++.++|+|||++....... ........+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+
T Consensus       348 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~  427 (495)
T 1opk_A          348 NCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ  427 (495)
T ss_dssp             GEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             hEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999987543321 22223344568999999988888999999999999999999 899999888877


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+. .+.+.+.|..+|+.+.++|.+||++
T Consensus       428 ~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~  458 (495)
T 1opk_A          428 VYELLE-KDYRMERPEGCPEKVYELMRACWQW  458 (495)
T ss_dssp             HHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCc
Confidence            777664 5567788899999999999999974

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4.7e-37  Score=232.79  Aligned_cols=184  Identities=26%  Similarity=0.434  Sum_probs=158.5

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+.+++|.+++....   .+++.+++.++.|++.||+|||+.|  ++|+||+|+
T Consensus        70 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~  144 (321)
T 2a2a_A           70 RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPE  144 (321)
T ss_dssp             HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred             HhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChH
Confidence            46789999999999999999999999999999999997644   3899999999999999999999999  999999999


Q ss_pred             cEEecCCC----cEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           82 NLLVDKKY----TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        82 ni~~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      ||+++.++    .++|+|||.+....... ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+.
T Consensus       145 NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  223 (321)
T 2a2a_A          145 NIMLLDKNIPIPHIKLIDFGLAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK  223 (321)
T ss_dssp             GEEESCTTSSSCCEEECCCTTCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred             HEEEecCCCCcCCEEEccCccceecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH
Confidence            99999887    79999999987544332 22344678899999999988899999999999999999999999999888


Q ss_pred             HHHHHHHHhcCccc--CCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRL--EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~--~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+....+.......  ..+..+|+.++++|.+||++
T Consensus       224 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~  259 (321)
T 2a2a_A          224 QETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVK  259 (321)
T ss_dssp             HHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCS
T ss_pred             HHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCC
Confidence            88887775432221  22367999999999999974

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-37  Score=238.20  Aligned_cols=186  Identities=32%  Similarity=0.571  Sum_probs=148.4

Q ss_pred             CCCCCCCCcccccceee-cCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            1 MKRLRHPNIVLFMGAVT-QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      |++++||||+++++++. .++..++||||+.+++|.+++.....  .+++.+++.++.|+++||+|||+.|  ++||||+
T Consensus       144 l~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlk  219 (373)
T 3c1x_A          144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLA  219 (373)
T ss_dssp             STTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCC
T ss_pred             HHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHCC--EecCccc
Confidence            56789999999999865 45678999999999999999976442  3789999999999999999999999  9999999


Q ss_pred             CCcEEecCCCcEEEcccccccccccccc----cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTFL----SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGN  154 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~  154 (191)
                      |+||+++.++.++|+|||++........    ......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||..
T Consensus       220 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~  299 (373)
T 3c1x_A          220 ARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD  299 (373)
T ss_dssp             GGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred             hheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCC
Confidence            9999999999999999999864432211    1122344568999999998889999999999999999999 6888887


Q ss_pred             CCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          155 LNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+..+....+. .+.+...|..+++.+.++|.+||++
T Consensus       300 ~~~~~~~~~~~-~~~~~~~p~~~~~~l~~li~~cl~~  335 (373)
T 3c1x_A          300 VNTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHP  335 (373)
T ss_dssp             SCSSCHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            76666665554 4456677889999999999999974

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=5.1e-37  Score=235.18  Aligned_cols=181  Identities=30%  Similarity=0.482  Sum_probs=155.7

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+. ++|.+.+....  ..+++.++..++.|+++||+|||+.|  ++||||+|+
T Consensus       109 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~  183 (348)
T 1u5q_A          109 QKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAG  183 (348)
T ss_dssp             HHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGG
T ss_pred             HhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHH
Confidence            46799999999999999999999999997 58888775322  23899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR---DEPSNEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      ||+++.++.++|+|||++......    ....+++.|+|||.+.   +..++.++|+||+|+++++|++|..||...+..
T Consensus       184 NIll~~~~~~kL~DfG~a~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  259 (348)
T 1u5q_A          184 NILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM  259 (348)
T ss_dssp             GEEEETTTEEEECCCTTCBSSSSB----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred             HEEECCCCCEEEeeccCceecCCC----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence            999999999999999998654322    2346788999999884   456788999999999999999999999998888


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .....+.....+...+..+|+.++++|.+||++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  292 (348)
T 1u5q_A          260 SALYHIAQNESPALQSGHWSEYFRNFVDSCLQK  292 (348)
T ss_dssp             HHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccc
Confidence            877777655555555678999999999999974

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=7e-37  Score=230.95  Aligned_cols=186  Identities=26%  Similarity=0.496  Sum_probs=159.3

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+.+++|.+++....  ..+++.+++.++.|++.||.+||+.|  ++|+||+|+
T Consensus        79 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~  154 (314)
T 3com_A           79 QQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAG  154 (314)
T ss_dssp             HTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred             HhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHH
Confidence            56899999999999999999999999999999999986322  23899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      ||+++.++.++|+|||.+..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+.....
T Consensus       155 Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~  234 (314)
T 3com_A          155 NILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI  234 (314)
T ss_dssp             GEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred             HEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            99999999999999999876554433344556788999999999888899999999999999999999999988877766


Q ss_pred             HHHHhcCc-ccCCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKGK-RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~~-~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+..... ....+..+|+.+.++|.+||++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  265 (314)
T 3com_A          235 FMIPTNPPPTFRKPELWSDNFTDFVKQCLVK  265 (314)
T ss_dssp             HHHHHSCCCCCSSGGGSCHHHHHHHHHHTCS
T ss_pred             HHHhcCCCcccCCcccCCHHHHHHHHHHccC
Confidence            65543322 3344667899999999999974

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=7.8e-38  Score=240.15  Aligned_cols=185  Identities=31%  Similarity=0.592  Sum_probs=154.9

Q ss_pred             CCCCcccccceeecCC-ceEEEEeccCCCCHHHHhcCCCC----------------------------------------
Q 029552            5 RHPNIVLFMGAVTQPP-NLSIVTEYLSRGSLYRLLHKPGV----------------------------------------   43 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~----------------------------------------   43 (191)
                      +||||+++++++.+.+ ..++||||+.+++|.+++.....                                        
T Consensus        84 ~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (359)
T 3vhe_A           84 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSA  163 (359)
T ss_dssp             CCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------
T ss_pred             CCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccc
Confidence            7999999999998755 49999999999999999975432                                        


Q ss_pred             -----------------------cccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecCCCcEEEccccccc
Q 029552           44 -----------------------REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR  100 (191)
Q Consensus        44 -----------------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~  100 (191)
                                             ...+++.+++.++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~  241 (359)
T 3vhe_A          164 SSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLAR  241 (359)
T ss_dssp             --------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGS
T ss_pred             ccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEecccee
Confidence                                   112889999999999999999999999  9999999999999999999999999986


Q ss_pred             ccccc--cccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCcccCCCCCC
Q 029552          101 LKANT--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNV  177 (191)
Q Consensus       101 ~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  177 (191)
                      .....  ........++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...............+.....|..+
T Consensus       242 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (359)
T 3vhe_A          242 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYT  321 (359)
T ss_dssp             CTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTC
T ss_pred             eecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCC
Confidence            44222  112233445678999999998889999999999999999998 999998866555555555566777888999


Q ss_pred             CHHHHHHHHHHhcC
Q 029552          178 NPHVASIIEACWAK  191 (191)
Q Consensus       178 s~~~~~li~~cl~~  191 (191)
                      ++.+.++|.+||++
T Consensus       322 ~~~l~~li~~~l~~  335 (359)
T 3vhe_A          322 TPEMYQTMLDCWHG  335 (359)
T ss_dssp             CHHHHHHHHHHTCS
T ss_pred             CHHHHHHHHHHccC
Confidence            99999999999974

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4e-37  Score=235.04  Aligned_cols=188  Identities=29%  Similarity=0.409  Sum_probs=154.2

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCC-------------------------------------Cc
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-------------------------------------VR   44 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------------------------------------~~   44 (191)
                      ++++||||+++++++.+++..++||||+++++|.+++....                                     ..
T Consensus        83 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (345)
T 3hko_A           83 KKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLD  162 (345)
T ss_dssp             HHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECC
T ss_pred             HhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence            46789999999999999999999999999999999985210                                     01


Q ss_pred             ccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecCCC--cEEEccccccccccccc----ccCCCCCCCCcc
Q 029552           45 EMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY--TVKVCDFGLSRLKANTF----LSSKSAAGTPEW  118 (191)
Q Consensus        45 ~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~--~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~  118 (191)
                      ..+++..++.++.|++.||+|||+.+  ++|+||+|+||+++.++  .++|+|||.+.......    .......+++.|
T Consensus       163 ~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y  240 (345)
T 3hko_A          163 FVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF  240 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGG
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccc
Confidence            23578889999999999999999999  99999999999998776  89999999987533211    122345678899


Q ss_pred             cCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCcccCCC--CCCCHHHHHHHHHHhcC
Q 029552          119 MAPEVLRD--EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP--RNVNPHVASIIEACWAK  191 (191)
Q Consensus       119 ~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~cl~~  191 (191)
                      +|||.+.+  ..++.++|+||||+++|+|++|..||...+..+....+.......+.|  ..+|+.++++|.+||++
T Consensus       241 ~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  317 (345)
T 3hko_A          241 VAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNR  317 (345)
T ss_dssp             CCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCS
T ss_pred             cCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCC
Confidence            99999875  567889999999999999999999999999888888886655544443  35899999999999974

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=9.3e-37  Score=243.47  Aligned_cols=184  Identities=33%  Similarity=0.506  Sum_probs=158.6

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++++++..|+||||+.+++|.+.+....   .+++.+++.++.|++.||+|||+.|  ++||||||
T Consensus        90 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp  164 (494)
T 3lij_A           90 LKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKP  164 (494)
T ss_dssp             HTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSG
T ss_pred             HHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCh
Confidence            467899999999999999999999999999999999886543   3899999999999999999999999  99999999


Q ss_pred             CcEEecCC---CcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           81 PNLLVDKK---YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      +||+++..   +.++|+|||++...... .......+++.|+|||.+.+ .++.++|+||+|+++|+|++|..||...+.
T Consensus       165 ~Nil~~~~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~  242 (494)
T 3lij_A          165 ENLLLESKEKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTD  242 (494)
T ss_dssp             GGEEESCSSTTCCEEECCCTTCEECBTT-BCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             hhEEEeCCCCCCcEEEEECCCCeECCCC-ccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999764   45999999998755433 22334568899999999864 588999999999999999999999999999


Q ss_pred             HHHHHHHHhcCcccCCC--CCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIP--RNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~cl~~  191 (191)
                      .+....+.......+.|  ..+|+.++++|.+||++
T Consensus       243 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  278 (494)
T 3lij_A          243 QEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQF  278 (494)
T ss_dssp             HHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCC
Confidence            99988887655544433  57999999999999974

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.9e-37  Score=251.02  Aligned_cols=185  Identities=29%  Similarity=0.549  Sum_probs=156.9

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+ +..++||||+.+++|.+++....  ..+++.+++.++.|++.||+|||+.+  ++||||+|
T Consensus       390 l~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp  464 (613)
T 2ozo_A          390 MHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAA  464 (613)
T ss_dssp             HTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred             HHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCH
Confidence            467899999999999976 56999999999999999996543  23899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccc---cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLN  156 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~  156 (191)
                      +||+++.++.++|+|||++........   ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+
T Consensus       465 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~  544 (613)
T 2ozo_A          465 RNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK  544 (613)
T ss_dssp             GGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             HHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence            999999999999999999875432211   1112233468999999998889999999999999999998 999999988


Q ss_pred             HHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+....+. .+.+.+.|..+++.+.++|.+||+.
T Consensus       545 ~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~  578 (613)
T 2ozo_A          545 GPEVMAFIE-QGKRMECPPECPPELYALMSDCWIY  578 (613)
T ss_dssp             SHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCS
T ss_pred             HHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcCC
Confidence            888888775 5567788999999999999999974

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-37  Score=230.57  Aligned_cols=184  Identities=29%  Similarity=0.551  Sum_probs=157.1

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++. .+..++|||++.+++|.+++....  ..+++.+++.++.|+++||++||+.|  ++|+||+|+
T Consensus        65 ~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~  139 (287)
T 1u59_A           65 HQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAAR  139 (287)
T ss_dssp             HHCCCTTBCCEEEEEE-SSSEEEEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred             HhCCCCCEeEEEEEec-CCCcEEEEEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchh
Confidence            4679999999999994 567999999999999999996533  23899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccccc---ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP  157 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~  157 (191)
                      ||+++.++.++|+|||.+.......   .......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||.....
T Consensus       140 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  219 (287)
T 1u59_A          140 NVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG  219 (287)
T ss_dssp             GEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred             eEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence            9999999999999999987543221   11222344678999999988888999999999999999998 9999999888


Q ss_pred             HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+....+. .+.+...|..+|+.+.++|.+||+.
T Consensus       220 ~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~l~~  252 (287)
T 1u59_A          220 PEVMAFIE-QGKRMECPPECPPELYALMSDCWIY  252 (287)
T ss_dssp             HHHHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCS
T ss_pred             HHHHHHHh-cCCcCCCCCCcCHHHHHHHHHHcCC
Confidence            87777765 4556778899999999999999974

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.5e-37  Score=233.31  Aligned_cols=188  Identities=33%  Similarity=0.550  Sum_probs=159.8

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC-------cccccHHHHHHHHHHHHHHHHHHHhCCCCe
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------REMLDERRRLNMAYDVAKGMNYLHRRNPPI   73 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~   73 (191)
                      |++++||||+++++++.+++..++||||+.+++|.+++.....       ...+++.+++.++.|++.||++||+.|  +
T Consensus        82 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i  159 (322)
T 1p4o_A           82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--F  159 (322)
T ss_dssp             GGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--C
T ss_pred             HHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--C
Confidence            4678999999999999999999999999999999999965221       123688999999999999999999999  9


Q ss_pred             eecCCCCCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCC
Q 029552           74 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQ  150 (191)
Q Consensus        74 ~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~  150 (191)
                      +|+||+|+||+++.++.++|+|||.+.......  .......++..|+|||.+.+..++.++|+||+|+++|+|++ |..
T Consensus       160 ~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~  239 (322)
T 1p4o_A          160 VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ  239 (322)
T ss_dssp             BCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCC
T ss_pred             ccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCC
Confidence            999999999999999999999999986543321  11223344678999999998889999999999999999999 899


Q ss_pred             CCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          151 PWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       151 pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ||...+.......+. .+.....+..+++.+.++|.+||+.
T Consensus       240 p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~  279 (322)
T 1p4o_A          240 PYQGLSNEQVLRFVM-EGGLLDKPDNCPDMLFELMRMCWQY  279 (322)
T ss_dssp             TTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             ccccCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcCC
Confidence            999988888877775 4455667889999999999999974

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.6e-37  Score=246.07  Aligned_cols=184  Identities=30%  Similarity=0.478  Sum_probs=159.2

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++|+||+.+++|.+.+....   .+++.+++.++.|++.||+|||++|  ++||||||
T Consensus        80 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp  154 (484)
T 3nyv_A           80 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKP  154 (484)
T ss_dssp             HTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred             HHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCH
Confidence            467899999999999999999999999999999999997644   3899999999999999999999999  99999999


Q ss_pred             CcEEe---cCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           81 PNLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      +||++   +.++.++|+|||++....... ......+++.|+|||.+.+ .++.++|+||+|+++|+|++|..||...+.
T Consensus       155 ~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~  232 (484)
T 3nyv_A          155 ENLLLESKSKDANIRIIDFGLSTHFEASK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE  232 (484)
T ss_dssp             GGEEESSSSTTCCEEECCTTHHHHBCCCC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             HHEEEecCCCCCcEEEEeeeeeEEccccc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH
Confidence            99999   567889999999886543321 1222357889999999877 588999999999999999999999999999


Q ss_pred             HHHHHHHHhcCcccCCC--CCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIP--RNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~cl~~  191 (191)
                      .+....+.......+.|  ..+|+.++++|.+||++
T Consensus       233 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  268 (484)
T 3nyv_A          233 YDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTY  268 (484)
T ss_dssp             HHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCS
T ss_pred             HHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCC
Confidence            99988887665554444  57999999999999974

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-37  Score=229.10  Aligned_cols=185  Identities=31%  Similarity=0.630  Sum_probs=155.4

Q ss_pred             CCCCCCCcccccceeecCCce-EEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNL-SIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~-~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      ++++||||+++++++.+.+.. ++++||+.+++|.+++.....  .+++.+++.++.|++.||+|||+.|  ++|+||+|
T Consensus        77 ~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp  152 (298)
T 3pls_A           77 RGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR--NPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAA  152 (298)
T ss_dssp             HTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred             HhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhcccc--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCc
Confidence            568999999999999876655 999999999999999976432  3889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccccc----ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhC-CCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTF----LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNL  155 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g-~~pf~~~  155 (191)
                      +||+++.++.++|+|||.+.......    .......++..|+|||.+.+..++.++|+||+|+++|+|++| .+||...
T Consensus       153 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~  232 (298)
T 3pls_A          153 RNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI  232 (298)
T ss_dssp             GGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred             ceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC
Confidence            99999999999999999986433221    222334556789999999998899999999999999999995 5566667


Q ss_pred             CHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          156 NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +.......+. .....+.|..+|+.+.++|.+||++
T Consensus       233 ~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~  267 (298)
T 3pls_A          233 DPFDLTHFLA-QGRRLPQPEYCPDSLYQVMQQCWEA  267 (298)
T ss_dssp             CGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CHHHHHHHhh-cCCCCCCCccchHHHHHHHHHHccC
Confidence            7666666664 5556777889999999999999974

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.8e-37  Score=239.27  Aligned_cols=185  Identities=26%  Similarity=0.396  Sum_probs=145.3

Q ss_pred             CCCCCCcccccceeec----CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            3 RLRHPNIVLFMGAVTQ----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         3 ~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      ..+||||++++++|+.    ++..|+||||+.+++|.+++...+ ...+++.+++.++.|++.||+|||+.|  ++||||
T Consensus       111 ~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDl  187 (400)
T 1nxk_A          111 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDV  187 (400)
T ss_dssp             HTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCC
T ss_pred             hcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCc
Confidence            3579999999999875    567899999999999999997643 234899999999999999999999999  999999


Q ss_pred             CCCcEEecC---CCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           79 KSPNLLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        79 ~p~ni~~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      ||+||+++.   ++.++|+|||++...... .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...
T Consensus       188 kp~Nill~~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  266 (400)
T 1nxk_A          188 KPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN  266 (400)
T ss_dssp             CGGGEEESSSSTTCCEEECCCTTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred             CcceEEEecCCCCccEEEEecccccccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence            999999987   788999999998754332 1223456788999999999888999999999999999999999999765


Q ss_pred             CHHH----HHHHHHhcCcccCC--CCCCCHHHHHHHHHHhcC
Q 029552          156 NPAQ----VVAAVGFKGKRLEI--PRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~~----~~~~~~~~~~~~~~--~~~~s~~~~~li~~cl~~  191 (191)
                      +...    ....+.......+.  ...+|+.++++|++||++
T Consensus       267 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  308 (400)
T 1nxk_A          267 HGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKT  308 (400)
T ss_dssp             TTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCS
T ss_pred             ccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCC
Confidence            4322    33344333333332  257999999999999974

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4.4e-37  Score=231.24  Aligned_cols=183  Identities=27%  Similarity=0.442  Sum_probs=157.8

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+.+..++||||+.+++|.+++...+   .+++.+++.++.|++.||++||+.|  ++|+||+|+
T Consensus        61 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~  135 (304)
T 2jam_A           61 KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPE  135 (304)
T ss_dssp             HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGG
T ss_pred             HhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHH
Confidence            46799999999999999999999999999999999986543   3899999999999999999999999  999999999


Q ss_pred             cEEe---cCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           82 NLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        82 ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      ||++   +.++.++|+|||.+......  ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..
T Consensus       136 NIl~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  213 (304)
T 2jam_A          136 NLLYLTPEENSKIMITDFGLSKMEQNG--IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES  213 (304)
T ss_dssp             GCEESSSSTTCCEEBCSCSTTCCCCCB--TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred             HEEEecCCCCCCEEEccCCcceecCCC--ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH
Confidence            9999   67889999999988644332  112234678899999999888999999999999999999999999998888


Q ss_pred             HHHHHHHhcCccc--CCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRL--EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~--~~~~~~s~~~~~li~~cl~~  191 (191)
                      .....+.......  +.+..+|+.++++|.+||++
T Consensus       214 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~  248 (304)
T 2jam_A          214 KLFEKIKEGYYEFESPFWDDISESAKDFICHLLEK  248 (304)
T ss_dssp             HHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCS
T ss_pred             HHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCC
Confidence            8888876554433  34578999999999999974

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.7e-37  Score=234.75  Aligned_cols=184  Identities=29%  Similarity=0.535  Sum_probs=155.9

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.++. .+++++++.+++|.+++.....  .+++.+++.++.|++.||+|||+.+  ++||||||+
T Consensus        72 ~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~  146 (327)
T 3poz_A           72 ASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAAR  146 (327)
T ss_dssp             HHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGG
T ss_pred             HhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChh
Confidence            4679999999999998754 7889999999999999976432  3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccc--cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA  158 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~  158 (191)
                      ||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||......
T Consensus       147 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  226 (327)
T 3poz_A          147 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS  226 (327)
T ss_dssp             GEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred             eEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH
Confidence            99999999999999999875433211  1222344668999999999989999999999999999999 99999988877


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +....+. .+...+.|..++..+.++|.+||++
T Consensus       227 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  258 (327)
T 3poz_A          227 EISSILE-KGERLPQPPICTIDVYMIMVKCWMI  258 (327)
T ss_dssp             GHHHHHH-TTCCCCCCTTBCHHHHHHHHHHTCS
T ss_pred             HHHHHHH-cCCCCCCCccCCHHHHHHHHHHcCC
Confidence            7766664 5566778889999999999999974

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2e-37  Score=244.90  Aligned_cols=185  Identities=35%  Similarity=0.588  Sum_probs=155.0

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+ +..++||||+.+++|.+++.... +..+++.+++.++.|++.||+|||+.+  ++||||+|+
T Consensus       234 ~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~  309 (452)
T 1fmk_A          234 KKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAA  309 (452)
T ss_dssp             HHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred             HhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChh
Confidence            56799999999999876 67899999999999999996422 223889999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ  159 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~~  159 (191)
                      ||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||......+
T Consensus       310 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~  389 (452)
T 1fmk_A          310 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE  389 (452)
T ss_dssp             GEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred             hEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999987543321 11222344668999999988889999999999999999999 899999999888


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+. .+.+.+.|..+|+.+.++|.+||++
T Consensus       390 ~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~  420 (452)
T 1fmk_A          390 VLDQVE-RGYRMPCPPECPESLHDLMCQCWRK  420 (452)
T ss_dssp             HHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHH-cCCCCCCCCCCCHHHHHHHHHHccC
Confidence            888775 5567788899999999999999974

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.1e-37  Score=232.19  Aligned_cols=186  Identities=23%  Similarity=0.379  Sum_probs=149.5

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++||||+.+ +|.+++...+.  .+++.++..++.|++.||+|||+.|  ++||||+|
T Consensus        54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp  128 (324)
T 3mtl_A           54 LKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKP  128 (324)
T ss_dssp             HSCCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCG
T ss_pred             HHhcCCCCCCeeeeEEeeCCEEEEEeccccc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCH
Confidence            4678999999999999999999999999975 89888865432  3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      +||+++.++.++|+|||.+..............++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+..+
T Consensus       129 ~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  208 (324)
T 3mtl_A          129 QNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE  208 (324)
T ss_dssp             GGEEECTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             HHEEECCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999999999999999998755444333344567889999999876 457899999999999999999999999988887


Q ss_pred             HHHHHHhcCccc----------------------------CCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRL----------------------------EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~----------------------------~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+......+                            ..+..+++.++++|.+||+.
T Consensus       209 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  268 (324)
T 3mtl_A          209 QLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQF  268 (324)
T ss_dssp             HHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCS
T ss_pred             HHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCc
Confidence            776664321111                            11236789999999999963

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4.8e-37  Score=229.80  Aligned_cols=188  Identities=30%  Similarity=0.495  Sum_probs=154.5

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++|+||+++++|.+++........+++..+..++.|++.||++||+.|  ++|+||+|+
T Consensus        74 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~  151 (295)
T 2clq_A           74 KHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGD  151 (295)
T ss_dssp             HTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred             HhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChh
Confidence            568999999999999999999999999999999999976433334678899999999999999999999  999999999


Q ss_pred             cEEecC-CCcEEEcccccccccccccccCCCCCCCCcccCccccccCC--CCCcchHHHHHHHHHHHHhCCCCCCCCC-H
Q 029552           82 NLLVDK-KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP--SNEKSDIYSFGVILWELATLQQPWGNLN-P  157 (191)
Q Consensus        82 ni~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Dv~slG~~~~~l~~g~~pf~~~~-~  157 (191)
                      ||+++. ++.++|+|||.+..............++..|+|||.+.+..  ++.++|+||||+++|+|++|..||.... .
T Consensus       152 Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  231 (295)
T 2clq_A          152 NVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP  231 (295)
T ss_dssp             GEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH
T ss_pred             hEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch
Confidence            999987 88999999999875543333334456788999999987643  6789999999999999999999997643 3


Q ss_pred             HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ................|..+++.+.++|.+||++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  265 (295)
T 2clq_A          232 QAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEP  265 (295)
T ss_dssp             HHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCS
T ss_pred             hHHHHhhccccccccccccCCHHHHHHHHHHccC
Confidence            3333333334556678889999999999999974

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.9e-37  Score=232.97  Aligned_cols=185  Identities=29%  Similarity=0.548  Sum_probs=153.0

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.++. .+++++++.+++|.+++.....  .+++.+++.++.|++.||+|||+.|  ++||||||
T Consensus        71 l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp  145 (327)
T 3lzb_A           71 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAA  145 (327)
T ss_dssp             HTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred             HHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCH
Confidence            46789999999999998764 8889999999999999975432  3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~  157 (191)
                      +||+++.++.++|+|||++.......  .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.....
T Consensus       146 ~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~  225 (327)
T 3lzb_A          146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA  225 (327)
T ss_dssp             GGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred             HHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence            99999999999999999987543321  11222334668999999999989999999999999999999 9999998888


Q ss_pred             HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+....+. .+...+.|..++..+.++|.+||+.
T Consensus       226 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~  258 (327)
T 3lzb_A          226 SEISSILE-KGERLPQPPICTIDVYMIMRKCWMI  258 (327)
T ss_dssp             GGHHHHHH-TTCCCCCCTTBCHHHHHHHHHHTCS
T ss_pred             HHHHHHHH-cCCCCCCCccCCHHHHHHHHHHcCC
Confidence            77777664 5567778889999999999999974

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=6.1e-37  Score=227.31  Aligned_cols=182  Identities=29%  Similarity=0.524  Sum_probs=151.3

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++|+||+.+++|.+++....   .+++.+++.++.|++.||++||+.|  ++|+||+|+
T Consensus        66 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~  140 (276)
T 2h6d_A           66 KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPE  140 (276)
T ss_dssp             HTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGG
T ss_pred             hcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChh
Confidence            56899999999999999999999999999999999997643   3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      ||+++.++.++|+|||.+...... .......+++.|+|||.+.+... +.++|+||+|+++++|++|..||........
T Consensus       141 Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  219 (276)
T 2h6d_A          141 NVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL  219 (276)
T ss_dssp             GEEECTTSCEEECCCCGGGCCCC--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             hEEECCCCCEEEeecccccccCCC-cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH
Confidence            999999999999999988754432 12233456788999999987765 5789999999999999999999999888888


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+..  .....|..++..+.++|.+||+.
T Consensus       220 ~~~~~~--~~~~~~~~~~~~l~~li~~~l~~  248 (276)
T 2h6d_A          220 FKKIRG--GVFYIPEYLNRSVATLLMHMLQV  248 (276)
T ss_dssp             HHHHHH--CCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             HHHhhc--CcccCchhcCHHHHHHHHHHccC
Confidence            777743  34567888999999999999974

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.5e-37  Score=229.87  Aligned_cols=183  Identities=28%  Similarity=0.540  Sum_probs=156.3

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++ +.+..++|+||+.+++|.+++....   .+++.+++.++.|+++||++||+.|  ++|+||+|+
T Consensus        73 ~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~  146 (291)
T 1xbb_A           73 QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAAR  146 (291)
T ss_dssp             HTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred             HhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcc
Confidence            568999999999998 5567899999999999999997644   3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccc---cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP  157 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~  157 (191)
                      ||+++.++.++|+|||.+........   ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.....
T Consensus       147 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~  226 (291)
T 1xbb_A          147 NVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG  226 (291)
T ss_dssp             GEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred             eEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence            99999999999999998865432211   1122234578999999988888889999999999999999 9999999888


Q ss_pred             HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ......+. .+.....|..+|+.+.++|.+||+.
T Consensus       227 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~  259 (291)
T 1xbb_A          227 SEVTAMLE-KGERMGCPAGCPREMYDLMNLCWTY  259 (291)
T ss_dssp             HHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            88777775 4556778899999999999999974

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=5.1e-37  Score=238.27  Aligned_cols=187  Identities=25%  Similarity=0.376  Sum_probs=147.9

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+.+++|.+++.... ...+++.++..++.||+.||+|||+.|  ++||||||+
T Consensus        81 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~  157 (389)
T 3gni_B           81 KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKAS  157 (389)
T ss_dssp             HHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred             HhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHH
Confidence            46799999999999999999999999999999999997542 123899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccc-------cccCCCCCCCCcccCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCC
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANT-------FLSSKSAAGTPEWMAPEVLRD--EPSNEKSDIYSFGVILWELATLQQPW  152 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~-------~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~pf  152 (191)
                      ||+++.++.++|+|||.+......       ........++..|+|||.+.+  ..++.++|+||+|+++|+|++|..||
T Consensus       158 NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf  237 (389)
T 3gni_B          158 HILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF  237 (389)
T ss_dssp             GEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             HEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCC
Confidence            999999999999999987532211       112223466788999999987  56889999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhcCc--------------------------------------------ccCCCCCCCHHHHHHHHHH
Q 029552          153 GNLNPAQVVAAVGFKGK--------------------------------------------RLEIPRNVNPHVASIIEAC  188 (191)
Q Consensus       153 ~~~~~~~~~~~~~~~~~--------------------------------------------~~~~~~~~s~~~~~li~~c  188 (191)
                      ...+.......+.....                                            ..+.+..+|+.++++|.+|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  317 (389)
T 3gni_B          238 KDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC  317 (389)
T ss_dssp             TTCCSTTHHHHC--------------------------------------------------------CCHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHH
Confidence            87555444433221110                                            1134567899999999999


Q ss_pred             hcC
Q 029552          189 WAK  191 (191)
Q Consensus       189 l~~  191 (191)
                      |+.
T Consensus       318 L~~  320 (389)
T 3gni_B          318 LQR  320 (389)
T ss_dssp             TCS
T ss_pred             hhc
Confidence            974

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=7.5e-37  Score=243.56  Aligned_cols=183  Identities=32%  Similarity=0.524  Sum_probs=156.9

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++|+||+.+++|.+.+....   .+++.++..++.|++.||+|||+.|  ++||||||+
T Consensus        76 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~  150 (486)
T 3mwu_A           76 KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPE  150 (486)
T ss_dssp             HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred             HhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchH
Confidence            56799999999999999999999999999999999886543   3899999999999999999999999  999999999


Q ss_pred             cEEec---CCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           82 NLLVD---KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        82 ni~~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      ||+++   .++.++|+|||++...... .......+++.|+|||.+.+. ++.++|+||+|+++|+|++|..||...+..
T Consensus       151 Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~  228 (486)
T 3mwu_A          151 NILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY  228 (486)
T ss_dssp             GEEESSSSTTCCEEECSCSCTTTBCCC-----CCTTGGGGCCGGGGGSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             HEEEecCCCCCCEEEEECCcCeECCCC-CccCCCcCCCCCCCHHHhCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99995   4567999999998754333 223345678899999999875 888999999999999999999999999999


Q ss_pred             HHHHHHHhcCcccCCC--CCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIP--RNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~--~~~s~~~~~li~~cl~~  191 (191)
                      +....+.......+.|  ..+|+.++++|.+||++
T Consensus       229 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  263 (486)
T 3mwu_A          229 DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTF  263 (486)
T ss_dssp             HHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCS
T ss_pred             HHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCC
Confidence            9888887655544444  57999999999999974

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.9e-37  Score=231.33  Aligned_cols=186  Identities=36%  Similarity=0.626  Sum_probs=159.9

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+.+++|.+++.... ...+++..++.++.|++.||++||+.|  ++|+||+|+
T Consensus        64 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~  140 (288)
T 3kfa_A           64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAAR  140 (288)
T ss_dssp             HHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGG
T ss_pred             HhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcc
Confidence            46789999999999999999999999999999999997533 234899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ  159 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~~  159 (191)
                      ||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...+...
T Consensus       141 Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~  220 (288)
T 3kfa_A          141 NCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ  220 (288)
T ss_dssp             GEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             eEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999987544332 11222234567999999998889999999999999999999 899999888877


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+. .......|..+|+.+.++|.+||++
T Consensus       221 ~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~  251 (288)
T 3kfa_A          221 VYELLE-KDYRMERPEGCPEKVYELMRACWQW  251 (288)
T ss_dssp             HHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHh-ccCCCCCCCCCCHHHHHHHHHHhCC
Confidence            777664 4556778889999999999999974

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.3e-37  Score=233.33  Aligned_cols=188  Identities=32%  Similarity=0.526  Sum_probs=157.3

Q ss_pred             CCC-CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC---------------cccccHHHHHHHHHHHHHHHHH
Q 029552            2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV---------------REMLDERRRLNMAYDVAKGMNY   65 (191)
Q Consensus         2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------------~~~~~~~~~~~~~~~i~~~l~~   65 (191)
                      +++ +||||+++++++.+++..++||||+++++|.+++.....               ...+++.+++.++.|+++||+|
T Consensus        81 ~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~  160 (313)
T 1t46_A           81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAF  160 (313)
T ss_dssp             HHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHH
T ss_pred             hhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHH
Confidence            345 899999999999999999999999999999999975432               1238899999999999999999


Q ss_pred             HHhCCCCeeecCCCCCcEEecCCCcEEEcccccccccccccc--cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHH
Q 029552           66 LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILW  143 (191)
Q Consensus        66 Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~  143 (191)
                      ||+.|  ++|+||+|+||+++.++.++|+|||.+........  ......++..|+|||.+.+..++.++|+||+|++++
T Consensus       161 lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  238 (313)
T 1t46_A          161 LASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW  238 (313)
T ss_dssp             HHHTT--CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred             HHHCC--eecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHH
Confidence            99999  99999999999999999999999998865433311  122233456799999998888999999999999999


Q ss_pred             HHHh-CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          144 ELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       144 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +|++ |..||.....................+..+|+.+.++|.+||++
T Consensus       239 ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  287 (313)
T 1t46_A          239 ELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDA  287 (313)
T ss_dssp             HHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             HHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCC
Confidence            9998 99999886655555555445566677888999999999999974

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.9e-36  Score=226.35  Aligned_cols=185  Identities=35%  Similarity=0.596  Sum_probs=153.1

Q ss_pred             CCCCCCCCcccccceeec----CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeec
Q 029552            1 MKRLRHPNIVLFMGAVTQ----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR   76 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~   76 (191)
                      |++++||||+++++++.+    +...++||||+++++|.+++...+   .+++..++.++.|++.||+|||+.+.+++|+
T Consensus        79 l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~  155 (290)
T 1t4h_A           79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRTPPIIHR  155 (290)
T ss_dssp             HTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCS
T ss_pred             HHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcCCCCEEEC
Confidence            467899999999998864    456899999999999999997643   3889999999999999999999986559999


Q ss_pred             CCCCCcEEec-CCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-
Q 029552           77 DLKSPNLLVD-KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN-  154 (191)
Q Consensus        77 ~l~p~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~-  154 (191)
                      ||+|+||+++ .++.++|+|||.+......  ......+++.|+|||.+.+. ++.++|+||+|+++++|++|..||.. 
T Consensus       156 dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~  232 (290)
T 1t4h_A          156 DLKCDNIFITGPTGSVKIGDLGLATLKRAS--FAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSEC  232 (290)
T ss_dssp             CCCGGGEEESSTTSCEEECCTTGGGGCCTT--SBEESCSSCCCCCGGGGGTC-CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             CCCHHHEEEECCCCCEEEeeCCCccccccc--ccccccCCcCcCCHHHHhcc-CCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence            9999999997 7889999999998654433  22234578899999988754 88999999999999999999999987 


Q ss_pred             CCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          155 LNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+.......+.........+...++.+.++|.+||+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  269 (290)
T 1t4h_A          233 QNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQ  269 (290)
T ss_dssp             SSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCS
T ss_pred             CcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccC
Confidence            4445555555444345556778899999999999974

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.5e-37  Score=239.32  Aligned_cols=184  Identities=16%  Similarity=0.270  Sum_probs=146.6

Q ss_pred             CCCCCCCcccccceeecC----CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecC
Q 029552            2 KRLRHPNIVLFMGAVTQP----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRD   77 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~   77 (191)
                      +.++||||+++++++.+.    ...++||||+ +++|.+++....  +.+++.+++.++.|++.||+|||+.+  ++|||
T Consensus       103 ~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrD  177 (364)
T 3op5_A          103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEHE--YVHGD  177 (364)
T ss_dssp             TTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCC
T ss_pred             hhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEEec
Confidence            467899999999998764    4589999999 899999997642  23899999999999999999999999  99999


Q ss_pred             CCCCcEEec--CCCcEEEcccccccccccccc-------cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhC
Q 029552           78 LKSPNLLVD--KKYTVKVCDFGLSRLKANTFL-------SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL  148 (191)
Q Consensus        78 l~p~ni~~~--~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g  148 (191)
                      |||+||+++  .++.++|+|||++........       ......++..|+|||.+.+..++.++|+||||+++|+|++|
T Consensus       178 lkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g  257 (364)
T 3op5_A          178 IKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTG  257 (364)
T ss_dssp             CCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             CCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhC
Confidence            999999998  889999999999865432211       11233478899999999999899999999999999999999


Q ss_pred             CCCCCCCC-HHHHHHHHHhcCcccC---------CCCCCCHHHHHHHHHHhcC
Q 029552          149 QQPWGNLN-PAQVVAAVGFKGKRLE---------IPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       149 ~~pf~~~~-~~~~~~~~~~~~~~~~---------~~~~~s~~~~~li~~cl~~  191 (191)
                      ..||.... ......... ......         .+.++|+.+.++|..||++
T Consensus       258 ~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  309 (364)
T 3op5_A          258 HLPWEDNLKDPKYVRDSK-IRYRENIASLMDKCFPAANAPGEIAKYMETVKLL  309 (364)
T ss_dssp             CCTTGGGTTCHHHHHHHH-HHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTC
T ss_pred             CCCccccccCHHHHHHHH-HHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcC
Confidence            99998532 222221111 111111         1267899999999999974

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=8.1e-37  Score=232.69  Aligned_cols=186  Identities=31%  Similarity=0.593  Sum_probs=158.7

Q ss_pred             CC-CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC-------------cccccHHHHHHHHHHHHHHHHHHHh
Q 029552            3 RL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------------REMLDERRRLNMAYDVAKGMNYLHR   68 (191)
Q Consensus         3 ~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~Lh~   68 (191)
                      ++ +||||+++++++.+++..++||||+.+++|.+++.....             ...+++.+++.++.|+++||+|||+
T Consensus        96 ~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~  175 (334)
T 2pvf_A           96 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS  175 (334)
T ss_dssp             HHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh
Confidence            34 899999999999999999999999999999999976432             1237899999999999999999999


Q ss_pred             CCCCeeecCCCCCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHH
Q 029552           69 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA  146 (191)
Q Consensus        69 ~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~  146 (191)
                      .|  ++|+||+|+||+++.++.++|+|||.+.......  .......++..|+|||.+.+..++.++|+||+|+++|+|+
T Consensus       176 ~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell  253 (334)
T 2pvf_A          176 QK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF  253 (334)
T ss_dssp             TT--EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred             CC--eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHH
Confidence            99  9999999999999999999999999987543321  1222334567899999998888899999999999999999


Q ss_pred             h-CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          147 T-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       147 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      + |..||......+....+. .+.....|..++..+.++|.+||++
T Consensus       254 t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~  298 (334)
T 2pvf_A          254 TLGGSPYPGIPVEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHA  298 (334)
T ss_dssp             TTSCCSSTTCCHHHHHHHHH-HTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             hCCCCCcCcCCHHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHccC
Confidence            9 999999988888777765 4456677889999999999999974

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-36  Score=231.13  Aligned_cols=184  Identities=29%  Similarity=0.486  Sum_probs=149.1

Q ss_pred             CCCCcccccceeec------CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            5 RHPNIVLFMGAVTQ------PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         5 ~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      +||||+++++++..      .+..++||||+.+++|.+++.... ...+++..++.++.|++.||+|||+.|  ++|+||
T Consensus        79 ~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dl  155 (326)
T 2x7f_A           79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK--VIHRDI  155 (326)
T ss_dssp             CSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCC
T ss_pred             CCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCC
Confidence            79999999999976      467999999999999999997543 234889999999999999999999999  999999


Q ss_pred             CCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 029552           79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQQPWG  153 (191)
Q Consensus        79 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Dv~slG~~~~~l~~g~~pf~  153 (191)
                      +|+||+++.++.++|+|||.+..............++..|+|||.+.     +..++.++|+||||+++|+|++|..||.
T Consensus       156 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  235 (326)
T 2x7f_A          156 KGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC  235 (326)
T ss_dssp             SGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred             cHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999998875443322333456788999999986     4567889999999999999999999999


Q ss_pred             CCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          154 NLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+.......+.....+...+..+|+.++++|.+||++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  273 (326)
T 2x7f_A          236 DMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVK  273 (326)
T ss_dssp             TSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCS
T ss_pred             CCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhcc
Confidence            98888777776554444445678999999999999964

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3e-36  Score=224.82  Aligned_cols=184  Identities=36%  Similarity=0.702  Sum_probs=153.2

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+..  ++||||+.+++|.+.+.....  .+++..++.++.|++.||+|||+.|.+++|+||+|
T Consensus        77 l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp  152 (287)
T 4f0f_A           77 MSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRS  152 (287)
T ss_dssp             HTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSG
T ss_pred             HHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccC--CccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCc
Confidence            35789999999999987655  799999999999888865432  38999999999999999999999876699999999


Q ss_pred             CcEEecCCCc-----EEEcccccccccccccccCCCCCCCCcccCccccc--cCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 029552           81 PNLLVDKKYT-----VKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR--DEPSNEKSDIYSFGVILWELATLQQPWG  153 (191)
Q Consensus        81 ~ni~~~~~~~-----~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~Dv~slG~~~~~l~~g~~pf~  153 (191)
                      +||+++.++.     ++|+|||.+......   .....++..|+|||.+.  ...++.++|+||+|+++|+|++|..||.
T Consensus       153 ~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  229 (287)
T 4f0f_A          153 PNIFLQSLDENAPVCAKVADFGLSQQSVHS---VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD  229 (287)
T ss_dssp             GGEEESCCCTTCSCCEEECCCTTCBCCSSC---EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             ceEEEeccCCCCceeEEeCCCCcccccccc---ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCc
Confidence            9999988776     999999988644332   23346788999999984  3446788999999999999999999998


Q ss_pred             CCC--HHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          154 NLN--PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       154 ~~~--~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...  .......+.........|..+|+.+.++|.+||++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  269 (287)
T 4f0f_A          230 EYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSG  269 (287)
T ss_dssp             TCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             cccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcC
Confidence            644  33345556556677788999999999999999974

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.4e-36  Score=243.00  Aligned_cols=183  Identities=31%  Similarity=0.533  Sum_probs=158.4

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++++++..++||||+.+++|.+.+....   .+++.+++.++.|++.||+|||+.|  ++||||+|+
T Consensus       101 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~  175 (504)
T 3q5i_A          101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKHN--IVHRDIKPE  175 (504)
T ss_dssp             HTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred             HhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHH
Confidence            56899999999999999999999999999999999886543   3899999999999999999999999  999999999


Q ss_pred             cEEecCCC---cEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           82 NLLVDKKY---TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        82 ni~~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      ||+++.++   .++|+|||++...... .......+++.|+|||.+.+ .++.++|+||+|+++|+|++|..||...+..
T Consensus       176 Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  253 (504)
T 3q5i_A          176 NILLENKNSLLNIKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ  253 (504)
T ss_dssp             GEEESSTTCCSSEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             HEEEecCCCCccEEEEECCCCEEcCCC-CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99998776   6999999998754433 22334568899999999875 4889999999999999999999999999999


Q ss_pred             HHHHHHHhcCcccCC--CCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEI--PRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~--~~~~s~~~~~li~~cl~~  191 (191)
                      +....+.......+.  ...+|+.++++|.+||++
T Consensus       254 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  288 (504)
T 3q5i_A          254 DIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTY  288 (504)
T ss_dssp             HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCC
Confidence            999888655443332  268999999999999973

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.2e-36  Score=228.11  Aligned_cols=186  Identities=32%  Similarity=0.571  Sum_probs=153.8

Q ss_pred             CCCCCCCCccccccee-ecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            1 MKRLRHPNIVLFMGAV-TQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      |++++||||+++++++ ..++..++||||+.+++|.+++.....  .+++.+++.++.|++.||++||+.|  ++|+||+
T Consensus        80 l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dik  155 (298)
T 3f66_A           80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLA  155 (298)
T ss_dssp             HHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTC--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred             HHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCc
Confidence            3578999999999985 456688999999999999999976432  3789999999999999999999999  9999999


Q ss_pred             CCcEEecCCCcEEEccccccccccccc----ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTF----LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGN  154 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~  154 (191)
                      |+||+++.++.++|+|||.+.......    .......++..|+|||.+.+..++.++|+||+|+++++|++ +..||..
T Consensus       156 p~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~  235 (298)
T 3f66_A          156 ARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD  235 (298)
T ss_dssp             GGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             hheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999986543321    11222344568999999998889999999999999999999 5778877


Q ss_pred             CCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          155 LNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+.......+. .+.....|..+++.+.++|.+||++
T Consensus       236 ~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~  271 (298)
T 3f66_A          236 VNTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHP  271 (298)
T ss_dssp             SCTTTHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCHHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHcCC
Confidence            77666666654 4456667888999999999999974

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.5e-37  Score=229.04  Aligned_cols=185  Identities=34%  Similarity=0.578  Sum_probs=158.3

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.++. .++|+|++.+++|.+++....  +.+++.+++.++.|+++||++||+.+  ++|+||+|+
T Consensus        76 ~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~  150 (291)
T 1u46_A           76 HSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAAR  150 (291)
T ss_dssp             HHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGG
T ss_pred             HhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchh
Confidence            4578999999999998765 899999999999999997532  23889999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccccc---ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP  157 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~  157 (191)
                      ||+++.++.++|+|||.+.......   .......++..|+|||.+.+..++.++|+||||+++++|++ |..||...+.
T Consensus       151 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~  230 (291)
T 1u46_A          151 NLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG  230 (291)
T ss_dssp             GEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             eEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH
Confidence            9999999999999999886543221   11223345668999999988888889999999999999999 9999999999


Q ss_pred             HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ......+.......+.+..+|+.+.++|.+||+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  264 (291)
T 1u46_A          231 SQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAH  264 (291)
T ss_dssp             HHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccC
Confidence            9988888777777788889999999999999974

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.6e-36  Score=231.27  Aligned_cols=177  Identities=24%  Similarity=0.427  Sum_probs=150.8

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCC-CHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG-SLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      |++++||||+++++++.+++..++|||++.++ +|.+++.....   +++..++.++.|++.||+|||+.|  ++|+|||
T Consensus        83 l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~---l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlk  157 (335)
T 3dls_A           83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR---LDEPLASYIFRQLVSAVGYLRLKD--IIHRDIK  157 (335)
T ss_dssp             HTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCC---CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCS
T ss_pred             HHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--eEEeccC
Confidence            46789999999999999999999999998766 99999976543   899999999999999999999999  9999999


Q ss_pred             CCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      |+||+++.++.++|+|||.+....... ......+++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||..... 
T Consensus       158 p~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-  235 (335)
T 3dls_A          158 DENIVIAEDFTIKLIDFGSAAYLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-  235 (335)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-
T ss_pred             HHHEEEcCCCcEEEeecccceECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-
Confidence            999999999999999999987544331 2223457889999999988776 7789999999999999999999986322 


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                             ........|..+|+.++++|.+||++
T Consensus       236 -------~~~~~~~~~~~~~~~l~~li~~~L~~  261 (335)
T 3dls_A          236 -------TVEAAIHPPYLVSKELMSLVSGLLQP  261 (335)
T ss_dssp             -------GTTTCCCCSSCCCHHHHHHHHHHTCS
T ss_pred             -------HHhhccCCCcccCHHHHHHHHHHccC
Confidence                   12234456778999999999999974

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.4e-37  Score=236.63  Aligned_cols=182  Identities=23%  Similarity=0.316  Sum_probs=148.1

Q ss_pred             CCCCCCCcccccceeec----CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecC
Q 029552            2 KRLRHPNIVLFMGAVTQ----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRD   77 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~   77 (191)
                      +.++||||+++++++.+    +...++||||+ +++|.+++...+   .+++.+++.++.|++.||+|||+.+  ++|||
T Consensus       103 ~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~D  176 (345)
T 2v62_A          103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE--YVHGD  176 (345)
T ss_dssp             HTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT--EECSC
T ss_pred             ccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCC
Confidence            45799999999999987    67899999999 899999997644   4899999999999999999999999  99999


Q ss_pred             CCCCcEEecCCC--cEEEccccccccccccc-------ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhC
Q 029552           78 LKSPNLLVDKKY--TVKVCDFGLSRLKANTF-------LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL  148 (191)
Q Consensus        78 l~p~ni~~~~~~--~~~l~d~~~~~~~~~~~-------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g  148 (191)
                      |+|+||+++.++  .++|+|||++.......       .......++..|+|||.+.+..++.++|+||||+++|+|++|
T Consensus       177 lkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g  256 (345)
T 2v62_A          177 IKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCG  256 (345)
T ss_dssp             CSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             cCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhC
Confidence            999999998877  99999999986543221       111334678899999999998899999999999999999999


Q ss_pred             CCCCCC--CCHHHHHHHHHhcCcccCCCC---------CCCHHHHHHHHHHhcC
Q 029552          149 QQPWGN--LNPAQVVAAVGFKGKRLEIPR---------NVNPHVASIIEACWAK  191 (191)
Q Consensus       149 ~~pf~~--~~~~~~~~~~~~~~~~~~~~~---------~~s~~~~~li~~cl~~  191 (191)
                      ..||..  .+........  .......|.         .+|+.++++|.+||++
T Consensus       257 ~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  308 (345)
T 2v62_A          257 KLPWEQNLKDPVAVQTAK--TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSL  308 (345)
T ss_dssp             SCTTGGGTTCHHHHHHHH--HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTC
T ss_pred             CCCccccccccHHHHHHH--HhhcccccHHHHhhccccccHHHHHHHHHHHhhc
Confidence            999964  2332222221  112222332         8999999999999974

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=5.2e-37  Score=229.87  Aligned_cols=186  Identities=31%  Similarity=0.539  Sum_probs=149.0

Q ss_pred             CCCCCCCCcccccceeec--CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            1 MKRLRHPNIVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      |++++||||+++++++..  ....++||||+.+++|.+++.....  .+++.+++.++.|++.||+|||+.+  ++|+||
T Consensus        65 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Di  140 (295)
T 3ugc_A           65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR--YIHRDL  140 (295)
T ss_dssp             HHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred             HHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcCC--cccCCC
Confidence            357899999999999854  4568999999999999999976432  3899999999999999999999999  999999


Q ss_pred             CCCcEEecCCCcEEEccccccccccccc---ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           79 KSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        79 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      +|+||+++.++.++|+|||.+.......   .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...
T Consensus       141 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~  220 (295)
T 3ugc_A          141 ATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP  220 (295)
T ss_dssp             SGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred             CHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence            9999999999999999999987543321   1122233455799999999888999999999999999999999988753


Q ss_pred             CHH----------------HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          156 NPA----------------QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~----------------~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...                .....+ ....+.+.|..+|+.+.++|++||++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~  271 (295)
T 3ugc_A          221 PAEFMRMIGNDKQGQMIVFHLIELL-KNNGRLPRPDGCPDEIYMIMTECWNN  271 (295)
T ss_dssp             HHHHHHHHCTTCCTHHHHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHSCS
T ss_pred             hHHHHhhhcCccccchhHHHHHHHH-hccCcCCCCcCcCHHHHHHHHHHcCC
Confidence            221                122222 34556778899999999999999974

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.6e-37  Score=230.46  Aligned_cols=185  Identities=23%  Similarity=0.398  Sum_probs=149.2

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+.+++|.+++.....   +++..+..++.|++.||+|||+.|  ++|+||+|+
T Consensus        57 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~  131 (311)
T 4agu_A           57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRG---VPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPE  131 (311)
T ss_dssp             HHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSC---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred             HhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcC---CCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChh
Confidence            467899999999999999999999999999999998876443   899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      ||+++.++.++|+|||.+..............++..|+|||.+.+ ..++.++|+||+|+++++|++|..||......+.
T Consensus       132 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~  211 (311)
T 4agu_A          132 NILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ  211 (311)
T ss_dssp             GEEECTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             hEEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999999999999999998765544333344567889999999876 4578999999999999999999999999887776


Q ss_pred             HHHHHhcCc-------------------ccCCC----------CCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGK-------------------RLEIP----------RNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~-------------------~~~~~----------~~~s~~~~~li~~cl~~  191 (191)
                      ...+.....                   ..+.+          +++|+.+.++|.+||+.
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  271 (311)
T 4agu_A          212 LYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHM  271 (311)
T ss_dssp             HHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCS
T ss_pred             HHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccC
Confidence            665432110                   11111          46899999999999974

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-36  Score=227.94  Aligned_cols=183  Identities=34%  Similarity=0.658  Sum_probs=146.8

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHh---CCCCeeecCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR---RNPPIVHRDL   78 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~---~~~~~~h~~l   78 (191)
                      ++++||||+++++++.+  ..++||||+++++|.+++........++..+++.++.|+++||+|||+   .|  ++|+||
T Consensus        56 ~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dl  131 (307)
T 2eva_A           56 SRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDL  131 (307)
T ss_dssp             HHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCC
T ss_pred             hcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCC
Confidence            46799999999998874  489999999999999999865544457889999999999999999999   78  999999


Q ss_pred             CCCcEEecCCCc-EEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           79 KSPNLLVDKKYT-VKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        79 ~p~ni~~~~~~~-~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      +|+||+++.++. ++|+|||.+......   .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||.....
T Consensus       132 kp~NIll~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~  208 (307)
T 2eva_A          132 KPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG  208 (307)
T ss_dssp             SGGGEEEETTTTEEEECCCCC---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS
T ss_pred             ChhHEEEeCCCCEEEEcccccccccccc---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc
Confidence            999999988886 799999988644322   1233578899999999998899999999999999999999999986432


Q ss_pred             -HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 -AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 -~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                       ..........+...+.+..+|+.+.++|.+||++
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  243 (307)
T 2eva_A          209 PAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSK  243 (307)
T ss_dssp             SHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCS
T ss_pred             cHHHHHHHHhcCCCCCcccccCHHHHHHHHHHhcC
Confidence             2222222235556777889999999999999974

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.5e-36  Score=232.11  Aligned_cols=153  Identities=33%  Similarity=0.536  Sum_probs=133.5

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhC-CCCeeecCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLK   79 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~~~~~h~~l~   79 (191)
                      |++++||||+++++++.+++..++||||+++++|.+++...+   .+++..+..++.|++.||+|||+. +  ++|+||+
T Consensus        85 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlk  159 (360)
T 3eqc_A           85 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVK  159 (360)
T ss_dssp             GGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCS
T ss_pred             HHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCcc
Confidence            467899999999999999999999999999999999997643   389999999999999999999985 9  9999999


Q ss_pred             CCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      |+||+++.++.++|+|||.+......  ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+...
T Consensus       160 p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  237 (360)
T 3eqc_A          160 PSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE  237 (360)
T ss_dssp             GGGEEECTTCCEEECCCCCCHHHHHH--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHH
T ss_pred             HHHEEECCCCCEEEEECCCCcccccc--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999999999999999988644332  2233467889999999999889999999999999999999999998766554


Q ss_pred             H
Q 029552          160 V  160 (191)
Q Consensus       160 ~  160 (191)
                      .
T Consensus       238 ~  238 (360)
T 3eqc_A          238 L  238 (360)
T ss_dssp             H
T ss_pred             H
Confidence            3

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.2e-36  Score=224.18  Aligned_cols=185  Identities=25%  Similarity=0.379  Sum_probs=152.6

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++|+||+++++|.+++....   .+++.+++.++.|++.||++||+.|  ++|+||+|+
T Consensus        60 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~  134 (276)
T 2yex_A           60 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPE  134 (276)
T ss_dssp             HTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred             HhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChH
Confidence            46799999999999999999999999999999999997643   3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccc--cccCCCCCCCCcccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      ||+++.++.++|+|||.+......  ........++..|+|||.+.+..+ +.++|+||+|+++++|++|..||......
T Consensus       135 Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~  214 (276)
T 2yex_A          135 NLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS  214 (276)
T ss_dssp             GEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT
T ss_pred             HEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Confidence            999999999999999988653322  122334567889999999987664 67899999999999999999999875443


Q ss_pred             -HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 -QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 -~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                       ...............+..+|+.++++|.+||++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  248 (276)
T 2yex_A          215 CQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVE  248 (276)
T ss_dssp             SHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCS
T ss_pred             HHHHHHhhhcccccCchhhcCHHHHHHHHHHCCC
Confidence             233333333333344467999999999999974

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.9e-36  Score=230.30  Aligned_cols=185  Identities=22%  Similarity=0.282  Sum_probs=146.8

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++||||+.+ +|.+++.....   +++.+++.++.|++.||+|||+.|  ++|+||||
T Consensus        87 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~---~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp  160 (329)
T 3gbz_A           87 LKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD---VSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKP  160 (329)
T ss_dssp             GGGCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred             HHHcCCCCcceEEEEEecCCEEEEEEecCCC-CHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCH
Confidence            4678999999999999999999999999975 99999976543   899999999999999999999999  99999999


Q ss_pred             CcEEec-----CCCcEEEcccccccccccccccCCCCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCC
Q 029552           81 PNLLVD-----KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGN  154 (191)
Q Consensus        81 ~ni~~~-----~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~pf~~  154 (191)
                      +||+++     ..+.++|+|||.+..............++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||..
T Consensus       161 ~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  240 (329)
T 3gbz_A          161 QNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPG  240 (329)
T ss_dssp             GGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence            999995     445599999999876544333334456688999999998754 78999999999999999999999999


Q ss_pred             CCHHHHHHHHHhcCcccC----------------------------CCCCCCHHHHHHHHHHhcC
Q 029552          155 LNPAQVVAAVGFKGKRLE----------------------------IPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~s~~~~~li~~cl~~  191 (191)
                      .+.......+......+.                            .+..+++.++++|.+||++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  305 (329)
T 3gbz_A          241 DSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEM  305 (329)
T ss_dssp             SSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCS
T ss_pred             CCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccC
Confidence            888777666643211110                            0112789999999999974

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.7e-37  Score=236.17  Aligned_cols=188  Identities=30%  Similarity=0.511  Sum_probs=157.1

Q ss_pred             CCC-CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC-----------cccccHHHHHHHHHHHHHHHHHHHhC
Q 029552            2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-----------REMLDERRRLNMAYDVAKGMNYLHRR   69 (191)
Q Consensus         2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~Lh~~   69 (191)
                      +++ +||||+++++++.+++..++||||+.+++|.+++.....           ...+++.+++.++.|++.||+|||+.
T Consensus       104 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~  183 (333)
T 2i1m_A          104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK  183 (333)
T ss_dssp             HHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC
Confidence            345 799999999999999999999999999999999964221           12378999999999999999999999


Q ss_pred             CCCeeecCCCCCcEEecCCCcEEEcccccccccccccc--cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh
Q 029552           70 NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT  147 (191)
Q Consensus        70 ~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~  147 (191)
                      |  ++|+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus       184 ~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t  261 (333)
T 2i1m_A          184 N--CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS  261 (333)
T ss_dssp             T--EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred             C--cccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHc
Confidence            9  99999999999999999999999999875433211  1222334568999999988889999999999999999998


Q ss_pred             -CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          148 -LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       148 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                       |..||...........+...+.....|..+++.+.++|.+||++
T Consensus       262 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  306 (333)
T 2i1m_A          262 LGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWAL  306 (333)
T ss_dssp             TSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcc
Confidence             89999886665555555556666777888999999999999974

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6.9e-37  Score=229.72  Aligned_cols=186  Identities=30%  Similarity=0.511  Sum_probs=153.6

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++|+||+++++|.+++.....  .+++.+++.++.|++.||+|||+.|  ++|+||+|+
T Consensus        71 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~  146 (302)
T 2j7t_A           71 ATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAG  146 (302)
T ss_dssp             HHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGG
T ss_pred             hcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHH
Confidence            457899999999999999999999999999999998865322  2899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccc-----ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL-----RDEPSNEKSDIYSFGVILWELATLQQPWGNLN  156 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~-----~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~  156 (191)
                      ||+++.++.++|+|||.+..............++..|+|||.+     .+..++.++|+||+|+++|+|++|..||...+
T Consensus       147 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  226 (302)
T 2j7t_A          147 NVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN  226 (302)
T ss_dssp             GEEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             HEEECCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence            9999999999999999875433322223345678899999988     35667889999999999999999999999988


Q ss_pred             HHHHHHHHHhcCc-ccCCCCCCCHHHHHHHHHHhcC
Q 029552          157 PAQVVAAVGFKGK-RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .......+..... ....+..+|..+.++|.+||++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  262 (302)
T 2j7t_A          227 PMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDK  262 (302)
T ss_dssp             HHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCS
T ss_pred             HHHHHHHHhccCCcccCCccccCHHHHHHHHHHccc
Confidence            8877776654433 2345678999999999999964

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=9.5e-37  Score=227.00  Aligned_cols=184  Identities=30%  Similarity=0.493  Sum_probs=153.1

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.++ ..++||||+.+++|.+++.....  .+++..++.++.|+++||++||+.|  ++|+||+|+
T Consensus        68 ~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~  142 (281)
T 3cc6_A           68 KNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVR  142 (281)
T ss_dssp             HHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGG
T ss_pred             HhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccc
Confidence            457899999999998754 57899999999999999975332  3889999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ  159 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~~  159 (191)
                      ||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......
T Consensus       143 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~  222 (281)
T 3cc6_A          143 NILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD  222 (281)
T ss_dssp             GEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG
T ss_pred             eEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH
Confidence            9999999999999999887543321 11223345678999999988889999999999999999998 999998877766


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+. .+...+.|..+++.+.++|.+||++
T Consensus       223 ~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~  253 (281)
T 3cc6_A          223 VIGVLE-KGDRLPKPDLCPPVLYTLMTRCWDY  253 (281)
T ss_dssp             HHHHHH-HTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHh-cCCCCCCCCCCCHHHHHHHHHHccC
Confidence            666664 4456677888999999999999974

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.4e-36  Score=227.95  Aligned_cols=187  Identities=29%  Similarity=0.508  Sum_probs=151.4

Q ss_pred             CCCCCCCcccccceeecCC-----ceEEEEeccCCCCHHHHhcCC---CCcccccHHHHHHHHHHHHHHHHHHHhCCCCe
Q 029552            2 KRLRHPNIVLFMGAVTQPP-----NLSIVTEYLSRGSLYRLLHKP---GVREMLDERRRLNMAYDVAKGMNYLHRRNPPI   73 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~   73 (191)
                      ++++||||+++++++.+.+     ..++|+||+.+++|.+++...   .....+++.+++.++.|+++||.|||+.|  +
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i  168 (313)
T 3brb_A           91 KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--F  168 (313)
T ss_dssp             HTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--C
T ss_pred             hcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--c
Confidence            5689999999999997655     359999999999999998421   12334899999999999999999999999  9


Q ss_pred             eecCCCCCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCC
Q 029552           74 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQ  150 (191)
Q Consensus        74 ~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~  150 (191)
                      +|+||+|+||+++.++.++|+|||.+.......  .......++..|+|||.+.+..++.++|+||||+++|+|++ |..
T Consensus       169 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~  248 (313)
T 3brb_A          169 LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMT  248 (313)
T ss_dssp             CCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             ccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCC
Confidence            999999999999999999999999886543221  12223345678999999998889999999999999999999 899


Q ss_pred             CCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          151 PWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       151 pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ||...........+. .+.....|..+++.+.++|.+||+.
T Consensus       249 p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~  288 (313)
T 3brb_A          249 PYPGVQNHEMYDYLL-HGHRLKQPEDCLDELYEIMYSCWRT  288 (313)
T ss_dssp             SSTTCCGGGHHHHHH-TTCCCCCBTTCCHHHHHHHHHTTCS
T ss_pred             CCccCCHHHHHHHHH-cCCCCCCCccccHHHHHHHHHHcCC
Confidence            999888877777664 4556778889999999999999963

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2e-36  Score=224.92  Aligned_cols=185  Identities=33%  Similarity=0.609  Sum_probs=157.1

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+ +..++||||+.+++|.+++.... ...+++.+++.++.|++.||++||+.|  ++|+||+|+
T Consensus        63 ~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~  138 (279)
T 1qpc_A           63 KQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAA  138 (279)
T ss_dssp             HHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred             HhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHh
Confidence            46799999999998864 46899999999999999997532 123889999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ  159 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~~  159 (191)
                      ||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||+|+++++|++ |..||...+..+
T Consensus       139 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  218 (279)
T 1qpc_A          139 NILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE  218 (279)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred             hEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH
Confidence            9999999999999999987544332 22223345668999999988888899999999999999999 899999988888


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+. .+.....|..+++.+.++|.+||+.
T Consensus       219 ~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~  249 (279)
T 1qpc_A          219 VIQNLE-RGYRMVRPDNCPEELYQLMRLCWKE  249 (279)
T ss_dssp             HHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHh-cccCCCCcccccHHHHHHHHHHhcc
Confidence            877775 4456677889999999999999974

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.7e-36  Score=227.36  Aligned_cols=186  Identities=31%  Similarity=0.532  Sum_probs=152.9

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++|+||+.+++|.+++...+  ..+++.+++.++.|++.||++||+.|  ++|+||+|
T Consensus        83 l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp  158 (319)
T 2y4i_B           83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKS  158 (319)
T ss_dssp             GTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCS
T ss_pred             HhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCh
Confidence            467899999999999999999999999999999999997644  23889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccc-----cccCCCCCCCCcccCcccccc---------CCCCCcchHHHHHHHHHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANT-----FLSSKSAAGTPEWMAPEVLRD---------EPSNEKSDIYSFGVILWELA  146 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~---------~~~~~~~Dv~slG~~~~~l~  146 (191)
                      +||+++ ++.++|+|||++......     ........++..|+|||.+.+         ..++.++|+||+|+++|+|+
T Consensus       159 ~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~  237 (319)
T 2y4i_B          159 KNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH  237 (319)
T ss_dssp             TTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHH
T ss_pred             hhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHH
Confidence            999998 679999999987543211     112223446778999999864         34677899999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          147 TLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       147 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +|..||...........+.........+..++..+.++|.+||++
T Consensus       238 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  282 (319)
T 2y4i_B          238 AREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAF  282 (319)
T ss_dssp             HSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCS
T ss_pred             hCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcC
Confidence            999999999888888777644444444457999999999999974

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.3e-36  Score=224.99  Aligned_cols=184  Identities=26%  Similarity=0.448  Sum_probs=154.6

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+.+++|.+++....   .+++.+++.++.|++.||++||+.|  ++|+||+|+
T Consensus        63 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~  137 (283)
T 3bhy_A           63 REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPE  137 (283)
T ss_dssp             HHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred             HhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChH
Confidence            46789999999999999999999999999999999997533   3899999999999999999999999  999999999


Q ss_pred             cEEecCCC----cEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           82 NLLVDKKY----TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        82 ni~~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      ||+++.++    .++|+|||.+....... ......+++.|+|||.+.+..++.++|+||+|+++++|++|..||...+.
T Consensus       138 Nil~~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  216 (283)
T 3bhy_A          138 NIMLLDKNVPNPRIKLIDFGIAHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK  216 (283)
T ss_dssp             GEEESCSSSSSCCEEECCCTTCEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred             HEEEecCCCCCCceEEEecccceeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch
Confidence            99998877    79999999887543321 22334578899999999988899999999999999999999999999888


Q ss_pred             HHHHHHHHhcCccc--CCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRL--EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~--~~~~~~s~~~~~li~~cl~~  191 (191)
                      ......+.......  ..+..+++.+.++|.+||++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  252 (283)
T 3bhy_A          217 QETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVK  252 (283)
T ss_dssp             HHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCS
T ss_pred             HHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccC
Confidence            88777775433222  23367899999999999964

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.9e-36  Score=230.42  Aligned_cols=185  Identities=23%  Similarity=0.346  Sum_probs=148.9

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+.+++|.++.....   .+++..++.++.|++.||++||+.|  ++|+||+|+
T Consensus        79 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~  153 (331)
T 4aaa_A           79 KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPE  153 (331)
T ss_dssp             HHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGG
T ss_pred             hhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChh
Confidence            46789999999999999999999999999999988876544   2899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      ||+++.++.++|+|||.+..............++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+..+.
T Consensus       154 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  233 (331)
T 4aaa_A          154 NILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ  233 (331)
T ss_dssp             GEEECTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             eEEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            9999999999999999987544433333445678899999998875 678899999999999999999999998887766


Q ss_pred             HHHHHhcCcc-------------------c----------CCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKR-------------------L----------EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~-------------------~----------~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+......                   .          ...+.+|+.+.++|.+||+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  293 (331)
T 4aaa_A          234 LYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHI  293 (331)
T ss_dssp             HHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhcc
Confidence            6554321100                   0          01236899999999999974

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=9.3e-37  Score=249.54  Aligned_cols=183  Identities=28%  Similarity=0.538  Sum_probs=155.9

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+ +..++||||+.+++|.+++....   .+++.+++.++.||+.||+|||+.+  ++||||||+
T Consensus       425 ~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~  498 (635)
T 4fl3_A          425 QQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAAR  498 (635)
T ss_dssp             HHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred             HhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChH
Confidence            46799999999999875 45899999999999999997643   3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccccc---ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNP  157 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~  157 (191)
                      ||+++.++.++|+|||++.......   .......++..|+|||.+.+..++.++||||+|+++|+|++ |..||...+.
T Consensus       499 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~  578 (635)
T 4fl3_A          499 NVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG  578 (635)
T ss_dssp             GEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred             hEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999987543221   11222234567999999999889999999999999999998 9999999999


Q ss_pred             HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+....+. .+.+...|..+|+.+.++|.+||+.
T Consensus       579 ~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~  611 (635)
T 4fl3_A          579 SEVTAMLE-KGERMGCPAGCPREMYDLMNLCWTY  611 (635)
T ss_dssp             HHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            88888775 5567788999999999999999974

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.4e-36  Score=226.76  Aligned_cols=183  Identities=25%  Similarity=0.319  Sum_probs=151.8

Q ss_pred             CCCCCcccccceeecCC-----ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            4 LRHPNIVLFMGAVTQPP-----NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         4 l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      ++||||+++++++.+..     ..++++|++. ++|.+++..... ..+++.+++.++.|++.||+|||+.+  ++|+||
T Consensus        71 ~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dl  146 (308)
T 3g33_A           71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANC--IVHRDL  146 (308)
T ss_dssp             HCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred             cCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCC
Confidence            46999999999998655     4899999997 599999976542 23899999999999999999999999  999999


Q ss_pred             CCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        79 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      ||+||+++.++.++|+|||.+...... .......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+..
T Consensus       147 kp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~  225 (308)
T 3g33_A          147 KPENILVTSGGTVKLADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA  225 (308)
T ss_dssp             CTTTEEECTTSCEEECSCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH
T ss_pred             CHHHEEEcCCCCEEEeeCccccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            999999999999999999998754332 1223345688999999999888999999999999999999999999998888


Q ss_pred             HHHHHHHhcCccc-------------------------CCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRL-------------------------EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~-------------------------~~~~~~s~~~~~li~~cl~~  191 (191)
                      .....+......+                         .....+++.+.++|.+||++
T Consensus       226 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  283 (308)
T 3g33_A          226 DQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTF  283 (308)
T ss_dssp             HHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCS
T ss_pred             HHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcC
Confidence            8777664321111                         01246899999999999974

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.1e-36  Score=225.18  Aligned_cols=186  Identities=37%  Similarity=0.660  Sum_probs=141.7

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++ ..+..++||||+.+++|.+++....  ..+++.+++.++.|++.||+|||+.+  ++|+||+|
T Consensus        74 l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp  148 (289)
T 3og7_A           74 LRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKS  148 (289)
T ss_dssp             HTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred             HHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCcc
Confidence            4678999999999955 5567899999999999999996543  23899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccc--cccCCCCCCCCcccCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLR---DEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      +||+++.++.++|+|||.+......  ........++..|+|||.+.   +..++.++|+||+|+++++|++|..||...
T Consensus       149 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  228 (289)
T 3og7_A          149 NNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI  228 (289)
T ss_dssp             GGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             ceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc
Confidence            9999999999999999988643321  11223345788999999986   556778999999999999999999999875


Q ss_pred             CHHHHH-HHHHhcCccc---CCCCCCCHHHHHHHHHHhcC
Q 029552          156 NPAQVV-AAVGFKGKRL---EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~~~~-~~~~~~~~~~---~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...... ..+.......   ..+..+|+.++++|.+||++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  268 (289)
T 3og7_A          229 NNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKK  268 (289)
T ss_dssp             CCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCS
T ss_pred             chHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccC
Confidence            554444 4443222222   23458999999999999974

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.7e-36  Score=227.59  Aligned_cols=186  Identities=32%  Similarity=0.503  Sum_probs=152.7

Q ss_pred             CCCCCCCcccccceeecC--CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            2 KRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      ++++||||+++++++.+.  ...++||||+.+++|.+++.....  .+++.+++.++.|++.||++||+.|  ++|+||+
T Consensus        78 ~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dik  153 (302)
T 4e5w_A           78 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLA  153 (302)
T ss_dssp             HTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCS
T ss_pred             HhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCc
Confidence            578999999999999876  668999999999999999954332  3899999999999999999999999  9999999


Q ss_pred             CCcEEecCCCcEEEccccccccccccc---ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC--
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN--  154 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~--  154 (191)
                      |+||+++.++.++|+|||.+.......   .......++..|+|||.+.+..++.++|+||+|+++|+|++|..|+..  
T Consensus       154 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  233 (302)
T 4e5w_A          154 ARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM  233 (302)
T ss_dssp             GGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred             hheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh
Confidence            999999999999999999987544332   223334566779999999888888999999999999999999887532  


Q ss_pred             ------------CCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          155 ------------LNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       155 ------------~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                                  .............+...+.|..+|+.+.++|.+||+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  282 (302)
T 4e5w_A          234 ALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEF  282 (302)
T ss_dssp             HHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCS
T ss_pred             hHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCC
Confidence                        2222333333345667778899999999999999974

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.2e-36  Score=225.88  Aligned_cols=188  Identities=26%  Similarity=0.470  Sum_probs=145.8

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCC-CcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      ++++||||+++++++.+++..++||||+.+++|.+++.... ....+++.+++.++.|++.||++||+.|  ++|+||+|
T Consensus        87 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p  164 (310)
T 2wqm_A           87 KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKP  164 (310)
T ss_dssp             HTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCG
T ss_pred             HhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcH
Confidence            56899999999999999999999999999999999986411 1234899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC--CCHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN--LNPA  158 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~--~~~~  158 (191)
                      +||+++.++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++|+|++|..||..  .+..
T Consensus       165 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~  244 (310)
T 2wqm_A          165 ANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY  244 (310)
T ss_dssp             GGEEECTTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH
T ss_pred             HHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH
Confidence            99999999999999999887554433333344678899999999988889999999999999999999999965  3444


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .....+.....+...+..+|+.++++|.+||+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  277 (310)
T 2wqm_A          245 SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINP  277 (310)
T ss_dssp             HHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHhhcccCCCCcccccCHHHHHHHHHHcCC
Confidence            455555433333333467999999999999974

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-36  Score=231.33  Aligned_cols=185  Identities=23%  Similarity=0.298  Sum_probs=153.7

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+.+ +|.+++....  ..+++.++..++.|+++||+|||+.|  ++|+||+|+
T Consensus        67 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~  141 (346)
T 1ua2_A           67 QELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPN  141 (346)
T ss_dssp             HHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGG
T ss_pred             hhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHH
Confidence            457899999999999999999999999986 8988886543  23888999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      ||+++.++.++|+|||++..............+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||...+..+.
T Consensus       142 Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~  221 (346)
T 1ua2_A          142 NLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ  221 (346)
T ss_dssp             GEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             HEEEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence            9999999999999999987654443334455678899999998765 478899999999999999999999999888777


Q ss_pred             HHHHHhcCcccC--------------------------CCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLE--------------------------IPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~--------------------------~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+......+.                          ....+|+.++++|.+||+.
T Consensus       222 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  278 (346)
T 1ua2_A          222 LTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLF  278 (346)
T ss_dssp             HHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCS
T ss_pred             HHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhcc
Confidence            766643211110                          1156789999999999963

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.1e-36  Score=226.36  Aligned_cols=184  Identities=37%  Similarity=0.690  Sum_probs=150.9

Q ss_pred             CCCCCCCCcccccceeec-CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQ-PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      |++++||||+++++++.+ ++..++|+||+.+++|.+++.... ...+++.+++.++.|++.||++||+.|  ++|+||+
T Consensus        68 l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk  144 (278)
T 1byg_A           68 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLA  144 (278)
T ss_dssp             HTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred             HHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCC
Confidence            467899999999998754 457999999999999999997532 223788999999999999999999999  9999999


Q ss_pred             CCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA  158 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~  158 (191)
                      |+||+++.++.++|+|||.+.......   ....++..|+|||.+.+..++.++|+||||+++++|++ |..||......
T Consensus       145 p~Nil~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  221 (278)
T 1byg_A          145 ARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK  221 (278)
T ss_dssp             GGGEEECTTSCEEECCCCC---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG
T ss_pred             cceEEEeCCCcEEEeeccccccccccc---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999999886543321   12345678999999988889999999999999999998 99999988877


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .....+. .+.....|..+|+.+.++|++||++
T Consensus       222 ~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~  253 (278)
T 1byg_A          222 DVVPRVE-KGYKMDAPDGCPPAVYEVMKNCWHL  253 (278)
T ss_dssp             GHHHHHT-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHHh-cCCCCCCcccCCHHHHHHHHHHhcC
Confidence            7777664 4456678889999999999999974

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.1e-36  Score=230.95  Aligned_cols=185  Identities=30%  Similarity=0.492  Sum_probs=146.0

Q ss_pred             CCCCCCCCcccccceeecCC----ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhC-------
Q 029552            1 MKRLRHPNIVLFMGAVTQPP----NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRR-------   69 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-------   69 (191)
                      |++++||||+++++++.+..    ..++||||+.+++|.+++....    +++.+++.++.|++.||+|||+.       
T Consensus        72 l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~al~~LH~~~~~l~~~  147 (322)
T 3soc_A           72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHEDIPGLKDG  147 (322)
T ss_dssp             STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHTCCEEEETTE
T ss_pred             HhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHhhccccccc
Confidence            56789999999999998754    3799999999999999997533    89999999999999999999999       


Q ss_pred             ---CCCeeecCCCCCcEEecCCCcEEEcccccccccccccc--cCCCCCCCCcccCccccccC-----CCCCcchHHHHH
Q 029552           70 ---NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDE-----PSNEKSDIYSFG  139 (191)
Q Consensus        70 ---~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~-----~~~~~~Dv~slG  139 (191)
                         +  ++|+||||+||+++.++.++|+|||.+........  ......++..|+|||.+.+.     .++.++|+||+|
T Consensus       148 ~~~~--ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG  225 (322)
T 3soc_A          148 HKPA--ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMG  225 (322)
T ss_dssp             EECE--EECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHH
T ss_pred             cCCC--EEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHH
Confidence               9  99999999999999999999999999865433321  22335678899999998874     334578999999


Q ss_pred             HHHHHHHhCCCCCCCC----------------CHHHHHHHHHhcCcccCCCC-----CCCHHHHHHHHHHhcC
Q 029552          140 VILWELATLQQPWGNL----------------NPAQVVAAVGFKGKRLEIPR-----NVNPHVASIIEACWAK  191 (191)
Q Consensus       140 ~~~~~l~~g~~pf~~~----------------~~~~~~~~~~~~~~~~~~~~-----~~s~~~~~li~~cl~~  191 (191)
                      +++|+|++|..||...                ........+.....++..+.     ..++.+.++|.+||++
T Consensus       226 ~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  298 (322)
T 3soc_A          226 LVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDH  298 (322)
T ss_dssp             HHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCS
T ss_pred             HHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccC
Confidence            9999999999999643                23333333433333333332     2345699999999974

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=9.9e-36  Score=226.16  Aligned_cols=183  Identities=25%  Similarity=0.458  Sum_probs=154.1

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      .||||+++++++.+++..++||||+.+++|.+++.... ...+++.+++.++.|++.||+|||+.|  ++||||+|+||+
T Consensus        87 ~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl  163 (327)
T 3lm5_A           87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNIL  163 (327)
T ss_dssp             TCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEE
T ss_pred             CCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEE
Confidence            57999999999999999999999999999999986532 234899999999999999999999999  999999999999


Q ss_pred             ecC---CCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           85 VDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        85 ~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      ++.   ++.++|+|||.+....... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+..
T Consensus       164 ~~~~~~~~~~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  242 (327)
T 3lm5_A          164 LSSIYPLGDIKIVDFGMSRKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY  242 (327)
T ss_dssp             ESCBTTBCCEEECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             EecCCCCCcEEEeeCccccccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH
Confidence            987   7899999999987554332 223456788999999999888999999999999999999999999998888887


Q ss_pred             HHHHhcCccc--CCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKGKRL--EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~~~~--~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+.......  +.+..+++.++++|.+||++
T Consensus       243 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~  274 (327)
T 3lm5_A          243 LNISQVNVDYSEETFSSVSQLATDFIQSLLVK  274 (327)
T ss_dssp             HHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCS
T ss_pred             HHHHhcccccCchhhcccCHHHHHHHHHHcCC
Confidence            7776544433  34467999999999999974

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=7.3e-37  Score=246.09  Aligned_cols=185  Identities=35%  Similarity=0.588  Sum_probs=159.0

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+ +..++||||+.+++|.+++.... ...+++.+++.++.||+.||+|||+++  ++||||+|+
T Consensus       317 ~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~  392 (535)
T 2h8h_A          317 KKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAA  392 (535)
T ss_dssp             HHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred             HhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHh
Confidence            56899999999999876 67999999999999999996422 223889999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ  159 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~~  159 (191)
                      ||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+
T Consensus       393 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~  472 (535)
T 2h8h_A          393 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE  472 (535)
T ss_dssp             GEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH
T ss_pred             hEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999987543321 12223344678999999988889999999999999999999 899999998888


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+. .+.+.+.|..+++.+.++|.+||++
T Consensus       473 ~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~  503 (535)
T 2h8h_A          473 VLDQVE-RGYRMPCPPECPESLHDLMCQCWRK  503 (535)
T ss_dssp             HHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            888775 5567778899999999999999974

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.5e-36  Score=226.17  Aligned_cols=182  Identities=18%  Similarity=0.241  Sum_probs=150.7

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      +|++++++++++.++...++||||+ +++|.+++...+.  .+++.+++.++.|++.||+|||+.|  ++|+||+|+||+
T Consensus        64 ~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl  138 (298)
T 1csn_A           64 GCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFL  138 (298)
T ss_dssp             TCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEE
T ss_pred             cCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEE
Confidence            7999999999999999999999999 8999999975432  3899999999999999999999999  999999999999


Q ss_pred             ecCCCc-----EEEcccccccccccccc-------cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 029552           85 VDKKYT-----VKVCDFGLSRLKANTFL-------SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW  152 (191)
Q Consensus        85 ~~~~~~-----~~l~d~~~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf  152 (191)
                      ++.++.     ++|+|||.+........       ......++..|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       139 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  218 (298)
T 1csn_A          139 IGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW  218 (298)
T ss_dssp             ECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             eccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCc
Confidence            987765     99999999875443311       123446788999999999988999999999999999999999999


Q ss_pred             CCC---CHHHHHHHHHhcCc---ccCCCCCCCHHHHHHHHHHhcC
Q 029552          153 GNL---NPAQVVAAVGFKGK---RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       153 ~~~---~~~~~~~~~~~~~~---~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...   ........+.....   ....+..+|+.+.++|.+||+.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  263 (298)
T 1csn_A          219 QGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNL  263 (298)
T ss_dssp             SSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHC
T ss_pred             chhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcC
Confidence            873   44444444432222   2223468999999999999963

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=6.6e-36  Score=223.03  Aligned_cols=187  Identities=28%  Similarity=0.449  Sum_probs=151.8

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCC-CcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      |++++||||+++++++.+.+..++||||+++++|.+.+.... ....+++..++.++.|++.||+|||+.|  ++|+||+
T Consensus        74 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dik  151 (285)
T 3is5_A           74 LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLK  151 (285)
T ss_dssp             HHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCS
T ss_pred             HHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCC
Confidence            357899999999999999999999999999999999885421 1234899999999999999999999999  9999999


Q ss_pred             CCcEEe---cCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 029552           80 SPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN  156 (191)
Q Consensus        80 p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~  156 (191)
                      |+||++   +.++.++|+|||.+...... .......++..|+|||.+.+ .++.++|+||+|+++++|++|..||...+
T Consensus       152 p~NIl~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~  229 (285)
T 3is5_A          152 PENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTS  229 (285)
T ss_dssp             GGGEEESSSSTTCCEEECCCCCCCC-----------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HHHEEEecCCCCCCEEEEeeecceecCCc-ccCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence            999999   45578999999998654333 22334567889999999864 47889999999999999999999999988


Q ss_pred             HHHHHHHHHhcCcccCC-CCCCCHHHHHHHHHHhcC
Q 029552          157 PAQVVAAVGFKGKRLEI-PRNVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~cl~~  191 (191)
                      ..+....+......... ...+++.+.++|.+||+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  265 (285)
T 3is5_A          230 LEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTK  265 (285)
T ss_dssp             HHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCS
T ss_pred             HHHHHhhhccCCcccccccCcCCHHHHHHHHHHccC
Confidence            88887777654443332 345899999999999974

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.5e-36  Score=228.98  Aligned_cols=184  Identities=26%  Similarity=0.413  Sum_probs=154.8

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHH------hcCCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCe
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRL------LHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPI   73 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~------~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~   73 (191)
                      |++++||||+++++++.+++..++||||+++++|.++      +.... ...+++.+++.++.|++.||+|||+ .|  +
T Consensus        97 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i  173 (348)
T 2pml_X           97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEKN--I  173 (348)
T ss_dssp             HTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTSC--E
T ss_pred             HHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccCC--E
Confidence            3678999999999999999999999999999999998      54421 2348999999999999999999999 99  9


Q ss_pred             eecCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCC-cchHHHHHHHHHHHHhCCCC
Q 029552           74 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNE-KSDIYSFGVILWELATLQQP  151 (191)
Q Consensus        74 ~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~-~~Dv~slG~~~~~l~~g~~p  151 (191)
                      +|+||+|+||+++.++.++|+|||.+......  ......++..|+|||.+.+. .++. ++|+||+|+++++|++|..|
T Consensus       174 ~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  251 (348)
T 2pml_X          174 CHRDVKPSNILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP  251 (348)
T ss_dssp             ECCCCCGGGEEECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             eecCCChHhEEEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999998754433  23345678899999999877 4555 89999999999999999999


Q ss_pred             CCCCCH-HHHHHHHHhcCcccCCC-------------------CCCCHHHHHHHHHHhcC
Q 029552          152 WGNLNP-AQVVAAVGFKGKRLEIP-------------------RNVNPHVASIIEACWAK  191 (191)
Q Consensus       152 f~~~~~-~~~~~~~~~~~~~~~~~-------------------~~~s~~~~~li~~cl~~  191 (191)
                      |..... .+....+..  .....|                   ..+|+.+.++|.+||+.
T Consensus       252 f~~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  309 (348)
T 2pml_X          252 FSLKISLVELFNNIRT--KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRK  309 (348)
T ss_dssp             SCCSSCSHHHHHHHTS--CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCS
T ss_pred             CCCCCcHHHHHHHHhc--cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccC
Confidence            998766 666666643  333444                   67999999999999973

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.2e-36  Score=232.13  Aligned_cols=181  Identities=24%  Similarity=0.440  Sum_probs=155.1

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      +||||+++++++...+..++||||+.+++|.+++....   .+++..+..++.|++.||+|||+.|  ++|+||+|+||+
T Consensus       158 ~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl  232 (365)
T 2y7j_A          158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENIL  232 (365)
T ss_dssp             TCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred             CCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEE
Confidence            79999999999999999999999999999999997533   3899999999999999999999999  999999999999


Q ss_pred             ecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC------CCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE------PSNEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        85 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~------~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      ++.++.++|+|||++...... .......+++.|+|||.+.+.      .++.++|+||||+++|+|++|..||...+..
T Consensus       233 ~~~~~~ikl~DfG~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~  311 (365)
T 2y7j_A          233 LDDNMQIRLSDFGFSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI  311 (365)
T ss_dssp             ECTTCCEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             ECCCCCEEEEecCcccccCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH
Confidence            999999999999988654432 223345678899999998643      4678999999999999999999999998888


Q ss_pred             HHHHHHHhcCcccCCC--CCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIP--RNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~--~~~s~~~~~li~~cl~~  191 (191)
                      .....+.........|  ..+|+.+.++|.+||+.
T Consensus       312 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~  346 (365)
T 2y7j_A          312 LMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQV  346 (365)
T ss_dssp             HHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCS
T ss_pred             HHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCC
Confidence            8877776544433322  57899999999999963

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.8e-36  Score=230.04  Aligned_cols=187  Identities=29%  Similarity=0.479  Sum_probs=156.9

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC----cccccHHHHHHHHHHHHHHHHHHHhCCCCeeecC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV----REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRD   77 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~   77 (191)
                      ++++||||+++++++.+++..++||||+++++|.+++.....    ...+++.+++.++.|++.||+|||+.|  ++|+|
T Consensus        88 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~d  165 (327)
T 2yfx_A           88 SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRD  165 (327)
T ss_dssp             HHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred             hhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCc
Confidence            457999999999999999999999999999999999975431    134889999999999999999999999  99999


Q ss_pred             CCCCcEEecC---CCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCC
Q 029552           78 LKSPNLLVDK---KYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQP  151 (191)
Q Consensus        78 l~p~ni~~~~---~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p  151 (191)
                      |+|+||+++.   +..++|+|||.+.......  .......++..|+|||.+.+..++.++|+||||+++|+|++ |..|
T Consensus       166 lkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p  245 (327)
T 2yfx_A          166 IAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP  245 (327)
T ss_dssp             CCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             CCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence            9999999984   4469999999886433221  11222345678999999988889999999999999999998 8999


Q ss_pred             CCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          152 WGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       152 f~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      |...........+. .+.....+..+++.+.++|.+||+.
T Consensus       246 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~  284 (327)
T 2yfx_A          246 YPSKSNQEVLEFVT-SGGRMDPPKNCPGPVYRIMTQCWQH  284 (327)
T ss_dssp             STTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCCcCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHhcC
Confidence            99988888777775 4456677889999999999999974

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.5e-37  Score=228.96  Aligned_cols=189  Identities=33%  Similarity=0.544  Sum_probs=154.4

Q ss_pred             CCCCCCCcccccceee--cCCceEEEEeccCCCCHHHHhcCCC-CcccccHHHHHHHHHHHHHHHHHHHhCCC---Ceee
Q 029552            2 KRLRHPNIVLFMGAVT--QPPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLHRRNP---PIVH   75 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~---~~~h   75 (191)
                      ++++||||+++++++.  .++..++||||+++++|.+++.... ....+++.+++.++.|++.||++||+.+.   .++|
T Consensus        60 ~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH  139 (279)
T 2w5a_A           60 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH  139 (279)
T ss_dssp             HHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CC
T ss_pred             HhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEE
Confidence            4679999999999884  4668999999999999999996522 12348999999999999999999999762   3999


Q ss_pred             cCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        76 ~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      +||+|+||+++.++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus       140 ~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  219 (279)
T 2w5a_A          140 RDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF  219 (279)
T ss_dssp             CCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc
Confidence            99999999999999999999998865433221112234577899999999888899999999999999999999999998


Q ss_pred             CHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          156 NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +.......+. .+.....|..+|+.++++|.+||+.
T Consensus       220 ~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~l~~  254 (279)
T 2w5a_A          220 SQKELAGKIR-EGKFRRIPYRYSDELNEIITRMLNL  254 (279)
T ss_dssp             SHHHHHHHHH-HTCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             CHHHHHHHHh-hcccccCCcccCHHHHHHHHHHcCC
Confidence            8887777775 3445577889999999999999974

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.8e-36  Score=230.41  Aligned_cols=184  Identities=20%  Similarity=0.268  Sum_probs=149.0

Q ss_pred             CCC-CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++ +||||+++++++.+++..++||||+ +++|.+++....  +.+++.+++.++.|++.||+|||+.|  ++||||||
T Consensus        59 ~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp  133 (330)
T 2izr_A           59 KQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKP  133 (330)
T ss_dssp             HHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCG
T ss_pred             HHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCH
Confidence            345 8999999999999999999999999 899999997542  23899999999999999999999999  99999999


Q ss_pred             CcEEecCCCc-----EEEcccccccccccccc-------cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhC
Q 029552           81 PNLLVDKKYT-----VKVCDFGLSRLKANTFL-------SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL  148 (191)
Q Consensus        81 ~ni~~~~~~~-----~~l~d~~~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g  148 (191)
                      +||+++.++.     ++|+|||++........       ......++..|+|||.+.+..++.++|+||||+++|+|++|
T Consensus       134 ~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g  213 (330)
T 2izr_A          134 ENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRG  213 (330)
T ss_dssp             GGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             HHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcC
Confidence            9999998887     99999999875433211       12345678899999999999899999999999999999999


Q ss_pred             CCCCCCC---CHHHHHHHHHhcCcccC---CCCCCCHHHHHHHHHHhcC
Q 029552          149 QQPWGNL---NPAQVVAAVGFKGKRLE---IPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       149 ~~pf~~~---~~~~~~~~~~~~~~~~~---~~~~~s~~~~~li~~cl~~  191 (191)
                      ..||...   ...+....+.......+   ....++ .++++|.+||+.
T Consensus       214 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~  261 (330)
T 2izr_A          214 SLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRL  261 (330)
T ss_dssp             SCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHC
T ss_pred             CCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhC
Confidence            9999873   33344444422111111   123455 999999999963

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.5e-36  Score=226.65  Aligned_cols=179  Identities=23%  Similarity=0.421  Sum_probs=149.5

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+.+++|.+++.....  .+++.+++.++.|++.||+|||+.+  ++||||+|+
T Consensus        67 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~  142 (289)
T 4fvq_A           67 SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAK  142 (289)
T ss_dssp             HTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGG
T ss_pred             HhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcc
Confidence            578999999999999999999999999999999999976432  3899999999999999999999999  999999999


Q ss_pred             cEEecCCCc--------EEEcccccccccccccccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhC-CCC
Q 029552           82 NLLVDKKYT--------VKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATL-QQP  151 (191)
Q Consensus        82 ni~~~~~~~--------~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g-~~p  151 (191)
                      ||+++.++.        ++|+|||.+........    ..++..|+|||.+.+ ..++.++|+||+|+++|+|++| ..|
T Consensus       143 NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~  218 (289)
T 4fvq_A          143 NILLIREEDRKTGNPPFIKLSDPGISITVLPKDI----LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP  218 (289)
T ss_dssp             GEEEEECCBGGGTBCCEEEECCCCSCTTTSCHHH----HHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             eEEEecCCcccccccceeeeccCcccccccCccc----cCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence            999988877        99999998864432211    124567999999987 5688899999999999999995 556


Q ss_pred             CCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          152 WGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       152 f~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      |...+.........   .....|...++.++++|.+||++
T Consensus       219 ~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~  255 (289)
T 4fvq_A          219 LSALDSQRKLQFYE---DRHQLPAPKAAELANLINNCMDY  255 (289)
T ss_dssp             TTTSCHHHHHHHHH---TTCCCCCCSSCTTHHHHHHHSCS
T ss_pred             ccccchHHHHHHhh---ccCCCCCCCCHHHHHHHHHHcCC
Confidence            66666655554443   35566778899999999999974

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=7.3e-36  Score=223.76  Aligned_cols=181  Identities=24%  Similarity=0.413  Sum_probs=155.1

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      +||||+++++++.+++..++||||+.+++|.+++....   .+++.+++.++.|++.||++||+.|  ++|+||+|+||+
T Consensus        82 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil  156 (298)
T 1phk_A           82 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENIL  156 (298)
T ss_dssp             TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred             CCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEE
Confidence            49999999999999999999999999999999997643   3899999999999999999999999  999999999999


Q ss_pred             ecCCCcEEEcccccccccccccccCCCCCCCCcccCccccc------cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           85 VDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR------DEPSNEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        85 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~------~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      ++.++.++|+|||.+...... .......++..|+|||.+.      ...++.++|+||||+++++|++|..||...+..
T Consensus       157 ~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  235 (298)
T 1phk_A          157 LDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM  235 (298)
T ss_dssp             ECTTCCEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             EcCCCcEEEecccchhhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH
Confidence            999999999999988654332 2233456788999999875      345678999999999999999999999998888


Q ss_pred             HHHHHHHhcCcccCCC--CCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIP--RNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~--~~~s~~~~~li~~cl~~  191 (191)
                      .....+.......+.+  ..+|+.++++|.+||+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  270 (298)
T 1phk_A          236 LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVV  270 (298)
T ss_dssp             HHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCS
T ss_pred             HHHHHHhcCCcccCcccccccCHHHHHHHHHHccC
Confidence            8877776554444333  46899999999999963

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7e-36  Score=229.40  Aligned_cols=180  Identities=24%  Similarity=0.385  Sum_probs=149.5

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      +||||+++++++.+++..++||||+.+++|.+++....   .+++.++..++.|++.||+|||+.+  ++|+||||+||+
T Consensus       117 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIl  191 (355)
T 1vzo_A          117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENIL  191 (355)
T ss_dssp             TCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEE
T ss_pred             CCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEE
Confidence            69999999999999999999999999999999997643   3899999999999999999999999  999999999999


Q ss_pred             ecCCCcEEEcccccccccccc-cccCCCCCCCCcccCccccccC--CCCCcchHHHHHHHHHHHHhCCCCCCCC----CH
Q 029552           85 VDKKYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLRDE--PSNEKSDIYSFGVILWELATLQQPWGNL----NP  157 (191)
Q Consensus        85 ~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~pf~~~----~~  157 (191)
                      ++.++.++|+|||++...... ........++..|+|||.+.+.  .++.++|+||||+++|+|++|..||...    ..
T Consensus       192 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~  271 (355)
T 1vzo_A          192 LDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ  271 (355)
T ss_dssp             ECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH
T ss_pred             ECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH
Confidence            999999999999988643222 1222334578899999999863  3678999999999999999999999642    33


Q ss_pred             HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ......+.  ....+.|..+++.++++|.+||++
T Consensus       272 ~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~  303 (355)
T 1vzo_A          272 AEISRRIL--KSEPPYPQEMSALAKDLIQRLLMK  303 (355)
T ss_dssp             HHHHHHHH--HCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHHHh--ccCCCCCcccCHHHHHHHHHHhhh
Confidence            33444442  235567889999999999999974

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.3e-36  Score=229.44  Aligned_cols=185  Identities=31%  Similarity=0.576  Sum_probs=152.8

Q ss_pred             CCCCcccccceeecCC-ceEEEEeccCCCCHHHHhcCCCC-------------cccccHHHHHHHHHHHHHHHHHHHhCC
Q 029552            5 RHPNIVLFMGAVTQPP-NLSIVTEYLSRGSLYRLLHKPGV-------------REMLDERRRLNMAYDVAKGMNYLHRRN   70 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~   70 (191)
                      +||||+++++++.+.+ ..++|+||+.+++|.+++.....             +..+++.+++.++.|+++||+|||+.|
T Consensus        89 ~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~  168 (316)
T 2xir_A           89 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK  168 (316)
T ss_dssp             CCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence            6999999999987654 59999999999999999976442             122789999999999999999999999


Q ss_pred             CCeeecCCCCCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-
Q 029552           71 PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-  147 (191)
Q Consensus        71 ~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-  147 (191)
                        ++|+||+|+||+++.++.++|+|||.+.......  .......++..|+|||.+.+..++.++|+||+|+++|+|++ 
T Consensus       169 --i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~  246 (316)
T 2xir_A          169 --CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL  246 (316)
T ss_dssp             --CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             --cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhC
Confidence              9999999999999999999999999886433221  11222334668999999998889999999999999999998 


Q ss_pred             CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          148 LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       148 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      |..||...............+.....|..+++.+.++|.+||++
T Consensus       247 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  290 (316)
T 2xir_A          247 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG  290 (316)
T ss_dssp             SCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCC
Confidence            99999876644444444345566778889999999999999974

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.5e-36  Score=227.72  Aligned_cols=165  Identities=23%  Similarity=0.335  Sum_probs=130.2

Q ss_pred             eEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecCCCcEEEcccccccc
Q 029552           22 LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL  101 (191)
Q Consensus        22 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~  101 (191)
                      .++||||+.+++|.+++.........++..++.++.|++.||+|||+.|  ++||||||+||+++.++.++|+|||.+..
T Consensus       136 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  213 (332)
T 3qd2_B          136 LYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTA  213 (332)
T ss_dssp             EEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccc
Confidence            8999999999999999987665555677789999999999999999999  99999999999999999999999999875


Q ss_pred             ccccc------------ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCc
Q 029552          102 KANTF------------LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK  169 (191)
Q Consensus       102 ~~~~~------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~  169 (191)
                      .....            .......+++.|+|||.+.+..++.++|+||+|+++|+|++|..|+..  .......+. ...
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~-~~~  290 (332)
T 3qd2_B          214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVR-NLK  290 (332)
T ss_dssp             CSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHH-TTC
T ss_pred             cccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhh-ccC
Confidence            44331            122334678899999999998899999999999999999998766432  122222221 222


Q ss_pred             ccCCCCCCCHHHHHHHHHHhcC
Q 029552          170 RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       170 ~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+..+...++.++++|.+||++
T Consensus       291 ~~~~~~~~~~~~~~li~~~l~~  312 (332)
T 3qd2_B          291 FPLLFTQKYPQEHMMVQDMLSP  312 (332)
T ss_dssp             CCHHHHHHCHHHHHHHHHHHCS
T ss_pred             CCcccccCChhHHHHHHHHccC
Confidence            2223346788999999999974

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-36  Score=228.48  Aligned_cols=187  Identities=26%  Similarity=0.403  Sum_probs=147.9

Q ss_pred             CCCCCCCcccccceeecCC--ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      ++++||||+++++++.+..  ..++||||+++++|.+++........+++.+++.++.|++.||+|||+.|  ++|+|||
T Consensus        62 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlk  139 (319)
T 4euu_A           62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIK  139 (319)
T ss_dssp             HHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCS
T ss_pred             HhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCC
Confidence            4678999999999998655  78999999999999999987554444899999999999999999999999  9999999


Q ss_pred             CCcEEe----cCCCcEEEcccccccccccccccCCCCCCCCcccCccccc--------cCCCCCcchHHHHHHHHHHHHh
Q 029552           80 SPNLLV----DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR--------DEPSNEKSDIYSFGVILWELAT  147 (191)
Q Consensus        80 p~ni~~----~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--------~~~~~~~~Dv~slG~~~~~l~~  147 (191)
                      |+||++    +.++.++|+|||.+....... ......++..|+|||.+.        +..++.++|+||+|+++|+|++
T Consensus       140 p~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~  218 (319)
T 4euu_A          140 PGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT  218 (319)
T ss_dssp             GGGEEEEECTTSCEEEEECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHH
T ss_pred             HHHEEEeccCCCCceEEEccCCCceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHh
Confidence            999998    777789999999987544332 223446788999999886        4567889999999999999999


Q ss_pred             CCCCCCCCC----HHHHHHHHHhcCcc-------------------c----CCCCCCCHHHHHHHHHHhcC
Q 029552          148 LQQPWGNLN----PAQVVAAVGFKGKR-------------------L----EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       148 g~~pf~~~~----~~~~~~~~~~~~~~-------------------~----~~~~~~s~~~~~li~~cl~~  191 (191)
                      |..||....    ..+....+......                   .    .++..+++.+.++|++||++
T Consensus       219 g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~  289 (319)
T 4euu_A          219 GSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA  289 (319)
T ss_dssp             SSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCC
T ss_pred             CCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccC
Confidence            999996422    23344444322210                   1    12234567899999999974

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.5e-36  Score=229.97  Aligned_cols=189  Identities=28%  Similarity=0.460  Sum_probs=149.2

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC-cccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      |++++||||+++++++.+++..++||||+.+++|.+++..... ...+++.+++.++.|+++||+|||+.|  ++|+||+
T Consensus        89 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlk  166 (321)
T 2qkw_B           89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVK  166 (321)
T ss_dssp             GGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCC
T ss_pred             HHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCC
Confidence            4678999999999999999999999999999999999965432 224889999999999999999999999  9999999


Q ss_pred             CCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      |+||+++.++.++|+|||.+.......  .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||....+
T Consensus       167 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~  246 (321)
T 2qkw_B          167 SINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP  246 (321)
T ss_dssp             STTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS
T ss_pred             HHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc
Confidence            999999999999999999987533221  112223467789999999888899999999999999999999999975443


Q ss_pred             HHHHH-------HHHhcC--------cccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVA-------AVGFKG--------KRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~-------~~~~~~--------~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+...       ......        .....+..++..+.+++.+||++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  295 (321)
T 2qkw_B          247 REMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLAL  295 (321)
T ss_dssp             SSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCS
T ss_pred             HHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCC
Confidence            22111       110000        01122334567899999999974

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.4e-35  Score=222.96  Aligned_cols=185  Identities=23%  Similarity=0.428  Sum_probs=152.3

Q ss_pred             CCCCCCCCccccccee--ecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            1 MKRLRHPNIVLFMGAV--TQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~--~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      |++++||||+++++++  .+++..++||||+.++ |.+++.... ...+++.+++.++.|++.||+|||+.|  ++|+||
T Consensus        60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl  135 (305)
T 2wtk_C           60 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDI  135 (305)
T ss_dssp             HTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCC
T ss_pred             HHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCC
Confidence            4678999999999998  4556899999999875 777775432 234899999999999999999999999  999999


Q ss_pred             CCCcEEecCCCcEEEcccccccccccc--cccCCCCCCCCcccCccccccCCC--CCcchHHHHHHHHHHHHhCCCCCCC
Q 029552           79 KSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEPS--NEKSDIYSFGVILWELATLQQPWGN  154 (191)
Q Consensus        79 ~p~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~--~~~~Dv~slG~~~~~l~~g~~pf~~  154 (191)
                      +|+||+++.++.++|+|||.+......  ........++..|+|||.+.+...  +.++|+||+|+++|+|++|..||..
T Consensus       136 kp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  215 (305)
T 2wtk_C          136 KPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG  215 (305)
T ss_dssp             SGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999998654321  112234457889999999876543  6789999999999999999999999


Q ss_pred             CCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          155 LNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+.......+..  .....|..+++.+.++|.+||++
T Consensus       216 ~~~~~~~~~i~~--~~~~~~~~~~~~l~~li~~~l~~  250 (305)
T 2wtk_C          216 DNIYKLFENIGK--GSYAIPGDCGPPLSDLLKGMLEY  250 (305)
T ss_dssp             SSHHHHHHHHHH--CCCCCCSSSCHHHHHHHHHHTCS
T ss_pred             chHHHHHHHHhc--CCCCCCCccCHHHHHHHHHHccC
Confidence            888888877753  34567889999999999999974

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.8e-35  Score=227.24  Aligned_cols=157  Identities=26%  Similarity=0.391  Sum_probs=136.8

Q ss_pred             CCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCc
Q 029552            3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN   82 (191)
Q Consensus         3 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~n   82 (191)
                      .++||||+++++++...+..++|||++ +++|.+++..... ..+++.+++.++.||+.||+|||+.|  ++||||||+|
T Consensus        92 ~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~N  167 (360)
T 3llt_A           92 DINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPEN  167 (360)
T ss_dssp             STTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGG
T ss_pred             CCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCccc
Confidence            346999999999999999999999999 8899999976442 23889999999999999999999999  9999999999


Q ss_pred             EEecC-------------------------CCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHH
Q 029552           83 LLVDK-------------------------KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYS  137 (191)
Q Consensus        83 i~~~~-------------------------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~s  137 (191)
                      |+++.                         ++.++|+|||.+......   .....+++.|+|||.+.+..++.++|+||
T Consensus       168 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Diws  244 (360)
T 3llt_A          168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWS  244 (360)
T ss_dssp             EEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHH
T ss_pred             EEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHH
Confidence            99975                         788999999998754332   23456788999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 029552          138 FGVILWELATLQQPWGNLNPAQVVAAVGF  166 (191)
Q Consensus       138 lG~~~~~l~~g~~pf~~~~~~~~~~~~~~  166 (191)
                      +|+++|+|++|..||...+..+....+..
T Consensus       245 lG~il~ell~g~~pf~~~~~~~~~~~~~~  273 (360)
T 3llt_A          245 FGCVLAELYTGSLLFRTHEHMEHLAMMES  273 (360)
T ss_dssp             HHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCCCcHHHHHHHHHH
Confidence            99999999999999998888777666543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.1e-36  Score=227.43  Aligned_cols=184  Identities=29%  Similarity=0.509  Sum_probs=152.1

Q ss_pred             CCCCCCCcccccceeecC--CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            2 KRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      ++++||||+++++++.+.  ...++||||+++++|.+++....    +++.+++.++.|++.||++||+.|  ++|+||+
T Consensus        88 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dik  161 (318)
T 3lxp_A           88 RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQH--YIHRDLA  161 (318)
T ss_dssp             HHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCS
T ss_pred             HhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCc
Confidence            467899999999999874  57899999999999999997643    889999999999999999999999  9999999


Q ss_pred             CCcEEecCCCcEEEccccccccccccc---ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN  156 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~  156 (191)
                      |+||+++.++.++|+|||.+.......   .......++..|+|||.+.+..++.++|+||+|+++++|++|..||....
T Consensus       162 p~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~  241 (318)
T 3lxp_A          162 ARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPP  241 (318)
T ss_dssp             GGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred             hheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccc
Confidence            999999999999999999987544321   12233445667999999998888899999999999999999999997633


Q ss_pred             HH--------------HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          157 PA--------------QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~--------------~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..              .........+...+.|..+|+.+.++|.+||++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  290 (318)
T 3lxp_A          242 TKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWET  290 (318)
T ss_dssp             HHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             hhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCC
Confidence            22              112223335557778899999999999999974

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.3e-36  Score=228.67  Aligned_cols=187  Identities=33%  Similarity=0.531  Sum_probs=154.0

Q ss_pred             CCCCCCCCcccccceee--cCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            1 MKRLRHPNIVLFMGAVT--QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      |++++||||+++++++.  +.+..++||||+++++|.+++.....  .+++.+++.++.|++.||+|||+.|  ++|+||
T Consensus        78 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Di  153 (327)
T 3lxl_A           78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRR--CVHRDL  153 (327)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT--EECSCC
T ss_pred             HHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCC
Confidence            35789999999999886  55679999999999999999975322  3899999999999999999999999  999999


Q ss_pred             CCCcEEecCCCcEEEccccccccccccc---ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           79 KSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        79 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      +|+||+++.++.++|+|||.+.......   .......++..|+|||.+.+..++.++|+||||+++++|++|..||...
T Consensus       154 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~  233 (327)
T 3lxl_A          154 AARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP  233 (327)
T ss_dssp             SGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred             ChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccc
Confidence            9999999999999999999987543321   1223345667799999998888889999999999999999999998654


Q ss_pred             CHH--------------HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          156 NPA--------------QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~--------------~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...              .........+...+.|..+|+.+.++|.+||++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  283 (327)
T 3lxl_A          234 SAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAP  283 (327)
T ss_dssp             HHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             cchhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCC
Confidence            332              222233335567778899999999999999974

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=6.7e-36  Score=232.43  Aligned_cols=188  Identities=21%  Similarity=0.260  Sum_probs=146.4

Q ss_pred             CCCCCCCCcccccceeecCC------ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCee
Q 029552            1 MKRLRHPNIVLFMGAVTQPP------NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIV   74 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~   74 (191)
                      |++++||||++++++|...+      ..++||||+.++.+............+++..++.++.|++.||+|||+.|  ++
T Consensus        86 l~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--iv  163 (394)
T 4e7w_A           86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--IC  163 (394)
T ss_dssp             HHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred             HHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cc
Confidence            35789999999999995433      38899999987444333321111234899999999999999999999999  99


Q ss_pred             ecCCCCCcEEec-CCCcEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCC
Q 029552           75 HRDLKSPNLLVD-KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPW  152 (191)
Q Consensus        75 h~~l~p~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf  152 (191)
                      ||||||+||+++ .++.++|+|||++....... ......++..|+|||.+.+. .++.++|+||+||++|+|++|..||
T Consensus       164 HrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf  242 (394)
T 4e7w_A          164 HRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF  242 (394)
T ss_dssp             CSCCSGGGEEEETTTTEEEECCCTTCEECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            999999999999 78999999999987543321 22334668899999998765 4889999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhcCcc---------------------------cCCCCCCCHHHHHHHHHHhcC
Q 029552          153 GNLNPAQVVAAVGFKGKR---------------------------LEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+.......+......                           ..++..+|+.+.++|.+||++
T Consensus       243 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  308 (394)
T 4e7w_A          243 PGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEY  308 (394)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred             CCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCC
Confidence            988877666555321100                           113456899999999999974

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.5e-35  Score=222.35  Aligned_cols=189  Identities=31%  Similarity=0.504  Sum_probs=150.4

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCC-----CCcccccHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-----GVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH   75 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h   75 (191)
                      |++++||||+++++++.+++..++||||+++++|.+++...     .....+++.+++.++.|++.||+|||+.|  ++|
T Consensus        67 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H  144 (303)
T 2vwi_A           67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIH  144 (303)
T ss_dssp             CCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred             HhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCC
Confidence            46789999999999999999999999999999999998631     11234899999999999999999999999  999


Q ss_pred             cCCCCCcEEecCCCcEEEccccccccccccc-----ccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCC
Q 029552           76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-----LSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQ  149 (191)
Q Consensus        76 ~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~  149 (191)
                      +||+|+||+++.++.++|+|||.+.......     .......++..|+|||.+.+ ..++.++|+||||+++|+|++|.
T Consensus       145 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~  224 (303)
T 2vwi_A          145 RDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA  224 (303)
T ss_dssp             CCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCC
Confidence            9999999999999999999999876433221     11223457788999999875 45788999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHHhcCcc--------cCCCCCCCHHHHHHHHHHhcC
Q 029552          150 QPWGNLNPAQVVAAVGFKGKR--------LEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       150 ~pf~~~~~~~~~~~~~~~~~~--------~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .||..................        ...+..+++.++++|.+||+.
T Consensus       225 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  274 (303)
T 2vwi_A          225 APYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQK  274 (303)
T ss_dssp             CTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCS
T ss_pred             CCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccC
Confidence            999987766555444322211        123457899999999999974

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-35  Score=223.39  Aligned_cols=178  Identities=22%  Similarity=0.244  Sum_probs=145.7

Q ss_pred             CCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcE
Q 029552            4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL   83 (191)
Q Consensus         4 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni   83 (191)
                      .+||||+++++++.+++..++|||++ +++|.+++...+.  .+++.+++.++.|++.||+|||+.+  ++|+||||+||
T Consensus       114 ~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NI  188 (311)
T 3p1a_A          114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANI  188 (311)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGE
T ss_pred             cCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHE
Confidence            38999999999999999999999999 5699888865432  3899999999999999999999999  99999999999


Q ss_pred             EecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 029552           84 LVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA  163 (191)
Q Consensus        84 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~  163 (191)
                      +++.++.++|+|||++...... .......+++.|+|||.+.+ .++.++|+||+|+++++|++|..|+....   ....
T Consensus       189 ll~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~  263 (311)
T 3p1a_A          189 FLGPRGRCKLGDFGLLVELGTA-GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---GWQQ  263 (311)
T ss_dssp             EECGGGCEEECCCTTCEECC-------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHH
T ss_pred             EECCCCCEEEccceeeeecccC-CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHH
Confidence            9999999999999997654433 22334467889999999887 58899999999999999999976655432   2333


Q ss_pred             HHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          164 VGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       164 ~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +.....+..++..+|+.+.++|.+||++
T Consensus       264 ~~~~~~~~~~~~~~~~~l~~li~~~L~~  291 (311)
T 3p1a_A          264 LRQGYLPPEFTAGLSSELRSVLVMMLEP  291 (311)
T ss_dssp             HTTTCCCHHHHTTSCHHHHHHHHHHSCS
T ss_pred             HhccCCCcccccCCCHHHHHHHHHHcCC
Confidence            4333334456778999999999999974

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=9.4e-36  Score=222.28  Aligned_cols=186  Identities=26%  Similarity=0.425  Sum_probs=143.2

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhC-CCCeeecCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLK   79 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~~~~~h~~l~   79 (191)
                      +.++||||+++++++.+++..++||||+++ +|.+++... ..+..+++.+++.++.|++.||+|||+. |  ++|+||+
T Consensus        61 ~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlk  137 (290)
T 3fme_A           61 RTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVK  137 (290)
T ss_dssp             TTCCCTTBCCEEEEEECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCS
T ss_pred             HhCCCCeEEEEeeeeeccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCC
Confidence            567999999999999999999999999975 887776431 1123489999999999999999999998 9  9999999


Q ss_pred             CCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccc----ccCCCCCcchHHHHHHHHHHHHhCCCCCCC-
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL----RDEPSNEKSDIYSFGVILWELATLQQPWGN-  154 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~----~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~-  154 (191)
                      |+||+++.++.++|+|||.+....... ......+++.|+|||.+    .+..++.++|+||+|+++++|++|..||.. 
T Consensus       138 p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  216 (290)
T 3fme_A          138 PSNVLINALGQVKMCDFGISGYLVDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW  216 (290)
T ss_dssp             GGGCEECTTCCEEBCCC----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC
T ss_pred             HHHEEECCCCCEEEeecCCcccccccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc
Confidence            999999999999999999986544332 22234578899999996    455678899999999999999999999986 


Q ss_pred             CCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          155 LNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+................+..+|+.+.++|.+||++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  253 (290)
T 3fme_A          217 GTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKK  253 (290)
T ss_dssp             SCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCS
T ss_pred             CchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhc
Confidence            4555555555444444444567999999999999974

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-35  Score=230.10  Aligned_cols=156  Identities=26%  Similarity=0.416  Sum_probs=130.4

Q ss_pred             CCC-CCCcccccceeecCC--ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            3 RLR-HPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         3 ~l~-h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      ++. ||||+++++++...+  ..|+||||+. ++|.+++...    .+++..+..++.|++.||+|||+.|  ++|||||
T Consensus        64 ~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlk  136 (388)
T 3oz6_A           64 ELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMK  136 (388)
T ss_dssp             HTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCC
T ss_pred             hccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCC
Confidence            455 999999999997543  7899999997 5999998753    3889999999999999999999999  9999999


Q ss_pred             CCcEEecCCCcEEEcccccccccccc---------------------cccCCCCCCCCcccCcccccc-CCCCCcchHHH
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANT---------------------FLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYS  137 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~---------------------~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~s  137 (191)
                      |+||+++.++.++|+|||++......                     ........+++.|+|||.+.+ ..++.++|+||
T Consensus       137 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  216 (388)
T 3oz6_A          137 PSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWS  216 (388)
T ss_dssp             GGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHH
T ss_pred             HHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHH
Confidence            99999999999999999998643211                     111223467889999999876 56889999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 029552          138 FGVILWELATLQQPWGNLNPAQVVAAVG  165 (191)
Q Consensus       138 lG~~~~~l~~g~~pf~~~~~~~~~~~~~  165 (191)
                      +||++|+|++|..||...+.......+.
T Consensus       217 lG~il~ell~g~~pf~~~~~~~~~~~i~  244 (388)
T 3oz6_A          217 LGCILGEILCGKPIFPGSSTMNQLERII  244 (388)
T ss_dssp             HHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999999999999988877776664

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=9.3e-36  Score=244.45  Aligned_cols=184  Identities=30%  Similarity=0.585  Sum_probs=155.3

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+ +..++||||+.+++|.+++.....  .+++..++.++.|++.||+|||+.|  ++||||+|+
T Consensus       446 ~~l~HpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~  520 (656)
T 2j0j_A          446 RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKF--SLDLASLILYAYQLSTALAYLESKR--FVHRDIAAR  520 (656)
T ss_dssp             HHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHTTT--TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred             HhCCCCCCCeEEEEEec-CceEEEEEcCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchH
Confidence            46799999999999854 568999999999999999975432  3889999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ  159 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~~  159 (191)
                      ||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||......+
T Consensus       521 NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  600 (656)
T 2j0j_A          521 NVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND  600 (656)
T ss_dssp             GEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             hEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence            9999999999999999987543321 11222344568999999988889999999999999999997 899999988888


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+. .+.+.+.|..+|+.+.++|.+||++
T Consensus       601 ~~~~i~-~~~~~~~~~~~~~~l~~li~~~l~~  631 (656)
T 2j0j_A          601 VIGRIE-NGERLPMPPNCPPTLYSLMTKCWAY  631 (656)
T ss_dssp             HHHHHH-HTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHH-cCCCCCCCccccHHHHHHHHHHcCC
Confidence            888775 4456778899999999999999974

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.1e-35  Score=224.59  Aligned_cols=181  Identities=25%  Similarity=0.429  Sum_probs=144.6

Q ss_pred             CCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcE
Q 029552            4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL   83 (191)
Q Consensus         4 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni   83 (191)
                      .+||||+++++++.+++..++||||+.+++|.+++....   .+++.+++.++.|++.||+|||+.+  ++|+||+|+||
T Consensus        68 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Ni  142 (316)
T 2ac3_A           68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENI  142 (316)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGE
T ss_pred             cCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHE
Confidence            479999999999999999999999999999999997643   3899999999999999999999999  99999999999


Q ss_pred             EecCCCc---EEEcccccccccccc-------cccCCCCCCCCcccCcccccc-----CCCCCcchHHHHHHHHHHHHhC
Q 029552           84 LVDKKYT---VKVCDFGLSRLKANT-------FLSSKSAAGTPEWMAPEVLRD-----EPSNEKSDIYSFGVILWELATL  148 (191)
Q Consensus        84 ~~~~~~~---~~l~d~~~~~~~~~~-------~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~Dv~slG~~~~~l~~g  148 (191)
                      +++.++.   ++|+|||++......       ........++..|+|||.+.+     ..++.++|+||+|+++|+|++|
T Consensus       143 l~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g  222 (316)
T 2ac3_A          143 LCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG  222 (316)
T ss_dssp             EESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHS
T ss_pred             EEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHC
Confidence            9988766   999999987643211       011223457889999999875     4467899999999999999999


Q ss_pred             CCCCCCCC---------------HHHHHHHHHhcCcccCCC----CCCCHHHHHHHHHHhcC
Q 029552          149 QQPWGNLN---------------PAQVVAAVGFKGKRLEIP----RNVNPHVASIIEACWAK  191 (191)
Q Consensus       149 ~~pf~~~~---------------~~~~~~~~~~~~~~~~~~----~~~s~~~~~li~~cl~~  191 (191)
                      ..||....               .......+...  ....|    ..+|+.++++|.+||++
T Consensus       223 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~li~~~L~~  282 (316)
T 2ac3_A          223 YPPFVGRCGSDCGWDRGEACPACQNMLFESIQEG--KYEFPDKDWAHISCAAKDLISKLLVR  282 (316)
T ss_dssp             SCSCCCCCCSCSCC----CCHHHHHHHHHHHHHC--CCCCCHHHHTTSCHHHHHHHHHHSCS
T ss_pred             CCCCcccccccccccccccchhHHHHHHHHHhcc--CcccCchhcccCCHHHHHHHHHHhhC
Confidence            99998654               23344445333  23333    46899999999999974

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.3e-36  Score=230.62  Aligned_cols=189  Identities=27%  Similarity=0.409  Sum_probs=149.2

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCC-CcccccHHHHHHHHHHHHHHHHHHHhC---CCCeeec
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLHRR---NPPIVHR   76 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~---~~~~~h~   76 (191)
                      |++++||||+++++++.+++..++||||+.+++|.+++.... ....+++..+..++.|++.||+|||+.   |  ++|+
T Consensus        81 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~  158 (326)
T 3uim_A           81 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHR  158 (326)
T ss_dssp             GGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECC
T ss_pred             HHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeC
Confidence            467899999999999999999999999999999999997643 233489999999999999999999999   9  9999


Q ss_pred             CCCCCcEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-
Q 029552           77 DLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN-  154 (191)
Q Consensus        77 ~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~-  154 (191)
                      ||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.. 
T Consensus       159 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  238 (326)
T 3uim_A          159 DVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA  238 (326)
T ss_dssp             CCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHH
T ss_pred             CCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccc
Confidence            999999999999999999999987543221 223334578899999999888889999999999999999999999952 


Q ss_pred             ----CCHHHHHHHHHhc------------CcccCCCCCCCHHHHHHHHHHhcC
Q 029552          155 ----LNPAQVVAAVGFK------------GKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       155 ----~~~~~~~~~~~~~------------~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                          .........+...            ......+...++.+.++|.+||++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  291 (326)
T 3uim_A          239 RLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQS  291 (326)
T ss_dssp             HHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCS
T ss_pred             ccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCc
Confidence                1111111111100            001122333457899999999974

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=6.8e-37  Score=236.72  Aligned_cols=178  Identities=13%  Similarity=0.177  Sum_probs=140.1

Q ss_pred             CCCCCCCCccccc-------ceeecCC-----------------ceEEEEeccCCCCHHHHhcCCCC----cccccHHHH
Q 029552            1 MKRLRHPNIVLFM-------GAVTQPP-----------------NLSIVTEYLSRGSLYRLLHKPGV----REMLDERRR   52 (191)
Q Consensus         1 L~~l~h~~i~~~~-------~~~~~~~-----------------~~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~   52 (191)
                      |++++||||++++       +++++++                 ..|++|||+ +|+|.+++...+.    ...+++..+
T Consensus       130 l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~  208 (377)
T 3byv_A          130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHAR  208 (377)
T ss_dssp             STTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHH
T ss_pred             ccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHH
Confidence            4567999999998       6555543                 388999999 5799999975321    122445888


Q ss_pred             HHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC-----
Q 029552           53 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-----  127 (191)
Q Consensus        53 ~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-----  127 (191)
                      +.++.|++.||+|||+.|  ++||||||+||+++.++.++|+|||++......   .....+ ..|+|||.+.+.     
T Consensus       209 ~~i~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~  282 (377)
T 3byv_A          209 LQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR---VVSSVS-RGFEPPELEARRATISY  282 (377)
T ss_dssp             HHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCGGGCEETTCE---EECCCC-TTCCCHHHHHHHTSTHH
T ss_pred             HHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEechhheecCCc---ccCCCC-cCccChhhhcccccccc
Confidence            889999999999999999  999999999999999999999999998754432   223355 899999999877     


Q ss_pred             ------CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          128 ------PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       128 ------~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                            .++.++|+||||+++|+|++|..||...+.......+      ...+..+|+.++++|.+||++
T Consensus       283 ~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~  346 (377)
T 3byv_A          283 HRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI------FRSCKNIPQPVRALLEGFLRY  346 (377)
T ss_dssp             HHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGG------GSSCCCCCHHHHHHHHHHTCS
T ss_pred             cccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhh------hhhccCCCHHHHHHHHHHcCC
Confidence                  7899999999999999999999999875544333322      234578999999999999974

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-35  Score=227.18  Aligned_cols=182  Identities=23%  Similarity=0.395  Sum_probs=146.7

Q ss_pred             CCCC--CCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            3 RLRH--PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         3 ~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++|  |||+++++++.+++..++|||+ .+++|.+++....   .+++.++..++.|++.||+|||+.+  ++||||||
T Consensus        63 ~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp  136 (343)
T 3dbq_A           63 KLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKP  136 (343)
T ss_dssp             HHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCG
T ss_pred             hhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCc
Confidence            4555  9999999999999999999995 5779999997644   3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccc--cCCCCCCCCcccCcccccc-----------CCCCCcchHHHHHHHHHHHHh
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRD-----------EPSNEKSDIYSFGVILWELAT  147 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~-----------~~~~~~~Dv~slG~~~~~l~~  147 (191)
                      +||+++ ++.++|+|||++........  ......+++.|+|||.+.+           ..++.++|+||+|+++|+|++
T Consensus       137 ~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~  215 (343)
T 3dbq_A          137 ANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY  215 (343)
T ss_dssp             GGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHH
T ss_pred             ceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHh
Confidence            999997 57899999999875433221  2234567899999999865           557889999999999999999


Q ss_pred             CCCCCCCC-CHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          148 LQQPWGNL-NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       148 g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      |..||... +.......+.........|...++.+.++|.+||++
T Consensus       216 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  260 (343)
T 3dbq_A          216 GKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR  260 (343)
T ss_dssp             SSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCS
T ss_pred             CCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCC
Confidence            99999874 444455555444556678888999999999999974

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-35  Score=226.92  Aligned_cols=180  Identities=26%  Similarity=0.404  Sum_probs=149.8

Q ss_pred             CCCCCCCcccccceeecCC------ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 029552            2 KRLRHPNIVLFMGAVTQPP------NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH   75 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h   75 (191)
                      ++++||||+++++++..++      .+|+||||+ +++|.+++...    .+++.++..++.|++.||+|||+.|  ++|
T Consensus        79 ~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~--ivH  151 (367)
T 1cm8_A           79 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG--IIH  151 (367)
T ss_dssp             HHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred             HhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ccc
Confidence            4678999999999997653      469999999 78999999753    2889999999999999999999999  999


Q ss_pred             cCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 029552           76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGN  154 (191)
Q Consensus        76 ~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~pf~~  154 (191)
                      |||||+||+++.++.++|+|||++......   .....++..|+|||.+.+ ..++.++|+||+||++++|++|..||..
T Consensus       152 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  228 (367)
T 1cm8_A          152 RDLKPGNLAVNEDCELKILDFGLARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG  228 (367)
T ss_dssp             CCCCGGGEEECTTCCEEECCCTTCEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCcCHHHEEEcCCCCEEEEeeecccccccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999998754432   223466889999999877 5689999999999999999999999998


Q ss_pred             CCHHHHHHHHHhcCc-----------------------------ccCCCCCCCHHHHHHHHHHhcC
Q 029552          155 LNPAQVVAAVGFKGK-----------------------------RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       155 ~~~~~~~~~~~~~~~-----------------------------~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+.......+.....                             .......+++.+.++|.+||..
T Consensus       229 ~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~  294 (367)
T 1cm8_A          229 SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVL  294 (367)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCS
T ss_pred             CCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccC
Confidence            887766655532111                             1123457899999999999963

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.3e-35  Score=222.55  Aligned_cols=183  Identities=33%  Similarity=0.582  Sum_probs=144.2

Q ss_pred             CCCCCCcccccceeec----CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHH--------hCC
Q 029552            3 RLRHPNIVLFMGAVTQ----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLH--------RRN   70 (191)
Q Consensus         3 ~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh--------~~~   70 (191)
                      +++||||+++++++.+    ....++||||+.+++|.++++..    .+++.+++.++.|++.||+|||        +.+
T Consensus        58 ~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~  133 (301)
T 3q4u_A           58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA  133 (301)
T ss_dssp             CCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE
T ss_pred             hccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC
Confidence            4799999999998653    34689999999999999999653    2899999999999999999999        889


Q ss_pred             CCeeecCCCCCcEEecCCCcEEEcccccccccccccc----cCCCCCCCCcccCccccccCC------CCCcchHHHHHH
Q 029552           71 PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL----SSKSAAGTPEWMAPEVLRDEP------SNEKSDIYSFGV  140 (191)
Q Consensus        71 ~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~------~~~~~Dv~slG~  140 (191)
                        ++||||||+||+++.++.++|+|||++........    ......+++.|+|||.+.+..      ++.++|+||+|+
T Consensus       134 --ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~  211 (301)
T 3q4u_A          134 --IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGL  211 (301)
T ss_dssp             --EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHH
T ss_pred             --eecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHH
Confidence              99999999999999999999999999865433211    123346788999999998763      346899999999


Q ss_pred             HHHHHHhC----------CCCCCCC-----CHHHHHHHHHhcCcccCCCC-----CCCHHHHHHHHHHhcC
Q 029552          141 ILWELATL----------QQPWGNL-----NPAQVVAAVGFKGKRLEIPR-----NVNPHVASIIEACWAK  191 (191)
Q Consensus       141 ~~~~l~~g----------~~pf~~~-----~~~~~~~~~~~~~~~~~~~~-----~~s~~~~~li~~cl~~  191 (191)
                      ++|+|++|          ..||...     ...............+..|.     .+++.+.++|.+||++
T Consensus       212 il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  282 (301)
T 3q4u_A          212 VLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQ  282 (301)
T ss_dssp             HHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCS
T ss_pred             HHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhc
Confidence            99999999          8888542     22333333333333444443     3668899999999974

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.4e-35  Score=220.10  Aligned_cols=183  Identities=32%  Similarity=0.522  Sum_probs=154.2

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+.+..++|+|++.+++|.+.+....   .+++.+++.++.|++.||++||+.|  ++|+||+|+
T Consensus        76 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~  150 (287)
T 2wei_A           76 KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPE  150 (287)
T ss_dssp             HTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGG
T ss_pred             HhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChh
Confidence            57899999999999999999999999999999999886533   3899999999999999999999999  999999999


Q ss_pred             cEEecCC---CcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           82 NLLVDKK---YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        82 ni~~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      ||+++.+   +.++|+|||.+....... ......++..|+|||.+.+. ++.++|+||||+++++|++|..||...+..
T Consensus       151 NIlv~~~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  228 (287)
T 2wei_A          151 NILLESKEKDCDIKIIDFGLSTCFQQNT-KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY  228 (287)
T ss_dssp             GEEESCSSTTCCEEECSTTGGGTBCCCS-SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             hEEEecCCCcccEEEeccCcceeecCCC-ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHH
Confidence            9999764   469999999886543321 11222356689999998765 788999999999999999999999999888


Q ss_pred             HHHHHHHhcCcccCCC--CCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIP--RNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~--~~~s~~~~~li~~cl~~  191 (191)
                      .....+.......+.|  ..+|+.+.++|.+||+.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  263 (287)
T 2wei_A          229 DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTF  263 (287)
T ss_dssp             HHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHccc
Confidence            8888876554444433  57999999999999963

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.8e-35  Score=226.36  Aligned_cols=187  Identities=22%  Similarity=0.318  Sum_probs=149.4

Q ss_pred             CCCCCCCCcccccceeec--------------------------------------CCceEEEEeccCCCCHHHHhcCC-
Q 029552            1 MKRLRHPNIVLFMGAVTQ--------------------------------------PPNLSIVTEYLSRGSLYRLLHKP-   41 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~--------------------------------------~~~~~lv~e~~~~~~L~~~~~~~-   41 (191)
                      |+.++||||++++++|..                                      +...++||||+.+ +|.+.+... 
T Consensus        54 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~  132 (383)
T 3eb0_A           54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFI  132 (383)
T ss_dssp             HTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSE-EHHHHHHHHH
T ss_pred             HHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHH
Confidence            467899999999999843                                      3348899999985 877776421 


Q ss_pred             CCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEec-CCCcEEEcccccccccccccccCCCCCCCCcccC
Q 029552           42 GVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA  120 (191)
Q Consensus        42 ~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~  120 (191)
                      .....+++..++.++.|++.||+|||+.|  ++||||||+||+++ .++.++|+|||.+...... .......++..|+|
T Consensus       133 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~a  209 (383)
T 3eb0_A          133 RSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRA  209 (383)
T ss_dssp             HTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCC
T ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccC
Confidence            11234899999999999999999999999  99999999999997 6889999999998754333 22334466888999


Q ss_pred             ccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCc---------------------------ccC
Q 029552          121 PEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK---------------------------RLE  172 (191)
Q Consensus       121 pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~---------------------------~~~  172 (191)
                      ||.+.+.. ++.++|+||+|+++|+|++|..||...+..+....+.....                           ...
T Consensus       210 PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (383)
T 3eb0_A          210 PELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKI  289 (383)
T ss_dssp             HHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHH
T ss_pred             HHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhh
Confidence            99987754 88999999999999999999999999888776666542111                           111


Q ss_pred             CCCCCCHHHHHHHHHHhcC
Q 029552          173 IPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       173 ~~~~~s~~~~~li~~cl~~  191 (191)
                      +|..+|+.+.++|.+||+.
T Consensus       290 ~~~~~~~~~~~li~~~L~~  308 (383)
T 3eb0_A          290 LPEGTPSLAIDLLEQILRY  308 (383)
T ss_dssp             SCTTCCHHHHHHHHHHCCS
T ss_pred             CCCCCCHHHHHHHHHHccC
Confidence            4667999999999999974

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6e-35  Score=222.15  Aligned_cols=183  Identities=35%  Similarity=0.601  Sum_probs=146.0

Q ss_pred             CCCCCCcccccceeecC----CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhC--------C
Q 029552            3 RLRHPNIVLFMGAVTQP----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRR--------N   70 (191)
Q Consensus         3 ~l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~--------~   70 (191)
                      .++||||+++++++.+.    ...++||||+.+++|.+++....    +++.+++.++.|++.||+|||+.        +
T Consensus        87 ~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~  162 (337)
T 3mdy_A           87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA  162 (337)
T ss_dssp             TCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC
T ss_pred             hhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhccC----CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC
Confidence            35899999999999876    67999999999999999996543    89999999999999999999998        8


Q ss_pred             CCeeecCCCCCcEEecCCCcEEEccccccccccccccc----CCCCCCCCcccCccccccCCCCCc------chHHHHHH
Q 029552           71 PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS----SKSAAGTPEWMAPEVLRDEPSNEK------SDIYSFGV  140 (191)
Q Consensus        71 ~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~------~Dv~slG~  140 (191)
                        ++||||||+||+++.++.++|+|||.+.........    .....++..|+|||.+.+......      +|+||+|+
T Consensus       163 --ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~  240 (337)
T 3mdy_A          163 --IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGL  240 (337)
T ss_dssp             --EECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHH
T ss_pred             --EEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHH
Confidence              999999999999999999999999998643322111    123467889999999987766655      89999999


Q ss_pred             HHHHHHhC----------CCCCCCC-----CHHHHHHHHHhcCcccCCCC-----CCCHHHHHHHHHHhcC
Q 029552          141 ILWELATL----------QQPWGNL-----NPAQVVAAVGFKGKRLEIPR-----NVNPHVASIIEACWAK  191 (191)
Q Consensus       141 ~~~~l~~g----------~~pf~~~-----~~~~~~~~~~~~~~~~~~~~-----~~s~~~~~li~~cl~~  191 (191)
                      ++|+|++|          ..||...     ........+.........|.     .+++.+.++|.+||++
T Consensus       241 il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  311 (337)
T 3mdy_A          241 ILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAH  311 (337)
T ss_dssp             HHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCS
T ss_pred             HHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhh
Confidence            99999999          7777642     22333333433444455553     5677899999999974

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.4e-35  Score=219.49  Aligned_cols=177  Identities=20%  Similarity=0.359  Sum_probs=146.1

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC-cccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-REMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL   83 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni   83 (191)
                      +||||+++++++.+++..++||||+++++|.+++..... ...+++.+++.++.|++.||+|||+.|  ++|+||+|+||
T Consensus        69 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NI  146 (289)
T 1x8b_A           69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNI  146 (289)
T ss_dssp             SCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred             CCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHE
Confidence            899999999999999999999999999999999975321 134899999999999999999999999  99999999999


Q ss_pred             EecCC-------------------CcEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHH
Q 029552           84 LVDKK-------------------YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILW  143 (191)
Q Consensus        84 ~~~~~-------------------~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~  143 (191)
                      +++.+                   ..++|+|||.+......    ....++..|+|||.+.+. .++.++|+||+|++++
T Consensus       147 l~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~  222 (289)
T 1x8b_A          147 FISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVV  222 (289)
T ss_dssp             EEC--------------------CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHH
T ss_pred             EEcCCCCCcccccccccccccCCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHH
Confidence            99844                   47999999988754432    234578899999998776 4557899999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          144 ELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       144 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +|++|..++.....   ...+. .+.....|..+|+.++++|.+||+.
T Consensus       223 ~l~~~~~~~~~~~~---~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  266 (289)
T 1x8b_A          223 CAAGAEPLPRNGDQ---WHEIR-QGRLPRIPQVLSQEFTELLKVMIHP  266 (289)
T ss_dssp             HHTTCCCCCSSSHH---HHHHH-TTCCCCCSSCCCHHHHHHHHHHTCS
T ss_pred             HHhcCCCCCcchhH---HHHHH-cCCCCCCCcccCHHHHHHHHHHhCC
Confidence            99999887765433   22232 3455677889999999999999974

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6.2e-35  Score=226.72  Aligned_cols=179  Identities=22%  Similarity=0.384  Sum_probs=146.7

Q ss_pred             CCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEe
Q 029552            6 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV   85 (191)
Q Consensus         6 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~   85 (191)
                      ||||+++++++..++..++||| +.+++|.+++....   .+++.++..++.||+.||+|||+.+  ++||||||+||++
T Consensus       115 ~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll  188 (390)
T 2zmd_A          115 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLI  188 (390)
T ss_dssp             CTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEE
T ss_pred             CCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEE
Confidence            6999999999999999999999 55789999997644   3889999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEccccccccccccc--ccCCCCCCCCcccCcccccc-----------CCCCCcchHHHHHHHHHHHHhCCCCC
Q 029552           86 DKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRD-----------EPSNEKSDIYSFGVILWELATLQQPW  152 (191)
Q Consensus        86 ~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~-----------~~~~~~~Dv~slG~~~~~l~~g~~pf  152 (191)
                      + ++.++|+|||++.......  .......+++.|+|||.+.+           ..++.++||||||+++|+|++|..||
T Consensus       189 ~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf  267 (390)
T 2zmd_A          189 V-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF  267 (390)
T ss_dssp             S-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             E-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcc
Confidence            5 5789999999987543321  12234568899999999865           35788999999999999999999999


Q ss_pred             CCC-CHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          153 GNL-NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       153 ~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ... +.......+.........|...+..++++|.+||++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  307 (390)
T 2zmd_A          268 QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR  307 (390)
T ss_dssp             TTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCS
T ss_pred             hhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHccc
Confidence            874 444555555544556677888899999999999974

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.3e-36  Score=225.97  Aligned_cols=187  Identities=32%  Similarity=0.478  Sum_probs=149.2

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+++++|.+++........+++..++.++.|++.||+|||+.|  ++|+||+|+
T Consensus        85 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~  162 (307)
T 2nru_A           85 AKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSA  162 (307)
T ss_dssp             HHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGG
T ss_pred             HhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHH
Confidence            467899999999999999999999999999999999975443445899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      ||+++.++.++|+|||.+.......  .......++..|+|||.+.+. ++.++|+||||+++|+|++|..||.......
T Consensus       163 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  241 (307)
T 2nru_A          163 NILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQ  241 (307)
T ss_dssp             GEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred             HEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence            9999999999999999886543321  122334678899999988764 7889999999999999999999998644322


Q ss_pred             ----HHHHHHhc---------CcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 ----VVAAVGFK---------GKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ----~~~~~~~~---------~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                          ....+...         ......+..+++.+.++|.+||+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  286 (307)
T 2nru_A          242 LLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHE  286 (307)
T ss_dssp             BTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCS
T ss_pred             HHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCC
Confidence                11111111         111223445678899999999974

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7.9e-35  Score=220.65  Aligned_cols=184  Identities=23%  Similarity=0.357  Sum_probs=152.8

Q ss_pred             CCCCCCcccccceee-----cCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecC
Q 029552            3 RLRHPNIVLFMGAVT-----QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRD   77 (191)
Q Consensus         3 ~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~   77 (191)
                      +++||||+++++++.     .....++|+||+. ++|.+++.... ...+++.+++.++.|++.||+|||+.|  ++|+|
T Consensus        70 ~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~d  145 (326)
T 1blx_A           70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRD  145 (326)
T ss_dssp             HTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCC
T ss_pred             ccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecc
Confidence            358999999999987     5567999999997 59999987543 223889999999999999999999999  99999


Q ss_pred             CCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           78 LKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        78 l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      |+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.
T Consensus       146 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  224 (326)
T 1blx_A          146 LKPQNILVTSSGQIKLADFGLARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD  224 (326)
T ss_dssp             CCGGGEEECTTCCEEECSCCSCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             CCHHHeEEcCCCCEEEecCcccccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence            99999999999999999999987544332 23345678899999999988899999999999999999999999999888


Q ss_pred             HHHHHHHHhcCc-------------------------ccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGK-------------------------RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~-------------------------~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ......+.....                         ...++..+++.++++|.+||++
T Consensus       225 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  283 (326)
T 1blx_A          225 VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTF  283 (326)
T ss_dssp             HHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCS
T ss_pred             HHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCC
Confidence            777666542110                         1123467899999999999974

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.2e-35  Score=232.70  Aligned_cols=183  Identities=26%  Similarity=0.403  Sum_probs=140.5

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.. +..++||||+.+++|.+++...+   .+++.+++.++.|++.||+|||+.+  ++||||||+
T Consensus       195 ~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~  268 (419)
T 3i6u_A          195 KKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPE  268 (419)
T ss_dssp             HHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGG
T ss_pred             HhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChH
Confidence            46799999999999865 45899999999999999987644   3899999999999999999999999  999999999


Q ss_pred             cEEecCCC---cEEEcccccccccccccccCCCCCCCCcccCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           82 NLLVDKKY---TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD---EPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        82 ni~~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~---~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      ||+++.++   .++|+|||++...... .......+++.|+|||.+.+   ..++.++|+||+|+++|+|++|..||...
T Consensus       269 NIll~~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~  347 (419)
T 3i6u_A          269 NVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH  347 (419)
T ss_dssp             GEEESSSSSSCCEEECCSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred             hEEEecCCCcceEEEeecccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence            99997654   4999999998765433 22334567889999999854   45677899999999999999999999864


Q ss_pred             CHH-HHHHHHHhcCcc--cCCCCCCCHHHHHHHHHHhcC
Q 029552          156 NPA-QVVAAVGFKGKR--LEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~-~~~~~~~~~~~~--~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ... .....+......  ...+..+|+.+.++|.+||++
T Consensus       348 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~  386 (419)
T 3i6u_A          348 RTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVV  386 (419)
T ss_dssp             SSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCS
T ss_pred             cchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccC
Confidence            433 233333322111  122357999999999999974

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=8e-35  Score=222.98  Aligned_cols=185  Identities=22%  Similarity=0.287  Sum_probs=147.6

Q ss_pred             CCCCCCCcccccceeec--------CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCe
Q 029552            2 KRLRHPNIVLFMGAVTQ--------PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPI   73 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~   73 (191)
                      ++++||||+++++++.+        .+..++||||+.+ +|.+.+.....  .+++.+++.++.|++.||+|||+.|  +
T Consensus        71 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~--i  145 (351)
T 3mi9_A           71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRNK--I  145 (351)
T ss_dssp             HHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred             HhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--e
Confidence            46789999999999976        4468999999975 77777765432  3899999999999999999999999  9


Q ss_pred             eecCCCCCcEEecCCCcEEEcccccccccccc----cccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhC
Q 029552           74 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT----FLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATL  148 (191)
Q Consensus        74 ~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g  148 (191)
                      +||||+|+||+++.++.++|+|||.+......    ........+++.|+|||.+.+. .++.++|+||+|+++|+|++|
T Consensus       146 vH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g  225 (351)
T 3mi9_A          146 LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR  225 (351)
T ss_dssp             ECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred             eCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhC
Confidence            99999999999999999999999998654321    1122334568899999998764 478999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhcCcccC--CCCC----------------------------CCHHHHHHHHHHhcC
Q 029552          149 QQPWGNLNPAQVVAAVGFKGKRLE--IPRN----------------------------VNPHVASIIEACWAK  191 (191)
Q Consensus       149 ~~pf~~~~~~~~~~~~~~~~~~~~--~~~~----------------------------~s~~~~~li~~cl~~  191 (191)
                      ..||...+.......+.......+  ..+.                            .++.++++|.+||++
T Consensus       226 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  298 (351)
T 3mi9_A          226 SPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL  298 (351)
T ss_dssp             SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCS
T ss_pred             CCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcC
Confidence            999999888877776643222111  1111                            277899999999974

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.1e-35  Score=223.26  Aligned_cols=186  Identities=31%  Similarity=0.510  Sum_probs=149.6

Q ss_pred             CCCCCCCcccccceeecCC--ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      ++++||||+++++++...+  ..++|+||+++++|.+++.....  .+++.+++.++.|+++||++||+.|  ++|+||+
T Consensus        97 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dik  172 (326)
T 2w1i_A           97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLA  172 (326)
T ss_dssp             HTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCC
T ss_pred             HhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCC
Confidence            5689999999999886543  78999999999999999976432  3899999999999999999999999  9999999


Q ss_pred             CCcEEecCCCcEEEcccccccccccccc---cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN  156 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~  156 (191)
                      |+||+++.++.++|+|||.+........   ......++..|+|||.+.+..++.++|+||||+++++|++|..||....
T Consensus       173 p~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~  252 (326)
T 2w1i_A          173 TRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP  252 (326)
T ss_dssp             GGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH
T ss_pred             cceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH
Confidence            9999999999999999999875433211   1223345667999999988888899999999999999999999886431


Q ss_pred             HH---------------HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          157 PA---------------QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~---------------~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..               ...........+.+.|..+|+.+.++|.+||++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  302 (326)
T 2w1i_A          253 AEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNN  302 (326)
T ss_dssp             HHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCS
T ss_pred             HHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCC
Confidence            11               011122224456677889999999999999974

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.8e-35  Score=225.97  Aligned_cols=150  Identities=15%  Similarity=0.150  Sum_probs=129.9

Q ss_pred             CCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCC--CcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG--VREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         3 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      ...|+||+++++++..++..++||||+++++|.+++....  ....+++.+++.++.|++.||+|||+.|  ++||||||
T Consensus       123 ~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp  200 (365)
T 3e7e_A          123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKP  200 (365)
T ss_dssp             GGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSG
T ss_pred             hhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCH
Confidence            3459999999999999999999999999999999996411  1234899999999999999999999999  99999999


Q ss_pred             CcEEecC-----------CCcEEEcccccccccc--cccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh
Q 029552           81 PNLLVDK-----------KYTVKVCDFGLSRLKA--NTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT  147 (191)
Q Consensus        81 ~ni~~~~-----------~~~~~l~d~~~~~~~~--~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~  147 (191)
                      +||+++.           ++.++|+|||++....  ..........++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus       201 ~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt  280 (365)
T 3e7e_A          201 DNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF  280 (365)
T ss_dssp             GGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHH
T ss_pred             HHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHh
Confidence            9999988           8999999999986432  11123344568899999999999989999999999999999999


Q ss_pred             CCCCCCC
Q 029552          148 LQQPWGN  154 (191)
Q Consensus       148 g~~pf~~  154 (191)
                      |..||..
T Consensus       281 g~~pf~~  287 (365)
T 3e7e_A          281 GTYMKVK  287 (365)
T ss_dssp             SSCCCEE
T ss_pred             CCCcccc
Confidence            9999864

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.6e-35  Score=234.53  Aligned_cols=155  Identities=28%  Similarity=0.418  Sum_probs=128.3

Q ss_pred             CCCCCCCcccccceeecC------CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 029552            2 KRLRHPNIVLFMGAVTQP------PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH   75 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h   75 (191)
                      +.++||||++++++|...      ...|+||||+.+ +|.+.+..     .+++.++..++.|++.||+|||+.|  ++|
T Consensus       116 ~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~--iiH  187 (464)
T 3ttj_A          116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIH  187 (464)
T ss_dssp             HHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred             HhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC--ccc
Confidence            467999999999999654      357999999976 57666643     1789999999999999999999999  999


Q ss_pred             cCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        76 ~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      |||||+||+++.++.++|+|||++...... .......+++.|+|||.+.+..++.++|+||+||++|+|++|..||...
T Consensus       188 rDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~  266 (464)
T 3ttj_A          188 RDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR  266 (464)
T ss_dssp             CCCCGGGEEECTTSCEEECCCCCC-----C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCCChHhEEEeCCCCEEEEEEEeeeecCCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999998755433 2233456788999999999999999999999999999999999999998


Q ss_pred             CHHHHHHHHH
Q 029552          156 NPAQVVAAVG  165 (191)
Q Consensus       156 ~~~~~~~~~~  165 (191)
                      +..+....+.
T Consensus       267 ~~~~~~~~i~  276 (464)
T 3ttj_A          267 DYIDQWNKVI  276 (464)
T ss_dssp             SHHHHHHHHH
T ss_pred             CHHHHHHHHH
Confidence            8777666654

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=6e-35  Score=228.80  Aligned_cols=187  Identities=22%  Similarity=0.303  Sum_probs=144.5

Q ss_pred             CCCCCCCCcccccceeecC------CceEEEEeccCCCCHHHHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhCCCCe
Q 029552            1 MKRLRHPNIVLFMGAVTQP------PNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDVAKGMNYLHRRNPPI   73 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~   73 (191)
                      |++++||||++++++|...      ...++||||+.+ +|.+.+... .....+++..++.++.||++||+|||+.|  +
T Consensus       101 l~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--i  177 (420)
T 1j1b_A          101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--I  177 (420)
T ss_dssp             HHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--E
T ss_pred             HHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--c
Confidence            3578999999999988431      236799999976 676665421 11234899999999999999999999999  9


Q ss_pred             eecCCCCCcEEecCC-CcEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCC
Q 029552           74 VHRDLKSPNLLVDKK-YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQP  151 (191)
Q Consensus        74 ~h~~l~p~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p  151 (191)
                      +||||||+||+++.+ +.+||+|||++....... ......++..|+|||.+.+. .++.++|+||+||++|+|++|..|
T Consensus       178 vHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~p  256 (420)
T 1j1b_A          178 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI  256 (420)
T ss_dssp             ECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccCCChhhEEEeCCCCeEEeccchhhhhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCC
Confidence            999999999999965 568999999987543321 22334678899999998765 688999999999999999999999


Q ss_pred             CCCCCHHHHHHHHHhcCc---------------ccC------------CCCCCCHHHHHHHHHHhcC
Q 029552          152 WGNLNPAQVVAAVGFKGK---------------RLE------------IPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       152 f~~~~~~~~~~~~~~~~~---------------~~~------------~~~~~s~~~~~li~~cl~~  191 (191)
                      |...+..+.+..+.....               ...            ++..+++.++++|.+||++
T Consensus       257 f~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~  323 (420)
T 1j1b_A          257 FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEY  323 (420)
T ss_dssp             SCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCS
T ss_pred             CCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccC
Confidence            998877665554432100               011            3456899999999999974

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=5.9e-35  Score=217.26  Aligned_cols=180  Identities=26%  Similarity=0.408  Sum_probs=148.0

Q ss_pred             CCCCCCCcccccceeec----------------CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHH
Q 029552            2 KRLRHPNIVLFMGAVTQ----------------PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNY   65 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~   65 (191)
                      ++++||||+++++++..                ....++||||+++++|.+++.... ...+++.+++.++.|++.||.+
T Consensus        59 ~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~  137 (284)
T 2a19_B           59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDY  137 (284)
T ss_dssp             HHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHH
T ss_pred             HhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHH
Confidence            46799999999998854                345899999999999999996532 2348999999999999999999


Q ss_pred             HHhCCCCeeecCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHH
Q 029552           66 LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL  145 (191)
Q Consensus        66 Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l  145 (191)
                      ||+.|  ++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|+++|+|
T Consensus       138 lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l  214 (284)
T 2a19_B          138 IHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL  214 (284)
T ss_dssp             HHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHH
T ss_pred             HHhCC--eeeccCCHHHEEEcCCCCEEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHH
Confidence            99999  9999999999999999999999999886544331 22344578899999999988889999999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          146 ATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       146 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ++|..|+...  ......+.    ....+..++..++++|.+||++
T Consensus       215 ~~~~~~~~~~--~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~  254 (284)
T 2a19_B          215 LHVCDTAFET--SKFFTDLR----DGIISDIFDKKEKTLLQKLLSK  254 (284)
T ss_dssp             HSCCSSHHHH--HHHHHHHH----TTCCCTTSCHHHHHHHHHHTCS
T ss_pred             HhcCCcchhH--HHHHHHhh----cccccccCCHHHHHHHHHHccC
Confidence            9999887532  22222232    2345678999999999999974

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=5.4e-35  Score=222.50  Aligned_cols=184  Identities=30%  Similarity=0.437  Sum_probs=140.8

Q ss_pred             CCCCCCCcccccceee-----cCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhC-------
Q 029552            2 KRLRHPNIVLFMGAVT-----QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRR-------   69 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-------   69 (191)
                      +.++||||+++++.+.     .....++||||+++++|.+++....    .++..++.++.|+++||+|||+.       
T Consensus        62 ~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~  137 (336)
T 3g2f_A           62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHY  137 (336)
T ss_dssp             TTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGC
T ss_pred             HhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhcccccc
Confidence            4689999999997553     2336789999999999999997543    57889999999999999999999       


Q ss_pred             --CCCeeecCCCCCcEEecCCCcEEEcccccccccccc--------cccCCCCCCCCcccCccccccC-------CCCCc
Q 029552           70 --NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--------FLSSKSAAGTPEWMAPEVLRDE-------PSNEK  132 (191)
Q Consensus        70 --~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~--------~~~~~~~~~~~~~~~pe~~~~~-------~~~~~  132 (191)
                        +  ++||||||+||+++.++.++|+|||++......        ........++..|+|||.+.+.       .++.+
T Consensus       138 ~~~--ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~  215 (336)
T 3g2f_A          138 KPA--ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQ  215 (336)
T ss_dssp             BCC--EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHH
T ss_pred             ccc--eeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccc
Confidence              9  999999999999999999999999998654321        1112234578899999998763       34567


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCC------------------HHHHHHHHHhcCcccCCCCC------CCHHHHHHHHHH
Q 029552          133 SDIYSFGVILWELATLQQPWGNLN------------------PAQVVAAVGFKGKRLEIPRN------VNPHVASIIEAC  188 (191)
Q Consensus       133 ~Dv~slG~~~~~l~~g~~pf~~~~------------------~~~~~~~~~~~~~~~~~~~~------~s~~~~~li~~c  188 (191)
                      +|+||+|+++|+|++|..||....                  .......+.....++.+|..      +++.+.++|.+|
T Consensus       216 ~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  295 (336)
T 3g2f_A          216 VDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC  295 (336)
T ss_dssp             HHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHH
T ss_pred             cchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHH
Confidence            999999999999999977653211                  12222333334445555554      345899999999


Q ss_pred             hcC
Q 029552          189 WAK  191 (191)
Q Consensus       189 l~~  191 (191)
                      |++
T Consensus       296 l~~  298 (336)
T 3g2f_A          296 WDQ  298 (336)
T ss_dssp             SCS
T ss_pred             hcC
Confidence            974

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.5e-35  Score=224.74  Aligned_cols=184  Identities=24%  Similarity=0.402  Sum_probs=126.1

Q ss_pred             CCCCCCcccccceeec----CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            3 RLRHPNIVLFMGAVTQ----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         3 ~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      .++||||+++++++..    +...++||||+.+++|.+++.... ...+++.+++.++.|++.||+|||+.|  ++|+||
T Consensus        78 ~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dl  154 (336)
T 3fhr_A           78 ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDV  154 (336)
T ss_dssp             HTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCC
T ss_pred             hcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCC
Confidence            4689999999999975    445899999999999999997654 234899999999999999999999999  999999


Q ss_pred             CCCcEEecCC---CcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           79 KSPNLLVDKK---YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        79 ~p~ni~~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      +|+||+++.+   +.++|+|||.+......  ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...
T Consensus       155 kp~NIll~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  232 (336)
T 3fhr_A          155 KPENLLYTSKEKDAVLKLTDFGFAKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN  232 (336)
T ss_dssp             SGGGEEESCSSTTCCEEECCCTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             CHHHEEEEecCCCceEEEeccccceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            9999999764   45999999998754433  223445688999999998888888999999999999999999999876


Q ss_pred             CHHHHHH----HHHhcCc--ccCCCCCCCHHHHHHHHHHhcC
Q 029552          156 NPAQVVA----AVGFKGK--RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~~~~~----~~~~~~~--~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .......    .+.....  +.+....+|+.++++|.+||+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  274 (336)
T 3fhr_A          233 TGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKT  274 (336)
T ss_dssp             ------------------CCCTTTSTTCCHHHHHHHHHHSCS
T ss_pred             cchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCC
Confidence            5544322    2211111  2222357999999999999964

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.3e-34  Score=222.63  Aligned_cols=184  Identities=19%  Similarity=0.315  Sum_probs=142.7

Q ss_pred             CCCCCCCcccccceeec-----CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeec
Q 029552            2 KRLRHPNIVLFMGAVTQ-----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR   76 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~   76 (191)
                      ++++||||+++++++..     ....++||||+. ++|.+.+....  ..+++.++..++.|++.||+|||+.|  ++|+
T Consensus        84 ~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~  158 (362)
T 3pg1_A           84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEAG--VVHR  158 (362)
T ss_dssp             HHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCC
T ss_pred             HhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCc--CEec
Confidence            46799999999999843     346899999997 58888886543  23899999999999999999999999  9999


Q ss_pred             CCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           77 DLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        77 ~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      ||+|+||+++.++.++|+|||.+...... .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...
T Consensus       159 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  237 (362)
T 3pg1_A          159 DLHPGNILLADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS  237 (362)
T ss_dssp             CCCGGGEEECTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCChHHEEEcCCCCEEEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999998643333 12233456788999999876 56889999999999999999999999998


Q ss_pred             CHHHHHHHHHhcCcc------------------------------cCCCCCCCHHHHHHHHHHhcC
Q 029552          156 NPAQVVAAVGFKGKR------------------------------LEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~~~~~~~~~~~~~------------------------------~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +..+....+......                              ...+..+++.+.++|.+||+.
T Consensus       238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  303 (362)
T 3pg1_A          238 TFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEF  303 (362)
T ss_dssp             SHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCS
T ss_pred             CHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcC
Confidence            877766665321111                              112356799999999999974

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=9.9e-35  Score=223.92  Aligned_cols=180  Identities=24%  Similarity=0.401  Sum_probs=135.7

Q ss_pred             CCCCCCCcccccceeecC------CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 029552            2 KRLRHPNIVLFMGAVTQP------PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH   75 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h   75 (191)
                      ++++||||+++++++...      ...++++|++ +++|.+++...    .+++.++..++.||+.||+|||+.|  ++|
T Consensus        83 ~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g--ivH  155 (367)
T 2fst_X           83 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD--IIH  155 (367)
T ss_dssp             HHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred             HhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eee
Confidence            467899999999998654      5689999999 67999988652    2899999999999999999999999  999


Q ss_pred             cCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 029552           76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGN  154 (191)
Q Consensus        76 ~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~pf~~  154 (191)
                      |||||+||+++.++.++|+|||++......   .....++..|+|||.+.+ ..++.++|+||+||++++|++|..||..
T Consensus       156 ~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  232 (367)
T 2fst_X          156 RDLKPSNLAVNEDCELKILDFGLARHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG  232 (367)
T ss_dssp             CCCCGGGEEECTTCCEEECC------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CCCCHhhEEECCCCCEEEeecccccccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999998754332   223467889999999877 5688999999999999999999999998


Q ss_pred             CCHHHHHHHHHhcCccc-----------------------------CCCCCCCHHHHHHHHHHhcC
Q 029552          155 LNPAQVVAAVGFKGKRL-----------------------------EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       155 ~~~~~~~~~~~~~~~~~-----------------------------~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+.......+......+                             ....++++.+.++|++||..
T Consensus       233 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~  298 (367)
T 2fst_X          233 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVL  298 (367)
T ss_dssp             SSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCS
T ss_pred             CCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCC
Confidence            88776665553211100                             01236789999999999963

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.2e-34  Score=223.11  Aligned_cols=183  Identities=25%  Similarity=0.412  Sum_probs=148.3

Q ss_pred             CCCCCCCcccccceeecC-----CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeec
Q 029552            2 KRLRHPNIVLFMGAVTQP-----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR   76 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~   76 (191)
                      ++++||||+++++++...     ...++|+|++.+ +|.+++....    +++.+++.++.|++.||+|||+.|  ++|+
T Consensus        80 ~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~~----~~~~~~~~i~~qi~~aL~~LH~~~--ivH~  152 (364)
T 3qyz_A           80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSAN--VLHR  152 (364)
T ss_dssp             HHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSE-EHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTT--EECC
T ss_pred             HhcCCCCCccceeEEecCCccccceEEEEEcccCc-CHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHCC--eecC
Confidence            467999999999999654     468999999975 9999886532    899999999999999999999999  9999


Q ss_pred             CCCCCcEEecCCCcEEEcccccccccccccc---cCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCC
Q 029552           77 DLKSPNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPW  152 (191)
Q Consensus        77 ~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~pf  152 (191)
                      ||+|+||+++.++.++|+|||.+........   ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||
T Consensus       153 Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf  232 (364)
T 3qyz_A          153 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF  232 (364)
T ss_dssp             CCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCC
Confidence            9999999999999999999999875443321   1234467889999998654 44789999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhcCcc-----------------------------cCCCCCCCHHHHHHHHHHhcC
Q 029552          153 GNLNPAQVVAAVGFKGKR-----------------------------LEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+..+....+......                             ...+.++++.+.++|.+||+.
T Consensus       233 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  300 (364)
T 3qyz_A          233 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTF  300 (364)
T ss_dssp             CCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCS
T ss_pred             CCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCC
Confidence            887766665554321100                             112356899999999999974

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4.2e-34  Score=224.76  Aligned_cols=144  Identities=33%  Similarity=0.491  Sum_probs=119.4

Q ss_pred             CCCCCCCcccccceeecC-----CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeec
Q 029552            2 KRLRHPNIVLFMGAVTQP-----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR   76 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~   76 (191)
                      ++++||||+++++++...     +..|+|||++. ++|.+++....   .+++.+++.++.||+.||+|||+.|  ++||
T Consensus        80 ~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~g--ivHr  153 (432)
T 3n9x_A           80 NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHESG--IIHR  153 (432)
T ss_dssp             HHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECC
T ss_pred             HHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC--CCCC
Confidence            467899999999999765     57999999996 59999997643   3899999999999999999999999  9999


Q ss_pred             CCCCCcEEecCCCcEEEcccccccccccccc----------------------cCCCCCCCCcccCcccc-ccCCCCCcc
Q 029552           77 DLKSPNLLVDKKYTVKVCDFGLSRLKANTFL----------------------SSKSAAGTPEWMAPEVL-RDEPSNEKS  133 (191)
Q Consensus        77 ~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~----------------------~~~~~~~~~~~~~pe~~-~~~~~~~~~  133 (191)
                      ||||+||+++.++.++|+|||++........                      ......++..|+|||.+ .+..++.++
T Consensus       154 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~  233 (432)
T 3n9x_A          154 DLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI  233 (432)
T ss_dssp             CCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHH
T ss_pred             CCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCccc
Confidence            9999999999999999999999875432211                      12345678899999986 555689999


Q ss_pred             hHHHHHHHHHHHHhCCCC
Q 029552          134 DIYSFGVILWELATLQQP  151 (191)
Q Consensus       134 Dv~slG~~~~~l~~g~~p  151 (191)
                      |+||+||++|+|++|..|
T Consensus       234 DiwSlG~il~ell~g~~p  251 (432)
T 3n9x_A          234 DIWSTGCIFAELLNMLQS  251 (432)
T ss_dssp             HHHHHHHHHHHHHTTCTT
T ss_pred             ccchHHHHHHHHHhcccc
Confidence            999999999999985333

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.6e-35  Score=222.48  Aligned_cols=183  Identities=26%  Similarity=0.397  Sum_probs=144.8

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++..++ .++||||+.+++|.+++....   .+++.+++.++.|++.||+|||+.|  ++|+||+|+
T Consensus        70 ~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~  143 (322)
T 2ycf_A           70 KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPE  143 (322)
T ss_dssp             HHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred             HhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHH
Confidence            4578999999999987655 899999999999999987643   3899999999999999999999999  999999999


Q ss_pred             cEEecCCCc---EEEcccccccccccccccCCCCCCCCcccCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           82 NLLVDKKYT---VKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR---DEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        82 ni~~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      ||+++.++.   ++|+|||.+....... ......++..|+|||.+.   ...++.++|+||||+++|+|++|..||...
T Consensus       144 NIl~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  222 (322)
T 2ycf_A          144 NVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH  222 (322)
T ss_dssp             GEEESSSSSSCCEEECCCTTCEECCCCH-HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCST
T ss_pred             HEEEecCCCCCeEEEccCccceeccccc-ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            999987664   9999999986543321 111234677899999874   456788999999999999999999999764


Q ss_pred             CHH-HHHHHHHhcCcc--cCCCCCCCHHHHHHHHHHhcC
Q 029552          156 NPA-QVVAAVGFKGKR--LEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~-~~~~~~~~~~~~--~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ... .....+......  ...+..+|+.+.++|.+||+.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  261 (322)
T 2ycf_A          223 RTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVV  261 (322)
T ss_dssp             TCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCS
T ss_pred             chHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHccc
Confidence            432 233333222111  122367899999999999973

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.4e-34  Score=216.51  Aligned_cols=184  Identities=20%  Similarity=0.265  Sum_probs=144.4

Q ss_pred             CCCCCCccccccee-ecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            3 RLRHPNIVLFMGAV-TQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         3 ~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +++|++++..+..+ .+++..++||||+ +++|.+++.....  .+++.+++.++.|++.||+|||+++  ++|+||+|+
T Consensus        60 ~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~  134 (296)
T 3uzp_A           60 MMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPD  134 (296)
T ss_dssp             HHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGG
T ss_pred             HhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHH
Confidence            45777766655544 6777889999999 8899999974332  3899999999999999999999999  999999999


Q ss_pred             cEEec---CCCcEEEcccccccccccccc-------cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 029552           82 NLLVD---KKYTVKVCDFGLSRLKANTFL-------SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQP  151 (191)
Q Consensus        82 ni~~~---~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p  151 (191)
                      ||+++   .++.++|+|||.+........       ......++..|+|||.+.+..++.++|+||+|+++|+|++|..|
T Consensus       135 NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p  214 (296)
T 3uzp_A          135 NFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP  214 (296)
T ss_dssp             GEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             HeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence            99994   788999999999875443321       12345678899999999998899999999999999999999999


Q ss_pred             CCCCCH---HHHHHHHHhc---CcccCCCCCCCHHHHHHHHHHhcC
Q 029552          152 WGNLNP---AQVVAAVGFK---GKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       152 f~~~~~---~~~~~~~~~~---~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      |.....   ......+...   ......+..+|+.+.++|.+||++
T Consensus       215 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  260 (296)
T 3uzp_A          215 WQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSL  260 (296)
T ss_dssp             TSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTS
T ss_pred             CCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhc
Confidence            986322   2222222211   112223478999999999999974

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.3e-35  Score=229.54  Aligned_cols=187  Identities=26%  Similarity=0.392  Sum_probs=147.1

Q ss_pred             CCCCCCCcccccceeecCC--ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      ++++||||+++++++.+.+  ..++||||+.+++|.+++........+++.+++.++.|++.||+|||+.|  ++|||||
T Consensus        62 ~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlk  139 (396)
T 4eut_A           62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIK  139 (396)
T ss_dssp             HHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCC
T ss_pred             HhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcC
Confidence            4678999999999998655  78999999999999999987554444899999999999999999999999  9999999


Q ss_pred             CCcEEe----cCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc--------CCCCCcchHHHHHHHHHHHHh
Q 029552           80 SPNLLV----DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD--------EPSNEKSDIYSFGVILWELAT  147 (191)
Q Consensus        80 p~ni~~----~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Dv~slG~~~~~l~~  147 (191)
                      |+||++    +.++.++|+|||.+....... ......++..|+|||.+.+        ..++.++|+||+|+++|+|++
T Consensus       140 p~NIll~~~~~~~~~~kL~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~t  218 (396)
T 4eut_A          140 PGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT  218 (396)
T ss_dssp             GGGEEEEECTTSCEEEEECCGGGCEECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHEEEeecCCCceeEEEecCCCceEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHH
Confidence            999998    777789999999987544332 2334567889999998865        345678999999999999999


Q ss_pred             CCCCCCC----CCHHHHHHHHHhcCcc-------------------c----CCCCCCCHHHHHHHHHHhcC
Q 029552          148 LQQPWGN----LNPAQVVAAVGFKGKR-------------------L----EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       148 g~~pf~~----~~~~~~~~~~~~~~~~-------------------~----~~~~~~s~~~~~li~~cl~~  191 (191)
                      |..||..    ....+....+......                   .    .++..+++.+.++|++||++
T Consensus       219 g~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~  289 (396)
T 4eut_A          219 GSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA  289 (396)
T ss_dssp             SSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCC
T ss_pred             CCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhcc
Confidence            9999964    2333444444332211                   0    11234567889999999874

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.2e-34  Score=223.73  Aligned_cols=155  Identities=29%  Similarity=0.420  Sum_probs=126.3

Q ss_pred             CCCCCCCcccccceeecCC------ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 029552            2 KRLRHPNIVLFMGAVTQPP------NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH   75 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h   75 (191)
                      ++++||||+++++++...+      ..++||||+.+ +|.+.+..     .+++.++..++.|++.||+|||+.|  ++|
T Consensus        79 ~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~--ivH  150 (371)
T 2xrw_A           79 KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIH  150 (371)
T ss_dssp             HHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred             HhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC--eec
Confidence            4679999999999997654      68999999975 78888853     2789999999999999999999999  999


Q ss_pred             cCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        76 ~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      |||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...
T Consensus       151 ~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  229 (371)
T 2xrw_A          151 RDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT  229 (371)
T ss_dssp             SCCCGGGEEECTTSCEEECCCCC-----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccCCHHHEEEcCCCCEEEEEeeccccccccc-ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999987544321 223346788999999999988999999999999999999999999998


Q ss_pred             CHHHHHHHHH
Q 029552          156 NPAQVVAAVG  165 (191)
Q Consensus       156 ~~~~~~~~~~  165 (191)
                      +.......+.
T Consensus       230 ~~~~~~~~i~  239 (371)
T 2xrw_A          230 DHIDQWNKVI  239 (371)
T ss_dssp             SHHHHHHHHH
T ss_pred             CHHHHHHHHH
Confidence            8877766654

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=8.5e-34  Score=222.78  Aligned_cols=156  Identities=24%  Similarity=0.300  Sum_probs=135.4

Q ss_pred             CCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCc
Q 029552            3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN   82 (191)
Q Consensus         3 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~n   82 (191)
                      ..+|+||+++++++...+..++|||++. ++|.+++..... ..+++.+++.++.||+.||+|||+.+  ++||||||+|
T Consensus       155 ~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~N  230 (429)
T 3kvw_A          155 KDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPEN  230 (429)
T ss_dssp             TTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGG
T ss_pred             ccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHH
Confidence            3479999999999999999999999996 599998875442 23899999999999999999999999  9999999999


Q ss_pred             EEecCCCc--EEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           83 LLVDKKYT--VKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        83 i~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      |+++.++.  ++|+|||++......   .....+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+..+.
T Consensus       231 ILl~~~~~~~vkL~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~  307 (429)
T 3kvw_A          231 ILLKQQGRSGIKVIDFGSSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ  307 (429)
T ss_dssp             EEESSTTSCCEEECCCTTCEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             eEEccCCCcceEEeecccceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99999887  999999998654332   2334678899999999998899999999999999999999999998887776


Q ss_pred             HHHHH
Q 029552          161 VAAVG  165 (191)
Q Consensus       161 ~~~~~  165 (191)
                      ...+.
T Consensus       308 l~~i~  312 (429)
T 3kvw_A          308 LACMI  312 (429)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            65553

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.5e-34  Score=214.24  Aligned_cols=184  Identities=21%  Similarity=0.270  Sum_probs=144.5

Q ss_pred             CCCCCCccccccee-ecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            3 RLRHPNIVLFMGAV-TQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         3 ~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +++|++++..+..+ .+++..++|||++ +++|.+++.....  .+++.+++.++.|++.||+|||+.|  ++|+||+|+
T Consensus        60 ~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~  134 (296)
T 4hgt_A           60 MMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPD  134 (296)
T ss_dssp             HHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred             HhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHH
Confidence            45677766655544 6777889999999 8899999974332  3899999999999999999999999  999999999


Q ss_pred             cEEe---cCCCcEEEcccccccccccccc-------cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 029552           82 NLLV---DKKYTVKVCDFGLSRLKANTFL-------SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQP  151 (191)
Q Consensus        82 ni~~---~~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p  151 (191)
                      ||++   +.++.++|+|||.+........       ......++..|+|||.+.+..++.++|+||+|+++|+|++|..|
T Consensus       135 NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p  214 (296)
T 4hgt_A          135 NFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP  214 (296)
T ss_dssp             GEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             HeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCC
Confidence            9999   7888999999999875433211       22345678899999999998899999999999999999999999


Q ss_pred             CCCCCHH---HHHHHHHhcCc---ccCCCCCCCHHHHHHHHHHhcC
Q 029552          152 WGNLNPA---QVVAAVGFKGK---RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       152 f~~~~~~---~~~~~~~~~~~---~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      |...+..   .....+.....   ....+..+|+.+.++|.+||++
T Consensus       215 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  260 (296)
T 4hgt_A          215 WQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSL  260 (296)
T ss_dssp             TSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTS
T ss_pred             CcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhc
Confidence            9763322   22222211111   1223378899999999999974

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.1e-34  Score=219.66  Aligned_cols=183  Identities=33%  Similarity=0.555  Sum_probs=147.2

Q ss_pred             CCCCCCcccccceeecCC----ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHH--------hCC
Q 029552            3 RLRHPNIVLFMGAVTQPP----NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLH--------RRN   70 (191)
Q Consensus         3 ~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh--------~~~   70 (191)
                      +++||||+++++++.+..    ..++||||+.+++|.+++.+..    +++.+++.++.|++.||+|||        +.+
T Consensus        92 ~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~  167 (342)
T 1b6c_B           92 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPA  167 (342)
T ss_dssp             CCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE
T ss_pred             hcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhccC----ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC
Confidence            378999999999998765    7999999999999999997532    889999999999999999999        889


Q ss_pred             CCeeecCCCCCcEEecCCCcEEEcccccccccccccc----cCCCCCCCCcccCccccccCCC------CCcchHHHHHH
Q 029552           71 PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL----SSKSAAGTPEWMAPEVLRDEPS------NEKSDIYSFGV  140 (191)
Q Consensus        71 ~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~------~~~~Dv~slG~  140 (191)
                        ++|+||+|+||+++.++.++|+|||.+........    ......++..|+|||.+.+...      +.++|+||+|+
T Consensus       168 --ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~  245 (342)
T 1b6c_B          168 --IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL  245 (342)
T ss_dssp             --EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHH
T ss_pred             --eeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHH
Confidence              99999999999999999999999999865443321    2234567889999999877632      25799999999


Q ss_pred             HHHHHHhC----------CCCCCCC-----CHHHHHHHHHhcCcccCCCC-----CCCHHHHHHHHHHhcC
Q 029552          141 ILWELATL----------QQPWGNL-----NPAQVVAAVGFKGKRLEIPR-----NVNPHVASIIEACWAK  191 (191)
Q Consensus       141 ~~~~l~~g----------~~pf~~~-----~~~~~~~~~~~~~~~~~~~~-----~~s~~~~~li~~cl~~  191 (191)
                      ++|+|++|          ..||...     ........+.....++..|.     .+++.+.++|.+||++
T Consensus       246 il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  316 (342)
T 1b6c_B          246 VFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA  316 (342)
T ss_dssp             HHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCS
T ss_pred             HHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhcc
Confidence            99999999          7898764     23444444433444445553     3456899999999974

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.4e-34  Score=218.33  Aligned_cols=185  Identities=28%  Similarity=0.507  Sum_probs=129.0

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcC--CCCcccccHHHHHHHHHHHHHHHHHHHhC-CCCeeecCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK--PGVREMLDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDL   78 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~~~~~h~~l   78 (191)
                      +.++||||+++++++.+++..++||||+.+ +|.+++..  ......+++..+..++.|++.||.+||+. |  ++|+||
T Consensus        76 ~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dl  152 (327)
T 3aln_A           76 RSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDI  152 (327)
T ss_dssp             SSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCC
T ss_pred             HcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCC
Confidence            567999999999999999999999999985 88877752  11123489999999999999999999998 9  999999


Q ss_pred             CCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccc----ccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 029552           79 KSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL----RDEPSNEKSDIYSFGVILWELATLQQPWGN  154 (191)
Q Consensus        79 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~----~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~  154 (191)
                      +|+||+++.++.++|+|||.+....... ......++..|+|||.+    .+..++.++|+||||+++|+|++|..||..
T Consensus       153 kp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  231 (327)
T 3aln_A          153 KPSNILLDRSGNIKLCDFGISGQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK  231 (327)
T ss_dssp             CGGGEEEETTTEEEECCCSSSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred             CHHHEEEcCCCCEEEccCCCceeccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            9999999999999999999986544331 22233577889999998    455678899999999999999999999987


Q ss_pred             CCHH-HHHHHHHhcCcccCCC----CCCCHHHHHHHHHHhcC
Q 029552          155 LNPA-QVVAAVGFKGKRLEIP----RNVNPHVASIIEACWAK  191 (191)
Q Consensus       155 ~~~~-~~~~~~~~~~~~~~~~----~~~s~~~~~li~~cl~~  191 (191)
                      .... +....+. .+....++    ..+++.+.++|.+||+.
T Consensus       232 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~  272 (327)
T 3aln_A          232 WNSVFDQLTQVV-KGDPPQLSNSEEREFSPSFINFVNLCLTK  272 (327)
T ss_dssp             C-------CCCC-CSCCCCCCCCSSCCCCHHHHHHHHHHTCS
T ss_pred             cchHHHHHHHHh-cCCCCCCCCcccccCCHHHHHHHHHHhhC
Confidence            5432 2222221 22222222    46899999999999974

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.5e-34  Score=220.71  Aligned_cols=186  Identities=22%  Similarity=0.258  Sum_probs=145.1

Q ss_pred             CCCCCCCcccccceeecCCc-------eEEEEeccCCCCHHHHhcC-CCCcccccHHHHHHHHHHHHHHHHHHH--hCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPN-------LSIVTEYLSRGSLYRLLHK-PGVREMLDERRRLNMAYDVAKGMNYLH--RRNP   71 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~-------~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~Lh--~~~~   71 (191)
                      ++++||||++++++|...+.       .++||||+.+ +|.+.+.. ......+++..+..++.|++.||.|||  +.| 
T Consensus        74 ~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~-  151 (360)
T 3e3p_A           74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN-  151 (360)
T ss_dssp             HHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC-
T ss_pred             HhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC-
Confidence            34689999999999965332       8899999986 55544421 111234889999999999999999999  999 


Q ss_pred             CeeecCCCCCcEEecC-CCcEEEcccccccccccccccCCCCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCC
Q 029552           72 PIVHRDLKSPNLLVDK-KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQ  149 (191)
Q Consensus        72 ~~~h~~l~p~ni~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~  149 (191)
                       ++|+||||+||+++. ++.++|+|||++....... ......++..|+|||.+.+.. ++.++|+||+|+++|+|++|.
T Consensus       152 -ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~  229 (360)
T 3e3p_A          152 -VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE  229 (360)
T ss_dssp             -CBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred             -eecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence             999999999999996 8899999999987544332 223345688999999987654 789999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHHhcCcc------------------------------cCCCCCCCHHHHHHHHHHhcC
Q 029552          150 QPWGNLNPAQVVAAVGFKGKR------------------------------LEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       150 ~pf~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .||...+.......+......                              ...+..+++.++++|.+||+.
T Consensus       230 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  301 (360)
T 3e3p_A          230 PIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQY  301 (360)
T ss_dssp             CSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCS
T ss_pred             CCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhcc
Confidence            999998887777666431110                              112234688999999999974

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4.1e-34  Score=220.74  Aligned_cols=179  Identities=25%  Similarity=0.396  Sum_probs=145.5

Q ss_pred             CCCCCCCcccccceeecCCce------EEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 029552            2 KRLRHPNIVLFMGAVTQPPNL------SIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH   75 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h   75 (191)
                      ++++||||+++++++...+..      ++||||+. ++|.+.+..     .+++.++..++.|++.||+|||+.|  ++|
T Consensus        96 ~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH  167 (371)
T 4exu_A           96 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSAG--VVH  167 (371)
T ss_dssp             HHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred             HhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--CcC
Confidence            467899999999999877654      99999997 589888743     2889999999999999999999999  999


Q ss_pred             cCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 029552           76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGN  154 (191)
Q Consensus        76 ~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~pf~~  154 (191)
                      +||+|+||+++.++.++|+|||.+......   .....+++.|+|||.+.+ ..++.++|+||||+++++|++|..||..
T Consensus       168 ~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  244 (371)
T 4exu_A          168 RDLKPGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG  244 (371)
T ss_dssp             SCCCGGGEEECTTCCEEECSTTCC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CCcCHHHeEECCCCCEEEEecCcccccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999998754433   223456889999999877 5688999999999999999999999999


Q ss_pred             CCHHHHHHHHHhcCcc-----------------------------cCCCCCCCHHHHHHHHHHhcC
Q 029552          155 LNPAQVVAAVGFKGKR-----------------------------LEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       155 ~~~~~~~~~~~~~~~~-----------------------------~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+..+....+......                             ...+..+|+.++++|.+||+.
T Consensus       245 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  310 (371)
T 4exu_A          245 KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLEL  310 (371)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCS
T ss_pred             CChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCC
Confidence            8877766665321110                             112356899999999999973

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.2e-34  Score=215.89  Aligned_cols=183  Identities=27%  Similarity=0.446  Sum_probs=139.9

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhC-CCCeeecCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLKS   80 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~~~~~h~~l~p   80 (191)
                      +.++||||+++++++.+++..++||||+ ++.+..+.....  ..+++..++.++.|+++||+|||+. |  ++|+||+|
T Consensus        79 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp  153 (318)
T 2dyl_A           79 KSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKP  153 (318)
T ss_dssp             HTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCG
T ss_pred             HhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCH
Confidence            4578999999999999999999999999 556666664322  2389999999999999999999995 9  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCC-
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQQPWGN-  154 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Dv~slG~~~~~l~~g~~pf~~-  154 (191)
                      +||+++.++.++|+|||.+....... ......++..|+|||.+.     +..++.++|+||+|+++|+|++|..||.. 
T Consensus       154 ~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  232 (318)
T 2dyl_A          154 SNILLDERGQIKLCDFGISGRLVDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC  232 (318)
T ss_dssp             GGEEECTTSCEEECCCTTC---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             HHEEECCCCCEEEEECCCchhccCCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999886443321 222345788999999984     44578899999999999999999999987 


Q ss_pred             CCHHHHHHHHHhcCcccCCC--CCCCHHHHHHHHHHhcC
Q 029552          155 LNPAQVVAAVGFKGKRLEIP--RNVNPHVASIIEACWAK  191 (191)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~cl~~  191 (191)
                      ....+....+... .....|  ..+|+.+.++|.+||++
T Consensus       233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~  270 (318)
T 2dyl_A          233 KTDFEVLTKVLQE-EPPLLPGHMGFSGDFQSFVKDCLTK  270 (318)
T ss_dssp             CSHHHHHHHHHHS-CCCCCCSSSCCCHHHHHHHHHHTCS
T ss_pred             CccHHHHHHHhcc-CCCCCCccCCCCHHHHHHHHHHccC
Confidence            4455555555432 333333  56899999999999974

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-34  Score=221.03  Aligned_cols=185  Identities=19%  Similarity=0.244  Sum_probs=144.4

Q ss_pred             CCCCCCccc---------------ccceeec-CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHH
Q 029552            3 RLRHPNIVL---------------FMGAVTQ-PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL   66 (191)
Q Consensus         3 ~l~h~~i~~---------------~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L   66 (191)
                      +++||||++               +++++.. ++..++||||+ +++|.+++.... ...+++.+++.++.|++.||+||
T Consensus        98 ~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~L  175 (352)
T 2jii_A           98 RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFL  175 (352)
T ss_dssp             HHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHH
Confidence            456777776               5666654 67899999999 899999997642 23489999999999999999999


Q ss_pred             HhCCCCeeecCCCCCcEEecCCC--cEEEcccccccccccccc-------cCCCCCCCCcccCccccccCCCCCcchHHH
Q 029552           67 HRRNPPIVHRDLKSPNLLVDKKY--TVKVCDFGLSRLKANTFL-------SSKSAAGTPEWMAPEVLRDEPSNEKSDIYS  137 (191)
Q Consensus        67 h~~~~~~~h~~l~p~ni~~~~~~--~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~s  137 (191)
                      |+.|  ++||||+|+||+++.++  .++|+|||++........       ......+++.|+|||.+.+..++.++|+||
T Consensus       176 H~~~--ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s  253 (352)
T 2jii_A          176 HENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQS  253 (352)
T ss_dssp             HHTT--CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHH
T ss_pred             HhCC--ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHH
Confidence            9999  99999999999999998  899999999865433211       112346788999999999988999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCC--HHHHHHHHHh-cCcccCCC------CCCCHHHHHHHHHHhcC
Q 029552          138 FGVILWELATLQQPWGNLN--PAQVVAAVGF-KGKRLEIP------RNVNPHVASIIEACWAK  191 (191)
Q Consensus       138 lG~~~~~l~~g~~pf~~~~--~~~~~~~~~~-~~~~~~~~------~~~s~~~~~li~~cl~~  191 (191)
                      ||+++|+|++|..||....  .......... ......++      ..+|+.+.++|.+||++
T Consensus       254 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  316 (352)
T 2jii_A          254 LGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMAL  316 (352)
T ss_dssp             HHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTC
T ss_pred             HHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhC
Confidence            9999999999999998753  3333332211 11111122      25799999999999974

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=7e-34  Score=213.03  Aligned_cols=184  Identities=27%  Similarity=0.427  Sum_probs=141.0

Q ss_pred             CCCCCCCCcccccceeec-------------CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHH
Q 029552            1 MKRLRHPNIVLFMGAVTQ-------------PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLH   67 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh   67 (191)
                      |++++||||+++++++.+             .+..++||||+++++|.+++....  ..+++.+++.++.|++.||++||
T Consensus        56 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH  133 (303)
T 1zy4_A           56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIH  133 (303)
T ss_dssp             HTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHH
Confidence            467899999999998754             356899999999999999997543  23788999999999999999999


Q ss_pred             hCCCCeeecCCCCCcEEecCCCcEEEcccccccccccc--------------cccCCCCCCCCcccCccccccC-CCCCc
Q 029552           68 RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--------------FLSSKSAAGTPEWMAPEVLRDE-PSNEK  132 (191)
Q Consensus        68 ~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~--------------~~~~~~~~~~~~~~~pe~~~~~-~~~~~  132 (191)
                      +.|  ++|+||+|+||+++.++.++|+|||.+......              ........++..|+|||.+.+. .++.+
T Consensus       134 ~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  211 (303)
T 1zy4_A          134 SQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEK  211 (303)
T ss_dssp             HTT--CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTH
T ss_pred             hCC--eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcch
Confidence            999  999999999999999999999999988654321              1112234567889999998765 57899


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCc--ccCCCCCCCHHHHHHHHHHhcC
Q 029552          133 SDIYSFGVILWELATLQQPWGNL-NPAQVVAAVGFKGK--RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       133 ~Dv~slG~~~~~l~~g~~pf~~~-~~~~~~~~~~~~~~--~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +|+||+|+++|+|++   ||... +.......+.....  +..++...++.++++|.+||++
T Consensus       212 ~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  270 (303)
T 1zy4_A          212 IDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDH  270 (303)
T ss_dssp             HHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCS
T ss_pred             hhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhc
Confidence            999999999999998   66543 33344444432222  2335567788899999999974

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=6.4e-35  Score=220.47  Aligned_cols=187  Identities=18%  Similarity=0.325  Sum_probs=144.9

Q ss_pred             CCCCCCCcccccceee----cCCceEEEEeccCCCCHHHHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeec
Q 029552            2 KRLRHPNIVLFMGAVT----QPPNLSIVTEYLSRGSLYRLLHKP-GVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR   76 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~   76 (191)
                      ++++||||+++++++.    .....++|+||+.+++|.+++... .....+++.+++.++.|+++||+|||+.+  ++|+
T Consensus        81 ~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~  158 (317)
T 2buj_A           81 RLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHR  158 (317)
T ss_dssp             HTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECC
T ss_pred             hhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccC
Confidence            5689999999999986    334789999999999999998642 11234899999999999999999999999  9999


Q ss_pred             CCCCCcEEecCCCcEEEccccccccccccccc---------CCCCCCCCcccCccccccCC---CCCcchHHHHHHHHHH
Q 029552           77 DLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS---------SKSAAGTPEWMAPEVLRDEP---SNEKSDIYSFGVILWE  144 (191)
Q Consensus        77 ~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~---------~~~~~~~~~~~~pe~~~~~~---~~~~~Dv~slG~~~~~  144 (191)
                      ||+|+||+++.++.++|+|||.+.........         .....++..|+|||.+.+..   ++.++|+||||+++|+
T Consensus       159 dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~e  238 (317)
T 2buj_A          159 DLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYA  238 (317)
T ss_dssp             CCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHH
Confidence            99999999999999999999987643221100         01123477899999987654   5789999999999999


Q ss_pred             HHhCCCCCCCCC--HHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          145 LATLQQPWGNLN--PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       145 l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      |++|..||....  .......+ ......+.+..+|+.+.++|.+||+.
T Consensus       239 l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~  286 (317)
T 2buj_A          239 MMFGEGPYDMVFQKGDSVALAV-QNQLSIPQSPRHSSALWQLLNSMMTV  286 (317)
T ss_dssp             HHHSSCTTHHHHHTTSCHHHHH-HCC--CCCCTTSCHHHHHHHHHHTCS
T ss_pred             HHhCCCChhhhhcccchhhHHh-hccCCCCccccCCHHHHHHHHHHhhc
Confidence            999999995411  11112222 23345556678999999999999974

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=7.6e-34  Score=217.76  Aligned_cols=179  Identities=24%  Similarity=0.393  Sum_probs=144.5

Q ss_pred             CCCCCCCcccccceeecCCc------eEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 029552            2 KRLRHPNIVLFMGAVTQPPN------LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH   75 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h   75 (191)
                      ++++||||+++++++...+.      .++||||+. ++|.+++..     .+++.++..++.|++.||+|||++|  ++|
T Consensus        78 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~--ivH  149 (353)
T 3coi_A           78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAG--VVH  149 (353)
T ss_dssp             HHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred             HhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccc
Confidence            46789999999999987654      499999997 588887743     2889999999999999999999999  999


Q ss_pred             cCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 029552           76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGN  154 (191)
Q Consensus        76 ~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~pf~~  154 (191)
                      +||+|+||+++.++.++|+|||.+......   .....++..|+|||.+.+ ..++.++|+||+|+++++|++|..||..
T Consensus       150 ~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  226 (353)
T 3coi_A          150 RDLKPGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG  226 (353)
T ss_dssp             SSCCGGGEEECTTCCEEECSTTCTTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBS
T ss_pred             CCCCHHHEeECCCCcEEEeecccccCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999998754332   223456889999999876 5678899999999999999999999998


Q ss_pred             CCHHHHHHHHHhcC-----------------------------cccCCCCCCCHHHHHHHHHHhcC
Q 029552          155 LNPAQVVAAVGFKG-----------------------------KRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       155 ~~~~~~~~~~~~~~-----------------------------~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+.......+....                             .....+..+|+.++++|.+||+.
T Consensus       227 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  292 (353)
T 3coi_A          227 KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLEL  292 (353)
T ss_dssp             SCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCS
T ss_pred             CCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCC
Confidence            88766655543210                             01123457899999999999963

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.2e-34  Score=214.94  Aligned_cols=184  Identities=22%  Similarity=0.366  Sum_probs=145.7

Q ss_pred             CCCCCCCCcccccceee--------------cCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHH
Q 029552            1 MKRLRHPNIVLFMGAVT--------------QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYL   66 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~--------------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L   66 (191)
                      |++++||||+++++++.              +.+..++||||+. ++|.+++...    .+++.+++.++.|++.||+||
T Consensus        62 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~l  136 (320)
T 2i6l_A           62 IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYI  136 (320)
T ss_dssp             HHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHH
Confidence            35789999999998873              4467899999997 5999999653    288999999999999999999


Q ss_pred             HhCCCCeeecCCCCCcEEec-CCCcEEEccccccccccccc---ccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHH
Q 029552           67 HRRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVI  141 (191)
Q Consensus        67 h~~~~~~~h~~l~p~ni~~~-~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~  141 (191)
                      |+.|  ++|+||+|+||+++ .++.++|+|||.+.......   .......++..|+|||.+.+ ..++.++|+||||++
T Consensus       137 H~~~--i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~i  214 (320)
T 2i6l_A          137 HSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCI  214 (320)
T ss_dssp             HHTT--CBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHH
T ss_pred             HhCC--EecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHH
Confidence            9999  99999999999997 56789999999987543221   11122344678999998765 567889999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhcCcc----------------------------cCCCCCCCHHHHHHHHHHhcC
Q 029552          142 LWELATLQQPWGNLNPAQVVAAVGFKGKR----------------------------LEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       142 ~~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +|+|++|..||...+..+....+......                            ...+..+|+.++++|++||++
T Consensus       215 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  292 (320)
T 2i6l_A          215 FAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTF  292 (320)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCS
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCC
Confidence            99999999999998877766655422110                            112357899999999999974

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.4e-34  Score=216.97  Aligned_cols=143  Identities=23%  Similarity=0.418  Sum_probs=124.4

Q ss_pred             CCC-CCCcccccceeec--CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            3 RLR-HPNIVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         3 ~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      +++ ||||+++++++.+  ....++||||+.+++|.+++..      +++.++..++.|++.||+|||+.|  ++||||+
T Consensus        86 ~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dik  157 (330)
T 3nsz_A           86 NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMG--IMHRDVK  157 (330)
T ss_dssp             HHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCS
T ss_pred             HcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCC
Confidence            455 9999999999987  6678999999999999999864      789999999999999999999999  9999999


Q ss_pred             CCcEEecCCC-cEEEcccccccccccccccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 029552           80 SPNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGN  154 (191)
Q Consensus        80 p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~pf~~  154 (191)
                      |+||+++.++ .++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||..
T Consensus       158 p~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~  233 (330)
T 3nsz_A          158 PHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH  233 (330)
T ss_dssp             GGGEEEETTTTEEEECCCTTCEECCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             HHHEEEcCCCCEEEEEeCCCceEcCCCC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            9999999776 89999999987544332 2334467888999999877 5688999999999999999999999954

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6.9e-34  Score=224.94  Aligned_cols=140  Identities=33%  Similarity=0.499  Sum_probs=116.3

Q ss_pred             CCCCCCCcccccceeec-----CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeec
Q 029552            2 KRLRHPNIVLFMGAVTQ-----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR   76 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~   76 (191)
                      ++++||||+++++++..     ....|+|||++. ++|.+++....   .+++.+++.++.||+.||+|||+.|  ++||
T Consensus       107 ~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~--iiHr  180 (458)
T 3rp9_A          107 NRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSAG--ILHR  180 (458)
T ss_dssp             HHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTT--CBCC
T ss_pred             HhCCCCCCCceEEEEecCCcccCceEEEEEeccc-cchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhCC--cCCC
Confidence            46799999999999943     357999999985 69999997644   3899999999999999999999999  9999


Q ss_pred             CCCCCcEEecCCCcEEEcccccccccccccc---------------------------cCCCCCCCCcccCcccc-ccCC
Q 029552           77 DLKSPNLLVDKKYTVKVCDFGLSRLKANTFL---------------------------SSKSAAGTPEWMAPEVL-RDEP  128 (191)
Q Consensus        77 ~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~pe~~-~~~~  128 (191)
                      ||||+||+++.++.++|+|||++........                           ......++..|+|||.+ .+..
T Consensus       181 DlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~  260 (458)
T 3rp9_A          181 DLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQEN  260 (458)
T ss_dssp             CCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCC
T ss_pred             CCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCC
Confidence            9999999999999999999999875432110                           11223568889999976 5566


Q ss_pred             CCCcchHHHHHHHHHHHHh
Q 029552          129 SNEKSDIYSFGVILWELAT  147 (191)
Q Consensus       129 ~~~~~Dv~slG~~~~~l~~  147 (191)
                      ++.++|+||+||++|+|++
T Consensus       261 ~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          261 YTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             CCTHHHHHHHHHHHHHHHT
T ss_pred             CCcHhHHHHHHHHHHHHHH
Confidence            8999999999999999998

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.3e-34  Score=220.05  Aligned_cols=184  Identities=30%  Similarity=0.479  Sum_probs=128.7

Q ss_pred             CC-CCCCcccccceee--------cCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCe
Q 029552            3 RL-RHPNIVLFMGAVT--------QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPI   73 (191)
Q Consensus         3 ~l-~h~~i~~~~~~~~--------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~   73 (191)
                      ++ +||||+++++++.        .....++++||+. ++|.+++......+.+++.+++.++.|++.||+|||+.+.++
T Consensus        81 ~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~i  159 (337)
T 3ll6_A           81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPI  159 (337)
T ss_dssp             HHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCC
T ss_pred             HhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCE
Confidence            34 4999999999983        3345899999996 699888864222334899999999999999999999986569


Q ss_pred             eecCCCCCcEEecCCCcEEEccccccccccccccc------------CCCCCCCCcccCcccc---ccCCCCCcchHHHH
Q 029552           74 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS------------SKSAAGTPEWMAPEVL---RDEPSNEKSDIYSF  138 (191)
Q Consensus        74 ~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~------------~~~~~~~~~~~~pe~~---~~~~~~~~~Dv~sl  138 (191)
                      +|+||+|+||+++.++.++|+|||.+.........            .....+++.|+|||.+   .+..++.++|+|||
T Consensus       160 vH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~sl  239 (337)
T 3ll6_A          160 IHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWAL  239 (337)
T ss_dssp             BCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHH
T ss_pred             EEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHH
Confidence            99999999999999999999999998754332111            1133467889999998   45567889999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          139 GVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       139 G~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      |+++|+|++|..||..........    .....+.+...+..+.++|.+||+.
T Consensus       240 G~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~  288 (337)
T 3ll6_A          240 GCILYLLCFRQHPFEDGAKLRIVN----GKYSIPPHDTQYTVFHSLIRAMLQV  288 (337)
T ss_dssp             HHHHHHHHHSSCCC----------------CCCCTTCCSSGGGHHHHHHHSCS
T ss_pred             HHHHHHHHhCCCCCcchhHHHhhc----CcccCCcccccchHHHHHHHHHccC
Confidence            999999999999998765544333    2234455677899999999999974

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=6e-34  Score=218.06  Aligned_cols=183  Identities=25%  Similarity=0.367  Sum_probs=145.4

Q ss_pred             CCCCCCCcccccceeecC-----CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeec
Q 029552            2 KRLRHPNIVLFMGAVTQP-----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR   76 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~   76 (191)
                      ++++||||+++++++...     ...++|+|++. ++|.+++...    .+++.++..++.|++.||+|||+.|  ++|+
T Consensus        64 ~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~  136 (353)
T 2b9h_A           64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGSN--VIHR  136 (353)
T ss_dssp             HHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECS
T ss_pred             HhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC--eecC
Confidence            467899999999987653     67999999997 5999988753    2899999999999999999999999  9999


Q ss_pred             CCCCCcEEecCCCcEEEcccccccccccccc----------cCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHH
Q 029552           77 DLKSPNLLVDKKYTVKVCDFGLSRLKANTFL----------SSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWEL  145 (191)
Q Consensus        77 ~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l  145 (191)
                      ||+|+||+++.++.++|+|||.+........          ......++..|+|||.+.+ ..++.++|+||+|+++|+|
T Consensus       137 Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l  216 (353)
T 2b9h_A          137 DLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL  216 (353)
T ss_dssp             CCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHH
T ss_pred             CCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHH
Confidence            9999999999999999999999875432211          1122356888999998764 5678899999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHHHhcCcc------------------------------cCCCCCCCHHHHHHHHHHhcC
Q 029552          146 ATLQQPWGNLNPAQVVAAVGFKGKR------------------------------LEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       146 ~~g~~pf~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ++|..||...+.......+......                              ...+..+|+.++++|.+||+.
T Consensus       217 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  292 (353)
T 2b9h_A          217 FLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVF  292 (353)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCS
T ss_pred             HhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCc
Confidence            9999999988766555443211000                              011247899999999999973

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2e-33  Score=213.61  Aligned_cols=153  Identities=25%  Similarity=0.351  Sum_probs=132.1

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      .|++++++++++.+++..++||||+ +++|.+++...+. ..+++.+++.++.|++.||+|||++|  ++|+||+|+||+
T Consensus        75 ~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil  150 (339)
T 1z57_A           75 STFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENIL  150 (339)
T ss_dssp             CTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEE
T ss_pred             CceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEE
Confidence            4667999999999999999999999 7899999976442 23889999999999999999999999  999999999999


Q ss_pred             ecC-------------------CCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHH
Q 029552           85 VDK-------------------KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL  145 (191)
Q Consensus        85 ~~~-------------------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l  145 (191)
                      ++.                   ++.++|+|||.+......   .....++..|+|||.+.+..++.++|+||||+++|+|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el  227 (339)
T 1z57_A          151 FVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEY  227 (339)
T ss_dssp             ESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHH
T ss_pred             EeccccccccCCccccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHH
Confidence            987                   567999999998754332   2344678899999999988899999999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHH
Q 029552          146 ATLQQPWGNLNPAQVVAAV  164 (191)
Q Consensus       146 ~~g~~pf~~~~~~~~~~~~  164 (191)
                      ++|..||...+..+....+
T Consensus       228 ~~g~~pf~~~~~~~~~~~~  246 (339)
T 1z57_A          228 YLGFTVFPTHDSKEHLAMM  246 (339)
T ss_dssp             HHSSCSCCCSCHHHHHHHH
T ss_pred             HhCCCCCCCCChHHHHHHH
Confidence            9999999988777655544

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.6e-33  Score=211.44  Aligned_cols=179  Identities=23%  Similarity=0.382  Sum_probs=143.9

Q ss_pred             CCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEe
Q 029552            6 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV   85 (191)
Q Consensus         6 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~   85 (191)
                      ||||+++++++.+++..++||| +.+++|.+++....   .+++.+++.++.|+++||+|||+.+  ++|+||+|+||++
T Consensus        87 ~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~  160 (313)
T 3cek_A           87 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLI  160 (313)
T ss_dssp             CTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE
T ss_pred             CCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEE
Confidence            6999999999999999999999 55789999997644   3889999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEcccccccccccccc--cCCCCCCCCcccCcccccc-----------CCCCCcchHHHHHHHHHHHHhCCCCC
Q 029552           86 DKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRD-----------EPSNEKSDIYSFGVILWELATLQQPW  152 (191)
Q Consensus        86 ~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~-----------~~~~~~~Dv~slG~~~~~l~~g~~pf  152 (191)
                      +. +.++|+|||.+........  ......++..|+|||.+.+           ..++.++|+||||+++|+|++|..||
T Consensus       161 ~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf  239 (313)
T 3cek_A          161 VD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF  239 (313)
T ss_dssp             ET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             EC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCch
Confidence            65 7899999999875433211  1223457889999999875           35677899999999999999999999


Q ss_pred             CCC-CHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          153 GNL-NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       153 ~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ... ........+.........|...++.+.++|.+||++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  279 (313)
T 3cek_A          240 QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR  279 (313)
T ss_dssp             TTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCS
T ss_pred             hhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccC
Confidence            875 344444445444556677888999999999999974

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.9e-35  Score=226.42  Aligned_cols=163  Identities=12%  Similarity=0.085  Sum_probs=125.4

Q ss_pred             ceEEEEeccCCCCHHHHhcCCCCcccccHHHH------HHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecCCCcEEEc
Q 029552           21 NLSIVTEYLSRGSLYRLLHKPGVREMLDERRR------LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVC   94 (191)
Q Consensus        21 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~------~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~   94 (191)
                      ..|+||||+. ++|.+++...+.  .+++..+      ..++.|+++||+|||++|  ++||||||+||+++.++.++|+
T Consensus       162 ~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~  236 (371)
T 3q60_A          162 NYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPDGRLMLG  236 (371)
T ss_dssp             EEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEETTCSGGGEEECTTSCEEEC
T ss_pred             eEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--CccCcCCHHHEEECCCCCEEEE
Confidence            3899999998 799999975321  1334444      567799999999999999  9999999999999999999999


Q ss_pred             ccccccccccccccCCCCCCCCcccCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HHhc
Q 029552           95 DFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD--EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA-----VGFK  167 (191)
Q Consensus        95 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~-----~~~~  167 (191)
                      |||++........   ...++..|+|||.+.+  ..++.++|+||+|+++|+|++|..||....+......     ....
T Consensus       237 DFG~a~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  313 (371)
T 3q60_A          237 DVSALWKVGTRGP---ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPG  313 (371)
T ss_dssp             CGGGEEETTCEEE---GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCC
T ss_pred             ecceeeecCCCcc---CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhcc
Confidence            9999875543321   2234589999999987  5688999999999999999999999987643211100     0001


Q ss_pred             --CcccCCCCCCCHHHHHHHHHHhcC
Q 029552          168 --GKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       168 --~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                        ....+.+..+|+.++++|.+||++
T Consensus       314 ~~~~~~~~~~~~~~~~~~li~~~L~~  339 (371)
T 3q60_A          314 TDSLAFGSCTPLPDFVKTLIGRFLNF  339 (371)
T ss_dssp             CCSCCCTTSSCCCHHHHHHHHHHTCS
T ss_pred             ccccchhhccCCCHHHHHHHHHHcCC
Confidence              112233358999999999999974

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.1e-34  Score=213.79  Aligned_cols=172  Identities=23%  Similarity=0.432  Sum_probs=141.7

Q ss_pred             CCCCcccccceeecCCceEEEEec-cCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEY-LSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL   83 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~-~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni   83 (191)
                      +||||+++++++.+.+..++|+|+ +.+++|.+++...+   .+++.+++.++.|+++||+|||+.|  ++|+||+|+||
T Consensus        96 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Ni  170 (312)
T 2iwi_A           96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENI  170 (312)
T ss_dssp             CCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGE
T ss_pred             CCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhE
Confidence            899999999999999999999999 78899999997643   3899999999999999999999999  99999999999


Q ss_pred             Eec-CCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           84 LVD-KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        84 ~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      +++ .++.++|+|||.+......  ......++..|+|||.+.+... +.++|+||+|+++|+|++|..||.....    
T Consensus       171 l~~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----  244 (312)
T 2iwi_A          171 LIDLRRGCAKLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----  244 (312)
T ss_dssp             EEETTTTEEEECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----
T ss_pred             EEeCCCCeEEEEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH----
Confidence            999 7889999999998755433  2234457889999999877665 3489999999999999999999976321    


Q ss_pred             HHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                        +.  .....++..++..++++|.+||+.
T Consensus       245 --~~--~~~~~~~~~~~~~~~~li~~~l~~  270 (312)
T 2iwi_A          245 --IL--EAELHFPAHVSPDCCALIRRCLAP  270 (312)
T ss_dssp             --HH--HTCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             --Hh--hhccCCcccCCHHHHHHHHHHccC
Confidence              11  134567789999999999999963

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=7.1e-34  Score=215.34  Aligned_cols=172  Identities=20%  Similarity=0.387  Sum_probs=145.5

Q ss_pred             CCCCcccccceeecCCceEEEEeccCC-CCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSR-GSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL   83 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni   83 (191)
                      .||||+++++++.+++..++|+|++.+ ++|.+++...+   .+++.+++.++.|+++||+|||+.+  ++|+||+|+||
T Consensus       106 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NI  180 (320)
T 3a99_A          106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENI  180 (320)
T ss_dssp             SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGE
T ss_pred             CCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHE
Confidence            479999999999999999999999975 89999997633   3899999999999999999999999  99999999999


Q ss_pred             Eec-CCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           84 LVD-KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        84 ~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      +++ .++.++|+|||.+......  ......++..|+|||.+.+... +.++|+||||+++|+|++|..||.....    
T Consensus       181 ll~~~~~~~kL~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----  254 (320)
T 3a99_A          181 LIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----  254 (320)
T ss_dssp             EEETTTTEEEECCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----
T ss_pred             EEeCCCCCEEEeeCccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh----
Confidence            999 7789999999998755433  2234467889999999877665 6788999999999999999999976321    


Q ss_pred             HHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                        +.  ......+..+++.+.++|.+||+.
T Consensus       255 --~~--~~~~~~~~~~~~~~~~li~~~l~~  280 (320)
T 3a99_A          255 --II--RGQVFFRQRVSSECQHLIRWCLAL  280 (320)
T ss_dssp             --HH--HCCCCCSSCCCHHHHHHHHHHTCS
T ss_pred             --hh--cccccccccCCHHHHHHHHHHccC
Confidence              11  124456788999999999999973

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-33  Score=222.00  Aligned_cols=184  Identities=23%  Similarity=0.349  Sum_probs=138.1

Q ss_pred             CC-CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            3 RL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         3 ~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++ +||||+++++++.+++..|+|||++. ++|.+++......  ..+.+++.++.|++.||+|||+.|  ++||||||+
T Consensus        73 ~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~  147 (432)
T 3p23_A           73 ESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFA--HLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPH  147 (432)
T ss_dssp             HSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCC--CCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTT
T ss_pred             hccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCC--ccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHH
Confidence            45 79999999999999999999999996 5999999765422  455567789999999999999999  999999999


Q ss_pred             cEEecCC-----CcEEEccccccccccccc---ccCCCCCCCCcccCcccccc---CCCCCcchHHHHHHHHHHHHh-CC
Q 029552           82 NLLVDKK-----YTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRD---EPSNEKSDIYSFGVILWELAT-LQ  149 (191)
Q Consensus        82 ni~~~~~-----~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~---~~~~~~~Dv~slG~~~~~l~~-g~  149 (191)
                      ||+++..     ..++|+|||++.......   .......+++.|+|||.+.+   ..++.++|+||+||++|+|++ |.
T Consensus       148 NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~  227 (432)
T 3p23_A          148 NILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS  227 (432)
T ss_dssp             SEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSC
T ss_pred             HEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCC
Confidence            9999532     257899999987543221   22234567899999999873   456778999999999999999 89


Q ss_pred             CCCCCCCHHHHHHHHHhcCccc-CCCCCCCHHHHHHHHHHhcC
Q 029552          150 QPWGNLNPAQVVAAVGFKGKRL-EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       150 ~pf~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~cl~~  191 (191)
                      .||................... ..+...+..++++|.+||++
T Consensus       228 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  270 (432)
T 3p23_A          228 HPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAM  270 (432)
T ss_dssp             BTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCS
T ss_pred             CCcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhC
Confidence            9997765555444332111111 11233567789999999974

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.2e-33  Score=223.00  Aligned_cols=184  Identities=21%  Similarity=0.270  Sum_probs=146.1

Q ss_pred             CCCC-CCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            3 RLRH-PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         3 ~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      .++| +++..+..++.+.+..++||||+ +++|.+++.....  .+++.+++.++.||+.||+|||+.+  ++||||||+
T Consensus        58 ~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~  132 (483)
T 3sv0_A           58 ILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPD  132 (483)
T ss_dssp             HTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGG
T ss_pred             HhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcc
Confidence            4555 55666666667888899999999 8899999974332  3899999999999999999999999  999999999


Q ss_pred             cEEe---cCCCcEEEcccccccccccccc-------cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 029552           82 NLLV---DKKYTVKVCDFGLSRLKANTFL-------SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQP  151 (191)
Q Consensus        82 ni~~---~~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p  151 (191)
                      ||++   +.++.++|+|||++........       ......++..|+|||.+.+..++.++||||||+++|+|++|..|
T Consensus       133 NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~P  212 (483)
T 3sv0_A          133 NFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP  212 (483)
T ss_dssp             GEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             eEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence            9999   5788999999999875443321       12245678899999999999999999999999999999999999


Q ss_pred             CCCCCH---HHHHHHHHhcC---cccCCCCCCCHHHHHHHHHHhcC
Q 029552          152 WGNLNP---AQVVAAVGFKG---KRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       152 f~~~~~---~~~~~~~~~~~---~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      |.....   ......+....   ....++..+++.+.++|.+||++
T Consensus       213 f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~  258 (483)
T 3sv0_A          213 WQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSL  258 (483)
T ss_dssp             TSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTC
T ss_pred             CccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcC
Confidence            986433   33333332221   12234478999999999999974

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.4e-33  Score=220.09  Aligned_cols=153  Identities=25%  Similarity=0.412  Sum_probs=120.0

Q ss_pred             CCCCCCCcccccceee--cCCceEEEEeccCCCCHHHHhcCCC------CcccccHHHHHHHHHHHHHHHHHHHhCCCCe
Q 029552            2 KRLRHPNIVLFMGAVT--QPPNLSIVTEYLSRGSLYRLLHKPG------VREMLDERRRLNMAYDVAKGMNYLHRRNPPI   73 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~   73 (191)
                      ++++||||+++++++.  .+...++||||+.+ +|.+++....      ....+++.+++.++.||+.||+|||+.|  +
T Consensus        73 ~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--i  149 (405)
T 3rgf_A           73 RELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--V  149 (405)
T ss_dssp             HHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--C
T ss_pred             HhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--E
Confidence            5679999999999995  46789999999975 8888775211      1123899999999999999999999999  9


Q ss_pred             eecCCCCCcEEe----cCCCcEEEccccccccccccc---ccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHH
Q 029552           74 VHRDLKSPNLLV----DKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWEL  145 (191)
Q Consensus        74 ~h~~l~p~ni~~----~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l  145 (191)
                      +||||||+||++    +.++.++|+|||++.......   .......++..|+|||.+.+. .++.++|+||+||++|+|
T Consensus       150 vH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~el  229 (405)
T 3rgf_A          150 LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL  229 (405)
T ss_dssp             CCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHH
T ss_pred             eCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHH
Confidence            999999999999    677899999999987544321   122334678899999998875 478899999999999999


Q ss_pred             HhCCCCCCCCCH
Q 029552          146 ATLQQPWGNLNP  157 (191)
Q Consensus       146 ~~g~~pf~~~~~  157 (191)
                      ++|..||.....
T Consensus       230 l~g~~pf~~~~~  241 (405)
T 3rgf_A          230 LTSEPIFHCRQE  241 (405)
T ss_dssp             HHSSCTTCCCC-
T ss_pred             HhCCCCCCCccc
Confidence            999999976543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.6e-33  Score=217.39  Aligned_cols=145  Identities=23%  Similarity=0.326  Sum_probs=122.7

Q ss_pred             CCCCcccccceee----cCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhC-CCCeeecCCC
Q 029552            5 RHPNIVLFMGAVT----QPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLK   79 (191)
Q Consensus         5 ~h~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~~~~~h~~l~   79 (191)
                      +||||++++++|.    ++...++|||++. ++|.+.+.... ...+++.+++.++.||+.||+|||++ |  ++|||||
T Consensus        99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDik  174 (397)
T 1wak_A           99 NREMVVQLLDDFKISGVNGTHICMVFEVLG-HHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIK  174 (397)
T ss_dssp             GGGGBCCEEEEEEEEETTEEEEEEEECCCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCS
T ss_pred             CcceeeeeecceeecCCCCceEEEEEeccC-ccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCC
Confidence            4889999999997    5568999999995 56666664432 12389999999999999999999998 9  9999999


Q ss_pred             CCcEEecCCC-------------------------------------------------cEEEcccccccccccccccCC
Q 029552           80 SPNLLVDKKY-------------------------------------------------TVKVCDFGLSRLKANTFLSSK  110 (191)
Q Consensus        80 p~ni~~~~~~-------------------------------------------------~~~l~d~~~~~~~~~~~~~~~  110 (191)
                      |+||+++.++                                                 .++|+|||.+......   ..
T Consensus       175 p~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~  251 (397)
T 1wak_A          175 PENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FT  251 (397)
T ss_dssp             GGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SC
T ss_pred             HHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---Cc
Confidence            9999998775                                                 7999999998754433   23


Q ss_pred             CCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 029552          111 SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN  156 (191)
Q Consensus       111 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~  156 (191)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++|..||...+
T Consensus       252 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  297 (397)
T 1wak_A          252 EDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHS  297 (397)
T ss_dssp             SCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred             cCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            3467889999999999889999999999999999999999997644

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=7.9e-33  Score=217.60  Aligned_cols=183  Identities=24%  Similarity=0.399  Sum_probs=134.6

Q ss_pred             CCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcc----cccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            4 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVRE----MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         4 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      .+||||+++++++.+++..++||||+. ++|.+++.......    ..++..++.++.|++.||+|||+.|  ++|||||
T Consensus        66 ~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLk  142 (434)
T 2rio_A           66 DDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLK  142 (434)
T ss_dssp             TTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCS
T ss_pred             cCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCC
Confidence            389999999999999999999999996 59999997644211    1133356789999999999999999  9999999


Q ss_pred             CCcEEecCC-------------CcEEEcccccccccccccc----cCCCCCCCCcccCcccccc-------CCCCCcchH
Q 029552           80 SPNLLVDKK-------------YTVKVCDFGLSRLKANTFL----SSKSAAGTPEWMAPEVLRD-------EPSNEKSDI  135 (191)
Q Consensus        80 p~ni~~~~~-------------~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~-------~~~~~~~Dv  135 (191)
                      |+||+++..             +.++|+|||++........    ......+++.|+|||.+.+       ..++.++|+
T Consensus       143 p~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Di  222 (434)
T 2rio_A          143 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDI  222 (434)
T ss_dssp             GGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHH
T ss_pred             hHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhh
Confidence            999999754             3799999999875443211    1223467889999999876       557889999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCcccCC-----CCCCCHHHHHHHHHHhcC
Q 029552          136 YSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEI-----PRNVNPHVASIIEACWAK  191 (191)
Q Consensus       136 ~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~-----~~~~s~~~~~li~~cl~~  191 (191)
                      ||+|+++|+|++ |..||........ . +.......+.     +..+|+.++++|.+||++
T Consensus       223 wSlG~il~ellt~g~~Pf~~~~~~~~-~-i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  282 (434)
T 2rio_A          223 FSMGCVFYYILSKGKHPFGDKYSRES-N-IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDH  282 (434)
T ss_dssp             HHHHHHHHHHHTTSCCTTCSTTTHHH-H-HHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCS
T ss_pred             HhHHHHHHHHHhCCCCCCCCchhhHH-H-HhcCCCCcccccccccccchHHHHHHHHHHhhC
Confidence            999999999999 8999987554432 2 2222222211     123568999999999974

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.8e-33  Score=213.38  Aligned_cols=153  Identities=21%  Similarity=0.329  Sum_probs=128.8

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLL   84 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~   84 (191)
                      .+++++.+.+++...+..++|||++ +++|.+.+.... ...+++.+++.++.||+.||+|||+.|  ++|+||+|+||+
T Consensus        80 ~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIl  155 (355)
T 2eu9_A           80 NKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENIL  155 (355)
T ss_dssp             SCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEE
T ss_pred             CceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEE
Confidence            3445899999999999999999999 557777665433 123899999999999999999999999  999999999999


Q ss_pred             e-------------------cCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHH
Q 029552           85 V-------------------DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL  145 (191)
Q Consensus        85 ~-------------------~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l  145 (191)
                      +                   +.++.++|+|||.+......   .....++..|+|||.+.+..++.++|+||||+++|+|
T Consensus       156 l~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el  232 (355)
T 2eu9_A          156 FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEY  232 (355)
T ss_dssp             ESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred             EecccccccccccccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHH
Confidence            9                   56788999999998754332   2334678899999999988899999999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHH
Q 029552          146 ATLQQPWGNLNPAQVVAAV  164 (191)
Q Consensus       146 ~~g~~pf~~~~~~~~~~~~  164 (191)
                      ++|..||...+..+....+
T Consensus       233 ~~g~~pf~~~~~~~~~~~~  251 (355)
T 2eu9_A          233 YRGFTLFQTHENREHLVMM  251 (355)
T ss_dssp             HHSSCSCCCSSHHHHHHHH
T ss_pred             HhCCCCCCCCCHHHHHHHH
Confidence            9999999988776655544

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6.3e-33  Score=226.00  Aligned_cols=187  Identities=22%  Similarity=0.285  Sum_probs=148.6

Q ss_pred             CCCCCCCcccccceeec------CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 029552            2 KRLRHPNIVLFMGAVTQ------PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH   75 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h   75 (191)
                      ++++||||+++++++..      ++..++||||+.+++|.+++........+++..++.++.|++.||+|||+.|  ++|
T Consensus        67 ~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVH  144 (676)
T 3qa8_A           67 KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIH  144 (676)
T ss_dssp             HHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCC
T ss_pred             HhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--Ccc
Confidence            46799999999998765      6778999999999999999987554445889999999999999999999999  999


Q ss_pred             cCCCCCcEEecCCCc---EEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 029552           76 RDLKSPNLLVDKKYT---VKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW  152 (191)
Q Consensus        76 ~~l~p~ni~~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf  152 (191)
                      +||+|+||+++.++.   ++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||
T Consensus       145 rDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf  223 (676)
T 3qa8_A          145 RDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF  223 (676)
T ss_dssp             CCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCCCHHHeEeecCCCceeEEEccccccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence            999999999997765   8999999987544332 233456788999999999888999999999999999999999999


Q ss_pred             CCCCHHHHHHH---------HHh-----c----CcccC----CCCCCCHHHHHHHHHHhcC
Q 029552          153 GNLNPAQVVAA---------VGF-----K----GKRLE----IPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       153 ~~~~~~~~~~~---------~~~-----~----~~~~~----~~~~~s~~~~~li~~cl~~  191 (191)
                      ...........         +..     .    ....+    ++..+++.+.++|.+||+.
T Consensus       224 ~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~  284 (676)
T 3qa8_A          224 LPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMW  284 (676)
T ss_dssp             CSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCS
T ss_pred             CcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccC
Confidence            77544322100         000     0    00111    2234678999999999973

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=6.3e-33  Score=213.76  Aligned_cols=145  Identities=23%  Similarity=0.357  Sum_probs=121.4

Q ss_pred             CCCCcccccceeecCC----ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhC-CCCeeecCCC
Q 029552            5 RHPNIVLFMGAVTQPP----NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLK   79 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~~~~~h~~l~   79 (191)
                      .||||+++++++...+    ..+++||++ +++|.+++.... ...+++.+++.++.||+.||+|||++ |  ++|+||+
T Consensus        84 ~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dik  159 (373)
T 1q8y_A           84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIK  159 (373)
T ss_dssp             HHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCS
T ss_pred             ccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCC
Confidence            4899999999997544    789999999 789999997533 22388999999999999999999998 9  9999999


Q ss_pred             CCcEEec------CCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 029552           80 SPNLLVD------KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWG  153 (191)
Q Consensus        80 p~ni~~~------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~  153 (191)
                      |+||+++      ..+.++|+|||++......   .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.
T Consensus       160 p~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  236 (373)
T 1q8y_A          160 PENVLMEIVDSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE  236 (373)
T ss_dssp             GGGEEEEEEETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             hHHeEEeccCCCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence            9999995      3347999999998754433   223467889999999999889999999999999999999999998


Q ss_pred             CCC
Q 029552          154 NLN  156 (191)
Q Consensus       154 ~~~  156 (191)
                      ..+
T Consensus       237 ~~~  239 (373)
T 1q8y_A          237 PDE  239 (373)
T ss_dssp             ---
T ss_pred             CCc
Confidence            654

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.98  E-value=1.6e-31  Score=206.99  Aligned_cols=154  Identities=25%  Similarity=0.307  Sum_probs=131.6

Q ss_pred             CCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHH--hCCCCeeecCCCCCcE
Q 029552            6 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLH--RRNPPIVHRDLKSPNL   83 (191)
Q Consensus         6 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh--~~~~~~~h~~l~p~ni   83 (191)
                      |++|+++++++..++..++|||++. ++|.+++..... ..+++..+..++.|++.||.|||  +.|  ++||||||+||
T Consensus       115 ~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~~~--ivHrDlkp~NI  190 (382)
T 2vx3_A          115 KYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATPELS--IIHCDLKPENI  190 (382)
T ss_dssp             GGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTSTTTC--EECCCCSGGGE
T ss_pred             ceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccCCCC--EEcCCCCcccE
Confidence            4569999999999999999999996 599999975432 23889999999999999999999  467  99999999999


Q ss_pred             Eec--CCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           84 LVD--KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        84 ~~~--~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      +++  .++.++|+|||++......   .....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+..
T Consensus       191 ll~~~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~  267 (382)
T 2vx3_A          191 LLCNPKRSAIKIVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQM  267 (382)
T ss_dssp             EESSTTSCCEEECCCTTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             EEecCCCCcEEEEeccCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            995  4678999999998755432   23456788999999999988999999999999999999999999998887777


Q ss_pred             HHHHh
Q 029552          162 AAVGF  166 (191)
Q Consensus       162 ~~~~~  166 (191)
                      ..+..
T Consensus       268 ~~i~~  272 (382)
T 2vx3_A          268 NKIVE  272 (382)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            66643

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.97  E-value=7.6e-32  Score=202.31  Aligned_cols=164  Identities=26%  Similarity=0.428  Sum_probs=129.6

Q ss_pred             CCCCCCcccccceeec----CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            3 RLRHPNIVLFMGAVTQ----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         3 ~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      ..+||||+++++++.+    +...++||||+++++|.+++.... ...+++.+++.++.|++.||+|||+.|  ++|+||
T Consensus        67 ~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl  143 (299)
T 3m2w_A           67 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDV  143 (299)
T ss_dssp             HTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCC
T ss_pred             hccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCC
Confidence            4589999999999976    667999999999999999997643 224899999999999999999999999  999999


Q ss_pred             CCCcEEecC---CCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           79 KSPNLLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        79 ~p~ni~~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      +|+||+++.   ++.++|+|||++....                      +..++.++|+||+|+++|+|++|..||...
T Consensus       144 kp~Nil~~~~~~~~~~kl~Dfg~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~  201 (299)
T 3m2w_A          144 KPENLLYTSKRPNAILKLTDFGFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSN  201 (299)
T ss_dssp             SGGGEEESSSSTTCCEEECCCTTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred             CHHHEEEecCCCCCcEEEeccccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            999999998   7889999999875322                      123567899999999999999999999876


Q ss_pred             CHHHHHHHHHhc--CcccCCC----CCCCHHHHHHHHHHhcC
Q 029552          156 NPAQVVAAVGFK--GKRLEIP----RNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~~~~~~~~~~--~~~~~~~----~~~s~~~~~li~~cl~~  191 (191)
                      ............  ......|    ..+|+.++++|.+||++
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  243 (299)
T 3m2w_A          202 HGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKT  243 (299)
T ss_dssp             ------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCS
T ss_pred             cchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHccc
Confidence            655443222111  1122233    57899999999999974

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=7.5e-33  Score=210.94  Aligned_cols=174  Identities=14%  Similarity=0.122  Sum_probs=134.5

Q ss_pred             CCCcccccceeec-------------CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHH-hCCC
Q 029552            6 HPNIVLFMGAVTQ-------------PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLH-RRNP   71 (191)
Q Consensus         6 h~~i~~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh-~~~~   71 (191)
                      ||||++++++|.+             ++..|+||||+.+|++.+.+.+    +.+++.+++.++.||+.||+||| +.| 
T Consensus       108 hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~~-  182 (336)
T 2vuw_A          108 PPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASLAVAEASLR-  182 (336)
T ss_dssp             CHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHHHHHHHHHC-
T ss_pred             cHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHhCC-
Confidence            6777777777765             7789999999999877666643    23799999999999999999999 999 


Q ss_pred             CeeecCCCCCcEEecCCC--------------------cEEEcccccccccccccccCCCCCCCCcccCccccccCCCCC
Q 029552           72 PIVHRDLKSPNLLVDKKY--------------------TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNE  131 (191)
Q Consensus        72 ~~~h~~l~p~ni~~~~~~--------------------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~  131 (191)
                       ++||||||+||+++.++                    .+||+|||++......     ...+++.|+|||.+.+.. +.
T Consensus       183 -ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE~~~g~~-~~  255 (336)
T 2vuw_A          183 -FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDEDLFTGDG-DY  255 (336)
T ss_dssp             -CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSGGGCCCS-SH
T ss_pred             -EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChhhhcCCC-cc
Confidence             99999999999999887                    8999999998765433     235678899999998876 88


Q ss_pred             cchHHHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHHhc-Cccc----CCCCCCCHHHHHHHHHHhcC
Q 029552          132 KSDIYSFGVI-LWELATLQQPWGNLNP-AQVVAAVGFK-GKRL----EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       132 ~~Dv~slG~~-~~~l~~g~~pf~~~~~-~~~~~~~~~~-~~~~----~~~~~~s~~~~~li~~cl~~  191 (191)
                      ++|+||++++ .+++++|..||..... ......+... ....    ..+..+|+.++++|++||++
T Consensus       256 ~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~  322 (336)
T 2vuw_A          256 QFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNF  322 (336)
T ss_dssp             HHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGS
T ss_pred             ceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhcc
Confidence            9999998777 7778889999854221 1122222211 1111    12235899999999999974

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.97  E-value=2.1e-32  Score=225.79  Aligned_cols=169  Identities=23%  Similarity=0.322  Sum_probs=135.2

Q ss_pred             CCCCCCCCcccccceeecCCc-----eEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 029552            1 MKRLRHPNIVLFMGAVTQPPN-----LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH   75 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h   75 (191)
                      |++++||||+++++++.+.+.     .|+||||+.+++|.+++..     .+++.+++.++.||+.||+|||++|  ++|
T Consensus       133 l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g--iiH  205 (681)
T 2pzi_A          133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG--LVY  205 (681)
T ss_dssp             GGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred             HHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC--Cee
Confidence            467899999999999987665     7999999999999887754     2899999999999999999999999  999


Q ss_pred             cCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        76 ~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      |||||+||+++.+ .++|+|||++......    ....+++.|+|||.+.+.. +.++|+||||+++++|++|..||...
T Consensus       206 rDlkp~NIll~~~-~~kl~DFG~a~~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~  279 (681)
T 2pzi_A          206 NDLKPENIMLTEE-QLKLIDLGAVSRINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGR  279 (681)
T ss_dssp             CCCSGGGEEECSS-CEEECCCTTCEETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred             cccChHHeEEeCC-cEEEEecccchhcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccc
Confidence            9999999999885 8999999998754432    3456788999999987764 78999999999999999999888752


Q ss_pred             CHHHHHHHHHhcCcccC-CCCCCCHHHHHHHHHHhcC
Q 029552          156 NPAQVVAAVGFKGKRLE-IPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~cl~~  191 (191)
                      ...         ..... ....+++.+.++|.+||++
T Consensus       280 ~~~---------~~~~~~~~~~~~~~l~~li~~~l~~  307 (681)
T 2pzi_A          280 YVD---------GLPEDDPVLKTYDSYGRLLRRAIDP  307 (681)
T ss_dssp             ECS---------SCCTTCHHHHHCHHHHHHHHHHTCS
T ss_pred             ccc---------cccccccccccCHHHHHHHhhhccC
Confidence            110         00000 0113468899999999974

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.97  E-value=4.6e-32  Score=202.51  Aligned_cols=156  Identities=15%  Similarity=0.172  Sum_probs=125.9

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..|+||||+++++|.++++..     ....++..++.|++.||+|||++|  ++|+||||+
T Consensus        86 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~  158 (286)
T 3uqc_A           86 SRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPS  158 (286)
T ss_dssp             HTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGG
T ss_pred             hcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcc
Confidence            4689999999999999999999999999999999999542     345578889999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      ||+++.+|.++|++.+.                    ++       .++.++|+||||+++|+|++|..||...+.....
T Consensus       159 NIll~~~g~~kl~~~~~--------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~  211 (286)
T 3uqc_A          159 RVRVSIDGDVVLAYPAT--------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL  211 (286)
T ss_dssp             GEEEETTSCEEECSCCC--------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS
T ss_pred             cEEEcCCCCEEEEeccc--------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh
Confidence            99999999999984432                    22       2678899999999999999999999875543211


Q ss_pred             H---HHHhcCcc--cCCCCCCCHHHHHHHHHHhcC
Q 029552          162 A---AVGFKGKR--LEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~---~~~~~~~~--~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .   ........  ...+.++|+.++++|.+||++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  246 (286)
T 3uqc_A          212 APAERDTAGQPIEPADIDRDIPFQISAVAARSVQG  246 (286)
T ss_dssp             EECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCT
T ss_pred             HHHHHHhccCCCChhhcccCCCHHHHHHHHHHccc
Confidence            1   00001111  123468999999999999975

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.97  E-value=1.3e-30  Score=203.87  Aligned_cols=158  Identities=15%  Similarity=0.192  Sum_probs=127.0

Q ss_pred             ceEEEEeccCCCCHHHHhcC----CCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecCCCcEEEccc
Q 029552           21 NLSIVTEYLSRGSLYRLLHK----PGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDF   96 (191)
Q Consensus        21 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~   96 (191)
                      ..+++|+.+ +++|.++++.    ......+++..++.++.|+++||+|||+.|  ++||||||+||+++.++.++|+||
T Consensus       179 ~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iiHrDiKp~NILl~~~~~~kL~DF  255 (413)
T 3dzo_A          179 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGF  255 (413)
T ss_dssp             SEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCG
T ss_pred             ceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcccceEEEecCCeEEEEec
Confidence            467888866 5799999841    112334888899999999999999999999  999999999999999999999999


Q ss_pred             ccccccccccccCCCCCCCCcccCcccc----------ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 029552           97 GLSRLKANTFLSSKSAAGTPEWMAPEVL----------RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF  166 (191)
Q Consensus        97 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~----------~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~  166 (191)
                      |++......   .....+ ..|+|||.+          .+..++.++|+||||+++|+|++|..||...+.......+  
T Consensus       256 G~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~--  329 (413)
T 3dzo_A          256 EHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI--  329 (413)
T ss_dssp             GGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGG--
T ss_pred             cceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHH--
Confidence            998755443   233455 899999998          4445778999999999999999999999876654433322  


Q ss_pred             cCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          167 KGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       167 ~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                          ......+|+.++++|.+||++
T Consensus       330 ----~~~~~~~~~~~~~li~~~l~~  350 (413)
T 3dzo_A          330 ----FRSCKNIPQPVRALLEGFLRY  350 (413)
T ss_dssp             ----GSSCCCCCHHHHHHHHHHTCS
T ss_pred             ----HhhcccCCHHHHHHHHHHccC
Confidence                233457899999999999974

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=1.8e-31  Score=215.84  Aligned_cols=138  Identities=14%  Similarity=0.113  Sum_probs=101.6

Q ss_pred             CCC-CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            2 KRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         2 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      +++ .|+||+++++++++++..||||||++|++|.+++...+.   +++.   +++.||+.||+|+|++|  |+||||||
T Consensus       296 ~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~---l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKP  367 (569)
T 4azs_A          296 TQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEE---IDRE---KILGSLLRSLAALEKQG--FWHDDVRP  367 (569)
T ss_dssp             HSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCC---CCHH---HHHHHHHHHHHHHHHTT--CEESCCCG
T ss_pred             HhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCC---CCHH---HHHHHHHHHHHHHHHCC--ceeccCch
Confidence            456 699999999999999999999999999999999987543   6654   47889999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL  148 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g  148 (191)
                      +||+++.+|.+||+|||++..............+++.|++||.+.+. +...+|+|++|++.+.+.++
T Consensus       368 eNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~  434 (569)
T 4azs_A          368 WNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQP  434 (569)
T ss_dssp             GGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTT
T ss_pred             HhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccc
Confidence            99999999999999999987554433333344678899999999875 56779999999987776554

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.87  E-value=5.8e-24  Score=171.09  Aligned_cols=137  Identities=18%  Similarity=0.227  Sum_probs=111.6

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++..++.+.+..|+||||+++++|.+++..           +..++.|++++|+|||+++  ++||||||+
T Consensus       394 ~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~  460 (540)
T 3en9_A          394 ALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND--VIHNDLTTS  460 (540)
T ss_dssp             HHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT--EECTTCCTT
T ss_pred             HhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc--CccCCCCHH
Confidence            467999999666666677788999999999999999865           4578999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccc-------cCCCCCCCCcccCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCC
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFL-------SSKSAAGTPEWMAPEVLRD--EPSNEKSDIYSFGVILWELATLQQPW  152 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~pf  152 (191)
                      ||+++.  .++|+|||++........       ......+++.|+|||.+.+  ..|+...|+|+..+-..+-..++.+|
T Consensus       461 NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          461 NFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             SEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             HEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            999999  999999999876543211       1123456789999999976  45677789999888777777776665


Q ss_pred             C
Q 029552          153 G  153 (191)
Q Consensus       153 ~  153 (191)
                      .
T Consensus       539 ~  539 (540)
T 3en9_A          539 V  539 (540)
T ss_dssp             C
T ss_pred             C
Confidence            3

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.66  E-value=3.2e-17  Score=121.90  Aligned_cols=77  Identities=21%  Similarity=0.248  Sum_probs=64.9

Q ss_pred             ccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcEEecCCC
Q 029552           10 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY   89 (191)
Q Consensus        10 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~   89 (191)
                      +++.+++.. +..++||||+++++|.+ +..         .+...++.|++.||++||+.|  ++||||||+||+++ ++
T Consensus       164 ~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~~  229 (282)
T 1zar_A          164 LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-EE  229 (282)
T ss_dssp             SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-TT
T ss_pred             CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-CC
Confidence            666665544 55799999999999988 422         123468999999999999999  99999999999999 99


Q ss_pred             cEEEccccccc
Q 029552           90 TVKVCDFGLSR  100 (191)
Q Consensus        90 ~~~l~d~~~~~  100 (191)
                      .++|+|||++.
T Consensus       230 ~vkl~DFG~a~  240 (282)
T 1zar_A          230 GIWIIDFPQSV  240 (282)
T ss_dssp             EEEECCCTTCE
T ss_pred             cEEEEECCCCe
Confidence            99999999875

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.45  E-value=4.9e-14  Score=103.38  Aligned_cols=71  Identities=23%  Similarity=0.299  Sum_probs=59.4

Q ss_pred             ceEEEEeccCC-C----CHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHH-hCCCCeeecCCCCCcEEecCCCcEEEc
Q 029552           21 NLSIVTEYLSR-G----SLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLH-RRNPPIVHRDLKSPNLLVDKKYTVKVC   94 (191)
Q Consensus        21 ~~~lv~e~~~~-~----~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh-~~~~~~~h~~l~p~ni~~~~~~~~~l~   94 (191)
                      ..++||||+.+ |    +|.+....      .++.++..++.|++.++.+|| +.|  ++||||+|+||+++.  .++|+
T Consensus       142 ~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g--ivHrDlkp~NILl~~--~~~li  211 (258)
T 1zth_A          142 KNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE--LVHADLSEYNIMYID--KVYFI  211 (258)
T ss_dssp             TTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC--EECSSCSTTSEEESS--SEEEC
T ss_pred             CCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEEcC--cEEEE
Confidence            57899999942 3    77776532      235567789999999999999 999  999999999999998  89999


Q ss_pred             ccccccc
Q 029552           95 DFGLSRL  101 (191)
Q Consensus        95 d~~~~~~  101 (191)
                      |||++..
T Consensus       212 DFG~a~~  218 (258)
T 1zth_A          212 DMGQAVT  218 (258)
T ss_dssp             CCTTCEE
T ss_pred             ECccccc
Confidence            9999853

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.23  E-value=4.2e-12  Score=97.69  Aligned_cols=84  Identities=12%  Similarity=0.109  Sum_probs=63.7

Q ss_pred             CCCcccccceeecC------CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            6 HPNIVLFMGAVTQP------PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         6 h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      |+|+.++++....-      ...++||||+.|.+|.++...         +....++.|++.++.+||+.|  ++|||||
T Consensus       164 ~~nL~rL~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g--IVHrDLK  232 (397)
T 4gyi_A          164 FAFMKALYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG--LIHGDFN  232 (397)
T ss_dssp             HHHHHHHHHTTCSCCCEEEEETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT--EECSCCS
T ss_pred             HHHHHHHHhcCCCCCeeeeccCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC--CcCCCCC
Confidence            66666665543211      123699999999888665432         123457889999999999999  9999999


Q ss_pred             CCcEEecCCC----------cEEEccccccc
Q 029552           80 SPNLLVDKKY----------TVKVCDFGLSR  100 (191)
Q Consensus        80 p~ni~~~~~~----------~~~l~d~~~~~  100 (191)
                      |.||+++.+|          .+.++||+.+.
T Consensus       233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V  263 (397)
T 4gyi_A          233 EFNILIREEKDAEDPSSITLTPIIIXFPQMV  263 (397)
T ss_dssp             TTSEEEEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred             HHHEEEeCCCCcccccccccceEEEEeCCcc
Confidence            9999998876          38999998764

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.89  E-value=3.2e-09  Score=77.58  Aligned_cols=86  Identities=13%  Similarity=0.046  Sum_probs=68.4

Q ss_pred             CCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHh-----------------
Q 029552            6 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-----------------   68 (191)
Q Consensus         6 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-----------------   68 (191)
                      +..++++++++.+.+..|+|||+++|.+|.+....        ......++.++.+++..||+                 
T Consensus        69 ~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~  140 (263)
T 3tm0_A           69 KLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLA  140 (263)
T ss_dssp             TSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHH
T ss_pred             CCCCCeEEEEEecCCceEEEEEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHH
Confidence            56678889888888899999999999999876421        11223577888999999998                 


Q ss_pred             ------------------------------------------CCCCeeecCCCCCcEEecCCCcEEEcccccccc
Q 029552           69 ------------------------------------------RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL  101 (191)
Q Consensus        69 ------------------------------------------~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~  101 (191)
                                                                ..  ++|+|++|.||+++.++.+.++||+.+..
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~--l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          141 ELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELV--FSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEE--EECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCce--EECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                                      33  88999999999998766667999987653

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.61  E-value=1e-07  Score=72.79  Aligned_cols=92  Identities=17%  Similarity=0.218  Sum_probs=70.0

Q ss_pred             CCCcccccceeecC---CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhC-------------
Q 029552            6 HPNIVLFMGAVTQP---PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRR-------------   69 (191)
Q Consensus         6 h~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-------------   69 (191)
                      +..+++++.++.+.   +..|+|||+++|.++.+...     ..++..+...++.++.+.|..||+.             
T Consensus        97 ~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~  171 (359)
T 3dxp_A           97 DVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKP  171 (359)
T ss_dssp             SSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCC
T ss_pred             CCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCC
Confidence            34567788777765   45899999999877744211     1267778888999999999999972             


Q ss_pred             -------------------------------------------CCCeeecCCCCCcEEecCCCc--EEEccccccccc
Q 029552           70 -------------------------------------------NPPIVHRDLKSPNLLVDKKYT--VKVCDFGLSRLK  102 (191)
Q Consensus        70 -------------------------------------------~~~~~h~~l~p~ni~~~~~~~--~~l~d~~~~~~~  102 (191)
                                                                 ...++|+|+++.||+++.++.  +.++||+.+...
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          172 GNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             SCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             CCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                                       013899999999999997753  689999987653

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.44  E-value=3.8e-07  Score=66.14  Aligned_cols=82  Identities=18%  Similarity=0.172  Sum_probs=59.5

Q ss_pred             cccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCC------------------
Q 029552            9 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRN------------------   70 (191)
Q Consensus         9 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~------------------   70 (191)
                      +++++.+..+++..++|||+++|.+|.  ...      ...   ..++.++.+.+..||+..                  
T Consensus        77 vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~------~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~  145 (264)
T 1nd4_A           77 CAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERAR  145 (264)
T ss_dssp             BCCEEEEEECSSCEEEEEECCSSEETT--TSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHH
T ss_pred             CCeEEEeccCCCCCEEEEEecCCcccC--cCc------CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHH
Confidence            566888888778899999999998884  211      111   134566667777777542                  


Q ss_pred             --------------------------------------CCeeecCCCCCcEEecCCCcEEEcccccccc
Q 029552           71 --------------------------------------PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL  101 (191)
Q Consensus        71 --------------------------------------~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~  101 (191)
                                                            ..++|+|++|.||+++.++.+.++||+.+..
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          146 TRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                                  0189999999999998776667999987653

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.44  E-value=1.2e-07  Score=70.72  Aligned_cols=127  Identities=20%  Similarity=0.192  Sum_probs=80.6

Q ss_pred             ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCC------------------------------
Q 029552           21 NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRN------------------------------   70 (191)
Q Consensus        21 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~------------------------------   70 (191)
                      ..|+||++++|.+|.+....     .++.++...++.++.+.+..||+..                              
T Consensus        90 ~~~~vm~~i~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (304)
T 3sg8_A           90 MSFAGFTKIKGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRE  164 (304)
T ss_dssp             CSCEEEECCCCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTT
T ss_pred             cceEEEcccCCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhccc
Confidence            35899999999888653321     1566677777888888888887511                              


Q ss_pred             --------------------------CCeeecCCCCCcEEecC--CCcEEEcccccccccccccccCCCCCCCCcccCcc
Q 029552           71 --------------------------PPIVHRDLKSPNLLVDK--KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPE  122 (191)
Q Consensus        71 --------------------------~~~~h~~l~p~ni~~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe  122 (191)
                                                ..++|+|++|.||+++.  ++.+.++||+.+................ .-.+|+
T Consensus       165 ~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~-~~~~~~  243 (304)
T 3sg8_A          165 LKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD-EEYGME  243 (304)
T ss_dssp             SCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT-TSCCHH
T ss_pred             CCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc-cccCHH
Confidence                                      12799999999999998  5567899999876543321111111100 001222


Q ss_pred             ccc----cCC-C---------CCcchHHHHHHHHHHHHhCCCCCC
Q 029552          123 VLR----DEP-S---------NEKSDIYSFGVILWELATLQQPWG  153 (191)
Q Consensus       123 ~~~----~~~-~---------~~~~Dv~slG~~~~~l~~g~~pf~  153 (191)
                      ...    .-. .         ....+.|+++.+++.+.+|..+|.
T Consensus       244 ~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          244 FVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            111    000 0         112588999999999999987763

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.25  E-value=8.6e-06  Score=57.44  Aligned_cols=122  Identities=19%  Similarity=0.211  Sum_probs=81.0

Q ss_pred             CCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCeeecCCCCCcEEecCCCcEEEcccccccccccccccC
Q 029552           31 RGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS  109 (191)
Q Consensus        31 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~  109 (191)
                      ..||.++++..+.  +++++++|.++.|.+.+|.-+-. ..  -...=+.|..|++..+|++.+.+- .+.         
T Consensus        32 ~vSL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~~-~s~---------   97 (229)
T 2yle_A           32 ALSLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAPA-ADD---------   97 (229)
T ss_dssp             EEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECCC-------------
T ss_pred             cccHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceecccc-ccc---------
Confidence            3589999976553  39999999999999999877632 22  112344568999999998877741 110         


Q ss_pred             CCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHh
Q 029552          110 KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACW  189 (191)
Q Consensus       110 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl  189 (191)
                         .....+.+||... ...+.+.-|+|||+++|..+-...|                   ...+..+|+.+..||..|-
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~LL~~Mt  154 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQLIDHMA  154 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHHHHHHT
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHHHHHHH
Confidence               1122456787763 3345778999999999998775433                   3456678888888888874

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.17  E-value=4.7e-06  Score=60.86  Aligned_cols=88  Identities=16%  Similarity=0.213  Sum_probs=64.7

Q ss_pred             cccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCC------------------
Q 029552            9 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRN------------------   70 (191)
Q Consensus         9 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~------------------   70 (191)
                      +++++.++++++..++|||+++|.++.+......       .....+..++.+.|..||+..                  
T Consensus        82 VP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~  154 (272)
T 4gkh_A           82 LPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQ  154 (272)
T ss_dssp             CCCEEEEEEETTEEEEEEECCCSEEHHHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHH
T ss_pred             cCeEEEEEEECCeEEEEEEeeCCccccccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHH
Confidence            5677888888899999999999988877654311       122345566667777777532                  


Q ss_pred             --------------------------------------CCeeecCCCCCcEEecCCCcEEEcccccccccc
Q 029552           71 --------------------------------------PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA  103 (191)
Q Consensus        71 --------------------------------------~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~  103 (191)
                                                            ..++|+|+++.||+++.++.+-++|++.+....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~gd  225 (272)
T 4gkh_A          155 SRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIAD  225 (272)
T ss_dssp             HHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEE
T ss_pred             HHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccCC
Confidence                                                  127899999999999988777899998776433

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.80  E-value=0.0001  Score=55.01  Aligned_cols=31  Identities=23%  Similarity=0.482  Sum_probs=25.1

Q ss_pred             eeecCCCCCcEEecC---CCc-EEEcccccccccc
Q 029552           73 IVHRDLKSPNLLVDK---KYT-VKVCDFGLSRLKA  103 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~---~~~-~~l~d~~~~~~~~  103 (191)
                      ++|+|++|.|++++.   ++. ..++||+.+....
T Consensus       192 ~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          192 LIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             EECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             eEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence            699999999999987   345 4899998776543

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.36  E-value=0.00035  Score=52.98  Aligned_cols=30  Identities=23%  Similarity=0.298  Sum_probs=25.2

Q ss_pred             eeecCCCCCcEEecCCCcEEEccccccccc
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLK  102 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~  102 (191)
                      ++|+|+++.||+++.++.+.++||+.+...
T Consensus       224 l~HgDl~~~Nil~~~~~~~~vIDwe~a~~g  253 (357)
T 3ats_A          224 LLWGDARVGNVLYRDFQPVAVLDWEMVALG  253 (357)
T ss_dssp             EECSSCSGGGEEEETTEEEEECCGGGCEEE
T ss_pred             EEeCCCCCCeEEEeCCcEEEEEcccccccC
Confidence            899999999999996545789999877643

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=96.26  E-value=0.0091  Score=44.60  Aligned_cols=29  Identities=21%  Similarity=0.343  Sum_probs=26.2

Q ss_pred             eeecCCCCCcEEecCCCcEEEcccccccc
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRL  101 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~~  101 (191)
                      ++|+|+++.||+++.++.+.++||+.+..
T Consensus       224 l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          224 LCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             EECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             eecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            99999999999998778899999987653

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=95.43  E-value=0.06  Score=39.61  Aligned_cols=29  Identities=24%  Similarity=0.312  Sum_probs=24.5

Q ss_pred             eeecCCCCCcEEecCCCcEEEccccccccc
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLK  102 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~  102 (191)
                      ++|+|+.+.||+ ..++.+.++||+.+...
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            899999999999 56667899999877643

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=95.40  E-value=0.02  Score=44.45  Aligned_cols=34  Identities=21%  Similarity=0.339  Sum_probs=28.4

Q ss_pred             HhCCCCeeecCCCCCcEEecCCCcEEEcccccccccc
Q 029552           67 HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA  103 (191)
Q Consensus        67 h~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~  103 (191)
                      +...  ++|+|++|.||+++.++ +.++||+.+....
T Consensus       230 ~~~~--liHGDl~~~Nil~~~~~-~~lID~e~a~~G~  263 (420)
T 2pyw_A          230 RAQA--LIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP  263 (420)
T ss_dssp             BCCE--EECSCCSGGGEEECSSC-EEECCCTTCEEEC
T ss_pred             CCCe--EEecCCCCCcEEEeCCC-CEEEeCcccccCc
Confidence            3455  99999999999998876 9999998876544

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=94.42  E-value=0.092  Score=39.15  Aligned_cols=25  Identities=24%  Similarity=0.332  Sum_probs=22.5

Q ss_pred             CeeecCCCCCcEEecCCCcEEEcccc
Q 029552           72 PIVHRDLKSPNLLVDKKYTVKVCDFG   97 (191)
Q Consensus        72 ~~~h~~l~p~ni~~~~~~~~~l~d~~   97 (191)
                      .++|+|+.+.|++++.++ +.+.|+.
T Consensus       208 ~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          208 SILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             EEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             eeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            499999999999999887 8899974

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=93.62  E-value=0.18  Score=35.48  Aligned_cols=82  Identities=13%  Similarity=0.084  Sum_probs=55.6

Q ss_pred             CCCCcccccceeecCCceEEEEeccC-CCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHH-HHHhCCCCeeecCCCCCc
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLS-RGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMN-YLHRRNPPIVHRDLKSPN   82 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~Lh~~~~~~~h~~l~p~n   82 (191)
                      .||+.  -..+-++++.+.+.++--. +.++. .+++      .+..+.++++.+++...+ ++++    -+|--++|+|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i~~------~~~~eKlrll~nl~~L~~~~~~~----r~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AIRK------TTLLSRIRAAIHLVSKVKHHSAR----RLIFIVCPEN  114 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HHHT------SCHHHHHHHHHHHHHHHSSCCSS----SEECCCCGGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HHHh------cCHHHHHHHHHHHHHHHHHhhhC----ceeEEEeCce
Confidence            45666  2233356666666666542 33344 3333      678888888888888766 4433    4577899999


Q ss_pred             EEecCCCcEEEcccccc
Q 029552           83 LLVDKKYTVKVCDFGLS   99 (191)
Q Consensus        83 i~~~~~~~~~l~d~~~~   99 (191)
                      ++++.++.+++.-.|+.
T Consensus       115 L~f~~~~~p~i~hRGi~  131 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVK  131 (219)
T ss_dssp             EEECTTCCEEESCCEET
T ss_pred             EEEeCCCcEEEEEcCCc
Confidence            99999999999987753

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=93.50  E-value=0.12  Score=36.31  Aligned_cols=115  Identities=9%  Similarity=0.067  Sum_probs=71.6

Q ss_pred             CCCCcccccceeecCCceEEEEeccC-CCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLS-RGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL   83 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni   83 (191)
                      .||+.+.. .+-++.+.+.+.++.-. +.++.. +.+      .+..+.++++.+|+...+++++    =+|--++|+|+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik~------~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~NL  110 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IKS------FTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDEL  110 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GGG------SCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGGE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HHh------cCHHHHHHHHHHHHHHHHHhcC----ceEEEEecceE
Confidence            46666654 34455665556565433 223322 322      6788899999999888755543    35778999999


Q ss_pred             EecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 029552           84 LVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWG  153 (191)
Q Consensus        84 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~  153 (191)
                      +++.++.+++.-.|+...                 ++|..     .+...-+-..-+++..++++...|.
T Consensus       111 ~f~~~~~p~i~~RGik~~-----------------l~P~~-----~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQNV-----------------VDPLP-----VSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EECTTSCEEESCCEETTT-----------------BSCCC-----CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEcCCCCEEEEEccCccC-----------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999997775321                 12221     1111222355677778888877764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=93.43  E-value=0.054  Score=40.16  Aligned_cols=29  Identities=21%  Similarity=0.229  Sum_probs=25.3

Q ss_pred             eeecCCCCCcEEecCCCcEEEcccccccc
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRL  101 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~~  101 (191)
                      ++|+|+++.||+++.++.+.++||+.+..
T Consensus       189 liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          189 VIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             EECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cCCCCCCccCEEEeCCceEEEecchhccC
Confidence            89999999999999876668999987754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=93.41  E-value=0.063  Score=40.08  Aligned_cols=31  Identities=39%  Similarity=0.473  Sum_probs=26.6

Q ss_pred             eeecCCCCCcEEecCC----CcEEEcccccccccc
Q 029552           73 IVHRDLKSPNLLVDKK----YTVKVCDFGLSRLKA  103 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~----~~~~l~d~~~~~~~~  103 (191)
                      ++|+|+++.||+++.+    +.+.++||+.+....
T Consensus       185 lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          185 FVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             EECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             eEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            9999999999999874    679999998876543

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=92.84  E-value=0.15  Score=37.82  Aligned_cols=29  Identities=21%  Similarity=0.192  Sum_probs=24.7

Q ss_pred             eeecCCCCCcEEecCCCcEEEcccccccccc
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA  103 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~  103 (191)
                      ++|+|+++.||+++ + .+.++||+.+....
T Consensus       197 l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g~  225 (328)
T 1zyl_A          197 RLHGDCHAGNILWR-D-GPMFVDLDDARNGP  225 (328)
T ss_dssp             ECCSSCSGGGEEES-S-SEEECCCTTCCEEC
T ss_pred             eeeCCCCcccEeEc-C-CCEEEECCCCCcCc
Confidence            88999999999998 4 79999998766443

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=92.78  E-value=0.12  Score=38.83  Aligned_cols=31  Identities=23%  Similarity=0.445  Sum_probs=27.1

Q ss_pred             eeecCCCCCcEEecCCCcEEEcccccccccc
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA  103 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~  103 (191)
                      ++|+|+.+.||+++.++.+.++||+.+....
T Consensus       208 ~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~  238 (339)
T 3i1a_A          208 LCHSDIHAGNVLVGNEESIYIIDWDEPMLAP  238 (339)
T ss_dssp             EECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred             eEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence            9999999999999988889999998766443

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=91.48  E-value=0.27  Score=37.57  Aligned_cols=29  Identities=21%  Similarity=0.375  Sum_probs=24.7

Q ss_pred             eeecCCCCCcEEecCCCcEEEccccccccc
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLK  102 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~  102 (191)
                      ++|||+++.||+++.+ .+.++|+..+...
T Consensus       229 L~HGDl~~~Nil~~~~-~~~lID~e~a~~G  257 (397)
T 2olc_A          229 LIHGDLHTGSIFASEH-ETKVIDPEFAFYG  257 (397)
T ss_dssp             EECSCCSGGGEEECSS-CEEECCCTTCEEE
T ss_pred             eeeCCCCcCcEEEeCC-CeEEEeCcccccC
Confidence            9999999999999876 4899999776543

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=89.84  E-value=0.18  Score=38.18  Aligned_cols=28  Identities=29%  Similarity=0.558  Sum_probs=23.6

Q ss_pred             eeecCCCCCcEEecCCCcEEEcccccccc
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRL  101 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~~  101 (191)
                      ++|+|+++.||+++.++ +.++||+.+..
T Consensus       214 l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          214 FCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             EECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             EEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            89999999999998654 89999987654

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=88.51  E-value=0.21  Score=38.94  Aligned_cols=29  Identities=28%  Similarity=0.460  Sum_probs=23.8

Q ss_pred             eeecCCCCCcEEecCC----------------------------CcEEEcccccccc
Q 029552           73 IVHRDLKSPNLLVDKK----------------------------YTVKVCDFGLSRL  101 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~----------------------------~~~~l~d~~~~~~  101 (191)
                      ++|+|+.+.||+++.+                            +.+.++||+.+..
T Consensus       251 ~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~  307 (429)
T 1nw1_A          251 FCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY  307 (429)
T ss_dssp             EECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred             EEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence            8999999999999875                            6789999977654

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=88.25  E-value=0.29  Score=38.50  Aligned_cols=14  Identities=36%  Similarity=0.548  Sum_probs=13.5

Q ss_pred             eeecCCCCCcEEec
Q 029552           73 IVHRDLKSPNLLVD   86 (191)
Q Consensus        73 ~~h~~l~p~ni~~~   86 (191)
                      ++|+|+.+.||+++
T Consensus       292 ~cHnDl~~gNIL~~  305 (458)
T 2qg7_A          292 LCHCDLLSSNIINT  305 (458)
T ss_dssp             EECSCCCGGGEEEC
T ss_pred             EEecCCCCCcEEee
Confidence            89999999999998

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=88.13  E-value=0.3  Score=37.43  Aligned_cols=29  Identities=24%  Similarity=0.442  Sum_probs=25.8

Q ss_pred             eeecCCCCCcEEecCC----CcEEEcccccccc
Q 029552           73 IVHRDLKSPNLLVDKK----YTVKVCDFGLSRL  101 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~----~~~~l~d~~~~~~  101 (191)
                      ++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       222 ~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          222 FCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             EECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             EEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            8999999999999876    6899999988764

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=85.61  E-value=0.5  Score=36.34  Aligned_cols=30  Identities=27%  Similarity=0.408  Sum_probs=24.9

Q ss_pred             eeecCCCCCcEEec------CCCcEEEccccccccc
Q 029552           73 IVHRDLKSPNLLVD------KKYTVKVCDFGLSRLK  102 (191)
Q Consensus        73 ~~h~~l~p~ni~~~------~~~~~~l~d~~~~~~~  102 (191)
                      ++|+|+.+.||++.      ..+.+.++||..+...
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n  281 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN  281 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence            67999999999993      4567999999987653

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=81.02  E-value=1.7  Score=31.44  Aligned_cols=24  Identities=29%  Similarity=0.245  Sum_probs=20.0

Q ss_pred             CeeecCCCCCcEEecCCCcEEEccc
Q 029552           72 PIVHRDLKSPNLLVDKKYTVKVCDF   96 (191)
Q Consensus        72 ~~~h~~l~p~ni~~~~~~~~~l~d~   96 (191)
                      +++|+|+.+.|++++.++. .+.|-
T Consensus       189 ~LvHGDlw~gNvl~~~~g~-~~iDp  212 (288)
T 3f7w_A          189 ARIHGDLWNGNVLWQDDGA-VVIDP  212 (288)
T ss_dssp             EEECSCCSGGGEEEETTEE-EECSC
T ss_pred             eeeecCCCCCcEEEcCCCe-EEEec
Confidence            4999999999999999874 46663

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=80.95  E-value=0.89  Score=35.39  Aligned_cols=29  Identities=28%  Similarity=0.584  Sum_probs=25.4

Q ss_pred             eeecCCCCCcEEecCCCcEEEccccccccc
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLK  102 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~  102 (191)
                      ++|+|+.+.|++ +.++.+.++||..+...
T Consensus       264 ~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~  292 (424)
T 3mes_A          264 FAHNDLQENNLL-QTQNNIRMIDYEYSAIN  292 (424)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             EECCCCCcccee-cCCCcEEEEecccCCcC
Confidence            899999999999 77788999999887643

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	191
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-58
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-57
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-55
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-54
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-54
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-52
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-52
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-51
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-51
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-51
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-51
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	7e-51
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	9e-51
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-50
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-50
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-49
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-49
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-48
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-47
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-47
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-47
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	8e-47
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-46
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-46
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-46
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-46
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-45
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-45
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-45
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-44
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-44
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-44
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-44
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-43
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-42
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-42
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	9e-42
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-41
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-40
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-40
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-39
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-39
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-38
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-36
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-34
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-34
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-33
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-33
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-32
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-31
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-31
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-30
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-30
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-30
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-29
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-28
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-27
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-25
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-24
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-23
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	9e-20
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-16
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-10

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 1e-58
 Identities = 67/200 (33%), Positives = 115/200 (57%), Gaps = 14/200 (7%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +++ RH NI+LFMG  T P  L+IVT++    SLY  LH    +   +  + +++A   A
Sbjct: 58  LRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTA 114

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTPEW 118
           +GM+YLH ++  I+HRDLKS N+ + +  TVK+ DFGL+ +  + +     +  +G+  W
Sbjct: 115 QGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172

Query: 119 MAPEVLRDE---PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL---- 171
           MAPEV+R +   P + +SD+Y+FG++L+EL T Q P+ N+N    +  +  +G       
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS 232

Query: 172 EIPRNVNPHVASIIEACWAK 191
           ++  N    +  ++  C  K
Sbjct: 233 KVRSNCPKAMKRLMAECLKK 252

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 2e-57
 Identities = 64/197 (32%), Positives = 100/197 (50%), Gaps = 7/197 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAY 57
           ++ L+HPNIV +   +    N  L IV EY   G L  ++ K    R+ LDE   L +  
Sbjct: 57  LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 116

Query: 58  DVAKGMNYLHRRN---PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
            +   +   HRR+     ++HRDLK  N+ +D K  VK+ DFGL+R+  +    +K+  G
Sbjct: 117 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG 176

Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP 174
           TP +M+PE +     NEKSDI+S G +L+EL  L  P+   +  ++   +  +GK   IP
Sbjct: 177 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-REGKFRRIP 235

Query: 175 RNVNPHVASIIEACWAK 191
              +  +  II      
Sbjct: 236 YRYSDELNEIITRMLNL 252

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 3e-55
 Identities = 68/193 (35%), Positives = 106/193 (54%), Gaps = 9/193 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPN-LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           M +LRH N+V  +G + +    L IVTEY+++GSL   L   G R +L     L  + DV
Sbjct: 54  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDV 112

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
            + M YL   N   VHRDL + N+LV +    KV DFGL++  ++T     +     +W 
Sbjct: 113 CEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWT 167

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE LR++  + KSD++SFG++LWE+ +  + P+  +    VV  V  KG +++ P    
Sbjct: 168 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCP 226

Query: 179 PHVASIIEACWAK 191
           P V  +++ CW  
Sbjct: 227 PAVYEVMKNCWHL 239

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 1e-54
 Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 10/197 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +    HPNIV  + A     NL I+ E+ + G++  ++ +      L E +   +     
Sbjct: 63  LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTL 120

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             +NYLH     I+HRDLK+ N+L      +K+ DFG+S     T     S  GTP WMA
Sbjct: 121 DALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMA 178

Query: 121 PEVL-----RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG-FKGKRLEIP 174
           PEV+     +D P + K+D++S G+ L E+A ++ P   LNP +V+  +   +   L  P
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP 238

Query: 175 RNVNPHVASIIEACWAK 191
              + +    ++ C  K
Sbjct: 239 SRWSSNFKDFLKKCLEK 255

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (433), Expect = 6e-54
 Identities = 68/197 (34%), Positives = 104/197 (52%), Gaps = 12/197 (6%)

Query: 1   MKRLRHPNIVLFMGA----VTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
           +K L+HPNIV F  +    V     + +VTE ++ G+L   L +  V   +  +   +  
Sbjct: 62  LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWC 118

Query: 57  YDVAKGMNYLHRRNPPIVHRDLKSPN-LLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT 115
             + KG+ +LH R PPI+HRDLK  N  +     +VK+ D GL+ LK  +F  +K+  GT
Sbjct: 119 RQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGT 176

Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW-GNLNPAQVVAAVGFKGKRLEIP 174
           PE+MAPE+   E  +E  D+Y+FG+ + E+AT + P+    N AQ+   V    K     
Sbjct: 177 PEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 235

Query: 175 RNVNPHVASIIEACWAK 191
           +   P V  IIE C  +
Sbjct: 236 KVAIPEVKEIIEGCIRQ 252

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (425), Expect = 1e-52
 Identities = 58/195 (29%), Positives = 101/195 (51%), Gaps = 10/195 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +L +P IV  +G V Q   L +V E    G L++ L     RE +       + + V+
Sbjct: 63  MHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVS 119

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAAGTPE 117
            GM YL  +N   VHRDL + N+L+  ++  K+ DFGLS+      + + +  +     +
Sbjct: 120 MGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177

Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE +     + +SD++S+GV +WE  +  Q+P+  +   +V+A +  +GKR+E P  
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPE 236

Query: 177 VNPHVASIIEACWAK 191
             P + +++  CW  
Sbjct: 237 CPPELYALMSDCWIY 251

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 2e-52
 Identities = 47/191 (24%), Positives = 83/191 (43%), Gaps = 9/191 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
              LRHPNI+   G       + ++ EY   G++YR L K       DE+R      ++A
Sbjct: 60  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELA 116

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             ++Y H +   ++HRD+K  NLL+     +K+ DFG S    ++     +  GT +++ 
Sbjct: 117 NALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLP 172

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PE++     +EK D++S GV+ +E    + P+      +    +         P  V   
Sbjct: 173 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEG 230

Query: 181 VASIIEACWAK 191
              +I      
Sbjct: 231 ARDLISRLLKH 241

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 1e-51
 Identities = 54/195 (27%), Positives = 99/195 (50%), Gaps = 11/195 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M++L +P IV  +G + +  +  +V E    G L + L +      + ++  + + + V+
Sbjct: 62  MQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVS 117

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAAGTPE 117
            GM YL   N   VHRDL + N+L+  ++  K+ DFGLS+      N + +        +
Sbjct: 118 MGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175

Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE +     + KSD++SFGV++WE  +  Q+P+  +  ++V A +  KG+R+  P  
Sbjct: 176 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAG 234

Query: 177 VNPHVASIIEACWAK 191
               +  ++  CW  
Sbjct: 235 CPREMYDLMNLCWTY 249

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 1e-51
 Identities = 54/176 (30%), Positives = 92/176 (52%), Gaps = 8/176 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +     P IV F GA      +SI  E++  GSL ++L K G    + E+    ++  V 
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVI 114

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           KG+ YL  ++  I+HRD+K  N+LV+ +  +K+CDFG+S    ++   + S  GT  +M+
Sbjct: 115 KGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMS 171

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPW--GNLNPAQVVAAVGFKGKRLEIP 174
           PE L+    + +SDI+S G+ L E+A  + P    +    +++     +G   E P
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 2e-51
 Identities = 62/192 (32%), Positives = 100/192 (52%), Gaps = 5/192 (2%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK+L+H  +V     VTQ P + I+TEY+  GSL   L  P     L   + L+MA  +A
Sbjct: 62  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIA 119

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEWM 119
           +GM ++  RN   +HRDL++ N+LV    + K+ DFGL+R ++ N + + + A    +W 
Sbjct: 120 EGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 179
           APE +       KSD++SFG++L E+ T  +          V     +G R+  P N   
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237

Query: 180 HVASIIEACWAK 191
            +  ++  CW +
Sbjct: 238 ELYQLMRLCWKE 249

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 4e-51
 Identities = 52/192 (27%), Positives = 93/192 (48%), Gaps = 7/192 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M+  ++PNIV ++ +      L +V EYL+ GSL  ++ +  +    DE +   +  +  
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECL 126

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           + + +LH     ++HRD+KS N+L+    +VK+ DFG             +  GTP WMA
Sbjct: 127 QALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNP 179
           PEV+  +    K DI+S G++  E+   + P+ N NP + +  +   G   L+ P  ++ 
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 244

Query: 180 HVASIIEACWAK 191
                +  C   
Sbjct: 245 IFRDFLNRCLDM 256

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 7e-51
 Identities = 63/193 (32%), Positives = 100/193 (51%), Gaps = 7/193 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  L H  +V   G  T+   + I+TEY++ G L   L +   R     ++ L M  DV 
Sbjct: 53  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVC 110

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEWM 119
           + M YL  +    +HRDL + N LV+ +  VKV DFGLSR +  + + SS  +     W 
Sbjct: 111 EAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 168

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
            PEVL     + KSDI++FGV++WE+ +L + P+     ++    +  +G RL  P   +
Sbjct: 169 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLAS 227

Query: 179 PHVASIIEACWAK 191
             V +I+ +CW +
Sbjct: 228 EKVYTIMYSCWHE 240

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 9e-51
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 26/215 (12%)

Query: 1   MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVR--------------- 44
           M +L  H NIV  +GA T    + ++ EY   G L   L     +               
Sbjct: 94  MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153

Query: 45  -----EMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS 99
                 +L     L  AY VAKGM +L  ++   VHRDL + N+LV     VK+CDFGL+
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGKVVKICDFGLA 211

Query: 100 RL--KANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLN 156
           R     + ++   +A    +WMAPE L +     KSD++S+G++LWE+ +L   P+  + 
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271

Query: 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK 191
                  +   G +++ P      +  I+++CWA 
Sbjct: 272 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAF 306

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  163 bits (414), Expect = 1e-50
 Identities = 51/194 (26%), Positives = 92/194 (47%), Gaps = 12/194 (6%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +++LRHPN + + G   +     +V EY    +   L      ++ L E     + +   
Sbjct: 69  LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGAL 125

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +G+ YLH  N  ++HRD+K+ N+L+ +   VK+ DFG + + A       S  GTP WMA
Sbjct: 126 QGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMA 179

Query: 121 PEVLR---DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 177
           PEV+    +   + K D++S G+   ELA  + P  N+N    +  +           + 
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW 239

Query: 178 NPHVASIIEACWAK 191
           + +  + +++C  K
Sbjct: 240 SEYFRNFVDSCLQK 253

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 3e-50
 Identities = 62/193 (32%), Positives = 99/193 (51%), Gaps = 7/193 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +L HP +V   G   +   + +V E++  G L   L     R +      L M  DV 
Sbjct: 54  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVC 111

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEWM 119
           +GM YL      ++HRDL + N LV +   +KV DFG++R +  + + SS       +W 
Sbjct: 112 EGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 169

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           +PEV      + KSD++SFGV++WE+ +  + P+ N + ++VV  +   G RL  PR  +
Sbjct: 170 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLAS 228

Query: 179 PHVASIIEACWAK 191
            HV  I+  CW +
Sbjct: 229 THVYQIMNHCWKE 241

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 2e-49
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 19/206 (9%)

Query: 1   MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM------------- 46
           + +L  HPNI+  +GA      L +  EY   G+L   L K  V E              
Sbjct: 64  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123

Query: 47  LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 106
           L  ++ L+ A DVA+GM+YL       +HRDL + N+LV + Y  K+ DFGLSR +   +
Sbjct: 124 LSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRGQ-EVY 180

Query: 107 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVG 165
           +          WMA E L        SD++S+GV+LWE+ +L   P+  +  A++   + 
Sbjct: 181 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240

Query: 166 FKGKRLEIPRNVNPHVASIIEACWAK 191
            +G RLE P N +  V  ++  CW +
Sbjct: 241 -QGYRLEKPLNCDDEVYDLMRQCWRE 265

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  158 bits (400), Expect = 9e-49
 Identities = 58/197 (29%), Positives = 99/197 (50%), Gaps = 11/197 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +  HPN++   G VT+   + I+TE++  GSL   L +   +      + + M   +A
Sbjct: 81  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF--TVIQLVGMLRGIA 138

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN-----TFLSSKSAAGT 115
            GM YL   N   VHRDL + N+LV+     KV DFGLSR   +     T+ S+      
Sbjct: 139 AGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 196

Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIP 174
             W APE ++       SD++S+G+++WE+ +  ++P+ ++    V+ A+  +  RL  P
Sbjct: 197 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPP 255

Query: 175 RNVNPHVASIIEACWAK 191
            +    +  ++  CW K
Sbjct: 256 MDCPSALHQLMLDCWQK 272

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 1e-48
 Identities = 64/195 (32%), Positives = 95/195 (48%), Gaps = 9/195 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  L H N++   G V  PP + +VTE    GSL   L K               A  VA
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVA 121

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAAGTPE 117
           +GM YL  +    +HRDL + NLL+  +  VK+ DFGL R      + ++  +       
Sbjct: 122 EGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179

Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE L+    +  SD + FGV LWE+ T  Q+PW  LN +Q++  +  +G+RL  P +
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239

Query: 177 VNPHVASIIEACWAK 191
               + +++  CWA 
Sbjct: 240 CPQDIYNVMVQCWAH 254

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  154 bits (391), Expect = 1e-47
 Identities = 66/192 (34%), Positives = 102/192 (53%), Gaps = 4/192 (2%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK ++HPN+V  +G  T+ P   I+TE+++ G+L   L +   R+ +     L MA  ++
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQIS 125

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEWM 119
             M YL ++N   +HRDL + N LV + + VKV DFGLSR +  +T+ +   A    +W 
Sbjct: 126 SAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 183

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 179
           APE L     + KSD+++FGV+LWE+AT             V  +  K  R+E P     
Sbjct: 184 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE 243

Query: 180 HVASIIEACWAK 191
            V  ++ ACW  
Sbjct: 244 KVYELMRACWQW 255

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 3e-47
 Identities = 67/193 (34%), Positives = 105/193 (54%), Gaps = 7/193 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           MK+LRH  +V     V++ P + IVTEY+S+GSL   L     + +    + ++MA  +A
Sbjct: 66  MKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIA 123

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KANTFLSSKSAAGTPEWM 119
            GM Y+ R N   VHRDL++ N+LV +    KV DFGL+RL + N + + + A    +W 
Sbjct: 124 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 181

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE         KSD++SFG++L EL T  + P+  +   +V+  V  +G R+  P    
Sbjct: 182 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 240

Query: 179 PHVASIIEACWAK 191
             +  ++  CW K
Sbjct: 241 ESLHDLMCQCWRK 253

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  153 bits (388), Expect = 5e-47
 Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 27/215 (12%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM-------------- 46
           M    +PNIV  +G       + ++ EY++ G L   L       +              
Sbjct: 70  MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129

Query: 47  -------LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS 99
                  L    +L +A  VA GM YL  R    VHRDL + N LV +   VK+ DFGLS
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLS 187

Query: 100 RL--KANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLN 156
           R    A+ + +  + A    WM PE +       +SD++++GV+LWE+ +    P+  + 
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247

Query: 157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK 191
             +V+  V   G  L  P N    + +++  CW+K
Sbjct: 248 HEEVIYYVR-DGNILACPENCPLELYNLMRLCWSK 281

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 8e-47
 Identities = 56/195 (28%), Positives = 95/195 (48%), Gaps = 9/195 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +  H NI+   G +++   + I+TEY+  G+L + L +          + + M   +A
Sbjct: 63  MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIA 120

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS---AAGTPE 117
            GM YL   N   VHRDL + N+LV+     KV DFGLSR+  +   ++ +         
Sbjct: 121 AGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178

Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW-GNLNPAQVVAAVGFKGKRLEIPRN 176
           W APE +        SD++SFG+++WE+ T  +     L+  +V+ A+   G RL  P +
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMD 237

Query: 177 VNPHVASIIEACWAK 191
               +  ++  CW +
Sbjct: 238 CPSAIYQLMMQCWQQ 252

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 1e-46
 Identities = 58/193 (30%), Positives = 97/193 (50%), Gaps = 8/193 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M++  HP+IV  +G +T+   + I+ E  + G L   L        LD    +  AY ++
Sbjct: 62  MRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLS 118

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEWM 119
             + YL  +    VHRD+ + N+LV     VK+ DFGLSR ++ +T+  +       +WM
Sbjct: 119 TALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 176

Query: 120 APEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           APE +        SD++ FGV +WE+     +P+  +    V+  +   G+RL +P N  
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCP 235

Query: 179 PHVASIIEACWAK 191
           P + S++  CWA 
Sbjct: 236 PTLYSLMTKCWAY 248

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 3e-46
 Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 11/197 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQPPN-LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           MK   HPN++  +G   +      +V  Y+  G L   +           +  +     V
Sbjct: 82  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQV 139

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----KANTFLSSKSAAGT 115
           AKGM +L   +   VHRDL + N ++D+K+TVKV DFGL+R     + ++  +   A   
Sbjct: 140 AKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 197

Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIP 174
            +WMA E L+ +    KSD++SFGV+LWEL T    P+ ++N   +   +  +G+RL  P
Sbjct: 198 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRRLLQP 256

Query: 175 RNVNPHVASIIEACWAK 191
                 +  ++  CW  
Sbjct: 257 EYCPDPLYEVMLKCWHP 273

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 4e-46
 Identities = 55/193 (28%), Positives = 95/193 (49%), Gaps = 7/193 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  + +P++   +G +     + ++T+ +  G L   + +   ++ +  +  LN    +A
Sbjct: 65  MASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 121

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTPEW 118
           KGMNYL  R   +VHRDL + N+LV     VK+ DFGL++L         ++      +W
Sbjct: 122 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           MA E +       +SD++S+GV +WEL T      +  PA  ++++  KG+RL  P    
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 239

Query: 179 PHVASIIEACWAK 191
             V  I+  CW  
Sbjct: 240 IDVYMIMVKCWMI 252

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 5e-46
 Identities = 48/195 (24%), Positives = 84/195 (43%), Gaps = 9/195 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
            K L H N+V F G   +     +  EY S G L+  +        + E       + + 
Sbjct: 57  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLM 113

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTPEW 118
            G+ YLH     I HRD+K  NLL+D++  +K+ DFGL+ +    N         GT  +
Sbjct: 114 AGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171

Query: 119 MAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPW-GNLNPAQVVAAVGFKGKRLEIPRN 176
           +APE+L+      E  D++S G++L  +   + PW    +  Q  +    K   L   + 
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 231

Query: 177 VNPHVASIIEACWAK 191
           ++    +++     +
Sbjct: 232 IDSAPLALLHKILVE 246

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 1e-45
 Identities = 44/193 (22%), Positives = 84/193 (43%), Gaps = 9/193 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M RL HP  V           L     Y   G L + + K G     DE        ++ 
Sbjct: 62  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIV 118

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA--NTFLSSKSAAGTPEW 118
             + YLH     I+HRDLK  N+L+++   +++ DFG +++ +  +    + S  GT ++
Sbjct: 119 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 178
           ++PE+L ++ + + SD+++ G I+++L     P+   N   +   +       + P    
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--IKLEYDFPEKFF 234

Query: 179 PHVASIIEACWAK 191
           P    ++E     
Sbjct: 235 PKARDLVEKLLVL 247

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 4e-45
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 21/210 (10%)

Query: 1   MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREM------------- 46
           +  L  H NIV  +GA T      ++TEY   G L   L +     +             
Sbjct: 80  LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 47  --LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--K 102
             LD    L+ +Y VAKGM +L  +N   +HRDL + N+L+      K+CDFGL+R    
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 103 ANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW-GNLNPAQVV 161
            + ++   +A    +WMAPE + +     +SD++S+G+ LWEL +L       +      
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257

Query: 162 AAVGFKGKRLEIPRNVNPHVASIIEACWAK 191
             +  +G R+  P +    +  I++ CW  
Sbjct: 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDA 287

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 8e-45
 Identities = 49/191 (25%), Positives = 87/191 (45%), Gaps = 7/191 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
                HP +           NL  V EYL+ G L   +         D  R    A ++ 
Sbjct: 57  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEII 113

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ +LH +   IV+RDLK  N+L+DK   +K+ DFG+ +        + +  GTP+++A
Sbjct: 114 LGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIA 171

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PE+L  +  N   D +SFGV+L+E+   Q P+   +  ++  ++  +      PR +   
Sbjct: 172 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRWLEKE 229

Query: 181 VASIIEACWAK 191
              ++   + +
Sbjct: 230 AKDLLVKLFVR 240

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  148 bits (375), Expect = 2e-44
 Identities = 44/195 (22%), Positives = 88/195 (45%), Gaps = 9/195 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M +L HP ++    A      + ++ E+LS G L+  +     +  + E   +N      
Sbjct: 80  MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQAC 137

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKY--TVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
           +G+ ++H  +  IVH D+K  N++ + K   +VK+ DFGL+       +   +   T E+
Sbjct: 138 EGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-ATAEF 194

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL--EIPRN 176
            APE++  EP    +D+++ GV+ + L +   P+   +  + +  V         +   +
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 254

Query: 177 VNPHVASIIEACWAK 191
           V+P     I+    K
Sbjct: 255 VSPEAKDFIKNLLQK 269

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  148 bits (374), Expect = 2e-44
 Identities = 49/195 (25%), Positives = 83/195 (42%), Gaps = 9/195 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           M  LRHP +V    A      + ++ E++S G L+  +     +  + E   +     V 
Sbjct: 77  MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVC 134

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKY--TVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
           KG+ ++H  N   VH DLK  N++   K    +K+ DFGL+    +   S K   GT E+
Sbjct: 135 KGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTA-HLDPKQSVKVTTGTAEF 191

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL--EIPRN 176
            APEV   +P    +D++S GV+ + L +   P+G  N  + +  V      +       
Sbjct: 192 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 251

Query: 177 VNPHVASIIEACWAK 191
           ++      I      
Sbjct: 252 ISEDGKDFIRKLLLA 266

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 5e-44
 Identities = 37/196 (18%), Positives = 87/196 (44%), Gaps = 11/196 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +   RH NI+    +      L ++ E++S   ++  ++       L+ER  ++  + V 
Sbjct: 55  LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVC 112

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKK--YTVKVCDFGLSRLKANTFLSSKSAAGTPEW 118
           + + +LH  N  I H D++  N++   +   T+K+ +FG +R       + +     PE+
Sbjct: 113 EALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEY 169

Query: 119 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK---RLEIPR 175
            APEV + +  +  +D++S G +++ L +   P+      Q++  +    +     E  +
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI-MNAEYTFDEEAFK 228

Query: 176 NVNPHVASIIEACWAK 191
            ++      ++    K
Sbjct: 229 EISIEAMDFVDRLLVK 244

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 6e-44
 Identities = 63/201 (31%), Positives = 101/201 (50%), Gaps = 13/201 (6%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-------VREMLDERRRL 53
           MK     ++V  +G V+Q     ++ E ++RG L   L           V       + +
Sbjct: 77  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 54  NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKS 111
            MA ++A GM YL+      VHRDL + N +V + +TVK+ DFG++R   + + +     
Sbjct: 137 QMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194

Query: 112 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 170
                 WM+PE L+D      SD++SFGV+LWE+ATL +QP+  L+  QV+  V  +G  
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-MEGGL 253

Query: 171 LEIPRNVNPHVASIIEACWAK 191
           L+ P N    +  ++  CW  
Sbjct: 254 LDKPDNCPDMLFELMRMCWQY 274

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 2e-43
 Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 18/207 (8%)

Query: 1   MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-------------VREM 46
           MK + +H NI+  +GA TQ   L ++ EY S+G+L   L                   E 
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 47  LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KAN 104
           L  +  ++ AY VA+GM YL  +    +HRDL + N+LV +   +K+ DFGL+R     +
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 105 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
            +  + +     +WMAPE L D     +SD++SFGV+LWE+ TL        P + +  +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249

Query: 165 GFKGKRLEIPRNVNPHVASIIEACWAK 191
             +G R++ P N    +  ++  CW  
Sbjct: 250 LKEGHRMDKPSNCTNELYMMMRDCWHA 276

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 1e-42
 Identities = 64/231 (27%), Positives = 101/231 (43%), Gaps = 44/231 (19%)

Query: 1   MKRLRHPNIVLFMGAVTQP----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
              LRH NI+ F+ A  +       L +V++Y   GSL+  L++      +     + +A
Sbjct: 51  TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLA 106

Query: 57  YDVAKGMNYLH------RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN----TF 106
              A G+ +LH      +  P I HRDLKS N+LV K  T  + D GL+    +      
Sbjct: 107 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 166

Query: 107 LSSKSAAGTPEWMAPEVLRDE------PSNEKSDIYSFGVILWELAT----------LQQ 150
           ++     GT  +MAPEVL D        S +++DIY+ G++ WE+A            Q 
Sbjct: 167 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226

Query: 151 PWGNLNPA-----QVVAAVGFKGKRLEIPRNVNPH-----VASIIEACWAK 191
           P+ +L P+     ++   V  +  R  IP           +A I+  CW  
Sbjct: 227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 277

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 7e-42
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 19/208 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPN-LSIVTEYLSRGSLYRLLHKPG-------------VREM 46
           +    H N+V  +GA T+P   L ++ E+   G+L   L                  ++ 
Sbjct: 71  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 47  LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KAN 104
           L     +  ++ VAKGM +L  R    +HRDL + N+L+ +K  VK+CDFGL+R   K  
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188

Query: 105 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAA 163
            ++    A    +WMAPE + D     +SD++SFGV+LWE+ +L   P+  +   +    
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248

Query: 164 VGFKGKRLEIPRNVNPHVASIIEACWAK 191
              +G R+  P    P +   +  CW  
Sbjct: 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHG 276

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  140 bits (354), Expect = 9e-42
 Identities = 55/196 (28%), Positives = 94/196 (47%), Gaps = 11/196 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           + +++HPNIV          +L ++ + +S G L+  + + G      ER    + + V 
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVL 117

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 117
             + YLH     IVHRDLK  NLL    D+   + + DFGLS+++    + S +A GTP 
Sbjct: 118 DAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-TACGTPG 174

Query: 118 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR-- 175
           ++APEVL  +P ++  D +S GVI + L     P+ + N A++   +       + P   
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD 234

Query: 176 NVNPHVASIIEACWAK 191
           +++      I     K
Sbjct: 235 DISDSAKDFIRHLMEK 250

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  137 bits (347), Expect = 5e-41
 Identities = 43/200 (21%), Positives = 88/200 (44%), Gaps = 15/200 (7%)

Query: 1   MKRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           ++++  HPNI+             +V + + +G L+  L +      L E+    +   +
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRAL 119

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 119
            + +  LH+ N  IVHRDLK  N+L+D    +K+ DFG S  + +     +   GTP ++
Sbjct: 120 LEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSC-QLDPGEKLREVCGTPSYL 176

Query: 120 APEVLRDEPS------NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEI 173
           APE++    +       ++ D++S GVI++ L     P+ +     ++  +     +   
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 236

Query: 174 PR--NVNPHVASIIEACWAK 191
           P   + +  V  ++      
Sbjct: 237 PEWDDYSDTVKDLVSRFLVV 256

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  137 bits (347), Expect = 3e-40
 Identities = 46/193 (23%), Positives = 89/193 (46%), Gaps = 9/193 (4%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +     P IV    A   P  LS + + ++ G L+  L +     +  E      A ++ 
Sbjct: 61  VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEII 117

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ ++H R   +V+RDLK  N+L+D+   V++ D GL+   +       ++ GT  +MA
Sbjct: 118 LGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMA 173

Query: 121 PEVL-RDEPSNEKSDIYSFGVILWELATLQQPW-GNLNPAQVVAAVGFKGKRLEIPRNVN 178
           PEVL +    +  +D +S G +L++L     P+  +    +           +E+P + +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 233

Query: 179 PHVASIIEACWAK 191
           P + S++E    +
Sbjct: 234 PELRSLLEGLLQR 246

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 4e-40
 Identities = 52/191 (27%), Positives = 93/191 (48%), Gaps = 7/191 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++  RHP +     A      L  V EY + G L+  L +     +  E R      ++ 
Sbjct: 59  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR---ERVFTEERARFYGAEIV 115

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             + YLH R+  +V+RD+K  NL++DK   +K+ DFGL +   +   + K+  GTPE++A
Sbjct: 116 SALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 173

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEVL D       D +  GV+++E+   + P+ N +  ++   +    + +  PR ++P 
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LMEEIRFPRTLSPE 231

Query: 181 VASIIEACWAK 191
             S++     K
Sbjct: 232 AKSLLAGLLKK 242

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  134 bits (338), Expect = 2e-39
 Identities = 48/191 (25%), Positives = 91/191 (47%), Gaps = 10/191 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +  + HP I+   G       + ++ +Y+  G L+ LL K    +          A +V 
Sbjct: 58  LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVC 114

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
             + YLH ++  I++RDLK  N+L+DK   +K+ DFG ++   +      +  GTP+++A
Sbjct: 115 LALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YTLCGTPDYIA 169

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PEV+  +P N+  D +SFG++++E+     P+ + N  +    +      L  P   N  
Sbjct: 170 PEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI--LNAELRFPPFFNED 227

Query: 181 VASIIEACWAK 191
           V  ++     +
Sbjct: 228 VKDLLSRLITR 238

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  132 bits (333), Expect = 6e-39
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 14/200 (7%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLS----IVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
              L HP IV                 IV EY+   +L  ++H  G    +  +R + + 
Sbjct: 61  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVI 117

Query: 57  YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAA 113
            D  + +N+ H+    I+HRD+K  N+++     VKV DFG++R      N+   + +  
Sbjct: 118 ADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175

Query: 114 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR--L 171
           GT ++++PE  R +  + +SD+YS G +L+E+ T + P+   +P  V      +      
Sbjct: 176 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 235

Query: 172 EIPRNVNPHVASIIEACWAK 191
                ++  + +++    AK
Sbjct: 236 ARHEGLSADLDAVVLKALAK 255

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 5e-38
 Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 17/204 (8%)

Query: 1   MKRLRHPNIV----LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
            +  + P+IV    ++         L IV E L  G L+  +   G  +   ER    + 
Sbjct: 59  WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIM 117

Query: 57  YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY---TVKVCDFGLSRLKANTFLSSKSAA 113
             + + + YLH  N  I HRD+K  NLL   K     +K+ DFG ++ +  +  S  +  
Sbjct: 118 KSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPC 174

Query: 114 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV--GFKGKRL 171
            TP ++APEVL  E  ++  D++S GVI++ L     P+ + +   +   +    +  + 
Sbjct: 175 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 234

Query: 172 EIPR----NVNPHVASIIEACWAK 191
           E P      V+  V  +I      
Sbjct: 235 EFPNPEWSEVSEEVKMLIRNLLKT 258

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 6e-36
 Identities = 51/197 (25%), Positives = 89/197 (45%), Gaps = 12/197 (6%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K ++HPN++          ++ ++ E ++ G L+  L +   +E L E         + 
Sbjct: 67  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQIL 123

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDK----KYTVKVCDFGLSRLKANTFLSSKSAAGTP 116
            G+ YLH     I H DLK  N+++      K  +K+ DFGL+  K +     K+  GTP
Sbjct: 124 NGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIFGTP 180

Query: 117 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL--EIP 174
           E++APE++  EP   ++D++S GVI + L +   P+      + +A V         E  
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240

Query: 175 RNVNPHVASIIEACWAK 191
            N +      I     K
Sbjct: 241 SNTSALAKDFIRRLLVK 257

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (303), Expect = 1e-34
 Identities = 34/195 (17%), Positives = 76/195 (38%), Gaps = 18/195 (9%)

Query: 1   MKRLR--HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYD 58
           +K++      ++  +    +P +  ++ E                R  L E    +  + 
Sbjct: 61  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQ 118

Query: 59  VAKGMNYLHRRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 117
           V + + + H     ++HRD+K  N+L+D  +  +K+ DFG   L  +T  +     GT  
Sbjct: 119 VLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF--DGTRV 174

Query: 118 WMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 176
           +  PE +R        + ++S G++L+++     P+ +               ++   + 
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR--------GQVFFRQR 226

Query: 177 VNPHVASIIEACWAK 191
           V+     +I  C A 
Sbjct: 227 VSSECQHLIRWCLAL 241

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  121 bits (304), Expect = 4e-34
 Identities = 44/191 (23%), Positives = 89/191 (46%), Gaps = 10/191 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ +  P +V    +     NL +V EY++ G ++  L + G      E      A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIV 151

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
               YLH  +  +++RDLK  NLL+D++  ++V DFG ++          +  GTPE +A
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLCGTPEALA 206

Query: 121 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 180
           PE++  +  N+  D ++ GV+++E+A    P+    P Q+   +     ++  P + +  
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS--GKVRFPSHFSSD 264

Query: 181 VASIIEACWAK 191
           +  ++      
Sbjct: 265 LKDLLRNLLQV 275

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  118 bits (297), Expect = 2e-33
 Identities = 32/209 (15%), Positives = 65/209 (31%), Gaps = 22/209 (10%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
            K L     +  +    Q    +++   L   SL  LL   G       +     A  + 
Sbjct: 54  YKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG--RKFSVKTVAMAAKQML 111

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYT-----VKVCDFGLSRLKANTFLSS------ 109
             +  +H ++  +V+RD+K  N L+ +  +     + V DFG+ +   +           
Sbjct: 112 ARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 169

Query: 110 -KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV------VA 162
            K+ +GT  +M+         + + D+ + G +         PW  L  A        + 
Sbjct: 170 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229

Query: 163 AVGFKGKRLEIPRNVNPHVASIIEACWAK 191
                    E+           +      
Sbjct: 230 EKKQSTPLRELCAGFPEEFYKYMHYARNL 258

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  117 bits (293), Expect = 6e-33
 Identities = 35/207 (16%), Positives = 72/207 (34%), Gaps = 20/207 (9%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
            K ++    +  +       + +++   L   SL  L +    +     +  L +A  + 
Sbjct: 56  YKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMI 113

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRL-------KANTFLSSK 110
             + Y+H +N   +HRD+K  N L+    K   V + DFGL++        +   +  +K
Sbjct: 114 SRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171

Query: 111 SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV------ 164
           +  GT  + +         + + D+ S G +L        PW  L  A            
Sbjct: 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 231

Query: 165 GFKGKRLEIPRNVNPHVASIIEACWAK 191
                   + +      A+ +  C + 
Sbjct: 232 KMSTPIEVLCKGYPSEFATYLNFCRSL 258

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 4e-32
 Identities = 40/165 (24%), Positives = 71/165 (43%), Gaps = 6/165 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           ++ L HPNI+  + A     N+S+V +++       +        +L             
Sbjct: 54  LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDN---SLVLTPSHIKAYMLMTL 110

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +G+ YLH+    I+HRDLK  NLL+D+   +K+ DFGL++   +   +      T  + A
Sbjct: 111 QGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRA 168

Query: 121 PEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           PE+L          D+++ G IL EL          +    +  +
Sbjct: 169 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 213

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 2e-31
 Identities = 41/169 (24%), Positives = 75/169 (44%), Gaps = 10/169 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQPPN-----LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNM 55
           ++   HPN+V      T         L++V E++ +     L   P     +      +M
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDM 121

Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT 115
            + + +G+++LH     +VHRDLK  N+LV     +K+ DFGL+R+  +  ++  S   T
Sbjct: 122 MFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI-YSFQMALTSVVVT 178

Query: 116 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
             + APEVL         D++S G I  E+   +  +   +    +  +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 227

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  113 bits (282), Expect = 2e-31
 Identities = 43/165 (26%), Positives = 73/165 (44%), Gaps = 6/165 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L+H NIV     +     L +V E+L +     L    G    L+     +    + 
Sbjct: 54  LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLL 110

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
            G+ Y H R   ++HRDLK  NLL++++  +K+ DFGL+R              T  + A
Sbjct: 111 NGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRA 168

Query: 121 PEVLR-DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           P+VL   +  +   DI+S G I  E+      +  ++ A  +  +
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI 213

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 2e-30
 Identities = 40/165 (24%), Positives = 73/165 (44%), Gaps = 5/165 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L HPNIV  +  +     L +V E+L +     +         L   +     + + 
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKS--YLFQLL 112

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           +G+ + H     ++HRDLK  NLL++ +  +K+ DFGL+R       +      T  + A
Sbjct: 113 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 170

Query: 121 PEVL-RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           PE+L   +  +   DI+S G I  E+ T +  +   +    +  +
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 2e-30
 Identities = 33/171 (19%), Positives = 59/171 (34%), Gaps = 9/171 (5%)

Query: 1   MKRLRHPNIVLFMGAVTQP------PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
           M++L H NIV                 L++V +Y+         H    ++ L       
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126

Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLK-SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 113
             Y + + + Y+H     I HRD+K    LL      +K+CDFG ++       +     
Sbjct: 127 YMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 184

Query: 114 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
                    +          D++S G +L EL   Q  +   +    +  +
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 4e-30
 Identities = 48/197 (24%), Positives = 89/197 (45%), Gaps = 11/197 (5%)

Query: 1   MKRLRH-PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDV 59
           ++ +R  P +V    A      L ++ +Y++ G L+  L +   RE   E        ++
Sbjct: 82  LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEI 138

Query: 60  AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEW 118
              + +LH+    I++RD+K  N+L+D    V + DFGLS    A+    +    GT E+
Sbjct: 139 VLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196

Query: 119 MAPEVLR--DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV--GFKGKRLEIP 174
           MAP+++R  D   ++  D +S GV+++EL T   P+         A +           P
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 256

Query: 175 RNVNPHVASIIEACWAK 191
           + ++     +I+    K
Sbjct: 257 QEMSALAKDLIQRLLMK 273

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 4e-29
 Identities = 43/172 (25%), Positives = 75/172 (43%), Gaps = 14/172 (8%)

Query: 1   MKRLRHPNIVLFMGAVTQPP----NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMA 56
           + R RH NI+     +  P         +  +L    LY+LL        L         
Sbjct: 60  LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH----LSNDHICYFL 115

Query: 57  YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAA 113
           Y + +G+ Y+H  N  ++HRDLK  NLL++    +K+CDFGL+R+     +         
Sbjct: 116 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 173

Query: 114 GTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
            T  + APE++ +     +  DI+S G IL E+ + +  +   +    +  +
Sbjct: 174 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 225

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 4e-28
 Identities = 36/177 (20%), Positives = 73/177 (41%), Gaps = 18/177 (10%)

Query: 1   MKRLRHPNIVLFMGAVTQPP--------NLSIVTEYLSRGSLYRLLHKPGVREMLDERRR 52
           ++ L+H N+V  +               ++ +V ++        L +      + + +R 
Sbjct: 63  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR- 121

Query: 53  LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----KANTFLS 108
             +   +  G+ Y+HR    I+HRD+K+ N+L+ +   +K+ DFGL+R     K +    
Sbjct: 122 --VMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177

Query: 109 SKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
             +   T  +  PE+L  E       D++  G I+ E+ T             +A +
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 6e-27
 Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 6/153 (3%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +K L+H NIV     +     L++V E+  +          G    LD     +  + + 
Sbjct: 55  LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG---DLDPEIVKSFLFQLL 111

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 120
           KG+ + H RN  ++HRDLK  NLL+++   +K+ +FGL+R          +   T  +  
Sbjct: 112 KGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRP 169

Query: 121 PEVLRDEPS-NEKSDIYSFGVILWELATLQQPW 152
           P+VL      +   D++S G I  ELA   +P 
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.4 bits (244), Expect = 2e-25
 Identities = 43/167 (25%), Positives = 71/167 (42%), Gaps = 17/167 (10%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLS------IVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
           +K +RH N++  +   T    L       +V  ++       + H+      L E R   
Sbjct: 71  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-----LGEDRIQF 125

Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
           + Y + KG+ Y+H       HRDLK  NL V++   +K+ DFGL+R   +          
Sbjct: 126 LVYQMLKGLRYIHAAGII--HRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVV 180

Query: 115 TPEWMAPEV-LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 160
           T  + APEV L      +  DI+S G I+ E+ T +  +   +    
Sbjct: 181 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 227

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.2 bits (233), Expect = 8e-24
 Identities = 42/170 (24%), Positives = 72/170 (42%), Gaps = 15/170 (8%)

Query: 1   MKRLRHPNIVLFMGAVTQPP------NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLN 54
           MK + H NI+  +   T         ++ +V E +       +  +       D  R   
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSY 123

Query: 55  MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 114
           + Y +  G+ +LH      +HRDLK  N++V    T+K+ DFGL+R    +F+ +     
Sbjct: 124 LLYQMLCGIKHLHSAGI--IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV-V 180

Query: 115 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
           T  + APEV+      E  DI+S G I+ E+   +  +   +       V
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 91.8 bits (227), Expect = 4e-23
 Identities = 34/157 (21%), Positives = 71/157 (45%), Gaps = 14/157 (8%)

Query: 1   MKRLR-HPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAY 57
           ++ LR  PNI+     V  P +   ++V E+++     +L         L +       Y
Sbjct: 83  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMY 136

Query: 58  DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-YTVKVCDFGLSRLKANTFLSSKSAAGTP 116
           ++ K ++Y H     I+HRD+K  N+++D +   +++ D+GL+               + 
Sbjct: 137 EILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNVRVASR 193

Query: 117 EWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPW 152
            +  PE+L D    +   D++S G +L  +   ++P+
Sbjct: 194 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.0 bits (204), Expect = 9e-20
 Identities = 41/170 (24%), Positives = 76/170 (44%), Gaps = 15/170 (8%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLS-----IVTEYLSRGSLYRLLHKPGVREMLDERRRLNM 55
           +K ++H N++  +   T   +L       +  +L    L  ++        L +     +
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----LTDDHVQFL 126

Query: 56  AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT 115
            Y + +G+ Y+H  +  I+HRDLK  NL V++   +K+ DFGL+R   +          T
Sbjct: 127 IYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVAT 181

Query: 116 PEWMAPEV-LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 164
             + APE+ L     N+  DI+S G I+ EL T +  +   +    +  +
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 231

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 73.5 bits (179), Expect = 2e-16
 Identities = 35/171 (20%), Positives = 67/171 (39%), Gaps = 23/171 (13%)

Query: 1   MKRLRHPNIV-------------LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREML 47
           ++R+   +               L       P  + +V  +   G     L K      +
Sbjct: 63  LQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI 122

Query: 48  DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD------KKYTVKVCDFGLSRL 101
                  ++  +  G++Y+HRR   I+H D+K  N+L++          +K+ D G +  
Sbjct: 123 PLIYVKQISKQLLLGLDYMHRR-CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 181

Query: 102 KANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 152
               + +S     T E+ +PEVL   P    +DI+S   +++EL T    +
Sbjct: 182 YDEHYTNSI---QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 229

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 53.6 bits (128), Expect = 7e-10
 Identities = 14/100 (14%), Positives = 31/100 (31%), Gaps = 17/100 (17%)

Query: 1   MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVA 60
           +++L+   +                       ++   L        +       +   + 
Sbjct: 68  LQKLQGLAVPKVYAW--------------EGNAVLMELIDAKELYRVRVENPDEVLDMIL 113

Query: 61  KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR 100
           + +   + R   IVH DL   N+LV  +  + + DF  S 
Sbjct: 114 EEVAKFYHRG--IVHGDLSQYNVLVS-EEGIWIIDFPQSV 150

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	191
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.95
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.64
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.93
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.37
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	95.66
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	93.91
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	87.41

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-48  Score=284.66  Aligned_cols=182  Identities=26%  Similarity=0.492  Sum_probs=163.8

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..|+||||+++|+|.+++.+.+   .+++.+++.++.||++||+|||++|  ++||||||
T Consensus        60 l~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp  134 (263)
T d2j4za1          60 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR--VIHRDIKP  134 (263)
T ss_dssp             HHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCG
T ss_pred             HHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeecc
Confidence            357899999999999999999999999999999999997644   3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.++.+||+|||++......  ......+++.|+|||.+.+..++.++|+||+||++|+|++|..||...+..+.
T Consensus       135 ~Nill~~~~~~kl~DFG~a~~~~~~--~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~  212 (263)
T d2j4za1         135 ENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET  212 (263)
T ss_dssp             GGEEECTTSCEEECCCCSCSCCCCC--CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred             ccceecCCCCEeecccceeeecCCC--cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH
Confidence            9999999999999999998754433  22345678999999999999999999999999999999999999999999888


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+.  ...+.+|..+|+.++++|.+||++
T Consensus       213 ~~~i~--~~~~~~p~~~s~~~~~li~~~L~~  241 (263)
T d2j4za1         213 YKRIS--RVEFTFPDFVTEGARDLISRLLKH  241 (263)
T ss_dssp             HHHHH--TTCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             HHHHH--cCCCCCCccCCHHHHHHHHHHccC
Confidence            88884  455678899999999999999974

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=284.67  Aligned_cols=185  Identities=28%  Similarity=0.517  Sum_probs=163.6

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||++++++|.+++..|+|||||++++|.+++.+..    +++.+++.++.||+.||+|||++|  ++||||||
T Consensus        71 l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~----l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp  144 (293)
T d1yhwa1          71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKS  144 (293)
T ss_dssp             HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred             HHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhccC----CCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcH
Confidence            356899999999999999999999999999999999886532    899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.+|.+||+|||++..............+++.|+|||.+.+..++.++|+||+||++|+|++|..||...+....
T Consensus       145 ~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~  224 (293)
T d1yhwa1         145 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA  224 (293)
T ss_dssp             GGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred             HHeEECCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH
Confidence            99999999999999999987654443444566789999999999999899999999999999999999999998888777


Q ss_pred             HHHHHhcC-cccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKG-KRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~-~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+.... ...+.|..+|+.++++|++||++
T Consensus       225 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  256 (293)
T d1yhwa1         225 LYLIATNGTPELQNPEKLSAIFRDFLNRCLDM  256 (293)
T ss_dssp             HHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCS
T ss_pred             HHHHHhCCCCCCCCcccCCHHHHHHHHHHccC
Confidence            66665433 34567788999999999999974

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-47  Score=287.85  Aligned_cols=184  Identities=28%  Similarity=0.514  Sum_probs=166.9

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||++++++|++++.+|+||||+++|+|.+++.+.+   .+++.+++.++.||+.||+|||++|  ++||||||
T Consensus        59 l~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP  133 (337)
T d1o6la_          59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKL  133 (337)
T ss_dssp             HHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCG
T ss_pred             HHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCH
Confidence            457899999999999999999999999999999999998644   3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.+|.+||+|||++..............+++.|+|||.+.+..++.++|+||+||++|+|++|..||...+..+.
T Consensus       134 ~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~  213 (337)
T d1o6la_         134 ENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL  213 (337)
T ss_dssp             GGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             HHeEecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH
Confidence            99999999999999999997654443444556789999999999999999999999999999999999999999999998


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+..  ..+++|..+|+.++++|++||++
T Consensus       214 ~~~i~~--~~~~~p~~~s~~~~dli~~~L~~  242 (337)
T d1o6la_         214 FELILM--EEIRFPRTLSPEAKSLLAGLLKK  242 (337)
T ss_dssp             HHHHHH--CCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             HHHHhc--CCCCCCccCCHHHHHHHHhhccC
Confidence            888854  45778999999999999999975

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-47  Score=282.68  Aligned_cols=183  Identities=23%  Similarity=0.455  Sum_probs=161.3

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||++++++|++++..|+||||+++|+|.+++...+   .+++.+++.++.|++.||+|||+.|  ++||||||+
T Consensus        63 ~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~  137 (288)
T d1uu3a_          63 SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPE  137 (288)
T ss_dssp             HHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred             HHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCcc
Confidence            56899999999999999999999999999999999987644   3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccc--cccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      ||+++.++.++|+|||++......  ........+++.|+|||.+.+..++.++||||+||++|+|++|..||...+..+
T Consensus       138 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~  217 (288)
T d1uu3a_         138 NILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL  217 (288)
T ss_dssp             GEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             ccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH
Confidence            999999999999999998754322  122334568999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+.  .....+|..+|+.++++|++||++
T Consensus       218 ~~~~i~--~~~~~~p~~~s~~~~~li~~~L~~  247 (288)
T d1uu3a_         218 IFQKII--KLEYDFPEKFFPKARDLVEKLLVL  247 (288)
T ss_dssp             HHHHHH--TTCCCCCTTCCHHHHHHHHTTSCS
T ss_pred             HHHHHH--cCCCCCCccCCHHHHHHHHHHccC
Confidence            888885  345678899999999999999975

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-47  Score=281.72  Aligned_cols=187  Identities=32%  Similarity=0.534  Sum_probs=161.4

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++|||||++|+|.+++.+.+  +.+++.++..++.||++||+|||++|  ++||||||
T Consensus        63 l~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp  138 (288)
T d2jfla1          63 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKA  138 (288)
T ss_dssp             HHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred             HHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecCh
Confidence            356899999999999999999999999999999999876432  23899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      +||+++.++.+||+|||++..............+++.|+|||.+.     +..++.++||||+||++|+|++|..||...
T Consensus       139 ~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~  218 (288)
T d2jfla1         139 GNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL  218 (288)
T ss_dssp             GGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             hheeECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC
Confidence            999999999999999999875444333344567899999999984     445788999999999999999999999998


Q ss_pred             CHHHHHHHHHhcCc-ccCCCCCCCHHHHHHHHHHhcC
Q 029552          156 NPAQVVAAVGFKGK-RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ++.+....+..... ....|..+|++++++|++||++
T Consensus       219 ~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~  255 (288)
T d2jfla1         219 NPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEK  255 (288)
T ss_dssp             CGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCS
T ss_pred             CHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccC
Confidence            88888877765433 3456778999999999999974

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-46  Score=275.94  Aligned_cols=186  Identities=25%  Similarity=0.373  Sum_probs=156.3

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..|+||||+++|+|.+++...+   .+++.+++.++.|+++||+|||++|  ++||||||
T Consensus        57 l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp  131 (271)
T d1nvra_          57 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKP  131 (271)
T ss_dssp             HHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCG
T ss_pred             HHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccH
Confidence            467899999999999999999999999999999999997644   3999999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccc--cccCCCCCCCCcccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      +||+++.++.+||+|||++......  ........+++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.
T Consensus       132 ~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~  211 (271)
T d1nvra_         132 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD  211 (271)
T ss_dssp             GGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST
T ss_pred             HHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh
Confidence            9999999999999999998754322  223345678999999999988775 5779999999999999999999976443


Q ss_pred             H-HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 A-QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~-~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      . ...............+..+|+.++++|++||++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  246 (271)
T d1nvra_         212 SCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVE  246 (271)
T ss_dssp             TSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCS
T ss_pred             HHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCC
Confidence            3 333444333334444568999999999999974

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-46  Score=275.95  Aligned_cols=190  Identities=33%  Similarity=0.538  Sum_probs=151.8

Q ss_pred             CCCCCCCCcccccceeec--CCceEEEEeccCCCCHHHHhcCCC-CcccccHHHHHHHHHHHHHHHHHHHhCCC---Cee
Q 029552            1 MKRLRHPNIVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKPG-VREMLDERRRLNMAYDVAKGMNYLHRRNP---PIV   74 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~---~~~   74 (191)
                      |++++||||+++++++.+  ++.+|+|||||++|+|.+++.+.. .++.+++.+++.++.|++.||+|||+.+.   .++
T Consensus        57 l~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~Ii  136 (269)
T d2java1          57 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVL  136 (269)
T ss_dssp             TTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC------
T ss_pred             HHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEE
Confidence            578999999999999865  456899999999999999986421 23348999999999999999999998541   299


Q ss_pred             ecCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 029552           75 HRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN  154 (191)
Q Consensus        75 h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~  154 (191)
                      ||||||+||+++.++.+||+|||++..............+++.|+|||.+.+..++.++||||+||++|+|++|..||..
T Consensus       137 HrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~  216 (269)
T d2java1         137 HRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA  216 (269)
T ss_dssp             ---CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             eCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC
Confidence            99999999999999999999999987655443344456788999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          155 LNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+..+....+.. +...+.|..+|+.++++|++||++
T Consensus       217 ~~~~~~~~~i~~-~~~~~~~~~~s~~l~~li~~~L~~  252 (269)
T d2java1         217 FSQKELAGKIRE-GKFRRIPYRYSDELNEIITRMLNL  252 (269)
T ss_dssp             SSHHHHHHHHHH-TCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             CCHHHHHHHHHc-CCCCCCCcccCHHHHHHHHHHcCC
Confidence            999888888753 445567889999999999999974

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-45  Score=276.62  Aligned_cols=185  Identities=28%  Similarity=0.470  Sum_probs=152.2

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||++++++|.+++..|+|||||++++|.+++...+   .+++.++..++.||+.||+|||++|  ++||||||
T Consensus        61 l~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp  135 (307)
T d1a06a_          61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKP  135 (307)
T ss_dssp             HHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred             HHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecc
Confidence            357899999999999999999999999999999999997644   3999999999999999999999999  99999999


Q ss_pred             CcEEec---CCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           81 PNLLVD---KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      +||++.   .++.++|+|||++...... .......+++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.
T Consensus       136 ~Nil~~~~~~~~~vkl~DFG~a~~~~~~-~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~  214 (307)
T d1a06a_         136 ENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND  214 (307)
T ss_dssp             GGEEESSSSTTCCEEECCC-------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cceeecccCCCceEEEeccceeEEccCC-CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH
Confidence            999995   4688999999998754433 223345689999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhcCcccC--CCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLE--IPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~cl~~  191 (191)
                      .+....+.......+  .+.++|+.++++|++||++
T Consensus       215 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  250 (307)
T d1a06a_         215 AKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEK  250 (307)
T ss_dssp             HHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCS
T ss_pred             HHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccC
Confidence            888888876554443  4468999999999999975

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-45  Score=270.39  Aligned_cols=185  Identities=35%  Similarity=0.593  Sum_probs=155.4

Q ss_pred             CCCCCCCCcccccceeec----CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeec
Q 029552            1 MKRLRHPNIVLFMGAVTQ----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR   76 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~   76 (191)
                      |++++||||++++++|++    +..+|+||||+++++|.+++.+..   .+++.+++.++.||++||+|||+++.+++||
T Consensus        62 l~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHr  138 (270)
T d1t4ha_          62 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRTPPIIHR  138 (270)
T ss_dssp             HTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCS
T ss_pred             HHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHCCCCEEeC
Confidence            468999999999999864    346899999999999999997643   3899999999999999999999987669999


Q ss_pred             CCCCCcEEec-CCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           77 DLKSPNLLVD-KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        77 ~l~p~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      ||||+||+++ .++.+||+|||++......  ......+++.|+|||.+.+ .++.++||||+||++|+|++|..||...
T Consensus       139 DiKp~NILl~~~~~~~Kl~DFGla~~~~~~--~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~  215 (270)
T d1t4ha_         139 DLKCDNIFITGPTGSVKIGDLGLATLKRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC  215 (270)
T ss_dssp             CCCGGGEEESSTTSCEEECCTTGGGGCCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             CcChhhceeeCCCCCEEEeecCcceeccCC--ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc
Confidence            9999999996 4789999999999754433  2334578999999999876 4899999999999999999999999764


Q ss_pred             -CHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          156 -NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 -~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                       +.......+.....+..++..+++.++++|++||++
T Consensus       216 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~  252 (270)
T d1t4ha_         216 QNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQ  252 (270)
T ss_dssp             SSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCS
T ss_pred             ccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccC
Confidence             455555666544445566778999999999999974

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-45  Score=275.05  Aligned_cols=186  Identities=31%  Similarity=0.583  Sum_probs=155.3

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++|||||++|+|.+++.....  .+++.++..++.|+++||+|||+++  ++||||||
T Consensus        81 l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp  156 (299)
T d1jpaa_          81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAA  156 (299)
T ss_dssp             HTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred             HHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHhhCC--CccCcccc
Confidence            4688999999999999999999999999999999998876432  3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccc-----cCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFL-----SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGN  154 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~  154 (191)
                      +||+++.++.+||+|||++........     ......+++.|+|||.+.+..++.++||||+||++|+|+| |..||.+
T Consensus       157 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~  236 (299)
T d1jpaa_         157 RNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD  236 (299)
T ss_dssp             GGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             ceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC
Confidence            999999999999999999875432211     1112345778999999999899999999999999999998 8999999


Q ss_pred             CCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          155 LNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+..+....+. .+.+++.|.++|+.++++|.+||++
T Consensus       237 ~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~  272 (299)
T d1jpaa_         237 MTNQDVINAIE-QDYRLPPPMDCPSALHQLMLDCWQK  272 (299)
T ss_dssp             CCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCHHHHHHHHH-cCCCCCCCccchHHHHHHHHHHcCC
Confidence            99988888885 5567788899999999999999974

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.4e-45  Score=275.75  Aligned_cols=181  Identities=27%  Similarity=0.524  Sum_probs=163.5

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..|+||||+.+++|..++.....   +++.+++.++.||+.||+|||++|  ++||||||
T Consensus        58 l~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp  132 (316)
T d1fota_          58 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKP  132 (316)
T ss_dssp             HHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCG
T ss_pred             HHhccCcChhheeeeEeeCCeeeeEeeecCCcccccccccccc---ccccHHHHHHHHHHHhhhhhccCc--EEccccCc
Confidence            3578999999999999999999999999999999999976543   789999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.+|.+||+|||++......   .....+++.|+|||.+.+..++.++|+||+||++|+|++|..||...+..+.
T Consensus       133 ~NILl~~~g~vkL~DFG~a~~~~~~---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~  209 (316)
T d1fota_         133 ENILLDKNGHIKITDFGFAKYVPDV---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT  209 (316)
T ss_dssp             GGEEECTTSCEEECCCSSCEECSSC---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred             hheeEcCCCCEEEecCccceEeccc---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH
Confidence            9999999999999999998765433   2345789999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+...  ...+|..+|++++++|++||++
T Consensus       210 ~~~i~~~--~~~~p~~~s~~~~~li~~~L~~  238 (316)
T d1fota_         210 YEKILNA--ELRFPPFFNEDVKDLLSRLITR  238 (316)
T ss_dssp             HHHHHHC--CCCCCTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHcC--CCCCCCCCCHHHHHHHHHHhhh
Confidence            8888543  4577889999999999999974

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-45  Score=275.70  Aligned_cols=182  Identities=27%  Similarity=0.464  Sum_probs=165.3

Q ss_pred             CCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCc
Q 029552            3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN   82 (191)
Q Consensus         3 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~n   82 (191)
                      .++||||+++++++++++..|+||||+++|+|.+++....   .+++.+++.++.||+.||+|||+++  ++||||||+|
T Consensus        59 ~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~N  133 (320)
T d1xjda_          59 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDN  133 (320)
T ss_dssp             HTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGG
T ss_pred             hCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccc
Confidence            5799999999999999999999999999999999997644   3899999999999999999999999  9999999999


Q ss_pred             EEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 029552           83 LLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVA  162 (191)
Q Consensus        83 i~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~~  162 (191)
                      |+++.++.++|+|||.+..............+++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+..+...
T Consensus       134 iL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~  213 (320)
T d1xjda_         134 ILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH  213 (320)
T ss_dssp             EEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             eeecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999998765544444555678999999999999999999999999999999999999999999999988


Q ss_pred             HHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          163 AVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       163 ~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+..  ..+.+|..+|+.++++|.+||++
T Consensus       214 ~i~~--~~~~~p~~~s~~~~dli~~~L~~  240 (320)
T d1xjda_         214 SIRM--DNPFYPRWLEKEAKDLLVKLFVR  240 (320)
T ss_dssp             HHHH--CCCCCCTTSCHHHHHHHHHHSCS
T ss_pred             HHHc--CCCCCCccCCHHHHHHHHHhccc
Confidence            8854  45678889999999999999975

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4e-45  Score=273.68  Aligned_cols=182  Identities=28%  Similarity=0.443  Sum_probs=160.4

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..|+|||||.+++|..++...+   .+++.+++.++.||+.||+|||++|  ++||||||
T Consensus        69 l~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp  143 (309)
T d1u5ra_          69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKA  143 (309)
T ss_dssp             HTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSG
T ss_pred             HHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCc
Confidence            468999999999999999999999999999999987765533   3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD---EPSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~---~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      +||+++.++.+||+|||++......    ....+++.|+|||.+.+   ..++.++||||+||++|+|++|..||...+.
T Consensus       144 ~NILl~~~~~~Kl~DFG~a~~~~~~----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~  219 (309)
T d1u5ra_         144 GNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA  219 (309)
T ss_dssp             GGEEEETTTEEEECCCTTCBSSSSB----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred             ceEEECCCCCEEEeecccccccCCC----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH
Confidence            9999999999999999998754432    34578999999999864   3478899999999999999999999999888


Q ss_pred             HHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+....+.....+...+..+|+.++++|.+||++
T Consensus       220 ~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~  253 (309)
T d1u5ra_         220 MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK  253 (309)
T ss_dssp             HHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcC
Confidence            8888888766555566678999999999999974

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-45  Score=271.89  Aligned_cols=185  Identities=30%  Similarity=0.555  Sum_probs=160.2

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+ +..|+||||+++|+|.+++....  ..+++.++..++.|+++||+|||+++  ++||||||
T Consensus        63 l~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp  137 (285)
T d1u59a_          63 MHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAA  137 (285)
T ss_dssp             HHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred             HHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCch
Confidence            356899999999999875 46899999999999999875433  23899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccccc---ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLN  156 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~  156 (191)
                      +||+++.++.+||+|||++.......   .......+++.|+|||.+.+..++.++||||+|+++|+|+| |..||...+
T Consensus       138 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~  217 (285)
T d1u59a_         138 RNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK  217 (285)
T ss_dssp             GGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             hheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999987543221   22223456788999999998889999999999999999998 899999988


Q ss_pred             HHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+....+. .+.+++.|.++|+++.++|.+||++
T Consensus       218 ~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~  251 (285)
T d1u59a_         218 GPEVMAFIE-QGKRMECPPECPPELYALMSDCWIY  251 (285)
T ss_dssp             THHHHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCS
T ss_pred             HHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcCC
Confidence            888887775 5677888999999999999999974

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-45  Score=271.11  Aligned_cols=184  Identities=29%  Similarity=0.559  Sum_probs=159.4

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++++ +..++||||+++|+|.+++.+..   .+++.+++.++.||++||+|||+.+  ++||||||
T Consensus        62 l~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp  135 (277)
T d1xbba_          62 MQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAA  135 (277)
T ss_dssp             HHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSG
T ss_pred             HHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcc
Confidence            357899999999999865 46789999999999999997644   3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccc---cccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANT---FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLN  156 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~  156 (191)
                      +||+++.++.++++|||++......   ........+++.|+|||.+.+..++.++||||+|+++|+|++ |..||...+
T Consensus       136 ~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~  215 (277)
T d1xbba_         136 RNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK  215 (277)
T ss_dssp             GGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             hhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC
Confidence            9999999999999999998643222   122233457789999999998889999999999999999998 899999999


Q ss_pred             HHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+....+. .+.+++.|..+|+.++++|.+||++
T Consensus       216 ~~~~~~~i~-~~~~~~~p~~~~~~~~~li~~cl~~  249 (277)
T d1xbba_         216 GSEVTAMLE-KGERMGCPAGCPREMYDLMNLCWTY  249 (277)
T ss_dssp             HHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHHHHH-cCCCCCCCcccCHHHHHHHHHHcCC
Confidence            888887775 5678889999999999999999974

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=8.3e-45  Score=276.30  Aligned_cols=186  Identities=24%  Similarity=0.422  Sum_probs=162.3

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||++++++|++++.+|+|||||++++|.+.+...+.  .+++.+++.++.||+.||+|||++|  ++||||||
T Consensus        80 l~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp  155 (352)
T d1koba_          80 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKP  155 (352)
T ss_dssp             HTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCG
T ss_pred             HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccccc
Confidence            4688999999999999999999999999999999998865442  3899999999999999999999999  99999999


Q ss_pred             CcEEec--CCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           81 PNLLVD--KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        81 ~ni~~~--~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      +||+++  .++.++|+|||++...... .......+++.|+|||.+.+..++.++||||+||++|+|++|..||...+..
T Consensus       156 ~NILl~~~~~~~vkL~DFGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~  234 (352)
T d1koba_         156 ENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL  234 (352)
T ss_dssp             GGEEESSTTCCCEEECCCTTCEECCTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred             ccccccccCCCeEEEeecccceecCCC-CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence            999997  5689999999998754433 1223346788999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhcCccc--CCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRL--EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~--~~~~~~s~~~~~li~~cl~~  191 (191)
                      +....+......+  ..+.++|+.++++|++||++
T Consensus       235 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  269 (352)
T d1koba_         235 ETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQK  269 (352)
T ss_dssp             HHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCS
T ss_pred             HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccC
Confidence            9888887655433  34568999999999999974

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-45  Score=277.08  Aligned_cols=187  Identities=33%  Similarity=0.528  Sum_probs=160.9

Q ss_pred             CC-CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC--------------------cccccHHHHHHHHHHHHH
Q 029552            3 RL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV--------------------REMLDERRRLNMAYDVAK   61 (191)
Q Consensus         3 ~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------------~~~~~~~~~~~~~~~i~~   61 (191)
                      ++ +||||+++++++.+.+..++|||||++|+|.+++.....                    ...+++.+++.++.|+++
T Consensus        96 ~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~  175 (325)
T d1rjba_          96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK  175 (325)
T ss_dssp             HHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHH
T ss_pred             HhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHH
Confidence            44 899999999999999999999999999999999965321                    134789999999999999


Q ss_pred             HHHHHHhCCCCeeecCCCCCcEEecCCCcEEEcccccccccccccc--cCCCCCCCCcccCccccccCCCCCcchHHHHH
Q 029552           62 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFG  139 (191)
Q Consensus        62 ~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG  139 (191)
                      ||+|||+++  ++||||||+||+++.++.+||+|||++........  ......+++.|+|||.+.+..++.++||||+|
T Consensus       176 gl~yLH~~~--IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~G  253 (325)
T d1rjba_         176 GMEFLEFKS--CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYG  253 (325)
T ss_dssp             HHHHHHHTT--EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred             HHHHHHhCC--eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchh
Confidence            999999999  99999999999999999999999999875433321  12234457899999999999999999999999


Q ss_pred             HHHHHHHh-CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          140 VILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       140 ~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      |++|+|+| |..||...+.......+...+.+++.|..+|+.++++|.+||++
T Consensus       254 vil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~  306 (325)
T d1rjba_         254 ILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAF  306 (325)
T ss_dssp             HHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCC
Confidence            99999998 89999987776666666667778899999999999999999974

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.1e-45  Score=270.77  Aligned_cols=187  Identities=36%  Similarity=0.602  Sum_probs=158.6

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||++++++|.+++..++||||+++|+|.+++.... ...+++..++.++.|+++||+|||++|  ++||||||
T Consensus        67 l~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp  143 (287)
T d1opja_          67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAA  143 (287)
T ss_dssp             HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred             HHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHCC--cccCcccc
Confidence            356899999999999999999999999999999999986533 234899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCC-CCCCHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW-GNLNPA  158 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf-~~~~~~  158 (191)
                      +||+++.++.+||+|||++....... .......++..|+|||.+.+..++.++||||+|+++|+|++|..|| ...+..
T Consensus       144 ~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~  223 (287)
T d1opja_         144 RNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS  223 (287)
T ss_dssp             GGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             CeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH
Confidence            99999999999999999987644332 2222334577899999999999999999999999999999976655 555555


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .....+ ..+.+++.|..+|+.++++|.+||++
T Consensus       224 ~~~~~i-~~~~~~~~~~~~~~~l~~li~~cl~~  255 (287)
T d1opja_         224 QVYELL-EKDYRMERPEGCPEKVYELMRACWQW  255 (287)
T ss_dssp             HHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHH-hcCCCCCCCccchHHHHHHHHHHcCC
Confidence            555555 46678889999999999999999974

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-44  Score=266.43  Aligned_cols=186  Identities=37%  Similarity=0.634  Sum_probs=150.1

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+ +..++||||+++|+|.+++...+.  .+++.++..++.||++||+|||+.+  ++||||||
T Consensus        58 l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp  132 (276)
T d1uwha_          58 LRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKS  132 (276)
T ss_dssp             HTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred             HHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCH
Confidence            468899999999997654 568999999999999999965432  3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccC---CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDE---PSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~---~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      +||+++.++.+||+|||++.......  .......+++.|+|||.+.+.   .++.++||||+|+++|+|+||..||...
T Consensus       133 ~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~  212 (276)
T d1uwha_         133 NNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI  212 (276)
T ss_dssp             GGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             HHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCC
Confidence            99999999999999999987543321  223345678999999998643   4688999999999999999999999986


Q ss_pred             CHHHHHHHHHhcCcc----cCCCCCCCHHHHHHHHHHhcC
Q 029552          156 NPAQVVAAVGFKGKR----LEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~~~~~~~~~~~~~----~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +...........+..    ...+.++|+.++++|.+||++
T Consensus       213 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~  252 (276)
T d1uwha_         213 NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKK  252 (276)
T ss_dssp             CCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCS
T ss_pred             ChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCC
Confidence            665544444333322    245778999999999999974

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-44  Score=274.59  Aligned_cols=181  Identities=24%  Similarity=0.447  Sum_probs=163.6

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||++++++|.+.+..++|+||+.+++|.+++.+.+   .+++.+++.++.||+.||.|||++|  ++||||||
T Consensus        95 l~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP  169 (350)
T d1rdqe_          95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKP  169 (350)
T ss_dssp             HTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred             HHHcCCCcEeecccccccccccccccccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCH
Confidence            468899999999999999999999999999999999997644   3899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      +||+++.+|.+||+|||++......   .....+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+....
T Consensus       170 ~NILl~~~g~ikL~DFG~a~~~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~  246 (350)
T d1rdqe_         170 ENLLIDQQGYIQVTDFGFAKRVKGR---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI  246 (350)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSC---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             HHcccCCCCCEEeeeceeeeecccc---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH
Confidence            9999999999999999998755433   2345678999999999999999999999999999999999999999999988


Q ss_pred             HHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+..  ..+..|..+|+.+.++|++||++
T Consensus       247 ~~~i~~--~~~~~p~~~s~~~~~li~~~L~~  275 (350)
T d1rdqe_         247 YEKIVS--GKVRFPSHFSSDLKDLLRNLLQV  275 (350)
T ss_dssp             HHHHHH--CCCCCCTTCCHHHHHHHHHHSCS
T ss_pred             HHHHhc--CCCCCCccCCHHHHHHHHHHhhh
Confidence            888854  35667889999999999999974

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-44  Score=265.06  Aligned_cols=185  Identities=32%  Similarity=0.609  Sum_probs=152.9

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+++|+|.+++.....  .++++.++.++.|+++||+|||+++  ++||||||+
T Consensus        55 ~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~  130 (263)
T d1sm2a_          55 MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAAR  130 (263)
T ss_dssp             HHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGG
T ss_pred             HhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHhhhccc--eeecccchh
Confidence            568999999999999999999999999999999999865432  3889999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQ  159 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g-~~pf~~~~~~~  159 (191)
                      ||+++.++.+||+|||++....... .......++..|+|||.+.+..++.++||||+|+++|+|+|+ .+||...+..+
T Consensus       131 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~  210 (263)
T d1sm2a_         131 NCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE  210 (263)
T ss_dssp             GEEECGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH
T ss_pred             heeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH
Confidence            9999999999999999987543332 222334567899999999999999999999999999999995 66777788878


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+. .+.++..|..+|+.+.++|.+||++
T Consensus       211 ~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~  241 (263)
T d1sm2a_         211 VVEDIS-TGFRLYKPRLASTHVYQIMNHCWKE  241 (263)
T ss_dssp             HHHHHH-HTCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHH-hcCCCCCccccCHHHHHHHHHHccC
Confidence            888775 4567778899999999999999974

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.6e-44  Score=274.78  Aligned_cols=183  Identities=26%  Similarity=0.409  Sum_probs=156.3

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +.++||||++++++|.+++..|+||||+.+++|.+++.+..   .+++.+++.++.||+.||+|||++|  ++||||||+
T Consensus        62 ~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~  136 (364)
T d1omwa3          62 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPA  136 (364)
T ss_dssp             SSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred             hcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccc
Confidence            56789999999999999999999999999999999997644   3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      ||+++.+|.+||+|||++......  ......+++.|+|||.+.. ..++.++|+||+||++|+|++|..||...+....
T Consensus       137 NILl~~~g~iKl~DFGla~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~  214 (364)
T d1omwa3         137 NILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK  214 (364)
T ss_dssp             GEEECSSSCEEECCCTTCEECSSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH
T ss_pred             eeEEcCCCcEEEeeeceeeecCCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999999999999999998754433  3344578999999999864 5689999999999999999999999986443332


Q ss_pred             HHHHH-hcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVG-FKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~-~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..... ........|..+|+.++++|.+||++
T Consensus       215 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  246 (364)
T d1omwa3         215 HEIDRMTLTMAVELPDSFSPELRSLLEGLLQR  246 (364)
T ss_dssp             HHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCS
T ss_pred             HHHHHhcccCCCCCCCCCCHHHHHHHHHHccc
Confidence            22221 24456677889999999999999975

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.5e-44  Score=274.67  Aligned_cols=186  Identities=26%  Similarity=0.410  Sum_probs=160.3

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||++++++|++++..|+|||||++|+|.+++.+..  +.+++.+++.++.||+.||+|||++|  ++||||||
T Consensus        77 l~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp  152 (350)
T d1koaa2          77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKP  152 (350)
T ss_dssp             HHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCG
T ss_pred             HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcC--Ceeeeech
Confidence            356899999999999999999999999999999999986433  23999999999999999999999999  99999999


Q ss_pred             CcEEecC--CCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           81 PNLLVDK--KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        81 ~ni~~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      +||+++.  ++.+||+|||++...... .......+++.|+|||++.+..++.++|+||+||++|+|++|..||...+..
T Consensus       153 ~NIll~~~~~~~vkL~DFG~a~~~~~~-~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~  231 (350)
T d1koaa2         153 ENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD  231 (350)
T ss_dssp             GGEEESSTTSCCEEECCCTTCEECCTT-SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             hHeeeccCCCCeEEEeecchheecccc-cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH
Confidence            9999964  578999999998754433 2223356789999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhcCcccC--CCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLE--IPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~--~~~~~s~~~~~li~~cl~~  191 (191)
                      +....+.......+  .+..+|+.++++|++||.+
T Consensus       232 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  266 (350)
T d1koaa2         232 ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLA  266 (350)
T ss_dssp             HHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCS
T ss_pred             HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccC
Confidence            98888865544333  3357999999999999974

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-44  Score=267.28  Aligned_cols=185  Identities=26%  Similarity=0.430  Sum_probs=161.3

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||++++++|++++.+|+|||||++|+|.+++...+   .+++.+++.++.|++.||+|||+++  ++||||||
T Consensus        67 l~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp  141 (293)
T d1jksa_          67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKP  141 (293)
T ss_dssp             HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred             HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhcc--eeeccccc
Confidence            356899999999999999999999999999999999997643   3999999999999999999999999  99999999


Q ss_pred             CcEEecCCC----cEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 029552           81 PNLLVDKKY----TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN  156 (191)
Q Consensus        81 ~ni~~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~  156 (191)
                      +||+++.++    .++++|||++...... .......+++.|+|||.+.+..++.++||||+||++|+|++|..||...+
T Consensus       142 ~Nill~~~~~~~~~vkl~DfG~a~~~~~~-~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~  220 (293)
T d1jksa_         142 ENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT  220 (293)
T ss_dssp             GGEEESCSSSSSCCEEECCCTTCEECTTS-CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ceEEEecCCCcccceEecchhhhhhcCCC-ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC
Confidence            999998776    4999999998755433 23344567889999999999889999999999999999999999999999


Q ss_pred             HHHHHHHHHhcCccc--CCCCCCCHHHHHHHHHHhcC
Q 029552          157 PAQVVAAVGFKGKRL--EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~~~~~~~~~~~~~~--~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+....+.......  ..+.++|+.++++|++||++
T Consensus       221 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  257 (293)
T d1jksa_         221 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK  257 (293)
T ss_dssp             HHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCS
T ss_pred             HHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccC
Confidence            999888886544332  23478999999999999974

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-44  Score=270.93  Aligned_cols=149  Identities=34%  Similarity=0.538  Sum_probs=133.3

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCeeecCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLK   79 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~~h~~l~   79 (191)
                      |++++||||++++++|.+++..|+||||+.+++|.+++.+.+   .+++.+++.++.|++.||.|||+ +|  ++|||||
T Consensus        58 l~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiK  132 (322)
T d1s9ja_          58 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVK  132 (322)
T ss_dssp             GGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCS
T ss_pred             HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccC
Confidence            568899999999999999999999999999999999997644   38999999999999999999997 59  9999999


Q ss_pred             CCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN  156 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~  156 (191)
                      |+||+++.+|.+||+|||++......  ......+++.|+|||.+.+..++.++|+||+||++|+|++|+.||...+
T Consensus       133 P~NILl~~~~~vkl~DFGla~~~~~~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~  207 (322)
T d1s9ja_         133 PSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  207 (322)
T ss_dssp             GGGEEECTTCCEEECCCCCCHHHHHH--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred             HHHeeECCCCCEEEeeCCCccccCCC--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            99999999999999999998754433  2334578999999999999999999999999999999999999997644

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=259.67  Aligned_cols=185  Identities=32%  Similarity=0.584  Sum_probs=163.2

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+++..++||||+.+|+|.+++.....  .+++..++.++.|+++||+|||+.|  ++||||+|+
T Consensus        54 ~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~  129 (258)
T d1k2pa_          54 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAAR  129 (258)
T ss_dssp             HTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGG
T ss_pred             HhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHhhcC--cccccccce
Confidence            578999999999999999999999999999999999755432  3889999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccc-cccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ  159 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~~  159 (191)
                      ||+++.++.+||+|||++...... ........++..|+|||.+.+..++.++||||+|+++|+|+| |..||...+..+
T Consensus       130 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~  209 (258)
T d1k2pa_         130 NCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE  209 (258)
T ss_dssp             GEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH
T ss_pred             eEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH
Confidence            999999999999999998643322 222334567788999999999999999999999999999998 799999999999


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+. .+.+++.|..+|+.++++|++||++
T Consensus       210 ~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~  240 (258)
T d1k2pa_         210 TAEHIA-QGLRLYRPHLASEKVYTIMYSCWHE  240 (258)
T ss_dssp             HHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCS
T ss_pred             HHHHHH-hCCCCCCcccccHHHHHHHHHHccC
Confidence            888886 5667888999999999999999975

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.4e-43  Score=261.66  Aligned_cols=183  Identities=23%  Similarity=0.387  Sum_probs=158.8

Q ss_pred             CCC-CCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            3 RLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         3 ~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      +++ ||||++++++|.+++..|+||||+++++|.+++...+   .+++++++.++.||++||+|||+.|  ++||||||+
T Consensus        65 ~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~  139 (277)
T d1phka_          65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN--IVHRDLKPE  139 (277)
T ss_dssp             HHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred             HhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcC--Ccccccccc
Confidence            455 9999999999999999999999999999999997644   3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCcccccc------CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD------EPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~------~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      ||+++.++.+||+|||++...... .......++..|+|||.+.+      ..++.++|+||+||++|+|++|..||...
T Consensus       140 Nill~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~  218 (277)
T d1phka_         140 NILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR  218 (277)
T ss_dssp             GEEECTTCCEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eEEEcCCCCeEEccchheeEccCC-CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC
Confidence            999999999999999999765443 23344568899999998853      23577899999999999999999999999


Q ss_pred             CHHHHHHHHHhcCcccC--CCCCCCHHHHHHHHHHhcC
Q 029552          156 NPAQVVAAVGFKGKRLE--IPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       156 ~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~cl~~  191 (191)
                      +..+....+.......+  .+.++|+.++++|.+||++
T Consensus       219 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  256 (277)
T d1phka_         219 KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVV  256 (277)
T ss_dssp             SHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCS
T ss_pred             CHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccC
Confidence            99888888876554433  3357999999999999974

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-43  Score=260.19  Aligned_cols=185  Identities=33%  Similarity=0.630  Sum_probs=157.5

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+ +..++||||+++|+|.+++.... +..+++.+++.++.||++||+|||+++  ++||||||+
T Consensus        63 ~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~  138 (272)
T d1qpca_          63 KQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAA  138 (272)
T ss_dssp             HHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred             HhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchh
Confidence            56899999999998765 56899999999999999886533 224899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccc-cccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQ  159 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g-~~pf~~~~~~~  159 (191)
                      ||+++.++.+||+|||++...... ........+++.|+|||.+.+..++.++||||+|+++|+|+|| .+||...+..+
T Consensus       139 NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~  218 (272)
T d1qpca_         139 NILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE  218 (272)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred             heeeecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999999765433 2223345677899999999988899999999999999999996 55667777777


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+. .+.++..|..+|+.++++|.+||++
T Consensus       219 ~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~  249 (272)
T d1qpca_         219 VIQNLE-RGYRMVRPDNCPEELYQLMRLCWKE  249 (272)
T ss_dssp             HHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHH-hcCCCCCcccChHHHHHHHHHHcCC
Confidence            777774 5677888999999999999999974

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-43  Score=259.46  Aligned_cols=186  Identities=31%  Similarity=0.593  Sum_probs=153.7

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+++..++|+||+.++++.+.+....  +.+++.++..++.|++.||+|||+.+  ++||||||
T Consensus        63 l~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp  138 (283)
T d1mqba_          63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAA  138 (283)
T ss_dssp             HHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred             HHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhccccc--cccCcccc
Confidence            357899999999999999999999999999999999886543  23899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccccc---ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCC-CCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLN  156 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~-pf~~~~  156 (191)
                      +||+++.++.+||+|||++.......   .......++..|+|||.+.+..++.++||||+|+++|+|+++.. |+...+
T Consensus       139 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~  218 (283)
T d1mqba_         139 RNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS  218 (283)
T ss_dssp             GGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             ceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC
Confidence            99999999999999999987543221   12223456788999999999999999999999999999999644 566667


Q ss_pred             HHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+....+. .+.+++.|.++|+.+.++|.+||++
T Consensus       219 ~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~  252 (283)
T d1mqba_         219 NHEVMKAIN-DGFRLPTPMDCPSAIYQLMMQCWQQ  252 (283)
T ss_dssp             HHHHHHHHH-TTCCCCCCTTCBHHHHHHHHHHTCS
T ss_pred             HHHHHHHHh-ccCCCCCchhhHHHHHHHHHHHCcC
Confidence            777766664 6678888999999999999999974

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-43  Score=260.25  Aligned_cols=185  Identities=31%  Similarity=0.598  Sum_probs=151.4

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+ +..++||||+.+|+|.+++....  ..+++.+++.++.||++||+|||+++  ++||||||
T Consensus        62 l~~l~HpnIv~l~~~~~~-~~~~iv~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp  136 (273)
T d1mp8a_          62 MRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAA  136 (273)
T ss_dssp             HHTCCCTTBCCEEEEECS-SSCEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred             HHhCCCCCEeeEEEEEec-CeEEEEEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhcccC--eeccccch
Confidence            357899999999999964 67899999999999999876433  23899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccc-cccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA  158 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~  158 (191)
                      +||+++.++.+||+|||++...... ........+++.|+|||.+.+..++.++||||+|+++|+|++ |..||...+..
T Consensus       137 ~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~  216 (273)
T d1mp8a_         137 RNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN  216 (273)
T ss_dssp             GGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred             hheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH
Confidence            9999999999999999998754322 122334456789999999999999999999999999999998 89999999988


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +....+. .+.+++.|.++|+.++++|.+||++
T Consensus       217 ~~~~~i~-~~~~~~~~~~~~~~~~~li~~cl~~  248 (273)
T d1mp8a_         217 DVIGRIE-NGERLPMPPNCPPTLYSLMTKCWAY  248 (273)
T ss_dssp             GHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            8888875 5667788999999999999999974

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-43  Score=258.93  Aligned_cols=186  Identities=34%  Similarity=0.567  Sum_probs=160.8

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.+ +..++||||++++++.+.+....  +.+++..++.++.|+++||+|||+.+  ++||||||
T Consensus        65 l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp  139 (273)
T d1u46a_          65 MHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAA  139 (273)
T ss_dssp             HHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCG
T ss_pred             HHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecH
Confidence            356899999999999976 46889999999999998886532  23899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccccc---ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLN  156 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~  156 (191)
                      +||+++.++.+||+|||++.......   .......++..|+|||.+.+..++.++||||+|+++|+|+| |..||...+
T Consensus       140 ~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~  219 (273)
T d1u46a_         140 RNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN  219 (273)
T ss_dssp             GGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             HHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC
Confidence            99999999999999999987543321   12223345678999999999989999999999999999998 899999999


Q ss_pred             HHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          157 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+....+...+.+++.|.++|+.++++|.+||++
T Consensus       220 ~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~  254 (273)
T d1u46a_         220 GSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAH  254 (273)
T ss_dssp             HHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCC
Confidence            99999999878888889999999999999999974

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-43  Score=264.77  Aligned_cols=186  Identities=19%  Similarity=0.362  Sum_probs=159.4

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||++++++|++++.+|+|||||++++|.+++...+.  .+++.+++.++.||+.||+|||+.|  ++||||||
T Consensus        55 l~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~--~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp  130 (321)
T d1tkia_          55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRP  130 (321)
T ss_dssp             HHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCG
T ss_pred             HHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccc
Confidence            3568999999999999999999999999999999999976442  3899999999999999999999999  99999999


Q ss_pred             CcEEecCC--CcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 029552           81 PNLLVDKK--YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA  158 (191)
Q Consensus        81 ~ni~~~~~--~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~  158 (191)
                      +||+++.+  +.++++|||++....... ......+++.|+|||...+..++.++|+||+||++|+|++|..||...+..
T Consensus       131 ~NIll~~~~~~~ikl~DFG~~~~~~~~~-~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~  209 (321)
T d1tkia_         131 ENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ  209 (321)
T ss_dssp             GGEEESSSSCCCEEECCCTTCEECCTTC-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred             cceeecCCCceEEEEcccchhhccccCC-cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH
Confidence            99999854  479999999987543321 222345678999999999988999999999999999999999999999999


Q ss_pred             HHHHHHHhcCcccC--CCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLE--IPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~--~~~~~s~~~~~li~~cl~~  191 (191)
                      +....+......++  .+..+|+.++++|.+||++
T Consensus       210 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  244 (321)
T d1tkia_         210 QIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVK  244 (321)
T ss_dssp             HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCS
T ss_pred             HHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccC
Confidence            99888865443322  2357999999999999974

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.1e-42  Score=257.10  Aligned_cols=186  Identities=26%  Similarity=0.467  Sum_probs=152.8

Q ss_pred             CCCCCCCCcccccceeecCC----ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeec
Q 029552            1 MKRLRHPNIVLFMGAVTQPP----NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHR   76 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~   76 (191)
                      |++++||||+++++++.+.+    ..|+||||+++++|.+++...+   .+++.+++.++.||++||+|||++|  ++||
T Consensus        61 l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~~--iiHr  135 (277)
T d1o6ya_          61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG--IIHR  135 (277)
T ss_dssp             HHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--EECC
T ss_pred             HHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhCC--ccCc
Confidence            35789999999999997544    3889999999999999987644   3899999999999999999999999  9999


Q ss_pred             CCCCCcEEecCCCcEEEcccccccccccc---cccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 029552           77 DLKSPNLLVDKKYTVKVCDFGLSRLKANT---FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWG  153 (191)
Q Consensus        77 ~l~p~ni~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~  153 (191)
                      ||||+||+++.++..+++|||.+......   ........+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.
T Consensus       136 DiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~  215 (277)
T d1o6ya_         136 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT  215 (277)
T ss_dssp             CCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCC
Confidence            99999999999999999999987543222   122334567899999999999989999999999999999999999999


Q ss_pred             CCCHHHHHHHHHhcCccc--CCCCCCCHHHHHHHHHHhcC
Q 029552          154 NLNPAQVVAAVGFKGKRL--EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..++.+....+......+  ..+.++|+.++++|++||++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~  255 (277)
T d1o6ya_         216 GDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAK  255 (277)
T ss_dssp             CSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCS
T ss_pred             CcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccC
Confidence            998888877776554433  34578999999999999975

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-42  Score=253.71  Aligned_cols=184  Identities=37%  Similarity=0.695  Sum_probs=153.9

Q ss_pred             CCCCCCCCcccccceeec-CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQ-PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      |++++||||+++++++.+ ++.+++||||+++|+|.+++.+.. ...+++..++.++.||+.||.|||+.+  ++||||+
T Consensus        54 l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlk  130 (262)
T d1byga_          54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLA  130 (262)
T ss_dssp             HTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred             HHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc--eeccccc
Confidence            468899999999998854 567899999999999999996532 224899999999999999999999999  9999999


Q ss_pred             CCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA  158 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~  158 (191)
                      |+||+++.++.++++|||.+......   .....++..|+|||.+.+..++.++||||+|+++|+|+| |..||...+..
T Consensus       131 p~Nil~~~~~~~kl~dfg~s~~~~~~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~  207 (262)
T d1byga_         131 ARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK  207 (262)
T ss_dssp             GGGEEECTTSCEEECCCCC---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG
T ss_pred             hHhheecCCCCEeecccccceecCCC---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH
Confidence            99999999999999999998754333   223355778999999998889999999999999999998 68899988888


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +....+. .+.+++.|..+|+.++++|++||++
T Consensus       208 ~~~~~i~-~~~~~~~~~~~~~~~~~li~~cl~~  239 (262)
T d1byga_         208 DVVPRVE-KGYKMDAPDGCPPAVYEVMKNCWHL  239 (262)
T ss_dssp             GHHHHHT-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHHH-cCCCCCCCccCCHHHHHHHHHHccc
Confidence            8888875 5678889999999999999999974

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-42  Score=256.64  Aligned_cols=185  Identities=23%  Similarity=0.274  Sum_probs=155.2

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||++++++|.++++.|+||||+.++++..+.....   .+++.++..++.||+.||+|||++|  ++||||||+
T Consensus        55 ~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~  129 (299)
T d1ua2a_          55 QELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPN  129 (299)
T ss_dssp             HHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCS---SCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGG
T ss_pred             HhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhccc---CCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcc
Confidence            56899999999999999999999999999887777765433   3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQV  160 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~  160 (191)
                      ||+++.++.+||+|||.+..............+++.|+|||.+.+. .++.++|+||+||++|+|++|..||...+..+.
T Consensus       130 NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~  209 (299)
T d1ua2a_         130 NLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ  209 (299)
T ss_dssp             GEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             eEEecCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH
Confidence            9999999999999999987655544444456788999999988655 578899999999999999999999999888887


Q ss_pred             HHHHHhcCccc--------------------------CCCCCCCHHHHHHHHHHhcC
Q 029552          161 VAAVGFKGKRL--------------------------EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       161 ~~~~~~~~~~~--------------------------~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+......+                          .....+|+.++++|.+||++
T Consensus       210 l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~  266 (299)
T d1ua2a_         210 LTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLF  266 (299)
T ss_dssp             HHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCS
T ss_pred             HHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccC
Confidence            77664321100                          01136789999999999974

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-42  Score=260.40  Aligned_cols=184  Identities=27%  Similarity=0.429  Sum_probs=148.8

Q ss_pred             CCCCCcccccceeec----CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            4 LRHPNIVLFMGAVTQ----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         4 l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      .+||||++++++|++    +..+|+|||||+||+|.+++.+.+. ..+++.+++.++.||+.||+|||+.|  ++|||||
T Consensus        62 ~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiK  138 (335)
T d2ozaa1          62 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVK  138 (335)
T ss_dssp             TTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCS
T ss_pred             cCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHcC--Ccccccc
Confidence            589999999999975    4578999999999999999976442 34999999999999999999999999  9999999


Q ss_pred             CCcEEecC---CCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 029552           80 SPNLLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN  156 (191)
Q Consensus        80 p~ni~~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~  156 (191)
                      |+||+++.   .+.+||+|||++...... .......+++.|+|||.+.+..++.++|+||+||++|+|++|..||...+
T Consensus       139 p~NIll~~~~~~~~~Kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~  217 (335)
T d2ozaa1         139 PENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH  217 (335)
T ss_dssp             GGGEEESCSSTTCCEEECCCTTCEECCCC-CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETT
T ss_pred             ccccccccccccccccccccceeeeccCC-CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCC
Confidence            99999975   457999999998754433 23445678999999999999889999999999999999999999998766


Q ss_pred             HHHHHHHHHh--cCcccCCC----CCCCHHHHHHHHHHhcC
Q 029552          157 PAQVVAAVGF--KGKRLEIP----RNVNPHVASIIEACWAK  191 (191)
Q Consensus       157 ~~~~~~~~~~--~~~~~~~~----~~~s~~~~~li~~cl~~  191 (191)
                      .......+..  ......+|    ..+|++++++|.+||++
T Consensus       218 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  258 (335)
T d2ozaa1         218 GLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKT  258 (335)
T ss_dssp             CC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCS
T ss_pred             HHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccC
Confidence            5444443322  12233333    36899999999999974

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-42  Score=255.42  Aligned_cols=185  Identities=35%  Similarity=0.593  Sum_probs=151.8

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.+ +..++||||+.+|+|..++.... .+.+++.+++.++.||+.||+|||+.+  ++||||||+
T Consensus        67 ~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~  142 (285)
T d1fmka3          67 KKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAA  142 (285)
T ss_dssp             HHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred             HhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh--eecccccce
Confidence            56899999999999865 56899999999999998886432 224899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccccc-ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCC-CCCCCCHHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQ  159 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~-pf~~~~~~~  159 (191)
                      ||+++.++.+||+|||++....... .......+++.|+|||.+....++.++||||+|+++|+|++|.. |+......+
T Consensus       143 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~  222 (285)
T d1fmka3         143 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE  222 (285)
T ss_dssp             GEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred             EEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999987543322 22233456889999999999999999999999999999999654 556677777


Q ss_pred             HHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+. .+.+++.|..+|+.++++|.+||++
T Consensus       223 ~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~  253 (285)
T d1fmka3         223 VLDQVE-RGYRMPCPPECPESLHDLMCQCWRK  253 (285)
T ss_dssp             HHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHH-hcCCCCCCcccCHHHHHHHHHHccc
Confidence            777765 5567788999999999999999974

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-41  Score=252.17  Aligned_cols=184  Identities=33%  Similarity=0.611  Sum_probs=162.3

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC-------------cccccHHHHHHHHHHHHHHHHHHHhCCC
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV-------------REMLDERRRLNMAYDVAKGMNYLHRRNP   71 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~   71 (191)
                      +||||++++++|.+++..++||||+.+|+|.+++.....             ...+++.++..++.||+.||+|||+.+ 
T Consensus        77 ~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~-  155 (299)
T d1fgka_          77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-  155 (299)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             CCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC-
Confidence            799999999999999999999999999999999975431             234899999999999999999999999 


Q ss_pred             CeeecCCCCCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-C
Q 029552           72 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-L  148 (191)
Q Consensus        72 ~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g  148 (191)
                       ++||||||+||+++.++.+||+|||.+.......  .......+++.|+|||.+.+..++.++||||+|+++|+|++ |
T Consensus       156 -ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g  234 (299)
T d1fgka_         156 -CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG  234 (299)
T ss_dssp             -CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred             -EEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCC
Confidence             9999999999999999999999999987554332  22334456778999999999999999999999999999998 6


Q ss_pred             CCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          149 QQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       149 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..||...+..+....+. .+.+++.|..+|+.++++|.+||++
T Consensus       235 ~~p~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~  276 (299)
T d1fgka_         235 GSPYPGVPVEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHA  276 (299)
T ss_dssp             CCSSTTCCHHHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCS
T ss_pred             CCCCCCCCHHHHHHHHH-cCCCCCCCccchHHHHHHHHHHccC
Confidence            88999999888887775 5678889999999999999999974

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-42  Score=255.55  Aligned_cols=187  Identities=34%  Similarity=0.640  Sum_probs=161.5

Q ss_pred             CCCC-CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCC-------------CcccccHHHHHHHHHHHHHHHHHH
Q 029552            1 MKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-------------VREMLDERRRLNMAYDVAKGMNYL   66 (191)
Q Consensus         1 L~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~~~~~~i~~~l~~L   66 (191)
                      |+++ +||||+++++++.+++..++||||+++|+|.+++.+..             ....+++.++..++.||+.|+.||
T Consensus        64 l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~l  143 (309)
T d1fvra_          64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL  143 (309)
T ss_dssp             HTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred             HHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhh
Confidence            3566 79999999999999999999999999999999996531             223589999999999999999999


Q ss_pred             HhCCCCeeecCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHH
Q 029552           67 HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA  146 (191)
Q Consensus        67 h~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~  146 (191)
                      |+.+  ++||||||+||+++.++.+||+|||++....... ......++..|+|||.+.+..++.++||||+|+++|+|+
T Consensus       144 H~~~--iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell  220 (309)
T d1fvra_         144 SQKQ--FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV  220 (309)
T ss_dssp             HHTT--EECSCCSGGGEEECGGGCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred             hcCC--ccccccccceEEEcCCCceEEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHH
Confidence            9999  9999999999999999999999999987544332 223445788999999999998999999999999999999


Q ss_pred             hCC-CCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          147 TLQ-QPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       147 ~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +|. .||...+..+....+. .+.+++.|.++|+.++++|.+||++
T Consensus       221 ~~~~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~cl~~  265 (309)
T d1fvra_         221 SLGGTPYCGMTCAELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWRE  265 (309)
T ss_dssp             TTSCCTTTTCCHHHHHHHGG-GTCCCCCCTTBCHHHHHHHHHHTCS
T ss_pred             hcCCCCCCCCCHHHHHHHHH-hcCCCCCCccCCHHHHHHHHHHcCC
Confidence            975 6899999999888875 4567888999999999999999974

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-42  Score=258.37  Aligned_cols=184  Identities=29%  Similarity=0.540  Sum_probs=155.8

Q ss_pred             CCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            2 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         2 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      ++++||||+++++++.++ ..+++++++.+++|.+.+.....  .+++.+++.++.||+.||+|||+++  ++||||||+
T Consensus        66 ~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~  140 (317)
T d1xkka_          66 ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAAR  140 (317)
T ss_dssp             HHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTSS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGG
T ss_pred             HhCCCCCEeeEEEEEecC-CeeEEEEeccCCccccccccccc--CCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhh
Confidence            568999999999999875 56788888999999988865432  3899999999999999999999999  999999999


Q ss_pred             cEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 029552           82 NLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPA  158 (191)
Q Consensus        82 ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~pf~~~~~~  158 (191)
                      ||+++.++.+||+|||++.......  .......++..|+|||.+.+..++.++||||+|+++|+|+| |..||...+..
T Consensus       141 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~  220 (317)
T d1xkka_         141 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS  220 (317)
T ss_dssp             GEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG
T ss_pred             cceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH
Confidence            9999999999999999987543321  12233456889999999999999999999999999999998 78999988887


Q ss_pred             HHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +....+. .+.+++.|..+|+.+.++|.+||++
T Consensus       221 ~~~~~i~-~~~~~~~p~~~~~~~~~li~~cl~~  252 (317)
T d1xkka_         221 EISSILE-KGERLPQPPICTIDVYMIMVKCWMI  252 (317)
T ss_dssp             GHHHHHH-HTCCCCCCTTBCHHHHHHHHHHTCS
T ss_pred             HHHHHHH-cCCCCCCCcccCHHHHHHHHHhCCC
Confidence            7777664 5677888999999999999999974

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.6e-41  Score=252.46  Aligned_cols=188  Identities=32%  Similarity=0.574  Sum_probs=161.2

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCC---------------------cccccHHHHHHHHHHH
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGV---------------------REMLDERRRLNMAYDV   59 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------------------~~~~~~~~~~~~~~~i   59 (191)
                      |++++||||+++++++.+++..++++|++.+++|.+++.....                     ...+++.+++.++.|+
T Consensus        70 l~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi  149 (301)
T d1lufa_          70 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV  149 (301)
T ss_dssp             HHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHH
T ss_pred             HHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHH
Confidence            4578999999999999999999999999999999999853221                     1237888999999999


Q ss_pred             HHHHHHHHhCCCCeeecCCCCCcEEecCCCcEEEcccccccccccc--cccCCCCCCCCcccCccccccCCCCCcchHHH
Q 029552           60 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYS  137 (191)
Q Consensus        60 ~~~l~~Lh~~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~s  137 (191)
                      +.||+|||+.+  ++||||||+||+++.++.+||+|||++......  ........+++.|+|||.+.+..++.++||||
T Consensus       150 ~~gl~ylH~~~--ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS  227 (301)
T d1lufa_         150 AAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWA  227 (301)
T ss_dssp             HHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHH
T ss_pred             HHHhhhcccCC--eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhcc
Confidence            99999999999  999999999999999999999999998643322  22233456778999999999999999999999


Q ss_pred             HHHHHHHHHhCC-CCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          138 FGVILWELATLQ-QPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       138 lG~~~~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +|+++|+|++|. .||...+..+....+. .+..++.|.++|+++.++|.+||++
T Consensus       228 ~Gvvl~ell~~~~~p~~~~~~~e~~~~v~-~~~~~~~p~~~~~~~~~li~~cl~~  281 (301)
T d1lufa_         228 YGVVLWEIFSYGLQPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSK  281 (301)
T ss_dssp             HHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             chhhHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCCccchHHHHHHHHHHcCC
Confidence            999999999995 6899999999888875 5567788999999999999999974

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-41  Score=250.35  Aligned_cols=186  Identities=31%  Similarity=0.564  Sum_probs=150.4

Q ss_pred             CCCCCcccccceeec-CCceEEEEeccCCCCHHHHhcCCCC-------------cccccHHHHHHHHHHHHHHHHHHHhC
Q 029552            4 LRHPNIVLFMGAVTQ-PPNLSIVTEYLSRGSLYRLLHKPGV-------------REMLDERRRLNMAYDVAKGMNYLHRR   69 (191)
Q Consensus         4 l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~Lh~~   69 (191)
                      ..|+||+.+++++.+ +...++|||||++|+|.+++.....             ...+++.++..++.||++||+|||++
T Consensus        74 ~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~  153 (299)
T d1ywna1          74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR  153 (299)
T ss_dssp             CCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             cCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC
Confidence            369999999998765 4568999999999999999964321             23488999999999999999999999


Q ss_pred             CCCeeecCCCCCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh
Q 029552           70 NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT  147 (191)
Q Consensus        70 ~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~  147 (191)
                      +  ++||||||+||+++.++.+||+|||++.......  .......+++.|+|||.+.+..++.++||||+||++|+|++
T Consensus       154 ~--ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt  231 (299)
T d1ywna1         154 K--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS  231 (299)
T ss_dssp             T--CCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             C--CcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHh
Confidence            9  9999999999999999999999999987543322  22334567889999999999999999999999999999998


Q ss_pred             C-CCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          148 L-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       148 g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      | ..||......+........+.+++.|..+|+.++++|.+||++
T Consensus       232 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  276 (299)
T d1ywna1         232 LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG  276 (299)
T ss_dssp             TSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCC
Confidence            7 5688876655555555556778889999999999999999974

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-40  Score=249.67  Aligned_cols=186  Identities=32%  Similarity=0.543  Sum_probs=153.5

Q ss_pred             CCCCCCCCcccccceeec-CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQ-PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK   79 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~   79 (191)
                      |++++||||+++++++.+ ++..++|||||++++|.+++.....  ..++..++.++.|++.||.|||+.+  ++|||||
T Consensus        82 l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK  157 (311)
T d1r0pa_          82 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLA  157 (311)
T ss_dssp             HHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred             HHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhcccC--cccCCcc
Confidence            357899999999999865 5679999999999999999876543  3778889999999999999999999  9999999


Q ss_pred             CCcEEecCCCcEEEccccccccccccc----ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-
Q 029552           80 SPNLLVDKKYTVKVCDFGLSRLKANTF----LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN-  154 (191)
Q Consensus        80 p~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~-  154 (191)
                      |+||+++.++.+||+|||++.......    .......++..|+|||.+.+..++.++||||+|+++|+|++|..||.. 
T Consensus       158 ~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~  237 (311)
T d1r0pa_         158 ARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD  237 (311)
T ss_dssp             GGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred             HHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCC
Confidence            999999999999999999987543321    112223567889999999999999999999999999999998777665 


Q ss_pred             CCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          155 LNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+.......+. .+.++..|..+++.+.++|.+||++
T Consensus       238 ~~~~~~~~~i~-~g~~~~~p~~~~~~l~~li~~cl~~  273 (311)
T d1r0pa_         238 VNTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHP  273 (311)
T ss_dssp             -----CHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCHHHHHHHHH-cCCCCCCcccCcHHHHHHHHHHcCC
Confidence            44444455543 5678888999999999999999975

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-40  Score=247.01  Aligned_cols=187  Identities=21%  Similarity=0.281  Sum_probs=152.7

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||++++++|.+++..|+||||+.++.+........  +.+++.+++.++.|++.||+|||+.|  ++||||||
T Consensus        55 l~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKp  130 (298)
T d1gz8a_          55 LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKP  130 (298)
T ss_dssp             HTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred             HHhCCCCcEEEeccccccccceeEEEeecCCchhhhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCc
Confidence            478999999999999999999999999997644443333322  23899999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      +||+++.++.++++|||.+..............+++.|+|||.+.... .+.++|+||+|+++|+|++|..||...+...
T Consensus       131 eNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~  210 (298)
T d1gz8a_         131 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID  210 (298)
T ss_dssp             GGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             hheeecccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH
Confidence            999999999999999999876655544555567889999999877665 4788999999999999999999999888777


Q ss_pred             HHHHHHhcCcc----------------cC-----------CCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGKR----------------LE-----------IPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~~----------------~~-----------~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+......                ..           ....+|+.++++|++||++
T Consensus       211 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~  269 (298)
T d1gz8a_         211 QLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHY  269 (298)
T ss_dssp             HHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccC
Confidence            66655321100                00           1136789999999999974

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-41  Score=247.35  Aligned_cols=172  Identities=20%  Similarity=0.383  Sum_probs=145.7

Q ss_pred             CCCCcccccceeecCCceEEEEeccCC-CCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCcE
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSR-GSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNL   83 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~ni   83 (191)
                      .||||++++++|++++..++|||++.+ +++.+++....   .+++++++.++.||++||+|||++|  ++||||||+||
T Consensus        67 ~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NI  141 (273)
T d1xwsa_          67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENI  141 (273)
T ss_dssp             SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred             CCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccce
Confidence            399999999999999999999999975 67888886533   3899999999999999999999999  99999999999


Q ss_pred             EecC-CCcEEEcccccccccccccccCCCCCCCCcccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 029552           84 LVDK-KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVV  161 (191)
Q Consensus        84 ~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~~~  161 (191)
                      +++. ++.++|+|||++......  ......+++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+     
T Consensus       142 ll~~~~~~vkl~DFG~a~~~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----  214 (273)
T d1xwsa_         142 LIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----  214 (273)
T ss_dssp             EEETTTTEEEECCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----
T ss_pred             EEecCCCeEEECccccceecccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----
Confidence            9985 478999999998754433  2334578999999999987765 567899999999999999999997632     


Q ss_pred             HHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          162 AAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       162 ~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                       .+.  .....++..+|++++++|++||++
T Consensus       215 -~i~--~~~~~~~~~~s~~~~~li~~~L~~  241 (273)
T d1xwsa_         215 -EII--RGQVFFRQRVSSECQHLIRWCLAL  241 (273)
T ss_dssp             -HHH--HCCCCCSSCCCHHHHHHHHHHTCS
T ss_pred             -HHh--hcccCCCCCCCHHHHHHHHHHccC
Confidence             221  234567889999999999999974

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-40  Score=245.42  Aligned_cols=184  Identities=23%  Similarity=0.344  Sum_probs=152.1

Q ss_pred             CCCCCCcccccceeec-----CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecC
Q 029552            3 RLRHPNIVLFMGAVTQ-----PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRD   77 (191)
Q Consensus         3 ~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~   77 (191)
                      .++||||++++++|..     ....++++|++.++++........  ..+++..++.++.|++.||+|||+++  ++|||
T Consensus        66 ~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrD  141 (305)
T d1blxa_          66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSHR--VVHRD  141 (305)
T ss_dssp             HTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCC
T ss_pred             hcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC--EEecC
Confidence            3589999999999852     346899999998876655544332  23899999999999999999999999  99999


Q ss_pred             CCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           78 LKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        78 l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      |||+||+++..+.++++|||.+...... .......+++.|+|||.+.+..++.++|+||+||++|+|++|..||...+.
T Consensus       142 iKp~NILi~~~~~~kl~dfg~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~  220 (305)
T d1blxa_         142 LKPQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD  220 (305)
T ss_dssp             CCGGGEEECTTCCEEECSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             CCccEEEEcCCCCeeecchhhhhhhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH
Confidence            9999999999999999999988754433 234456789999999999999999999999999999999999999999888


Q ss_pred             HHHHHHHHhcC-------------------------cccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGFKG-------------------------KRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~~~-------------------------~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+....+....                         .....+..+|+.+++||.+||++
T Consensus       221 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~  279 (305)
T d1blxa_         221 VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTF  279 (305)
T ss_dssp             HHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCS
T ss_pred             HHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcC
Confidence            87777653210                         01124567899999999999974

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1e-39  Score=242.18  Aligned_cols=186  Identities=23%  Similarity=0.297  Sum_probs=151.7

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||++++++|.+++..+++++++.++.+..+....+   .+++.+++.++.||+.||+|||+.+  ++||||||
T Consensus        54 l~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp  128 (286)
T d1ob3a_          54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKP  128 (286)
T ss_dssp             GGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred             HHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcC---CcchhhhHHHHHHHHHHHHHhccCc--EEecCCCC
Confidence            568899999999999999999999999998877777665543   3999999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQ  159 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf~~~~~~~  159 (191)
                      +||+++.++.++++|||.+..............+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||.+.+..+
T Consensus       129 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~  208 (286)
T d1ob3a_         129 QNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD  208 (286)
T ss_dssp             GGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ceeeEcCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH
Confidence            99999999999999999987655444444455678899999998765 46899999999999999999999999988777


Q ss_pred             HHHHHHhcCc---------------------------ccCCCCCCCHHHHHHHHHHhcC
Q 029552          160 VVAAVGFKGK---------------------------RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       160 ~~~~~~~~~~---------------------------~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ....+.....                           ....+..+|+.++++|++||++
T Consensus       209 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~  267 (286)
T d1ob3a_         209 QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKL  267 (286)
T ss_dssp             HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCS
T ss_pred             HHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccC
Confidence            7666432100                           1123467899999999999974

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-40  Score=245.77  Aligned_cols=185  Identities=32%  Similarity=0.539  Sum_probs=158.6

Q ss_pred             CCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCC---------------CcccccHHHHHHHHHHHHHHHHHHHhC
Q 029552            5 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG---------------VREMLDERRRLNMAYDVAKGMNYLHRR   69 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~   69 (191)
                      +||||+++++++.+++..++|||||++++|.+++.+..               ....+++.++..++.||++|++|||++
T Consensus        85 ~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~  164 (311)
T d1t46a_          85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK  164 (311)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            69999999999999999999999999999999986432               122488999999999999999999999


Q ss_pred             CCCeeecCCCCCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHh
Q 029552           70 NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT  147 (191)
Q Consensus        70 ~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~  147 (191)
                      +  ++||||||+||+++.++.++++|||.+.......  .......+++.|+|||.+.+..++.++||||||+++|+|+|
T Consensus       165 ~--ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt  242 (311)
T d1t46a_         165 N--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS  242 (311)
T ss_dssp             T--CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             C--eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHh
Confidence            9  9999999999999999999999999987544321  22233456789999999998889999999999999999998


Q ss_pred             -CCCCCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          148 -LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       148 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                       |.+||...+..+.+..+...+.++..|..+|+.++++|.+||++
T Consensus       243 ~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~  287 (311)
T d1t46a_         243 LGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDA  287 (311)
T ss_dssp             TTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             CCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCC
Confidence             56667777776666666667788888999999999999999974

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-39  Score=241.79  Aligned_cols=188  Identities=34%  Similarity=0.568  Sum_probs=162.5

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCC-------CcccccHHHHHHHHHHHHHHHHHHHhCCCCe
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPG-------VREMLDERRRLNMAYDVAKGMNYLHRRNPPI   73 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~   73 (191)
                      |++++||||+++++++..++..++||||+.+|+|.+++....       ....++..++..++.|+++||.|||+.+  +
T Consensus        77 l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--i  154 (308)
T d1p4oa_          77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--F  154 (308)
T ss_dssp             GGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--C
T ss_pred             HHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--e
Confidence            467899999999999999999999999999999999885321       1123678899999999999999999999  9


Q ss_pred             eecCCCCCcEEecCCCcEEEccccccccccccc--ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhC-CC
Q 029552           74 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQ  150 (191)
Q Consensus        74 ~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g-~~  150 (191)
                      +||||||+||+++.++.+||+|||++.......  .......+++.|+|||.+.+..++.++|+||+|+++|+|+|| ..
T Consensus       155 vHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~  234 (308)
T d1p4oa_         155 VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ  234 (308)
T ss_dssp             BCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCC
T ss_pred             eeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCC
Confidence            999999999999999999999999987543321  223334567899999999999999999999999999999998 58


Q ss_pred             CCCCCCHHHHHHHHHhcCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          151 PWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       151 pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ||...+..+....+. .+.+++.|..+|+.++++|.+||++
T Consensus       235 p~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~  274 (308)
T d1p4oa_         235 PYQGLSNEQVLRFVM-EGGLLDKPDNCPDMLFELMRMCWQY  274 (308)
T ss_dssp             TTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCCCCCHHHHHHHHH-hCCCCCCcccchHHHHHHHHHHcCC
Confidence            899999999888876 5567888999999999999999974

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-40  Score=246.13  Aligned_cols=185  Identities=24%  Similarity=0.381  Sum_probs=152.9

Q ss_pred             CCCCC-CCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            2 KRLRH-PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         2 ~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      ++++| |||++++++++++...++++||+.+++|.+++...+.   +++..+..++.||+.||+|||+.|  ++||||||
T Consensus        83 ~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp  157 (322)
T d1vzoa_          83 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKL  157 (322)
T ss_dssp             HHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCG
T ss_pred             HhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCc
Confidence            45666 8999999999999999999999999999999976443   789999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEccccccccccc-ccccCCCCCCCCcccCccccccCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKAN-TFLSSKSAAGTPEWMAPEVLRDEP--SNEKSDIYSFGVILWELATLQQPWGNLNP  157 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Dv~slG~~~~~l~~g~~pf~~~~~  157 (191)
                      +||+++.++.++|+|||++..... .........+++.|++||.+.+..  ++.++||||+||++|+|++|..||...+.
T Consensus       158 ~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~  237 (322)
T d1vzoa_         158 ENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE  237 (322)
T ss_dssp             GGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS
T ss_pred             cceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999999999999999865432 223334456788999999987653  57789999999999999999999976544


Q ss_pred             HHHHHHHHh--cCcccCCCCCCCHHHHHHHHHHhcC
Q 029552          158 AQVVAAVGF--KGKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       158 ~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ......+..  ....+++|..+|+.++++|++||++
T Consensus       238 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~  273 (322)
T d1vzoa_         238 KNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMK  273 (322)
T ss_dssp             CCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHccc
Confidence            433333322  2335667889999999999999974

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-38  Score=237.74  Aligned_cols=188  Identities=21%  Similarity=0.262  Sum_probs=145.3

Q ss_pred             CCCCCCCCcccccceeec------CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCee
Q 029552            1 MKRLRHPNIVLFMGAVTQ------PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIV   74 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~   74 (191)
                      |++++||||++++++|..      ..+.++||||+.++.+..+.........+++.+++.++.||+.||+|||++|  |+
T Consensus        67 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--Ii  144 (350)
T d1q5ka_          67 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--IC  144 (350)
T ss_dssp             HHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EE
T ss_pred             HHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--Cc
Confidence            356899999999999843      2357899999987544444322122334899999999999999999999999  99


Q ss_pred             ecCCCCCcEEecCCC-cEEEcccccccccccccccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCC
Q 029552           75 HRDLKSPNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPW  152 (191)
Q Consensus        75 h~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~pf  152 (191)
                      ||||||+||+++.++ .+||+|||++...... .......++..|+|||.+.+ ..++.++|+||+||++|+|++|..||
T Consensus       145 HrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf  223 (350)
T d1q5ka_         145 HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF  223 (350)
T ss_dssp             CCCCCGGGEEECTTTCCEEECCCTTCEECCTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSS
T ss_pred             ccCCCcceEEEecCCCceeEecccchhhccCC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCC
Confidence            999999999999775 8999999998754333 22334567889999998765 46899999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhcCc---------------cc------------CCCCCCCHHHHHHHHHHhcC
Q 029552          153 GNLNPAQVVAAVGFKGK---------------RL------------EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       153 ~~~~~~~~~~~~~~~~~---------------~~------------~~~~~~s~~~~~li~~cl~~  191 (191)
                      ...+.......+.....               ..            .....+|+.+++||.+||++
T Consensus       224 ~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~  289 (350)
T d1q5ka_         224 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEY  289 (350)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCS
T ss_pred             CCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccC
Confidence            98877766655432100               00            12346899999999999974

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-38  Score=234.15  Aligned_cols=185  Identities=32%  Similarity=0.511  Sum_probs=143.3

Q ss_pred             CCCCCCCCcccccceeecCC----ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHh--------
Q 029552            1 MKRLRHPNIVLFMGAVTQPP----NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR--------   68 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~--------   68 (191)
                      +++++||||+++++++.+.+    .+|+||||+.+|+|.+++++..    +++.+++.++.|++.|+.|||+        
T Consensus        51 ~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~----l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~  126 (303)
T d1vjya_          51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGK  126 (303)
T ss_dssp             STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCB
T ss_pred             HhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHhhhhhccC
Confidence            35789999999999997543    5899999999999999997643    7899999999999999999997        


Q ss_pred             CCCCeeecCCCCCcEEecCCCcEEEccccccccccccc----ccCCCCCCCCcccCccccccCC------CCCcchHHHH
Q 029552           69 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF----LSSKSAAGTPEWMAPEVLRDEP------SNEKSDIYSF  138 (191)
Q Consensus        69 ~~~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~------~~~~~Dv~sl  138 (191)
                      .|  ++||||||+||+++.++.+||+|||++.......    .......+++.|+|||.+.+..      ++.++||||+
T Consensus       127 ~~--IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~  204 (303)
T d1vjya_         127 PA--IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM  204 (303)
T ss_dssp             CE--EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHH
T ss_pred             CC--eeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhh
Confidence            47  9999999999999999999999999987543321    1233456889999999987653      4567899999


Q ss_pred             HHHHHHHHhCCCCCCC---------------CCHHHHHHHHHhcCcccCCCCC-----CCHHHHHHHHHHhcC
Q 029552          139 GVILWELATLQQPWGN---------------LNPAQVVAAVGFKGKRLEIPRN-----VNPHVASIIEACWAK  191 (191)
Q Consensus       139 G~~~~~l~~g~~pf~~---------------~~~~~~~~~~~~~~~~~~~~~~-----~s~~~~~li~~cl~~  191 (191)
                      |+++|+|+||..||..               ...............++.+|..     .+..+.++|.+||+.
T Consensus       205 Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~  277 (303)
T d1vjya_         205 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA  277 (303)
T ss_dssp             HHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCS
T ss_pred             HHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHccc
Confidence            9999999999876632               2233344444333444455443     235689999999974

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-37  Score=232.70  Aligned_cols=181  Identities=26%  Similarity=0.402  Sum_probs=148.9

Q ss_pred             CCCCCCCCcccccceeecCC------ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCee
Q 029552            1 MKRLRHPNIVLFMGAVTQPP------NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIV   74 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~   74 (191)
                      |++++||||++++++|...+      .+|+||||+ +.+|..+....    .+++..++.++.||+.||+|||++|  ++
T Consensus        71 l~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~--Ii  143 (346)
T d1cm8a_          71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG--II  143 (346)
T ss_dssp             HHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred             HHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhCC--Cc
Confidence            35689999999999997654      579999999 56888877643    3899999999999999999999999  99


Q ss_pred             ecCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCC
Q 029552           75 HRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWG  153 (191)
Q Consensus        75 h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~pf~  153 (191)
                      ||||||+||+++.++.++++|||.+......   .....+++.|+|||.+.+. .++.++|+||+||++|+|++|..||.
T Consensus       144 HrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~  220 (346)
T d1cm8a_         144 HRDLKPGNLAVNEDCELKILDFGLARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK  220 (346)
T ss_dssp             CCCCCGGGEEECTTCCEEECCCTTCEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ccccCcchhhcccccccccccccceeccCCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCC
Confidence            9999999999999999999999998755433   2345678899999998764 46889999999999999999999999


Q ss_pred             CCCHHHHHHHHHhcCc-----------------------------ccCCCCCCCHHHHHHHHHHhcC
Q 029552          154 NLNPAQVVAAVGFKGK-----------------------------RLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       154 ~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ..+.......+.....                             ....+.++|+.+++||++||.+
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~  287 (346)
T d1cm8a_         221 GSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVL  287 (346)
T ss_dssp             CSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCS
T ss_pred             CCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcC
Confidence            8877665544322111                             1123467899999999999974

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-36  Score=225.44  Aligned_cols=186  Identities=23%  Similarity=0.323  Sum_probs=153.5

Q ss_pred             CCCCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      |++++||||+++++++.++...+++++++.+++|..++...+   .+++.+++.++.|++.||+|||++|  ++||||||
T Consensus        55 l~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP  129 (292)
T d1unla_          55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKP  129 (292)
T ss_dssp             HTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred             HHhcCcCCEEeeccccccccceeEEeeecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcCC--EeeecccC
Confidence            467899999999999999999999999999999988887644   3889999999999999999999999  99999999


Q ss_pred             CcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCC-CCCHH
Q 029552           81 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWG-NLNPA  158 (191)
Q Consensus        81 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~pf~-~~~~~  158 (191)
                      +||+++.++.++++|||.+...............+..|.|||.+.+.. ++.++|+||+||++|+|++|..||. ..+..
T Consensus       130 ~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~  209 (292)
T d1unla_         130 QNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD  209 (292)
T ss_dssp             GGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH
T ss_pred             cccccccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH
Confidence            999999999999999999986655544445556677899999887665 5889999999999999999998864 45555


Q ss_pred             HHHHHHHhc---------------------------CcccCCCCCCCHHHHHHHHHHhcC
Q 029552          159 QVVAAVGFK---------------------------GKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       159 ~~~~~~~~~---------------------------~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      +....+...                           ......+..+|+.+++||++||++
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~  269 (292)
T d1unla_         210 DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKC  269 (292)
T ss_dssp             HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCS
T ss_pred             HHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccC
Confidence            544443221                           111223456899999999999963

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-37  Score=232.08  Aligned_cols=184  Identities=25%  Similarity=0.407  Sum_probs=145.3

Q ss_pred             CCCCCCCCcccccceeecCC-----ceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 029552            1 MKRLRHPNIVLFMGAVTQPP-----NLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH   75 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h   75 (191)
                      |++++||||+++++++....     ..++++ ++.+++|.+++....    +++.+++.++.|++.||+|||++|  ++|
T Consensus        60 l~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~-~~~~g~L~~~l~~~~----l~~~~i~~i~~qil~al~yLH~~~--iiH  132 (345)
T d1pmea_          60 LLRFRHENIIGINDIIRAPTIEQMKDVYLVT-HLMGADLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSAN--VLH  132 (345)
T ss_dssp             HHHCCCTTBCCCCEEECCSSTTTCCCEEEEE-ECCCEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred             HHHcCCCCCCcEEEEEeeccccccceEEEEE-eecCCchhhhhhcCC----CCHHHHHHHHHHHHHHHHHHHHCC--CcC
Confidence            45789999999999986543     345554 566889999997532    899999999999999999999999  999


Q ss_pred             cCCCCCcEEecCCCcEEEccccccccccccc---ccCCCCCCCCcccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCC
Q 029552           76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQP  151 (191)
Q Consensus        76 ~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p  151 (191)
                      |||||+||+++.++.++|+|||++.......   .......+++.|+|||.+.. ..++.++|+||+|+++|+|++|..|
T Consensus       133 RDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~p  212 (345)
T d1pmea_         133 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI  212 (345)
T ss_dssp             CCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCC
Confidence            9999999999999999999999986543321   22344567889999999854 4568899999999999999999999


Q ss_pred             CCCCCHHHHHHHHHhcCcc-----------------------------cCCCCCCCHHHHHHHHHHhcC
Q 029552          152 WGNLNPAQVVAAVGFKGKR-----------------------------LEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       152 f~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~s~~~~~li~~cl~~  191 (191)
                      |...+..............                             .....++|+.++++|.+||++
T Consensus       213 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  281 (345)
T d1pmea_         213 FPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTF  281 (345)
T ss_dssp             CCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCS
T ss_pred             CCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccC
Confidence            9887765554443211000                             012346889999999999974

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1e-36  Score=226.58  Aligned_cols=183  Identities=18%  Similarity=0.233  Sum_probs=148.1

Q ss_pred             CCC-CCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCC
Q 029552            3 RLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP   81 (191)
Q Consensus         3 ~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~   81 (191)
                      .++ |+|++++++++.++...++|||++ +++|.+++...+.  .++..++..++.|++.||++||+.|  ++||||||+
T Consensus        56 ~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~  130 (293)
T d1csna_          56 LLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPD  130 (293)
T ss_dssp             HTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGG
T ss_pred             HhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCcc
Confidence            454 489999999999999999999999 6799999875442  3899999999999999999999999  999999999


Q ss_pred             cEEecC-----CCcEEEccccccccccccc-------ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCC
Q 029552           82 NLLVDK-----KYTVKVCDFGLSRLKANTF-------LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ  149 (191)
Q Consensus        82 ni~~~~-----~~~~~l~d~~~~~~~~~~~-------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~  149 (191)
                      ||+++.     .+.++|+|||++.......       .......+++.|+|||.+.+..++.++|+||+|+++|+|++|.
T Consensus       131 Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~  210 (293)
T d1csna_         131 NFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS  210 (293)
T ss_dssp             GEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             ceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCC
Confidence            999964     5689999999987543221       1223446899999999999999999999999999999999999


Q ss_pred             CCCCC---CCHHHHHHHHHhcCc---ccCCCCCCCHHHHHHHHHHhc
Q 029552          150 QPWGN---LNPAQVVAAVGFKGK---RLEIPRNVNPHVASIIEACWA  190 (191)
Q Consensus       150 ~pf~~---~~~~~~~~~~~~~~~---~~~~~~~~s~~~~~li~~cl~  190 (191)
                      .||..   .+.......+.....   ...++.++|+.+.++|+.||+
T Consensus       211 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~  257 (293)
T d1csna_         211 LPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARN  257 (293)
T ss_dssp             CTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHH
T ss_pred             CcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhc
Confidence            99974   333333433332222   223457899999999999985

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-36  Score=225.70  Aligned_cols=161  Identities=21%  Similarity=0.276  Sum_probs=132.0

Q ss_pred             CCCCCCCCcccccceeec--------CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCC
Q 029552            1 MKRLRHPNIVLFMGAVTQ--------PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPP   72 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~   72 (191)
                      |++++||||+++++++..        ++..|++||++.++++........   .+++.+++.++.|++.||+|||++|  
T Consensus        63 l~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~---~~~~~~~~~i~~qil~~l~~lH~~~--  137 (318)
T d3blha1          63 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRNK--  137 (318)
T ss_dssp             HHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTC---CCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhccc---ccccHHHHHHHHHHHHHHHHhccCC--
Confidence            357899999999998854        346899999998776665554422   3899999999999999999999999  


Q ss_pred             eeecCCCCCcEEecCCCcEEEcccccccccccc----cccCCCCCCCCcccCccccccC-CCCCcchHHHHHHHHHHHHh
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT----FLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELAT  147 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~  147 (191)
                      ++||||||+||+++.++.++++|||++......    ........+++.|+|||.+.+. .++.++|+||+||++|+|++
T Consensus       138 ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~  217 (318)
T d3blha1         138 ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT  217 (318)
T ss_dssp             EECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred             EEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhh
Confidence            999999999999999999999999998643321    1122334678899999998765 57899999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHHh
Q 029552          148 LQQPWGNLNPAQVVAAVGF  166 (191)
Q Consensus       148 g~~pf~~~~~~~~~~~~~~  166 (191)
                      |..||...+.......+..
T Consensus       218 g~~pf~~~~~~~~~~~i~~  236 (318)
T d3blha1         218 RSPIMQGNTEQHQLALISQ  236 (318)
T ss_dssp             SSCSCCCSSHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHH
Confidence            9999998888777766543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-35  Score=221.16  Aligned_cols=185  Identities=20%  Similarity=0.252  Sum_probs=140.3

Q ss_pred             CCCCCCCcc-cccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCC
Q 029552            2 KRLRHPNIV-LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS   80 (191)
Q Consensus         2 ~~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p   80 (191)
                      ++++|++++ .+..++.+++..++||||+. ++|.+.+....  +.+++.++..++.|++.||+|||++|  ++||||||
T Consensus        57 ~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp  131 (299)
T d1ckia_          57 KMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKP  131 (299)
T ss_dssp             HHSTTSTTCCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCG
T ss_pred             HHccCCCcccEEEEEEecCCEEEEEEEEcC-Cchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCH
Confidence            356666655 55566678888999999995 57777665433  23899999999999999999999999  99999999


Q ss_pred             CcEEecC---CCcEEEccccccccccccc-------ccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 029552           81 PNLLVDK---KYTVKVCDFGLSRLKANTF-------LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ  150 (191)
Q Consensus        81 ~ni~~~~---~~~~~l~d~~~~~~~~~~~-------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~  150 (191)
                      +||+++.   +..++++|||++.......       .......+++.|+|||.+.+..++.++|+||+|+++|+|++|..
T Consensus       132 ~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~  211 (299)
T d1ckia_         132 DNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSL  211 (299)
T ss_dssp             GGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             hhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCC
Confidence            9999864   4569999999987543321       12234568999999999999999999999999999999999999


Q ss_pred             CCCCCCHHHHHHHHHh---c---CcccCCCCCCCHHHHHHHHHHhcC
Q 029552          151 PWGNLNPAQVVAAVGF---K---GKRLEIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       151 pf~~~~~~~~~~~~~~---~---~~~~~~~~~~s~~~~~li~~cl~~  191 (191)
                      ||...........+..   .   ......+.++|+.+.++|.+||++
T Consensus       212 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~  258 (299)
T d1ckia_         212 PWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSL  258 (299)
T ss_dssp             TTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHS
T ss_pred             cccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccC
Confidence            9987655544333211   1   112234568999999999999964

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.2e-35  Score=222.63  Aligned_cols=147  Identities=22%  Similarity=0.385  Sum_probs=124.0

Q ss_pred             CCC-CCCCcccccceeec--CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCC
Q 029552            2 KRL-RHPNIVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDL   78 (191)
Q Consensus         2 ~~l-~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l   78 (191)
                      +++ .||||++++++|..  ....++||||+.+++|..+.+.      +++.+++.++.||+.||+|||++|  ++||||
T Consensus        84 ~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~------l~e~~i~~i~~qil~aL~~LH~~g--IvHrDi  155 (328)
T d3bqca1          84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMG--IMHRDV  155 (328)
T ss_dssp             HHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTTS------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCC
T ss_pred             HhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhcC------CCHHHHHHHHHHHHHHHHHHhhcc--cccccc
Confidence            345 49999999999974  4569999999999999876532      899999999999999999999999  999999


Q ss_pred             CCCcEEecCCC-cEEEcccccccccccccccCCCCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 029552           79 KSPNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLN  156 (191)
Q Consensus        79 ~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~pf~~~~  156 (191)
                      ||+||+++.++ .++++|||.+...... .......++..|+|||.+.+.. ++.++|+||+||++++|++|..||....
T Consensus       156 Kp~NILi~~~~~~vkl~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~  234 (328)
T d3bqca1         156 KPHNVMIDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH  234 (328)
T ss_dssp             SGGGEEEETTTTEEEECCGGGCEECCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             cccceEEcCCCCeeeecccccceeccCC-CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence            99999998655 6899999998754333 2334456788999999987654 6899999999999999999999997654


Q ss_pred             H
Q 029552          157 P  157 (191)
Q Consensus       157 ~  157 (191)
                      .
T Consensus       235 ~  235 (328)
T d3bqca1         235 D  235 (328)
T ss_dssp             S
T ss_pred             h
Confidence            3

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-35  Score=225.77  Aligned_cols=182  Identities=24%  Similarity=0.360  Sum_probs=143.3

Q ss_pred             CCCCCCCCcccccceeecC-----CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 029552            1 MKRLRHPNIVLFMGAVTQP-----PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVH   75 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h   75 (191)
                      |++++||||+++++++...     ...+++++++.+++|.+++...    .+++.+++.++.||+.||+|||++|  ++|
T Consensus        71 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~g--iiH  144 (348)
T d2gfsa1          71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD--IIH  144 (348)
T ss_dssp             HHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred             HHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCC--Ccc
Confidence            3578999999999998533     3345566677899999999653    2899999999999999999999999  999


Q ss_pred             cCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCC
Q 029552           76 RDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGN  154 (191)
Q Consensus        76 ~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~pf~~  154 (191)
                      |||||+||+++.++.++++|||.+......   .....++..|+|||...+.. ++.++|+||+|+++|+|++|..||..
T Consensus       145 rDiKp~NILi~~~~~~kl~dfg~a~~~~~~---~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~  221 (348)
T d2gfsa1         145 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG  221 (348)
T ss_dssp             CCCCGGGEEECTTCCEEECCC----CCTGG---GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccCCccccccccccccccccchhcccCcc---cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCC
Confidence            999999999999999999999988654332   23445677899999876654 58899999999999999999999998


Q ss_pred             CCHHHHHHHHHhcCccc-----------------------------CCCCCCCHHHHHHHHHHhcC
Q 029552          155 LNPAQVVAAVGFKGKRL-----------------------------EIPRNVNPHVASIIEACWAK  191 (191)
Q Consensus       155 ~~~~~~~~~~~~~~~~~-----------------------------~~~~~~s~~~~~li~~cl~~  191 (191)
                      .+.......+.......                             ....++|+.+++||++||.+
T Consensus       222 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~  287 (348)
T d2gfsa1         222 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVL  287 (348)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCS
T ss_pred             CCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcC
Confidence            88777666653321111                             01246899999999999974

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-35  Score=226.09  Aligned_cols=155  Identities=28%  Similarity=0.406  Sum_probs=123.7

Q ss_pred             CCCCCCCCcccccceeec------CCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCee
Q 029552            1 MKRLRHPNIVLFMGAVTQ------PPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIV   74 (191)
Q Consensus         1 L~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~   74 (191)
                      |++++||||++++++|..      ..+.|+||||+.++.+. .+..     .+++.+++.++.|++.||+|||++|  ++
T Consensus        70 l~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~-~~~~-----~~~~~~i~~~~~qil~gl~~LH~~g--ii  141 (355)
T d2b1pa1          70 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ-VIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--II  141 (355)
T ss_dssp             HHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHH-HHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred             HHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHH-hhhc-----CCCHHHHHHHHHHHHHHHHHhhhcc--cc
Confidence            356899999999999953      36789999999775554 4432     2899999999999999999999999  99


Q ss_pred             ecCCCCCcEEecCCCcEEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 029552           75 HRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN  154 (191)
Q Consensus        75 h~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~  154 (191)
                      ||||||+||+++.++.++++|||.+...... .......++..|+|||.+.+..++.++|+||+||++++|++|..||..
T Consensus       142 HrDlKP~Nil~~~~~~~kl~df~~~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~  220 (355)
T d2b1pa1         142 HRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG  220 (355)
T ss_dssp             CSCCCGGGEEECTTCCEEECCCCC----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cccCCccccccccccceeeechhhhhccccc-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCC
Confidence            9999999999999999999999987654433 223334567899999999999999999999999999999999999988


Q ss_pred             CCHHHHHHHH
Q 029552          155 LNPAQVVAAV  164 (191)
Q Consensus       155 ~~~~~~~~~~  164 (191)
                      .+.......+
T Consensus       221 ~~~~~~~~~i  230 (355)
T d2b1pa1         221 RDYIDQWNKV  230 (355)
T ss_dssp             SSHHHHHHHH
T ss_pred             CCHHHHHHHH
Confidence            7776665544

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.95  E-value=4.3e-29  Score=190.18  Aligned_cols=146  Identities=21%  Similarity=0.292  Sum_probs=113.8

Q ss_pred             CCCCcccccceeecC--CceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCeeecCCCCC
Q 029552            5 RHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKSP   81 (191)
Q Consensus         5 ~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~~h~~l~p~   81 (191)
                      .|+||+++++++...  ...+++++++..+..............+++..+..++.|++.|++|||+ .|  ++||||||+
T Consensus        78 ~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~  155 (362)
T d1q8ya_          78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPE  155 (362)
T ss_dssp             HHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGG
T ss_pred             CcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChh
Confidence            579999999988643  4555666665444433333222223448999999999999999999997 88  999999999


Q ss_pred             cEEecCCCc------EEEcccccccccccccccCCCCCCCCcccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 029552           82 NLLVDKKYT------VKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL  155 (191)
Q Consensus        82 ni~~~~~~~------~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~pf~~~  155 (191)
                      ||+++.++.      ++++|||.+......   .....+++.|+|||.+.+..++.++|+||+|+++++|++|..||...
T Consensus       156 NIll~~~~~~~~~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~  232 (362)
T d1q8ya_         156 NVLMEIVDSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD  232 (362)
T ss_dssp             GEEEEEEETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             HeeeeccCcccccceeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence            999987653      899999988644332   33456788999999999888999999999999999999999999754

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.64  E-value=2.2e-17  Score=114.31  Aligned_cols=82  Identities=21%  Similarity=0.240  Sum_probs=64.7

Q ss_pred             CCCCCCcccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCeeecCCCCCc
Q 029552            3 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN   82 (191)
Q Consensus         3 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~~h~~l~p~n   82 (191)
                      ++.|+++++.+++.    ..+++||++++..+.+          ++...+..++.|+++++++||+.|  ++||||||+|
T Consensus        70 ~l~~~~v~~~~~~~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~N  133 (191)
T d1zara2          70 KLQGLAVPKVYAWE----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYN  133 (191)
T ss_dssp             HTTTSSSCCEEEEE----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTS
T ss_pred             HccCCCcceEEEec----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhh
Confidence            46777887766542    2379999998755432          334445678899999999999999  9999999999


Q ss_pred             EEecCCCcEEEcccccccc
Q 029552           83 LLVDKKYTVKVCDFGLSRL  101 (191)
Q Consensus        83 i~~~~~~~~~l~d~~~~~~  101 (191)
                      |++++++ ++++|||.+..
T Consensus       134 ILv~~~~-~~liDFG~a~~  151 (191)
T d1zara2         134 VLVSEEG-IWIIDFPQSVE  151 (191)
T ss_dssp             EEEETTE-EEECCCTTCEE
T ss_pred             eeeeCCC-EEEEECCCccc
Confidence            9999764 89999998754

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.93  E-value=8.9e-06  Score=57.33  Aligned_cols=86  Identities=12%  Similarity=0.032  Sum_probs=59.2

Q ss_pred             cccccceeecCCceEEEEeccCCCCHHHHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhCC------------------
Q 029552            9 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKPGVREMLDERRRLNMAYDVAKGMNYLHRRN------------------   70 (191)
Q Consensus         9 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~------------------   70 (191)
                      +++++.+..+++..++||++.+|.++.+......     .   ...++.++.+.+..||+..                  
T Consensus        72 vP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~~-----~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~  143 (263)
T d1j7la_          72 VPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQ-----S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELD  143 (263)
T ss_dssp             CCCEEEEEEETTEEEEEEECCSSEEHHHHTTTCS-----C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHH
T ss_pred             CCcEEEEEecCCceEEEEEecccccccccccccc-----c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHH
Confidence            4567777788889999999999988866543211     1   1123344555555555421                  


Q ss_pred             ---------------------------------------CCeeecCCCCCcEEecCCCcEEEccccccccc
Q 029552           71 ---------------------------------------PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK  102 (191)
Q Consensus        71 ---------------------------------------~~~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~  102 (191)
                                                             ..++|+|+.|.||+++.++...++||+.+...
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g  214 (263)
T d1j7la_         144 YLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA  214 (263)
T ss_dssp             HHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             HHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence                                                   01789999999999998766679999876543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.37  E-value=0.00015  Score=50.47  Aligned_cols=29  Identities=24%  Similarity=0.339  Sum_probs=25.2

Q ss_pred             eeecCCCCCcEEecCCCcEEEcccccccc
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRL  101 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~~  101 (191)
                      ++|+|++|.||+++.++.+.++||+.+..
T Consensus       177 liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         177 VTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             EEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            79999999999999877678999987654

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=95.66  E-value=0.011  Score=43.71  Aligned_cols=30  Identities=20%  Similarity=0.337  Sum_probs=25.6

Q ss_pred             eeecCCCCCcEEecCCCcEEEcccccccccc
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA  103 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~~  103 (191)
                      ++|||++|.||++++++ ++++|+..+..+.
T Consensus       225 LiHGDl~~gNIlv~~~~-~~vID~E~a~~G~  254 (392)
T d2pula1         225 LIHGDLHTGSIFASEHE-TKVIDPEFAFYGP  254 (392)
T ss_dssp             EECSCCCGGGEEECSSC-EEECCCTTCEEEC
T ss_pred             eeccCCcCCceeEcCCc-eEEechhhcccCC
Confidence            89999999999998765 8999998876443

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=93.91  E-value=0.011  Score=42.11  Aligned_cols=29  Identities=21%  Similarity=0.229  Sum_probs=26.3

Q ss_pred             eeecCCCCCcEEecCCCcEEEcccccccc
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRL  101 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~~  101 (191)
                      ++|+|+.++|++++.+....+.||+.+..
T Consensus       185 iIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         185 VIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             EECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccCCcchhhhhcccccceeEeccccccc
Confidence            99999999999999887779999998764

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=87.41  E-value=0.58  Score=33.02  Aligned_cols=28  Identities=21%  Similarity=0.195  Sum_probs=22.8

Q ss_pred             eeecCCCCCcEEecCCCcEEEccccccccc
Q 029552           73 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLK  102 (191)
Q Consensus        73 ~~h~~l~p~ni~~~~~~~~~l~d~~~~~~~  102 (191)
                      ++|+|+++.||+++.+  ..++||+-+...
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~~g  221 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDARNG  221 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCCEE
T ss_pred             eecCCCCcccEEEeCC--ceEEechhcccC
Confidence            8999999999999743  458999877643